data_6if9_residue ############################ # Computer software used # ############################ save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 6if9 _Structure_validation_residue.Date_analyzed 2019-04-05 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.356 0 N-CA-C 112.531 -0.228 . . . . 73.13 112.531 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.481 ' HA ' ' O ' ' A' ' 44' ' ' GLY . 4.6 p -82.09 135.1 35.36 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.828 0.347 . . . . 73.43 111.151 -179.822 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 3.4 tttt -121.56 135.94 54.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.223 -0.444 . . . . 75.55 110.894 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.633 HG23 ' CZ ' ' A' ' 10' ' ' PHE . 15.9 tt -136.78 153.39 30.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.208 -0.451 . . . . 73.2 111.127 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.53 ' HA ' ' O ' ' A' ' 21' ' ' TYR . 17.9 m -134.01 143.89 48.38 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.193 -0.458 . . . . 75.43 111.14 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.633 ' CZ ' HG23 ' A' ' 8' ' ' ILE . 0.8 OUTLIER -131.28 127.9 38.71 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.203 -0.453 . . . . 72.03 110.894 -179.983 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.533 ' CG ' ' HA ' ' A' ' 16' ' ' PHE . 11.1 m-85 -113.19 132.51 55.46 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.161 -0.472 . . . . 71.12 110.868 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.11 -16.07 28.89 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.102 -0.499 . . . . 74.42 110.876 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.428 ' HB2' ' O ' ' A' ' 17' ' ' GLN . 72.2 m-20 -134.68 150.54 50.64 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.174 -0.467 . . . . 72.54 110.847 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.484 ' N ' ' HB3' ' A' ' 38' ' ' ASN . 38.7 mtmt -55.25 -176.12 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.181 -0.463 . . . . 75.42 110.873 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 18.8 m120 46.54 32.48 1.65 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.193 -0.458 . . . . 70.33 110.869 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.533 ' HA ' ' CG ' ' A' ' 11' ' ' TYR . 3.0 m-85 49.68 63.94 1.96 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.174 -0.466 . . . . 72.54 110.887 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . 0.428 ' O ' ' HB2' ' A' ' 13' ' ' ASP . 3.8 mt-30 -138.76 158.59 43.94 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.132 -0.485 . . . . 74.44 110.892 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 92.86 -148.86 19.25 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.716 -0.754 . . . . 73.45 112.473 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.423 ' O ' ' CD1' ' A' ' 34' ' ' LEU . 0.3 OUTLIER -69.04 78.06 0.33 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.767 0.318 . . . . 73.54 110.911 -179.861 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.465 ' HB2' ' CE1' ' A' ' 11' ' ' TYR . 0.6 OUTLIER -77.14 130.11 36.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.456 . . . . 73.43 110.891 -179.905 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.53 ' O ' ' HA ' ' A' ' 9' ' ' THR . 90.7 t80 -124.02 124.87 43.51 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.169 -0.469 . . . . 74.44 110.93 -179.845 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.441 ' OD1' ' CD ' ' A' ' 20' ' ' ARG . 1.1 m-20 -121.9 134.45 54.86 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.109 -0.496 . . . . 64.35 110.833 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -167.86 135.81 2.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.167 -0.47 . . . . 75.42 110.882 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -101.27 0.04 36.62 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.212 -0.449 . . . . 73.12 110.863 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.436 ' O ' ' SG ' ' A' ' 27' ' ' CYS . 16.5 t -104.37 164.88 11.42 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.172 -0.467 . . . . 70.22 110.914 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 35.6 m-20 -58.24 120.84 9.4 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.209 -0.451 . . . . 73.53 110.879 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.52 ' HB2' ' HB3' ' A' ' 30' ' ' PHE . 1.8 m -115.95 51.94 0.93 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.208 -0.451 . . . . 61.34 110.886 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.494 ' C ' ' HA ' ' A' ' 82' ' ' SER . . . -47.33 -21.27 0.27 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.223 -0.444 . . . . 74.14 111.083 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 56.8 t0 -128.54 42.33 3.34 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.223 -0.444 . . . . 63.42 110.866 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.785 ' O ' ' CD2' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -80.99 15.33 1.87 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.217 -0.447 . . . . 75.43 110.858 -179.852 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.487 ' HB2' ' HB3' ' A' ' 81' ' ' SER . 28.5 t60 -80.01 -39.57 29.68 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.142 -0.481 . . . . 74.41 110.885 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.7 t -57.93 -13.94 5.39 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.202 -0.454 . . . . 75.15 111.119 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -99.96 -27.14 13.73 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.27 -0.423 . . . . 73.33 110.907 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.423 ' CD1' ' O ' ' A' ' 19' ' ' ARG . 18.0 tp -142.65 136.31 28.97 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.162 -0.472 . . . . 71.52 110.916 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 23.8 m -98.81 -42.42 7.19 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.174 -0.467 . . . . 72.04 110.861 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -118.54 141.37 48.64 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.135 -0.484 . . . . 63.12 110.861 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.543 ' HB3' ' HB2' ' A' ' 80' ' ' LEU . 3.1 p -109.95 83.97 1.85 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.188 -0.46 . . . . 73.32 110.858 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.484 ' HB3' ' N ' ' A' ' 14' ' ' LYS . 0.2 OUTLIER -75.33 -70.64 0.41 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.157 -0.474 . . . . 74.52 110.872 -179.911 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 5.0 p -111.77 124.38 52.21 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.192 -0.458 . . . . 74.4 110.836 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.626 ' O ' ' HB2' ' A' ' 67' ' ' TYR . 45.1 mt -117.67 148.36 20.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.123 -0.489 . . . . 72.51 111.149 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.512 ' N ' HG23 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -143.49 120.57 11.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.181 -0.463 . . . . 54.43 110.9 179.85 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.556 HG22 ' HB2' ' A' ' 47' ' ' TRP . 1.9 t -104.98 115.53 47.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.22 -0.446 . . . . 74.43 111.096 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -110.35 80.27 1.29 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.227 -0.442 . . . . 61.43 110.872 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.481 ' O ' ' HA ' ' A' ' 6' ' ' THR . . . 127.89 106.85 1.37 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.736 -0.745 . . . . 74.32 112.485 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 51.95 177.98 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.738 -0.744 . . . . 71.24 112.494 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.505 HG21 ' HA ' ' A' ' 63' ' ' PRO . 1.9 m -80.91 165.79 21.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.813 0.34 . . . . 70.41 111.112 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . 0.613 ' CD1' ' HB ' ' A' ' 8' ' ' ILE . 3.3 m95 -138.91 130.05 26.75 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.449 . . . . 74.15 110.901 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.587 ' O ' ' N ' ' A' ' 84' ' ' ARG . . . -94.09 129.66 40.56 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.214 -0.448 . . . . 64.33 111.103 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.534 HG11 HD12 ' A' ' 80' ' ' LEU . 12.5 m -126.86 131.32 71.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.259 -0.428 . . . . 74.1 111.121 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.763 ' HB3' ' HA ' ' A' ' 56' ' ' ALA . 42.1 m-85 -97.28 147.73 23.84 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.182 -0.463 . . . . 74.52 110.928 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.62 ' OE1' ' HB3' ' A' ' 57' ' ' TRP . 47.3 tt0 -49.97 -78.12 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.094 -0.503 . . . . 73.33 110.867 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.539 ' HB2' ' HB2' ' A' ' 57' ' ' TRP . 1.2 mtp180 -93.5 143.99 27.52 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.609 0.719 . . . . 75.43 110.875 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.692 ' HA ' ' OG ' ' A' ' 82' ' ' SER . 54.2 Cg_endo -69.71 141.11 44.54 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.754 2.303 . . . . 65.21 112.366 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 63.42 -11.13 0.1 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.238 -0.437 . . . . 73.0 110.903 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.631 ' H ' ' C ' ' A' ' 53' ' ' PRO . 2.5 m-30 -104.7 -20.58 13.59 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.168 -0.469 . . . . 74.32 110.899 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.763 ' HA ' ' HB3' ' A' ' 50' ' ' TYR . . . 50.29 25.58 1.9 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.134 -0.485 . . . . 71.3 111.09 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . 0.632 ' O ' ' C ' ' A' ' 58' ' ' TYR . 0.1 OUTLIER -49.21 -164.92 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.234 -0.439 . . . . 70.34 110.952 -179.929 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.632 ' C ' ' O ' ' A' ' 57' ' ' TRP . 7.0 m-30 -13.27 101.69 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.274 -0.421 . . . . 73.54 110.948 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.574 ' HB2' ' HA ' ' A' ' 150' ' ' TYR . 1.9 mpt? -65.45 157.56 29.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.136 -0.483 . . . . 74.44 110.936 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.459 ' O ' ' CG2' ' A' ' 49' ' ' VAL . 3.2 t80 -175.01 101.37 0.08 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.255 -0.43 . . . . 75.25 110.927 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.42 ' H ' HD13 ' A' ' 61' ' ' ILE . 4.4 mp -88.24 116.21 29.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.163 -0.471 . . . . 75.23 111.121 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.401 ' O ' ' CG2' ' A' ' 46' ' ' THR . 0.3 OUTLIER -80.33 128.24 73.57 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.605 0.717 . . . . 75.21 110.958 179.898 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.505 ' HA ' HG21 ' A' ' 46' ' ' THR . 53.3 Cg_endo -69.78 -173.41 0.71 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.678 2.252 . . . . 70.22 112.357 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -88.44 161.6 16.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.265 -0.425 . . . . 75.24 110.924 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 112.64 -168.44 12.65 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.734 -0.746 . . . . 74.3 112.47 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -108.09 153.92 22.43 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.873 0.368 . . . . 74.14 110.915 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.626 ' HB2' ' O ' ' A' ' 40' ' ' ILE . 10.2 m-85 -143.48 83.83 10.51 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.625 0.726 . . . . 74.53 110.934 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.471 ' HD2' ' HG3' ' A' ' 72' ' ' ARG . 53.8 Cg_endo -69.77 0.78 5.16 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.679 2.253 . . . . 70.11 112.354 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.515 ' HB2' ' HG2' ' A' ' 72' ' ' ARG . 46.2 mt-10 -156.09 143.84 19.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.197 -0.456 . . . . 73.52 110.878 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.722 ' HA ' ' NE1' ' A' ' 73' ' ' TRP . 32.4 p90 -55.34 -21.98 17.37 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.157 -0.474 . . . . 74.15 110.944 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -79.14 -17.56 54.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.134 -0.484 . . . . 72.11 110.898 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.515 ' HG2' ' HB2' ' A' ' 69' ' ' GLU . 27.8 mmt180 -69.34 -8.11 43.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.185 -0.461 . . . . 74.0 110.889 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . 0.722 ' NE1' ' HA ' ' A' ' 70' ' ' TYR . 0.0 OUTLIER -136.94 18.99 3.01 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.169 -0.469 . . . . 75.14 110.876 -179.973 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' MET . . . . . 0.481 ' C ' ' O ' ' A' ' 73' ' ' TRP . 0.0 OUTLIER 32.11 47.71 0.09 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.255 -0.43 . . . . 74.11 110.835 179.921 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -59.92 120.38 22.48 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.71 -0.757 . . . . 75.34 112.531 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.595 HD12 ' N ' ' A' ' 76' ' ' LEU . 0.0 OUTLIER -63.56 -15.42 57.98 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.809 0.338 . . . . 73.42 110.937 -179.91 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.57 ' HB2' HD22 ' A' ' 76' ' ' LEU . 35.5 t-20 -156.38 134.62 11.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.185 -0.461 . . . . 72.53 110.896 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -83.27 23.06 0.93 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.17 -0.468 . . . . 74.34 110.839 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 4.1 ttm-85 -110.16 80.77 1.34 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.232 -0.44 . . . . 74.54 110.886 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.543 ' HB2' ' HB3' ' A' ' 37' ' ' CYS . 0.0 OUTLIER -87.91 133.99 33.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.224 -0.443 . . . . 74.01 110.871 -179.932 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.63 ' HB3' ' HB3' ' A' ' 53' ' ' PRO . 1.0 OUTLIER -150.32 -124.94 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.188 -0.46 . . . . 73.11 110.83 -179.96 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.692 ' OG ' ' HA ' ' A' ' 53' ' ' PRO . 0.1 OUTLIER -36.15 104.89 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.145 -0.48 . . . . 64.45 110.86 -179.784 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . 0.517 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 19.5 p -121.32 135.3 55.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.096 -0.502 . . . . 74.0 110.935 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . 0.587 ' N ' ' O ' ' A' ' 48' ' ' ALA . 9.4 mmt85 -120.62 138.46 53.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.254 -0.43 . . . . 75.23 110.883 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.434 ' N ' ' CZ3' ' A' ' 47' ' ' TRP . . . -59.42 129.02 39.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.196 -0.457 . . . . 74.24 111.115 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.477 HG21 ' CB ' ' A' ' 48' ' ' ALA . 40.9 t -113.24 129.9 68.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.239 -0.437 . . . . 74.0 111.085 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . 0.469 ' O ' ' C ' ' A' ' 88' ' ' LEU . 82.9 m-70 -111.52 107.46 16.65 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.154 -0.476 . . . . 73.14 110.892 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.469 ' C ' ' O ' ' A' ' 87' ' ' HIS . 0.0 OUTLIER -32.66 141.86 0.18 Allowed Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.645 0.736 . . . . 64.21 110.904 -179.92 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.459 ' HB3' ' H ' ' A' ' 136' ' ' VAL . 53.4 Cg_endo -69.79 98.02 0.67 Allowed 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.693 2.262 . . . . 74.45 112.329 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -100.76 138.72 37.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.231 -0.441 . . . . 70.44 110.831 -179.808 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 105.1 115.81 4.13 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.707 -0.759 . . . . 74.23 112.51 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 52.31 48.33 54.2 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.684 -0.769 . . . . 53.13 112.514 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.438 ' HB2' ' H ' ' A' ' 94' ' ' TYR . 24.7 pt20 38.95 -153.31 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.778 0.323 . . . . 75.24 110.924 -179.847 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.609 ' HA ' ' CG ' ' A' ' 134' ' ' GLU . 33.0 t80 -106.23 104.08 13.7 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.229 -0.441 . . . . 73.12 110.903 -179.845 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.482 ' H ' ' CG ' ' A' ' 134' ' ' GLU . 33.5 tptt -96.92 132.23 42.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.153 -0.476 . . . . 73.1 110.906 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -149.42 135.91 12.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.197 -0.456 . . . . 72.14 111.166 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.42 ' HB2' ' O ' ' A' ' 131' ' ' LYS . 0.8 OUTLIER -107.31 132.5 53.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.195 -0.457 . . . . 75.43 110.898 179.983 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 2.8 mt -118.18 130.84 72.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.234 -0.439 . . . . 75.22 111.149 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.666 ' HB2' ' HB2' ' A' ' 129' ' ' SER . 5.7 m-85 -120.21 152.59 37.49 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.141 -0.481 . . . . 74.12 110.948 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 70.7 tt0 -81.06 -68.83 0.65 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.206 -0.452 . . . . 73.53 110.865 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.507 ' C ' ' HB2' ' A' ' 128' ' ' HIS . 33.1 mttt -89.19 166.3 13.9 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.186 -0.461 . . . . 74.52 110.888 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -80.25 160.99 44.72 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.746 -0.74 . . . . 74.45 112.504 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.426 ' HA ' ' HB2' ' A' ' 158' ' ' ARG . 41.1 t0 66.08 52.05 1.23 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.81 0.338 . . . . 74.22 110.878 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.638 ' CE1' ' HD2' ' A' ' 131' ' ' LYS . 6.9 m-85 48.19 33.23 3.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.2 -0.455 . . . . 73.43 110.862 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.46 ' C ' ' HB2' ' A' ' 101' ' ' LYS . 43.8 m -108.97 155.53 20.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.125 -0.489 . . . . 74.23 110.875 -179.8 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 89.52 -163.83 31.4 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.776 -0.726 . . . . 72.43 112.488 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -76.36 123.49 26.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.794 0.33 . . . . 73.21 110.931 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 3.5 ttp -107.71 131.42 54.44 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.187 -0.46 . . . . 71.03 110.897 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -133.79 137.02 44.88 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.208 -0.451 . . . . 73.45 110.95 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -117.04 107.47 14.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.143 -0.48 . . . . 71.42 110.841 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 10.1 t -123.04 155.98 35.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.133 -0.485 . . . . 75.24 111.104 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.439 ' HA ' ' O ' ' A' ' 94' ' ' TYR . 1.7 t -135.47 45.68 2.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.208 -0.451 . . . . 73.32 111.132 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -152.72 158.66 42.64 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.229 -0.441 . . . . 75.1 110.87 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -51.33 156.4 1.2 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.126 -0.488 . . . . 72.54 110.862 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . 0.526 ' O ' ' HB2' ' A' ' 172' ' ' SER . 39.7 t -146.42 113.28 4.4 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.632 0.729 . . . . 54.13 110.862 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.419 ' O ' ' C ' ' A' ' 143' ' ' PRO . 53.4 Cg_endo -69.74 -30.71 21.93 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.665 2.243 . . . . 75.13 112.333 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' SER . . . . . 0.636 ' HB3' ' CB ' ' A' ' 120' ' ' GLU . 0.1 OUTLIER -149.57 101.35 3.08 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.211 -0.449 . . . . 75.33 110.848 -179.815 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.537 ' HB ' ' O ' ' A' ' 171' ' ' GLN . 3.0 tt -54.66 -29.74 21.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.175 -0.466 . . . . 74.22 111.163 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' MET . . . . . 0.582 ' O ' ' HA ' ' A' ' 123' ' ' HIS . 0.6 OUTLIER -86.53 -45.08 11.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.145 -0.48 . . . . 73.23 110.899 179.817 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.636 ' CB ' ' HB3' ' A' ' 117' ' ' SER . 6.6 tp10 -65.78 -12.87 57.55 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.245 -0.434 . . . . 72.02 110.887 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 27.8 tp60 -114.51 -51.17 2.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.176 -0.466 . . . . 75.54 110.872 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . 0.461 ' HB2' ' O ' ' A' ' 118' ' ' ILE . 44.0 m-85 -102.89 -19.65 14.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.197 -0.456 . . . . 73.2 110.872 -179.884 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . 0.582 ' HA ' ' O ' ' A' ' 119' ' ' MET . 29.6 m-70 71.72 28.63 2.69 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.16 -0.473 . . . . 73.22 110.896 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 10.7 mtt -103.95 85.94 2.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.234 -0.439 . . . . 74.43 110.91 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 4.0 ptp180 -51.44 -38.11 52.01 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.205 -0.452 . . . . 74.44 110.859 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.46 ' HG2' ' HA ' ' A' ' 169' ' ' ALA . 13.2 mt-10 -142.23 133.03 25.61 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.17 -0.468 . . . . 74.23 110.858 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.426 ' O ' ' HB3' ' A' ' 168' ' ' PRO . 3.8 mm -92.08 97.07 6.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.155 -0.475 . . . . 72.34 111.13 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . 0.507 ' HB2' ' C ' ' A' ' 101' ' ' LYS . 13.9 m170 -67.75 -34.04 76.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.133 -0.485 . . . . 73.12 110.891 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 0.666 ' HB2' ' HB2' ' A' ' 99' ' ' PHE . 58.2 m -129.43 136.61 50.15 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.184 -0.462 . . . . 75.24 110.868 -179.822 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . 0.526 ' O ' ' O ' ' A' ' 155' ' ' LYS . 3.4 m -131.74 119.93 22.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.128 -0.487 . . . . 64.3 110.894 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.679 ' HA ' ' HA ' ' A' ' 156' ' ' GLU . 2.0 mtpp -115.45 150.71 36.02 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.179 -0.464 . . . . 72.33 110.911 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.51 ' HB ' ' O ' ' A' ' 131' ' ' LYS . 16.4 t 83.59 163.42 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.198 -0.456 . . . . 73.2 111.137 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.451 ' CD1' ' O ' ' A' ' 154' ' ' LYS . 0.0 OUTLIER -174.86 123.67 0.25 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.163 -0.471 . . . . 75.32 110.899 179.994 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.609 ' CG ' ' HA ' ' A' ' 94' ' ' TYR . 0.0 OUTLIER -91.86 172.85 8.19 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.231 -0.441 . . . . 75.41 110.894 179.923 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -41.96 -47.25 5.2 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.696 -0.764 . . . . 73.34 112.466 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.587 ' HA ' HD13 ' A' ' 152' ' ' LEU . 5.2 t -148.87 142.54 18.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.819 0.342 . . . . 75.12 111.093 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' TRP . . . . . 0.7 ' HB3' ' CB ' ' A' ' 152' ' ' LEU . 25.0 t90 -149.43 148.17 29.13 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.142 -0.481 . . . . 73.25 110.925 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 20.3 mt -125.75 132.5 70.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.224 -0.444 . . . . 75.34 111.175 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 0.502 ' CB ' ' HB2' ' A' ' 150' ' ' TYR . 0.1 OUTLIER -100.84 152.98 19.87 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.169 -0.468 . . . . 73.13 110.866 179.981 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . 0.491 ' CD2' ' HA ' ' A' ' 145' ' ' TYR . 0.8 OUTLIER -129.14 127.16 40.85 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.146 -0.479 . . . . 75.1 110.922 -179.832 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . 0.622 ' O ' ' HB2' ' A' ' 171' ' ' GLN . 0.6 OUTLIER -61.63 -25.86 67.63 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.14 -0.482 . . . . 64.35 110.884 179.998 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.741 ' HB3' ' HD2' ' A' ' 143' ' ' PRO . 9.3 mp -114.64 173.07 3.09 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.659 0.742 . . . . 71.34 110.891 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . 0.741 ' HD2' ' HB3' ' A' ' 142' ' ' LEU . 53.8 Cg_endo -69.77 -90.34 0.0 OUTLIER 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.665 2.243 . . . . 73.32 112.349 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . 0.697 ' O ' ' N ' ' A' ' 146' ' ' ARG . 0.7 OUTLIER -51.88 97.73 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.247 -0.433 . . . . 73.3 110.903 179.993 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . 0.636 ' C ' ' O ' ' A' ' 144' ' ' ASN . 0.1 OUTLIER 12.46 53.19 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.215 -0.448 . . . . 74.12 110.883 -179.941 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . 0.697 ' N ' ' O ' ' A' ' 144' ' ' ASN . 20.7 mtt180 -120.4 173.54 7.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.175 -0.466 . . . . 72.4 110.851 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 79.83 179.51 52.42 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.712 -0.756 . . . . 74.34 112.49 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -74.02 146.58 43.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.799 0.333 . . . . 75.42 110.894 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' GLN . . . . . 0.426 ' HA ' ' O ' ' A' ' 139' ' ' PHE . 16.8 mt-30 -85.92 153.86 21.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.455 . . . . 74.3 110.895 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . 0.574 ' HA ' ' HB2' ' A' ' 59' ' ' MET . 76.8 m-85 -135.12 122.3 21.51 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.191 -0.458 . . . . 73.03 110.964 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 33.5 tp -66.55 135.94 54.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.067 -0.515 . . . . 71.33 110.935 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.7 ' CB ' ' HB3' ' A' ' 137' ' ' TRP . 0.0 OUTLIER -70.08 133.97 47.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.223 -0.444 . . . . 75.43 110.878 179.906 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -163.21 25.42 0.09 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.167 -0.469 . . . . 75.22 110.853 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.716 ' HA ' ' CE1' ' A' ' 157' ' ' TYR . 0.1 OUTLIER -113.03 -169.42 1.48 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.15 -0.477 . . . . 74.41 110.888 179.993 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.685 ' HG3' ' O ' ' A' ' 154' ' ' LYS . 0.6 OUTLIER -167.25 -122.06 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.245 -0.434 . . . . 74.22 110.925 179.866 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . 0.679 ' HA ' ' HA ' ' A' ' 131' ' ' LYS . 0.7 OUTLIER -73.03 -1.26 16.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.241 -0.436 . . . . 75.15 110.832 179.976 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . 0.716 ' CE1' ' HA ' ' A' ' 154' ' ' LYS . 20.1 m-30 -27.26 141.03 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.195 -0.457 . . . . 73.41 110.892 -179.799 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . 0.65 ' O ' ' OG ' ' A' ' 129' ' ' SER . 9.9 ptp180 -107.62 -41.14 5.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.129 -0.487 . . . . 75.24 110.868 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -87.43 150.34 48.73 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.562 0.696 . . . . 73.25 110.902 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . 0.473 ' HB3' ' HB3' ' A' ' 168' ' ' PRO . 53.7 Cg_endo -69.8 -24.17 29.8 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.64 2.227 . . . . 75.22 112.371 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.548 HD11 ' H ' ' A' ' 161' ' ' ILE . 3.6 mp -69.25 -10.82 14.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.23 -0.441 . . . . 74.22 111.107 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . 0.653 ' HB3' ' CD1' ' A' ' 157' ' ' TYR . 0.5 OUTLIER -75.79 -14.11 60.3 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.19 -0.459 . . . . 65.54 110.869 179.879 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 24.8 t90 -88.69 -12.7 41.6 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.189 -0.459 . . . . 72.31 110.933 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 106.66 -37.03 4.03 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.751 -0.738 . . . . 71.13 112.487 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . 0.4 ' O ' ' C ' ' A' ' 166' ' ' ALA . . . -77.1 126.77 31.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.796 0.331 . . . . 63.23 111.062 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . 0.4 ' C ' ' O ' ' A' ' 165' ' ' ALA . . . -37.56 -41.36 0.46 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 74.43 111.101 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' SER . . . . . 0.529 ' C ' ' H ' ' A' ' 169' ' ' ALA . 0.3 OUTLIER -130.28 155.64 80.6 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.66 0.743 . . . . 75.55 110.82 -179.778 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . 0.473 ' HB3' ' HB3' ' A' ' 160' ' ' PRO . 53.6 Cg_endo -69.78 27.29 0.18 Allowed 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.674 2.249 . . . . 72.14 112.312 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . 0.529 ' H ' ' C ' ' A' ' 167' ' ' SER . . . -65.63 104.6 1.06 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.213 -0.449 . . . . 70.34 111.147 179.839 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 2.8 t -151.75 161.97 3.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.21 -0.45 . . . . 72.25 111.127 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' GLN . . . . . 0.651 ' OE1' ' HB3' ' A' ' 143' ' ' PRO . 1.8 tm0? -109.4 -82.08 0.57 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.213 -0.449 . . . . 75.52 110.91 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' SER . . . . . 0.735 ' OG ' ' O ' ' A' ' 143' ' ' PRO . 21.6 p -130.87 176.22 8.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.208 -0.451 . . . . 52.4 110.831 -179.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' PHE . . . . . 0.447 ' HB3' ' CE1' ' A' ' 139' ' ' PHE . 32.2 p90 -144.31 173.78 11.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.114 -0.494 . . . . 74.44 110.885 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . 0.432 ' HG2' ' CE2' ' A' ' 140' ' ' TYR . 0.0 OUTLIER -147.4 141.36 25.9 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.152 -0.476 . . . . 75.14 110.88 -179.883 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . 0.407 ' HB3' ' CD1' ' A' ' 94' ' ' TYR . 0.0 OUTLIER -86.32 -177.23 6.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.18 -0.464 . . . . 74.13 110.909 -179.945 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . 0.468 HD11 ' C ' ' A' ' 136' ' ' VAL . 2.9 mt -132.51 139.09 50.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.215 -0.448 . . . . 61.55 111.11 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 2.1 p -149.32 155.4 8.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.185 -0.461 . . . . 64.4 111.173 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.2 -0.455 . . . . 74.34 110.859 -179.96 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.318 0 N-CA-C 112.492 -0.243 . . . . 63.02 112.492 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.426 ' HB ' ' O ' ' A' ' 44' ' ' GLY . 12.2 p -82.23 133.11 35.24 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.839 0.352 . . . . 71.11 111.134 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 3.1 tttt -122.37 138.33 54.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.241 -0.436 . . . . 71.34 110.888 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.611 HD13 ' CE1' ' A' ' 10' ' ' PHE . 12.5 tt -136.64 149.75 26.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.233 -0.44 . . . . 70.31 111.142 179.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.471 HG21 ' CE2' ' A' ' 11' ' ' TYR . 24.8 m -133.62 129.13 36.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.181 -0.463 . . . . 71.55 111.139 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.611 ' CE1' HD13 ' A' ' 8' ' ' ILE . 0.4 OUTLIER -117.3 131.89 56.72 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.208 -0.451 . . . . 75.3 110.845 -179.977 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.526 ' CG ' ' HA ' ' A' ' 16' ' ' PHE . 44.1 m-85 -114.95 132.35 56.6 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.138 -0.483 . . . . 75.51 110.94 -179.834 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.468 ' HG2' ' HB2' ' A' ' 36' ' ' ARG . 0.0 OUTLIER -61.98 -24.63 67.14 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.162 -0.472 . . . . 73.33 110.876 -179.949 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 65.7 m-20 -126.12 150.42 48.25 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.16 -0.473 . . . . 73.24 110.836 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.522 ' N ' ' HB3' ' A' ' 38' ' ' ASN . 4.6 mtmm -55.04 -179.83 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.189 -0.46 . . . . 75.52 110.866 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 52.0 m-80 49.38 38.46 14.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.233 -0.44 . . . . 64.41 110.889 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.526 ' HA ' ' CG ' ' A' ' 11' ' ' TYR . 3.4 m-85 45.14 60.17 3.13 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.17 -0.468 . . . . 74.4 110.859 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -136.46 160.06 39.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.142 -0.481 . . . . 74.33 110.906 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 92.84 -150.99 20.26 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.751 -0.738 . . . . 50.2 112.518 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.487 ' O ' HD13 ' A' ' 34' ' ' LEU . 0.0 OUTLIER -67.49 79.62 0.17 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.812 0.339 . . . . 71.23 110.905 -179.888 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.42 ' HB2' ' CE1' ' A' ' 11' ' ' TYR . 0.7 OUTLIER -78.95 125.9 29.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 73.21 110.857 -179.897 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.483 ' CD2' ' CD2' ' A' ' 30' ' ' PHE . 82.4 t80 -121.18 124.35 44.5 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.182 -0.463 . . . . 75.14 110.905 -179.841 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.47 ' CG ' HG23 ' A' ' 9' ' ' THR . 1.0 OUTLIER -119.22 134.62 55.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.131 -0.486 . . . . 70.54 110.885 179.877 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -166.75 135.71 2.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.231 -0.44 . . . . 72.51 110.851 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -105.07 5.72 32.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.187 -0.461 . . . . 73.33 110.882 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 12.1 t -108.73 168.38 9.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.168 -0.469 . . . . 63.22 110.886 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 78.8 m-20 -64.64 116.72 6.5 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.232 -0.44 . . . . 74.34 110.887 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.441 ' HB2' ' SG ' ' A' ' 83' ' ' CYS . 7.4 m -119.42 54.4 0.99 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.203 -0.453 . . . . 74.51 110.872 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.532 ' C ' ' HA ' ' A' ' 82' ' ' SER . . . -45.88 -20.28 0.08 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.183 -0.462 . . . . 73.54 111.095 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.406 ' N ' ' C ' ' A' ' 27' ' ' CYS . 59.7 t0 -128.32 43.56 3.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.224 -0.444 . . . . 75.41 110.879 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.776 ' O ' ' CD2' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -80.97 14.72 2.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.174 -0.466 . . . . 74.02 110.884 -179.873 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.49 ' HB2' ' HB3' ' A' ' 81' ' ' SER . 27.6 t60 -77.72 -38.66 46.7 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.159 -0.473 . . . . 74.23 110.845 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.6 t -58.22 -12.57 3.73 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.208 -0.451 . . . . 73.23 111.121 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -101.48 -28.37 12.6 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.18 -0.464 . . . . 75.45 110.941 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.487 HD13 ' O ' ' A' ' 19' ' ' ARG . 16.0 tp -141.15 141.7 34.12 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.149 -0.478 . . . . 72.01 110.927 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -111.57 -31.11 7.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.187 -0.46 . . . . 70.21 110.908 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.468 ' HB2' ' HG2' ' A' ' 12' ' ' GLU . 1.6 mtp85 -116.78 142.41 46.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.092 -0.504 . . . . 74.22 110.845 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.635 ' SG ' ' HB2' ' A' ' 80' ' ' LEU . 1.8 p -118.99 51.44 1.12 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.188 -0.46 . . . . 72.43 110.864 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.522 ' HB3' ' N ' ' A' ' 14' ' ' LYS . 1.9 m-80 -52.35 -62.68 1.48 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.165 -0.471 . . . . 64.2 110.896 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 9.3 p -121.8 127.78 50.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.201 -0.454 . . . . 75.01 110.809 -179.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.472 ' O ' ' N ' ' A' ' 67' ' ' TYR . 4.5 mt -127.15 148.59 31.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.124 -0.489 . . . . 73.12 111.135 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.47 ' N ' HG23 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -140.46 122.0 15.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.17 -0.468 . . . . 74.13 110.863 179.84 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.463 ' HA ' ' HA ' ' A' ' 8' ' ' ILE . 0.9 OUTLIER -103.92 117.43 49.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.189 -0.459 . . . . 74.21 111.145 179.876 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -112.44 81.14 1.43 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.223 -0.444 . . . . 73.24 110.89 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.426 ' O ' ' HB ' ' A' ' 6' ' ' THR . . . 130.63 100.02 0.86 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.736 -0.745 . . . . 72.01 112.534 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 55.21 175.85 0.14 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.712 -0.756 . . . . 64.42 112.491 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.504 HG21 ' HA ' ' A' ' 63' ' ' PRO . 5.9 m -80.29 165.99 21.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.812 0.339 . . . . 65.54 111.137 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . 0.587 ' CD1' ' HB ' ' A' ' 8' ' ' ILE . 14.6 m95 -136.76 129.94 31.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.208 -0.451 . . . . 71.42 110.909 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.483 ' O ' ' N ' ' A' ' 84' ' ' ARG . . . -97.46 114.06 25.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.456 . . . . 72.02 111.111 179.843 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.515 ' O ' ' O ' ' A' ' 60' ' ' TYR . 5.1 m -116.8 134.04 61.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.243 -0.435 . . . . 72.11 111.151 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.718 ' HB3' ' HA ' ' A' ' 56' ' ' ALA . 35.1 m-85 -97.07 151.86 19.33 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.185 -0.461 . . . . 72.32 110.954 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.573 ' HB2' ' O ' ' A' ' 58' ' ' TYR . 8.8 tt0 -47.76 -78.84 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.143 -0.48 . . . . 62.21 110.892 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.606 ' HB3' ' CD1' ' A' ' 55' ' ' PHE . 4.7 mtp180 -90.25 143.95 30.33 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.656 0.741 . . . . 75.21 110.826 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.707 ' HA ' ' OG ' ' A' ' 82' ' ' SER . 53.9 Cg_endo -69.75 134.56 28.29 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.66 2.24 . . . . 75.33 112.372 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 66.2 -8.55 0.34 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.233 -0.439 . . . . 74.21 110.847 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.606 ' CD1' ' HB3' ' A' ' 52' ' ' ARG . 4.6 m-30 -101.75 -26.81 13.35 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.216 -0.447 . . . . 63.13 110.919 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.718 ' HA ' ' HB3' ' A' ' 50' ' ' TYR . . . 58.71 22.87 10.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.145 -0.479 . . . . 75.24 111.109 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . 0.645 ' O ' ' C ' ' A' ' 58' ' ' TYR . 2.4 m95 -52.17 -165.89 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.251 -0.432 . . . . 71.03 110.925 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.645 ' C ' ' O ' ' A' ' 57' ' ' TRP . 6.5 m-30 -12.46 103.62 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.231 -0.441 . . . . 74.31 110.936 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.51 ' HB2' ' O ' ' A' ' 149' ' ' GLN . 2.5 mpt? -62.29 147.48 47.99 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.128 -0.487 . . . . 73.33 110.903 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.592 ' OH ' ' HA3' ' A' ' 75' ' ' GLY . 0.3 OUTLIER -164.29 92.27 0.64 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.236 -0.438 . . . . 74.21 110.865 -179.88 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.506 ' N ' ' CD1' ' A' ' 61' ' ' ILE . 1.6 mp -85.06 120.2 35.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.154 -0.475 . . . . 74.22 111.117 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -87.55 126.15 62.96 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-O 121.658 0.742 . . . . 73.22 110.878 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.504 ' HA ' HG21 ' A' ' 46' ' ' THR . 53.5 Cg_endo -69.83 -168.03 0.26 Allowed 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.684 2.256 . . . . 70.43 112.307 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.05 161.12 14.57 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.24 -0.437 . . . . 73.05 110.931 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 111.66 -157.52 14.9 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.775 -0.726 . . . . 64.41 112.507 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 5.3 mp0 -115.0 158.75 21.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.85 0.357 . . . . 73.52 110.904 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.472 ' N ' ' O ' ' A' ' 40' ' ' ILE . 7.2 m-85 -149.52 79.73 7.93 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 121.676 0.75 . . . . 75.23 110.976 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.567 ' HD2' ' HG3' ' A' ' 72' ' ' ARG . 53.6 Cg_endo -69.81 1.11 4.77 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.7 2.266 . . . . 65.44 112.29 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 86.3 mt-10 -159.15 154.36 25.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.25 -0.432 . . . . 75.31 110.903 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.836 ' O ' ' CD1' ' A' ' 73' ' ' TRP . 25.6 p90 -65.39 -12.19 49.75 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.135 -0.484 . . . . 75.52 110.949 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -86.75 -13.65 44.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.127 -0.488 . . . . 75.33 110.878 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.567 ' HG3' ' HD2' ' A' ' 68' ' ' PRO . 24.1 mmt180 -73.58 -27.09 61.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.221 -0.445 . . . . 74.33 110.919 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . 0.836 ' CD1' ' O ' ' A' ' 70' ' ' TYR . 0.6 OUTLIER -105.97 11.22 31.9 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.157 -0.474 . . . . 75.24 110.957 179.979 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' MET . . . . . 0.506 ' C ' ' O ' ' A' ' 73' ' ' TRP . 0.4 OUTLIER 29.19 56.76 0.13 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.212 -0.449 . . . . 74.22 110.849 179.909 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.592 ' HA3' ' OH ' ' A' ' 60' ' ' TYR . . . -96.92 -140.27 11.19 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.733 -0.746 . . . . 63.13 112.51 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.535 HD12 ' CE2' ' A' ' 60' ' ' TYR . 0.0 OUTLIER -141.95 -84.1 0.19 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.831 0.348 . . . . 75.24 110.905 -179.946 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 -77.47 145.85 36.81 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.465 . . . . 73.52 110.915 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 -101.44 33.29 2.98 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.198 -0.456 . . . . 62.03 110.858 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -104.78 72.13 1.01 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.208 -0.451 . . . . 75.53 110.874 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.635 ' HB2' ' SG ' ' A' ' 37' ' ' CYS . 0.1 OUTLIER -77.83 130.25 36.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.162 -0.472 . . . . 74.54 110.906 -179.955 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.601 ' HB3' ' HB3' ' A' ' 53' ' ' PRO . 0.9 OUTLIER -146.92 -127.93 0.06 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.218 -0.446 . . . . 63.13 110.874 -179.929 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.707 ' OG ' ' HA ' ' A' ' 53' ' ' PRO . 0.7 OUTLIER -27.58 123.49 0.1 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.117 -0.492 . . . . 75.44 110.872 -179.845 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . 0.448 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 5.4 p -131.14 143.06 50.35 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.146 -0.479 . . . . 74.25 110.87 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . 0.483 ' N ' ' O ' ' A' ' 48' ' ' ALA . 5.7 mmt85 -140.59 131.37 25.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.189 -0.459 . . . . 71.22 110.9 -179.843 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.414 ' HB1' ' OG1' ' A' ' 6' ' ' THR . . . -56.27 123.88 16.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.22 -0.446 . . . . 74.32 111.043 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.47 ' CG2' ' HB3' ' A' ' 48' ' ' ALA . 1.9 t -115.93 143.31 26.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.21 -0.45 . . . . 74.31 111.113 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . 0.572 ' O ' ' CG2' ' A' ' 136' ' ' VAL . 34.9 m80 -111.23 106.45 15.44 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.184 -0.462 . . . . 73.41 110.878 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.48 ' C ' ' O ' ' A' ' 87' ' ' HIS . 0.0 OUTLIER -31.64 150.17 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.659 0.742 . . . . 74.54 110.909 -179.975 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.567 ' HB3' ' H ' ' A' ' 136' ' ' VAL . 53.5 Cg_endo -69.77 83.39 0.7 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.674 2.249 . . . . 63.44 112.326 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -88.76 -173.35 4.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.188 -0.46 . . . . 73.33 110.832 -179.834 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 51.26 58.49 9.69 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.761 -0.733 . . . . 73.12 112.439 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 117.68 26.22 2.89 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.724 -0.751 . . . . 73.03 112.454 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 27.5 pt20 39.56 -148.57 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.826 0.346 . . . . 73.41 110.916 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.492 ' CD1' ' HG2' ' A' ' 134' ' ' GLU . 8.2 t80 -98.79 101.02 12.29 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.26 -0.427 . . . . 75.55 110.906 -179.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.433 ' O ' HG12 ' A' ' 132' ' ' VAL . 38.2 tptt -107.91 130.34 55.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.126 -0.488 . . . . 73.33 110.896 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 4.2 tt -147.36 137.72 17.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.238 -0.437 . . . . 75.41 111.131 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.48 ' O ' ' HA ' ' A' ' 130' ' ' CYS . 0.5 OUTLIER -109.92 113.35 26.01 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.211 -0.449 . . . . 74.01 110.942 179.905 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 2.7 mp -93.66 136.17 26.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.163 -0.471 . . . . 75.0 111.15 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.618 ' HB2' ' HB2' ' A' ' 129' ' ' SER . 53.2 m-85 -124.73 140.1 53.24 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.194 -0.457 . . . . 73.41 110.855 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 64.6 tt0 -69.68 -75.17 0.12 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.148 -0.478 . . . . 73.12 110.889 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 16.5 mttt -84.51 170.41 13.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.138 -0.483 . . . . 75.12 110.893 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.423 ' CA ' ' HB3' ' A' ' 128' ' ' HIS . . . -73.73 159.62 53.1 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.724 -0.75 . . . . 72.01 112.478 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.47 ' HA ' ' HB2' ' A' ' 158' ' ' ARG . 60.9 t0 64.17 37.18 9.04 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.819 0.342 . . . . 73.44 110.844 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.554 ' CZ ' ' HB3' ' A' ' 158' ' ' ARG . 5.0 m-85 51.66 45.19 28.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.192 -0.458 . . . . 73.24 110.89 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 5.1 m -112.45 148.87 33.48 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.112 -0.495 . . . . 71.2 110.865 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 95.34 -132.5 11.13 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.776 -0.726 . . . . 63.03 112.519 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 43.3 tp60 -91.68 126.11 36.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.813 0.339 . . . . 75.01 110.948 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' MET . . . . . 0.462 ' HB2' ' CE1' ' A' ' 99' ' ' PHE . 4.8 ttt -113.55 131.56 56.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.168 -0.469 . . . . 71.44 110.849 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -136.26 136.38 39.79 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.215 -0.448 . . . . 73.45 110.93 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -118.37 109.2 16.0 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.115 -0.493 . . . . 74.44 110.896 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 14.1 t -123.46 145.68 48.63 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.132 -0.486 . . . . 73.04 111.18 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.474 ' O ' ' OG1' ' A' ' 112' ' ' THR . 0.8 OUTLIER -118.2 38.31 3.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.249 -0.432 . . . . 63.43 111.133 -179.944 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -150.94 170.43 19.35 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.228 -0.442 . . . . 72.02 110.898 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 -65.79 176.11 1.7 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.201 -0.454 . . . . 72.33 110.868 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 46.6 t -156.01 122.62 2.64 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.599 0.714 . . . . 72.11 110.891 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.475 ' C ' ' OG ' ' A' ' 172' ' ' SER . 54.0 Cg_endo -69.79 -31.24 20.76 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.646 2.23 . . . . 65.41 112.338 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' SER . . . . . 0.651 ' HB3' ' CB ' ' A' ' 120' ' ' GLU . 0.1 OUTLIER -152.99 92.97 1.69 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.222 -0.445 . . . . 45.33 110.872 -179.86 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.681 ' HB ' ' O ' ' A' ' 171' ' ' GLN . 5.0 tt -49.01 -28.78 2.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.157 -0.474 . . . . 74.02 111.155 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' MET . . . . . 0.583 ' O ' ' HA ' ' A' ' 123' ' ' HIS . 15.7 ttp -86.36 -45.19 11.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.186 -0.461 . . . . 75.43 110.848 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.651 ' CB ' ' HB3' ' A' ' 117' ' ' SER . 10.1 tp10 -66.75 -13.37 61.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.232 -0.44 . . . . 63.12 110.875 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -114.52 -51.9 2.73 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.185 -0.461 . . . . 74.14 110.897 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . 0.482 ' HB2' ' O ' ' A' ' 118' ' ' ILE . 14.6 m-85 -101.89 -18.67 15.6 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.24 -0.437 . . . . 74.35 110.935 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . 0.583 ' HA ' ' O ' ' A' ' 119' ' ' MET . 16.6 m80 68.42 32.72 4.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.078 -0.51 . . . . 74.14 110.892 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.418 ' O ' HG22 ' A' ' 118' ' ' ILE . 9.3 mtt -111.04 84.62 1.96 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.183 -0.462 . . . . 71.12 110.819 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 3.9 ptp180 -52.93 -34.87 57.41 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.23 -0.441 . . . . 74.12 110.884 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.464 ' HG2' ' HA ' ' A' ' 169' ' ' ALA . 35.0 mt-10 -142.34 128.77 20.1 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.192 -0.458 . . . . 75.24 110.864 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.451 ' O ' ' HB3' ' A' ' 168' ' ' PRO . 4.1 mm -87.89 101.16 11.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.146 -0.479 . . . . 74.21 111.159 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . 0.423 ' HB3' ' CA ' ' A' ' 102' ' ' GLY . 22.3 m80 -69.65 -35.24 75.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.165 -0.471 . . . . 72.45 110.861 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 0.618 ' HB2' ' HB2' ' A' ' 99' ' ' PHE . 6.2 m -135.4 152.2 51.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.255 -0.43 . . . . 72.11 110.87 -179.803 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . 0.48 ' HA ' ' O ' ' A' ' 97' ' ' GLN . 0.0 OUTLIER -156.22 118.24 3.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.144 -0.48 . . . . 70.05 110.901 -179.934 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.519 ' O ' ' HB ' ' A' ' 132' ' ' VAL . 3.7 mtpp -105.66 161.2 14.59 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.182 -0.463 . . . . 74.5 110.875 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.522 ' O ' ' CE ' ' A' ' 154' ' ' LYS . 16.0 t 86.03 165.97 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.469 . . . . 74.52 111.154 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.53 ' O ' ' HG ' ' A' ' 133' ' ' LEU . 1.0 OUTLIER -166.2 131.19 2.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.182 -0.463 . . . . 74.11 110.895 179.941 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.492 ' HG2' ' CD1' ' A' ' 94' ' ' TYR . 0.8 OUTLIER -105.29 147.72 27.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.192 -0.458 . . . . 72.23 110.9 179.921 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . 0.483 ' C ' ' O ' ' A' ' 134' ' ' GLU . . . -31.37 -45.63 0.14 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.746 -0.74 . . . . 51.34 112.508 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.615 ' HA ' HD13 ' A' ' 152' ' ' LEU . 0.7 OUTLIER -149.94 135.6 11.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.823 0.344 . . . . 75.31 111.116 -179.98 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' TRP . . . . . 0.64 ' HB3' ' CB ' ' A' ' 152' ' ' LEU . 24.0 t90 -150.14 149.59 30.46 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.131 -0.486 . . . . 75.43 110.92 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.414 ' HA ' ' O ' ' A' ' 150' ' ' TYR . 16.6 mt -124.17 132.04 71.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.275 -0.421 . . . . 72.13 111.118 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 0.515 ' CB ' ' HB2' ' A' ' 150' ' ' TYR . 0.1 OUTLIER -99.09 139.13 35.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.167 -0.47 . . . . 74.33 110.884 179.966 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . 0.484 ' CD2' ' HA ' ' A' ' 145' ' ' TYR . 0.1 OUTLIER -110.59 126.86 54.89 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.159 -0.473 . . . . 74.23 110.914 -179.843 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . 0.557 ' O ' ' HB2' ' A' ' 171' ' ' GLN . 26.6 tt0 -66.08 -27.83 68.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.101 -0.5 . . . . 71.24 110.886 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.612 ' HB3' ' HD2' ' A' ' 143' ' ' PRO . 9.9 mp -109.73 169.71 6.13 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.632 0.729 . . . . 73.45 110.929 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . 0.708 ' O ' ' HB2' ' A' ' 172' ' ' SER . 53.5 Cg_endo -69.73 -89.15 0.0 OUTLIER 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.713 2.276 . . . . 73.05 112.338 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . 0.73 ' O ' ' N ' ' A' ' 146' ' ' ARG . 1.1 m-20 -48.43 96.43 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.218 -0.446 . . . . 75.13 110.924 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . 0.636 ' C ' ' O ' ' A' ' 144' ' ' ASN . 20.1 m-85 12.54 51.6 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.191 -0.459 . . . . 73.22 110.905 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . 0.73 ' N ' ' O ' ' A' ' 144' ' ' ASN . 11.4 mtp85 -127.01 178.62 5.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.132 -0.485 . . . . 73.3 110.876 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 86.78 167.16 43.39 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.73 -0.747 . . . . 63.13 112.469 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.468 ' HA ' ' CD2' ' A' ' 76' ' ' LEU . 2.8 mpt_? -65.48 142.18 58.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.796 0.331 . . . . 74.22 110.86 -179.857 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' GLN . . . . . 0.51 ' O ' ' HB2' ' A' ' 59' ' ' MET . 51.4 mt-30 -81.29 155.57 25.98 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.173 -0.467 . . . . 74.14 110.907 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . 0.515 ' HB2' ' CB ' ' A' ' 139' ' ' PHE . 95.9 m-85 -138.29 123.01 18.71 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.231 -0.44 . . . . 74.42 110.924 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.419 ' HB2' HD12 ' A' ' 61' ' ' ILE . 21.3 tp -64.66 132.7 50.42 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.101 -0.499 . . . . 72.13 110.97 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.64 ' CB ' ' HB3' ' A' ' 137' ' ' TRP . 0.0 OUTLIER -68.45 133.29 48.41 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.218 -0.446 . . . . 74.54 110.906 179.912 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -163.28 25.95 0.09 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.147 -0.479 . . . . 74.45 110.907 179.843 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.734 ' HA ' ' CE1' ' A' ' 157' ' ' TYR . 0.0 OUTLIER -108.89 -173.86 2.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.148 -0.478 . . . . 73.12 110.872 -179.99 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.659 ' HG3' ' O ' ' A' ' 154' ' ' LYS . 4.0 mptt -164.93 -124.43 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.218 -0.446 . . . . 74.42 110.911 179.827 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . 0.491 ' HA ' ' HA ' ' A' ' 131' ' ' LYS . 4.4 tm-20 -71.5 1.37 6.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.223 -0.444 . . . . 71.52 110.851 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . 0.734 ' CE1' ' HA ' ' A' ' 154' ' ' LYS . 21.3 m-30 -31.23 143.81 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.191 -0.459 . . . . 72.43 110.938 -179.836 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . 0.554 ' HB3' ' CZ ' ' A' ' 104' ' ' PHE . 0.0 OUTLIER -115.35 -40.68 3.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.128 -0.487 . . . . 72.51 110.897 -179.989 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . 0.464 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 0.2 OUTLIER -81.01 150.89 69.59 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.553 0.692 . . . . 73.34 110.918 179.966 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . 0.542 ' HA ' ' NE1' ' A' ' 163' ' ' TRP . 53.5 Cg_endo -69.78 -27.47 26.35 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.655 2.237 . . . . 74.31 112.346 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.557 HD11 ' H ' ' A' ' 161' ' ' ILE . 3.8 mp -67.21 -3.5 2.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.236 -0.438 . . . . 73.54 111.114 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . 0.659 ' HB3' ' CD1' ' A' ' 157' ' ' TYR . 0.3 OUTLIER -76.61 -23.21 53.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.215 -0.448 . . . . 71.33 110.876 179.818 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' TRP . . . . . 0.542 ' NE1' ' HA ' ' A' ' 160' ' ' PRO . 1.7 m95 -79.96 -1.37 39.19 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.198 -0.455 . . . . 74.24 110.931 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 92.46 -35.22 4.12 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.728 -0.749 . . . . 74.25 112.475 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . 0.415 ' O ' ' C ' ' A' ' 166' ' ' ALA . . . -77.37 129.2 35.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.826 0.346 . . . . 71.31 111.091 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . 0.415 ' C ' ' O ' ' A' ' 165' ' ' ALA . . . -37.08 -40.08 0.28 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.224 -0.443 . . . . 73.34 111.117 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' SER . . . . . 0.519 ' C ' ' H ' ' A' ' 169' ' ' ALA . 0.3 OUTLIER -129.29 157.32 76.53 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.61 0.719 . . . . 74.15 110.867 -179.767 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . 0.497 ' HD3' ' HB2' ' A' ' 160' ' ' PRO . 53.4 Cg_endo -69.73 29.07 0.18 Allowed 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.667 2.245 . . . . 71.52 112.324 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . 0.519 ' H ' ' C ' ' A' ' 167' ' ' SER . . . -66.01 106.58 1.63 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.244 -0.435 . . . . 63.31 111.094 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 3.3 t -152.08 165.92 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.224 -0.444 . . . . 72.43 111.083 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' GLN . . . . . 0.681 ' O ' ' HB ' ' A' ' 118' ' ' ILE . 2.6 mm-40 -123.72 -87.11 0.63 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.142 -0.481 . . . . 74.42 110.884 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' SER . . . . . 0.708 ' HB2' ' O ' ' A' ' 143' ' ' PRO . 3.1 m -111.11 175.65 5.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.174 -0.466 . . . . 64.35 110.897 -179.804 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' PHE . . . . . 0.434 ' HB3' ' CD2' ' A' ' 139' ' ' PHE . 1.8 p90 -147.94 158.58 44.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.168 -0.469 . . . . 71.42 110.899 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . 0.422 ' HG2' ' CD2' ' A' ' 140' ' ' TYR . 0.0 OUTLIER -133.93 139.75 46.34 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.12 -0.491 . . . . 73.34 110.837 -179.857 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -95.38 -170.08 2.1 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.177 -0.465 . . . . 75.21 110.851 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . 0.46 HD11 ' C ' ' A' ' 136' ' ' VAL . 3.3 mt -139.21 135.79 41.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.145 -0.479 . . . . 72.44 111.16 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 25.9 t -148.8 150.11 14.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.192 -0.458 . . . . 70.33 111.1 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.259 0 CA-C-N 116.134 -0.484 . . . . 74.12 110.936 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.312 0 N-CA-C 112.462 -0.255 . . . . 71.32 112.462 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.484 ' C ' ' HE1' ' A' ' 47' ' ' TRP . 11.2 p -82.58 133.1 35.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.882 0.372 . . . . 73.43 111.122 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 3.5 tttt -121.15 137.65 54.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.242 -0.435 . . . . 65.25 110.895 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.596 ' HB ' ' CD1' ' A' ' 47' ' ' TRP . 11.6 tt -137.33 149.41 25.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.209 -0.451 . . . . 73.53 111.166 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.484 HG23 ' CG ' ' A' ' 22' ' ' ASP . 24.5 m -131.74 129.02 40.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.178 -0.464 . . . . 64.13 111.133 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.568 ' CE1' HD13 ' A' ' 8' ' ' ILE . 0.6 OUTLIER -116.15 132.35 56.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.16 -0.473 . . . . 73.32 110.875 -179.957 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.543 ' CG ' ' HA ' ' A' ' 16' ' ' PHE . 49.1 m-85 -116.01 131.92 56.8 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.16 -0.473 . . . . 73.23 110.966 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.472 ' HG2' ' HB2' ' A' ' 36' ' ' ARG . 0.0 OUTLIER -60.7 -25.73 66.61 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 74.34 110.92 179.987 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 -125.96 151.23 47.28 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.114 -0.494 . . . . 75.1 110.855 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.431 ' HG3' ' HB3' ' A' ' 38' ' ' ASN . 19.7 mtmt -54.94 -178.21 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 62.25 110.936 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 24.7 m-20 47.68 38.72 8.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.256 -0.429 . . . . 70.23 110.894 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.543 ' HA ' ' CG ' ' A' ' 11' ' ' TYR . 3.0 m-85 44.71 60.48 2.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.15 -0.477 . . . . 72.13 110.885 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -135.97 158.78 43.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.088 -0.505 . . . . 74.32 110.882 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 93.47 -151.51 20.39 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.76 -0.733 . . . . 73.45 112.491 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.487 ' O ' HD13 ' A' ' 34' ' ' LEU . 0.3 OUTLIER -67.27 80.85 0.14 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.794 0.331 . . . . 75.31 110.937 -179.869 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.418 ' HA ' ' O ' ' A' ' 10' ' ' PHE . 0.7 OUTLIER -79.38 126.31 30.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.209 -0.45 . . . . 73.34 110.911 -179.89 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.478 ' CD2' ' CD2' ' A' ' 30' ' ' PHE . 85.9 t80 -121.46 124.03 43.47 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.221 -0.445 . . . . 74.41 110.909 -179.827 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.484 ' CG ' HG23 ' A' ' 9' ' ' THR . 1.0 OUTLIER -119.14 134.84 54.97 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.134 -0.485 . . . . 73.44 110.835 179.934 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -166.94 135.81 2.78 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.156 -0.474 . . . . 73.23 110.899 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -104.53 5.75 34.19 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 72.25 110.844 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 13.9 t -110.71 164.49 12.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.193 -0.458 . . . . 73.54 110.868 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -60.82 117.54 5.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.186 -0.461 . . . . 65.25 110.86 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.463 ' HB2' ' SG ' ' A' ' 83' ' ' CYS . 18.7 m -117.48 55.51 0.85 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.245 -0.434 . . . . 54.51 110.864 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.52 ' O ' ' HA ' ' A' ' 82' ' ' SER . . . -46.64 -19.14 0.08 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.208 -0.451 . . . . 62.24 111.158 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.402 ' N ' ' C ' ' A' ' 27' ' ' CYS . 52.4 t0 -128.71 42.14 3.37 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.212 -0.449 . . . . 65.14 110.872 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.805 ' O ' ' CD2' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -80.45 15.75 1.54 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.459 . . . . 74.15 110.864 -179.893 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.51 ' HB2' ' HB3' ' A' ' 81' ' ' SER . 33.2 t60 -80.65 -38.15 29.67 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.163 -0.471 . . . . 75.45 110.785 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.7 t -60.16 -12.52 8.77 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.245 -0.434 . . . . 73.33 111.137 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -101.34 -27.6 13.08 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.246 -0.434 . . . . 72.45 110.925 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.487 HD13 ' O ' ' A' ' 19' ' ' ARG . 19.1 tp -141.94 140.53 32.8 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.133 -0.485 . . . . 71.51 110.888 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.1 m -109.07 -31.95 7.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.221 -0.445 . . . . 61.33 110.883 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.541 ' NH2' HD22 ' A' ' 38' ' ' ASN . 1.8 mtp85 -116.82 142.0 47.49 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.128 -0.487 . . . . 74.5 110.872 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.577 ' HB3' ' HB2' ' A' ' 80' ' ' LEU . 0.9 OUTLIER -118.37 52.09 1.05 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.22 -0.445 . . . . 61.45 110.869 -179.957 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.541 HD22 ' NH2' ' A' ' 36' ' ' ARG . 3.0 m120 -53.01 -70.78 0.08 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.203 -0.453 . . . . 73.41 110.866 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 8.7 p -112.86 128.42 56.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.203 -0.453 . . . . 74.24 110.887 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.473 ' O ' ' N ' ' A' ' 67' ' ' TYR . 5.4 mt -127.41 150.1 32.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.097 -0.501 . . . . 71.31 111.131 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.472 ' N ' HG23 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -141.47 122.75 14.83 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.17 -0.468 . . . . 75.21 110.892 179.848 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.523 HG22 ' HB2' ' A' ' 47' ' ' TRP . 1.4 t -104.43 116.59 48.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.23 -0.441 . . . . 70.35 111.176 179.84 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -111.55 80.97 1.37 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.161 -0.472 . . . . 74.25 110.866 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.425 ' O ' ' HA ' ' A' ' 6' ' ' THR . . . 128.75 103.69 1.13 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.745 -0.74 . . . . 72.22 112.527 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 53.97 178.09 0.12 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.75 -0.738 . . . . 72.4 112.464 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.534 HG21 ' HA ' ' A' ' 63' ' ' PRO . 3.1 m -81.36 165.66 21.14 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.729 0.299 . . . . 74.31 111.177 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . 0.596 ' CD1' ' HB ' ' A' ' 8' ' ' ILE . 6.2 m95 -139.86 130.09 25.22 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.216 -0.447 . . . . 73.51 110.925 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.599 ' O ' ' N ' ' A' ' 84' ' ' ARG . . . -95.12 129.01 42.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.203 -0.453 . . . . 74.55 111.152 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.646 ' O ' ' O ' ' A' ' 60' ' ' TYR . 14.1 m -127.47 127.27 68.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.233 -0.439 . . . . 74.51 111.115 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.747 ' HB3' ' HA ' ' A' ' 56' ' ' ALA . 45.8 m-85 -93.36 147.51 22.87 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.137 -0.483 . . . . 74.43 110.927 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.657 ' OE1' ' HB3' ' A' ' 57' ' ' TRP . 54.7 tt0 -48.5 -78.48 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.113 -0.494 . . . . 75.21 110.862 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.54 ' HB3' ' CD1' ' A' ' 55' ' ' PHE . 0.0 OUTLIER -92.98 143.81 27.41 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.652 0.739 . . . . 74.44 110.878 -179.907 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.715 ' HA ' ' OG ' ' A' ' 82' ' ' SER . 53.8 Cg_endo -69.75 141.59 45.67 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.688 2.259 . . . . 74.33 112.34 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 62.53 -10.98 0.08 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.19 -0.459 . . . . 74.31 110.876 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.625 ' H ' ' C ' ' A' ' 53' ' ' PRO . 2.6 m-30 -104.34 -20.19 13.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.455 . . . . 74.43 110.869 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.747 ' HA ' ' HB3' ' A' ' 50' ' ' TYR . . . 48.55 26.44 1.19 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.168 -0.469 . . . . 72.55 111.117 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . 0.657 ' HB3' ' OE1' ' A' ' 51' ' ' GLU . 0.0 OUTLIER -50.7 -159.98 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.233 -0.44 . . . . 72.33 110.919 -179.978 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.627 ' C ' ' O ' ' A' ' 57' ' ' TRP . 6.0 m-30 -15.5 103.84 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.213 -0.448 . . . . 75.22 110.914 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.451 ' HB2' ' O ' ' A' ' 149' ' ' GLN . 0.8 OUTLIER -62.44 145.14 54.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.124 -0.489 . . . . 73.14 110.892 179.891 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.646 ' O ' ' O ' ' A' ' 49' ' ' VAL . 0.4 OUTLIER -160.76 100.12 1.27 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.218 -0.447 . . . . 74.13 110.945 -179.89 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.571 ' N ' ' CD1' ' A' ' 61' ' ' ILE . 1.3 mp -94.22 117.17 37.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.101 -0.5 . . . . 73.33 111.157 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -84.21 125.84 71.25 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.618 0.723 . . . . 74.52 110.92 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.534 ' HA ' HG21 ' A' ' 46' ' ' THR . 53.7 Cg_endo -69.68 -165.58 0.16 Allowed 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.68 2.253 . . . . 75.21 112.381 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.22 159.86 14.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.238 -0.437 . . . . 63.14 110.885 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 113.62 -149.95 18.58 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.791 -0.719 . . . . 60.42 112.495 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -122.94 160.36 26.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.859 0.362 . . . . 75.23 110.93 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.473 ' N ' ' O ' ' A' ' 40' ' ' ILE . 5.9 m-85 -150.05 79.1 7.78 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.668 0.747 . . . . 75.52 110.924 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.52 ' HD2' ' HG3' ' A' ' 72' ' ' ARG . 53.4 Cg_endo -69.81 0.48 5.62 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.721 2.281 . . . . 74.44 112.305 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 76.3 mt-10 -157.31 156.17 31.92 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.247 -0.433 . . . . 75.32 110.906 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.832 ' O ' ' CD1' ' A' ' 73' ' ' TRP . 11.7 p90 -68.35 -6.87 26.69 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.248 -0.433 . . . . 75.23 110.895 -179.851 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -87.12 -13.48 44.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.141 -0.481 . . . . 74.25 110.891 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.52 ' HG3' ' HD2' ' A' ' 68' ' ' PRO . 21.2 mmt180 -73.5 -24.64 60.2 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.224 -0.444 . . . . 73.05 110.891 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . 0.832 ' CD1' ' O ' ' A' ' 70' ' ' TYR . 0.5 OUTLIER -111.8 25.13 11.93 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.179 -0.464 . . . . 75.3 110.934 -179.975 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' MET . . . . . 0.567 ' HB2' ' O ' ' A' ' 73' ' ' TRP . 2.0 mmt 87.38 -38.47 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.248 -0.433 . . . . 75.14 110.927 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 88.93 45.83 4.7 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.724 -0.751 . . . . 64.11 112.495 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.539 ' HB2' ' CE2' ' A' ' 60' ' ' TYR . 0.4 OUTLIER -67.08 -74.95 0.1 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.837 0.351 . . . . 74.02 110.94 -179.957 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -129.28 136.13 49.66 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.188 -0.46 . . . . 74.22 110.859 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.424 ' C ' ' SG ' ' A' ' 37' ' ' CYS . 24.4 m-20 -90.35 18.54 6.0 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.187 -0.46 . . . . 72.31 110.858 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -112.33 86.45 2.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.199 -0.455 . . . . 73.32 110.874 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.577 ' HB2' ' HB3' ' A' ' 37' ' ' CYS . 0.0 OUTLIER -89.86 133.24 34.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.216 -0.447 . . . . 73.03 110.947 -179.992 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.634 ' HB3' ' HB3' ' A' ' 53' ' ' PRO . 0.8 OUTLIER -151.23 -127.93 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.203 -0.453 . . . . 70.23 110.875 -179.923 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.715 ' OG ' ' HA ' ' A' ' 53' ' ' PRO . 0.1 OUTLIER -33.98 102.16 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 73.23 110.847 -179.845 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . 0.533 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 30.2 p -118.82 133.35 55.9 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.125 -0.488 . . . . 75.3 110.882 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . 0.599 ' N ' ' O ' ' A' ' 48' ' ' ALA . 13.7 mmt85 -119.94 144.25 47.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.228 -0.442 . . . . 73.42 110.862 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.419 ' N ' ' CZ3' ' A' ' 47' ' ' TRP . . . -63.61 127.66 32.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.178 -0.465 . . . . 65.45 111.095 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.468 HG23 ' HB3' ' A' ' 48' ' ' ALA . 46.7 t -115.78 137.86 48.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 74.12 111.113 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . 0.42 ' O ' ' C ' ' A' ' 88' ' ' LEU . 34.0 m80 -111.58 112.82 24.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.205 -0.452 . . . . 74.22 110.825 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.442 ' H ' HD22 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -35.82 143.23 0.27 Allowed Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.594 0.712 . . . . 74.52 110.872 -179.967 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.554 ' HB3' ' H ' ' A' ' 136' ' ' VAL . 53.9 Cg_endo -69.81 78.62 1.01 Allowed 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.695 2.263 . . . . 72.42 112.334 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -78.03 -177.01 4.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.223 -0.444 . . . . 73.33 110.852 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 74.8 -97.46 1.0 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.736 -0.745 . . . . 60.23 112.466 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.411 ' O ' ' C ' ' A' ' 93' ' ' GLN . . . -90.29 44.61 2.94 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.779 -0.724 . . . . 72.24 112.496 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.446 ' O ' ' HG2' ' A' ' 134' ' ' GLU . 5.9 pt20 37.19 -122.17 0.19 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.876 0.37 . . . . 72.12 110.917 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.526 ' O ' ' HA ' ' A' ' 112' ' ' THR . 0.1 OUTLIER -121.41 103.59 9.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.196 -0.456 . . . . 75.2 110.934 -179.9 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.456 ' HG3' HG11 ' A' ' 132' ' ' VAL . 41.4 tptt -114.83 126.15 54.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.114 -0.494 . . . . 73.32 110.862 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 8.2 tt -147.57 137.94 17.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.23 -0.441 . . . . 74.12 111.127 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.437 ' HB2' ' O ' ' A' ' 131' ' ' LYS . 0.6 OUTLIER -108.7 131.67 54.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.182 -0.463 . . . . 74.55 110.877 179.937 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.418 HG21 HG13 ' A' ' 127' ' ' ILE . 1.1 mp -115.64 134.5 58.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.455 . . . . 72.22 111.136 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.597 ' HB2' ' CB ' ' A' ' 129' ' ' SER . 7.1 m-85 -122.66 155.15 36.99 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.197 -0.456 . . . . 71.42 110.855 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.523 ' HA ' ' CE ' ' A' ' 124' ' ' MET . 56.6 tt0 -84.75 -44.0 13.74 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.183 -0.462 . . . . 72.1 110.854 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.47 ' HB2' ' C ' ' A' ' 105' ' ' SER . 55.9 mttt -117.61 155.0 30.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.182 -0.463 . . . . 62.04 110.894 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -73.82 169.48 53.57 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.757 -0.735 . . . . 73.53 112.436 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.429 ' HA ' ' HB2' ' A' ' 158' ' ' ARG . 36.9 t70 63.25 40.3 8.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.798 0.333 . . . . 65.44 110.814 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.626 ' CE1' ' HD2' ' A' ' 131' ' ' LYS . 11.6 m-85 54.89 49.27 18.16 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.25 -0.432 . . . . 63.0 110.867 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.47 ' C ' ' HB2' ' A' ' 101' ' ' LYS . 69.5 m -127.93 161.85 28.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.169 -0.469 . . . . 74.04 110.841 -179.825 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 83.04 -172.48 51.5 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.715 -0.755 . . . . 71.22 112.472 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 36.8 tp60 -67.62 120.59 14.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.78 0.324 . . . . 74.22 110.921 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 5.6 ttp -106.65 132.01 53.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.191 -0.459 . . . . 75.22 110.89 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -137.12 137.45 39.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.274 -0.421 . . . . 75.43 110.909 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -114.66 112.76 23.38 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.092 -0.504 . . . . 74.22 110.903 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 13.9 t -121.28 132.18 54.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.168 -0.469 . . . . 74.34 111.168 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.526 ' HA ' ' O ' ' A' ' 94' ' ' TYR . 1.8 t -112.29 37.1 3.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.246 -0.434 . . . . 72.15 111.129 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -151.03 165.43 33.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.229 -0.441 . . . . 70.53 110.857 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -53.11 161.22 0.88 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.142 -0.481 . . . . 74.35 110.83 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . 0.61 ' O ' ' HB2' ' A' ' 172' ' ' SER . 20.4 t -146.9 110.92 4.11 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.651 0.738 . . . . 75.1 110.882 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.512 ' O ' ' C ' ' A' ' 143' ' ' PRO . 53.6 Cg_endo -69.82 -38.6 7.45 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.647 2.231 . . . . 74.4 112.309 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' SER . . . . . 0.6 ' HB3' ' CB ' ' A' ' 120' ' ' GLU . 0.1 OUTLIER -147.28 105.41 3.75 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.238 -0.437 . . . . 75.23 110.839 -179.839 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.61 ' HB ' ' O ' ' A' ' 171' ' ' GLN . 3.4 tt -58.07 -27.94 32.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.125 -0.489 . . . . 72.11 111.118 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' MET . . . . . 0.683 ' O ' ' HA ' ' A' ' 123' ' ' HIS . 8.6 ttp -86.77 -40.57 14.86 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.17 -0.468 . . . . 73.33 110.875 179.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.6 ' CB ' ' HB3' ' A' ' 117' ' ' SER . 14.7 tp10 -70.52 -13.52 62.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.264 -0.426 . . . . 72.31 110.879 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 7.6 tp-100 -116.25 -50.71 2.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.152 -0.477 . . . . 73.15 110.944 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . 0.487 ' HB2' ' O ' ' A' ' 118' ' ' ILE . 46.8 m-85 -101.26 -13.85 17.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.222 -0.445 . . . . 74.53 110.917 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . 0.683 ' HA ' ' O ' ' A' ' 119' ' ' MET . 27.9 m-70 69.16 24.86 5.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.125 -0.488 . . . . 64.24 110.828 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.523 ' CE ' ' HA ' ' A' ' 100' ' ' GLU . 0.9 OUTLIER -96.47 145.24 25.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.248 -0.433 . . . . 71.33 110.891 179.975 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 5.1 ptp180 -110.62 -40.91 4.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.249 -0.432 . . . . 74.31 110.862 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.435 ' HB3' ' HG2' ' A' ' 168' ' ' PRO . 17.6 mt-10 -141.05 116.13 9.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.205 -0.452 . . . . 73.42 110.864 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.473 ' CD1' ' N ' ' A' ' 127' ' ' ILE . 1.0 OUTLIER -74.8 99.78 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.149 -0.478 . . . . 73.24 111.126 179.954 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . 0.401 ' CD2' ' HG3' ' A' ' 168' ' ' PRO . 24.8 m170 -73.33 -28.13 61.9 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.113 -0.494 . . . . 75.21 110.884 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 0.597 ' CB ' ' HB2' ' A' ' 99' ' ' PHE . 0.5 OUTLIER -132.31 136.93 47.24 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.225 -0.443 . . . . 74.24 110.872 -179.741 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . 0.58 ' HB3' ' HD2' ' A' ' 154' ' ' LYS . 0.1 OUTLIER -135.09 118.15 16.43 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.218 -0.446 . . . . 74.24 110.881 -179.977 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.631 ' HA ' ' HA ' ' A' ' 156' ' ' GLU . 6.0 mtpp -118.59 152.53 35.85 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.153 -0.476 . . . . 71.34 110.859 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.499 ' HB ' ' O ' ' A' ' 131' ' ' LYS . 16.6 t 82.74 163.4 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.217 -0.447 . . . . 53.24 111.108 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.455 ' O ' ' HG ' ' A' ' 133' ' ' LEU . 0.0 OUTLIER -179.73 123.57 0.07 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.17 -0.468 . . . . 73.23 110.911 179.942 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.516 ' O ' ' C ' ' A' ' 135' ' ' GLY . 0.1 OUTLIER -94.27 167.1 11.75 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.153 -0.476 . . . . 65.12 110.915 179.908 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . 0.516 ' C ' ' O ' ' A' ' 134' ' ' GLU . . . -27.93 -57.82 0.12 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.745 -0.74 . . . . 64.41 112.463 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.73 ' HA ' HD13 ' A' ' 152' ' ' LEU . 2.8 t -145.66 144.44 21.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.809 0.338 . . . . 74.11 111.167 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' TRP . . . . . 0.557 ' HB3' ' CB ' ' A' ' 152' ' ' LEU . 7.4 t-105 -143.52 152.98 42.13 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.22 -0.445 . . . . 75.45 110.974 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.481 ' CD1' ' HB ' ' A' ' 61' ' ' ILE . 2.8 mm -119.21 132.02 70.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.271 -0.422 . . . . 72.34 111.156 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 0.572 ' CB ' ' HB2' ' A' ' 150' ' ' TYR . 0.2 OUTLIER -111.41 146.37 37.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.187 -0.46 . . . . 72.52 110.858 179.951 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . 0.411 ' CD2' ' HA ' ' A' ' 145' ' ' TYR . 3.4 m-85 -127.79 130.01 47.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.069 -0.514 . . . . 74.54 110.889 -179.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . 0.605 ' O ' ' HB2' ' A' ' 171' ' ' GLN . 0.2 OUTLIER -60.34 -25.78 66.08 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.081 -0.509 . . . . 75.22 110.877 -179.984 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.778 ' HB3' ' HD2' ' A' ' 143' ' ' PRO . 9.7 mp -114.66 173.88 2.66 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.657 0.742 . . . . 73.34 110.88 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . 0.778 ' HD2' ' HB3' ' A' ' 142' ' ' LEU . 53.7 Cg_endo -69.77 -91.62 0.01 OUTLIER 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.726 2.284 . . . . 75.45 112.281 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . 0.71 ' O ' ' N ' ' A' ' 146' ' ' ARG . 0.9 OUTLIER -50.98 97.89 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.154 -0.476 . . . . 63.31 110.858 -179.926 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . 0.641 ' C ' ' O ' ' A' ' 144' ' ' ASN . 0.1 OUTLIER 12.1 53.09 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.143 -0.48 . . . . 72.13 110.923 -179.924 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . 0.71 ' N ' ' O ' ' A' ' 144' ' ' ASN . 11.3 mtp85 -118.76 174.71 6.12 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.095 -0.502 . . . . 75.04 110.844 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 80.84 -173.0 54.62 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.733 -0.746 . . . . 71.12 112.495 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -80.58 150.46 29.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.749 0.309 . . . . 63.4 110.893 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' GLN . . . . . 0.451 ' O ' ' HB2' ' A' ' 59' ' ' MET . 8.4 mt-30 -81.73 153.62 26.45 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.185 -0.461 . . . . 74.34 110.889 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . 0.572 ' HB2' ' CB ' ' A' ' 139' ' ' PHE . 98.3 m-85 -139.28 129.44 25.26 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.218 -0.446 . . . . 60.52 110.945 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.532 ' CA ' HD12 ' A' ' 61' ' ' ILE . 13.3 tp -81.78 121.72 26.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.092 -0.504 . . . . 70.04 110.911 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.73 HD13 ' HA ' ' A' ' 136' ' ' VAL . 0.0 OUTLIER -53.77 135.86 40.82 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.191 -0.459 . . . . 73.32 110.948 179.886 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -164.07 27.75 0.08 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.206 -0.452 . . . . 74.15 110.828 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.781 ' O ' ' HG3' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -116.71 -172.74 2.25 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.214 -0.448 . . . . 75.53 110.889 179.969 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.781 ' HG3' ' O ' ' A' ' 154' ' ' LYS . 0.0 OUTLIER -162.39 -128.92 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.221 -0.445 . . . . 73.3 110.908 179.875 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . 0.631 ' HA ' ' HA ' ' A' ' 131' ' ' LYS . 0.2 OUTLIER -68.0 1.13 2.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.213 -0.449 . . . . 74.44 110.936 179.956 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . 0.743 ' CD1' ' HB2' ' A' ' 154' ' ' LYS . 20.3 m-30 -28.78 143.47 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.094 -0.503 . . . . 75.25 110.933 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . 0.57 ' O ' ' OG ' ' A' ' 129' ' ' SER . 9.5 ptp180 -110.91 -43.4 3.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.158 -0.474 . . . . 74.11 110.921 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -82.45 151.24 65.16 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.519 0.676 . . . . 72.33 110.93 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . 0.511 ' HB3' ' HB3' ' A' ' 168' ' ' PRO . 54.0 Cg_endo -69.74 -26.67 27.45 Favored 'Trans proline' 0 C--O 1.231 0.136 0 C-N-CA 122.7 2.266 . . . . 75.15 112.347 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.546 HD11 ' H ' ' A' ' 161' ' ' ILE . 3.6 mp -65.44 -11.78 12.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.224 -0.444 . . . . 74.04 111.074 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . 0.676 ' HB3' ' CD1' ' A' ' 157' ' ' TYR . 0.3 OUTLIER -75.0 -18.88 60.29 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.151 -0.477 . . . . 74.54 110.837 179.936 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 13.3 t90 -82.06 0.23 41.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.197 -0.456 . . . . 73.45 110.938 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 91.91 -36.2 3.74 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.75 -0.738 . . . . 72.14 112.507 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -79.68 128.39 33.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.777 0.322 . . . . 74.54 111.099 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -39.41 -38.28 0.54 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.194 -0.457 . . . . 50.02 111.101 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' SER . . . . . 0.523 ' C ' ' H ' ' A' ' 169' ' ' ALA . 0.5 OUTLIER -128.18 154.26 78.77 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.642 0.734 . . . . 64.31 110.892 -179.822 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . 0.511 ' HB3' ' HB3' ' A' ' 160' ' ' PRO . 54.4 Cg_endo -69.74 25.13 0.17 Allowed 'Trans proline' 0 C--O 1.231 0.147 0 C-N-CA 122.742 2.294 . . . . 73.54 112.352 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . 0.523 ' H ' ' C ' ' A' ' 167' ' ' SER . . . -65.89 103.65 0.96 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.223 -0.444 . . . . 72.13 111.11 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 2.6 t -152.14 163.43 2.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.225 -0.443 . . . . 63.22 111.145 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' GLN . . . . . 0.661 ' OE1' ' HB3' ' A' ' 143' ' ' PRO . 1.8 mm-40 -114.26 -89.57 0.54 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.19 -0.459 . . . . 74.42 110.914 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' SER . . . . . 0.751 ' OG ' ' O ' ' A' ' 143' ' ' PRO . 12.6 p -126.9 177.05 6.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.194 -0.457 . . . . 61.1 110.852 -179.829 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -145.8 174.38 11.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.105 -0.498 . . . . 74.34 110.883 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.18 154.61 46.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.179 -0.464 . . . . 74.3 110.88 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.15 -169.91 2.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.16 -0.473 . . . . 75.31 110.864 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . 0.446 HD11 ' HB ' ' A' ' 136' ' ' VAL . 4.5 mt -134.51 136.85 52.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.21 -0.45 . . . . 74.35 111.173 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 10.7 t -140.31 153.43 22.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.218 -0.446 . . . . 74.43 111.142 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 116.133 -0.485 . . . . 74.43 110.855 -179.921 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.376 0 N-CA-C 112.489 -0.245 . . . . 73.21 112.489 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.483 ' C ' ' HE1' ' A' ' 47' ' ' TRP . 6.9 p -82.8 135.81 34.85 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.908 0.385 . . . . 75.43 111.117 -179.86 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 3.6 tttt -122.54 135.24 54.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 73.02 110.937 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.576 ' HB ' ' CD1' ' A' ' 47' ' ' TRP . 15.2 tt -136.75 150.61 27.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.21 -0.45 . . . . 64.2 111.125 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.479 ' HA ' ' O ' ' A' ' 21' ' ' TYR . 13.6 m -127.4 146.29 50.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.187 -0.461 . . . . 74.42 111.164 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.465 ' CD2' ' N ' ' A' ' 10' ' ' PHE . 0.2 OUTLIER -134.07 127.17 31.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.206 -0.452 . . . . 73.21 110.888 179.999 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.539 ' CG ' ' HA ' ' A' ' 16' ' ' PHE . 26.2 m-85 -113.41 131.82 55.86 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.149 -0.478 . . . . 71.11 110.923 -179.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.414 ' HB2' ' HB2' ' A' ' 19' ' ' ARG . 0.0 OUTLIER -60.26 -15.43 24.79 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.121 -0.49 . . . . 73.22 110.9 179.987 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.445 ' HB2' ' O ' ' A' ' 17' ' ' GLN . 71.2 m-20 -134.89 150.57 50.45 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.156 -0.475 . . . . 70.02 110.873 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.488 ' N ' ' HB3' ' A' ' 38' ' ' ASN . 39.4 mtmt -55.7 -177.78 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.182 -0.463 . . . . 74.35 110.857 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 22.7 m-20 48.14 33.26 3.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.17 -0.468 . . . . 75.3 110.888 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.539 ' HA ' ' CG ' ' A' ' 11' ' ' TYR . 3.3 m-85 49.22 64.3 1.79 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.164 -0.471 . . . . 73.34 110.853 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . 0.445 ' O ' ' HB2' ' A' ' 13' ' ' ASP . 15.6 mt-30 -140.07 158.07 44.63 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.146 -0.479 . . . . 75.42 110.934 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 93.28 -150.63 20.0 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.775 -0.726 . . . . 74.43 112.476 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.436 ' O ' ' CD1' ' A' ' 34' ' ' LEU . 0.2 OUTLIER -66.72 78.51 0.11 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.754 0.311 . . . . 75.54 110.851 -179.829 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.455 ' HB2' ' CE1' ' A' ' 11' ' ' TYR . 0.7 OUTLIER -77.04 128.88 35.27 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.232 -0.44 . . . . 74.54 110.876 -179.921 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.479 ' O ' ' HA ' ' A' ' 9' ' ' THR . 88.1 t80 -123.06 125.72 45.73 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.21 -0.45 . . . . 75.2 110.943 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.428 ' CG ' HG23 ' A' ' 9' ' ' THR . 1.3 m-20 -123.33 132.63 54.05 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.156 -0.474 . . . . 72.31 110.857 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -166.0 138.33 3.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 65.34 110.927 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -104.72 4.48 32.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.195 -0.457 . . . . 73.12 110.846 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 14.9 t -108.55 164.2 12.56 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.21 -0.45 . . . . 64.35 110.882 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -60.25 117.49 5.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.173 -0.467 . . . . 73.31 110.832 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.45 ' HB3' ' CB ' ' A' ' 30' ' ' PHE . 16.6 m -117.07 54.05 0.88 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.173 -0.467 . . . . 74.13 110.894 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.523 ' O ' ' HA ' ' A' ' 82' ' ' SER . . . -47.67 -18.84 0.17 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 71.53 111.06 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 58.3 t0 -127.26 40.07 3.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.236 -0.438 . . . . 75.43 110.845 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.779 ' O ' ' CD2' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -80.77 14.12 2.3 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.224 -0.444 . . . . 72.45 110.896 -179.927 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.47 ' HB2' ' HB3' ' A' ' 53' ' ' PRO . 36.2 t60 -78.47 -37.75 42.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.121 -0.49 . . . . 71.32 110.893 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.5 t -58.19 -15.18 8.89 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.199 -0.455 . . . . 75.24 111.149 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -98.53 -27.97 13.8 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.243 -0.435 . . . . 73.44 110.899 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.436 ' CD1' ' O ' ' A' ' 19' ' ' ARG . 15.6 tp -140.87 134.92 30.78 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.129 -0.487 . . . . 74.54 110.878 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 23.3 m -99.74 -41.49 7.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.187 -0.46 . . . . 73.0 110.866 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -119.14 143.08 47.4 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.13 -0.486 . . . . 74.22 110.865 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.645 ' SG ' ' HB2' ' A' ' 80' ' ' LEU . 1.8 p -115.65 89.75 3.17 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.193 -0.458 . . . . 74.51 110.919 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.488 ' HB3' ' N ' ' A' ' 14' ' ' LYS . 3.6 m-20 -85.46 -54.01 4.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.193 -0.458 . . . . 74.14 110.87 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 9.7 p -125.32 128.12 47.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 71.42 110.854 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.494 HG23 ' N ' ' A' ' 41' ' ' LYS . 11.0 mt -127.05 152.08 34.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.11 -0.495 . . . . 74.25 111.123 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.494 ' N ' HG23 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -142.78 118.33 10.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.188 -0.46 . . . . 74.55 110.877 179.852 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.567 HG23 ' HB ' ' A' ' 8' ' ' ILE . 1.9 t -101.2 115.15 42.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.187 -0.46 . . . . 72.22 111.111 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -111.28 79.96 1.26 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.181 -0.463 . . . . 72.22 110.889 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.465 ' O ' ' HA ' ' A' ' 6' ' ' THR . . . 129.44 103.33 1.07 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.72 -0.752 . . . . 74.44 112.467 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 52.84 178.1 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.704 -0.76 . . . . 74.32 112.49 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.531 HG21 ' HA ' ' A' ' 63' ' ' PRO . 3.0 m -79.65 164.78 23.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.794 0.331 . . . . 72.32 111.119 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . 0.576 ' CD1' ' HB ' ' A' ' 8' ' ' ILE . 2.7 m95 -137.69 130.02 29.34 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.155 -0.475 . . . . 75.32 110.857 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.585 ' O ' ' N ' ' A' ' 84' ' ' ARG . . . -92.77 131.26 37.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.227 -0.442 . . . . 74.21 111.151 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.725 ' O ' ' O ' ' A' ' 60' ' ' TYR . 19.6 m -132.56 127.51 56.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.241 -0.436 . . . . 73.24 111.105 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.736 ' HB3' ' HA ' ' A' ' 56' ' ' ALA . 38.9 m-85 -94.75 148.3 22.43 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.218 -0.447 . . . . 74.15 110.92 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.539 ' OE1' ' HB2' ' A' ' 58' ' ' TYR . 7.1 tt0 -50.91 -76.55 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.148 -0.478 . . . . 75.51 110.855 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.557 ' HB3' ' CD1' ' A' ' 55' ' ' PHE . 19.2 mmm-85 -89.92 140.7 27.73 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.64 0.733 . . . . 72.2 110.846 -179.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.731 ' HA ' ' OG ' ' A' ' 82' ' ' SER . 54.1 Cg_endo -69.75 137.8 36.35 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.733 2.289 . . . . 71.45 112.322 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 65.32 -11.18 0.17 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.246 -0.434 . . . . 73.25 110.897 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.582 ' H ' ' C ' ' A' ' 53' ' ' PRO . 4.9 m-30 -100.85 -32.19 10.79 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.159 -0.473 . . . . 74.24 110.876 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.736 ' HA ' ' HB3' ' A' ' 50' ' ' TYR . . . 63.42 22.44 13.25 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.185 -0.461 . . . . 74.24 111.107 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . 0.629 ' O ' ' C ' ' A' ' 58' ' ' TYR . 1.2 t90 -51.4 -159.69 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.216 -0.447 . . . . 73.11 110.923 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.629 ' C ' ' O ' ' A' ' 57' ' ' TRP . 5.8 m-30 -13.72 101.43 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.278 -0.419 . . . . 71.54 110.929 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 2.1 mpt? -59.67 149.28 31.02 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.067 -0.515 . . . . 74.24 110.886 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.725 ' O ' ' O ' ' A' ' 49' ' ' VAL . 0.4 OUTLIER -163.93 105.08 0.91 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.232 -0.44 . . . . 75.5 110.923 -179.876 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.637 ' N ' ' CD1' ' A' ' 61' ' ' ILE . 0.9 OUTLIER -98.86 115.72 40.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.114 -0.494 . . . . 74.43 111.114 179.904 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.427 HD12 HD12 ' A' ' 40' ' ' ILE . 0.4 OUTLIER -83.64 123.71 76.07 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.6 0.714 . . . . 74.31 110.939 179.877 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.531 ' HA ' HG21 ' A' ' 46' ' ' THR . 54.3 Cg_endo -69.74 -165.21 0.15 Allowed 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.73 2.286 . . . . 74.23 112.341 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.64 159.57 14.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.233 -0.44 . . . . 73.51 110.907 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 112.88 -155.52 16.23 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.715 -0.755 . . . . 62.54 112.448 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -114.81 160.42 19.47 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.877 0.37 . . . . 74.11 110.859 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.458 ' OH ' ' HG2' ' A' ' 63' ' ' PRO . 10.8 m-85 -149.58 83.81 6.27 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.71 0.766 . . . . 74.32 110.919 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.8 -4.73 14.65 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.65 2.234 . . . . 71.43 112.325 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -156.89 148.23 22.2 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.244 -0.435 . . . . 75.33 110.919 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.99 ' O ' ' CD1' ' A' ' 73' ' ' TRP . 44.6 p90 -57.44 -42.44 82.45 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.164 -0.471 . . . . 70.44 110.936 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -51.94 -15.79 0.6 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.102 -0.499 . . . . 71.52 110.89 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 28.7 mmt180 -69.16 -9.22 51.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.179 -0.464 . . . . 75.25 110.902 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . 0.99 ' CD1' ' O ' ' A' ' 70' ' ' TYR . 0.5 OUTLIER -128.8 21.63 5.9 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.18 -0.463 . . . . 73.21 110.905 -179.946 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' MET . . . . . 0.623 ' O ' ' C ' ' A' ' 75' ' ' GLY . 24.1 mmt 79.54 27.44 0.36 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.276 -0.42 . . . . 73.24 110.878 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.623 ' C ' ' O ' ' A' ' 74' ' ' MET . . . 15.74 61.94 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.698 -0.763 . . . . 70.13 112.514 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.585 ' HB2' ' CE2' ' A' ' 60' ' ' TYR . 59.9 mt -58.89 -80.34 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.843 0.354 . . . . 73.55 110.902 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.589 ' O ' ' CB ' ' A' ' 78' ' ' ASP . 3.8 t-20 -113.56 -41.84 3.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.193 -0.458 . . . . 72.32 110.898 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.589 ' CB ' ' O ' ' A' ' 77' ' ' ASN . 2.6 t70 91.04 16.38 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.18 -0.464 . . . . 74.24 110.891 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.428 ' NE ' ' HD3' ' A' ' 52' ' ' ARG . 4.9 ttm105 -110.92 97.66 6.99 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.143 -0.481 . . . . 73.41 110.845 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.645 ' HB2' ' SG ' ' A' ' 37' ' ' CYS . 0.1 OUTLIER -95.6 131.7 41.53 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.18 -0.463 . . . . 71.11 110.912 -179.985 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.672 ' HB3' ' HB3' ' A' ' 53' ' ' PRO . 1.2 m -153.03 -123.58 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.208 -0.451 . . . . 74.34 110.877 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.731 ' OG ' ' HA ' ' A' ' 53' ' ' PRO . 0.0 OUTLIER -41.65 101.86 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.138 -0.483 . . . . 74.25 110.797 -179.757 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . 0.585 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 21.3 p -117.43 136.15 53.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.109 -0.496 . . . . 74.2 110.857 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . 0.585 ' N ' ' O ' ' A' ' 48' ' ' ALA . 6.6 mmt85 -123.43 138.38 54.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.149 -0.478 . . . . 71.04 110.865 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.448 ' N ' ' CZ3' ' A' ' 47' ' ' TRP . . . -57.71 128.67 38.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.202 -0.454 . . . . 74.11 111.044 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.508 HG21 ' CB ' ' A' ' 48' ' ' ALA . 12.3 t -111.71 139.6 35.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.18 -0.463 . . . . 62.02 111.113 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . 0.475 ' O ' ' C ' ' A' ' 88' ' ' LEU . 29.8 m80 -111.84 106.01 14.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.173 -0.467 . . . . 75.11 110.854 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.475 ' C ' ' O ' ' A' ' 87' ' ' HIS . 0.0 OUTLIER -31.9 143.22 0.13 Allowed Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.619 0.723 . . . . 75.32 110.888 -179.949 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.534 ' HB3' ' H ' ' A' ' 136' ' ' VAL . 53.7 Cg_endo -69.82 105.73 1.55 Allowed 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.652 2.235 . . . . 64.12 112.291 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.03 177.35 4.88 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.206 -0.452 . . . . 72.32 110.805 -179.835 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 50.12 63.16 4.48 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.741 -0.742 . . . . 50.33 112.486 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.424 ' O ' ' C ' ' A' ' 93' ' ' GLN . . . 124.25 21.72 2.24 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.754 -0.736 . . . . 72.01 112.454 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.448 ' O ' ' HG2' ' A' ' 134' ' ' GLU . 5.3 pt20 36.59 -121.29 0.16 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.815 0.341 . . . . 73.43 110.859 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.548 ' O ' ' HA ' ' A' ' 112' ' ' THR . 0.1 OUTLIER -120.92 100.8 7.29 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.141 -0.482 . . . . 65.53 110.911 -179.853 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.471 ' H ' ' HG2' ' A' ' 134' ' ' GLU . 45.6 tptt -110.82 128.27 55.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.112 -0.494 . . . . 74.01 110.907 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.43 HG22 ' CH2' ' A' ' 137' ' ' TRP . 0.0 OUTLIER -149.11 142.38 18.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.253 -0.431 . . . . 70.3 111.12 179.82 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.471 ' HB2' ' O ' ' A' ' 131' ' ' LYS . 2.8 mt-30 -112.1 126.94 55.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.137 -0.483 . . . . 74.42 110.911 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.444 HG23 HG13 ' A' ' 127' ' ' ILE . 4.9 mp -108.33 131.26 59.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.237 -0.438 . . . . 75.03 111.115 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.656 ' HB2' ' HB2' ' A' ' 129' ' ' SER . 6.4 m-85 -120.15 148.19 43.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.172 -0.467 . . . . 75.43 110.883 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -74.88 -75.59 0.16 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.159 -0.473 . . . . 73.4 110.912 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.42 ' C ' ' HB3' ' A' ' 128' ' ' HIS . 36.7 mttt -83.14 176.19 9.39 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.168 -0.469 . . . . 74.13 110.926 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -88.79 160.41 29.98 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.764 -0.731 . . . . 72.31 112.476 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.415 ' HA ' ' HB2' ' A' ' 158' ' ' ARG . 27.8 t0 65.15 53.42 1.35 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.883 0.373 . . . . 73.23 110.893 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.632 ' CE1' ' HD2' ' A' ' 131' ' ' LYS . 6.1 m-85 48.38 33.74 4.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.457 . . . . 70.15 110.876 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.411 ' C ' ' HB2' ' A' ' 101' ' ' LYS . 45.4 m -109.47 151.61 26.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.101 -0.499 . . . . 74.25 110.848 -179.795 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 91.35 -164.4 29.44 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.675 -0.774 . . . . 71.25 112.467 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 5.0 tp-100 -75.41 129.65 37.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.805 0.336 . . . . 72.51 110.945 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 3.8 ttp -112.47 144.96 41.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.197 -0.456 . . . . 71.42 110.887 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 -148.84 141.73 24.72 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.212 -0.449 . . . . 74.14 110.949 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -123.78 108.66 12.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.1 -0.5 . . . . 74.15 110.938 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 5.0 t -121.47 145.69 47.68 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.175 -0.466 . . . . 74.22 111.132 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.548 ' HA ' ' O ' ' A' ' 94' ' ' TYR . 4.4 t -120.96 41.91 3.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.245 -0.434 . . . . 73.33 111.152 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -151.19 157.08 42.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.224 -0.444 . . . . 74.32 110.904 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -53.85 157.86 2.23 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.145 -0.479 . . . . 73.41 110.823 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . 0.664 ' O ' ' HB2' ' A' ' 172' ' ' SER . 73.2 m -146.89 115.2 4.36 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-O 121.626 0.727 . . . . 75.01 110.898 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.455 ' O ' ' C ' ' A' ' 143' ' ' PRO . 53.3 Cg_endo -69.82 -30.3 22.24 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.648 2.232 . . . . 75.41 112.328 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' SER . . . . . 0.616 ' HB3' ' CB ' ' A' ' 120' ' ' GLU . 0.1 OUTLIER -148.26 99.82 3.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.251 -0.431 . . . . 72.05 110.814 -179.854 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.54 ' HB ' ' O ' ' A' ' 171' ' ' GLN . 5.6 tt -52.86 -26.56 11.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.12 -0.491 . . . . 74.3 111.124 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' MET . . . . . 0.599 ' O ' ' HA ' ' A' ' 123' ' ' HIS . 14.4 ttp -86.75 -41.26 14.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.198 -0.455 . . . . 75.33 110.89 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.616 ' CB ' ' HB3' ' A' ' 117' ' ' SER . 34.5 tp10 -64.33 -12.98 47.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.215 -0.448 . . . . 73.23 110.854 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . 0.402 ' HG3' ' H ' ' A' ' 122' ' ' PHE . 0.0 OUTLIER -114.62 -51.56 2.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.189 -0.46 . . . . 72.34 110.946 -179.96 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . 0.405 ' HB2' ' O ' ' A' ' 118' ' ' ILE . 12.1 m-30 -101.22 -18.17 16.27 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.217 -0.447 . . . . 61.21 110.935 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . 0.599 ' HA ' ' O ' ' A' ' 119' ' ' MET . 11.8 m80 74.39 21.29 2.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.135 -0.484 . . . . 73.31 110.901 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 6.5 mtt -94.27 131.91 39.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.188 -0.46 . . . . 65.34 110.873 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 4.9 ptp180 -95.23 -38.55 10.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.181 -0.463 . . . . 65.22 110.877 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.456 ' HG2' ' HA ' ' A' ' 169' ' ' ALA . 25.2 mt-10 -141.25 118.62 11.45 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.159 -0.473 . . . . 64.14 110.875 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.48 ' O ' ' HB3' ' A' ' 168' ' ' PRO . 3.0 mm -80.08 101.09 4.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.163 -0.471 . . . . 75.45 111.138 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . 0.42 ' HB3' ' C ' ' A' ' 101' ' ' LYS . 0.4 OUTLIER -73.19 -32.58 64.9 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.171 -0.468 . . . . 72.45 110.846 179.888 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 0.656 ' HB2' ' HB2' ' A' ' 99' ' ' PHE . 66.5 m -128.47 138.89 52.51 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.193 -0.458 . . . . 65.02 110.83 -179.719 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . 0.573 ' O ' ' O ' ' A' ' 155' ' ' LYS . 3.8 m -136.05 120.43 18.02 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.149 -0.478 . . . . 73.33 110.865 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.652 ' HA ' ' HA ' ' A' ' 156' ' ' GLU . 3.6 mtpp -116.35 152.21 34.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.131 -0.486 . . . . 74.15 110.892 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.538 ' HB ' ' O ' ' A' ' 131' ' ' LYS . 19.4 t 85.6 162.46 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.226 -0.443 . . . . 75.31 111.145 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.471 ' CD1' ' O ' ' A' ' 154' ' ' LYS . 0.0 OUTLIER -177.33 124.59 0.14 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.223 -0.444 . . . . 64.42 110.929 179.933 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.501 ' O ' ' C ' ' A' ' 135' ' ' GLY . 0.1 OUTLIER -98.26 168.23 10.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.162 -0.472 . . . . 72.12 110.895 179.936 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . 0.501 ' C ' ' O ' ' A' ' 134' ' ' GLU . . . -29.17 -70.04 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.751 -0.738 . . . . 72.13 112.447 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.672 ' HA ' HD13 ' A' ' 152' ' ' LEU . 3.0 t -133.82 145.43 33.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.834 0.349 . . . . 73.55 111.109 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' TRP . . . . . 0.493 ' N ' ' HG ' ' A' ' 152' ' ' LEU . 0.1 OUTLIER -150.1 162.8 39.7 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.187 -0.461 . . . . 75.15 110.866 -179.975 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.551 HD12 ' HB ' ' A' ' 61' ' ' ILE . 22.6 mt -138.48 134.03 43.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.208 -0.451 . . . . 75.41 111.136 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 0.441 ' HB2' ' HB2' ' A' ' 150' ' ' TYR . 0.2 OUTLIER -103.68 159.16 15.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.176 -0.465 . . . . 73.33 110.884 179.957 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . 0.47 ' CD2' ' HA ' ' A' ' 145' ' ' TYR . 0.5 OUTLIER -131.61 128.46 39.18 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.123 -0.49 . . . . 75.43 110.905 -179.875 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . 0.566 ' O ' ' HB2' ' A' ' 171' ' ' GLN . 7.0 tt0 -60.76 -27.75 68.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.089 -0.505 . . . . 64.23 110.858 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.767 ' HB3' ' HD2' ' A' ' 143' ' ' PRO . 10.1 mp -114.97 173.46 2.89 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.588 0.709 . . . . 74.45 110.938 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . 0.767 ' HD2' ' HB3' ' A' ' 142' ' ' LEU . 53.2 Cg_endo -69.77 -90.61 0.0 OUTLIER 'Trans proline' 0 C--N 1.34 0.129 0 C-N-CA 122.694 2.263 . . . . 72.43 112.327 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . 0.723 ' O ' ' N ' ' A' ' 146' ' ' ARG . 2.4 m-20 -50.73 98.57 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.181 -0.463 . . . . 74.33 110.87 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . 0.638 ' C ' ' O ' ' A' ' 144' ' ' ASN . 0.1 OUTLIER 12.67 51.77 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.163 -0.471 . . . . 74.03 110.945 -179.959 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . 0.723 ' N ' ' O ' ' A' ' 144' ' ' ASN . 22.3 mtt-85 -119.46 173.43 6.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.132 -0.486 . . . . 75.34 110.921 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 79.84 172.27 43.6 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.737 -0.744 . . . . 62.05 112.462 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 19.3 mtp180 -68.55 150.61 47.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.755 0.312 . . . . 73.42 110.888 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' GLN . . . . . 0.563 ' HB2' ' HA ' ' A' ' 60' ' ' TYR . 55.4 mt-30 -86.02 153.21 22.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.236 -0.438 . . . . 75.4 110.932 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . 0.441 ' HB2' ' HB2' ' A' ' 139' ' ' PHE . 76.1 m-85 -133.91 123.02 23.98 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.222 -0.445 . . . . 74.13 110.934 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.551 ' CA ' HD12 ' A' ' 61' ' ' ILE . 12.1 tp -70.32 125.24 26.24 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.144 -0.48 . . . . 74.34 110.909 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.672 HD13 ' HA ' ' A' ' 136' ' ' VAL . 0.0 OUTLIER -59.94 132.58 54.4 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.177 -0.465 . . . . 74.51 110.871 179.948 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -163.56 24.98 0.08 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.138 -0.483 . . . . 75.33 110.862 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.678 ' O ' ' HG3' ' A' ' 155' ' ' LYS . 0.1 OUTLIER -112.41 -171.1 1.79 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.186 -0.461 . . . . 74.4 110.923 179.954 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.678 ' HG3' ' O ' ' A' ' 154' ' ' LYS . 0.2 OUTLIER -165.67 -122.39 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.207 -0.452 . . . . 75.33 110.858 179.87 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . 0.652 ' HA ' ' HA ' ' A' ' 131' ' ' LYS . 0.4 OUTLIER -71.39 0.42 8.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.232 -0.44 . . . . 73.32 110.913 -179.99 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . 0.661 ' CD1' ' HB3' ' A' ' 162' ' ' ASP . 16.8 m-30 -28.49 142.49 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.128 -0.487 . . . . 74.32 110.938 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . 0.606 ' O ' ' OG ' ' A' ' 129' ' ' SER . 11.1 ptp180 -112.18 -33.74 6.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.126 -0.488 . . . . 74.4 110.862 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -101.1 152.28 37.85 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.541 0.686 . . . . 72.01 110.914 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.73 -22.64 31.92 Favored 'Trans proline' 0 C--O 1.232 0.206 0 C-N-CA 122.694 2.262 . . . . 73.25 112.354 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.473 HD11 ' H ' ' A' ' 161' ' ' ILE . 4.0 mp -76.67 -2.89 4.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.226 -0.443 . . . . 75.12 111.146 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . 0.661 ' HB3' ' CD1' ' A' ' 157' ' ' TYR . 1.4 t0 -72.47 -17.34 61.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.19 -0.459 . . . . 74.4 110.878 179.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' TRP . . . . . 0.52 ' O ' ' CG ' ' A' ' 163' ' ' TRP . 6.2 t-105 -109.99 10.21 24.24 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.168 -0.469 . . . . 73.44 110.934 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 87.71 -31.63 4.53 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.69 -0.767 . . . . 64.42 112.503 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -54.35 119.35 5.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.799 0.333 . . . . 71.32 111.103 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -49.1 -26.14 2.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.202 -0.454 . . . . 74.01 111.1 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' SER . . . . . 0.495 ' C ' ' H ' ' A' ' 169' ' ' ALA . 0.3 OUTLIER -154.98 159.36 31.89 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.635 0.731 . . . . 63.03 110.855 -179.794 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . 0.48 ' HB3' ' O ' ' A' ' 127' ' ' ILE . 53.5 Cg_endo -69.81 19.21 0.19 Allowed 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.679 2.253 . . . . 75.51 112.32 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . 0.495 ' H ' ' C ' ' A' ' 167' ' ' SER . . . -63.01 102.58 0.38 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.236 -0.438 . . . . 72.23 111.083 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 3.4 t -153.09 162.15 2.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.223 -0.444 . . . . 70.32 111.147 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' GLN . . . . . 0.688 ' OE1' ' HB3' ' A' ' 143' ' ' PRO . 1.7 mm-40 -112.21 -88.38 0.53 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.209 -0.45 . . . . 71.31 110.93 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' SER . . . . . 0.758 ' OG ' ' O ' ' A' ' 143' ' ' PRO . 45.7 p -121.67 177.92 5.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.156 -0.475 . . . . 72.44 110.882 -179.801 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 2.0 p90 -141.97 168.34 19.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.161 -0.472 . . . . 71.0 110.861 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . 0.448 ' HD2' ' CE2' ' A' ' 140' ' ' TYR . 0.0 OUTLIER -135.21 156.16 49.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.11 -0.496 . . . . 72.4 110.911 -179.937 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . 0.409 ' HD2' ' CE2' ' A' ' 94' ' ' TYR . 0.0 OUTLIER -100.68 -164.48 1.12 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.178 -0.464 . . . . 75.14 110.868 -179.922 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . 0.435 HD11 ' C ' ' A' ' 136' ' ' VAL . 5.6 mt -137.0 130.5 45.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.164 -0.471 . . . . 74.1 111.09 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 7.4 p -98.43 155.84 3.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.198 -0.456 . . . . 74.13 111.103 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.174 -0.467 . . . . 73.34 110.877 -179.987 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.352 0 N-CA-C 112.511 -0.235 . . . . 65.24 112.511 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.449 ' C ' ' HE1' ' A' ' 47' ' ' TRP . 9.9 p -82.67 133.78 35.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.871 0.367 . . . . 73.2 111.149 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 3.0 tttt -122.08 137.08 54.94 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.176 -0.465 . . . . 75.55 110.856 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.67 HG23 ' CZ ' ' A' ' 10' ' ' PHE . 14.3 tt -137.16 152.94 28.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.197 -0.456 . . . . 74.13 111.148 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.499 ' HA ' ' O ' ' A' ' 21' ' ' TYR . 23.0 m -136.63 136.95 39.6 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.208 -0.451 . . . . 74.3 111.14 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.67 ' CZ ' HG23 ' A' ' 8' ' ' ILE . 0.2 OUTLIER -125.23 129.3 49.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.225 -0.443 . . . . 71.21 110.883 -179.992 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.533 ' CG ' ' HA ' ' A' ' 16' ' ' PHE . 33.9 m-85 -112.38 131.93 55.28 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.138 -0.483 . . . . 74.21 110.953 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.416 ' HB2' ' HB2' ' A' ' 19' ' ' ARG . 0.1 OUTLIER -62.2 -16.45 53.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.147 -0.479 . . . . 74.21 110.89 -179.985 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.412 ' HB2' ' O ' ' A' ' 17' ' ' GLN . 70.7 m-20 -133.83 148.8 51.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.13 -0.487 . . . . 71.53 110.886 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.603 ' N ' ' HB3' ' A' ' 38' ' ' ASN . 3.5 mtmm -54.53 -179.19 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.217 -0.447 . . . . 73.3 110.927 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 22.3 m-20 49.64 32.87 5.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.259 -0.428 . . . . 74.22 110.906 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.533 ' HA ' ' CG ' ' A' ' 11' ' ' TYR . 4.0 m-85 49.79 62.45 2.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.137 -0.483 . . . . 75.24 110.919 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . 0.412 ' O ' ' HB2' ' A' ' 13' ' ' ASP . 4.1 mt-30 -138.85 161.89 36.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.115 -0.493 . . . . 75.44 110.894 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 91.78 -149.76 19.93 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.771 -0.728 . . . . 65.21 112.493 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.432 ' O ' ' CD1' ' A' ' 34' ' ' LEU . 0.0 OUTLIER -69.41 77.58 0.39 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.812 0.339 . . . . 73.44 110.889 -179.845 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.429 ' CD ' ' OD2' ' A' ' 22' ' ' ASP . 0.0 OUTLIER -75.79 129.11 36.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.181 -0.463 . . . . 74.31 110.871 -179.907 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.499 ' O ' ' HA ' ' A' ' 9' ' ' THR . 90.6 t80 -123.03 124.4 43.03 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.172 -0.467 . . . . 74.45 110.922 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.432 ' CG ' HG23 ' A' ' 9' ' ' THR . 1.1 m-20 -121.02 133.52 55.26 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.143 -0.481 . . . . 74.43 110.851 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -166.77 133.94 2.5 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.168 -0.469 . . . . 73.34 110.924 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -99.76 2.18 43.92 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.189 -0.459 . . . . 74.2 110.935 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.458 ' O ' ' SG ' ' A' ' 27' ' ' CYS . 18.6 t -106.46 164.96 11.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.17 -0.468 . . . . 71.31 110.881 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -56.93 120.78 8.52 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.201 -0.454 . . . . 74.01 110.866 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.577 ' HB2' ' HB3' ' A' ' 30' ' ' PHE . 0.6 OUTLIER -115.64 50.14 1.03 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.212 -0.449 . . . . 71.02 110.875 -179.894 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.508 ' O ' ' HA ' ' A' ' 82' ' ' SER . . . -47.69 -21.43 0.37 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.163 -0.471 . . . . 63.44 111.093 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 58.5 t0 -128.68 42.11 3.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.235 -0.439 . . . . 74.13 110.89 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.731 ' O ' ' CD2' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -81.45 13.98 2.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.166 -0.47 . . . . 74.14 110.925 -179.932 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.431 ' HB2' ' HB3' ' A' ' 81' ' ' SER . 29.7 t60 -78.19 -39.05 41.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.138 -0.483 . . . . 74.22 110.824 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.7 t -57.93 -14.93 7.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.221 -0.445 . . . . 73.4 111.139 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -99.6 -26.26 14.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.233 -0.44 . . . . 73.42 110.928 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.432 ' CD1' ' O ' ' A' ' 19' ' ' ARG . 15.5 tp -142.89 133.12 24.58 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.129 -0.487 . . . . 72.41 110.923 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 22.3 m -97.51 -43.28 7.32 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.169 -0.469 . . . . 75.14 110.865 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 1.6 tmm_? -117.27 142.57 46.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.146 -0.479 . . . . 75.43 110.886 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.661 ' SG ' ' HB2' ' A' ' 80' ' ' LEU . 1.5 p -111.65 89.19 2.99 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.204 -0.453 . . . . 74.44 110.893 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.603 ' HB3' ' N ' ' A' ' 14' ' ' LYS . 0.3 OUTLIER -81.73 -61.99 1.77 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.176 -0.465 . . . . 64.15 110.89 -179.906 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 10.4 p -124.17 125.93 45.29 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.196 -0.457 . . . . 74.44 110.847 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.519 ' O ' ' HB2' ' A' ' 67' ' ' TYR . 2.6 mt -124.06 151.55 29.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.13 -0.486 . . . . 73.41 111.139 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.473 ' N ' HG23 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -142.32 121.97 13.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.145 -0.479 . . . . 74.4 110.862 179.887 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.55 HG22 ' HB2' ' A' ' 47' ' ' TRP . 1.0 OUTLIER -104.82 118.84 52.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.22 -0.445 . . . . 73.51 111.118 179.876 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -114.07 77.73 1.09 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.146 -0.479 . . . . 75.31 110.836 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.416 ' O ' ' HA ' ' A' ' 6' ' ' THR . . . 135.46 99.14 0.58 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.714 -0.755 . . . . 42.24 112.476 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 54.75 176.8 0.14 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.733 -0.746 . . . . 72.22 112.473 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.55 HG21 ' HA ' ' A' ' 63' ' ' PRO . 1.9 m -75.82 169.24 18.53 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.789 0.328 . . . . 72.42 111.156 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . 0.578 ' CD1' ' HB ' ' A' ' 8' ' ' ILE . 6.0 m95 -143.02 129.35 19.94 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.251 -0.431 . . . . 73.44 110.907 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.585 ' O ' ' N ' ' A' ' 84' ' ' ARG . . . -90.98 129.19 37.01 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.206 -0.452 . . . . 75.02 111.143 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.78 ' O ' ' O ' ' A' ' 60' ' ' TYR . 17.3 m -129.34 125.66 62.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.277 -0.419 . . . . 72.41 111.107 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.781 ' HB3' ' HA ' ' A' ' 56' ' ' ALA . 44.0 m-85 -93.73 148.38 22.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.182 -0.463 . . . . 72.31 110.926 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.559 ' HB2' ' O ' ' A' ' 58' ' ' TYR . 7.0 tt0 -48.72 -79.89 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.152 -0.476 . . . . 75.44 110.877 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.539 ' HB3' ' CD1' ' A' ' 55' ' ' PHE . 0.0 OUTLIER -92.75 145.15 29.77 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.617 0.723 . . . . 71.32 110.845 -179.908 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.728 ' HA ' ' OG ' ' A' ' 82' ' ' SER . 53.9 Cg_endo -69.79 140.78 43.41 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.678 2.252 . . . . 73.33 112.381 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 62.9 -11.03 0.09 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.227 -0.442 . . . . 74.21 110.924 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.626 ' H ' ' C ' ' A' ' 53' ' ' PRO . 2.6 m-30 -104.0 -21.37 13.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.162 -0.472 . . . . 73.32 110.913 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.781 ' HA ' ' HB3' ' A' ' 50' ' ' TYR . . . 50.05 25.98 1.9 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.135 -0.484 . . . . 74.23 111.063 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . 0.637 ' O ' ' C ' ' A' ' 58' ' ' TYR . 0.0 OUTLIER -50.07 -161.36 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.233 -0.44 . . . . 73.32 110.941 -179.997 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.637 ' C ' ' O ' ' A' ' 57' ' ' TRP . 6.3 m-30 -14.24 101.59 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.227 -0.442 . . . . 74.55 110.926 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.445 ' HB2' ' O ' ' A' ' 149' ' ' GLN . 0.5 OUTLIER -58.41 146.15 35.93 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.087 -0.506 . . . . 73.15 110.905 179.903 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.78 ' O ' ' O ' ' A' ' 49' ' ' VAL . 0.3 OUTLIER -159.07 112.28 2.29 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.253 -0.43 . . . . 74.23 110.885 -179.863 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.605 ' CD1' ' N ' ' A' ' 61' ' ' ILE . 1.0 OUTLIER -104.95 114.84 45.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.097 -0.502 . . . . 74.44 111.15 179.898 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -84.95 124.86 71.97 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.617 0.722 . . . . 74.41 110.934 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.55 ' HA ' HG21 ' A' ' 46' ' ' THR . 53.7 Cg_endo -69.75 -165.29 0.15 Allowed 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.647 2.232 . . . . 75.35 112.357 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.42 160.37 14.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.223 -0.444 . . . . 74.34 110.887 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 112.91 -152.11 18.05 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.697 -0.763 . . . . 62.13 112.486 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 11.2 mp0 -118.69 159.44 23.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.844 0.354 . . . . 75.0 110.937 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.519 ' HB2' ' O ' ' A' ' 40' ' ' ILE . 13.0 m-85 -147.94 82.43 7.84 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.655 0.741 . . . . 54.4 110.924 -179.854 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.7 -3.67 12.44 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.731 2.288 . . . . 74.32 112.355 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -157.72 147.68 20.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.178 -0.464 . . . . 75.25 110.856 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.882 ' O ' ' CD1' ' A' ' 73' ' ' TRP . 44.6 p90 -57.53 -41.47 80.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.121 -0.49 . . . . 72.2 110.927 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -53.35 -17.1 1.63 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.138 -0.483 . . . . 72.0 110.945 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 29.3 mmt180 -63.62 -36.29 83.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 74.44 110.852 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . 0.882 ' CD1' ' O ' ' A' ' 70' ' ' TYR . 0.3 OUTLIER -98.61 25.41 6.47 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.243 -0.435 . . . . 63.43 110.907 -179.958 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' MET . . . . . 0.566 ' O ' ' C ' ' A' ' 75' ' ' GLY . 1.6 mtp 75.53 26.87 1.08 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.264 -0.425 . . . . 75.32 110.886 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.566 ' C ' ' O ' ' A' ' 74' ' ' MET . . . 23.51 54.57 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.763 -0.732 . . . . 63.12 112.481 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.506 ' CB ' ' CE2' ' A' ' 60' ' ' TYR . 0.2 OUTLIER -56.69 -74.46 0.05 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.781 0.324 . . . . 70.14 110.918 -179.917 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.766 ' O ' ' CB ' ' A' ' 78' ' ' ASP . 28.0 t-20 -113.75 -80.55 0.59 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.214 -0.448 . . . . 74.24 110.897 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.766 ' CB ' ' O ' ' A' ' 77' ' ' ASN . 27.8 t70 129.45 5.38 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.182 -0.463 . . . . 75.22 110.911 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -107.3 92.28 4.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.211 -0.45 . . . . 71.55 110.893 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.661 ' HB2' ' SG ' ' A' ' 37' ' ' CYS . 0.2 OUTLIER -90.7 129.5 36.79 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.186 -0.461 . . . . 75.23 110.923 -179.959 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.592 ' HB3' ' HB3' ' A' ' 53' ' ' PRO . 0.9 OUTLIER -153.66 -123.42 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.23 -0.441 . . . . 74.41 110.897 -179.945 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.728 ' OG ' ' HA ' ' A' ' 53' ' ' PRO . 0.0 OUTLIER -41.46 101.91 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.168 -0.469 . . . . 71.12 110.877 -179.824 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . 0.512 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 31.5 p -121.16 135.38 55.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.095 -0.502 . . . . 70.11 110.887 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . 0.585 ' N ' ' O ' ' A' ' 48' ' ' ALA . 10.9 mmt85 -119.62 150.94 39.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.2 -0.455 . . . . 73.13 110.832 -179.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -66.65 127.14 31.24 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.176 -0.465 . . . . 74.35 111.102 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.478 ' CG2' ' CB ' ' A' ' 48' ' ' ALA . 52.9 t -116.94 137.56 50.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.245 -0.434 . . . . 65.51 111.127 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . 0.438 ' O ' ' CG2' ' A' ' 136' ' ' VAL . 29.4 m80 -111.17 126.54 54.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.124 -0.489 . . . . 75.45 110.88 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -39.63 137.99 1.03 Allowed Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.598 0.713 . . . . 75.45 110.899 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 80.71 0.87 Allowed 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.713 2.275 . . . . 74.52 112.329 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -90.58 -177.12 4.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 64.41 110.838 -179.835 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 67.41 117.52 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.756 -0.735 . . . . 74.23 112.496 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 50.02 40.23 35.17 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.747 -0.74 . . . . 53.41 112.536 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.429 ' HB2' ' H ' ' A' ' 94' ' ' TYR . 5.2 pt20 40.21 -156.65 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.802 0.334 . . . . 75.02 110.901 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.576 ' HA ' ' CG ' ' A' ' 134' ' ' GLU . 0.1 OUTLIER -97.47 104.81 16.87 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.204 -0.453 . . . . 75.55 110.909 -179.875 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 45.7 tptt -105.99 131.34 53.4 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.132 -0.485 . . . . 74.42 110.885 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -150.23 137.38 13.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.252 -0.431 . . . . 75.15 111.141 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.431 ' HB2' ' O ' ' A' ' 131' ' ' LYS . 0.8 OUTLIER -112.77 135.6 53.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.205 -0.452 . . . . 74.31 110.93 179.935 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 1.5 mt -114.52 142.62 26.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.166 -0.47 . . . . 72.13 111.13 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.635 ' HB2' ' HB2' ' A' ' 129' ' ' SER . 57.1 m-85 -131.29 134.28 46.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.182 -0.463 . . . . 74.21 110.832 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 64.2 tt0 -63.59 -74.46 0.1 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.126 -0.488 . . . . 74.43 110.869 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.444 ' C ' ' HB3' ' A' ' 128' ' ' HIS . 9.7 mttt -83.11 177.45 8.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.142 -0.481 . . . . 74.24 110.854 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.436 ' HA2' ' HB3' ' A' ' 128' ' ' HIS . . . -83.61 161.1 38.34 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.732 -0.747 . . . . 75.32 112.49 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.427 ' HA ' ' HB2' ' A' ' 158' ' ' ARG . 30.4 t0 61.76 32.86 18.12 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.851 0.357 . . . . 71.35 110.885 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.566 ' HA ' ' CD2' ' A' ' 99' ' ' PHE . 21.1 m-85 59.35 48.88 9.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.191 -0.458 . . . . 75.15 110.924 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 4.4 m -114.25 150.06 34.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 73.24 110.85 -179.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 89.81 -127.73 8.88 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.721 -0.752 . . . . 73.33 112.506 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 -99.18 139.41 34.87 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.806 0.336 . . . . 73.43 110.885 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 4.4 ttp -128.74 146.17 50.97 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.183 -0.462 . . . . 74.23 110.862 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 18.9 m-85 -148.25 136.79 21.5 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.267 -0.424 . . . . 74.42 110.918 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -115.3 99.26 7.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.097 -0.501 . . . . 73.04 110.912 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 13.6 t -112.58 132.03 55.33 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.135 -0.484 . . . . 60.43 111.156 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.427 ' OG1' ' O ' ' A' ' 112' ' ' THR . 1.7 t -97.4 33.3 2.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.177 -0.465 . . . . 75.33 111.128 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -149.88 -176.05 5.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.199 -0.455 . . . . 71.4 110.917 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.497 ' CB ' ' HA ' ' A' ' 174' ' ' ARG . 5.3 p30 -103.45 171.29 7.45 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.184 -0.462 . . . . 74.01 110.895 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . 0.482 ' O ' ' HB2' ' A' ' 172' ' ' SER . 16.7 p -152.02 146.14 18.31 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.602 0.715 . . . . 71.13 110.908 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.417 ' O ' ' CA ' ' A' ' 143' ' ' PRO . 53.2 Cg_endo -69.8 -28.5 24.98 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.665 2.243 . . . . 62.14 112.305 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' SER . . . . . 0.616 ' HB3' ' CB ' ' A' ' 120' ' ' GLU . 0.1 OUTLIER -147.59 105.85 3.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.25 -0.432 . . . . 73.54 110.862 -179.858 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.631 ' HB ' ' O ' ' A' ' 171' ' ' GLN . 3.6 tt -58.09 -29.77 37.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.165 -0.471 . . . . 73.24 111.146 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' MET . . . . . 0.595 ' O ' ' HA ' ' A' ' 123' ' ' HIS . 27.0 ttp -86.4 -43.72 12.61 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.458 . . . . 60.01 110.91 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.616 ' CB ' ' HB3' ' A' ' 117' ' ' SER . 9.4 tp10 -66.49 -13.21 60.56 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.223 -0.444 . . . . 74.21 110.857 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -114.62 -49.97 2.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.194 -0.457 . . . . 74.43 110.954 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . 0.466 ' HB2' ' O ' ' A' ' 118' ' ' ILE . 63.2 m-85 -103.03 -20.37 14.22 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.2 -0.455 . . . . 74.42 110.874 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . 0.595 ' HA ' ' O ' ' A' ' 119' ' ' MET . 28.3 m-70 72.75 26.88 2.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.136 -0.484 . . . . 73.52 110.851 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.4 ' O ' HG22 ' A' ' 118' ' ' ILE . 16.9 mtt -102.06 88.75 3.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.196 -0.456 . . . . 72.22 110.885 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 2.0 ptp85 -52.04 -42.86 63.43 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.26 -0.427 . . . . 74.45 110.869 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.455 ' HG2' ' HA ' ' A' ' 169' ' ' ALA . 13.4 mt-10 -137.2 130.75 31.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.213 -0.449 . . . . 71.25 110.902 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 3.4 mm -89.48 87.68 2.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.173 -0.467 . . . . 63.45 111.147 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . 0.444 ' HB3' ' C ' ' A' ' 101' ' ' LYS . 0.7 OUTLIER -62.4 -31.98 72.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.201 -0.454 . . . . 62.31 110.871 179.911 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 0.635 ' HB2' ' HB2' ' A' ' 99' ' ' PHE . 0.4 OUTLIER -134.35 142.38 47.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.172 -0.467 . . . . 74.03 110.801 -179.747 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . 0.624 ' O ' ' O ' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -143.17 117.61 9.69 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.151 -0.477 . . . . 74.24 110.882 -179.987 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.716 ' HA ' ' HA ' ' A' ' 156' ' ' GLU . 4.6 mtpp -106.67 150.86 25.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.217 -0.447 . . . . 73.22 110.915 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.409 ' O ' HD23 ' A' ' 133' ' ' LEU . 3.4 t 74.27 165.84 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.234 -0.439 . . . . 74.24 111.11 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.501 HD11 ' HG2' ' A' ' 154' ' ' LYS . 0.2 OUTLIER 172.77 128.84 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.136 -0.484 . . . . 70.01 110.936 179.929 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.576 ' CG ' ' HA ' ' A' ' 94' ' ' TYR . 0.7 OUTLIER -79.83 163.1 24.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.213 -0.449 . . . . 71.31 110.876 179.944 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . 0.441 ' C ' ' O ' ' A' ' 134' ' ' GLU . . . -34.71 -42.98 0.36 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.777 -0.725 . . . . 74.41 112.455 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.73 ' HA ' HD13 ' A' ' 152' ' ' LEU . 2.1 t -146.61 137.74 18.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.825 0.345 . . . . 74.4 111.148 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' TRP . . . . . 0.562 ' HB3' ' HB3' ' A' ' 152' ' ' LEU . 9.9 t-105 -138.46 157.12 46.82 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.151 -0.477 . . . . 74.34 110.886 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.437 HG12 HG13 ' A' ' 176' ' ' ILE . 18.2 mm -121.44 132.31 70.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.206 -0.452 . . . . 73.35 111.142 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 0.563 ' CB ' ' HB2' ' A' ' 150' ' ' TYR . 0.1 OUTLIER -118.87 137.61 53.32 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.163 -0.471 . . . . 70.02 110.92 179.945 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . 0.466 ' CD2' ' HA ' ' A' ' 145' ' ' TYR . 3.4 m-85 -119.37 132.05 55.79 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.13 -0.486 . . . . 71.4 110.923 -179.836 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . 0.669 ' O ' ' HB2' ' A' ' 171' ' ' GLN . 10.9 tt0 -60.04 -27.61 67.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.096 -0.502 . . . . 73.53 110.895 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.776 ' HB3' ' HD2' ' A' ' 143' ' ' PRO . 10.0 mp -112.85 173.74 2.69 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-O 121.614 0.721 . . . . 75.41 110.899 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . 0.776 ' HD2' ' HB3' ' A' ' 142' ' ' LEU . 53.9 Cg_endo -69.79 -88.8 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.71 2.273 . . . . 74.42 112.312 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . 0.686 ' O ' ' N ' ' A' ' 146' ' ' ARG . 1.4 m-20 -52.91 96.56 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.26 -0.427 . . . . 74.2 110.861 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . 0.633 ' C ' ' O ' ' A' ' 144' ' ' ASN . 0.1 OUTLIER 13.12 52.9 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.144 -0.48 . . . . 71.04 110.935 -179.94 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . 0.686 ' N ' ' O ' ' A' ' 144' ' ' ASN . 8.8 mtp85 -119.38 179.36 4.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.141 -0.481 . . . . 73.43 110.89 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 77.02 -177.69 52.06 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.726 -0.749 . . . . 74.11 112.486 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 5.7 mtp180 -74.11 156.23 37.62 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.756 0.312 . . . . 71.12 110.913 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' GLN . . . . . 0.445 ' O ' ' HB2' ' A' ' 59' ' ' MET . 0.8 OUTLIER -85.67 151.24 24.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.256 -0.429 . . . . 73.33 110.909 -179.974 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . 0.563 ' HB2' ' CB ' ' A' ' 139' ' ' PHE . 73.8 m-85 -137.67 122.8 19.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.209 -0.45 . . . . 73.4 110.914 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.478 ' CA ' HD12 ' A' ' 61' ' ' ILE . 10.5 tp -81.56 121.9 26.89 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.147 -0.479 . . . . 74.42 110.932 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.73 HD13 ' HA ' ' A' ' 136' ' ' VAL . 0.0 OUTLIER -51.71 139.33 21.4 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.162 -0.472 . . . . 75.14 110.925 179.916 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -162.68 26.45 0.1 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.208 -0.451 . . . . 64.43 110.822 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.927 ' HB2' ' CD1' ' A' ' 157' ' ' TYR . 2.9 ptmt -127.44 -173.49 2.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.162 -0.472 . . . . 74.02 110.906 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.745 ' HD2' ' C ' ' A' ' 154' ' ' LYS . 0.8 OUTLIER -161.58 -117.17 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.187 -0.46 . . . . 64.23 110.882 179.812 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . 0.716 ' HA ' ' HA ' ' A' ' 131' ' ' LYS . 3.2 tm-20 -71.15 0.44 7.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.224 -0.444 . . . . 64.55 110.918 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . 0.927 ' CD1' ' HB2' ' A' ' 154' ' ' LYS . 13.6 m-30 -32.93 147.05 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.146 -0.479 . . . . 75.25 110.922 -179.836 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . 0.517 ' HB3' ' CZ ' ' A' ' 104' ' ' PHE . 9.8 ptp180 -113.0 -33.54 6.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.106 -0.497 . . . . 74.14 110.887 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 7.0 ptpt -99.04 151.86 37.55 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.597 0.713 . . . . 73.02 110.859 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.79 -25.71 28.16 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.716 2.278 . . . . 75.24 112.298 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.48 HD11 ' H ' ' A' ' 161' ' ' ILE . 3.8 mp -73.83 -6.03 7.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.251 -0.431 . . . . 75.33 111.111 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . 0.684 ' HB3' ' CD1' ' A' ' 157' ' ' TYR . 1.7 t0 -73.04 -15.73 61.51 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.194 -0.457 . . . . 73.11 110.913 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 4.8 t90 -109.94 12.65 23.71 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.197 -0.456 . . . . 75.31 110.95 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 85.6 -34.51 3.31 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.753 -0.736 . . . . 55.31 112.493 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -55.31 119.86 6.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.772 0.32 . . . . 73.34 111.118 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -49.93 -26.69 4.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.216 -0.447 . . . . 73.0 111.098 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' SER . . . . . 0.504 ' C ' ' H ' ' A' ' 169' ' ' ALA . 0.3 OUTLIER -154.55 158.18 32.25 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.688 0.756 . . . . 54.44 110.819 -179.772 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.7 18.5 0.19 Allowed 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.752 2.301 . . . . 71.54 112.321 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . 0.504 ' H ' ' C ' ' A' ' 167' ' ' SER . . . -63.45 102.97 0.47 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.235 -0.439 . . . . 72.24 111.13 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 3.1 t -153.37 163.61 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.173 -0.467 . . . . 72.15 111.105 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' GLN . . . . . 0.669 ' HB2' ' O ' ' A' ' 141' ' ' GLU . 1.9 mm-40 -110.23 -87.07 0.53 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.146 -0.479 . . . . 73.12 110.898 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' SER . . . . . 0.747 ' OG ' ' O ' ' A' ' 143' ' ' PRO . 47.0 p -125.48 172.92 9.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.213 -0.449 . . . . 71.03 110.857 -179.777 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 5.9 p90 -145.77 164.69 31.09 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.142 -0.481 . . . . 74.55 110.828 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . 0.497 ' HA ' ' CB ' ' A' ' 114' ' ' ASP . 0.0 OUTLIER -135.56 151.28 50.15 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.091 -0.504 . . . . 74.22 110.834 -179.909 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . 0.422 ' HG3' ' OD1' ' A' ' 114' ' ' ASP . 0.0 OUTLIER -104.62 139.51 39.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.195 -0.457 . . . . 73.24 110.863 -179.911 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . 0.437 HG13 HG12 ' A' ' 138' ' ' ILE . 1.2 mt -77.25 132.45 32.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.17 -0.468 . . . . 61.11 111.172 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 7.7 p -118.21 155.73 20.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.189 -0.46 . . . . 73.04 111.103 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.14 -0.482 . . . . 75.04 110.88 -179.989 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.304 0 N-CA-C 112.466 -0.254 . . . . 72.24 112.466 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.479 ' HA ' ' O ' ' A' ' 44' ' ' GLY . 5.7 p -82.1 136.03 35.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.886 0.374 . . . . 75.43 111.098 -179.845 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 3.2 tttt -122.24 136.11 54.85 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.178 -0.464 . . . . 75.51 110.899 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.624 ' HB ' ' CD1' ' A' ' 47' ' ' TRP . 15.4 tt -136.84 151.49 27.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.2 -0.454 . . . . 71.24 111.102 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.506 ' HA ' ' O ' ' A' ' 21' ' ' TYR . 17.1 m -132.81 140.07 47.8 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.161 -0.472 . . . . 65.23 111.165 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.55 ' CE1' HD13 ' A' ' 8' ' ' ILE . 1.0 OUTLIER -127.99 127.7 43.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.17 -0.468 . . . . 75.41 110.873 -179.947 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.527 ' CG ' ' HA ' ' A' ' 16' ' ' PHE . 14.1 m-85 -112.72 132.4 55.23 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.202 -0.454 . . . . 74.23 110.91 -179.831 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.423 ' HB2' ' HB2' ' A' ' 19' ' ' ARG . 0.0 OUTLIER -61.04 -14.71 25.3 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.125 -0.489 . . . . 74.22 110.924 179.991 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.431 ' HB2' ' O ' ' A' ' 17' ' ' GLN . 74.4 m-20 -135.93 150.43 49.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.137 -0.483 . . . . 73.15 110.868 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.481 ' N ' ' HB3' ' A' ' 38' ' ' ASN . 40.8 mtmt -55.25 -176.17 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.152 -0.476 . . . . 70.13 110.89 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 16.1 m120 46.43 32.43 1.58 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.227 -0.442 . . . . 71.44 110.939 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.527 ' HA ' ' CG ' ' A' ' 11' ' ' TYR . 3.6 m-85 49.67 64.33 1.81 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.154 -0.476 . . . . 73.34 110.877 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . 0.431 ' O ' ' HB2' ' A' ' 13' ' ' ASP . 9.9 mt-30 -139.32 159.78 41.35 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.145 -0.48 . . . . 74.11 110.891 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 92.35 -148.19 19.03 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.786 -0.721 . . . . 71.43 112.455 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.432 ' O ' ' CD1' ' A' ' 34' ' ' LEU . 0.0 OUTLIER -70.02 77.78 0.49 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.859 0.361 . . . . 74.35 110.834 -179.795 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.448 ' HB2' ' CE1' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -76.87 129.1 35.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.163 -0.471 . . . . 74.5 110.877 -179.956 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.506 ' O ' ' HA ' ' A' ' 9' ' ' THR . 90.7 t80 -123.01 124.39 43.02 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.182 -0.463 . . . . 74.44 110.925 -179.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.462 ' CG ' HG23 ' A' ' 9' ' ' THR . 1.3 m-20 -121.06 133.99 55.26 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.142 -0.481 . . . . 74.31 110.856 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -168.13 135.59 2.17 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.213 -0.449 . . . . 71.13 110.908 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -100.94 -2.6 31.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.193 -0.458 . . . . 74.15 110.871 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.424 ' O ' ' SG ' ' A' ' 27' ' ' CYS . 15.6 t -100.9 165.68 11.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.201 -0.454 . . . . 72.0 110.904 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -59.14 120.26 8.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.2 -0.455 . . . . 74.51 110.855 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.53 ' HB2' ' HB3' ' A' ' 30' ' ' PHE . 1.7 m -115.29 51.0 0.94 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.204 -0.453 . . . . 52.44 110.879 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.489 ' O ' ' HA ' ' A' ' 82' ' ' SER . . . -46.43 -22.16 0.24 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.178 -0.464 . . . . 72.01 111.081 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 55.5 t0 -127.94 42.83 3.25 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.194 -0.457 . . . . 73.15 110.885 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.777 ' O ' ' CD2' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -81.17 15.68 1.83 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.459 . . . . 73.53 110.869 -179.929 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.503 ' HB2' ' HB3' ' A' ' 81' ' ' SER . 29.7 t60 -80.3 -39.26 29.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 74.22 110.889 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.7 t -58.43 -13.8 6.27 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.204 -0.453 . . . . 54.41 111.166 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -100.07 -26.95 13.79 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.236 -0.438 . . . . 74.52 110.947 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.432 ' CD1' ' O ' ' A' ' 19' ' ' ARG . 18.0 tp -142.79 135.11 27.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.144 -0.48 . . . . 65.23 110.93 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 25.3 m -97.63 -42.51 7.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.165 -0.47 . . . . 74.11 110.849 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -118.77 141.83 48.27 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.077 -0.511 . . . . 74.04 110.84 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.55 ' HB3' ' HB2' ' A' ' 80' ' ' LEU . 3.3 p -110.17 84.86 2.0 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.197 -0.456 . . . . 62.11 110.861 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.481 ' HB3' ' N ' ' A' ' 14' ' ' LYS . 0.2 OUTLIER -76.07 -71.1 0.4 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.238 -0.437 . . . . 75.3 110.871 -179.934 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 5.2 p -111.53 124.07 51.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.184 -0.462 . . . . 65.22 110.903 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.618 ' O ' ' HB2' ' A' ' 67' ' ' TYR . 43.0 mt -117.25 149.32 19.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.151 -0.477 . . . . 75.04 111.113 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.483 ' N ' HG23 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -144.67 120.36 10.49 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.126 -0.488 . . . . 70.44 110.93 179.812 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.57 HG22 ' HB2' ' A' ' 47' ' ' TRP . 1.5 t -105.25 116.32 48.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.216 -0.447 . . . . 73.23 111.123 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -111.11 79.22 1.18 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.174 -0.467 . . . . 73.43 110.897 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.479 ' O ' ' HA ' ' A' ' 6' ' ' THR . . . 129.9 104.31 1.08 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.74 -0.743 . . . . 71.14 112.513 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 53.08 175.18 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.681 -0.771 . . . . 63.42 112.526 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.489 HG21 ' HA ' ' A' ' 63' ' ' PRO . 1.0 OUTLIER -76.84 169.03 19.07 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.74 0.305 . . . . 71.34 111.148 -179.856 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . 0.624 ' CD1' ' HB ' ' A' ' 8' ' ' ILE . 3.6 m95 -141.68 130.18 22.58 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.238 -0.437 . . . . 74.22 110.917 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.595 ' O ' ' N ' ' A' ' 84' ' ' ARG . . . -94.16 127.12 39.81 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.212 -0.449 . . . . 64.2 111.066 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.522 HG11 HD12 ' A' ' 80' ' ' LEU . 12.2 m -125.33 131.01 72.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.203 -0.453 . . . . 73.41 111.119 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.75 ' HB3' ' HA ' ' A' ' 56' ' ' ALA . 43.1 m-85 -98.32 147.3 24.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.174 -0.466 . . . . 75.41 110.937 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.644 ' OE1' ' HB3' ' A' ' 57' ' ' TRP . 46.9 tt0 -48.93 -79.68 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.13 -0.487 . . . . 73.02 110.865 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.53 ' HB3' ' CD1' ' A' ' 55' ' ' PHE . 0.0 OUTLIER -92.24 143.82 28.05 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.599 0.714 . . . . 73.03 110.853 -179.856 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.697 ' HA ' ' OG ' ' A' ' 82' ' ' SER . 53.7 Cg_endo -69.73 141.38 45.2 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.694 2.263 . . . . 73.55 112.381 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 63.54 -11.22 0.11 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.261 -0.427 . . . . 74.32 110.85 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.629 ' H ' ' C ' ' A' ' 53' ' ' PRO . 2.6 m-30 -104.45 -21.47 13.46 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.228 -0.442 . . . . 74.33 110.863 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.75 ' HA ' ' HB3' ' A' ' 50' ' ' TYR . . . 51.35 25.85 2.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.116 -0.493 . . . . 72.54 111.108 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . 0.644 ' HB3' ' OE1' ' A' ' 51' ' ' GLU . 0.0 OUTLIER -49.48 -163.1 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.215 -0.448 . . . . 74.1 110.948 179.995 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.638 ' C ' ' O ' ' A' ' 57' ' ' TRP . 6.1 m-30 -13.41 102.6 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.219 -0.446 . . . . 74.22 110.992 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.42 ' HB2' ' O ' ' A' ' 149' ' ' GLN . 2.0 mpt? -67.85 148.26 51.42 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.13 -0.486 . . . . 75.44 110.872 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.425 ' O ' ' O ' ' A' ' 49' ' ' VAL . 3.0 t80 -164.7 108.17 0.89 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.211 -0.449 . . . . 71.43 110.905 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.55 ' N ' ' CD1' ' A' ' 61' ' ' ILE . 1.4 mp -93.67 116.88 35.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.131 -0.486 . . . . 75.13 111.089 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -83.95 127.96 64.95 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.559 0.695 . . . . 74.35 110.901 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.489 ' HA ' HG21 ' A' ' 46' ' ' THR . 53.6 Cg_endo -69.76 -172.85 0.62 Allowed 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.652 2.235 . . . . 75.42 112.344 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.35 161.79 16.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.225 -0.443 . . . . 73.45 110.864 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 112.83 -165.61 12.06 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.702 -0.761 . . . . 44.44 112.459 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -109.93 154.36 23.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.901 0.382 . . . . 74.0 110.881 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.618 ' HB2' ' O ' ' A' ' 40' ' ' ILE . 10.7 m-85 -143.88 83.75 10.19 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.699 0.762 . . . . 71.41 110.944 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.477 ' HD2' ' HG3' ' A' ' 72' ' ' ARG . 53.8 Cg_endo -69.74 0.79 5.11 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.709 2.272 . . . . 73.44 112.344 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.518 ' HB2' ' HG2' ' A' ' 72' ' ' ARG . 41.3 mt-10 -155.88 144.11 19.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.457 . . . . 64.0 110.929 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.714 ' HA ' ' NE1' ' A' ' 73' ' ' TRP . 32.3 p90 -55.92 -21.65 21.67 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.172 -0.467 . . . . 72.53 110.883 -179.813 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -79.78 -16.47 55.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.144 -0.48 . . . . 74.04 110.921 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.518 ' HG2' ' HB2' ' A' ' 69' ' ' GLU . 28.1 mmt180 -69.47 -9.17 52.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.161 -0.472 . . . . 74.43 110.848 -179.895 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . 0.72 ' N ' ' CD1' ' A' ' 73' ' ' TRP . 0.0 OUTLIER -134.49 16.52 3.68 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.197 -0.456 . . . . 75.24 110.911 -179.966 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' MET . . . . . 0.406 ' C ' ' O ' ' A' ' 73' ' ' TRP . 0.0 OUTLIER 37.75 42.91 0.43 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.284 -0.416 . . . . 73.31 110.866 179.911 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -58.03 120.59 22.46 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.753 -0.737 . . . . 72.5 112.515 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.58 HD22 ' HB2' ' A' ' 77' ' ' ASN . 0.0 OUTLIER -70.05 -10.7 59.56 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.787 0.327 . . . . 71.54 110.872 -179.898 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.58 ' HB2' HD22 ' A' ' 76' ' ' LEU . 30.2 t-20 -156.36 131.24 9.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.199 -0.455 . . . . 73.53 110.904 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -83.95 23.06 1.06 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.186 -0.461 . . . . 63.22 110.868 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -109.92 78.47 1.13 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.195 -0.457 . . . . 75.43 110.891 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.55 ' HB2' ' HB3' ' A' ' 37' ' ' CYS . 0.0 OUTLIER -85.77 133.51 33.99 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.167 -0.47 . . . . 74.12 110.929 -179.999 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.589 ' HB3' ' HB3' ' A' ' 53' ' ' PRO . 0.9 OUTLIER -150.03 -125.04 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.184 -0.462 . . . . 65.2 110.912 -179.947 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.697 ' OG ' ' HA ' ' A' ' 53' ' ' PRO . 0.0 OUTLIER -35.03 103.81 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.12 -0.491 . . . . 65.44 110.832 -179.833 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . 0.502 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 19.8 p -121.88 134.45 54.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.152 -0.476 . . . . 74.31 110.854 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . 0.595 ' N ' ' O ' ' A' ' 48' ' ' ALA . 11.6 mmt85 -120.4 139.51 52.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.184 -0.462 . . . . 74.52 110.871 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.431 ' N ' ' CZ3' ' A' ' 47' ' ' TRP . . . -58.15 129.17 40.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 73.51 111.111 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.499 HG13 ' CG1' ' A' ' 136' ' ' VAL . 55.5 t -113.23 133.74 58.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.194 -0.457 . . . . 64.22 111.093 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . 0.454 ' O ' ' C ' ' A' ' 88' ' ' LEU . 23.1 m80 -114.43 111.21 21.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.113 -0.494 . . . . 75.14 110.827 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.454 ' C ' ' O ' ' A' ' 87' ' ' HIS . 0.0 OUTLIER -33.39 140.13 0.24 Allowed Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.564 0.697 . . . . 74.1 110.937 -179.986 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.56 ' HB3' ' H ' ' A' ' 136' ' ' VAL . 53.7 Cg_endo -69.79 105.13 1.44 Allowed 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.718 2.278 . . . . 74.14 112.331 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -106.16 -177.97 3.52 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.201 -0.454 . . . . 74.31 110.833 -179.815 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 45.45 63.22 2.82 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.74 -0.743 . . . . 45.23 112.476 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.41 ' O ' ' C ' ' A' ' 93' ' ' GLN . . . 123.82 20.65 2.53 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.716 -0.754 . . . . 74.44 112.493 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.456 ' O ' ' HG2' ' A' ' 134' ' ' GLU . 2.0 pt20 37.47 -120.67 0.2 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.839 0.352 . . . . 73.12 110.901 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.481 ' O ' ' HA ' ' A' ' 112' ' ' THR . 0.0 OUTLIER -124.87 100.78 6.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.19 -0.459 . . . . 73.35 110.945 -179.86 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.415 ' H ' ' HG2' ' A' ' 134' ' ' GLU . 31.3 tptt -110.69 126.53 54.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.173 -0.467 . . . . 73.3 110.929 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 8.0 tt -147.54 136.17 15.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.198 -0.456 . . . . 74.43 111.108 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.413 ' HB2' ' O ' ' A' ' 131' ' ' LYS . 1.2 mt-30 -107.82 131.56 54.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.203 -0.453 . . . . 74.12 110.925 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 13.1 pt -111.41 136.79 46.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.192 -0.458 . . . . 71.3 111.117 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.568 ' HB2' ' CB ' ' A' ' 129' ' ' SER . 62.4 m-85 -124.82 136.9 54.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.196 -0.456 . . . . 72.31 110.895 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -68.95 -58.3 4.31 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.099 -0.501 . . . . 73.11 110.905 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 21.0 mttt -101.59 149.46 24.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.126 -0.488 . . . . 75.23 110.942 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -57.8 163.72 7.94 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.755 -0.736 . . . . 74.12 112.469 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.505 ' HA ' ' HB2' ' A' ' 158' ' ' ARG . 42.1 t0 64.13 29.0 14.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.853 0.359 . . . . 71.44 110.912 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.666 ' CZ ' ' HB3' ' A' ' 158' ' ' ARG . 5.1 m-85 57.51 46.07 18.48 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.174 -0.466 . . . . 75.01 110.888 -179.873 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 2.3 m -114.08 158.02 21.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.181 -0.463 . . . . 72.2 110.871 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 86.88 -137.09 14.52 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.711 -0.756 . . . . 53.51 112.488 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 38.1 tp60 -90.39 126.6 35.93 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.812 0.339 . . . . 75.51 110.934 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' MET . . . . . 0.444 ' HB2' ' CE1' ' A' ' 99' ' ' PHE . 19.1 ttp -113.17 146.3 39.49 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.215 -0.448 . . . . 73.34 110.875 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -152.6 137.19 16.87 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.192 -0.458 . . . . 74.53 110.95 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -119.31 113.8 21.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.161 -0.472 . . . . 74.21 110.905 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 14.6 t -124.24 145.9 49.07 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.163 -0.471 . . . . 75.24 111.108 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.481 ' HA ' ' O ' ' A' ' 94' ' ' TYR . 1.5 t -122.92 41.64 3.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.205 -0.452 . . . . 65.0 111.129 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -150.59 -172.74 4.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.262 -0.426 . . . . 72.23 110.888 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -84.39 164.57 18.83 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.159 -0.473 . . . . 74.2 110.836 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 8.2 t -157.89 129.14 3.77 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.64 0.733 . . . . 74.42 110.914 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.701 ' O ' ' HB2' ' A' ' 172' ' ' SER . 53.9 Cg_endo -69.75 -44.15 2.25 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.718 2.279 . . . . 73.21 112.384 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' SER . . . . . 0.62 ' HB3' ' CB ' ' A' ' 120' ' ' GLU . 0.1 OUTLIER -138.8 102.78 4.65 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.172 -0.467 . . . . 74.33 110.874 -179.859 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.602 ' HB ' ' O ' ' A' ' 171' ' ' GLN . 3.0 tt -51.13 -30.08 9.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.101 -0.5 . . . . 75.4 111.144 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' MET . . . . . 0.561 ' O ' ' HA ' ' A' ' 123' ' ' HIS . 3.6 ttt -85.32 -46.19 11.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.159 -0.473 . . . . 72.55 110.867 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.62 ' CB ' ' HB3' ' A' ' 117' ' ' SER . 14.1 tp10 -63.42 -13.6 41.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.183 -0.462 . . . . 73.51 110.866 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 26.3 tp60 -114.7 -52.91 2.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.156 -0.475 . . . . 72.34 110.931 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . 0.5 ' HB2' ' O ' ' A' ' 118' ' ' ILE . 86.7 m-85 -99.33 -22.44 15.58 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.456 . . . . 74.43 110.864 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . 0.561 ' HA ' ' O ' ' A' ' 119' ' ' MET . 0.5 OUTLIER 76.67 24.6 0.96 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.176 -0.466 . . . . 70.25 110.87 179.984 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.469 ' O ' ' CG2' ' A' ' 118' ' ' ILE . 9.4 mtt -103.38 81.79 1.97 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.186 -0.461 . . . . 74.42 110.865 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 2.1 ptp85 -46.82 -40.99 14.8 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.251 -0.431 . . . . 74.42 110.854 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.491 ' HB3' ' HG2' ' A' ' 168' ' ' PRO . 32.7 mt-10 -142.67 130.43 21.54 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.162 -0.472 . . . . 74.22 110.9 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.427 ' O ' ' HB3' ' A' ' 168' ' ' PRO . 1.3 mp -87.69 97.1 6.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.219 -0.446 . . . . 63.52 111.13 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . 0.443 ' HA ' ' HB3' ' A' ' 160' ' ' PRO . 16.8 m170 -69.67 -25.99 64.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.218 -0.446 . . . . 74.54 110.908 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 0.568 ' CB ' ' HB2' ' A' ' 99' ' ' PHE . 0.0 OUTLIER -136.68 139.02 41.67 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.158 -0.474 . . . . 75.25 110.828 -179.788 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . 0.598 ' O ' ' O ' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -138.17 119.52 14.76 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.108 -0.497 . . . . 74.23 110.846 -179.975 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.631 ' HA ' ' HA ' ' A' ' 156' ' ' GLU . 4.4 mtpp -113.08 152.31 29.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.15 -0.477 . . . . 64.41 110.897 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.476 ' CB ' ' O ' ' A' ' 131' ' ' LYS . 10.8 t 84.15 163.58 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.183 -0.462 . . . . 74.43 111.13 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.419 ' HB3' ' HA ' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -177.45 124.58 0.13 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.198 -0.456 . . . . 71.4 110.973 179.943 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.542 ' O ' ' C ' ' A' ' 135' ' ' GLY . 0.2 OUTLIER -99.58 167.09 10.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.165 -0.471 . . . . 75.13 110.887 179.965 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . 0.542 ' C ' ' O ' ' A' ' 134' ' ' GLU . . . -24.93 -74.03 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.698 -0.763 . . . . 72.44 112.528 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.727 ' HA ' HD13 ' A' ' 152' ' ' LEU . 3.1 t -135.01 147.97 29.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.84 0.353 . . . . 72.13 111.127 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' TRP . . . . . 0.549 ' H ' ' CD1' ' A' ' 152' ' ' LEU . 0.0 OUTLIER -152.03 162.41 41.13 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.202 -0.454 . . . . 71.33 110.929 179.977 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.486 HD12 ' HB ' ' A' ' 61' ' ' ILE . 19.4 mt -135.15 137.69 49.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.234 -0.439 . . . . 74.04 111.1 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -110.93 146.12 37.14 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.154 -0.475 . . . . 72.45 110.892 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . 0.704 ' CE2' ' HA ' ' A' ' 145' ' ' TYR . 0.6 OUTLIER -107.08 131.14 54.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.13 -0.486 . . . . 72.25 110.912 -179.831 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . 0.596 ' O ' ' NE2' ' A' ' 171' ' ' GLN . 7.5 tt0 -70.66 -27.3 63.93 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.086 -0.507 . . . . 73.22 110.9 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.582 ' O ' ' HB3' ' A' ' 172' ' ' SER . 5.8 mp -113.37 147.15 36.82 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.58 0.705 . . . . 73.43 110.931 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . 0.683 ' CD ' ' HG2' ' A' ' 171' ' ' GLN . 53.9 Cg_endo -69.7 43.68 0.38 Allowed 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.694 2.262 . . . . 74.05 112.349 179.834 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . 1.093 ' O ' ' N ' ' A' ' 146' ' ' ARG . 0.4 OUTLIER 177.87 111.49 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.209 -0.45 . . . . 71.42 110.888 179.96 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . 0.704 ' HA ' ' CE2' ' A' ' 140' ' ' TYR . 0.1 OUTLIER -6.59 52.18 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.156 -0.475 . . . . 73.15 110.876 -179.892 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . 1.093 ' N ' ' O ' ' A' ' 144' ' ' ASN . 40.7 mtt180 -140.16 170.52 15.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.121 -0.49 . . . . 73.43 110.885 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 81.0 -167.61 49.92 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.706 -0.759 . . . . 61.13 112.464 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.401 ' HG2' ' CD1' ' A' ' 58' ' ' TYR . 0.5 OUTLIER -88.58 142.98 27.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.778 0.323 . . . . 74.0 110.901 -179.935 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' GLN . . . . . 0.42 ' O ' ' HB2' ' A' ' 59' ' ' MET . 74.0 mt-30 -84.07 162.83 20.2 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.157 -0.474 . . . . 74.12 110.931 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -134.96 116.73 15.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.238 -0.437 . . . . 74.3 110.985 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.427 ' CA ' HD12 ' A' ' 61' ' ' ILE . 9.9 tp -68.6 119.09 12.48 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.129 -0.487 . . . . 74.25 110.877 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.727 HD13 ' HA ' ' A' ' 136' ' ' VAL . 0.0 OUTLIER -51.4 135.45 27.22 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.18 -0.464 . . . . 72.44 110.903 179.899 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -163.37 24.84 0.08 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.177 -0.465 . . . . 75.43 110.848 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.778 ' HB2' ' CD1' ' A' ' 157' ' ' TYR . 0.0 OUTLIER -115.47 -173.54 2.35 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.252 -0.431 . . . . 74.12 110.913 -179.996 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.747 ' HD2' ' C ' ' A' ' 154' ' ' LYS . 0.8 OUTLIER -161.48 -124.56 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.264 -0.425 . . . . 73.33 110.904 179.907 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . 0.631 ' HA ' ' HA ' ' A' ' 131' ' ' LYS . 1.7 tm-20 -70.43 2.74 3.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 74.22 110.876 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . 0.778 ' CD1' ' HB2' ' A' ' 154' ' ' LYS . 18.4 m-30 -32.79 147.04 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.167 -0.469 . . . . 72.14 110.904 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . 0.666 ' HB3' ' CZ ' ' A' ' 104' ' ' PHE . 8.2 ptp180 -113.5 -37.45 4.63 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.097 -0.501 . . . . 73.3 110.844 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -89.01 152.54 48.44 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.576 0.703 . . . . 63.44 110.869 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . 0.521 ' HB3' ' HB3' ' A' ' 168' ' ' PRO . 54.3 Cg_endo -69.74 -29.29 24.2 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.658 2.239 . . . . 71.11 112.369 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.516 HD11 ' H ' ' A' ' 161' ' ' ILE . 4.3 mp -66.37 -10.5 11.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.216 -0.447 . . . . 74.32 111.161 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . 0.677 ' HB3' ' CD1' ' A' ' 157' ' ' TYR . 0.5 OUTLIER -77.0 -13.94 59.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.143 -0.481 . . . . 74.04 110.853 179.848 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 26.3 t90 -87.95 -7.68 56.78 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.245 -0.434 . . . . 74.12 110.921 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 99.3 -36.82 3.81 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.755 -0.736 . . . . 63.2 112.454 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -76.88 126.7 31.42 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.8 0.333 . . . . 72.23 111.149 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -37.27 -42.83 0.49 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.229 -0.441 . . . . 62.3 111.053 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' SER . . . . . 0.528 ' C ' ' H ' ' A' ' 169' ' ' ALA . 0.5 OUTLIER -127.64 152.34 76.65 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.68 0.752 . . . . 71.45 110.835 -179.786 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . 0.521 ' HB3' ' HB3' ' A' ' 160' ' ' PRO . 53.7 Cg_endo -69.76 27.97 0.18 Allowed 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.689 2.259 . . . . 71.4 112.379 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . 0.528 ' H ' ' C ' ' A' ' 167' ' ' SER . . . -67.6 99.98 0.83 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.215 -0.448 . . . . 55.32 111.149 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.475 ' HA ' ' NE2' ' A' ' 171' ' ' GLN . 1.4 t -155.41 173.62 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.195 -0.457 . . . . 63.53 111.108 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' GLN . . . . . 0.683 ' HG2' ' CD ' ' A' ' 143' ' ' PRO . 0.0 OUTLIER -159.17 -97.55 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.165 -0.47 . . . . 75.43 110.91 -179.998 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' SER . . . . . 0.701 ' HB2' ' O ' ' A' ' 116' ' ' PRO . 0.0 OUTLIER -64.62 153.77 38.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.23 -0.441 . . . . 61.53 110.851 -179.791 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 1.2 p90 -151.96 158.21 42.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.146 -0.479 . . . . 73.33 110.888 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . 0.455 ' HG2' ' CE2' ' A' ' 140' ' ' TYR . 1.3 ptp180 -130.22 142.39 50.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.17 -0.468 . . . . 73.44 110.935 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . 0.435 ' HD2' ' CE2' ' A' ' 94' ' ' TYR . 0.0 OUTLIER -98.19 -169.21 1.77 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.21 -0.45 . . . . 74.41 110.902 -179.882 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . 0.466 HD11 ' C ' ' A' ' 136' ' ' VAL . 4.1 mt -139.05 132.03 38.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.222 -0.444 . . . . 72.44 111.17 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 4.8 p -144.62 155.83 14.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.208 -0.451 . . . . 75.34 111.085 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.125 -0.488 . . . . 72.04 110.933 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.287 0 N-CA-C 112.475 -0.25 . . . . 73.2 112.475 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.441 ' HA ' ' O ' ' A' ' 44' ' ' GLY . 10.9 p -82.33 136.11 35.07 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.898 0.38 . . . . 75.32 111.122 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.434 ' N ' ' HE1' ' A' ' 47' ' ' TRP . 2.6 tttt -127.91 138.12 52.54 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.203 -0.453 . . . . 74.41 110.852 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.547 HD13 ' CE1' ' A' ' 10' ' ' PHE . 16.0 tt -136.68 150.89 27.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.165 -0.47 . . . . 74.34 111.084 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.404 ' CG2' ' CE2' ' A' ' 11' ' ' TYR . 9.3 m -132.55 140.94 48.51 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.159 -0.473 . . . . 64.1 111.111 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.547 ' CE1' HD13 ' A' ' 8' ' ' ILE . 1.6 m-85 -129.2 131.68 47.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.228 -0.442 . . . . 75.44 110.924 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.528 ' CG ' ' HA ' ' A' ' 16' ' ' PHE . 6.2 m-85 -117.41 134.09 55.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.142 -0.481 . . . . 74.35 110.915 -179.825 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.419 ' HA ' ' O ' ' A' ' 36' ' ' ARG . 0.0 OUTLIER -56.83 -28.56 61.74 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.129 -0.487 . . . . 72.5 110.848 -179.968 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 49.4 m-20 -123.29 155.42 37.26 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.201 -0.454 . . . . 61.22 110.855 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 7.9 mtmm -57.41 -173.35 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 72.54 110.884 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 23.3 m-20 44.34 34.76 1.11 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.2 -0.454 . . . . 75.25 110.851 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.528 ' HA ' ' CG ' ' A' ' 11' ' ' TYR . 2.6 m-85 47.7 59.8 3.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.227 -0.442 . . . . 75.33 110.878 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 10.6 mt-30 -133.23 154.14 50.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.172 -0.467 . . . . 73.32 110.918 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 95.67 -154.43 20.96 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.768 -0.73 . . . . 44.13 112.446 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.426 ' O ' ' CD1' ' A' ' 34' ' ' LEU . 0.6 OUTLIER -63.65 81.7 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.857 0.361 . . . . 75.12 110.86 -179.838 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.495 ' HB2' ' CE1' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -81.05 127.52 32.69 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.193 -0.458 . . . . 75.55 110.859 -179.918 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.449 ' CZ ' ' CD1' ' A' ' 33' ' ' TYR . 82.8 t80 -124.23 125.71 44.86 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.217 -0.447 . . . . 72.31 110.903 -179.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -111.25 131.45 55.13 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.11 -0.495 . . . . 74.23 110.876 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -142.58 143.12 32.31 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.19 -0.459 . . . . 74.41 110.856 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -125.64 5.09 7.5 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.191 -0.459 . . . . 74.23 110.894 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 50.6 t -129.71 159.19 37.25 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.137 -0.483 . . . . 64.25 110.91 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -42.87 108.48 0.1 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.177 -0.465 . . . . 64.22 110.878 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.598 ' HB3' ' HB3' ' A' ' 30' ' ' PHE . 0.1 OUTLIER -119.8 51.38 1.18 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.202 -0.453 . . . . 64.55 110.887 -179.92 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.539 ' C ' ' HA ' ' A' ' 82' ' ' SER . . . -50.61 -14.61 0.2 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.209 -0.451 . . . . 65.53 111.08 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 63.6 t0 -127.3 42.21 3.37 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.227 -0.442 . . . . 64.51 110.88 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.819 ' O ' ' CD2' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -82.28 14.34 3.0 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.192 -0.458 . . . . 73.44 110.849 -179.885 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.494 ' HB2' ' HB3' ' A' ' 53' ' ' PRO . 31.3 t60 -76.8 -44.4 32.82 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.158 -0.474 . . . . 65.42 110.854 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.405 HG21 ' CD2' ' A' ' 33' ' ' TYR . 9.7 t -54.7 -13.57 1.06 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.156 -0.475 . . . . 73.52 111.147 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.486 ' CD1' ' HA ' ' A' ' 30' ' ' PHE . 12.3 m-85 -97.27 -29.65 13.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.224 -0.444 . . . . 71.3 110.91 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.435 ' O ' ' O ' ' A' ' 31' ' ' HIS . 31.7 tp -137.85 140.35 40.41 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.101 -0.5 . . . . 72.55 110.907 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 2.6 m -104.16 -38.71 6.8 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.155 -0.475 . . . . 70.42 110.861 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.419 ' O ' ' HA ' ' A' ' 12' ' ' GLU . 0.2 OUTLIER -111.18 140.85 45.4 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.172 -0.467 . . . . 75.11 110.839 -179.928 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.471 ' SG ' ' CB ' ' A' ' 80' ' ' LEU . 2.0 m -122.46 76.35 1.32 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.157 -0.474 . . . . 71.54 110.871 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -80.15 -71.11 0.47 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.142 -0.481 . . . . 73.1 110.842 -179.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 4.8 p -104.52 134.54 47.53 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.157 -0.474 . . . . 73.15 110.869 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.634 ' O ' ' HB2' ' A' ' 67' ' ' TYR . 19.4 mt -126.86 151.69 33.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.124 -0.489 . . . . 73.41 111.147 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.456 ' HD2' ' CE2' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -146.59 122.12 10.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.201 -0.454 . . . . 75.33 110.856 179.894 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.48 ' HA ' ' HA ' ' A' ' 8' ' ' ILE . 1.4 t -108.41 114.63 47.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.259 -0.428 . . . . 74.3 111.134 179.824 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.407 ' N ' ' O ' ' A' ' 7' ' ' LYS . 1.5 mm-40 -109.79 79.06 1.17 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.193 -0.458 . . . . 72.41 110.827 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.441 ' O ' ' HA ' ' A' ' 6' ' ' THR . . . 134.2 102.72 0.76 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.794 -0.717 . . . . 55.01 112.524 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 52.21 -178.26 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.723 -0.751 . . . . 72.23 112.471 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.496 HG21 ' HA ' ' A' ' 63' ' ' PRO . 0.6 OUTLIER -81.57 172.19 13.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.809 0.338 . . . . 74.11 111.117 -179.846 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . 0.467 ' CD1' ' HB ' ' A' ' 8' ' ' ILE . 13.2 m95 -142.59 130.04 21.23 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.214 -0.448 . . . . 70.31 110.898 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.509 ' CB ' ' CG2' ' A' ' 86' ' ' VAL . . . -97.39 108.89 21.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.234 -0.439 . . . . 71.43 111.109 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.522 ' HA ' ' HA ' ' A' ' 83' ' ' CYS . 4.2 m -111.45 130.96 64.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.215 -0.448 . . . . 73.14 111.13 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.641 ' HB3' ' HA ' ' A' ' 56' ' ' ALA . 56.6 m-85 -93.88 148.56 22.02 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.177 -0.465 . . . . 75.14 110.947 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.639 ' OE1' ' HB3' ' A' ' 57' ' ' TRP . 39.1 tt0 -45.38 -78.22 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.103 -0.499 . . . . 63.5 110.892 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.634 ' HB3' ' CD2' ' A' ' 55' ' ' PHE . 0.2 OUTLIER -90.78 144.77 30.81 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.574 0.702 . . . . 74.24 110.906 -179.924 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.7 ' HA ' ' OG ' ' A' ' 82' ' ' SER . 54.0 Cg_endo -69.79 131.38 21.08 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.688 2.259 . . . . 74.3 112.35 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 67.8 -8.2 0.54 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.218 -0.446 . . . . 72.3 110.891 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.634 ' CD2' ' HB3' ' A' ' 52' ' ' ARG . 6.2 m-30 -98.43 -27.73 13.94 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.181 -0.463 . . . . 73.14 110.884 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.641 ' HA ' ' HB3' ' A' ' 50' ' ' TYR . . . 62.79 16.42 9.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.173 -0.467 . . . . 64.32 111.153 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . 0.646 ' O ' ' C ' ' A' ' 58' ' ' TYR . 0.1 OUTLIER -49.02 -167.94 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.176 -0.465 . . . . 73.53 110.923 -179.958 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.646 ' C ' ' O ' ' A' ' 57' ' ' TRP . 8.1 m-30 -13.06 103.08 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.217 -0.447 . . . . 72.34 110.908 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.422 ' HB2' ' O ' ' A' ' 149' ' ' GLN . 1.9 mpt? -68.54 148.66 50.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.148 -0.478 . . . . 73.42 110.844 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.449 ' O ' ' O ' ' A' ' 49' ' ' VAL . 3.3 t80 -163.66 108.77 1.05 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.232 -0.44 . . . . 72.44 110.943 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.543 ' N ' ' CD1' ' A' ' 61' ' ' ILE . 1.5 mp -95.02 116.13 35.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.081 -0.508 . . . . 74.1 111.121 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -84.07 128.78 61.23 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.611 0.719 . . . . 75.41 110.932 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.496 ' HA ' HG21 ' A' ' 46' ' ' THR . 53.8 Cg_endo -69.74 -172.74 0.61 Allowed 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.705 2.27 . . . . 74.24 112.368 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -88.12 161.96 17.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.246 -0.434 . . . . 75.25 110.877 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 112.2 -167.94 12.55 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.719 -0.753 . . . . 42.11 112.457 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -108.05 156.44 19.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.855 0.359 . . . . 73.33 110.862 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.634 ' HB2' ' O ' ' A' ' 40' ' ' ILE . 15.7 m-85 -144.19 84.39 9.5 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.684 0.754 . . . . 74.13 110.904 -179.869 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.453 ' HD2' ' HG3' ' A' ' 72' ' ' ARG . 53.2 Cg_endo -69.83 2.83 3.21 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.7 2.267 . . . . 73.4 112.344 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.582 ' HB2' ' HG2' ' A' ' 72' ' ' ARG . 52.6 mt-10 -157.38 143.45 17.7 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.199 -0.455 . . . . 75.32 110.889 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.731 ' HA ' ' NE1' ' A' ' 73' ' ' TRP . 30.6 p90 -55.35 -21.39 14.99 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.161 -0.472 . . . . 52.33 110.916 -179.86 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -81.25 -17.15 50.48 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.099 -0.501 . . . . 74.02 110.876 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.582 ' HG2' ' HB2' ' A' ' 69' ' ' GLU . 33.0 mmt180 -68.32 -10.61 56.06 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.233 -0.439 . . . . 74.35 110.853 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . 0.731 ' NE1' ' HA ' ' A' ' 70' ' ' TYR . 0.0 OUTLIER -133.13 17.7 4.1 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.182 -0.463 . . . . 74.43 110.869 -179.953 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 40.56 37.45 0.47 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.275 -0.42 . . . . 73.33 110.868 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -52.06 114.22 3.08 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.738 -0.744 . . . . 64.4 112.521 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.592 HD12 ' N ' ' A' ' 76' ' ' LEU . 0.0 OUTLIER -63.82 -16.7 61.93 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.781 0.324 . . . . 74.32 110.87 -179.889 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.523 ' HB2' HD21 ' A' ' 76' ' ' LEU . 57.8 t-20 -157.87 130.53 7.32 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.194 -0.457 . . . . 75.14 110.936 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -77.5 9.17 3.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.174 -0.466 . . . . 62.15 110.879 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.419 ' HG2' ' O ' ' A' ' 79' ' ' ARG . 24.1 ttt85 -88.9 38.38 0.88 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.205 -0.452 . . . . 71.34 110.889 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.471 ' CB ' ' SG ' ' A' ' 37' ' ' CYS . 0.1 OUTLIER -56.7 126.84 28.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.143 -0.481 . . . . 74.34 110.87 -179.931 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.641 ' HB3' ' HB3' ' A' ' 53' ' ' PRO . 4.4 m -142.8 -117.55 0.1 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.191 -0.459 . . . . 73.34 110.889 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.7 ' OG ' ' HA ' ' A' ' 53' ' ' PRO . 0.4 OUTLIER -30.38 130.36 0.1 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.127 -0.488 . . . . 75.4 110.844 -179.848 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . 0.522 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 11.0 p -138.74 144.43 39.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.176 -0.466 . . . . 75.43 110.855 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . 0.508 ' N ' ' O ' ' A' ' 48' ' ' ALA . 0.6 OUTLIER -141.31 128.17 20.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.165 -0.47 . . . . 74.23 110.905 -179.865 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.429 ' N ' ' CZ3' ' A' ' 47' ' ' TRP . . . -49.64 126.89 14.61 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.24 -0.437 . . . . 51.32 111.126 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.509 ' CG2' ' CB ' ' A' ' 48' ' ' ALA . 48.4 t -114.17 132.9 61.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.214 -0.448 . . . . 75.04 111.126 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . 0.431 ' O ' ' CG2' ' A' ' 136' ' ' VAL . 20.3 m-70 -108.15 105.18 14.8 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.16 -0.473 . . . . 75.32 110.872 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.426 ' C ' ' O ' ' A' ' 87' ' ' HIS . 0.0 OUTLIER -35.55 144.29 0.24 Allowed Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.566 0.698 . . . . 72.31 110.931 179.993 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.507 ' HA ' ' HA3' ' A' ' 135' ' ' GLY . 54.1 Cg_endo -69.76 87.67 0.55 Allowed 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.684 2.256 . . . . 74.43 112.323 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -105.92 -177.57 3.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.265 -0.425 . . . . 51.52 110.846 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 60.88 23.94 61.96 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.74 -0.743 . . . . 73.33 112.5 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.413 ' O ' ' C ' ' A' ' 93' ' ' GLN . . . 153.24 34.33 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.735 -0.745 . . . . 44.41 112.452 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.492 ' O ' ' CG ' ' A' ' 134' ' ' GLU . 23.6 pt20 36.37 -135.07 0.05 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.811 0.339 . . . . 63.01 110.916 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.48 ' O ' ' HA ' ' A' ' 112' ' ' THR . 13.9 t80 -119.71 106.8 12.49 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.184 -0.462 . . . . 70.35 110.907 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.44 ' H ' ' HG2' ' A' ' 134' ' ' GLU . 36.3 tptt -108.65 128.69 55.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.107 -0.497 . . . . 75.52 110.922 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 6.8 tt -148.39 144.17 18.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.231 -0.44 . . . . 73.3 111.116 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.578 ' O ' ' HA ' ' A' ' 130' ' ' CYS . 1.3 mt-30 -115.97 111.57 20.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.153 -0.476 . . . . 74.53 110.897 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 2.7 mm -86.49 140.97 15.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.222 -0.445 . . . . 75.42 111.11 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.573 ' HB2' ' HB2' ' A' ' 129' ' ' SER . 57.4 m-85 -130.91 133.16 45.6 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.201 -0.454 . . . . 73.54 110.878 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 60.6 tt0 -61.4 -80.14 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.189 -0.459 . . . . 74.43 110.878 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 12.2 mttt -85.51 162.44 18.92 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.145 -0.479 . . . . 71.41 110.898 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -67.86 162.28 48.55 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.691 -0.766 . . . . 62.45 112.512 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.5 ' HA ' ' HB2' ' A' ' 158' ' ' ARG . 36.5 t70 64.46 27.16 13.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.861 0.362 . . . . 75.15 110.876 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.525 ' CZ ' ' HB3' ' A' ' 158' ' ' ARG . 8.8 m-85 59.57 48.14 9.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.153 -0.476 . . . . 74.53 110.915 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 2.9 m -113.45 143.92 43.68 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.148 -0.478 . . . . 75.32 110.85 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 96.41 -124.15 7.98 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.74 -0.743 . . . . 74.14 112.447 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 4.9 tp-100 -102.77 143.62 32.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.799 0.333 . . . . 74.25 110.841 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 2.9 ttp -130.33 146.43 51.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.182 -0.463 . . . . 74.31 110.84 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 11.8 m-85 -148.13 137.5 22.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.174 -0.466 . . . . 75.23 110.925 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -118.63 101.24 7.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.121 -0.49 . . . . 75.3 110.88 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 8.1 t -118.24 153.21 34.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 73.05 111.177 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.48 ' HA ' ' O ' ' A' ' 94' ' ' TYR . 1.4 t -125.45 47.25 2.22 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.223 -0.444 . . . . 72.31 111.116 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 75.0 mm-40 -148.32 -175.2 4.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.264 -0.426 . . . . 72.35 110.863 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -101.94 150.96 22.67 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.134 -0.485 . . . . 71.05 110.884 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 11.1 m -143.03 136.83 14.37 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.638 0.732 . . . . 74.21 110.857 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.746 ' O ' ' HB2' ' A' ' 172' ' ' SER . 53.9 Cg_endo -69.72 -34.34 14.9 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.752 2.301 . . . . 73.23 112.354 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' SER . . . . . 0.618 ' HB3' ' CB ' ' A' ' 120' ' ' GLU . 0.1 OUTLIER -140.79 97.96 3.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.178 -0.464 . . . . 74.11 110.839 -179.831 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.523 ' HB ' ' O ' ' A' ' 171' ' ' GLN . 5.0 tt -49.54 -28.33 3.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.146 -0.479 . . . . 71.21 111.132 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' MET . . . . . 0.569 ' O ' ' HA ' ' A' ' 123' ' ' HIS . 7.2 ttt -84.71 -42.61 15.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.157 -0.474 . . . . 73.42 110.89 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.618 ' CB ' ' HB3' ' A' ' 117' ' ' SER . 24.3 tp10 -62.5 -13.22 28.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.218 -0.446 . . . . 63.22 110.907 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.92 -52.93 2.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.152 -0.476 . . . . 73.31 110.931 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 12.0 m-30 -101.93 -18.93 15.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.205 -0.452 . . . . 74.13 110.885 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . 0.569 ' HA ' ' O ' ' A' ' 119' ' ' MET . 10.7 m80 74.5 24.62 1.74 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.136 -0.484 . . . . 74.11 110.86 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.411 ' O ' ' CG2' ' A' ' 118' ' ' ILE . 8.6 mtt -100.39 83.31 2.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.223 -0.444 . . . . 75.32 110.921 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 3.6 ptp180 -49.5 -33.05 13.5 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.186 -0.461 . . . . 75.32 110.888 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.525 ' HB3' ' HG2' ' A' ' 168' ' ' PRO . 16.0 mt-10 -145.44 129.23 17.26 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.122 -0.49 . . . . 75.43 110.886 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.443 ' O ' ' HB3' ' A' ' 168' ' ' PRO . 3.0 mm -87.33 91.13 3.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.147 -0.479 . . . . 73.24 111.122 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 13.7 m170 -61.9 -34.45 76.07 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.187 -0.461 . . . . 74.25 110.865 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 0.573 ' HB2' ' HB2' ' A' ' 99' ' ' PHE . 0.6 OUTLIER -135.05 152.13 51.41 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.224 -0.444 . . . . 74.42 110.887 -179.751 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . 0.597 ' O ' ' O ' ' A' ' 155' ' ' LYS . 0.1 OUTLIER -155.25 121.04 5.07 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.157 -0.474 . . . . 70.13 110.852 -179.94 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.642 ' HA ' ' HA ' ' A' ' 156' ' ' GLU . 8.7 mtpp -108.57 153.85 22.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.191 -0.459 . . . . 74.12 110.88 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.509 ' CB ' ' O ' ' A' ' 131' ' ' LYS . 11.3 t 85.76 164.7 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.197 -0.456 . . . . 73.35 111.14 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.411 ' O ' ' HG ' ' A' ' 133' ' ' LEU . 0.0 OUTLIER -176.93 122.76 0.14 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.189 -0.46 . . . . 73.21 110.921 179.918 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.614 ' O ' ' C ' ' A' ' 135' ' ' GLY . 0.0 OUTLIER -98.75 159.12 15.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.13 -0.486 . . . . 73.02 110.873 179.95 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . 0.614 ' C ' ' O ' ' A' ' 134' ' ' GLU . . . -13.57 -75.63 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.769 -0.729 . . . . 63.44 112.497 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.765 ' HA ' HD13 ' A' ' 152' ' ' LEU . 5.6 t -136.1 148.81 27.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.821 0.343 . . . . 75.54 111.129 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' TRP . . . . . 0.619 ' HB3' ' CB ' ' A' ' 152' ' ' LEU . 22.8 t90 -146.2 148.65 32.74 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.157 -0.474 . . . . 75.21 110.934 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.444 HD12 ' HB ' ' A' ' 61' ' ' ILE . 0.4 OUTLIER -118.05 135.11 59.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.245 -0.434 . . . . 72.32 111.123 179.953 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 0.467 ' CE1' ' HB3' ' A' ' 173' ' ' PHE . 0.1 OUTLIER -110.07 147.51 33.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.173 -0.467 . . . . 74.25 110.863 179.977 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . 0.691 ' HB2' ' O ' ' A' ' 172' ' ' SER . 0.8 OUTLIER -115.32 129.67 56.67 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.18 -0.464 . . . . 75.3 110.898 -179.855 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . 0.625 ' O ' ' NE2' ' A' ' 171' ' ' GLN . 8.1 tt0 -69.34 -28.6 66.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.126 -0.488 . . . . 75.01 110.926 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.777 ' O ' ' HB3' ' A' ' 172' ' ' SER . 5.9 mp -113.41 148.48 39.73 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.629 0.728 . . . . 74.33 110.876 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . 0.668 ' CD ' ' HG2' ' A' ' 171' ' ' GLN . 53.5 Cg_endo -69.74 43.95 0.39 Allowed 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.695 2.263 . . . . 75.04 112.328 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . 1.093 ' O ' ' N ' ' A' ' 146' ' ' ARG . 0.4 OUTLIER 177.47 111.23 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.261 -0.427 . . . . 75.42 110.928 179.996 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . 0.658 ' C ' ' O ' ' A' ' 144' ' ' ASN . 0.2 OUTLIER -6.36 52.37 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.159 -0.473 . . . . 74.12 110.911 -179.895 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . 1.093 ' N ' ' O ' ' A' ' 144' ' ' ASN . 26.9 mtt180 -138.85 167.12 22.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.11 -0.495 . . . . 73.24 110.858 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 83.89 -165.35 41.79 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.692 -0.766 . . . . 64.44 112.5 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -88.07 146.45 25.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.751 0.31 . . . . 73.24 110.912 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' GLN . . . . . 0.422 ' O ' ' HB2' ' A' ' 59' ' ' MET . 28.2 mt-30 -88.59 161.91 16.66 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.239 -0.437 . . . . 75.22 110.903 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . 0.461 ' HB2' ' CB ' ' A' ' 139' ' ' PHE . 85.9 m-85 -135.72 130.87 34.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.162 -0.472 . . . . 74.33 110.932 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.449 ' CA ' HD12 ' A' ' 61' ' ' ILE . 9.2 tp -82.87 120.34 25.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.152 -0.476 . . . . 74.23 110.914 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.847 HD11 ' O ' ' A' ' 152' ' ' LEU . 0.0 OUTLIER -51.62 136.77 26.17 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.208 -0.451 . . . . 75.13 110.888 179.877 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -164.53 24.93 0.06 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.207 -0.451 . . . . 75.52 110.834 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.836 ' HB2' ' CD1' ' A' ' 157' ' ' TYR . 0.0 OUTLIER -119.42 -176.57 3.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.239 -0.437 . . . . 75.34 110.936 179.968 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.69 ' HD2' ' C ' ' A' ' 154' ' ' LYS . 1.1 mptt -159.09 -121.72 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.216 -0.447 . . . . 74.44 110.912 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . 0.642 ' HA ' ' HA ' ' A' ' 131' ' ' LYS . 2.9 tm-20 -68.93 0.09 4.91 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.175 -0.466 . . . . 75.03 110.881 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . 0.836 ' CD1' ' HB2' ' A' ' 154' ' ' LYS . 16.5 m-30 -32.01 147.5 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.151 -0.477 . . . . 72.12 110.968 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . 0.525 ' HB3' ' CZ ' ' A' ' 104' ' ' PHE . 6.8 ptp180 -112.5 -41.78 3.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.145 -0.479 . . . . 74.22 110.85 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . 0.409 ' HB2' HD13 ' A' ' 161' ' ' ILE . 0.2 OUTLIER -85.95 150.57 53.11 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.56 0.695 . . . . 75.34 110.906 179.972 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . 0.507 ' HB3' ' HB3' ' A' ' 168' ' ' PRO . 54.1 Cg_endo -69.74 -31.57 20.36 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.719 2.279 . . . . 71.02 112.364 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.409 HD13 ' HB2' ' A' ' 159' ' ' LYS . 3.5 mp -62.25 -12.75 8.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.236 -0.438 . . . . 72.0 111.115 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . 0.592 ' HB3' ' CD1' ' A' ' 157' ' ' TYR . 0.5 OUTLIER -70.44 -12.26 61.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.216 -0.447 . . . . 55.2 110.874 179.842 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 75.4 t-105 -90.95 -12.96 34.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.23 -0.441 . . . . 74.5 110.928 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 93.03 -35.25 4.17 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.769 -0.729 . . . . 73.11 112.487 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -79.84 123.24 27.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.818 0.342 . . . . 61.23 111.076 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -49.38 122.6 6.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.167 -0.469 . . . . 64.44 111.094 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' SER . . . . . 0.508 ' C ' ' H ' ' A' ' 169' ' ' ALA . 0.5 OUTLIER 64.89 140.86 0.06 OUTLIER Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.637 0.732 . . . . 72.31 110.909 -179.768 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . 0.525 ' HG2' ' HB3' ' A' ' 126' ' ' GLU . 53.5 Cg_endo -69.8 33.6 0.2 Allowed 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.717 2.278 . . . . 74.53 112.317 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . 0.508 ' H ' ' C ' ' A' ' 167' ' ' SER . . . -67.19 98.28 0.59 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.233 -0.44 . . . . 74.21 111.148 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.481 ' HA ' ' NE2' ' A' ' 171' ' ' GLN . 1.1 t -156.97 175.32 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.221 -0.445 . . . . 65.25 111.13 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' GLN . . . . . 0.701 ' CD ' ' N ' ' A' ' 171' ' ' GLN . 0.0 OUTLIER -160.66 -99.93 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.146 -0.479 . . . . 54.3 110.911 -179.957 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' SER . . . . . 0.777 ' HB3' ' O ' ' A' ' 142' ' ' LEU . 0.1 OUTLIER -52.46 140.61 22.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.168 -0.469 . . . . 72.51 110.868 -179.793 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' PHE . . . . . 0.467 ' HB3' ' CE1' ' A' ' 139' ' ' PHE . 18.9 p90 -156.44 149.84 24.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.114 -0.494 . . . . 64.54 110.89 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . 0.456 ' HD3' ' CE2' ' A' ' 140' ' ' TYR . 0.0 OUTLIER -149.21 157.58 43.48 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.128 -0.487 . . . . 73.55 110.851 -179.899 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . 0.411 ' HG2' ' N ' ' A' ' 176' ' ' ILE . 0.0 OUTLIER -106.29 172.08 7.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.221 -0.445 . . . . 73.13 110.854 -179.938 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . 0.426 ' CD1' ' HB ' ' A' ' 136' ' ' VAL . 6.5 mt -97.78 143.38 12.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.175 -0.466 . . . . 73.55 111.132 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 67.8 t -48.36 140.72 2.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.164 -0.471 . . . . 73.4 111.128 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 116.213 -0.448 . . . . 74.24 110.907 -179.973 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.322 0 N-CA-C 112.468 -0.253 . . . . 60.01 112.468 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.474 ' C ' ' HE1' ' A' ' 47' ' ' TRP . 5.2 p -82.41 134.3 35.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.906 0.384 . . . . 64.31 111.105 -179.832 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 3.9 tttt -120.06 135.87 54.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.176 -0.465 . . . . 75.04 110.906 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.659 HG23 ' CZ ' ' A' ' 10' ' ' PHE . 15.5 tt -137.14 151.88 27.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.231 -0.44 . . . . 64.3 111.159 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.505 ' HA ' ' O ' ' A' ' 21' ' ' TYR . 18.1 m -132.86 142.45 48.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.192 -0.458 . . . . 71.22 111.153 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.659 ' CZ ' HG23 ' A' ' 8' ' ' ILE . 0.8 OUTLIER -130.08 129.03 43.07 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.25 -0.432 . . . . 74.35 110.875 -179.965 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.534 ' CG ' ' HA ' ' A' ' 16' ' ' PHE . 12.5 m-85 -114.4 131.65 56.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.136 -0.484 . . . . 74.24 110.93 -179.867 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.413 ' HB2' ' HB2' ' A' ' 19' ' ' ARG . 0.1 OUTLIER -59.5 -16.49 24.83 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.117 -0.492 . . . . 72.43 110.864 -179.97 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.435 ' HB2' ' O ' ' A' ' 17' ' ' GLN . 72.2 m-20 -134.14 150.56 51.12 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.167 -0.469 . . . . 71.12 110.885 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.462 ' N ' ' HB3' ' A' ' 38' ' ' ASN . 34.2 mtmt -55.61 -176.58 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.196 -0.456 . . . . 64.3 110.864 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 20.2 m120 47.22 32.45 2.1 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.194 -0.457 . . . . 64.11 110.908 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.534 ' HA ' ' CG ' ' A' ' 11' ' ' TYR . 3.3 m-85 49.74 62.66 2.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 73.11 110.916 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . 0.435 ' O ' ' HB2' ' A' ' 13' ' ' ASP . 18.3 mt-30 -137.75 159.22 42.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.116 -0.493 . . . . 71.21 110.895 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 92.7 -148.49 19.11 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.765 -0.731 . . . . 74.14 112.482 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.431 ' O ' ' CD1' ' A' ' 34' ' ' LEU . 0.3 OUTLIER -69.75 78.43 0.45 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.797 0.332 . . . . 75.54 110.844 -179.8 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.468 ' HB2' ' CE1' ' A' ' 11' ' ' TYR . 0.6 OUTLIER -76.88 130.35 37.46 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.188 -0.46 . . . . 72.13 110.845 -179.91 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.505 ' O ' ' HA ' ' A' ' 9' ' ' THR . 89.2 t80 -124.33 123.65 40.67 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.193 -0.458 . . . . 74.25 110.895 -179.829 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.46 ' CG ' HG23 ' A' ' 9' ' ' THR . 1.2 m-20 -121.14 133.78 55.21 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.089 -0.505 . . . . 75.14 110.856 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -168.31 136.67 2.26 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.196 -0.457 . . . . 74.33 110.916 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -101.93 -0.69 33.46 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.185 -0.461 . . . . 74.3 110.839 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.444 ' O ' ' SG ' ' A' ' 27' ' ' CYS . 16.8 t -102.85 164.34 11.68 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.226 -0.443 . . . . 75.12 110.911 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -57.68 120.86 9.1 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.238 -0.437 . . . . 70.42 110.894 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.501 ' HB2' ' HB3' ' A' ' 30' ' ' PHE . 1.8 m -116.63 51.13 1.0 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.185 -0.461 . . . . 75.14 110.853 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.489 ' C ' ' HA ' ' A' ' 82' ' ' SER . . . -47.07 -21.1 0.2 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.226 -0.443 . . . . 73.02 111.099 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 55.0 t0 -128.17 41.77 3.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.202 -0.454 . . . . 74.42 110.862 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.773 ' O ' ' CD2' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -81.35 13.18 3.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.184 -0.462 . . . . 73.04 110.851 -179.881 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.443 ' HB2' ' HB3' ' A' ' 81' ' ' SER . 28.8 t60 -78.75 -40.44 33.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.143 -0.48 . . . . 73.1 110.803 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.7 t -56.33 -16.14 5.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.197 -0.456 . . . . 75.44 111.126 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -98.26 -25.95 14.69 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.21 -0.45 . . . . 65.13 110.932 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.431 ' CD1' ' O ' ' A' ' 19' ' ' ARG . 16.3 tp -144.13 131.58 20.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.076 -0.511 . . . . 72.13 110.901 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 24.5 m -93.81 -42.88 8.88 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.193 -0.458 . . . . 74.14 110.839 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 1.1 tmm_? -118.41 140.64 49.54 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.163 -0.471 . . . . 72.1 110.861 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.488 ' HB3' ' HB2' ' A' ' 80' ' ' LEU . 4.0 p -108.71 81.08 1.4 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.164 -0.471 . . . . 74.43 110.913 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.462 ' HB3' ' N ' ' A' ' 14' ' ' LYS . 0.2 OUTLIER -70.4 -73.26 0.17 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.17 -0.468 . . . . 75.11 110.879 -179.882 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 4.3 p -109.21 125.03 51.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.208 -0.451 . . . . 74.11 110.841 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.568 ' O ' ' HB2' ' A' ' 67' ' ' TYR . 45.3 mt -118.05 148.83 20.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.127 -0.488 . . . . 73.54 111.11 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.487 ' N ' HG23 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -144.69 119.26 9.73 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.207 -0.451 . . . . 74.23 110.847 179.868 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.512 HG22 ' HB2' ' A' ' 47' ' ' TRP . 2.0 t -104.04 115.66 46.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.186 -0.461 . . . . 72.14 111.121 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -110.27 79.39 1.2 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.202 -0.454 . . . . 73.42 110.884 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.448 ' O ' ' HA ' ' A' ' 6' ' ' THR . . . 129.31 106.89 1.25 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.704 -0.76 . . . . 70.42 112.501 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 51.89 -178.75 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.764 -0.732 . . . . 61.24 112.463 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.514 HG21 ' HA ' ' A' ' 63' ' ' PRO . 1.2 m -83.23 168.29 16.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.749 0.309 . . . . 73.44 111.137 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . 0.614 ' CD1' ' HB ' ' A' ' 8' ' ' ILE . 3.4 m95 -141.04 130.19 23.44 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.276 -0.42 . . . . 74.44 110.918 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.6 ' O ' ' N ' ' A' ' 84' ' ' ARG . . . -93.52 129.27 39.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.275 -0.42 . . . . 74.33 111.102 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.539 HG11 HD12 ' A' ' 80' ' ' LEU . 15.5 m -129.02 125.83 63.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.206 -0.452 . . . . 75.21 111.108 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.708 ' HB3' ' HA ' ' A' ' 56' ' ' ALA . 42.8 m-85 -92.16 150.11 21.1 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.16 -0.473 . . . . 72.43 110.929 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.647 ' OE1' ' HB3' ' A' ' 57' ' ' TRP . 54.2 tt0 -49.99 -78.94 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.099 -0.5 . . . . 55.24 110.865 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.539 ' HB3' ' CD2' ' A' ' 55' ' ' PHE . 0.0 OUTLIER -93.66 144.68 28.58 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.626 0.727 . . . . 75.3 110.848 -179.867 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.719 ' HA ' ' OG ' ' A' ' 82' ' ' SER . 53.8 Cg_endo -69.78 141.76 46.01 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.702 2.268 . . . . 74.0 112.346 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 63.38 -11.89 0.09 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.226 -0.443 . . . . 75.21 110.878 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.631 ' H ' ' C ' ' A' ' 53' ' ' PRO . 2.5 m-30 -104.01 -19.13 14.31 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.148 -0.478 . . . . 73.12 110.893 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.708 ' HA ' ' HB3' ' A' ' 50' ' ' TYR . . . 49.47 25.46 1.37 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.138 -0.483 . . . . 71.33 111.09 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . 0.647 ' HB3' ' OE1' ' A' ' 51' ' ' GLU . 0.0 OUTLIER -50.01 -166.06 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.243 -0.435 . . . . 74.55 110.982 -179.988 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.636 ' C ' ' O ' ' A' ' 57' ' ' TRP . 10.0 m-30 -14.1 101.32 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.267 -0.424 . . . . 75.34 110.913 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.47 ' HB2' ' HA ' ' A' ' 150' ' ' TYR . 1.6 mpt? -64.14 157.57 25.22 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.089 -0.505 . . . . 75.41 110.879 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.513 ' O ' ' CG2' ' A' ' 49' ' ' VAL . 2.6 t80 -170.48 103.98 0.27 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.259 -0.428 . . . . 64.32 110.925 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.535 HD13 ' HB2' ' A' ' 151' ' ' LEU . 0.8 OUTLIER -91.23 115.09 29.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.115 -0.493 . . . . 70.44 111.113 179.904 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -81.84 126.32 75.65 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.595 0.712 . . . . 73.23 110.949 179.861 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.514 ' HA ' HG21 ' A' ' 46' ' ' THR . 53.9 Cg_endo -69.71 -176.1 1.36 Allowed 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.729 2.286 . . . . 73.51 112.348 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -84.51 161.66 20.16 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.238 -0.437 . . . . 73.5 110.899 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 113.64 -162.47 12.37 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.74 -0.743 . . . . 55.54 112.491 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -115.68 156.45 25.89 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.899 0.38 . . . . 74.35 110.847 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.568 ' HB2' ' O ' ' A' ' 40' ' ' ILE . 9.4 m-85 -145.17 83.72 9.07 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.669 0.747 . . . . 74.54 110.943 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.437 ' HD2' ' HG3' ' A' ' 72' ' ' ARG . 53.8 Cg_endo -69.77 0.67 5.32 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.686 2.257 . . . . 72.12 112.326 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.456 ' HB2' ' HG2' ' A' ' 72' ' ' ARG . 42.4 mt-10 -155.79 142.72 18.99 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.268 -0.424 . . . . 74.31 110.922 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.683 ' HA ' ' NE1' ' A' ' 73' ' ' TRP . 24.1 p90 -56.11 -21.38 21.97 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.205 -0.452 . . . . 74.12 110.899 -179.838 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -78.2 -18.42 55.51 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.094 -0.503 . . . . 73.44 110.894 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.456 ' HG2' ' HB2' ' A' ' 69' ' ' GLU . 29.4 mmt180 -67.52 -9.25 40.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.213 -0.449 . . . . 71.3 110.919 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . 0.714 ' N ' ' CD1' ' A' ' 73' ' ' TRP . 0.0 OUTLIER -135.51 5.89 3.22 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.175 -0.466 . . . . 74.04 110.93 -179.979 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 11.6 mtp 45.42 68.64 0.54 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.234 -0.439 . . . . 64.42 110.934 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -60.66 120.79 24.33 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.749 -0.739 . . . . 71.23 112.47 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.508 HD11 ' N ' ' A' ' 77' ' ' ASN . 0.0 OUTLIER -70.75 -8.79 54.82 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.805 0.336 . . . . 73.44 110.897 -179.954 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.581 ' O ' ' CB ' ' A' ' 78' ' ' ASP . 10.7 t-20 -151.46 -41.83 0.12 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.217 -0.447 . . . . 73.22 110.885 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.581 ' CB ' ' O ' ' A' ' 77' ' ' ASN . 1.8 t70 89.88 7.68 0.1 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.186 -0.461 . . . . 72.51 110.872 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -105.81 91.43 3.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.181 -0.463 . . . . 75.33 110.888 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.539 HD12 HG11 ' A' ' 49' ' ' VAL . 0.1 OUTLIER -90.28 135.54 33.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.172 -0.467 . . . . 75.2 110.965 -180.0 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.623 ' HB3' ' HB3' ' A' ' 53' ' ' PRO . 1.2 m -151.94 -118.66 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.198 -0.455 . . . . 75.1 110.884 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.719 ' OG ' ' HA ' ' A' ' 53' ' ' PRO . 0.2 OUTLIER -44.57 101.8 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.142 -0.481 . . . . 70.13 110.851 -179.824 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . 0.52 ' HA ' ' O ' ' A' ' 48' ' ' ALA . 15.9 p -115.77 141.43 48.11 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.133 -0.485 . . . . 75.41 110.887 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . 0.6 ' N ' ' O ' ' A' ' 48' ' ' ALA . 13.8 mmt85 -128.38 134.7 48.88 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.218 -0.447 . . . . 63.24 110.884 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.465 ' N ' ' CZ3' ' A' ' 47' ' ' TRP . . . -53.06 127.44 24.05 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.456 . . . . 53.43 111.08 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.518 ' CG2' ' CB ' ' A' ' 48' ' ' ALA . 73.7 t -115.05 135.43 55.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.238 -0.437 . . . . 73.45 111.136 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 28.7 m-70 -112.08 120.2 41.03 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.15 -0.477 . . . . 74.35 110.859 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -40.04 137.65 1.18 Allowed Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.62 0.724 . . . . 73.43 110.942 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.622 ' HB3' ' H ' ' A' ' 136' ' ' VAL . 53.9 Cg_endo -69.72 81.17 0.83 Allowed 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.7 2.266 . . . . 75.52 112.363 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -98.72 119.15 36.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.242 -0.435 . . . . 72.12 110.881 -179.856 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 130.51 85.98 0.39 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.755 -0.735 . . . . 64.51 112.496 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 88.1 35.63 8.81 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.782 -0.723 . . . . 73.52 112.471 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.451 ' O ' ' HG3' ' A' ' 134' ' ' GLU . 12.4 pt20 39.47 -154.18 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.832 0.349 . . . . 73.4 110.917 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.61 ' O ' ' HA ' ' A' ' 112' ' ' THR . 28.0 m-85 -96.17 102.35 14.12 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.199 -0.455 . . . . 71.34 110.919 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.49 ' H ' ' CG ' ' A' ' 134' ' ' GLU . 35.4 tptt -109.58 126.18 53.33 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.139 -0.482 . . . . 72.44 110.895 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 5.3 tt -150.6 137.19 12.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.189 -0.46 . . . . 74.34 111.119 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -108.14 135.11 50.04 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.17 -0.468 . . . . 72.12 110.917 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 26.0 mm -115.37 134.7 57.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.231 -0.44 . . . . 75.31 111.113 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.608 ' HB2' ' HB2' ' A' ' 129' ' ' SER . 61.7 m-85 -123.13 140.07 53.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 75.04 110.885 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.542 ' HA ' ' CE ' ' A' ' 124' ' ' MET . 58.6 tt0 -75.06 -52.64 10.54 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.161 -0.472 . . . . 72.34 110.922 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 40.8 mttt -106.8 155.29 19.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.136 -0.484 . . . . 72.44 110.932 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.406 ' N ' ' HB3' ' A' ' 128' ' ' HIS . . . -62.24 157.3 36.6 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.772 -0.728 . . . . 70.11 112.467 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.531 ' HA ' ' HB2' ' A' ' 158' ' ' ARG . 12.8 t70 69.48 39.92 1.52 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.896 0.379 . . . . 63.44 110.878 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.514 ' HA ' ' CD1' ' A' ' 99' ' ' PHE . 2.1 m-85 55.32 25.13 7.16 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.176 -0.465 . . . . 74.2 110.886 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 68.0 m -92.94 166.83 12.19 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.18 -0.464 . . . . 70.13 110.831 -179.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 79.18 -157.66 43.16 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.75 -0.738 . . . . 74.33 112.511 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 4.3 tp-100 -75.08 119.58 19.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.794 0.33 . . . . 73.24 110.931 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' MET . . . . . 0.467 ' HB2' ' CE1' ' A' ' 99' ' ' PHE . 18.8 ttp -104.36 145.46 30.22 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.23 -0.441 . . . . 74.1 110.864 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -148.66 134.84 19.29 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.195 -0.457 . . . . 75.0 110.926 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -113.38 89.28 3.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 74.34 110.907 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 15.0 t -101.04 130.55 47.07 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.115 -0.493 . . . . 74.12 111.163 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.61 ' HA ' ' O ' ' A' ' 94' ' ' TYR . 0.6 OUTLIER -104.83 30.68 5.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.229 -0.441 . . . . 72.31 111.148 -179.974 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -154.05 133.12 12.49 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.216 -0.447 . . . . 75.52 110.876 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 39.1 p30 -51.3 170.24 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.141 -0.481 . . . . 74.34 110.864 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . 0.485 ' O ' ' HB2' ' A' ' 172' ' ' SER . 14.1 p -152.37 144.24 16.44 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.594 0.711 . . . . 71.41 110.915 -179.898 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.434 ' O ' ' C ' ' A' ' 143' ' ' PRO . 53.6 Cg_endo -69.76 -31.16 21.08 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.712 2.275 . . . . 71.44 112.385 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' SER . . . . . 0.618 ' HB3' ' CB ' ' A' ' 120' ' ' GLU . 0.1 OUTLIER -147.41 106.66 3.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.193 -0.458 . . . . 64.33 110.88 -179.875 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.658 ' HB ' ' O ' ' A' ' 171' ' ' GLN . 4.0 tt -58.14 -28.18 33.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.131 -0.486 . . . . 75.12 111.088 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' MET . . . . . 0.694 ' O ' ' HA ' ' A' ' 123' ' ' HIS . 27.1 ttp -87.46 -41.47 13.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.185 -0.462 . . . . 74.51 110.915 179.831 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.618 ' CB ' ' HB3' ' A' ' 117' ' ' SER . 15.5 tp10 -68.65 -12.33 61.23 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.223 -0.444 . . . . 72.45 110.876 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 18.6 tp60 -115.94 -48.46 2.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.167 -0.469 . . . . 74.13 110.917 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . 0.48 ' HB2' ' O ' ' A' ' 118' ' ' ILE . 44.6 m-85 -103.99 -13.78 16.19 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.189 -0.46 . . . . 73.41 110.897 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . 0.694 ' HA ' ' O ' ' A' ' 119' ' ' MET . 10.8 m80 71.46 20.18 4.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.106 -0.497 . . . . 74.1 110.825 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.542 ' CE ' ' HA ' ' A' ' 100' ' ' GLU . 0.0 OUTLIER -93.42 139.59 30.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.208 -0.451 . . . . 74.13 110.854 179.97 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 5.3 ptp180 -102.36 -44.92 5.25 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.188 -0.46 . . . . 72.54 110.827 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.446 ' HG2' ' HA ' ' A' ' 169' ' ' ALA . 10.8 mt-10 -138.17 117.23 12.54 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.209 -0.45 . . . . 73.3 110.858 -179.89 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.428 HD11 HD13 ' A' ' 118' ' ' ILE . 2.5 mm -77.41 93.93 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.131 -0.486 . . . . 72.25 111.087 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . 0.406 ' HB3' ' N ' ' A' ' 102' ' ' GLY . 0.6 OUTLIER -63.78 -36.08 82.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.467 . . . . 74.12 110.877 179.849 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 0.608 ' HB2' ' HB2' ' A' ' 99' ' ' PHE . 0.6 OUTLIER -132.32 146.21 51.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.205 -0.452 . . . . 75.23 110.851 -179.756 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . 0.623 ' O ' ' O ' ' A' ' 155' ' ' LYS . 0.5 OUTLIER -145.27 120.49 10.18 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.15 -0.477 . . . . 73.33 110.849 -179.937 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.637 ' HA ' ' HA ' ' A' ' 156' ' ' GLU . 1.3 mtpt -107.39 153.93 22.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.152 -0.477 . . . . 75.11 110.894 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.443 ' CB ' ' O ' ' A' ' 131' ' ' LYS . 4.8 t 82.71 165.27 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.207 -0.451 . . . . 74.4 111.119 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.485 ' CD1' ' O ' ' A' ' 154' ' ' LYS . 0.0 OUTLIER -176.47 126.02 0.18 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.187 -0.46 . . . . 74.13 110.884 179.988 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.49 ' CG ' ' H ' ' A' ' 95' ' ' LYS . 0.0 OUTLIER -94.39 159.23 15.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.172 -0.467 . . . . 75.1 110.893 179.95 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . 0.485 ' C ' ' O ' ' A' ' 134' ' ' GLU . . . -31.05 -48.82 0.2 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.764 -0.732 . . . . 72.41 112.451 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.627 ' HA ' ' CD1' ' A' ' 152' ' ' LEU . 2.3 t -150.99 133.5 6.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.814 0.34 . . . . 74.21 111.105 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' TRP . . . . . 0.573 ' H ' ' CG ' ' A' ' 152' ' ' LEU . 3.6 t-105 -133.5 150.7 51.7 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.173 -0.467 . . . . 74.45 110.88 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.493 ' CD1' ' HB ' ' A' ' 61' ' ' ILE . 22.1 mm -114.12 128.77 70.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.18 -0.463 . . . . 73.54 111.139 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 0.507 ' CB ' ' HB2' ' A' ' 150' ' ' TYR . 0.5 OUTLIER -114.91 149.59 36.99 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.217 -0.447 . . . . 75.21 110.875 179.953 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . 0.482 ' CD2' ' HA ' ' A' ' 145' ' ' TYR . 2.3 m-85 -134.98 133.17 39.2 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.131 -0.486 . . . . 74.53 110.902 -179.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . 0.689 ' O ' ' HB2' ' A' ' 171' ' ' GLN . 0.8 OUTLIER -59.93 -26.49 65.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.147 -0.478 . . . . 73.22 110.911 179.966 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.755 ' HB3' ' HD2' ' A' ' 143' ' ' PRO . 9.7 mp -112.15 173.13 3.03 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.595 0.712 . . . . 73.12 110.883 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . 0.755 ' HD2' ' HB3' ' A' ' 142' ' ' LEU . 53.8 Cg_endo -69.76 -89.68 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.645 2.23 . . . . 74.3 112.357 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . 0.686 ' O ' ' N ' ' A' ' 146' ' ' ARG . 2.3 m-20 -52.81 97.0 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.183 -0.462 . . . . 74.4 110.923 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . 0.64 ' C ' ' O ' ' A' ' 144' ' ' ASN . 0.1 OUTLIER 12.78 53.25 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.18 -0.463 . . . . 74.34 110.962 -179.899 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . 0.686 ' N ' ' O ' ' A' ' 144' ' ' ASN . 38.1 mtt85 -119.46 179.1 4.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.1 -0.5 . . . . 74.45 110.865 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 73.98 -174.05 49.59 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.723 -0.751 . . . . 70.33 112.509 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.404 ' HG2' ' CD1' ' A' ' 58' ' ' TYR . 0.2 OUTLIER -75.91 151.75 37.27 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.758 0.313 . . . . 72.21 110.868 -179.883 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -88.5 149.82 23.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.186 -0.461 . . . . 74.34 110.946 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . 0.507 ' HB2' ' CB ' ' A' ' 139' ' ' PHE . 82.4 m-85 -134.07 129.5 36.12 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.205 -0.452 . . . . 72.31 110.9 -179.847 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.535 ' HB2' HD13 ' A' ' 61' ' ' ILE . 16.8 tp -81.67 122.72 27.99 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.129 -0.487 . . . . 72.34 110.882 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.627 ' CD1' ' HA ' ' A' ' 136' ' ' VAL . 0.0 OUTLIER -54.54 135.36 46.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.2 -0.455 . . . . 72.53 110.915 179.871 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -163.25 25.74 0.09 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.183 -0.462 . . . . 62.33 110.9 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.775 ' HA ' ' CE1' ' A' ' 157' ' ' TYR . 0.0 OUTLIER -117.27 -173.7 2.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.133 -0.485 . . . . 72.45 110.874 179.984 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.751 ' HG3' ' O ' ' A' ' 154' ' ' LYS . 0.5 OUTLIER -161.87 -124.77 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.18 -0.464 . . . . 74.13 110.901 179.886 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . 0.637 ' HA ' ' HA ' ' A' ' 131' ' ' LYS . 0.7 OUTLIER -69.09 -0.41 5.79 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.226 -0.443 . . . . 74.2 110.921 179.928 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . 0.775 ' CE1' ' HA ' ' A' ' 154' ' ' LYS . 18.5 m-30 -31.08 146.95 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.122 -0.49 . . . . 74.24 110.93 -179.822 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . 0.531 ' HB2' ' HA ' ' A' ' 103' ' ' ASP . 8.5 ptp180 -112.29 -39.49 4.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.117 -0.492 . . . . 73.42 110.867 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . 0.439 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 2.6 ptpp? -92.01 150.96 41.43 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.602 0.715 . . . . 72.43 110.881 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . 0.437 ' HA ' ' CZ2' ' A' ' 163' ' ' TRP . 53.9 Cg_endo -69.7 -23.05 31.49 Favored 'Trans proline' 0 C--O 1.232 0.214 0 C-N-CA 122.717 2.278 . . . . 73.21 112.352 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.476 HD11 ' H ' ' A' ' 161' ' ' ILE . 3.9 mp -76.62 2.32 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.226 -0.443 . . . . 71.52 111.105 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . 0.673 ' HB3' ' CD1' ' A' ' 157' ' ' TYR . 0.6 OUTLIER -73.07 -19.86 61.08 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.176 -0.465 . . . . 74.2 110.855 179.855 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' TRP . . . . . 0.605 ' CD1' ' N ' ' A' ' 163' ' ' TRP . 0.0 OUTLIER -109.13 13.92 24.21 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.182 -0.463 . . . . 74.22 110.928 -179.965 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 85.04 -30.53 3.93 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.75 -0.738 . . . . 74.43 112.496 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -54.19 120.1 6.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.742 0.306 . . . . 71.02 111.1 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -49.67 -25.65 3.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.214 -0.448 . . . . 75.51 111.136 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' SER . . . . . 0.502 ' C ' ' H ' ' A' ' 169' ' ' ALA . 0.3 OUTLIER -155.61 160.13 31.09 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.708 0.766 . . . . 55.13 110.85 -179.804 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . 0.42 ' HG2' ' HB3' ' A' ' 126' ' ' GLU . 53.8 Cg_endo -69.78 20.36 0.18 Allowed 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.717 2.278 . . . . 72.41 112.296 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . 0.502 ' H ' ' C ' ' A' ' 167' ' ' SER . . . -63.18 103.64 0.5 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.245 -0.434 . . . . 75.44 111.124 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 3.4 t -152.91 160.87 2.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.24 -0.436 . . . . 73.22 111.15 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' GLN . . . . . 0.689 ' HB2' ' O ' ' A' ' 141' ' ' GLU . 1.9 mm-40 -109.73 -88.03 0.5 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.215 -0.448 . . . . 73.54 110.913 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' SER . . . . . 0.699 ' OG ' ' O ' ' A' ' 143' ' ' PRO . 15.4 p -130.6 178.39 6.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.177 -0.465 . . . . 74.22 110.817 -179.789 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -143.79 168.07 20.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.107 -0.497 . . . . 74.23 110.864 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . 0.415 ' HG2' ' CE2' ' A' ' 140' ' ' TYR . 2.1 ppt_? -133.39 156.66 47.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.163 -0.471 . . . . 74.25 110.913 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . 0.413 ' HB2' ' CE1' ' A' ' 94' ' ' TYR . 6.2 ptt85 -98.18 150.72 21.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.259 -0.428 . . . . 74.04 110.869 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . 0.511 ' CD1' ' HB ' ' A' ' 136' ' ' VAL . 15.4 mt -83.1 152.31 3.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.217 -0.447 . . . . 65.24 111.116 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 7.5 p -126.29 147.2 31.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.129 -0.487 . . . . 71.51 111.132 179.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.215 -0.448 . . . . 63.53 110.933 179.982 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.304 0 N-CA-C 112.444 -0.262 . . . . 62.03 112.444 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.438 ' HA ' ' O ' ' A' ' 44' ' ' GLY . 9.8 p -82.68 135.61 34.98 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.837 0.351 . . . . 54.31 111.158 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.406 ' HA ' ' HA ' ' A' ' 24' ' ' ASP . 2.8 tttt -123.47 135.75 54.23 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.217 -0.447 . . . . 65.21 110.9 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.639 HG23 ' CZ ' ' A' ' 10' ' ' PHE . 14.5 tt -136.71 152.05 28.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.25 -0.432 . . . . 75.43 111.148 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.441 HG21 ' CE2' ' A' ' 11' ' ' TYR . 15.3 m -133.98 142.66 47.75 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.19 -0.459 . . . . 60.34 111.129 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.639 ' CZ ' HG23 ' A' ' 8' ' ' ILE . 0.3 OUTLIER -130.01 128.72 42.59 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.226 -0.443 . . . . 73.44 110.92 179.997 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.531 ' CG ' ' HA ' ' A' ' 16' ' ' PHE . 24.1 m-85 -113.54 131.96 55.88 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.164 -0.471 . . . . 72.34 110.973 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.424 ' HA ' ' O ' ' A' ' 36' ' ' ARG . 0.0 OUTLIER -61.08 -13.63 18.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.123 -0.489 . . . . 63.3 110.914 -179.955 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.43 ' HB2' ' O ' ' A' ' 17' ' ' GLN . 77.1 m-20 -136.95 150.78 48.38 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.124 -0.489 . . . . 73.12 110.868 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 4.8 mtmm -55.22 -175.95 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.198 -0.456 . . . . 75.23 110.852 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 20.2 m-20 45.53 33.25 1.3 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.156 -0.475 . . . . 74.4 110.885 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.531 ' HA ' ' CG ' ' A' ' 11' ' ' TYR . 2.7 m-85 49.22 64.77 1.6 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.169 -0.469 . . . . 72.13 110.896 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . 0.43 ' O ' ' HB2' ' A' ' 13' ' ' ASP . 8.0 mt-30 -139.46 159.96 40.96 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.154 -0.476 . . . . 70.25 110.886 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 92.7 -150.03 19.84 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.78 -0.724 . . . . 55.11 112.521 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.409 ' O ' ' CD1' ' A' ' 34' ' ' LEU . 0.3 OUTLIER -69.9 78.79 0.47 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.803 0.335 . . . . 72.55 110.89 -179.885 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.445 ' HA ' ' O ' ' A' ' 10' ' ' PHE . 0.0 OUTLIER -76.24 129.51 36.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.205 -0.452 . . . . 73.34 110.856 -179.871 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.469 ' CD2' ' CD2' ' A' ' 30' ' ' PHE . 69.2 t80 -124.26 125.31 44.16 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.184 -0.462 . . . . 65.22 110.903 -179.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.408 ' OD1' ' CD ' ' A' ' 20' ' ' ARG . 1.2 m-20 -118.83 134.54 55.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.113 -0.494 . . . . 73.24 110.925 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 8.8 t -161.17 129.66 4.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.23 -0.441 . . . . 74.51 110.897 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.406 ' HA ' ' HA ' ' A' ' 7' ' ' LYS . 14.1 p-10 -97.33 4.39 50.81 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.178 -0.465 . . . . 75.04 110.89 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 46.9 t -113.52 159.66 19.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.179 -0.464 . . . . 74.1 110.855 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -42.67 119.67 1.51 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.162 -0.472 . . . . 71.33 110.854 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.52 ' HB2' ' HB3' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -114.6 40.55 2.54 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.187 -0.461 . . . . 74.33 110.9 -179.913 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.558 ' O ' ' HA ' ' A' ' 82' ' ' SER . . . -51.12 -21.22 1.81 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.15 -0.477 . . . . 74.42 111.119 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 59.9 t0 -128.86 38.32 3.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.168 -0.469 . . . . 75.31 110.888 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.773 ' O ' ' CD2' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -80.27 13.92 2.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.186 -0.461 . . . . 64.41 110.878 -179.885 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.439 ' CG ' ' HG3' ' A' ' 53' ' ' PRO . 36.2 t60 -77.65 -36.81 51.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.147 -0.479 . . . . 65.42 110.875 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.7 t -59.81 -14.52 15.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.196 -0.456 . . . . 73.42 111.156 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -100.99 -24.97 14.23 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.202 -0.454 . . . . 71.13 110.877 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.409 ' CD1' ' O ' ' A' ' 19' ' ' ARG . 23.9 tp -141.62 123.93 15.67 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.125 -0.489 . . . . 62.52 110.943 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 27.0 m -82.83 -49.32 9.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.211 -0.45 . . . . 74.02 110.829 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.424 ' O ' ' HA ' ' A' ' 12' ' ' GLU . 0.1 OUTLIER -114.04 143.25 45.07 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.131 -0.486 . . . . 74.21 110.834 -179.925 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.571 ' HB2' ' HB2' ' A' ' 80' ' ' LEU . 57.6 m -122.93 104.76 9.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.174 -0.466 . . . . 74.21 110.906 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 10.9 m-20 -97.49 -67.15 0.86 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.226 -0.443 . . . . 71.52 110.892 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 10.6 p -105.68 133.66 50.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.207 -0.451 . . . . 74.31 110.895 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.479 ' O ' ' N ' ' A' ' 67' ' ' TYR . 6.9 mt -130.01 149.53 33.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.135 -0.484 . . . . 72.11 111.114 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.462 ' N ' HG23 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -142.51 119.07 11.0 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.155 -0.475 . . . . 75.01 110.906 179.853 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.604 HG22 ' HB2' ' A' ' 47' ' ' TRP . 1.0 OUTLIER -104.76 117.47 50.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.268 -0.424 . . . . 64.2 111.098 179.908 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -112.55 76.67 0.99 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.155 -0.475 . . . . 74.44 110.896 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.438 ' O ' ' HA ' ' A' ' 6' ' ' THR . . . 139.21 99.61 0.45 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.723 -0.751 . . . . 60.31 112.479 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 55.59 177.78 0.25 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.743 -0.741 . . . . 75.11 112.479 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.5 HG21 ' HA ' ' A' ' 63' ' ' PRO . 2.2 m -76.46 168.7 19.61 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.719 0.295 . . . . 75.34 111.18 -179.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . 0.604 ' HB2' HG22 ' A' ' 42' ' ' VAL . 7.7 m95 -143.32 128.36 18.54 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.261 -0.427 . . . . 74.41 110.93 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.598 ' O ' ' N ' ' A' ' 84' ' ' ARG . . . -89.83 127.62 36.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.221 -0.445 . . . . 63.0 111.093 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.564 ' CG2' ' O ' ' A' ' 60' ' ' TYR . 26.9 m -127.62 141.72 45.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.181 -0.463 . . . . 73.32 111.144 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.783 ' HB3' ' CB ' ' A' ' 56' ' ' ALA . 5.0 m-85 -122.53 155.44 36.22 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.189 -0.459 . . . . 75.24 110.903 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.588 ' C ' ' HB3' ' A' ' 56' ' ' ALA . 35.3 mp0 -53.19 -94.8 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.081 -0.509 . . . . 75.52 110.928 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.819 ' N ' ' HB3' ' A' ' 56' ' ' ALA . 3.4 mtp180 -72.0 136.46 82.31 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.556 0.693 . . . . 75.25 110.863 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.592 ' HA ' ' OG ' ' A' ' 82' ' ' SER . 53.8 Cg_endo -69.79 131.64 21.62 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.676 2.251 . . . . 73.14 112.321 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.429 ' H ' ' HB3' ' A' ' 82' ' ' SER . 4.3 t-20 77.07 -5.35 2.19 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.169 -0.469 . . . . 75.12 110.916 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.417 ' CE1' ' HB3' ' A' ' 54' ' ' ASN . 0.1 OUTLIER -144.73 -73.4 0.25 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.158 -0.474 . . . . 74.01 110.852 -179.981 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.819 ' HB3' ' N ' ' A' ' 52' ' ' ARG . . . 37.96 80.29 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.177 -0.465 . . . . 75.23 111.107 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . 0.458 ' O ' ' CG ' ' A' ' 58' ' ' TYR . 31.4 m95 -64.96 53.07 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.215 -0.448 . . . . 73.13 110.903 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.575 ' CB ' ' OE1' ' A' ' 51' ' ' GLU . 0.5 OUTLIER -177.19 124.39 0.14 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.252 -0.431 . . . . 74.53 110.911 -179.921 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.505 ' HG3' ' CE2' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -81.79 139.71 34.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.136 -0.484 . . . . 70.42 110.874 179.903 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.715 ' OH ' ' O ' ' A' ' 73' ' ' TRP . 1.0 OUTLIER -154.7 86.24 1.13 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.248 -0.433 . . . . 74.13 110.906 -179.876 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.53 HD11 ' HA ' ' A' ' 151' ' ' LEU . 1.6 mp -80.42 118.88 28.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.145 -0.48 . . . . 73.24 111.109 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -87.06 127.86 57.83 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.615 0.721 . . . . 74.52 110.929 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.5 ' HA ' HG21 ' A' ' 46' ' ' THR . 53.4 Cg_endo -69.81 -174.24 0.88 Allowed 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.701 2.268 . . . . 71.54 112.34 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -87.02 162.89 17.37 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.203 -0.453 . . . . 73.34 110.943 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 113.37 -161.03 12.82 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.767 -0.73 . . . . 73.22 112.469 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -111.99 160.24 17.65 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.862 0.363 . . . . 74.22 110.906 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.479 ' N ' ' O ' ' A' ' 40' ' ' ILE . 20.6 m-85 -149.16 81.6 7.39 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.646 0.736 . . . . 74.44 110.898 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.493 ' HD2' ' HG3' ' A' ' 72' ' ' ARG . 53.8 Cg_endo -69.7 -3.57 12.24 Favored 'Trans proline' 0 C--O 1.231 0.155 0 C-N-CA 122.706 2.271 . . . . 54.44 112.345 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -157.77 149.36 21.75 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.224 -0.443 . . . . 75.22 110.927 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.778 ' O ' ' CD1' ' A' ' 73' ' ' TRP . 35.4 p90 -55.28 -41.27 72.06 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.163 -0.471 . . . . 75.24 110.979 -179.845 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -51.66 -21.89 2.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.099 -0.5 . . . . 75.43 110.938 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.493 ' HG3' ' HD2' ' A' ' 68' ' ' PRO . 28.9 mmt180 -61.8 -39.74 92.8 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.189 -0.46 . . . . 74.34 110.891 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . 0.778 ' CD1' ' O ' ' A' ' 70' ' ' TYR . 0.3 OUTLIER -92.88 34.17 1.11 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.168 -0.469 . . . . 72.44 110.934 -179.999 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' MET . . . . . 0.404 ' HB2' ' O ' ' A' ' 73' ' ' TRP . 34.5 mmm 75.19 17.66 2.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.258 -0.428 . . . . 71.44 110.913 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.419 ' N ' ' HD1' ' A' ' 73' ' ' TRP . . . 42.98 44.0 5.6 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.759 -0.734 . . . . 74.22 112.484 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.462 ' CB ' ' CE2' ' A' ' 60' ' ' TYR . 0.5 OUTLIER -67.45 -74.12 0.12 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.877 0.37 . . . . 74.41 110.933 -179.907 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 12.6 t-20 -154.02 138.96 17.22 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.164 -0.471 . . . . 75.3 110.879 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -87.61 13.61 10.0 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.164 -0.471 . . . . 73.25 110.87 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.503 ' HD3' ' HB3' ' A' ' 51' ' ' GLU . 38.7 ttt85 -84.29 44.97 1.06 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.182 -0.463 . . . . 72.25 110.866 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.571 ' HB2' ' HB2' ' A' ' 37' ' ' CYS . 0.1 OUTLIER -66.12 125.59 25.99 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.2 -0.454 . . . . 74.43 110.928 -179.995 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.554 ' HB3' ' HB3' ' A' ' 53' ' ' PRO . 3.7 m -151.07 -109.2 0.06 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.186 -0.461 . . . . 73.52 110.879 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.592 ' OG ' ' HA ' ' A' ' 53' ' ' PRO . 0.0 OUTLIER -51.32 102.23 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.147 -0.479 . . . . 74.53 110.869 -179.827 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . 0.564 ' HA ' ' O ' ' A' ' 48' ' ' ALA . 14.6 p -126.55 135.33 51.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.155 -0.475 . . . . 71.31 110.855 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . 0.598 ' N ' ' O ' ' A' ' 48' ' ' ALA . 2.1 mmt85 -118.29 159.87 22.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.162 -0.472 . . . . 72.13 110.863 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -74.3 125.96 29.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.208 -0.451 . . . . 73.3 111.067 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.455 HG23 ' HB3' ' A' ' 48' ' ' ALA . 18.0 t -120.31 145.31 26.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.202 -0.454 . . . . 72.51 111.102 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . 0.451 ' O ' ' CG2' ' A' ' 136' ' ' VAL . 70.0 m-70 -110.78 112.36 24.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.176 -0.465 . . . . 74.34 110.905 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.402 ' C ' ' O ' ' A' ' 87' ' ' HIS . 0.0 OUTLIER -37.91 152.28 0.15 Allowed Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 121.626 0.727 . . . . 73.44 110.887 -179.956 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.495 ' HB3' ' H ' ' A' ' 136' ' ' VAL . 54.3 Cg_endo -69.67 83.15 0.69 Allowed 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.673 2.248 . . . . 72.34 112.361 179.809 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.2 t -90.23 -177.34 5.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.275 -0.42 . . . . 72.05 110.846 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 70.35 -81.94 0.37 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.702 -0.761 . . . . 65.14 112.489 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.41 ' O ' ' C ' ' A' ' 93' ' ' GLN . . . -92.58 34.16 4.63 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.739 -0.743 . . . . 54.4 112.53 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.435 ' O ' ' HG2' ' A' ' 134' ' ' GLU . 14.6 pt20 37.54 -121.58 0.21 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.868 0.366 . . . . 75.43 110.903 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.678 ' CZ ' ' HA ' ' A' ' 175' ' ' ARG . 1.4 t80 -121.91 99.29 6.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.228 -0.442 . . . . 74.42 110.945 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.458 ' HG3' HG11 ' A' ' 132' ' ' VAL . 23.8 tptt -119.27 127.14 52.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.153 -0.476 . . . . 72.51 110.846 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.457 HG21 ' CZ2' ' A' ' 137' ' ' TRP . 0.4 OUTLIER -150.1 138.61 14.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.189 -0.46 . . . . 73.21 111.099 179.901 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.446 ' HB2' ' O ' ' A' ' 131' ' ' LYS . 0.7 OUTLIER -110.38 124.3 51.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.175 -0.466 . . . . 73.12 110.916 179.904 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 29.6 mm -107.19 133.23 52.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.172 -0.467 . . . . 74.22 111.168 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.622 ' HB2' ' HB2' ' A' ' 129' ' ' SER . 7.7 m-85 -123.41 144.76 49.28 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.199 -0.455 . . . . 74.35 110.896 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 71.7 tt0 -72.85 -74.43 0.17 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.16 -0.473 . . . . 74.43 110.923 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.488 ' C ' ' HB2' ' A' ' 128' ' ' HIS . 31.9 mttt -85.2 167.12 15.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.09 -0.505 . . . . 72.22 110.887 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.421 ' HA2' ' OG ' ' A' ' 129' ' ' SER . . . -80.9 158.03 40.17 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.77 -0.729 . . . . 52.11 112.495 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.465 ' HA ' ' HB2' ' A' ' 158' ' ' ARG . 33.2 t70 68.1 54.27 0.6 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.799 0.333 . . . . 72.51 110.833 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.699 ' CE1' ' HD2' ' A' ' 131' ' ' LYS . 7.2 m-85 47.39 29.99 1.45 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.197 -0.456 . . . . 63.12 110.905 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.449 ' C ' ' HB2' ' A' ' 101' ' ' LYS . 48.0 m -105.47 152.11 23.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.103 -0.499 . . . . 75.44 110.889 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 89.42 -165.2 32.36 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.723 -0.751 . . . . 53.3 112.441 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 5.9 tp-100 -73.43 129.09 37.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.827 0.346 . . . . 73.44 110.867 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 1.6 ttt -114.76 131.39 56.8 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.215 -0.448 . . . . 73.23 110.89 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -134.94 137.2 42.89 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.229 -0.441 . . . . 74.3 110.918 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -110.8 94.48 5.02 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.119 -0.491 . . . . 65.34 110.884 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 9.1 t -102.38 130.29 49.09 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.14 -0.482 . . . . 72.11 111.111 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.54 ' O ' ' OG1' ' A' ' 112' ' ' THR . 0.0 OUTLIER -109.84 37.3 2.7 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.206 -0.452 . . . . 64.23 111.103 -179.952 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -151.78 -176.36 5.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.22 -0.446 . . . . 73.14 110.853 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -80.49 179.58 7.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.107 -0.497 . . . . 75.12 110.839 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . 0.562 ' O ' ' HB2' ' A' ' 172' ' ' SER . 45.7 t -167.3 125.02 0.97 Allowed Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.549 0.69 . . . . 75.32 110.903 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.72 -30.37 22.58 Favored 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.657 2.238 . . . . 73.42 112.33 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' SER . . . . . 0.612 ' HB3' ' CB ' ' A' ' 120' ' ' GLU . 0.1 OUTLIER -150.19 101.93 3.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.202 -0.454 . . . . 71.34 110.86 -179.843 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.608 ' HB ' ' O ' ' A' ' 171' ' ' GLN . 4.0 tt -52.56 -29.67 13.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.145 -0.48 . . . . 73.14 111.1 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' MET . . . . . 0.577 ' O ' ' HA ' ' A' ' 123' ' ' HIS . 0.8 OUTLIER -85.55 -45.11 12.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.184 -0.462 . . . . 75.23 110.848 179.906 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.612 ' CB ' ' HB3' ' A' ' 117' ' ' SER . 8.4 tp10 -65.45 -13.75 59.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.262 -0.427 . . . . 62.01 110.859 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -114.22 -51.97 2.75 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.169 -0.469 . . . . 74.52 110.896 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . 0.453 ' HB2' ' O ' ' A' ' 118' ' ' ILE . 54.1 m-85 -101.24 -20.3 15.32 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.195 -0.457 . . . . 73.42 110.902 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . 0.577 ' HA ' ' O ' ' A' ' 119' ' ' MET . 12.6 m80 71.24 30.61 2.58 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.132 -0.485 . . . . 71.23 110.869 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.419 ' O ' HG22 ' A' ' 118' ' ' ILE . 5.2 mtt -108.99 86.42 2.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.224 -0.444 . . . . 73.12 110.902 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 2.0 ptp85 -51.94 -35.57 46.4 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.209 -0.45 . . . . 75.25 110.877 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.499 ' HB3' ' HG2' ' A' ' 168' ' ' PRO . 28.9 mt-10 -142.39 131.7 23.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.201 -0.454 . . . . 73.24 110.896 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.454 ' O ' ' HB3' ' A' ' 168' ' ' PRO . 3.5 mm -91.38 91.46 3.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.17 -0.468 . . . . 74.41 111.14 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . 0.488 ' HB2' ' C ' ' A' ' 101' ' ' LYS . 13.3 m170 -60.58 -35.43 76.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.183 -0.462 . . . . 74.21 110.86 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 0.622 ' HB2' ' HB2' ' A' ' 99' ' ' PHE . 66.5 m -131.09 140.08 49.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.222 -0.444 . . . . 71.43 110.829 -179.763 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . 0.616 ' O ' ' O ' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -139.18 121.59 16.09 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.134 -0.484 . . . . 70.44 110.855 179.999 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.699 ' HD2' ' CE1' ' A' ' 104' ' ' PHE . 6.3 mtpp -115.33 153.15 31.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.153 -0.476 . . . . 74.03 110.925 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.512 ' HB ' ' O ' ' A' ' 131' ' ' LYS . 16.1 t 84.34 164.57 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.242 -0.435 . . . . 73.12 111.126 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.449 ' O ' ' HG ' ' A' ' 133' ' ' LEU . 0.0 OUTLIER -178.44 121.98 0.1 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.136 -0.484 . . . . 74.41 110.91 179.976 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.513 ' O ' ' C ' ' A' ' 135' ' ' GLY . 0.1 OUTLIER -94.03 167.02 11.86 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.186 -0.461 . . . . 73.24 110.89 179.922 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . 0.513 ' C ' ' O ' ' A' ' 134' ' ' GLU . . . -27.8 -55.89 0.12 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.717 -0.754 . . . . 74.31 112.517 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.767 ' HA ' HD13 ' A' ' 152' ' ' LEU . 3.2 t -144.51 137.36 22.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.806 0.336 . . . . 71.42 111.12 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' TRP . . . . . 0.694 ' CB ' ' HB3' ' A' ' 152' ' ' LEU . 0.0 OUTLIER -129.82 142.46 50.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.157 -0.474 . . . . 73.05 110.92 179.914 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.493 ' HB ' ' HG2' ' A' ' 174' ' ' ARG . 11.4 mm -114.99 134.35 58.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.195 -0.457 . . . . 64.51 111.12 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 0.518 ' CB ' ' HB2' ' A' ' 150' ' ' TYR . 0.8 OUTLIER -123.33 145.38 48.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.172 -0.467 . . . . 73.2 110.881 179.932 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . 0.483 ' CE2' ' CD ' ' A' ' 174' ' ' ARG . 0.3 OUTLIER -126.99 133.85 50.48 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.164 -0.471 . . . . 72.13 110.93 -179.899 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . 0.654 ' O ' ' HB2' ' A' ' 171' ' ' GLN . 0.2 OUTLIER -59.97 -27.2 66.63 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.105 -0.498 . . . . 71.2 110.89 -179.979 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.712 ' HB3' ' HD2' ' A' ' 143' ' ' PRO . 9.7 mp -112.91 171.79 4.04 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.617 0.722 . . . . 74.44 110.897 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . 0.757 ' O ' ' OG ' ' A' ' 172' ' ' SER . 54.0 Cg_endo -69.74 -92.71 0.01 OUTLIER 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.737 2.291 . . . . 74.44 112.323 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . 0.732 ' O ' ' N ' ' A' ' 146' ' ' ARG . 0.8 OUTLIER -49.99 99.21 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.217 -0.447 . . . . 64.44 110.913 -179.984 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . 0.641 ' C ' ' O ' ' A' ' 144' ' ' ASN . 19.8 m-85 11.64 52.44 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.218 -0.446 . . . . 75.02 110.928 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . 0.732 ' N ' ' O ' ' A' ' 144' ' ' ASN . 21.1 mtt180 -118.6 173.28 6.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.098 -0.501 . . . . 73.3 110.875 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 78.97 -176.1 54.82 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.713 -0.756 . . . . 75.42 112.52 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -80.64 144.01 32.65 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.746 0.308 . . . . 74.53 110.87 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -71.63 162.93 28.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.218 -0.446 . . . . 73.12 110.904 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . 0.518 ' HB2' ' CB ' ' A' ' 139' ' ' PHE . 78.9 m-85 -145.89 128.19 15.82 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.202 -0.454 . . . . 74.43 110.945 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.53 ' HA ' HD11 ' A' ' 61' ' ' ILE . 15.1 tp -85.94 123.21 31.02 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.161 -0.472 . . . . 74.14 110.89 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.767 HD13 ' HA ' ' A' ' 136' ' ' VAL . 0.0 OUTLIER -58.33 142.23 48.72 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.183 -0.462 . . . . 73.33 110.903 179.887 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -162.99 25.44 0.09 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.156 -0.474 . . . . 74.02 110.88 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.918 ' HB2' ' CD1' ' A' ' 157' ' ' TYR . 3.1 ptmt -123.17 -172.38 2.49 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.189 -0.459 . . . . 74.31 110.874 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.713 ' HD2' ' C ' ' A' ' 154' ' ' LYS . 0.4 OUTLIER -159.8 -123.79 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.236 -0.438 . . . . 73.02 110.903 179.91 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . 0.641 ' HA ' ' HA ' ' A' ' 131' ' ' LYS . 0.8 OUTLIER -66.02 -3.74 5.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.208 -0.451 . . . . 70.32 110.897 179.96 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . 0.918 ' CD1' ' HB2' ' A' ' 154' ' ' LYS . 13.3 m-30 -27.62 140.01 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.158 -0.473 . . . . 75.04 110.946 -179.847 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . 0.574 ' O ' ' OG ' ' A' ' 129' ' ' SER . 8.2 ptp180 -103.8 -46.18 4.57 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.159 -0.473 . . . . 75.41 110.853 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 2.4 ptpp? -81.68 149.25 63.78 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.546 0.688 . . . . 73.2 110.87 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . 0.457 ' CB ' ' HD3' ' A' ' 168' ' ' PRO . 53.7 Cg_endo -69.74 -26.74 27.38 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.703 2.269 . . . . 71.21 112.34 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.489 HD11 ' H ' ' A' ' 161' ' ' ILE . 4.1 mp -69.95 -10.62 13.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.215 -0.448 . . . . 74.42 111.152 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . 0.606 ' HB3' ' CD1' ' A' ' 157' ' ' TYR . 1.0 OUTLIER -70.65 -12.79 61.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 73.33 110.859 179.865 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' TRP . . . . . 0.437 ' CD2' ' O ' ' A' ' 163' ' ' TRP . 11.5 t-105 -90.13 -19.65 24.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.193 -0.458 . . . . 72.23 110.879 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 103.21 -37.11 3.89 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.772 -0.727 . . . . 75.13 112.536 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -78.29 123.1 26.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.843 0.354 . . . . 73.01 111.03 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -49.79 121.46 5.3 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.192 -0.458 . . . . 75.33 111.133 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' SER . . . . . 0.509 ' C ' ' H ' ' A' ' 169' ' ' ALA . 0.4 OUTLIER 64.94 143.81 0.08 OUTLIER Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.623 0.725 . . . . 75.44 110.886 -179.781 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . 0.499 ' HG2' ' HB3' ' A' ' 126' ' ' GLU . 53.8 Cg_endo -69.74 33.12 0.19 Allowed 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.675 2.25 . . . . 71.25 112.319 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . 0.509 ' H ' ' C ' ' A' ' 167' ' ' SER . . . -67.32 105.17 1.69 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.27 -0.423 . . . . 74.4 111.077 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 3.3 t -153.5 163.4 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.203 -0.453 . . . . 74.32 111.176 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' GLN . . . . . 0.664 ' OE1' ' HB3' ' A' ' 143' ' ' PRO . 2.0 mm-40 -111.77 -90.21 0.5 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.192 -0.458 . . . . 74.32 110.913 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' SER . . . . . 0.757 ' OG ' ' O ' ' A' ' 143' ' ' PRO . 36.2 p -122.19 -179.72 4.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.187 -0.46 . . . . 63.41 110.851 -179.82 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -146.54 174.78 11.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.113 -0.494 . . . . 72.0 110.898 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . 0.493 ' HG2' ' HB ' ' A' ' 138' ' ' ILE . 0.0 OUTLIER -147.01 158.05 43.8 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.144 -0.48 . . . . 65.22 110.911 -179.933 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . 0.678 ' HA ' ' CZ ' ' A' ' 94' ' ' TYR . 0.0 OUTLIER -95.14 -179.95 4.99 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.198 -0.455 . . . . 75.32 110.847 -179.908 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . 0.472 ' CD1' ' HB ' ' A' ' 136' ' ' VAL . 1.8 mt -126.45 132.45 70.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.161 -0.472 . . . . 75.53 111.119 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 42.2 t -126.09 150.08 31.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.199 -0.455 . . . . 74.13 111.156 179.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.193 -0.458 . . . . 74.41 110.935 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.326 0 N-CA-C 112.49 -0.244 . . . . 52.42 112.49 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.451 ' HA ' ' O ' ' A' ' 44' ' ' GLY . 2.8 p -82.83 135.15 35.04 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.858 0.361 . . . . 75.34 111.17 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 3.9 tttt -121.2 137.12 54.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.244 -0.434 . . . . 74.33 110.89 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.681 HG23 ' CE2' ' A' ' 10' ' ' PHE . 13.3 tt -137.32 147.07 26.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.214 -0.448 . . . . 73.25 111.145 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.425 ' CG2' ' CE2' ' A' ' 11' ' ' TYR . 13.8 m -126.5 129.16 48.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.168 -0.469 . . . . 63.1 111.132 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.681 ' CE2' HG23 ' A' ' 8' ' ' ILE . 1.5 m-85 -114.69 130.15 56.78 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.245 -0.434 . . . . 74.22 110.906 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.508 ' CG ' ' HA ' ' A' ' 16' ' ' PHE . 41.4 m-85 -115.67 130.86 57.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.156 -0.475 . . . . 75.14 110.938 -179.839 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.487 ' HG2' ' HB2' ' A' ' 36' ' ' ARG . 0.0 OUTLIER -60.24 -26.52 66.5 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.172 -0.467 . . . . 74.54 110.871 -179.976 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 68.9 m-20 -124.32 151.22 44.55 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.119 -0.491 . . . . 74.03 110.872 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.516 ' N ' ' HB3' ' A' ' 38' ' ' ASN . 35.0 mtmt -56.26 -178.58 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.162 -0.472 . . . . 71.11 110.885 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 28.1 m-20 49.78 35.41 9.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.239 -0.437 . . . . 75.23 110.893 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.508 ' HA ' ' CG ' ' A' ' 11' ' ' TYR . 3.8 m-85 48.05 57.6 5.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.17 -0.468 . . . . 74.21 110.894 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -134.46 160.26 38.55 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.125 -0.488 . . . . 75.13 110.943 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 94.0 -151.47 20.27 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.776 -0.726 . . . . 64.2 112.501 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.441 ' O ' ' CD1' ' A' ' 34' ' ' LEU . 0.0 OUTLIER -68.71 80.0 0.29 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.813 0.34 . . . . 75.12 110.864 -179.874 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.455 ' HA ' ' O ' ' A' ' 10' ' ' PHE . 0.5 OUTLIER -78.28 124.89 28.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.169 -0.468 . . . . 73.32 110.879 -179.922 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.424 ' CD2' ' CD2' ' A' ' 30' ' ' PHE . 86.9 t80 -122.42 124.87 44.65 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.194 -0.457 . . . . 72.53 110.917 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -109.94 130.33 55.54 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.146 -0.479 . . . . 73.13 110.852 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -142.0 145.96 35.03 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.173 -0.467 . . . . 64.43 110.868 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -130.73 5.7 4.66 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.178 -0.465 . . . . 54.32 110.905 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.42 ' O ' ' C ' ' A' ' 26' ' ' ASP . 38.2 t -132.15 160.41 36.12 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.151 -0.477 . . . . 75.1 110.897 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.42 ' C ' ' O ' ' A' ' 25' ' ' CYS . 6.2 m-20 -35.59 108.88 0.08 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.168 -0.469 . . . . 71.31 110.853 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.691 ' HB3' ' HB3' ' A' ' 30' ' ' PHE . 0.5 OUTLIER -119.24 45.82 2.03 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.167 -0.469 . . . . 71.43 110.883 -179.892 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.589 ' O ' ' HA ' ' A' ' 82' ' ' SER . . . -55.08 -11.14 0.62 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.204 -0.453 . . . . 63.24 111.143 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 60.6 t0 -130.81 39.13 3.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.219 -0.446 . . . . 72.41 110.831 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.833 ' O ' ' CD2' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -82.8 16.55 2.19 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.232 -0.44 . . . . 70.2 110.897 -179.916 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.484 ' HB2' ' HB3' ' A' ' 81' ' ' SER . 46.5 t60 -81.78 -29.61 32.66 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.172 -0.467 . . . . 73.02 110.851 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.7 t -68.66 -7.07 29.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.218 -0.446 . . . . 71.33 111.14 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -107.01 -29.44 9.42 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.197 -0.456 . . . . 75.34 110.925 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.441 ' CD1' ' O ' ' A' ' 19' ' ' ARG . 24.0 tp -138.26 145.32 41.18 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.139 -0.482 . . . . 74.24 110.903 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.2 m -113.37 -32.51 6.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.158 -0.474 . . . . 72.32 110.837 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.487 ' HB2' ' HG2' ' A' ' 12' ' ' GLU . 1.4 mtp85 -116.22 142.37 46.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.162 -0.472 . . . . 72.52 110.869 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.634 ' SG ' ' HB2' ' A' ' 80' ' ' LEU . 1.7 p -119.91 54.94 1.0 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.184 -0.462 . . . . 72.52 110.917 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.516 ' HB3' ' N ' ' A' ' 14' ' ' LYS . 1.8 m-80 -55.59 -64.96 0.68 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.156 -0.474 . . . . 73.34 110.871 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 5.9 p -116.95 130.94 57.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.261 -0.427 . . . . 75.3 110.863 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.464 ' O ' ' N ' ' A' ' 67' ' ' TYR . 12.1 mt -126.87 149.15 31.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.164 -0.471 . . . . 72.03 111.066 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.451 ' N ' HG23 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -143.73 120.7 11.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.125 -0.488 . . . . 72.52 110.884 179.83 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.575 HG23 ' HB ' ' A' ' 8' ' ' ILE . 2.1 t -102.85 115.04 44.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.21 -0.45 . . . . 75.0 111.133 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -109.47 81.05 1.38 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.203 -0.453 . . . . 65.42 110.895 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.451 ' O ' ' HA ' ' A' ' 6' ' ' THR . . . 127.32 108.52 1.51 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.776 -0.726 . . . . 73.21 112.478 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 50.78 -179.54 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.72 -0.753 . . . . 72.33 112.511 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.485 HG21 ' HA ' ' A' ' 63' ' ' PRO . 15.3 m -84.47 159.64 20.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.736 0.303 . . . . 71.1 111.203 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . 0.599 ' CD1' ' HB ' ' A' ' 8' ' ' ILE . 3.3 m95 -131.92 130.24 41.31 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.264 -0.426 . . . . 73.4 110.914 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.602 ' HB2' HG13 ' A' ' 61' ' ' ILE . . . -91.4 124.6 35.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.236 -0.438 . . . . 62.45 111.103 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.548 HG11 ' CD1' ' A' ' 80' ' ' LEU . 13.7 m -126.87 131.35 71.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.204 -0.453 . . . . 74.32 111.133 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.966 ' HB3' ' CB ' ' A' ' 56' ' ' ALA . 4.6 m-85 -106.68 145.37 32.07 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.141 -0.481 . . . . 75.42 110.864 -179.874 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.45 ' HG2' ' N ' ' A' ' 52' ' ' ARG . 0.8 OUTLIER -50.51 -86.41 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.079 -0.509 . . . . 74.1 110.829 -179.936 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.792 ' H ' ' HA ' ' A' ' 56' ' ' ALA . 7.7 mmm180 -77.63 138.34 62.77 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.608 0.718 . . . . 72.34 110.84 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.711 ' HB3' ' HB3' ' A' ' 81' ' ' SER . 53.7 Cg_endo -69.81 136.41 32.8 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.702 2.268 . . . . 71.41 112.352 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.427 ' C ' ' CD1' ' A' ' 55' ' ' PHE . 1.3 m120 64.99 -4.92 0.44 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.201 -0.454 . . . . 73.21 110.889 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.522 ' H ' ' C ' ' A' ' 53' ' ' PRO . 0.1 OUTLIER -137.86 -70.39 0.44 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.153 -0.476 . . . . 71.23 110.878 -179.989 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.966 ' CB ' ' HB3' ' A' ' 50' ' ' TYR . . . 38.87 74.9 0.08 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.168 -0.469 . . . . 62.11 111.088 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . 0.415 ' O ' ' CD2' ' A' ' 58' ' ' TYR . 9.8 m0 -63.6 30.59 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.174 -0.466 . . . . 65.4 110.924 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.653 ' H ' ' C ' ' A' ' 56' ' ' ALA . 1.2 m-30 -163.13 109.5 1.16 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.233 -0.439 . . . . 74.13 110.898 -179.867 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.414 ' HG3' ' CE2' ' A' ' 50' ' ' TYR . 0.3 OUTLIER -68.79 140.24 55.28 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.166 -0.47 . . . . 73.42 110.88 179.879 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.617 ' OH ' ' O ' ' A' ' 73' ' ' TRP . 0.9 OUTLIER -150.47 81.97 1.35 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.221 -0.445 . . . . 74.54 110.879 -179.875 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.602 HG13 ' HB2' ' A' ' 48' ' ' ALA . 1.1 mp -75.14 115.5 16.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.139 -0.482 . . . . 72.22 111.107 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.417 ' O ' HG21 ' A' ' 46' ' ' THR . 0.3 OUTLIER -82.4 124.05 78.4 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.579 0.704 . . . . 75.14 110.88 179.911 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.485 ' HA ' HG21 ' A' ' 46' ' ' THR . 53.2 Cg_endo -69.82 -174.04 0.84 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.604 2.203 . . . . 74.33 112.373 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.0 163.33 18.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.26 -0.427 . . . . 74.13 110.925 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 113.05 -160.41 13.14 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.75 -0.738 . . . . 41.15 112.509 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -115.13 158.25 22.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.858 0.361 . . . . 74.53 110.869 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.464 ' N ' ' O ' ' A' ' 40' ' ' ILE . 11.2 m-85 -148.21 83.24 7.29 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.671 0.748 . . . . 74.5 110.878 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.433 ' HD2' ' HG3' ' A' ' 72' ' ' ARG . 53.5 Cg_endo -69.77 -4.98 15.12 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.728 2.285 . . . . 74.42 112.324 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -157.58 141.14 15.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.202 -0.454 . . . . 75.43 110.94 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.896 ' O ' ' CD1' ' A' ' 73' ' ' TRP . 44.9 p90 -51.55 -41.24 60.95 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.177 -0.465 . . . . 72.05 110.896 -179.834 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -52.02 -20.05 2.2 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.156 -0.474 . . . . 74.54 110.917 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.433 ' HG3' ' HD2' ' A' ' 68' ' ' PRO . 28.2 mmt180 -64.03 -30.24 71.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.188 -0.46 . . . . 74.14 110.872 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . 0.896 ' CD1' ' O ' ' A' ' 70' ' ' TYR . 0.5 OUTLIER -103.88 30.66 4.97 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.192 -0.458 . . . . 73.53 110.951 179.983 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' MET . . . . . 0.439 ' O ' ' C ' ' A' ' 75' ' ' GLY . 0.0 OUTLIER 74.64 23.82 1.79 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.225 -0.443 . . . . 63.52 110.88 179.918 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.44 ' N ' ' HD1' ' A' ' 73' ' ' TRP . . . 33.03 49.37 0.43 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.697 -0.763 . . . . 42.11 112.525 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.496 ' CB ' ' CE2' ' A' ' 60' ' ' TYR . 0.6 OUTLIER -65.46 -77.61 0.06 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.806 0.336 . . . . 73.23 110.909 -179.908 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -135.79 134.17 38.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.161 -0.472 . . . . 63.41 110.888 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -90.09 17.0 7.42 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.122 -0.49 . . . . 74.22 110.88 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 6.0 ttm105 -107.36 77.18 1.12 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.174 -0.466 . . . . 74.33 110.844 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.634 ' HB2' ' SG ' ' A' ' 37' ' ' CYS . 0.1 OUTLIER -82.32 134.43 35.26 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.172 -0.467 . . . . 73.44 110.928 -179.99 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.711 ' HB3' ' HB3' ' A' ' 53' ' ' PRO . 1.5 m -154.32 -124.38 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.196 -0.456 . . . . 73.22 110.866 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.686 ' OG ' ' HA ' ' A' ' 53' ' ' PRO . 0.0 OUTLIER -36.28 106.88 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 72.33 110.891 -179.846 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . 0.522 ' HA ' ' O ' ' A' ' 48' ' ' ALA . 27.9 p -130.13 132.78 46.24 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.147 -0.479 . . . . 75.41 110.881 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . 0.565 ' N ' ' O ' ' A' ' 48' ' ' ALA . 4.1 mmt180 -123.41 146.46 47.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.205 -0.452 . . . . 72.32 110.876 -179.839 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -64.99 124.97 23.46 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.244 -0.434 . . . . 75.04 111.11 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.509 ' CG2' ' HB3' ' A' ' 48' ' ' ALA . 2.7 t -118.67 146.67 22.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.185 -0.461 . . . . 64.51 111.127 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . 0.472 ' O ' ' CG2' ' A' ' 136' ' ' VAL . 22.3 m-70 -110.11 112.5 24.53 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.189 -0.459 . . . . 71.42 110.92 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -38.04 151.27 0.16 Allowed Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.647 0.737 . . . . 73.44 110.875 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.538 ' HB3' ' H ' ' A' ' 136' ' ' VAL . 53.8 Cg_endo -69.76 98.78 0.7 Allowed 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.644 2.23 . . . . 62.53 112.354 179.816 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -105.56 -178.44 3.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.199 -0.455 . . . . 60.24 110.826 -179.822 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 48.9 84.89 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.764 -0.731 . . . . 62.14 112.443 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 100.72 29.45 6.55 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.777 -0.725 . . . . 73.51 112.475 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.447 ' O ' ' HG2' ' A' ' 134' ' ' GLU . 6.1 pt20 38.35 -129.6 0.22 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.852 0.358 . . . . 74.33 110.912 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.624 ' HA ' ' HG2' ' A' ' 134' ' ' GLU . 0.4 OUTLIER -117.13 103.73 10.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.211 -0.45 . . . . 73.24 110.943 -179.878 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.415 ' H ' ' HG2' ' A' ' 134' ' ' GLU . 38.9 tptt -110.8 125.77 53.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.129 -0.487 . . . . 75.15 110.886 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.429 HG21 HD13 ' A' ' 96' ' ' ILE . 0.0 OUTLIER -149.84 136.96 13.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.238 -0.437 . . . . 73.5 111.149 179.829 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.421 ' HB2' ' O ' ' A' ' 131' ' ' LYS . 2.4 mt-30 -107.86 132.7 53.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.183 -0.462 . . . . 74.11 110.917 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 1.2 mp -111.29 140.8 28.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.176 -0.466 . . . . 74.11 111.158 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.644 ' HB2' ' HB2' ' A' ' 129' ' ' SER . 47.5 m-85 -130.97 134.65 46.92 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.192 -0.458 . . . . 74.32 110.868 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 51.1 tt0 -62.82 -78.86 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.15 -0.477 . . . . 74.03 110.907 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 6.6 mttt -83.97 162.68 20.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.117 -0.492 . . . . 73.21 110.851 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.4 ' CA ' ' HB3' ' A' ' 128' ' ' HIS . . . -70.4 163.2 53.09 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.726 -0.75 . . . . 72.43 112.466 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.482 ' HA ' ' HB2' ' A' ' 158' ' ' ARG . 33.4 t0 63.62 26.29 14.58 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.842 0.353 . . . . 64.23 110.888 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.464 ' CZ ' ' HB3' ' A' ' 158' ' ' ARG . 14.8 m-85 61.49 48.48 5.84 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.207 -0.451 . . . . 73.21 110.831 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 2.3 m -113.67 148.04 37.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.16 -0.473 . . . . 73.54 110.807 -179.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 92.27 -121.81 6.6 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.692 -0.766 . . . . 74.41 112.452 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 7.5 tp-100 -104.88 147.21 27.99 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.822 0.344 . . . . 74.52 110.916 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 3.7 ttp -136.65 136.79 39.42 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.205 -0.452 . . . . 75.43 110.919 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 12.9 m-85 -143.95 137.41 27.76 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.249 -0.432 . . . . 74.12 110.959 -179.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -114.93 111.14 20.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.153 -0.476 . . . . 75.45 110.933 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 11.7 t -118.1 139.46 51.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.157 -0.474 . . . . 70.32 111.122 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.57 ' HA ' ' O ' ' A' ' 94' ' ' TYR . 2.1 t -117.66 40.49 3.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.177 -0.465 . . . . 62.32 111.152 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -153.15 163.31 40.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.227 -0.442 . . . . 73.33 110.887 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -51.34 159.3 0.7 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.182 -0.463 . . . . 72.15 110.855 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . 0.606 ' O ' ' HB2' ' A' ' 172' ' ' SER . 41.9 t -147.85 111.34 3.86 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.589 0.709 . . . . 62.21 110.892 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.456 ' O ' ' C ' ' A' ' 143' ' ' PRO . 53.7 Cg_endo -69.8 -31.98 19.3 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.663 2.242 . . . . 74.32 112.303 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' SER . . . . . 0.631 ' HB3' ' CB ' ' A' ' 120' ' ' GLU . 0.2 OUTLIER -149.06 105.5 3.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.238 -0.437 . . . . 74.22 110.865 -179.819 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.624 ' HB ' ' O ' ' A' ' 171' ' ' GLN . 3.7 tt -61.93 -30.52 48.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.15 -0.477 . . . . 70.22 111.153 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' MET . . . . . 0.627 ' O ' ' HA ' ' A' ' 123' ' ' HIS . 38.5 ttp -86.68 -38.6 16.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 73.23 110.894 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.631 ' CB ' ' HB3' ' A' ' 117' ' ' SER . 5.3 tp10 -72.71 -13.44 61.34 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.222 -0.445 . . . . 73.51 110.89 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 28.1 tp60 -114.8 -41.18 3.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.126 -0.488 . . . . 73.03 110.914 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . 0.514 ' HB2' ' O ' ' A' ' 118' ' ' ILE . 51.8 m-85 -112.05 -20.61 11.89 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.216 -0.447 . . . . 65.44 110.913 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . 0.627 ' HA ' ' O ' ' A' ' 119' ' ' MET . 13.0 m80 72.8 27.02 2.25 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.124 -0.489 . . . . 74.4 110.856 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 9.3 mtt -101.31 90.75 4.22 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.183 -0.462 . . . . 72.2 110.861 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 4.1 ptp180 -53.49 -43.94 68.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.268 -0.424 . . . . 64.23 110.912 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.462 ' HG2' ' HA ' ' A' ' 169' ' ' ALA . 8.7 mt-10 -137.59 130.55 30.34 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.146 -0.479 . . . . 75.11 110.883 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.433 ' O ' ' HB3' ' A' ' 168' ' ' PRO . 3.5 mm -88.79 91.48 3.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.104 -0.498 . . . . 74.43 111.165 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . 0.518 ' CD2' ' HG3' ' A' ' 168' ' ' PRO . 52.4 m80 -65.51 -30.16 70.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.147 -0.478 . . . . 74.02 110.857 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 0.644 ' HB2' ' HB2' ' A' ' 99' ' ' PHE . 0.4 OUTLIER -135.08 144.42 47.2 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.205 -0.452 . . . . 75.53 110.865 -179.765 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . 0.662 ' O ' ' O ' ' A' ' 155' ' ' LYS . 0.1 OUTLIER -146.53 119.71 8.89 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.138 -0.483 . . . . 72.22 110.858 -179.934 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.635 ' HA ' ' HA ' ' A' ' 156' ' ' GLU . 6.0 mtpp -107.38 153.54 22.63 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.172 -0.467 . . . . 75.13 110.859 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.464 ' HB ' ' O ' ' A' ' 131' ' ' LYS . 9.8 t 82.28 165.54 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.239 -0.437 . . . . 61.41 111.133 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.464 ' CD1' ' O ' ' A' ' 154' ' ' LYS . 0.0 OUTLIER -176.91 124.2 0.15 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.17 -0.468 . . . . 75.13 110.934 179.956 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.624 ' HG2' ' HA ' ' A' ' 94' ' ' TYR . 0.0 OUTLIER -97.44 164.02 12.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.227 -0.442 . . . . 72.11 110.924 179.919 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . 0.544 ' C ' ' O ' ' A' ' 134' ' ' GLU . . . -24.7 -61.18 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.746 -0.74 . . . . 62.21 112.451 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.65 ' HA ' HD13 ' A' ' 152' ' ' LEU . 1.7 t -147.44 154.19 11.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.817 0.341 . . . . 72.55 111.15 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' TRP . . . . . 0.724 ' HB3' ' HB3' ' A' ' 152' ' ' LEU . 0.7 OUTLIER -152.09 149.05 28.39 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.188 -0.46 . . . . 73.43 110.887 -179.994 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.478 ' CD1' ' HB ' ' A' ' 61' ' ' ILE . 5.6 mm -116.55 135.42 56.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.21 -0.45 . . . . 73.33 111.163 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 0.465 ' HB2' ' HB2' ' A' ' 150' ' ' TYR . 1.4 m-85 -112.25 165.02 12.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.209 -0.451 . . . . 73.4 110.866 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . 0.462 ' HB3' ' O ' ' A' ' 146' ' ' ARG . 5.2 m-85 -144.8 132.03 20.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.147 -0.479 . . . . 75.22 110.887 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . 0.641 ' O ' ' HB2' ' A' ' 171' ' ' GLN . 0.0 OUTLIER -57.92 -27.79 63.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.091 -0.504 . . . . 63.42 110.876 -179.997 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.752 ' HB3' ' HD2' ' A' ' 143' ' ' PRO . 9.5 mp -114.1 173.28 2.96 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.614 0.721 . . . . 74.34 110.94 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . 0.752 ' HD2' ' HB3' ' A' ' 142' ' ' LEU . 53.3 Cg_endo -69.8 -90.46 0.0 OUTLIER 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.697 2.264 . . . . 72.21 112.324 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . 0.721 ' O ' ' N ' ' A' ' 146' ' ' ARG . 0.5 OUTLIER -50.79 97.81 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.213 -0.449 . . . . 75.42 110.937 179.985 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . 0.653 ' C ' ' O ' ' A' ' 144' ' ' ASN . 0.2 OUTLIER 11.46 53.34 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.173 -0.467 . . . . 72.41 110.937 -179.875 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . 0.721 ' N ' ' O ' ' A' ' 144' ' ' ASN . 22.5 mtt180 -121.5 160.2 24.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.148 -0.478 . . . . 75.35 110.859 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 93.26 -172.4 33.33 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.696 -0.764 . . . . 62.41 112.493 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 4.1 mpt_? -79.65 155.05 28.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.79 0.328 . . . . 73.54 110.88 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -81.56 151.83 27.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.213 -0.449 . . . . 71.31 110.919 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . 0.465 ' HB2' ' HB2' ' A' ' 139' ' ' PHE . 69.4 m-85 -151.96 103.11 2.87 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.178 -0.464 . . . . 73.11 110.893 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.406 ' HB2' ' CD1' ' A' ' 61' ' ' ILE . 0.1 OUTLIER -69.92 137.33 51.48 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.096 -0.502 . . . . 73.04 110.892 179.988 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.724 ' HB3' ' HB3' ' A' ' 137' ' ' TRP . 0.0 OUTLIER -72.7 151.87 41.97 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.189 -0.46 . . . . 70.3 110.905 179.898 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -162.66 24.34 0.1 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.165 -0.471 . . . . 75.34 110.859 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 1.016 ' HB2' ' CD1' ' A' ' 157' ' ' TYR . 6.1 ptmt -115.29 -166.79 1.16 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.187 -0.461 . . . . 70.25 110.895 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.693 ' HG3' ' O ' ' A' ' 154' ' ' LYS . 0.9 OUTLIER -158.47 -122.42 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.238 -0.437 . . . . 74.13 110.914 179.852 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . 0.635 ' HA ' ' HA ' ' A' ' 131' ' ' LYS . 2.4 tm-20 -68.56 -0.33 4.99 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.222 -0.445 . . . . 75.33 110.943 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . 1.016 ' CD1' ' HB2' ' A' ' 154' ' ' LYS . 9.5 m-30 -32.55 146.15 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.12 -0.491 . . . . 61.44 110.901 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . 0.482 ' HB2' ' HA ' ' A' ' 103' ' ' ASP . 7.5 ptp180 -110.13 -39.7 4.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.107 -0.497 . . . . 74.54 110.902 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 2.4 ptpp? -91.39 151.2 42.49 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.58 0.705 . . . . 74.42 110.896 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 -25.73 28.28 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.734 2.289 . . . . 74.22 112.295 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.474 HD11 ' H ' ' A' ' 161' ' ' ILE . 4.0 mp -73.98 -6.16 7.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.265 -0.425 . . . . 74.14 111.129 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . 0.601 ' HB3' ' CD1' ' A' ' 157' ' ' TYR . 1.6 t0 -72.54 -13.45 61.41 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.197 -0.456 . . . . 54.31 110.868 179.842 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 82.2 t90 -107.14 -3.43 19.91 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.189 -0.46 . . . . 72.14 110.917 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 100.12 -35.35 4.84 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.753 -0.737 . . . . 71.13 112.475 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -57.1 121.07 9.16 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.812 0.339 . . . . 63.1 111.098 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -46.99 -30.48 2.62 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.224 -0.444 . . . . 74.04 111.087 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' SER . . . . . 0.509 ' C ' ' H ' ' A' ' 169' ' ' ALA . 0.5 OUTLIER -151.49 154.41 33.4 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.697 0.76 . . . . 75.53 110.826 -179.74 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . 0.518 ' HG3' ' CD2' ' A' ' 128' ' ' HIS . 53.5 Cg_endo -69.73 22.53 0.17 Allowed 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.639 2.226 . . . . 63.44 112.399 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . 0.509 ' H ' ' C ' ' A' ' 167' ' ' SER . . . -65.65 101.25 0.6 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.201 -0.454 . . . . 74.03 111.121 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 2.4 t -153.59 163.77 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.235 -0.439 . . . . 72.12 111.133 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' GLN . . . . . 0.641 ' HB2' ' O ' ' A' ' 141' ' ' GLU . 1.8 mm-40 -111.23 -87.2 0.54 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.21 -0.45 . . . . 71.42 110.941 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' SER . . . . . 0.734 ' OG ' ' O ' ' A' ' 143' ' ' PRO . 24.8 p -125.97 175.53 7.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.218 -0.446 . . . . 71.0 110.86 -179.792 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 10.7 p90 -144.14 168.25 20.47 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.166 -0.47 . . . . 75.42 110.889 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.32 156.6 48.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.133 -0.485 . . . . 75.25 110.862 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . 0.444 ' HD2' ' CE2' ' A' ' 94' ' ' TYR . 0.8 OUTLIER -88.68 -175.76 5.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.194 -0.457 . . . . 74.21 110.838 -179.916 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . 0.486 ' CD1' ' HB ' ' A' ' 136' ' ' VAL . 5.6 mt -129.7 131.69 66.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.151 -0.477 . . . . 65.32 111.127 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 18.9 t -125.38 153.22 32.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.177 -0.465 . . . . 74.34 111.149 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.218 -0.446 . . . . 75.14 110.847 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.266 0 N-CA-C 112.465 -0.254 . . . . 71.32 112.465 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.431 ' HA ' ' O ' ' A' ' 44' ' ' GLY . 14.7 p -81.85 137.32 35.28 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.852 0.358 . . . . 72.11 111.143 -179.878 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.422 ' HA ' ' HA ' ' A' ' 24' ' ' ASP . 2.4 tttt -125.69 135.62 52.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.238 -0.437 . . . . 73.5 110.887 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.624 HG23 ' CZ ' ' A' ' 10' ' ' PHE . 14.6 tt -135.98 153.78 32.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.216 -0.447 . . . . 74.32 111.094 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.433 ' HA ' ' O ' ' A' ' 21' ' ' TYR . 12.9 m -135.77 145.91 47.06 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.151 -0.477 . . . . 74.1 111.143 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.624 ' CZ ' HG23 ' A' ' 8' ' ' ILE . 0.3 OUTLIER -133.6 128.52 35.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.208 -0.451 . . . . 75.34 110.835 -179.954 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.544 ' CG ' ' HA ' ' A' ' 16' ' ' PHE . 22.1 m-85 -113.65 132.54 55.73 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.182 -0.463 . . . . 72.41 110.914 -179.869 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.401 ' HA ' ' O ' ' A' ' 36' ' ' ARG . 0.0 OUTLIER -60.71 -14.38 20.68 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.108 -0.496 . . . . 72.24 110.883 -179.989 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.44 ' HB2' ' O ' ' A' ' 17' ' ' GLN . 78.1 m-20 -136.38 150.96 49.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.146 -0.479 . . . . 72.34 110.852 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.425 ' HG3' ' HB3' ' A' ' 38' ' ' ASN . 4.5 mtmm -55.25 -176.2 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.165 -0.471 . . . . 74.44 110.919 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 19.4 m120 45.31 34.18 1.42 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.234 -0.439 . . . . 75.34 110.849 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.544 ' HA ' ' CG ' ' A' ' 11' ' ' TYR . 2.2 m-85 48.39 67.32 0.87 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.211 -0.449 . . . . 74.52 110.905 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . 0.44 ' O ' ' HB2' ' A' ' 13' ' ' ASP . 4.7 mt-30 -141.78 158.13 44.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.145 -0.48 . . . . 75.03 110.876 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 92.85 -150.29 19.92 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.759 -0.734 . . . . 24.03 112.497 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.4 ' O ' ' CD1' ' A' ' 34' ' ' LEU . 2.2 mtt180 -68.74 79.9 0.29 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.827 0.346 . . . . 70.22 110.872 -179.855 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.465 ' HA ' ' O ' ' A' ' 10' ' ' PHE . 0.5 OUTLIER -77.96 129.13 34.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.199 -0.455 . . . . 74.24 110.89 -179.953 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.433 ' O ' ' HA ' ' A' ' 9' ' ' THR . 70.3 t80 -123.86 125.98 45.61 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.177 -0.465 . . . . 64.2 110.948 -179.87 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.41 ' OD2' ' CD ' ' A' ' 20' ' ' ARG . 1.3 m-20 -119.41 134.81 55.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.109 -0.496 . . . . 74.15 110.85 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 9.4 t -160.44 129.4 4.87 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.177 -0.465 . . . . 74.42 110.858 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.422 ' HA ' ' HA ' ' A' ' 7' ' ' LYS . 2.5 p30 -97.65 5.36 49.48 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.157 -0.474 . . . . 75.04 110.841 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 47.5 t -114.91 160.65 19.27 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.186 -0.461 . . . . 63.11 110.892 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 87.4 m-20 -43.06 120.11 1.72 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.202 -0.453 . . . . 72.35 110.904 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.554 ' CB ' ' HB3' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -114.37 40.35 2.55 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.21 -0.45 . . . . 73.12 110.862 -179.907 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.56 ' O ' ' HB3' ' A' ' 82' ' ' SER . . . -50.47 -21.76 1.62 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.239 -0.437 . . . . 64.03 111.126 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 60.8 t0 -130.5 40.02 3.56 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.212 -0.449 . . . . 72.2 110.871 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.762 ' O ' ' CD2' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -80.04 14.54 1.8 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.15 -0.477 . . . . 70.22 110.911 -179.914 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.426 ' CG ' ' HG3' ' A' ' 53' ' ' PRO . 40.7 t60 -77.63 -35.11 52.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.138 -0.483 . . . . 64.32 110.842 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.6 t -61.95 -12.23 17.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.254 -0.43 . . . . 74.31 111.119 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -102.29 -26.56 13.27 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.265 -0.425 . . . . 73.13 110.894 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.4 ' CD1' ' O ' ' A' ' 19' ' ' ARG . 28.0 tp -139.33 130.43 26.54 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.146 -0.479 . . . . 74.13 110.944 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 21.1 m -91.24 -44.73 9.04 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.167 -0.469 . . . . 71.21 110.866 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.401 ' O ' ' HA ' ' A' ' 12' ' ' GLU . 0.0 OUTLIER -114.28 145.49 41.68 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.103 -0.499 . . . . 75.42 110.893 -179.918 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.576 ' SG ' ' CB ' ' A' ' 80' ' ' LEU . 3.5 m -126.76 106.35 9.3 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.184 -0.462 . . . . 64.01 110.861 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.425 ' HB3' ' HG3' ' A' ' 14' ' ' LYS . 11.3 m-20 -104.07 -62.43 1.31 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.174 -0.466 . . . . 75.11 110.905 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 9.7 p -111.96 133.19 54.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.46 . . . . 70.22 110.903 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.498 ' O ' ' N ' ' A' ' 67' ' ' TYR . 8.9 mt -129.19 151.56 35.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.14 -0.482 . . . . 72.2 111.122 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.47 ' N ' HG23 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -143.05 121.03 12.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.149 -0.478 . . . . 75.41 110.862 179.84 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.632 HG22 ' HB2' ' A' ' 47' ' ' TRP . 1.3 t -107.62 116.79 51.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.212 -0.449 . . . . 75.05 111.148 179.833 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -112.18 76.5 0.98 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.177 -0.465 . . . . 72.33 110.932 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.431 ' O ' ' HA ' ' A' ' 6' ' ' THR . . . 142.37 94.09 0.21 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.738 -0.744 . . . . 72.54 112.441 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 56.49 174.26 0.21 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.763 -0.732 . . . . 75.4 112.49 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.485 HG21 ' HA ' ' A' ' 63' ' ' PRO . 1.2 m -69.09 169.99 10.84 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.793 0.33 . . . . 74.43 111.126 -179.867 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . 0.632 ' HB2' HG22 ' A' ' 42' ' ' VAL . 5.3 m95 -145.53 128.91 16.88 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.208 -0.451 . . . . 74.41 110.924 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.627 ' O ' ' N ' ' A' ' 84' ' ' ARG . . . -88.54 126.62 35.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.234 -0.439 . . . . 75.14 111.105 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.671 ' O ' ' O ' ' A' ' 60' ' ' TYR . 27.2 m -126.77 139.58 51.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.211 -0.45 . . . . 74.31 111.177 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.878 ' HB3' ' CB ' ' A' ' 56' ' ' ALA . 5.0 m-85 -116.55 144.47 44.33 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.17 -0.468 . . . . 73.13 110.949 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.575 ' HG2' ' N ' ' A' ' 52' ' ' ARG . 0.3 OUTLIER -48.61 -84.67 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.141 -0.481 . . . . 74.33 110.867 -179.971 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.728 ' H ' ' HA ' ' A' ' 56' ' ' ALA . 0.2 OUTLIER -81.46 136.72 48.78 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.573 0.701 . . . . 74.44 110.915 -179.935 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.633 ' HB3' ' HB3' ' A' ' 81' ' ' SER . 53.8 Cg_endo -69.7 137.89 36.7 Favored 'Trans proline' 0 C--N 1.341 0.14 0 C-N-CA 122.681 2.254 . . . . 74.24 112.376 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.468 ' C ' ' CD2' ' A' ' 55' ' ' PHE . 2.0 m120 69.22 -5.87 1.03 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.277 -0.419 . . . . 73.51 110.885 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.468 ' CD2' ' C ' ' A' ' 54' ' ' ASN . 0.1 OUTLIER -143.51 -75.43 0.26 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.131 -0.486 . . . . 75.53 110.875 -179.913 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.878 ' CB ' ' HB3' ' A' ' 50' ' ' TYR . . . 45.87 81.27 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.14 -0.482 . . . . 72.34 111.09 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . 0.455 ' O ' ' CD2' ' A' ' 58' ' ' TYR . 18.9 m0 -65.32 35.48 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.227 -0.442 . . . . 74.53 110.908 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.613 ' H ' ' C ' ' A' ' 56' ' ' ALA . 1.2 m-30 -165.06 117.26 1.18 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.257 -0.429 . . . . 74.55 110.913 -179.844 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.422 ' HB2' ' HA ' ' A' ' 150' ' ' TYR . 1.0 OUTLIER -78.7 130.66 36.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.105 -0.498 . . . . 73.55 110.899 179.925 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.671 ' O ' ' O ' ' A' ' 49' ' ' VAL . 13.8 t80 -139.51 98.17 3.43 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.262 -0.427 . . . . 72.11 110.922 -179.864 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 4.0 mp -83.56 111.16 19.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.1 -0.5 . . . . 74.41 111.15 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.408 HD13 HG23 ' A' ' 49' ' ' VAL . 0.3 OUTLIER -79.88 127.05 78.68 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.608 0.718 . . . . 74.34 110.923 179.898 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.485 ' HA ' HG21 ' A' ' 46' ' ' THR . 53.7 Cg_endo -69.76 -165.04 0.14 Allowed 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.688 2.259 . . . . 72.31 112.348 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.91 160.68 14.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.236 -0.438 . . . . 75.13 110.928 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 112.61 -151.92 18.03 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.71 -0.757 . . . . 62.32 112.498 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -116.05 161.57 18.69 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.863 0.363 . . . . 74.54 110.884 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.498 ' N ' ' O ' ' A' ' 40' ' ' ILE . 13.6 m-85 -149.56 82.38 6.81 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.69 0.757 . . . . 72.15 110.929 -179.857 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.457 ' HD2' ' HG3' ' A' ' 72' ' ' ARG . 53.9 Cg_endo -69.74 -0.3 6.7 Favored 'Trans proline' 0 N--CA 1.465 -0.19 0 C-N-CA 122.72 2.28 . . . . 61.34 112.379 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -157.99 155.39 29.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.181 -0.463 . . . . 74.41 110.867 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.594 ' O ' ' CD1' ' A' ' 73' ' ' TRP . 24.9 p90 -62.18 -37.46 85.34 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.152 -0.476 . . . . 63.21 110.915 -179.854 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.577 ' HA ' ' CA ' ' A' ' 75' ' ' GLY . 6.6 pt20 -61.25 -10.6 7.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.12 -0.491 . . . . 74.44 110.922 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.457 ' HG3' ' HD2' ' A' ' 68' ' ' PRO . 25.2 mmt180 -65.82 -45.11 83.53 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.186 -0.461 . . . . 74.53 110.872 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . 0.757 ' O ' ' CB ' ' A' ' 74' ' ' MET . 0.4 OUTLIER -81.11 -5.45 57.68 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.182 -0.463 . . . . 74.52 110.902 -179.944 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' MET . . . . . 0.757 ' CB ' ' O ' ' A' ' 73' ' ' TRP . 8.4 mmm 131.21 -3.98 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.207 -0.451 . . . . 73.22 110.889 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.577 ' CA ' ' HA ' ' A' ' 71' ' ' GLN . . . 76.2 17.22 80.14 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.7 -0.762 . . . . 62.55 112.451 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.517 HD13 ' CD2' ' A' ' 60' ' ' TYR . 0.0 OUTLIER -63.45 -154.25 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.787 0.327 . . . . 65.44 110.963 -179.905 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -65.06 131.71 47.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.275 -0.421 . . . . 73.54 110.87 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -87.93 11.91 14.58 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.178 -0.465 . . . . 63.12 110.878 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.539 ' O ' ' O ' ' A' ' 51' ' ' GLU . 0.0 OUTLIER -87.95 49.44 1.8 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.169 -0.469 . . . . 73.41 110.852 -179.872 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.579 HD12 ' HB ' ' A' ' 49' ' ' VAL . 0.1 OUTLIER -59.89 127.08 30.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.191 -0.458 . . . . 74.42 110.891 -179.943 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.633 ' HB3' ' HB3' ' A' ' 53' ' ' PRO . 5.3 m -149.83 -114.99 0.06 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.188 -0.46 . . . . 71.22 110.897 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.577 ' OG ' ' HA ' ' A' ' 53' ' ' PRO . 0.1 OUTLIER -42.43 102.48 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.155 -0.475 . . . . 71.52 110.849 -179.776 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . 0.485 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 8.7 p -130.42 134.02 46.8 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.133 -0.485 . . . . 72.2 110.865 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . 0.627 ' N ' ' O ' ' A' ' 48' ' ' ALA . 0.9 OUTLIER -117.33 158.44 24.39 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.16 -0.473 . . . . 73.53 110.854 -179.862 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.404 ' HB1' ' OG1' ' A' ' 6' ' ' THR . . . -70.58 131.77 44.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.2 -0.454 . . . . 63.33 111.075 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.528 ' CG2' ' CB ' ' A' ' 48' ' ' ALA . 71.3 t -117.06 129.07 74.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.162 -0.472 . . . . 73.14 111.142 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . 0.526 ' O ' ' CG2' ' A' ' 136' ' ' VAL . 16.9 m80 -113.79 107.39 15.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.179 -0.464 . . . . 74.31 110.824 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.477 ' C ' ' O ' ' A' ' 87' ' ' HIS . 0.0 OUTLIER -31.69 148.67 0.05 OUTLIER Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.574 0.702 . . . . 74.53 110.955 -179.999 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.546 ' HA ' ' HA3' ' A' ' 135' ' ' GLY . 53.4 Cg_endo -69.8 93.23 0.52 Allowed 'Trans proline' 0 C--O 1.231 0.136 0 C-N-CA 122.689 2.259 . . . . 73.22 112.323 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -104.61 -174.22 2.49 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.205 -0.452 . . . . 73.01 110.881 -179.872 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 49.55 64.18 3.6 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.755 -0.736 . . . . 64.43 112.464 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 122.6 24.22 2.17 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.751 -0.738 . . . . 71.21 112.515 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 41.5 -158.73 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.822 0.344 . . . . 64.51 110.892 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.486 ' HA ' ' HG2' ' A' ' 134' ' ' GLU . 31.5 t80 -99.77 102.78 14.33 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.187 -0.46 . . . . 75.33 110.905 -179.837 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.415 ' HD2' ' HA ' ' A' ' 95' ' ' LYS . 42.8 tptt -112.61 130.03 56.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.132 -0.485 . . . . 72.45 110.887 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.465 ' HB ' ' OE1' ' A' ' 134' ' ' GLU . 0.0 OUTLIER -148.83 137.44 15.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.232 -0.44 . . . . 75.14 111.127 179.888 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.402 ' HB2' ' O ' ' A' ' 131' ' ' LYS . 0.9 OUTLIER -111.16 132.2 54.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.15 -0.477 . . . . 72.31 110.905 179.935 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 3.1 mp -113.17 135.54 52.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.211 -0.45 . . . . 71.35 111.094 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.654 ' HB2' ' HB2' ' A' ' 129' ' ' SER . 48.7 m-85 -126.48 136.34 52.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.148 -0.478 . . . . 74.52 110.835 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 51.9 tt0 -65.6 -75.29 0.09 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.101 -0.499 . . . . 70.52 110.883 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.411 ' C ' ' HB2' ' A' ' 128' ' ' HIS . 6.0 mttt -85.64 158.6 20.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.143 -0.481 . . . . 74.2 110.939 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -66.54 164.4 41.93 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.782 -0.723 . . . . 71.44 112.512 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.412 ' HA ' ' HB2' ' A' ' 158' ' ' ARG . 38.7 t70 61.67 27.89 17.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.88 0.371 . . . . 65.32 110.843 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.496 ' HA ' ' CD2' ' A' ' 99' ' ' PHE . 14.9 m-85 59.52 52.68 5.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.193 -0.458 . . . . 74.51 110.916 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.2 m -118.13 148.9 41.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.102 -0.499 . . . . 74.04 110.827 -179.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 90.8 -125.19 7.86 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.724 -0.75 . . . . 74.3 112.532 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -98.85 139.55 34.36 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.756 0.312 . . . . 75.43 110.958 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 1.3 ttp -130.99 137.0 49.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.214 -0.448 . . . . 74.12 110.857 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 13.3 m-85 -141.29 136.56 31.72 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.244 -0.434 . . . . 75.05 110.953 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -117.74 103.85 10.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.146 -0.479 . . . . 75.41 110.874 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 13.1 t -117.33 140.69 49.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.166 -0.47 . . . . 61.01 111.166 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.522 ' O ' ' OG1' ' A' ' 112' ' ' THR . 0.1 OUTLIER -101.52 27.72 6.1 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.209 -0.45 . . . . 64.54 111.142 -179.962 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -143.67 -174.96 4.39 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.213 -0.449 . . . . 72.43 110.852 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.469 ' CB ' ' HA ' ' A' ' 174' ' ' ARG . 9.2 p30 -107.96 177.43 4.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.146 -0.479 . . . . 74.2 110.899 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . 0.425 ' O ' ' HB2' ' A' ' 172' ' ' SER . 18.4 p -155.98 148.86 18.14 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 121.578 0.704 . . . . 74.2 110.916 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 -25.65 28.36 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.68 2.253 . . . . 74.35 112.364 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' SER . . . . . 0.609 ' HB3' ' CB ' ' A' ' 120' ' ' GLU . 0.1 OUTLIER -150.77 107.4 3.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.192 -0.458 . . . . 72.12 110.879 -179.861 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.552 ' HB ' ' O ' ' A' ' 171' ' ' GLN . 4.0 tt -59.08 -29.81 42.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.142 -0.481 . . . . 72.31 111.152 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' MET . . . . . 0.595 ' O ' ' HA ' ' A' ' 123' ' ' HIS . 54.8 ttp -86.39 -42.66 13.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.168 -0.469 . . . . 73.31 110.877 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.609 ' CB ' ' HB3' ' A' ' 117' ' ' SER . 8.5 tp10 -67.59 -13.14 61.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.24 -0.437 . . . . 75.34 110.9 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 22.2 tp60 -114.53 -48.11 2.88 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.158 -0.473 . . . . 70.23 110.944 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . 0.447 ' HB2' ' O ' ' A' ' 118' ' ' ILE . 47.6 m-85 -105.68 -20.1 13.56 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.217 -0.447 . . . . 71.13 110.878 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . 0.595 ' HA ' ' O ' ' A' ' 119' ' ' MET . 10.7 m80 72.61 28.14 2.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.201 -0.454 . . . . 63.53 110.83 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.411 ' O ' HG22 ' A' ' 118' ' ' ILE . 4.6 mtt -105.44 84.49 2.1 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.222 -0.444 . . . . 70.45 110.873 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 3.7 ptp180 -50.98 -34.81 30.6 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.196 -0.456 . . . . 75.01 110.885 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.5 ' HG2' ' HA ' ' A' ' 169' ' ' ALA . 18.4 mt-10 -144.8 135.27 24.39 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.16 -0.473 . . . . 75.35 110.872 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.463 ' O ' ' HB3' ' A' ' 168' ' ' PRO . 3.7 mm -96.04 100.71 11.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.147 -0.478 . . . . 74.52 111.122 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . 0.411 ' HB2' ' C ' ' A' ' 101' ' ' LYS . 14.7 m170 -71.34 -30.77 66.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.194 -0.457 . . . . 74.34 110.879 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 0.654 ' HB2' ' HB2' ' A' ' 99' ' ' PHE . 0.4 OUTLIER -133.85 140.08 46.64 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.158 -0.473 . . . . 73.14 110.87 -179.778 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . 0.573 ' O ' ' O ' ' A' ' 155' ' ' LYS . 2.7 m -140.45 117.59 11.24 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.112 -0.494 . . . . 64.42 110.846 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.677 ' HA ' ' HA ' ' A' ' 156' ' ' GLU . 2.9 mtpp -106.44 154.55 20.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.196 -0.456 . . . . 72.12 110.872 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.409 ' CB ' ' O ' ' A' ' 131' ' ' LYS . 4.8 t 79.59 166.38 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.203 -0.453 . . . . 75.12 111.115 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.518 ' HB3' ' HA ' ' A' ' 155' ' ' LYS . 0.1 OUTLIER -171.19 128.52 0.71 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.159 -0.473 . . . . 73.31 110.905 179.992 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.486 ' HG2' ' HA ' ' A' ' 94' ' ' TYR . 0.3 OUTLIER -97.3 155.98 16.64 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.181 -0.463 . . . . 75.53 110.877 179.905 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . 0.546 ' HA3' ' HA ' ' A' ' 89' ' ' PRO . . . -30.53 -48.42 0.16 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.75 -0.738 . . . . 74.04 112.488 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.653 ' HA ' HD13 ' A' ' 152' ' ' LEU . 3.1 t -150.18 137.68 13.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.842 0.353 . . . . 62.34 111.136 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' TRP . . . . . 0.72 ' HB3' ' CB ' ' A' ' 152' ' ' LEU . 16.5 t90 -144.3 137.63 27.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.19 -0.459 . . . . 75.15 110.897 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.528 ' CG2' ' HB2' ' A' ' 149' ' ' GLN . 34.2 mt -111.69 132.05 61.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.212 -0.449 . . . . 72.45 111.097 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 0.539 ' CD2' ' HB3' ' A' ' 173' ' ' PHE . 0.1 OUTLIER -96.88 178.25 5.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.181 -0.463 . . . . 73.14 110.844 179.994 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . 0.518 ' CE2' ' HG2' ' A' ' 174' ' ' ARG . 0.3 OUTLIER -155.07 124.06 6.21 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.143 -0.48 . . . . 74.21 110.921 -179.836 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . 0.602 ' O ' ' HB2' ' A' ' 171' ' ' GLN . 0.1 OUTLIER -61.44 -29.71 70.12 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.158 -0.474 . . . . 62.3 110.859 -179.982 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.734 ' HB3' ' HD2' ' A' ' 143' ' ' PRO . 9.1 mp -114.54 172.89 3.22 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.562 0.696 . . . . 74.34 110.94 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . 0.741 ' O ' ' OG ' ' A' ' 172' ' ' SER . 53.4 Cg_endo -69.76 -90.73 0.01 OUTLIER 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.669 2.246 . . . . 75.41 112.324 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . 0.698 ' O ' ' N ' ' A' ' 146' ' ' ARG . 1.6 m-20 -54.21 95.79 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.201 -0.454 . . . . 75.2 110.907 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . 0.649 ' C ' ' O ' ' A' ' 144' ' ' ASN . 0.1 OUTLIER 12.08 53.94 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.175 -0.466 . . . . 73.32 110.95 -179.876 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . 0.698 ' N ' ' O ' ' A' ' 144' ' ' ASN . 8.8 mtp85 -116.38 163.03 16.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.098 -0.501 . . . . 75.51 110.851 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 74.31 -172.67 51.86 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.722 -0.752 . . . . 61.43 112.481 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 4.7 mpt_? -86.7 134.02 33.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.764 0.316 . . . . 73.51 110.88 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' GLN . . . . . 0.63 ' OE1' ' HA ' ' A' ' 60' ' ' TYR . 0.3 OUTLIER -87.76 163.42 16.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.163 -0.471 . . . . 74.05 110.957 -179.952 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . 0.423 ' HB2' ' HB2' ' A' ' 139' ' ' PHE . 5.2 m-85 -126.8 151.42 48.3 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.234 -0.439 . . . . 75.3 110.958 -179.896 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 29.7 tp -85.65 140.08 30.86 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.125 -0.489 . . . . 74.42 110.868 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.72 ' CB ' ' HB3' ' A' ' 137' ' ' TRP . 0.0 OUTLIER -69.96 138.24 52.14 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.167 -0.47 . . . . 74.03 110.893 179.883 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -165.84 27.53 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.216 -0.447 . . . . 72.1 110.872 179.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.82 ' HB2' ' CD1' ' A' ' 157' ' ' TYR . 0.0 OUTLIER -118.61 -172.42 2.28 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.177 -0.465 . . . . 75.35 110.931 179.952 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.751 ' HD2' ' C ' ' A' ' 154' ' ' LYS . 1.0 OUTLIER -161.63 -123.2 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.236 -0.438 . . . . 73.54 110.855 179.844 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . 0.677 ' HA ' ' HA ' ' A' ' 131' ' ' LYS . 2.7 tm-20 -71.65 2.63 4.95 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.207 -0.451 . . . . 74.22 110.911 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . 0.82 ' CD1' ' HB2' ' A' ' 154' ' ' LYS . 18.5 m-30 -32.33 147.3 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.14 -0.482 . . . . 74.53 110.91 -179.836 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . 0.475 ' HB3' ' CZ ' ' A' ' 104' ' ' PHE . 8.7 ptp180 -113.64 -35.76 5.1 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.133 -0.485 . . . . 75.51 110.885 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . 0.485 ' HB2' HD13 ' A' ' 161' ' ' ILE . 0.2 OUTLIER -92.27 152.94 42.9 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.551 0.691 . . . . 75.42 110.905 179.987 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . 0.453 ' HB3' ' HB3' ' A' ' 168' ' ' PRO . 53.7 Cg_endo -69.75 -35.0 13.49 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.679 2.252 . . . . 75.53 112.35 179.893 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.485 HD13 ' HB2' ' A' ' 159' ' ' LYS . 3.2 mp -57.56 -15.85 4.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.444 . . . . 75.22 111.125 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . 0.657 ' HB3' ' CD1' ' A' ' 157' ' ' TYR . 0.4 OUTLIER -71.69 -13.74 61.83 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.206 -0.452 . . . . 63.2 110.829 179.884 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 22.3 t90 -87.98 -16.28 34.2 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.192 -0.458 . . . . 73.12 110.881 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 109.82 -37.36 3.81 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.758 -0.734 . . . . 54.31 112.483 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . 0.424 ' O ' ' C ' ' A' ' 166' ' ' ALA . . . -78.92 127.17 31.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.797 0.332 . . . . 61.52 111.066 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . 0.424 ' C ' ' O ' ' A' ' 165' ' ' ALA . . . -35.94 -42.18 0.27 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.231 -0.44 . . . . 72.04 111.11 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' SER . . . . . 0.524 ' C ' ' H ' ' A' ' 169' ' ' ALA . 0.5 OUTLIER -129.78 153.57 80.88 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.654 0.74 . . . . 75.22 110.864 -179.811 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . 0.463 ' HB3' ' O ' ' A' ' 127' ' ' ILE . 53.9 Cg_endo -69.72 29.04 0.18 Allowed 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.691 2.261 . . . . 75.23 112.357 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . 0.524 ' H ' ' C ' ' A' ' 167' ' ' SER . . . -66.28 103.95 1.1 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.236 -0.438 . . . . 75.31 111.09 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 2.6 t -151.57 163.33 2.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.459 . . . . 73.22 111.127 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' GLN . . . . . 0.671 ' OE1' ' HB3' ' A' ' 143' ' ' PRO . 1.6 tm0? -112.26 -83.31 0.59 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.157 -0.474 . . . . 75.22 110.897 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' SER . . . . . 0.741 ' OG ' ' O ' ' A' ' 143' ' ' PRO . 54.4 p -124.55 174.91 7.51 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.203 -0.453 . . . . 70.42 110.805 -179.788 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 173' ' ' PHE . . . . . 0.539 ' HB3' ' CD2' ' A' ' 139' ' ' PHE . 39.6 p90 -148.76 164.83 33.25 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.101 -0.5 . . . . 74.43 110.919 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . 0.518 ' HG2' ' CE2' ' A' ' 140' ' ' TYR . 0.0 OUTLIER -136.16 142.75 44.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.209 -0.45 . . . . 73.42 110.906 -179.921 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . 0.402 ' HG3' ' OD1' ' A' ' 114' ' ' ASP . 0.0 OUTLIER -90.59 -176.62 4.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.199 -0.455 . . . . 73.04 110.838 -179.911 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . 0.434 HD11 ' C ' ' A' ' 136' ' ' VAL . 2.4 mt -133.84 132.21 56.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.174 -0.467 . . . . 73.13 111.112 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 83.1 t -150.04 140.56 16.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.213 -0.449 . . . . 71.34 111.138 179.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.163 -0.471 . . . . 73.54 110.894 -179.986 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.293 0 N-CA-C 112.491 -0.244 . . . . 53.5 112.491 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.446 ' C ' ' HE1' ' A' ' 47' ' ' TRP . 6.6 p -81.94 133.61 35.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.833 0.349 . . . . 74.24 111.151 -179.88 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 2.7 tttt -120.94 136.93 54.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.262 -0.426 . . . . 75.41 110.912 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.573 ' HB ' ' CD1' ' A' ' 47' ' ' TRP . 13.7 tt -136.92 152.18 28.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.236 -0.438 . . . . 70.3 111.153 179.821 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.49 ' HA ' ' O ' ' A' ' 21' ' ' TYR . 15.5 m -134.0 138.15 45.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.192 -0.458 . . . . 74.2 111.113 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.515 ' N ' ' CD2' ' A' ' 10' ' ' PHE . 0.2 OUTLIER -126.74 128.53 46.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.2 -0.455 . . . . 71.32 110.882 179.995 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.536 ' CG ' ' HA ' ' A' ' 16' ' ' PHE . 26.3 m-85 -113.45 132.0 55.82 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.118 -0.492 . . . . 71.35 110.876 -179.833 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.415 ' HB2' ' HB2' ' A' ' 19' ' ' ARG . 0.1 OUTLIER -61.69 -15.14 37.71 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.107 -0.497 . . . . 73.43 110.89 179.99 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.426 ' HB2' ' O ' ' A' ' 17' ' ' GLN . 72.5 m-20 -134.91 150.42 50.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.142 -0.481 . . . . 64.32 110.865 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.532 ' N ' ' HB3' ' A' ' 38' ' ' ASN . 36.7 mtmt -56.16 -178.77 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.224 -0.443 . . . . 74.42 110.914 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 25.4 m-20 49.44 31.52 4.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.212 -0.449 . . . . 73.12 110.898 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.536 ' HA ' ' CG ' ' A' ' 11' ' ' TYR . 3.7 m-85 50.9 63.54 2.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.179 -0.464 . . . . 75.41 110.922 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . 0.426 ' O ' ' HB2' ' A' ' 13' ' ' ASP . 24.6 mt-30 -139.52 160.85 38.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.15 -0.477 . . . . 74.04 110.898 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 92.0 -149.29 19.62 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.8 -0.714 . . . . 64.34 112.485 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.425 ' O ' ' CD1' ' A' ' 34' ' ' LEU . 0.0 OUTLIER -69.21 77.8 0.36 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.756 0.312 . . . . 74.14 110.852 -179.865 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.439 ' HB2' ' CE1' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -76.3 129.01 36.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 72.11 110.882 -179.919 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.49 ' O ' ' HA ' ' A' ' 9' ' ' THR . 91.4 t80 -122.95 125.57 45.55 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.213 -0.449 . . . . 74.14 110.888 -179.81 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.472 ' CG ' HG23 ' A' ' 9' ' ' THR . 1.4 m-20 -121.73 133.51 54.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.121 -0.49 . . . . 75.53 110.866 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -166.99 135.43 2.67 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.217 -0.447 . . . . 72.11 110.878 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -103.22 5.55 37.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.17 -0.468 . . . . 55.11 110.815 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 49.7 t -110.08 158.85 17.86 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.231 -0.44 . . . . 72.02 110.864 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -43.3 120.17 1.8 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.172 -0.467 . . . . 73.13 110.83 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.594 ' HB2' ' HB3' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -115.6 42.33 2.31 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.204 -0.453 . . . . 73.03 110.868 -179.951 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.558 ' O ' ' HA ' ' A' ' 82' ' ' SER . . . -51.12 -20.11 1.37 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.229 -0.441 . . . . 74.11 111.126 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 63.2 t0 -128.5 37.57 4.1 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.218 -0.446 . . . . 73.15 110.864 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.763 ' O ' ' CD2' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -80.97 15.68 1.74 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.198 -0.456 . . . . 73.22 110.857 -179.892 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.418 ' CG ' ' HG3' ' A' ' 53' ' ' PRO . 39.3 t60 -80.02 -34.0 38.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.189 -0.459 . . . . 71.03 110.864 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.6 t -63.24 -10.84 17.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.216 -0.447 . . . . 72.53 111.136 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -103.32 -28.87 11.6 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.193 -0.458 . . . . 74.21 110.925 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.425 ' CD1' ' O ' ' A' ' 19' ' ' ARG . 16.0 tp -139.02 141.25 38.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.133 -0.485 . . . . 74.4 110.89 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 20.7 m -105.35 -42.05 5.36 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.174 -0.466 . . . . 71.04 110.863 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -118.49 143.0 47.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.178 -0.464 . . . . 75.31 110.907 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.685 ' SG ' ' HB2' ' A' ' 80' ' ' LEU . 3.9 p -115.05 87.22 2.61 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.204 -0.453 . . . . 72.24 110.9 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.532 ' HB3' ' N ' ' A' ' 14' ' ' LYS . 3.3 m-20 -82.76 -50.85 8.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 64.4 110.852 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 9.8 p -129.4 127.14 40.37 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.163 -0.472 . . . . 74.11 110.821 -179.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.479 ' O ' ' N ' ' A' ' 67' ' ' TYR . 13.5 mt -125.44 152.1 31.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.103 -0.499 . . . . 72.32 111.15 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.437 ' N ' HG23 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -144.85 118.55 9.2 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.201 -0.454 . . . . 74.33 110.932 179.845 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.517 HG22 ' HB2' ' A' ' 47' ' ' TRP . 1.3 t -104.02 116.7 48.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.259 -0.428 . . . . 64.51 111.175 179.85 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -111.54 77.65 1.06 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.197 -0.456 . . . . 72.41 110.887 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.445 ' O ' ' HA ' ' A' ' 6' ' ' THR . . . 135.4 101.87 0.68 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.762 -0.732 . . . . 51.24 112.512 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 53.91 179.65 0.14 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.767 -0.73 . . . . 74.2 112.493 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.492 HG21 ' HA ' ' A' ' 63' ' ' PRO . 1.4 m -80.25 169.28 18.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.797 0.332 . . . . 72.44 111.12 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . 0.573 ' CD1' ' HB ' ' A' ' 8' ' ' ILE . 5.7 m95 -141.18 130.1 23.13 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.194 -0.457 . . . . 72.52 110.945 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.613 ' O ' ' N ' ' A' ' 84' ' ' ARG . . . -90.58 127.02 36.13 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.222 -0.445 . . . . 73.22 111.125 179.892 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.788 ' O ' ' O ' ' A' ' 60' ' ' TYR . 35.7 m -128.84 124.48 61.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.213 -0.449 . . . . 70.2 111.135 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.715 ' HB3' ' HA ' ' A' ' 56' ' ' ALA . 49.5 m-85 -94.51 150.15 20.53 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.21 -0.45 . . . . 74.03 110.901 -179.91 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.677 ' OE1' ' HB3' ' A' ' 57' ' ' TRP . 58.1 tt0 -49.27 -79.51 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.106 -0.497 . . . . 74.1 110.901 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.544 ' HB2' ' HB2' ' A' ' 57' ' ' TRP . 0.0 OUTLIER -92.54 143.77 27.73 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.607 0.718 . . . . 74.43 110.893 -179.951 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.639 ' HA ' ' OG ' ' A' ' 82' ' ' SER . 53.3 Cg_endo -69.82 142.41 47.57 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.739 2.293 . . . . 74.24 112.301 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 61.95 -9.75 0.08 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.236 -0.438 . . . . 73.52 110.89 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.621 ' H ' ' C ' ' A' ' 53' ' ' PRO . 2.7 m-30 -105.92 -20.4 13.44 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.184 -0.462 . . . . 73.43 110.901 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.715 ' HA ' ' HB3' ' A' ' 50' ' ' TYR . . . 50.02 27.15 2.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.168 -0.469 . . . . 72.1 111.068 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . 0.677 ' HB3' ' OE1' ' A' ' 51' ' ' GLU . 0.1 OUTLIER -50.69 -163.69 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.23 -0.441 . . . . 75.24 110.907 -179.959 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.636 ' C ' ' O ' ' A' ' 57' ' ' TRP . 5.4 m-30 -13.1 101.2 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.235 -0.439 . . . . 72.1 110.954 -179.841 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.43 142.89 36.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.072 -0.513 . . . . 73.33 110.873 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.788 ' O ' ' O ' ' A' ' 49' ' ' VAL . 0.3 OUTLIER -153.4 112.41 3.75 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.255 -0.43 . . . . 73.23 110.938 -179.896 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.587 ' N ' ' CD1' ' A' ' 61' ' ' ILE . 1.1 mp -102.82 114.19 41.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.13 -0.486 . . . . 72.04 111.153 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -85.41 122.46 73.56 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 121.632 0.73 . . . . 74.13 110.89 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.492 ' HA ' HG21 ' A' ' 46' ' ' THR . 54.1 Cg_endo -69.7 -166.34 0.18 Allowed 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.699 2.266 . . . . 75.01 112.339 179.868 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.44 160.96 14.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.164 -0.471 . . . . 75.03 110.896 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 113.48 -152.7 17.93 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.743 -0.741 . . . . 62.32 112.517 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -118.4 159.26 23.76 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.867 0.365 . . . . 74.15 110.891 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.479 ' N ' ' O ' ' A' ' 40' ' ' ILE . 11.5 m-85 -147.32 84.02 7.47 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.665 0.745 . . . . 74.24 110.942 -179.85 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 -4.68 14.51 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.655 2.237 . . . . 70.14 112.393 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 89.3 mt-10 -157.49 147.84 20.88 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.158 -0.474 . . . . 75.33 110.889 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.941 ' O ' ' CD1' ' A' ' 73' ' ' TRP . 44.4 p90 -57.97 -41.07 82.16 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.181 -0.463 . . . . 73.43 110.911 -179.882 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -52.8 -15.69 0.8 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.098 -0.501 . . . . 73.4 110.948 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 29.2 mmt180 -65.77 -17.6 64.74 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.189 -0.46 . . . . 73.22 110.845 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . 0.941 ' CD1' ' O ' ' A' ' 70' ' ' TYR . 0.4 OUTLIER -121.14 22.39 10.95 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.2 -0.455 . . . . 73.3 110.896 -179.948 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' MET . . . . . 0.594 ' O ' ' C ' ' A' ' 75' ' ' GLY . 0.0 OUTLIER 75.67 30.22 0.8 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.278 -0.419 . . . . 72.23 110.9 179.943 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.594 ' C ' ' O ' ' A' ' 74' ' ' MET . . . 17.11 59.06 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.678 -0.773 . . . . 72.55 112.508 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.47 ' CB ' ' HE2' ' A' ' 60' ' ' TYR . 0.0 OUTLIER -55.01 -72.38 0.07 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.836 0.35 . . . . 72.52 110.944 -179.955 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.498 ' O ' ' CB ' ' A' ' 78' ' ' ASP . 16.3 t-20 -121.16 -37.93 2.88 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.172 -0.467 . . . . 73.41 110.857 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.498 ' CB ' ' O ' ' A' ' 77' ' ' ASN . 0.0 OUTLIER 83.83 10.35 0.47 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.206 -0.452 . . . . 64.01 110.882 179.925 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -105.74 86.89 2.47 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.186 -0.461 . . . . 74.15 110.88 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.685 ' HB2' ' SG ' ' A' ' 37' ' ' CYS . 0.1 OUTLIER -86.95 131.38 34.11 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.182 -0.463 . . . . 70.31 110.886 -179.965 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.636 ' HB3' ' HB3' ' A' ' 53' ' ' PRO . 1.4 m -153.82 -119.23 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.158 -0.473 . . . . 74.4 110.843 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.639 ' OG ' ' HA ' ' A' ' 53' ' ' PRO . 0.1 OUTLIER -46.38 97.76 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.142 -0.481 . . . . 71.51 110.871 -179.814 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . 0.519 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 9.7 p -122.78 134.96 54.41 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.186 -0.461 . . . . 74.01 110.86 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . 0.613 ' N ' ' O ' ' A' ' 48' ' ' ALA . 2.2 mmt85 -117.66 156.57 27.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.176 -0.466 . . . . 74.11 110.87 -179.843 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -68.42 129.05 38.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 72.15 111.119 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.513 ' CG2' ' CB ' ' A' ' 48' ' ' ALA . 38.3 t -115.56 139.17 43.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.24 -0.437 . . . . 72.33 111.114 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . 0.467 ' O ' ' C ' ' A' ' 88' ' ' LEU . 9.2 m170 -114.12 108.59 17.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.161 -0.472 . . . . 75.22 110.892 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.467 ' C ' ' O ' ' A' ' 87' ' ' HIS . 0.0 OUTLIER -32.79 148.15 0.06 OUTLIER Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.577 0.703 . . . . 75.34 110.908 -179.972 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.6 ' HA ' ' HA3' ' A' ' 135' ' ' GLY . 53.3 Cg_endo -69.82 100.38 0.82 Allowed 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.658 2.239 . . . . 73.52 112.303 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -105.72 -175.65 2.85 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.194 -0.457 . . . . 73.23 110.867 -179.855 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 46.36 57.91 6.17 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.7 -0.762 . . . . 72.1 112.509 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 125.44 26.63 1.29 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.763 -0.732 . . . . 73.33 112.49 -179.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.518 ' O ' ' CG ' ' A' ' 134' ' ' GLU . 5.7 pt20 38.27 -124.49 0.27 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.792 0.33 . . . . 73.43 110.935 -179.861 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.579 ' HA ' ' HG2' ' A' ' 134' ' ' GLU . 0.0 OUTLIER -125.76 103.38 7.78 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.173 -0.467 . . . . 75.33 110.888 -179.857 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.477 ' H ' ' HG2' ' A' ' 134' ' ' GLU . 12.6 tptp -113.34 130.96 56.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.079 -0.51 . . . . 74.54 110.875 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 7.6 tt -149.05 138.25 15.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.185 -0.461 . . . . 74.32 111.13 179.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.471 ' HB2' ' O ' ' A' ' 131' ' ' LYS . 0.9 OUTLIER -110.52 139.38 45.81 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.153 -0.476 . . . . 73.33 110.878 179.962 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.41 HG22 HG13 ' A' ' 127' ' ' ILE . 1.2 mp -116.74 148.58 19.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 73.24 111.102 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.628 ' HB2' ' HB2' ' A' ' 129' ' ' SER . 38.6 m-85 -134.1 133.94 41.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.205 -0.452 . . . . 75.23 110.848 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 77.2 tt0 -65.26 -61.25 2.24 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.159 -0.473 . . . . 73.05 110.878 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 35.4 mttt -99.79 162.21 13.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.134 -0.485 . . . . 73.43 110.872 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -68.16 159.83 51.18 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.73 -0.747 . . . . 73.34 112.48 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.493 ' HA ' ' HB2' ' A' ' 158' ' ' ARG . 25.7 t0 67.22 39.0 3.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.855 0.359 . . . . 53.23 110.888 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.58 ' CZ ' ' HB3' ' A' ' 158' ' ' ARG . 3.6 m-85 58.06 19.65 6.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.202 -0.454 . . . . 74.25 110.894 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 70.4 m -88.23 161.55 17.15 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.15 -0.477 . . . . 74.55 110.88 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 82.26 -159.0 38.65 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.726 -0.75 . . . . 74.53 112.454 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 4.1 tp-100 -82.86 129.19 34.97 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.786 0.327 . . . . 73.01 110.887 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' MET . . . . . 0.452 ' HB2' ' CD1' ' A' ' 99' ' ' PHE . 0.0 OUTLIER -118.69 160.39 21.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.195 -0.457 . . . . 74.12 110.862 179.954 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 29.9 m-85 -154.72 135.87 13.94 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.205 -0.452 . . . . 75.45 110.911 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -110.98 102.0 10.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.139 -0.482 . . . . 74.51 110.906 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 9.0 t -113.38 128.56 56.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.148 -0.478 . . . . 52.4 111.14 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.423 ' O ' ' OG1' ' A' ' 112' ' ' THR . 1.8 t -93.4 32.6 1.33 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.222 -0.444 . . . . 74.32 111.162 -180.0 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -153.79 -174.85 5.11 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.211 -0.449 . . . . 71.13 110.895 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -90.16 -175.18 4.45 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.154 -0.475 . . . . 63.13 110.839 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . 0.654 ' O ' ' HB2' ' A' ' 172' ' ' SER . 39.0 t -161.19 136.17 5.53 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.606 0.717 . . . . 75.3 110.854 -179.893 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.497 ' O ' ' C ' ' A' ' 143' ' ' PRO . 53.4 Cg_endo -69.81 -34.51 14.28 Favored 'Trans proline' 0 C--N 1.341 0.134 0 C-N-CA 122.669 2.246 . . . . 70.35 112.324 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' SER . . . . . 0.618 ' HB3' ' CB ' ' A' ' 120' ' ' GLU . 0.1 OUTLIER -147.04 97.28 2.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.228 -0.442 . . . . 65.43 110.88 -179.844 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.646 ' HB ' ' O ' ' A' ' 171' ' ' GLN . 3.7 tt -50.81 -28.8 6.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.158 -0.473 . . . . 71.43 111.107 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' MET . . . . . 0.571 ' O ' ' HA ' ' A' ' 123' ' ' HIS . 21.7 ttp -85.95 -44.96 11.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.169 -0.469 . . . . 72.44 110.896 179.848 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.618 ' CB ' ' HB3' ' A' ' 117' ' ' SER . 17.5 tp10 -66.17 -14.14 61.36 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.242 -0.435 . . . . 74.13 110.9 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 7.1 tp-100 -113.69 -51.49 2.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.121 -0.491 . . . . 65.32 110.882 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . 0.485 ' HB2' ' O ' ' A' ' 118' ' ' ILE . 77.2 m-85 -101.81 -21.53 14.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.187 -0.46 . . . . 70.01 110.845 -179.912 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . 0.571 ' HA ' ' O ' ' A' ' 119' ' ' MET . 29.3 m-70 71.87 30.83 2.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.155 -0.475 . . . . 72.41 110.91 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 4.1 mtt -106.79 88.65 2.8 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.174 -0.466 . . . . 75.14 110.829 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 4.0 ptp180 -53.34 -38.44 63.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.252 -0.431 . . . . 74.53 110.864 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.464 ' HB3' ' HG2' ' A' ' 168' ' ' PRO . 18.2 mt-10 -140.2 130.58 25.31 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.166 -0.47 . . . . 75.23 110.87 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.424 ' O ' ' HB3' ' A' ' 168' ' ' PRO . 3.0 mm -87.57 96.88 6.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.173 -0.467 . . . . 75.45 111.09 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . 0.429 ' HA ' ' HB3' ' A' ' 160' ' ' PRO . 17.0 m170 -66.03 -35.93 81.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.132 -0.485 . . . . 63.33 110.867 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 0.628 ' HB2' ' HB2' ' A' ' 99' ' ' PHE . 0.6 OUTLIER -135.54 147.45 48.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.225 -0.443 . . . . 72.4 110.884 -179.809 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . 0.553 ' O ' ' O ' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -144.78 120.39 10.43 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.192 -0.458 . . . . 64.45 110.924 -179.989 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.627 ' HA ' ' HA ' ' A' ' 156' ' ' GLU . 4.4 mtpt -111.25 154.32 24.62 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.156 -0.475 . . . . 72.13 110.938 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.489 ' HB ' ' O ' ' A' ' 131' ' ' LYS . 13.0 t 83.32 163.59 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 73.4 111.131 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.439 ' CD1' ' O ' ' A' ' 154' ' ' LYS . 0.0 OUTLIER -178.86 122.2 0.09 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.176 -0.465 . . . . 64.22 110.898 179.95 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.579 ' HG2' ' HA ' ' A' ' 94' ' ' TYR . 0.1 OUTLIER -96.13 166.6 11.67 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.165 -0.47 . . . . 73.22 110.895 179.923 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . 0.6 ' HA3' ' HA ' ' A' ' 89' ' ' PRO . . . -24.42 -73.71 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.691 -0.766 . . . . 53.01 112.532 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.659 ' HA ' HD13 ' A' ' 152' ' ' LEU . 4.7 t -132.45 146.97 32.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.833 0.349 . . . . 74.12 111.126 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' TRP . . . . . 0.584 ' O ' ' HB3' ' A' ' 152' ' ' LEU . 2.6 t-105 -149.6 141.98 24.25 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.17 -0.468 . . . . 75.11 110.924 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.466 ' CG2' ' HB2' ' A' ' 149' ' ' GLN . 59.5 mt -115.59 132.34 65.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.258 -0.428 . . . . 74.2 111.177 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 0.413 ' O ' ' HA ' ' A' ' 149' ' ' GLN . 0.3 OUTLIER -99.74 179.58 4.49 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.166 -0.47 . . . . 71.13 110.878 179.99 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . 0.555 ' CE1' ' HB3' ' A' ' 149' ' ' GLN . 1.4 m-85 -152.39 126.08 8.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.136 -0.483 . . . . 74.53 110.905 -179.867 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . 0.597 ' O ' ' HB2' ' A' ' 171' ' ' GLN . 3.2 tt0 -61.05 -26.49 67.66 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.142 -0.481 . . . . 70.32 110.907 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.726 ' HB3' ' HD2' ' A' ' 143' ' ' PRO . 8.4 mp -116.24 173.29 3.12 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.59 0.709 . . . . 75.25 110.892 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . 0.752 ' O ' ' OG ' ' A' ' 172' ' ' SER . 54.0 Cg_endo -69.73 -89.68 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.145 0 C-N-CA 122.724 2.283 . . . . 71.23 112.373 179.813 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . 0.704 ' O ' ' N ' ' A' ' 146' ' ' ARG . 1.0 OUTLIER -54.69 95.7 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.232 -0.44 . . . . 72.12 110.931 179.957 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . 0.646 ' C ' ' O ' ' A' ' 144' ' ' ASN . 0.1 OUTLIER 12.69 53.01 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.17 -0.468 . . . . 74.31 110.89 -179.913 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . 0.704 ' N ' ' O ' ' A' ' 144' ' ' ASN . 10.1 mtp85 -118.69 172.46 7.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.159 -0.473 . . . . 74.2 110.862 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 70.59 -175.34 37.41 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.713 -0.756 . . . . 74.32 112.479 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.421 ' HG3' HD21 ' A' ' 76' ' ' LEU . 3.9 mtp180 -83.28 130.7 35.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.776 0.322 . . . . 73.32 110.87 -179.867 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' GLN . . . . . 0.728 ' OE1' ' HA ' ' A' ' 60' ' ' TYR . 0.3 OUTLIER -85.79 158.7 19.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.178 -0.464 . . . . 74.2 110.9 -179.926 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -123.59 158.27 31.84 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.206 -0.452 . . . . 72.43 110.957 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.477 ' CA ' HD12 ' A' ' 61' ' ' ILE . 13.4 tp -92.01 134.65 34.62 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.108 -0.496 . . . . 74.42 110.917 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.659 HD13 ' HA ' ' A' ' 136' ' ' VAL . 0.0 OUTLIER -63.94 132.59 51.17 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.218 -0.446 . . . . 75.31 110.895 179.884 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -163.69 26.04 0.08 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.174 -0.467 . . . . 64.24 110.854 179.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.789 ' HB2' ' CD1' ' A' ' 157' ' ' TYR . 5.6 pttt -116.13 -173.03 2.28 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.167 -0.469 . . . . 75.43 110.854 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.77 ' HG3' ' O ' ' A' ' 154' ' ' LYS . 0.1 OUTLIER -161.75 -124.53 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.183 -0.462 . . . . 74.24 110.898 179.867 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . 0.633 ' HG2' ' O ' ' A' ' 156' ' ' GLU . 0.3 OUTLIER -71.42 2.2 5.27 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.228 -0.442 . . . . 71.32 110.904 179.976 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . 0.789 ' CD1' ' HB2' ' A' ' 154' ' ' LYS . 20.5 m-30 -30.17 144.85 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.153 -0.476 . . . . 71.14 110.93 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . 0.58 ' HB3' ' CZ ' ' A' ' 104' ' ' PHE . 9.4 ptp180 -112.67 -44.13 3.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.128 -0.487 . . . . 73.54 110.881 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . 0.476 ' HB2' HD11 ' A' ' 161' ' ' ILE . 0.7 OUTLIER -80.48 152.17 72.65 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.596 0.712 . . . . 74.42 110.865 179.982 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . 0.429 ' HB3' ' HA ' ' A' ' 128' ' ' HIS . 54.2 Cg_endo -69.76 -32.83 17.8 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.693 2.262 . . . . 74.14 112.335 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.496 HD11 ' H ' ' A' ' 161' ' ' ILE . 3.6 mp -55.34 -19.04 4.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.224 -0.444 . . . . 74.24 111.143 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . 0.657 ' HB3' ' CD1' ' A' ' 157' ' ' TYR . 0.3 OUTLIER -73.57 -23.0 59.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.202 -0.454 . . . . 70.33 110.891 179.826 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' TRP . . . . . 0.489 ' CD1' ' HB3' ' A' ' 165' ' ' ALA . 2.1 t-105 -67.53 -17.7 64.76 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.2 -0.455 . . . . 74.12 110.963 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 114.3 -38.63 3.09 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.689 -0.767 . . . . 74.0 112.473 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . 0.489 ' HB3' ' CD1' ' A' ' 163' ' ' TRP . . . -90.91 140.68 29.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.81 0.338 . . . . 63.14 111.063 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -40.97 -35.13 0.48 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.196 -0.456 . . . . 70.24 111.09 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' SER . . . . . 0.522 ' C ' ' H ' ' A' ' 169' ' ' ALA . 0.3 OUTLIER -129.51 156.82 78.02 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.665 0.745 . . . . 75.55 110.9 -179.803 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . 0.464 ' HG2' ' HB3' ' A' ' 126' ' ' GLU . 53.9 Cg_endo -69.76 25.27 0.17 Allowed 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.697 2.264 . . . . 74.41 112.356 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . 0.522 ' H ' ' C ' ' A' ' 167' ' ' SER . . . -64.3 103.88 0.69 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.197 -0.456 . . . . 62.14 111.149 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 3.5 t -153.66 162.17 2.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.238 -0.437 . . . . 75.11 111.122 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' GLN . . . . . 0.646 ' O ' ' HB ' ' A' ' 118' ' ' ILE . 1.9 mm-40 -112.54 -85.19 0.58 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.15 -0.477 . . . . 63.42 110.926 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' SER . . . . . 0.752 ' OG ' ' O ' ' A' ' 143' ' ' PRO . 32.0 p -129.54 178.78 6.22 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.204 -0.453 . . . . 74.14 110.87 -179.84 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -145.91 176.44 9.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.092 -0.504 . . . . 75.41 110.894 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . 0.429 ' HG2' ' HB ' ' A' ' 138' ' ' ILE . 0.2 OUTLIER -134.47 151.15 50.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.179 -0.464 . . . . 72.42 110.86 -179.903 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . 0.545 ' HD2' ' CE1' ' A' ' 94' ' ' TYR . 1.7 ptt180 -102.34 147.98 26.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.186 -0.461 . . . . 74.34 110.835 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 3.9 mt -100.34 126.66 53.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.16 -0.473 . . . . 75.33 111.126 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 9.6 p -127.38 153.09 36.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.161 -0.472 . . . . 70.05 111.083 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.142 -0.481 . . . . 75.53 110.904 179.997 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.314 0 N-CA-C 112.508 -0.237 . . . . 73.35 112.508 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.428 ' HA ' ' O ' ' A' ' 44' ' ' GLY . 5.3 p -82.23 134.05 35.28 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.872 0.367 . . . . 73.53 111.126 -179.832 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 2.8 tttt -121.44 136.44 54.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.26 -0.427 . . . . 74.15 110.899 179.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.579 ' HB ' ' CD1' ' A' ' 47' ' ' TRP . 12.7 tt -136.69 147.49 27.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.271 -0.422 . . . . 75.14 111.156 179.827 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.517 HG23 ' CG ' ' A' ' 22' ' ' ASP . 15.9 m -130.01 129.95 44.36 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.175 -0.466 . . . . 75.03 111.106 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.544 ' CE1' HD13 ' A' ' 8' ' ' ILE . 0.4 OUTLIER -117.05 131.1 57.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.171 -0.468 . . . . 64.12 110.896 -179.988 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.524 ' CG ' ' HA ' ' A' ' 16' ' ' PHE . 43.5 m-85 -116.46 131.21 57.01 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.179 -0.464 . . . . 73.45 110.916 -179.86 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.505 ' HG2' ' HB2' ' A' ' 36' ' ' ARG . 0.0 OUTLIER -60.91 -23.94 65.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.092 -0.504 . . . . 73.35 110.899 -179.999 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 68.6 m-20 -127.87 152.48 47.79 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.187 -0.46 . . . . 73.44 110.848 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.465 ' N ' ' HB3' ' A' ' 38' ' ' ASN . 4.2 mtmm -56.05 -176.98 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.175 -0.466 . . . . 75.11 110.893 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 69.9 m-20 46.99 37.74 5.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.209 -0.45 . . . . 73.03 110.896 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.524 ' HA ' ' CG ' ' A' ' 11' ' ' TYR . 4.3 m-85 45.91 56.59 5.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.145 -0.48 . . . . 72.33 110.93 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 4.1 mt-30 -132.16 159.91 37.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.142 -0.481 . . . . 74.34 110.928 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 93.81 -150.93 20.05 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.722 -0.752 . . . . 74.31 112.449 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.454 ' O ' HD13 ' A' ' 34' ' ' LEU . 0.0 OUTLIER -68.9 80.02 0.3 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.81 0.338 . . . . 75.54 110.843 -179.811 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.458 ' HB2' ' CE1' ' A' ' 11' ' ' TYR . 0.8 OUTLIER -77.99 127.99 33.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.203 -0.453 . . . . 74.2 110.862 -179.891 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.411 ' CD2' ' CD2' ' A' ' 30' ' ' PHE . 90.5 t80 -124.25 125.59 44.65 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.223 -0.444 . . . . 72.43 110.957 -179.883 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.517 ' CG ' HG23 ' A' ' 9' ' ' THR . 1.5 m-20 -118.99 132.49 56.07 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.14 -0.482 . . . . 70.42 110.865 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 12.6 t -161.3 131.01 4.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.208 -0.451 . . . . 65.41 110.888 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -102.12 4.17 39.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 71.24 110.888 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 48.7 t -112.9 159.46 19.04 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.46 . . . . 71.11 110.893 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -42.24 119.97 1.51 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.165 -0.47 . . . . 64.04 110.847 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.596 ' HB2' ' HB3' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -114.83 43.32 1.98 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.18 -0.464 . . . . 72.11 110.895 -179.925 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.53 ' O ' ' HA ' ' A' ' 82' ' ' SER . . . -49.97 -21.22 1.13 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.179 -0.464 . . . . 65.03 111.093 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 64.7 t0 -129.47 40.63 3.57 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.224 -0.444 . . . . 75.11 110.867 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.763 ' O ' ' CD2' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -82.06 16.39 1.95 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.207 -0.451 . . . . 75.5 110.833 -179.904 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.442 ' HB2' ' HB3' ' A' ' 81' ' ' SER . 34.4 t60 -78.62 -40.82 33.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.213 -0.449 . . . . 75.52 110.891 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.425 HG21 ' CD2' ' A' ' 33' ' ' TYR . 10.0 t -61.73 -10.65 9.24 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.201 -0.454 . . . . 73.42 111.12 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.488 ' CD1' ' HA ' ' A' ' 30' ' ' PHE . 12.2 m-85 -99.43 -30.77 12.0 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.217 -0.447 . . . . 74.02 110.95 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.454 HD13 ' O ' ' A' ' 19' ' ' ARG . 16.7 tp -141.54 146.15 36.0 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.126 -0.488 . . . . 75.34 110.933 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.2 m -112.09 -34.65 5.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.154 -0.475 . . . . 74.2 110.847 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.505 ' HB2' ' HG2' ' A' ' 12' ' ' GLU . 1.8 mtp85 -115.6 140.87 48.77 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.119 -0.491 . . . . 75.51 110.884 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.599 ' SG ' ' HB2' ' A' ' 80' ' ' LEU . 1.6 p -116.86 54.45 0.86 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.184 -0.462 . . . . 73.11 110.899 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.465 ' HB3' ' N ' ' A' ' 14' ' ' LYS . 1.9 m-80 -55.02 -65.71 0.53 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.182 -0.463 . . . . 73.41 110.91 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 7.6 p -116.27 128.15 55.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.181 -0.463 . . . . 71.42 110.832 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.493 ' O ' ' N ' ' A' ' 67' ' ' TYR . 12.0 mt -124.67 147.47 29.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.088 -0.505 . . . . 74.34 111.13 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.471 ' N ' HG23 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -141.67 118.7 11.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.149 -0.478 . . . . 74.23 110.884 179.86 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.513 HG22 ' HB2' ' A' ' 47' ' ' TRP . 1.0 OUTLIER -104.35 117.46 49.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.461 . . . . 74.03 111.088 179.908 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -112.34 77.68 1.06 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.173 -0.467 . . . . 51.41 110.868 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.428 ' O ' ' HA ' ' A' ' 6' ' ' THR . . . 136.88 98.31 0.51 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.73 -0.748 . . . . 70.44 112.468 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 55.36 177.86 0.22 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.725 -0.75 . . . . 73.44 112.426 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.503 HG21 ' HA ' ' A' ' 63' ' ' PRO . 1.0 OUTLIER -76.32 171.13 15.08 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.77 0.319 . . . . 73.24 111.166 -179.901 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . 0.579 ' CD1' ' HB ' ' A' ' 8' ' ' ILE . 6.1 m95 -143.47 128.77 18.85 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.251 -0.431 . . . . 71.31 110.921 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.617 ' O ' ' N ' ' A' ' 84' ' ' ARG . . . -90.88 126.33 36.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.191 -0.459 . . . . 73.12 111.096 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.623 ' O ' ' O ' ' A' ' 60' ' ' TYR . 26.9 m -126.32 130.1 71.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.202 -0.454 . . . . 75.33 111.083 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.786 ' HB3' ' HA ' ' A' ' 56' ' ' ALA . 52.4 m-85 -100.41 148.02 25.19 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.161 -0.472 . . . . 75.02 110.973 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.55 ' HB3' ' HB3' ' A' ' 57' ' ' TRP . 58.4 tt0 -49.75 -78.07 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.105 -0.498 . . . . 75.01 110.873 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.482 ' HB3' ' CD1' ' A' ' 55' ' ' PHE . 0.1 OUTLIER -93.36 141.57 24.13 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.614 0.721 . . . . 75.14 110.859 -179.878 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.654 ' HB3' ' HB3' ' A' ' 81' ' ' SER . 53.7 Cg_endo -69.76 145.25 56.6 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.691 2.261 . . . . 64.22 112.341 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 61.9 -11.02 0.07 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.201 -0.454 . . . . 74.33 110.925 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.645 ' H ' ' C ' ' A' ' 53' ' ' PRO . 1.8 m-30 -108.16 -21.29 12.85 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.163 -0.472 . . . . 74.01 110.831 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.786 ' HA ' ' HB3' ' A' ' 50' ' ' TYR . . . 50.96 26.77 2.85 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.183 -0.462 . . . . 72.44 111.069 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . 0.641 ' O ' ' C ' ' A' ' 58' ' ' TYR . 0.8 OUTLIER -48.63 -164.5 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.245 -0.434 . . . . 75.32 110.899 -179.967 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.641 ' C ' ' O ' ' A' ' 57' ' ' TRP . 5.3 m-30 -11.76 100.15 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.236 -0.438 . . . . 73.34 110.933 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.45 ' HB2' ' HA ' ' A' ' 150' ' ' TYR . 0.0 OUTLIER -60.41 153.36 23.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.154 -0.476 . . . . 74.23 110.869 179.911 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.623 ' O ' ' O ' ' A' ' 49' ' ' VAL . 2.1 t80 -168.65 107.95 0.48 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.193 -0.458 . . . . 74.42 110.914 -179.871 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.453 ' HB ' HD12 ' A' ' 138' ' ' ILE . 4.9 mp -95.73 118.65 42.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.148 -0.478 . . . . 71.03 111.131 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -87.45 126.0 63.64 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.587 0.708 . . . . 74.03 110.927 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.503 ' HA ' HG21 ' A' ' 46' ' ' THR . 54.0 Cg_endo -69.76 -172.81 0.62 Allowed 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.662 2.241 . . . . 63.21 112.346 179.871 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.67 161.71 15.96 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.209 -0.451 . . . . 75.11 110.917 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 112.87 -159.49 13.64 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.707 -0.758 . . . . 74.02 112.5 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -114.71 158.5 21.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.865 0.364 . . . . 72.33 110.913 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.493 ' N ' ' O ' ' A' ' 40' ' ' ILE . 7.2 m-85 -149.44 80.42 7.69 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.681 0.753 . . . . 75.41 110.895 -179.837 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.607 ' HD2' ' HG3' ' A' ' 72' ' ' ARG . 53.7 Cg_endo -69.78 1.13 4.73 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.682 2.255 . . . . 75.12 112.321 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -157.91 155.1 28.96 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.24 -0.436 . . . . 75.34 110.873 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.807 ' O ' ' CD1' ' A' ' 73' ' ' TRP . 18.9 p90 -66.97 -7.97 26.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.164 -0.471 . . . . 74.2 110.947 -179.883 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -90.44 -16.32 29.23 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.102 -0.499 . . . . 74.42 110.909 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.607 ' HG3' ' HD2' ' A' ' 68' ' ' PRO . 25.5 mmt180 -75.01 -22.87 58.23 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.203 -0.453 . . . . 73.14 110.919 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . 0.807 ' CD1' ' O ' ' A' ' 70' ' ' TYR . 0.5 OUTLIER -109.39 8.22 25.35 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.148 -0.478 . . . . 71.01 110.927 -179.967 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' MET . . . . . 0.504 ' C ' ' O ' ' A' ' 73' ' ' TRP . 0.0 OUTLIER 30.23 55.48 0.17 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.205 -0.452 . . . . 72.51 110.903 179.954 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.527 ' CA ' ' OH ' ' A' ' 60' ' ' TYR . . . -91.77 -170.14 41.65 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.781 -0.723 . . . . 72.11 112.469 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.435 ' CD2' ' HA ' ' A' ' 148' ' ' ARG . 0.1 OUTLIER -107.87 -74.28 0.66 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.834 0.35 . . . . 75.2 110.915 -179.936 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -96.84 147.01 24.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.146 -0.479 . . . . 74.24 110.914 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.412 ' O ' ' SG ' ' A' ' 37' ' ' CYS . 15.8 p30 -95.71 34.05 1.56 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.203 -0.453 . . . . 63.15 110.877 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 4.3 ttm-85 -105.69 79.47 1.44 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 74.34 110.851 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.599 ' HB2' ' SG ' ' A' ' 37' ' ' CYS . 0.1 OUTLIER -82.82 130.3 35.11 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.179 -0.464 . . . . 74.43 110.955 179.976 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.654 ' HB3' ' HB3' ' A' ' 53' ' ' PRO . 1.3 m -152.24 -123.51 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.22 -0.446 . . . . 74.25 110.858 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.575 ' OG ' ' HA ' ' A' ' 53' ' ' PRO . 0.2 OUTLIER -41.0 99.98 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.118 -0.492 . . . . 73.25 110.855 -179.82 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . 0.485 ' SG ' ' HB2' ' A' ' 27' ' ' CYS . 8.9 p -127.0 134.38 50.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.131 -0.486 . . . . 64.3 110.863 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . 0.617 ' N ' ' O ' ' A' ' 48' ' ' ALA . 4.5 mmt85 -115.47 158.32 22.72 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.194 -0.457 . . . . 72.4 110.902 -179.879 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.404 ' HB1' ' OG1' ' A' ' 6' ' ' THR . . . -72.08 129.61 38.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.46 . . . . 73.04 111.104 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.5 ' CG2' ' CB ' ' A' ' 48' ' ' ALA . 61.5 t -116.02 136.23 53.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.213 -0.449 . . . . 72.44 111.142 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . 0.43 ' O ' ' C ' ' A' ' 88' ' ' LEU . 40.2 m80 -113.89 108.09 16.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.162 -0.472 . . . . 74.13 110.872 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.43 ' C ' ' O ' ' A' ' 87' ' ' HIS . 0.0 OUTLIER -35.39 144.94 0.22 Allowed Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.621 0.724 . . . . 75.33 110.91 -179.971 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.465 ' HB3' ' H ' ' A' ' 136' ' ' VAL . 53.9 Cg_endo -69.73 104.24 1.28 Allowed 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.678 2.252 . . . . 74.45 112.317 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -103.16 165.68 10.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.231 -0.441 . . . . 65.45 110.859 -179.836 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 66.65 129.02 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.737 -0.744 . . . . 74.11 112.535 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.404 ' C ' ' HG2' ' A' ' 93' ' ' GLN . . . 51.1 33.92 30.78 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.721 -0.752 . . . . 73.01 112.495 -179.893 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.453 ' O ' ' CG ' ' A' ' 134' ' ' GLU . 6.3 pt20 39.07 -154.72 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.848 0.356 . . . . 71.24 110.911 -179.883 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.471 ' HA ' ' CG ' ' A' ' 134' ' ' GLU . 25.2 t80 -95.19 108.26 20.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.178 -0.464 . . . . 73.44 110.935 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 11.7 tptt -107.88 127.94 54.18 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.111 -0.495 . . . . 74.44 110.89 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -152.25 134.37 5.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.186 -0.461 . . . . 73.51 111.138 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.415 ' HB2' ' O ' ' A' ' 131' ' ' LYS . 1.2 mt-30 -109.08 124.63 51.07 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.169 -0.469 . . . . 72.54 110.913 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 7.9 mt -101.19 140.64 19.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.2 -0.455 . . . . 73.42 111.136 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.512 ' CD2' ' HA ' ' A' ' 104' ' ' PHE . 48.1 m-85 -129.0 146.02 51.09 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 64.22 110.835 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -80.19 -28.65 38.67 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.095 -0.502 . . . . 71.4 110.866 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 29.5 mttt -122.11 166.26 14.82 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.152 -0.476 . . . . 64.01 110.908 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.454 ' HA2' ' HB3' ' A' ' 129' ' ' SER . . . -68.48 178.98 22.13 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.751 -0.738 . . . . 52.45 112.473 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.403 ' C ' ' CG ' ' A' ' 104' ' ' PHE . 38.4 t70 40.91 36.26 0.41 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.845 0.355 . . . . 73.41 110.865 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.672 ' CD2' ' N ' ' A' ' 104' ' ' PHE . 0.0 OUTLIER 50.95 73.13 0.31 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.171 -0.468 . . . . 74.12 110.918 -179.877 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 1.2 m -139.52 161.04 38.46 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.119 -0.491 . . . . 44.23 110.879 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 79.79 -142.2 24.28 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.78 -0.724 . . . . 74.24 112.49 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 3.1 tp-100 -71.03 111.76 6.65 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.749 0.309 . . . . 71.02 110.933 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' MET . . . . . 0.491 ' HB2' ' CE2' ' A' ' 99' ' ' PHE . 5.9 ttp -106.62 149.12 27.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.254 -0.43 . . . . 74.51 110.894 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -153.19 135.15 14.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.227 -0.442 . . . . 73.41 110.891 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -110.19 97.55 7.0 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.117 -0.492 . . . . 74.13 110.888 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 9.7 t -110.3 132.19 54.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.141 -0.481 . . . . 71.54 111.134 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.445 ' O ' ' OG1' ' A' ' 112' ' ' THR . 1.1 t -119.37 36.43 4.48 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.182 -0.463 . . . . 74.14 111.162 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 53.5 mt-10 -151.34 165.59 33.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.241 -0.436 . . . . 72.42 110.891 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -56.25 164.24 1.38 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.136 -0.484 . . . . 63.44 110.856 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . 0.491 ' O ' ' HB2' ' A' ' 172' ' ' SER . 18.4 t -153.12 117.59 2.84 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.617 0.722 . . . . 74.13 110.886 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.426 ' O ' ' C ' ' A' ' 143' ' ' PRO . 53.4 Cg_endo -69.75 -31.97 19.52 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.716 2.277 . . . . 73.22 112.311 -179.906 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' SER . . . . . 0.626 ' HB3' ' CB ' ' A' ' 120' ' ' GLU . 0.1 OUTLIER -148.82 104.51 3.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.23 -0.441 . . . . 61.14 110.914 -179.834 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.502 ' O ' ' HB2' ' A' ' 122' ' ' PHE . 2.9 tt -57.84 -29.46 35.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.131 -0.486 . . . . 65.43 111.129 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' MET . . . . . 0.597 ' O ' ' HA ' ' A' ' 123' ' ' HIS . 11.6 ttp -86.77 -42.96 12.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 71.43 110.835 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.626 ' CB ' ' HB3' ' A' ' 117' ' ' SER . 6.7 tp10 -67.66 -13.23 61.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.271 -0.422 . . . . 72.32 110.856 -179.916 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 28.3 tp60 -115.48 -48.72 2.78 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.151 -0.477 . . . . 72.43 110.894 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . 0.502 ' HB2' ' O ' ' A' ' 118' ' ' ILE . 33.8 m-85 -103.69 -20.28 14.03 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.253 -0.431 . . . . 75.13 110.912 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . 0.597 ' HA ' ' O ' ' A' ' 119' ' ' MET . 0.2 OUTLIER 71.9 26.41 2.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.114 -0.493 . . . . 71.33 110.854 -179.977 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 7.1 mtt -102.56 83.99 2.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.214 -0.448 . . . . 74.25 110.868 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 1.8 ptp85 -52.12 -29.94 24.11 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.264 -0.426 . . . . 74.42 110.852 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.492 ' HG2' ' HA ' ' A' ' 169' ' ' ALA . 20.9 mt-10 -146.22 130.73 17.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.215 -0.448 . . . . 63.55 110.921 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.412 ' O ' ' HB3' ' A' ' 168' ' ' PRO . 4.4 mm -91.37 103.92 14.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.15 -0.477 . . . . 71.13 111.137 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . 0.405 ' HB3' ' N ' ' A' ' 102' ' ' GLY . 2.3 m170 -71.53 -29.61 64.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.169 -0.469 . . . . 75.13 110.865 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 0.454 ' HB3' ' HA2' ' A' ' 102' ' ' GLY . 0.3 OUTLIER -153.55 152.74 31.26 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.182 -0.463 . . . . 73.53 110.824 -179.819 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . 0.733 ' O ' ' HB2' ' A' ' 157' ' ' TYR . 0.0 OUTLIER -146.57 112.12 5.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.085 -0.507 . . . . 60.03 110.885 -179.942 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.746 ' HA ' ' HA ' ' A' ' 156' ' ' GLU . 13.4 mtpt -90.78 147.74 23.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 74.51 110.908 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.506 ' CB ' ' O ' ' A' ' 131' ' ' LYS . 11.3 t 85.03 165.33 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.283 -0.417 . . . . 72.32 111.149 179.875 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -179.1 127.79 0.1 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.176 -0.466 . . . . 74.41 110.876 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.471 ' CG ' ' HA ' ' A' ' 94' ' ' TYR . 0.0 OUTLIER -89.14 -171.51 3.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.116 -0.493 . . . . 71.24 110.881 179.94 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . 0.446 ' C ' HG23 ' A' ' 136' ' ' VAL . . . -48.79 -52.83 19.7 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.77 -0.729 . . . . 50.32 112.463 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.663 ' HA ' HD13 ' A' ' 152' ' ' LEU . 3.6 t -147.48 146.92 17.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.841 0.353 . . . . 73.32 111.1 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' TRP . . . . . 0.657 ' HB3' ' CB ' ' A' ' 152' ' ' LEU . 23.0 t90 -147.04 143.13 28.14 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.196 -0.457 . . . . 75.4 110.932 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.453 HD12 ' HB ' ' A' ' 61' ' ' ILE . 14.0 mt -123.53 133.69 68.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.244 -0.434 . . . . 72.0 111.119 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 0.501 ' CE1' ' HB3' ' A' ' 173' ' ' PHE . 0.1 OUTLIER -99.41 166.42 11.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.173 -0.467 . . . . 74.32 110.918 179.936 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -142.17 125.96 17.05 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.159 -0.473 . . . . 64.41 110.925 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . 0.615 ' O ' ' HB2' ' A' ' 171' ' ' GLN . 0.5 OUTLIER -58.77 -25.22 62.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.119 -0.492 . . . . 74.01 110.928 179.977 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.77 ' HB3' ' HD2' ' A' ' 143' ' ' PRO . 9.3 mp -115.65 173.67 2.84 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.635 0.731 . . . . 75.03 110.898 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . 0.805 ' O ' ' OG ' ' A' ' 172' ' ' SER . 54.3 Cg_endo -69.74 -87.59 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.667 2.245 . . . . 62.5 112.325 179.826 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . 0.699 ' O ' ' N ' ' A' ' 146' ' ' ARG . 1.1 m-20 -53.71 96.23 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.205 -0.452 . . . . 54.44 110.889 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . 0.641 ' C ' ' O ' ' A' ' 144' ' ' ASN . 0.0 OUTLIER 13.23 52.6 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.136 -0.484 . . . . 75.34 110.933 -179.933 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . 0.699 ' N ' ' O ' ' A' ' 144' ' ' ASN . 10.6 mtp85 -119.49 174.66 6.25 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.108 -0.496 . . . . 74.3 110.843 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 79.64 -179.96 52.71 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.754 -0.736 . . . . 74.31 112.469 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.435 ' HA ' ' CD2' ' A' ' 76' ' ' LEU . 17.2 mtt180 -71.67 144.41 49.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.808 0.337 . . . . 74.12 110.896 -179.893 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' GLN . . . . . 0.508 ' HB2' ' HA ' ' A' ' 60' ' ' TYR . 49.5 mt-30 -83.28 148.51 27.33 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.158 -0.474 . . . . 75.11 110.937 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . 0.481 ' HB2' ' CB ' ' A' ' 139' ' ' PHE . 87.3 m-85 -132.81 118.92 19.59 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.221 -0.445 . . . . 74.2 110.902 -179.824 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 18.7 tp -69.91 136.37 50.53 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.095 -0.502 . . . . 75.15 110.951 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.663 HD13 ' HA ' ' A' ' 136' ' ' VAL . 0.0 OUTLIER -74.02 135.81 43.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.208 -0.451 . . . . 74.35 110.945 179.873 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . 0.928 ' O ' ' HB2' ' A' ' 154' ' ' LYS . 54.5 t0 -161.39 109.65 1.51 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.21 -0.45 . . . . 74.0 110.877 179.852 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.928 ' HB2' ' O ' ' A' ' 153' ' ' ASP . 0.4 OUTLIER 156.07 -133.29 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.235 -0.439 . . . . 75.24 110.913 179.996 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.5 ' HG3' ' O ' ' A' ' 154' ' ' LYS . 0.4 OUTLIER -164.98 -94.78 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.185 -0.461 . . . . 75.43 110.868 179.861 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . 0.746 ' HA ' ' HA ' ' A' ' 131' ' ' LYS . 0.3 OUTLIER -89.76 9.34 27.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.262 -0.426 . . . . 74.25 110.908 179.927 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . 0.793 ' CZ ' ' HB3' ' A' ' 154' ' ' LYS . 1.9 m-85 20.4 108.14 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.124 -0.489 . . . . 65.4 110.945 -179.859 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.35 -34.03 8.9 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.151 -0.477 . . . . 74.11 110.856 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 2.8 ptpt -108.92 158.72 33.43 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.654 0.74 . . . . 75.54 110.862 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . 0.443 ' HB2' ' HD3' ' A' ' 168' ' ' PRO . 53.9 Cg_endo -69.73 -21.57 33.43 Favored 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.7 2.267 . . . . 64.21 112.322 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.451 HD11 ' H ' ' A' ' 161' ' ' ILE . 3.4 mp -82.5 3.75 2.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.244 -0.435 . . . . 54.3 111.149 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -64.58 -12.85 49.47 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.163 -0.471 . . . . 72.23 110.839 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' TRP . . . . . 0.487 ' CZ2' ' HB2' ' A' ' 130' ' ' CYS . 19.7 m-90 -105.47 -16.24 14.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.217 -0.447 . . . . 74.3 110.957 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 112.13 -35.33 4.72 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.743 -0.741 . . . . 52.31 112.491 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -62.68 126.58 27.81 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.759 0.314 . . . . 71.25 111.126 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -41.01 -37.5 0.83 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.217 -0.447 . . . . 74.04 111.135 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' SER . . . . . 0.521 ' C ' ' H ' ' A' ' 169' ' ' ALA . 0.3 OUTLIER -130.66 157.33 78.0 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.665 0.745 . . . . 64.35 110.863 -179.811 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . 0.443 ' HD3' ' HB2' ' A' ' 160' ' ' PRO . 53.6 Cg_endo -69.74 24.0 0.17 Allowed 'Trans proline' 0 C--N 1.341 0.137 0 C-N-CA 122.642 2.228 . . . . 75.41 112.397 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . 0.521 ' H ' ' C ' ' A' ' 167' ' ' SER . . . -65.57 107.02 1.58 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.204 -0.453 . . . . 75.2 111.097 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 3.3 t -152.94 159.83 3.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.195 -0.457 . . . . 74.21 111.155 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' GLN . . . . . 0.625 ' OE1' ' HB3' ' A' ' 143' ' ' PRO . 1.7 tm0? -105.7 -81.19 0.54 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.202 -0.454 . . . . 74.31 110.933 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 172' ' ' SER . . . . . 0.805 ' OG ' ' O ' ' A' ' 143' ' ' PRO . 51.6 p -127.2 -178.23 4.36 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 74.04 110.88 -179.817 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 173' ' ' PHE . . . . . 0.501 ' HB3' ' CE1' ' A' ' 139' ' ' PHE . 27.5 p90 -142.66 167.07 22.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.181 -0.463 . . . . 74.45 110.871 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.88 130.1 19.74 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.127 -0.488 . . . . 64.45 110.852 -179.876 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.47 -169.96 1.62 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.179 -0.464 . . . . 73.54 110.849 -179.896 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . 0.414 HG12 HD13 ' A' ' 138' ' ' ILE . 3.7 mt -137.12 134.19 47.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 71.32 111.141 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 95.3 t -150.45 142.37 16.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.181 -0.463 . . . . 74.35 111.121 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 . . . . . 0 C--N 1.33 -0.261 0 CA-C-N 116.175 -0.466 . . . . 72.03 110.922 179.985 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.317 0 N-CA-C 112.49 -0.244 . . . . 71.22 112.49 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.435 ' HB ' ' O ' ' A' ' 44' ' ' GLY . 12.8 p -82.56 133.18 35.19 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.847 0.356 . . . . 73.25 111.132 -179.844 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 3.0 tttt -122.4 137.74 54.76 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.214 -0.448 . . . . 73.54 110.908 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.65 HG23 ' CZ ' ' A' ' 10' ' ' PHE . 15.1 tt -138.38 149.48 24.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.181 -0.463 . . . . 75.23 111.168 179.871 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.478 HG21 ' CE2' ' A' ' 11' ' ' TYR . 15.3 m -129.22 140.4 51.49 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.174 -0.466 . . . . 72.02 111.105 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.65 ' CZ ' HG23 ' A' ' 8' ' ' ILE . 0.7 OUTLIER -126.56 130.86 51.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.183 -0.462 . . . . 71.01 110.855 -179.973 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.536 ' CG ' ' HA ' ' A' ' 16' ' ' PHE . 44.5 m-85 -117.41 129.82 56.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.114 -0.494 . . . . 72.43 110.926 -179.877 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.489 ' HG2' ' HB2' ' A' ' 36' ' ' ARG . 0.0 OUTLIER -59.04 -23.95 62.44 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.105 -0.498 . . . . 75.14 110.864 -179.951 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 -127.54 152.67 47.31 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.144 -0.48 . . . . 72.43 110.853 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.42 ' N ' ' HB3' ' A' ' 38' ' ' ASN . 4.2 mtmp? -56.02 -175.36 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.16 -0.473 . . . . 61.22 110.916 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 22.0 m-20 46.02 36.08 2.83 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.242 -0.435 . . . . 74.15 110.879 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.536 ' HA ' ' CG ' ' A' ' 11' ' ' TYR . 4.4 m-85 47.12 57.7 5.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.218 -0.446 . . . . 74.34 110.901 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -132.85 159.91 38.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.141 -0.481 . . . . 74.15 110.879 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 93.41 -151.39 20.34 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.74 -0.743 . . . . 63.45 112.486 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.49 ' O ' HD13 ' A' ' 34' ' ' LEU . 0.0 OUTLIER -67.95 80.92 0.21 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.788 0.327 . . . . 74.41 110.854 -179.84 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.481 ' HA ' ' O ' ' A' ' 10' ' ' PHE . 0.0 OUTLIER -78.83 128.91 33.99 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.222 -0.445 . . . . 75.3 110.864 -179.926 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.511 ' CD2' ' CD2' ' A' ' 30' ' ' PHE . 81.3 t80 -124.57 123.6 40.44 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.174 -0.466 . . . . 73.43 110.876 -179.825 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.458 ' CG ' HG23 ' A' ' 9' ' ' THR . 1.3 m-20 -119.17 134.02 55.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.116 -0.493 . . . . 74.45 110.871 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -165.95 136.61 3.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.234 -0.439 . . . . 73.31 110.887 -179.886 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -105.1 4.82 31.84 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.202 -0.454 . . . . 74.4 110.85 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 13.4 t -108.14 165.98 11.08 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.22 -0.445 . . . . 71.51 110.916 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -62.67 116.75 5.45 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.195 -0.457 . . . . 62.32 110.857 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.45 ' HB2' ' SG ' ' A' ' 83' ' ' CYS . 7.9 m -118.11 53.93 0.94 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.194 -0.457 . . . . 74.14 110.87 -179.924 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.526 ' C ' ' HA ' ' A' ' 82' ' ' SER . . . -45.83 -19.72 0.07 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.156 -0.474 . . . . 64.02 111.106 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 53.1 t0 -128.46 42.01 3.39 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.246 -0.433 . . . . 62.43 110.853 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.784 ' O ' ' CD2' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -80.63 13.98 2.3 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.214 -0.448 . . . . 73.11 110.87 -179.899 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.456 ' HB2' ' HB3' ' A' ' 53' ' ' PRO . 29.0 t60 -78.74 -37.18 41.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.157 -0.474 . . . . 75.1 110.852 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.5 t -59.27 -13.17 6.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.182 -0.463 . . . . 75.43 111.095 -179.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -101.39 -26.41 13.6 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.263 -0.426 . . . . 74.03 110.95 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.49 HD13 ' O ' ' A' ' 19' ' ' ARG . 16.6 tp -142.87 139.96 31.05 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.073 -0.512 . . . . 74.33 110.966 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.1 m -109.05 -32.16 7.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.201 -0.454 . . . . 74.12 110.859 -179.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.489 ' HB2' ' HG2' ' A' ' 12' ' ' GLU . 1.9 mtp85 -115.59 140.36 49.25 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.102 -0.499 . . . . 74.42 110.905 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.543 ' SG ' ' O ' ' A' ' 78' ' ' ASP . 1.3 p -117.65 54.23 0.91 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.249 -0.432 . . . . 71.43 110.866 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.42 ' HB3' ' N ' ' A' ' 14' ' ' LYS . 1.9 m-80 -54.29 -70.09 0.11 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.465 . . . . 74.2 110.9 -179.889 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 6.4 p -111.83 129.53 56.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.175 -0.466 . . . . 74.23 110.85 -179.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.508 ' O ' ' N ' ' A' ' 67' ' ' TYR . 20.1 mt -126.08 151.35 32.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.104 -0.498 . . . . 74.31 111.09 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.479 ' N ' HG23 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -143.74 119.33 10.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.147 -0.479 . . . . 75.21 110.894 179.825 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.54 HG23 ' HB ' ' A' ' 8' ' ' ILE . 1.2 t -103.98 116.13 47.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.227 -0.442 . . . . 72.32 111.134 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -112.36 80.53 1.35 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.199 -0.455 . . . . 71.03 110.894 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.435 ' O ' ' HB ' ' A' ' 6' ' ' THR . . . 130.34 102.06 0.95 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.727 -0.749 . . . . 74.13 112.493 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 54.35 178.36 0.14 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.763 -0.732 . . . . 73.22 112.523 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.502 HG21 ' HA ' ' A' ' 63' ' ' PRO . 1.3 m -81.99 171.47 14.37 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.725 0.297 . . . . 71.25 111.153 -179.886 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . 0.582 ' CD1' ' HB ' ' A' ' 8' ' ' ILE . 15.9 m95 -141.92 130.0 22.04 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.217 -0.447 . . . . 74.22 110.915 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.53 ' CB ' ' CG2' ' A' ' 86' ' ' VAL . . . -95.37 111.99 23.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.231 -0.44 . . . . 72.14 111.113 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.554 ' O ' ' O ' ' A' ' 60' ' ' TYR . 5.6 m -115.0 129.55 71.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.218 -0.447 . . . . 73.33 111.153 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.752 ' HB3' ' HA ' ' A' ' 56' ' ' ALA . 35.7 m-85 -95.61 150.6 20.16 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.148 -0.478 . . . . 73.31 110.89 -179.876 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.613 ' HB2' ' O ' ' A' ' 58' ' ' TYR . 7.1 tt0 -46.51 -77.77 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.104 -0.498 . . . . 74.55 110.889 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.611 ' HB3' ' CD1' ' A' ' 55' ' ' PHE . 1.6 mtp180 -93.44 145.95 30.93 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.567 0.699 . . . . 75.11 110.877 -179.853 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.673 ' HA ' ' OG ' ' A' ' 82' ' ' SER . 53.7 Cg_endo -69.76 134.12 27.22 Favored 'Trans proline' 0 C--N 1.34 0.126 0 C-N-CA 122.715 2.276 . . . . 74.02 112.329 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 66.38 -9.88 0.29 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.267 -0.424 . . . . 75.33 110.899 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.611 ' CD1' ' HB3' ' A' ' 52' ' ' ARG . 4.2 m-30 -100.22 -25.92 14.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.176 -0.465 . . . . 73.4 110.868 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.752 ' HA ' ' HB3' ' A' ' 50' ' ' TYR . . . 57.09 23.0 7.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.17 -0.468 . . . . 75.35 111.092 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . 0.643 ' O ' ' C ' ' A' ' 58' ' ' TYR . 3.4 m0 -52.49 -165.0 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.21 -0.45 . . . . 74.43 110.897 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.643 ' C ' ' O ' ' A' ' 57' ' ' TRP . 5.4 m-30 -12.1 103.84 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.246 -0.434 . . . . 73.35 110.917 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.492 ' HB2' ' HA ' ' A' ' 150' ' ' TYR . 2.0 mpt? -61.52 148.12 43.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.138 -0.483 . . . . 73.32 110.848 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.572 ' CE2' ' HG ' ' A' ' 76' ' ' LEU . 0.3 OUTLIER -161.01 97.66 1.15 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.204 -0.453 . . . . 74.24 110.919 -179.834 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.459 ' CD1' ' HA ' ' A' ' 151' ' ' LEU . 4.6 mp -89.18 114.52 27.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.14 -0.482 . . . . 75.12 111.101 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.428 HD12 HD12 ' A' ' 40' ' ' ILE . 0.6 OUTLIER -85.16 122.21 73.96 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.598 0.713 . . . . 72.12 110.927 179.906 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.502 ' HA ' HG21 ' A' ' 46' ' ' THR . 54.0 Cg_endo -69.71 -167.49 0.23 Allowed 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.736 2.291 . . . . 73.21 112.324 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.55 160.98 14.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.205 -0.452 . . . . 75.54 110.941 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 114.93 -146.57 18.83 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.714 -0.755 . . . . 73.33 112.516 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -128.3 158.37 38.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.876 0.369 . . . . 72.3 110.912 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.508 ' N ' ' O ' ' A' ' 40' ' ' ILE . 5.7 m-85 -146.78 81.62 9.06 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.648 0.737 . . . . 75.23 110.911 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.483 ' HD2' ' HG3' ' A' ' 72' ' ' ARG . 53.8 Cg_endo -69.81 1.4 4.51 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.643 2.229 . . . . 74.23 112.344 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 86.2 mt-10 -156.9 155.08 30.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.212 -0.449 . . . . 71.23 110.891 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.82 ' O ' ' CD1' ' A' ' 73' ' ' TRP . 8.9 p90 -70.6 -1.93 12.67 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.161 -0.472 . . . . 74.11 110.954 -179.907 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -91.22 -13.82 32.12 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.132 -0.485 . . . . 73.4 110.968 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.483 ' HG3' ' HD2' ' A' ' 68' ' ' PRO . 23.2 mmt180 -73.7 -5.35 40.04 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.162 -0.472 . . . . 75.3 110.902 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . 0.82 ' CD1' ' O ' ' A' ' 70' ' ' TYR . 0.4 OUTLIER -134.71 4.93 3.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.165 -0.47 . . . . 73.41 110.877 -179.933 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' MET . . . . . 0.466 ' CB ' ' O ' ' A' ' 73' ' ' TRP . 0.0 OUTLIER 81.13 -17.89 0.53 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.263 -0.426 . . . . 73.43 110.893 179.956 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.477 ' N ' ' CD1' ' A' ' 73' ' ' TRP . . . 40.32 57.66 2.59 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.757 -0.735 . . . . 71.21 112.461 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.572 ' HG ' ' CE2' ' A' ' 60' ' ' TYR . 3.1 pp -50.85 -36.84 39.73 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.787 0.327 . . . . 74.12 110.878 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.562 ' O ' ' CB ' ' A' ' 78' ' ' ASP . 23.7 t-20 -121.82 -47.13 2.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.202 -0.454 . . . . 74.12 110.864 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.562 ' CB ' ' O ' ' A' ' 77' ' ' ASN . 6.3 t0 89.61 5.3 0.14 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.193 -0.458 . . . . 75.33 110.862 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 1.2 ttm-85 -110.46 102.29 10.92 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.176 -0.465 . . . . 75.21 110.898 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.538 ' HB2' ' SG ' ' A' ' 37' ' ' CYS . 0.0 OUTLIER -101.12 134.68 43.77 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.225 -0.443 . . . . 73.52 110.93 -179.996 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.578 ' HB3' ' HB3' ' A' ' 53' ' ' PRO . 1.2 m -151.15 -119.35 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.212 -0.449 . . . . 74.54 110.859 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.673 ' OG ' ' HA ' ' A' ' 53' ' ' PRO . 0.5 OUTLIER -38.31 107.65 0.07 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.168 -0.469 . . . . 63.33 110.882 -179.789 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . 0.516 ' HA ' ' O ' ' A' ' 48' ' ' ALA . 8.3 p -115.96 146.66 41.92 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.164 -0.471 . . . . 73.14 110.859 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . 0.49 ' N ' ' O ' ' A' ' 48' ' ' ALA . 0.1 OUTLIER -144.59 128.95 17.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.192 -0.458 . . . . 73.51 110.866 -179.834 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.46 ' N ' ' CZ3' ' A' ' 47' ' ' TRP . . . -48.47 127.81 13.76 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.209 -0.45 . . . . 64.42 111.101 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.53 ' CG2' ' CB ' ' A' ' 48' ' ' ALA . 25.0 t -115.17 139.02 43.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.2 -0.454 . . . . 74.33 111.14 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . 0.556 ' O ' ' CG2' ' A' ' 136' ' ' VAL . 11.8 m170 -112.41 107.11 15.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.164 -0.471 . . . . 74.3 110.835 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.472 ' C ' ' O ' ' A' ' 87' ' ' HIS . 0.0 OUTLIER -32.57 152.96 0.04 OUTLIER Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.619 0.723 . . . . 73.13 110.906 -179.996 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.569 ' HA ' ' HA3' ' A' ' 135' ' ' GLY . 53.6 Cg_endo -69.79 84.72 0.65 Allowed 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.689 2.26 . . . . 74.23 112.335 179.845 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -83.27 -171.29 3.49 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.228 -0.442 . . . . 72.12 110.832 -179.842 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 72.05 68.03 1.7 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.754 -0.736 . . . . 74.01 112.442 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 97.03 -69.88 0.79 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.764 -0.731 . . . . 71.11 112.513 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.427 ' HB2' ' H ' ' A' ' 94' ' ' TYR . 6.0 pt20 171.39 -148.88 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.774 0.321 . . . . 65.13 110.933 -179.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.516 ' O ' ' HA ' ' A' ' 112' ' ' THR . 0.0 OUTLIER -107.53 101.78 11.09 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.184 -0.462 . . . . 74.41 110.918 -179.865 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.454 ' O ' HG12 ' A' ' 132' ' ' VAL . 28.2 tptt -102.07 130.0 48.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.096 -0.502 . . . . 73.33 110.917 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -149.29 135.26 11.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.238 -0.437 . . . . 64.04 111.158 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -107.87 131.59 54.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.156 -0.474 . . . . 72.45 110.915 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 1.5 mp -113.46 131.31 65.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.186 -0.461 . . . . 73.31 111.104 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.624 ' HB2' ' HB2' ' A' ' 129' ' ' SER . 74.0 m-85 -122.19 136.87 54.97 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.162 -0.472 . . . . 73.14 110.895 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 57.3 tt0 -67.31 -73.94 0.13 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.167 -0.469 . . . . 75.32 110.867 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.506 ' C ' ' HB2' ' A' ' 128' ' ' HIS . 5.1 mttt -84.54 165.73 17.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.193 -0.458 . . . . 75.42 110.954 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -72.23 160.58 54.1 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.757 -0.735 . . . . 73.04 112.461 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.428 ' HA ' ' HB2' ' A' ' 158' ' ' ARG . 29.5 t70 62.56 32.68 16.35 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.819 0.343 . . . . 74.25 110.878 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.493 ' CZ ' ' HB3' ' A' ' 158' ' ' ARG . 13.5 m-85 56.98 49.16 14.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.185 -0.461 . . . . 74.4 110.866 -179.892 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.1 m -113.62 150.97 32.37 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.206 -0.452 . . . . 74.04 110.85 -179.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 89.24 -123.67 6.98 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.762 -0.733 . . . . 75.43 112.471 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 54.8 tp60 -101.21 141.26 34.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.79 0.329 . . . . 74.44 110.877 -179.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 3.2 ttp -131.5 131.52 43.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.211 -0.45 . . . . 74.35 110.876 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 10.0 m-85 -136.81 137.31 39.64 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.451 . . . . 70.43 110.958 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -118.91 112.71 19.98 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.12 -0.491 . . . . 64.32 110.891 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 11.9 t -125.51 150.41 47.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.152 -0.476 . . . . 72.15 111.104 -179.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.516 ' HA ' ' O ' ' A' ' 94' ' ' TYR . 1.4 t -124.49 47.76 2.06 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.177 -0.465 . . . . 74.31 111.112 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -152.58 -178.21 6.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.227 -0.442 . . . . 72.21 110.893 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -73.86 164.98 25.93 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.165 -0.47 . . . . 63.24 110.849 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . 0.536 ' O ' ' HB2' ' A' ' 172' ' ' SER . 4.8 t -154.33 113.69 2.47 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.591 0.71 . . . . 74.31 110.889 -179.924 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.41 ' O ' ' CA ' ' A' ' 143' ' ' PRO . 53.1 Cg_endo -69.81 -30.2 22.4 Favored 'Trans proline' 0 C--O 1.231 0.15 0 C-N-CA 122.686 2.257 . . . . 71.32 112.328 -179.895 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' SER . . . . . 0.637 ' HB3' ' CB ' ' A' ' 120' ' ' GLU . 0.1 OUTLIER -149.97 98.02 2.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.19 -0.459 . . . . 75.23 110.898 -179.857 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.511 ' HB ' ' O ' ' A' ' 171' ' ' GLN . 3.0 tt -50.55 -29.16 6.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.132 -0.486 . . . . 75.45 111.099 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' MET . . . . . 0.573 ' O ' ' HA ' ' A' ' 123' ' ' HIS . 0.0 OUTLIER -86.39 -45.94 10.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.198 -0.456 . . . . 74.34 110.876 179.866 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.637 ' CB ' ' HB3' ' A' ' 117' ' ' SER . 16.5 tp10 -64.87 -12.94 54.34 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.222 -0.445 . . . . 73.14 110.868 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -113.25 -51.88 2.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.184 -0.462 . . . . 74.01 110.968 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . 0.417 ' HB2' ' O ' ' A' ' 118' ' ' ILE . 93.8 m-85 -103.4 -20.05 14.21 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.155 -0.475 . . . . 74.55 110.905 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . 0.573 ' HA ' ' O ' ' A' ' 119' ' ' MET . 10.9 m80 73.26 26.62 2.06 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.177 -0.465 . . . . 64.21 110.867 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 6.0 mtt -101.16 85.55 2.85 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.221 -0.445 . . . . 73.13 110.862 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 1.7 ptp85 -51.33 -34.11 32.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.254 -0.43 . . . . 74.22 110.89 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.479 ' HG2' ' HA ' ' A' ' 169' ' ' ALA . 40.7 mt-10 -144.34 138.07 27.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.19 -0.459 . . . . 64.53 110.883 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.42 ' O ' ' HB3' ' A' ' 168' ' ' PRO . 3.4 mm -99.88 96.6 5.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.115 -0.493 . . . . 74.32 111.129 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . 0.506 ' HB2' ' C ' ' A' ' 101' ' ' LYS . 11.0 m170 -69.43 -31.69 70.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.232 -0.44 . . . . 72.3 110.831 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 0.624 ' HB2' ' HB2' ' A' ' 99' ' ' PHE . 0.3 OUTLIER -132.65 145.34 51.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.247 -0.433 . . . . 73.31 110.854 -179.778 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . 0.583 ' HB3' ' HD2' ' A' ' 154' ' ' LYS . 0.3 OUTLIER -147.25 119.1 8.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.149 -0.478 . . . . 43.3 110.874 -179.931 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.564 ' HA ' ' HA ' ' A' ' 156' ' ' GLU . 6.9 mtpp -108.14 157.83 17.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.176 -0.466 . . . . 73.24 110.924 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.454 HG12 ' O ' ' A' ' 95' ' ' LYS . 3.5 t 81.58 169.06 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.237 -0.438 . . . . 75.34 111.089 179.836 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.566 ' O ' ' CD1' ' A' ' 133' ' ' LEU . 0.2 OUTLIER -165.85 128.18 2.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.138 -0.483 . . . . 74.53 110.912 179.927 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.516 ' O ' ' C ' ' A' ' 135' ' ' GLY . 1.4 mp0 -98.15 141.26 31.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.456 . . . . 73.41 110.888 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . 0.569 ' HA3' ' HA ' ' A' ' 89' ' ' PRO . . . -27.25 -44.79 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.735 -0.745 . . . . 62.0 112.479 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.654 ' HA ' HD13 ' A' ' 152' ' ' LEU . 2.0 t -149.85 127.88 2.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.834 0.349 . . . . 75.33 111.157 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' TRP . . . . . 0.662 ' HB3' ' CB ' ' A' ' 152' ' ' LEU . 26.1 t90 -142.08 145.53 34.42 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.173 -0.467 . . . . 73.53 110.893 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.433 HD12 ' HB ' ' A' ' 61' ' ' ILE . 7.1 mt -123.19 130.01 74.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.252 -0.431 . . . . 74.13 111.11 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 0.555 ' CB ' ' HB2' ' A' ' 150' ' ' TYR . 0.1 OUTLIER -97.36 147.36 24.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.155 -0.475 . . . . 72.24 110.897 179.965 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . 0.437 ' CD2' ' HA ' ' A' ' 145' ' ' TYR . 8.6 m-85 -124.26 124.69 42.97 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.124 -0.489 . . . . 74.25 110.895 -179.846 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . 0.549 ' O ' ' HB2' ' A' ' 171' ' ' GLN . 0.0 OUTLIER -58.96 -25.24 63.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.133 -0.485 . . . . 72.21 110.909 179.996 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.837 ' HB3' ' HD2' ' A' ' 143' ' ' PRO . 9.1 mp -118.06 175.9 1.87 Allowed Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.603 0.716 . . . . 74.12 110.886 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . 0.837 ' HD2' ' HB3' ' A' ' 142' ' ' LEU . 54.0 Cg_endo -69.74 -90.98 0.01 OUTLIER 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.66 2.24 . . . . 73.55 112.378 179.836 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . 0.995 ' O ' ' HG2' ' A' ' 146' ' ' ARG . 0.0 OUTLIER -49.6 86.26 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.175 -0.466 . . . . 74.43 110.872 -179.968 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . 0.59 ' C ' ' O ' ' A' ' 144' ' ' ASN . 2.6 m-85 19.73 43.03 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.185 -0.461 . . . . 70.21 110.897 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . 0.995 ' HG2' ' O ' ' A' ' 144' ' ' ASN . 12.8 mmm-85 -101.21 178.49 4.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.092 -0.504 . . . . 75.23 110.853 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 73.51 -166.31 54.65 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.735 -0.745 . . . . 75.42 112.467 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -86.25 159.81 19.34 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.77 0.319 . . . . 72.11 110.848 -179.806 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' GLN . . . . . 0.487 ' HB2' ' HA ' ' A' ' 60' ' ' TYR . 50.3 mt-30 -94.41 153.16 18.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.163 -0.471 . . . . 74.04 110.874 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . 0.555 ' HB2' ' CB ' ' A' ' 139' ' ' PHE . 95.9 m-85 -135.11 119.2 17.55 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.183 -0.462 . . . . 71.41 110.976 -179.899 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.459 ' HA ' ' CD1' ' A' ' 61' ' ' ILE . 22.8 tp -65.11 136.8 57.14 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.09 -0.505 . . . . 75.13 110.894 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.662 ' CB ' ' HB3' ' A' ' 137' ' ' TRP . 0.0 OUTLIER -73.03 134.23 44.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.222 -0.445 . . . . 72.34 110.945 179.85 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -165.27 30.88 0.06 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.212 -0.449 . . . . 73.01 110.908 179.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.763 ' O ' ' HG3' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -111.76 -172.27 2.01 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.16 -0.473 . . . . 70.14 110.945 179.947 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.763 ' HG3' ' O ' ' A' ' 154' ' ' LYS . 0.0 OUTLIER -159.86 -129.43 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.239 -0.437 . . . . 75.24 110.869 179.849 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . 0.564 ' HA ' ' HA ' ' A' ' 131' ' ' LYS . 2.1 tm-20 -70.27 4.94 1.92 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.215 -0.448 . . . . 74.24 110.883 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . 0.785 ' CD1' ' HB3' ' A' ' 162' ' ' ASP . 21.2 m-30 -30.7 148.19 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.135 -0.484 . . . . 72.0 110.895 -179.818 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . 0.493 ' HB3' ' CZ ' ' A' ' 104' ' ' PHE . 10.4 ptp180 -118.54 -31.87 4.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.065 -0.516 . . . . 75.3 110.841 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . 0.522 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 2.1 ptpp? -99.64 153.22 37.89 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.584 0.707 . . . . 74.21 110.889 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . 0.463 ' HB3' ' HB3' ' A' ' 168' ' ' PRO . 53.4 Cg_endo -69.82 -25.23 28.54 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.693 2.262 . . . . 75.31 112.312 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.475 HD11 ' H ' ' A' ' 161' ' ' ILE . 3.8 mp -75.46 4.19 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.229 -0.441 . . . . 73.04 111.131 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . 0.785 ' HB3' ' CD1' ' A' ' 157' ' ' TYR . 0.2 OUTLIER -72.63 -21.12 61.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.151 -0.477 . . . . 72.23 110.831 179.856 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' TRP . . . . . 0.51 ' CD1' ' N ' ' A' ' 163' ' ' TRP . 0.0 OUTLIER -108.65 13.47 25.16 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.238 -0.437 . . . . 74.42 110.92 -179.934 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 84.94 -29.21 4.26 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.724 -0.75 . . . . 75.12 112.502 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -53.65 118.95 4.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.798 0.332 . . . . 63.41 111.092 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -48.78 -26.1 2.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.249 -0.432 . . . . 74.44 111.123 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' SER . . . . . 0.511 ' C ' ' H ' ' A' ' 169' ' ' ALA . 0.3 OUTLIER -155.71 157.19 31.4 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.69 0.757 . . . . 75.31 110.791 -179.779 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . 0.504 ' HG3' ' CD2' ' A' ' 128' ' ' HIS . 54.0 Cg_endo -69.78 22.24 0.17 Allowed 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.666 2.244 . . . . 73.32 112.353 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . 0.511 ' H ' ' C ' ' A' ' 167' ' ' SER . . . -64.66 103.76 0.73 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.239 -0.437 . . . . 62.1 111.071 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 2.9 t -152.59 160.91 2.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.169 -0.469 . . . . 74.41 111.11 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' GLN . . . . . 0.639 ' OE1' ' HB3' ' A' ' 143' ' ' PRO . 1.7 tm0? -108.13 -81.66 0.56 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.194 -0.457 . . . . 73.05 110.877 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 172' ' ' SER . . . . . 0.702 ' OG ' ' O ' ' A' ' 143' ' ' PRO . 24.9 p -129.8 179.48 5.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 65.4 110.834 -179.795 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 27.4 p90 -144.2 167.81 21.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.14 -0.482 . . . . 75.13 110.853 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -139.13 135.98 34.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.139 -0.482 . . . . 73.24 110.876 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . 0.47 ' HD2' ' CE2' ' A' ' 94' ' ' TYR . 0.1 OUTLIER -82.93 -167.04 1.5 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.196 -0.456 . . . . 75.3 110.879 -179.937 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . 0.542 HD11 ' C ' ' A' ' 136' ' ' VAL . 4.2 mt -139.75 132.72 35.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.194 -0.457 . . . . 75.31 111.151 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 11.5 t -132.77 147.68 31.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.159 -0.473 . . . . 74.55 111.08 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.178 -0.464 . . . . 73.14 110.852 -179.992 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.315 0 N-CA-C 112.554 -0.218 . . . . 65.32 112.554 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.464 ' C ' ' HE1' ' A' ' 47' ' ' TRP . 6.3 p -81.76 135.72 35.46 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.859 0.361 . . . . 72.44 111.135 -179.884 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 3.2 tttt -121.93 135.84 54.89 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.198 -0.455 . . . . 74.32 110.911 179.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.631 HG23 ' CE2' ' A' ' 10' ' ' PHE . 15.1 tt -136.91 150.54 26.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.232 -0.44 . . . . 74.52 111.132 179.839 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.473 HG21 ' CE2' ' A' ' 11' ' ' TYR . 9.9 m -131.01 142.05 50.29 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.162 -0.472 . . . . 70.14 111.158 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.631 ' CE2' HG23 ' A' ' 8' ' ' ILE . 1.2 m-85 -128.48 129.95 46.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 74.15 110.863 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.52 ' CG ' ' HA ' ' A' ' 16' ' ' PHE . 18.9 m-85 -116.23 131.4 56.95 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.188 -0.46 . . . . 74.23 110.886 -179.832 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.485 ' HG2' ' HB2' ' A' ' 36' ' ' ARG . 0.0 OUTLIER -58.24 -25.41 61.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.141 -0.481 . . . . 73.45 110.897 179.978 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 59.5 m-20 -127.16 152.57 47.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.144 -0.48 . . . . 71.34 110.905 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.477 ' N ' ' HB3' ' A' ' 38' ' ' ASN . 34.8 mtmt -56.08 -175.35 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.266 -0.424 . . . . 75.32 110.938 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 18.6 m120 46.96 34.13 2.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.233 -0.44 . . . . 75.3 110.882 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.52 ' HA ' ' CG ' ' A' ' 11' ' ' TYR . 4.2 m-85 48.51 57.18 6.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.217 -0.447 . . . . 74.1 110.867 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 14.7 mt-30 -131.98 157.24 44.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.12 -0.491 . . . . 71.44 110.92 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 95.5 -150.79 19.78 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.775 -0.726 . . . . 45.12 112.537 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.475 ' O ' HD13 ' A' ' 34' ' ' LEU . 0.1 OUTLIER -69.45 81.08 0.39 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.746 0.308 . . . . 74.22 110.889 -179.878 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.456 ' HB2' ' CE1' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -79.21 128.67 33.59 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.203 -0.453 . . . . 74.45 110.862 -179.884 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.47 ' CD2' ' CD2' ' A' ' 30' ' ' PHE . 75.6 t80 -124.41 125.06 43.65 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.181 -0.463 . . . . 65.02 110.944 -179.849 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.461 ' CG ' HG23 ' A' ' 9' ' ' THR . 1.4 m-20 -119.08 133.7 55.65 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.136 -0.484 . . . . 74.43 110.83 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 10.1 t -161.33 133.05 5.61 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 63.14 110.885 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -100.86 -3.07 30.47 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.16 -0.473 . . . . 73.42 110.875 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.466 ' O ' ' SG ' ' A' ' 27' ' ' CYS . 34.3 t -106.61 160.99 15.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.456 . . . . 74.03 110.905 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -48.16 120.38 3.52 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.216 -0.447 . . . . 73.51 110.828 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.63 ' HB2' ' HB3' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -115.54 46.61 1.46 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.218 -0.446 . . . . 73.45 110.832 -179.884 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.561 ' O ' ' HA ' ' A' ' 82' ' ' SER . . . -49.12 -21.01 0.65 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.191 -0.458 . . . . 74.52 111.1 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 60.8 t0 -128.56 40.86 3.59 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.224 -0.444 . . . . 72.43 110.889 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.792 ' O ' ' CD2' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -81.46 16.92 1.51 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.177 -0.465 . . . . 75.32 110.842 -179.874 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.51 ' HB2' ' HB3' ' A' ' 81' ' ' SER . 37.6 t60 -81.45 -35.14 30.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.158 -0.474 . . . . 75.21 110.9 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.8 t -64.52 -7.93 11.98 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.169 -0.469 . . . . 72.53 111.152 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -106.09 -28.21 10.64 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.215 -0.448 . . . . 72.53 110.895 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.475 HD13 ' O ' ' A' ' 19' ' ' ARG . 19.1 tp -141.36 144.83 34.75 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.121 -0.49 . . . . 74.02 110.882 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.1 m -111.29 -33.79 6.33 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.138 -0.483 . . . . 73.34 110.842 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.485 ' HB2' ' HG2' ' A' ' 12' ' ' GLU . 2.3 mtp85 -116.66 140.64 49.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.095 -0.502 . . . . 74.25 110.903 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.62 ' HB3' ' HB2' ' A' ' 80' ' ' LEU . 6.3 p -117.37 59.08 0.78 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.199 -0.455 . . . . 74.04 110.873 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.477 ' HB3' ' N ' ' A' ' 14' ' ' LYS . 1.3 m-80 -57.38 -72.55 0.08 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.224 -0.443 . . . . 72.33 110.849 -179.859 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 4.5 p -108.08 127.06 53.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.204 -0.453 . . . . 63.52 110.901 -179.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.635 ' O ' ' HB2' ' A' ' 67' ' ' TYR . 23.3 mt -120.55 149.18 23.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.187 -0.46 . . . . 74.22 111.127 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.465 ' N ' HG23 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -143.73 121.55 11.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.122 -0.49 . . . . 74.2 110.89 179.842 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.596 HG22 ' HB2' ' A' ' 47' ' ' TRP . 1.5 t -107.04 115.65 48.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.203 -0.453 . . . . 75.42 111.074 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -111.36 79.26 1.19 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.116 -0.493 . . . . 74.33 110.908 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.429 ' O ' ' HA ' ' A' ' 6' ' ' THR . . . 132.75 102.12 0.81 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.737 -0.744 . . . . 62.22 112.508 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 53.2 178.12 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.761 -0.733 . . . . 72.23 112.469 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.486 HG21 ' HA ' ' A' ' 63' ' ' PRO . 0.7 OUTLIER -76.78 170.63 16.11 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.729 0.3 . . . . 73.33 111.168 -179.875 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . 0.599 ' CD1' ' HB ' ' A' ' 8' ' ' ILE . 4.0 m95 -144.66 129.98 18.75 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.215 -0.448 . . . . 74.31 110.938 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.596 ' O ' ' N ' ' A' ' 84' ' ' ARG . . . -93.2 126.1 38.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.243 -0.435 . . . . 74.32 111.136 179.893 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.473 ' HA ' ' HA ' ' A' ' 83' ' ' CYS . 17.2 m -124.58 142.18 42.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.22 -0.446 . . . . 71.32 111.113 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.909 ' HB3' ' CB ' ' A' ' 56' ' ' ALA . 7.0 m-85 -116.92 143.53 45.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.127 -0.488 . . . . 73.23 110.977 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.573 ' HG2' ' N ' ' A' ' 52' ' ' ARG . 0.3 OUTLIER -49.47 -83.63 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.154 -0.475 . . . . 74.23 110.865 -179.976 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.772 ' H ' ' HA ' ' A' ' 56' ' ' ALA . 1.2 mtp180 -81.67 138.58 47.26 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.562 0.696 . . . . 75.23 110.914 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.682 ' HA ' ' OG ' ' A' ' 82' ' ' SER . 53.8 Cg_endo -69.75 138.14 37.17 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.672 2.248 . . . . 71.43 112.366 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.467 ' C ' ' CD2' ' A' ' 55' ' ' PHE . 6.3 m-20 66.67 -6.75 0.5 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.245 -0.434 . . . . 74.33 110.87 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.518 ' H ' ' C ' ' A' ' 53' ' ' PRO . 0.0 OUTLIER -139.86 -75.82 0.34 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.223 -0.444 . . . . 75.31 110.885 -179.966 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.909 ' CB ' ' HB3' ' A' ' 50' ' ' TYR . . . 45.71 79.98 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.19 -0.459 . . . . 74.31 111.044 179.906 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . 0.546 ' O ' ' CD2' ' A' ' 58' ' ' TYR . 54.1 m95 -64.72 33.71 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.257 -0.429 . . . . 71.3 110.901 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.63 ' H ' ' C ' ' A' ' 56' ' ' ALA . 1.4 m-30 -163.25 120.61 1.88 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.22 -0.446 . . . . 74.23 110.91 -179.927 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.476 ' HB2' ' HA ' ' A' ' 150' ' ' TYR . 1.0 OUTLIER -85.74 138.84 31.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.099 -0.5 . . . . 74.25 110.873 179.895 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.515 ' CE2' ' HG ' ' A' ' 76' ' ' LEU . 2.8 t80 -153.28 101.68 2.55 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.223 -0.444 . . . . 74.44 110.92 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.51 ' N ' ' CD1' ' A' ' 61' ' ' ILE . 1.8 mp -90.25 116.98 32.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.134 -0.485 . . . . 74.43 111.156 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -82.74 130.88 56.46 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 121.554 0.693 . . . . 75.32 110.962 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.486 ' HA ' HG21 ' A' ' 46' ' ' THR . 53.9 Cg_endo -69.72 -171.94 0.52 Allowed 'Trans proline' 0 C--N 1.341 0.132 0 C-N-CA 122.663 2.242 . . . . 74.12 112.359 179.887 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.92 162.53 14.73 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.219 -0.446 . . . . 63.21 110.937 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 112.3 -168.47 12.7 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.78 -0.724 . . . . 70.21 112.498 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -107.47 152.29 24.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.893 0.378 . . . . 72.42 110.89 -179.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.635 ' HB2' ' O ' ' A' ' 40' ' ' ILE . 11.2 m-85 -141.25 84.95 12.29 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.716 0.77 . . . . 74.44 110.935 -179.864 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.454 ' HD2' ' HG3' ' A' ' 72' ' ' ARG . 53.8 Cg_endo -69.79 0.17 6.06 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.701 2.267 . . . . 64.31 112.353 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.499 ' HB2' ' HG2' ' A' ' 72' ' ' ARG . 51.7 mt-10 -155.47 142.43 19.1 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.21 -0.45 . . . . 75.12 110.917 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.692 ' HA ' ' CE2' ' A' ' 73' ' ' TRP . 26.8 p90 -55.75 -20.06 13.38 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.145 -0.48 . . . . 73.12 110.963 -179.878 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -80.97 -16.01 54.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.093 -0.503 . . . . 74.42 110.9 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.499 ' HG2' ' HB2' ' A' ' 69' ' ' GLU . 27.9 mmt180 -69.88 -9.26 54.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.212 -0.449 . . . . 74.32 110.894 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . 0.728 ' N ' ' CD1' ' A' ' 73' ' ' TRP . 0.0 OUTLIER -133.74 17.53 3.9 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.187 -0.46 . . . . 71.43 110.919 -179.976 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' MET . . . . . 0.443 ' C ' ' O ' ' A' ' 73' ' ' TRP . 19.8 ptp 34.82 47.64 0.26 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.232 -0.44 . . . . 73.34 110.882 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -66.75 117.75 9.72 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.701 -0.761 . . . . 65.12 112.49 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.515 ' HG ' ' CE2' ' A' ' 60' ' ' TYR . 0.7 OUTLIER -61.08 -34.78 75.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.824 0.345 . . . . 71.21 110.927 -179.936 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 13.5 t-20 -125.57 134.12 52.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.183 -0.462 . . . . 72.53 110.889 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -88.4 16.36 6.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.181 -0.463 . . . . 54.44 110.886 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -108.51 80.19 1.32 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.16 -0.473 . . . . 75.22 110.834 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.62 ' HB2' ' HB3' ' A' ' 37' ' ' CYS . 0.0 OUTLIER -81.39 134.36 35.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 74.51 110.905 179.992 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.656 ' HB3' ' HB3' ' A' ' 53' ' ' PRO . 1.5 m -150.74 -118.89 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.188 -0.46 . . . . 74.52 110.86 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.682 ' OG ' ' HA ' ' A' ' 53' ' ' PRO . 0.0 OUTLIER -41.19 103.03 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.151 -0.477 . . . . 73.55 110.872 -179.815 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . 0.495 ' CA ' ' O ' ' A' ' 48' ' ' ALA . 24.7 p -126.83 131.67 51.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.138 -0.483 . . . . 54.22 110.883 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . 0.596 ' N ' ' O ' ' A' ' 48' ' ' ALA . 8.9 mmt85 -113.63 151.21 32.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.181 -0.463 . . . . 75.55 110.852 -179.86 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.456 ' HB1' ' OG1' ' A' ' 6' ' ' THR . . . -68.41 128.34 36.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.19 -0.459 . . . . 63.14 111.095 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.47 HG13 HG12 ' A' ' 136' ' ' VAL . 90.4 t -115.63 128.46 72.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.225 -0.443 . . . . 72.1 111.126 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . 0.485 ' O ' ' CG2' ' A' ' 136' ' ' VAL . 62.3 m80 -108.34 121.71 45.49 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.143 -0.48 . . . . 74.32 110.831 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.411 ' C ' ' O ' ' A' ' 87' ' ' HIS . 0.2 OUTLIER -37.47 138.01 0.62 Allowed Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.578 0.704 . . . . 75.31 110.904 -179.979 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.664 ' HB3' ' H ' ' A' ' 136' ' ' VAL . 53.7 Cg_endo -69.76 98.53 0.69 Allowed 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.662 2.241 . . . . 72.42 112.352 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -101.19 -176.29 3.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.204 -0.453 . . . . 72.44 110.868 -179.854 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 53.98 51.49 49.48 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.742 -0.742 . . . . 74.13 112.505 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.428 ' O ' ' C ' ' A' ' 93' ' ' GLN . . . 126.41 28.24 1.01 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.752 -0.737 . . . . 71.54 112.476 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.483 ' O ' ' HG2' ' A' ' 134' ' ' GLU . 11.4 pt20 36.25 -117.92 0.13 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.839 0.352 . . . . 75.32 110.893 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.543 ' O ' ' HA ' ' A' ' 112' ' ' THR . 0.0 OUTLIER -123.57 99.75 6.46 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.159 -0.473 . . . . 74.25 110.881 -179.863 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.435 ' HG3' HG11 ' A' ' 132' ' ' VAL . 46.2 tptt -111.07 128.32 55.84 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.118 -0.492 . . . . 74.11 110.915 179.863 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.443 HG13 ' CZ3' ' A' ' 137' ' ' TRP . 0.0 OUTLIER -150.55 141.36 16.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.229 -0.441 . . . . 74.22 111.157 179.831 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.46 ' HB2' ' O ' ' A' ' 131' ' ' LYS . 2.2 mt-30 -108.44 130.93 55.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.214 -0.448 . . . . 74.42 110.874 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 1.3 mp -111.25 135.38 50.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.162 -0.472 . . . . 72.14 111.146 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.633 ' HB2' ' HB2' ' A' ' 129' ' ' SER . 8.3 m-85 -125.15 144.27 50.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.199 -0.455 . . . . 74.43 110.934 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 78.5 tt0 -71.36 -75.92 0.12 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.2 -0.454 . . . . 75.02 110.892 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.457 ' C ' ' HB3' ' A' ' 128' ' ' HIS . 41.4 mttt -82.35 175.06 10.55 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.178 -0.464 . . . . 75.03 110.906 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.433 ' N ' ' HB3' ' A' ' 128' ' ' HIS . . . -88.24 158.24 28.8 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.736 -0.745 . . . . 54.12 112.497 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.451 ' HA ' ' HB2' ' A' ' 158' ' ' ARG . 27.9 t0 67.2 54.42 0.73 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.819 0.342 . . . . 71.52 110.82 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.656 ' CE1' ' HD2' ' A' ' 131' ' ' LYS . 6.8 m-85 48.19 31.64 2.68 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.202 -0.454 . . . . 64.41 110.912 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.42 ' C ' ' HB2' ' A' ' 101' ' ' LYS . 49.2 m -107.36 150.62 26.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.159 -0.473 . . . . 73.52 110.873 -179.796 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 91.32 -164.65 29.63 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.69 -0.767 . . . . 50.34 112.441 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 45.0 tp60 -74.67 130.27 39.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.802 0.334 . . . . 71.11 110.938 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -115.76 131.82 56.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.207 -0.451 . . . . 74.03 110.904 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -137.63 138.09 39.12 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.222 -0.444 . . . . 73.5 110.932 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -114.86 111.66 21.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.145 -0.48 . . . . 74.05 110.937 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 12.2 t -122.06 142.2 50.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.165 -0.47 . . . . 74.25 111.115 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.543 ' HA ' ' O ' ' A' ' 94' ' ' TYR . 3.8 t -119.02 39.14 3.62 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.182 -0.463 . . . . 75.2 111.125 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -151.29 156.32 40.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.233 -0.44 . . . . 74.55 110.912 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -53.7 159.68 1.53 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.131 -0.486 . . . . 73.51 110.914 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . 0.543 ' O ' ' HB2' ' A' ' 172' ' ' SER . 29.4 t -146.32 120.17 5.23 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-O 121.6 0.714 . . . . 74.52 110.918 -179.884 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.452 ' O ' ' C ' ' A' ' 143' ' ' PRO . 53.7 Cg_endo -69.67 -32.76 18.31 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.668 2.245 . . . . 73.15 112.361 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' SER . . . . . 0.636 ' HB3' ' CB ' ' A' ' 120' ' ' GLU . 0.1 OUTLIER -148.63 101.72 3.24 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.186 -0.461 . . . . 71.44 110.842 -179.772 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.543 ' HB ' ' O ' ' A' ' 171' ' ' GLN . 3.3 tt -54.47 -29.57 20.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.123 -0.49 . . . . 70.11 111.156 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' MET . . . . . 0.592 ' O ' ' HA ' ' A' ' 123' ' ' HIS . 49.2 ttp -86.2 -44.29 12.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 63.01 110.902 179.819 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.636 ' CB ' ' HB3' ' A' ' 117' ' ' SER . 12.6 tp10 -66.48 -12.47 57.53 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.223 -0.444 . . . . 73.0 110.865 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 25.0 tp60 -114.64 -49.06 2.83 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.156 -0.474 . . . . 72.34 110.934 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . 0.438 ' HB2' ' O ' ' A' ' 118' ' ' ILE . 86.1 m-85 -105.23 -19.15 13.9 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.197 -0.456 . . . . 71.14 110.865 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . 0.592 ' HA ' ' O ' ' A' ' 119' ' ' MET . 11.4 m80 72.18 26.94 2.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.154 -0.475 . . . . 73.52 110.875 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.4 ' HB3' ' CD1' ' A' ' 127' ' ' ILE . 8.9 mtt -102.2 86.44 2.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.182 -0.463 . . . . 72.33 110.876 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 1.7 ptp85 -51.59 -34.54 37.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.245 -0.434 . . . . 70.44 110.913 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.475 ' HG2' ' HA ' ' A' ' 169' ' ' ALA . 35.9 mt-10 -144.89 133.57 22.19 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.152 -0.476 . . . . 73.43 110.897 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.472 ' N ' ' HB2' ' A' ' 168' ' ' PRO . 3.5 mm -94.73 89.77 2.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.147 -0.478 . . . . 73.25 111.15 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . 0.457 ' HB3' ' C ' ' A' ' 101' ' ' LYS . 0.6 OUTLIER -62.58 -33.27 74.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.2 -0.455 . . . . 63.44 110.846 179.862 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 0.633 ' HB2' ' HB2' ' A' ' 99' ' ' PHE . 69.9 m -130.58 141.53 50.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 74.22 110.871 -179.747 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . 0.614 ' O ' ' O ' ' A' ' 155' ' ' LYS . 0.1 OUTLIER -142.84 122.31 13.19 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.178 -0.464 . . . . 62.24 110.91 -179.959 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.656 ' HD2' ' CE1' ' A' ' 104' ' ' PHE . 7.1 mtpp -115.74 155.61 27.46 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.169 -0.469 . . . . 73.25 110.861 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.521 ' HB ' ' O ' ' A' ' 131' ' ' LYS . 18.1 t 84.92 163.72 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.242 -0.435 . . . . 74.3 111.114 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.465 ' O ' ' HG ' ' A' ' 133' ' ' LEU . 0.0 OUTLIER -178.95 122.86 0.09 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.162 -0.472 . . . . 73.44 110.898 180.0 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.483 ' HG2' ' O ' ' A' ' 93' ' ' GLN . 0.0 OUTLIER -92.49 171.23 9.17 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.225 -0.443 . . . . 74.2 110.912 179.863 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . 0.455 ' C ' ' O ' ' A' ' 134' ' ' GLU . . . -32.67 -53.08 0.47 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.754 -0.736 . . . . 74.24 112.482 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.736 ' HA ' HD13 ' A' ' 152' ' ' LEU . 4.1 t -148.81 146.13 17.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.858 0.361 . . . . 64.12 111.109 -179.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' TRP . . . . . 0.562 ' HB3' ' HB3' ' A' ' 152' ' ' LEU . 0.7 OUTLIER -150.01 163.34 38.4 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.146 -0.479 . . . . 74.42 110.893 179.975 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.46 HD12 ' HB ' ' A' ' 61' ' ' ILE . 4.7 mt -143.18 136.65 25.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.186 -0.461 . . . . 71.14 111.109 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 0.464 ' HB2' ' HB2' ' A' ' 150' ' ' TYR . 0.2 OUTLIER -102.55 168.79 9.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.204 -0.453 . . . . 73.33 110.882 179.989 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . 0.46 ' CD2' ' HA ' ' A' ' 145' ' ' TYR . 0.5 OUTLIER -139.88 127.65 21.91 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.131 -0.486 . . . . 71.22 110.959 -179.85 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . 0.596 ' O ' ' HB2' ' A' ' 171' ' ' GLN . 0.7 OUTLIER -60.79 -28.41 68.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.134 -0.484 . . . . 75.42 110.893 -179.986 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.763 ' HB3' ' HD2' ' A' ' 143' ' ' PRO . 9.2 mp -115.06 173.63 2.81 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.621 0.724 . . . . 73.32 110.909 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . 0.763 ' HD2' ' HB3' ' A' ' 142' ' ' LEU . 53.8 Cg_endo -69.76 -89.59 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.603 2.202 . . . . 71.52 112.363 179.852 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . 0.711 ' O ' ' N ' ' A' ' 146' ' ' ARG . 1.3 m-20 -53.13 97.63 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.203 -0.453 . . . . 72.41 110.911 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . 0.637 ' C ' ' O ' ' A' ' 144' ' ' ASN . 33.1 m-85 12.51 52.36 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.169 -0.469 . . . . 73.42 110.932 -179.882 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . 0.711 ' N ' ' O ' ' A' ' 144' ' ' ASN . 19.5 mtt-85 -117.85 172.6 7.28 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.095 -0.502 . . . . 64.11 110.91 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 77.55 -176.86 53.35 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.759 -0.734 . . . . 61.25 112.523 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -78.08 149.62 33.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.76 0.314 . . . . 75.04 110.895 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 63.3 mt-30 -85.71 157.24 20.34 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.217 -0.447 . . . . 75.52 110.945 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . 0.476 ' HA ' ' HB2' ' A' ' 59' ' ' MET . 88.8 m-85 -137.78 109.78 7.22 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.229 -0.441 . . . . 74.03 110.905 -179.837 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.407 ' CA ' HD12 ' A' ' 61' ' ' ILE . 20.2 tp -59.76 136.11 57.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.097 -0.502 . . . . 74.53 110.924 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.736 HD13 ' HA ' ' A' ' 136' ' ' VAL . 0.0 OUTLIER -68.93 137.17 53.57 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.18 -0.464 . . . . 74.51 110.905 179.881 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -164.15 24.94 0.07 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.223 -0.444 . . . . 73.24 110.922 179.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.919 ' HB2' ' CD1' ' A' ' 157' ' ' TYR . 2.2 ptmt -122.0 -174.62 2.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.131 -0.486 . . . . 72.22 110.872 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.67 ' HG3' ' O ' ' A' ' 154' ' ' LYS . 0.0 OUTLIER -158.66 -124.8 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.243 -0.435 . . . . 74.14 110.891 179.871 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . 0.617 ' HA ' ' HA ' ' A' ' 131' ' ' LYS . 0.5 OUTLIER -64.75 -4.67 4.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.45 . . . . 74.43 110.89 179.943 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . 0.919 ' CD1' ' HB2' ' A' ' 154' ' ' LYS . 14.2 m-30 -26.42 141.33 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.143 -0.48 . . . . 72.2 110.899 -179.854 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . 0.495 ' O ' ' OG ' ' A' ' 129' ' ' SER . 8.2 ptp180 -105.17 -46.04 4.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.158 -0.474 . . . . 74.54 110.843 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . 0.471 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 3.3 ptpp? -84.59 150.42 56.63 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.537 0.684 . . . . 71.14 110.92 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . 0.654 ' O ' ' CD1' ' A' ' 163' ' ' TRP . 54.0 Cg_endo -69.77 -29.49 23.72 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.692 2.261 . . . . 73.21 112.33 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 2.0 mp -71.96 6.85 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.197 -0.456 . . . . 74.44 111.169 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . 0.607 ' HB3' ' CD1' ' A' ' 157' ' ' TYR . 0.9 OUTLIER -76.99 -18.05 58.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.109 -0.496 . . . . 73.15 110.838 179.896 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' TRP . . . . . 0.654 ' CD1' ' O ' ' A' ' 160' ' ' PRO . 0.4 OUTLIER -109.21 12.83 24.73 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.25 -0.432 . . . . 73.12 110.955 -179.941 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 81.25 -44.08 2.99 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.706 -0.759 . . . . 71.24 112.488 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . 0.471 ' HB2' ' CD1' ' A' ' 163' ' ' TRP . . . -52.3 121.49 7.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.813 0.339 . . . . 62.44 111.095 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -64.67 122.14 16.15 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.208 -0.451 . . . . 65.0 111.126 179.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' SER . . . . . 0.52 ' C ' ' H ' ' A' ' 169' ' ' ALA . 0.4 OUTLIER 63.23 146.46 0.09 OUTLIER Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 121.673 0.749 . . . . 65.21 110.866 -179.786 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . 0.472 ' HB2' ' N ' ' A' ' 127' ' ' ILE . 53.5 Cg_endo -69.81 23.75 0.17 Allowed 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.664 2.243 . . . . 72.32 112.37 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . 0.52 ' H ' ' C ' ' A' ' 167' ' ' SER . . . -62.39 102.75 0.34 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.189 -0.46 . . . . 65.22 111.086 179.848 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 3.4 t -154.87 162.49 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.208 -0.451 . . . . 72.25 111.112 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 171' ' ' GLN . . . . . 0.668 ' OE1' ' HB3' ' A' ' 143' ' ' PRO . 1.6 tm0? -109.93 -83.05 0.57 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.156 -0.474 . . . . 64.23 110.925 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 172' ' ' SER . . . . . 0.742 ' OG ' ' O ' ' A' ' 143' ' ' PRO . 52.5 p -123.83 177.14 5.88 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.234 -0.439 . . . . 64.33 110.878 -179.858 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -140.45 168.0 20.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.136 -0.484 . . . . 74.23 110.893 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . 0.428 ' HD2' ' CE2' ' A' ' 140' ' ' TYR . 0.1 OUTLIER -134.66 152.64 51.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.112 -0.494 . . . . 75.32 110.866 -179.904 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.29 167.77 10.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.184 -0.462 . . . . 70.24 110.886 -179.911 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . 0.413 HD11 ' C ' ' A' ' 136' ' ' VAL . 2.6 mt -116.63 141.52 34.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.165 -0.47 . . . . 73.25 111.16 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 3.2 p -149.97 155.85 7.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.195 -0.457 . . . . 74.25 111.108 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 116.143 -0.48 . . . . 64.4 110.895 179.996 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.305 0 N-CA-C 112.466 -0.254 . . . . 65.4 112.466 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.463 ' C ' ' HE1' ' A' ' 47' ' ' TRP . 7.2 p -82.46 136.72 34.86 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.867 0.365 . . . . 75.13 111.153 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.41 ' N ' ' HE1' ' A' ' 47' ' ' TRP . 2.5 tttt -126.93 136.76 52.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.236 -0.438 . . . . 74.3 110.907 179.878 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.537 HD13 ' CE1' ' A' ' 10' ' ' PHE . 16.5 tt -136.5 154.56 32.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.22 -0.445 . . . . 75.32 111.129 179.881 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.453 HG21 ' CE2' ' A' ' 11' ' ' TYR . 13.7 m -134.55 151.41 51.08 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.162 -0.472 . . . . 70.31 111.157 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.537 ' CE1' HD13 ' A' ' 8' ' ' ILE . 1.2 m-85 -140.45 129.59 23.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.454 . . . . 75.04 110.863 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.538 ' CG ' ' HA ' ' A' ' 16' ' ' PHE . 8.2 m-85 -115.36 133.15 56.3 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.154 -0.475 . . . . 74.34 110.942 -179.872 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.443 ' HG2' ' HB2' ' A' ' 36' ' ' ARG . 0.0 OUTLIER -56.6 -25.0 51.6 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.181 -0.463 . . . . 73.44 110.89 -179.974 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.405 ' HB2' ' O ' ' A' ' 17' ' ' GLN . 62.8 m-20 -126.38 155.8 41.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.159 -0.473 . . . . 74.41 110.91 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.401 ' HG2' ' HA ' ' A' ' 69' ' ' GLU . 11.2 mtmt -57.99 -173.58 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.206 -0.452 . . . . 74.4 110.899 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 23.9 m-20 43.95 34.41 0.92 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.244 -0.435 . . . . 64.25 110.867 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.538 ' HA ' ' CG ' ' A' ' 11' ' ' TYR . 3.1 m-85 48.05 62.9 2.27 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.21 -0.45 . . . . 74.45 110.829 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . 0.405 ' O ' ' HB2' ' A' ' 13' ' ' ASP . 10.6 mt-30 -136.55 154.68 50.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.181 -0.463 . . . . 71.4 110.902 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 95.28 -152.94 20.6 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.711 -0.757 . . . . 72.53 112.485 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.449 ' O ' ' CD1' ' A' ' 34' ' ' LEU . 0.0 OUTLIER -65.21 81.13 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.844 0.354 . . . . 74.11 110.891 -179.867 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.447 ' HB2' ' CE1' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -79.97 128.92 34.04 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.189 -0.46 . . . . 70.31 110.835 -179.859 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.471 ' CD2' ' CD2' ' A' ' 30' ' ' PHE . 72.2 t80 -123.53 126.12 46.11 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.221 -0.445 . . . . 70.42 110.944 -179.854 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.411 ' OD2' ' CD ' ' A' ' 20' ' ' ARG . 1.1 m-20 -121.71 134.41 54.95 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.17 -0.468 . . . . 73.41 110.874 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 6.7 t -163.02 134.39 4.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.165 -0.471 . . . . 74.13 110.922 -179.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.405 ' HA ' ' HA ' ' A' ' 7' ' ' LYS . 5.0 p-10 -101.96 3.56 39.11 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.203 -0.453 . . . . 72.21 110.875 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 42.2 t -110.62 158.79 18.2 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.197 -0.456 . . . . 61.31 110.893 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -40.7 119.75 1.16 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.234 -0.439 . . . . 71.22 110.889 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.542 ' CB ' ' HB3' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -114.51 39.95 2.68 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.175 -0.466 . . . . 73.34 110.879 -179.896 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.571 ' O ' ' HB3' ' A' ' 82' ' ' SER . . . -50.86 -21.35 1.65 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.218 -0.447 . . . . 63.42 111.078 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 58.1 t0 -130.45 39.44 3.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.215 -0.448 . . . . 75.0 110.843 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.81 ' O ' ' CD2' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -81.09 15.27 1.94 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.213 -0.449 . . . . 74.33 110.885 -179.876 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.415 ' CG ' ' HG3' ' A' ' 53' ' ' PRO . 44.5 t60 -80.57 -35.02 34.86 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.157 -0.474 . . . . 73.3 110.867 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.7 t -62.96 -10.65 14.46 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.169 -0.469 . . . . 75.5 111.154 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -103.53 -27.29 12.45 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.231 -0.44 . . . . 75.4 110.92 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.449 ' CD1' ' O ' ' A' ' 19' ' ' ARG . 30.4 tp -138.17 138.73 38.88 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.137 -0.483 . . . . 75.24 110.905 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.5 m -104.11 -36.15 7.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.169 -0.469 . . . . 62.43 110.824 -179.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.443 ' HB2' ' HG2' ' A' ' 12' ' ' GLU . 0.7 OUTLIER -112.98 139.86 48.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.131 -0.486 . . . . 75.51 110.863 -179.92 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.476 ' SG ' ' CB ' ' A' ' 80' ' ' LEU . 2.2 m -121.41 69.87 0.92 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.193 -0.458 . . . . 73.35 110.93 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -72.04 -71.86 0.26 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.214 -0.448 . . . . 74.41 110.889 -179.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 4.9 p -104.54 134.61 47.43 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.165 -0.47 . . . . 61.22 110.867 -179.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.563 ' O ' ' HB2' ' A' ' 67' ' ' TYR . 20.8 mt -126.51 151.65 33.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.135 -0.484 . . . . 74.34 111.124 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.463 ' HD2' ' CE2' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -145.0 124.75 13.34 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.155 -0.475 . . . . 72.11 110.918 179.834 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.528 HG22 ' HB2' ' A' ' 47' ' ' TRP . 1.2 t -111.99 116.03 51.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.214 -0.448 . . . . 72.34 111.16 179.882 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -112.95 77.63 1.06 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.217 -0.447 . . . . 73.14 110.886 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.413 ' O ' ' HA ' ' A' ' 6' ' ' THR . . . 139.08 97.49 0.38 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.685 -0.769 . . . . 74.52 112.464 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 52.52 -179.9 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.729 -0.748 . . . . 63.55 112.476 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.481 HG21 ' HA ' ' A' ' 63' ' ' PRO . 1.4 m -74.52 170.05 16.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.75 0.31 . . . . 75.14 111.162 -179.886 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . 0.528 ' HB2' HG22 ' A' ' 42' ' ' VAL . 4.5 m95 -142.92 130.03 20.77 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.245 -0.434 . . . . 75.14 110.887 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.633 ' O ' ' N ' ' A' ' 84' ' ' ARG . . . -87.36 127.09 35.2 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.225 -0.443 . . . . 75.44 111.115 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.68 ' O ' ' O ' ' A' ' 60' ' ' TYR . 34.5 m -129.7 131.71 66.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.263 -0.426 . . . . 75.02 111.127 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.708 ' HB3' ' HA ' ' A' ' 56' ' ' ALA . 58.8 m-85 -103.01 147.92 26.34 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.192 -0.458 . . . . 71.31 110.913 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.653 ' OE1' ' HB3' ' A' ' 57' ' ' TRP . 63.7 tt0 -50.19 -78.99 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.133 -0.485 . . . . 64.54 110.858 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.586 ' HB3' ' HB2' ' A' ' 55' ' ' PHE . 0.5 OUTLIER -91.04 138.01 26.22 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.618 0.723 . . . . 74.31 110.869 -179.908 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.712 ' HB3' ' HB3' ' A' ' 81' ' ' SER . 53.7 Cg_endo -69.82 145.98 58.43 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.655 2.237 . . . . 71.42 112.349 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 63.15 -7.67 0.15 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.239 -0.437 . . . . 73.25 110.917 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.614 ' CD1' ' O ' ' A' ' 53' ' ' PRO . 30.8 m-85 -113.72 -20.32 11.21 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.173 -0.467 . . . . 72.21 110.864 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.708 ' HA ' ' HB3' ' A' ' 50' ' ' TYR . . . 52.37 27.27 4.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.188 -0.46 . . . . 65.14 111.105 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . 0.653 ' HB3' ' OE1' ' A' ' 51' ' ' GLU . 0.0 OUTLIER -49.28 -164.36 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.225 -0.443 . . . . 74.45 110.888 -179.956 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.637 ' C ' ' O ' ' A' ' 57' ' ' TRP . 4.7 m-30 -12.55 101.39 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.182 -0.463 . . . . 74.22 110.951 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.432 ' HB2' ' O ' ' A' ' 149' ' ' GLN . 2.3 mpt? -60.74 155.93 18.1 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.17 -0.468 . . . . 75.21 110.856 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.68 ' O ' ' O ' ' A' ' 49' ' ' VAL . 2.7 t80 -170.74 120.63 0.56 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.202 -0.454 . . . . 75.32 110.972 -179.872 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.611 ' N ' ' CD1' ' A' ' 61' ' ' ILE . 1.0 OUTLIER -106.2 114.24 44.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.165 -0.47 . . . . 62.22 111.15 179.923 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -83.75 124.65 74.82 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.583 0.706 . . . . 75.24 110.933 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.481 ' HA ' HG21 ' A' ' 46' ' ' THR . 53.3 Cg_endo -69.75 -171.3 0.46 Allowed 'Trans proline' 0 C--O 1.231 0.141 0 C-N-CA 122.706 2.271 . . . . 74.34 112.295 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.79 163.2 15.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.189 -0.459 . . . . 73.42 110.908 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 114.35 -158.42 14.33 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.795 -0.717 . . . . 73.45 112.472 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -118.28 154.3 32.53 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.871 0.367 . . . . 74.04 110.868 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.563 ' HB2' ' O ' ' A' ' 40' ' ' ILE . 17.5 m-85 -140.94 84.14 13.47 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.691 0.758 . . . . 74.53 110.959 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.442 ' HD2' ' HG3' ' A' ' 72' ' ' ARG . 53.1 Cg_endo -69.84 2.79 3.25 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.643 2.229 . . . . 74.5 112.35 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.58 ' HB2' ' HG2' ' A' ' 72' ' ' ARG . 48.4 mt-10 -157.56 144.21 17.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.183 -0.462 . . . . 74.03 110.893 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.697 ' HA ' ' NE1' ' A' ' 73' ' ' TRP . 35.4 p90 -55.78 -25.97 43.74 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.127 -0.488 . . . . 71.25 110.896 -179.801 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -76.51 -15.81 59.79 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.154 -0.475 . . . . 65.24 110.931 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.58 ' HG2' ' HB2' ' A' ' 69' ' ' GLU . 32.0 mmt180 -67.27 -15.98 64.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.201 -0.454 . . . . 75.22 110.874 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . 0.745 ' N ' ' CD1' ' A' ' 73' ' ' TRP . 0.0 OUTLIER -125.14 21.88 7.99 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.202 -0.454 . . . . 74.52 110.939 -179.959 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' MET . . . . . 0.574 ' O ' ' C ' ' A' ' 75' ' ' GLY . 2.1 ttm 75.87 -16.4 0.6 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.258 -0.428 . . . . 72.3 110.88 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.574 ' C ' ' O ' ' A' ' 74' ' ' MET . . . 21.93 57.5 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.762 -0.732 . . . . 71.52 112.496 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.579 HD11 ' N ' ' A' ' 77' ' ' ASN . 0.0 OUTLIER -56.48 -10.93 1.07 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.835 0.35 . . . . 73.43 110.927 -179.935 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.579 ' N ' HD11 ' A' ' 76' ' ' LEU . 37.0 t-20 -149.33 -48.67 0.14 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.219 -0.446 . . . . 74.32 110.853 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.556 ' CB ' ' O ' ' A' ' 77' ' ' ASN . 5.2 t0 87.22 -7.73 0.64 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.192 -0.458 . . . . 72.4 110.901 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.465 ' HG2' ' O ' ' A' ' 79' ' ' ARG . 8.7 ttt85 -85.39 50.15 1.9 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.178 -0.464 . . . . 65.42 110.874 -179.897 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.545 ' CD1' HG11 ' A' ' 49' ' ' VAL . 0.1 OUTLIER -59.36 130.65 47.95 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.195 -0.457 . . . . 72.53 110.937 179.998 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.712 ' HB3' ' HB3' ' A' ' 53' ' ' PRO . 12.3 m -151.6 -111.77 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.182 -0.463 . . . . 73.43 110.849 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.571 ' HB3' ' O ' ' A' ' 28' ' ' ALA . 1.0 OUTLIER -47.87 97.12 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.155 -0.475 . . . . 74.04 110.851 -179.802 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . 0.571 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 7.6 p -123.89 135.23 53.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.167 -0.469 . . . . 71.25 110.858 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . 0.633 ' N ' ' O ' ' A' ' 48' ' ' ALA . 0.9 OUTLIER -115.12 154.82 28.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.154 -0.475 . . . . 74.32 110.89 -179.9 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.455 ' HB1' ' OG1' ' A' ' 6' ' ' THR . . . -68.17 130.06 41.77 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.191 -0.458 . . . . 73.41 111.048 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.501 HG23 ' HB3' ' A' ' 48' ' ' ALA . 37.7 t -115.03 133.34 61.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.208 -0.451 . . . . 73.21 111.179 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . 0.451 ' O ' ' C ' ' A' ' 88' ' ' LEU . 39.9 m80 -111.26 108.48 18.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.202 -0.454 . . . . 74.3 110.87 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.451 ' C ' ' O ' ' A' ' 87' ' ' HIS . 0.0 OUTLIER -33.4 147.04 0.1 OUTLIER Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.566 0.698 . . . . 74.34 110.943 -179.96 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.5 ' HB3' ' H ' ' A' ' 136' ' ' VAL . 53.6 Cg_endo -69.78 95.52 0.56 Allowed 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.68 2.253 . . . . 62.02 112.328 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -88.89 -174.87 4.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.225 -0.443 . . . . 72.12 110.844 -179.847 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 64.0 108.48 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.766 -0.731 . . . . 65.35 112.525 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 69.41 -84.34 0.26 Allowed Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.695 -0.764 . . . . 74.44 112.481 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.421 ' O ' ' HG2' ' A' ' 134' ' ' GLU . 19.5 pt20 178.74 -136.79 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.842 0.353 . . . . 75.4 110.945 -179.863 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.647 ' HA ' ' HG2' ' A' ' 134' ' ' GLU . 0.0 OUTLIER -113.86 103.2 10.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.202 -0.454 . . . . 74.43 110.96 -179.877 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 29.1 tptt -107.41 128.79 54.79 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.127 -0.488 . . . . 74.33 110.896 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -151.08 133.97 6.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.194 -0.457 . . . . 74.32 111.136 179.828 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.411 ' HB2' ' O ' ' A' ' 131' ' ' LYS . 0.3 OUTLIER -105.76 126.61 52.37 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.142 -0.481 . . . . 74.35 110.911 179.948 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 13.0 mt -105.08 138.51 29.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.186 -0.461 . . . . 73.01 111.103 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.657 ' HB2' ' HB2' ' A' ' 129' ' ' SER . 46.7 m-85 -125.75 139.9 53.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.166 -0.47 . . . . 71.13 110.87 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 79.0 tt0 -71.89 -70.8 0.31 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.119 -0.491 . . . . 73.12 110.875 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 41.4 mttt -87.9 171.02 10.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.157 -0.474 . . . . 71.52 110.858 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -75.47 155.05 46.58 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.801 -0.714 . . . . 72.4 112.481 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.596 ' HA ' ' HB2' ' A' ' 158' ' ' ARG . 16.1 t0 68.03 45.26 1.35 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.85 0.357 . . . . 64.31 110.863 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.429 ' HA ' ' CD1' ' A' ' 99' ' ' PHE . 0.7 OUTLIER 50.7 29.17 4.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.183 -0.462 . . . . 75.01 110.89 -179.905 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 71.2 m -96.82 159.06 15.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.149 -0.478 . . . . 74.05 110.911 -179.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 87.1 -145.06 19.64 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.774 -0.727 . . . . 75.13 112.493 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 3.8 tp-100 -87.66 125.01 34.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.8 0.333 . . . . 72.15 110.906 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' MET . . . . . 0.478 ' HB2' ' CE1' ' A' ' 99' ' ' PHE . 23.4 ttp -107.64 144.35 34.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.198 -0.455 . . . . 74.51 110.889 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -149.51 135.5 18.85 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.275 -0.421 . . . . 75.4 110.884 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -114.93 102.68 10.19 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.102 -0.499 . . . . 63.5 110.909 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 14.6 t -114.07 144.19 43.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 74.32 111.102 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.479 ' O ' ' OG1' ' A' ' 112' ' ' THR . 0.8 OUTLIER -124.4 36.35 4.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.252 -0.431 . . . . 63.44 111.135 -179.988 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -143.84 -172.52 3.76 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.232 -0.44 . . . . 73.33 110.867 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -86.31 162.54 18.18 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.112 -0.494 . . . . 74.43 110.88 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . 0.401 ' HB3' ' CE2' ' A' ' 173' ' ' PHE . 0.8 OUTLIER -157.25 120.76 2.21 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-O 121.585 0.707 . . . . 73.52 110.92 -179.918 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.596 ' O ' ' OG ' ' A' ' 172' ' ' SER . 54.1 Cg_endo -69.73 -33.5 16.6 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.642 2.228 . . . . 65.24 112.401 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' SER . . . . . 0.66 ' HB3' ' CB ' ' A' ' 120' ' ' GLU . 0.2 OUTLIER -138.68 103.57 4.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.22 -0.445 . . . . 75.12 110.846 -179.862 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.664 ' HB ' ' O ' ' A' ' 171' ' ' GLN . 4.9 tt -57.91 -29.87 36.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.135 -0.484 . . . . 73.42 111.148 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' MET . . . . . 0.594 ' O ' ' HA ' ' A' ' 123' ' ' HIS . 2.8 ttt -87.89 -45.62 10.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.165 -0.47 . . . . 72.45 110.864 179.873 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.66 ' CB ' ' HB3' ' A' ' 117' ' ' SER . 6.7 tp10 -62.86 -13.5 34.7 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.235 -0.439 . . . . 75.24 110.89 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 7.8 tp-100 -114.64 -50.09 2.8 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.186 -0.461 . . . . 74.4 110.963 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . 0.567 ' HB2' ' O ' ' A' ' 118' ' ' ILE . 96.1 m-85 -100.07 -20.64 15.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.165 -0.47 . . . . 73.15 110.881 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . 0.594 ' HA ' ' O ' ' A' ' 119' ' ' MET . 13.4 m-70 76.42 22.07 1.3 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.17 -0.468 . . . . 74.43 110.888 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.485 ' O ' HG22 ' A' ' 118' ' ' ILE . 3.5 mtt -97.67 118.74 34.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.174 -0.466 . . . . 74.23 110.856 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 5.8 ptp180 -79.58 -45.79 18.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.203 -0.453 . . . . 74.02 110.863 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.436 ' HB3' ' HG2' ' A' ' 168' ' ' PRO . 19.9 mt-10 -140.45 117.36 11.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.181 -0.463 . . . . 75.24 110.836 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.426 ' O ' ' HB3' ' A' ' 168' ' ' PRO . 3.2 mm -73.52 92.49 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.128 -0.487 . . . . 74.12 111.112 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -64.89 -34.0 77.35 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.156 -0.475 . . . . 72.13 110.868 179.874 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 0.657 ' HB2' ' HB2' ' A' ' 99' ' ' PHE . 4.7 m -133.97 155.03 50.68 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.207 -0.452 . . . . 74.32 110.845 -179.802 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . 0.663 ' O ' ' O ' ' A' ' 155' ' ' LYS . 0.1 OUTLIER -156.59 123.04 5.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.112 -0.494 . . . . 65.33 110.844 -179.951 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.618 ' HA ' ' HA ' ' A' ' 156' ' ' GLU . 1.9 mtpt -108.22 154.21 22.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.16 -0.473 . . . . 75.21 110.885 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.484 ' CB ' ' O ' ' A' ' 131' ' ' LYS . 8.3 t 83.45 165.03 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.215 -0.448 . . . . 74.31 111.136 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.477 ' CD1' ' O ' ' A' ' 154' ' ' LYS . 0.0 OUTLIER -178.49 123.69 0.1 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.125 -0.489 . . . . 55.22 110.905 179.977 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.647 ' HG2' ' HA ' ' A' ' 94' ' ' TYR . 0.1 OUTLIER -98.64 164.41 12.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.21 -0.45 . . . . 73.53 110.856 179.928 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . 0.557 ' C ' ' O ' ' A' ' 134' ' ' GLU . . . -23.06 -63.1 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.736 -0.745 . . . . 71.03 112.487 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.7 ' HA ' HD13 ' A' ' 152' ' ' LEU . 3.1 t -144.44 146.34 20.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.804 0.335 . . . . 74.14 111.126 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' TRP . . . . . 0.607 ' HB3' ' HB3' ' A' ' 152' ' ' LEU . 6.3 t-105 -143.19 149.56 38.17 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.164 -0.471 . . . . 74.1 110.945 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 3.5 mm -114.59 134.73 56.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.285 -0.416 . . . . 73.13 111.161 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 0.456 ' CB ' ' HB2' ' A' ' 150' ' ' TYR . 0.1 OUTLIER -117.23 142.65 46.79 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.204 -0.453 . . . . 73.22 110.846 -179.989 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . 0.506 ' CE2' ' HA ' ' A' ' 145' ' ' TYR . 3.9 m-85 -120.79 130.4 53.98 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.14 -0.482 . . . . 73.51 110.932 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . 0.437 ' O ' ' HB2' ' A' ' 171' ' ' GLN . 2.9 tt0 -61.77 -47.62 84.35 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.121 -0.49 . . . . 75.41 110.885 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 1.042 ' O ' ' HB2' ' A' ' 172' ' ' SER . 7.1 mp -97.41 152.56 38.29 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.588 0.709 . . . . 74.51 110.922 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . 0.689 ' HB3' ' OE1' ' A' ' 171' ' ' GLN . 54.3 Cg_endo -69.68 44.76 0.42 Allowed 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.709 2.273 . . . . 71.21 112.379 179.854 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . 1.084 ' O ' ' N ' ' A' ' 146' ' ' ARG . 0.0 OUTLIER 179.06 106.62 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.228 -0.442 . . . . 74.34 110.885 -179.989 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . 0.668 ' C ' ' O ' ' A' ' 144' ' ' ASN . 0.0 OUTLIER -3.51 51.25 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.204 -0.453 . . . . 72.24 110.938 -179.948 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . 1.084 ' N ' ' O ' ' A' ' 144' ' ' ASN . 36.7 mtt180 -131.47 163.27 28.33 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.118 -0.492 . . . . 72.03 110.881 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 82.8 -162.69 41.34 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.75 -0.738 . . . . 73.5 112.472 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -84.97 148.96 25.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.753 0.311 . . . . 74.33 110.84 -179.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' GLN . . . . . 0.432 ' O ' ' HB2' ' A' ' 59' ' ' MET . 19.3 mt-30 -95.73 135.09 37.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.159 -0.473 . . . . 72.21 110.901 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . 0.456 ' HB2' ' CB ' ' A' ' 139' ' ' PHE . 41.6 m-85 -109.95 127.06 54.54 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.164 -0.471 . . . . 73.14 110.856 -179.841 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.49 ' CA ' HD12 ' A' ' 61' ' ' ILE . 6.8 tp -83.01 120.89 26.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.088 -0.505 . . . . 61.33 110.947 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.7 HD13 ' HA ' ' A' ' 136' ' ' VAL . 0.0 OUTLIER -50.46 133.11 25.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.2 -0.454 . . . . 73.55 110.962 179.887 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -162.09 23.16 0.11 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.216 -0.447 . . . . 52.54 110.868 179.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.82 ' HB2' ' CD1' ' A' ' 157' ' ' TYR . 3.2 ptmt -119.97 -174.02 2.67 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.191 -0.459 . . . . 74.4 110.91 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.671 ' HG3' ' O ' ' A' ' 154' ' ' LYS . 1.7 mptt -158.4 -119.43 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.249 -0.432 . . . . 75.35 110.934 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . 0.618 ' HA ' ' HA ' ' A' ' 131' ' ' LYS . 1.2 tm-20 -72.47 0.74 9.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.201 -0.454 . . . . 73.5 110.931 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . 0.82 ' CD1' ' HB2' ' A' ' 154' ' ' LYS . 12.9 m-30 -34.97 154.11 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.106 -0.497 . . . . 75.42 110.929 -179.868 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . 0.596 ' HB2' ' HA ' ' A' ' 103' ' ' ASP . 8.0 ptp180 -116.7 -44.22 2.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.074 -0.512 . . . . 75.43 110.883 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . 0.4 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 3.1 ptpp? -86.25 150.13 51.3 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.6 0.714 . . . . 73.44 110.854 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . 0.41 ' HG2' HD11 ' A' ' 161' ' ' ILE . 54.2 Cg_endo -69.78 -23.49 30.66 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.64 2.227 . . . . 74.12 112.377 179.86 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.457 HD11 ' H ' ' A' ' 161' ' ' ILE . 3.5 mp -78.71 4.09 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.212 -0.449 . . . . 73.14 111.138 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . 0.536 ' HB3' ' CD1' ' A' ' 157' ' ' TYR . 1.0 OUTLIER -72.96 -16.91 61.52 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.19 -0.459 . . . . 72.55 110.819 179.853 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' TRP . . . . . 0.673 ' CD1' ' N ' ' A' ' 163' ' ' TRP . 0.0 OUTLIER -115.82 13.54 16.11 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.217 -0.447 . . . . 75.45 110.864 -179.943 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 88.64 -31.88 4.74 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.762 -0.732 . . . . 75.03 112.489 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . 0.412 ' HB1' ' CE3' ' A' ' 163' ' ' TRP . . . -51.53 118.55 3.4 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.783 0.325 . . . . 62.41 111.1 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -50.73 -31.5 16.81 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.248 -0.433 . . . . 72.23 111.114 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 167' ' ' SER . . . . . 0.53 ' C ' ' H ' ' A' ' 169' ' ' ALA . 0.3 OUTLIER -149.98 156.44 38.01 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.701 0.763 . . . . 74.24 110.835 -179.826 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . 0.436 ' HG2' ' HB3' ' A' ' 126' ' ' GLU . 53.9 Cg_endo -69.73 24.95 0.17 Allowed 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.727 2.285 . . . . 75.24 112.312 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . 0.53 ' H ' ' C ' ' A' ' 167' ' ' SER . . . -65.55 100.93 0.55 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.265 -0.425 . . . . 71.3 111.082 179.91 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 1.9 t -154.42 165.35 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.213 -0.449 . . . . 74.44 111.12 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 171' ' ' GLN . . . . . 0.689 ' OE1' ' HB3' ' A' ' 143' ' ' PRO . 2.2 mm-40 -147.53 -101.2 0.09 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.128 -0.487 . . . . 75.44 110.876 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 172' ' ' SER . . . . . 1.042 ' HB2' ' O ' ' A' ' 142' ' ' LEU . 0.3 OUTLIER -56.31 143.73 33.03 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.196 -0.456 . . . . 73.43 110.902 -179.8 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 173' ' ' PHE . . . . . 0.401 ' CE2' ' HB3' ' A' ' 115' ' ' CYS . 31.2 p90 -152.1 132.79 13.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.184 -0.462 . . . . 74.21 110.92 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.51 165.47 23.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.186 -0.461 . . . . 75.34 110.861 -179.878 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.12 -161.28 0.82 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.209 -0.45 . . . . 74.2 110.877 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . 0.524 ' CD1' ' CG1' ' A' ' 136' ' ' VAL . 3.5 mt -139.3 138.79 40.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 63.24 111.144 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 5.0 p -145.34 152.34 14.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.188 -0.46 . . . . 72.0 111.106 179.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.149 -0.478 . . . . 75.34 110.896 -179.961 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.366 0 N-CA-C 112.497 -0.241 . . . . 72.1 112.497 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.481 ' C ' ' HE1' ' A' ' 47' ' ' TRP . 8.0 p -82.98 135.87 34.73 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.867 0.365 . . . . 71.25 111.155 -179.862 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 3.2 tttt -123.94 136.17 54.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.189 -0.459 . . . . 70.14 110.9 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.613 HG23 ' CZ ' ' A' ' 10' ' ' PHE . 16.2 tt -137.47 150.89 25.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.223 -0.444 . . . . 75.21 111.151 179.861 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.449 HG21 ' CE2' ' A' ' 11' ' ' TYR . 10.1 m -130.21 146.08 51.8 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.196 -0.456 . . . . 72.34 111.163 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.613 ' CZ ' HG23 ' A' ' 8' ' ' ILE . 1.5 m-85 -132.33 129.1 39.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.205 -0.452 . . . . 75.31 110.865 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.531 ' CG ' ' HA ' ' A' ' 16' ' ' PHE . 18.4 m-85 -115.65 132.13 56.73 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.135 -0.484 . . . . 73.14 110.974 -179.894 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.465 ' HG2' ' HB2' ' A' ' 36' ' ' ARG . 0.0 OUTLIER -58.6 -24.36 60.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.123 -0.49 . . . . 74.33 110.891 -179.976 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 64.9 m-20 -127.63 152.73 47.3 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.113 -0.494 . . . . 71.03 110.89 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.413 ' N ' ' HB3' ' A' ' 38' ' ' ASN . 32.5 mtmt -56.09 -175.25 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 75.12 110.922 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 25.7 m-20 46.51 33.6 2.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.258 -0.428 . . . . 73.53 110.897 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.531 ' HA ' ' CG ' ' A' ' 11' ' ' TYR . 3.4 m-85 48.91 58.9 4.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.147 -0.478 . . . . 75.01 110.842 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -133.49 157.78 44.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 73.31 110.905 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 94.25 -149.88 19.57 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.679 -0.772 . . . . 72.33 112.474 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.459 ' O ' HD13 ' A' ' 34' ' ' LEU . 0.1 OUTLIER -69.06 81.59 0.32 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.833 0.349 . . . . 74.24 110.881 -179.832 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.47 ' HB2' ' CE1' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -79.63 129.6 34.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.201 -0.454 . . . . 72.21 110.874 -179.898 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.449 ' O ' ' HA ' ' A' ' 9' ' ' THR . 88.8 t80 -125.54 125.32 43.03 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.204 -0.453 . . . . 73.42 110.899 -179.842 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.426 ' CG ' HG23 ' A' ' 9' ' ' THR . 1.4 m-20 -119.9 134.47 55.23 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.121 -0.491 . . . . 62.12 110.895 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 11.3 t -162.98 135.19 5.31 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.158 -0.474 . . . . 71.1 110.915 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -102.66 -5.19 24.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.188 -0.46 . . . . 74.34 110.928 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.49 ' O ' ' SG ' ' A' ' 27' ' ' CYS . 20.0 t -102.54 165.08 11.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.14 -0.482 . . . . 73.51 110.851 -179.908 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -55.26 120.95 7.83 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.155 -0.475 . . . . 72.03 110.878 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.591 ' HB2' ' HB3' ' A' ' 30' ' ' PHE . 0.2 OUTLIER -116.39 49.97 1.09 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.225 -0.443 . . . . 62.52 110.924 -179.93 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.525 ' O ' ' HA ' ' A' ' 82' ' ' SER . . . -46.86 -22.23 0.29 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.191 -0.458 . . . . 74.42 111.096 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 63.3 t0 -129.19 42.76 3.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.189 -0.46 . . . . 64.41 110.85 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.775 ' O ' ' CD2' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -79.13 15.82 1.08 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.192 -0.458 . . . . 64.23 110.887 -179.936 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.44 ' HB2' ' HB3' ' A' ' 81' ' ' SER . 27.1 t60 -77.2 -45.67 25.84 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.161 -0.472 . . . . 75.45 110.841 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.429 HG21 ' CD2' ' A' ' 33' ' ' TYR . 8.9 t -55.69 -14.5 2.27 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.191 -0.458 . . . . 70.33 111.175 -179.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.493 ' CD1' ' HA ' ' A' ' 30' ' ' PHE . 11.4 m-85 -96.1 -30.26 13.64 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.197 -0.456 . . . . 72.12 110.865 -179.907 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.459 HD13 ' O ' ' A' ' 19' ' ' ARG . 19.3 tp -143.5 143.12 31.42 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.178 -0.464 . . . . 74.21 110.94 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.2 m -108.52 -34.73 6.66 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.185 -0.461 . . . . 73.13 110.883 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.488 ' NH2' HD22 ' A' ' 38' ' ' ASN . 1.8 mtp85 -115.89 139.8 49.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.13 -0.486 . . . . 75.44 110.86 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.603 ' HB3' ' HB2' ' A' ' 80' ' ' LEU . 5.2 p -117.28 61.31 0.75 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.144 -0.48 . . . . 74.33 110.894 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.488 HD22 ' NH2' ' A' ' 36' ' ' ARG . 3.0 m120 -60.26 -69.62 0.21 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.133 -0.485 . . . . 73.14 110.869 -179.874 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 5.0 p -110.67 127.28 55.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.18 -0.463 . . . . 73.13 110.873 -179.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.652 ' O ' ' HB2' ' A' ' 67' ' ' TYR . 29.9 mt -121.01 148.49 24.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.134 -0.485 . . . . 72.32 111.126 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.484 ' N ' HG23 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -142.27 121.99 13.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 75.24 110.902 179.823 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.586 HG22 ' HB2' ' A' ' 47' ' ' TRP . 1.5 t -106.64 115.27 47.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.22 -0.445 . . . . 70.34 111.114 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -111.58 79.93 1.26 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.165 -0.47 . . . . 63.43 110.895 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.447 ' O ' ' HA ' ' A' ' 6' ' ' THR . . . 132.13 100.63 0.8 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.75 -0.738 . . . . 55.0 112.531 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 53.47 178.36 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.724 -0.75 . . . . 64.44 112.467 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.5 HG21 ' HA ' ' A' ' 63' ' ' PRO . 0.8 OUTLIER -76.74 168.06 20.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.774 0.321 . . . . 73.34 111.11 -179.831 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . 0.586 ' HB2' HG22 ' A' ' 42' ' ' VAL . 3.6 m95 -142.87 129.42 20.19 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.191 -0.459 . . . . 75.33 110.897 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.603 ' O ' ' N ' ' A' ' 84' ' ' ARG . . . -92.69 126.84 37.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.191 -0.459 . . . . 61.14 111.086 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.488 HG11 HD12 ' A' ' 80' ' ' LEU . 15.1 m -124.49 145.73 31.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.231 -0.44 . . . . 62.54 111.105 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.916 ' HB3' ' CB ' ' A' ' 56' ' ' ALA . 6.8 m-85 -119.31 141.35 49.07 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.125 -0.489 . . . . 70.24 110.925 -179.905 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.549 ' HG2' ' N ' ' A' ' 52' ' ' ARG . 0.3 OUTLIER -48.87 -82.18 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.166 -0.47 . . . . 74.54 110.903 179.99 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.775 ' H ' ' HA ' ' A' ' 56' ' ' ALA . 2.1 mtp180 -82.92 137.58 43.48 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.607 0.718 . . . . 75.02 110.88 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.698 ' HA ' ' OG ' ' A' ' 82' ' ' SER . 54.1 Cg_endo -69.76 137.53 35.69 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.703 2.269 . . . . 74.24 112.33 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.462 ' C ' ' CD2' ' A' ' 55' ' ' PHE . 0.9 OUTLIER 67.16 -6.27 0.61 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.241 -0.436 . . . . 75.34 110.904 179.994 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.509 ' H ' ' C ' ' A' ' 53' ' ' PRO . 0.0 OUTLIER -140.22 -74.91 0.34 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.165 -0.47 . . . . 73.44 110.905 -179.962 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.916 ' CB ' ' HB3' ' A' ' 50' ' ' TYR . . . 45.16 78.91 0.05 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.117 -0.492 . . . . 60.14 111.128 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . 0.557 ' O ' ' CD2' ' A' ' 58' ' ' TYR . 24.9 t-105 -64.18 31.55 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.279 -0.418 . . . . 74.11 110.939 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.648 ' H ' ' C ' ' A' ' 56' ' ' ALA . 1.9 m-30 -162.57 116.75 1.76 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.189 -0.46 . . . . 74.54 110.929 -179.848 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.518 ' HB2' ' HA ' ' A' ' 150' ' ' TYR . 1.8 mpt? -81.9 143.51 31.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.085 -0.507 . . . . 73.41 110.884 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.476 ' O ' ' O ' ' A' ' 49' ' ' VAL . 3.1 t80 -156.95 107.15 2.28 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.223 -0.444 . . . . 74.13 110.963 -179.861 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.577 ' N ' ' CD1' ' A' ' 61' ' ' ILE . 1.3 mp -94.57 116.66 36.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.096 -0.502 . . . . 75.41 111.102 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -82.73 130.17 59.29 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.569 0.699 . . . . 75.34 110.92 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.5 ' HA ' HG21 ' A' ' 46' ' ' THR . 53.7 Cg_endo -69.71 -173.64 0.75 Allowed 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.645 2.23 . . . . 72.21 112.38 179.869 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.21 162.17 16.04 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.221 -0.445 . . . . 74.2 110.903 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 112.01 -168.69 12.81 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.752 -0.737 . . . . 72.04 112.512 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 8.7 mp0 -107.07 152.97 23.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.842 0.353 . . . . 72.3 110.898 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.652 ' HB2' ' O ' ' A' ' 40' ' ' ILE . 12.9 m-85 -141.84 84.72 11.76 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.75 0.785 . . . . 74.2 110.914 -179.864 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.45 ' HD2' ' HG3' ' A' ' 72' ' ' ARG . 53.7 Cg_endo -69.75 0.48 5.58 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.693 2.262 . . . . 74.43 112.341 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.499 ' HB2' ' HG2' ' A' ' 72' ' ' ARG . 48.6 mt-10 -155.37 142.49 19.26 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.231 -0.441 . . . . 71.24 110.88 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.696 ' HA ' ' NE1' ' A' ' 73' ' ' TRP . 28.4 p90 -55.7 -20.27 13.75 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.169 -0.468 . . . . 73.12 110.956 -179.887 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -80.41 -16.93 53.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.121 -0.49 . . . . 73.24 110.908 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.499 ' HG2' ' HB2' ' A' ' 69' ' ' GLU . 31.3 mmt180 -69.49 -8.76 49.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.229 -0.442 . . . . 72.53 110.876 -179.915 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . 0.708 ' N ' ' CD1' ' A' ' 73' ' ' TRP . 0.0 OUTLIER -135.35 16.79 3.41 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.208 -0.451 . . . . 72.11 110.893 -179.95 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' MET . . . . . 0.411 ' C ' ' O ' ' A' ' 73' ' ' TRP . 15.8 mtm 36.95 43.95 0.33 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.266 -0.425 . . . . 75.0 110.896 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -56.51 119.14 13.61 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.741 -0.742 . . . . 64.23 112.451 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.58 HD22 ' HB2' ' A' ' 77' ' ' ASN . 0.0 OUTLIER -68.69 -8.7 44.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.792 0.33 . . . . 74.33 110.913 -179.911 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.58 ' HB2' HD22 ' A' ' 76' ' ' LEU . 12.8 t-20 -152.77 138.15 17.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.189 -0.46 . . . . 73.34 110.884 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -89.67 13.15 14.9 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.185 -0.461 . . . . 74.31 110.85 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.412 ' HD3' ' HA ' ' A' ' 52' ' ' ARG . 1.2 ttm-85 -110.95 81.64 1.46 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.217 -0.447 . . . . 74.13 110.85 -179.869 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.603 ' HB2' ' HB3' ' A' ' 37' ' ' CYS . 0.0 OUTLIER -83.77 134.65 34.72 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.198 -0.456 . . . . 74.43 110.935 179.993 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.638 ' HB3' ' HB3' ' A' ' 53' ' ' PRO . 1.3 m -150.38 -123.79 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.173 -0.467 . . . . 72.24 110.832 -179.907 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.698 ' OG ' ' HA ' ' A' ' 53' ' ' PRO . 0.0 OUTLIER -34.28 105.79 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.172 -0.467 . . . . 71.5 110.841 -179.826 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . 0.491 ' HA ' ' O ' ' A' ' 48' ' ' ALA . 31.7 p -128.2 132.4 48.83 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.149 -0.478 . . . . 75.45 110.89 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . 0.603 ' N ' ' O ' ' A' ' 48' ' ' ALA . 10.7 mmt85 -116.61 149.39 39.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.188 -0.46 . . . . 74.34 110.918 -179.894 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -66.33 129.37 39.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.253 -0.431 . . . . 50.1 111.094 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.432 ' CG2' ' CB ' ' A' ' 48' ' ' ALA . 76.2 t -114.76 135.65 53.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.211 -0.45 . . . . 73.32 111.167 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . 0.417 ' O ' ' CG2' ' A' ' 136' ' ' VAL . 6.1 m-70 -111.8 113.03 25.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 74.22 110.836 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.443 ' H ' HD22 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -38.07 141.12 0.53 Allowed Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.587 0.708 . . . . 63.1 110.939 -179.966 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.566 ' HB3' ' H ' ' A' ' 136' ' ' VAL . 53.6 Cg_endo -69.79 79.95 0.92 Allowed 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.654 2.236 . . . . 74.55 112.365 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -91.55 -177.15 4.72 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.174 -0.467 . . . . 71.53 110.855 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 61.15 38.87 96.31 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.717 -0.754 . . . . 71.0 112.487 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.415 ' O ' ' C ' ' A' ' 93' ' ' GLN . . . 134.14 33.55 0.32 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.728 -0.749 . . . . 64.33 112.48 -179.914 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.604 ' O ' ' HG3' ' A' ' 134' ' ' GLU . 21.6 pt20 37.26 -131.38 0.13 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.846 0.355 . . . . 73.13 110.89 -179.874 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.562 ' HA ' ' HG3' ' A' ' 134' ' ' GLU . 0.1 OUTLIER -117.37 112.1 20.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.45 . . . . 74.41 110.9 -179.831 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.557 ' H ' ' CG ' ' A' ' 134' ' ' GLU . 31.8 tptt -119.16 128.66 54.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.134 -0.484 . . . . 74.24 110.886 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.44 HG13 ' CZ3' ' A' ' 137' ' ' TRP . 0.0 OUTLIER -152.26 139.54 13.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.24 -0.436 . . . . 71.44 111.111 179.865 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -105.85 122.8 46.84 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.159 -0.473 . . . . 72.24 110.947 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 2.6 mt -101.93 130.61 51.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.232 -0.44 . . . . 72.43 111.127 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.687 ' HB2' ' HB2' ' A' ' 129' ' ' SER . 43.9 m-85 -118.46 147.84 43.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.18 -0.463 . . . . 73.32 110.87 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 56.5 tt0 -81.69 -56.15 4.18 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.13 -0.486 . . . . 74.41 110.906 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 45.9 mttt -101.92 172.32 7.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.134 -0.485 . . . . 75.02 110.921 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.411 ' HA2' ' OG ' ' A' ' 129' ' ' SER . . . -71.52 153.09 50.19 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.703 -0.761 . . . . 75.34 112.467 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.449 ' HA ' ' HB2' ' A' ' 158' ' ' ARG . 41.0 t0 65.42 46.22 2.61 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.894 0.378 . . . . 64.52 110.892 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.576 ' N ' ' CD2' ' A' ' 104' ' ' PHE . 0.2 OUTLIER 47.66 32.1 2.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.184 -0.462 . . . . 73.31 110.864 -179.898 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 57.7 m -94.03 164.04 13.24 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.179 -0.464 . . . . 74.14 110.879 -179.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 80.57 -136.29 16.31 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.763 -0.732 . . . . 72.42 112.52 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -90.89 121.07 32.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.784 0.325 . . . . 74.13 110.895 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 4.6 ttp -106.57 134.97 48.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.218 -0.446 . . . . 65.01 110.929 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -141.39 136.67 31.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.252 -0.431 . . . . 72.35 110.952 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -117.3 111.55 19.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.115 -0.493 . . . . 74.02 110.847 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 11.8 t -119.96 147.62 44.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.195 -0.457 . . . . 74.15 111.185 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.47 ' O ' ' OG1' ' A' ' 112' ' ' THR . 0.6 OUTLIER -128.38 27.73 5.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.242 -0.436 . . . . 65.44 111.153 179.982 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -141.06 156.64 45.97 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.249 -0.432 . . . . 74.24 110.933 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -50.32 162.35 0.23 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.179 -0.464 . . . . 73.25 110.881 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . 0.531 ' O ' ' HB2' ' A' ' 172' ' ' SER . 52.6 t -153.18 120.31 3.0 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.647 0.737 . . . . 75.04 110.816 -179.884 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.41 ' O ' ' CA ' ' A' ' 143' ' ' PRO . 53.3 Cg_endo -69.83 -30.85 21.33 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.708 2.272 . . . . 71.13 112.315 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' SER . . . . . 0.643 ' HB3' ' CB ' ' A' ' 120' ' ' GLU . 0.1 OUTLIER -149.58 112.8 4.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.254 -0.43 . . . . 71.41 110.828 -179.836 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.594 ' HB ' ' O ' ' A' ' 171' ' ' GLN . 3.9 tt -64.54 -31.6 54.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.129 -0.487 . . . . 75.14 111.116 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' MET . . . . . 0.64 ' O ' ' HA ' ' A' ' 123' ' ' HIS . 0.0 OUTLIER -86.33 -39.2 16.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.206 -0.452 . . . . 73.52 110.928 179.807 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.643 ' CB ' ' HB3' ' A' ' 117' ' ' SER . 4.7 tp10 -70.79 -13.88 62.21 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.212 -0.449 . . . . 71.13 110.924 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 25.2 tp60 -114.72 -46.26 2.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.114 -0.493 . . . . 73.32 110.926 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . 0.474 ' HB2' ' O ' ' A' ' 118' ' ' ILE . 74.5 m-85 -106.98 -19.08 13.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.189 -0.459 . . . . 73.41 110.9 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . 0.64 ' HA ' ' O ' ' A' ' 119' ' ' MET . 30.4 m-70 72.35 26.87 2.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.11 -0.496 . . . . 75.44 110.8 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.437 ' O ' HG22 ' A' ' 118' ' ' ILE . 7.6 mtt -108.93 74.76 0.92 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.243 -0.435 . . . . 72.05 110.878 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 1.7 ptp85 -49.96 -26.31 4.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.229 -0.442 . . . . 75.4 110.849 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.404 ' HG2' ' HA ' ' A' ' 169' ' ' ALA . 24.7 mt-10 -144.01 130.38 19.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.149 -0.478 . . . . 63.32 110.878 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.475 ' O ' ' HB3' ' A' ' 168' ' ' PRO . 4.0 mm -96.45 104.76 16.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.072 -0.513 . . . . 65.3 111.107 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 8.2 m80 -72.22 -33.0 67.24 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.201 -0.454 . . . . 74.53 110.872 179.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 0.687 ' HB2' ' HB2' ' A' ' 99' ' ' PHE . 16.8 m -134.77 144.04 47.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.225 -0.443 . . . . 74.11 110.857 -179.81 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . 0.565 ' O ' ' O ' ' A' ' 155' ' ' LYS . 1.1 m -142.52 115.04 8.51 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.129 -0.487 . . . . 45.11 110.885 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.565 ' HA ' ' HA ' ' A' ' 156' ' ' GLU . 7.2 mtpp -109.62 153.57 24.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.166 -0.47 . . . . 75.22 110.914 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.518 ' HB ' ' O ' ' A' ' 131' ' ' LYS . 16.2 t 85.25 162.87 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.247 -0.433 . . . . 73.53 111.1 179.855 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.455 ' HB3' ' HA ' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -175.77 126.61 0.23 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.134 -0.485 . . . . 74.4 110.897 179.944 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.604 ' HG3' ' O ' ' A' ' 93' ' ' GLN . 10.1 mm-40 -99.99 164.38 12.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.186 -0.461 . . . . 72.32 110.881 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . 0.552 ' C ' ' O ' ' A' ' 134' ' ' GLU . . . -23.91 -63.07 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.746 -0.74 . . . . 73.22 112.467 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.713 ' HA ' HD13 ' A' ' 152' ' ' LEU . 10.4 t -144.45 145.99 20.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.858 0.361 . . . . 73.42 111.089 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' TRP . . . . . 0.593 ' HB3' ' CB ' ' A' ' 152' ' ' LEU . 4.7 t90 -140.12 156.64 46.47 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.161 -0.472 . . . . 74.43 110.929 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.405 HD11 ' HB ' ' A' ' 61' ' ' ILE . 6.4 mm -122.37 134.98 63.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.242 -0.435 . . . . 75.31 111.14 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 0.538 ' CB ' ' HB2' ' A' ' 150' ' ' TYR . 0.0 OUTLIER -112.73 151.97 29.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.156 -0.474 . . . . 73.01 110.878 179.922 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . 0.408 ' CD2' ' HA ' ' A' ' 145' ' ' TYR . 5.5 m-85 -133.7 129.79 37.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.111 -0.495 . . . . 75.42 110.912 -179.85 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . 0.691 ' O ' ' HB2' ' A' ' 171' ' ' GLN . 0.8 OUTLIER -63.03 -30.43 71.59 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.102 -0.499 . . . . 64.14 110.849 -179.949 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.726 ' HB3' ' HD2' ' A' ' 143' ' ' PRO . 8.9 mp -112.02 172.93 3.15 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.637 0.732 . . . . 72.04 110.909 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . 0.726 ' HD2' ' HB3' ' A' ' 142' ' ' LEU . 53.9 Cg_endo -69.77 -90.51 0.0 OUTLIER 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.701 2.267 . . . . 75.21 112.337 179.857 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . 0.705 ' O ' ' N ' ' A' ' 146' ' ' ARG . 0.7 OUTLIER -53.48 96.21 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.215 -0.448 . . . . 74.1 110.881 -179.976 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . 0.642 ' C ' ' O ' ' A' ' 144' ' ' ASN . 0.0 OUTLIER 13.33 51.97 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.115 -0.493 . . . . 73.12 110.934 -179.911 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . 0.705 ' N ' ' O ' ' A' ' 144' ' ' ASN . 21.2 mtt180 -117.84 163.87 15.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.108 -0.496 . . . . 74.13 110.893 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 84.85 -171.6 47.05 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.742 -0.742 . . . . 62.15 112.482 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -82.05 155.02 25.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.741 0.305 . . . . 74.51 110.87 -179.869 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -92.81 159.99 15.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.15 -0.477 . . . . 74.11 110.897 -179.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . 0.538 ' HB2' ' CB ' ' A' ' 139' ' ' PHE . 79.8 m-85 -140.85 130.76 24.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.182 -0.463 . . . . 73.43 110.903 -179.835 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.489 ' CA ' HD12 ' A' ' 61' ' ' ILE . 20.2 tp -78.9 123.95 27.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.104 -0.498 . . . . 74.54 110.89 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.713 HD13 ' HA ' ' A' ' 136' ' ' VAL . 0.0 OUTLIER -53.82 137.06 39.26 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.222 -0.445 . . . . 74.43 110.951 179.832 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -161.09 25.92 0.14 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.173 -0.467 . . . . 72.33 110.851 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.798 ' HB2' ' CD1' ' A' ' 157' ' ' TYR . 0.0 OUTLIER -118.06 -177.32 3.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.207 -0.451 . . . . 73.44 110.852 -179.971 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.762 ' HD2' ' C ' ' A' ' 154' ' ' LYS . 0.3 OUTLIER -161.23 -124.39 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.197 -0.456 . . . . 74.24 110.924 179.834 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . 0.565 ' HA ' ' HA ' ' A' ' 131' ' ' LYS . 3.0 tm-20 -67.27 4.19 1.02 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.184 -0.462 . . . . 73.34 110.866 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . 0.798 ' CD1' ' HB2' ' A' ' 154' ' ' LYS . 18.0 m-30 -35.08 151.33 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.168 -0.469 . . . . 74.42 110.918 -179.856 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . 0.505 ' O ' ' OG ' ' A' ' 129' ' ' SER . 0.0 OUTLIER -122.93 -35.53 3.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.109 -0.496 . . . . 75.21 110.916 179.985 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -88.44 150.93 47.63 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.553 0.692 . . . . 74.53 110.891 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 -26.32 27.69 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.648 2.232 . . . . 73.51 112.36 179.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.487 HD11 ' H ' ' A' ' 161' ' ' ILE . 4.2 mp -70.46 -8.81 11.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.232 -0.44 . . . . 73.4 111.139 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . 0.65 ' HB3' ' CD1' ' A' ' 157' ' ' TYR . 0.4 OUTLIER -75.81 -14.26 60.29 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.173 -0.467 . . . . 74.25 110.852 179.829 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 28.1 t-105 -89.63 -9.44 49.64 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.233 -0.44 . . . . 74.24 110.97 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 101.88 -36.51 4.19 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.707 -0.759 . . . . 73.03 112.509 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -75.46 127.69 33.67 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.816 0.341 . . . . 72.41 111.117 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -38.1 -39.96 0.45 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.249 -0.432 . . . . 71.41 111.105 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 167' ' ' SER . . . . . 0.526 ' C ' ' H ' ' A' ' 169' ' ' ALA . 0.3 OUTLIER -132.11 157.71 77.5 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.673 0.749 . . . . 73.41 110.824 -179.775 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . 0.475 ' HB3' ' O ' ' A' ' 127' ' ' ILE . 54.0 Cg_endo -69.75 28.43 0.18 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.668 2.245 . . . . 73.3 112.372 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . 0.526 ' H ' ' C ' ' A' ' 167' ' ' SER . . . -68.84 106.58 2.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.217 -0.447 . . . . 74.52 111.069 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 2.6 t -153.43 164.63 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.233 -0.439 . . . . 55.13 111.143 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 171' ' ' GLN . . . . . 0.691 ' HB2' ' O ' ' A' ' 141' ' ' GLU . 2.1 mm-40 -112.85 -86.81 0.56 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.162 -0.472 . . . . 64.25 110.9 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 172' ' ' SER . . . . . 0.721 ' OG ' ' O ' ' A' ' 143' ' ' PRO . 56.7 p -124.41 176.91 6.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.465 . . . . 72.3 110.85 -179.8 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -144.81 168.83 19.29 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.103 -0.498 . . . . 74.42 110.911 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 7.8 mtp85 -138.73 139.25 38.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.144 -0.48 . . . . 65.42 110.882 -179.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.7 154.73 17.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.19 -0.459 . . . . 75.13 110.885 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . 0.433 HD11 ' HB ' ' A' ' 136' ' ' VAL . 2.2 mt -96.0 132.83 39.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.197 -0.456 . . . . 74.02 111.143 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 11.5 p -51.62 147.38 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.224 -0.444 . . . . 73.03 111.104 179.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.167 -0.47 . . . . 75.45 110.847 179.947 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.345 0 N-CA-C 112.468 -0.253 . . . . 74.35 112.468 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.45 ' HA ' ' O ' ' A' ' 44' ' ' GLY . 19.3 p -82.66 133.73 35.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.864 0.364 . . . . 75.13 111.135 -179.865 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 2.9 tttt -123.44 136.94 54.87 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.213 -0.449 . . . . 74.12 110.918 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.648 ' HB ' ' CD1' ' A' ' 47' ' ' TRP . 16.9 tt -137.48 152.1 26.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.199 -0.455 . . . . 74.11 111.101 179.908 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.535 ' HA ' ' O ' ' A' ' 21' ' ' TYR . 13.5 m -132.74 145.13 50.77 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.149 -0.478 . . . . 72.24 111.144 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.628 ' CE2' HG23 ' A' ' 8' ' ' ILE . 1.1 m-85 -132.42 126.03 32.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.214 -0.448 . . . . 72.53 110.831 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.54 ' CG ' ' HA ' ' A' ' 16' ' ' PHE . 12.8 m-85 -112.01 132.83 54.56 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.132 -0.486 . . . . 73.3 110.935 -179.877 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.448 ' HB2' ' HB2' ' A' ' 19' ' ' ARG . 0.0 OUTLIER -61.92 -15.04 40.04 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.115 -0.493 . . . . 71.34 110.935 179.96 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.446 ' HB2' ' O ' ' A' ' 17' ' ' GLN . 71.4 m-20 -134.67 149.01 50.46 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.125 -0.489 . . . . 72.32 110.901 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.547 ' N ' ' HB3' ' A' ' 38' ' ' ASN . 5.8 mtmt -54.26 -176.94 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.198 -0.456 . . . . 63.31 110.911 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 16.6 m120 47.52 30.99 1.81 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.255 -0.43 . . . . 64.34 110.919 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.54 ' HA ' ' CG ' ' A' ' 11' ' ' TYR . 3.3 m-85 51.05 64.51 1.81 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.175 -0.466 . . . . 74.22 110.862 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . 0.446 ' O ' ' HB2' ' A' ' 13' ' ' ASP . 14.2 mt-30 -139.76 158.92 43.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.141 -0.482 . . . . 75.12 110.89 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 92.61 -148.79 19.26 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.729 -0.748 . . . . 35.21 112.51 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.448 ' HB2' ' HB2' ' A' ' 12' ' ' GLU . 0.0 OUTLIER -68.12 77.65 0.24 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.852 0.358 . . . . 73.54 110.879 -179.834 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.454 ' HB2' ' CE1' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -77.86 129.36 35.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.178 -0.465 . . . . 73.2 110.863 -179.882 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.535 ' O ' ' HA ' ' A' ' 9' ' ' THR . 90.8 t80 -123.49 123.99 41.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 75.21 110.888 -179.823 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.437 ' CG ' HG23 ' A' ' 9' ' ' THR . 1.3 m-20 -120.57 133.96 55.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.141 -0.481 . . . . 74.54 110.885 179.873 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -167.72 136.79 2.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.168 -0.469 . . . . 73.43 110.86 -179.912 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -105.37 5.18 31.57 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.157 -0.474 . . . . 72.35 110.919 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 11.7 t -107.1 169.35 8.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.183 -0.462 . . . . 74.24 110.897 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -64.66 116.89 6.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.172 -0.467 . . . . 74.23 110.874 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.422 ' HB2' ' SG ' ' A' ' 83' ' ' CYS . 4.7 m -118.06 53.67 0.95 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.198 -0.456 . . . . 75.32 110.852 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.525 ' C ' ' HA ' ' A' ' 82' ' ' SER . . . -46.28 -21.05 0.13 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.157 -0.474 . . . . 63.42 111.099 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -127.71 43.61 3.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.209 -0.45 . . . . 74.31 110.895 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.777 ' O ' ' CD2' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -81.11 15.51 1.86 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.19 -0.459 . . . . 74.13 110.837 -179.885 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.542 ' HB2' ' HB3' ' A' ' 81' ' ' SER . 30.7 t60 -78.86 -39.3 35.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.145 -0.48 . . . . 71.34 110.826 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.6 t -56.83 -13.89 2.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.229 -0.441 . . . . 65.45 111.155 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -99.61 -28.08 13.37 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.216 -0.447 . . . . 72.44 110.906 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.405 HD13 ' O ' ' A' ' 19' ' ' ARG . 18.2 tp -141.12 137.25 32.64 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.157 -0.474 . . . . 75.24 110.916 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 30.6 m -101.07 -43.06 6.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.184 -0.462 . . . . 61.52 110.867 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -118.0 140.97 48.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.118 -0.492 . . . . 72.41 110.854 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.701 ' SG ' ' HB2' ' A' ' 80' ' ' LEU . 5.6 p -110.21 87.4 2.51 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.225 -0.443 . . . . 74.31 110.904 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.547 ' HB3' ' N ' ' A' ' 14' ' ' LYS . 0.2 OUTLIER -78.62 -65.17 1.02 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.186 -0.461 . . . . 75.31 110.881 -179.878 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 5.0 p -118.41 123.9 46.36 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.157 -0.474 . . . . 75.35 110.856 -179.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.647 ' O ' ' HB2' ' A' ' 67' ' ' TYR . 25.6 mt -117.27 150.62 19.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.13 -0.486 . . . . 74.24 111.094 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.467 ' N ' HG23 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -145.53 119.22 9.18 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.108 -0.497 . . . . 75.22 110.877 179.871 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.513 HG23 ' HB ' ' A' ' 8' ' ' ILE . 1.4 t -103.54 116.21 46.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.238 -0.437 . . . . 64.44 111.14 179.89 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -111.04 79.94 1.25 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.233 -0.44 . . . . 74.42 110.884 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.45 ' O ' ' HA ' ' A' ' 6' ' ' THR . . . 127.17 108.84 1.55 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.793 -0.717 . . . . 75.12 112.476 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 52.44 179.79 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.706 -0.759 . . . . 74.42 112.491 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.524 HG21 ' HA ' ' A' ' 63' ' ' PRO . 1.3 m -86.39 169.89 12.5 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.78 0.324 . . . . 74.02 111.154 -179.887 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . 0.648 ' CD1' ' HB ' ' A' ' 8' ' ' ILE . 17.8 m95 -140.86 130.8 24.51 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.203 -0.453 . . . . 75.41 110.913 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.501 ' O ' ' HA ' ' A' ' 83' ' ' CYS . . . -100.28 107.53 19.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.257 -0.429 . . . . 74.52 111.099 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.493 ' O ' ' O ' ' A' ' 60' ' ' TYR . 4.9 m -107.7 125.52 64.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.205 -0.452 . . . . 61.3 111.157 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.711 ' HB3' ' HA ' ' A' ' 56' ' ' ALA . 39.9 m-85 -89.05 148.12 23.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.222 -0.445 . . . . 74.31 110.899 -179.89 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.536 ' HB2' ' HB2' ' A' ' 58' ' ' TYR . 59.6 tt0 -48.06 -77.85 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.134 -0.485 . . . . 72.41 110.889 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.565 ' HB3' ' HB2' ' A' ' 55' ' ' PHE . 0.2 OUTLIER -89.76 141.37 28.32 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.623 0.725 . . . . 74.31 110.868 -179.914 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.711 ' HA ' ' OG ' ' A' ' 82' ' ' SER . 53.6 Cg_endo -69.78 138.17 37.11 Favored 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.675 2.25 . . . . 64.2 112.356 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 2.3 t30 65.15 -10.0 0.19 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.264 -0.426 . . . . 73.13 110.884 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.568 ' H ' ' C ' ' A' ' 53' ' ' PRO . 3.3 m-30 -103.19 -23.32 13.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.175 -0.466 . . . . 73.41 110.856 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.711 ' HA ' ' HB3' ' A' ' 50' ' ' TYR . . . 55.61 23.36 6.02 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.194 -0.457 . . . . 64.34 111.095 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . 0.63 ' O ' ' C ' ' A' ' 58' ' ' TYR . 0.7 OUTLIER -51.67 -165.79 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.236 -0.438 . . . . 74.41 110.887 -179.975 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.63 ' C ' ' O ' ' A' ' 57' ' ' TRP . 11.1 m-30 -14.08 100.57 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.281 -0.418 . . . . 71.14 110.886 -179.85 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.498 ' HB2' ' HA ' ' A' ' 150' ' ' TYR . 0.0 OUTLIER -58.7 158.87 7.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.151 -0.477 . . . . 75.04 110.876 179.91 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.608 ' OH ' ' O ' ' A' ' 73' ' ' TRP . 0.4 OUTLIER -172.23 97.3 0.16 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.257 -0.429 . . . . 72.12 110.906 -179.843 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.506 ' HB ' HD11 ' A' ' 138' ' ' ILE . 2.5 mp -94.32 119.01 41.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.103 -0.498 . . . . 74.15 111.129 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.502 ' CD1' HD12 ' A' ' 40' ' ' ILE . 0.3 OUTLIER -88.06 128.92 51.96 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-O 121.557 0.694 . . . . 75.22 110.938 179.912 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.524 ' HA ' HG21 ' A' ' 46' ' ' THR . 53.5 Cg_endo -69.72 -170.53 0.4 Allowed 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.688 2.259 . . . . 74.21 112.358 179.885 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -88.69 161.36 16.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.244 -0.435 . . . . 74.02 110.892 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 112.58 -166.37 12.16 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.759 -0.734 . . . . 53.43 112.534 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -111.04 150.99 28.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.913 0.387 . . . . 75.45 110.867 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.647 ' HB2' ' O ' ' A' ' 40' ' ' ILE . 10.0 m-85 -140.13 84.44 14.82 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.707 0.765 . . . . 73.51 110.911 -179.874 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.409 ' HD2' ' HG3' ' A' ' 72' ' ' ARG . 53.8 Cg_endo -69.75 -1.06 7.83 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.739 2.293 . . . . 75.53 112.329 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.469 ' HB2' ' HG2' ' A' ' 72' ' ' ARG . 80.7 mt-10 -154.63 142.6 20.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.23 -0.441 . . . . 75.23 110.905 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.732 ' HA ' ' NE1' ' A' ' 73' ' ' TRP . 35.9 p90 -55.13 -23.79 22.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.464 . . . . 73.32 110.93 -179.865 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -76.43 -16.53 59.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.166 -0.47 . . . . 75.05 110.93 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.469 ' HG2' ' HB2' ' A' ' 69' ' ' GLU . 28.3 mmt180 -70.64 -6.36 36.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.209 -0.45 . . . . 73.12 110.879 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . 0.732 ' NE1' ' HA ' ' A' ' 70' ' ' TYR . 0.0 OUTLIER -139.35 26.58 2.37 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.181 -0.463 . . . . 73.0 110.933 -179.951 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' MET . . . . . 0.473 ' HB2' ' O ' ' A' ' 73' ' ' TRP . 0.0 OUTLIER 75.84 -11.0 1.18 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.23 -0.441 . . . . 72.23 110.891 179.954 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.413 ' C ' ' O ' ' A' ' 74' ' ' MET . . . 37.27 46.55 1.38 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.76 -0.733 . . . . 55.14 112.456 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.5 ' CB ' ' CE2' ' A' ' 60' ' ' TYR . 0.1 OUTLIER -45.83 -63.25 1.01 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.819 0.342 . . . . 71.5 110.92 -179.927 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -127.32 126.11 42.01 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.208 -0.451 . . . . 70.03 110.873 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -76.03 1.69 14.78 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.187 -0.461 . . . . 65.24 110.889 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -99.89 73.85 1.79 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.176 -0.465 . . . . 74.53 110.837 -179.873 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.701 ' HB2' ' SG ' ' A' ' 37' ' ' CYS . 0.1 OUTLIER -81.87 133.08 35.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.155 -0.475 . . . . 75.23 110.874 -179.977 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.607 ' HB3' ' HB3' ' A' ' 53' ' ' PRO . 0.9 OUTLIER -148.31 -130.45 0.06 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.193 -0.458 . . . . 75.34 110.921 -179.957 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.711 ' OG ' ' HA ' ' A' ' 53' ' ' PRO . 0.6 OUTLIER -25.78 131.4 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.124 -0.489 . . . . 72.54 110.893 -179.851 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . 0.501 ' HA ' ' O ' ' A' ' 48' ' ' ALA . 6.9 p -138.1 140.87 40.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.141 -0.482 . . . . 73.12 110.87 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . 0.477 ' N ' ' O ' ' A' ' 48' ' ' ALA . 6.4 mmt85 -139.78 128.36 23.01 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.225 -0.443 . . . . 75.43 110.851 -179.823 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.449 ' N ' ' CZ3' ' A' ' 47' ' ' TRP . . . -50.56 129.59 22.6 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.195 -0.457 . . . . 73.13 111.096 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.495 HG21 ' CB ' ' A' ' 48' ' ' ALA . 25.5 t -114.51 142.04 28.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.276 -0.42 . . . . 75.2 111.09 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . 0.43 ' O ' ' C ' ' A' ' 88' ' ' LEU . 6.7 m-70 -112.24 110.56 20.88 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.161 -0.472 . . . . 74.23 110.851 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.457 ' H ' HD22 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -35.95 144.13 0.26 Allowed Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.646 0.736 . . . . 63.24 110.9 -179.959 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.546 ' HB3' ' H ' ' A' ' 136' ' ' VAL . 53.7 Cg_endo -69.7 98.66 0.69 Allowed 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.671 2.247 . . . . 74.31 112.357 179.857 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -104.51 -175.35 2.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.263 -0.426 . . . . 74.02 110.878 -179.84 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 50.95 58.84 8.8 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.757 -0.735 . . . . 74.33 112.523 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.412 ' O ' ' C ' ' A' ' 93' ' ' GLN . . . 123.46 26.07 1.68 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.747 -0.74 . . . . 70.51 112.488 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.429 ' O ' ' HG2' ' A' ' 134' ' ' GLU . 14.6 pt20 37.32 -123.05 0.21 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.834 0.35 . . . . 75.53 110.905 -179.856 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.532 ' HA ' ' HG2' ' A' ' 134' ' ' GLU . 0.1 OUTLIER -123.75 104.41 8.96 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.172 -0.467 . . . . 73.24 110.907 -179.852 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.463 ' HG3' HG11 ' A' ' 132' ' ' VAL . 34.1 tptt -114.37 127.78 56.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.099 -0.5 . . . . 72.33 110.895 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 6.3 tt -149.45 136.93 13.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.221 -0.445 . . . . 74.14 111.073 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.446 ' HB2' ' O ' ' A' ' 131' ' ' LYS . 0.7 OUTLIER -107.25 123.91 48.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.15 -0.477 . . . . 74.24 110.907 179.949 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 43.9 mm -105.39 131.06 55.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.193 -0.458 . . . . 72.4 111.121 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.698 ' HB2' ' HB2' ' A' ' 129' ' ' SER . 45.9 m-85 -118.79 150.39 39.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.152 -0.476 . . . . 74.34 110.897 179.911 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 50.8 tt0 -85.76 -56.08 3.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.187 -0.461 . . . . 71.1 110.852 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 47.6 mttt -101.01 164.93 11.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.167 -0.47 . . . . 75.53 110.89 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.403 ' HA2' ' OG ' ' A' ' 129' ' ' SER . . . -65.53 152.4 51.51 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.768 -0.73 . . . . 74.45 112.49 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.404 ' HA ' ' HB2' ' A' ' 158' ' ' ARG . 27.8 t0 65.76 45.37 2.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.831 0.348 . . . . 75.14 110.852 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.576 ' N ' ' CD2' ' A' ' 104' ' ' PHE . 0.1 OUTLIER 47.48 33.81 3.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.233 -0.44 . . . . 75.24 110.912 -179.881 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 53.3 m -96.35 159.61 14.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.164 -0.471 . . . . 75.04 110.861 -179.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 83.91 -135.67 14.01 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.695 -0.764 . . . . 75.22 112.49 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 37.7 tp60 -88.65 120.67 30.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.783 0.325 . . . . 64.51 110.879 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 3.5 ttp -108.25 132.8 53.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.154 -0.475 . . . . 72.11 110.862 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -137.72 137.09 37.97 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.221 -0.445 . . . . 70.24 110.925 -179.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -119.33 104.43 10.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.097 -0.501 . . . . 75.42 110.854 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 8.9 t -112.82 133.38 54.85 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.183 -0.462 . . . . 54.41 111.152 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.492 ' HA ' ' O ' ' A' ' 94' ' ' TYR . 1.6 t -115.5 32.49 6.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.22 -0.446 . . . . 75.4 111.131 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -142.38 -173.91 3.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.219 -0.446 . . . . 75.33 110.88 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -72.08 150.66 43.71 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.117 -0.492 . . . . 75.13 110.837 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . 0.425 ' O ' ' HB2' ' A' ' 172' ' ' SER . 57.4 m -140.99 107.16 6.27 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-O 121.631 0.729 . . . . 75.1 110.884 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.618 ' O ' ' CB ' ' A' ' 172' ' ' SER . 53.3 Cg_endo -69.74 -35.97 11.73 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.657 2.238 . . . . 71.25 112.311 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' SER . . . . . 0.6 ' HB3' ' CB ' ' A' ' 120' ' ' GLU . 0.1 OUTLIER -142.0 112.37 7.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.228 -0.442 . . . . 72.03 110.865 -179.78 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.543 ' O ' ' HB2' ' A' ' 122' ' ' PHE . 5.4 tt -67.24 -32.87 59.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.18 -0.463 . . . . 73.34 111.104 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' MET . . . . . 0.641 ' O ' ' HA ' ' A' ' 123' ' ' HIS . 0.0 OUTLIER -87.28 -38.99 15.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.178 -0.464 . . . . 73.23 110.897 179.855 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.6 ' CB ' ' HB3' ' A' ' 117' ' ' SER . 3.9 tp10 -72.18 -15.43 61.96 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.218 -0.446 . . . . 72.44 110.896 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 13.0 mm100 -114.44 -45.82 3.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.123 -0.49 . . . . 75.05 110.925 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . 0.543 ' HB2' ' O ' ' A' ' 118' ' ' ILE . 47.4 m-85 -106.23 -19.71 13.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.195 -0.457 . . . . 74.31 110.879 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . 0.641 ' HA ' ' O ' ' A' ' 119' ' ' MET . 12.3 m80 70.58 29.21 3.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.137 -0.483 . . . . 73.14 110.889 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.448 ' O ' HG22 ' A' ' 118' ' ' ILE . 4.0 mtt -107.19 83.42 1.82 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.208 -0.451 . . . . 71.43 110.838 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 4.0 ptp180 -50.58 -35.43 30.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.239 -0.437 . . . . 65.03 110.86 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.451 ' HB3' ' HG2' ' A' ' 168' ' ' PRO . 18.8 mt-10 -142.42 136.14 29.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.231 -0.44 . . . . 75.15 110.899 -179.915 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.453 ' O ' ' HB3' ' A' ' 168' ' ' PRO . 3.9 mm -96.3 104.47 15.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.174 -0.466 . . . . 64.54 111.076 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 12.6 m170 -70.79 -34.95 72.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.157 -0.474 . . . . 72.34 110.833 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 0.698 ' HB2' ' HB2' ' A' ' 99' ' ' PHE . 13.7 m -133.75 149.85 51.47 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.204 -0.453 . . . . 64.14 110.883 -179.822 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . 0.498 ' HB3' ' CD ' ' A' ' 154' ' ' LYS . 0.1 OUTLIER -148.68 117.92 6.85 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.151 -0.477 . . . . 74.13 110.865 -179.913 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.495 ' O ' ' HB ' ' A' ' 132' ' ' VAL . 11.2 mtpt -113.87 155.56 25.53 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.21 -0.45 . . . . 73.33 110.892 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.517 ' O ' ' HE2' ' A' ' 154' ' ' LYS . 15.5 t 83.43 160.91 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.221 -0.445 . . . . 70.25 111.104 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.68 ' HG ' ' HG3' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -177.79 127.3 0.13 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.166 -0.47 . . . . 74.04 110.923 179.911 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.532 ' HG2' ' HA ' ' A' ' 94' ' ' TYR . 0.1 OUTLIER -97.8 171.34 8.37 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.162 -0.472 . . . . 70.04 110.898 179.938 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . 0.493 ' C ' ' O ' ' A' ' 134' ' ' GLU . . . -30.41 -78.84 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.741 -0.742 . . . . 72.43 112.468 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.623 ' HA ' HD13 ' A' ' 152' ' ' LEU . 2.8 t -128.53 144.91 36.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.781 0.324 . . . . 72.13 111.158 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' TRP . . . . . 0.634 ' HB3' ' CB ' ' A' ' 152' ' ' LEU . 60.2 t-105 -146.14 163.94 33.77 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.214 -0.448 . . . . 74.53 110.897 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.506 HD11 ' HB ' ' A' ' 61' ' ' ILE . 5.8 mm -132.74 138.07 52.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.231 -0.441 . . . . 75.44 111.091 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 0.75 ' HB2' ' HB2' ' A' ' 150' ' ' TYR . 69.7 m-85 -114.49 152.48 31.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.139 -0.482 . . . . 74.12 110.855 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . 0.722 ' CD2' ' HA ' ' A' ' 145' ' ' TYR . 13.7 m-85 -128.34 144.19 51.1 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.149 -0.478 . . . . 74.44 110.878 -179.874 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . 0.563 ' C ' ' HB2' ' A' ' 171' ' ' GLN . 27.4 tt0 -84.77 -7.96 59.0 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.106 -0.497 . . . . 75.22 110.864 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.515 ' C ' ' H ' ' A' ' 144' ' ' ASN . 7.2 mp -120.05 149.07 48.29 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.579 0.704 . . . . 74.14 110.954 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . 0.719 ' HD3' ' CD ' ' A' ' 171' ' ' GLN . 54.0 Cg_endo -69.71 32.75 0.19 Allowed 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.695 2.264 . . . . 73.13 112.375 179.857 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . 1.007 ' O ' ' N ' ' A' ' 146' ' ' ARG . 0.0 OUTLIER -169.34 101.91 0.35 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.201 -0.454 . . . . 73.43 110.923 -179.961 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . 0.722 ' HA ' ' CD2' ' A' ' 140' ' ' TYR . 0.3 OUTLIER 3.59 48.39 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.155 -0.475 . . . . 75.24 110.945 -179.866 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . 1.007 ' N ' ' O ' ' A' ' 144' ' ' ASN . 1.1 mtp85 -136.16 178.02 7.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.069 -0.514 . . . . 71.55 110.835 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 83.04 -175.48 53.01 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.764 -0.731 . . . . 64.05 112.482 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 53.3 mtt180 -62.45 146.22 52.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.705 0.288 . . . . 74.34 110.852 -179.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' GLN . . . . . 0.433 ' O ' ' HB2' ' A' ' 59' ' ' MET . 1.4 mt-30 -98.22 135.39 39.92 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.202 -0.454 . . . . 74.02 110.933 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . 0.75 ' HB2' ' HB2' ' A' ' 139' ' ' PHE . 54.5 m-85 -121.46 125.43 46.84 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.23 -0.441 . . . . 73.51 110.888 -179.863 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.488 ' HA ' HD12 ' A' ' 61' ' ' ILE . 19.8 tp -76.89 122.71 25.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.113 -0.494 . . . . 73.53 110.908 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.657 ' CD1' ' O ' ' A' ' 152' ' ' LEU . 0.0 OUTLIER -50.74 130.71 25.19 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.156 -0.475 . . . . 75.44 110.893 179.893 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -163.86 26.48 0.08 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.21 -0.45 . . . . 75.21 110.837 179.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.84 ' O ' ' HG3' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -108.09 -174.76 2.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.191 -0.458 . . . . 75.12 110.865 -179.999 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.84 ' HG3' ' O ' ' A' ' 154' ' ' LYS . 1.5 mptt -162.44 -127.74 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.195 -0.457 . . . . 74.44 110.936 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . 0.585 ' HG2' ' O ' ' A' ' 156' ' ' GLU . 2.2 tm-20 -70.46 6.91 1.2 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.247 -0.433 . . . . 74.51 110.835 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . 0.691 ' CE1' ' HA ' ' A' ' 154' ' ' LYS . 18.9 m-30 -32.44 149.97 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.176 -0.466 . . . . 74.23 110.894 -179.835 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . 0.522 ' O ' ' OG ' ' A' ' 129' ' ' SER . 0.0 OUTLIER -126.5 -34.73 2.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.108 -0.496 . . . . 73.5 110.864 -179.992 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -89.07 151.69 47.22 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.638 0.732 . . . . 74.11 110.892 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . 0.465 ' HB3' ' HB3' ' A' ' 168' ' ' PRO . 54.1 Cg_endo -69.72 -24.11 30.2 Favored 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 122.645 2.23 . . . . 75.55 112.401 179.896 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.537 HD11 ' H ' ' A' ' 161' ' ' ILE . 3.7 mp -69.41 -9.39 12.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.189 -0.459 . . . . 71.4 111.131 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . 0.675 ' HB3' ' CD1' ' A' ' 157' ' ' TYR . 0.3 OUTLIER -77.2 -13.38 59.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.14 -0.482 . . . . 72.42 110.87 179.88 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -87.64 3.17 48.78 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.186 -0.461 . . . . 73.22 110.968 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 88.42 -36.15 3.47 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.713 -0.756 . . . . 72.23 112.516 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -80.76 129.86 34.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.795 0.331 . . . . 62.15 111.086 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -37.95 -38.33 0.3 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.218 -0.447 . . . . 74.3 111.121 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 167' ' ' SER . . . . . 0.517 ' C ' ' H ' ' A' ' 169' ' ' ALA . 0.3 OUTLIER -127.12 158.88 67.67 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.647 0.737 . . . . 74.1 110.857 -179.785 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . 0.465 ' HB3' ' HB3' ' A' ' 160' ' ' PRO . 54.5 Cg_endo -69.7 26.3 0.17 Allowed 'Trans proline' 0 C--N 1.341 0.132 0 C-N-CA 122.715 2.277 . . . . 75.33 112.355 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . 0.517 ' H ' ' C ' ' A' ' 167' ' ' SER . . . -65.95 107.81 1.98 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.25 -0.432 . . . . 74.21 111.129 179.909 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 19.2 t -151.15 160.52 3.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.215 -0.448 . . . . 65.13 111.141 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 171' ' ' GLN . . . . . 0.719 ' CD ' ' HD3' ' A' ' 143' ' ' PRO . 6.5 mm-40 -109.41 -91.85 0.44 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.175 -0.466 . . . . 74.41 110.922 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 172' ' ' SER . . . . . 0.618 ' CB ' ' O ' ' A' ' 116' ' ' PRO . 60.1 p -127.98 168.91 14.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.199 -0.455 . . . . 74.31 110.873 -179.821 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 173' ' ' PHE . . . . . 0.612 ' CD1' ' N ' ' A' ' 173' ' ' PHE . 0.1 OUTLIER -146.75 165.79 28.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.146 -0.479 . . . . 70.45 110.918 -179.953 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -146.33 169.93 17.82 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.185 -0.462 . . . . 74.13 110.852 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . 0.491 ' HB3' ' CZ3' ' A' ' 137' ' ' TRP . 0.0 OUTLIER -89.1 -162.26 0.85 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.12 -0.491 . . . . 74.32 110.86 -179.913 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . 0.465 HD11 ' HB ' ' A' ' 136' ' ' VAL . 27.4 mt -124.68 141.82 43.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.157 -0.474 . . . . 74.01 111.133 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 44.1 t -75.25 140.88 16.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.171 -0.468 . . . . 72.22 111.123 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.217 -0.447 . . . . 75.21 110.856 -179.972 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.339 0 N-CA-C 112.501 -0.239 . . . . 61.51 112.501 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.439 ' OG1' ' HB1' ' A' ' 85' ' ' ALA . 20.0 p -82.35 138.84 34.39 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.89 0.376 . . . . 74.01 111.105 -179.833 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.453 ' N ' ' HE1' ' A' ' 47' ' ' TRP . 2.9 tttt -124.91 134.66 52.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.232 -0.44 . . . . 74.32 110.878 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.503 HD13 ' CE1' ' A' ' 10' ' ' PHE . 15.4 tt -136.56 149.2 26.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.21 -0.45 . . . . 74.15 111.189 179.833 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.492 HG21 ' CE2' ' A' ' 11' ' ' TYR . 10.3 m -130.87 141.35 50.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.184 -0.462 . . . . 70.24 111.145 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.503 ' CE1' HD13 ' A' ' 8' ' ' ILE . 0.9 OUTLIER -128.83 128.36 43.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.275 -0.421 . . . . 72.3 110.845 -179.981 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.528 ' CG ' ' HA ' ' A' ' 16' ' ' PHE . 22.9 m-85 -114.28 132.12 56.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.102 -0.499 . . . . 60.34 110.927 -179.862 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.445 ' HG2' ' HB2' ' A' ' 36' ' ' ARG . 0.0 OUTLIER -60.01 -23.47 63.7 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.145 -0.479 . . . . 64.12 110.888 -179.98 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 65.6 m-20 -128.58 152.41 48.35 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.142 -0.481 . . . . 73.33 110.869 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.43 ' N ' ' HB3' ' A' ' 38' ' ' ASN . 31.8 mtmt -55.67 -175.18 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.166 -0.47 . . . . 75.31 110.897 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 17.8 m120 46.43 33.58 1.98 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.237 -0.438 . . . . 63.13 110.84 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.528 ' HA ' ' CG ' ' A' ' 11' ' ' TYR . 4.0 m-85 48.95 57.97 5.86 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.181 -0.463 . . . . 71.24 110.899 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 -132.81 158.56 42.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.153 -0.476 . . . . 72.12 110.931 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 94.7 -150.52 19.76 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.746 -0.74 . . . . 53.03 112.447 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.457 ' O ' ' CD1' ' A' ' 34' ' ' LEU . 0.0 OUTLIER -69.6 80.45 0.41 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.794 0.33 . . . . 74.43 110.875 -179.838 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.445 ' HB2' ' CE1' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -79.11 128.5 33.36 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.188 -0.46 . . . . 73.51 110.835 -179.927 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.471 ' CD2' ' CD2' ' A' ' 30' ' ' PHE . 71.2 t80 -124.49 125.36 44.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.15 -0.477 . . . . 74.45 110.921 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.461 ' CG ' HG23 ' A' ' 9' ' ' THR . 1.2 m-20 -119.48 132.61 55.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.128 -0.487 . . . . 73.01 110.91 179.899 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 10.4 t -157.09 130.25 7.83 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.195 -0.457 . . . . 65.21 110.907 -179.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.402 ' HA ' ' HA ' ' A' ' 7' ' ' LYS . 3.9 p30 -99.4 5.76 46.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.214 -0.448 . . . . 74.31 110.866 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 47.1 t -117.68 161.46 19.63 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.208 -0.451 . . . . 74.44 110.9 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 31.5 m-20 -45.12 120.51 2.44 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.176 -0.465 . . . . 72.1 110.887 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.579 ' HB2' ' HB3' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -114.27 43.87 1.8 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.185 -0.461 . . . . 64.1 110.869 -179.909 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.543 ' O ' ' HA ' ' A' ' 82' ' ' SER . . . -49.67 -21.53 1.07 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 72.42 111.105 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 60.2 t0 -129.58 40.99 3.51 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.222 -0.445 . . . . 73.44 110.862 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.795 ' O ' ' CD2' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -81.48 17.79 1.31 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.211 -0.449 . . . . 72.42 110.907 -179.934 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.548 ' HB2' ' HB3' ' A' ' 81' ' ' SER . 40.7 t60 -81.98 -33.56 30.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.166 -0.47 . . . . 65.41 110.845 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.0 t -66.96 -5.67 13.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.194 -0.457 . . . . 73.13 111.114 -179.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -108.29 -27.68 9.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.231 -0.44 . . . . 74.42 110.92 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.457 ' CD1' ' O ' ' A' ' 19' ' ' ARG . 23.3 tp -141.51 145.99 35.85 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.111 -0.495 . . . . 75.14 110.95 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.3 m -112.66 -34.93 5.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.181 -0.463 . . . . 73.1 110.806 -179.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.494 ' NH2' HD22 ' A' ' 38' ' ' ASN . 2.0 mtp85 -115.79 142.09 47.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.148 -0.478 . . . . 74.22 110.842 -179.877 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.62 ' SG ' ' HB2' ' A' ' 80' ' ' LEU . 6.3 p -120.02 64.81 0.82 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.139 -0.482 . . . . 74.31 110.899 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.494 HD22 ' NH2' ' A' ' 36' ' ' ARG . 3.0 m120 -63.66 -66.64 0.51 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.17 -0.468 . . . . 74.41 110.893 -179.885 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 5.0 p -113.81 127.31 55.95 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.113 -0.494 . . . . 75.43 110.881 -179.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.67 ' O ' ' HB2' ' A' ' 67' ' ' TYR . 18.7 mt -120.95 149.37 23.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.131 -0.486 . . . . 71.32 111.146 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.483 ' N ' HG23 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -143.5 119.3 10.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.189 -0.459 . . . . 71.01 110.902 179.874 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.601 HG22 ' HB2' ' A' ' 47' ' ' TRP . 1.0 OUTLIER -106.06 118.07 52.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.245 -0.434 . . . . 74.23 111.152 179.877 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -114.76 76.73 1.01 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.178 -0.465 . . . . 65.24 110.888 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 140.87 90.13 0.17 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.788 -0.72 . . . . 74.45 112.524 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 58.46 172.36 0.36 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.75 -0.738 . . . . 45.42 112.484 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.526 HG21 ' HA ' ' A' ' 63' ' ' PRO . 0.2 OUTLIER -66.01 172.35 3.79 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.828 0.347 . . . . 73.31 111.132 -179.867 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . 0.601 ' HB2' HG22 ' A' ' 42' ' ' VAL . 6.6 m95 -146.97 129.55 15.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.2 -0.454 . . . . 73.11 110.948 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.602 ' O ' ' N ' ' A' ' 84' ' ' ARG . . . -91.13 127.7 36.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.263 -0.426 . . . . 75.04 111.092 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.559 HG11 ' CD1' ' A' ' 80' ' ' LEU . 21.1 m -125.86 145.0 34.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.215 -0.448 . . . . 74.34 111.115 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.88 ' HB3' ' CB ' ' A' ' 56' ' ' ALA . 6.7 m-85 -122.84 143.68 49.7 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.212 -0.449 . . . . 75.52 110.925 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.603 ' HG2' ' N ' ' A' ' 52' ' ' ARG . 0.5 OUTLIER -49.46 -84.04 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.176 -0.465 . . . . 63.4 110.871 179.987 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.728 ' H ' ' HA ' ' A' ' 56' ' ' ALA . 0.8 OUTLIER -81.91 136.43 47.59 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.586 0.707 . . . . 75.11 110.866 -179.89 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.625 ' HB3' ' HB3' ' A' ' 81' ' ' SER . 53.4 Cg_endo -69.74 135.79 31.41 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.668 2.245 . . . . 71.43 112.326 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.445 ' HB3' ' CE2' ' A' ' 55' ' ' PHE . 7.1 t-20 72.17 -6.15 1.59 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.174 -0.466 . . . . 74.34 110.945 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.445 ' CE2' ' HB3' ' A' ' 54' ' ' ASN . 0.1 OUTLIER -144.46 -75.36 0.24 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.136 -0.484 . . . . 72.31 110.877 -179.996 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.88 ' CB ' ' HB3' ' A' ' 50' ' ' TYR . . . 47.58 82.55 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.132 -0.485 . . . . 63.25 111.059 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . 0.61 ' O ' ' CD2' ' A' ' 58' ' ' TYR . 28.5 m0 -64.41 31.08 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.254 -0.43 . . . . 75.25 110.938 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.665 ' H ' ' C ' ' A' ' 56' ' ' ALA . 3.8 m-85 -160.29 115.6 2.3 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.264 -0.426 . . . . 73.25 110.935 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -82.39 136.59 34.94 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.128 -0.487 . . . . 75.42 110.85 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.616 ' HA ' ' OE1' ' A' ' 149' ' ' GLN . 5.4 t80 -146.39 124.86 12.37 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.243 -0.435 . . . . 75.12 110.9 -179.899 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.605 ' N ' ' CD1' ' A' ' 61' ' ' ILE . 1.0 OUTLIER -109.21 116.95 53.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.13 -0.486 . . . . 74.14 111.164 179.883 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -89.34 129.17 48.48 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.635 0.731 . . . . 64.32 110.909 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.526 ' HA ' HG21 ' A' ' 46' ' ' THR . 53.5 Cg_endo -69.8 -175.28 1.11 Allowed 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.664 2.242 . . . . 72.52 112.323 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.48 162.7 15.58 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.216 -0.447 . . . . 73.23 110.897 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 112.34 -171.56 14.15 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.797 -0.716 . . . . 73.45 112.533 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -103.5 150.96 23.4 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.871 0.367 . . . . 74.14 110.885 -179.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.67 ' HB2' ' O ' ' A' ' 40' ' ' ILE . 19.7 m-85 -139.26 85.34 15.59 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.669 0.747 . . . . 74.22 110.923 -179.853 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.442 ' HD2' ' HG3' ' A' ' 72' ' ' ARG . 53.9 Cg_endo -69.72 -0.01 6.26 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.687 2.258 . . . . 72.04 112.373 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.518 ' HB2' ' HG2' ' A' ' 72' ' ' ARG . 49.3 mt-10 -155.81 142.18 18.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.177 -0.465 . . . . 63.43 110.855 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.726 ' HA ' ' NE1' ' A' ' 73' ' ' TRP . 30.0 p90 -54.85 -20.52 8.9 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.158 -0.473 . . . . 72.22 110.918 -179.857 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -80.41 -18.72 48.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.144 -0.48 . . . . 74.11 110.945 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.518 ' HG2' ' HB2' ' A' ' 69' ' ' GLU . 26.5 mmt180 -69.9 -7.35 39.62 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.466 . . . . 72.34 110.887 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . 0.726 ' NE1' ' HA ' ' A' ' 70' ' ' TYR . 0.0 OUTLIER -139.28 18.49 2.58 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.176 -0.465 . . . . 72.23 110.929 -179.957 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' MET . . . . . 0.461 ' C ' ' O ' ' A' ' 73' ' ' TRP . 0.0 OUTLIER 33.54 43.98 0.06 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.212 -0.449 . . . . 73.23 110.863 179.95 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -53.31 125.44 31.43 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.784 -0.722 . . . . 63.24 112.472 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.2 mt -52.85 -53.98 40.98 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.862 0.363 . . . . 72.23 110.9 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 -130.68 151.66 50.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.198 -0.456 . . . . 71.21 110.866 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -84.22 13.29 5.38 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.201 -0.454 . . . . 62.33 110.864 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.6 67.72 0.91 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 74.14 110.87 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.62 ' HB2' ' SG ' ' A' ' 37' ' ' CYS . 0.1 OUTLIER -72.0 132.9 44.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.225 -0.443 . . . . 73.05 110.919 -179.98 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.625 ' HB3' ' HB3' ' A' ' 53' ' ' PRO . 1.3 m -151.09 -122.48 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.193 -0.458 . . . . 73.21 110.841 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.56 ' O ' ' N ' ' A' ' 50' ' ' TYR . 0.1 OUTLIER -38.33 106.06 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.136 -0.484 . . . . 74.23 110.844 -179.782 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . 0.493 ' SG ' ' HB2' ' A' ' 27' ' ' CYS . 9.3 p -134.38 131.34 38.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.15 -0.477 . . . . 75.04 110.904 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . 0.602 ' N ' ' O ' ' A' ' 48' ' ' ALA . 2.9 mmt-85 -113.76 164.75 13.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 74.25 110.874 -179.835 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.439 ' HB1' ' OG1' ' A' ' 6' ' ' THR . . . -79.82 130.31 35.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.219 -0.446 . . . . 70.33 111.084 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 54.3 t -116.07 136.05 54.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.195 -0.457 . . . . 75.34 111.162 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . 0.463 ' O ' ' CG2' ' A' ' 136' ' ' VAL . 45.8 m80 -114.92 105.8 13.42 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.183 -0.462 . . . . 74.12 110.854 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.451 ' C ' ' O ' ' A' ' 87' ' ' HIS . 0.0 OUTLIER -34.02 146.55 0.13 Allowed Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.56 0.695 . . . . 75.04 110.926 -179.976 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.556 ' HB3' ' H ' ' A' ' 136' ' ' VAL . 53.5 Cg_endo -69.77 109.99 2.45 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.669 2.246 . . . . 75.12 112.356 179.843 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -106.83 158.84 16.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.236 -0.438 . . . . 74.23 110.841 -179.818 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 49.7 79.52 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.743 -0.742 . . . . 64.53 112.488 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 124.64 11.19 4.59 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.725 -0.75 . . . . 62.41 112.492 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.438 ' O ' ' HG2' ' A' ' 134' ' ' GLU . 14.8 pt20 38.02 -122.84 0.25 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.824 0.345 . . . . 72.44 110.923 -179.833 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.488 ' O ' ' HA ' ' A' ' 112' ' ' THR . 0.2 OUTLIER -124.19 101.97 7.47 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.209 -0.45 . . . . 74.2 110.903 -179.876 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.428 ' H ' ' HG2' ' A' ' 134' ' ' GLU . 47.4 tptt -110.89 126.55 54.82 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.07 -0.514 . . . . 75.44 110.893 179.886 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.436 HG21 HD13 ' A' ' 96' ' ' ILE . 0.0 OUTLIER -149.38 138.04 14.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.262 -0.426 . . . . 71.15 111.146 179.808 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.457 ' HB2' ' O ' ' A' ' 131' ' ' LYS . 2.2 mt-30 -105.52 121.23 43.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.182 -0.463 . . . . 73.44 110.889 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 23.0 mm -97.75 131.23 45.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.15 -0.477 . . . . 73.44 111.125 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.665 ' CB ' ' HB2' ' A' ' 129' ' ' SER . 37.6 m-85 -120.96 140.54 51.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.181 -0.463 . . . . 75.13 110.868 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 59.6 tt0 -75.79 -61.7 1.84 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.15 -0.477 . . . . 73.13 110.907 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 39.9 mttt -96.6 171.42 8.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.128 -0.487 . . . . 71.25 110.898 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.428 ' HA2' ' OG ' ' A' ' 129' ' ' SER . . . -70.5 153.46 51.68 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.719 -0.753 . . . . 72.12 112.493 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.439 ' HA ' ' HB2' ' A' ' 158' ' ' ARG . 26.8 t0 65.27 46.11 2.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.802 0.334 . . . . 74.11 110.861 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.593 ' N ' ' CD2' ' A' ' 104' ' ' PHE . 0.1 OUTLIER 47.54 33.18 2.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.227 -0.442 . . . . 75.12 110.853 -179.948 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 57.8 m -96.13 159.45 14.95 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.168 -0.469 . . . . 64.44 110.847 -179.774 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 84.92 -137.29 15.4 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.748 -0.739 . . . . 74.21 112.504 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 30.1 tp60 -88.84 114.2 25.2 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.805 0.336 . . . . 71.42 110.94 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 1.5 ttp -101.36 144.12 30.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.185 -0.461 . . . . 72.33 110.9 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -149.47 136.01 19.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.218 -0.446 . . . . 75.02 110.899 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -117.36 102.49 9.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.107 -0.497 . . . . 65.32 110.867 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 11.9 t -113.05 129.15 56.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.166 -0.47 . . . . 61.23 111.134 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.488 ' HA ' ' O ' ' A' ' 94' ' ' TYR . 1.5 t -96.74 22.52 8.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.224 -0.443 . . . . 74.53 111.199 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -151.2 137.56 18.53 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.155 -0.475 . . . . 74.15 110.848 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 30.7 p30 -53.89 178.27 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.16 -0.473 . . . . 74.42 110.882 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . 0.498 ' O ' ' HB2' ' A' ' 172' ' ' SER . 0.8 OUTLIER -155.65 151.31 21.89 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.57 0.7 . . . . 70.1 110.888 -179.92 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.453 ' O ' ' C ' ' A' ' 143' ' ' PRO . 54.1 Cg_endo -69.77 -33.94 15.54 Favored 'Trans proline' 0 C--O 1.231 0.134 0 C-N-CA 122.659 2.24 . . . . 73.25 112.383 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' SER . . . . . 0.615 ' HB3' ' CB ' ' A' ' 120' ' ' GLU . 0.1 OUTLIER -148.3 109.55 4.35 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 64.41 110.83 -179.821 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.601 ' HB ' ' O ' ' A' ' 171' ' ' GLN . 4.3 tt -60.45 -30.0 45.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.156 -0.475 . . . . 72.54 111.125 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' MET . . . . . 0.604 ' O ' ' HA ' ' A' ' 123' ' ' HIS . 5.0 ttt -86.14 -41.91 14.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.227 -0.442 . . . . 74.34 110.835 179.873 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.615 ' CB ' ' HB3' ' A' ' 117' ' ' SER . 10.0 tp10 -68.03 -14.11 62.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.229 -0.441 . . . . 71.24 110.913 -179.924 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 6.9 tp-100 -115.17 -48.27 2.82 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.092 -0.503 . . . . 72.23 110.91 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . 0.522 ' HB2' ' O ' ' A' ' 118' ' ' ILE . 53.4 m-85 -103.34 -20.4 14.1 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.198 -0.455 . . . . 75.12 110.879 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . 0.604 ' HA ' ' O ' ' A' ' 119' ' ' MET . 0.1 OUTLIER 71.33 29.87 2.68 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.104 -0.498 . . . . 63.04 110.859 -179.997 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.409 ' O ' HG22 ' A' ' 118' ' ' ILE . 4.5 mtt -107.85 86.34 2.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.256 -0.429 . . . . 74.11 110.892 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 1.9 ptp85 -51.97 -40.44 60.89 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.239 -0.437 . . . . 72.3 110.886 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.462 ' HB3' ' HG2' ' A' ' 168' ' ' PRO . 12.9 mt-10 -137.51 133.51 34.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.191 -0.458 . . . . 73.51 110.907 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.457 ' CG2' ' O ' ' A' ' 129' ' ' SER . 3.7 mm -93.48 101.57 12.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.135 -0.484 . . . . 71.41 111.149 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 11.8 m80 -69.9 -34.16 73.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.2 -0.455 . . . . 74.21 110.855 179.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 0.665 ' HB2' ' CB ' ' A' ' 99' ' ' PHE . 8.3 m -134.02 154.3 51.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.231 -0.44 . . . . 60.13 110.838 -179.756 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . 0.571 ' HB3' ' HD2' ' A' ' 154' ' ' LYS . 0.1 OUTLIER -155.13 118.54 4.46 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.154 -0.475 . . . . 75.43 110.886 -179.929 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.522 ' HA ' ' HA ' ' A' ' 156' ' ' GLU . 7.7 mtpp -112.86 154.0 27.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.201 -0.454 . . . . 55.34 110.912 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.52 ' HB ' ' O ' ' A' ' 131' ' ' LYS . 15.2 t 87.17 162.57 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.218 -0.446 . . . . 72.22 111.127 179.9 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.431 ' HB3' ' HA ' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -179.65 125.63 0.08 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.161 -0.472 . . . . 72.22 110.895 179.939 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.438 ' HG2' ' O ' ' A' ' 93' ' ' GLN . 0.0 OUTLIER -93.71 176.9 6.19 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.186 -0.461 . . . . 71.44 110.867 179.953 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . 0.492 ' HA3' ' HA ' ' A' ' 89' ' ' PRO . . . -37.26 -67.41 0.45 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.768 -0.73 . . . . 65.14 112.488 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.712 ' HA ' HD13 ' A' ' 152' ' ' LEU . 13.4 t -140.65 145.24 25.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.913 0.387 . . . . 74.21 111.073 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' TRP . . . . . 0.548 ' H ' ' CD1' ' A' ' 152' ' ' LEU . 0.1 OUTLIER -147.51 168.68 21.33 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.117 -0.492 . . . . 73.35 110.898 179.988 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.556 ' CG2' ' HB2' ' A' ' 149' ' ' GLN . 63.0 mt -138.13 133.72 44.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.219 -0.446 . . . . 73.32 111.153 179.879 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 0.469 ' HB2' ' HB2' ' A' ' 150' ' ' TYR . 83.6 m-85 -98.4 179.92 4.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.191 -0.459 . . . . 72.34 110.855 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . 0.424 ' CE2' ' HD2' ' A' ' 174' ' ' ARG . 0.4 OUTLIER -153.54 126.0 8.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.145 -0.479 . . . . 74.13 110.936 -179.829 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . 0.585 ' O ' ' HB2' ' A' ' 171' ' ' GLN . 27.0 tt0 -62.85 -28.1 69.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.125 -0.489 . . . . 74.44 110.926 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.733 ' HB3' ' HD2' ' A' ' 143' ' ' PRO . 9.4 mp -115.88 173.5 2.96 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.565 0.698 . . . . 73.03 110.928 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . 0.733 ' HD2' ' HB3' ' A' ' 142' ' ' LEU . 54.0 Cg_endo -69.73 -90.92 0.01 OUTLIER 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.653 2.235 . . . . 71.43 112.373 179.836 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . 0.727 ' O ' ' N ' ' A' ' 146' ' ' ARG . 1.6 m-80 -54.05 96.69 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 75.33 110.881 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . 0.652 ' C ' ' O ' ' A' ' 144' ' ' ASN . 5.8 m-85 11.87 53.1 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.157 -0.474 . . . . 74.32 110.895 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . 0.727 ' N ' ' O ' ' A' ' 144' ' ' ASN . 19.5 mtt-85 -116.8 170.41 8.63 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.113 -0.494 . . . . 74.13 110.88 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 70.39 -172.08 42.41 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.747 -0.74 . . . . 75.11 112.481 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.75 132.62 34.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.761 0.315 . . . . 73.42 110.897 -179.851 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' GLN . . . . . 0.616 ' OE1' ' HA ' ' A' ' 60' ' ' TYR . 0.8 OUTLIER -88.53 157.73 18.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.204 -0.453 . . . . 72.45 110.928 -179.922 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . 0.469 ' HB2' ' HB2' ' A' ' 139' ' ' PHE . 12.6 m-85 -122.84 141.48 51.82 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.187 -0.46 . . . . 71.14 110.891 -179.83 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.433 ' CA ' HD12 ' A' ' 61' ' ' ILE . 7.8 tp -76.16 123.65 26.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.105 -0.498 . . . . 75.33 110.858 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.712 HD13 ' HA ' ' A' ' 136' ' ' VAL . 0.0 OUTLIER -50.9 135.5 24.24 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.179 -0.464 . . . . 74.11 110.911 179.847 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -165.4 27.68 0.05 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.193 -0.458 . . . . 72.53 110.882 179.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.766 ' O ' ' HG3' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -114.88 -175.23 2.64 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.224 -0.444 . . . . 61.24 110.874 -179.993 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.766 ' HG3' ' O ' ' A' ' 154' ' ' LYS . 0.0 OUTLIER -161.02 -127.54 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.202 -0.454 . . . . 71.41 110.887 179.878 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . 0.577 ' HG2' ' O ' ' A' ' 156' ' ' GLU . 2.9 tm-20 -68.54 6.0 0.92 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.245 -0.434 . . . . 74.15 110.895 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . 0.762 ' CE1' ' HA ' ' A' ' 154' ' ' LYS . 20.4 m-30 -34.61 152.85 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.141 -0.481 . . . . 75.21 110.869 -179.828 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . 0.458 ' O ' ' OG ' ' A' ' 129' ' ' SER . 0.0 OUTLIER -125.76 -35.74 2.48 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.132 -0.486 . . . . 73.32 110.865 -179.99 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -86.72 151.23 52.32 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.563 0.697 . . . . 73.32 110.866 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . 0.438 ' HB2' ' HD3' ' A' ' 168' ' ' PRO . 53.6 Cg_endo -69.74 -28.01 25.85 Favored 'Trans proline' 0 C--O 1.232 0.207 0 C-N-CA 122.658 2.238 . . . . 71.35 112.316 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.552 HD11 ' H ' ' A' ' 161' ' ' ILE . 3.6 mp -64.08 -11.75 10.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.258 -0.428 . . . . 73.11 111.133 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . 0.639 ' HB3' ' CD1' ' A' ' 157' ' ' TYR . 0.3 OUTLIER -75.32 -13.42 60.42 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.152 -0.477 . . . . 72.22 110.896 179.813 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' TRP . . . . . 0.44 ' CH2' ' CE1' ' A' ' 139' ' ' PHE . 3.4 m95 -87.16 0.16 55.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.227 -0.442 . . . . 72.05 110.93 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 91.64 -35.68 3.89 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.743 -0.741 . . . . 71.33 112.461 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -82.05 130.75 35.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.798 0.332 . . . . 61.53 111.144 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -39.01 -38.42 0.45 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.244 -0.435 . . . . 72.33 111.069 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 167' ' ' SER . . . . . 0.523 ' C ' ' H ' ' A' ' 169' ' ' ALA . 0.3 OUTLIER -128.35 156.35 76.99 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.666 0.746 . . . . 73.51 110.858 -179.765 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . 0.462 ' HG2' ' HB3' ' A' ' 126' ' ' GLU . 54.1 Cg_endo -69.72 27.86 0.18 Allowed 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.715 2.277 . . . . 75.34 112.332 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . 0.523 ' H ' ' C ' ' A' ' 167' ' ' SER . . . -68.27 104.61 1.89 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.246 -0.434 . . . . 74.42 111.111 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 3.4 t -152.94 164.37 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.188 -0.46 . . . . 72.54 111.149 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 171' ' ' GLN . . . . . 0.666 ' OE1' ' HB3' ' A' ' 143' ' ' PRO . 1.7 mm-40 -113.88 -85.79 0.59 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.244 -0.435 . . . . 74.11 110.867 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 172' ' ' SER . . . . . 0.72 ' OG ' ' O ' ' A' ' 143' ' ' PRO . 33.6 p -127.05 -179.53 4.89 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.198 -0.456 . . . . 73.52 110.863 -179.815 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -145.49 170.89 15.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.077 -0.511 . . . . 75.24 110.875 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . 0.424 ' HD2' ' CE2' ' A' ' 140' ' ' TYR . 0.0 OUTLIER -136.09 157.58 46.49 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.152 -0.477 . . . . 74.55 110.865 -179.89 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . 0.47 ' HD2' ' CE2' ' A' ' 94' ' ' TYR . 1.8 ptt180 -98.86 -171.93 2.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.142 -0.481 . . . . 74.42 110.905 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 3.5 mt -125.33 130.99 72.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.223 -0.444 . . . . 75.05 111.085 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 9.1 p -53.84 137.67 14.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.182 -0.463 . . . . 72.24 111.135 179.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.203 -0.453 . . . . 73.23 110.883 -179.951 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.323 0 N-CA-C 112.491 -0.244 . . . . 70.31 112.491 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.453 ' OG1' ' HB1' ' A' ' 85' ' ' ALA . 26.2 p -81.54 136.48 35.6 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.85 0.357 . . . . 74.43 111.165 -179.876 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 2.6 tttt -124.67 136.96 54.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.228 -0.442 . . . . 73.3 110.919 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.556 HD13 ' CE1' ' A' ' 10' ' ' PHE . 16.0 tt -136.98 148.98 26.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.219 -0.446 . . . . 71.44 111.168 179.862 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.502 HG21 ' CE2' ' A' ' 11' ' ' TYR . 19.0 m -132.58 137.36 47.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.218 -0.446 . . . . 72.31 111.184 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.556 ' CE1' HD13 ' A' ' 8' ' ' ILE . 0.5 OUTLIER -125.46 128.06 47.47 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.183 -0.462 . . . . 75.35 110.874 -179.982 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.553 ' CG ' ' HA ' ' A' ' 16' ' ' PHE . 17.0 m-85 -113.16 131.98 55.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.103 -0.499 . . . . 73.42 110.937 -179.831 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.44 ' HB2' ' HB2' ' A' ' 19' ' ' ARG . 0.0 OUTLIER -61.71 -14.53 32.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.162 -0.472 . . . . 74.33 110.852 -179.958 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.419 ' HB2' ' O ' ' A' ' 17' ' ' GLN . 77.4 m-20 -135.41 149.56 49.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.138 -0.483 . . . . 73.12 110.89 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.517 ' N ' ' HB3' ' A' ' 38' ' ' ASN . 30.3 mtmm -54.61 -176.68 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.224 -0.444 . . . . 73.5 110.874 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 16.5 m120 46.99 30.58 1.29 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.185 -0.461 . . . . 74.3 110.908 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.553 ' HA ' ' CG ' ' A' ' 11' ' ' TYR . 3.6 m-85 51.24 65.38 1.5 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.152 -0.477 . . . . 75.41 110.867 -180.0 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . 0.419 ' O ' ' HB2' ' A' ' 13' ' ' ASP . 16.9 mt-30 -140.26 160.87 38.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.113 -0.494 . . . . 75.42 110.899 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 90.98 -147.99 19.16 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.736 -0.745 . . . . 73.42 112.519 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.44 ' HB2' ' HB2' ' A' ' 12' ' ' GLU . 0.0 OUTLIER -68.9 77.47 0.32 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.83 0.348 . . . . 71.11 110.908 -179.893 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.437 ' HB2' ' CE1' ' A' ' 11' ' ' TYR . 0.7 OUTLIER -77.83 127.82 33.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.148 -0.478 . . . . 75.1 110.846 -179.892 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.496 ' O ' ' HA ' ' A' ' 9' ' ' THR . 88.2 t80 -122.01 124.0 42.97 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.199 -0.455 . . . . 75.13 110.922 -179.889 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.498 ' CG ' HG23 ' A' ' 9' ' ' THR . 1.2 m-20 -120.19 134.37 55.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.1 -0.5 . . . . 74.23 110.86 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -167.49 134.32 2.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.199 -0.455 . . . . 70.0 110.889 -179.887 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -102.2 5.45 40.2 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.174 -0.466 . . . . 74.14 110.857 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 11.7 t -107.79 169.38 8.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.171 -0.468 . . . . 71.21 110.932 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -64.96 117.15 7.19 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.198 -0.455 . . . . 52.35 110.875 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.431 ' HB2' ' HB3' ' A' ' 30' ' ' PHE . 4.4 m -116.95 53.65 0.89 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.178 -0.465 . . . . 73.24 110.876 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.525 ' C ' ' HA ' ' A' ' 82' ' ' SER . . . -46.44 -20.72 0.13 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.176 -0.465 . . . . 74.25 111.126 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 57.0 t0 -128.3 42.71 3.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.21 -0.45 . . . . 72.31 110.877 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.76 ' O ' ' CD2' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -80.0 14.44 1.83 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.187 -0.461 . . . . 74.42 110.92 -179.905 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.511 ' HB2' ' HB3' ' A' ' 81' ' ' SER . 28.3 t60 -77.61 -40.13 43.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.104 -0.498 . . . . 74.23 110.853 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.6 t -56.15 -14.98 3.08 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.215 -0.448 . . . . 63.55 111.129 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -99.07 -27.23 13.93 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.258 -0.428 . . . . 65.22 110.896 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.415 ' CD1' ' O ' ' A' ' 19' ' ' ARG . 17.4 tp -141.97 135.84 29.75 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.146 -0.479 . . . . 74.3 110.909 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 20.5 m -99.36 -42.62 6.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 74.42 110.876 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -118.15 141.48 48.45 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.104 -0.498 . . . . 75.14 110.849 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.635 ' SG ' ' HB2' ' A' ' 80' ' ' LEU . 4.6 p -110.73 86.77 2.38 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.148 -0.478 . . . . 71.31 110.877 -179.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.517 ' HB3' ' N ' ' A' ' 14' ' ' LYS . 0.2 OUTLIER -77.97 -66.29 0.86 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.175 -0.466 . . . . 75.1 110.851 -179.863 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 6.1 p -117.08 123.11 46.01 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.201 -0.454 . . . . 63.22 110.84 -179.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.644 ' O ' ' HB2' ' A' ' 67' ' ' TYR . 27.2 mt -116.27 150.2 18.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.092 -0.503 . . . . 72.3 111.107 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.467 ' HD2' ' CE2' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -145.63 118.51 8.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.211 -0.45 . . . . 73.04 110.901 179.832 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.48 HG23 ' CB ' ' A' ' 8' ' ' ILE . 1.3 t -104.87 115.7 47.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.244 -0.435 . . . . 75.15 111.172 179.836 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -110.84 77.82 1.07 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.164 -0.471 . . . . 73.21 110.901 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.404 ' O ' ' HA ' ' A' ' 6' ' ' THR . . . 135.28 101.98 0.69 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.768 -0.729 . . . . 73.31 112.493 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 53.74 179.17 0.12 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.747 -0.739 . . . . 73.01 112.515 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.481 HG21 ' HA ' ' A' ' 63' ' ' PRO . 0.6 OUTLIER -79.67 172.61 13.56 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.819 0.342 . . . . 74.12 111.121 -179.885 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . 0.518 ' CD1' ' HB ' ' A' ' 8' ' ' ILE . 14.8 m95 -144.07 130.2 19.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 73.54 110.906 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.516 ' O ' ' HA ' ' A' ' 83' ' ' CYS . . . -97.18 112.0 23.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.288 -0.415 . . . . 74.02 111.158 179.858 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.424 ' HA ' ' HA ' ' A' ' 83' ' ' CYS . 3.6 m -113.12 129.73 68.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.227 -0.442 . . . . 72.05 111.117 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.676 ' HB3' ' HA ' ' A' ' 56' ' ' ALA . 33.0 m-85 -95.78 148.59 22.42 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.156 -0.475 . . . . 74.44 110.92 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.636 ' OE1' ' HB3' ' A' ' 57' ' ' TRP . 35.1 tt0 -45.43 -80.85 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.099 -0.501 . . . . 73.35 110.885 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.615 ' HB3' ' CD2' ' A' ' 55' ' ' PHE . 0.3 OUTLIER -90.54 146.38 34.22 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.621 0.724 . . . . 74.5 110.88 -179.891 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.692 ' HA ' ' OG ' ' A' ' 82' ' ' SER . 54.2 Cg_endo -69.71 134.71 28.74 Favored 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.701 2.267 . . . . 74.5 112.38 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 1.5 t30 65.63 -9.84 0.23 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.214 -0.448 . . . . 75.15 110.884 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.615 ' CD2' ' HB3' ' A' ' 52' ' ' ARG . 4.7 m-30 -98.75 -24.16 15.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.173 -0.467 . . . . 75.22 110.914 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.676 ' HA ' ' HB3' ' A' ' 50' ' ' TYR . . . 56.62 20.83 5.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.102 -0.499 . . . . 72.12 111.141 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . 0.636 ' HB3' ' OE1' ' A' ' 51' ' ' GLU . 0.1 OUTLIER -50.7 -166.11 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.167 -0.47 . . . . 71.45 110.93 -179.958 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.633 ' HB2' ' CD ' ' A' ' 51' ' ' GLU . 6.9 m-30 -13.08 101.87 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.251 -0.431 . . . . 74.14 110.877 -179.866 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.73 154.24 42.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.12 -0.491 . . . . 75.22 110.883 179.881 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.422 ' CE2' ' HB3' ' A' ' 76' ' ' LEU . 5.1 t80 -173.72 102.13 0.11 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.213 -0.449 . . . . 73.34 110.906 -179.895 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.449 HD11 ' HA ' ' A' ' 151' ' ' LEU . 4.8 mp -88.21 118.71 34.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.093 -0.503 . . . . 73.21 111.076 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -83.61 129.59 59.21 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.603 0.716 . . . . 64.24 110.856 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.481 ' HA ' HG21 ' A' ' 46' ' ' THR . 53.3 Cg_endo -69.87 -172.34 0.58 Allowed 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.652 2.234 . . . . 65.44 112.288 179.878 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -88.74 161.9 16.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 73.4 110.911 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 112.07 -167.74 12.5 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.778 -0.725 . . . . 75.25 112.511 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -109.08 154.45 22.24 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.901 0.381 . . . . 71.21 110.862 -179.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.644 ' HB2' ' O ' ' A' ' 40' ' ' ILE . 14.6 m-85 -142.05 84.96 11.3 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.667 0.746 . . . . 74.02 110.925 -179.893 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.469 ' HD2' ' HG3' ' A' ' 72' ' ' ARG . 53.8 Cg_endo -69.73 -0.06 6.34 Favored 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.682 2.254 . . . . 64.01 112.335 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.537 ' HB2' ' HG2' ' A' ' 72' ' ' ARG . 47.9 mt-10 -156.5 143.53 18.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.226 -0.443 . . . . 71.12 110.891 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.73 ' HA ' ' NE1' ' A' ' 73' ' ' TRP . 35.9 p90 -54.43 -22.35 12.35 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.161 -0.472 . . . . 74.21 110.915 -179.836 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -79.55 -18.05 52.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.121 -0.491 . . . . 74.42 110.907 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.537 ' HG2' ' HB2' ' A' ' 69' ' ' GLU . 28.2 mmt180 -69.28 -7.75 39.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.453 . . . . 65.52 110.883 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . 0.73 ' NE1' ' HA ' ' A' ' 70' ' ' TYR . 0.0 OUTLIER -138.6 15.82 2.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.183 -0.462 . . . . 64.24 110.925 -179.971 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' MET . . . . . 0.431 ' C ' ' O ' ' A' ' 73' ' ' TRP . 0.0 OUTLIER 36.0 43.84 0.22 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.213 -0.449 . . . . 73.42 110.894 179.93 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -51.93 123.92 22.31 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.763 -0.732 . . . . 43.3 112.506 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.422 ' HB3' ' CE2' ' A' ' 60' ' ' TYR . 1.1 pt? -59.09 -33.2 70.56 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.803 0.335 . . . . 73.23 110.864 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.413 ' C ' ' H ' ' A' ' 79' ' ' ARG . 17.7 t-20 -147.49 139.43 24.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.239 -0.437 . . . . 75.41 110.902 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -78.12 18.51 0.51 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.168 -0.469 . . . . 75.01 110.896 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.413 ' H ' ' C ' ' A' ' 77' ' ' ASN . 0.1 OUTLIER -107.17 73.28 0.92 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.186 -0.461 . . . . 74.45 110.873 -179.895 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.635 ' HB2' ' SG ' ' A' ' 37' ' ' CYS . 0.0 OUTLIER -82.31 133.98 35.25 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.228 -0.442 . . . . 71.21 110.871 -179.955 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.576 ' OG ' ' HD3' ' A' ' 53' ' ' PRO . 0.9 OUTLIER -147.56 -126.34 0.06 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.173 -0.467 . . . . 71.41 110.889 -179.942 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.692 ' OG ' ' HA ' ' A' ' 53' ' ' PRO . 0.4 OUTLIER -29.88 123.34 0.17 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.148 -0.478 . . . . 72.5 110.866 -179.844 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . 0.516 ' HA ' ' O ' ' A' ' 48' ' ' ALA . 9.2 p -133.42 141.56 47.91 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.149 -0.478 . . . . 73.54 110.873 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . 0.466 ' N ' ' O ' ' A' ' 48' ' ' ALA . 1.5 mmt85 -138.44 130.22 28.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.204 -0.453 . . . . 75.11 110.886 -179.872 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.453 ' HB1' ' OG1' ' A' ' 6' ' ' THR . . . -50.87 128.84 22.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.21 -0.45 . . . . 74.35 111.095 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.507 ' CG2' ' CB ' ' A' ' 48' ' ' ALA . 54.3 t -114.61 130.64 68.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.19 -0.459 . . . . 74.02 111.16 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . 0.458 ' O ' ' C ' ' A' ' 88' ' ' LEU . 72.1 m-70 -114.67 119.03 35.33 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.154 -0.475 . . . . 71.31 110.881 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.458 ' C ' ' O ' ' A' ' 87' ' ' HIS . 0.0 OUTLIER -33.64 146.1 0.12 Allowed Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.556 0.693 . . . . 74.51 110.915 -179.956 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.708 ' HA ' ' HA3' ' A' ' 135' ' ' GLY . 53.4 Cg_endo -69.74 -79.29 0.01 OUTLIER 'Trans proline' 0 C--O 1.231 0.151 0 C-N-CA 122.721 2.281 . . . . 74.43 112.306 179.879 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.48 ' H ' ' HG2' ' A' ' 89' ' ' PRO . 67.2 m -109.07 -178.56 3.61 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.183 -0.462 . . . . 74.11 110.893 -179.827 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -100.94 4.15 55.96 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.794 -0.717 . . . . 43.11 112.488 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -125.19 -55.43 0.17 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.744 -0.741 . . . . 73.35 112.523 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.493 ' HG3' ' OG1' ' A' ' 112' ' ' THR . 11.5 pt20 -165.88 -170.05 1.66 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.837 0.351 . . . . 74.22 110.888 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.774 ' CD2' ' HB2' ' A' ' 134' ' ' GLU . 38.8 t80 -116.43 106.07 13.21 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.199 -0.455 . . . . 74.34 110.919 -179.859 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.457 ' HA ' ' HB ' ' A' ' 112' ' ' THR . 36.7 tptt -74.95 126.2 30.49 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.131 -0.486 . . . . 74.3 110.913 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -149.1 140.92 17.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.228 -0.442 . . . . 75.12 111.122 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.433 ' HB2' ' O ' ' A' ' 131' ' ' LYS . 1.3 mt-30 -109.63 125.84 53.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.197 -0.456 . . . . 73.14 110.888 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 2.3 mp -106.05 132.86 52.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.153 -0.476 . . . . 72.51 111.15 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.711 ' HB2' ' HB2' ' A' ' 129' ' ' SER . 46.3 m-85 -119.38 150.45 40.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.18 -0.464 . . . . 73.4 110.925 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.544 ' HA ' ' CE ' ' A' ' 124' ' ' MET . 62.9 tt0 -85.15 -52.18 6.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.177 -0.465 . . . . 62.13 110.892 -179.873 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 40.7 mttt -105.48 166.47 10.41 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.099 -0.501 . . . . 75.13 110.868 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.409 ' HA2' ' OG ' ' A' ' 129' ' ' SER . . . -67.12 152.46 52.75 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.722 -0.751 . . . . 73.31 112.522 179.885 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.419 ' HA ' ' HB2' ' A' ' 158' ' ' ARG . 42.3 t0 66.78 46.16 1.76 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.829 0.347 . . . . 72.01 110.885 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.546 ' CD2' ' N ' ' A' ' 104' ' ' PHE . 0.3 OUTLIER 48.3 33.08 3.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.208 -0.451 . . . . 74.2 110.866 -179.904 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 57.8 m -96.5 160.82 14.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.16 -0.473 . . . . 72.4 110.846 -179.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 81.97 -143.74 23.39 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.712 -0.756 . . . . 61.44 112.479 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 38.1 tp60 -80.13 120.45 24.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.755 0.312 . . . . 73.43 110.877 -179.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 5.7 ttp -108.84 134.17 51.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.212 -0.449 . . . . 62.13 110.886 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -139.22 135.5 34.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.205 -0.452 . . . . 70.21 110.925 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -114.83 94.52 4.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.061 -0.518 . . . . 75.24 110.872 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 5.7 t -114.77 144.13 43.98 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.148 -0.478 . . . . 75.15 111.165 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.493 ' OG1' ' HG3' ' A' ' 93' ' ' GLN . 6.6 t -129.66 47.28 2.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.234 -0.439 . . . . 73.11 111.112 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -151.54 157.92 42.89 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.221 -0.445 . . . . 73.51 110.882 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.405 ' OD1' ' HG3' ' A' ' 175' ' ' ARG . 2.6 m-20 -56.2 148.46 18.21 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.112 -0.494 . . . . 75.01 110.874 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . 0.742 ' O ' ' HB2' ' A' ' 172' ' ' SER . 42.7 t -139.23 124.3 11.69 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.616 0.722 . . . . 71.31 110.899 -179.907 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.532 ' O ' ' C ' ' A' ' 143' ' ' PRO . 53.6 Cg_endo -69.78 -30.44 22.16 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.688 2.259 . . . . 75.43 112.322 -179.89 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' SER . . . . . 0.613 ' HB3' ' CB ' ' A' ' 120' ' ' GLU . 0.1 OUTLIER -149.18 106.72 3.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.201 -0.454 . . . . 42.13 110.853 -179.877 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.57 ' HB ' ' O ' ' A' ' 171' ' ' GLN . 3.9 tt -61.7 -30.48 48.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.127 -0.488 . . . . 74.42 111.1 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' MET . . . . . 0.701 ' O ' ' HA ' ' A' ' 123' ' ' HIS . 0.1 OUTLIER -91.02 -42.01 10.77 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.186 -0.461 . . . . 75.35 110.949 179.819 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.613 ' CB ' ' HB3' ' A' ' 117' ' ' SER . 2.9 tp10 -70.26 -11.79 61.15 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.201 -0.454 . . . . 74.44 110.861 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 29.8 mm100 -112.93 -52.14 2.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.183 -0.462 . . . . 63.12 110.966 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 30.9 m-85 -102.75 14.18 32.59 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.194 -0.457 . . . . 64.54 110.88 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . 0.701 ' HA ' ' O ' ' A' ' 119' ' ' MET . 21.5 m-70 47.13 25.11 0.48 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.118 -0.492 . . . . 74.43 110.835 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.544 ' CE ' ' HA ' ' A' ' 100' ' ' GLU . 0.0 OUTLIER -100.78 124.93 47.13 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.239 -0.437 . . . . 74.42 110.892 179.953 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 3.0 ptp85 -96.71 -35.05 11.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.257 -0.428 . . . . 74.2 110.838 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.463 ' HB3' ' HG2' ' A' ' 168' ' ' PRO . 34.8 mt-10 -145.54 115.52 7.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.18 -0.464 . . . . 64.13 110.859 -179.905 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.411 HD11 HD13 ' A' ' 118' ' ' ILE . 3.1 mm -74.13 100.45 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.121 -0.49 . . . . 74.44 111.11 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . 0.41 ' CD2' ' HG3' ' A' ' 168' ' ' PRO . 12.9 m170 -69.04 -36.21 77.46 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.138 -0.483 . . . . 75.1 110.867 179.85 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 0.711 ' HB2' ' HB2' ' A' ' 99' ' ' PHE . 19.3 m -134.03 144.18 48.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.193 -0.458 . . . . 74.31 110.875 -179.795 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . 0.629 ' O ' ' O ' ' A' ' 155' ' ' LYS . 1.4 m -140.31 114.65 9.24 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.124 -0.489 . . . . 74.33 110.925 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.513 ' HA ' ' O ' ' A' ' 155' ' ' LYS . 5.5 mtpp -110.22 150.63 28.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.178 -0.465 . . . . 72.44 110.92 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.47 ' HB ' ' O ' ' A' ' 131' ' ' LYS . 12.6 t 81.2 158.49 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.233 -0.44 . . . . 73.01 111.164 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.487 ' CD2' ' HG2' ' A' ' 155' ' ' LYS . 0.1 OUTLIER 176.27 124.29 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.213 -0.449 . . . . 72.35 110.96 179.957 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.774 ' HB2' ' CD2' ' A' ' 94' ' ' TYR . 3.7 mm-40 -86.8 -167.82 2.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.196 -0.456 . . . . 65.45 110.884 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . 0.708 ' HA3' ' HA ' ' A' ' 89' ' ' PRO . . . -48.77 -92.85 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.759 -0.734 . . . . 75.5 112.465 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.584 ' HA ' HD13 ' A' ' 152' ' ' LEU . 2.3 t -103.21 148.26 8.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.779 0.323 . . . . 73.24 111.17 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' TRP . . . . . 0.625 ' CD1' ' C ' ' A' ' 137' ' ' TRP . 0.0 OUTLIER -156.73 158.84 37.64 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.227 -0.442 . . . . 75.01 110.932 179.919 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.46 ' N ' ' CG ' ' A' ' 137' ' ' TRP . 5.0 mt -134.25 136.44 53.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.262 -0.426 . . . . 74.12 111.145 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 0.42 ' HB2' ' HB2' ' A' ' 150' ' ' TYR . 0.1 OUTLIER -102.15 160.36 14.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.157 -0.474 . . . . 72.31 110.848 179.983 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -129.33 115.51 17.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.124 -0.489 . . . . 70.11 110.908 -179.846 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . 0.578 ' O ' ' HB2' ' A' ' 171' ' ' GLN . 0.6 OUTLIER -54.91 -33.39 62.04 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.128 -0.487 . . . . 75.03 110.841 -179.983 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.725 ' HB3' ' HD2' ' A' ' 143' ' ' PRO . 8.8 mp -113.36 172.81 3.25 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.643 0.735 . . . . 74.02 110.914 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . 0.792 ' O ' ' OG ' ' A' ' 172' ' ' SER . 53.1 Cg_endo -69.78 -93.15 0.01 OUTLIER 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.7 2.266 . . . . 65.23 112.355 179.882 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . 0.745 ' O ' ' N ' ' A' ' 146' ' ' ARG . 0.3 OUTLIER -50.18 99.05 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.22 -0.445 . . . . 75.44 110.906 179.971 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . 0.643 ' C ' ' O ' ' A' ' 144' ' ' ASN . 34.5 m-85 11.59 52.23 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.199 -0.455 . . . . 75.43 110.942 -179.905 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . 0.745 ' N ' ' O ' ' A' ' 144' ' ' ASN . 12.4 mtp85 -117.86 172.14 7.59 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.128 -0.487 . . . . 73.33 110.892 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 80.11 -170.27 53.58 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.747 -0.739 . . . . 60.45 112.448 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -92.54 152.62 19.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.767 0.318 . . . . 75.05 110.881 -179.84 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 -88.25 150.34 23.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.256 -0.429 . . . . 73.24 110.893 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . 0.42 ' HB2' ' HB2' ' A' ' 139' ' ' PHE . 96.2 m-85 -130.5 122.42 27.62 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.164 -0.471 . . . . 75.52 110.906 -179.876 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.449 ' HA ' HD11 ' A' ' 61' ' ' ILE . 33.9 tp -62.49 134.51 56.51 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.098 -0.501 . . . . 75.32 110.946 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.621 ' CB ' ' HB3' ' A' ' 137' ' ' TRP . 0.0 OUTLIER -63.8 133.24 53.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.17 -0.468 . . . . 75.45 110.878 179.991 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -165.76 25.21 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.174 -0.466 . . . . 75.35 110.875 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.793 ' HA ' ' CE1' ' A' ' 157' ' ' TYR . 0.2 OUTLIER -106.65 -156.62 0.58 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.182 -0.463 . . . . 75.22 110.876 179.991 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.629 ' O ' ' O ' ' A' ' 130' ' ' CYS . 0.0 OUTLIER 168.9 -132.95 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.179 -0.464 . . . . 74.31 110.868 179.888 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . 0.548 ' H ' ' HB3' ' A' ' 155' ' ' LYS . 2.6 tm-20 -61.57 3.29 0.14 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.176 -0.465 . . . . 64.42 110.886 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . 0.793 ' CE1' ' HA ' ' A' ' 154' ' ' LYS . 15.1 m-30 -34.37 150.22 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.184 -0.462 . . . . 64.23 110.865 -179.831 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . 0.537 ' O ' ' OG ' ' A' ' 129' ' ' SER . 0.0 OUTLIER -126.31 -38.69 2.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.073 -0.512 . . . . 74.34 110.84 -179.961 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . 0.432 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 0.3 OUTLIER -85.12 150.8 55.9 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.538 0.685 . . . . 73.15 110.915 179.969 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . 0.508 ' HB3' ' HB3' ' A' ' 168' ' ' PRO . 53.5 Cg_endo -69.78 -23.29 30.87 Favored 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.726 2.284 . . . . 65.33 112.339 179.892 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.473 HD11 ' H ' ' A' ' 161' ' ' ILE . 4.0 mp -75.47 -3.24 4.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.179 -0.464 . . . . 75.24 111.117 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . 0.687 ' HB3' ' CD1' ' A' ' 157' ' ' TYR . 0.3 OUTLIER -76.53 -14.44 60.02 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.164 -0.471 . . . . 74.1 110.838 179.911 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 11.4 t90 -94.61 2.24 55.62 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.226 -0.443 . . . . 74.54 110.875 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 90.42 -36.21 3.64 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.752 -0.737 . . . . 75.04 112.526 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -71.77 128.12 34.75 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.766 0.317 . . . . 70.14 111.137 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -42.16 -34.89 0.82 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.198 -0.456 . . . . 44.33 111.086 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 167' ' ' SER . . . . . 0.519 ' C ' ' H ' ' A' ' 169' ' ' ALA . 0.3 OUTLIER -131.25 157.84 76.96 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.663 0.744 . . . . 75.25 110.861 -179.771 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . 0.508 ' HB3' ' HB3' ' A' ' 160' ' ' PRO . 54.3 Cg_endo -69.69 21.46 0.17 Allowed 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.699 2.266 . . . . 74.21 112.406 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . 0.519 ' H ' ' C ' ' A' ' 167' ' ' SER . . . -62.47 102.05 0.29 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.181 -0.463 . . . . 74.53 111.129 179.881 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 2.8 t -154.12 155.63 5.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.188 -0.46 . . . . 74.15 111.129 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 171' ' ' GLN . . . . . 0.578 ' HB2' ' O ' ' A' ' 141' ' ' GLU . 1.5 tm0? -116.75 -134.71 0.34 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.162 -0.472 . . . . 75.33 110.935 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 172' ' ' SER . . . . . 0.792 ' OG ' ' O ' ' A' ' 143' ' ' PRO . 12.1 p -64.46 171.87 2.94 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.246 -0.434 . . . . 73.03 110.896 -179.843 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 173' ' ' PHE . . . . . 0.466 ' CG ' ' HH2' ' A' ' 137' ' ' TRP . 2.3 p90 -147.43 175.57 10.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.111 -0.495 . . . . 72.13 110.881 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . 0.437 ' HG2' ' O ' ' A' ' 174' ' ' ARG . 1.7 ptm180 -140.32 136.62 33.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.166 -0.47 . . . . 73.44 110.897 -179.912 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . 0.425 ' HB2' ' HB3' ' A' ' 94' ' ' TYR . 0.0 OUTLIER -105.56 138.26 42.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.18 -0.464 . . . . 73.21 110.881 -179.913 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . 0.447 HD11 ' C ' ' A' ' 136' ' ' VAL . 1.9 mt -79.44 144.93 10.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.194 -0.457 . . . . 75.04 111.138 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 4.6 p -136.19 156.28 36.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.175 -0.466 . . . . 72.12 111.135 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.146 -0.479 . . . . 74.44 110.884 -179.944 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 38.9 mtm . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.764 0.316 . . . . 72.34 110.871 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -60.71 -66.32 0.55 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.234 -0.439 . . . . 73.11 110.867 -179.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 51.48 34.32 11.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.148 -0.478 . . . . 74.22 110.951 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 4.0 t -71.24 -32.26 68.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.172 -0.467 . . . . 63.15 111.182 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 160.32 125.45 0.78 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.781 -0.724 . . . . 73.13 112.531 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.481 ' HA ' ' O ' ' A' ' 44' ' ' GLY . 4.6 p -82.09 135.1 35.36 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.828 0.347 . . . . 73.43 111.151 -179.822 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 3.4 tttt -121.56 135.94 54.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.223 -0.444 . . . . 75.55 110.894 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.633 HG23 ' CZ ' ' A' ' 10' ' ' PHE . 15.9 tt -136.78 153.39 30.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.208 -0.451 . . . . 73.2 111.127 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.53 ' HA ' ' O ' ' A' ' 21' ' ' TYR . 17.9 m -134.01 143.89 48.38 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.193 -0.458 . . . . 75.43 111.14 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.633 ' CZ ' HG23 ' A' ' 8' ' ' ILE . 0.8 OUTLIER -131.28 127.9 38.71 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.203 -0.453 . . . . 72.03 110.894 -179.983 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.533 ' CG ' ' HA ' ' A' ' 16' ' ' PHE . 11.1 m-85 -113.19 132.51 55.46 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.161 -0.472 . . . . 71.12 110.868 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.11 -16.07 28.89 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.102 -0.499 . . . . 74.42 110.876 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.428 ' HB2' ' O ' ' A' ' 17' ' ' GLN . 72.2 m-20 -134.68 150.54 50.64 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.174 -0.467 . . . . 72.54 110.847 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.484 ' N ' ' HB3' ' A' ' 38' ' ' ASN . 38.7 mtmt -55.25 -176.12 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.181 -0.463 . . . . 75.42 110.873 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 18.8 m120 46.54 32.48 1.65 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.193 -0.458 . . . . 70.33 110.869 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.533 ' HA ' ' CG ' ' A' ' 11' ' ' TYR . 3.0 m-85 49.68 63.94 1.96 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.174 -0.466 . . . . 72.54 110.887 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.428 ' O ' ' HB2' ' A' ' 13' ' ' ASP . 3.8 mt-30 -138.76 158.59 43.94 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.132 -0.485 . . . . 74.44 110.892 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 92.86 -148.86 19.25 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.716 -0.754 . . . . 73.45 112.473 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.423 ' O ' ' CD1' ' A' ' 34' ' ' LEU . 0.3 OUTLIER -69.04 78.06 0.33 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.767 0.318 . . . . 73.54 110.911 -179.861 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.465 ' HB2' ' CE1' ' A' ' 11' ' ' TYR . 0.6 OUTLIER -77.14 130.11 36.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.456 . . . . 73.43 110.891 -179.905 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.53 ' O ' ' HA ' ' A' ' 9' ' ' THR . 90.7 t80 -124.02 124.87 43.51 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.169 -0.469 . . . . 74.44 110.93 -179.845 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.441 ' OD1' ' CD ' ' A' ' 20' ' ' ARG . 1.1 m-20 -121.9 134.45 54.86 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.109 -0.496 . . . . 64.35 110.833 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -167.86 135.81 2.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.167 -0.47 . . . . 75.42 110.882 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -101.27 0.04 36.62 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.212 -0.449 . . . . 73.12 110.863 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.436 ' O ' ' SG ' ' A' ' 27' ' ' CYS . 16.5 t -104.37 164.88 11.42 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.172 -0.467 . . . . 70.22 110.914 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 35.6 m-20 -58.24 120.84 9.4 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.209 -0.451 . . . . 73.53 110.879 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.52 ' HB2' ' HB3' ' A' ' 30' ' ' PHE . 1.8 m -115.95 51.94 0.93 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.208 -0.451 . . . . 61.34 110.886 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.494 ' C ' ' HA ' ' A' ' 82' ' ' SER . . . -47.33 -21.27 0.27 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.223 -0.444 . . . . 74.14 111.083 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 56.8 t0 -128.54 42.33 3.34 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.223 -0.444 . . . . 63.42 110.866 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.785 ' O ' ' CD2' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -80.99 15.33 1.87 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.217 -0.447 . . . . 75.43 110.858 -179.852 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.487 ' HB2' ' HB3' ' A' ' 81' ' ' SER . 28.5 t60 -80.01 -39.57 29.68 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.142 -0.481 . . . . 74.41 110.885 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.7 t -57.93 -13.94 5.39 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.202 -0.454 . . . . 75.15 111.119 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -99.96 -27.14 13.73 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.27 -0.423 . . . . 73.33 110.907 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.423 ' CD1' ' O ' ' A' ' 19' ' ' ARG . 18.0 tp -142.65 136.31 28.97 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.162 -0.472 . . . . 71.52 110.916 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 23.8 m -98.81 -42.42 7.19 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.174 -0.467 . . . . 72.04 110.861 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -118.54 141.37 48.64 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.135 -0.484 . . . . 63.12 110.861 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.543 ' HB3' ' HB2' ' A' ' 80' ' ' LEU . 3.1 p -109.95 83.97 1.85 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.188 -0.46 . . . . 73.32 110.858 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.484 ' HB3' ' N ' ' A' ' 14' ' ' LYS . 0.2 OUTLIER -75.33 -70.64 0.41 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.157 -0.474 . . . . 74.52 110.872 -179.911 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 5.0 p -111.77 124.38 52.21 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.192 -0.458 . . . . 74.4 110.836 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.626 ' O ' ' HB2' ' A' ' 67' ' ' TYR . 45.1 mt -117.67 148.36 20.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.123 -0.489 . . . . 72.51 111.149 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.512 ' N ' HG23 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -143.49 120.57 11.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.181 -0.463 . . . . 54.43 110.9 179.85 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.556 HG22 ' HB2' ' A' ' 47' ' ' TRP . 1.9 t -104.98 115.53 47.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.22 -0.446 . . . . 74.43 111.096 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -110.35 80.27 1.29 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.227 -0.442 . . . . 61.43 110.872 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.481 ' O ' ' HA ' ' A' ' 6' ' ' THR . . . 127.89 106.85 1.37 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.736 -0.745 . . . . 74.32 112.485 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 51.95 177.98 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.738 -0.744 . . . . 71.24 112.494 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.505 HG21 ' HA ' ' A' ' 63' ' ' PRO . 1.9 m -80.91 165.79 21.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.813 0.34 . . . . 70.41 111.112 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.613 ' CD1' ' HB ' ' A' ' 8' ' ' ILE . 3.3 m95 -138.91 130.05 26.75 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.449 . . . . 74.15 110.901 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.587 ' O ' ' N ' ' A' ' 84' ' ' ARG . . . -94.09 129.66 40.56 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.214 -0.448 . . . . 64.33 111.103 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.534 HG11 HD12 ' A' ' 80' ' ' LEU . 12.5 m -126.86 131.32 71.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.259 -0.428 . . . . 74.1 111.121 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.763 ' HB3' ' HA ' ' A' ' 56' ' ' ALA . 42.1 m-85 -97.28 147.73 23.84 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.182 -0.463 . . . . 74.52 110.928 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.62 ' OE1' ' HB3' ' A' ' 57' ' ' TRP . 47.3 tt0 -49.97 -78.12 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.094 -0.503 . . . . 73.33 110.867 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.539 ' HB2' ' HB2' ' A' ' 57' ' ' TRP . 1.2 mtp180 -93.5 143.99 27.52 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.609 0.719 . . . . 75.43 110.875 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.692 ' HA ' ' OG ' ' A' ' 82' ' ' SER . 54.2 Cg_endo -69.71 141.11 44.54 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.754 2.303 . . . . 65.21 112.366 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 63.42 -11.13 0.1 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.238 -0.437 . . . . 73.0 110.903 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.631 ' H ' ' C ' ' A' ' 53' ' ' PRO . 2.5 m-30 -104.7 -20.58 13.59 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.168 -0.469 . . . . 74.32 110.899 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.763 ' HA ' ' HB3' ' A' ' 50' ' ' TYR . . . 50.29 25.58 1.9 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.134 -0.485 . . . . 71.3 111.09 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . 0.632 ' O ' ' C ' ' A' ' 58' ' ' TYR . 0.1 OUTLIER -49.21 -164.92 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.234 -0.439 . . . . 70.34 110.952 -179.929 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.632 ' C ' ' O ' ' A' ' 57' ' ' TRP . 7.0 m-30 -13.27 101.69 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.274 -0.421 . . . . 73.54 110.948 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.574 ' HB2' ' HA ' ' A' ' 150' ' ' TYR . 1.9 mpt? -65.45 157.56 29.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.136 -0.483 . . . . 74.44 110.936 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.459 ' O ' ' CG2' ' A' ' 49' ' ' VAL . 3.2 t80 -175.01 101.37 0.08 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.255 -0.43 . . . . 75.25 110.927 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.42 ' H ' HD13 ' A' ' 61' ' ' ILE . 4.4 mp -88.24 116.21 29.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.163 -0.471 . . . . 75.23 111.121 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.401 ' O ' ' CG2' ' A' ' 46' ' ' THR . 0.3 OUTLIER -80.33 128.24 73.57 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.605 0.717 . . . . 75.21 110.958 179.898 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.505 ' HA ' HG21 ' A' ' 46' ' ' THR . 53.3 Cg_endo -69.78 -173.41 0.71 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.678 2.252 . . . . 70.22 112.357 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -88.44 161.6 16.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.265 -0.425 . . . . 75.24 110.924 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 112.64 -168.44 12.65 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.734 -0.746 . . . . 74.3 112.47 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -108.09 153.92 22.43 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.873 0.368 . . . . 74.14 110.915 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.626 ' HB2' ' O ' ' A' ' 40' ' ' ILE . 10.2 m-85 -143.48 83.83 10.51 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.625 0.726 . . . . 74.53 110.934 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.471 ' HD2' ' HG3' ' A' ' 72' ' ' ARG . 53.8 Cg_endo -69.77 0.78 5.16 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.679 2.253 . . . . 70.11 112.354 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.515 ' HB2' ' HG2' ' A' ' 72' ' ' ARG . 46.2 mt-10 -156.09 143.84 19.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.197 -0.456 . . . . 73.52 110.878 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.722 ' HA ' ' NE1' ' A' ' 73' ' ' TRP . 32.4 p90 -55.34 -21.98 17.37 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.157 -0.474 . . . . 74.15 110.944 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -79.14 -17.56 54.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.134 -0.484 . . . . 72.11 110.898 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.515 ' HG2' ' HB2' ' A' ' 69' ' ' GLU . 27.8 mmt180 -69.34 -8.11 43.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.185 -0.461 . . . . 74.0 110.889 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . 0.722 ' NE1' ' HA ' ' A' ' 70' ' ' TYR . 0.0 OUTLIER -136.94 18.99 3.01 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.169 -0.469 . . . . 75.14 110.876 -179.973 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' MET . . . . . 0.481 ' C ' ' O ' ' A' ' 73' ' ' TRP . 0.0 OUTLIER 32.11 47.71 0.09 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.255 -0.43 . . . . 74.11 110.835 179.921 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -59.92 120.38 22.48 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.71 -0.757 . . . . 75.34 112.531 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.595 HD12 ' N ' ' A' ' 76' ' ' LEU . 0.0 OUTLIER -63.56 -15.42 57.98 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.809 0.338 . . . . 73.42 110.937 -179.91 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.57 ' HB2' HD22 ' A' ' 76' ' ' LEU . 35.5 t-20 -156.38 134.62 11.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.185 -0.461 . . . . 72.53 110.896 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -83.27 23.06 0.93 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.17 -0.468 . . . . 74.34 110.839 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 4.1 ttm-85 -110.16 80.77 1.34 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.232 -0.44 . . . . 74.54 110.886 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.543 ' HB2' ' HB3' ' A' ' 37' ' ' CYS . 0.0 OUTLIER -87.91 133.99 33.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.224 -0.443 . . . . 74.01 110.871 -179.932 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.63 ' HB3' ' HB3' ' A' ' 53' ' ' PRO . 1.0 OUTLIER -150.32 -124.94 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.188 -0.46 . . . . 73.11 110.83 -179.96 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.692 ' OG ' ' HA ' ' A' ' 53' ' ' PRO . 0.1 OUTLIER -36.15 104.89 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.145 -0.48 . . . . 64.45 110.86 -179.784 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . 0.517 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 19.5 p -121.32 135.3 55.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.096 -0.502 . . . . 74.0 110.935 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.587 ' N ' ' O ' ' A' ' 48' ' ' ALA . 9.4 mmt85 -120.62 138.46 53.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.254 -0.43 . . . . 75.23 110.883 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.434 ' N ' ' CZ3' ' A' ' 47' ' ' TRP . . . -59.42 129.02 39.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.196 -0.457 . . . . 74.24 111.115 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.477 HG21 ' CB ' ' A' ' 48' ' ' ALA . 40.9 t -113.24 129.9 68.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.239 -0.437 . . . . 74.0 111.085 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . 0.469 ' O ' ' C ' ' A' ' 88' ' ' LEU . 82.9 m-70 -111.52 107.46 16.65 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.154 -0.476 . . . . 73.14 110.892 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.469 ' C ' ' O ' ' A' ' 87' ' ' HIS . 0.0 OUTLIER -32.66 141.86 0.18 Allowed Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.645 0.736 . . . . 64.21 110.904 -179.92 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.459 ' HB3' ' H ' ' A' ' 136' ' ' VAL . 53.4 Cg_endo -69.79 98.02 0.67 Allowed 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.693 2.262 . . . . 74.45 112.329 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -100.76 138.72 37.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.231 -0.441 . . . . 70.44 110.831 -179.808 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 105.1 115.81 4.13 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.707 -0.759 . . . . 74.23 112.51 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 52.31 48.33 54.2 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.684 -0.769 . . . . 53.13 112.514 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.438 ' HB2' ' H ' ' A' ' 94' ' ' TYR . 24.7 pt20 38.95 -153.31 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.778 0.323 . . . . 75.24 110.924 -179.847 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.609 ' HA ' ' CG ' ' A' ' 134' ' ' GLU . 33.0 t80 -106.23 104.08 13.7 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.229 -0.441 . . . . 73.12 110.903 -179.845 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.482 ' H ' ' CG ' ' A' ' 134' ' ' GLU . 33.5 tptt -96.92 132.23 42.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.153 -0.476 . . . . 73.1 110.906 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -149.42 135.91 12.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.197 -0.456 . . . . 72.14 111.166 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.42 ' HB2' ' O ' ' A' ' 131' ' ' LYS . 0.8 OUTLIER -107.31 132.5 53.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.195 -0.457 . . . . 75.43 110.898 179.983 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 2.8 mt -118.18 130.84 72.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.234 -0.439 . . . . 75.22 111.149 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.666 ' HB2' ' HB2' ' A' ' 129' ' ' SER . 5.7 m-85 -120.21 152.59 37.49 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.141 -0.481 . . . . 74.12 110.948 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 70.7 tt0 -81.06 -68.83 0.65 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.206 -0.452 . . . . 73.53 110.865 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.507 ' C ' ' HB2' ' A' ' 128' ' ' HIS . 33.1 mttt -89.19 166.3 13.9 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.186 -0.461 . . . . 74.52 110.888 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -80.25 160.99 44.72 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.746 -0.74 . . . . 74.45 112.504 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.426 ' HA ' ' HB2' ' A' ' 158' ' ' ARG . 41.1 t0 66.08 52.05 1.23 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.81 0.338 . . . . 74.22 110.878 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.638 ' CE1' ' HD2' ' A' ' 131' ' ' LYS . 6.9 m-85 48.19 33.23 3.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.2 -0.455 . . . . 73.43 110.862 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.46 ' C ' ' HB2' ' A' ' 101' ' ' LYS . 43.8 m -108.97 155.53 20.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.125 -0.489 . . . . 74.23 110.875 -179.8 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 89.52 -163.83 31.4 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.776 -0.726 . . . . 72.43 112.488 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -76.36 123.49 26.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.794 0.33 . . . . 73.21 110.931 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 3.5 ttp -107.71 131.42 54.44 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.187 -0.46 . . . . 71.03 110.897 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -133.79 137.02 44.88 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.208 -0.451 . . . . 73.45 110.95 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -117.04 107.47 14.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.143 -0.48 . . . . 71.42 110.841 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 10.1 t -123.04 155.98 35.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.133 -0.485 . . . . 75.24 111.104 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.439 ' HA ' ' O ' ' A' ' 94' ' ' TYR . 1.7 t -135.47 45.68 2.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.208 -0.451 . . . . 73.32 111.132 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -152.72 158.66 42.64 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.229 -0.441 . . . . 75.1 110.87 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -51.33 156.4 1.2 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.126 -0.488 . . . . 72.54 110.862 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . 0.526 ' O ' ' HB2' ' A' ' 172' ' ' SER . 39.7 t -146.42 113.28 4.4 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.632 0.729 . . . . 54.13 110.862 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.419 ' O ' ' C ' ' A' ' 143' ' ' PRO . 53.4 Cg_endo -69.74 -30.71 21.93 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.665 2.243 . . . . 75.13 112.333 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.636 ' HB3' ' CB ' ' A' ' 120' ' ' GLU . 0.1 OUTLIER -149.57 101.35 3.08 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.211 -0.449 . . . . 75.33 110.848 -179.815 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.537 ' HB ' ' O ' ' A' ' 171' ' ' GLN . 3.0 tt -54.66 -29.74 21.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.175 -0.466 . . . . 74.22 111.163 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' MET . . . . . 0.582 ' O ' ' HA ' ' A' ' 123' ' ' HIS . 0.6 OUTLIER -86.53 -45.08 11.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.145 -0.48 . . . . 73.23 110.899 179.817 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.636 ' CB ' ' HB3' ' A' ' 117' ' ' SER . 6.6 tp10 -65.78 -12.87 57.55 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.245 -0.434 . . . . 72.02 110.887 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 27.8 tp60 -114.51 -51.17 2.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.176 -0.466 . . . . 75.54 110.872 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . 0.461 ' HB2' ' O ' ' A' ' 118' ' ' ILE . 44.0 m-85 -102.89 -19.65 14.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.197 -0.456 . . . . 73.2 110.872 -179.884 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . 0.582 ' HA ' ' O ' ' A' ' 119' ' ' MET . 29.6 m-70 71.72 28.63 2.69 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.16 -0.473 . . . . 73.22 110.896 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 10.7 mtt -103.95 85.94 2.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.234 -0.439 . . . . 74.43 110.91 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 4.0 ptp180 -51.44 -38.11 52.01 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.205 -0.452 . . . . 74.44 110.859 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.46 ' HG2' ' HA ' ' A' ' 169' ' ' ALA . 13.2 mt-10 -142.23 133.03 25.61 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.17 -0.468 . . . . 74.23 110.858 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.426 ' O ' ' HB3' ' A' ' 168' ' ' PRO . 3.8 mm -92.08 97.07 6.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.155 -0.475 . . . . 72.34 111.13 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . 0.507 ' HB2' ' C ' ' A' ' 101' ' ' LYS . 13.9 m170 -67.75 -34.04 76.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.133 -0.485 . . . . 73.12 110.891 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.666 ' HB2' ' HB2' ' A' ' 99' ' ' PHE . 58.2 m -129.43 136.61 50.15 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.184 -0.462 . . . . 75.24 110.868 -179.822 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . 0.526 ' O ' ' O ' ' A' ' 155' ' ' LYS . 3.4 m -131.74 119.93 22.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.128 -0.487 . . . . 64.3 110.894 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.679 ' HA ' ' HA ' ' A' ' 156' ' ' GLU . 2.0 mtpp -115.45 150.71 36.02 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.179 -0.464 . . . . 72.33 110.911 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.51 ' HB ' ' O ' ' A' ' 131' ' ' LYS . 16.4 t 83.59 163.42 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.198 -0.456 . . . . 73.2 111.137 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.451 ' CD1' ' O ' ' A' ' 154' ' ' LYS . 0.0 OUTLIER -174.86 123.67 0.25 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.163 -0.471 . . . . 75.32 110.899 179.994 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.609 ' CG ' ' HA ' ' A' ' 94' ' ' TYR . 0.0 OUTLIER -91.86 172.85 8.19 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.231 -0.441 . . . . 75.41 110.894 179.923 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -41.96 -47.25 5.2 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.696 -0.764 . . . . 73.34 112.466 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.587 ' HA ' HD13 ' A' ' 152' ' ' LEU . 5.2 t -148.87 142.54 18.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.819 0.342 . . . . 75.12 111.093 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . 0.7 ' HB3' ' CB ' ' A' ' 152' ' ' LEU . 25.0 t90 -149.43 148.17 29.13 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.142 -0.481 . . . . 73.25 110.925 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 20.3 mt -125.75 132.5 70.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.224 -0.444 . . . . 75.34 111.175 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.502 ' CB ' ' HB2' ' A' ' 150' ' ' TYR . 0.1 OUTLIER -100.84 152.98 19.87 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.169 -0.468 . . . . 73.13 110.866 179.981 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . 0.491 ' CD2' ' HA ' ' A' ' 145' ' ' TYR . 0.8 OUTLIER -129.14 127.16 40.85 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.146 -0.479 . . . . 75.1 110.922 -179.832 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . 0.622 ' O ' ' HB2' ' A' ' 171' ' ' GLN . 0.6 OUTLIER -61.63 -25.86 67.63 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.14 -0.482 . . . . 64.35 110.884 179.998 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.741 ' HB3' ' HD2' ' A' ' 143' ' ' PRO . 9.3 mp -114.64 173.07 3.09 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.659 0.742 . . . . 71.34 110.891 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . 0.741 ' HD2' ' HB3' ' A' ' 142' ' ' LEU . 53.8 Cg_endo -69.77 -90.34 0.0 OUTLIER 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.665 2.243 . . . . 73.32 112.349 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . 0.697 ' O ' ' N ' ' A' ' 146' ' ' ARG . 0.7 OUTLIER -51.88 97.73 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.247 -0.433 . . . . 73.3 110.903 179.993 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . 0.636 ' C ' ' O ' ' A' ' 144' ' ' ASN . 0.1 OUTLIER 12.46 53.19 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.215 -0.448 . . . . 74.12 110.883 -179.941 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . 0.697 ' N ' ' O ' ' A' ' 144' ' ' ASN . 20.7 mtt180 -120.4 173.54 7.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.175 -0.466 . . . . 72.4 110.851 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 79.83 179.51 52.42 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.712 -0.756 . . . . 74.34 112.49 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -74.02 146.58 43.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.799 0.333 . . . . 75.42 110.894 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . 0.426 ' HA ' ' O ' ' A' ' 139' ' ' PHE . 16.8 mt-30 -85.92 153.86 21.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.455 . . . . 74.3 110.895 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . 0.574 ' HA ' ' HB2' ' A' ' 59' ' ' MET . 76.8 m-85 -135.12 122.3 21.51 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.191 -0.458 . . . . 73.03 110.964 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 33.5 tp -66.55 135.94 54.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.067 -0.515 . . . . 71.33 110.935 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.7 ' CB ' ' HB3' ' A' ' 137' ' ' TRP . 0.0 OUTLIER -70.08 133.97 47.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.223 -0.444 . . . . 75.43 110.878 179.906 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -163.21 25.42 0.09 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.167 -0.469 . . . . 75.22 110.853 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.716 ' HA ' ' CE1' ' A' ' 157' ' ' TYR . 0.1 OUTLIER -113.03 -169.42 1.48 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.15 -0.477 . . . . 74.41 110.888 179.993 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.685 ' HG3' ' O ' ' A' ' 154' ' ' LYS . 0.6 OUTLIER -167.25 -122.06 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.245 -0.434 . . . . 74.22 110.925 179.866 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.679 ' HA ' ' HA ' ' A' ' 131' ' ' LYS . 0.7 OUTLIER -73.03 -1.26 16.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.241 -0.436 . . . . 75.15 110.832 179.976 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . 0.716 ' CE1' ' HA ' ' A' ' 154' ' ' LYS . 20.1 m-30 -27.26 141.03 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.195 -0.457 . . . . 73.41 110.892 -179.799 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . 0.65 ' O ' ' OG ' ' A' ' 129' ' ' SER . 9.9 ptp180 -107.62 -41.14 5.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.129 -0.487 . . . . 75.24 110.868 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -87.43 150.34 48.73 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.562 0.696 . . . . 73.25 110.902 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . 0.473 ' HB3' ' HB3' ' A' ' 168' ' ' PRO . 53.7 Cg_endo -69.8 -24.17 29.8 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.64 2.227 . . . . 75.22 112.371 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.548 HD11 ' H ' ' A' ' 161' ' ' ILE . 3.6 mp -69.25 -10.82 14.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.23 -0.441 . . . . 74.22 111.107 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . 0.653 ' HB3' ' CD1' ' A' ' 157' ' ' TYR . 0.5 OUTLIER -75.79 -14.11 60.3 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.19 -0.459 . . . . 65.54 110.869 179.879 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 24.8 t90 -88.69 -12.7 41.6 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.189 -0.459 . . . . 72.31 110.933 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 106.66 -37.03 4.03 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.751 -0.738 . . . . 71.13 112.487 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . 0.4 ' O ' ' C ' ' A' ' 166' ' ' ALA . . . -77.1 126.77 31.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.796 0.331 . . . . 63.23 111.062 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . 0.4 ' C ' ' O ' ' A' ' 165' ' ' ALA . . . -37.56 -41.36 0.46 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 74.43 111.101 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' SER . . . . . 0.529 ' C ' ' H ' ' A' ' 169' ' ' ALA . 0.3 OUTLIER -130.28 155.64 80.6 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.66 0.743 . . . . 75.55 110.82 -179.778 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . 0.473 ' HB3' ' HB3' ' A' ' 160' ' ' PRO . 53.6 Cg_endo -69.78 27.29 0.18 Allowed 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.674 2.249 . . . . 72.14 112.312 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . 0.529 ' H ' ' C ' ' A' ' 167' ' ' SER . . . -65.63 104.6 1.06 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.213 -0.449 . . . . 70.34 111.147 179.839 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 2.8 t -151.75 161.97 3.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.21 -0.45 . . . . 72.25 111.127 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' GLN . . . . . 0.651 ' OE1' ' HB3' ' A' ' 143' ' ' PRO . 1.8 tm0? -109.4 -82.08 0.57 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.213 -0.449 . . . . 75.52 110.91 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' SER . . . . . 0.735 ' OG ' ' O ' ' A' ' 143' ' ' PRO . 21.6 p -130.87 176.22 8.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.208 -0.451 . . . . 52.4 110.831 -179.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . 0.447 ' HB3' ' CE1' ' A' ' 139' ' ' PHE . 32.2 p90 -144.31 173.78 11.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.114 -0.494 . . . . 74.44 110.885 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . 0.432 ' HG2' ' CE2' ' A' ' 140' ' ' TYR . 0.0 OUTLIER -147.4 141.36 25.9 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.152 -0.476 . . . . 75.14 110.88 -179.883 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . 0.407 ' HB3' ' CD1' ' A' ' 94' ' ' TYR . 0.0 OUTLIER -86.32 -177.23 6.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.18 -0.464 . . . . 74.13 110.909 -179.945 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . 0.468 HD11 ' C ' ' A' ' 136' ' ' VAL . 2.9 mt -132.51 139.09 50.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.215 -0.448 . . . . 61.55 111.11 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 2.1 p -149.32 155.4 8.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.185 -0.461 . . . . 64.4 111.173 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.2 -0.455 . . . . 74.34 110.859 -179.96 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.817 0.342 . . . . 73.42 110.902 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 57.1 p -167.37 148.44 5.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.254 -0.43 . . . . 53.12 110.896 -179.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 29.7 mmtp -99.43 36.49 1.75 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.15 -0.477 . . . . 75.32 110.87 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 5.0 t -147.34 122.86 10.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.25 -0.432 . . . . 75.02 111.137 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 61.24 92.7 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.733 -0.746 . . . . 63.02 112.492 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.426 ' HB ' ' O ' ' A' ' 44' ' ' GLY . 12.2 p -82.23 133.11 35.24 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.839 0.352 . . . . 71.11 111.134 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 3.1 tttt -122.37 138.33 54.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.241 -0.436 . . . . 71.34 110.888 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.611 HD13 ' CE1' ' A' ' 10' ' ' PHE . 12.5 tt -136.64 149.75 26.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.233 -0.44 . . . . 70.31 111.142 179.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.471 HG21 ' CE2' ' A' ' 11' ' ' TYR . 24.8 m -133.62 129.13 36.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.181 -0.463 . . . . 71.55 111.139 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.611 ' CE1' HD13 ' A' ' 8' ' ' ILE . 0.4 OUTLIER -117.3 131.89 56.72 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.208 -0.451 . . . . 75.3 110.845 -179.977 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.526 ' CG ' ' HA ' ' A' ' 16' ' ' PHE . 44.1 m-85 -114.95 132.35 56.6 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.138 -0.483 . . . . 75.51 110.94 -179.834 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.468 ' HG2' ' HB2' ' A' ' 36' ' ' ARG . 0.0 OUTLIER -61.98 -24.63 67.14 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.162 -0.472 . . . . 73.33 110.876 -179.949 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 65.7 m-20 -126.12 150.42 48.25 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.16 -0.473 . . . . 73.24 110.836 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.522 ' N ' ' HB3' ' A' ' 38' ' ' ASN . 4.6 mtmm -55.04 -179.83 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.189 -0.46 . . . . 75.52 110.866 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 52.0 m-80 49.38 38.46 14.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.233 -0.44 . . . . 64.41 110.889 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.526 ' HA ' ' CG ' ' A' ' 11' ' ' TYR . 3.4 m-85 45.14 60.17 3.13 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.17 -0.468 . . . . 74.4 110.859 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -136.46 160.06 39.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.142 -0.481 . . . . 74.33 110.906 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 92.84 -150.99 20.26 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.751 -0.738 . . . . 50.2 112.518 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.487 ' O ' HD13 ' A' ' 34' ' ' LEU . 0.0 OUTLIER -67.49 79.62 0.17 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.812 0.339 . . . . 71.23 110.905 -179.888 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.42 ' HB2' ' CE1' ' A' ' 11' ' ' TYR . 0.7 OUTLIER -78.95 125.9 29.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 73.21 110.857 -179.897 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.483 ' CD2' ' CD2' ' A' ' 30' ' ' PHE . 82.4 t80 -121.18 124.35 44.5 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.182 -0.463 . . . . 75.14 110.905 -179.841 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.47 ' CG ' HG23 ' A' ' 9' ' ' THR . 1.0 OUTLIER -119.22 134.62 55.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.131 -0.486 . . . . 70.54 110.885 179.877 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -166.75 135.71 2.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.231 -0.44 . . . . 72.51 110.851 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -105.07 5.72 32.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.187 -0.461 . . . . 73.33 110.882 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 12.1 t -108.73 168.38 9.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.168 -0.469 . . . . 63.22 110.886 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 78.8 m-20 -64.64 116.72 6.5 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.232 -0.44 . . . . 74.34 110.887 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.441 ' HB2' ' SG ' ' A' ' 83' ' ' CYS . 7.4 m -119.42 54.4 0.99 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.203 -0.453 . . . . 74.51 110.872 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.532 ' C ' ' HA ' ' A' ' 82' ' ' SER . . . -45.88 -20.28 0.08 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.183 -0.462 . . . . 73.54 111.095 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.406 ' N ' ' C ' ' A' ' 27' ' ' CYS . 59.7 t0 -128.32 43.56 3.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.224 -0.444 . . . . 75.41 110.879 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.776 ' O ' ' CD2' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -80.97 14.72 2.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.174 -0.466 . . . . 74.02 110.884 -179.873 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.49 ' HB2' ' HB3' ' A' ' 81' ' ' SER . 27.6 t60 -77.72 -38.66 46.7 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.159 -0.473 . . . . 74.23 110.845 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.6 t -58.22 -12.57 3.73 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.208 -0.451 . . . . 73.23 111.121 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -101.48 -28.37 12.6 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.18 -0.464 . . . . 75.45 110.941 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.487 HD13 ' O ' ' A' ' 19' ' ' ARG . 16.0 tp -141.15 141.7 34.12 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.149 -0.478 . . . . 72.01 110.927 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -111.57 -31.11 7.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.187 -0.46 . . . . 70.21 110.908 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.468 ' HB2' ' HG2' ' A' ' 12' ' ' GLU . 1.6 mtp85 -116.78 142.41 46.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.092 -0.504 . . . . 74.22 110.845 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.635 ' SG ' ' HB2' ' A' ' 80' ' ' LEU . 1.8 p -118.99 51.44 1.12 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.188 -0.46 . . . . 72.43 110.864 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.522 ' HB3' ' N ' ' A' ' 14' ' ' LYS . 1.9 m-80 -52.35 -62.68 1.48 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.165 -0.471 . . . . 64.2 110.896 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 9.3 p -121.8 127.78 50.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.201 -0.454 . . . . 75.01 110.809 -179.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.472 ' O ' ' N ' ' A' ' 67' ' ' TYR . 4.5 mt -127.15 148.59 31.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.124 -0.489 . . . . 73.12 111.135 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.47 ' N ' HG23 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -140.46 122.0 15.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.17 -0.468 . . . . 74.13 110.863 179.84 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.463 ' HA ' ' HA ' ' A' ' 8' ' ' ILE . 0.9 OUTLIER -103.92 117.43 49.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.189 -0.459 . . . . 74.21 111.145 179.876 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -112.44 81.14 1.43 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.223 -0.444 . . . . 73.24 110.89 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.426 ' O ' ' HB ' ' A' ' 6' ' ' THR . . . 130.63 100.02 0.86 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.736 -0.745 . . . . 72.01 112.534 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 55.21 175.85 0.14 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.712 -0.756 . . . . 64.42 112.491 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.504 HG21 ' HA ' ' A' ' 63' ' ' PRO . 5.9 m -80.29 165.99 21.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.812 0.339 . . . . 65.54 111.137 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.587 ' CD1' ' HB ' ' A' ' 8' ' ' ILE . 14.6 m95 -136.76 129.94 31.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.208 -0.451 . . . . 71.42 110.909 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.483 ' O ' ' N ' ' A' ' 84' ' ' ARG . . . -97.46 114.06 25.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.456 . . . . 72.02 111.111 179.843 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.515 ' O ' ' O ' ' A' ' 60' ' ' TYR . 5.1 m -116.8 134.04 61.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.243 -0.435 . . . . 72.11 111.151 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.718 ' HB3' ' HA ' ' A' ' 56' ' ' ALA . 35.1 m-85 -97.07 151.86 19.33 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.185 -0.461 . . . . 72.32 110.954 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.573 ' HB2' ' O ' ' A' ' 58' ' ' TYR . 8.8 tt0 -47.76 -78.84 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.143 -0.48 . . . . 62.21 110.892 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.606 ' HB3' ' CD1' ' A' ' 55' ' ' PHE . 4.7 mtp180 -90.25 143.95 30.33 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.656 0.741 . . . . 75.21 110.826 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.707 ' HA ' ' OG ' ' A' ' 82' ' ' SER . 53.9 Cg_endo -69.75 134.56 28.29 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.66 2.24 . . . . 75.33 112.372 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 66.2 -8.55 0.34 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.233 -0.439 . . . . 74.21 110.847 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.606 ' CD1' ' HB3' ' A' ' 52' ' ' ARG . 4.6 m-30 -101.75 -26.81 13.35 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.216 -0.447 . . . . 63.13 110.919 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.718 ' HA ' ' HB3' ' A' ' 50' ' ' TYR . . . 58.71 22.87 10.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.145 -0.479 . . . . 75.24 111.109 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . 0.645 ' O ' ' C ' ' A' ' 58' ' ' TYR . 2.4 m95 -52.17 -165.89 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.251 -0.432 . . . . 71.03 110.925 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.645 ' C ' ' O ' ' A' ' 57' ' ' TRP . 6.5 m-30 -12.46 103.62 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.231 -0.441 . . . . 74.31 110.936 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.51 ' HB2' ' O ' ' A' ' 149' ' ' GLN . 2.5 mpt? -62.29 147.48 47.99 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.128 -0.487 . . . . 73.33 110.903 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.592 ' OH ' ' HA3' ' A' ' 75' ' ' GLY . 0.3 OUTLIER -164.29 92.27 0.64 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.236 -0.438 . . . . 74.21 110.865 -179.88 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.506 ' N ' ' CD1' ' A' ' 61' ' ' ILE . 1.6 mp -85.06 120.2 35.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.154 -0.475 . . . . 74.22 111.117 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -87.55 126.15 62.96 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-O 121.658 0.742 . . . . 73.22 110.878 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.504 ' HA ' HG21 ' A' ' 46' ' ' THR . 53.5 Cg_endo -69.83 -168.03 0.26 Allowed 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.684 2.256 . . . . 70.43 112.307 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.05 161.12 14.57 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.24 -0.437 . . . . 73.05 110.931 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 111.66 -157.52 14.9 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.775 -0.726 . . . . 64.41 112.507 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 5.3 mp0 -115.0 158.75 21.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.85 0.357 . . . . 73.52 110.904 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.472 ' N ' ' O ' ' A' ' 40' ' ' ILE . 7.2 m-85 -149.52 79.73 7.93 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 121.676 0.75 . . . . 75.23 110.976 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.567 ' HD2' ' HG3' ' A' ' 72' ' ' ARG . 53.6 Cg_endo -69.81 1.11 4.77 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.7 2.266 . . . . 65.44 112.29 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 86.3 mt-10 -159.15 154.36 25.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.25 -0.432 . . . . 75.31 110.903 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.836 ' O ' ' CD1' ' A' ' 73' ' ' TRP . 25.6 p90 -65.39 -12.19 49.75 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.135 -0.484 . . . . 75.52 110.949 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -86.75 -13.65 44.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.127 -0.488 . . . . 75.33 110.878 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.567 ' HG3' ' HD2' ' A' ' 68' ' ' PRO . 24.1 mmt180 -73.58 -27.09 61.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.221 -0.445 . . . . 74.33 110.919 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . 0.836 ' CD1' ' O ' ' A' ' 70' ' ' TYR . 0.6 OUTLIER -105.97 11.22 31.9 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.157 -0.474 . . . . 75.24 110.957 179.979 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' MET . . . . . 0.506 ' C ' ' O ' ' A' ' 73' ' ' TRP . 0.4 OUTLIER 29.19 56.76 0.13 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.212 -0.449 . . . . 74.22 110.849 179.909 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.592 ' HA3' ' OH ' ' A' ' 60' ' ' TYR . . . -96.92 -140.27 11.19 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.733 -0.746 . . . . 63.13 112.51 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.535 HD12 ' CE2' ' A' ' 60' ' ' TYR . 0.0 OUTLIER -141.95 -84.1 0.19 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.831 0.348 . . . . 75.24 110.905 -179.946 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 -77.47 145.85 36.81 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.465 . . . . 73.52 110.915 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 -101.44 33.29 2.98 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.198 -0.456 . . . . 62.03 110.858 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -104.78 72.13 1.01 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.208 -0.451 . . . . 75.53 110.874 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.635 ' HB2' ' SG ' ' A' ' 37' ' ' CYS . 0.1 OUTLIER -77.83 130.25 36.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.162 -0.472 . . . . 74.54 110.906 -179.955 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.601 ' HB3' ' HB3' ' A' ' 53' ' ' PRO . 0.9 OUTLIER -146.92 -127.93 0.06 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.218 -0.446 . . . . 63.13 110.874 -179.929 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.707 ' OG ' ' HA ' ' A' ' 53' ' ' PRO . 0.7 OUTLIER -27.58 123.49 0.1 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.117 -0.492 . . . . 75.44 110.872 -179.845 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . 0.448 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 5.4 p -131.14 143.06 50.35 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.146 -0.479 . . . . 74.25 110.87 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.483 ' N ' ' O ' ' A' ' 48' ' ' ALA . 5.7 mmt85 -140.59 131.37 25.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.189 -0.459 . . . . 71.22 110.9 -179.843 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.414 ' HB1' ' OG1' ' A' ' 6' ' ' THR . . . -56.27 123.88 16.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.22 -0.446 . . . . 74.32 111.043 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.47 ' CG2' ' HB3' ' A' ' 48' ' ' ALA . 1.9 t -115.93 143.31 26.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.21 -0.45 . . . . 74.31 111.113 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . 0.572 ' O ' ' CG2' ' A' ' 136' ' ' VAL . 34.9 m80 -111.23 106.45 15.44 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.184 -0.462 . . . . 73.41 110.878 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.48 ' C ' ' O ' ' A' ' 87' ' ' HIS . 0.0 OUTLIER -31.64 150.17 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.659 0.742 . . . . 74.54 110.909 -179.975 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.567 ' HB3' ' H ' ' A' ' 136' ' ' VAL . 53.5 Cg_endo -69.77 83.39 0.7 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.674 2.249 . . . . 63.44 112.326 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -88.76 -173.35 4.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.188 -0.46 . . . . 73.33 110.832 -179.834 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 51.26 58.49 9.69 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.761 -0.733 . . . . 73.12 112.439 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 117.68 26.22 2.89 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.724 -0.751 . . . . 73.03 112.454 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 27.5 pt20 39.56 -148.57 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.826 0.346 . . . . 73.41 110.916 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.492 ' CD1' ' HG2' ' A' ' 134' ' ' GLU . 8.2 t80 -98.79 101.02 12.29 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.26 -0.427 . . . . 75.55 110.906 -179.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.433 ' O ' HG12 ' A' ' 132' ' ' VAL . 38.2 tptt -107.91 130.34 55.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.126 -0.488 . . . . 73.33 110.896 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 4.2 tt -147.36 137.72 17.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.238 -0.437 . . . . 75.41 111.131 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.48 ' O ' ' HA ' ' A' ' 130' ' ' CYS . 0.5 OUTLIER -109.92 113.35 26.01 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.211 -0.449 . . . . 74.01 110.942 179.905 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 2.7 mp -93.66 136.17 26.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.163 -0.471 . . . . 75.0 111.15 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.618 ' HB2' ' HB2' ' A' ' 129' ' ' SER . 53.2 m-85 -124.73 140.1 53.24 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.194 -0.457 . . . . 73.41 110.855 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 64.6 tt0 -69.68 -75.17 0.12 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.148 -0.478 . . . . 73.12 110.889 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 16.5 mttt -84.51 170.41 13.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.138 -0.483 . . . . 75.12 110.893 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.423 ' CA ' ' HB3' ' A' ' 128' ' ' HIS . . . -73.73 159.62 53.1 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.724 -0.75 . . . . 72.01 112.478 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.47 ' HA ' ' HB2' ' A' ' 158' ' ' ARG . 60.9 t0 64.17 37.18 9.04 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.819 0.342 . . . . 73.44 110.844 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.554 ' CZ ' ' HB3' ' A' ' 158' ' ' ARG . 5.0 m-85 51.66 45.19 28.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.192 -0.458 . . . . 73.24 110.89 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 5.1 m -112.45 148.87 33.48 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.112 -0.495 . . . . 71.2 110.865 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 95.34 -132.5 11.13 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.776 -0.726 . . . . 63.03 112.519 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 43.3 tp60 -91.68 126.11 36.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.813 0.339 . . . . 75.01 110.948 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' MET . . . . . 0.462 ' HB2' ' CE1' ' A' ' 99' ' ' PHE . 4.8 ttt -113.55 131.56 56.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.168 -0.469 . . . . 71.44 110.849 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -136.26 136.38 39.79 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.215 -0.448 . . . . 73.45 110.93 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -118.37 109.2 16.0 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.115 -0.493 . . . . 74.44 110.896 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 14.1 t -123.46 145.68 48.63 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.132 -0.486 . . . . 73.04 111.18 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.474 ' O ' ' OG1' ' A' ' 112' ' ' THR . 0.8 OUTLIER -118.2 38.31 3.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.249 -0.432 . . . . 63.43 111.133 -179.944 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -150.94 170.43 19.35 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.228 -0.442 . . . . 72.02 110.898 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 -65.79 176.11 1.7 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.201 -0.454 . . . . 72.33 110.868 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 46.6 t -156.01 122.62 2.64 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.599 0.714 . . . . 72.11 110.891 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.475 ' C ' ' OG ' ' A' ' 172' ' ' SER . 54.0 Cg_endo -69.79 -31.24 20.76 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.646 2.23 . . . . 65.41 112.338 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.651 ' HB3' ' CB ' ' A' ' 120' ' ' GLU . 0.1 OUTLIER -152.99 92.97 1.69 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.222 -0.445 . . . . 45.33 110.872 -179.86 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.681 ' HB ' ' O ' ' A' ' 171' ' ' GLN . 5.0 tt -49.01 -28.78 2.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.157 -0.474 . . . . 74.02 111.155 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' MET . . . . . 0.583 ' O ' ' HA ' ' A' ' 123' ' ' HIS . 15.7 ttp -86.36 -45.19 11.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.186 -0.461 . . . . 75.43 110.848 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.651 ' CB ' ' HB3' ' A' ' 117' ' ' SER . 10.1 tp10 -66.75 -13.37 61.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.232 -0.44 . . . . 63.12 110.875 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -114.52 -51.9 2.73 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.185 -0.461 . . . . 74.14 110.897 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . 0.482 ' HB2' ' O ' ' A' ' 118' ' ' ILE . 14.6 m-85 -101.89 -18.67 15.6 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.24 -0.437 . . . . 74.35 110.935 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . 0.583 ' HA ' ' O ' ' A' ' 119' ' ' MET . 16.6 m80 68.42 32.72 4.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.078 -0.51 . . . . 74.14 110.892 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.418 ' O ' HG22 ' A' ' 118' ' ' ILE . 9.3 mtt -111.04 84.62 1.96 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.183 -0.462 . . . . 71.12 110.819 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 3.9 ptp180 -52.93 -34.87 57.41 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.23 -0.441 . . . . 74.12 110.884 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.464 ' HG2' ' HA ' ' A' ' 169' ' ' ALA . 35.0 mt-10 -142.34 128.77 20.1 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.192 -0.458 . . . . 75.24 110.864 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.451 ' O ' ' HB3' ' A' ' 168' ' ' PRO . 4.1 mm -87.89 101.16 11.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.146 -0.479 . . . . 74.21 111.159 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . 0.423 ' HB3' ' CA ' ' A' ' 102' ' ' GLY . 22.3 m80 -69.65 -35.24 75.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.165 -0.471 . . . . 72.45 110.861 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.618 ' HB2' ' HB2' ' A' ' 99' ' ' PHE . 6.2 m -135.4 152.2 51.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.255 -0.43 . . . . 72.11 110.87 -179.803 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . 0.48 ' HA ' ' O ' ' A' ' 97' ' ' GLN . 0.0 OUTLIER -156.22 118.24 3.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.144 -0.48 . . . . 70.05 110.901 -179.934 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.519 ' O ' ' HB ' ' A' ' 132' ' ' VAL . 3.7 mtpp -105.66 161.2 14.59 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.182 -0.463 . . . . 74.5 110.875 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.522 ' O ' ' CE ' ' A' ' 154' ' ' LYS . 16.0 t 86.03 165.97 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.469 . . . . 74.52 111.154 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.53 ' O ' ' HG ' ' A' ' 133' ' ' LEU . 1.0 OUTLIER -166.2 131.19 2.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.182 -0.463 . . . . 74.11 110.895 179.941 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.492 ' HG2' ' CD1' ' A' ' 94' ' ' TYR . 0.8 OUTLIER -105.29 147.72 27.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.192 -0.458 . . . . 72.23 110.9 179.921 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . 0.483 ' C ' ' O ' ' A' ' 134' ' ' GLU . . . -31.37 -45.63 0.14 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.746 -0.74 . . . . 51.34 112.508 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.615 ' HA ' HD13 ' A' ' 152' ' ' LEU . 0.7 OUTLIER -149.94 135.6 11.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.823 0.344 . . . . 75.31 111.116 -179.98 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . 0.64 ' HB3' ' CB ' ' A' ' 152' ' ' LEU . 24.0 t90 -150.14 149.59 30.46 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.131 -0.486 . . . . 75.43 110.92 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.414 ' HA ' ' O ' ' A' ' 150' ' ' TYR . 16.6 mt -124.17 132.04 71.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.275 -0.421 . . . . 72.13 111.118 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.515 ' CB ' ' HB2' ' A' ' 150' ' ' TYR . 0.1 OUTLIER -99.09 139.13 35.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.167 -0.47 . . . . 74.33 110.884 179.966 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . 0.484 ' CD2' ' HA ' ' A' ' 145' ' ' TYR . 0.1 OUTLIER -110.59 126.86 54.89 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.159 -0.473 . . . . 74.23 110.914 -179.843 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . 0.557 ' O ' ' HB2' ' A' ' 171' ' ' GLN . 26.6 tt0 -66.08 -27.83 68.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.101 -0.5 . . . . 71.24 110.886 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.612 ' HB3' ' HD2' ' A' ' 143' ' ' PRO . 9.9 mp -109.73 169.71 6.13 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.632 0.729 . . . . 73.45 110.929 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . 0.708 ' O ' ' HB2' ' A' ' 172' ' ' SER . 53.5 Cg_endo -69.73 -89.15 0.0 OUTLIER 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.713 2.276 . . . . 73.05 112.338 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . 0.73 ' O ' ' N ' ' A' ' 146' ' ' ARG . 1.1 m-20 -48.43 96.43 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.218 -0.446 . . . . 75.13 110.924 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . 0.636 ' C ' ' O ' ' A' ' 144' ' ' ASN . 20.1 m-85 12.54 51.6 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.191 -0.459 . . . . 73.22 110.905 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . 0.73 ' N ' ' O ' ' A' ' 144' ' ' ASN . 11.4 mtp85 -127.01 178.62 5.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.132 -0.485 . . . . 73.3 110.876 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 86.78 167.16 43.39 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.73 -0.747 . . . . 63.13 112.469 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.468 ' HA ' ' CD2' ' A' ' 76' ' ' LEU . 2.8 mpt_? -65.48 142.18 58.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.796 0.331 . . . . 74.22 110.86 -179.857 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . 0.51 ' O ' ' HB2' ' A' ' 59' ' ' MET . 51.4 mt-30 -81.29 155.57 25.98 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.173 -0.467 . . . . 74.14 110.907 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . 0.515 ' HB2' ' CB ' ' A' ' 139' ' ' PHE . 95.9 m-85 -138.29 123.01 18.71 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.231 -0.44 . . . . 74.42 110.924 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.419 ' HB2' HD12 ' A' ' 61' ' ' ILE . 21.3 tp -64.66 132.7 50.42 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.101 -0.499 . . . . 72.13 110.97 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.64 ' CB ' ' HB3' ' A' ' 137' ' ' TRP . 0.0 OUTLIER -68.45 133.29 48.41 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.218 -0.446 . . . . 74.54 110.906 179.912 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -163.28 25.95 0.09 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.147 -0.479 . . . . 74.45 110.907 179.843 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.734 ' HA ' ' CE1' ' A' ' 157' ' ' TYR . 0.0 OUTLIER -108.89 -173.86 2.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.148 -0.478 . . . . 73.12 110.872 -179.99 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.659 ' HG3' ' O ' ' A' ' 154' ' ' LYS . 4.0 mptt -164.93 -124.43 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.218 -0.446 . . . . 74.42 110.911 179.827 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.491 ' HA ' ' HA ' ' A' ' 131' ' ' LYS . 4.4 tm-20 -71.5 1.37 6.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.223 -0.444 . . . . 71.52 110.851 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . 0.734 ' CE1' ' HA ' ' A' ' 154' ' ' LYS . 21.3 m-30 -31.23 143.81 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.191 -0.459 . . . . 72.43 110.938 -179.836 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . 0.554 ' HB3' ' CZ ' ' A' ' 104' ' ' PHE . 0.0 OUTLIER -115.35 -40.68 3.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.128 -0.487 . . . . 72.51 110.897 -179.989 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . 0.464 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 0.2 OUTLIER -81.01 150.89 69.59 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.553 0.692 . . . . 73.34 110.918 179.966 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . 0.542 ' HA ' ' NE1' ' A' ' 163' ' ' TRP . 53.5 Cg_endo -69.78 -27.47 26.35 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.655 2.237 . . . . 74.31 112.346 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.557 HD11 ' H ' ' A' ' 161' ' ' ILE . 3.8 mp -67.21 -3.5 2.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.236 -0.438 . . . . 73.54 111.114 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . 0.659 ' HB3' ' CD1' ' A' ' 157' ' ' TYR . 0.3 OUTLIER -76.61 -23.21 53.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.215 -0.448 . . . . 71.33 110.876 179.818 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' TRP . . . . . 0.542 ' NE1' ' HA ' ' A' ' 160' ' ' PRO . 1.7 m95 -79.96 -1.37 39.19 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.198 -0.455 . . . . 74.24 110.931 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 92.46 -35.22 4.12 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.728 -0.749 . . . . 74.25 112.475 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . 0.415 ' O ' ' C ' ' A' ' 166' ' ' ALA . . . -77.37 129.2 35.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.826 0.346 . . . . 71.31 111.091 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . 0.415 ' C ' ' O ' ' A' ' 165' ' ' ALA . . . -37.08 -40.08 0.28 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.224 -0.443 . . . . 73.34 111.117 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' SER . . . . . 0.519 ' C ' ' H ' ' A' ' 169' ' ' ALA . 0.3 OUTLIER -129.29 157.32 76.53 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.61 0.719 . . . . 74.15 110.867 -179.767 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . 0.497 ' HD3' ' HB2' ' A' ' 160' ' ' PRO . 53.4 Cg_endo -69.73 29.07 0.18 Allowed 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.667 2.245 . . . . 71.52 112.324 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . 0.519 ' H ' ' C ' ' A' ' 167' ' ' SER . . . -66.01 106.58 1.63 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.244 -0.435 . . . . 63.31 111.094 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 3.3 t -152.08 165.92 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.224 -0.444 . . . . 72.43 111.083 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' GLN . . . . . 0.681 ' O ' ' HB ' ' A' ' 118' ' ' ILE . 2.6 mm-40 -123.72 -87.11 0.63 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.142 -0.481 . . . . 74.42 110.884 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' SER . . . . . 0.708 ' HB2' ' O ' ' A' ' 143' ' ' PRO . 3.1 m -111.11 175.65 5.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.174 -0.466 . . . . 64.35 110.897 -179.804 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . 0.434 ' HB3' ' CD2' ' A' ' 139' ' ' PHE . 1.8 p90 -147.94 158.58 44.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.168 -0.469 . . . . 71.42 110.899 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . 0.422 ' HG2' ' CD2' ' A' ' 140' ' ' TYR . 0.0 OUTLIER -133.93 139.75 46.34 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.12 -0.491 . . . . 73.34 110.837 -179.857 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -95.38 -170.08 2.1 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.177 -0.465 . . . . 75.21 110.851 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . 0.46 HD11 ' C ' ' A' ' 136' ' ' VAL . 3.3 mt -139.21 135.79 41.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.145 -0.479 . . . . 72.44 111.16 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 25.9 t -148.8 150.11 14.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.192 -0.458 . . . . 70.33 111.1 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.259 0 CA-C-N 116.134 -0.484 . . . . 74.12 110.936 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.79 0.329 . . . . 74.42 110.903 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -169.96 175.83 4.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.231 -0.441 . . . . 63.22 110.879 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 3.0 mtpm? -73.84 -36.75 64.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.151 -0.477 . . . . 74.11 110.879 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 8.8 t -51.83 -36.2 47.28 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.265 -0.425 . . . . 75.0 111.131 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -118.44 101.51 0.9 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.75 -0.738 . . . . 71.32 112.462 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.484 ' C ' ' HE1' ' A' ' 47' ' ' TRP . 11.2 p -82.58 133.1 35.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.882 0.372 . . . . 73.43 111.122 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 3.5 tttt -121.15 137.65 54.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.242 -0.435 . . . . 65.25 110.895 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.596 ' HB ' ' CD1' ' A' ' 47' ' ' TRP . 11.6 tt -137.33 149.41 25.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.209 -0.451 . . . . 73.53 111.166 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.484 HG23 ' CG ' ' A' ' 22' ' ' ASP . 24.5 m -131.74 129.02 40.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.178 -0.464 . . . . 64.13 111.133 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.568 ' CE1' HD13 ' A' ' 8' ' ' ILE . 0.6 OUTLIER -116.15 132.35 56.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.16 -0.473 . . . . 73.32 110.875 -179.957 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.543 ' CG ' ' HA ' ' A' ' 16' ' ' PHE . 49.1 m-85 -116.01 131.92 56.8 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.16 -0.473 . . . . 73.23 110.966 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.472 ' HG2' ' HB2' ' A' ' 36' ' ' ARG . 0.0 OUTLIER -60.7 -25.73 66.61 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 74.34 110.92 179.987 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 -125.96 151.23 47.28 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.114 -0.494 . . . . 75.1 110.855 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.431 ' HG3' ' HB3' ' A' ' 38' ' ' ASN . 19.7 mtmt -54.94 -178.21 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 62.25 110.936 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 24.7 m-20 47.68 38.72 8.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.256 -0.429 . . . . 70.23 110.894 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.543 ' HA ' ' CG ' ' A' ' 11' ' ' TYR . 3.0 m-85 44.71 60.48 2.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.15 -0.477 . . . . 72.13 110.885 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -135.97 158.78 43.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.088 -0.505 . . . . 74.32 110.882 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 93.47 -151.51 20.39 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.76 -0.733 . . . . 73.45 112.491 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.487 ' O ' HD13 ' A' ' 34' ' ' LEU . 0.3 OUTLIER -67.27 80.85 0.14 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.794 0.331 . . . . 75.31 110.937 -179.869 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.418 ' HA ' ' O ' ' A' ' 10' ' ' PHE . 0.7 OUTLIER -79.38 126.31 30.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.209 -0.45 . . . . 73.34 110.911 -179.89 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.478 ' CD2' ' CD2' ' A' ' 30' ' ' PHE . 85.9 t80 -121.46 124.03 43.47 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.221 -0.445 . . . . 74.41 110.909 -179.827 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.484 ' CG ' HG23 ' A' ' 9' ' ' THR . 1.0 OUTLIER -119.14 134.84 54.97 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.134 -0.485 . . . . 73.44 110.835 179.934 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -166.94 135.81 2.78 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.156 -0.474 . . . . 73.23 110.899 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -104.53 5.75 34.19 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 72.25 110.844 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 13.9 t -110.71 164.49 12.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.193 -0.458 . . . . 73.54 110.868 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -60.82 117.54 5.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.186 -0.461 . . . . 65.25 110.86 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.463 ' HB2' ' SG ' ' A' ' 83' ' ' CYS . 18.7 m -117.48 55.51 0.85 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.245 -0.434 . . . . 54.51 110.864 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.52 ' O ' ' HA ' ' A' ' 82' ' ' SER . . . -46.64 -19.14 0.08 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.208 -0.451 . . . . 62.24 111.158 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.402 ' N ' ' C ' ' A' ' 27' ' ' CYS . 52.4 t0 -128.71 42.14 3.37 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.212 -0.449 . . . . 65.14 110.872 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.805 ' O ' ' CD2' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -80.45 15.75 1.54 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.459 . . . . 74.15 110.864 -179.893 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.51 ' HB2' ' HB3' ' A' ' 81' ' ' SER . 33.2 t60 -80.65 -38.15 29.67 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.163 -0.471 . . . . 75.45 110.785 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.7 t -60.16 -12.52 8.77 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.245 -0.434 . . . . 73.33 111.137 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -101.34 -27.6 13.08 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.246 -0.434 . . . . 72.45 110.925 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.487 HD13 ' O ' ' A' ' 19' ' ' ARG . 19.1 tp -141.94 140.53 32.8 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.133 -0.485 . . . . 71.51 110.888 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.1 m -109.07 -31.95 7.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.221 -0.445 . . . . 61.33 110.883 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.541 ' NH2' HD22 ' A' ' 38' ' ' ASN . 1.8 mtp85 -116.82 142.0 47.49 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.128 -0.487 . . . . 74.5 110.872 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.577 ' HB3' ' HB2' ' A' ' 80' ' ' LEU . 0.9 OUTLIER -118.37 52.09 1.05 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.22 -0.445 . . . . 61.45 110.869 -179.957 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.541 HD22 ' NH2' ' A' ' 36' ' ' ARG . 3.0 m120 -53.01 -70.78 0.08 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.203 -0.453 . . . . 73.41 110.866 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 8.7 p -112.86 128.42 56.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.203 -0.453 . . . . 74.24 110.887 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.473 ' O ' ' N ' ' A' ' 67' ' ' TYR . 5.4 mt -127.41 150.1 32.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.097 -0.501 . . . . 71.31 111.131 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.472 ' N ' HG23 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -141.47 122.75 14.83 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.17 -0.468 . . . . 75.21 110.892 179.848 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.523 HG22 ' HB2' ' A' ' 47' ' ' TRP . 1.4 t -104.43 116.59 48.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.23 -0.441 . . . . 70.35 111.176 179.84 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -111.55 80.97 1.37 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.161 -0.472 . . . . 74.25 110.866 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.425 ' O ' ' HA ' ' A' ' 6' ' ' THR . . . 128.75 103.69 1.13 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.745 -0.74 . . . . 72.22 112.527 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 53.97 178.09 0.12 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.75 -0.738 . . . . 72.4 112.464 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.534 HG21 ' HA ' ' A' ' 63' ' ' PRO . 3.1 m -81.36 165.66 21.14 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.729 0.299 . . . . 74.31 111.177 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.596 ' CD1' ' HB ' ' A' ' 8' ' ' ILE . 6.2 m95 -139.86 130.09 25.22 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.216 -0.447 . . . . 73.51 110.925 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.599 ' O ' ' N ' ' A' ' 84' ' ' ARG . . . -95.12 129.01 42.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.203 -0.453 . . . . 74.55 111.152 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.646 ' O ' ' O ' ' A' ' 60' ' ' TYR . 14.1 m -127.47 127.27 68.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.233 -0.439 . . . . 74.51 111.115 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.747 ' HB3' ' HA ' ' A' ' 56' ' ' ALA . 45.8 m-85 -93.36 147.51 22.87 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.137 -0.483 . . . . 74.43 110.927 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.657 ' OE1' ' HB3' ' A' ' 57' ' ' TRP . 54.7 tt0 -48.5 -78.48 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.113 -0.494 . . . . 75.21 110.862 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.54 ' HB3' ' CD1' ' A' ' 55' ' ' PHE . 0.0 OUTLIER -92.98 143.81 27.41 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.652 0.739 . . . . 74.44 110.878 -179.907 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.715 ' HA ' ' OG ' ' A' ' 82' ' ' SER . 53.8 Cg_endo -69.75 141.59 45.67 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.688 2.259 . . . . 74.33 112.34 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 62.53 -10.98 0.08 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.19 -0.459 . . . . 74.31 110.876 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.625 ' H ' ' C ' ' A' ' 53' ' ' PRO . 2.6 m-30 -104.34 -20.19 13.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.455 . . . . 74.43 110.869 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.747 ' HA ' ' HB3' ' A' ' 50' ' ' TYR . . . 48.55 26.44 1.19 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.168 -0.469 . . . . 72.55 111.117 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . 0.657 ' HB3' ' OE1' ' A' ' 51' ' ' GLU . 0.0 OUTLIER -50.7 -159.98 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.233 -0.44 . . . . 72.33 110.919 -179.978 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.627 ' C ' ' O ' ' A' ' 57' ' ' TRP . 6.0 m-30 -15.5 103.84 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.213 -0.448 . . . . 75.22 110.914 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.451 ' HB2' ' O ' ' A' ' 149' ' ' GLN . 0.8 OUTLIER -62.44 145.14 54.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.124 -0.489 . . . . 73.14 110.892 179.891 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.646 ' O ' ' O ' ' A' ' 49' ' ' VAL . 0.4 OUTLIER -160.76 100.12 1.27 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.218 -0.447 . . . . 74.13 110.945 -179.89 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.571 ' N ' ' CD1' ' A' ' 61' ' ' ILE . 1.3 mp -94.22 117.17 37.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.101 -0.5 . . . . 73.33 111.157 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -84.21 125.84 71.25 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.618 0.723 . . . . 74.52 110.92 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.534 ' HA ' HG21 ' A' ' 46' ' ' THR . 53.7 Cg_endo -69.68 -165.58 0.16 Allowed 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.68 2.253 . . . . 75.21 112.381 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.22 159.86 14.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.238 -0.437 . . . . 63.14 110.885 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 113.62 -149.95 18.58 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.791 -0.719 . . . . 60.42 112.495 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -122.94 160.36 26.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.859 0.362 . . . . 75.23 110.93 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.473 ' N ' ' O ' ' A' ' 40' ' ' ILE . 5.9 m-85 -150.05 79.1 7.78 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.668 0.747 . . . . 75.52 110.924 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.52 ' HD2' ' HG3' ' A' ' 72' ' ' ARG . 53.4 Cg_endo -69.81 0.48 5.62 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.721 2.281 . . . . 74.44 112.305 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 76.3 mt-10 -157.31 156.17 31.92 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.247 -0.433 . . . . 75.32 110.906 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.832 ' O ' ' CD1' ' A' ' 73' ' ' TRP . 11.7 p90 -68.35 -6.87 26.69 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.248 -0.433 . . . . 75.23 110.895 -179.851 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -87.12 -13.48 44.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.141 -0.481 . . . . 74.25 110.891 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.52 ' HG3' ' HD2' ' A' ' 68' ' ' PRO . 21.2 mmt180 -73.5 -24.64 60.2 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.224 -0.444 . . . . 73.05 110.891 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . 0.832 ' CD1' ' O ' ' A' ' 70' ' ' TYR . 0.5 OUTLIER -111.8 25.13 11.93 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.179 -0.464 . . . . 75.3 110.934 -179.975 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' MET . . . . . 0.567 ' HB2' ' O ' ' A' ' 73' ' ' TRP . 2.0 mmt 87.38 -38.47 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.248 -0.433 . . . . 75.14 110.927 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 88.93 45.83 4.7 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.724 -0.751 . . . . 64.11 112.495 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.539 ' HB2' ' CE2' ' A' ' 60' ' ' TYR . 0.4 OUTLIER -67.08 -74.95 0.1 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.837 0.351 . . . . 74.02 110.94 -179.957 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -129.28 136.13 49.66 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.188 -0.46 . . . . 74.22 110.859 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.424 ' C ' ' SG ' ' A' ' 37' ' ' CYS . 24.4 m-20 -90.35 18.54 6.0 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.187 -0.46 . . . . 72.31 110.858 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -112.33 86.45 2.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.199 -0.455 . . . . 73.32 110.874 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.577 ' HB2' ' HB3' ' A' ' 37' ' ' CYS . 0.0 OUTLIER -89.86 133.24 34.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.216 -0.447 . . . . 73.03 110.947 -179.992 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.634 ' HB3' ' HB3' ' A' ' 53' ' ' PRO . 0.8 OUTLIER -151.23 -127.93 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.203 -0.453 . . . . 70.23 110.875 -179.923 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.715 ' OG ' ' HA ' ' A' ' 53' ' ' PRO . 0.1 OUTLIER -33.98 102.16 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 73.23 110.847 -179.845 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . 0.533 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 30.2 p -118.82 133.35 55.9 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.125 -0.488 . . . . 75.3 110.882 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.599 ' N ' ' O ' ' A' ' 48' ' ' ALA . 13.7 mmt85 -119.94 144.25 47.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.228 -0.442 . . . . 73.42 110.862 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.419 ' N ' ' CZ3' ' A' ' 47' ' ' TRP . . . -63.61 127.66 32.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.178 -0.465 . . . . 65.45 111.095 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.468 HG23 ' HB3' ' A' ' 48' ' ' ALA . 46.7 t -115.78 137.86 48.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 74.12 111.113 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . 0.42 ' O ' ' C ' ' A' ' 88' ' ' LEU . 34.0 m80 -111.58 112.82 24.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.205 -0.452 . . . . 74.22 110.825 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.442 ' H ' HD22 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -35.82 143.23 0.27 Allowed Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.594 0.712 . . . . 74.52 110.872 -179.967 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.554 ' HB3' ' H ' ' A' ' 136' ' ' VAL . 53.9 Cg_endo -69.81 78.62 1.01 Allowed 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.695 2.263 . . . . 72.42 112.334 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -78.03 -177.01 4.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.223 -0.444 . . . . 73.33 110.852 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 74.8 -97.46 1.0 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.736 -0.745 . . . . 60.23 112.466 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.411 ' O ' ' C ' ' A' ' 93' ' ' GLN . . . -90.29 44.61 2.94 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.779 -0.724 . . . . 72.24 112.496 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.446 ' O ' ' HG2' ' A' ' 134' ' ' GLU . 5.9 pt20 37.19 -122.17 0.19 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.876 0.37 . . . . 72.12 110.917 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.526 ' O ' ' HA ' ' A' ' 112' ' ' THR . 0.1 OUTLIER -121.41 103.59 9.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.196 -0.456 . . . . 75.2 110.934 -179.9 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.456 ' HG3' HG11 ' A' ' 132' ' ' VAL . 41.4 tptt -114.83 126.15 54.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.114 -0.494 . . . . 73.32 110.862 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 8.2 tt -147.57 137.94 17.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.23 -0.441 . . . . 74.12 111.127 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.437 ' HB2' ' O ' ' A' ' 131' ' ' LYS . 0.6 OUTLIER -108.7 131.67 54.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.182 -0.463 . . . . 74.55 110.877 179.937 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.418 HG21 HG13 ' A' ' 127' ' ' ILE . 1.1 mp -115.64 134.5 58.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.455 . . . . 72.22 111.136 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.597 ' HB2' ' CB ' ' A' ' 129' ' ' SER . 7.1 m-85 -122.66 155.15 36.99 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.197 -0.456 . . . . 71.42 110.855 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.523 ' HA ' ' CE ' ' A' ' 124' ' ' MET . 56.6 tt0 -84.75 -44.0 13.74 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.183 -0.462 . . . . 72.1 110.854 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.47 ' HB2' ' C ' ' A' ' 105' ' ' SER . 55.9 mttt -117.61 155.0 30.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.182 -0.463 . . . . 62.04 110.894 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -73.82 169.48 53.57 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.757 -0.735 . . . . 73.53 112.436 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.429 ' HA ' ' HB2' ' A' ' 158' ' ' ARG . 36.9 t70 63.25 40.3 8.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.798 0.333 . . . . 65.44 110.814 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.626 ' CE1' ' HD2' ' A' ' 131' ' ' LYS . 11.6 m-85 54.89 49.27 18.16 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.25 -0.432 . . . . 63.0 110.867 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.47 ' C ' ' HB2' ' A' ' 101' ' ' LYS . 69.5 m -127.93 161.85 28.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.169 -0.469 . . . . 74.04 110.841 -179.825 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 83.04 -172.48 51.5 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.715 -0.755 . . . . 71.22 112.472 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 36.8 tp60 -67.62 120.59 14.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.78 0.324 . . . . 74.22 110.921 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 5.6 ttp -106.65 132.01 53.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.191 -0.459 . . . . 75.22 110.89 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -137.12 137.45 39.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.274 -0.421 . . . . 75.43 110.909 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -114.66 112.76 23.38 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.092 -0.504 . . . . 74.22 110.903 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 13.9 t -121.28 132.18 54.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.168 -0.469 . . . . 74.34 111.168 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.526 ' HA ' ' O ' ' A' ' 94' ' ' TYR . 1.8 t -112.29 37.1 3.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.246 -0.434 . . . . 72.15 111.129 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -151.03 165.43 33.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.229 -0.441 . . . . 70.53 110.857 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -53.11 161.22 0.88 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.142 -0.481 . . . . 74.35 110.83 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . 0.61 ' O ' ' HB2' ' A' ' 172' ' ' SER . 20.4 t -146.9 110.92 4.11 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.651 0.738 . . . . 75.1 110.882 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.512 ' O ' ' C ' ' A' ' 143' ' ' PRO . 53.6 Cg_endo -69.82 -38.6 7.45 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.647 2.231 . . . . 74.4 112.309 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.6 ' HB3' ' CB ' ' A' ' 120' ' ' GLU . 0.1 OUTLIER -147.28 105.41 3.75 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.238 -0.437 . . . . 75.23 110.839 -179.839 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.61 ' HB ' ' O ' ' A' ' 171' ' ' GLN . 3.4 tt -58.07 -27.94 32.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.125 -0.489 . . . . 72.11 111.118 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' MET . . . . . 0.683 ' O ' ' HA ' ' A' ' 123' ' ' HIS . 8.6 ttp -86.77 -40.57 14.86 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.17 -0.468 . . . . 73.33 110.875 179.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.6 ' CB ' ' HB3' ' A' ' 117' ' ' SER . 14.7 tp10 -70.52 -13.52 62.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.264 -0.426 . . . . 72.31 110.879 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 7.6 tp-100 -116.25 -50.71 2.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.152 -0.477 . . . . 73.15 110.944 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . 0.487 ' HB2' ' O ' ' A' ' 118' ' ' ILE . 46.8 m-85 -101.26 -13.85 17.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.222 -0.445 . . . . 74.53 110.917 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . 0.683 ' HA ' ' O ' ' A' ' 119' ' ' MET . 27.9 m-70 69.16 24.86 5.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.125 -0.488 . . . . 64.24 110.828 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.523 ' CE ' ' HA ' ' A' ' 100' ' ' GLU . 0.9 OUTLIER -96.47 145.24 25.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.248 -0.433 . . . . 71.33 110.891 179.975 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 5.1 ptp180 -110.62 -40.91 4.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.249 -0.432 . . . . 74.31 110.862 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.435 ' HB3' ' HG2' ' A' ' 168' ' ' PRO . 17.6 mt-10 -141.05 116.13 9.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.205 -0.452 . . . . 73.42 110.864 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.473 ' CD1' ' N ' ' A' ' 127' ' ' ILE . 1.0 OUTLIER -74.8 99.78 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.149 -0.478 . . . . 73.24 111.126 179.954 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . 0.401 ' CD2' ' HG3' ' A' ' 168' ' ' PRO . 24.8 m170 -73.33 -28.13 61.9 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.113 -0.494 . . . . 75.21 110.884 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.597 ' CB ' ' HB2' ' A' ' 99' ' ' PHE . 0.5 OUTLIER -132.31 136.93 47.24 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.225 -0.443 . . . . 74.24 110.872 -179.741 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . 0.58 ' HB3' ' HD2' ' A' ' 154' ' ' LYS . 0.1 OUTLIER -135.09 118.15 16.43 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.218 -0.446 . . . . 74.24 110.881 -179.977 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.631 ' HA ' ' HA ' ' A' ' 156' ' ' GLU . 6.0 mtpp -118.59 152.53 35.85 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.153 -0.476 . . . . 71.34 110.859 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.499 ' HB ' ' O ' ' A' ' 131' ' ' LYS . 16.6 t 82.74 163.4 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.217 -0.447 . . . . 53.24 111.108 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.455 ' O ' ' HG ' ' A' ' 133' ' ' LEU . 0.0 OUTLIER -179.73 123.57 0.07 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.17 -0.468 . . . . 73.23 110.911 179.942 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.516 ' O ' ' C ' ' A' ' 135' ' ' GLY . 0.1 OUTLIER -94.27 167.1 11.75 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.153 -0.476 . . . . 65.12 110.915 179.908 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . 0.516 ' C ' ' O ' ' A' ' 134' ' ' GLU . . . -27.93 -57.82 0.12 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.745 -0.74 . . . . 64.41 112.463 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.73 ' HA ' HD13 ' A' ' 152' ' ' LEU . 2.8 t -145.66 144.44 21.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.809 0.338 . . . . 74.11 111.167 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . 0.557 ' HB3' ' CB ' ' A' ' 152' ' ' LEU . 7.4 t-105 -143.52 152.98 42.13 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.22 -0.445 . . . . 75.45 110.974 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.481 ' CD1' ' HB ' ' A' ' 61' ' ' ILE . 2.8 mm -119.21 132.02 70.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.271 -0.422 . . . . 72.34 111.156 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.572 ' CB ' ' HB2' ' A' ' 150' ' ' TYR . 0.2 OUTLIER -111.41 146.37 37.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.187 -0.46 . . . . 72.52 110.858 179.951 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . 0.411 ' CD2' ' HA ' ' A' ' 145' ' ' TYR . 3.4 m-85 -127.79 130.01 47.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.069 -0.514 . . . . 74.54 110.889 -179.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . 0.605 ' O ' ' HB2' ' A' ' 171' ' ' GLN . 0.2 OUTLIER -60.34 -25.78 66.08 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.081 -0.509 . . . . 75.22 110.877 -179.984 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.778 ' HB3' ' HD2' ' A' ' 143' ' ' PRO . 9.7 mp -114.66 173.88 2.66 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.657 0.742 . . . . 73.34 110.88 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . 0.778 ' HD2' ' HB3' ' A' ' 142' ' ' LEU . 53.7 Cg_endo -69.77 -91.62 0.01 OUTLIER 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.726 2.284 . . . . 75.45 112.281 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . 0.71 ' O ' ' N ' ' A' ' 146' ' ' ARG . 0.9 OUTLIER -50.98 97.89 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.154 -0.476 . . . . 63.31 110.858 -179.926 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . 0.641 ' C ' ' O ' ' A' ' 144' ' ' ASN . 0.1 OUTLIER 12.1 53.09 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.143 -0.48 . . . . 72.13 110.923 -179.924 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . 0.71 ' N ' ' O ' ' A' ' 144' ' ' ASN . 11.3 mtp85 -118.76 174.71 6.12 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.095 -0.502 . . . . 75.04 110.844 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 80.84 -173.0 54.62 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.733 -0.746 . . . . 71.12 112.495 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -80.58 150.46 29.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.749 0.309 . . . . 63.4 110.893 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . 0.451 ' O ' ' HB2' ' A' ' 59' ' ' MET . 8.4 mt-30 -81.73 153.62 26.45 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.185 -0.461 . . . . 74.34 110.889 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . 0.572 ' HB2' ' CB ' ' A' ' 139' ' ' PHE . 98.3 m-85 -139.28 129.44 25.26 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.218 -0.446 . . . . 60.52 110.945 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.532 ' CA ' HD12 ' A' ' 61' ' ' ILE . 13.3 tp -81.78 121.72 26.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.092 -0.504 . . . . 70.04 110.911 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.73 HD13 ' HA ' ' A' ' 136' ' ' VAL . 0.0 OUTLIER -53.77 135.86 40.82 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.191 -0.459 . . . . 73.32 110.948 179.886 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -164.07 27.75 0.08 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.206 -0.452 . . . . 74.15 110.828 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.781 ' O ' ' HG3' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -116.71 -172.74 2.25 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.214 -0.448 . . . . 75.53 110.889 179.969 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.781 ' HG3' ' O ' ' A' ' 154' ' ' LYS . 0.0 OUTLIER -162.39 -128.92 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.221 -0.445 . . . . 73.3 110.908 179.875 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.631 ' HA ' ' HA ' ' A' ' 131' ' ' LYS . 0.2 OUTLIER -68.0 1.13 2.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.213 -0.449 . . . . 74.44 110.936 179.956 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . 0.743 ' CD1' ' HB2' ' A' ' 154' ' ' LYS . 20.3 m-30 -28.78 143.47 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.094 -0.503 . . . . 75.25 110.933 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . 0.57 ' O ' ' OG ' ' A' ' 129' ' ' SER . 9.5 ptp180 -110.91 -43.4 3.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.158 -0.474 . . . . 74.11 110.921 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -82.45 151.24 65.16 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.519 0.676 . . . . 72.33 110.93 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . 0.511 ' HB3' ' HB3' ' A' ' 168' ' ' PRO . 54.0 Cg_endo -69.74 -26.67 27.45 Favored 'Trans proline' 0 C--O 1.231 0.136 0 C-N-CA 122.7 2.266 . . . . 75.15 112.347 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.546 HD11 ' H ' ' A' ' 161' ' ' ILE . 3.6 mp -65.44 -11.78 12.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.224 -0.444 . . . . 74.04 111.074 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . 0.676 ' HB3' ' CD1' ' A' ' 157' ' ' TYR . 0.3 OUTLIER -75.0 -18.88 60.29 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.151 -0.477 . . . . 74.54 110.837 179.936 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 13.3 t90 -82.06 0.23 41.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.197 -0.456 . . . . 73.45 110.938 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 91.91 -36.2 3.74 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.75 -0.738 . . . . 72.14 112.507 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -79.68 128.39 33.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.777 0.322 . . . . 74.54 111.099 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -39.41 -38.28 0.54 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.194 -0.457 . . . . 50.02 111.101 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' SER . . . . . 0.523 ' C ' ' H ' ' A' ' 169' ' ' ALA . 0.5 OUTLIER -128.18 154.26 78.77 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.642 0.734 . . . . 64.31 110.892 -179.822 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . 0.511 ' HB3' ' HB3' ' A' ' 160' ' ' PRO . 54.4 Cg_endo -69.74 25.13 0.17 Allowed 'Trans proline' 0 C--O 1.231 0.147 0 C-N-CA 122.742 2.294 . . . . 73.54 112.352 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . 0.523 ' H ' ' C ' ' A' ' 167' ' ' SER . . . -65.89 103.65 0.96 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.223 -0.444 . . . . 72.13 111.11 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 2.6 t -152.14 163.43 2.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.225 -0.443 . . . . 63.22 111.145 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' GLN . . . . . 0.661 ' OE1' ' HB3' ' A' ' 143' ' ' PRO . 1.8 mm-40 -114.26 -89.57 0.54 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.19 -0.459 . . . . 74.42 110.914 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' SER . . . . . 0.751 ' OG ' ' O ' ' A' ' 143' ' ' PRO . 12.6 p -126.9 177.05 6.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.194 -0.457 . . . . 61.1 110.852 -179.829 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -145.8 174.38 11.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.105 -0.498 . . . . 74.34 110.883 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.18 154.61 46.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.179 -0.464 . . . . 74.3 110.88 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.15 -169.91 2.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.16 -0.473 . . . . 75.31 110.864 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . 0.446 HD11 ' HB ' ' A' ' 136' ' ' VAL . 4.5 mt -134.51 136.85 52.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.21 -0.45 . . . . 74.35 111.173 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 10.7 t -140.31 153.43 22.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.218 -0.446 . . . . 74.43 111.142 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 116.133 -0.485 . . . . 74.43 110.855 -179.921 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.81 0.338 . . . . 71.31 110.857 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.8 m -156.84 176.55 12.6 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.215 -0.448 . . . . 72.13 110.816 -179.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -73.01 -37.21 67.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.14 -0.482 . . . . 75.05 110.925 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER 51.98 -172.42 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.216 -0.447 . . . . 73.1 111.116 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -79.61 146.6 28.77 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.765 -0.731 . . . . 73.21 112.489 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.483 ' C ' ' HE1' ' A' ' 47' ' ' TRP . 6.9 p -82.8 135.81 34.85 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.908 0.385 . . . . 75.43 111.117 -179.86 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 3.6 tttt -122.54 135.24 54.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 73.02 110.937 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.576 ' HB ' ' CD1' ' A' ' 47' ' ' TRP . 15.2 tt -136.75 150.61 27.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.21 -0.45 . . . . 64.2 111.125 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.479 ' HA ' ' O ' ' A' ' 21' ' ' TYR . 13.6 m -127.4 146.29 50.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.187 -0.461 . . . . 74.42 111.164 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.465 ' CD2' ' N ' ' A' ' 10' ' ' PHE . 0.2 OUTLIER -134.07 127.17 31.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.206 -0.452 . . . . 73.21 110.888 179.999 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.539 ' CG ' ' HA ' ' A' ' 16' ' ' PHE . 26.2 m-85 -113.41 131.82 55.86 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.149 -0.478 . . . . 71.11 110.923 -179.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.414 ' HB2' ' HB2' ' A' ' 19' ' ' ARG . 0.0 OUTLIER -60.26 -15.43 24.79 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.121 -0.49 . . . . 73.22 110.9 179.987 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.445 ' HB2' ' O ' ' A' ' 17' ' ' GLN . 71.2 m-20 -134.89 150.57 50.45 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.156 -0.475 . . . . 70.02 110.873 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.488 ' N ' ' HB3' ' A' ' 38' ' ' ASN . 39.4 mtmt -55.7 -177.78 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.182 -0.463 . . . . 74.35 110.857 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 22.7 m-20 48.14 33.26 3.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.17 -0.468 . . . . 75.3 110.888 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.539 ' HA ' ' CG ' ' A' ' 11' ' ' TYR . 3.3 m-85 49.22 64.3 1.79 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.164 -0.471 . . . . 73.34 110.853 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.445 ' O ' ' HB2' ' A' ' 13' ' ' ASP . 15.6 mt-30 -140.07 158.07 44.63 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.146 -0.479 . . . . 75.42 110.934 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 93.28 -150.63 20.0 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.775 -0.726 . . . . 74.43 112.476 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.436 ' O ' ' CD1' ' A' ' 34' ' ' LEU . 0.2 OUTLIER -66.72 78.51 0.11 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.754 0.311 . . . . 75.54 110.851 -179.829 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.455 ' HB2' ' CE1' ' A' ' 11' ' ' TYR . 0.7 OUTLIER -77.04 128.88 35.27 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.232 -0.44 . . . . 74.54 110.876 -179.921 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.479 ' O ' ' HA ' ' A' ' 9' ' ' THR . 88.1 t80 -123.06 125.72 45.73 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.21 -0.45 . . . . 75.2 110.943 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.428 ' CG ' HG23 ' A' ' 9' ' ' THR . 1.3 m-20 -123.33 132.63 54.05 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.156 -0.474 . . . . 72.31 110.857 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -166.0 138.33 3.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 65.34 110.927 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -104.72 4.48 32.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.195 -0.457 . . . . 73.12 110.846 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 14.9 t -108.55 164.2 12.56 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.21 -0.45 . . . . 64.35 110.882 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -60.25 117.49 5.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.173 -0.467 . . . . 73.31 110.832 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.45 ' HB3' ' CB ' ' A' ' 30' ' ' PHE . 16.6 m -117.07 54.05 0.88 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.173 -0.467 . . . . 74.13 110.894 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.523 ' O ' ' HA ' ' A' ' 82' ' ' SER . . . -47.67 -18.84 0.17 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 71.53 111.06 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 58.3 t0 -127.26 40.07 3.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.236 -0.438 . . . . 75.43 110.845 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.779 ' O ' ' CD2' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -80.77 14.12 2.3 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.224 -0.444 . . . . 72.45 110.896 -179.927 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.47 ' HB2' ' HB3' ' A' ' 53' ' ' PRO . 36.2 t60 -78.47 -37.75 42.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.121 -0.49 . . . . 71.32 110.893 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.5 t -58.19 -15.18 8.89 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.199 -0.455 . . . . 75.24 111.149 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -98.53 -27.97 13.8 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.243 -0.435 . . . . 73.44 110.899 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.436 ' CD1' ' O ' ' A' ' 19' ' ' ARG . 15.6 tp -140.87 134.92 30.78 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.129 -0.487 . . . . 74.54 110.878 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 23.3 m -99.74 -41.49 7.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.187 -0.46 . . . . 73.0 110.866 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -119.14 143.08 47.4 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.13 -0.486 . . . . 74.22 110.865 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.645 ' SG ' ' HB2' ' A' ' 80' ' ' LEU . 1.8 p -115.65 89.75 3.17 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.193 -0.458 . . . . 74.51 110.919 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.488 ' HB3' ' N ' ' A' ' 14' ' ' LYS . 3.6 m-20 -85.46 -54.01 4.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.193 -0.458 . . . . 74.14 110.87 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 9.7 p -125.32 128.12 47.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 71.42 110.854 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.494 HG23 ' N ' ' A' ' 41' ' ' LYS . 11.0 mt -127.05 152.08 34.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.11 -0.495 . . . . 74.25 111.123 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.494 ' N ' HG23 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -142.78 118.33 10.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.188 -0.46 . . . . 74.55 110.877 179.852 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.567 HG23 ' HB ' ' A' ' 8' ' ' ILE . 1.9 t -101.2 115.15 42.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.187 -0.46 . . . . 72.22 111.111 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -111.28 79.96 1.26 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.181 -0.463 . . . . 72.22 110.889 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.465 ' O ' ' HA ' ' A' ' 6' ' ' THR . . . 129.44 103.33 1.07 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.72 -0.752 . . . . 74.44 112.467 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 52.84 178.1 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.704 -0.76 . . . . 74.32 112.49 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.531 HG21 ' HA ' ' A' ' 63' ' ' PRO . 3.0 m -79.65 164.78 23.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.794 0.331 . . . . 72.32 111.119 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.576 ' CD1' ' HB ' ' A' ' 8' ' ' ILE . 2.7 m95 -137.69 130.02 29.34 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.155 -0.475 . . . . 75.32 110.857 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.585 ' O ' ' N ' ' A' ' 84' ' ' ARG . . . -92.77 131.26 37.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.227 -0.442 . . . . 74.21 111.151 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.725 ' O ' ' O ' ' A' ' 60' ' ' TYR . 19.6 m -132.56 127.51 56.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.241 -0.436 . . . . 73.24 111.105 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.736 ' HB3' ' HA ' ' A' ' 56' ' ' ALA . 38.9 m-85 -94.75 148.3 22.43 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.218 -0.447 . . . . 74.15 110.92 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.539 ' OE1' ' HB2' ' A' ' 58' ' ' TYR . 7.1 tt0 -50.91 -76.55 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.148 -0.478 . . . . 75.51 110.855 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.557 ' HB3' ' CD1' ' A' ' 55' ' ' PHE . 19.2 mmm-85 -89.92 140.7 27.73 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.64 0.733 . . . . 72.2 110.846 -179.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.731 ' HA ' ' OG ' ' A' ' 82' ' ' SER . 54.1 Cg_endo -69.75 137.8 36.35 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.733 2.289 . . . . 71.45 112.322 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 65.32 -11.18 0.17 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.246 -0.434 . . . . 73.25 110.897 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.582 ' H ' ' C ' ' A' ' 53' ' ' PRO . 4.9 m-30 -100.85 -32.19 10.79 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.159 -0.473 . . . . 74.24 110.876 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.736 ' HA ' ' HB3' ' A' ' 50' ' ' TYR . . . 63.42 22.44 13.25 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.185 -0.461 . . . . 74.24 111.107 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . 0.629 ' O ' ' C ' ' A' ' 58' ' ' TYR . 1.2 t90 -51.4 -159.69 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.216 -0.447 . . . . 73.11 110.923 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.629 ' C ' ' O ' ' A' ' 57' ' ' TRP . 5.8 m-30 -13.72 101.43 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.278 -0.419 . . . . 71.54 110.929 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 2.1 mpt? -59.67 149.28 31.02 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.067 -0.515 . . . . 74.24 110.886 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.725 ' O ' ' O ' ' A' ' 49' ' ' VAL . 0.4 OUTLIER -163.93 105.08 0.91 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.232 -0.44 . . . . 75.5 110.923 -179.876 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.637 ' N ' ' CD1' ' A' ' 61' ' ' ILE . 0.9 OUTLIER -98.86 115.72 40.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.114 -0.494 . . . . 74.43 111.114 179.904 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.427 HD12 HD12 ' A' ' 40' ' ' ILE . 0.4 OUTLIER -83.64 123.71 76.07 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.6 0.714 . . . . 74.31 110.939 179.877 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.531 ' HA ' HG21 ' A' ' 46' ' ' THR . 54.3 Cg_endo -69.74 -165.21 0.15 Allowed 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.73 2.286 . . . . 74.23 112.341 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.64 159.57 14.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.233 -0.44 . . . . 73.51 110.907 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 112.88 -155.52 16.23 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.715 -0.755 . . . . 62.54 112.448 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -114.81 160.42 19.47 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.877 0.37 . . . . 74.11 110.859 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.458 ' OH ' ' HG2' ' A' ' 63' ' ' PRO . 10.8 m-85 -149.58 83.81 6.27 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.71 0.766 . . . . 74.32 110.919 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.8 -4.73 14.65 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.65 2.234 . . . . 71.43 112.325 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -156.89 148.23 22.2 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.244 -0.435 . . . . 75.33 110.919 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.99 ' O ' ' CD1' ' A' ' 73' ' ' TRP . 44.6 p90 -57.44 -42.44 82.45 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.164 -0.471 . . . . 70.44 110.936 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -51.94 -15.79 0.6 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.102 -0.499 . . . . 71.52 110.89 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 28.7 mmt180 -69.16 -9.22 51.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.179 -0.464 . . . . 75.25 110.902 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . 0.99 ' CD1' ' O ' ' A' ' 70' ' ' TYR . 0.5 OUTLIER -128.8 21.63 5.9 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.18 -0.463 . . . . 73.21 110.905 -179.946 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' MET . . . . . 0.623 ' O ' ' C ' ' A' ' 75' ' ' GLY . 24.1 mmt 79.54 27.44 0.36 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.276 -0.42 . . . . 73.24 110.878 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.623 ' C ' ' O ' ' A' ' 74' ' ' MET . . . 15.74 61.94 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.698 -0.763 . . . . 70.13 112.514 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.585 ' HB2' ' CE2' ' A' ' 60' ' ' TYR . 59.9 mt -58.89 -80.34 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.843 0.354 . . . . 73.55 110.902 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.589 ' O ' ' CB ' ' A' ' 78' ' ' ASP . 3.8 t-20 -113.56 -41.84 3.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.193 -0.458 . . . . 72.32 110.898 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.589 ' CB ' ' O ' ' A' ' 77' ' ' ASN . 2.6 t70 91.04 16.38 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.18 -0.464 . . . . 74.24 110.891 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.428 ' NE ' ' HD3' ' A' ' 52' ' ' ARG . 4.9 ttm105 -110.92 97.66 6.99 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.143 -0.481 . . . . 73.41 110.845 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.645 ' HB2' ' SG ' ' A' ' 37' ' ' CYS . 0.1 OUTLIER -95.6 131.7 41.53 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.18 -0.463 . . . . 71.11 110.912 -179.985 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.672 ' HB3' ' HB3' ' A' ' 53' ' ' PRO . 1.2 m -153.03 -123.58 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.208 -0.451 . . . . 74.34 110.877 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.731 ' OG ' ' HA ' ' A' ' 53' ' ' PRO . 0.0 OUTLIER -41.65 101.86 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.138 -0.483 . . . . 74.25 110.797 -179.757 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . 0.585 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 21.3 p -117.43 136.15 53.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.109 -0.496 . . . . 74.2 110.857 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.585 ' N ' ' O ' ' A' ' 48' ' ' ALA . 6.6 mmt85 -123.43 138.38 54.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.149 -0.478 . . . . 71.04 110.865 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.448 ' N ' ' CZ3' ' A' ' 47' ' ' TRP . . . -57.71 128.67 38.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.202 -0.454 . . . . 74.11 111.044 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.508 HG21 ' CB ' ' A' ' 48' ' ' ALA . 12.3 t -111.71 139.6 35.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.18 -0.463 . . . . 62.02 111.113 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . 0.475 ' O ' ' C ' ' A' ' 88' ' ' LEU . 29.8 m80 -111.84 106.01 14.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.173 -0.467 . . . . 75.11 110.854 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.475 ' C ' ' O ' ' A' ' 87' ' ' HIS . 0.0 OUTLIER -31.9 143.22 0.13 Allowed Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.619 0.723 . . . . 75.32 110.888 -179.949 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.534 ' HB3' ' H ' ' A' ' 136' ' ' VAL . 53.7 Cg_endo -69.82 105.73 1.55 Allowed 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.652 2.235 . . . . 64.12 112.291 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.03 177.35 4.88 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.206 -0.452 . . . . 72.32 110.805 -179.835 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 50.12 63.16 4.48 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.741 -0.742 . . . . 50.33 112.486 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.424 ' O ' ' C ' ' A' ' 93' ' ' GLN . . . 124.25 21.72 2.24 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.754 -0.736 . . . . 72.01 112.454 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.448 ' O ' ' HG2' ' A' ' 134' ' ' GLU . 5.3 pt20 36.59 -121.29 0.16 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.815 0.341 . . . . 73.43 110.859 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.548 ' O ' ' HA ' ' A' ' 112' ' ' THR . 0.1 OUTLIER -120.92 100.8 7.29 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.141 -0.482 . . . . 65.53 110.911 -179.853 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.471 ' H ' ' HG2' ' A' ' 134' ' ' GLU . 45.6 tptt -110.82 128.27 55.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.112 -0.494 . . . . 74.01 110.907 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.43 HG22 ' CH2' ' A' ' 137' ' ' TRP . 0.0 OUTLIER -149.11 142.38 18.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.253 -0.431 . . . . 70.3 111.12 179.82 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.471 ' HB2' ' O ' ' A' ' 131' ' ' LYS . 2.8 mt-30 -112.1 126.94 55.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.137 -0.483 . . . . 74.42 110.911 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.444 HG23 HG13 ' A' ' 127' ' ' ILE . 4.9 mp -108.33 131.26 59.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.237 -0.438 . . . . 75.03 111.115 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.656 ' HB2' ' HB2' ' A' ' 129' ' ' SER . 6.4 m-85 -120.15 148.19 43.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.172 -0.467 . . . . 75.43 110.883 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -74.88 -75.59 0.16 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.159 -0.473 . . . . 73.4 110.912 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.42 ' C ' ' HB3' ' A' ' 128' ' ' HIS . 36.7 mttt -83.14 176.19 9.39 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.168 -0.469 . . . . 74.13 110.926 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -88.79 160.41 29.98 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.764 -0.731 . . . . 72.31 112.476 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.415 ' HA ' ' HB2' ' A' ' 158' ' ' ARG . 27.8 t0 65.15 53.42 1.35 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.883 0.373 . . . . 73.23 110.893 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.632 ' CE1' ' HD2' ' A' ' 131' ' ' LYS . 6.1 m-85 48.38 33.74 4.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.457 . . . . 70.15 110.876 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.411 ' C ' ' HB2' ' A' ' 101' ' ' LYS . 45.4 m -109.47 151.61 26.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.101 -0.499 . . . . 74.25 110.848 -179.795 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 91.35 -164.4 29.44 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.675 -0.774 . . . . 71.25 112.467 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 5.0 tp-100 -75.41 129.65 37.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.805 0.336 . . . . 72.51 110.945 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 3.8 ttp -112.47 144.96 41.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.197 -0.456 . . . . 71.42 110.887 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 -148.84 141.73 24.72 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.212 -0.449 . . . . 74.14 110.949 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -123.78 108.66 12.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.1 -0.5 . . . . 74.15 110.938 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 5.0 t -121.47 145.69 47.68 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.175 -0.466 . . . . 74.22 111.132 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.548 ' HA ' ' O ' ' A' ' 94' ' ' TYR . 4.4 t -120.96 41.91 3.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.245 -0.434 . . . . 73.33 111.152 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -151.19 157.08 42.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.224 -0.444 . . . . 74.32 110.904 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -53.85 157.86 2.23 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.145 -0.479 . . . . 73.41 110.823 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . 0.664 ' O ' ' HB2' ' A' ' 172' ' ' SER . 73.2 m -146.89 115.2 4.36 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-O 121.626 0.727 . . . . 75.01 110.898 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.455 ' O ' ' C ' ' A' ' 143' ' ' PRO . 53.3 Cg_endo -69.82 -30.3 22.24 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.648 2.232 . . . . 75.41 112.328 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.616 ' HB3' ' CB ' ' A' ' 120' ' ' GLU . 0.1 OUTLIER -148.26 99.82 3.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.251 -0.431 . . . . 72.05 110.814 -179.854 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.54 ' HB ' ' O ' ' A' ' 171' ' ' GLN . 5.6 tt -52.86 -26.56 11.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.12 -0.491 . . . . 74.3 111.124 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' MET . . . . . 0.599 ' O ' ' HA ' ' A' ' 123' ' ' HIS . 14.4 ttp -86.75 -41.26 14.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.198 -0.455 . . . . 75.33 110.89 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.616 ' CB ' ' HB3' ' A' ' 117' ' ' SER . 34.5 tp10 -64.33 -12.98 47.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.215 -0.448 . . . . 73.23 110.854 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.402 ' HG3' ' H ' ' A' ' 122' ' ' PHE . 0.0 OUTLIER -114.62 -51.56 2.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.189 -0.46 . . . . 72.34 110.946 -179.96 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . 0.405 ' HB2' ' O ' ' A' ' 118' ' ' ILE . 12.1 m-30 -101.22 -18.17 16.27 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.217 -0.447 . . . . 61.21 110.935 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . 0.599 ' HA ' ' O ' ' A' ' 119' ' ' MET . 11.8 m80 74.39 21.29 2.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.135 -0.484 . . . . 73.31 110.901 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 6.5 mtt -94.27 131.91 39.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.188 -0.46 . . . . 65.34 110.873 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 4.9 ptp180 -95.23 -38.55 10.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.181 -0.463 . . . . 65.22 110.877 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.456 ' HG2' ' HA ' ' A' ' 169' ' ' ALA . 25.2 mt-10 -141.25 118.62 11.45 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.159 -0.473 . . . . 64.14 110.875 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.48 ' O ' ' HB3' ' A' ' 168' ' ' PRO . 3.0 mm -80.08 101.09 4.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.163 -0.471 . . . . 75.45 111.138 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . 0.42 ' HB3' ' C ' ' A' ' 101' ' ' LYS . 0.4 OUTLIER -73.19 -32.58 64.9 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.171 -0.468 . . . . 72.45 110.846 179.888 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.656 ' HB2' ' HB2' ' A' ' 99' ' ' PHE . 66.5 m -128.47 138.89 52.51 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.193 -0.458 . . . . 65.02 110.83 -179.719 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . 0.573 ' O ' ' O ' ' A' ' 155' ' ' LYS . 3.8 m -136.05 120.43 18.02 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.149 -0.478 . . . . 73.33 110.865 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.652 ' HA ' ' HA ' ' A' ' 156' ' ' GLU . 3.6 mtpp -116.35 152.21 34.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.131 -0.486 . . . . 74.15 110.892 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.538 ' HB ' ' O ' ' A' ' 131' ' ' LYS . 19.4 t 85.6 162.46 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.226 -0.443 . . . . 75.31 111.145 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.471 ' CD1' ' O ' ' A' ' 154' ' ' LYS . 0.0 OUTLIER -177.33 124.59 0.14 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.223 -0.444 . . . . 64.42 110.929 179.933 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.501 ' O ' ' C ' ' A' ' 135' ' ' GLY . 0.1 OUTLIER -98.26 168.23 10.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.162 -0.472 . . . . 72.12 110.895 179.936 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . 0.501 ' C ' ' O ' ' A' ' 134' ' ' GLU . . . -29.17 -70.04 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.751 -0.738 . . . . 72.13 112.447 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.672 ' HA ' HD13 ' A' ' 152' ' ' LEU . 3.0 t -133.82 145.43 33.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.834 0.349 . . . . 73.55 111.109 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . 0.493 ' N ' ' HG ' ' A' ' 152' ' ' LEU . 0.1 OUTLIER -150.1 162.8 39.7 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.187 -0.461 . . . . 75.15 110.866 -179.975 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.551 HD12 ' HB ' ' A' ' 61' ' ' ILE . 22.6 mt -138.48 134.03 43.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.208 -0.451 . . . . 75.41 111.136 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.441 ' HB2' ' HB2' ' A' ' 150' ' ' TYR . 0.2 OUTLIER -103.68 159.16 15.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.176 -0.465 . . . . 73.33 110.884 179.957 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . 0.47 ' CD2' ' HA ' ' A' ' 145' ' ' TYR . 0.5 OUTLIER -131.61 128.46 39.18 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.123 -0.49 . . . . 75.43 110.905 -179.875 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . 0.566 ' O ' ' HB2' ' A' ' 171' ' ' GLN . 7.0 tt0 -60.76 -27.75 68.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.089 -0.505 . . . . 64.23 110.858 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.767 ' HB3' ' HD2' ' A' ' 143' ' ' PRO . 10.1 mp -114.97 173.46 2.89 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.588 0.709 . . . . 74.45 110.938 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . 0.767 ' HD2' ' HB3' ' A' ' 142' ' ' LEU . 53.2 Cg_endo -69.77 -90.61 0.0 OUTLIER 'Trans proline' 0 C--N 1.34 0.129 0 C-N-CA 122.694 2.263 . . . . 72.43 112.327 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . 0.723 ' O ' ' N ' ' A' ' 146' ' ' ARG . 2.4 m-20 -50.73 98.57 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.181 -0.463 . . . . 74.33 110.87 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . 0.638 ' C ' ' O ' ' A' ' 144' ' ' ASN . 0.1 OUTLIER 12.67 51.77 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.163 -0.471 . . . . 74.03 110.945 -179.959 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . 0.723 ' N ' ' O ' ' A' ' 144' ' ' ASN . 22.3 mtt-85 -119.46 173.43 6.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.132 -0.486 . . . . 75.34 110.921 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 79.84 172.27 43.6 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.737 -0.744 . . . . 62.05 112.462 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 19.3 mtp180 -68.55 150.61 47.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.755 0.312 . . . . 73.42 110.888 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . 0.563 ' HB2' ' HA ' ' A' ' 60' ' ' TYR . 55.4 mt-30 -86.02 153.21 22.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.236 -0.438 . . . . 75.4 110.932 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . 0.441 ' HB2' ' HB2' ' A' ' 139' ' ' PHE . 76.1 m-85 -133.91 123.02 23.98 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.222 -0.445 . . . . 74.13 110.934 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.551 ' CA ' HD12 ' A' ' 61' ' ' ILE . 12.1 tp -70.32 125.24 26.24 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.144 -0.48 . . . . 74.34 110.909 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.672 HD13 ' HA ' ' A' ' 136' ' ' VAL . 0.0 OUTLIER -59.94 132.58 54.4 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.177 -0.465 . . . . 74.51 110.871 179.948 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -163.56 24.98 0.08 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.138 -0.483 . . . . 75.33 110.862 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.678 ' O ' ' HG3' ' A' ' 155' ' ' LYS . 0.1 OUTLIER -112.41 -171.1 1.79 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.186 -0.461 . . . . 74.4 110.923 179.954 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.678 ' HG3' ' O ' ' A' ' 154' ' ' LYS . 0.2 OUTLIER -165.67 -122.39 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.207 -0.452 . . . . 75.33 110.858 179.87 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.652 ' HA ' ' HA ' ' A' ' 131' ' ' LYS . 0.4 OUTLIER -71.39 0.42 8.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.232 -0.44 . . . . 73.32 110.913 -179.99 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . 0.661 ' CD1' ' HB3' ' A' ' 162' ' ' ASP . 16.8 m-30 -28.49 142.49 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.128 -0.487 . . . . 74.32 110.938 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . 0.606 ' O ' ' OG ' ' A' ' 129' ' ' SER . 11.1 ptp180 -112.18 -33.74 6.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.126 -0.488 . . . . 74.4 110.862 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -101.1 152.28 37.85 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.541 0.686 . . . . 72.01 110.914 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.73 -22.64 31.92 Favored 'Trans proline' 0 C--O 1.232 0.206 0 C-N-CA 122.694 2.262 . . . . 73.25 112.354 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.473 HD11 ' H ' ' A' ' 161' ' ' ILE . 4.0 mp -76.67 -2.89 4.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.226 -0.443 . . . . 75.12 111.146 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . 0.661 ' HB3' ' CD1' ' A' ' 157' ' ' TYR . 1.4 t0 -72.47 -17.34 61.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.19 -0.459 . . . . 74.4 110.878 179.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' TRP . . . . . 0.52 ' O ' ' CG ' ' A' ' 163' ' ' TRP . 6.2 t-105 -109.99 10.21 24.24 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.168 -0.469 . . . . 73.44 110.934 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 87.71 -31.63 4.53 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.69 -0.767 . . . . 64.42 112.503 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -54.35 119.35 5.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.799 0.333 . . . . 71.32 111.103 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -49.1 -26.14 2.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.202 -0.454 . . . . 74.01 111.1 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' SER . . . . . 0.495 ' C ' ' H ' ' A' ' 169' ' ' ALA . 0.3 OUTLIER -154.98 159.36 31.89 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.635 0.731 . . . . 63.03 110.855 -179.794 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . 0.48 ' HB3' ' O ' ' A' ' 127' ' ' ILE . 53.5 Cg_endo -69.81 19.21 0.19 Allowed 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.679 2.253 . . . . 75.51 112.32 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . 0.495 ' H ' ' C ' ' A' ' 167' ' ' SER . . . -63.01 102.58 0.38 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.236 -0.438 . . . . 72.23 111.083 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 3.4 t -153.09 162.15 2.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.223 -0.444 . . . . 70.32 111.147 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' GLN . . . . . 0.688 ' OE1' ' HB3' ' A' ' 143' ' ' PRO . 1.7 mm-40 -112.21 -88.38 0.53 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.209 -0.45 . . . . 71.31 110.93 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' SER . . . . . 0.758 ' OG ' ' O ' ' A' ' 143' ' ' PRO . 45.7 p -121.67 177.92 5.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.156 -0.475 . . . . 72.44 110.882 -179.801 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 2.0 p90 -141.97 168.34 19.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.161 -0.472 . . . . 71.0 110.861 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . 0.448 ' HD2' ' CE2' ' A' ' 140' ' ' TYR . 0.0 OUTLIER -135.21 156.16 49.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.11 -0.496 . . . . 72.4 110.911 -179.937 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . 0.409 ' HD2' ' CE2' ' A' ' 94' ' ' TYR . 0.0 OUTLIER -100.68 -164.48 1.12 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.178 -0.464 . . . . 75.14 110.868 -179.922 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . 0.435 HD11 ' C ' ' A' ' 136' ' ' VAL . 5.6 mt -137.0 130.5 45.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.164 -0.471 . . . . 74.1 111.09 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 7.4 p -98.43 155.84 3.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.198 -0.456 . . . . 74.13 111.103 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.174 -0.467 . . . . 73.34 110.877 -179.987 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.78 0.324 . . . . 74.42 110.869 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.8 m -149.51 -175.96 5.21 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.216 -0.447 . . . . 60.34 110.864 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -99.17 36.41 1.73 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.15 -0.477 . . . . 75.41 110.889 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 15.2 t -94.94 35.5 1.26 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.235 -0.439 . . . . 73.35 111.168 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 141.83 117.11 1.28 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.729 -0.748 . . . . 65.24 112.511 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.449 ' C ' ' HE1' ' A' ' 47' ' ' TRP . 9.9 p -82.67 133.78 35.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.871 0.367 . . . . 73.2 111.149 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 3.0 tttt -122.08 137.08 54.94 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.176 -0.465 . . . . 75.55 110.856 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.67 HG23 ' CZ ' ' A' ' 10' ' ' PHE . 14.3 tt -137.16 152.94 28.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.197 -0.456 . . . . 74.13 111.148 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.499 ' HA ' ' O ' ' A' ' 21' ' ' TYR . 23.0 m -136.63 136.95 39.6 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.208 -0.451 . . . . 74.3 111.14 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.67 ' CZ ' HG23 ' A' ' 8' ' ' ILE . 0.2 OUTLIER -125.23 129.3 49.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.225 -0.443 . . . . 71.21 110.883 -179.992 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.533 ' CG ' ' HA ' ' A' ' 16' ' ' PHE . 33.9 m-85 -112.38 131.93 55.28 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.138 -0.483 . . . . 74.21 110.953 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.416 ' HB2' ' HB2' ' A' ' 19' ' ' ARG . 0.1 OUTLIER -62.2 -16.45 53.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.147 -0.479 . . . . 74.21 110.89 -179.985 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.412 ' HB2' ' O ' ' A' ' 17' ' ' GLN . 70.7 m-20 -133.83 148.8 51.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.13 -0.487 . . . . 71.53 110.886 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.603 ' N ' ' HB3' ' A' ' 38' ' ' ASN . 3.5 mtmm -54.53 -179.19 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.217 -0.447 . . . . 73.3 110.927 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 22.3 m-20 49.64 32.87 5.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.259 -0.428 . . . . 74.22 110.906 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.533 ' HA ' ' CG ' ' A' ' 11' ' ' TYR . 4.0 m-85 49.79 62.45 2.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.137 -0.483 . . . . 75.24 110.919 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.412 ' O ' ' HB2' ' A' ' 13' ' ' ASP . 4.1 mt-30 -138.85 161.89 36.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.115 -0.493 . . . . 75.44 110.894 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 91.78 -149.76 19.93 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.771 -0.728 . . . . 65.21 112.493 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.432 ' O ' ' CD1' ' A' ' 34' ' ' LEU . 0.0 OUTLIER -69.41 77.58 0.39 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.812 0.339 . . . . 73.44 110.889 -179.845 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.429 ' CD ' ' OD2' ' A' ' 22' ' ' ASP . 0.0 OUTLIER -75.79 129.11 36.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.181 -0.463 . . . . 74.31 110.871 -179.907 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.499 ' O ' ' HA ' ' A' ' 9' ' ' THR . 90.6 t80 -123.03 124.4 43.03 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.172 -0.467 . . . . 74.45 110.922 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.432 ' CG ' HG23 ' A' ' 9' ' ' THR . 1.1 m-20 -121.02 133.52 55.26 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.143 -0.481 . . . . 74.43 110.851 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -166.77 133.94 2.5 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.168 -0.469 . . . . 73.34 110.924 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -99.76 2.18 43.92 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.189 -0.459 . . . . 74.2 110.935 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.458 ' O ' ' SG ' ' A' ' 27' ' ' CYS . 18.6 t -106.46 164.96 11.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.17 -0.468 . . . . 71.31 110.881 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -56.93 120.78 8.52 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.201 -0.454 . . . . 74.01 110.866 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.577 ' HB2' ' HB3' ' A' ' 30' ' ' PHE . 0.6 OUTLIER -115.64 50.14 1.03 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.212 -0.449 . . . . 71.02 110.875 -179.894 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.508 ' O ' ' HA ' ' A' ' 82' ' ' SER . . . -47.69 -21.43 0.37 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.163 -0.471 . . . . 63.44 111.093 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 58.5 t0 -128.68 42.11 3.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.235 -0.439 . . . . 74.13 110.89 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.731 ' O ' ' CD2' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -81.45 13.98 2.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.166 -0.47 . . . . 74.14 110.925 -179.932 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.431 ' HB2' ' HB3' ' A' ' 81' ' ' SER . 29.7 t60 -78.19 -39.05 41.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.138 -0.483 . . . . 74.22 110.824 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.7 t -57.93 -14.93 7.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.221 -0.445 . . . . 73.4 111.139 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -99.6 -26.26 14.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.233 -0.44 . . . . 73.42 110.928 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.432 ' CD1' ' O ' ' A' ' 19' ' ' ARG . 15.5 tp -142.89 133.12 24.58 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.129 -0.487 . . . . 72.41 110.923 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 22.3 m -97.51 -43.28 7.32 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.169 -0.469 . . . . 75.14 110.865 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 1.6 tmm_? -117.27 142.57 46.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.146 -0.479 . . . . 75.43 110.886 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.661 ' SG ' ' HB2' ' A' ' 80' ' ' LEU . 1.5 p -111.65 89.19 2.99 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.204 -0.453 . . . . 74.44 110.893 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.603 ' HB3' ' N ' ' A' ' 14' ' ' LYS . 0.3 OUTLIER -81.73 -61.99 1.77 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.176 -0.465 . . . . 64.15 110.89 -179.906 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 10.4 p -124.17 125.93 45.29 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.196 -0.457 . . . . 74.44 110.847 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.519 ' O ' ' HB2' ' A' ' 67' ' ' TYR . 2.6 mt -124.06 151.55 29.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.13 -0.486 . . . . 73.41 111.139 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.473 ' N ' HG23 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -142.32 121.97 13.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.145 -0.479 . . . . 74.4 110.862 179.887 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.55 HG22 ' HB2' ' A' ' 47' ' ' TRP . 1.0 OUTLIER -104.82 118.84 52.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.22 -0.445 . . . . 73.51 111.118 179.876 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -114.07 77.73 1.09 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.146 -0.479 . . . . 75.31 110.836 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.416 ' O ' ' HA ' ' A' ' 6' ' ' THR . . . 135.46 99.14 0.58 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.714 -0.755 . . . . 42.24 112.476 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 54.75 176.8 0.14 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.733 -0.746 . . . . 72.22 112.473 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.55 HG21 ' HA ' ' A' ' 63' ' ' PRO . 1.9 m -75.82 169.24 18.53 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.789 0.328 . . . . 72.42 111.156 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.578 ' CD1' ' HB ' ' A' ' 8' ' ' ILE . 6.0 m95 -143.02 129.35 19.94 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.251 -0.431 . . . . 73.44 110.907 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.585 ' O ' ' N ' ' A' ' 84' ' ' ARG . . . -90.98 129.19 37.01 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.206 -0.452 . . . . 75.02 111.143 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.78 ' O ' ' O ' ' A' ' 60' ' ' TYR . 17.3 m -129.34 125.66 62.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.277 -0.419 . . . . 72.41 111.107 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.781 ' HB3' ' HA ' ' A' ' 56' ' ' ALA . 44.0 m-85 -93.73 148.38 22.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.182 -0.463 . . . . 72.31 110.926 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.559 ' HB2' ' O ' ' A' ' 58' ' ' TYR . 7.0 tt0 -48.72 -79.89 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.152 -0.476 . . . . 75.44 110.877 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.539 ' HB3' ' CD1' ' A' ' 55' ' ' PHE . 0.0 OUTLIER -92.75 145.15 29.77 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.617 0.723 . . . . 71.32 110.845 -179.908 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.728 ' HA ' ' OG ' ' A' ' 82' ' ' SER . 53.9 Cg_endo -69.79 140.78 43.41 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.678 2.252 . . . . 73.33 112.381 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 62.9 -11.03 0.09 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.227 -0.442 . . . . 74.21 110.924 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.626 ' H ' ' C ' ' A' ' 53' ' ' PRO . 2.6 m-30 -104.0 -21.37 13.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.162 -0.472 . . . . 73.32 110.913 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.781 ' HA ' ' HB3' ' A' ' 50' ' ' TYR . . . 50.05 25.98 1.9 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.135 -0.484 . . . . 74.23 111.063 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . 0.637 ' O ' ' C ' ' A' ' 58' ' ' TYR . 0.0 OUTLIER -50.07 -161.36 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.233 -0.44 . . . . 73.32 110.941 -179.997 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.637 ' C ' ' O ' ' A' ' 57' ' ' TRP . 6.3 m-30 -14.24 101.59 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.227 -0.442 . . . . 74.55 110.926 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.445 ' HB2' ' O ' ' A' ' 149' ' ' GLN . 0.5 OUTLIER -58.41 146.15 35.93 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.087 -0.506 . . . . 73.15 110.905 179.903 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.78 ' O ' ' O ' ' A' ' 49' ' ' VAL . 0.3 OUTLIER -159.07 112.28 2.29 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.253 -0.43 . . . . 74.23 110.885 -179.863 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.605 ' CD1' ' N ' ' A' ' 61' ' ' ILE . 1.0 OUTLIER -104.95 114.84 45.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.097 -0.502 . . . . 74.44 111.15 179.898 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -84.95 124.86 71.97 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.617 0.722 . . . . 74.41 110.934 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.55 ' HA ' HG21 ' A' ' 46' ' ' THR . 53.7 Cg_endo -69.75 -165.29 0.15 Allowed 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.647 2.232 . . . . 75.35 112.357 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.42 160.37 14.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.223 -0.444 . . . . 74.34 110.887 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 112.91 -152.11 18.05 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.697 -0.763 . . . . 62.13 112.486 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 11.2 mp0 -118.69 159.44 23.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.844 0.354 . . . . 75.0 110.937 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.519 ' HB2' ' O ' ' A' ' 40' ' ' ILE . 13.0 m-85 -147.94 82.43 7.84 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.655 0.741 . . . . 54.4 110.924 -179.854 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.7 -3.67 12.44 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.731 2.288 . . . . 74.32 112.355 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -157.72 147.68 20.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.178 -0.464 . . . . 75.25 110.856 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.882 ' O ' ' CD1' ' A' ' 73' ' ' TRP . 44.6 p90 -57.53 -41.47 80.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.121 -0.49 . . . . 72.2 110.927 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -53.35 -17.1 1.63 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.138 -0.483 . . . . 72.0 110.945 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 29.3 mmt180 -63.62 -36.29 83.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 74.44 110.852 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . 0.882 ' CD1' ' O ' ' A' ' 70' ' ' TYR . 0.3 OUTLIER -98.61 25.41 6.47 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.243 -0.435 . . . . 63.43 110.907 -179.958 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' MET . . . . . 0.566 ' O ' ' C ' ' A' ' 75' ' ' GLY . 1.6 mtp 75.53 26.87 1.08 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.264 -0.425 . . . . 75.32 110.886 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.566 ' C ' ' O ' ' A' ' 74' ' ' MET . . . 23.51 54.57 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.763 -0.732 . . . . 63.12 112.481 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.506 ' CB ' ' CE2' ' A' ' 60' ' ' TYR . 0.2 OUTLIER -56.69 -74.46 0.05 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.781 0.324 . . . . 70.14 110.918 -179.917 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.766 ' O ' ' CB ' ' A' ' 78' ' ' ASP . 28.0 t-20 -113.75 -80.55 0.59 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.214 -0.448 . . . . 74.24 110.897 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.766 ' CB ' ' O ' ' A' ' 77' ' ' ASN . 27.8 t70 129.45 5.38 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.182 -0.463 . . . . 75.22 110.911 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -107.3 92.28 4.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.211 -0.45 . . . . 71.55 110.893 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.661 ' HB2' ' SG ' ' A' ' 37' ' ' CYS . 0.2 OUTLIER -90.7 129.5 36.79 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.186 -0.461 . . . . 75.23 110.923 -179.959 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.592 ' HB3' ' HB3' ' A' ' 53' ' ' PRO . 0.9 OUTLIER -153.66 -123.42 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.23 -0.441 . . . . 74.41 110.897 -179.945 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.728 ' OG ' ' HA ' ' A' ' 53' ' ' PRO . 0.0 OUTLIER -41.46 101.91 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.168 -0.469 . . . . 71.12 110.877 -179.824 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . 0.512 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 31.5 p -121.16 135.38 55.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.095 -0.502 . . . . 70.11 110.887 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.585 ' N ' ' O ' ' A' ' 48' ' ' ALA . 10.9 mmt85 -119.62 150.94 39.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.2 -0.455 . . . . 73.13 110.832 -179.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -66.65 127.14 31.24 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.176 -0.465 . . . . 74.35 111.102 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.478 ' CG2' ' CB ' ' A' ' 48' ' ' ALA . 52.9 t -116.94 137.56 50.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.245 -0.434 . . . . 65.51 111.127 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . 0.438 ' O ' ' CG2' ' A' ' 136' ' ' VAL . 29.4 m80 -111.17 126.54 54.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.124 -0.489 . . . . 75.45 110.88 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -39.63 137.99 1.03 Allowed Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.598 0.713 . . . . 75.45 110.899 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 80.71 0.87 Allowed 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.713 2.275 . . . . 74.52 112.329 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -90.58 -177.12 4.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 64.41 110.838 -179.835 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 67.41 117.52 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.756 -0.735 . . . . 74.23 112.496 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 50.02 40.23 35.17 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.747 -0.74 . . . . 53.41 112.536 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.429 ' HB2' ' H ' ' A' ' 94' ' ' TYR . 5.2 pt20 40.21 -156.65 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.802 0.334 . . . . 75.02 110.901 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.576 ' HA ' ' CG ' ' A' ' 134' ' ' GLU . 0.1 OUTLIER -97.47 104.81 16.87 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.204 -0.453 . . . . 75.55 110.909 -179.875 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 45.7 tptt -105.99 131.34 53.4 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.132 -0.485 . . . . 74.42 110.885 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -150.23 137.38 13.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.252 -0.431 . . . . 75.15 111.141 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.431 ' HB2' ' O ' ' A' ' 131' ' ' LYS . 0.8 OUTLIER -112.77 135.6 53.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.205 -0.452 . . . . 74.31 110.93 179.935 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 1.5 mt -114.52 142.62 26.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.166 -0.47 . . . . 72.13 111.13 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.635 ' HB2' ' HB2' ' A' ' 129' ' ' SER . 57.1 m-85 -131.29 134.28 46.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.182 -0.463 . . . . 74.21 110.832 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 64.2 tt0 -63.59 -74.46 0.1 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.126 -0.488 . . . . 74.43 110.869 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.444 ' C ' ' HB3' ' A' ' 128' ' ' HIS . 9.7 mttt -83.11 177.45 8.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.142 -0.481 . . . . 74.24 110.854 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.436 ' HA2' ' HB3' ' A' ' 128' ' ' HIS . . . -83.61 161.1 38.34 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.732 -0.747 . . . . 75.32 112.49 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.427 ' HA ' ' HB2' ' A' ' 158' ' ' ARG . 30.4 t0 61.76 32.86 18.12 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.851 0.357 . . . . 71.35 110.885 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.566 ' HA ' ' CD2' ' A' ' 99' ' ' PHE . 21.1 m-85 59.35 48.88 9.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.191 -0.458 . . . . 75.15 110.924 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 4.4 m -114.25 150.06 34.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 73.24 110.85 -179.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 89.81 -127.73 8.88 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.721 -0.752 . . . . 73.33 112.506 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 -99.18 139.41 34.87 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.806 0.336 . . . . 73.43 110.885 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 4.4 ttp -128.74 146.17 50.97 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.183 -0.462 . . . . 74.23 110.862 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 18.9 m-85 -148.25 136.79 21.5 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.267 -0.424 . . . . 74.42 110.918 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -115.3 99.26 7.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.097 -0.501 . . . . 73.04 110.912 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 13.6 t -112.58 132.03 55.33 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.135 -0.484 . . . . 60.43 111.156 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.427 ' OG1' ' O ' ' A' ' 112' ' ' THR . 1.7 t -97.4 33.3 2.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.177 -0.465 . . . . 75.33 111.128 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -149.88 -176.05 5.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.199 -0.455 . . . . 71.4 110.917 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.497 ' CB ' ' HA ' ' A' ' 174' ' ' ARG . 5.3 p30 -103.45 171.29 7.45 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.184 -0.462 . . . . 74.01 110.895 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . 0.482 ' O ' ' HB2' ' A' ' 172' ' ' SER . 16.7 p -152.02 146.14 18.31 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.602 0.715 . . . . 71.13 110.908 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.417 ' O ' ' CA ' ' A' ' 143' ' ' PRO . 53.2 Cg_endo -69.8 -28.5 24.98 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.665 2.243 . . . . 62.14 112.305 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.616 ' HB3' ' CB ' ' A' ' 120' ' ' GLU . 0.1 OUTLIER -147.59 105.85 3.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.25 -0.432 . . . . 73.54 110.862 -179.858 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.631 ' HB ' ' O ' ' A' ' 171' ' ' GLN . 3.6 tt -58.09 -29.77 37.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.165 -0.471 . . . . 73.24 111.146 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' MET . . . . . 0.595 ' O ' ' HA ' ' A' ' 123' ' ' HIS . 27.0 ttp -86.4 -43.72 12.61 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.458 . . . . 60.01 110.91 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.616 ' CB ' ' HB3' ' A' ' 117' ' ' SER . 9.4 tp10 -66.49 -13.21 60.56 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.223 -0.444 . . . . 74.21 110.857 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -114.62 -49.97 2.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.194 -0.457 . . . . 74.43 110.954 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . 0.466 ' HB2' ' O ' ' A' ' 118' ' ' ILE . 63.2 m-85 -103.03 -20.37 14.22 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.2 -0.455 . . . . 74.42 110.874 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . 0.595 ' HA ' ' O ' ' A' ' 119' ' ' MET . 28.3 m-70 72.75 26.88 2.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.136 -0.484 . . . . 73.52 110.851 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.4 ' O ' HG22 ' A' ' 118' ' ' ILE . 16.9 mtt -102.06 88.75 3.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.196 -0.456 . . . . 72.22 110.885 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 2.0 ptp85 -52.04 -42.86 63.43 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.26 -0.427 . . . . 74.45 110.869 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.455 ' HG2' ' HA ' ' A' ' 169' ' ' ALA . 13.4 mt-10 -137.2 130.75 31.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.213 -0.449 . . . . 71.25 110.902 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 3.4 mm -89.48 87.68 2.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.173 -0.467 . . . . 63.45 111.147 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . 0.444 ' HB3' ' C ' ' A' ' 101' ' ' LYS . 0.7 OUTLIER -62.4 -31.98 72.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.201 -0.454 . . . . 62.31 110.871 179.911 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.635 ' HB2' ' HB2' ' A' ' 99' ' ' PHE . 0.4 OUTLIER -134.35 142.38 47.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.172 -0.467 . . . . 74.03 110.801 -179.747 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . 0.624 ' O ' ' O ' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -143.17 117.61 9.69 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.151 -0.477 . . . . 74.24 110.882 -179.987 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.716 ' HA ' ' HA ' ' A' ' 156' ' ' GLU . 4.6 mtpp -106.67 150.86 25.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.217 -0.447 . . . . 73.22 110.915 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.409 ' O ' HD23 ' A' ' 133' ' ' LEU . 3.4 t 74.27 165.84 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.234 -0.439 . . . . 74.24 111.11 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.501 HD11 ' HG2' ' A' ' 154' ' ' LYS . 0.2 OUTLIER 172.77 128.84 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.136 -0.484 . . . . 70.01 110.936 179.929 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.576 ' CG ' ' HA ' ' A' ' 94' ' ' TYR . 0.7 OUTLIER -79.83 163.1 24.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.213 -0.449 . . . . 71.31 110.876 179.944 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . 0.441 ' C ' ' O ' ' A' ' 134' ' ' GLU . . . -34.71 -42.98 0.36 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.777 -0.725 . . . . 74.41 112.455 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.73 ' HA ' HD13 ' A' ' 152' ' ' LEU . 2.1 t -146.61 137.74 18.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.825 0.345 . . . . 74.4 111.148 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . 0.562 ' HB3' ' HB3' ' A' ' 152' ' ' LEU . 9.9 t-105 -138.46 157.12 46.82 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.151 -0.477 . . . . 74.34 110.886 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.437 HG12 HG13 ' A' ' 176' ' ' ILE . 18.2 mm -121.44 132.31 70.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.206 -0.452 . . . . 73.35 111.142 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.563 ' CB ' ' HB2' ' A' ' 150' ' ' TYR . 0.1 OUTLIER -118.87 137.61 53.32 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.163 -0.471 . . . . 70.02 110.92 179.945 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . 0.466 ' CD2' ' HA ' ' A' ' 145' ' ' TYR . 3.4 m-85 -119.37 132.05 55.79 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.13 -0.486 . . . . 71.4 110.923 -179.836 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . 0.669 ' O ' ' HB2' ' A' ' 171' ' ' GLN . 10.9 tt0 -60.04 -27.61 67.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.096 -0.502 . . . . 73.53 110.895 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.776 ' HB3' ' HD2' ' A' ' 143' ' ' PRO . 10.0 mp -112.85 173.74 2.69 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-O 121.614 0.721 . . . . 75.41 110.899 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . 0.776 ' HD2' ' HB3' ' A' ' 142' ' ' LEU . 53.9 Cg_endo -69.79 -88.8 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.71 2.273 . . . . 74.42 112.312 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . 0.686 ' O ' ' N ' ' A' ' 146' ' ' ARG . 1.4 m-20 -52.91 96.56 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.26 -0.427 . . . . 74.2 110.861 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . 0.633 ' C ' ' O ' ' A' ' 144' ' ' ASN . 0.1 OUTLIER 13.12 52.9 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.144 -0.48 . . . . 71.04 110.935 -179.94 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . 0.686 ' N ' ' O ' ' A' ' 144' ' ' ASN . 8.8 mtp85 -119.38 179.36 4.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.141 -0.481 . . . . 73.43 110.89 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 77.02 -177.69 52.06 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.726 -0.749 . . . . 74.11 112.486 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 5.7 mtp180 -74.11 156.23 37.62 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.756 0.312 . . . . 71.12 110.913 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . 0.445 ' O ' ' HB2' ' A' ' 59' ' ' MET . 0.8 OUTLIER -85.67 151.24 24.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.256 -0.429 . . . . 73.33 110.909 -179.974 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . 0.563 ' HB2' ' CB ' ' A' ' 139' ' ' PHE . 73.8 m-85 -137.67 122.8 19.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.209 -0.45 . . . . 73.4 110.914 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.478 ' CA ' HD12 ' A' ' 61' ' ' ILE . 10.5 tp -81.56 121.9 26.89 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.147 -0.479 . . . . 74.42 110.932 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.73 HD13 ' HA ' ' A' ' 136' ' ' VAL . 0.0 OUTLIER -51.71 139.33 21.4 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.162 -0.472 . . . . 75.14 110.925 179.916 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -162.68 26.45 0.1 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.208 -0.451 . . . . 64.43 110.822 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.927 ' HB2' ' CD1' ' A' ' 157' ' ' TYR . 2.9 ptmt -127.44 -173.49 2.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.162 -0.472 . . . . 74.02 110.906 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.745 ' HD2' ' C ' ' A' ' 154' ' ' LYS . 0.8 OUTLIER -161.58 -117.17 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.187 -0.46 . . . . 64.23 110.882 179.812 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.716 ' HA ' ' HA ' ' A' ' 131' ' ' LYS . 3.2 tm-20 -71.15 0.44 7.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.224 -0.444 . . . . 64.55 110.918 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . 0.927 ' CD1' ' HB2' ' A' ' 154' ' ' LYS . 13.6 m-30 -32.93 147.05 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.146 -0.479 . . . . 75.25 110.922 -179.836 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . 0.517 ' HB3' ' CZ ' ' A' ' 104' ' ' PHE . 9.8 ptp180 -113.0 -33.54 6.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.106 -0.497 . . . . 74.14 110.887 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 7.0 ptpt -99.04 151.86 37.55 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.597 0.713 . . . . 73.02 110.859 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.79 -25.71 28.16 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.716 2.278 . . . . 75.24 112.298 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.48 HD11 ' H ' ' A' ' 161' ' ' ILE . 3.8 mp -73.83 -6.03 7.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.251 -0.431 . . . . 75.33 111.111 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . 0.684 ' HB3' ' CD1' ' A' ' 157' ' ' TYR . 1.7 t0 -73.04 -15.73 61.51 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.194 -0.457 . . . . 73.11 110.913 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 4.8 t90 -109.94 12.65 23.71 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.197 -0.456 . . . . 75.31 110.95 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 85.6 -34.51 3.31 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.753 -0.736 . . . . 55.31 112.493 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -55.31 119.86 6.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.772 0.32 . . . . 73.34 111.118 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -49.93 -26.69 4.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.216 -0.447 . . . . 73.0 111.098 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' SER . . . . . 0.504 ' C ' ' H ' ' A' ' 169' ' ' ALA . 0.3 OUTLIER -154.55 158.18 32.25 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.688 0.756 . . . . 54.44 110.819 -179.772 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.7 18.5 0.19 Allowed 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.752 2.301 . . . . 71.54 112.321 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . 0.504 ' H ' ' C ' ' A' ' 167' ' ' SER . . . -63.45 102.97 0.47 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.235 -0.439 . . . . 72.24 111.13 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 3.1 t -153.37 163.61 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.173 -0.467 . . . . 72.15 111.105 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' GLN . . . . . 0.669 ' HB2' ' O ' ' A' ' 141' ' ' GLU . 1.9 mm-40 -110.23 -87.07 0.53 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.146 -0.479 . . . . 73.12 110.898 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' SER . . . . . 0.747 ' OG ' ' O ' ' A' ' 143' ' ' PRO . 47.0 p -125.48 172.92 9.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.213 -0.449 . . . . 71.03 110.857 -179.777 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 5.9 p90 -145.77 164.69 31.09 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.142 -0.481 . . . . 74.55 110.828 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . 0.497 ' HA ' ' CB ' ' A' ' 114' ' ' ASP . 0.0 OUTLIER -135.56 151.28 50.15 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.091 -0.504 . . . . 74.22 110.834 -179.909 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . 0.422 ' HG3' ' OD1' ' A' ' 114' ' ' ASP . 0.0 OUTLIER -104.62 139.51 39.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.195 -0.457 . . . . 73.24 110.863 -179.911 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . 0.437 HG13 HG12 ' A' ' 138' ' ' ILE . 1.2 mt -77.25 132.45 32.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.17 -0.468 . . . . 61.11 111.172 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 7.7 p -118.21 155.73 20.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.189 -0.46 . . . . 73.04 111.103 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.14 -0.482 . . . . 75.04 110.88 -179.989 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.757 0.313 . . . . 74.43 110.842 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.8 m -157.7 -174.64 4.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.262 -0.426 . . . . 75.45 110.854 -179.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 12.6 mttt -77.21 59.59 1.79 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.117 -0.492 . . . . 74.13 110.891 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 3.2 t -127.64 64.48 1.35 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.237 -0.438 . . . . 72.13 111.155 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -162.71 57.78 0.29 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.751 -0.737 . . . . 72.24 112.466 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.479 ' HA ' ' O ' ' A' ' 44' ' ' GLY . 5.7 p -82.1 136.03 35.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.886 0.374 . . . . 75.43 111.098 -179.845 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 3.2 tttt -122.24 136.11 54.85 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.178 -0.464 . . . . 75.51 110.899 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.624 ' HB ' ' CD1' ' A' ' 47' ' ' TRP . 15.4 tt -136.84 151.49 27.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.2 -0.454 . . . . 71.24 111.102 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.506 ' HA ' ' O ' ' A' ' 21' ' ' TYR . 17.1 m -132.81 140.07 47.8 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.161 -0.472 . . . . 65.23 111.165 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.55 ' CE1' HD13 ' A' ' 8' ' ' ILE . 1.0 OUTLIER -127.99 127.7 43.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.17 -0.468 . . . . 75.41 110.873 -179.947 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.527 ' CG ' ' HA ' ' A' ' 16' ' ' PHE . 14.1 m-85 -112.72 132.4 55.23 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.202 -0.454 . . . . 74.23 110.91 -179.831 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.423 ' HB2' ' HB2' ' A' ' 19' ' ' ARG . 0.0 OUTLIER -61.04 -14.71 25.3 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.125 -0.489 . . . . 74.22 110.924 179.991 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.431 ' HB2' ' O ' ' A' ' 17' ' ' GLN . 74.4 m-20 -135.93 150.43 49.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.137 -0.483 . . . . 73.15 110.868 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.481 ' N ' ' HB3' ' A' ' 38' ' ' ASN . 40.8 mtmt -55.25 -176.17 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.152 -0.476 . . . . 70.13 110.89 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 16.1 m120 46.43 32.43 1.58 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.227 -0.442 . . . . 71.44 110.939 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.527 ' HA ' ' CG ' ' A' ' 11' ' ' TYR . 3.6 m-85 49.67 64.33 1.81 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.154 -0.476 . . . . 73.34 110.877 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.431 ' O ' ' HB2' ' A' ' 13' ' ' ASP . 9.9 mt-30 -139.32 159.78 41.35 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.145 -0.48 . . . . 74.11 110.891 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 92.35 -148.19 19.03 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.786 -0.721 . . . . 71.43 112.455 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.432 ' O ' ' CD1' ' A' ' 34' ' ' LEU . 0.0 OUTLIER -70.02 77.78 0.49 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.859 0.361 . . . . 74.35 110.834 -179.795 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.448 ' HB2' ' CE1' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -76.87 129.1 35.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.163 -0.471 . . . . 74.5 110.877 -179.956 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.506 ' O ' ' HA ' ' A' ' 9' ' ' THR . 90.7 t80 -123.01 124.39 43.02 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.182 -0.463 . . . . 74.44 110.925 -179.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.462 ' CG ' HG23 ' A' ' 9' ' ' THR . 1.3 m-20 -121.06 133.99 55.26 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.142 -0.481 . . . . 74.31 110.856 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -168.13 135.59 2.17 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.213 -0.449 . . . . 71.13 110.908 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -100.94 -2.6 31.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.193 -0.458 . . . . 74.15 110.871 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.424 ' O ' ' SG ' ' A' ' 27' ' ' CYS . 15.6 t -100.9 165.68 11.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.201 -0.454 . . . . 72.0 110.904 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -59.14 120.26 8.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.2 -0.455 . . . . 74.51 110.855 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.53 ' HB2' ' HB3' ' A' ' 30' ' ' PHE . 1.7 m -115.29 51.0 0.94 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.204 -0.453 . . . . 52.44 110.879 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.489 ' O ' ' HA ' ' A' ' 82' ' ' SER . . . -46.43 -22.16 0.24 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.178 -0.464 . . . . 72.01 111.081 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 55.5 t0 -127.94 42.83 3.25 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.194 -0.457 . . . . 73.15 110.885 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.777 ' O ' ' CD2' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -81.17 15.68 1.83 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.459 . . . . 73.53 110.869 -179.929 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.503 ' HB2' ' HB3' ' A' ' 81' ' ' SER . 29.7 t60 -80.3 -39.26 29.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 74.22 110.889 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.7 t -58.43 -13.8 6.27 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.204 -0.453 . . . . 54.41 111.166 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -100.07 -26.95 13.79 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.236 -0.438 . . . . 74.52 110.947 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.432 ' CD1' ' O ' ' A' ' 19' ' ' ARG . 18.0 tp -142.79 135.11 27.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.144 -0.48 . . . . 65.23 110.93 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 25.3 m -97.63 -42.51 7.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.165 -0.47 . . . . 74.11 110.849 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -118.77 141.83 48.27 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.077 -0.511 . . . . 74.04 110.84 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.55 ' HB3' ' HB2' ' A' ' 80' ' ' LEU . 3.3 p -110.17 84.86 2.0 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.197 -0.456 . . . . 62.11 110.861 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.481 ' HB3' ' N ' ' A' ' 14' ' ' LYS . 0.2 OUTLIER -76.07 -71.1 0.4 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.238 -0.437 . . . . 75.3 110.871 -179.934 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 5.2 p -111.53 124.07 51.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.184 -0.462 . . . . 65.22 110.903 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.618 ' O ' ' HB2' ' A' ' 67' ' ' TYR . 43.0 mt -117.25 149.32 19.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.151 -0.477 . . . . 75.04 111.113 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.483 ' N ' HG23 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -144.67 120.36 10.49 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.126 -0.488 . . . . 70.44 110.93 179.812 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.57 HG22 ' HB2' ' A' ' 47' ' ' TRP . 1.5 t -105.25 116.32 48.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.216 -0.447 . . . . 73.23 111.123 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -111.11 79.22 1.18 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.174 -0.467 . . . . 73.43 110.897 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.479 ' O ' ' HA ' ' A' ' 6' ' ' THR . . . 129.9 104.31 1.08 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.74 -0.743 . . . . 71.14 112.513 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 53.08 175.18 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.681 -0.771 . . . . 63.42 112.526 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.489 HG21 ' HA ' ' A' ' 63' ' ' PRO . 1.0 OUTLIER -76.84 169.03 19.07 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.74 0.305 . . . . 71.34 111.148 -179.856 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.624 ' CD1' ' HB ' ' A' ' 8' ' ' ILE . 3.6 m95 -141.68 130.18 22.58 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.238 -0.437 . . . . 74.22 110.917 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.595 ' O ' ' N ' ' A' ' 84' ' ' ARG . . . -94.16 127.12 39.81 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.212 -0.449 . . . . 64.2 111.066 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.522 HG11 HD12 ' A' ' 80' ' ' LEU . 12.2 m -125.33 131.01 72.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.203 -0.453 . . . . 73.41 111.119 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.75 ' HB3' ' HA ' ' A' ' 56' ' ' ALA . 43.1 m-85 -98.32 147.3 24.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.174 -0.466 . . . . 75.41 110.937 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.644 ' OE1' ' HB3' ' A' ' 57' ' ' TRP . 46.9 tt0 -48.93 -79.68 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.13 -0.487 . . . . 73.02 110.865 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.53 ' HB3' ' CD1' ' A' ' 55' ' ' PHE . 0.0 OUTLIER -92.24 143.82 28.05 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.599 0.714 . . . . 73.03 110.853 -179.856 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.697 ' HA ' ' OG ' ' A' ' 82' ' ' SER . 53.7 Cg_endo -69.73 141.38 45.2 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.694 2.263 . . . . 73.55 112.381 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 63.54 -11.22 0.11 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.261 -0.427 . . . . 74.32 110.85 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.629 ' H ' ' C ' ' A' ' 53' ' ' PRO . 2.6 m-30 -104.45 -21.47 13.46 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.228 -0.442 . . . . 74.33 110.863 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.75 ' HA ' ' HB3' ' A' ' 50' ' ' TYR . . . 51.35 25.85 2.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.116 -0.493 . . . . 72.54 111.108 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . 0.644 ' HB3' ' OE1' ' A' ' 51' ' ' GLU . 0.0 OUTLIER -49.48 -163.1 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.215 -0.448 . . . . 74.1 110.948 179.995 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.638 ' C ' ' O ' ' A' ' 57' ' ' TRP . 6.1 m-30 -13.41 102.6 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.219 -0.446 . . . . 74.22 110.992 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.42 ' HB2' ' O ' ' A' ' 149' ' ' GLN . 2.0 mpt? -67.85 148.26 51.42 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.13 -0.486 . . . . 75.44 110.872 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.425 ' O ' ' O ' ' A' ' 49' ' ' VAL . 3.0 t80 -164.7 108.17 0.89 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.211 -0.449 . . . . 71.43 110.905 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.55 ' N ' ' CD1' ' A' ' 61' ' ' ILE . 1.4 mp -93.67 116.88 35.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.131 -0.486 . . . . 75.13 111.089 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -83.95 127.96 64.95 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.559 0.695 . . . . 74.35 110.901 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.489 ' HA ' HG21 ' A' ' 46' ' ' THR . 53.6 Cg_endo -69.76 -172.85 0.62 Allowed 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.652 2.235 . . . . 75.42 112.344 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.35 161.79 16.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.225 -0.443 . . . . 73.45 110.864 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 112.83 -165.61 12.06 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.702 -0.761 . . . . 44.44 112.459 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -109.93 154.36 23.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.901 0.382 . . . . 74.0 110.881 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.618 ' HB2' ' O ' ' A' ' 40' ' ' ILE . 10.7 m-85 -143.88 83.75 10.19 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.699 0.762 . . . . 71.41 110.944 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.477 ' HD2' ' HG3' ' A' ' 72' ' ' ARG . 53.8 Cg_endo -69.74 0.79 5.11 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.709 2.272 . . . . 73.44 112.344 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.518 ' HB2' ' HG2' ' A' ' 72' ' ' ARG . 41.3 mt-10 -155.88 144.11 19.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.457 . . . . 64.0 110.929 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.714 ' HA ' ' NE1' ' A' ' 73' ' ' TRP . 32.3 p90 -55.92 -21.65 21.67 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.172 -0.467 . . . . 72.53 110.883 -179.813 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -79.78 -16.47 55.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.144 -0.48 . . . . 74.04 110.921 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.518 ' HG2' ' HB2' ' A' ' 69' ' ' GLU . 28.1 mmt180 -69.47 -9.17 52.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.161 -0.472 . . . . 74.43 110.848 -179.895 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . 0.72 ' N ' ' CD1' ' A' ' 73' ' ' TRP . 0.0 OUTLIER -134.49 16.52 3.68 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.197 -0.456 . . . . 75.24 110.911 -179.966 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' MET . . . . . 0.406 ' C ' ' O ' ' A' ' 73' ' ' TRP . 0.0 OUTLIER 37.75 42.91 0.43 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.284 -0.416 . . . . 73.31 110.866 179.911 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -58.03 120.59 22.46 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.753 -0.737 . . . . 72.5 112.515 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.58 HD22 ' HB2' ' A' ' 77' ' ' ASN . 0.0 OUTLIER -70.05 -10.7 59.56 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.787 0.327 . . . . 71.54 110.872 -179.898 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.58 ' HB2' HD22 ' A' ' 76' ' ' LEU . 30.2 t-20 -156.36 131.24 9.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.199 -0.455 . . . . 73.53 110.904 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -83.95 23.06 1.06 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.186 -0.461 . . . . 63.22 110.868 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -109.92 78.47 1.13 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.195 -0.457 . . . . 75.43 110.891 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.55 ' HB2' ' HB3' ' A' ' 37' ' ' CYS . 0.0 OUTLIER -85.77 133.51 33.99 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.167 -0.47 . . . . 74.12 110.929 -179.999 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.589 ' HB3' ' HB3' ' A' ' 53' ' ' PRO . 0.9 OUTLIER -150.03 -125.04 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.184 -0.462 . . . . 65.2 110.912 -179.947 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.697 ' OG ' ' HA ' ' A' ' 53' ' ' PRO . 0.0 OUTLIER -35.03 103.81 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.12 -0.491 . . . . 65.44 110.832 -179.833 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . 0.502 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 19.8 p -121.88 134.45 54.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.152 -0.476 . . . . 74.31 110.854 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.595 ' N ' ' O ' ' A' ' 48' ' ' ALA . 11.6 mmt85 -120.4 139.51 52.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.184 -0.462 . . . . 74.52 110.871 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.431 ' N ' ' CZ3' ' A' ' 47' ' ' TRP . . . -58.15 129.17 40.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 73.51 111.111 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.499 HG13 ' CG1' ' A' ' 136' ' ' VAL . 55.5 t -113.23 133.74 58.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.194 -0.457 . . . . 64.22 111.093 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . 0.454 ' O ' ' C ' ' A' ' 88' ' ' LEU . 23.1 m80 -114.43 111.21 21.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.113 -0.494 . . . . 75.14 110.827 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.454 ' C ' ' O ' ' A' ' 87' ' ' HIS . 0.0 OUTLIER -33.39 140.13 0.24 Allowed Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.564 0.697 . . . . 74.1 110.937 -179.986 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.56 ' HB3' ' H ' ' A' ' 136' ' ' VAL . 53.7 Cg_endo -69.79 105.13 1.44 Allowed 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.718 2.278 . . . . 74.14 112.331 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -106.16 -177.97 3.52 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.201 -0.454 . . . . 74.31 110.833 -179.815 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 45.45 63.22 2.82 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.74 -0.743 . . . . 45.23 112.476 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.41 ' O ' ' C ' ' A' ' 93' ' ' GLN . . . 123.82 20.65 2.53 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.716 -0.754 . . . . 74.44 112.493 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.456 ' O ' ' HG2' ' A' ' 134' ' ' GLU . 2.0 pt20 37.47 -120.67 0.2 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.839 0.352 . . . . 73.12 110.901 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.481 ' O ' ' HA ' ' A' ' 112' ' ' THR . 0.0 OUTLIER -124.87 100.78 6.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.19 -0.459 . . . . 73.35 110.945 -179.86 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.415 ' H ' ' HG2' ' A' ' 134' ' ' GLU . 31.3 tptt -110.69 126.53 54.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.173 -0.467 . . . . 73.3 110.929 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 8.0 tt -147.54 136.17 15.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.198 -0.456 . . . . 74.43 111.108 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.413 ' HB2' ' O ' ' A' ' 131' ' ' LYS . 1.2 mt-30 -107.82 131.56 54.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.203 -0.453 . . . . 74.12 110.925 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 13.1 pt -111.41 136.79 46.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.192 -0.458 . . . . 71.3 111.117 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.568 ' HB2' ' CB ' ' A' ' 129' ' ' SER . 62.4 m-85 -124.82 136.9 54.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.196 -0.456 . . . . 72.31 110.895 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -68.95 -58.3 4.31 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.099 -0.501 . . . . 73.11 110.905 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 21.0 mttt -101.59 149.46 24.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.126 -0.488 . . . . 75.23 110.942 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -57.8 163.72 7.94 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.755 -0.736 . . . . 74.12 112.469 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.505 ' HA ' ' HB2' ' A' ' 158' ' ' ARG . 42.1 t0 64.13 29.0 14.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.853 0.359 . . . . 71.44 110.912 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.666 ' CZ ' ' HB3' ' A' ' 158' ' ' ARG . 5.1 m-85 57.51 46.07 18.48 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.174 -0.466 . . . . 75.01 110.888 -179.873 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 2.3 m -114.08 158.02 21.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.181 -0.463 . . . . 72.2 110.871 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 86.88 -137.09 14.52 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.711 -0.756 . . . . 53.51 112.488 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 38.1 tp60 -90.39 126.6 35.93 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.812 0.339 . . . . 75.51 110.934 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' MET . . . . . 0.444 ' HB2' ' CE1' ' A' ' 99' ' ' PHE . 19.1 ttp -113.17 146.3 39.49 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.215 -0.448 . . . . 73.34 110.875 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -152.6 137.19 16.87 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.192 -0.458 . . . . 74.53 110.95 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -119.31 113.8 21.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.161 -0.472 . . . . 74.21 110.905 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 14.6 t -124.24 145.9 49.07 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.163 -0.471 . . . . 75.24 111.108 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.481 ' HA ' ' O ' ' A' ' 94' ' ' TYR . 1.5 t -122.92 41.64 3.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.205 -0.452 . . . . 65.0 111.129 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -150.59 -172.74 4.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.262 -0.426 . . . . 72.23 110.888 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -84.39 164.57 18.83 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.159 -0.473 . . . . 74.2 110.836 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 8.2 t -157.89 129.14 3.77 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.64 0.733 . . . . 74.42 110.914 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.701 ' O ' ' HB2' ' A' ' 172' ' ' SER . 53.9 Cg_endo -69.75 -44.15 2.25 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.718 2.279 . . . . 73.21 112.384 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.62 ' HB3' ' CB ' ' A' ' 120' ' ' GLU . 0.1 OUTLIER -138.8 102.78 4.65 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.172 -0.467 . . . . 74.33 110.874 -179.859 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.602 ' HB ' ' O ' ' A' ' 171' ' ' GLN . 3.0 tt -51.13 -30.08 9.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.101 -0.5 . . . . 75.4 111.144 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' MET . . . . . 0.561 ' O ' ' HA ' ' A' ' 123' ' ' HIS . 3.6 ttt -85.32 -46.19 11.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.159 -0.473 . . . . 72.55 110.867 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.62 ' CB ' ' HB3' ' A' ' 117' ' ' SER . 14.1 tp10 -63.42 -13.6 41.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.183 -0.462 . . . . 73.51 110.866 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 26.3 tp60 -114.7 -52.91 2.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.156 -0.475 . . . . 72.34 110.931 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . 0.5 ' HB2' ' O ' ' A' ' 118' ' ' ILE . 86.7 m-85 -99.33 -22.44 15.58 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.456 . . . . 74.43 110.864 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . 0.561 ' HA ' ' O ' ' A' ' 119' ' ' MET . 0.5 OUTLIER 76.67 24.6 0.96 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.176 -0.466 . . . . 70.25 110.87 179.984 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.469 ' O ' ' CG2' ' A' ' 118' ' ' ILE . 9.4 mtt -103.38 81.79 1.97 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.186 -0.461 . . . . 74.42 110.865 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 2.1 ptp85 -46.82 -40.99 14.8 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.251 -0.431 . . . . 74.42 110.854 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.491 ' HB3' ' HG2' ' A' ' 168' ' ' PRO . 32.7 mt-10 -142.67 130.43 21.54 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.162 -0.472 . . . . 74.22 110.9 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.427 ' O ' ' HB3' ' A' ' 168' ' ' PRO . 1.3 mp -87.69 97.1 6.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.219 -0.446 . . . . 63.52 111.13 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . 0.443 ' HA ' ' HB3' ' A' ' 160' ' ' PRO . 16.8 m170 -69.67 -25.99 64.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.218 -0.446 . . . . 74.54 110.908 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.568 ' CB ' ' HB2' ' A' ' 99' ' ' PHE . 0.0 OUTLIER -136.68 139.02 41.67 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.158 -0.474 . . . . 75.25 110.828 -179.788 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . 0.598 ' O ' ' O ' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -138.17 119.52 14.76 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.108 -0.497 . . . . 74.23 110.846 -179.975 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.631 ' HA ' ' HA ' ' A' ' 156' ' ' GLU . 4.4 mtpp -113.08 152.31 29.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.15 -0.477 . . . . 64.41 110.897 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.476 ' CB ' ' O ' ' A' ' 131' ' ' LYS . 10.8 t 84.15 163.58 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.183 -0.462 . . . . 74.43 111.13 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.419 ' HB3' ' HA ' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -177.45 124.58 0.13 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.198 -0.456 . . . . 71.4 110.973 179.943 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.542 ' O ' ' C ' ' A' ' 135' ' ' GLY . 0.2 OUTLIER -99.58 167.09 10.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.165 -0.471 . . . . 75.13 110.887 179.965 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . 0.542 ' C ' ' O ' ' A' ' 134' ' ' GLU . . . -24.93 -74.03 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.698 -0.763 . . . . 72.44 112.528 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.727 ' HA ' HD13 ' A' ' 152' ' ' LEU . 3.1 t -135.01 147.97 29.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.84 0.353 . . . . 72.13 111.127 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . 0.549 ' H ' ' CD1' ' A' ' 152' ' ' LEU . 0.0 OUTLIER -152.03 162.41 41.13 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.202 -0.454 . . . . 71.33 110.929 179.977 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.486 HD12 ' HB ' ' A' ' 61' ' ' ILE . 19.4 mt -135.15 137.69 49.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.234 -0.439 . . . . 74.04 111.1 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -110.93 146.12 37.14 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.154 -0.475 . . . . 72.45 110.892 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . 0.704 ' CE2' ' HA ' ' A' ' 145' ' ' TYR . 0.6 OUTLIER -107.08 131.14 54.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.13 -0.486 . . . . 72.25 110.912 -179.831 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . 0.596 ' O ' ' NE2' ' A' ' 171' ' ' GLN . 7.5 tt0 -70.66 -27.3 63.93 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.086 -0.507 . . . . 73.22 110.9 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.582 ' O ' ' HB3' ' A' ' 172' ' ' SER . 5.8 mp -113.37 147.15 36.82 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.58 0.705 . . . . 73.43 110.931 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . 0.683 ' CD ' ' HG2' ' A' ' 171' ' ' GLN . 53.9 Cg_endo -69.7 43.68 0.38 Allowed 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.694 2.262 . . . . 74.05 112.349 179.834 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . 1.093 ' O ' ' N ' ' A' ' 146' ' ' ARG . 0.4 OUTLIER 177.87 111.49 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.209 -0.45 . . . . 71.42 110.888 179.96 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . 0.704 ' HA ' ' CE2' ' A' ' 140' ' ' TYR . 0.1 OUTLIER -6.59 52.18 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.156 -0.475 . . . . 73.15 110.876 -179.892 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . 1.093 ' N ' ' O ' ' A' ' 144' ' ' ASN . 40.7 mtt180 -140.16 170.52 15.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.121 -0.49 . . . . 73.43 110.885 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 81.0 -167.61 49.92 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.706 -0.759 . . . . 61.13 112.464 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.401 ' HG2' ' CD1' ' A' ' 58' ' ' TYR . 0.5 OUTLIER -88.58 142.98 27.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.778 0.323 . . . . 74.0 110.901 -179.935 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . 0.42 ' O ' ' HB2' ' A' ' 59' ' ' MET . 74.0 mt-30 -84.07 162.83 20.2 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.157 -0.474 . . . . 74.12 110.931 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -134.96 116.73 15.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.238 -0.437 . . . . 74.3 110.985 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.427 ' CA ' HD12 ' A' ' 61' ' ' ILE . 9.9 tp -68.6 119.09 12.48 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.129 -0.487 . . . . 74.25 110.877 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.727 HD13 ' HA ' ' A' ' 136' ' ' VAL . 0.0 OUTLIER -51.4 135.45 27.22 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.18 -0.464 . . . . 72.44 110.903 179.899 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -163.37 24.84 0.08 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.177 -0.465 . . . . 75.43 110.848 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.778 ' HB2' ' CD1' ' A' ' 157' ' ' TYR . 0.0 OUTLIER -115.47 -173.54 2.35 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.252 -0.431 . . . . 74.12 110.913 -179.996 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.747 ' HD2' ' C ' ' A' ' 154' ' ' LYS . 0.8 OUTLIER -161.48 -124.56 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.264 -0.425 . . . . 73.33 110.904 179.907 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.631 ' HA ' ' HA ' ' A' ' 131' ' ' LYS . 1.7 tm-20 -70.43 2.74 3.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 74.22 110.876 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . 0.778 ' CD1' ' HB2' ' A' ' 154' ' ' LYS . 18.4 m-30 -32.79 147.04 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.167 -0.469 . . . . 72.14 110.904 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . 0.666 ' HB3' ' CZ ' ' A' ' 104' ' ' PHE . 8.2 ptp180 -113.5 -37.45 4.63 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.097 -0.501 . . . . 73.3 110.844 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -89.01 152.54 48.44 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.576 0.703 . . . . 63.44 110.869 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . 0.521 ' HB3' ' HB3' ' A' ' 168' ' ' PRO . 54.3 Cg_endo -69.74 -29.29 24.2 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.658 2.239 . . . . 71.11 112.369 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.516 HD11 ' H ' ' A' ' 161' ' ' ILE . 4.3 mp -66.37 -10.5 11.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.216 -0.447 . . . . 74.32 111.161 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . 0.677 ' HB3' ' CD1' ' A' ' 157' ' ' TYR . 0.5 OUTLIER -77.0 -13.94 59.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.143 -0.481 . . . . 74.04 110.853 179.848 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 26.3 t90 -87.95 -7.68 56.78 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.245 -0.434 . . . . 74.12 110.921 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 99.3 -36.82 3.81 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.755 -0.736 . . . . 63.2 112.454 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -76.88 126.7 31.42 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.8 0.333 . . . . 72.23 111.149 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -37.27 -42.83 0.49 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.229 -0.441 . . . . 62.3 111.053 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' SER . . . . . 0.528 ' C ' ' H ' ' A' ' 169' ' ' ALA . 0.5 OUTLIER -127.64 152.34 76.65 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.68 0.752 . . . . 71.45 110.835 -179.786 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . 0.521 ' HB3' ' HB3' ' A' ' 160' ' ' PRO . 53.7 Cg_endo -69.76 27.97 0.18 Allowed 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.689 2.259 . . . . 71.4 112.379 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . 0.528 ' H ' ' C ' ' A' ' 167' ' ' SER . . . -67.6 99.98 0.83 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.215 -0.448 . . . . 55.32 111.149 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.475 ' HA ' ' NE2' ' A' ' 171' ' ' GLN . 1.4 t -155.41 173.62 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.195 -0.457 . . . . 63.53 111.108 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' GLN . . . . . 0.683 ' HG2' ' CD ' ' A' ' 143' ' ' PRO . 0.0 OUTLIER -159.17 -97.55 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.165 -0.47 . . . . 75.43 110.91 -179.998 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' SER . . . . . 0.701 ' HB2' ' O ' ' A' ' 116' ' ' PRO . 0.0 OUTLIER -64.62 153.77 38.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.23 -0.441 . . . . 61.53 110.851 -179.791 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 1.2 p90 -151.96 158.21 42.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.146 -0.479 . . . . 73.33 110.888 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . 0.455 ' HG2' ' CE2' ' A' ' 140' ' ' TYR . 1.3 ptp180 -130.22 142.39 50.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.17 -0.468 . . . . 73.44 110.935 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . 0.435 ' HD2' ' CE2' ' A' ' 94' ' ' TYR . 0.0 OUTLIER -98.19 -169.21 1.77 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.21 -0.45 . . . . 74.41 110.902 -179.882 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . 0.466 HD11 ' C ' ' A' ' 136' ' ' VAL . 4.1 mt -139.05 132.03 38.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.222 -0.444 . . . . 72.44 111.17 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 4.8 p -144.62 155.83 14.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.208 -0.451 . . . . 75.34 111.085 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.125 -0.488 . . . . 72.04 110.933 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.066 0 CA-C-O 120.829 0.347 . . . . 75.3 110.903 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.4 p -95.24 73.81 3.36 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.206 -0.452 . . . . 73.21 110.839 -179.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.51 61.09 3.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.115 -0.493 . . . . 72.45 110.911 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 27.1 p -53.98 -35.79 62.2 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.178 -0.464 . . . . 73.32 111.142 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 159.8 128.27 0.96 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.727 -0.749 . . . . 73.2 112.475 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.441 ' HA ' ' O ' ' A' ' 44' ' ' GLY . 10.9 p -82.33 136.11 35.07 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.898 0.38 . . . . 75.32 111.122 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.434 ' N ' ' HE1' ' A' ' 47' ' ' TRP . 2.6 tttt -127.91 138.12 52.54 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.203 -0.453 . . . . 74.41 110.852 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.547 HD13 ' CE1' ' A' ' 10' ' ' PHE . 16.0 tt -136.68 150.89 27.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.165 -0.47 . . . . 74.34 111.084 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.404 ' CG2' ' CE2' ' A' ' 11' ' ' TYR . 9.3 m -132.55 140.94 48.51 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.159 -0.473 . . . . 64.1 111.111 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.547 ' CE1' HD13 ' A' ' 8' ' ' ILE . 1.6 m-85 -129.2 131.68 47.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.228 -0.442 . . . . 75.44 110.924 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.528 ' CG ' ' HA ' ' A' ' 16' ' ' PHE . 6.2 m-85 -117.41 134.09 55.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.142 -0.481 . . . . 74.35 110.915 -179.825 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.419 ' HA ' ' O ' ' A' ' 36' ' ' ARG . 0.0 OUTLIER -56.83 -28.56 61.74 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.129 -0.487 . . . . 72.5 110.848 -179.968 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 49.4 m-20 -123.29 155.42 37.26 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.201 -0.454 . . . . 61.22 110.855 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 7.9 mtmm -57.41 -173.35 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 72.54 110.884 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 23.3 m-20 44.34 34.76 1.11 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.2 -0.454 . . . . 75.25 110.851 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.528 ' HA ' ' CG ' ' A' ' 11' ' ' TYR . 2.6 m-85 47.7 59.8 3.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.227 -0.442 . . . . 75.33 110.878 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 10.6 mt-30 -133.23 154.14 50.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.172 -0.467 . . . . 73.32 110.918 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 95.67 -154.43 20.96 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.768 -0.73 . . . . 44.13 112.446 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.426 ' O ' ' CD1' ' A' ' 34' ' ' LEU . 0.6 OUTLIER -63.65 81.7 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.857 0.361 . . . . 75.12 110.86 -179.838 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.495 ' HB2' ' CE1' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -81.05 127.52 32.69 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.193 -0.458 . . . . 75.55 110.859 -179.918 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.449 ' CZ ' ' CD1' ' A' ' 33' ' ' TYR . 82.8 t80 -124.23 125.71 44.86 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.217 -0.447 . . . . 72.31 110.903 -179.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -111.25 131.45 55.13 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.11 -0.495 . . . . 74.23 110.876 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -142.58 143.12 32.31 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.19 -0.459 . . . . 74.41 110.856 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -125.64 5.09 7.5 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.191 -0.459 . . . . 74.23 110.894 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 50.6 t -129.71 159.19 37.25 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.137 -0.483 . . . . 64.25 110.91 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -42.87 108.48 0.1 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.177 -0.465 . . . . 64.22 110.878 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.598 ' HB3' ' HB3' ' A' ' 30' ' ' PHE . 0.1 OUTLIER -119.8 51.38 1.18 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.202 -0.453 . . . . 64.55 110.887 -179.92 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.539 ' C ' ' HA ' ' A' ' 82' ' ' SER . . . -50.61 -14.61 0.2 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.209 -0.451 . . . . 65.53 111.08 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 63.6 t0 -127.3 42.21 3.37 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.227 -0.442 . . . . 64.51 110.88 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.819 ' O ' ' CD2' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -82.28 14.34 3.0 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.192 -0.458 . . . . 73.44 110.849 -179.885 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.494 ' HB2' ' HB3' ' A' ' 53' ' ' PRO . 31.3 t60 -76.8 -44.4 32.82 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.158 -0.474 . . . . 65.42 110.854 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.405 HG21 ' CD2' ' A' ' 33' ' ' TYR . 9.7 t -54.7 -13.57 1.06 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.156 -0.475 . . . . 73.52 111.147 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.486 ' CD1' ' HA ' ' A' ' 30' ' ' PHE . 12.3 m-85 -97.27 -29.65 13.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.224 -0.444 . . . . 71.3 110.91 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.435 ' O ' ' O ' ' A' ' 31' ' ' HIS . 31.7 tp -137.85 140.35 40.41 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.101 -0.5 . . . . 72.55 110.907 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 2.6 m -104.16 -38.71 6.8 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.155 -0.475 . . . . 70.42 110.861 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.419 ' O ' ' HA ' ' A' ' 12' ' ' GLU . 0.2 OUTLIER -111.18 140.85 45.4 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.172 -0.467 . . . . 75.11 110.839 -179.928 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.471 ' SG ' ' CB ' ' A' ' 80' ' ' LEU . 2.0 m -122.46 76.35 1.32 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.157 -0.474 . . . . 71.54 110.871 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -80.15 -71.11 0.47 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.142 -0.481 . . . . 73.1 110.842 -179.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 4.8 p -104.52 134.54 47.53 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.157 -0.474 . . . . 73.15 110.869 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.634 ' O ' ' HB2' ' A' ' 67' ' ' TYR . 19.4 mt -126.86 151.69 33.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.124 -0.489 . . . . 73.41 111.147 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.456 ' HD2' ' CE2' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -146.59 122.12 10.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.201 -0.454 . . . . 75.33 110.856 179.894 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.48 ' HA ' ' HA ' ' A' ' 8' ' ' ILE . 1.4 t -108.41 114.63 47.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.259 -0.428 . . . . 74.3 111.134 179.824 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.407 ' N ' ' O ' ' A' ' 7' ' ' LYS . 1.5 mm-40 -109.79 79.06 1.17 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.193 -0.458 . . . . 72.41 110.827 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.441 ' O ' ' HA ' ' A' ' 6' ' ' THR . . . 134.2 102.72 0.76 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.794 -0.717 . . . . 55.01 112.524 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 52.21 -178.26 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.723 -0.751 . . . . 72.23 112.471 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.496 HG21 ' HA ' ' A' ' 63' ' ' PRO . 0.6 OUTLIER -81.57 172.19 13.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.809 0.338 . . . . 74.11 111.117 -179.846 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.467 ' CD1' ' HB ' ' A' ' 8' ' ' ILE . 13.2 m95 -142.59 130.04 21.23 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.214 -0.448 . . . . 70.31 110.898 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.509 ' CB ' ' CG2' ' A' ' 86' ' ' VAL . . . -97.39 108.89 21.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.234 -0.439 . . . . 71.43 111.109 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.522 ' HA ' ' HA ' ' A' ' 83' ' ' CYS . 4.2 m -111.45 130.96 64.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.215 -0.448 . . . . 73.14 111.13 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.641 ' HB3' ' HA ' ' A' ' 56' ' ' ALA . 56.6 m-85 -93.88 148.56 22.02 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.177 -0.465 . . . . 75.14 110.947 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.639 ' OE1' ' HB3' ' A' ' 57' ' ' TRP . 39.1 tt0 -45.38 -78.22 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.103 -0.499 . . . . 63.5 110.892 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.634 ' HB3' ' CD2' ' A' ' 55' ' ' PHE . 0.2 OUTLIER -90.78 144.77 30.81 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.574 0.702 . . . . 74.24 110.906 -179.924 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.7 ' HA ' ' OG ' ' A' ' 82' ' ' SER . 54.0 Cg_endo -69.79 131.38 21.08 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.688 2.259 . . . . 74.3 112.35 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 67.8 -8.2 0.54 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.218 -0.446 . . . . 72.3 110.891 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.634 ' CD2' ' HB3' ' A' ' 52' ' ' ARG . 6.2 m-30 -98.43 -27.73 13.94 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.181 -0.463 . . . . 73.14 110.884 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.641 ' HA ' ' HB3' ' A' ' 50' ' ' TYR . . . 62.79 16.42 9.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.173 -0.467 . . . . 64.32 111.153 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . 0.646 ' O ' ' C ' ' A' ' 58' ' ' TYR . 0.1 OUTLIER -49.02 -167.94 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.176 -0.465 . . . . 73.53 110.923 -179.958 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.646 ' C ' ' O ' ' A' ' 57' ' ' TRP . 8.1 m-30 -13.06 103.08 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.217 -0.447 . . . . 72.34 110.908 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.422 ' HB2' ' O ' ' A' ' 149' ' ' GLN . 1.9 mpt? -68.54 148.66 50.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.148 -0.478 . . . . 73.42 110.844 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.449 ' O ' ' O ' ' A' ' 49' ' ' VAL . 3.3 t80 -163.66 108.77 1.05 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.232 -0.44 . . . . 72.44 110.943 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.543 ' N ' ' CD1' ' A' ' 61' ' ' ILE . 1.5 mp -95.02 116.13 35.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.081 -0.508 . . . . 74.1 111.121 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -84.07 128.78 61.23 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.611 0.719 . . . . 75.41 110.932 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.496 ' HA ' HG21 ' A' ' 46' ' ' THR . 53.8 Cg_endo -69.74 -172.74 0.61 Allowed 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.705 2.27 . . . . 74.24 112.368 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -88.12 161.96 17.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.246 -0.434 . . . . 75.25 110.877 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 112.2 -167.94 12.55 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.719 -0.753 . . . . 42.11 112.457 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -108.05 156.44 19.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.855 0.359 . . . . 73.33 110.862 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.634 ' HB2' ' O ' ' A' ' 40' ' ' ILE . 15.7 m-85 -144.19 84.39 9.5 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.684 0.754 . . . . 74.13 110.904 -179.869 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.453 ' HD2' ' HG3' ' A' ' 72' ' ' ARG . 53.2 Cg_endo -69.83 2.83 3.21 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.7 2.267 . . . . 73.4 112.344 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.582 ' HB2' ' HG2' ' A' ' 72' ' ' ARG . 52.6 mt-10 -157.38 143.45 17.7 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.199 -0.455 . . . . 75.32 110.889 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.731 ' HA ' ' NE1' ' A' ' 73' ' ' TRP . 30.6 p90 -55.35 -21.39 14.99 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.161 -0.472 . . . . 52.33 110.916 -179.86 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -81.25 -17.15 50.48 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.099 -0.501 . . . . 74.02 110.876 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.582 ' HG2' ' HB2' ' A' ' 69' ' ' GLU . 33.0 mmt180 -68.32 -10.61 56.06 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.233 -0.439 . . . . 74.35 110.853 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . 0.731 ' NE1' ' HA ' ' A' ' 70' ' ' TYR . 0.0 OUTLIER -133.13 17.7 4.1 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.182 -0.463 . . . . 74.43 110.869 -179.953 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 40.56 37.45 0.47 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.275 -0.42 . . . . 73.33 110.868 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -52.06 114.22 3.08 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.738 -0.744 . . . . 64.4 112.521 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.592 HD12 ' N ' ' A' ' 76' ' ' LEU . 0.0 OUTLIER -63.82 -16.7 61.93 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.781 0.324 . . . . 74.32 110.87 -179.889 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.523 ' HB2' HD21 ' A' ' 76' ' ' LEU . 57.8 t-20 -157.87 130.53 7.32 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.194 -0.457 . . . . 75.14 110.936 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -77.5 9.17 3.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.174 -0.466 . . . . 62.15 110.879 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.419 ' HG2' ' O ' ' A' ' 79' ' ' ARG . 24.1 ttt85 -88.9 38.38 0.88 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.205 -0.452 . . . . 71.34 110.889 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.471 ' CB ' ' SG ' ' A' ' 37' ' ' CYS . 0.1 OUTLIER -56.7 126.84 28.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.143 -0.481 . . . . 74.34 110.87 -179.931 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.641 ' HB3' ' HB3' ' A' ' 53' ' ' PRO . 4.4 m -142.8 -117.55 0.1 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.191 -0.459 . . . . 73.34 110.889 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.7 ' OG ' ' HA ' ' A' ' 53' ' ' PRO . 0.4 OUTLIER -30.38 130.36 0.1 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.127 -0.488 . . . . 75.4 110.844 -179.848 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . 0.522 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 11.0 p -138.74 144.43 39.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.176 -0.466 . . . . 75.43 110.855 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.508 ' N ' ' O ' ' A' ' 48' ' ' ALA . 0.6 OUTLIER -141.31 128.17 20.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.165 -0.47 . . . . 74.23 110.905 -179.865 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.429 ' N ' ' CZ3' ' A' ' 47' ' ' TRP . . . -49.64 126.89 14.61 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.24 -0.437 . . . . 51.32 111.126 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.509 ' CG2' ' CB ' ' A' ' 48' ' ' ALA . 48.4 t -114.17 132.9 61.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.214 -0.448 . . . . 75.04 111.126 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . 0.431 ' O ' ' CG2' ' A' ' 136' ' ' VAL . 20.3 m-70 -108.15 105.18 14.8 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.16 -0.473 . . . . 75.32 110.872 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.426 ' C ' ' O ' ' A' ' 87' ' ' HIS . 0.0 OUTLIER -35.55 144.29 0.24 Allowed Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.566 0.698 . . . . 72.31 110.931 179.993 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.507 ' HA ' ' HA3' ' A' ' 135' ' ' GLY . 54.1 Cg_endo -69.76 87.67 0.55 Allowed 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.684 2.256 . . . . 74.43 112.323 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -105.92 -177.57 3.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.265 -0.425 . . . . 51.52 110.846 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 60.88 23.94 61.96 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.74 -0.743 . . . . 73.33 112.5 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.413 ' O ' ' C ' ' A' ' 93' ' ' GLN . . . 153.24 34.33 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.735 -0.745 . . . . 44.41 112.452 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.492 ' O ' ' CG ' ' A' ' 134' ' ' GLU . 23.6 pt20 36.37 -135.07 0.05 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.811 0.339 . . . . 63.01 110.916 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.48 ' O ' ' HA ' ' A' ' 112' ' ' THR . 13.9 t80 -119.71 106.8 12.49 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.184 -0.462 . . . . 70.35 110.907 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.44 ' H ' ' HG2' ' A' ' 134' ' ' GLU . 36.3 tptt -108.65 128.69 55.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.107 -0.497 . . . . 75.52 110.922 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 6.8 tt -148.39 144.17 18.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.231 -0.44 . . . . 73.3 111.116 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.578 ' O ' ' HA ' ' A' ' 130' ' ' CYS . 1.3 mt-30 -115.97 111.57 20.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.153 -0.476 . . . . 74.53 110.897 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 2.7 mm -86.49 140.97 15.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.222 -0.445 . . . . 75.42 111.11 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.573 ' HB2' ' HB2' ' A' ' 129' ' ' SER . 57.4 m-85 -130.91 133.16 45.6 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.201 -0.454 . . . . 73.54 110.878 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 60.6 tt0 -61.4 -80.14 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.189 -0.459 . . . . 74.43 110.878 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 12.2 mttt -85.51 162.44 18.92 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.145 -0.479 . . . . 71.41 110.898 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -67.86 162.28 48.55 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.691 -0.766 . . . . 62.45 112.512 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.5 ' HA ' ' HB2' ' A' ' 158' ' ' ARG . 36.5 t70 64.46 27.16 13.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.861 0.362 . . . . 75.15 110.876 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.525 ' CZ ' ' HB3' ' A' ' 158' ' ' ARG . 8.8 m-85 59.57 48.14 9.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.153 -0.476 . . . . 74.53 110.915 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 2.9 m -113.45 143.92 43.68 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.148 -0.478 . . . . 75.32 110.85 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 96.41 -124.15 7.98 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.74 -0.743 . . . . 74.14 112.447 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 4.9 tp-100 -102.77 143.62 32.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.799 0.333 . . . . 74.25 110.841 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 2.9 ttp -130.33 146.43 51.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.182 -0.463 . . . . 74.31 110.84 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 11.8 m-85 -148.13 137.5 22.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.174 -0.466 . . . . 75.23 110.925 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -118.63 101.24 7.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.121 -0.49 . . . . 75.3 110.88 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 8.1 t -118.24 153.21 34.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 73.05 111.177 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.48 ' HA ' ' O ' ' A' ' 94' ' ' TYR . 1.4 t -125.45 47.25 2.22 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.223 -0.444 . . . . 72.31 111.116 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 75.0 mm-40 -148.32 -175.2 4.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.264 -0.426 . . . . 72.35 110.863 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -101.94 150.96 22.67 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.134 -0.485 . . . . 71.05 110.884 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 11.1 m -143.03 136.83 14.37 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.638 0.732 . . . . 74.21 110.857 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.746 ' O ' ' HB2' ' A' ' 172' ' ' SER . 53.9 Cg_endo -69.72 -34.34 14.9 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.752 2.301 . . . . 73.23 112.354 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.618 ' HB3' ' CB ' ' A' ' 120' ' ' GLU . 0.1 OUTLIER -140.79 97.96 3.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.178 -0.464 . . . . 74.11 110.839 -179.831 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.523 ' HB ' ' O ' ' A' ' 171' ' ' GLN . 5.0 tt -49.54 -28.33 3.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.146 -0.479 . . . . 71.21 111.132 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' MET . . . . . 0.569 ' O ' ' HA ' ' A' ' 123' ' ' HIS . 7.2 ttt -84.71 -42.61 15.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.157 -0.474 . . . . 73.42 110.89 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.618 ' CB ' ' HB3' ' A' ' 117' ' ' SER . 24.3 tp10 -62.5 -13.22 28.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.218 -0.446 . . . . 63.22 110.907 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.92 -52.93 2.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.152 -0.476 . . . . 73.31 110.931 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 12.0 m-30 -101.93 -18.93 15.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.205 -0.452 . . . . 74.13 110.885 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . 0.569 ' HA ' ' O ' ' A' ' 119' ' ' MET . 10.7 m80 74.5 24.62 1.74 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.136 -0.484 . . . . 74.11 110.86 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.411 ' O ' ' CG2' ' A' ' 118' ' ' ILE . 8.6 mtt -100.39 83.31 2.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.223 -0.444 . . . . 75.32 110.921 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 3.6 ptp180 -49.5 -33.05 13.5 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.186 -0.461 . . . . 75.32 110.888 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.525 ' HB3' ' HG2' ' A' ' 168' ' ' PRO . 16.0 mt-10 -145.44 129.23 17.26 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.122 -0.49 . . . . 75.43 110.886 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.443 ' O ' ' HB3' ' A' ' 168' ' ' PRO . 3.0 mm -87.33 91.13 3.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.147 -0.479 . . . . 73.24 111.122 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 13.7 m170 -61.9 -34.45 76.07 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.187 -0.461 . . . . 74.25 110.865 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.573 ' HB2' ' HB2' ' A' ' 99' ' ' PHE . 0.6 OUTLIER -135.05 152.13 51.41 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.224 -0.444 . . . . 74.42 110.887 -179.751 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . 0.597 ' O ' ' O ' ' A' ' 155' ' ' LYS . 0.1 OUTLIER -155.25 121.04 5.07 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.157 -0.474 . . . . 70.13 110.852 -179.94 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.642 ' HA ' ' HA ' ' A' ' 156' ' ' GLU . 8.7 mtpp -108.57 153.85 22.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.191 -0.459 . . . . 74.12 110.88 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.509 ' CB ' ' O ' ' A' ' 131' ' ' LYS . 11.3 t 85.76 164.7 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.197 -0.456 . . . . 73.35 111.14 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.411 ' O ' ' HG ' ' A' ' 133' ' ' LEU . 0.0 OUTLIER -176.93 122.76 0.14 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.189 -0.46 . . . . 73.21 110.921 179.918 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.614 ' O ' ' C ' ' A' ' 135' ' ' GLY . 0.0 OUTLIER -98.75 159.12 15.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.13 -0.486 . . . . 73.02 110.873 179.95 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . 0.614 ' C ' ' O ' ' A' ' 134' ' ' GLU . . . -13.57 -75.63 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.769 -0.729 . . . . 63.44 112.497 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.765 ' HA ' HD13 ' A' ' 152' ' ' LEU . 5.6 t -136.1 148.81 27.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.821 0.343 . . . . 75.54 111.129 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . 0.619 ' HB3' ' CB ' ' A' ' 152' ' ' LEU . 22.8 t90 -146.2 148.65 32.74 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.157 -0.474 . . . . 75.21 110.934 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.444 HD12 ' HB ' ' A' ' 61' ' ' ILE . 0.4 OUTLIER -118.05 135.11 59.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.245 -0.434 . . . . 72.32 111.123 179.953 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.467 ' CE1' ' HB3' ' A' ' 173' ' ' PHE . 0.1 OUTLIER -110.07 147.51 33.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.173 -0.467 . . . . 74.25 110.863 179.977 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . 0.691 ' HB2' ' O ' ' A' ' 172' ' ' SER . 0.8 OUTLIER -115.32 129.67 56.67 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.18 -0.464 . . . . 75.3 110.898 -179.855 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . 0.625 ' O ' ' NE2' ' A' ' 171' ' ' GLN . 8.1 tt0 -69.34 -28.6 66.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.126 -0.488 . . . . 75.01 110.926 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.777 ' O ' ' HB3' ' A' ' 172' ' ' SER . 5.9 mp -113.41 148.48 39.73 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.629 0.728 . . . . 74.33 110.876 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . 0.668 ' CD ' ' HG2' ' A' ' 171' ' ' GLN . 53.5 Cg_endo -69.74 43.95 0.39 Allowed 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.695 2.263 . . . . 75.04 112.328 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . 1.093 ' O ' ' N ' ' A' ' 146' ' ' ARG . 0.4 OUTLIER 177.47 111.23 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.261 -0.427 . . . . 75.42 110.928 179.996 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . 0.658 ' C ' ' O ' ' A' ' 144' ' ' ASN . 0.2 OUTLIER -6.36 52.37 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.159 -0.473 . . . . 74.12 110.911 -179.895 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . 1.093 ' N ' ' O ' ' A' ' 144' ' ' ASN . 26.9 mtt180 -138.85 167.12 22.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.11 -0.495 . . . . 73.24 110.858 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 83.89 -165.35 41.79 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.692 -0.766 . . . . 64.44 112.5 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -88.07 146.45 25.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.751 0.31 . . . . 73.24 110.912 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . 0.422 ' O ' ' HB2' ' A' ' 59' ' ' MET . 28.2 mt-30 -88.59 161.91 16.66 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.239 -0.437 . . . . 75.22 110.903 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . 0.461 ' HB2' ' CB ' ' A' ' 139' ' ' PHE . 85.9 m-85 -135.72 130.87 34.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.162 -0.472 . . . . 74.33 110.932 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.449 ' CA ' HD12 ' A' ' 61' ' ' ILE . 9.2 tp -82.87 120.34 25.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.152 -0.476 . . . . 74.23 110.914 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.847 HD11 ' O ' ' A' ' 152' ' ' LEU . 0.0 OUTLIER -51.62 136.77 26.17 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.208 -0.451 . . . . 75.13 110.888 179.877 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -164.53 24.93 0.06 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.207 -0.451 . . . . 75.52 110.834 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.836 ' HB2' ' CD1' ' A' ' 157' ' ' TYR . 0.0 OUTLIER -119.42 -176.57 3.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.239 -0.437 . . . . 75.34 110.936 179.968 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.69 ' HD2' ' C ' ' A' ' 154' ' ' LYS . 1.1 mptt -159.09 -121.72 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.216 -0.447 . . . . 74.44 110.912 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.642 ' HA ' ' HA ' ' A' ' 131' ' ' LYS . 2.9 tm-20 -68.93 0.09 4.91 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.175 -0.466 . . . . 75.03 110.881 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . 0.836 ' CD1' ' HB2' ' A' ' 154' ' ' LYS . 16.5 m-30 -32.01 147.5 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.151 -0.477 . . . . 72.12 110.968 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . 0.525 ' HB3' ' CZ ' ' A' ' 104' ' ' PHE . 6.8 ptp180 -112.5 -41.78 3.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.145 -0.479 . . . . 74.22 110.85 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . 0.409 ' HB2' HD13 ' A' ' 161' ' ' ILE . 0.2 OUTLIER -85.95 150.57 53.11 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.56 0.695 . . . . 75.34 110.906 179.972 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . 0.507 ' HB3' ' HB3' ' A' ' 168' ' ' PRO . 54.1 Cg_endo -69.74 -31.57 20.36 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.719 2.279 . . . . 71.02 112.364 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.409 HD13 ' HB2' ' A' ' 159' ' ' LYS . 3.5 mp -62.25 -12.75 8.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.236 -0.438 . . . . 72.0 111.115 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . 0.592 ' HB3' ' CD1' ' A' ' 157' ' ' TYR . 0.5 OUTLIER -70.44 -12.26 61.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.216 -0.447 . . . . 55.2 110.874 179.842 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 75.4 t-105 -90.95 -12.96 34.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.23 -0.441 . . . . 74.5 110.928 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 93.03 -35.25 4.17 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.769 -0.729 . . . . 73.11 112.487 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -79.84 123.24 27.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.818 0.342 . . . . 61.23 111.076 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -49.38 122.6 6.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.167 -0.469 . . . . 64.44 111.094 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' SER . . . . . 0.508 ' C ' ' H ' ' A' ' 169' ' ' ALA . 0.5 OUTLIER 64.89 140.86 0.06 OUTLIER Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.637 0.732 . . . . 72.31 110.909 -179.768 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . 0.525 ' HG2' ' HB3' ' A' ' 126' ' ' GLU . 53.5 Cg_endo -69.8 33.6 0.2 Allowed 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.717 2.278 . . . . 74.53 112.317 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . 0.508 ' H ' ' C ' ' A' ' 167' ' ' SER . . . -67.19 98.28 0.59 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.233 -0.44 . . . . 74.21 111.148 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.481 ' HA ' ' NE2' ' A' ' 171' ' ' GLN . 1.1 t -156.97 175.32 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.221 -0.445 . . . . 65.25 111.13 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' GLN . . . . . 0.701 ' CD ' ' N ' ' A' ' 171' ' ' GLN . 0.0 OUTLIER -160.66 -99.93 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.146 -0.479 . . . . 54.3 110.911 -179.957 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' SER . . . . . 0.777 ' HB3' ' O ' ' A' ' 142' ' ' LEU . 0.1 OUTLIER -52.46 140.61 22.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.168 -0.469 . . . . 72.51 110.868 -179.793 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . 0.467 ' HB3' ' CE1' ' A' ' 139' ' ' PHE . 18.9 p90 -156.44 149.84 24.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.114 -0.494 . . . . 64.54 110.89 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . 0.456 ' HD3' ' CE2' ' A' ' 140' ' ' TYR . 0.0 OUTLIER -149.21 157.58 43.48 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.128 -0.487 . . . . 73.55 110.851 -179.899 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . 0.411 ' HG2' ' N ' ' A' ' 176' ' ' ILE . 0.0 OUTLIER -106.29 172.08 7.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.221 -0.445 . . . . 73.13 110.854 -179.938 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . 0.426 ' CD1' ' HB ' ' A' ' 136' ' ' VAL . 6.5 mt -97.78 143.38 12.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.175 -0.466 . . . . 73.55 111.132 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 67.8 t -48.36 140.72 2.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.164 -0.471 . . . . 73.4 111.128 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 116.213 -0.448 . . . . 74.24 110.907 -179.973 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.066 0 CA-C-O 120.803 0.335 . . . . 74.24 110.846 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.7 p -65.36 -61.34 2.17 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.206 -0.452 . . . . 71.52 110.847 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 52.29 59.66 4.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.103 -0.499 . . . . 74.2 110.935 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 6.9 p -83.68 53.4 2.53 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.174 -0.466 . . . . 74.34 111.114 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 68.05 125.81 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.798 -0.715 . . . . 60.01 112.468 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.474 ' C ' ' HE1' ' A' ' 47' ' ' TRP . 5.2 p -82.41 134.3 35.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.906 0.384 . . . . 64.31 111.105 -179.832 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 3.9 tttt -120.06 135.87 54.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.176 -0.465 . . . . 75.04 110.906 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.659 HG23 ' CZ ' ' A' ' 10' ' ' PHE . 15.5 tt -137.14 151.88 27.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.231 -0.44 . . . . 64.3 111.159 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.505 ' HA ' ' O ' ' A' ' 21' ' ' TYR . 18.1 m -132.86 142.45 48.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.192 -0.458 . . . . 71.22 111.153 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.659 ' CZ ' HG23 ' A' ' 8' ' ' ILE . 0.8 OUTLIER -130.08 129.03 43.07 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.25 -0.432 . . . . 74.35 110.875 -179.965 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.534 ' CG ' ' HA ' ' A' ' 16' ' ' PHE . 12.5 m-85 -114.4 131.65 56.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.136 -0.484 . . . . 74.24 110.93 -179.867 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.413 ' HB2' ' HB2' ' A' ' 19' ' ' ARG . 0.1 OUTLIER -59.5 -16.49 24.83 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.117 -0.492 . . . . 72.43 110.864 -179.97 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.435 ' HB2' ' O ' ' A' ' 17' ' ' GLN . 72.2 m-20 -134.14 150.56 51.12 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.167 -0.469 . . . . 71.12 110.885 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.462 ' N ' ' HB3' ' A' ' 38' ' ' ASN . 34.2 mtmt -55.61 -176.58 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.196 -0.456 . . . . 64.3 110.864 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 20.2 m120 47.22 32.45 2.1 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.194 -0.457 . . . . 64.11 110.908 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.534 ' HA ' ' CG ' ' A' ' 11' ' ' TYR . 3.3 m-85 49.74 62.66 2.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 73.11 110.916 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.435 ' O ' ' HB2' ' A' ' 13' ' ' ASP . 18.3 mt-30 -137.75 159.22 42.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.116 -0.493 . . . . 71.21 110.895 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 92.7 -148.49 19.11 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.765 -0.731 . . . . 74.14 112.482 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.431 ' O ' ' CD1' ' A' ' 34' ' ' LEU . 0.3 OUTLIER -69.75 78.43 0.45 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.797 0.332 . . . . 75.54 110.844 -179.8 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.468 ' HB2' ' CE1' ' A' ' 11' ' ' TYR . 0.6 OUTLIER -76.88 130.35 37.46 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.188 -0.46 . . . . 72.13 110.845 -179.91 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.505 ' O ' ' HA ' ' A' ' 9' ' ' THR . 89.2 t80 -124.33 123.65 40.67 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.193 -0.458 . . . . 74.25 110.895 -179.829 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.46 ' CG ' HG23 ' A' ' 9' ' ' THR . 1.2 m-20 -121.14 133.78 55.21 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.089 -0.505 . . . . 75.14 110.856 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -168.31 136.67 2.26 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.196 -0.457 . . . . 74.33 110.916 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -101.93 -0.69 33.46 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.185 -0.461 . . . . 74.3 110.839 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.444 ' O ' ' SG ' ' A' ' 27' ' ' CYS . 16.8 t -102.85 164.34 11.68 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.226 -0.443 . . . . 75.12 110.911 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -57.68 120.86 9.1 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.238 -0.437 . . . . 70.42 110.894 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.501 ' HB2' ' HB3' ' A' ' 30' ' ' PHE . 1.8 m -116.63 51.13 1.0 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.185 -0.461 . . . . 75.14 110.853 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.489 ' C ' ' HA ' ' A' ' 82' ' ' SER . . . -47.07 -21.1 0.2 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.226 -0.443 . . . . 73.02 111.099 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 55.0 t0 -128.17 41.77 3.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.202 -0.454 . . . . 74.42 110.862 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.773 ' O ' ' CD2' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -81.35 13.18 3.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.184 -0.462 . . . . 73.04 110.851 -179.881 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.443 ' HB2' ' HB3' ' A' ' 81' ' ' SER . 28.8 t60 -78.75 -40.44 33.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.143 -0.48 . . . . 73.1 110.803 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.7 t -56.33 -16.14 5.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.197 -0.456 . . . . 75.44 111.126 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -98.26 -25.95 14.69 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.21 -0.45 . . . . 65.13 110.932 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.431 ' CD1' ' O ' ' A' ' 19' ' ' ARG . 16.3 tp -144.13 131.58 20.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.076 -0.511 . . . . 72.13 110.901 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 24.5 m -93.81 -42.88 8.88 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.193 -0.458 . . . . 74.14 110.839 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 1.1 tmm_? -118.41 140.64 49.54 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.163 -0.471 . . . . 72.1 110.861 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.488 ' HB3' ' HB2' ' A' ' 80' ' ' LEU . 4.0 p -108.71 81.08 1.4 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.164 -0.471 . . . . 74.43 110.913 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.462 ' HB3' ' N ' ' A' ' 14' ' ' LYS . 0.2 OUTLIER -70.4 -73.26 0.17 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.17 -0.468 . . . . 75.11 110.879 -179.882 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 4.3 p -109.21 125.03 51.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.208 -0.451 . . . . 74.11 110.841 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.568 ' O ' ' HB2' ' A' ' 67' ' ' TYR . 45.3 mt -118.05 148.83 20.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.127 -0.488 . . . . 73.54 111.11 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.487 ' N ' HG23 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -144.69 119.26 9.73 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.207 -0.451 . . . . 74.23 110.847 179.868 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.512 HG22 ' HB2' ' A' ' 47' ' ' TRP . 2.0 t -104.04 115.66 46.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.186 -0.461 . . . . 72.14 111.121 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -110.27 79.39 1.2 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.202 -0.454 . . . . 73.42 110.884 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.448 ' O ' ' HA ' ' A' ' 6' ' ' THR . . . 129.31 106.89 1.25 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.704 -0.76 . . . . 70.42 112.501 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 51.89 -178.75 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.764 -0.732 . . . . 61.24 112.463 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.514 HG21 ' HA ' ' A' ' 63' ' ' PRO . 1.2 m -83.23 168.29 16.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.749 0.309 . . . . 73.44 111.137 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.614 ' CD1' ' HB ' ' A' ' 8' ' ' ILE . 3.4 m95 -141.04 130.19 23.44 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.276 -0.42 . . . . 74.44 110.918 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.6 ' O ' ' N ' ' A' ' 84' ' ' ARG . . . -93.52 129.27 39.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.275 -0.42 . . . . 74.33 111.102 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.539 HG11 HD12 ' A' ' 80' ' ' LEU . 15.5 m -129.02 125.83 63.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.206 -0.452 . . . . 75.21 111.108 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.708 ' HB3' ' HA ' ' A' ' 56' ' ' ALA . 42.8 m-85 -92.16 150.11 21.1 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.16 -0.473 . . . . 72.43 110.929 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.647 ' OE1' ' HB3' ' A' ' 57' ' ' TRP . 54.2 tt0 -49.99 -78.94 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.099 -0.5 . . . . 55.24 110.865 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.539 ' HB3' ' CD2' ' A' ' 55' ' ' PHE . 0.0 OUTLIER -93.66 144.68 28.58 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.626 0.727 . . . . 75.3 110.848 -179.867 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.719 ' HA ' ' OG ' ' A' ' 82' ' ' SER . 53.8 Cg_endo -69.78 141.76 46.01 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.702 2.268 . . . . 74.0 112.346 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 63.38 -11.89 0.09 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.226 -0.443 . . . . 75.21 110.878 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.631 ' H ' ' C ' ' A' ' 53' ' ' PRO . 2.5 m-30 -104.01 -19.13 14.31 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.148 -0.478 . . . . 73.12 110.893 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.708 ' HA ' ' HB3' ' A' ' 50' ' ' TYR . . . 49.47 25.46 1.37 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.138 -0.483 . . . . 71.33 111.09 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . 0.647 ' HB3' ' OE1' ' A' ' 51' ' ' GLU . 0.0 OUTLIER -50.01 -166.06 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.243 -0.435 . . . . 74.55 110.982 -179.988 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.636 ' C ' ' O ' ' A' ' 57' ' ' TRP . 10.0 m-30 -14.1 101.32 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.267 -0.424 . . . . 75.34 110.913 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.47 ' HB2' ' HA ' ' A' ' 150' ' ' TYR . 1.6 mpt? -64.14 157.57 25.22 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.089 -0.505 . . . . 75.41 110.879 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.513 ' O ' ' CG2' ' A' ' 49' ' ' VAL . 2.6 t80 -170.48 103.98 0.27 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.259 -0.428 . . . . 64.32 110.925 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.535 HD13 ' HB2' ' A' ' 151' ' ' LEU . 0.8 OUTLIER -91.23 115.09 29.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.115 -0.493 . . . . 70.44 111.113 179.904 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -81.84 126.32 75.65 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.595 0.712 . . . . 73.23 110.949 179.861 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.514 ' HA ' HG21 ' A' ' 46' ' ' THR . 53.9 Cg_endo -69.71 -176.1 1.36 Allowed 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.729 2.286 . . . . 73.51 112.348 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -84.51 161.66 20.16 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.238 -0.437 . . . . 73.5 110.899 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 113.64 -162.47 12.37 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.74 -0.743 . . . . 55.54 112.491 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -115.68 156.45 25.89 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.899 0.38 . . . . 74.35 110.847 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.568 ' HB2' ' O ' ' A' ' 40' ' ' ILE . 9.4 m-85 -145.17 83.72 9.07 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.669 0.747 . . . . 74.54 110.943 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.437 ' HD2' ' HG3' ' A' ' 72' ' ' ARG . 53.8 Cg_endo -69.77 0.67 5.32 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.686 2.257 . . . . 72.12 112.326 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.456 ' HB2' ' HG2' ' A' ' 72' ' ' ARG . 42.4 mt-10 -155.79 142.72 18.99 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.268 -0.424 . . . . 74.31 110.922 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.683 ' HA ' ' NE1' ' A' ' 73' ' ' TRP . 24.1 p90 -56.11 -21.38 21.97 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.205 -0.452 . . . . 74.12 110.899 -179.838 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -78.2 -18.42 55.51 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.094 -0.503 . . . . 73.44 110.894 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.456 ' HG2' ' HB2' ' A' ' 69' ' ' GLU . 29.4 mmt180 -67.52 -9.25 40.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.213 -0.449 . . . . 71.3 110.919 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . 0.714 ' N ' ' CD1' ' A' ' 73' ' ' TRP . 0.0 OUTLIER -135.51 5.89 3.22 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.175 -0.466 . . . . 74.04 110.93 -179.979 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 11.6 mtp 45.42 68.64 0.54 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.234 -0.439 . . . . 64.42 110.934 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -60.66 120.79 24.33 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.749 -0.739 . . . . 71.23 112.47 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.508 HD11 ' N ' ' A' ' 77' ' ' ASN . 0.0 OUTLIER -70.75 -8.79 54.82 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.805 0.336 . . . . 73.44 110.897 -179.954 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.581 ' O ' ' CB ' ' A' ' 78' ' ' ASP . 10.7 t-20 -151.46 -41.83 0.12 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.217 -0.447 . . . . 73.22 110.885 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.581 ' CB ' ' O ' ' A' ' 77' ' ' ASN . 1.8 t70 89.88 7.68 0.1 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.186 -0.461 . . . . 72.51 110.872 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -105.81 91.43 3.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.181 -0.463 . . . . 75.33 110.888 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.539 HD12 HG11 ' A' ' 49' ' ' VAL . 0.1 OUTLIER -90.28 135.54 33.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.172 -0.467 . . . . 75.2 110.965 -180.0 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.623 ' HB3' ' HB3' ' A' ' 53' ' ' PRO . 1.2 m -151.94 -118.66 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.198 -0.455 . . . . 75.1 110.884 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.719 ' OG ' ' HA ' ' A' ' 53' ' ' PRO . 0.2 OUTLIER -44.57 101.8 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.142 -0.481 . . . . 70.13 110.851 -179.824 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . 0.52 ' HA ' ' O ' ' A' ' 48' ' ' ALA . 15.9 p -115.77 141.43 48.11 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.133 -0.485 . . . . 75.41 110.887 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.6 ' N ' ' O ' ' A' ' 48' ' ' ALA . 13.8 mmt85 -128.38 134.7 48.88 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.218 -0.447 . . . . 63.24 110.884 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.465 ' N ' ' CZ3' ' A' ' 47' ' ' TRP . . . -53.06 127.44 24.05 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.456 . . . . 53.43 111.08 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.518 ' CG2' ' CB ' ' A' ' 48' ' ' ALA . 73.7 t -115.05 135.43 55.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.238 -0.437 . . . . 73.45 111.136 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 28.7 m-70 -112.08 120.2 41.03 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.15 -0.477 . . . . 74.35 110.859 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -40.04 137.65 1.18 Allowed Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.62 0.724 . . . . 73.43 110.942 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.622 ' HB3' ' H ' ' A' ' 136' ' ' VAL . 53.9 Cg_endo -69.72 81.17 0.83 Allowed 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.7 2.266 . . . . 75.52 112.363 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -98.72 119.15 36.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.242 -0.435 . . . . 72.12 110.881 -179.856 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 130.51 85.98 0.39 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.755 -0.735 . . . . 64.51 112.496 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 88.1 35.63 8.81 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.782 -0.723 . . . . 73.52 112.471 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.451 ' O ' ' HG3' ' A' ' 134' ' ' GLU . 12.4 pt20 39.47 -154.18 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.832 0.349 . . . . 73.4 110.917 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.61 ' O ' ' HA ' ' A' ' 112' ' ' THR . 28.0 m-85 -96.17 102.35 14.12 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.199 -0.455 . . . . 71.34 110.919 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.49 ' H ' ' CG ' ' A' ' 134' ' ' GLU . 35.4 tptt -109.58 126.18 53.33 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.139 -0.482 . . . . 72.44 110.895 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 5.3 tt -150.6 137.19 12.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.189 -0.46 . . . . 74.34 111.119 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -108.14 135.11 50.04 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.17 -0.468 . . . . 72.12 110.917 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 26.0 mm -115.37 134.7 57.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.231 -0.44 . . . . 75.31 111.113 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.608 ' HB2' ' HB2' ' A' ' 129' ' ' SER . 61.7 m-85 -123.13 140.07 53.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 75.04 110.885 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.542 ' HA ' ' CE ' ' A' ' 124' ' ' MET . 58.6 tt0 -75.06 -52.64 10.54 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.161 -0.472 . . . . 72.34 110.922 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 40.8 mttt -106.8 155.29 19.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.136 -0.484 . . . . 72.44 110.932 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.406 ' N ' ' HB3' ' A' ' 128' ' ' HIS . . . -62.24 157.3 36.6 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.772 -0.728 . . . . 70.11 112.467 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.531 ' HA ' ' HB2' ' A' ' 158' ' ' ARG . 12.8 t70 69.48 39.92 1.52 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.896 0.379 . . . . 63.44 110.878 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.514 ' HA ' ' CD1' ' A' ' 99' ' ' PHE . 2.1 m-85 55.32 25.13 7.16 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.176 -0.465 . . . . 74.2 110.886 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 68.0 m -92.94 166.83 12.19 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.18 -0.464 . . . . 70.13 110.831 -179.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 79.18 -157.66 43.16 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.75 -0.738 . . . . 74.33 112.511 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 4.3 tp-100 -75.08 119.58 19.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.794 0.33 . . . . 73.24 110.931 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' MET . . . . . 0.467 ' HB2' ' CE1' ' A' ' 99' ' ' PHE . 18.8 ttp -104.36 145.46 30.22 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.23 -0.441 . . . . 74.1 110.864 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -148.66 134.84 19.29 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.195 -0.457 . . . . 75.0 110.926 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -113.38 89.28 3.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 74.34 110.907 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 15.0 t -101.04 130.55 47.07 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.115 -0.493 . . . . 74.12 111.163 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.61 ' HA ' ' O ' ' A' ' 94' ' ' TYR . 0.6 OUTLIER -104.83 30.68 5.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.229 -0.441 . . . . 72.31 111.148 -179.974 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -154.05 133.12 12.49 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.216 -0.447 . . . . 75.52 110.876 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 39.1 p30 -51.3 170.24 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.141 -0.481 . . . . 74.34 110.864 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . 0.485 ' O ' ' HB2' ' A' ' 172' ' ' SER . 14.1 p -152.37 144.24 16.44 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.594 0.711 . . . . 71.41 110.915 -179.898 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.434 ' O ' ' C ' ' A' ' 143' ' ' PRO . 53.6 Cg_endo -69.76 -31.16 21.08 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.712 2.275 . . . . 71.44 112.385 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.618 ' HB3' ' CB ' ' A' ' 120' ' ' GLU . 0.1 OUTLIER -147.41 106.66 3.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.193 -0.458 . . . . 64.33 110.88 -179.875 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.658 ' HB ' ' O ' ' A' ' 171' ' ' GLN . 4.0 tt -58.14 -28.18 33.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.131 -0.486 . . . . 75.12 111.088 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' MET . . . . . 0.694 ' O ' ' HA ' ' A' ' 123' ' ' HIS . 27.1 ttp -87.46 -41.47 13.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.185 -0.462 . . . . 74.51 110.915 179.831 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.618 ' CB ' ' HB3' ' A' ' 117' ' ' SER . 15.5 tp10 -68.65 -12.33 61.23 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.223 -0.444 . . . . 72.45 110.876 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 18.6 tp60 -115.94 -48.46 2.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.167 -0.469 . . . . 74.13 110.917 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . 0.48 ' HB2' ' O ' ' A' ' 118' ' ' ILE . 44.6 m-85 -103.99 -13.78 16.19 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.189 -0.46 . . . . 73.41 110.897 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . 0.694 ' HA ' ' O ' ' A' ' 119' ' ' MET . 10.8 m80 71.46 20.18 4.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.106 -0.497 . . . . 74.1 110.825 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.542 ' CE ' ' HA ' ' A' ' 100' ' ' GLU . 0.0 OUTLIER -93.42 139.59 30.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.208 -0.451 . . . . 74.13 110.854 179.97 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 5.3 ptp180 -102.36 -44.92 5.25 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.188 -0.46 . . . . 72.54 110.827 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.446 ' HG2' ' HA ' ' A' ' 169' ' ' ALA . 10.8 mt-10 -138.17 117.23 12.54 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.209 -0.45 . . . . 73.3 110.858 -179.89 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.428 HD11 HD13 ' A' ' 118' ' ' ILE . 2.5 mm -77.41 93.93 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.131 -0.486 . . . . 72.25 111.087 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . 0.406 ' HB3' ' N ' ' A' ' 102' ' ' GLY . 0.6 OUTLIER -63.78 -36.08 82.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.467 . . . . 74.12 110.877 179.849 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.608 ' HB2' ' HB2' ' A' ' 99' ' ' PHE . 0.6 OUTLIER -132.32 146.21 51.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.205 -0.452 . . . . 75.23 110.851 -179.756 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . 0.623 ' O ' ' O ' ' A' ' 155' ' ' LYS . 0.5 OUTLIER -145.27 120.49 10.18 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.15 -0.477 . . . . 73.33 110.849 -179.937 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.637 ' HA ' ' HA ' ' A' ' 156' ' ' GLU . 1.3 mtpt -107.39 153.93 22.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.152 -0.477 . . . . 75.11 110.894 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.443 ' CB ' ' O ' ' A' ' 131' ' ' LYS . 4.8 t 82.71 165.27 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.207 -0.451 . . . . 74.4 111.119 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.485 ' CD1' ' O ' ' A' ' 154' ' ' LYS . 0.0 OUTLIER -176.47 126.02 0.18 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.187 -0.46 . . . . 74.13 110.884 179.988 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.49 ' CG ' ' H ' ' A' ' 95' ' ' LYS . 0.0 OUTLIER -94.39 159.23 15.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.172 -0.467 . . . . 75.1 110.893 179.95 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . 0.485 ' C ' ' O ' ' A' ' 134' ' ' GLU . . . -31.05 -48.82 0.2 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.764 -0.732 . . . . 72.41 112.451 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.627 ' HA ' ' CD1' ' A' ' 152' ' ' LEU . 2.3 t -150.99 133.5 6.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.814 0.34 . . . . 74.21 111.105 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . 0.573 ' H ' ' CG ' ' A' ' 152' ' ' LEU . 3.6 t-105 -133.5 150.7 51.7 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.173 -0.467 . . . . 74.45 110.88 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.493 ' CD1' ' HB ' ' A' ' 61' ' ' ILE . 22.1 mm -114.12 128.77 70.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.18 -0.463 . . . . 73.54 111.139 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.507 ' CB ' ' HB2' ' A' ' 150' ' ' TYR . 0.5 OUTLIER -114.91 149.59 36.99 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.217 -0.447 . . . . 75.21 110.875 179.953 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . 0.482 ' CD2' ' HA ' ' A' ' 145' ' ' TYR . 2.3 m-85 -134.98 133.17 39.2 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.131 -0.486 . . . . 74.53 110.902 -179.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . 0.689 ' O ' ' HB2' ' A' ' 171' ' ' GLN . 0.8 OUTLIER -59.93 -26.49 65.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.147 -0.478 . . . . 73.22 110.911 179.966 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.755 ' HB3' ' HD2' ' A' ' 143' ' ' PRO . 9.7 mp -112.15 173.13 3.03 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.595 0.712 . . . . 73.12 110.883 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . 0.755 ' HD2' ' HB3' ' A' ' 142' ' ' LEU . 53.8 Cg_endo -69.76 -89.68 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.645 2.23 . . . . 74.3 112.357 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . 0.686 ' O ' ' N ' ' A' ' 146' ' ' ARG . 2.3 m-20 -52.81 97.0 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.183 -0.462 . . . . 74.4 110.923 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . 0.64 ' C ' ' O ' ' A' ' 144' ' ' ASN . 0.1 OUTLIER 12.78 53.25 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.18 -0.463 . . . . 74.34 110.962 -179.899 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . 0.686 ' N ' ' O ' ' A' ' 144' ' ' ASN . 38.1 mtt85 -119.46 179.1 4.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.1 -0.5 . . . . 74.45 110.865 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 73.98 -174.05 49.59 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.723 -0.751 . . . . 70.33 112.509 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.404 ' HG2' ' CD1' ' A' ' 58' ' ' TYR . 0.2 OUTLIER -75.91 151.75 37.27 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.758 0.313 . . . . 72.21 110.868 -179.883 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -88.5 149.82 23.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.186 -0.461 . . . . 74.34 110.946 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . 0.507 ' HB2' ' CB ' ' A' ' 139' ' ' PHE . 82.4 m-85 -134.07 129.5 36.12 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.205 -0.452 . . . . 72.31 110.9 -179.847 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.535 ' HB2' HD13 ' A' ' 61' ' ' ILE . 16.8 tp -81.67 122.72 27.99 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.129 -0.487 . . . . 72.34 110.882 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.627 ' CD1' ' HA ' ' A' ' 136' ' ' VAL . 0.0 OUTLIER -54.54 135.36 46.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.2 -0.455 . . . . 72.53 110.915 179.871 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -163.25 25.74 0.09 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.183 -0.462 . . . . 62.33 110.9 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.775 ' HA ' ' CE1' ' A' ' 157' ' ' TYR . 0.0 OUTLIER -117.27 -173.7 2.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.133 -0.485 . . . . 72.45 110.874 179.984 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.751 ' HG3' ' O ' ' A' ' 154' ' ' LYS . 0.5 OUTLIER -161.87 -124.77 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.18 -0.464 . . . . 74.13 110.901 179.886 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.637 ' HA ' ' HA ' ' A' ' 131' ' ' LYS . 0.7 OUTLIER -69.09 -0.41 5.79 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.226 -0.443 . . . . 74.2 110.921 179.928 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . 0.775 ' CE1' ' HA ' ' A' ' 154' ' ' LYS . 18.5 m-30 -31.08 146.95 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.122 -0.49 . . . . 74.24 110.93 -179.822 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . 0.531 ' HB2' ' HA ' ' A' ' 103' ' ' ASP . 8.5 ptp180 -112.29 -39.49 4.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.117 -0.492 . . . . 73.42 110.867 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . 0.439 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 2.6 ptpp? -92.01 150.96 41.43 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.602 0.715 . . . . 72.43 110.881 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . 0.437 ' HA ' ' CZ2' ' A' ' 163' ' ' TRP . 53.9 Cg_endo -69.7 -23.05 31.49 Favored 'Trans proline' 0 C--O 1.232 0.214 0 C-N-CA 122.717 2.278 . . . . 73.21 112.352 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.476 HD11 ' H ' ' A' ' 161' ' ' ILE . 3.9 mp -76.62 2.32 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.226 -0.443 . . . . 71.52 111.105 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . 0.673 ' HB3' ' CD1' ' A' ' 157' ' ' TYR . 0.6 OUTLIER -73.07 -19.86 61.08 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.176 -0.465 . . . . 74.2 110.855 179.855 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' TRP . . . . . 0.605 ' CD1' ' N ' ' A' ' 163' ' ' TRP . 0.0 OUTLIER -109.13 13.92 24.21 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.182 -0.463 . . . . 74.22 110.928 -179.965 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 85.04 -30.53 3.93 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.75 -0.738 . . . . 74.43 112.496 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -54.19 120.1 6.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.742 0.306 . . . . 71.02 111.1 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -49.67 -25.65 3.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.214 -0.448 . . . . 75.51 111.136 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' SER . . . . . 0.502 ' C ' ' H ' ' A' ' 169' ' ' ALA . 0.3 OUTLIER -155.61 160.13 31.09 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.708 0.766 . . . . 55.13 110.85 -179.804 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . 0.42 ' HG2' ' HB3' ' A' ' 126' ' ' GLU . 53.8 Cg_endo -69.78 20.36 0.18 Allowed 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.717 2.278 . . . . 72.41 112.296 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . 0.502 ' H ' ' C ' ' A' ' 167' ' ' SER . . . -63.18 103.64 0.5 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.245 -0.434 . . . . 75.44 111.124 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 3.4 t -152.91 160.87 2.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.24 -0.436 . . . . 73.22 111.15 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' GLN . . . . . 0.689 ' HB2' ' O ' ' A' ' 141' ' ' GLU . 1.9 mm-40 -109.73 -88.03 0.5 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.215 -0.448 . . . . 73.54 110.913 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' SER . . . . . 0.699 ' OG ' ' O ' ' A' ' 143' ' ' PRO . 15.4 p -130.6 178.39 6.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.177 -0.465 . . . . 74.22 110.817 -179.789 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -143.79 168.07 20.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.107 -0.497 . . . . 74.23 110.864 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . 0.415 ' HG2' ' CE2' ' A' ' 140' ' ' TYR . 2.1 ppt_? -133.39 156.66 47.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.163 -0.471 . . . . 74.25 110.913 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . 0.413 ' HB2' ' CE1' ' A' ' 94' ' ' TYR . 6.2 ptt85 -98.18 150.72 21.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.259 -0.428 . . . . 74.04 110.869 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . 0.511 ' CD1' ' HB ' ' A' ' 136' ' ' VAL . 15.4 mt -83.1 152.31 3.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.217 -0.447 . . . . 65.24 111.116 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 7.5 p -126.29 147.2 31.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.129 -0.487 . . . . 71.51 111.132 179.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.215 -0.448 . . . . 63.53 110.933 179.982 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.788 0.328 . . . . 74.34 110.849 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.9 m -140.48 -176.49 4.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.245 -0.434 . . . . 74.42 110.878 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 31.7 mttt -101.53 41.63 1.19 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.138 -0.483 . . . . 72.43 110.897 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 3.3 t -102.11 65.7 0.98 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.239 -0.437 . . . . 65.22 111.157 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 111.46 114.0 3.41 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.754 -0.736 . . . . 62.03 112.444 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.438 ' HA ' ' O ' ' A' ' 44' ' ' GLY . 9.8 p -82.68 135.61 34.98 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.837 0.351 . . . . 54.31 111.158 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.406 ' HA ' ' HA ' ' A' ' 24' ' ' ASP . 2.8 tttt -123.47 135.75 54.23 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.217 -0.447 . . . . 65.21 110.9 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.639 HG23 ' CZ ' ' A' ' 10' ' ' PHE . 14.5 tt -136.71 152.05 28.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.25 -0.432 . . . . 75.43 111.148 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.441 HG21 ' CE2' ' A' ' 11' ' ' TYR . 15.3 m -133.98 142.66 47.75 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.19 -0.459 . . . . 60.34 111.129 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.639 ' CZ ' HG23 ' A' ' 8' ' ' ILE . 0.3 OUTLIER -130.01 128.72 42.59 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.226 -0.443 . . . . 73.44 110.92 179.997 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.531 ' CG ' ' HA ' ' A' ' 16' ' ' PHE . 24.1 m-85 -113.54 131.96 55.88 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.164 -0.471 . . . . 72.34 110.973 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.424 ' HA ' ' O ' ' A' ' 36' ' ' ARG . 0.0 OUTLIER -61.08 -13.63 18.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.123 -0.489 . . . . 63.3 110.914 -179.955 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.43 ' HB2' ' O ' ' A' ' 17' ' ' GLN . 77.1 m-20 -136.95 150.78 48.38 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.124 -0.489 . . . . 73.12 110.868 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 4.8 mtmm -55.22 -175.95 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.198 -0.456 . . . . 75.23 110.852 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 20.2 m-20 45.53 33.25 1.3 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.156 -0.475 . . . . 74.4 110.885 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.531 ' HA ' ' CG ' ' A' ' 11' ' ' TYR . 2.7 m-85 49.22 64.77 1.6 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.169 -0.469 . . . . 72.13 110.896 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.43 ' O ' ' HB2' ' A' ' 13' ' ' ASP . 8.0 mt-30 -139.46 159.96 40.96 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.154 -0.476 . . . . 70.25 110.886 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 92.7 -150.03 19.84 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.78 -0.724 . . . . 55.11 112.521 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.409 ' O ' ' CD1' ' A' ' 34' ' ' LEU . 0.3 OUTLIER -69.9 78.79 0.47 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.803 0.335 . . . . 72.55 110.89 -179.885 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.445 ' HA ' ' O ' ' A' ' 10' ' ' PHE . 0.0 OUTLIER -76.24 129.51 36.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.205 -0.452 . . . . 73.34 110.856 -179.871 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.469 ' CD2' ' CD2' ' A' ' 30' ' ' PHE . 69.2 t80 -124.26 125.31 44.16 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.184 -0.462 . . . . 65.22 110.903 -179.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.408 ' OD1' ' CD ' ' A' ' 20' ' ' ARG . 1.2 m-20 -118.83 134.54 55.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.113 -0.494 . . . . 73.24 110.925 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 8.8 t -161.17 129.66 4.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.23 -0.441 . . . . 74.51 110.897 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.406 ' HA ' ' HA ' ' A' ' 7' ' ' LYS . 14.1 p-10 -97.33 4.39 50.81 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.178 -0.465 . . . . 75.04 110.89 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 46.9 t -113.52 159.66 19.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.179 -0.464 . . . . 74.1 110.855 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -42.67 119.67 1.51 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.162 -0.472 . . . . 71.33 110.854 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.52 ' HB2' ' HB3' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -114.6 40.55 2.54 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.187 -0.461 . . . . 74.33 110.9 -179.913 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.558 ' O ' ' HA ' ' A' ' 82' ' ' SER . . . -51.12 -21.22 1.81 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.15 -0.477 . . . . 74.42 111.119 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 59.9 t0 -128.86 38.32 3.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.168 -0.469 . . . . 75.31 110.888 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.773 ' O ' ' CD2' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -80.27 13.92 2.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.186 -0.461 . . . . 64.41 110.878 -179.885 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.439 ' CG ' ' HG3' ' A' ' 53' ' ' PRO . 36.2 t60 -77.65 -36.81 51.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.147 -0.479 . . . . 65.42 110.875 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.7 t -59.81 -14.52 15.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.196 -0.456 . . . . 73.42 111.156 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -100.99 -24.97 14.23 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.202 -0.454 . . . . 71.13 110.877 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.409 ' CD1' ' O ' ' A' ' 19' ' ' ARG . 23.9 tp -141.62 123.93 15.67 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.125 -0.489 . . . . 62.52 110.943 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 27.0 m -82.83 -49.32 9.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.211 -0.45 . . . . 74.02 110.829 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.424 ' O ' ' HA ' ' A' ' 12' ' ' GLU . 0.1 OUTLIER -114.04 143.25 45.07 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.131 -0.486 . . . . 74.21 110.834 -179.925 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.571 ' HB2' ' HB2' ' A' ' 80' ' ' LEU . 57.6 m -122.93 104.76 9.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.174 -0.466 . . . . 74.21 110.906 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 10.9 m-20 -97.49 -67.15 0.86 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.226 -0.443 . . . . 71.52 110.892 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 10.6 p -105.68 133.66 50.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.207 -0.451 . . . . 74.31 110.895 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.479 ' O ' ' N ' ' A' ' 67' ' ' TYR . 6.9 mt -130.01 149.53 33.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.135 -0.484 . . . . 72.11 111.114 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.462 ' N ' HG23 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -142.51 119.07 11.0 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.155 -0.475 . . . . 75.01 110.906 179.853 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.604 HG22 ' HB2' ' A' ' 47' ' ' TRP . 1.0 OUTLIER -104.76 117.47 50.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.268 -0.424 . . . . 64.2 111.098 179.908 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -112.55 76.67 0.99 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.155 -0.475 . . . . 74.44 110.896 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.438 ' O ' ' HA ' ' A' ' 6' ' ' THR . . . 139.21 99.61 0.45 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.723 -0.751 . . . . 60.31 112.479 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 55.59 177.78 0.25 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.743 -0.741 . . . . 75.11 112.479 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.5 HG21 ' HA ' ' A' ' 63' ' ' PRO . 2.2 m -76.46 168.7 19.61 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.719 0.295 . . . . 75.34 111.18 -179.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.604 ' HB2' HG22 ' A' ' 42' ' ' VAL . 7.7 m95 -143.32 128.36 18.54 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.261 -0.427 . . . . 74.41 110.93 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.598 ' O ' ' N ' ' A' ' 84' ' ' ARG . . . -89.83 127.62 36.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.221 -0.445 . . . . 63.0 111.093 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.564 ' CG2' ' O ' ' A' ' 60' ' ' TYR . 26.9 m -127.62 141.72 45.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.181 -0.463 . . . . 73.32 111.144 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.783 ' HB3' ' CB ' ' A' ' 56' ' ' ALA . 5.0 m-85 -122.53 155.44 36.22 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.189 -0.459 . . . . 75.24 110.903 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.588 ' C ' ' HB3' ' A' ' 56' ' ' ALA . 35.3 mp0 -53.19 -94.8 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.081 -0.509 . . . . 75.52 110.928 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.819 ' N ' ' HB3' ' A' ' 56' ' ' ALA . 3.4 mtp180 -72.0 136.46 82.31 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.556 0.693 . . . . 75.25 110.863 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.592 ' HA ' ' OG ' ' A' ' 82' ' ' SER . 53.8 Cg_endo -69.79 131.64 21.62 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.676 2.251 . . . . 73.14 112.321 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.429 ' H ' ' HB3' ' A' ' 82' ' ' SER . 4.3 t-20 77.07 -5.35 2.19 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.169 -0.469 . . . . 75.12 110.916 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.417 ' CE1' ' HB3' ' A' ' 54' ' ' ASN . 0.1 OUTLIER -144.73 -73.4 0.25 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.158 -0.474 . . . . 74.01 110.852 -179.981 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.819 ' HB3' ' N ' ' A' ' 52' ' ' ARG . . . 37.96 80.29 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.177 -0.465 . . . . 75.23 111.107 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . 0.458 ' O ' ' CG ' ' A' ' 58' ' ' TYR . 31.4 m95 -64.96 53.07 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.215 -0.448 . . . . 73.13 110.903 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.575 ' CB ' ' OE1' ' A' ' 51' ' ' GLU . 0.5 OUTLIER -177.19 124.39 0.14 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.252 -0.431 . . . . 74.53 110.911 -179.921 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.505 ' HG3' ' CE2' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -81.79 139.71 34.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.136 -0.484 . . . . 70.42 110.874 179.903 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.715 ' OH ' ' O ' ' A' ' 73' ' ' TRP . 1.0 OUTLIER -154.7 86.24 1.13 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.248 -0.433 . . . . 74.13 110.906 -179.876 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.53 HD11 ' HA ' ' A' ' 151' ' ' LEU . 1.6 mp -80.42 118.88 28.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.145 -0.48 . . . . 73.24 111.109 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -87.06 127.86 57.83 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.615 0.721 . . . . 74.52 110.929 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.5 ' HA ' HG21 ' A' ' 46' ' ' THR . 53.4 Cg_endo -69.81 -174.24 0.88 Allowed 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.701 2.268 . . . . 71.54 112.34 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -87.02 162.89 17.37 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.203 -0.453 . . . . 73.34 110.943 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 113.37 -161.03 12.82 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.767 -0.73 . . . . 73.22 112.469 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -111.99 160.24 17.65 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.862 0.363 . . . . 74.22 110.906 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.479 ' N ' ' O ' ' A' ' 40' ' ' ILE . 20.6 m-85 -149.16 81.6 7.39 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.646 0.736 . . . . 74.44 110.898 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.493 ' HD2' ' HG3' ' A' ' 72' ' ' ARG . 53.8 Cg_endo -69.7 -3.57 12.24 Favored 'Trans proline' 0 C--O 1.231 0.155 0 C-N-CA 122.706 2.271 . . . . 54.44 112.345 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -157.77 149.36 21.75 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.224 -0.443 . . . . 75.22 110.927 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.778 ' O ' ' CD1' ' A' ' 73' ' ' TRP . 35.4 p90 -55.28 -41.27 72.06 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.163 -0.471 . . . . 75.24 110.979 -179.845 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -51.66 -21.89 2.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.099 -0.5 . . . . 75.43 110.938 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.493 ' HG3' ' HD2' ' A' ' 68' ' ' PRO . 28.9 mmt180 -61.8 -39.74 92.8 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.189 -0.46 . . . . 74.34 110.891 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . 0.778 ' CD1' ' O ' ' A' ' 70' ' ' TYR . 0.3 OUTLIER -92.88 34.17 1.11 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.168 -0.469 . . . . 72.44 110.934 -179.999 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' MET . . . . . 0.404 ' HB2' ' O ' ' A' ' 73' ' ' TRP . 34.5 mmm 75.19 17.66 2.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.258 -0.428 . . . . 71.44 110.913 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.419 ' N ' ' HD1' ' A' ' 73' ' ' TRP . . . 42.98 44.0 5.6 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.759 -0.734 . . . . 74.22 112.484 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.462 ' CB ' ' CE2' ' A' ' 60' ' ' TYR . 0.5 OUTLIER -67.45 -74.12 0.12 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.877 0.37 . . . . 74.41 110.933 -179.907 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 12.6 t-20 -154.02 138.96 17.22 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.164 -0.471 . . . . 75.3 110.879 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -87.61 13.61 10.0 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.164 -0.471 . . . . 73.25 110.87 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.503 ' HD3' ' HB3' ' A' ' 51' ' ' GLU . 38.7 ttt85 -84.29 44.97 1.06 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.182 -0.463 . . . . 72.25 110.866 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.571 ' HB2' ' HB2' ' A' ' 37' ' ' CYS . 0.1 OUTLIER -66.12 125.59 25.99 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.2 -0.454 . . . . 74.43 110.928 -179.995 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.554 ' HB3' ' HB3' ' A' ' 53' ' ' PRO . 3.7 m -151.07 -109.2 0.06 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.186 -0.461 . . . . 73.52 110.879 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.592 ' OG ' ' HA ' ' A' ' 53' ' ' PRO . 0.0 OUTLIER -51.32 102.23 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.147 -0.479 . . . . 74.53 110.869 -179.827 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . 0.564 ' HA ' ' O ' ' A' ' 48' ' ' ALA . 14.6 p -126.55 135.33 51.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.155 -0.475 . . . . 71.31 110.855 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.598 ' N ' ' O ' ' A' ' 48' ' ' ALA . 2.1 mmt85 -118.29 159.87 22.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.162 -0.472 . . . . 72.13 110.863 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -74.3 125.96 29.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.208 -0.451 . . . . 73.3 111.067 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.455 HG23 ' HB3' ' A' ' 48' ' ' ALA . 18.0 t -120.31 145.31 26.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.202 -0.454 . . . . 72.51 111.102 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . 0.451 ' O ' ' CG2' ' A' ' 136' ' ' VAL . 70.0 m-70 -110.78 112.36 24.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.176 -0.465 . . . . 74.34 110.905 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.402 ' C ' ' O ' ' A' ' 87' ' ' HIS . 0.0 OUTLIER -37.91 152.28 0.15 Allowed Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 121.626 0.727 . . . . 73.44 110.887 -179.956 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.495 ' HB3' ' H ' ' A' ' 136' ' ' VAL . 54.3 Cg_endo -69.67 83.15 0.69 Allowed 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.673 2.248 . . . . 72.34 112.361 179.809 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.2 t -90.23 -177.34 5.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.275 -0.42 . . . . 72.05 110.846 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 70.35 -81.94 0.37 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.702 -0.761 . . . . 65.14 112.489 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.41 ' O ' ' C ' ' A' ' 93' ' ' GLN . . . -92.58 34.16 4.63 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.739 -0.743 . . . . 54.4 112.53 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.435 ' O ' ' HG2' ' A' ' 134' ' ' GLU . 14.6 pt20 37.54 -121.58 0.21 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.868 0.366 . . . . 75.43 110.903 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.678 ' CZ ' ' HA ' ' A' ' 175' ' ' ARG . 1.4 t80 -121.91 99.29 6.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.228 -0.442 . . . . 74.42 110.945 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.458 ' HG3' HG11 ' A' ' 132' ' ' VAL . 23.8 tptt -119.27 127.14 52.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.153 -0.476 . . . . 72.51 110.846 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.457 HG21 ' CZ2' ' A' ' 137' ' ' TRP . 0.4 OUTLIER -150.1 138.61 14.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.189 -0.46 . . . . 73.21 111.099 179.901 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.446 ' HB2' ' O ' ' A' ' 131' ' ' LYS . 0.7 OUTLIER -110.38 124.3 51.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.175 -0.466 . . . . 73.12 110.916 179.904 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 29.6 mm -107.19 133.23 52.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.172 -0.467 . . . . 74.22 111.168 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.622 ' HB2' ' HB2' ' A' ' 129' ' ' SER . 7.7 m-85 -123.41 144.76 49.28 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.199 -0.455 . . . . 74.35 110.896 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 71.7 tt0 -72.85 -74.43 0.17 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.16 -0.473 . . . . 74.43 110.923 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.488 ' C ' ' HB2' ' A' ' 128' ' ' HIS . 31.9 mttt -85.2 167.12 15.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.09 -0.505 . . . . 72.22 110.887 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.421 ' HA2' ' OG ' ' A' ' 129' ' ' SER . . . -80.9 158.03 40.17 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.77 -0.729 . . . . 52.11 112.495 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.465 ' HA ' ' HB2' ' A' ' 158' ' ' ARG . 33.2 t70 68.1 54.27 0.6 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.799 0.333 . . . . 72.51 110.833 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.699 ' CE1' ' HD2' ' A' ' 131' ' ' LYS . 7.2 m-85 47.39 29.99 1.45 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.197 -0.456 . . . . 63.12 110.905 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.449 ' C ' ' HB2' ' A' ' 101' ' ' LYS . 48.0 m -105.47 152.11 23.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.103 -0.499 . . . . 75.44 110.889 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 89.42 -165.2 32.36 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.723 -0.751 . . . . 53.3 112.441 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 5.9 tp-100 -73.43 129.09 37.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.827 0.346 . . . . 73.44 110.867 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 1.6 ttt -114.76 131.39 56.8 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.215 -0.448 . . . . 73.23 110.89 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -134.94 137.2 42.89 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.229 -0.441 . . . . 74.3 110.918 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -110.8 94.48 5.02 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.119 -0.491 . . . . 65.34 110.884 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 9.1 t -102.38 130.29 49.09 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.14 -0.482 . . . . 72.11 111.111 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.54 ' O ' ' OG1' ' A' ' 112' ' ' THR . 0.0 OUTLIER -109.84 37.3 2.7 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.206 -0.452 . . . . 64.23 111.103 -179.952 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -151.78 -176.36 5.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.22 -0.446 . . . . 73.14 110.853 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -80.49 179.58 7.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.107 -0.497 . . . . 75.12 110.839 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . 0.562 ' O ' ' HB2' ' A' ' 172' ' ' SER . 45.7 t -167.3 125.02 0.97 Allowed Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.549 0.69 . . . . 75.32 110.903 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.72 -30.37 22.58 Favored 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.657 2.238 . . . . 73.42 112.33 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.612 ' HB3' ' CB ' ' A' ' 120' ' ' GLU . 0.1 OUTLIER -150.19 101.93 3.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.202 -0.454 . . . . 71.34 110.86 -179.843 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.608 ' HB ' ' O ' ' A' ' 171' ' ' GLN . 4.0 tt -52.56 -29.67 13.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.145 -0.48 . . . . 73.14 111.1 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' MET . . . . . 0.577 ' O ' ' HA ' ' A' ' 123' ' ' HIS . 0.8 OUTLIER -85.55 -45.11 12.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.184 -0.462 . . . . 75.23 110.848 179.906 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.612 ' CB ' ' HB3' ' A' ' 117' ' ' SER . 8.4 tp10 -65.45 -13.75 59.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.262 -0.427 . . . . 62.01 110.859 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -114.22 -51.97 2.75 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.169 -0.469 . . . . 74.52 110.896 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . 0.453 ' HB2' ' O ' ' A' ' 118' ' ' ILE . 54.1 m-85 -101.24 -20.3 15.32 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.195 -0.457 . . . . 73.42 110.902 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . 0.577 ' HA ' ' O ' ' A' ' 119' ' ' MET . 12.6 m80 71.24 30.61 2.58 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.132 -0.485 . . . . 71.23 110.869 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.419 ' O ' HG22 ' A' ' 118' ' ' ILE . 5.2 mtt -108.99 86.42 2.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.224 -0.444 . . . . 73.12 110.902 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 2.0 ptp85 -51.94 -35.57 46.4 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.209 -0.45 . . . . 75.25 110.877 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.499 ' HB3' ' HG2' ' A' ' 168' ' ' PRO . 28.9 mt-10 -142.39 131.7 23.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.201 -0.454 . . . . 73.24 110.896 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.454 ' O ' ' HB3' ' A' ' 168' ' ' PRO . 3.5 mm -91.38 91.46 3.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.17 -0.468 . . . . 74.41 111.14 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . 0.488 ' HB2' ' C ' ' A' ' 101' ' ' LYS . 13.3 m170 -60.58 -35.43 76.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.183 -0.462 . . . . 74.21 110.86 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.622 ' HB2' ' HB2' ' A' ' 99' ' ' PHE . 66.5 m -131.09 140.08 49.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.222 -0.444 . . . . 71.43 110.829 -179.763 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . 0.616 ' O ' ' O ' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -139.18 121.59 16.09 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.134 -0.484 . . . . 70.44 110.855 179.999 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.699 ' HD2' ' CE1' ' A' ' 104' ' ' PHE . 6.3 mtpp -115.33 153.15 31.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.153 -0.476 . . . . 74.03 110.925 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.512 ' HB ' ' O ' ' A' ' 131' ' ' LYS . 16.1 t 84.34 164.57 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.242 -0.435 . . . . 73.12 111.126 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.449 ' O ' ' HG ' ' A' ' 133' ' ' LEU . 0.0 OUTLIER -178.44 121.98 0.1 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.136 -0.484 . . . . 74.41 110.91 179.976 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.513 ' O ' ' C ' ' A' ' 135' ' ' GLY . 0.1 OUTLIER -94.03 167.02 11.86 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.186 -0.461 . . . . 73.24 110.89 179.922 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . 0.513 ' C ' ' O ' ' A' ' 134' ' ' GLU . . . -27.8 -55.89 0.12 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.717 -0.754 . . . . 74.31 112.517 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.767 ' HA ' HD13 ' A' ' 152' ' ' LEU . 3.2 t -144.51 137.36 22.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.806 0.336 . . . . 71.42 111.12 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . 0.694 ' CB ' ' HB3' ' A' ' 152' ' ' LEU . 0.0 OUTLIER -129.82 142.46 50.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.157 -0.474 . . . . 73.05 110.92 179.914 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.493 ' HB ' ' HG2' ' A' ' 174' ' ' ARG . 11.4 mm -114.99 134.35 58.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.195 -0.457 . . . . 64.51 111.12 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.518 ' CB ' ' HB2' ' A' ' 150' ' ' TYR . 0.8 OUTLIER -123.33 145.38 48.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.172 -0.467 . . . . 73.2 110.881 179.932 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . 0.483 ' CE2' ' CD ' ' A' ' 174' ' ' ARG . 0.3 OUTLIER -126.99 133.85 50.48 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.164 -0.471 . . . . 72.13 110.93 -179.899 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . 0.654 ' O ' ' HB2' ' A' ' 171' ' ' GLN . 0.2 OUTLIER -59.97 -27.2 66.63 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.105 -0.498 . . . . 71.2 110.89 -179.979 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.712 ' HB3' ' HD2' ' A' ' 143' ' ' PRO . 9.7 mp -112.91 171.79 4.04 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.617 0.722 . . . . 74.44 110.897 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . 0.757 ' O ' ' OG ' ' A' ' 172' ' ' SER . 54.0 Cg_endo -69.74 -92.71 0.01 OUTLIER 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.737 2.291 . . . . 74.44 112.323 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . 0.732 ' O ' ' N ' ' A' ' 146' ' ' ARG . 0.8 OUTLIER -49.99 99.21 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.217 -0.447 . . . . 64.44 110.913 -179.984 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . 0.641 ' C ' ' O ' ' A' ' 144' ' ' ASN . 19.8 m-85 11.64 52.44 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.218 -0.446 . . . . 75.02 110.928 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . 0.732 ' N ' ' O ' ' A' ' 144' ' ' ASN . 21.1 mtt180 -118.6 173.28 6.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.098 -0.501 . . . . 73.3 110.875 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 78.97 -176.1 54.82 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.713 -0.756 . . . . 75.42 112.52 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -80.64 144.01 32.65 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.746 0.308 . . . . 74.53 110.87 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -71.63 162.93 28.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.218 -0.446 . . . . 73.12 110.904 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . 0.518 ' HB2' ' CB ' ' A' ' 139' ' ' PHE . 78.9 m-85 -145.89 128.19 15.82 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.202 -0.454 . . . . 74.43 110.945 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.53 ' HA ' HD11 ' A' ' 61' ' ' ILE . 15.1 tp -85.94 123.21 31.02 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.161 -0.472 . . . . 74.14 110.89 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.767 HD13 ' HA ' ' A' ' 136' ' ' VAL . 0.0 OUTLIER -58.33 142.23 48.72 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.183 -0.462 . . . . 73.33 110.903 179.887 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -162.99 25.44 0.09 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.156 -0.474 . . . . 74.02 110.88 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.918 ' HB2' ' CD1' ' A' ' 157' ' ' TYR . 3.1 ptmt -123.17 -172.38 2.49 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.189 -0.459 . . . . 74.31 110.874 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.713 ' HD2' ' C ' ' A' ' 154' ' ' LYS . 0.4 OUTLIER -159.8 -123.79 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.236 -0.438 . . . . 73.02 110.903 179.91 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.641 ' HA ' ' HA ' ' A' ' 131' ' ' LYS . 0.8 OUTLIER -66.02 -3.74 5.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.208 -0.451 . . . . 70.32 110.897 179.96 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . 0.918 ' CD1' ' HB2' ' A' ' 154' ' ' LYS . 13.3 m-30 -27.62 140.01 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.158 -0.473 . . . . 75.04 110.946 -179.847 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . 0.574 ' O ' ' OG ' ' A' ' 129' ' ' SER . 8.2 ptp180 -103.8 -46.18 4.57 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.159 -0.473 . . . . 75.41 110.853 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 2.4 ptpp? -81.68 149.25 63.78 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.546 0.688 . . . . 73.2 110.87 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . 0.457 ' CB ' ' HD3' ' A' ' 168' ' ' PRO . 53.7 Cg_endo -69.74 -26.74 27.38 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.703 2.269 . . . . 71.21 112.34 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.489 HD11 ' H ' ' A' ' 161' ' ' ILE . 4.1 mp -69.95 -10.62 13.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.215 -0.448 . . . . 74.42 111.152 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . 0.606 ' HB3' ' CD1' ' A' ' 157' ' ' TYR . 1.0 OUTLIER -70.65 -12.79 61.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 73.33 110.859 179.865 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' TRP . . . . . 0.437 ' CD2' ' O ' ' A' ' 163' ' ' TRP . 11.5 t-105 -90.13 -19.65 24.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.193 -0.458 . . . . 72.23 110.879 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 103.21 -37.11 3.89 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.772 -0.727 . . . . 75.13 112.536 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -78.29 123.1 26.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.843 0.354 . . . . 73.01 111.03 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -49.79 121.46 5.3 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.192 -0.458 . . . . 75.33 111.133 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' SER . . . . . 0.509 ' C ' ' H ' ' A' ' 169' ' ' ALA . 0.4 OUTLIER 64.94 143.81 0.08 OUTLIER Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.623 0.725 . . . . 75.44 110.886 -179.781 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . 0.499 ' HG2' ' HB3' ' A' ' 126' ' ' GLU . 53.8 Cg_endo -69.74 33.12 0.19 Allowed 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.675 2.25 . . . . 71.25 112.319 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . 0.509 ' H ' ' C ' ' A' ' 167' ' ' SER . . . -67.32 105.17 1.69 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.27 -0.423 . . . . 74.4 111.077 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 3.3 t -153.5 163.4 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.203 -0.453 . . . . 74.32 111.176 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' GLN . . . . . 0.664 ' OE1' ' HB3' ' A' ' 143' ' ' PRO . 2.0 mm-40 -111.77 -90.21 0.5 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.192 -0.458 . . . . 74.32 110.913 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' SER . . . . . 0.757 ' OG ' ' O ' ' A' ' 143' ' ' PRO . 36.2 p -122.19 -179.72 4.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.187 -0.46 . . . . 63.41 110.851 -179.82 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -146.54 174.78 11.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.113 -0.494 . . . . 72.0 110.898 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . 0.493 ' HG2' ' HB ' ' A' ' 138' ' ' ILE . 0.0 OUTLIER -147.01 158.05 43.8 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.144 -0.48 . . . . 65.22 110.911 -179.933 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . 0.678 ' HA ' ' CZ ' ' A' ' 94' ' ' TYR . 0.0 OUTLIER -95.14 -179.95 4.99 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.198 -0.455 . . . . 75.32 110.847 -179.908 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . 0.472 ' CD1' ' HB ' ' A' ' 136' ' ' VAL . 1.8 mt -126.45 132.45 70.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.161 -0.472 . . . . 75.53 111.119 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 42.2 t -126.09 150.08 31.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.199 -0.455 . . . . 74.13 111.156 179.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.193 -0.458 . . . . 74.41 110.935 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.0 mtm . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.769 0.319 . . . . 71.34 110.894 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -152.11 129.44 11.3 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.227 -0.442 . . . . 74.32 110.835 -179.774 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.426 ' O ' ' C ' ' A' ' 4' ' ' THR . 0.0 OUTLIER -75.3 -65.85 0.84 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.098 -0.501 . . . . 74.24 110.947 179.913 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.426 ' C ' ' O ' ' A' ' 3' ' ' LYS . 7.4 t 36.15 48.6 0.56 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.229 -0.441 . . . . 72.01 111.13 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 70.67 125.57 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.765 -0.731 . . . . 52.42 112.49 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.451 ' HA ' ' O ' ' A' ' 44' ' ' GLY . 2.8 p -82.83 135.15 35.04 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.858 0.361 . . . . 75.34 111.17 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 3.9 tttt -121.2 137.12 54.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.244 -0.434 . . . . 74.33 110.89 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.681 HG23 ' CE2' ' A' ' 10' ' ' PHE . 13.3 tt -137.32 147.07 26.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.214 -0.448 . . . . 73.25 111.145 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.425 ' CG2' ' CE2' ' A' ' 11' ' ' TYR . 13.8 m -126.5 129.16 48.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.168 -0.469 . . . . 63.1 111.132 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.681 ' CE2' HG23 ' A' ' 8' ' ' ILE . 1.5 m-85 -114.69 130.15 56.78 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.245 -0.434 . . . . 74.22 110.906 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.508 ' CG ' ' HA ' ' A' ' 16' ' ' PHE . 41.4 m-85 -115.67 130.86 57.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.156 -0.475 . . . . 75.14 110.938 -179.839 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.487 ' HG2' ' HB2' ' A' ' 36' ' ' ARG . 0.0 OUTLIER -60.24 -26.52 66.5 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.172 -0.467 . . . . 74.54 110.871 -179.976 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 68.9 m-20 -124.32 151.22 44.55 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.119 -0.491 . . . . 74.03 110.872 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.516 ' N ' ' HB3' ' A' ' 38' ' ' ASN . 35.0 mtmt -56.26 -178.58 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.162 -0.472 . . . . 71.11 110.885 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 28.1 m-20 49.78 35.41 9.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.239 -0.437 . . . . 75.23 110.893 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.508 ' HA ' ' CG ' ' A' ' 11' ' ' TYR . 3.8 m-85 48.05 57.6 5.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.17 -0.468 . . . . 74.21 110.894 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -134.46 160.26 38.55 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.125 -0.488 . . . . 75.13 110.943 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 94.0 -151.47 20.27 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.776 -0.726 . . . . 64.2 112.501 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.441 ' O ' ' CD1' ' A' ' 34' ' ' LEU . 0.0 OUTLIER -68.71 80.0 0.29 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.813 0.34 . . . . 75.12 110.864 -179.874 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.455 ' HA ' ' O ' ' A' ' 10' ' ' PHE . 0.5 OUTLIER -78.28 124.89 28.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.169 -0.468 . . . . 73.32 110.879 -179.922 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.424 ' CD2' ' CD2' ' A' ' 30' ' ' PHE . 86.9 t80 -122.42 124.87 44.65 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.194 -0.457 . . . . 72.53 110.917 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -109.94 130.33 55.54 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.146 -0.479 . . . . 73.13 110.852 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -142.0 145.96 35.03 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.173 -0.467 . . . . 64.43 110.868 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -130.73 5.7 4.66 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.178 -0.465 . . . . 54.32 110.905 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.42 ' O ' ' C ' ' A' ' 26' ' ' ASP . 38.2 t -132.15 160.41 36.12 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.151 -0.477 . . . . 75.1 110.897 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.42 ' C ' ' O ' ' A' ' 25' ' ' CYS . 6.2 m-20 -35.59 108.88 0.08 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.168 -0.469 . . . . 71.31 110.853 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.691 ' HB3' ' HB3' ' A' ' 30' ' ' PHE . 0.5 OUTLIER -119.24 45.82 2.03 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.167 -0.469 . . . . 71.43 110.883 -179.892 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.589 ' O ' ' HA ' ' A' ' 82' ' ' SER . . . -55.08 -11.14 0.62 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.204 -0.453 . . . . 63.24 111.143 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 60.6 t0 -130.81 39.13 3.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.219 -0.446 . . . . 72.41 110.831 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.833 ' O ' ' CD2' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -82.8 16.55 2.19 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.232 -0.44 . . . . 70.2 110.897 -179.916 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.484 ' HB2' ' HB3' ' A' ' 81' ' ' SER . 46.5 t60 -81.78 -29.61 32.66 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.172 -0.467 . . . . 73.02 110.851 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.7 t -68.66 -7.07 29.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.218 -0.446 . . . . 71.33 111.14 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -107.01 -29.44 9.42 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.197 -0.456 . . . . 75.34 110.925 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.441 ' CD1' ' O ' ' A' ' 19' ' ' ARG . 24.0 tp -138.26 145.32 41.18 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.139 -0.482 . . . . 74.24 110.903 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.2 m -113.37 -32.51 6.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.158 -0.474 . . . . 72.32 110.837 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.487 ' HB2' ' HG2' ' A' ' 12' ' ' GLU . 1.4 mtp85 -116.22 142.37 46.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.162 -0.472 . . . . 72.52 110.869 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.634 ' SG ' ' HB2' ' A' ' 80' ' ' LEU . 1.7 p -119.91 54.94 1.0 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.184 -0.462 . . . . 72.52 110.917 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.516 ' HB3' ' N ' ' A' ' 14' ' ' LYS . 1.8 m-80 -55.59 -64.96 0.68 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.156 -0.474 . . . . 73.34 110.871 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 5.9 p -116.95 130.94 57.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.261 -0.427 . . . . 75.3 110.863 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.464 ' O ' ' N ' ' A' ' 67' ' ' TYR . 12.1 mt -126.87 149.15 31.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.164 -0.471 . . . . 72.03 111.066 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.451 ' N ' HG23 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -143.73 120.7 11.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.125 -0.488 . . . . 72.52 110.884 179.83 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.575 HG23 ' HB ' ' A' ' 8' ' ' ILE . 2.1 t -102.85 115.04 44.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.21 -0.45 . . . . 75.0 111.133 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -109.47 81.05 1.38 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.203 -0.453 . . . . 65.42 110.895 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.451 ' O ' ' HA ' ' A' ' 6' ' ' THR . . . 127.32 108.52 1.51 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.776 -0.726 . . . . 73.21 112.478 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 50.78 -179.54 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.72 -0.753 . . . . 72.33 112.511 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.485 HG21 ' HA ' ' A' ' 63' ' ' PRO . 15.3 m -84.47 159.64 20.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.736 0.303 . . . . 71.1 111.203 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.599 ' CD1' ' HB ' ' A' ' 8' ' ' ILE . 3.3 m95 -131.92 130.24 41.31 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.264 -0.426 . . . . 73.4 110.914 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.602 ' HB2' HG13 ' A' ' 61' ' ' ILE . . . -91.4 124.6 35.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.236 -0.438 . . . . 62.45 111.103 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.548 HG11 ' CD1' ' A' ' 80' ' ' LEU . 13.7 m -126.87 131.35 71.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.204 -0.453 . . . . 74.32 111.133 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.966 ' HB3' ' CB ' ' A' ' 56' ' ' ALA . 4.6 m-85 -106.68 145.37 32.07 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.141 -0.481 . . . . 75.42 110.864 -179.874 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.45 ' HG2' ' N ' ' A' ' 52' ' ' ARG . 0.8 OUTLIER -50.51 -86.41 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.079 -0.509 . . . . 74.1 110.829 -179.936 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.792 ' H ' ' HA ' ' A' ' 56' ' ' ALA . 7.7 mmm180 -77.63 138.34 62.77 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.608 0.718 . . . . 72.34 110.84 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.711 ' HB3' ' HB3' ' A' ' 81' ' ' SER . 53.7 Cg_endo -69.81 136.41 32.8 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.702 2.268 . . . . 71.41 112.352 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.427 ' C ' ' CD1' ' A' ' 55' ' ' PHE . 1.3 m120 64.99 -4.92 0.44 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.201 -0.454 . . . . 73.21 110.889 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.522 ' H ' ' C ' ' A' ' 53' ' ' PRO . 0.1 OUTLIER -137.86 -70.39 0.44 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.153 -0.476 . . . . 71.23 110.878 -179.989 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.966 ' CB ' ' HB3' ' A' ' 50' ' ' TYR . . . 38.87 74.9 0.08 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.168 -0.469 . . . . 62.11 111.088 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . 0.415 ' O ' ' CD2' ' A' ' 58' ' ' TYR . 9.8 m0 -63.6 30.59 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.174 -0.466 . . . . 65.4 110.924 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.653 ' H ' ' C ' ' A' ' 56' ' ' ALA . 1.2 m-30 -163.13 109.5 1.16 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.233 -0.439 . . . . 74.13 110.898 -179.867 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.414 ' HG3' ' CE2' ' A' ' 50' ' ' TYR . 0.3 OUTLIER -68.79 140.24 55.28 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.166 -0.47 . . . . 73.42 110.88 179.879 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.617 ' OH ' ' O ' ' A' ' 73' ' ' TRP . 0.9 OUTLIER -150.47 81.97 1.35 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.221 -0.445 . . . . 74.54 110.879 -179.875 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.602 HG13 ' HB2' ' A' ' 48' ' ' ALA . 1.1 mp -75.14 115.5 16.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.139 -0.482 . . . . 72.22 111.107 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.417 ' O ' HG21 ' A' ' 46' ' ' THR . 0.3 OUTLIER -82.4 124.05 78.4 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.579 0.704 . . . . 75.14 110.88 179.911 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.485 ' HA ' HG21 ' A' ' 46' ' ' THR . 53.2 Cg_endo -69.82 -174.04 0.84 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.604 2.203 . . . . 74.33 112.373 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.0 163.33 18.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.26 -0.427 . . . . 74.13 110.925 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 113.05 -160.41 13.14 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.75 -0.738 . . . . 41.15 112.509 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -115.13 158.25 22.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.858 0.361 . . . . 74.53 110.869 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.464 ' N ' ' O ' ' A' ' 40' ' ' ILE . 11.2 m-85 -148.21 83.24 7.29 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.671 0.748 . . . . 74.5 110.878 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.433 ' HD2' ' HG3' ' A' ' 72' ' ' ARG . 53.5 Cg_endo -69.77 -4.98 15.12 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.728 2.285 . . . . 74.42 112.324 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -157.58 141.14 15.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.202 -0.454 . . . . 75.43 110.94 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.896 ' O ' ' CD1' ' A' ' 73' ' ' TRP . 44.9 p90 -51.55 -41.24 60.95 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.177 -0.465 . . . . 72.05 110.896 -179.834 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -52.02 -20.05 2.2 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.156 -0.474 . . . . 74.54 110.917 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.433 ' HG3' ' HD2' ' A' ' 68' ' ' PRO . 28.2 mmt180 -64.03 -30.24 71.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.188 -0.46 . . . . 74.14 110.872 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . 0.896 ' CD1' ' O ' ' A' ' 70' ' ' TYR . 0.5 OUTLIER -103.88 30.66 4.97 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.192 -0.458 . . . . 73.53 110.951 179.983 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' MET . . . . . 0.439 ' O ' ' C ' ' A' ' 75' ' ' GLY . 0.0 OUTLIER 74.64 23.82 1.79 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.225 -0.443 . . . . 63.52 110.88 179.918 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.44 ' N ' ' HD1' ' A' ' 73' ' ' TRP . . . 33.03 49.37 0.43 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.697 -0.763 . . . . 42.11 112.525 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.496 ' CB ' ' CE2' ' A' ' 60' ' ' TYR . 0.6 OUTLIER -65.46 -77.61 0.06 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.806 0.336 . . . . 73.23 110.909 -179.908 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -135.79 134.17 38.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.161 -0.472 . . . . 63.41 110.888 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -90.09 17.0 7.42 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.122 -0.49 . . . . 74.22 110.88 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 6.0 ttm105 -107.36 77.18 1.12 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.174 -0.466 . . . . 74.33 110.844 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.634 ' HB2' ' SG ' ' A' ' 37' ' ' CYS . 0.1 OUTLIER -82.32 134.43 35.26 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.172 -0.467 . . . . 73.44 110.928 -179.99 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.711 ' HB3' ' HB3' ' A' ' 53' ' ' PRO . 1.5 m -154.32 -124.38 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.196 -0.456 . . . . 73.22 110.866 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.686 ' OG ' ' HA ' ' A' ' 53' ' ' PRO . 0.0 OUTLIER -36.28 106.88 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 72.33 110.891 -179.846 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . 0.522 ' HA ' ' O ' ' A' ' 48' ' ' ALA . 27.9 p -130.13 132.78 46.24 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.147 -0.479 . . . . 75.41 110.881 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.565 ' N ' ' O ' ' A' ' 48' ' ' ALA . 4.1 mmt180 -123.41 146.46 47.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.205 -0.452 . . . . 72.32 110.876 -179.839 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -64.99 124.97 23.46 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.244 -0.434 . . . . 75.04 111.11 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.509 ' CG2' ' HB3' ' A' ' 48' ' ' ALA . 2.7 t -118.67 146.67 22.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.185 -0.461 . . . . 64.51 111.127 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . 0.472 ' O ' ' CG2' ' A' ' 136' ' ' VAL . 22.3 m-70 -110.11 112.5 24.53 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.189 -0.459 . . . . 71.42 110.92 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -38.04 151.27 0.16 Allowed Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.647 0.737 . . . . 73.44 110.875 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.538 ' HB3' ' H ' ' A' ' 136' ' ' VAL . 53.8 Cg_endo -69.76 98.78 0.7 Allowed 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.644 2.23 . . . . 62.53 112.354 179.816 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -105.56 -178.44 3.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.199 -0.455 . . . . 60.24 110.826 -179.822 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 48.9 84.89 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.764 -0.731 . . . . 62.14 112.443 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 100.72 29.45 6.55 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.777 -0.725 . . . . 73.51 112.475 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.447 ' O ' ' HG2' ' A' ' 134' ' ' GLU . 6.1 pt20 38.35 -129.6 0.22 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.852 0.358 . . . . 74.33 110.912 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.624 ' HA ' ' HG2' ' A' ' 134' ' ' GLU . 0.4 OUTLIER -117.13 103.73 10.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.211 -0.45 . . . . 73.24 110.943 -179.878 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.415 ' H ' ' HG2' ' A' ' 134' ' ' GLU . 38.9 tptt -110.8 125.77 53.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.129 -0.487 . . . . 75.15 110.886 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.429 HG21 HD13 ' A' ' 96' ' ' ILE . 0.0 OUTLIER -149.84 136.96 13.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.238 -0.437 . . . . 73.5 111.149 179.829 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.421 ' HB2' ' O ' ' A' ' 131' ' ' LYS . 2.4 mt-30 -107.86 132.7 53.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.183 -0.462 . . . . 74.11 110.917 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 1.2 mp -111.29 140.8 28.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.176 -0.466 . . . . 74.11 111.158 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.644 ' HB2' ' HB2' ' A' ' 129' ' ' SER . 47.5 m-85 -130.97 134.65 46.92 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.192 -0.458 . . . . 74.32 110.868 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 51.1 tt0 -62.82 -78.86 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.15 -0.477 . . . . 74.03 110.907 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 6.6 mttt -83.97 162.68 20.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.117 -0.492 . . . . 73.21 110.851 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.4 ' CA ' ' HB3' ' A' ' 128' ' ' HIS . . . -70.4 163.2 53.09 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.726 -0.75 . . . . 72.43 112.466 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.482 ' HA ' ' HB2' ' A' ' 158' ' ' ARG . 33.4 t0 63.62 26.29 14.58 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.842 0.353 . . . . 64.23 110.888 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.464 ' CZ ' ' HB3' ' A' ' 158' ' ' ARG . 14.8 m-85 61.49 48.48 5.84 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.207 -0.451 . . . . 73.21 110.831 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 2.3 m -113.67 148.04 37.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.16 -0.473 . . . . 73.54 110.807 -179.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 92.27 -121.81 6.6 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.692 -0.766 . . . . 74.41 112.452 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 7.5 tp-100 -104.88 147.21 27.99 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.822 0.344 . . . . 74.52 110.916 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 3.7 ttp -136.65 136.79 39.42 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.205 -0.452 . . . . 75.43 110.919 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 12.9 m-85 -143.95 137.41 27.76 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.249 -0.432 . . . . 74.12 110.959 -179.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -114.93 111.14 20.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.153 -0.476 . . . . 75.45 110.933 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 11.7 t -118.1 139.46 51.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.157 -0.474 . . . . 70.32 111.122 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.57 ' HA ' ' O ' ' A' ' 94' ' ' TYR . 2.1 t -117.66 40.49 3.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.177 -0.465 . . . . 62.32 111.152 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -153.15 163.31 40.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.227 -0.442 . . . . 73.33 110.887 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -51.34 159.3 0.7 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.182 -0.463 . . . . 72.15 110.855 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . 0.606 ' O ' ' HB2' ' A' ' 172' ' ' SER . 41.9 t -147.85 111.34 3.86 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.589 0.709 . . . . 62.21 110.892 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.456 ' O ' ' C ' ' A' ' 143' ' ' PRO . 53.7 Cg_endo -69.8 -31.98 19.3 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.663 2.242 . . . . 74.32 112.303 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.631 ' HB3' ' CB ' ' A' ' 120' ' ' GLU . 0.2 OUTLIER -149.06 105.5 3.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.238 -0.437 . . . . 74.22 110.865 -179.819 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.624 ' HB ' ' O ' ' A' ' 171' ' ' GLN . 3.7 tt -61.93 -30.52 48.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.15 -0.477 . . . . 70.22 111.153 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' MET . . . . . 0.627 ' O ' ' HA ' ' A' ' 123' ' ' HIS . 38.5 ttp -86.68 -38.6 16.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 73.23 110.894 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.631 ' CB ' ' HB3' ' A' ' 117' ' ' SER . 5.3 tp10 -72.71 -13.44 61.34 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.222 -0.445 . . . . 73.51 110.89 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 28.1 tp60 -114.8 -41.18 3.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.126 -0.488 . . . . 73.03 110.914 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . 0.514 ' HB2' ' O ' ' A' ' 118' ' ' ILE . 51.8 m-85 -112.05 -20.61 11.89 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.216 -0.447 . . . . 65.44 110.913 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . 0.627 ' HA ' ' O ' ' A' ' 119' ' ' MET . 13.0 m80 72.8 27.02 2.25 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.124 -0.489 . . . . 74.4 110.856 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 9.3 mtt -101.31 90.75 4.22 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.183 -0.462 . . . . 72.2 110.861 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 4.1 ptp180 -53.49 -43.94 68.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.268 -0.424 . . . . 64.23 110.912 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.462 ' HG2' ' HA ' ' A' ' 169' ' ' ALA . 8.7 mt-10 -137.59 130.55 30.34 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.146 -0.479 . . . . 75.11 110.883 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.433 ' O ' ' HB3' ' A' ' 168' ' ' PRO . 3.5 mm -88.79 91.48 3.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.104 -0.498 . . . . 74.43 111.165 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . 0.518 ' CD2' ' HG3' ' A' ' 168' ' ' PRO . 52.4 m80 -65.51 -30.16 70.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.147 -0.478 . . . . 74.02 110.857 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.644 ' HB2' ' HB2' ' A' ' 99' ' ' PHE . 0.4 OUTLIER -135.08 144.42 47.2 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.205 -0.452 . . . . 75.53 110.865 -179.765 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . 0.662 ' O ' ' O ' ' A' ' 155' ' ' LYS . 0.1 OUTLIER -146.53 119.71 8.89 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.138 -0.483 . . . . 72.22 110.858 -179.934 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.635 ' HA ' ' HA ' ' A' ' 156' ' ' GLU . 6.0 mtpp -107.38 153.54 22.63 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.172 -0.467 . . . . 75.13 110.859 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.464 ' HB ' ' O ' ' A' ' 131' ' ' LYS . 9.8 t 82.28 165.54 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.239 -0.437 . . . . 61.41 111.133 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.464 ' CD1' ' O ' ' A' ' 154' ' ' LYS . 0.0 OUTLIER -176.91 124.2 0.15 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.17 -0.468 . . . . 75.13 110.934 179.956 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.624 ' HG2' ' HA ' ' A' ' 94' ' ' TYR . 0.0 OUTLIER -97.44 164.02 12.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.227 -0.442 . . . . 72.11 110.924 179.919 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . 0.544 ' C ' ' O ' ' A' ' 134' ' ' GLU . . . -24.7 -61.18 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.746 -0.74 . . . . 62.21 112.451 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.65 ' HA ' HD13 ' A' ' 152' ' ' LEU . 1.7 t -147.44 154.19 11.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.817 0.341 . . . . 72.55 111.15 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . 0.724 ' HB3' ' HB3' ' A' ' 152' ' ' LEU . 0.7 OUTLIER -152.09 149.05 28.39 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.188 -0.46 . . . . 73.43 110.887 -179.994 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.478 ' CD1' ' HB ' ' A' ' 61' ' ' ILE . 5.6 mm -116.55 135.42 56.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.21 -0.45 . . . . 73.33 111.163 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.465 ' HB2' ' HB2' ' A' ' 150' ' ' TYR . 1.4 m-85 -112.25 165.02 12.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.209 -0.451 . . . . 73.4 110.866 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . 0.462 ' HB3' ' O ' ' A' ' 146' ' ' ARG . 5.2 m-85 -144.8 132.03 20.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.147 -0.479 . . . . 75.22 110.887 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . 0.641 ' O ' ' HB2' ' A' ' 171' ' ' GLN . 0.0 OUTLIER -57.92 -27.79 63.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.091 -0.504 . . . . 63.42 110.876 -179.997 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.752 ' HB3' ' HD2' ' A' ' 143' ' ' PRO . 9.5 mp -114.1 173.28 2.96 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.614 0.721 . . . . 74.34 110.94 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . 0.752 ' HD2' ' HB3' ' A' ' 142' ' ' LEU . 53.3 Cg_endo -69.8 -90.46 0.0 OUTLIER 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.697 2.264 . . . . 72.21 112.324 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . 0.721 ' O ' ' N ' ' A' ' 146' ' ' ARG . 0.5 OUTLIER -50.79 97.81 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.213 -0.449 . . . . 75.42 110.937 179.985 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . 0.653 ' C ' ' O ' ' A' ' 144' ' ' ASN . 0.2 OUTLIER 11.46 53.34 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.173 -0.467 . . . . 72.41 110.937 -179.875 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . 0.721 ' N ' ' O ' ' A' ' 144' ' ' ASN . 22.5 mtt180 -121.5 160.2 24.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.148 -0.478 . . . . 75.35 110.859 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 93.26 -172.4 33.33 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.696 -0.764 . . . . 62.41 112.493 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 4.1 mpt_? -79.65 155.05 28.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.79 0.328 . . . . 73.54 110.88 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -81.56 151.83 27.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.213 -0.449 . . . . 71.31 110.919 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . 0.465 ' HB2' ' HB2' ' A' ' 139' ' ' PHE . 69.4 m-85 -151.96 103.11 2.87 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.178 -0.464 . . . . 73.11 110.893 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.406 ' HB2' ' CD1' ' A' ' 61' ' ' ILE . 0.1 OUTLIER -69.92 137.33 51.48 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.096 -0.502 . . . . 73.04 110.892 179.988 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.724 ' HB3' ' HB3' ' A' ' 137' ' ' TRP . 0.0 OUTLIER -72.7 151.87 41.97 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.189 -0.46 . . . . 70.3 110.905 179.898 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -162.66 24.34 0.1 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.165 -0.471 . . . . 75.34 110.859 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 1.016 ' HB2' ' CD1' ' A' ' 157' ' ' TYR . 6.1 ptmt -115.29 -166.79 1.16 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.187 -0.461 . . . . 70.25 110.895 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.693 ' HG3' ' O ' ' A' ' 154' ' ' LYS . 0.9 OUTLIER -158.47 -122.42 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.238 -0.437 . . . . 74.13 110.914 179.852 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.635 ' HA ' ' HA ' ' A' ' 131' ' ' LYS . 2.4 tm-20 -68.56 -0.33 4.99 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.222 -0.445 . . . . 75.33 110.943 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . 1.016 ' CD1' ' HB2' ' A' ' 154' ' ' LYS . 9.5 m-30 -32.55 146.15 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.12 -0.491 . . . . 61.44 110.901 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . 0.482 ' HB2' ' HA ' ' A' ' 103' ' ' ASP . 7.5 ptp180 -110.13 -39.7 4.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.107 -0.497 . . . . 74.54 110.902 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 2.4 ptpp? -91.39 151.2 42.49 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.58 0.705 . . . . 74.42 110.896 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 -25.73 28.28 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.734 2.289 . . . . 74.22 112.295 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.474 HD11 ' H ' ' A' ' 161' ' ' ILE . 4.0 mp -73.98 -6.16 7.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.265 -0.425 . . . . 74.14 111.129 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . 0.601 ' HB3' ' CD1' ' A' ' 157' ' ' TYR . 1.6 t0 -72.54 -13.45 61.41 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.197 -0.456 . . . . 54.31 110.868 179.842 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 82.2 t90 -107.14 -3.43 19.91 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.189 -0.46 . . . . 72.14 110.917 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 100.12 -35.35 4.84 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.753 -0.737 . . . . 71.13 112.475 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -57.1 121.07 9.16 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.812 0.339 . . . . 63.1 111.098 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -46.99 -30.48 2.62 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.224 -0.444 . . . . 74.04 111.087 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' SER . . . . . 0.509 ' C ' ' H ' ' A' ' 169' ' ' ALA . 0.5 OUTLIER -151.49 154.41 33.4 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.697 0.76 . . . . 75.53 110.826 -179.74 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . 0.518 ' HG3' ' CD2' ' A' ' 128' ' ' HIS . 53.5 Cg_endo -69.73 22.53 0.17 Allowed 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.639 2.226 . . . . 63.44 112.399 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . 0.509 ' H ' ' C ' ' A' ' 167' ' ' SER . . . -65.65 101.25 0.6 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.201 -0.454 . . . . 74.03 111.121 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 2.4 t -153.59 163.77 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.235 -0.439 . . . . 72.12 111.133 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' GLN . . . . . 0.641 ' HB2' ' O ' ' A' ' 141' ' ' GLU . 1.8 mm-40 -111.23 -87.2 0.54 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.21 -0.45 . . . . 71.42 110.941 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' SER . . . . . 0.734 ' OG ' ' O ' ' A' ' 143' ' ' PRO . 24.8 p -125.97 175.53 7.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.218 -0.446 . . . . 71.0 110.86 -179.792 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 10.7 p90 -144.14 168.25 20.47 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.166 -0.47 . . . . 75.42 110.889 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.32 156.6 48.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.133 -0.485 . . . . 75.25 110.862 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . 0.444 ' HD2' ' CE2' ' A' ' 94' ' ' TYR . 0.8 OUTLIER -88.68 -175.76 5.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.194 -0.457 . . . . 74.21 110.838 -179.916 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . 0.486 ' CD1' ' HB ' ' A' ' 136' ' ' VAL . 5.6 mt -129.7 131.69 66.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.151 -0.477 . . . . 65.32 111.127 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 18.9 t -125.38 153.22 32.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.177 -0.465 . . . . 74.34 111.149 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.218 -0.446 . . . . 75.14 110.847 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.9 mtt . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.79 0.328 . . . . 75.01 110.919 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 11.2 m -137.21 37.57 2.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.214 -0.448 . . . . 74.22 110.888 -179.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 52.79 39.3 28.52 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.112 -0.494 . . . . 63.41 110.92 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.8 t -114.65 -35.98 4.69 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.206 -0.452 . . . . 72.41 111.135 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -166.26 122.3 1.05 Allowed Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.727 -0.749 . . . . 71.32 112.465 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.431 ' HA ' ' O ' ' A' ' 44' ' ' GLY . 14.7 p -81.85 137.32 35.28 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.852 0.358 . . . . 72.11 111.143 -179.878 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.422 ' HA ' ' HA ' ' A' ' 24' ' ' ASP . 2.4 tttt -125.69 135.62 52.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.238 -0.437 . . . . 73.5 110.887 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.624 HG23 ' CZ ' ' A' ' 10' ' ' PHE . 14.6 tt -135.98 153.78 32.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.216 -0.447 . . . . 74.32 111.094 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.433 ' HA ' ' O ' ' A' ' 21' ' ' TYR . 12.9 m -135.77 145.91 47.06 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.151 -0.477 . . . . 74.1 111.143 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.624 ' CZ ' HG23 ' A' ' 8' ' ' ILE . 0.3 OUTLIER -133.6 128.52 35.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.208 -0.451 . . . . 75.34 110.835 -179.954 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.544 ' CG ' ' HA ' ' A' ' 16' ' ' PHE . 22.1 m-85 -113.65 132.54 55.73 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.182 -0.463 . . . . 72.41 110.914 -179.869 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.401 ' HA ' ' O ' ' A' ' 36' ' ' ARG . 0.0 OUTLIER -60.71 -14.38 20.68 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.108 -0.496 . . . . 72.24 110.883 -179.989 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.44 ' HB2' ' O ' ' A' ' 17' ' ' GLN . 78.1 m-20 -136.38 150.96 49.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.146 -0.479 . . . . 72.34 110.852 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.425 ' HG3' ' HB3' ' A' ' 38' ' ' ASN . 4.5 mtmm -55.25 -176.2 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.165 -0.471 . . . . 74.44 110.919 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 19.4 m120 45.31 34.18 1.42 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.234 -0.439 . . . . 75.34 110.849 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.544 ' HA ' ' CG ' ' A' ' 11' ' ' TYR . 2.2 m-85 48.39 67.32 0.87 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.211 -0.449 . . . . 74.52 110.905 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.44 ' O ' ' HB2' ' A' ' 13' ' ' ASP . 4.7 mt-30 -141.78 158.13 44.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.145 -0.48 . . . . 75.03 110.876 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 92.85 -150.29 19.92 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.759 -0.734 . . . . 24.03 112.497 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.4 ' O ' ' CD1' ' A' ' 34' ' ' LEU . 2.2 mtt180 -68.74 79.9 0.29 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.827 0.346 . . . . 70.22 110.872 -179.855 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.465 ' HA ' ' O ' ' A' ' 10' ' ' PHE . 0.5 OUTLIER -77.96 129.13 34.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.199 -0.455 . . . . 74.24 110.89 -179.953 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.433 ' O ' ' HA ' ' A' ' 9' ' ' THR . 70.3 t80 -123.86 125.98 45.61 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.177 -0.465 . . . . 64.2 110.948 -179.87 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.41 ' OD2' ' CD ' ' A' ' 20' ' ' ARG . 1.3 m-20 -119.41 134.81 55.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.109 -0.496 . . . . 74.15 110.85 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 9.4 t -160.44 129.4 4.87 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.177 -0.465 . . . . 74.42 110.858 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.422 ' HA ' ' HA ' ' A' ' 7' ' ' LYS . 2.5 p30 -97.65 5.36 49.48 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.157 -0.474 . . . . 75.04 110.841 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 47.5 t -114.91 160.65 19.27 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.186 -0.461 . . . . 63.11 110.892 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 87.4 m-20 -43.06 120.11 1.72 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.202 -0.453 . . . . 72.35 110.904 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.554 ' CB ' ' HB3' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -114.37 40.35 2.55 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.21 -0.45 . . . . 73.12 110.862 -179.907 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.56 ' O ' ' HB3' ' A' ' 82' ' ' SER . . . -50.47 -21.76 1.62 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.239 -0.437 . . . . 64.03 111.126 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 60.8 t0 -130.5 40.02 3.56 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.212 -0.449 . . . . 72.2 110.871 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.762 ' O ' ' CD2' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -80.04 14.54 1.8 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.15 -0.477 . . . . 70.22 110.911 -179.914 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.426 ' CG ' ' HG3' ' A' ' 53' ' ' PRO . 40.7 t60 -77.63 -35.11 52.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.138 -0.483 . . . . 64.32 110.842 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.6 t -61.95 -12.23 17.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.254 -0.43 . . . . 74.31 111.119 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -102.29 -26.56 13.27 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.265 -0.425 . . . . 73.13 110.894 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.4 ' CD1' ' O ' ' A' ' 19' ' ' ARG . 28.0 tp -139.33 130.43 26.54 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.146 -0.479 . . . . 74.13 110.944 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 21.1 m -91.24 -44.73 9.04 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.167 -0.469 . . . . 71.21 110.866 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.401 ' O ' ' HA ' ' A' ' 12' ' ' GLU . 0.0 OUTLIER -114.28 145.49 41.68 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.103 -0.499 . . . . 75.42 110.893 -179.918 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.576 ' SG ' ' CB ' ' A' ' 80' ' ' LEU . 3.5 m -126.76 106.35 9.3 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.184 -0.462 . . . . 64.01 110.861 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.425 ' HB3' ' HG3' ' A' ' 14' ' ' LYS . 11.3 m-20 -104.07 -62.43 1.31 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.174 -0.466 . . . . 75.11 110.905 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 9.7 p -111.96 133.19 54.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.46 . . . . 70.22 110.903 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.498 ' O ' ' N ' ' A' ' 67' ' ' TYR . 8.9 mt -129.19 151.56 35.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.14 -0.482 . . . . 72.2 111.122 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.47 ' N ' HG23 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -143.05 121.03 12.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.149 -0.478 . . . . 75.41 110.862 179.84 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.632 HG22 ' HB2' ' A' ' 47' ' ' TRP . 1.3 t -107.62 116.79 51.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.212 -0.449 . . . . 75.05 111.148 179.833 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -112.18 76.5 0.98 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.177 -0.465 . . . . 72.33 110.932 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.431 ' O ' ' HA ' ' A' ' 6' ' ' THR . . . 142.37 94.09 0.21 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.738 -0.744 . . . . 72.54 112.441 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 56.49 174.26 0.21 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.763 -0.732 . . . . 75.4 112.49 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.485 HG21 ' HA ' ' A' ' 63' ' ' PRO . 1.2 m -69.09 169.99 10.84 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.793 0.33 . . . . 74.43 111.126 -179.867 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.632 ' HB2' HG22 ' A' ' 42' ' ' VAL . 5.3 m95 -145.53 128.91 16.88 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.208 -0.451 . . . . 74.41 110.924 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.627 ' O ' ' N ' ' A' ' 84' ' ' ARG . . . -88.54 126.62 35.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.234 -0.439 . . . . 75.14 111.105 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.671 ' O ' ' O ' ' A' ' 60' ' ' TYR . 27.2 m -126.77 139.58 51.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.211 -0.45 . . . . 74.31 111.177 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.878 ' HB3' ' CB ' ' A' ' 56' ' ' ALA . 5.0 m-85 -116.55 144.47 44.33 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.17 -0.468 . . . . 73.13 110.949 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.575 ' HG2' ' N ' ' A' ' 52' ' ' ARG . 0.3 OUTLIER -48.61 -84.67 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.141 -0.481 . . . . 74.33 110.867 -179.971 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.728 ' H ' ' HA ' ' A' ' 56' ' ' ALA . 0.2 OUTLIER -81.46 136.72 48.78 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.573 0.701 . . . . 74.44 110.915 -179.935 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.633 ' HB3' ' HB3' ' A' ' 81' ' ' SER . 53.8 Cg_endo -69.7 137.89 36.7 Favored 'Trans proline' 0 C--N 1.341 0.14 0 C-N-CA 122.681 2.254 . . . . 74.24 112.376 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.468 ' C ' ' CD2' ' A' ' 55' ' ' PHE . 2.0 m120 69.22 -5.87 1.03 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.277 -0.419 . . . . 73.51 110.885 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.468 ' CD2' ' C ' ' A' ' 54' ' ' ASN . 0.1 OUTLIER -143.51 -75.43 0.26 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.131 -0.486 . . . . 75.53 110.875 -179.913 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.878 ' CB ' ' HB3' ' A' ' 50' ' ' TYR . . . 45.87 81.27 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.14 -0.482 . . . . 72.34 111.09 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . 0.455 ' O ' ' CD2' ' A' ' 58' ' ' TYR . 18.9 m0 -65.32 35.48 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.227 -0.442 . . . . 74.53 110.908 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.613 ' H ' ' C ' ' A' ' 56' ' ' ALA . 1.2 m-30 -165.06 117.26 1.18 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.257 -0.429 . . . . 74.55 110.913 -179.844 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.422 ' HB2' ' HA ' ' A' ' 150' ' ' TYR . 1.0 OUTLIER -78.7 130.66 36.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.105 -0.498 . . . . 73.55 110.899 179.925 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.671 ' O ' ' O ' ' A' ' 49' ' ' VAL . 13.8 t80 -139.51 98.17 3.43 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.262 -0.427 . . . . 72.11 110.922 -179.864 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 4.0 mp -83.56 111.16 19.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.1 -0.5 . . . . 74.41 111.15 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.408 HD13 HG23 ' A' ' 49' ' ' VAL . 0.3 OUTLIER -79.88 127.05 78.68 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.608 0.718 . . . . 74.34 110.923 179.898 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.485 ' HA ' HG21 ' A' ' 46' ' ' THR . 53.7 Cg_endo -69.76 -165.04 0.14 Allowed 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.688 2.259 . . . . 72.31 112.348 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.91 160.68 14.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.236 -0.438 . . . . 75.13 110.928 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 112.61 -151.92 18.03 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.71 -0.757 . . . . 62.32 112.498 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -116.05 161.57 18.69 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.863 0.363 . . . . 74.54 110.884 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.498 ' N ' ' O ' ' A' ' 40' ' ' ILE . 13.6 m-85 -149.56 82.38 6.81 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.69 0.757 . . . . 72.15 110.929 -179.857 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.457 ' HD2' ' HG3' ' A' ' 72' ' ' ARG . 53.9 Cg_endo -69.74 -0.3 6.7 Favored 'Trans proline' 0 N--CA 1.465 -0.19 0 C-N-CA 122.72 2.28 . . . . 61.34 112.379 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -157.99 155.39 29.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.181 -0.463 . . . . 74.41 110.867 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.594 ' O ' ' CD1' ' A' ' 73' ' ' TRP . 24.9 p90 -62.18 -37.46 85.34 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.152 -0.476 . . . . 63.21 110.915 -179.854 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.577 ' HA ' ' CA ' ' A' ' 75' ' ' GLY . 6.6 pt20 -61.25 -10.6 7.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.12 -0.491 . . . . 74.44 110.922 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.457 ' HG3' ' HD2' ' A' ' 68' ' ' PRO . 25.2 mmt180 -65.82 -45.11 83.53 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.186 -0.461 . . . . 74.53 110.872 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . 0.757 ' O ' ' CB ' ' A' ' 74' ' ' MET . 0.4 OUTLIER -81.11 -5.45 57.68 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.182 -0.463 . . . . 74.52 110.902 -179.944 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' MET . . . . . 0.757 ' CB ' ' O ' ' A' ' 73' ' ' TRP . 8.4 mmm 131.21 -3.98 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.207 -0.451 . . . . 73.22 110.889 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.577 ' CA ' ' HA ' ' A' ' 71' ' ' GLN . . . 76.2 17.22 80.14 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.7 -0.762 . . . . 62.55 112.451 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.517 HD13 ' CD2' ' A' ' 60' ' ' TYR . 0.0 OUTLIER -63.45 -154.25 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.787 0.327 . . . . 65.44 110.963 -179.905 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -65.06 131.71 47.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.275 -0.421 . . . . 73.54 110.87 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -87.93 11.91 14.58 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.178 -0.465 . . . . 63.12 110.878 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.539 ' O ' ' O ' ' A' ' 51' ' ' GLU . 0.0 OUTLIER -87.95 49.44 1.8 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.169 -0.469 . . . . 73.41 110.852 -179.872 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.579 HD12 ' HB ' ' A' ' 49' ' ' VAL . 0.1 OUTLIER -59.89 127.08 30.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.191 -0.458 . . . . 74.42 110.891 -179.943 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.633 ' HB3' ' HB3' ' A' ' 53' ' ' PRO . 5.3 m -149.83 -114.99 0.06 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.188 -0.46 . . . . 71.22 110.897 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.577 ' OG ' ' HA ' ' A' ' 53' ' ' PRO . 0.1 OUTLIER -42.43 102.48 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.155 -0.475 . . . . 71.52 110.849 -179.776 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . 0.485 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 8.7 p -130.42 134.02 46.8 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.133 -0.485 . . . . 72.2 110.865 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.627 ' N ' ' O ' ' A' ' 48' ' ' ALA . 0.9 OUTLIER -117.33 158.44 24.39 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.16 -0.473 . . . . 73.53 110.854 -179.862 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.404 ' HB1' ' OG1' ' A' ' 6' ' ' THR . . . -70.58 131.77 44.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.2 -0.454 . . . . 63.33 111.075 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.528 ' CG2' ' CB ' ' A' ' 48' ' ' ALA . 71.3 t -117.06 129.07 74.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.162 -0.472 . . . . 73.14 111.142 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . 0.526 ' O ' ' CG2' ' A' ' 136' ' ' VAL . 16.9 m80 -113.79 107.39 15.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.179 -0.464 . . . . 74.31 110.824 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.477 ' C ' ' O ' ' A' ' 87' ' ' HIS . 0.0 OUTLIER -31.69 148.67 0.05 OUTLIER Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.574 0.702 . . . . 74.53 110.955 -179.999 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.546 ' HA ' ' HA3' ' A' ' 135' ' ' GLY . 53.4 Cg_endo -69.8 93.23 0.52 Allowed 'Trans proline' 0 C--O 1.231 0.136 0 C-N-CA 122.689 2.259 . . . . 73.22 112.323 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -104.61 -174.22 2.49 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.205 -0.452 . . . . 73.01 110.881 -179.872 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 49.55 64.18 3.6 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.755 -0.736 . . . . 64.43 112.464 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 122.6 24.22 2.17 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.751 -0.738 . . . . 71.21 112.515 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 41.5 -158.73 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.822 0.344 . . . . 64.51 110.892 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.486 ' HA ' ' HG2' ' A' ' 134' ' ' GLU . 31.5 t80 -99.77 102.78 14.33 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.187 -0.46 . . . . 75.33 110.905 -179.837 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.415 ' HD2' ' HA ' ' A' ' 95' ' ' LYS . 42.8 tptt -112.61 130.03 56.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.132 -0.485 . . . . 72.45 110.887 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.465 ' HB ' ' OE1' ' A' ' 134' ' ' GLU . 0.0 OUTLIER -148.83 137.44 15.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.232 -0.44 . . . . 75.14 111.127 179.888 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.402 ' HB2' ' O ' ' A' ' 131' ' ' LYS . 0.9 OUTLIER -111.16 132.2 54.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.15 -0.477 . . . . 72.31 110.905 179.935 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 3.1 mp -113.17 135.54 52.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.211 -0.45 . . . . 71.35 111.094 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.654 ' HB2' ' HB2' ' A' ' 129' ' ' SER . 48.7 m-85 -126.48 136.34 52.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.148 -0.478 . . . . 74.52 110.835 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 51.9 tt0 -65.6 -75.29 0.09 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.101 -0.499 . . . . 70.52 110.883 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.411 ' C ' ' HB2' ' A' ' 128' ' ' HIS . 6.0 mttt -85.64 158.6 20.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.143 -0.481 . . . . 74.2 110.939 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -66.54 164.4 41.93 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.782 -0.723 . . . . 71.44 112.512 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.412 ' HA ' ' HB2' ' A' ' 158' ' ' ARG . 38.7 t70 61.67 27.89 17.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.88 0.371 . . . . 65.32 110.843 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.496 ' HA ' ' CD2' ' A' ' 99' ' ' PHE . 14.9 m-85 59.52 52.68 5.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.193 -0.458 . . . . 74.51 110.916 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.2 m -118.13 148.9 41.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.102 -0.499 . . . . 74.04 110.827 -179.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 90.8 -125.19 7.86 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.724 -0.75 . . . . 74.3 112.532 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -98.85 139.55 34.36 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.756 0.312 . . . . 75.43 110.958 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 1.3 ttp -130.99 137.0 49.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.214 -0.448 . . . . 74.12 110.857 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 13.3 m-85 -141.29 136.56 31.72 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.244 -0.434 . . . . 75.05 110.953 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -117.74 103.85 10.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.146 -0.479 . . . . 75.41 110.874 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 13.1 t -117.33 140.69 49.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.166 -0.47 . . . . 61.01 111.166 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.522 ' O ' ' OG1' ' A' ' 112' ' ' THR . 0.1 OUTLIER -101.52 27.72 6.1 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.209 -0.45 . . . . 64.54 111.142 -179.962 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -143.67 -174.96 4.39 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.213 -0.449 . . . . 72.43 110.852 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.469 ' CB ' ' HA ' ' A' ' 174' ' ' ARG . 9.2 p30 -107.96 177.43 4.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.146 -0.479 . . . . 74.2 110.899 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . 0.425 ' O ' ' HB2' ' A' ' 172' ' ' SER . 18.4 p -155.98 148.86 18.14 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 121.578 0.704 . . . . 74.2 110.916 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 -25.65 28.36 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.68 2.253 . . . . 74.35 112.364 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.609 ' HB3' ' CB ' ' A' ' 120' ' ' GLU . 0.1 OUTLIER -150.77 107.4 3.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.192 -0.458 . . . . 72.12 110.879 -179.861 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.552 ' HB ' ' O ' ' A' ' 171' ' ' GLN . 4.0 tt -59.08 -29.81 42.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.142 -0.481 . . . . 72.31 111.152 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' MET . . . . . 0.595 ' O ' ' HA ' ' A' ' 123' ' ' HIS . 54.8 ttp -86.39 -42.66 13.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.168 -0.469 . . . . 73.31 110.877 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.609 ' CB ' ' HB3' ' A' ' 117' ' ' SER . 8.5 tp10 -67.59 -13.14 61.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.24 -0.437 . . . . 75.34 110.9 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 22.2 tp60 -114.53 -48.11 2.88 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.158 -0.473 . . . . 70.23 110.944 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . 0.447 ' HB2' ' O ' ' A' ' 118' ' ' ILE . 47.6 m-85 -105.68 -20.1 13.56 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.217 -0.447 . . . . 71.13 110.878 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . 0.595 ' HA ' ' O ' ' A' ' 119' ' ' MET . 10.7 m80 72.61 28.14 2.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.201 -0.454 . . . . 63.53 110.83 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.411 ' O ' HG22 ' A' ' 118' ' ' ILE . 4.6 mtt -105.44 84.49 2.1 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.222 -0.444 . . . . 70.45 110.873 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 3.7 ptp180 -50.98 -34.81 30.6 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.196 -0.456 . . . . 75.01 110.885 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.5 ' HG2' ' HA ' ' A' ' 169' ' ' ALA . 18.4 mt-10 -144.8 135.27 24.39 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.16 -0.473 . . . . 75.35 110.872 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.463 ' O ' ' HB3' ' A' ' 168' ' ' PRO . 3.7 mm -96.04 100.71 11.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.147 -0.478 . . . . 74.52 111.122 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . 0.411 ' HB2' ' C ' ' A' ' 101' ' ' LYS . 14.7 m170 -71.34 -30.77 66.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.194 -0.457 . . . . 74.34 110.879 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.654 ' HB2' ' HB2' ' A' ' 99' ' ' PHE . 0.4 OUTLIER -133.85 140.08 46.64 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.158 -0.473 . . . . 73.14 110.87 -179.778 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . 0.573 ' O ' ' O ' ' A' ' 155' ' ' LYS . 2.7 m -140.45 117.59 11.24 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.112 -0.494 . . . . 64.42 110.846 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.677 ' HA ' ' HA ' ' A' ' 156' ' ' GLU . 2.9 mtpp -106.44 154.55 20.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.196 -0.456 . . . . 72.12 110.872 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.409 ' CB ' ' O ' ' A' ' 131' ' ' LYS . 4.8 t 79.59 166.38 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.203 -0.453 . . . . 75.12 111.115 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.518 ' HB3' ' HA ' ' A' ' 155' ' ' LYS . 0.1 OUTLIER -171.19 128.52 0.71 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.159 -0.473 . . . . 73.31 110.905 179.992 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.486 ' HG2' ' HA ' ' A' ' 94' ' ' TYR . 0.3 OUTLIER -97.3 155.98 16.64 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.181 -0.463 . . . . 75.53 110.877 179.905 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . 0.546 ' HA3' ' HA ' ' A' ' 89' ' ' PRO . . . -30.53 -48.42 0.16 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.75 -0.738 . . . . 74.04 112.488 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.653 ' HA ' HD13 ' A' ' 152' ' ' LEU . 3.1 t -150.18 137.68 13.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.842 0.353 . . . . 62.34 111.136 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . 0.72 ' HB3' ' CB ' ' A' ' 152' ' ' LEU . 16.5 t90 -144.3 137.63 27.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.19 -0.459 . . . . 75.15 110.897 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.528 ' CG2' ' HB2' ' A' ' 149' ' ' GLN . 34.2 mt -111.69 132.05 61.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.212 -0.449 . . . . 72.45 111.097 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.539 ' CD2' ' HB3' ' A' ' 173' ' ' PHE . 0.1 OUTLIER -96.88 178.25 5.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.181 -0.463 . . . . 73.14 110.844 179.994 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . 0.518 ' CE2' ' HG2' ' A' ' 174' ' ' ARG . 0.3 OUTLIER -155.07 124.06 6.21 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.143 -0.48 . . . . 74.21 110.921 -179.836 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . 0.602 ' O ' ' HB2' ' A' ' 171' ' ' GLN . 0.1 OUTLIER -61.44 -29.71 70.12 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.158 -0.474 . . . . 62.3 110.859 -179.982 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.734 ' HB3' ' HD2' ' A' ' 143' ' ' PRO . 9.1 mp -114.54 172.89 3.22 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.562 0.696 . . . . 74.34 110.94 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . 0.741 ' O ' ' OG ' ' A' ' 172' ' ' SER . 53.4 Cg_endo -69.76 -90.73 0.01 OUTLIER 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.669 2.246 . . . . 75.41 112.324 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . 0.698 ' O ' ' N ' ' A' ' 146' ' ' ARG . 1.6 m-20 -54.21 95.79 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.201 -0.454 . . . . 75.2 110.907 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . 0.649 ' C ' ' O ' ' A' ' 144' ' ' ASN . 0.1 OUTLIER 12.08 53.94 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.175 -0.466 . . . . 73.32 110.95 -179.876 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . 0.698 ' N ' ' O ' ' A' ' 144' ' ' ASN . 8.8 mtp85 -116.38 163.03 16.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.098 -0.501 . . . . 75.51 110.851 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 74.31 -172.67 51.86 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.722 -0.752 . . . . 61.43 112.481 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 4.7 mpt_? -86.7 134.02 33.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.764 0.316 . . . . 73.51 110.88 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . 0.63 ' OE1' ' HA ' ' A' ' 60' ' ' TYR . 0.3 OUTLIER -87.76 163.42 16.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.163 -0.471 . . . . 74.05 110.957 -179.952 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . 0.423 ' HB2' ' HB2' ' A' ' 139' ' ' PHE . 5.2 m-85 -126.8 151.42 48.3 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.234 -0.439 . . . . 75.3 110.958 -179.896 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 29.7 tp -85.65 140.08 30.86 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.125 -0.489 . . . . 74.42 110.868 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.72 ' CB ' ' HB3' ' A' ' 137' ' ' TRP . 0.0 OUTLIER -69.96 138.24 52.14 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.167 -0.47 . . . . 74.03 110.893 179.883 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -165.84 27.53 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.216 -0.447 . . . . 72.1 110.872 179.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.82 ' HB2' ' CD1' ' A' ' 157' ' ' TYR . 0.0 OUTLIER -118.61 -172.42 2.28 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.177 -0.465 . . . . 75.35 110.931 179.952 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.751 ' HD2' ' C ' ' A' ' 154' ' ' LYS . 1.0 OUTLIER -161.63 -123.2 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.236 -0.438 . . . . 73.54 110.855 179.844 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.677 ' HA ' ' HA ' ' A' ' 131' ' ' LYS . 2.7 tm-20 -71.65 2.63 4.95 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.207 -0.451 . . . . 74.22 110.911 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . 0.82 ' CD1' ' HB2' ' A' ' 154' ' ' LYS . 18.5 m-30 -32.33 147.3 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.14 -0.482 . . . . 74.53 110.91 -179.836 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . 0.475 ' HB3' ' CZ ' ' A' ' 104' ' ' PHE . 8.7 ptp180 -113.64 -35.76 5.1 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.133 -0.485 . . . . 75.51 110.885 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . 0.485 ' HB2' HD13 ' A' ' 161' ' ' ILE . 0.2 OUTLIER -92.27 152.94 42.9 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.551 0.691 . . . . 75.42 110.905 179.987 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . 0.453 ' HB3' ' HB3' ' A' ' 168' ' ' PRO . 53.7 Cg_endo -69.75 -35.0 13.49 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.679 2.252 . . . . 75.53 112.35 179.893 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.485 HD13 ' HB2' ' A' ' 159' ' ' LYS . 3.2 mp -57.56 -15.85 4.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.444 . . . . 75.22 111.125 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . 0.657 ' HB3' ' CD1' ' A' ' 157' ' ' TYR . 0.4 OUTLIER -71.69 -13.74 61.83 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.206 -0.452 . . . . 63.2 110.829 179.884 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 22.3 t90 -87.98 -16.28 34.2 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.192 -0.458 . . . . 73.12 110.881 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 109.82 -37.36 3.81 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.758 -0.734 . . . . 54.31 112.483 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . 0.424 ' O ' ' C ' ' A' ' 166' ' ' ALA . . . -78.92 127.17 31.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.797 0.332 . . . . 61.52 111.066 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . 0.424 ' C ' ' O ' ' A' ' 165' ' ' ALA . . . -35.94 -42.18 0.27 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.231 -0.44 . . . . 72.04 111.11 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' SER . . . . . 0.524 ' C ' ' H ' ' A' ' 169' ' ' ALA . 0.5 OUTLIER -129.78 153.57 80.88 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.654 0.74 . . . . 75.22 110.864 -179.811 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . 0.463 ' HB3' ' O ' ' A' ' 127' ' ' ILE . 53.9 Cg_endo -69.72 29.04 0.18 Allowed 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.691 2.261 . . . . 75.23 112.357 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . 0.524 ' H ' ' C ' ' A' ' 167' ' ' SER . . . -66.28 103.95 1.1 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.236 -0.438 . . . . 75.31 111.09 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 2.6 t -151.57 163.33 2.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.459 . . . . 73.22 111.127 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' GLN . . . . . 0.671 ' OE1' ' HB3' ' A' ' 143' ' ' PRO . 1.6 tm0? -112.26 -83.31 0.59 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.157 -0.474 . . . . 75.22 110.897 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' SER . . . . . 0.741 ' OG ' ' O ' ' A' ' 143' ' ' PRO . 54.4 p -124.55 174.91 7.51 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.203 -0.453 . . . . 70.42 110.805 -179.788 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . 0.539 ' HB3' ' CD2' ' A' ' 139' ' ' PHE . 39.6 p90 -148.76 164.83 33.25 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.101 -0.5 . . . . 74.43 110.919 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . 0.518 ' HG2' ' CE2' ' A' ' 140' ' ' TYR . 0.0 OUTLIER -136.16 142.75 44.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.209 -0.45 . . . . 73.42 110.906 -179.921 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . 0.402 ' HG3' ' OD1' ' A' ' 114' ' ' ASP . 0.0 OUTLIER -90.59 -176.62 4.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.199 -0.455 . . . . 73.04 110.838 -179.911 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . 0.434 HD11 ' C ' ' A' ' 136' ' ' VAL . 2.4 mt -133.84 132.21 56.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.174 -0.467 . . . . 73.13 111.112 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 83.1 t -150.04 140.56 16.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.213 -0.449 . . . . 71.34 111.138 179.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.163 -0.471 . . . . 73.54 110.894 -179.986 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.793 0.33 . . . . 74.11 110.881 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.4 m -152.54 -170.93 3.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.253 -0.43 . . . . 63.11 110.864 -179.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -90.88 63.5 5.26 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.129 -0.487 . . . . 74.45 110.913 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 8.1 t -167.18 -37.6 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.161 -0.472 . . . . 73.32 111.148 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -84.43 78.14 2.04 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.747 -0.739 . . . . 53.5 112.491 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.446 ' C ' ' HE1' ' A' ' 47' ' ' TRP . 6.6 p -81.94 133.61 35.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.833 0.349 . . . . 74.24 111.151 -179.88 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 2.7 tttt -120.94 136.93 54.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.262 -0.426 . . . . 75.41 110.912 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.573 ' HB ' ' CD1' ' A' ' 47' ' ' TRP . 13.7 tt -136.92 152.18 28.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.236 -0.438 . . . . 70.3 111.153 179.821 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.49 ' HA ' ' O ' ' A' ' 21' ' ' TYR . 15.5 m -134.0 138.15 45.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.192 -0.458 . . . . 74.2 111.113 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.515 ' N ' ' CD2' ' A' ' 10' ' ' PHE . 0.2 OUTLIER -126.74 128.53 46.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.2 -0.455 . . . . 71.32 110.882 179.995 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.536 ' CG ' ' HA ' ' A' ' 16' ' ' PHE . 26.3 m-85 -113.45 132.0 55.82 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.118 -0.492 . . . . 71.35 110.876 -179.833 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.415 ' HB2' ' HB2' ' A' ' 19' ' ' ARG . 0.1 OUTLIER -61.69 -15.14 37.71 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.107 -0.497 . . . . 73.43 110.89 179.99 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.426 ' HB2' ' O ' ' A' ' 17' ' ' GLN . 72.5 m-20 -134.91 150.42 50.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.142 -0.481 . . . . 64.32 110.865 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.532 ' N ' ' HB3' ' A' ' 38' ' ' ASN . 36.7 mtmt -56.16 -178.77 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.224 -0.443 . . . . 74.42 110.914 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 25.4 m-20 49.44 31.52 4.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.212 -0.449 . . . . 73.12 110.898 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.536 ' HA ' ' CG ' ' A' ' 11' ' ' TYR . 3.7 m-85 50.9 63.54 2.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.179 -0.464 . . . . 75.41 110.922 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.426 ' O ' ' HB2' ' A' ' 13' ' ' ASP . 24.6 mt-30 -139.52 160.85 38.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.15 -0.477 . . . . 74.04 110.898 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 92.0 -149.29 19.62 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.8 -0.714 . . . . 64.34 112.485 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.425 ' O ' ' CD1' ' A' ' 34' ' ' LEU . 0.0 OUTLIER -69.21 77.8 0.36 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.756 0.312 . . . . 74.14 110.852 -179.865 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.439 ' HB2' ' CE1' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -76.3 129.01 36.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 72.11 110.882 -179.919 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.49 ' O ' ' HA ' ' A' ' 9' ' ' THR . 91.4 t80 -122.95 125.57 45.55 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.213 -0.449 . . . . 74.14 110.888 -179.81 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.472 ' CG ' HG23 ' A' ' 9' ' ' THR . 1.4 m-20 -121.73 133.51 54.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.121 -0.49 . . . . 75.53 110.866 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -166.99 135.43 2.67 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.217 -0.447 . . . . 72.11 110.878 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -103.22 5.55 37.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.17 -0.468 . . . . 55.11 110.815 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 49.7 t -110.08 158.85 17.86 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.231 -0.44 . . . . 72.02 110.864 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -43.3 120.17 1.8 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.172 -0.467 . . . . 73.13 110.83 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.594 ' HB2' ' HB3' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -115.6 42.33 2.31 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.204 -0.453 . . . . 73.03 110.868 -179.951 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.558 ' O ' ' HA ' ' A' ' 82' ' ' SER . . . -51.12 -20.11 1.37 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.229 -0.441 . . . . 74.11 111.126 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 63.2 t0 -128.5 37.57 4.1 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.218 -0.446 . . . . 73.15 110.864 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.763 ' O ' ' CD2' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -80.97 15.68 1.74 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.198 -0.456 . . . . 73.22 110.857 -179.892 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.418 ' CG ' ' HG3' ' A' ' 53' ' ' PRO . 39.3 t60 -80.02 -34.0 38.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.189 -0.459 . . . . 71.03 110.864 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.6 t -63.24 -10.84 17.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.216 -0.447 . . . . 72.53 111.136 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -103.32 -28.87 11.6 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.193 -0.458 . . . . 74.21 110.925 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.425 ' CD1' ' O ' ' A' ' 19' ' ' ARG . 16.0 tp -139.02 141.25 38.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.133 -0.485 . . . . 74.4 110.89 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 20.7 m -105.35 -42.05 5.36 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.174 -0.466 . . . . 71.04 110.863 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -118.49 143.0 47.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.178 -0.464 . . . . 75.31 110.907 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.685 ' SG ' ' HB2' ' A' ' 80' ' ' LEU . 3.9 p -115.05 87.22 2.61 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.204 -0.453 . . . . 72.24 110.9 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.532 ' HB3' ' N ' ' A' ' 14' ' ' LYS . 3.3 m-20 -82.76 -50.85 8.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 64.4 110.852 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 9.8 p -129.4 127.14 40.37 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.163 -0.472 . . . . 74.11 110.821 -179.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.479 ' O ' ' N ' ' A' ' 67' ' ' TYR . 13.5 mt -125.44 152.1 31.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.103 -0.499 . . . . 72.32 111.15 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.437 ' N ' HG23 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -144.85 118.55 9.2 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.201 -0.454 . . . . 74.33 110.932 179.845 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.517 HG22 ' HB2' ' A' ' 47' ' ' TRP . 1.3 t -104.02 116.7 48.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.259 -0.428 . . . . 64.51 111.175 179.85 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -111.54 77.65 1.06 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.197 -0.456 . . . . 72.41 110.887 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.445 ' O ' ' HA ' ' A' ' 6' ' ' THR . . . 135.4 101.87 0.68 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.762 -0.732 . . . . 51.24 112.512 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 53.91 179.65 0.14 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.767 -0.73 . . . . 74.2 112.493 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.492 HG21 ' HA ' ' A' ' 63' ' ' PRO . 1.4 m -80.25 169.28 18.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.797 0.332 . . . . 72.44 111.12 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.573 ' CD1' ' HB ' ' A' ' 8' ' ' ILE . 5.7 m95 -141.18 130.1 23.13 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.194 -0.457 . . . . 72.52 110.945 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.613 ' O ' ' N ' ' A' ' 84' ' ' ARG . . . -90.58 127.02 36.13 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.222 -0.445 . . . . 73.22 111.125 179.892 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.788 ' O ' ' O ' ' A' ' 60' ' ' TYR . 35.7 m -128.84 124.48 61.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.213 -0.449 . . . . 70.2 111.135 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.715 ' HB3' ' HA ' ' A' ' 56' ' ' ALA . 49.5 m-85 -94.51 150.15 20.53 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.21 -0.45 . . . . 74.03 110.901 -179.91 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.677 ' OE1' ' HB3' ' A' ' 57' ' ' TRP . 58.1 tt0 -49.27 -79.51 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.106 -0.497 . . . . 74.1 110.901 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.544 ' HB2' ' HB2' ' A' ' 57' ' ' TRP . 0.0 OUTLIER -92.54 143.77 27.73 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.607 0.718 . . . . 74.43 110.893 -179.951 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.639 ' HA ' ' OG ' ' A' ' 82' ' ' SER . 53.3 Cg_endo -69.82 142.41 47.57 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.739 2.293 . . . . 74.24 112.301 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 61.95 -9.75 0.08 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.236 -0.438 . . . . 73.52 110.89 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.621 ' H ' ' C ' ' A' ' 53' ' ' PRO . 2.7 m-30 -105.92 -20.4 13.44 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.184 -0.462 . . . . 73.43 110.901 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.715 ' HA ' ' HB3' ' A' ' 50' ' ' TYR . . . 50.02 27.15 2.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.168 -0.469 . . . . 72.1 111.068 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . 0.677 ' HB3' ' OE1' ' A' ' 51' ' ' GLU . 0.1 OUTLIER -50.69 -163.69 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.23 -0.441 . . . . 75.24 110.907 -179.959 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.636 ' C ' ' O ' ' A' ' 57' ' ' TRP . 5.4 m-30 -13.1 101.2 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.235 -0.439 . . . . 72.1 110.954 -179.841 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.43 142.89 36.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.072 -0.513 . . . . 73.33 110.873 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.788 ' O ' ' O ' ' A' ' 49' ' ' VAL . 0.3 OUTLIER -153.4 112.41 3.75 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.255 -0.43 . . . . 73.23 110.938 -179.896 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.587 ' N ' ' CD1' ' A' ' 61' ' ' ILE . 1.1 mp -102.82 114.19 41.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.13 -0.486 . . . . 72.04 111.153 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -85.41 122.46 73.56 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 121.632 0.73 . . . . 74.13 110.89 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.492 ' HA ' HG21 ' A' ' 46' ' ' THR . 54.1 Cg_endo -69.7 -166.34 0.18 Allowed 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.699 2.266 . . . . 75.01 112.339 179.868 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.44 160.96 14.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.164 -0.471 . . . . 75.03 110.896 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 113.48 -152.7 17.93 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.743 -0.741 . . . . 62.32 112.517 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -118.4 159.26 23.76 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.867 0.365 . . . . 74.15 110.891 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.479 ' N ' ' O ' ' A' ' 40' ' ' ILE . 11.5 m-85 -147.32 84.02 7.47 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.665 0.745 . . . . 74.24 110.942 -179.85 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 -4.68 14.51 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.655 2.237 . . . . 70.14 112.393 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 89.3 mt-10 -157.49 147.84 20.88 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.158 -0.474 . . . . 75.33 110.889 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.941 ' O ' ' CD1' ' A' ' 73' ' ' TRP . 44.4 p90 -57.97 -41.07 82.16 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.181 -0.463 . . . . 73.43 110.911 -179.882 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -52.8 -15.69 0.8 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.098 -0.501 . . . . 73.4 110.948 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 29.2 mmt180 -65.77 -17.6 64.74 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.189 -0.46 . . . . 73.22 110.845 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . 0.941 ' CD1' ' O ' ' A' ' 70' ' ' TYR . 0.4 OUTLIER -121.14 22.39 10.95 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.2 -0.455 . . . . 73.3 110.896 -179.948 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' MET . . . . . 0.594 ' O ' ' C ' ' A' ' 75' ' ' GLY . 0.0 OUTLIER 75.67 30.22 0.8 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.278 -0.419 . . . . 72.23 110.9 179.943 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.594 ' C ' ' O ' ' A' ' 74' ' ' MET . . . 17.11 59.06 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.678 -0.773 . . . . 72.55 112.508 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.47 ' CB ' ' HE2' ' A' ' 60' ' ' TYR . 0.0 OUTLIER -55.01 -72.38 0.07 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.836 0.35 . . . . 72.52 110.944 -179.955 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.498 ' O ' ' CB ' ' A' ' 78' ' ' ASP . 16.3 t-20 -121.16 -37.93 2.88 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.172 -0.467 . . . . 73.41 110.857 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.498 ' CB ' ' O ' ' A' ' 77' ' ' ASN . 0.0 OUTLIER 83.83 10.35 0.47 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.206 -0.452 . . . . 64.01 110.882 179.925 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -105.74 86.89 2.47 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.186 -0.461 . . . . 74.15 110.88 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.685 ' HB2' ' SG ' ' A' ' 37' ' ' CYS . 0.1 OUTLIER -86.95 131.38 34.11 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.182 -0.463 . . . . 70.31 110.886 -179.965 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.636 ' HB3' ' HB3' ' A' ' 53' ' ' PRO . 1.4 m -153.82 -119.23 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.158 -0.473 . . . . 74.4 110.843 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.639 ' OG ' ' HA ' ' A' ' 53' ' ' PRO . 0.1 OUTLIER -46.38 97.76 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.142 -0.481 . . . . 71.51 110.871 -179.814 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . 0.519 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 9.7 p -122.78 134.96 54.41 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.186 -0.461 . . . . 74.01 110.86 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.613 ' N ' ' O ' ' A' ' 48' ' ' ALA . 2.2 mmt85 -117.66 156.57 27.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.176 -0.466 . . . . 74.11 110.87 -179.843 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -68.42 129.05 38.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 72.15 111.119 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.513 ' CG2' ' CB ' ' A' ' 48' ' ' ALA . 38.3 t -115.56 139.17 43.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.24 -0.437 . . . . 72.33 111.114 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . 0.467 ' O ' ' C ' ' A' ' 88' ' ' LEU . 9.2 m170 -114.12 108.59 17.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.161 -0.472 . . . . 75.22 110.892 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.467 ' C ' ' O ' ' A' ' 87' ' ' HIS . 0.0 OUTLIER -32.79 148.15 0.06 OUTLIER Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.577 0.703 . . . . 75.34 110.908 -179.972 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.6 ' HA ' ' HA3' ' A' ' 135' ' ' GLY . 53.3 Cg_endo -69.82 100.38 0.82 Allowed 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.658 2.239 . . . . 73.52 112.303 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -105.72 -175.65 2.85 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.194 -0.457 . . . . 73.23 110.867 -179.855 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 46.36 57.91 6.17 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.7 -0.762 . . . . 72.1 112.509 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 125.44 26.63 1.29 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.763 -0.732 . . . . 73.33 112.49 -179.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.518 ' O ' ' CG ' ' A' ' 134' ' ' GLU . 5.7 pt20 38.27 -124.49 0.27 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.792 0.33 . . . . 73.43 110.935 -179.861 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.579 ' HA ' ' HG2' ' A' ' 134' ' ' GLU . 0.0 OUTLIER -125.76 103.38 7.78 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.173 -0.467 . . . . 75.33 110.888 -179.857 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.477 ' H ' ' HG2' ' A' ' 134' ' ' GLU . 12.6 tptp -113.34 130.96 56.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.079 -0.51 . . . . 74.54 110.875 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 7.6 tt -149.05 138.25 15.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.185 -0.461 . . . . 74.32 111.13 179.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.471 ' HB2' ' O ' ' A' ' 131' ' ' LYS . 0.9 OUTLIER -110.52 139.38 45.81 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.153 -0.476 . . . . 73.33 110.878 179.962 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.41 HG22 HG13 ' A' ' 127' ' ' ILE . 1.2 mp -116.74 148.58 19.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 73.24 111.102 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.628 ' HB2' ' HB2' ' A' ' 129' ' ' SER . 38.6 m-85 -134.1 133.94 41.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.205 -0.452 . . . . 75.23 110.848 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 77.2 tt0 -65.26 -61.25 2.24 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.159 -0.473 . . . . 73.05 110.878 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 35.4 mttt -99.79 162.21 13.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.134 -0.485 . . . . 73.43 110.872 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -68.16 159.83 51.18 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.73 -0.747 . . . . 73.34 112.48 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.493 ' HA ' ' HB2' ' A' ' 158' ' ' ARG . 25.7 t0 67.22 39.0 3.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.855 0.359 . . . . 53.23 110.888 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.58 ' CZ ' ' HB3' ' A' ' 158' ' ' ARG . 3.6 m-85 58.06 19.65 6.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.202 -0.454 . . . . 74.25 110.894 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 70.4 m -88.23 161.55 17.15 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.15 -0.477 . . . . 74.55 110.88 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 82.26 -159.0 38.65 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.726 -0.75 . . . . 74.53 112.454 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 4.1 tp-100 -82.86 129.19 34.97 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.786 0.327 . . . . 73.01 110.887 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' MET . . . . . 0.452 ' HB2' ' CD1' ' A' ' 99' ' ' PHE . 0.0 OUTLIER -118.69 160.39 21.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.195 -0.457 . . . . 74.12 110.862 179.954 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 29.9 m-85 -154.72 135.87 13.94 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.205 -0.452 . . . . 75.45 110.911 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -110.98 102.0 10.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.139 -0.482 . . . . 74.51 110.906 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 9.0 t -113.38 128.56 56.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.148 -0.478 . . . . 52.4 111.14 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.423 ' O ' ' OG1' ' A' ' 112' ' ' THR . 1.8 t -93.4 32.6 1.33 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.222 -0.444 . . . . 74.32 111.162 -180.0 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -153.79 -174.85 5.11 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.211 -0.449 . . . . 71.13 110.895 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -90.16 -175.18 4.45 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.154 -0.475 . . . . 63.13 110.839 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . 0.654 ' O ' ' HB2' ' A' ' 172' ' ' SER . 39.0 t -161.19 136.17 5.53 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.606 0.717 . . . . 75.3 110.854 -179.893 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.497 ' O ' ' C ' ' A' ' 143' ' ' PRO . 53.4 Cg_endo -69.81 -34.51 14.28 Favored 'Trans proline' 0 C--N 1.341 0.134 0 C-N-CA 122.669 2.246 . . . . 70.35 112.324 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.618 ' HB3' ' CB ' ' A' ' 120' ' ' GLU . 0.1 OUTLIER -147.04 97.28 2.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.228 -0.442 . . . . 65.43 110.88 -179.844 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.646 ' HB ' ' O ' ' A' ' 171' ' ' GLN . 3.7 tt -50.81 -28.8 6.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.158 -0.473 . . . . 71.43 111.107 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' MET . . . . . 0.571 ' O ' ' HA ' ' A' ' 123' ' ' HIS . 21.7 ttp -85.95 -44.96 11.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.169 -0.469 . . . . 72.44 110.896 179.848 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.618 ' CB ' ' HB3' ' A' ' 117' ' ' SER . 17.5 tp10 -66.17 -14.14 61.36 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.242 -0.435 . . . . 74.13 110.9 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 7.1 tp-100 -113.69 -51.49 2.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.121 -0.491 . . . . 65.32 110.882 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . 0.485 ' HB2' ' O ' ' A' ' 118' ' ' ILE . 77.2 m-85 -101.81 -21.53 14.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.187 -0.46 . . . . 70.01 110.845 -179.912 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . 0.571 ' HA ' ' O ' ' A' ' 119' ' ' MET . 29.3 m-70 71.87 30.83 2.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.155 -0.475 . . . . 72.41 110.91 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 4.1 mtt -106.79 88.65 2.8 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.174 -0.466 . . . . 75.14 110.829 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 4.0 ptp180 -53.34 -38.44 63.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.252 -0.431 . . . . 74.53 110.864 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.464 ' HB3' ' HG2' ' A' ' 168' ' ' PRO . 18.2 mt-10 -140.2 130.58 25.31 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.166 -0.47 . . . . 75.23 110.87 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.424 ' O ' ' HB3' ' A' ' 168' ' ' PRO . 3.0 mm -87.57 96.88 6.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.173 -0.467 . . . . 75.45 111.09 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . 0.429 ' HA ' ' HB3' ' A' ' 160' ' ' PRO . 17.0 m170 -66.03 -35.93 81.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.132 -0.485 . . . . 63.33 110.867 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.628 ' HB2' ' HB2' ' A' ' 99' ' ' PHE . 0.6 OUTLIER -135.54 147.45 48.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.225 -0.443 . . . . 72.4 110.884 -179.809 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . 0.553 ' O ' ' O ' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -144.78 120.39 10.43 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.192 -0.458 . . . . 64.45 110.924 -179.989 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.627 ' HA ' ' HA ' ' A' ' 156' ' ' GLU . 4.4 mtpt -111.25 154.32 24.62 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.156 -0.475 . . . . 72.13 110.938 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.489 ' HB ' ' O ' ' A' ' 131' ' ' LYS . 13.0 t 83.32 163.59 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 73.4 111.131 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.439 ' CD1' ' O ' ' A' ' 154' ' ' LYS . 0.0 OUTLIER -178.86 122.2 0.09 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.176 -0.465 . . . . 64.22 110.898 179.95 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.579 ' HG2' ' HA ' ' A' ' 94' ' ' TYR . 0.1 OUTLIER -96.13 166.6 11.67 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.165 -0.47 . . . . 73.22 110.895 179.923 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . 0.6 ' HA3' ' HA ' ' A' ' 89' ' ' PRO . . . -24.42 -73.71 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.691 -0.766 . . . . 53.01 112.532 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.659 ' HA ' HD13 ' A' ' 152' ' ' LEU . 4.7 t -132.45 146.97 32.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.833 0.349 . . . . 74.12 111.126 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . 0.584 ' O ' ' HB3' ' A' ' 152' ' ' LEU . 2.6 t-105 -149.6 141.98 24.25 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.17 -0.468 . . . . 75.11 110.924 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.466 ' CG2' ' HB2' ' A' ' 149' ' ' GLN . 59.5 mt -115.59 132.34 65.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.258 -0.428 . . . . 74.2 111.177 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.413 ' O ' ' HA ' ' A' ' 149' ' ' GLN . 0.3 OUTLIER -99.74 179.58 4.49 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.166 -0.47 . . . . 71.13 110.878 179.99 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . 0.555 ' CE1' ' HB3' ' A' ' 149' ' ' GLN . 1.4 m-85 -152.39 126.08 8.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.136 -0.483 . . . . 74.53 110.905 -179.867 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . 0.597 ' O ' ' HB2' ' A' ' 171' ' ' GLN . 3.2 tt0 -61.05 -26.49 67.66 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.142 -0.481 . . . . 70.32 110.907 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.726 ' HB3' ' HD2' ' A' ' 143' ' ' PRO . 8.4 mp -116.24 173.29 3.12 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.59 0.709 . . . . 75.25 110.892 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . 0.752 ' O ' ' OG ' ' A' ' 172' ' ' SER . 54.0 Cg_endo -69.73 -89.68 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.145 0 C-N-CA 122.724 2.283 . . . . 71.23 112.373 179.813 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . 0.704 ' O ' ' N ' ' A' ' 146' ' ' ARG . 1.0 OUTLIER -54.69 95.7 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.232 -0.44 . . . . 72.12 110.931 179.957 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . 0.646 ' C ' ' O ' ' A' ' 144' ' ' ASN . 0.1 OUTLIER 12.69 53.01 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.17 -0.468 . . . . 74.31 110.89 -179.913 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . 0.704 ' N ' ' O ' ' A' ' 144' ' ' ASN . 10.1 mtp85 -118.69 172.46 7.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.159 -0.473 . . . . 74.2 110.862 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 70.59 -175.34 37.41 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.713 -0.756 . . . . 74.32 112.479 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.421 ' HG3' HD21 ' A' ' 76' ' ' LEU . 3.9 mtp180 -83.28 130.7 35.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.776 0.322 . . . . 73.32 110.87 -179.867 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . 0.728 ' OE1' ' HA ' ' A' ' 60' ' ' TYR . 0.3 OUTLIER -85.79 158.7 19.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.178 -0.464 . . . . 74.2 110.9 -179.926 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -123.59 158.27 31.84 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.206 -0.452 . . . . 72.43 110.957 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.477 ' CA ' HD12 ' A' ' 61' ' ' ILE . 13.4 tp -92.01 134.65 34.62 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.108 -0.496 . . . . 74.42 110.917 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.659 HD13 ' HA ' ' A' ' 136' ' ' VAL . 0.0 OUTLIER -63.94 132.59 51.17 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.218 -0.446 . . . . 75.31 110.895 179.884 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -163.69 26.04 0.08 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.174 -0.467 . . . . 64.24 110.854 179.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.789 ' HB2' ' CD1' ' A' ' 157' ' ' TYR . 5.6 pttt -116.13 -173.03 2.28 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.167 -0.469 . . . . 75.43 110.854 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.77 ' HG3' ' O ' ' A' ' 154' ' ' LYS . 0.1 OUTLIER -161.75 -124.53 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.183 -0.462 . . . . 74.24 110.898 179.867 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.633 ' HG2' ' O ' ' A' ' 156' ' ' GLU . 0.3 OUTLIER -71.42 2.2 5.27 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.228 -0.442 . . . . 71.32 110.904 179.976 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . 0.789 ' CD1' ' HB2' ' A' ' 154' ' ' LYS . 20.5 m-30 -30.17 144.85 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.153 -0.476 . . . . 71.14 110.93 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . 0.58 ' HB3' ' CZ ' ' A' ' 104' ' ' PHE . 9.4 ptp180 -112.67 -44.13 3.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.128 -0.487 . . . . 73.54 110.881 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . 0.476 ' HB2' HD11 ' A' ' 161' ' ' ILE . 0.7 OUTLIER -80.48 152.17 72.65 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.596 0.712 . . . . 74.42 110.865 179.982 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . 0.429 ' HB3' ' HA ' ' A' ' 128' ' ' HIS . 54.2 Cg_endo -69.76 -32.83 17.8 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.693 2.262 . . . . 74.14 112.335 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.496 HD11 ' H ' ' A' ' 161' ' ' ILE . 3.6 mp -55.34 -19.04 4.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.224 -0.444 . . . . 74.24 111.143 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . 0.657 ' HB3' ' CD1' ' A' ' 157' ' ' TYR . 0.3 OUTLIER -73.57 -23.0 59.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.202 -0.454 . . . . 70.33 110.891 179.826 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' TRP . . . . . 0.489 ' CD1' ' HB3' ' A' ' 165' ' ' ALA . 2.1 t-105 -67.53 -17.7 64.76 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.2 -0.455 . . . . 74.12 110.963 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 114.3 -38.63 3.09 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.689 -0.767 . . . . 74.0 112.473 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . 0.489 ' HB3' ' CD1' ' A' ' 163' ' ' TRP . . . -90.91 140.68 29.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.81 0.338 . . . . 63.14 111.063 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -40.97 -35.13 0.48 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.196 -0.456 . . . . 70.24 111.09 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' SER . . . . . 0.522 ' C ' ' H ' ' A' ' 169' ' ' ALA . 0.3 OUTLIER -129.51 156.82 78.02 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.665 0.745 . . . . 75.55 110.9 -179.803 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . 0.464 ' HG2' ' HB3' ' A' ' 126' ' ' GLU . 53.9 Cg_endo -69.76 25.27 0.17 Allowed 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.697 2.264 . . . . 74.41 112.356 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . 0.522 ' H ' ' C ' ' A' ' 167' ' ' SER . . . -64.3 103.88 0.69 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.197 -0.456 . . . . 62.14 111.149 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 3.5 t -153.66 162.17 2.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.238 -0.437 . . . . 75.11 111.122 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' GLN . . . . . 0.646 ' O ' ' HB ' ' A' ' 118' ' ' ILE . 1.9 mm-40 -112.54 -85.19 0.58 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.15 -0.477 . . . . 63.42 110.926 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' SER . . . . . 0.752 ' OG ' ' O ' ' A' ' 143' ' ' PRO . 32.0 p -129.54 178.78 6.22 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.204 -0.453 . . . . 74.14 110.87 -179.84 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -145.91 176.44 9.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.092 -0.504 . . . . 75.41 110.894 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . 0.429 ' HG2' ' HB ' ' A' ' 138' ' ' ILE . 0.2 OUTLIER -134.47 151.15 50.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.179 -0.464 . . . . 72.42 110.86 -179.903 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . 0.545 ' HD2' ' CE1' ' A' ' 94' ' ' TYR . 1.7 ptt180 -102.34 147.98 26.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.186 -0.461 . . . . 74.34 110.835 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 3.9 mt -100.34 126.66 53.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.16 -0.473 . . . . 75.33 111.126 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 9.6 p -127.38 153.09 36.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.161 -0.472 . . . . 70.05 111.083 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.142 -0.481 . . . . 75.53 110.904 179.997 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.23 0.06 0 CA-C-O 120.811 0.339 . . . . 74.54 110.866 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -86.5 151.86 23.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.222 -0.445 . . . . 75.13 110.86 -179.803 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 20.8 mttt -90.84 64.18 5.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.149 -0.478 . . . . 75.25 110.933 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.0 t -116.32 70.43 0.76 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.225 -0.443 . . . . 71.31 111.165 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 101.71 117.65 4.26 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.748 -0.739 . . . . 73.35 112.508 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.428 ' HA ' ' O ' ' A' ' 44' ' ' GLY . 5.3 p -82.23 134.05 35.28 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.872 0.367 . . . . 73.53 111.126 -179.832 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 2.8 tttt -121.44 136.44 54.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.26 -0.427 . . . . 74.15 110.899 179.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.579 ' HB ' ' CD1' ' A' ' 47' ' ' TRP . 12.7 tt -136.69 147.49 27.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.271 -0.422 . . . . 75.14 111.156 179.827 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.517 HG23 ' CG ' ' A' ' 22' ' ' ASP . 15.9 m -130.01 129.95 44.36 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.175 -0.466 . . . . 75.03 111.106 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.544 ' CE1' HD13 ' A' ' 8' ' ' ILE . 0.4 OUTLIER -117.05 131.1 57.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.171 -0.468 . . . . 64.12 110.896 -179.988 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.524 ' CG ' ' HA ' ' A' ' 16' ' ' PHE . 43.5 m-85 -116.46 131.21 57.01 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.179 -0.464 . . . . 73.45 110.916 -179.86 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.505 ' HG2' ' HB2' ' A' ' 36' ' ' ARG . 0.0 OUTLIER -60.91 -23.94 65.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.092 -0.504 . . . . 73.35 110.899 -179.999 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 68.6 m-20 -127.87 152.48 47.79 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.187 -0.46 . . . . 73.44 110.848 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.465 ' N ' ' HB3' ' A' ' 38' ' ' ASN . 4.2 mtmm -56.05 -176.98 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.175 -0.466 . . . . 75.11 110.893 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 69.9 m-20 46.99 37.74 5.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.209 -0.45 . . . . 73.03 110.896 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.524 ' HA ' ' CG ' ' A' ' 11' ' ' TYR . 4.3 m-85 45.91 56.59 5.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.145 -0.48 . . . . 72.33 110.93 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 4.1 mt-30 -132.16 159.91 37.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.142 -0.481 . . . . 74.34 110.928 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 93.81 -150.93 20.05 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.722 -0.752 . . . . 74.31 112.449 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.454 ' O ' HD13 ' A' ' 34' ' ' LEU . 0.0 OUTLIER -68.9 80.02 0.3 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.81 0.338 . . . . 75.54 110.843 -179.811 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.458 ' HB2' ' CE1' ' A' ' 11' ' ' TYR . 0.8 OUTLIER -77.99 127.99 33.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.203 -0.453 . . . . 74.2 110.862 -179.891 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.411 ' CD2' ' CD2' ' A' ' 30' ' ' PHE . 90.5 t80 -124.25 125.59 44.65 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.223 -0.444 . . . . 72.43 110.957 -179.883 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.517 ' CG ' HG23 ' A' ' 9' ' ' THR . 1.5 m-20 -118.99 132.49 56.07 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.14 -0.482 . . . . 70.42 110.865 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 12.6 t -161.3 131.01 4.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.208 -0.451 . . . . 65.41 110.888 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -102.12 4.17 39.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 71.24 110.888 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 48.7 t -112.9 159.46 19.04 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.46 . . . . 71.11 110.893 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -42.24 119.97 1.51 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.165 -0.47 . . . . 64.04 110.847 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.596 ' HB2' ' HB3' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -114.83 43.32 1.98 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.18 -0.464 . . . . 72.11 110.895 -179.925 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.53 ' O ' ' HA ' ' A' ' 82' ' ' SER . . . -49.97 -21.22 1.13 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.179 -0.464 . . . . 65.03 111.093 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 64.7 t0 -129.47 40.63 3.57 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.224 -0.444 . . . . 75.11 110.867 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.763 ' O ' ' CD2' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -82.06 16.39 1.95 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.207 -0.451 . . . . 75.5 110.833 -179.904 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.442 ' HB2' ' HB3' ' A' ' 81' ' ' SER . 34.4 t60 -78.62 -40.82 33.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.213 -0.449 . . . . 75.52 110.891 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.425 HG21 ' CD2' ' A' ' 33' ' ' TYR . 10.0 t -61.73 -10.65 9.24 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.201 -0.454 . . . . 73.42 111.12 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.488 ' CD1' ' HA ' ' A' ' 30' ' ' PHE . 12.2 m-85 -99.43 -30.77 12.0 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.217 -0.447 . . . . 74.02 110.95 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.454 HD13 ' O ' ' A' ' 19' ' ' ARG . 16.7 tp -141.54 146.15 36.0 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.126 -0.488 . . . . 75.34 110.933 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.2 m -112.09 -34.65 5.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.154 -0.475 . . . . 74.2 110.847 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.505 ' HB2' ' HG2' ' A' ' 12' ' ' GLU . 1.8 mtp85 -115.6 140.87 48.77 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.119 -0.491 . . . . 75.51 110.884 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.599 ' SG ' ' HB2' ' A' ' 80' ' ' LEU . 1.6 p -116.86 54.45 0.86 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.184 -0.462 . . . . 73.11 110.899 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.465 ' HB3' ' N ' ' A' ' 14' ' ' LYS . 1.9 m-80 -55.02 -65.71 0.53 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.182 -0.463 . . . . 73.41 110.91 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 7.6 p -116.27 128.15 55.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.181 -0.463 . . . . 71.42 110.832 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.493 ' O ' ' N ' ' A' ' 67' ' ' TYR . 12.0 mt -124.67 147.47 29.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.088 -0.505 . . . . 74.34 111.13 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.471 ' N ' HG23 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -141.67 118.7 11.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.149 -0.478 . . . . 74.23 110.884 179.86 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.513 HG22 ' HB2' ' A' ' 47' ' ' TRP . 1.0 OUTLIER -104.35 117.46 49.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.461 . . . . 74.03 111.088 179.908 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -112.34 77.68 1.06 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.173 -0.467 . . . . 51.41 110.868 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.428 ' O ' ' HA ' ' A' ' 6' ' ' THR . . . 136.88 98.31 0.51 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.73 -0.748 . . . . 70.44 112.468 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 55.36 177.86 0.22 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.725 -0.75 . . . . 73.44 112.426 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.503 HG21 ' HA ' ' A' ' 63' ' ' PRO . 1.0 OUTLIER -76.32 171.13 15.08 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.77 0.319 . . . . 73.24 111.166 -179.901 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.579 ' CD1' ' HB ' ' A' ' 8' ' ' ILE . 6.1 m95 -143.47 128.77 18.85 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.251 -0.431 . . . . 71.31 110.921 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.617 ' O ' ' N ' ' A' ' 84' ' ' ARG . . . -90.88 126.33 36.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.191 -0.459 . . . . 73.12 111.096 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.623 ' O ' ' O ' ' A' ' 60' ' ' TYR . 26.9 m -126.32 130.1 71.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.202 -0.454 . . . . 75.33 111.083 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.786 ' HB3' ' HA ' ' A' ' 56' ' ' ALA . 52.4 m-85 -100.41 148.02 25.19 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.161 -0.472 . . . . 75.02 110.973 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.55 ' HB3' ' HB3' ' A' ' 57' ' ' TRP . 58.4 tt0 -49.75 -78.07 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.105 -0.498 . . . . 75.01 110.873 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.482 ' HB3' ' CD1' ' A' ' 55' ' ' PHE . 0.1 OUTLIER -93.36 141.57 24.13 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.614 0.721 . . . . 75.14 110.859 -179.878 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.654 ' HB3' ' HB3' ' A' ' 81' ' ' SER . 53.7 Cg_endo -69.76 145.25 56.6 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.691 2.261 . . . . 64.22 112.341 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 61.9 -11.02 0.07 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.201 -0.454 . . . . 74.33 110.925 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.645 ' H ' ' C ' ' A' ' 53' ' ' PRO . 1.8 m-30 -108.16 -21.29 12.85 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.163 -0.472 . . . . 74.01 110.831 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.786 ' HA ' ' HB3' ' A' ' 50' ' ' TYR . . . 50.96 26.77 2.85 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.183 -0.462 . . . . 72.44 111.069 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . 0.641 ' O ' ' C ' ' A' ' 58' ' ' TYR . 0.8 OUTLIER -48.63 -164.5 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.245 -0.434 . . . . 75.32 110.899 -179.967 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.641 ' C ' ' O ' ' A' ' 57' ' ' TRP . 5.3 m-30 -11.76 100.15 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.236 -0.438 . . . . 73.34 110.933 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.45 ' HB2' ' HA ' ' A' ' 150' ' ' TYR . 0.0 OUTLIER -60.41 153.36 23.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.154 -0.476 . . . . 74.23 110.869 179.911 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.623 ' O ' ' O ' ' A' ' 49' ' ' VAL . 2.1 t80 -168.65 107.95 0.48 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.193 -0.458 . . . . 74.42 110.914 -179.871 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.453 ' HB ' HD12 ' A' ' 138' ' ' ILE . 4.9 mp -95.73 118.65 42.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.148 -0.478 . . . . 71.03 111.131 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -87.45 126.0 63.64 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.587 0.708 . . . . 74.03 110.927 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.503 ' HA ' HG21 ' A' ' 46' ' ' THR . 54.0 Cg_endo -69.76 -172.81 0.62 Allowed 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.662 2.241 . . . . 63.21 112.346 179.871 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.67 161.71 15.96 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.209 -0.451 . . . . 75.11 110.917 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 112.87 -159.49 13.64 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.707 -0.758 . . . . 74.02 112.5 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -114.71 158.5 21.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.865 0.364 . . . . 72.33 110.913 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.493 ' N ' ' O ' ' A' ' 40' ' ' ILE . 7.2 m-85 -149.44 80.42 7.69 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.681 0.753 . . . . 75.41 110.895 -179.837 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.607 ' HD2' ' HG3' ' A' ' 72' ' ' ARG . 53.7 Cg_endo -69.78 1.13 4.73 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.682 2.255 . . . . 75.12 112.321 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -157.91 155.1 28.96 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.24 -0.436 . . . . 75.34 110.873 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.807 ' O ' ' CD1' ' A' ' 73' ' ' TRP . 18.9 p90 -66.97 -7.97 26.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.164 -0.471 . . . . 74.2 110.947 -179.883 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -90.44 -16.32 29.23 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.102 -0.499 . . . . 74.42 110.909 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.607 ' HG3' ' HD2' ' A' ' 68' ' ' PRO . 25.5 mmt180 -75.01 -22.87 58.23 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.203 -0.453 . . . . 73.14 110.919 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . 0.807 ' CD1' ' O ' ' A' ' 70' ' ' TYR . 0.5 OUTLIER -109.39 8.22 25.35 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.148 -0.478 . . . . 71.01 110.927 -179.967 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' MET . . . . . 0.504 ' C ' ' O ' ' A' ' 73' ' ' TRP . 0.0 OUTLIER 30.23 55.48 0.17 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.205 -0.452 . . . . 72.51 110.903 179.954 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.527 ' CA ' ' OH ' ' A' ' 60' ' ' TYR . . . -91.77 -170.14 41.65 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.781 -0.723 . . . . 72.11 112.469 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.435 ' CD2' ' HA ' ' A' ' 148' ' ' ARG . 0.1 OUTLIER -107.87 -74.28 0.66 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.834 0.35 . . . . 75.2 110.915 -179.936 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -96.84 147.01 24.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.146 -0.479 . . . . 74.24 110.914 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.412 ' O ' ' SG ' ' A' ' 37' ' ' CYS . 15.8 p30 -95.71 34.05 1.56 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.203 -0.453 . . . . 63.15 110.877 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 4.3 ttm-85 -105.69 79.47 1.44 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 74.34 110.851 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.599 ' HB2' ' SG ' ' A' ' 37' ' ' CYS . 0.1 OUTLIER -82.82 130.3 35.11 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.179 -0.464 . . . . 74.43 110.955 179.976 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.654 ' HB3' ' HB3' ' A' ' 53' ' ' PRO . 1.3 m -152.24 -123.51 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.22 -0.446 . . . . 74.25 110.858 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.575 ' OG ' ' HA ' ' A' ' 53' ' ' PRO . 0.2 OUTLIER -41.0 99.98 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.118 -0.492 . . . . 73.25 110.855 -179.82 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . 0.485 ' SG ' ' HB2' ' A' ' 27' ' ' CYS . 8.9 p -127.0 134.38 50.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.131 -0.486 . . . . 64.3 110.863 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.617 ' N ' ' O ' ' A' ' 48' ' ' ALA . 4.5 mmt85 -115.47 158.32 22.72 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.194 -0.457 . . . . 72.4 110.902 -179.879 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.404 ' HB1' ' OG1' ' A' ' 6' ' ' THR . . . -72.08 129.61 38.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.46 . . . . 73.04 111.104 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.5 ' CG2' ' CB ' ' A' ' 48' ' ' ALA . 61.5 t -116.02 136.23 53.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.213 -0.449 . . . . 72.44 111.142 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . 0.43 ' O ' ' C ' ' A' ' 88' ' ' LEU . 40.2 m80 -113.89 108.09 16.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.162 -0.472 . . . . 74.13 110.872 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.43 ' C ' ' O ' ' A' ' 87' ' ' HIS . 0.0 OUTLIER -35.39 144.94 0.22 Allowed Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.621 0.724 . . . . 75.33 110.91 -179.971 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.465 ' HB3' ' H ' ' A' ' 136' ' ' VAL . 53.9 Cg_endo -69.73 104.24 1.28 Allowed 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.678 2.252 . . . . 74.45 112.317 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -103.16 165.68 10.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.231 -0.441 . . . . 65.45 110.859 -179.836 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 66.65 129.02 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.737 -0.744 . . . . 74.11 112.535 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.404 ' C ' ' HG2' ' A' ' 93' ' ' GLN . . . 51.1 33.92 30.78 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.721 -0.752 . . . . 73.01 112.495 -179.893 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.453 ' O ' ' CG ' ' A' ' 134' ' ' GLU . 6.3 pt20 39.07 -154.72 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.848 0.356 . . . . 71.24 110.911 -179.883 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.471 ' HA ' ' CG ' ' A' ' 134' ' ' GLU . 25.2 t80 -95.19 108.26 20.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.178 -0.464 . . . . 73.44 110.935 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 11.7 tptt -107.88 127.94 54.18 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.111 -0.495 . . . . 74.44 110.89 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -152.25 134.37 5.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.186 -0.461 . . . . 73.51 111.138 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.415 ' HB2' ' O ' ' A' ' 131' ' ' LYS . 1.2 mt-30 -109.08 124.63 51.07 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.169 -0.469 . . . . 72.54 110.913 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 7.9 mt -101.19 140.64 19.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.2 -0.455 . . . . 73.42 111.136 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.512 ' CD2' ' HA ' ' A' ' 104' ' ' PHE . 48.1 m-85 -129.0 146.02 51.09 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 64.22 110.835 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -80.19 -28.65 38.67 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.095 -0.502 . . . . 71.4 110.866 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 29.5 mttt -122.11 166.26 14.82 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.152 -0.476 . . . . 64.01 110.908 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.454 ' HA2' ' HB3' ' A' ' 129' ' ' SER . . . -68.48 178.98 22.13 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.751 -0.738 . . . . 52.45 112.473 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.403 ' C ' ' CG ' ' A' ' 104' ' ' PHE . 38.4 t70 40.91 36.26 0.41 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.845 0.355 . . . . 73.41 110.865 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.672 ' CD2' ' N ' ' A' ' 104' ' ' PHE . 0.0 OUTLIER 50.95 73.13 0.31 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.171 -0.468 . . . . 74.12 110.918 -179.877 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 1.2 m -139.52 161.04 38.46 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.119 -0.491 . . . . 44.23 110.879 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 79.79 -142.2 24.28 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.78 -0.724 . . . . 74.24 112.49 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 3.1 tp-100 -71.03 111.76 6.65 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.749 0.309 . . . . 71.02 110.933 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' MET . . . . . 0.491 ' HB2' ' CE2' ' A' ' 99' ' ' PHE . 5.9 ttp -106.62 149.12 27.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.254 -0.43 . . . . 74.51 110.894 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -153.19 135.15 14.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.227 -0.442 . . . . 73.41 110.891 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -110.19 97.55 7.0 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.117 -0.492 . . . . 74.13 110.888 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 9.7 t -110.3 132.19 54.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.141 -0.481 . . . . 71.54 111.134 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.445 ' O ' ' OG1' ' A' ' 112' ' ' THR . 1.1 t -119.37 36.43 4.48 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.182 -0.463 . . . . 74.14 111.162 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 53.5 mt-10 -151.34 165.59 33.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.241 -0.436 . . . . 72.42 110.891 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -56.25 164.24 1.38 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.136 -0.484 . . . . 63.44 110.856 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . 0.491 ' O ' ' HB2' ' A' ' 172' ' ' SER . 18.4 t -153.12 117.59 2.84 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.617 0.722 . . . . 74.13 110.886 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.426 ' O ' ' C ' ' A' ' 143' ' ' PRO . 53.4 Cg_endo -69.75 -31.97 19.52 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.716 2.277 . . . . 73.22 112.311 -179.906 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.626 ' HB3' ' CB ' ' A' ' 120' ' ' GLU . 0.1 OUTLIER -148.82 104.51 3.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.23 -0.441 . . . . 61.14 110.914 -179.834 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.502 ' O ' ' HB2' ' A' ' 122' ' ' PHE . 2.9 tt -57.84 -29.46 35.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.131 -0.486 . . . . 65.43 111.129 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' MET . . . . . 0.597 ' O ' ' HA ' ' A' ' 123' ' ' HIS . 11.6 ttp -86.77 -42.96 12.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 71.43 110.835 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.626 ' CB ' ' HB3' ' A' ' 117' ' ' SER . 6.7 tp10 -67.66 -13.23 61.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.271 -0.422 . . . . 72.32 110.856 -179.916 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 28.3 tp60 -115.48 -48.72 2.78 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.151 -0.477 . . . . 72.43 110.894 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . 0.502 ' HB2' ' O ' ' A' ' 118' ' ' ILE . 33.8 m-85 -103.69 -20.28 14.03 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.253 -0.431 . . . . 75.13 110.912 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . 0.597 ' HA ' ' O ' ' A' ' 119' ' ' MET . 0.2 OUTLIER 71.9 26.41 2.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.114 -0.493 . . . . 71.33 110.854 -179.977 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 7.1 mtt -102.56 83.99 2.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.214 -0.448 . . . . 74.25 110.868 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 1.8 ptp85 -52.12 -29.94 24.11 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.264 -0.426 . . . . 74.42 110.852 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.492 ' HG2' ' HA ' ' A' ' 169' ' ' ALA . 20.9 mt-10 -146.22 130.73 17.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.215 -0.448 . . . . 63.55 110.921 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.412 ' O ' ' HB3' ' A' ' 168' ' ' PRO . 4.4 mm -91.37 103.92 14.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.15 -0.477 . . . . 71.13 111.137 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . 0.405 ' HB3' ' N ' ' A' ' 102' ' ' GLY . 2.3 m170 -71.53 -29.61 64.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.169 -0.469 . . . . 75.13 110.865 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.454 ' HB3' ' HA2' ' A' ' 102' ' ' GLY . 0.3 OUTLIER -153.55 152.74 31.26 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.182 -0.463 . . . . 73.53 110.824 -179.819 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . 0.733 ' O ' ' HB2' ' A' ' 157' ' ' TYR . 0.0 OUTLIER -146.57 112.12 5.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.085 -0.507 . . . . 60.03 110.885 -179.942 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.746 ' HA ' ' HA ' ' A' ' 156' ' ' GLU . 13.4 mtpt -90.78 147.74 23.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 74.51 110.908 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.506 ' CB ' ' O ' ' A' ' 131' ' ' LYS . 11.3 t 85.03 165.33 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.283 -0.417 . . . . 72.32 111.149 179.875 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -179.1 127.79 0.1 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.176 -0.466 . . . . 74.41 110.876 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.471 ' CG ' ' HA ' ' A' ' 94' ' ' TYR . 0.0 OUTLIER -89.14 -171.51 3.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.116 -0.493 . . . . 71.24 110.881 179.94 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . 0.446 ' C ' HG23 ' A' ' 136' ' ' VAL . . . -48.79 -52.83 19.7 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.77 -0.729 . . . . 50.32 112.463 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.663 ' HA ' HD13 ' A' ' 152' ' ' LEU . 3.6 t -147.48 146.92 17.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.841 0.353 . . . . 73.32 111.1 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . 0.657 ' HB3' ' CB ' ' A' ' 152' ' ' LEU . 23.0 t90 -147.04 143.13 28.14 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.196 -0.457 . . . . 75.4 110.932 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.453 HD12 ' HB ' ' A' ' 61' ' ' ILE . 14.0 mt -123.53 133.69 68.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.244 -0.434 . . . . 72.0 111.119 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.501 ' CE1' ' HB3' ' A' ' 173' ' ' PHE . 0.1 OUTLIER -99.41 166.42 11.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.173 -0.467 . . . . 74.32 110.918 179.936 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -142.17 125.96 17.05 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.159 -0.473 . . . . 64.41 110.925 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . 0.615 ' O ' ' HB2' ' A' ' 171' ' ' GLN . 0.5 OUTLIER -58.77 -25.22 62.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.119 -0.492 . . . . 74.01 110.928 179.977 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.77 ' HB3' ' HD2' ' A' ' 143' ' ' PRO . 9.3 mp -115.65 173.67 2.84 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.635 0.731 . . . . 75.03 110.898 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . 0.805 ' O ' ' OG ' ' A' ' 172' ' ' SER . 54.3 Cg_endo -69.74 -87.59 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.667 2.245 . . . . 62.5 112.325 179.826 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . 0.699 ' O ' ' N ' ' A' ' 146' ' ' ARG . 1.1 m-20 -53.71 96.23 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.205 -0.452 . . . . 54.44 110.889 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . 0.641 ' C ' ' O ' ' A' ' 144' ' ' ASN . 0.0 OUTLIER 13.23 52.6 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.136 -0.484 . . . . 75.34 110.933 -179.933 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . 0.699 ' N ' ' O ' ' A' ' 144' ' ' ASN . 10.6 mtp85 -119.49 174.66 6.25 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.108 -0.496 . . . . 74.3 110.843 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 79.64 -179.96 52.71 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.754 -0.736 . . . . 74.31 112.469 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.435 ' HA ' ' CD2' ' A' ' 76' ' ' LEU . 17.2 mtt180 -71.67 144.41 49.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.808 0.337 . . . . 74.12 110.896 -179.893 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . 0.508 ' HB2' ' HA ' ' A' ' 60' ' ' TYR . 49.5 mt-30 -83.28 148.51 27.33 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.158 -0.474 . . . . 75.11 110.937 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . 0.481 ' HB2' ' CB ' ' A' ' 139' ' ' PHE . 87.3 m-85 -132.81 118.92 19.59 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.221 -0.445 . . . . 74.2 110.902 -179.824 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 18.7 tp -69.91 136.37 50.53 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.095 -0.502 . . . . 75.15 110.951 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.663 HD13 ' HA ' ' A' ' 136' ' ' VAL . 0.0 OUTLIER -74.02 135.81 43.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.208 -0.451 . . . . 74.35 110.945 179.873 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . 0.928 ' O ' ' HB2' ' A' ' 154' ' ' LYS . 54.5 t0 -161.39 109.65 1.51 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.21 -0.45 . . . . 74.0 110.877 179.852 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.928 ' HB2' ' O ' ' A' ' 153' ' ' ASP . 0.4 OUTLIER 156.07 -133.29 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.235 -0.439 . . . . 75.24 110.913 179.996 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.5 ' HG3' ' O ' ' A' ' 154' ' ' LYS . 0.4 OUTLIER -164.98 -94.78 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.185 -0.461 . . . . 75.43 110.868 179.861 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.746 ' HA ' ' HA ' ' A' ' 131' ' ' LYS . 0.3 OUTLIER -89.76 9.34 27.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.262 -0.426 . . . . 74.25 110.908 179.927 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . 0.793 ' CZ ' ' HB3' ' A' ' 154' ' ' LYS . 1.9 m-85 20.4 108.14 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.124 -0.489 . . . . 65.4 110.945 -179.859 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.35 -34.03 8.9 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.151 -0.477 . . . . 74.11 110.856 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 2.8 ptpt -108.92 158.72 33.43 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.654 0.74 . . . . 75.54 110.862 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . 0.443 ' HB2' ' HD3' ' A' ' 168' ' ' PRO . 53.9 Cg_endo -69.73 -21.57 33.43 Favored 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.7 2.267 . . . . 64.21 112.322 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.451 HD11 ' H ' ' A' ' 161' ' ' ILE . 3.4 mp -82.5 3.75 2.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.244 -0.435 . . . . 54.3 111.149 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -64.58 -12.85 49.47 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.163 -0.471 . . . . 72.23 110.839 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' TRP . . . . . 0.487 ' CZ2' ' HB2' ' A' ' 130' ' ' CYS . 19.7 m-90 -105.47 -16.24 14.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.217 -0.447 . . . . 74.3 110.957 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 112.13 -35.33 4.72 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.743 -0.741 . . . . 52.31 112.491 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -62.68 126.58 27.81 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.759 0.314 . . . . 71.25 111.126 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -41.01 -37.5 0.83 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.217 -0.447 . . . . 74.04 111.135 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' SER . . . . . 0.521 ' C ' ' H ' ' A' ' 169' ' ' ALA . 0.3 OUTLIER -130.66 157.33 78.0 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.665 0.745 . . . . 64.35 110.863 -179.811 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . 0.443 ' HD3' ' HB2' ' A' ' 160' ' ' PRO . 53.6 Cg_endo -69.74 24.0 0.17 Allowed 'Trans proline' 0 C--N 1.341 0.137 0 C-N-CA 122.642 2.228 . . . . 75.41 112.397 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . 0.521 ' H ' ' C ' ' A' ' 167' ' ' SER . . . -65.57 107.02 1.58 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.204 -0.453 . . . . 75.2 111.097 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 3.3 t -152.94 159.83 3.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.195 -0.457 . . . . 74.21 111.155 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' GLN . . . . . 0.625 ' OE1' ' HB3' ' A' ' 143' ' ' PRO . 1.7 tm0? -105.7 -81.19 0.54 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.202 -0.454 . . . . 74.31 110.933 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' SER . . . . . 0.805 ' OG ' ' O ' ' A' ' 143' ' ' PRO . 51.6 p -127.2 -178.23 4.36 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 74.04 110.88 -179.817 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . 0.501 ' HB3' ' CE1' ' A' ' 139' ' ' PHE . 27.5 p90 -142.66 167.07 22.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.181 -0.463 . . . . 74.45 110.871 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.88 130.1 19.74 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.127 -0.488 . . . . 64.45 110.852 -179.876 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.47 -169.96 1.62 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.179 -0.464 . . . . 73.54 110.849 -179.896 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . 0.414 HG12 HD13 ' A' ' 138' ' ' ILE . 3.7 mt -137.12 134.19 47.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 71.32 111.141 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 95.3 t -150.45 142.37 16.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.181 -0.463 . . . . 74.35 111.121 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 . . . . . 0 C--N 1.33 -0.261 0 CA-C-N 116.175 -0.466 . . . . 72.03 110.922 179.985 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.753 0.311 . . . . 74.2 110.895 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -116.47 -62.57 1.57 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.226 -0.443 . . . . 73.22 110.816 -179.767 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 39.5 mmtm 51.35 34.73 12.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.142 -0.481 . . . . 74.13 110.894 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 6.7 t -74.23 -33.74 63.45 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.212 -0.449 . . . . 63.51 111.162 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 177.23 117.91 0.53 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.712 -0.756 . . . . 71.22 112.49 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.435 ' HB ' ' O ' ' A' ' 44' ' ' GLY . 12.8 p -82.56 133.18 35.19 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.847 0.356 . . . . 73.25 111.132 -179.844 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 3.0 tttt -122.4 137.74 54.76 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.214 -0.448 . . . . 73.54 110.908 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.65 HG23 ' CZ ' ' A' ' 10' ' ' PHE . 15.1 tt -138.38 149.48 24.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.181 -0.463 . . . . 75.23 111.168 179.871 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.478 HG21 ' CE2' ' A' ' 11' ' ' TYR . 15.3 m -129.22 140.4 51.49 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.174 -0.466 . . . . 72.02 111.105 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.65 ' CZ ' HG23 ' A' ' 8' ' ' ILE . 0.7 OUTLIER -126.56 130.86 51.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.183 -0.462 . . . . 71.01 110.855 -179.973 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.536 ' CG ' ' HA ' ' A' ' 16' ' ' PHE . 44.5 m-85 -117.41 129.82 56.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.114 -0.494 . . . . 72.43 110.926 -179.877 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.489 ' HG2' ' HB2' ' A' ' 36' ' ' ARG . 0.0 OUTLIER -59.04 -23.95 62.44 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.105 -0.498 . . . . 75.14 110.864 -179.951 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 -127.54 152.67 47.31 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.144 -0.48 . . . . 72.43 110.853 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.42 ' N ' ' HB3' ' A' ' 38' ' ' ASN . 4.2 mtmp? -56.02 -175.36 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.16 -0.473 . . . . 61.22 110.916 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 22.0 m-20 46.02 36.08 2.83 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.242 -0.435 . . . . 74.15 110.879 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.536 ' HA ' ' CG ' ' A' ' 11' ' ' TYR . 4.4 m-85 47.12 57.7 5.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.218 -0.446 . . . . 74.34 110.901 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -132.85 159.91 38.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.141 -0.481 . . . . 74.15 110.879 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 93.41 -151.39 20.34 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.74 -0.743 . . . . 63.45 112.486 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.49 ' O ' HD13 ' A' ' 34' ' ' LEU . 0.0 OUTLIER -67.95 80.92 0.21 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.788 0.327 . . . . 74.41 110.854 -179.84 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.481 ' HA ' ' O ' ' A' ' 10' ' ' PHE . 0.0 OUTLIER -78.83 128.91 33.99 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.222 -0.445 . . . . 75.3 110.864 -179.926 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.511 ' CD2' ' CD2' ' A' ' 30' ' ' PHE . 81.3 t80 -124.57 123.6 40.44 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.174 -0.466 . . . . 73.43 110.876 -179.825 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.458 ' CG ' HG23 ' A' ' 9' ' ' THR . 1.3 m-20 -119.17 134.02 55.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.116 -0.493 . . . . 74.45 110.871 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -165.95 136.61 3.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.234 -0.439 . . . . 73.31 110.887 -179.886 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -105.1 4.82 31.84 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.202 -0.454 . . . . 74.4 110.85 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 13.4 t -108.14 165.98 11.08 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.22 -0.445 . . . . 71.51 110.916 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -62.67 116.75 5.45 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.195 -0.457 . . . . 62.32 110.857 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.45 ' HB2' ' SG ' ' A' ' 83' ' ' CYS . 7.9 m -118.11 53.93 0.94 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.194 -0.457 . . . . 74.14 110.87 -179.924 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.526 ' C ' ' HA ' ' A' ' 82' ' ' SER . . . -45.83 -19.72 0.07 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.156 -0.474 . . . . 64.02 111.106 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 53.1 t0 -128.46 42.01 3.39 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.246 -0.433 . . . . 62.43 110.853 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.784 ' O ' ' CD2' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -80.63 13.98 2.3 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.214 -0.448 . . . . 73.11 110.87 -179.899 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.456 ' HB2' ' HB3' ' A' ' 53' ' ' PRO . 29.0 t60 -78.74 -37.18 41.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.157 -0.474 . . . . 75.1 110.852 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.5 t -59.27 -13.17 6.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.182 -0.463 . . . . 75.43 111.095 -179.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -101.39 -26.41 13.6 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.263 -0.426 . . . . 74.03 110.95 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.49 HD13 ' O ' ' A' ' 19' ' ' ARG . 16.6 tp -142.87 139.96 31.05 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.073 -0.512 . . . . 74.33 110.966 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.1 m -109.05 -32.16 7.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.201 -0.454 . . . . 74.12 110.859 -179.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.489 ' HB2' ' HG2' ' A' ' 12' ' ' GLU . 1.9 mtp85 -115.59 140.36 49.25 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.102 -0.499 . . . . 74.42 110.905 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.543 ' SG ' ' O ' ' A' ' 78' ' ' ASP . 1.3 p -117.65 54.23 0.91 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.249 -0.432 . . . . 71.43 110.866 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.42 ' HB3' ' N ' ' A' ' 14' ' ' LYS . 1.9 m-80 -54.29 -70.09 0.11 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.465 . . . . 74.2 110.9 -179.889 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 6.4 p -111.83 129.53 56.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.175 -0.466 . . . . 74.23 110.85 -179.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.508 ' O ' ' N ' ' A' ' 67' ' ' TYR . 20.1 mt -126.08 151.35 32.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.104 -0.498 . . . . 74.31 111.09 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.479 ' N ' HG23 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -143.74 119.33 10.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.147 -0.479 . . . . 75.21 110.894 179.825 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.54 HG23 ' HB ' ' A' ' 8' ' ' ILE . 1.2 t -103.98 116.13 47.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.227 -0.442 . . . . 72.32 111.134 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -112.36 80.53 1.35 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.199 -0.455 . . . . 71.03 110.894 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.435 ' O ' ' HB ' ' A' ' 6' ' ' THR . . . 130.34 102.06 0.95 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.727 -0.749 . . . . 74.13 112.493 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 54.35 178.36 0.14 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.763 -0.732 . . . . 73.22 112.523 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.502 HG21 ' HA ' ' A' ' 63' ' ' PRO . 1.3 m -81.99 171.47 14.37 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.725 0.297 . . . . 71.25 111.153 -179.886 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.582 ' CD1' ' HB ' ' A' ' 8' ' ' ILE . 15.9 m95 -141.92 130.0 22.04 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.217 -0.447 . . . . 74.22 110.915 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.53 ' CB ' ' CG2' ' A' ' 86' ' ' VAL . . . -95.37 111.99 23.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.231 -0.44 . . . . 72.14 111.113 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.554 ' O ' ' O ' ' A' ' 60' ' ' TYR . 5.6 m -115.0 129.55 71.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.218 -0.447 . . . . 73.33 111.153 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.752 ' HB3' ' HA ' ' A' ' 56' ' ' ALA . 35.7 m-85 -95.61 150.6 20.16 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.148 -0.478 . . . . 73.31 110.89 -179.876 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.613 ' HB2' ' O ' ' A' ' 58' ' ' TYR . 7.1 tt0 -46.51 -77.77 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.104 -0.498 . . . . 74.55 110.889 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.611 ' HB3' ' CD1' ' A' ' 55' ' ' PHE . 1.6 mtp180 -93.44 145.95 30.93 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.567 0.699 . . . . 75.11 110.877 -179.853 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.673 ' HA ' ' OG ' ' A' ' 82' ' ' SER . 53.7 Cg_endo -69.76 134.12 27.22 Favored 'Trans proline' 0 C--N 1.34 0.126 0 C-N-CA 122.715 2.276 . . . . 74.02 112.329 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 66.38 -9.88 0.29 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.267 -0.424 . . . . 75.33 110.899 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.611 ' CD1' ' HB3' ' A' ' 52' ' ' ARG . 4.2 m-30 -100.22 -25.92 14.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.176 -0.465 . . . . 73.4 110.868 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.752 ' HA ' ' HB3' ' A' ' 50' ' ' TYR . . . 57.09 23.0 7.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.17 -0.468 . . . . 75.35 111.092 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . 0.643 ' O ' ' C ' ' A' ' 58' ' ' TYR . 3.4 m0 -52.49 -165.0 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.21 -0.45 . . . . 74.43 110.897 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.643 ' C ' ' O ' ' A' ' 57' ' ' TRP . 5.4 m-30 -12.1 103.84 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.246 -0.434 . . . . 73.35 110.917 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.492 ' HB2' ' HA ' ' A' ' 150' ' ' TYR . 2.0 mpt? -61.52 148.12 43.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.138 -0.483 . . . . 73.32 110.848 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.572 ' CE2' ' HG ' ' A' ' 76' ' ' LEU . 0.3 OUTLIER -161.01 97.66 1.15 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.204 -0.453 . . . . 74.24 110.919 -179.834 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.459 ' CD1' ' HA ' ' A' ' 151' ' ' LEU . 4.6 mp -89.18 114.52 27.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.14 -0.482 . . . . 75.12 111.101 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.428 HD12 HD12 ' A' ' 40' ' ' ILE . 0.6 OUTLIER -85.16 122.21 73.96 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.598 0.713 . . . . 72.12 110.927 179.906 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.502 ' HA ' HG21 ' A' ' 46' ' ' THR . 54.0 Cg_endo -69.71 -167.49 0.23 Allowed 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.736 2.291 . . . . 73.21 112.324 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.55 160.98 14.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.205 -0.452 . . . . 75.54 110.941 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 114.93 -146.57 18.83 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.714 -0.755 . . . . 73.33 112.516 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -128.3 158.37 38.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.876 0.369 . . . . 72.3 110.912 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.508 ' N ' ' O ' ' A' ' 40' ' ' ILE . 5.7 m-85 -146.78 81.62 9.06 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.648 0.737 . . . . 75.23 110.911 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.483 ' HD2' ' HG3' ' A' ' 72' ' ' ARG . 53.8 Cg_endo -69.81 1.4 4.51 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.643 2.229 . . . . 74.23 112.344 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 86.2 mt-10 -156.9 155.08 30.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.212 -0.449 . . . . 71.23 110.891 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.82 ' O ' ' CD1' ' A' ' 73' ' ' TRP . 8.9 p90 -70.6 -1.93 12.67 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.161 -0.472 . . . . 74.11 110.954 -179.907 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -91.22 -13.82 32.12 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.132 -0.485 . . . . 73.4 110.968 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.483 ' HG3' ' HD2' ' A' ' 68' ' ' PRO . 23.2 mmt180 -73.7 -5.35 40.04 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.162 -0.472 . . . . 75.3 110.902 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . 0.82 ' CD1' ' O ' ' A' ' 70' ' ' TYR . 0.4 OUTLIER -134.71 4.93 3.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.165 -0.47 . . . . 73.41 110.877 -179.933 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' MET . . . . . 0.466 ' CB ' ' O ' ' A' ' 73' ' ' TRP . 0.0 OUTLIER 81.13 -17.89 0.53 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.263 -0.426 . . . . 73.43 110.893 179.956 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.477 ' N ' ' CD1' ' A' ' 73' ' ' TRP . . . 40.32 57.66 2.59 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.757 -0.735 . . . . 71.21 112.461 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.572 ' HG ' ' CE2' ' A' ' 60' ' ' TYR . 3.1 pp -50.85 -36.84 39.73 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.787 0.327 . . . . 74.12 110.878 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.562 ' O ' ' CB ' ' A' ' 78' ' ' ASP . 23.7 t-20 -121.82 -47.13 2.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.202 -0.454 . . . . 74.12 110.864 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.562 ' CB ' ' O ' ' A' ' 77' ' ' ASN . 6.3 t0 89.61 5.3 0.14 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.193 -0.458 . . . . 75.33 110.862 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 1.2 ttm-85 -110.46 102.29 10.92 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.176 -0.465 . . . . 75.21 110.898 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.538 ' HB2' ' SG ' ' A' ' 37' ' ' CYS . 0.0 OUTLIER -101.12 134.68 43.77 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.225 -0.443 . . . . 73.52 110.93 -179.996 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.578 ' HB3' ' HB3' ' A' ' 53' ' ' PRO . 1.2 m -151.15 -119.35 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.212 -0.449 . . . . 74.54 110.859 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.673 ' OG ' ' HA ' ' A' ' 53' ' ' PRO . 0.5 OUTLIER -38.31 107.65 0.07 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.168 -0.469 . . . . 63.33 110.882 -179.789 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . 0.516 ' HA ' ' O ' ' A' ' 48' ' ' ALA . 8.3 p -115.96 146.66 41.92 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.164 -0.471 . . . . 73.14 110.859 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.49 ' N ' ' O ' ' A' ' 48' ' ' ALA . 0.1 OUTLIER -144.59 128.95 17.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.192 -0.458 . . . . 73.51 110.866 -179.834 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.46 ' N ' ' CZ3' ' A' ' 47' ' ' TRP . . . -48.47 127.81 13.76 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.209 -0.45 . . . . 64.42 111.101 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.53 ' CG2' ' CB ' ' A' ' 48' ' ' ALA . 25.0 t -115.17 139.02 43.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.2 -0.454 . . . . 74.33 111.14 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . 0.556 ' O ' ' CG2' ' A' ' 136' ' ' VAL . 11.8 m170 -112.41 107.11 15.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.164 -0.471 . . . . 74.3 110.835 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.472 ' C ' ' O ' ' A' ' 87' ' ' HIS . 0.0 OUTLIER -32.57 152.96 0.04 OUTLIER Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.619 0.723 . . . . 73.13 110.906 -179.996 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.569 ' HA ' ' HA3' ' A' ' 135' ' ' GLY . 53.6 Cg_endo -69.79 84.72 0.65 Allowed 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.689 2.26 . . . . 74.23 112.335 179.845 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -83.27 -171.29 3.49 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.228 -0.442 . . . . 72.12 110.832 -179.842 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 72.05 68.03 1.7 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.754 -0.736 . . . . 74.01 112.442 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 97.03 -69.88 0.79 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.764 -0.731 . . . . 71.11 112.513 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.427 ' HB2' ' H ' ' A' ' 94' ' ' TYR . 6.0 pt20 171.39 -148.88 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.774 0.321 . . . . 65.13 110.933 -179.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.516 ' O ' ' HA ' ' A' ' 112' ' ' THR . 0.0 OUTLIER -107.53 101.78 11.09 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.184 -0.462 . . . . 74.41 110.918 -179.865 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.454 ' O ' HG12 ' A' ' 132' ' ' VAL . 28.2 tptt -102.07 130.0 48.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.096 -0.502 . . . . 73.33 110.917 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -149.29 135.26 11.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.238 -0.437 . . . . 64.04 111.158 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -107.87 131.59 54.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.156 -0.474 . . . . 72.45 110.915 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 1.5 mp -113.46 131.31 65.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.186 -0.461 . . . . 73.31 111.104 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.624 ' HB2' ' HB2' ' A' ' 129' ' ' SER . 74.0 m-85 -122.19 136.87 54.97 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.162 -0.472 . . . . 73.14 110.895 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 57.3 tt0 -67.31 -73.94 0.13 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.167 -0.469 . . . . 75.32 110.867 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.506 ' C ' ' HB2' ' A' ' 128' ' ' HIS . 5.1 mttt -84.54 165.73 17.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.193 -0.458 . . . . 75.42 110.954 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -72.23 160.58 54.1 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.757 -0.735 . . . . 73.04 112.461 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.428 ' HA ' ' HB2' ' A' ' 158' ' ' ARG . 29.5 t70 62.56 32.68 16.35 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.819 0.343 . . . . 74.25 110.878 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.493 ' CZ ' ' HB3' ' A' ' 158' ' ' ARG . 13.5 m-85 56.98 49.16 14.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.185 -0.461 . . . . 74.4 110.866 -179.892 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.1 m -113.62 150.97 32.37 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.206 -0.452 . . . . 74.04 110.85 -179.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 89.24 -123.67 6.98 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.762 -0.733 . . . . 75.43 112.471 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 54.8 tp60 -101.21 141.26 34.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.79 0.329 . . . . 74.44 110.877 -179.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 3.2 ttp -131.5 131.52 43.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.211 -0.45 . . . . 74.35 110.876 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 10.0 m-85 -136.81 137.31 39.64 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.451 . . . . 70.43 110.958 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -118.91 112.71 19.98 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.12 -0.491 . . . . 64.32 110.891 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 11.9 t -125.51 150.41 47.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.152 -0.476 . . . . 72.15 111.104 -179.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.516 ' HA ' ' O ' ' A' ' 94' ' ' TYR . 1.4 t -124.49 47.76 2.06 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.177 -0.465 . . . . 74.31 111.112 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -152.58 -178.21 6.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.227 -0.442 . . . . 72.21 110.893 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -73.86 164.98 25.93 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.165 -0.47 . . . . 63.24 110.849 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . 0.536 ' O ' ' HB2' ' A' ' 172' ' ' SER . 4.8 t -154.33 113.69 2.47 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.591 0.71 . . . . 74.31 110.889 -179.924 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.41 ' O ' ' CA ' ' A' ' 143' ' ' PRO . 53.1 Cg_endo -69.81 -30.2 22.4 Favored 'Trans proline' 0 C--O 1.231 0.15 0 C-N-CA 122.686 2.257 . . . . 71.32 112.328 -179.895 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.637 ' HB3' ' CB ' ' A' ' 120' ' ' GLU . 0.1 OUTLIER -149.97 98.02 2.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.19 -0.459 . . . . 75.23 110.898 -179.857 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.511 ' HB ' ' O ' ' A' ' 171' ' ' GLN . 3.0 tt -50.55 -29.16 6.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.132 -0.486 . . . . 75.45 111.099 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' MET . . . . . 0.573 ' O ' ' HA ' ' A' ' 123' ' ' HIS . 0.0 OUTLIER -86.39 -45.94 10.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.198 -0.456 . . . . 74.34 110.876 179.866 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.637 ' CB ' ' HB3' ' A' ' 117' ' ' SER . 16.5 tp10 -64.87 -12.94 54.34 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.222 -0.445 . . . . 73.14 110.868 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -113.25 -51.88 2.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.184 -0.462 . . . . 74.01 110.968 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . 0.417 ' HB2' ' O ' ' A' ' 118' ' ' ILE . 93.8 m-85 -103.4 -20.05 14.21 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.155 -0.475 . . . . 74.55 110.905 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . 0.573 ' HA ' ' O ' ' A' ' 119' ' ' MET . 10.9 m80 73.26 26.62 2.06 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.177 -0.465 . . . . 64.21 110.867 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 6.0 mtt -101.16 85.55 2.85 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.221 -0.445 . . . . 73.13 110.862 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 1.7 ptp85 -51.33 -34.11 32.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.254 -0.43 . . . . 74.22 110.89 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.479 ' HG2' ' HA ' ' A' ' 169' ' ' ALA . 40.7 mt-10 -144.34 138.07 27.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.19 -0.459 . . . . 64.53 110.883 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.42 ' O ' ' HB3' ' A' ' 168' ' ' PRO . 3.4 mm -99.88 96.6 5.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.115 -0.493 . . . . 74.32 111.129 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . 0.506 ' HB2' ' C ' ' A' ' 101' ' ' LYS . 11.0 m170 -69.43 -31.69 70.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.232 -0.44 . . . . 72.3 110.831 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.624 ' HB2' ' HB2' ' A' ' 99' ' ' PHE . 0.3 OUTLIER -132.65 145.34 51.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.247 -0.433 . . . . 73.31 110.854 -179.778 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . 0.583 ' HB3' ' HD2' ' A' ' 154' ' ' LYS . 0.3 OUTLIER -147.25 119.1 8.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.149 -0.478 . . . . 43.3 110.874 -179.931 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.564 ' HA ' ' HA ' ' A' ' 156' ' ' GLU . 6.9 mtpp -108.14 157.83 17.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.176 -0.466 . . . . 73.24 110.924 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.454 HG12 ' O ' ' A' ' 95' ' ' LYS . 3.5 t 81.58 169.06 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.237 -0.438 . . . . 75.34 111.089 179.836 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.566 ' O ' ' CD1' ' A' ' 133' ' ' LEU . 0.2 OUTLIER -165.85 128.18 2.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.138 -0.483 . . . . 74.53 110.912 179.927 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.516 ' O ' ' C ' ' A' ' 135' ' ' GLY . 1.4 mp0 -98.15 141.26 31.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.456 . . . . 73.41 110.888 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . 0.569 ' HA3' ' HA ' ' A' ' 89' ' ' PRO . . . -27.25 -44.79 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.735 -0.745 . . . . 62.0 112.479 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.654 ' HA ' HD13 ' A' ' 152' ' ' LEU . 2.0 t -149.85 127.88 2.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.834 0.349 . . . . 75.33 111.157 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . 0.662 ' HB3' ' CB ' ' A' ' 152' ' ' LEU . 26.1 t90 -142.08 145.53 34.42 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.173 -0.467 . . . . 73.53 110.893 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.433 HD12 ' HB ' ' A' ' 61' ' ' ILE . 7.1 mt -123.19 130.01 74.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.252 -0.431 . . . . 74.13 111.11 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.555 ' CB ' ' HB2' ' A' ' 150' ' ' TYR . 0.1 OUTLIER -97.36 147.36 24.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.155 -0.475 . . . . 72.24 110.897 179.965 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . 0.437 ' CD2' ' HA ' ' A' ' 145' ' ' TYR . 8.6 m-85 -124.26 124.69 42.97 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.124 -0.489 . . . . 74.25 110.895 -179.846 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . 0.549 ' O ' ' HB2' ' A' ' 171' ' ' GLN . 0.0 OUTLIER -58.96 -25.24 63.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.133 -0.485 . . . . 72.21 110.909 179.996 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.837 ' HB3' ' HD2' ' A' ' 143' ' ' PRO . 9.1 mp -118.06 175.9 1.87 Allowed Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.603 0.716 . . . . 74.12 110.886 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . 0.837 ' HD2' ' HB3' ' A' ' 142' ' ' LEU . 54.0 Cg_endo -69.74 -90.98 0.01 OUTLIER 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.66 2.24 . . . . 73.55 112.378 179.836 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . 0.995 ' O ' ' HG2' ' A' ' 146' ' ' ARG . 0.0 OUTLIER -49.6 86.26 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.175 -0.466 . . . . 74.43 110.872 -179.968 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . 0.59 ' C ' ' O ' ' A' ' 144' ' ' ASN . 2.6 m-85 19.73 43.03 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.185 -0.461 . . . . 70.21 110.897 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . 0.995 ' HG2' ' O ' ' A' ' 144' ' ' ASN . 12.8 mmm-85 -101.21 178.49 4.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.092 -0.504 . . . . 75.23 110.853 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 73.51 -166.31 54.65 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.735 -0.745 . . . . 75.42 112.467 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -86.25 159.81 19.34 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.77 0.319 . . . . 72.11 110.848 -179.806 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . 0.487 ' HB2' ' HA ' ' A' ' 60' ' ' TYR . 50.3 mt-30 -94.41 153.16 18.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.163 -0.471 . . . . 74.04 110.874 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . 0.555 ' HB2' ' CB ' ' A' ' 139' ' ' PHE . 95.9 m-85 -135.11 119.2 17.55 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.183 -0.462 . . . . 71.41 110.976 -179.899 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.459 ' HA ' ' CD1' ' A' ' 61' ' ' ILE . 22.8 tp -65.11 136.8 57.14 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.09 -0.505 . . . . 75.13 110.894 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.662 ' CB ' ' HB3' ' A' ' 137' ' ' TRP . 0.0 OUTLIER -73.03 134.23 44.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.222 -0.445 . . . . 72.34 110.945 179.85 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -165.27 30.88 0.06 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.212 -0.449 . . . . 73.01 110.908 179.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.763 ' O ' ' HG3' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -111.76 -172.27 2.01 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.16 -0.473 . . . . 70.14 110.945 179.947 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.763 ' HG3' ' O ' ' A' ' 154' ' ' LYS . 0.0 OUTLIER -159.86 -129.43 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.239 -0.437 . . . . 75.24 110.869 179.849 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.564 ' HA ' ' HA ' ' A' ' 131' ' ' LYS . 2.1 tm-20 -70.27 4.94 1.92 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.215 -0.448 . . . . 74.24 110.883 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . 0.785 ' CD1' ' HB3' ' A' ' 162' ' ' ASP . 21.2 m-30 -30.7 148.19 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.135 -0.484 . . . . 72.0 110.895 -179.818 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . 0.493 ' HB3' ' CZ ' ' A' ' 104' ' ' PHE . 10.4 ptp180 -118.54 -31.87 4.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.065 -0.516 . . . . 75.3 110.841 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . 0.522 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 2.1 ptpp? -99.64 153.22 37.89 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.584 0.707 . . . . 74.21 110.889 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . 0.463 ' HB3' ' HB3' ' A' ' 168' ' ' PRO . 53.4 Cg_endo -69.82 -25.23 28.54 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.693 2.262 . . . . 75.31 112.312 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.475 HD11 ' H ' ' A' ' 161' ' ' ILE . 3.8 mp -75.46 4.19 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.229 -0.441 . . . . 73.04 111.131 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . 0.785 ' HB3' ' CD1' ' A' ' 157' ' ' TYR . 0.2 OUTLIER -72.63 -21.12 61.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.151 -0.477 . . . . 72.23 110.831 179.856 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' TRP . . . . . 0.51 ' CD1' ' N ' ' A' ' 163' ' ' TRP . 0.0 OUTLIER -108.65 13.47 25.16 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.238 -0.437 . . . . 74.42 110.92 -179.934 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 84.94 -29.21 4.26 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.724 -0.75 . . . . 75.12 112.502 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -53.65 118.95 4.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.798 0.332 . . . . 63.41 111.092 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -48.78 -26.1 2.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.249 -0.432 . . . . 74.44 111.123 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' SER . . . . . 0.511 ' C ' ' H ' ' A' ' 169' ' ' ALA . 0.3 OUTLIER -155.71 157.19 31.4 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.69 0.757 . . . . 75.31 110.791 -179.779 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . 0.504 ' HG3' ' CD2' ' A' ' 128' ' ' HIS . 54.0 Cg_endo -69.78 22.24 0.17 Allowed 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.666 2.244 . . . . 73.32 112.353 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . 0.511 ' H ' ' C ' ' A' ' 167' ' ' SER . . . -64.66 103.76 0.73 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.239 -0.437 . . . . 62.1 111.071 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 2.9 t -152.59 160.91 2.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.169 -0.469 . . . . 74.41 111.11 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' GLN . . . . . 0.639 ' OE1' ' HB3' ' A' ' 143' ' ' PRO . 1.7 tm0? -108.13 -81.66 0.56 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.194 -0.457 . . . . 73.05 110.877 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' SER . . . . . 0.702 ' OG ' ' O ' ' A' ' 143' ' ' PRO . 24.9 p -129.8 179.48 5.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 65.4 110.834 -179.795 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 27.4 p90 -144.2 167.81 21.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.14 -0.482 . . . . 75.13 110.853 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -139.13 135.98 34.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.139 -0.482 . . . . 73.24 110.876 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . 0.47 ' HD2' ' CE2' ' A' ' 94' ' ' TYR . 0.1 OUTLIER -82.93 -167.04 1.5 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.196 -0.456 . . . . 75.3 110.879 -179.937 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . 0.542 HD11 ' C ' ' A' ' 136' ' ' VAL . 4.2 mt -139.75 132.72 35.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.194 -0.457 . . . . 75.31 111.151 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 11.5 t -132.77 147.68 31.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.159 -0.473 . . . . 74.55 111.08 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.178 -0.464 . . . . 73.14 110.852 -179.992 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.2 mtm . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.839 0.352 . . . . 74.44 110.905 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -150.9 153.23 34.91 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.198 -0.456 . . . . 74.3 110.843 -179.796 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 30.8 mmtp -101.67 58.68 0.85 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.149 -0.478 . . . . 74.01 110.876 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 25.9 p -53.68 -39.77 65.4 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.255 -0.429 . . . . 74.11 111.126 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 161.83 145.99 4.51 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.747 -0.739 . . . . 65.32 112.554 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.464 ' C ' ' HE1' ' A' ' 47' ' ' TRP . 6.3 p -81.76 135.72 35.46 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.859 0.361 . . . . 72.44 111.135 -179.884 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 3.2 tttt -121.93 135.84 54.89 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.198 -0.455 . . . . 74.32 110.911 179.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.631 HG23 ' CE2' ' A' ' 10' ' ' PHE . 15.1 tt -136.91 150.54 26.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.232 -0.44 . . . . 74.52 111.132 179.839 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.473 HG21 ' CE2' ' A' ' 11' ' ' TYR . 9.9 m -131.01 142.05 50.29 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.162 -0.472 . . . . 70.14 111.158 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.631 ' CE2' HG23 ' A' ' 8' ' ' ILE . 1.2 m-85 -128.48 129.95 46.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 74.15 110.863 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.52 ' CG ' ' HA ' ' A' ' 16' ' ' PHE . 18.9 m-85 -116.23 131.4 56.95 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.188 -0.46 . . . . 74.23 110.886 -179.832 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.485 ' HG2' ' HB2' ' A' ' 36' ' ' ARG . 0.0 OUTLIER -58.24 -25.41 61.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.141 -0.481 . . . . 73.45 110.897 179.978 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 59.5 m-20 -127.16 152.57 47.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.144 -0.48 . . . . 71.34 110.905 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.477 ' N ' ' HB3' ' A' ' 38' ' ' ASN . 34.8 mtmt -56.08 -175.35 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.266 -0.424 . . . . 75.32 110.938 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 18.6 m120 46.96 34.13 2.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.233 -0.44 . . . . 75.3 110.882 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.52 ' HA ' ' CG ' ' A' ' 11' ' ' TYR . 4.2 m-85 48.51 57.18 6.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.217 -0.447 . . . . 74.1 110.867 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 14.7 mt-30 -131.98 157.24 44.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.12 -0.491 . . . . 71.44 110.92 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 95.5 -150.79 19.78 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.775 -0.726 . . . . 45.12 112.537 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.475 ' O ' HD13 ' A' ' 34' ' ' LEU . 0.1 OUTLIER -69.45 81.08 0.39 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.746 0.308 . . . . 74.22 110.889 -179.878 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.456 ' HB2' ' CE1' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -79.21 128.67 33.59 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.203 -0.453 . . . . 74.45 110.862 -179.884 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.47 ' CD2' ' CD2' ' A' ' 30' ' ' PHE . 75.6 t80 -124.41 125.06 43.65 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.181 -0.463 . . . . 65.02 110.944 -179.849 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.461 ' CG ' HG23 ' A' ' 9' ' ' THR . 1.4 m-20 -119.08 133.7 55.65 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.136 -0.484 . . . . 74.43 110.83 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 10.1 t -161.33 133.05 5.61 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 63.14 110.885 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -100.86 -3.07 30.47 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.16 -0.473 . . . . 73.42 110.875 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.466 ' O ' ' SG ' ' A' ' 27' ' ' CYS . 34.3 t -106.61 160.99 15.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.456 . . . . 74.03 110.905 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -48.16 120.38 3.52 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.216 -0.447 . . . . 73.51 110.828 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.63 ' HB2' ' HB3' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -115.54 46.61 1.46 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.218 -0.446 . . . . 73.45 110.832 -179.884 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.561 ' O ' ' HA ' ' A' ' 82' ' ' SER . . . -49.12 -21.01 0.65 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.191 -0.458 . . . . 74.52 111.1 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 60.8 t0 -128.56 40.86 3.59 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.224 -0.444 . . . . 72.43 110.889 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.792 ' O ' ' CD2' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -81.46 16.92 1.51 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.177 -0.465 . . . . 75.32 110.842 -179.874 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.51 ' HB2' ' HB3' ' A' ' 81' ' ' SER . 37.6 t60 -81.45 -35.14 30.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.158 -0.474 . . . . 75.21 110.9 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.8 t -64.52 -7.93 11.98 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.169 -0.469 . . . . 72.53 111.152 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -106.09 -28.21 10.64 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.215 -0.448 . . . . 72.53 110.895 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.475 HD13 ' O ' ' A' ' 19' ' ' ARG . 19.1 tp -141.36 144.83 34.75 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.121 -0.49 . . . . 74.02 110.882 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.1 m -111.29 -33.79 6.33 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.138 -0.483 . . . . 73.34 110.842 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.485 ' HB2' ' HG2' ' A' ' 12' ' ' GLU . 2.3 mtp85 -116.66 140.64 49.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.095 -0.502 . . . . 74.25 110.903 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.62 ' HB3' ' HB2' ' A' ' 80' ' ' LEU . 6.3 p -117.37 59.08 0.78 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.199 -0.455 . . . . 74.04 110.873 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.477 ' HB3' ' N ' ' A' ' 14' ' ' LYS . 1.3 m-80 -57.38 -72.55 0.08 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.224 -0.443 . . . . 72.33 110.849 -179.859 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 4.5 p -108.08 127.06 53.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.204 -0.453 . . . . 63.52 110.901 -179.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.635 ' O ' ' HB2' ' A' ' 67' ' ' TYR . 23.3 mt -120.55 149.18 23.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.187 -0.46 . . . . 74.22 111.127 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.465 ' N ' HG23 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -143.73 121.55 11.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.122 -0.49 . . . . 74.2 110.89 179.842 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.596 HG22 ' HB2' ' A' ' 47' ' ' TRP . 1.5 t -107.04 115.65 48.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.203 -0.453 . . . . 75.42 111.074 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -111.36 79.26 1.19 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.116 -0.493 . . . . 74.33 110.908 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.429 ' O ' ' HA ' ' A' ' 6' ' ' THR . . . 132.75 102.12 0.81 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.737 -0.744 . . . . 62.22 112.508 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 53.2 178.12 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.761 -0.733 . . . . 72.23 112.469 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.486 HG21 ' HA ' ' A' ' 63' ' ' PRO . 0.7 OUTLIER -76.78 170.63 16.11 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.729 0.3 . . . . 73.33 111.168 -179.875 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.599 ' CD1' ' HB ' ' A' ' 8' ' ' ILE . 4.0 m95 -144.66 129.98 18.75 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.215 -0.448 . . . . 74.31 110.938 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.596 ' O ' ' N ' ' A' ' 84' ' ' ARG . . . -93.2 126.1 38.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.243 -0.435 . . . . 74.32 111.136 179.893 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.473 ' HA ' ' HA ' ' A' ' 83' ' ' CYS . 17.2 m -124.58 142.18 42.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.22 -0.446 . . . . 71.32 111.113 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.909 ' HB3' ' CB ' ' A' ' 56' ' ' ALA . 7.0 m-85 -116.92 143.53 45.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.127 -0.488 . . . . 73.23 110.977 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.573 ' HG2' ' N ' ' A' ' 52' ' ' ARG . 0.3 OUTLIER -49.47 -83.63 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.154 -0.475 . . . . 74.23 110.865 -179.976 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.772 ' H ' ' HA ' ' A' ' 56' ' ' ALA . 1.2 mtp180 -81.67 138.58 47.26 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.562 0.696 . . . . 75.23 110.914 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.682 ' HA ' ' OG ' ' A' ' 82' ' ' SER . 53.8 Cg_endo -69.75 138.14 37.17 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.672 2.248 . . . . 71.43 112.366 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.467 ' C ' ' CD2' ' A' ' 55' ' ' PHE . 6.3 m-20 66.67 -6.75 0.5 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.245 -0.434 . . . . 74.33 110.87 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.518 ' H ' ' C ' ' A' ' 53' ' ' PRO . 0.0 OUTLIER -139.86 -75.82 0.34 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.223 -0.444 . . . . 75.31 110.885 -179.966 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.909 ' CB ' ' HB3' ' A' ' 50' ' ' TYR . . . 45.71 79.98 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.19 -0.459 . . . . 74.31 111.044 179.906 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . 0.546 ' O ' ' CD2' ' A' ' 58' ' ' TYR . 54.1 m95 -64.72 33.71 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.257 -0.429 . . . . 71.3 110.901 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.63 ' H ' ' C ' ' A' ' 56' ' ' ALA . 1.4 m-30 -163.25 120.61 1.88 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.22 -0.446 . . . . 74.23 110.91 -179.927 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.476 ' HB2' ' HA ' ' A' ' 150' ' ' TYR . 1.0 OUTLIER -85.74 138.84 31.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.099 -0.5 . . . . 74.25 110.873 179.895 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.515 ' CE2' ' HG ' ' A' ' 76' ' ' LEU . 2.8 t80 -153.28 101.68 2.55 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.223 -0.444 . . . . 74.44 110.92 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.51 ' N ' ' CD1' ' A' ' 61' ' ' ILE . 1.8 mp -90.25 116.98 32.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.134 -0.485 . . . . 74.43 111.156 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -82.74 130.88 56.46 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 121.554 0.693 . . . . 75.32 110.962 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.486 ' HA ' HG21 ' A' ' 46' ' ' THR . 53.9 Cg_endo -69.72 -171.94 0.52 Allowed 'Trans proline' 0 C--N 1.341 0.132 0 C-N-CA 122.663 2.242 . . . . 74.12 112.359 179.887 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.92 162.53 14.73 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.219 -0.446 . . . . 63.21 110.937 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 112.3 -168.47 12.7 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.78 -0.724 . . . . 70.21 112.498 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -107.47 152.29 24.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.893 0.378 . . . . 72.42 110.89 -179.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.635 ' HB2' ' O ' ' A' ' 40' ' ' ILE . 11.2 m-85 -141.25 84.95 12.29 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.716 0.77 . . . . 74.44 110.935 -179.864 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.454 ' HD2' ' HG3' ' A' ' 72' ' ' ARG . 53.8 Cg_endo -69.79 0.17 6.06 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.701 2.267 . . . . 64.31 112.353 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.499 ' HB2' ' HG2' ' A' ' 72' ' ' ARG . 51.7 mt-10 -155.47 142.43 19.1 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.21 -0.45 . . . . 75.12 110.917 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.692 ' HA ' ' CE2' ' A' ' 73' ' ' TRP . 26.8 p90 -55.75 -20.06 13.38 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.145 -0.48 . . . . 73.12 110.963 -179.878 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -80.97 -16.01 54.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.093 -0.503 . . . . 74.42 110.9 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.499 ' HG2' ' HB2' ' A' ' 69' ' ' GLU . 27.9 mmt180 -69.88 -9.26 54.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.212 -0.449 . . . . 74.32 110.894 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . 0.728 ' N ' ' CD1' ' A' ' 73' ' ' TRP . 0.0 OUTLIER -133.74 17.53 3.9 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.187 -0.46 . . . . 71.43 110.919 -179.976 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' MET . . . . . 0.443 ' C ' ' O ' ' A' ' 73' ' ' TRP . 19.8 ptp 34.82 47.64 0.26 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.232 -0.44 . . . . 73.34 110.882 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -66.75 117.75 9.72 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.701 -0.761 . . . . 65.12 112.49 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.515 ' HG ' ' CE2' ' A' ' 60' ' ' TYR . 0.7 OUTLIER -61.08 -34.78 75.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.824 0.345 . . . . 71.21 110.927 -179.936 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 13.5 t-20 -125.57 134.12 52.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.183 -0.462 . . . . 72.53 110.889 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -88.4 16.36 6.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.181 -0.463 . . . . 54.44 110.886 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -108.51 80.19 1.32 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.16 -0.473 . . . . 75.22 110.834 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.62 ' HB2' ' HB3' ' A' ' 37' ' ' CYS . 0.0 OUTLIER -81.39 134.36 35.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 74.51 110.905 179.992 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.656 ' HB3' ' HB3' ' A' ' 53' ' ' PRO . 1.5 m -150.74 -118.89 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.188 -0.46 . . . . 74.52 110.86 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.682 ' OG ' ' HA ' ' A' ' 53' ' ' PRO . 0.0 OUTLIER -41.19 103.03 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.151 -0.477 . . . . 73.55 110.872 -179.815 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . 0.495 ' CA ' ' O ' ' A' ' 48' ' ' ALA . 24.7 p -126.83 131.67 51.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.138 -0.483 . . . . 54.22 110.883 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.596 ' N ' ' O ' ' A' ' 48' ' ' ALA . 8.9 mmt85 -113.63 151.21 32.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.181 -0.463 . . . . 75.55 110.852 -179.86 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.456 ' HB1' ' OG1' ' A' ' 6' ' ' THR . . . -68.41 128.34 36.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.19 -0.459 . . . . 63.14 111.095 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.47 HG13 HG12 ' A' ' 136' ' ' VAL . 90.4 t -115.63 128.46 72.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.225 -0.443 . . . . 72.1 111.126 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . 0.485 ' O ' ' CG2' ' A' ' 136' ' ' VAL . 62.3 m80 -108.34 121.71 45.49 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.143 -0.48 . . . . 74.32 110.831 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.411 ' C ' ' O ' ' A' ' 87' ' ' HIS . 0.2 OUTLIER -37.47 138.01 0.62 Allowed Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.578 0.704 . . . . 75.31 110.904 -179.979 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.664 ' HB3' ' H ' ' A' ' 136' ' ' VAL . 53.7 Cg_endo -69.76 98.53 0.69 Allowed 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.662 2.241 . . . . 72.42 112.352 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -101.19 -176.29 3.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.204 -0.453 . . . . 72.44 110.868 -179.854 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 53.98 51.49 49.48 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.742 -0.742 . . . . 74.13 112.505 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.428 ' O ' ' C ' ' A' ' 93' ' ' GLN . . . 126.41 28.24 1.01 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.752 -0.737 . . . . 71.54 112.476 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.483 ' O ' ' HG2' ' A' ' 134' ' ' GLU . 11.4 pt20 36.25 -117.92 0.13 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.839 0.352 . . . . 75.32 110.893 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.543 ' O ' ' HA ' ' A' ' 112' ' ' THR . 0.0 OUTLIER -123.57 99.75 6.46 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.159 -0.473 . . . . 74.25 110.881 -179.863 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.435 ' HG3' HG11 ' A' ' 132' ' ' VAL . 46.2 tptt -111.07 128.32 55.84 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.118 -0.492 . . . . 74.11 110.915 179.863 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.443 HG13 ' CZ3' ' A' ' 137' ' ' TRP . 0.0 OUTLIER -150.55 141.36 16.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.229 -0.441 . . . . 74.22 111.157 179.831 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.46 ' HB2' ' O ' ' A' ' 131' ' ' LYS . 2.2 mt-30 -108.44 130.93 55.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.214 -0.448 . . . . 74.42 110.874 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 1.3 mp -111.25 135.38 50.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.162 -0.472 . . . . 72.14 111.146 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.633 ' HB2' ' HB2' ' A' ' 129' ' ' SER . 8.3 m-85 -125.15 144.27 50.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.199 -0.455 . . . . 74.43 110.934 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 78.5 tt0 -71.36 -75.92 0.12 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.2 -0.454 . . . . 75.02 110.892 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.457 ' C ' ' HB3' ' A' ' 128' ' ' HIS . 41.4 mttt -82.35 175.06 10.55 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.178 -0.464 . . . . 75.03 110.906 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.433 ' N ' ' HB3' ' A' ' 128' ' ' HIS . . . -88.24 158.24 28.8 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.736 -0.745 . . . . 54.12 112.497 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.451 ' HA ' ' HB2' ' A' ' 158' ' ' ARG . 27.9 t0 67.2 54.42 0.73 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.819 0.342 . . . . 71.52 110.82 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.656 ' CE1' ' HD2' ' A' ' 131' ' ' LYS . 6.8 m-85 48.19 31.64 2.68 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.202 -0.454 . . . . 64.41 110.912 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.42 ' C ' ' HB2' ' A' ' 101' ' ' LYS . 49.2 m -107.36 150.62 26.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.159 -0.473 . . . . 73.52 110.873 -179.796 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 91.32 -164.65 29.63 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.69 -0.767 . . . . 50.34 112.441 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 45.0 tp60 -74.67 130.27 39.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.802 0.334 . . . . 71.11 110.938 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -115.76 131.82 56.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.207 -0.451 . . . . 74.03 110.904 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -137.63 138.09 39.12 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.222 -0.444 . . . . 73.5 110.932 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -114.86 111.66 21.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.145 -0.48 . . . . 74.05 110.937 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 12.2 t -122.06 142.2 50.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.165 -0.47 . . . . 74.25 111.115 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.543 ' HA ' ' O ' ' A' ' 94' ' ' TYR . 3.8 t -119.02 39.14 3.62 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.182 -0.463 . . . . 75.2 111.125 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -151.29 156.32 40.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.233 -0.44 . . . . 74.55 110.912 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -53.7 159.68 1.53 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.131 -0.486 . . . . 73.51 110.914 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . 0.543 ' O ' ' HB2' ' A' ' 172' ' ' SER . 29.4 t -146.32 120.17 5.23 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-O 121.6 0.714 . . . . 74.52 110.918 -179.884 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.452 ' O ' ' C ' ' A' ' 143' ' ' PRO . 53.7 Cg_endo -69.67 -32.76 18.31 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.668 2.245 . . . . 73.15 112.361 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.636 ' HB3' ' CB ' ' A' ' 120' ' ' GLU . 0.1 OUTLIER -148.63 101.72 3.24 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.186 -0.461 . . . . 71.44 110.842 -179.772 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.543 ' HB ' ' O ' ' A' ' 171' ' ' GLN . 3.3 tt -54.47 -29.57 20.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.123 -0.49 . . . . 70.11 111.156 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' MET . . . . . 0.592 ' O ' ' HA ' ' A' ' 123' ' ' HIS . 49.2 ttp -86.2 -44.29 12.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 63.01 110.902 179.819 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.636 ' CB ' ' HB3' ' A' ' 117' ' ' SER . 12.6 tp10 -66.48 -12.47 57.53 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.223 -0.444 . . . . 73.0 110.865 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 25.0 tp60 -114.64 -49.06 2.83 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.156 -0.474 . . . . 72.34 110.934 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . 0.438 ' HB2' ' O ' ' A' ' 118' ' ' ILE . 86.1 m-85 -105.23 -19.15 13.9 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.197 -0.456 . . . . 71.14 110.865 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . 0.592 ' HA ' ' O ' ' A' ' 119' ' ' MET . 11.4 m80 72.18 26.94 2.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.154 -0.475 . . . . 73.52 110.875 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.4 ' HB3' ' CD1' ' A' ' 127' ' ' ILE . 8.9 mtt -102.2 86.44 2.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.182 -0.463 . . . . 72.33 110.876 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 1.7 ptp85 -51.59 -34.54 37.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.245 -0.434 . . . . 70.44 110.913 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.475 ' HG2' ' HA ' ' A' ' 169' ' ' ALA . 35.9 mt-10 -144.89 133.57 22.19 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.152 -0.476 . . . . 73.43 110.897 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.472 ' N ' ' HB2' ' A' ' 168' ' ' PRO . 3.5 mm -94.73 89.77 2.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.147 -0.478 . . . . 73.25 111.15 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . 0.457 ' HB3' ' C ' ' A' ' 101' ' ' LYS . 0.6 OUTLIER -62.58 -33.27 74.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.2 -0.455 . . . . 63.44 110.846 179.862 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.633 ' HB2' ' HB2' ' A' ' 99' ' ' PHE . 69.9 m -130.58 141.53 50.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 74.22 110.871 -179.747 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . 0.614 ' O ' ' O ' ' A' ' 155' ' ' LYS . 0.1 OUTLIER -142.84 122.31 13.19 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.178 -0.464 . . . . 62.24 110.91 -179.959 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.656 ' HD2' ' CE1' ' A' ' 104' ' ' PHE . 7.1 mtpp -115.74 155.61 27.46 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.169 -0.469 . . . . 73.25 110.861 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.521 ' HB ' ' O ' ' A' ' 131' ' ' LYS . 18.1 t 84.92 163.72 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.242 -0.435 . . . . 74.3 111.114 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.465 ' O ' ' HG ' ' A' ' 133' ' ' LEU . 0.0 OUTLIER -178.95 122.86 0.09 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.162 -0.472 . . . . 73.44 110.898 180.0 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.483 ' HG2' ' O ' ' A' ' 93' ' ' GLN . 0.0 OUTLIER -92.49 171.23 9.17 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.225 -0.443 . . . . 74.2 110.912 179.863 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . 0.455 ' C ' ' O ' ' A' ' 134' ' ' GLU . . . -32.67 -53.08 0.47 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.754 -0.736 . . . . 74.24 112.482 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.736 ' HA ' HD13 ' A' ' 152' ' ' LEU . 4.1 t -148.81 146.13 17.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.858 0.361 . . . . 64.12 111.109 -179.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . 0.562 ' HB3' ' HB3' ' A' ' 152' ' ' LEU . 0.7 OUTLIER -150.01 163.34 38.4 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.146 -0.479 . . . . 74.42 110.893 179.975 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.46 HD12 ' HB ' ' A' ' 61' ' ' ILE . 4.7 mt -143.18 136.65 25.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.186 -0.461 . . . . 71.14 111.109 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.464 ' HB2' ' HB2' ' A' ' 150' ' ' TYR . 0.2 OUTLIER -102.55 168.79 9.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.204 -0.453 . . . . 73.33 110.882 179.989 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . 0.46 ' CD2' ' HA ' ' A' ' 145' ' ' TYR . 0.5 OUTLIER -139.88 127.65 21.91 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.131 -0.486 . . . . 71.22 110.959 -179.85 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . 0.596 ' O ' ' HB2' ' A' ' 171' ' ' GLN . 0.7 OUTLIER -60.79 -28.41 68.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.134 -0.484 . . . . 75.42 110.893 -179.986 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.763 ' HB3' ' HD2' ' A' ' 143' ' ' PRO . 9.2 mp -115.06 173.63 2.81 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.621 0.724 . . . . 73.32 110.909 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . 0.763 ' HD2' ' HB3' ' A' ' 142' ' ' LEU . 53.8 Cg_endo -69.76 -89.59 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.603 2.202 . . . . 71.52 112.363 179.852 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . 0.711 ' O ' ' N ' ' A' ' 146' ' ' ARG . 1.3 m-20 -53.13 97.63 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.203 -0.453 . . . . 72.41 110.911 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . 0.637 ' C ' ' O ' ' A' ' 144' ' ' ASN . 33.1 m-85 12.51 52.36 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.169 -0.469 . . . . 73.42 110.932 -179.882 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . 0.711 ' N ' ' O ' ' A' ' 144' ' ' ASN . 19.5 mtt-85 -117.85 172.6 7.28 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.095 -0.502 . . . . 64.11 110.91 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 77.55 -176.86 53.35 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.759 -0.734 . . . . 61.25 112.523 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -78.08 149.62 33.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.76 0.314 . . . . 75.04 110.895 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 63.3 mt-30 -85.71 157.24 20.34 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.217 -0.447 . . . . 75.52 110.945 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . 0.476 ' HA ' ' HB2' ' A' ' 59' ' ' MET . 88.8 m-85 -137.78 109.78 7.22 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.229 -0.441 . . . . 74.03 110.905 -179.837 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.407 ' CA ' HD12 ' A' ' 61' ' ' ILE . 20.2 tp -59.76 136.11 57.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.097 -0.502 . . . . 74.53 110.924 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.736 HD13 ' HA ' ' A' ' 136' ' ' VAL . 0.0 OUTLIER -68.93 137.17 53.57 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.18 -0.464 . . . . 74.51 110.905 179.881 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -164.15 24.94 0.07 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.223 -0.444 . . . . 73.24 110.922 179.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.919 ' HB2' ' CD1' ' A' ' 157' ' ' TYR . 2.2 ptmt -122.0 -174.62 2.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.131 -0.486 . . . . 72.22 110.872 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.67 ' HG3' ' O ' ' A' ' 154' ' ' LYS . 0.0 OUTLIER -158.66 -124.8 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.243 -0.435 . . . . 74.14 110.891 179.871 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.617 ' HA ' ' HA ' ' A' ' 131' ' ' LYS . 0.5 OUTLIER -64.75 -4.67 4.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.45 . . . . 74.43 110.89 179.943 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . 0.919 ' CD1' ' HB2' ' A' ' 154' ' ' LYS . 14.2 m-30 -26.42 141.33 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.143 -0.48 . . . . 72.2 110.899 -179.854 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . 0.495 ' O ' ' OG ' ' A' ' 129' ' ' SER . 8.2 ptp180 -105.17 -46.04 4.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.158 -0.474 . . . . 74.54 110.843 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . 0.471 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 3.3 ptpp? -84.59 150.42 56.63 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.537 0.684 . . . . 71.14 110.92 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . 0.654 ' O ' ' CD1' ' A' ' 163' ' ' TRP . 54.0 Cg_endo -69.77 -29.49 23.72 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.692 2.261 . . . . 73.21 112.33 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 2.0 mp -71.96 6.85 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.197 -0.456 . . . . 74.44 111.169 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . 0.607 ' HB3' ' CD1' ' A' ' 157' ' ' TYR . 0.9 OUTLIER -76.99 -18.05 58.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.109 -0.496 . . . . 73.15 110.838 179.896 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' TRP . . . . . 0.654 ' CD1' ' O ' ' A' ' 160' ' ' PRO . 0.4 OUTLIER -109.21 12.83 24.73 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.25 -0.432 . . . . 73.12 110.955 -179.941 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 81.25 -44.08 2.99 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.706 -0.759 . . . . 71.24 112.488 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . 0.471 ' HB2' ' CD1' ' A' ' 163' ' ' TRP . . . -52.3 121.49 7.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.813 0.339 . . . . 62.44 111.095 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -64.67 122.14 16.15 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.208 -0.451 . . . . 65.0 111.126 179.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' SER . . . . . 0.52 ' C ' ' H ' ' A' ' 169' ' ' ALA . 0.4 OUTLIER 63.23 146.46 0.09 OUTLIER Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 121.673 0.749 . . . . 65.21 110.866 -179.786 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . 0.472 ' HB2' ' N ' ' A' ' 127' ' ' ILE . 53.5 Cg_endo -69.81 23.75 0.17 Allowed 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.664 2.243 . . . . 72.32 112.37 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . 0.52 ' H ' ' C ' ' A' ' 167' ' ' SER . . . -62.39 102.75 0.34 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.189 -0.46 . . . . 65.22 111.086 179.848 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 3.4 t -154.87 162.49 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.208 -0.451 . . . . 72.25 111.112 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' GLN . . . . . 0.668 ' OE1' ' HB3' ' A' ' 143' ' ' PRO . 1.6 tm0? -109.93 -83.05 0.57 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.156 -0.474 . . . . 64.23 110.925 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' SER . . . . . 0.742 ' OG ' ' O ' ' A' ' 143' ' ' PRO . 52.5 p -123.83 177.14 5.88 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.234 -0.439 . . . . 64.33 110.878 -179.858 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -140.45 168.0 20.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.136 -0.484 . . . . 74.23 110.893 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . 0.428 ' HD2' ' CE2' ' A' ' 140' ' ' TYR . 0.1 OUTLIER -134.66 152.64 51.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.112 -0.494 . . . . 75.32 110.866 -179.904 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.29 167.77 10.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.184 -0.462 . . . . 70.24 110.886 -179.911 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . 0.413 HD11 ' C ' ' A' ' 136' ' ' VAL . 2.6 mt -116.63 141.52 34.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.165 -0.47 . . . . 73.25 111.16 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 3.2 p -149.97 155.85 7.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.195 -0.457 . . . . 74.25 111.108 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 116.143 -0.48 . . . . 64.4 110.895 179.996 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.786 0.327 . . . . 72.31 110.881 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -144.29 109.28 5.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.225 -0.443 . . . . 65.25 110.833 -179.775 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 9.1 mmtp -95.34 36.08 1.27 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.164 -0.471 . . . . 75.54 110.931 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.9 t -62.68 -33.66 75.54 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.254 -0.43 . . . . 70.44 111.156 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 160.97 139.76 2.73 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.768 -0.729 . . . . 65.4 112.466 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.463 ' C ' ' HE1' ' A' ' 47' ' ' TRP . 7.2 p -82.46 136.72 34.86 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.867 0.365 . . . . 75.13 111.153 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.41 ' N ' ' HE1' ' A' ' 47' ' ' TRP . 2.5 tttt -126.93 136.76 52.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.236 -0.438 . . . . 74.3 110.907 179.878 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.537 HD13 ' CE1' ' A' ' 10' ' ' PHE . 16.5 tt -136.5 154.56 32.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.22 -0.445 . . . . 75.32 111.129 179.881 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.453 HG21 ' CE2' ' A' ' 11' ' ' TYR . 13.7 m -134.55 151.41 51.08 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.162 -0.472 . . . . 70.31 111.157 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.537 ' CE1' HD13 ' A' ' 8' ' ' ILE . 1.2 m-85 -140.45 129.59 23.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.454 . . . . 75.04 110.863 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.538 ' CG ' ' HA ' ' A' ' 16' ' ' PHE . 8.2 m-85 -115.36 133.15 56.3 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.154 -0.475 . . . . 74.34 110.942 -179.872 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.443 ' HG2' ' HB2' ' A' ' 36' ' ' ARG . 0.0 OUTLIER -56.6 -25.0 51.6 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.181 -0.463 . . . . 73.44 110.89 -179.974 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.405 ' HB2' ' O ' ' A' ' 17' ' ' GLN . 62.8 m-20 -126.38 155.8 41.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.159 -0.473 . . . . 74.41 110.91 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.401 ' HG2' ' HA ' ' A' ' 69' ' ' GLU . 11.2 mtmt -57.99 -173.58 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.206 -0.452 . . . . 74.4 110.899 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 23.9 m-20 43.95 34.41 0.92 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.244 -0.435 . . . . 64.25 110.867 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.538 ' HA ' ' CG ' ' A' ' 11' ' ' TYR . 3.1 m-85 48.05 62.9 2.27 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.21 -0.45 . . . . 74.45 110.829 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.405 ' O ' ' HB2' ' A' ' 13' ' ' ASP . 10.6 mt-30 -136.55 154.68 50.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.181 -0.463 . . . . 71.4 110.902 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 95.28 -152.94 20.6 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.711 -0.757 . . . . 72.53 112.485 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.449 ' O ' ' CD1' ' A' ' 34' ' ' LEU . 0.0 OUTLIER -65.21 81.13 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.844 0.354 . . . . 74.11 110.891 -179.867 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.447 ' HB2' ' CE1' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -79.97 128.92 34.04 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.189 -0.46 . . . . 70.31 110.835 -179.859 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.471 ' CD2' ' CD2' ' A' ' 30' ' ' PHE . 72.2 t80 -123.53 126.12 46.11 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.221 -0.445 . . . . 70.42 110.944 -179.854 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.411 ' OD2' ' CD ' ' A' ' 20' ' ' ARG . 1.1 m-20 -121.71 134.41 54.95 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.17 -0.468 . . . . 73.41 110.874 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 6.7 t -163.02 134.39 4.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.165 -0.471 . . . . 74.13 110.922 -179.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.405 ' HA ' ' HA ' ' A' ' 7' ' ' LYS . 5.0 p-10 -101.96 3.56 39.11 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.203 -0.453 . . . . 72.21 110.875 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 42.2 t -110.62 158.79 18.2 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.197 -0.456 . . . . 61.31 110.893 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -40.7 119.75 1.16 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.234 -0.439 . . . . 71.22 110.889 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.542 ' CB ' ' HB3' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -114.51 39.95 2.68 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.175 -0.466 . . . . 73.34 110.879 -179.896 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.571 ' O ' ' HB3' ' A' ' 82' ' ' SER . . . -50.86 -21.35 1.65 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.218 -0.447 . . . . 63.42 111.078 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 58.1 t0 -130.45 39.44 3.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.215 -0.448 . . . . 75.0 110.843 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.81 ' O ' ' CD2' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -81.09 15.27 1.94 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.213 -0.449 . . . . 74.33 110.885 -179.876 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.415 ' CG ' ' HG3' ' A' ' 53' ' ' PRO . 44.5 t60 -80.57 -35.02 34.86 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.157 -0.474 . . . . 73.3 110.867 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.7 t -62.96 -10.65 14.46 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.169 -0.469 . . . . 75.5 111.154 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -103.53 -27.29 12.45 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.231 -0.44 . . . . 75.4 110.92 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.449 ' CD1' ' O ' ' A' ' 19' ' ' ARG . 30.4 tp -138.17 138.73 38.88 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.137 -0.483 . . . . 75.24 110.905 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.5 m -104.11 -36.15 7.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.169 -0.469 . . . . 62.43 110.824 -179.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.443 ' HB2' ' HG2' ' A' ' 12' ' ' GLU . 0.7 OUTLIER -112.98 139.86 48.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.131 -0.486 . . . . 75.51 110.863 -179.92 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.476 ' SG ' ' CB ' ' A' ' 80' ' ' LEU . 2.2 m -121.41 69.87 0.92 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.193 -0.458 . . . . 73.35 110.93 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -72.04 -71.86 0.26 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.214 -0.448 . . . . 74.41 110.889 -179.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 4.9 p -104.54 134.61 47.43 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.165 -0.47 . . . . 61.22 110.867 -179.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.563 ' O ' ' HB2' ' A' ' 67' ' ' TYR . 20.8 mt -126.51 151.65 33.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.135 -0.484 . . . . 74.34 111.124 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.463 ' HD2' ' CE2' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -145.0 124.75 13.34 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.155 -0.475 . . . . 72.11 110.918 179.834 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.528 HG22 ' HB2' ' A' ' 47' ' ' TRP . 1.2 t -111.99 116.03 51.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.214 -0.448 . . . . 72.34 111.16 179.882 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -112.95 77.63 1.06 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.217 -0.447 . . . . 73.14 110.886 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.413 ' O ' ' HA ' ' A' ' 6' ' ' THR . . . 139.08 97.49 0.38 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.685 -0.769 . . . . 74.52 112.464 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 52.52 -179.9 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.729 -0.748 . . . . 63.55 112.476 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.481 HG21 ' HA ' ' A' ' 63' ' ' PRO . 1.4 m -74.52 170.05 16.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.75 0.31 . . . . 75.14 111.162 -179.886 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.528 ' HB2' HG22 ' A' ' 42' ' ' VAL . 4.5 m95 -142.92 130.03 20.77 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.245 -0.434 . . . . 75.14 110.887 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.633 ' O ' ' N ' ' A' ' 84' ' ' ARG . . . -87.36 127.09 35.2 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.225 -0.443 . . . . 75.44 111.115 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.68 ' O ' ' O ' ' A' ' 60' ' ' TYR . 34.5 m -129.7 131.71 66.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.263 -0.426 . . . . 75.02 111.127 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.708 ' HB3' ' HA ' ' A' ' 56' ' ' ALA . 58.8 m-85 -103.01 147.92 26.34 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.192 -0.458 . . . . 71.31 110.913 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.653 ' OE1' ' HB3' ' A' ' 57' ' ' TRP . 63.7 tt0 -50.19 -78.99 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.133 -0.485 . . . . 64.54 110.858 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.586 ' HB3' ' HB2' ' A' ' 55' ' ' PHE . 0.5 OUTLIER -91.04 138.01 26.22 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.618 0.723 . . . . 74.31 110.869 -179.908 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.712 ' HB3' ' HB3' ' A' ' 81' ' ' SER . 53.7 Cg_endo -69.82 145.98 58.43 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.655 2.237 . . . . 71.42 112.349 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 63.15 -7.67 0.15 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.239 -0.437 . . . . 73.25 110.917 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.614 ' CD1' ' O ' ' A' ' 53' ' ' PRO . 30.8 m-85 -113.72 -20.32 11.21 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.173 -0.467 . . . . 72.21 110.864 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.708 ' HA ' ' HB3' ' A' ' 50' ' ' TYR . . . 52.37 27.27 4.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.188 -0.46 . . . . 65.14 111.105 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . 0.653 ' HB3' ' OE1' ' A' ' 51' ' ' GLU . 0.0 OUTLIER -49.28 -164.36 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.225 -0.443 . . . . 74.45 110.888 -179.956 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.637 ' C ' ' O ' ' A' ' 57' ' ' TRP . 4.7 m-30 -12.55 101.39 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.182 -0.463 . . . . 74.22 110.951 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.432 ' HB2' ' O ' ' A' ' 149' ' ' GLN . 2.3 mpt? -60.74 155.93 18.1 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.17 -0.468 . . . . 75.21 110.856 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.68 ' O ' ' O ' ' A' ' 49' ' ' VAL . 2.7 t80 -170.74 120.63 0.56 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.202 -0.454 . . . . 75.32 110.972 -179.872 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.611 ' N ' ' CD1' ' A' ' 61' ' ' ILE . 1.0 OUTLIER -106.2 114.24 44.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.165 -0.47 . . . . 62.22 111.15 179.923 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -83.75 124.65 74.82 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.583 0.706 . . . . 75.24 110.933 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.481 ' HA ' HG21 ' A' ' 46' ' ' THR . 53.3 Cg_endo -69.75 -171.3 0.46 Allowed 'Trans proline' 0 C--O 1.231 0.141 0 C-N-CA 122.706 2.271 . . . . 74.34 112.295 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.79 163.2 15.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.189 -0.459 . . . . 73.42 110.908 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 114.35 -158.42 14.33 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.795 -0.717 . . . . 73.45 112.472 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -118.28 154.3 32.53 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.871 0.367 . . . . 74.04 110.868 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.563 ' HB2' ' O ' ' A' ' 40' ' ' ILE . 17.5 m-85 -140.94 84.14 13.47 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.691 0.758 . . . . 74.53 110.959 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.442 ' HD2' ' HG3' ' A' ' 72' ' ' ARG . 53.1 Cg_endo -69.84 2.79 3.25 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.643 2.229 . . . . 74.5 112.35 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.58 ' HB2' ' HG2' ' A' ' 72' ' ' ARG . 48.4 mt-10 -157.56 144.21 17.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.183 -0.462 . . . . 74.03 110.893 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.697 ' HA ' ' NE1' ' A' ' 73' ' ' TRP . 35.4 p90 -55.78 -25.97 43.74 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.127 -0.488 . . . . 71.25 110.896 -179.801 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -76.51 -15.81 59.79 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.154 -0.475 . . . . 65.24 110.931 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.58 ' HG2' ' HB2' ' A' ' 69' ' ' GLU . 32.0 mmt180 -67.27 -15.98 64.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.201 -0.454 . . . . 75.22 110.874 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . 0.745 ' N ' ' CD1' ' A' ' 73' ' ' TRP . 0.0 OUTLIER -125.14 21.88 7.99 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.202 -0.454 . . . . 74.52 110.939 -179.959 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' MET . . . . . 0.574 ' O ' ' C ' ' A' ' 75' ' ' GLY . 2.1 ttm 75.87 -16.4 0.6 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.258 -0.428 . . . . 72.3 110.88 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.574 ' C ' ' O ' ' A' ' 74' ' ' MET . . . 21.93 57.5 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.762 -0.732 . . . . 71.52 112.496 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.579 HD11 ' N ' ' A' ' 77' ' ' ASN . 0.0 OUTLIER -56.48 -10.93 1.07 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.835 0.35 . . . . 73.43 110.927 -179.935 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.579 ' N ' HD11 ' A' ' 76' ' ' LEU . 37.0 t-20 -149.33 -48.67 0.14 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.219 -0.446 . . . . 74.32 110.853 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.556 ' CB ' ' O ' ' A' ' 77' ' ' ASN . 5.2 t0 87.22 -7.73 0.64 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.192 -0.458 . . . . 72.4 110.901 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.465 ' HG2' ' O ' ' A' ' 79' ' ' ARG . 8.7 ttt85 -85.39 50.15 1.9 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.178 -0.464 . . . . 65.42 110.874 -179.897 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.545 ' CD1' HG11 ' A' ' 49' ' ' VAL . 0.1 OUTLIER -59.36 130.65 47.95 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.195 -0.457 . . . . 72.53 110.937 179.998 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.712 ' HB3' ' HB3' ' A' ' 53' ' ' PRO . 12.3 m -151.6 -111.77 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.182 -0.463 . . . . 73.43 110.849 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.571 ' HB3' ' O ' ' A' ' 28' ' ' ALA . 1.0 OUTLIER -47.87 97.12 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.155 -0.475 . . . . 74.04 110.851 -179.802 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . 0.571 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 7.6 p -123.89 135.23 53.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.167 -0.469 . . . . 71.25 110.858 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.633 ' N ' ' O ' ' A' ' 48' ' ' ALA . 0.9 OUTLIER -115.12 154.82 28.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.154 -0.475 . . . . 74.32 110.89 -179.9 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.455 ' HB1' ' OG1' ' A' ' 6' ' ' THR . . . -68.17 130.06 41.77 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.191 -0.458 . . . . 73.41 111.048 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.501 HG23 ' HB3' ' A' ' 48' ' ' ALA . 37.7 t -115.03 133.34 61.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.208 -0.451 . . . . 73.21 111.179 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . 0.451 ' O ' ' C ' ' A' ' 88' ' ' LEU . 39.9 m80 -111.26 108.48 18.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.202 -0.454 . . . . 74.3 110.87 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.451 ' C ' ' O ' ' A' ' 87' ' ' HIS . 0.0 OUTLIER -33.4 147.04 0.1 OUTLIER Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.566 0.698 . . . . 74.34 110.943 -179.96 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.5 ' HB3' ' H ' ' A' ' 136' ' ' VAL . 53.6 Cg_endo -69.78 95.52 0.56 Allowed 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.68 2.253 . . . . 62.02 112.328 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -88.89 -174.87 4.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.225 -0.443 . . . . 72.12 110.844 -179.847 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 64.0 108.48 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.766 -0.731 . . . . 65.35 112.525 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 69.41 -84.34 0.26 Allowed Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.695 -0.764 . . . . 74.44 112.481 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.421 ' O ' ' HG2' ' A' ' 134' ' ' GLU . 19.5 pt20 178.74 -136.79 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.842 0.353 . . . . 75.4 110.945 -179.863 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.647 ' HA ' ' HG2' ' A' ' 134' ' ' GLU . 0.0 OUTLIER -113.86 103.2 10.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.202 -0.454 . . . . 74.43 110.96 -179.877 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 29.1 tptt -107.41 128.79 54.79 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.127 -0.488 . . . . 74.33 110.896 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -151.08 133.97 6.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.194 -0.457 . . . . 74.32 111.136 179.828 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.411 ' HB2' ' O ' ' A' ' 131' ' ' LYS . 0.3 OUTLIER -105.76 126.61 52.37 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.142 -0.481 . . . . 74.35 110.911 179.948 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 13.0 mt -105.08 138.51 29.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.186 -0.461 . . . . 73.01 111.103 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.657 ' HB2' ' HB2' ' A' ' 129' ' ' SER . 46.7 m-85 -125.75 139.9 53.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.166 -0.47 . . . . 71.13 110.87 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 79.0 tt0 -71.89 -70.8 0.31 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.119 -0.491 . . . . 73.12 110.875 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 41.4 mttt -87.9 171.02 10.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.157 -0.474 . . . . 71.52 110.858 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -75.47 155.05 46.58 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.801 -0.714 . . . . 72.4 112.481 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.596 ' HA ' ' HB2' ' A' ' 158' ' ' ARG . 16.1 t0 68.03 45.26 1.35 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.85 0.357 . . . . 64.31 110.863 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.429 ' HA ' ' CD1' ' A' ' 99' ' ' PHE . 0.7 OUTLIER 50.7 29.17 4.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.183 -0.462 . . . . 75.01 110.89 -179.905 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 71.2 m -96.82 159.06 15.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.149 -0.478 . . . . 74.05 110.911 -179.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 87.1 -145.06 19.64 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.774 -0.727 . . . . 75.13 112.493 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 3.8 tp-100 -87.66 125.01 34.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.8 0.333 . . . . 72.15 110.906 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' MET . . . . . 0.478 ' HB2' ' CE1' ' A' ' 99' ' ' PHE . 23.4 ttp -107.64 144.35 34.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.198 -0.455 . . . . 74.51 110.889 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -149.51 135.5 18.85 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.275 -0.421 . . . . 75.4 110.884 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -114.93 102.68 10.19 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.102 -0.499 . . . . 63.5 110.909 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 14.6 t -114.07 144.19 43.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 74.32 111.102 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.479 ' O ' ' OG1' ' A' ' 112' ' ' THR . 0.8 OUTLIER -124.4 36.35 4.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.252 -0.431 . . . . 63.44 111.135 -179.988 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -143.84 -172.52 3.76 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.232 -0.44 . . . . 73.33 110.867 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -86.31 162.54 18.18 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.112 -0.494 . . . . 74.43 110.88 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . 0.401 ' HB3' ' CE2' ' A' ' 173' ' ' PHE . 0.8 OUTLIER -157.25 120.76 2.21 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-O 121.585 0.707 . . . . 73.52 110.92 -179.918 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.596 ' O ' ' OG ' ' A' ' 172' ' ' SER . 54.1 Cg_endo -69.73 -33.5 16.6 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.642 2.228 . . . . 65.24 112.401 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.66 ' HB3' ' CB ' ' A' ' 120' ' ' GLU . 0.2 OUTLIER -138.68 103.57 4.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.22 -0.445 . . . . 75.12 110.846 -179.862 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.664 ' HB ' ' O ' ' A' ' 171' ' ' GLN . 4.9 tt -57.91 -29.87 36.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.135 -0.484 . . . . 73.42 111.148 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' MET . . . . . 0.594 ' O ' ' HA ' ' A' ' 123' ' ' HIS . 2.8 ttt -87.89 -45.62 10.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.165 -0.47 . . . . 72.45 110.864 179.873 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.66 ' CB ' ' HB3' ' A' ' 117' ' ' SER . 6.7 tp10 -62.86 -13.5 34.7 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.235 -0.439 . . . . 75.24 110.89 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 7.8 tp-100 -114.64 -50.09 2.8 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.186 -0.461 . . . . 74.4 110.963 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . 0.567 ' HB2' ' O ' ' A' ' 118' ' ' ILE . 96.1 m-85 -100.07 -20.64 15.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.165 -0.47 . . . . 73.15 110.881 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . 0.594 ' HA ' ' O ' ' A' ' 119' ' ' MET . 13.4 m-70 76.42 22.07 1.3 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.17 -0.468 . . . . 74.43 110.888 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.485 ' O ' HG22 ' A' ' 118' ' ' ILE . 3.5 mtt -97.67 118.74 34.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.174 -0.466 . . . . 74.23 110.856 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 5.8 ptp180 -79.58 -45.79 18.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.203 -0.453 . . . . 74.02 110.863 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.436 ' HB3' ' HG2' ' A' ' 168' ' ' PRO . 19.9 mt-10 -140.45 117.36 11.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.181 -0.463 . . . . 75.24 110.836 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.426 ' O ' ' HB3' ' A' ' 168' ' ' PRO . 3.2 mm -73.52 92.49 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.128 -0.487 . . . . 74.12 111.112 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -64.89 -34.0 77.35 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.156 -0.475 . . . . 72.13 110.868 179.874 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.657 ' HB2' ' HB2' ' A' ' 99' ' ' PHE . 4.7 m -133.97 155.03 50.68 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.207 -0.452 . . . . 74.32 110.845 -179.802 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . 0.663 ' O ' ' O ' ' A' ' 155' ' ' LYS . 0.1 OUTLIER -156.59 123.04 5.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.112 -0.494 . . . . 65.33 110.844 -179.951 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.618 ' HA ' ' HA ' ' A' ' 156' ' ' GLU . 1.9 mtpt -108.22 154.21 22.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.16 -0.473 . . . . 75.21 110.885 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.484 ' CB ' ' O ' ' A' ' 131' ' ' LYS . 8.3 t 83.45 165.03 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.215 -0.448 . . . . 74.31 111.136 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.477 ' CD1' ' O ' ' A' ' 154' ' ' LYS . 0.0 OUTLIER -178.49 123.69 0.1 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.125 -0.489 . . . . 55.22 110.905 179.977 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.647 ' HG2' ' HA ' ' A' ' 94' ' ' TYR . 0.1 OUTLIER -98.64 164.41 12.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.21 -0.45 . . . . 73.53 110.856 179.928 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . 0.557 ' C ' ' O ' ' A' ' 134' ' ' GLU . . . -23.06 -63.1 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.736 -0.745 . . . . 71.03 112.487 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.7 ' HA ' HD13 ' A' ' 152' ' ' LEU . 3.1 t -144.44 146.34 20.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.804 0.335 . . . . 74.14 111.126 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . 0.607 ' HB3' ' HB3' ' A' ' 152' ' ' LEU . 6.3 t-105 -143.19 149.56 38.17 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.164 -0.471 . . . . 74.1 110.945 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 3.5 mm -114.59 134.73 56.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.285 -0.416 . . . . 73.13 111.161 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.456 ' CB ' ' HB2' ' A' ' 150' ' ' TYR . 0.1 OUTLIER -117.23 142.65 46.79 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.204 -0.453 . . . . 73.22 110.846 -179.989 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . 0.506 ' CE2' ' HA ' ' A' ' 145' ' ' TYR . 3.9 m-85 -120.79 130.4 53.98 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.14 -0.482 . . . . 73.51 110.932 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . 0.437 ' O ' ' HB2' ' A' ' 171' ' ' GLN . 2.9 tt0 -61.77 -47.62 84.35 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.121 -0.49 . . . . 75.41 110.885 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 1.042 ' O ' ' HB2' ' A' ' 172' ' ' SER . 7.1 mp -97.41 152.56 38.29 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.588 0.709 . . . . 74.51 110.922 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . 0.689 ' HB3' ' OE1' ' A' ' 171' ' ' GLN . 54.3 Cg_endo -69.68 44.76 0.42 Allowed 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.709 2.273 . . . . 71.21 112.379 179.854 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . 1.084 ' O ' ' N ' ' A' ' 146' ' ' ARG . 0.0 OUTLIER 179.06 106.62 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.228 -0.442 . . . . 74.34 110.885 -179.989 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . 0.668 ' C ' ' O ' ' A' ' 144' ' ' ASN . 0.0 OUTLIER -3.51 51.25 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.204 -0.453 . . . . 72.24 110.938 -179.948 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . 1.084 ' N ' ' O ' ' A' ' 144' ' ' ASN . 36.7 mtt180 -131.47 163.27 28.33 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.118 -0.492 . . . . 72.03 110.881 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 82.8 -162.69 41.34 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.75 -0.738 . . . . 73.5 112.472 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -84.97 148.96 25.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.753 0.311 . . . . 74.33 110.84 -179.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . 0.432 ' O ' ' HB2' ' A' ' 59' ' ' MET . 19.3 mt-30 -95.73 135.09 37.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.159 -0.473 . . . . 72.21 110.901 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . 0.456 ' HB2' ' CB ' ' A' ' 139' ' ' PHE . 41.6 m-85 -109.95 127.06 54.54 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.164 -0.471 . . . . 73.14 110.856 -179.841 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.49 ' CA ' HD12 ' A' ' 61' ' ' ILE . 6.8 tp -83.01 120.89 26.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.088 -0.505 . . . . 61.33 110.947 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.7 HD13 ' HA ' ' A' ' 136' ' ' VAL . 0.0 OUTLIER -50.46 133.11 25.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.2 -0.454 . . . . 73.55 110.962 179.887 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -162.09 23.16 0.11 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.216 -0.447 . . . . 52.54 110.868 179.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.82 ' HB2' ' CD1' ' A' ' 157' ' ' TYR . 3.2 ptmt -119.97 -174.02 2.67 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.191 -0.459 . . . . 74.4 110.91 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.671 ' HG3' ' O ' ' A' ' 154' ' ' LYS . 1.7 mptt -158.4 -119.43 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.249 -0.432 . . . . 75.35 110.934 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.618 ' HA ' ' HA ' ' A' ' 131' ' ' LYS . 1.2 tm-20 -72.47 0.74 9.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.201 -0.454 . . . . 73.5 110.931 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . 0.82 ' CD1' ' HB2' ' A' ' 154' ' ' LYS . 12.9 m-30 -34.97 154.11 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.106 -0.497 . . . . 75.42 110.929 -179.868 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . 0.596 ' HB2' ' HA ' ' A' ' 103' ' ' ASP . 8.0 ptp180 -116.7 -44.22 2.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.074 -0.512 . . . . 75.43 110.883 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . 0.4 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 3.1 ptpp? -86.25 150.13 51.3 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.6 0.714 . . . . 73.44 110.854 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . 0.41 ' HG2' HD11 ' A' ' 161' ' ' ILE . 54.2 Cg_endo -69.78 -23.49 30.66 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.64 2.227 . . . . 74.12 112.377 179.86 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.457 HD11 ' H ' ' A' ' 161' ' ' ILE . 3.5 mp -78.71 4.09 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.212 -0.449 . . . . 73.14 111.138 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . 0.536 ' HB3' ' CD1' ' A' ' 157' ' ' TYR . 1.0 OUTLIER -72.96 -16.91 61.52 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.19 -0.459 . . . . 72.55 110.819 179.853 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' TRP . . . . . 0.673 ' CD1' ' N ' ' A' ' 163' ' ' TRP . 0.0 OUTLIER -115.82 13.54 16.11 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.217 -0.447 . . . . 75.45 110.864 -179.943 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 88.64 -31.88 4.74 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.762 -0.732 . . . . 75.03 112.489 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . 0.412 ' HB1' ' CE3' ' A' ' 163' ' ' TRP . . . -51.53 118.55 3.4 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.783 0.325 . . . . 62.41 111.1 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -50.73 -31.5 16.81 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.248 -0.433 . . . . 72.23 111.114 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' SER . . . . . 0.53 ' C ' ' H ' ' A' ' 169' ' ' ALA . 0.3 OUTLIER -149.98 156.44 38.01 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.701 0.763 . . . . 74.24 110.835 -179.826 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . 0.436 ' HG2' ' HB3' ' A' ' 126' ' ' GLU . 53.9 Cg_endo -69.73 24.95 0.17 Allowed 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.727 2.285 . . . . 75.24 112.312 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . 0.53 ' H ' ' C ' ' A' ' 167' ' ' SER . . . -65.55 100.93 0.55 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.265 -0.425 . . . . 71.3 111.082 179.91 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 1.9 t -154.42 165.35 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.213 -0.449 . . . . 74.44 111.12 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' GLN . . . . . 0.689 ' OE1' ' HB3' ' A' ' 143' ' ' PRO . 2.2 mm-40 -147.53 -101.2 0.09 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.128 -0.487 . . . . 75.44 110.876 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' SER . . . . . 1.042 ' HB2' ' O ' ' A' ' 142' ' ' LEU . 0.3 OUTLIER -56.31 143.73 33.03 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.196 -0.456 . . . . 73.43 110.902 -179.8 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . 0.401 ' CE2' ' HB3' ' A' ' 115' ' ' CYS . 31.2 p90 -152.1 132.79 13.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.184 -0.462 . . . . 74.21 110.92 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.51 165.47 23.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.186 -0.461 . . . . 75.34 110.861 -179.878 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.12 -161.28 0.82 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.209 -0.45 . . . . 74.2 110.877 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . 0.524 ' CD1' ' CG1' ' A' ' 136' ' ' VAL . 3.5 mt -139.3 138.79 40.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 63.24 111.144 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 5.0 p -145.34 152.34 14.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.188 -0.46 . . . . 72.0 111.106 179.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.149 -0.478 . . . . 75.34 110.896 -179.961 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.7 mmt . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.76 0.315 . . . . 74.34 110.859 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.1 m -159.4 -171.5 3.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.212 -0.449 . . . . 65.5 110.892 -179.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.5 mmmp? -77.88 60.82 2.38 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.156 -0.475 . . . . 72.21 110.886 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.7 t -130.88 77.51 1.79 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.224 -0.444 . . . . 63.54 111.19 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -177.35 47.27 0.1 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.714 -0.755 . . . . 72.1 112.497 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.481 ' C ' ' HE1' ' A' ' 47' ' ' TRP . 8.0 p -82.98 135.87 34.73 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.867 0.365 . . . . 71.25 111.155 -179.862 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 3.2 tttt -123.94 136.17 54.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.189 -0.459 . . . . 70.14 110.9 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.613 HG23 ' CZ ' ' A' ' 10' ' ' PHE . 16.2 tt -137.47 150.89 25.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.223 -0.444 . . . . 75.21 111.151 179.861 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.449 HG21 ' CE2' ' A' ' 11' ' ' TYR . 10.1 m -130.21 146.08 51.8 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.196 -0.456 . . . . 72.34 111.163 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.613 ' CZ ' HG23 ' A' ' 8' ' ' ILE . 1.5 m-85 -132.33 129.1 39.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.205 -0.452 . . . . 75.31 110.865 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.531 ' CG ' ' HA ' ' A' ' 16' ' ' PHE . 18.4 m-85 -115.65 132.13 56.73 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.135 -0.484 . . . . 73.14 110.974 -179.894 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.465 ' HG2' ' HB2' ' A' ' 36' ' ' ARG . 0.0 OUTLIER -58.6 -24.36 60.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.123 -0.49 . . . . 74.33 110.891 -179.976 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 64.9 m-20 -127.63 152.73 47.3 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.113 -0.494 . . . . 71.03 110.89 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.413 ' N ' ' HB3' ' A' ' 38' ' ' ASN . 32.5 mtmt -56.09 -175.25 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 75.12 110.922 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 25.7 m-20 46.51 33.6 2.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.258 -0.428 . . . . 73.53 110.897 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.531 ' HA ' ' CG ' ' A' ' 11' ' ' TYR . 3.4 m-85 48.91 58.9 4.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.147 -0.478 . . . . 75.01 110.842 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -133.49 157.78 44.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 73.31 110.905 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 94.25 -149.88 19.57 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.679 -0.772 . . . . 72.33 112.474 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.459 ' O ' HD13 ' A' ' 34' ' ' LEU . 0.1 OUTLIER -69.06 81.59 0.32 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.833 0.349 . . . . 74.24 110.881 -179.832 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.47 ' HB2' ' CE1' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -79.63 129.6 34.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.201 -0.454 . . . . 72.21 110.874 -179.898 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.449 ' O ' ' HA ' ' A' ' 9' ' ' THR . 88.8 t80 -125.54 125.32 43.03 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.204 -0.453 . . . . 73.42 110.899 -179.842 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.426 ' CG ' HG23 ' A' ' 9' ' ' THR . 1.4 m-20 -119.9 134.47 55.23 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.121 -0.491 . . . . 62.12 110.895 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 11.3 t -162.98 135.19 5.31 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.158 -0.474 . . . . 71.1 110.915 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -102.66 -5.19 24.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.188 -0.46 . . . . 74.34 110.928 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.49 ' O ' ' SG ' ' A' ' 27' ' ' CYS . 20.0 t -102.54 165.08 11.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.14 -0.482 . . . . 73.51 110.851 -179.908 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -55.26 120.95 7.83 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.155 -0.475 . . . . 72.03 110.878 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.591 ' HB2' ' HB3' ' A' ' 30' ' ' PHE . 0.2 OUTLIER -116.39 49.97 1.09 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.225 -0.443 . . . . 62.52 110.924 -179.93 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.525 ' O ' ' HA ' ' A' ' 82' ' ' SER . . . -46.86 -22.23 0.29 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.191 -0.458 . . . . 74.42 111.096 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 63.3 t0 -129.19 42.76 3.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.189 -0.46 . . . . 64.41 110.85 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.775 ' O ' ' CD2' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -79.13 15.82 1.08 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.192 -0.458 . . . . 64.23 110.887 -179.936 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.44 ' HB2' ' HB3' ' A' ' 81' ' ' SER . 27.1 t60 -77.2 -45.67 25.84 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.161 -0.472 . . . . 75.45 110.841 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.429 HG21 ' CD2' ' A' ' 33' ' ' TYR . 8.9 t -55.69 -14.5 2.27 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.191 -0.458 . . . . 70.33 111.175 -179.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.493 ' CD1' ' HA ' ' A' ' 30' ' ' PHE . 11.4 m-85 -96.1 -30.26 13.64 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.197 -0.456 . . . . 72.12 110.865 -179.907 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.459 HD13 ' O ' ' A' ' 19' ' ' ARG . 19.3 tp -143.5 143.12 31.42 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.178 -0.464 . . . . 74.21 110.94 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.2 m -108.52 -34.73 6.66 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.185 -0.461 . . . . 73.13 110.883 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.488 ' NH2' HD22 ' A' ' 38' ' ' ASN . 1.8 mtp85 -115.89 139.8 49.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.13 -0.486 . . . . 75.44 110.86 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.603 ' HB3' ' HB2' ' A' ' 80' ' ' LEU . 5.2 p -117.28 61.31 0.75 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.144 -0.48 . . . . 74.33 110.894 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.488 HD22 ' NH2' ' A' ' 36' ' ' ARG . 3.0 m120 -60.26 -69.62 0.21 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.133 -0.485 . . . . 73.14 110.869 -179.874 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 5.0 p -110.67 127.28 55.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.18 -0.463 . . . . 73.13 110.873 -179.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.652 ' O ' ' HB2' ' A' ' 67' ' ' TYR . 29.9 mt -121.01 148.49 24.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.134 -0.485 . . . . 72.32 111.126 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.484 ' N ' HG23 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -142.27 121.99 13.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 75.24 110.902 179.823 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.586 HG22 ' HB2' ' A' ' 47' ' ' TRP . 1.5 t -106.64 115.27 47.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.22 -0.445 . . . . 70.34 111.114 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -111.58 79.93 1.26 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.165 -0.47 . . . . 63.43 110.895 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.447 ' O ' ' HA ' ' A' ' 6' ' ' THR . . . 132.13 100.63 0.8 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.75 -0.738 . . . . 55.0 112.531 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 53.47 178.36 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.724 -0.75 . . . . 64.44 112.467 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.5 HG21 ' HA ' ' A' ' 63' ' ' PRO . 0.8 OUTLIER -76.74 168.06 20.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.774 0.321 . . . . 73.34 111.11 -179.831 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.586 ' HB2' HG22 ' A' ' 42' ' ' VAL . 3.6 m95 -142.87 129.42 20.19 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.191 -0.459 . . . . 75.33 110.897 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.603 ' O ' ' N ' ' A' ' 84' ' ' ARG . . . -92.69 126.84 37.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.191 -0.459 . . . . 61.14 111.086 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.488 HG11 HD12 ' A' ' 80' ' ' LEU . 15.1 m -124.49 145.73 31.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.231 -0.44 . . . . 62.54 111.105 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.916 ' HB3' ' CB ' ' A' ' 56' ' ' ALA . 6.8 m-85 -119.31 141.35 49.07 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.125 -0.489 . . . . 70.24 110.925 -179.905 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.549 ' HG2' ' N ' ' A' ' 52' ' ' ARG . 0.3 OUTLIER -48.87 -82.18 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.166 -0.47 . . . . 74.54 110.903 179.99 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.775 ' H ' ' HA ' ' A' ' 56' ' ' ALA . 2.1 mtp180 -82.92 137.58 43.48 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.607 0.718 . . . . 75.02 110.88 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.698 ' HA ' ' OG ' ' A' ' 82' ' ' SER . 54.1 Cg_endo -69.76 137.53 35.69 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.703 2.269 . . . . 74.24 112.33 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.462 ' C ' ' CD2' ' A' ' 55' ' ' PHE . 0.9 OUTLIER 67.16 -6.27 0.61 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.241 -0.436 . . . . 75.34 110.904 179.994 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.509 ' H ' ' C ' ' A' ' 53' ' ' PRO . 0.0 OUTLIER -140.22 -74.91 0.34 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.165 -0.47 . . . . 73.44 110.905 -179.962 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.916 ' CB ' ' HB3' ' A' ' 50' ' ' TYR . . . 45.16 78.91 0.05 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.117 -0.492 . . . . 60.14 111.128 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . 0.557 ' O ' ' CD2' ' A' ' 58' ' ' TYR . 24.9 t-105 -64.18 31.55 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.279 -0.418 . . . . 74.11 110.939 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.648 ' H ' ' C ' ' A' ' 56' ' ' ALA . 1.9 m-30 -162.57 116.75 1.76 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.189 -0.46 . . . . 74.54 110.929 -179.848 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.518 ' HB2' ' HA ' ' A' ' 150' ' ' TYR . 1.8 mpt? -81.9 143.51 31.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.085 -0.507 . . . . 73.41 110.884 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.476 ' O ' ' O ' ' A' ' 49' ' ' VAL . 3.1 t80 -156.95 107.15 2.28 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.223 -0.444 . . . . 74.13 110.963 -179.861 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.577 ' N ' ' CD1' ' A' ' 61' ' ' ILE . 1.3 mp -94.57 116.66 36.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.096 -0.502 . . . . 75.41 111.102 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -82.73 130.17 59.29 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.569 0.699 . . . . 75.34 110.92 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.5 ' HA ' HG21 ' A' ' 46' ' ' THR . 53.7 Cg_endo -69.71 -173.64 0.75 Allowed 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.645 2.23 . . . . 72.21 112.38 179.869 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.21 162.17 16.04 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.221 -0.445 . . . . 74.2 110.903 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 112.01 -168.69 12.81 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.752 -0.737 . . . . 72.04 112.512 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 8.7 mp0 -107.07 152.97 23.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.842 0.353 . . . . 72.3 110.898 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.652 ' HB2' ' O ' ' A' ' 40' ' ' ILE . 12.9 m-85 -141.84 84.72 11.76 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.75 0.785 . . . . 74.2 110.914 -179.864 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.45 ' HD2' ' HG3' ' A' ' 72' ' ' ARG . 53.7 Cg_endo -69.75 0.48 5.58 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.693 2.262 . . . . 74.43 112.341 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.499 ' HB2' ' HG2' ' A' ' 72' ' ' ARG . 48.6 mt-10 -155.37 142.49 19.26 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.231 -0.441 . . . . 71.24 110.88 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.696 ' HA ' ' NE1' ' A' ' 73' ' ' TRP . 28.4 p90 -55.7 -20.27 13.75 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.169 -0.468 . . . . 73.12 110.956 -179.887 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -80.41 -16.93 53.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.121 -0.49 . . . . 73.24 110.908 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.499 ' HG2' ' HB2' ' A' ' 69' ' ' GLU . 31.3 mmt180 -69.49 -8.76 49.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.229 -0.442 . . . . 72.53 110.876 -179.915 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . 0.708 ' N ' ' CD1' ' A' ' 73' ' ' TRP . 0.0 OUTLIER -135.35 16.79 3.41 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.208 -0.451 . . . . 72.11 110.893 -179.95 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' MET . . . . . 0.411 ' C ' ' O ' ' A' ' 73' ' ' TRP . 15.8 mtm 36.95 43.95 0.33 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.266 -0.425 . . . . 75.0 110.896 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -56.51 119.14 13.61 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.741 -0.742 . . . . 64.23 112.451 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.58 HD22 ' HB2' ' A' ' 77' ' ' ASN . 0.0 OUTLIER -68.69 -8.7 44.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.792 0.33 . . . . 74.33 110.913 -179.911 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.58 ' HB2' HD22 ' A' ' 76' ' ' LEU . 12.8 t-20 -152.77 138.15 17.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.189 -0.46 . . . . 73.34 110.884 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -89.67 13.15 14.9 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.185 -0.461 . . . . 74.31 110.85 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.412 ' HD3' ' HA ' ' A' ' 52' ' ' ARG . 1.2 ttm-85 -110.95 81.64 1.46 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.217 -0.447 . . . . 74.13 110.85 -179.869 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.603 ' HB2' ' HB3' ' A' ' 37' ' ' CYS . 0.0 OUTLIER -83.77 134.65 34.72 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.198 -0.456 . . . . 74.43 110.935 179.993 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.638 ' HB3' ' HB3' ' A' ' 53' ' ' PRO . 1.3 m -150.38 -123.79 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.173 -0.467 . . . . 72.24 110.832 -179.907 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.698 ' OG ' ' HA ' ' A' ' 53' ' ' PRO . 0.0 OUTLIER -34.28 105.79 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.172 -0.467 . . . . 71.5 110.841 -179.826 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . 0.491 ' HA ' ' O ' ' A' ' 48' ' ' ALA . 31.7 p -128.2 132.4 48.83 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.149 -0.478 . . . . 75.45 110.89 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.603 ' N ' ' O ' ' A' ' 48' ' ' ALA . 10.7 mmt85 -116.61 149.39 39.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.188 -0.46 . . . . 74.34 110.918 -179.894 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -66.33 129.37 39.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.253 -0.431 . . . . 50.1 111.094 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.432 ' CG2' ' CB ' ' A' ' 48' ' ' ALA . 76.2 t -114.76 135.65 53.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.211 -0.45 . . . . 73.32 111.167 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . 0.417 ' O ' ' CG2' ' A' ' 136' ' ' VAL . 6.1 m-70 -111.8 113.03 25.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 74.22 110.836 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.443 ' H ' HD22 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -38.07 141.12 0.53 Allowed Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.587 0.708 . . . . 63.1 110.939 -179.966 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.566 ' HB3' ' H ' ' A' ' 136' ' ' VAL . 53.6 Cg_endo -69.79 79.95 0.92 Allowed 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.654 2.236 . . . . 74.55 112.365 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -91.55 -177.15 4.72 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.174 -0.467 . . . . 71.53 110.855 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 61.15 38.87 96.31 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.717 -0.754 . . . . 71.0 112.487 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.415 ' O ' ' C ' ' A' ' 93' ' ' GLN . . . 134.14 33.55 0.32 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.728 -0.749 . . . . 64.33 112.48 -179.914 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.604 ' O ' ' HG3' ' A' ' 134' ' ' GLU . 21.6 pt20 37.26 -131.38 0.13 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.846 0.355 . . . . 73.13 110.89 -179.874 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.562 ' HA ' ' HG3' ' A' ' 134' ' ' GLU . 0.1 OUTLIER -117.37 112.1 20.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.45 . . . . 74.41 110.9 -179.831 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.557 ' H ' ' CG ' ' A' ' 134' ' ' GLU . 31.8 tptt -119.16 128.66 54.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.134 -0.484 . . . . 74.24 110.886 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.44 HG13 ' CZ3' ' A' ' 137' ' ' TRP . 0.0 OUTLIER -152.26 139.54 13.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.24 -0.436 . . . . 71.44 111.111 179.865 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -105.85 122.8 46.84 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.159 -0.473 . . . . 72.24 110.947 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 2.6 mt -101.93 130.61 51.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.232 -0.44 . . . . 72.43 111.127 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.687 ' HB2' ' HB2' ' A' ' 129' ' ' SER . 43.9 m-85 -118.46 147.84 43.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.18 -0.463 . . . . 73.32 110.87 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 56.5 tt0 -81.69 -56.15 4.18 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.13 -0.486 . . . . 74.41 110.906 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 45.9 mttt -101.92 172.32 7.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.134 -0.485 . . . . 75.02 110.921 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.411 ' HA2' ' OG ' ' A' ' 129' ' ' SER . . . -71.52 153.09 50.19 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.703 -0.761 . . . . 75.34 112.467 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.449 ' HA ' ' HB2' ' A' ' 158' ' ' ARG . 41.0 t0 65.42 46.22 2.61 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.894 0.378 . . . . 64.52 110.892 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.576 ' N ' ' CD2' ' A' ' 104' ' ' PHE . 0.2 OUTLIER 47.66 32.1 2.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.184 -0.462 . . . . 73.31 110.864 -179.898 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 57.7 m -94.03 164.04 13.24 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.179 -0.464 . . . . 74.14 110.879 -179.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 80.57 -136.29 16.31 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.763 -0.732 . . . . 72.42 112.52 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -90.89 121.07 32.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.784 0.325 . . . . 74.13 110.895 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 4.6 ttp -106.57 134.97 48.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.218 -0.446 . . . . 65.01 110.929 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -141.39 136.67 31.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.252 -0.431 . . . . 72.35 110.952 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -117.3 111.55 19.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.115 -0.493 . . . . 74.02 110.847 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 11.8 t -119.96 147.62 44.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.195 -0.457 . . . . 74.15 111.185 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.47 ' O ' ' OG1' ' A' ' 112' ' ' THR . 0.6 OUTLIER -128.38 27.73 5.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.242 -0.436 . . . . 65.44 111.153 179.982 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -141.06 156.64 45.97 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.249 -0.432 . . . . 74.24 110.933 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -50.32 162.35 0.23 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.179 -0.464 . . . . 73.25 110.881 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . 0.531 ' O ' ' HB2' ' A' ' 172' ' ' SER . 52.6 t -153.18 120.31 3.0 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.647 0.737 . . . . 75.04 110.816 -179.884 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.41 ' O ' ' CA ' ' A' ' 143' ' ' PRO . 53.3 Cg_endo -69.83 -30.85 21.33 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.708 2.272 . . . . 71.13 112.315 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.643 ' HB3' ' CB ' ' A' ' 120' ' ' GLU . 0.1 OUTLIER -149.58 112.8 4.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.254 -0.43 . . . . 71.41 110.828 -179.836 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.594 ' HB ' ' O ' ' A' ' 171' ' ' GLN . 3.9 tt -64.54 -31.6 54.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.129 -0.487 . . . . 75.14 111.116 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' MET . . . . . 0.64 ' O ' ' HA ' ' A' ' 123' ' ' HIS . 0.0 OUTLIER -86.33 -39.2 16.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.206 -0.452 . . . . 73.52 110.928 179.807 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.643 ' CB ' ' HB3' ' A' ' 117' ' ' SER . 4.7 tp10 -70.79 -13.88 62.21 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.212 -0.449 . . . . 71.13 110.924 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 25.2 tp60 -114.72 -46.26 2.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.114 -0.493 . . . . 73.32 110.926 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . 0.474 ' HB2' ' O ' ' A' ' 118' ' ' ILE . 74.5 m-85 -106.98 -19.08 13.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.189 -0.459 . . . . 73.41 110.9 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . 0.64 ' HA ' ' O ' ' A' ' 119' ' ' MET . 30.4 m-70 72.35 26.87 2.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.11 -0.496 . . . . 75.44 110.8 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.437 ' O ' HG22 ' A' ' 118' ' ' ILE . 7.6 mtt -108.93 74.76 0.92 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.243 -0.435 . . . . 72.05 110.878 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 1.7 ptp85 -49.96 -26.31 4.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.229 -0.442 . . . . 75.4 110.849 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.404 ' HG2' ' HA ' ' A' ' 169' ' ' ALA . 24.7 mt-10 -144.01 130.38 19.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.149 -0.478 . . . . 63.32 110.878 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.475 ' O ' ' HB3' ' A' ' 168' ' ' PRO . 4.0 mm -96.45 104.76 16.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.072 -0.513 . . . . 65.3 111.107 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 8.2 m80 -72.22 -33.0 67.24 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.201 -0.454 . . . . 74.53 110.872 179.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.687 ' HB2' ' HB2' ' A' ' 99' ' ' PHE . 16.8 m -134.77 144.04 47.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.225 -0.443 . . . . 74.11 110.857 -179.81 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . 0.565 ' O ' ' O ' ' A' ' 155' ' ' LYS . 1.1 m -142.52 115.04 8.51 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.129 -0.487 . . . . 45.11 110.885 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.565 ' HA ' ' HA ' ' A' ' 156' ' ' GLU . 7.2 mtpp -109.62 153.57 24.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.166 -0.47 . . . . 75.22 110.914 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.518 ' HB ' ' O ' ' A' ' 131' ' ' LYS . 16.2 t 85.25 162.87 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.247 -0.433 . . . . 73.53 111.1 179.855 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.455 ' HB3' ' HA ' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -175.77 126.61 0.23 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.134 -0.485 . . . . 74.4 110.897 179.944 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.604 ' HG3' ' O ' ' A' ' 93' ' ' GLN . 10.1 mm-40 -99.99 164.38 12.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.186 -0.461 . . . . 72.32 110.881 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . 0.552 ' C ' ' O ' ' A' ' 134' ' ' GLU . . . -23.91 -63.07 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.746 -0.74 . . . . 73.22 112.467 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.713 ' HA ' HD13 ' A' ' 152' ' ' LEU . 10.4 t -144.45 145.99 20.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.858 0.361 . . . . 73.42 111.089 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . 0.593 ' HB3' ' CB ' ' A' ' 152' ' ' LEU . 4.7 t90 -140.12 156.64 46.47 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.161 -0.472 . . . . 74.43 110.929 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.405 HD11 ' HB ' ' A' ' 61' ' ' ILE . 6.4 mm -122.37 134.98 63.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.242 -0.435 . . . . 75.31 111.14 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.538 ' CB ' ' HB2' ' A' ' 150' ' ' TYR . 0.0 OUTLIER -112.73 151.97 29.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.156 -0.474 . . . . 73.01 110.878 179.922 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . 0.408 ' CD2' ' HA ' ' A' ' 145' ' ' TYR . 5.5 m-85 -133.7 129.79 37.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.111 -0.495 . . . . 75.42 110.912 -179.85 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . 0.691 ' O ' ' HB2' ' A' ' 171' ' ' GLN . 0.8 OUTLIER -63.03 -30.43 71.59 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.102 -0.499 . . . . 64.14 110.849 -179.949 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.726 ' HB3' ' HD2' ' A' ' 143' ' ' PRO . 8.9 mp -112.02 172.93 3.15 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.637 0.732 . . . . 72.04 110.909 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . 0.726 ' HD2' ' HB3' ' A' ' 142' ' ' LEU . 53.9 Cg_endo -69.77 -90.51 0.0 OUTLIER 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.701 2.267 . . . . 75.21 112.337 179.857 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . 0.705 ' O ' ' N ' ' A' ' 146' ' ' ARG . 0.7 OUTLIER -53.48 96.21 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.215 -0.448 . . . . 74.1 110.881 -179.976 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . 0.642 ' C ' ' O ' ' A' ' 144' ' ' ASN . 0.0 OUTLIER 13.33 51.97 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.115 -0.493 . . . . 73.12 110.934 -179.911 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . 0.705 ' N ' ' O ' ' A' ' 144' ' ' ASN . 21.2 mtt180 -117.84 163.87 15.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.108 -0.496 . . . . 74.13 110.893 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 84.85 -171.6 47.05 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.742 -0.742 . . . . 62.15 112.482 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -82.05 155.02 25.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.741 0.305 . . . . 74.51 110.87 -179.869 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -92.81 159.99 15.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.15 -0.477 . . . . 74.11 110.897 -179.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . 0.538 ' HB2' ' CB ' ' A' ' 139' ' ' PHE . 79.8 m-85 -140.85 130.76 24.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.182 -0.463 . . . . 73.43 110.903 -179.835 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.489 ' CA ' HD12 ' A' ' 61' ' ' ILE . 20.2 tp -78.9 123.95 27.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.104 -0.498 . . . . 74.54 110.89 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.713 HD13 ' HA ' ' A' ' 136' ' ' VAL . 0.0 OUTLIER -53.82 137.06 39.26 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.222 -0.445 . . . . 74.43 110.951 179.832 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -161.09 25.92 0.14 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.173 -0.467 . . . . 72.33 110.851 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.798 ' HB2' ' CD1' ' A' ' 157' ' ' TYR . 0.0 OUTLIER -118.06 -177.32 3.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.207 -0.451 . . . . 73.44 110.852 -179.971 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.762 ' HD2' ' C ' ' A' ' 154' ' ' LYS . 0.3 OUTLIER -161.23 -124.39 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.197 -0.456 . . . . 74.24 110.924 179.834 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.565 ' HA ' ' HA ' ' A' ' 131' ' ' LYS . 3.0 tm-20 -67.27 4.19 1.02 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.184 -0.462 . . . . 73.34 110.866 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . 0.798 ' CD1' ' HB2' ' A' ' 154' ' ' LYS . 18.0 m-30 -35.08 151.33 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.168 -0.469 . . . . 74.42 110.918 -179.856 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . 0.505 ' O ' ' OG ' ' A' ' 129' ' ' SER . 0.0 OUTLIER -122.93 -35.53 3.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.109 -0.496 . . . . 75.21 110.916 179.985 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -88.44 150.93 47.63 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.553 0.692 . . . . 74.53 110.891 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 -26.32 27.69 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.648 2.232 . . . . 73.51 112.36 179.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.487 HD11 ' H ' ' A' ' 161' ' ' ILE . 4.2 mp -70.46 -8.81 11.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.232 -0.44 . . . . 73.4 111.139 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . 0.65 ' HB3' ' CD1' ' A' ' 157' ' ' TYR . 0.4 OUTLIER -75.81 -14.26 60.29 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.173 -0.467 . . . . 74.25 110.852 179.829 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 28.1 t-105 -89.63 -9.44 49.64 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.233 -0.44 . . . . 74.24 110.97 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 101.88 -36.51 4.19 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.707 -0.759 . . . . 73.03 112.509 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -75.46 127.69 33.67 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.816 0.341 . . . . 72.41 111.117 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -38.1 -39.96 0.45 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.249 -0.432 . . . . 71.41 111.105 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' SER . . . . . 0.526 ' C ' ' H ' ' A' ' 169' ' ' ALA . 0.3 OUTLIER -132.11 157.71 77.5 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.673 0.749 . . . . 73.41 110.824 -179.775 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . 0.475 ' HB3' ' O ' ' A' ' 127' ' ' ILE . 54.0 Cg_endo -69.75 28.43 0.18 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.668 2.245 . . . . 73.3 112.372 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . 0.526 ' H ' ' C ' ' A' ' 167' ' ' SER . . . -68.84 106.58 2.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.217 -0.447 . . . . 74.52 111.069 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 2.6 t -153.43 164.63 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.233 -0.439 . . . . 55.13 111.143 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' GLN . . . . . 0.691 ' HB2' ' O ' ' A' ' 141' ' ' GLU . 2.1 mm-40 -112.85 -86.81 0.56 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.162 -0.472 . . . . 64.25 110.9 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' SER . . . . . 0.721 ' OG ' ' O ' ' A' ' 143' ' ' PRO . 56.7 p -124.41 176.91 6.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.465 . . . . 72.3 110.85 -179.8 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -144.81 168.83 19.29 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.103 -0.498 . . . . 74.42 110.911 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 7.8 mtp85 -138.73 139.25 38.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.144 -0.48 . . . . 65.42 110.882 -179.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.7 154.73 17.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.19 -0.459 . . . . 75.13 110.885 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . 0.433 HD11 ' HB ' ' A' ' 136' ' ' VAL . 2.2 mt -96.0 132.83 39.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.197 -0.456 . . . . 74.02 111.143 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 11.5 p -51.62 147.38 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.224 -0.444 . . . . 73.03 111.104 179.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.167 -0.47 . . . . 75.45 110.847 179.947 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.4 mtt . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.778 0.323 . . . . 73.42 110.864 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.5 m -160.5 -173.54 4.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.253 -0.431 . . . . 73.11 110.908 -179.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 20.0 mtpt -84.67 54.02 2.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.164 -0.471 . . . . 75.31 110.898 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.0 t -116.38 -33.68 4.86 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.213 -0.449 . . . . 73.11 111.129 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -76.13 71.12 2.02 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.781 -0.723 . . . . 74.35 112.468 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.45 ' HA ' ' O ' ' A' ' 44' ' ' GLY . 19.3 p -82.66 133.73 35.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.864 0.364 . . . . 75.13 111.135 -179.865 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 2.9 tttt -123.44 136.94 54.87 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.213 -0.449 . . . . 74.12 110.918 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.648 ' HB ' ' CD1' ' A' ' 47' ' ' TRP . 16.9 tt -137.48 152.1 26.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.199 -0.455 . . . . 74.11 111.101 179.908 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.535 ' HA ' ' O ' ' A' ' 21' ' ' TYR . 13.5 m -132.74 145.13 50.77 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.149 -0.478 . . . . 72.24 111.144 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.628 ' CE2' HG23 ' A' ' 8' ' ' ILE . 1.1 m-85 -132.42 126.03 32.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.214 -0.448 . . . . 72.53 110.831 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.54 ' CG ' ' HA ' ' A' ' 16' ' ' PHE . 12.8 m-85 -112.01 132.83 54.56 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.132 -0.486 . . . . 73.3 110.935 -179.877 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.448 ' HB2' ' HB2' ' A' ' 19' ' ' ARG . 0.0 OUTLIER -61.92 -15.04 40.04 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.115 -0.493 . . . . 71.34 110.935 179.96 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.446 ' HB2' ' O ' ' A' ' 17' ' ' GLN . 71.4 m-20 -134.67 149.01 50.46 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.125 -0.489 . . . . 72.32 110.901 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.547 ' N ' ' HB3' ' A' ' 38' ' ' ASN . 5.8 mtmt -54.26 -176.94 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.198 -0.456 . . . . 63.31 110.911 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 16.6 m120 47.52 30.99 1.81 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.255 -0.43 . . . . 64.34 110.919 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.54 ' HA ' ' CG ' ' A' ' 11' ' ' TYR . 3.3 m-85 51.05 64.51 1.81 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.175 -0.466 . . . . 74.22 110.862 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.446 ' O ' ' HB2' ' A' ' 13' ' ' ASP . 14.2 mt-30 -139.76 158.92 43.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.141 -0.482 . . . . 75.12 110.89 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 92.61 -148.79 19.26 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.729 -0.748 . . . . 35.21 112.51 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.448 ' HB2' ' HB2' ' A' ' 12' ' ' GLU . 0.0 OUTLIER -68.12 77.65 0.24 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.852 0.358 . . . . 73.54 110.879 -179.834 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.454 ' HB2' ' CE1' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -77.86 129.36 35.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.178 -0.465 . . . . 73.2 110.863 -179.882 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.535 ' O ' ' HA ' ' A' ' 9' ' ' THR . 90.8 t80 -123.49 123.99 41.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 75.21 110.888 -179.823 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.437 ' CG ' HG23 ' A' ' 9' ' ' THR . 1.3 m-20 -120.57 133.96 55.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.141 -0.481 . . . . 74.54 110.885 179.873 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -167.72 136.79 2.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.168 -0.469 . . . . 73.43 110.86 -179.912 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -105.37 5.18 31.57 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.157 -0.474 . . . . 72.35 110.919 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 11.7 t -107.1 169.35 8.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.183 -0.462 . . . . 74.24 110.897 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -64.66 116.89 6.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.172 -0.467 . . . . 74.23 110.874 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.422 ' HB2' ' SG ' ' A' ' 83' ' ' CYS . 4.7 m -118.06 53.67 0.95 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.198 -0.456 . . . . 75.32 110.852 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.525 ' C ' ' HA ' ' A' ' 82' ' ' SER . . . -46.28 -21.05 0.13 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.157 -0.474 . . . . 63.42 111.099 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -127.71 43.61 3.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.209 -0.45 . . . . 74.31 110.895 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.777 ' O ' ' CD2' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -81.11 15.51 1.86 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.19 -0.459 . . . . 74.13 110.837 -179.885 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.542 ' HB2' ' HB3' ' A' ' 81' ' ' SER . 30.7 t60 -78.86 -39.3 35.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.145 -0.48 . . . . 71.34 110.826 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.6 t -56.83 -13.89 2.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.229 -0.441 . . . . 65.45 111.155 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -99.61 -28.08 13.37 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.216 -0.447 . . . . 72.44 110.906 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.405 HD13 ' O ' ' A' ' 19' ' ' ARG . 18.2 tp -141.12 137.25 32.64 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.157 -0.474 . . . . 75.24 110.916 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 30.6 m -101.07 -43.06 6.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.184 -0.462 . . . . 61.52 110.867 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -118.0 140.97 48.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.118 -0.492 . . . . 72.41 110.854 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.701 ' SG ' ' HB2' ' A' ' 80' ' ' LEU . 5.6 p -110.21 87.4 2.51 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.225 -0.443 . . . . 74.31 110.904 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.547 ' HB3' ' N ' ' A' ' 14' ' ' LYS . 0.2 OUTLIER -78.62 -65.17 1.02 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.186 -0.461 . . . . 75.31 110.881 -179.878 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 5.0 p -118.41 123.9 46.36 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.157 -0.474 . . . . 75.35 110.856 -179.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.647 ' O ' ' HB2' ' A' ' 67' ' ' TYR . 25.6 mt -117.27 150.62 19.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.13 -0.486 . . . . 74.24 111.094 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.467 ' N ' HG23 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -145.53 119.22 9.18 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.108 -0.497 . . . . 75.22 110.877 179.871 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.513 HG23 ' HB ' ' A' ' 8' ' ' ILE . 1.4 t -103.54 116.21 46.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.238 -0.437 . . . . 64.44 111.14 179.89 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -111.04 79.94 1.25 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.233 -0.44 . . . . 74.42 110.884 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.45 ' O ' ' HA ' ' A' ' 6' ' ' THR . . . 127.17 108.84 1.55 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.793 -0.717 . . . . 75.12 112.476 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 52.44 179.79 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.706 -0.759 . . . . 74.42 112.491 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.524 HG21 ' HA ' ' A' ' 63' ' ' PRO . 1.3 m -86.39 169.89 12.5 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.78 0.324 . . . . 74.02 111.154 -179.887 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.648 ' CD1' ' HB ' ' A' ' 8' ' ' ILE . 17.8 m95 -140.86 130.8 24.51 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.203 -0.453 . . . . 75.41 110.913 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.501 ' O ' ' HA ' ' A' ' 83' ' ' CYS . . . -100.28 107.53 19.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.257 -0.429 . . . . 74.52 111.099 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.493 ' O ' ' O ' ' A' ' 60' ' ' TYR . 4.9 m -107.7 125.52 64.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.205 -0.452 . . . . 61.3 111.157 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.711 ' HB3' ' HA ' ' A' ' 56' ' ' ALA . 39.9 m-85 -89.05 148.12 23.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.222 -0.445 . . . . 74.31 110.899 -179.89 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.536 ' HB2' ' HB2' ' A' ' 58' ' ' TYR . 59.6 tt0 -48.06 -77.85 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.134 -0.485 . . . . 72.41 110.889 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.565 ' HB3' ' HB2' ' A' ' 55' ' ' PHE . 0.2 OUTLIER -89.76 141.37 28.32 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.623 0.725 . . . . 74.31 110.868 -179.914 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.711 ' HA ' ' OG ' ' A' ' 82' ' ' SER . 53.6 Cg_endo -69.78 138.17 37.11 Favored 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.675 2.25 . . . . 64.2 112.356 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 2.3 t30 65.15 -10.0 0.19 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.264 -0.426 . . . . 73.13 110.884 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.568 ' H ' ' C ' ' A' ' 53' ' ' PRO . 3.3 m-30 -103.19 -23.32 13.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.175 -0.466 . . . . 73.41 110.856 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.711 ' HA ' ' HB3' ' A' ' 50' ' ' TYR . . . 55.61 23.36 6.02 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.194 -0.457 . . . . 64.34 111.095 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . 0.63 ' O ' ' C ' ' A' ' 58' ' ' TYR . 0.7 OUTLIER -51.67 -165.79 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.236 -0.438 . . . . 74.41 110.887 -179.975 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.63 ' C ' ' O ' ' A' ' 57' ' ' TRP . 11.1 m-30 -14.08 100.57 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.281 -0.418 . . . . 71.14 110.886 -179.85 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.498 ' HB2' ' HA ' ' A' ' 150' ' ' TYR . 0.0 OUTLIER -58.7 158.87 7.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.151 -0.477 . . . . 75.04 110.876 179.91 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.608 ' OH ' ' O ' ' A' ' 73' ' ' TRP . 0.4 OUTLIER -172.23 97.3 0.16 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.257 -0.429 . . . . 72.12 110.906 -179.843 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.506 ' HB ' HD11 ' A' ' 138' ' ' ILE . 2.5 mp -94.32 119.01 41.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.103 -0.498 . . . . 74.15 111.129 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.502 ' CD1' HD12 ' A' ' 40' ' ' ILE . 0.3 OUTLIER -88.06 128.92 51.96 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-O 121.557 0.694 . . . . 75.22 110.938 179.912 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.524 ' HA ' HG21 ' A' ' 46' ' ' THR . 53.5 Cg_endo -69.72 -170.53 0.4 Allowed 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.688 2.259 . . . . 74.21 112.358 179.885 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -88.69 161.36 16.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.244 -0.435 . . . . 74.02 110.892 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 112.58 -166.37 12.16 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.759 -0.734 . . . . 53.43 112.534 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -111.04 150.99 28.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.913 0.387 . . . . 75.45 110.867 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.647 ' HB2' ' O ' ' A' ' 40' ' ' ILE . 10.0 m-85 -140.13 84.44 14.82 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.707 0.765 . . . . 73.51 110.911 -179.874 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.409 ' HD2' ' HG3' ' A' ' 72' ' ' ARG . 53.8 Cg_endo -69.75 -1.06 7.83 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.739 2.293 . . . . 75.53 112.329 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.469 ' HB2' ' HG2' ' A' ' 72' ' ' ARG . 80.7 mt-10 -154.63 142.6 20.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.23 -0.441 . . . . 75.23 110.905 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.732 ' HA ' ' NE1' ' A' ' 73' ' ' TRP . 35.9 p90 -55.13 -23.79 22.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.464 . . . . 73.32 110.93 -179.865 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -76.43 -16.53 59.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.166 -0.47 . . . . 75.05 110.93 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.469 ' HG2' ' HB2' ' A' ' 69' ' ' GLU . 28.3 mmt180 -70.64 -6.36 36.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.209 -0.45 . . . . 73.12 110.879 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . 0.732 ' NE1' ' HA ' ' A' ' 70' ' ' TYR . 0.0 OUTLIER -139.35 26.58 2.37 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.181 -0.463 . . . . 73.0 110.933 -179.951 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' MET . . . . . 0.473 ' HB2' ' O ' ' A' ' 73' ' ' TRP . 0.0 OUTLIER 75.84 -11.0 1.18 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.23 -0.441 . . . . 72.23 110.891 179.954 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.413 ' C ' ' O ' ' A' ' 74' ' ' MET . . . 37.27 46.55 1.38 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.76 -0.733 . . . . 55.14 112.456 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.5 ' CB ' ' CE2' ' A' ' 60' ' ' TYR . 0.1 OUTLIER -45.83 -63.25 1.01 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.819 0.342 . . . . 71.5 110.92 -179.927 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -127.32 126.11 42.01 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.208 -0.451 . . . . 70.03 110.873 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -76.03 1.69 14.78 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.187 -0.461 . . . . 65.24 110.889 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -99.89 73.85 1.79 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.176 -0.465 . . . . 74.53 110.837 -179.873 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.701 ' HB2' ' SG ' ' A' ' 37' ' ' CYS . 0.1 OUTLIER -81.87 133.08 35.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.155 -0.475 . . . . 75.23 110.874 -179.977 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.607 ' HB3' ' HB3' ' A' ' 53' ' ' PRO . 0.9 OUTLIER -148.31 -130.45 0.06 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.193 -0.458 . . . . 75.34 110.921 -179.957 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.711 ' OG ' ' HA ' ' A' ' 53' ' ' PRO . 0.6 OUTLIER -25.78 131.4 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.124 -0.489 . . . . 72.54 110.893 -179.851 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . 0.501 ' HA ' ' O ' ' A' ' 48' ' ' ALA . 6.9 p -138.1 140.87 40.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.141 -0.482 . . . . 73.12 110.87 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.477 ' N ' ' O ' ' A' ' 48' ' ' ALA . 6.4 mmt85 -139.78 128.36 23.01 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.225 -0.443 . . . . 75.43 110.851 -179.823 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.449 ' N ' ' CZ3' ' A' ' 47' ' ' TRP . . . -50.56 129.59 22.6 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.195 -0.457 . . . . 73.13 111.096 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.495 HG21 ' CB ' ' A' ' 48' ' ' ALA . 25.5 t -114.51 142.04 28.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.276 -0.42 . . . . 75.2 111.09 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . 0.43 ' O ' ' C ' ' A' ' 88' ' ' LEU . 6.7 m-70 -112.24 110.56 20.88 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.161 -0.472 . . . . 74.23 110.851 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.457 ' H ' HD22 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -35.95 144.13 0.26 Allowed Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.646 0.736 . . . . 63.24 110.9 -179.959 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.546 ' HB3' ' H ' ' A' ' 136' ' ' VAL . 53.7 Cg_endo -69.7 98.66 0.69 Allowed 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.671 2.247 . . . . 74.31 112.357 179.857 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -104.51 -175.35 2.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.263 -0.426 . . . . 74.02 110.878 -179.84 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 50.95 58.84 8.8 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.757 -0.735 . . . . 74.33 112.523 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.412 ' O ' ' C ' ' A' ' 93' ' ' GLN . . . 123.46 26.07 1.68 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.747 -0.74 . . . . 70.51 112.488 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.429 ' O ' ' HG2' ' A' ' 134' ' ' GLU . 14.6 pt20 37.32 -123.05 0.21 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.834 0.35 . . . . 75.53 110.905 -179.856 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.532 ' HA ' ' HG2' ' A' ' 134' ' ' GLU . 0.1 OUTLIER -123.75 104.41 8.96 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.172 -0.467 . . . . 73.24 110.907 -179.852 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.463 ' HG3' HG11 ' A' ' 132' ' ' VAL . 34.1 tptt -114.37 127.78 56.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.099 -0.5 . . . . 72.33 110.895 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 6.3 tt -149.45 136.93 13.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.221 -0.445 . . . . 74.14 111.073 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.446 ' HB2' ' O ' ' A' ' 131' ' ' LYS . 0.7 OUTLIER -107.25 123.91 48.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.15 -0.477 . . . . 74.24 110.907 179.949 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 43.9 mm -105.39 131.06 55.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.193 -0.458 . . . . 72.4 111.121 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.698 ' HB2' ' HB2' ' A' ' 129' ' ' SER . 45.9 m-85 -118.79 150.39 39.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.152 -0.476 . . . . 74.34 110.897 179.911 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 50.8 tt0 -85.76 -56.08 3.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.187 -0.461 . . . . 71.1 110.852 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 47.6 mttt -101.01 164.93 11.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.167 -0.47 . . . . 75.53 110.89 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.403 ' HA2' ' OG ' ' A' ' 129' ' ' SER . . . -65.53 152.4 51.51 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.768 -0.73 . . . . 74.45 112.49 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.404 ' HA ' ' HB2' ' A' ' 158' ' ' ARG . 27.8 t0 65.76 45.37 2.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.831 0.348 . . . . 75.14 110.852 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.576 ' N ' ' CD2' ' A' ' 104' ' ' PHE . 0.1 OUTLIER 47.48 33.81 3.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.233 -0.44 . . . . 75.24 110.912 -179.881 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 53.3 m -96.35 159.61 14.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.164 -0.471 . . . . 75.04 110.861 -179.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 83.91 -135.67 14.01 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.695 -0.764 . . . . 75.22 112.49 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 37.7 tp60 -88.65 120.67 30.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.783 0.325 . . . . 64.51 110.879 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 3.5 ttp -108.25 132.8 53.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.154 -0.475 . . . . 72.11 110.862 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -137.72 137.09 37.97 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.221 -0.445 . . . . 70.24 110.925 -179.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -119.33 104.43 10.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.097 -0.501 . . . . 75.42 110.854 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 8.9 t -112.82 133.38 54.85 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.183 -0.462 . . . . 54.41 111.152 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.492 ' HA ' ' O ' ' A' ' 94' ' ' TYR . 1.6 t -115.5 32.49 6.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.22 -0.446 . . . . 75.4 111.131 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -142.38 -173.91 3.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.219 -0.446 . . . . 75.33 110.88 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -72.08 150.66 43.71 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.117 -0.492 . . . . 75.13 110.837 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . 0.425 ' O ' ' HB2' ' A' ' 172' ' ' SER . 57.4 m -140.99 107.16 6.27 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-O 121.631 0.729 . . . . 75.1 110.884 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.618 ' O ' ' CB ' ' A' ' 172' ' ' SER . 53.3 Cg_endo -69.74 -35.97 11.73 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.657 2.238 . . . . 71.25 112.311 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.6 ' HB3' ' CB ' ' A' ' 120' ' ' GLU . 0.1 OUTLIER -142.0 112.37 7.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.228 -0.442 . . . . 72.03 110.865 -179.78 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.543 ' O ' ' HB2' ' A' ' 122' ' ' PHE . 5.4 tt -67.24 -32.87 59.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.18 -0.463 . . . . 73.34 111.104 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' MET . . . . . 0.641 ' O ' ' HA ' ' A' ' 123' ' ' HIS . 0.0 OUTLIER -87.28 -38.99 15.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.178 -0.464 . . . . 73.23 110.897 179.855 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.6 ' CB ' ' HB3' ' A' ' 117' ' ' SER . 3.9 tp10 -72.18 -15.43 61.96 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.218 -0.446 . . . . 72.44 110.896 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 13.0 mm100 -114.44 -45.82 3.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.123 -0.49 . . . . 75.05 110.925 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . 0.543 ' HB2' ' O ' ' A' ' 118' ' ' ILE . 47.4 m-85 -106.23 -19.71 13.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.195 -0.457 . . . . 74.31 110.879 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . 0.641 ' HA ' ' O ' ' A' ' 119' ' ' MET . 12.3 m80 70.58 29.21 3.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.137 -0.483 . . . . 73.14 110.889 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.448 ' O ' HG22 ' A' ' 118' ' ' ILE . 4.0 mtt -107.19 83.42 1.82 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.208 -0.451 . . . . 71.43 110.838 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 4.0 ptp180 -50.58 -35.43 30.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.239 -0.437 . . . . 65.03 110.86 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.451 ' HB3' ' HG2' ' A' ' 168' ' ' PRO . 18.8 mt-10 -142.42 136.14 29.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.231 -0.44 . . . . 75.15 110.899 -179.915 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.453 ' O ' ' HB3' ' A' ' 168' ' ' PRO . 3.9 mm -96.3 104.47 15.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.174 -0.466 . . . . 64.54 111.076 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 12.6 m170 -70.79 -34.95 72.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.157 -0.474 . . . . 72.34 110.833 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.698 ' HB2' ' HB2' ' A' ' 99' ' ' PHE . 13.7 m -133.75 149.85 51.47 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.204 -0.453 . . . . 64.14 110.883 -179.822 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . 0.498 ' HB3' ' CD ' ' A' ' 154' ' ' LYS . 0.1 OUTLIER -148.68 117.92 6.85 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.151 -0.477 . . . . 74.13 110.865 -179.913 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.495 ' O ' ' HB ' ' A' ' 132' ' ' VAL . 11.2 mtpt -113.87 155.56 25.53 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.21 -0.45 . . . . 73.33 110.892 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.517 ' O ' ' HE2' ' A' ' 154' ' ' LYS . 15.5 t 83.43 160.91 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.221 -0.445 . . . . 70.25 111.104 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.68 ' HG ' ' HG3' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -177.79 127.3 0.13 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.166 -0.47 . . . . 74.04 110.923 179.911 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.532 ' HG2' ' HA ' ' A' ' 94' ' ' TYR . 0.1 OUTLIER -97.8 171.34 8.37 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.162 -0.472 . . . . 70.04 110.898 179.938 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . 0.493 ' C ' ' O ' ' A' ' 134' ' ' GLU . . . -30.41 -78.84 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.741 -0.742 . . . . 72.43 112.468 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.623 ' HA ' HD13 ' A' ' 152' ' ' LEU . 2.8 t -128.53 144.91 36.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.781 0.324 . . . . 72.13 111.158 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . 0.634 ' HB3' ' CB ' ' A' ' 152' ' ' LEU . 60.2 t-105 -146.14 163.94 33.77 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.214 -0.448 . . . . 74.53 110.897 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.506 HD11 ' HB ' ' A' ' 61' ' ' ILE . 5.8 mm -132.74 138.07 52.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.231 -0.441 . . . . 75.44 111.091 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.75 ' HB2' ' HB2' ' A' ' 150' ' ' TYR . 69.7 m-85 -114.49 152.48 31.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.139 -0.482 . . . . 74.12 110.855 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . 0.722 ' CD2' ' HA ' ' A' ' 145' ' ' TYR . 13.7 m-85 -128.34 144.19 51.1 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.149 -0.478 . . . . 74.44 110.878 -179.874 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . 0.563 ' C ' ' HB2' ' A' ' 171' ' ' GLN . 27.4 tt0 -84.77 -7.96 59.0 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.106 -0.497 . . . . 75.22 110.864 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.515 ' C ' ' H ' ' A' ' 144' ' ' ASN . 7.2 mp -120.05 149.07 48.29 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.579 0.704 . . . . 74.14 110.954 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . 0.719 ' HD3' ' CD ' ' A' ' 171' ' ' GLN . 54.0 Cg_endo -69.71 32.75 0.19 Allowed 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.695 2.264 . . . . 73.13 112.375 179.857 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . 1.007 ' O ' ' N ' ' A' ' 146' ' ' ARG . 0.0 OUTLIER -169.34 101.91 0.35 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.201 -0.454 . . . . 73.43 110.923 -179.961 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . 0.722 ' HA ' ' CD2' ' A' ' 140' ' ' TYR . 0.3 OUTLIER 3.59 48.39 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.155 -0.475 . . . . 75.24 110.945 -179.866 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . 1.007 ' N ' ' O ' ' A' ' 144' ' ' ASN . 1.1 mtp85 -136.16 178.02 7.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.069 -0.514 . . . . 71.55 110.835 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 83.04 -175.48 53.01 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.764 -0.731 . . . . 64.05 112.482 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 53.3 mtt180 -62.45 146.22 52.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.705 0.288 . . . . 74.34 110.852 -179.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . 0.433 ' O ' ' HB2' ' A' ' 59' ' ' MET . 1.4 mt-30 -98.22 135.39 39.92 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.202 -0.454 . . . . 74.02 110.933 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . 0.75 ' HB2' ' HB2' ' A' ' 139' ' ' PHE . 54.5 m-85 -121.46 125.43 46.84 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.23 -0.441 . . . . 73.51 110.888 -179.863 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.488 ' HA ' HD12 ' A' ' 61' ' ' ILE . 19.8 tp -76.89 122.71 25.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.113 -0.494 . . . . 73.53 110.908 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.657 ' CD1' ' O ' ' A' ' 152' ' ' LEU . 0.0 OUTLIER -50.74 130.71 25.19 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.156 -0.475 . . . . 75.44 110.893 179.893 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -163.86 26.48 0.08 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.21 -0.45 . . . . 75.21 110.837 179.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.84 ' O ' ' HG3' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -108.09 -174.76 2.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.191 -0.458 . . . . 75.12 110.865 -179.999 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.84 ' HG3' ' O ' ' A' ' 154' ' ' LYS . 1.5 mptt -162.44 -127.74 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.195 -0.457 . . . . 74.44 110.936 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.585 ' HG2' ' O ' ' A' ' 156' ' ' GLU . 2.2 tm-20 -70.46 6.91 1.2 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.247 -0.433 . . . . 74.51 110.835 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . 0.691 ' CE1' ' HA ' ' A' ' 154' ' ' LYS . 18.9 m-30 -32.44 149.97 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.176 -0.466 . . . . 74.23 110.894 -179.835 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . 0.522 ' O ' ' OG ' ' A' ' 129' ' ' SER . 0.0 OUTLIER -126.5 -34.73 2.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.108 -0.496 . . . . 73.5 110.864 -179.992 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -89.07 151.69 47.22 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.638 0.732 . . . . 74.11 110.892 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . 0.465 ' HB3' ' HB3' ' A' ' 168' ' ' PRO . 54.1 Cg_endo -69.72 -24.11 30.2 Favored 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 122.645 2.23 . . . . 75.55 112.401 179.896 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.537 HD11 ' H ' ' A' ' 161' ' ' ILE . 3.7 mp -69.41 -9.39 12.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.189 -0.459 . . . . 71.4 111.131 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . 0.675 ' HB3' ' CD1' ' A' ' 157' ' ' TYR . 0.3 OUTLIER -77.2 -13.38 59.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.14 -0.482 . . . . 72.42 110.87 179.88 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -87.64 3.17 48.78 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.186 -0.461 . . . . 73.22 110.968 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 88.42 -36.15 3.47 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.713 -0.756 . . . . 72.23 112.516 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -80.76 129.86 34.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.795 0.331 . . . . 62.15 111.086 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -37.95 -38.33 0.3 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.218 -0.447 . . . . 74.3 111.121 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' SER . . . . . 0.517 ' C ' ' H ' ' A' ' 169' ' ' ALA . 0.3 OUTLIER -127.12 158.88 67.67 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.647 0.737 . . . . 74.1 110.857 -179.785 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . 0.465 ' HB3' ' HB3' ' A' ' 160' ' ' PRO . 54.5 Cg_endo -69.7 26.3 0.17 Allowed 'Trans proline' 0 C--N 1.341 0.132 0 C-N-CA 122.715 2.277 . . . . 75.33 112.355 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . 0.517 ' H ' ' C ' ' A' ' 167' ' ' SER . . . -65.95 107.81 1.98 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.25 -0.432 . . . . 74.21 111.129 179.909 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 19.2 t -151.15 160.52 3.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.215 -0.448 . . . . 65.13 111.141 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' GLN . . . . . 0.719 ' CD ' ' HD3' ' A' ' 143' ' ' PRO . 6.5 mm-40 -109.41 -91.85 0.44 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.175 -0.466 . . . . 74.41 110.922 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' SER . . . . . 0.618 ' CB ' ' O ' ' A' ' 116' ' ' PRO . 60.1 p -127.98 168.91 14.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.199 -0.455 . . . . 74.31 110.873 -179.821 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . 0.612 ' CD1' ' N ' ' A' ' 173' ' ' PHE . 0.1 OUTLIER -146.75 165.79 28.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.146 -0.479 . . . . 70.45 110.918 -179.953 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -146.33 169.93 17.82 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.185 -0.462 . . . . 74.13 110.852 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . 0.491 ' HB3' ' CZ3' ' A' ' 137' ' ' TRP . 0.0 OUTLIER -89.1 -162.26 0.85 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.12 -0.491 . . . . 74.32 110.86 -179.913 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . 0.465 HD11 ' HB ' ' A' ' 136' ' ' VAL . 27.4 mt -124.68 141.82 43.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.157 -0.474 . . . . 74.01 111.133 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 44.1 t -75.25 140.88 16.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.171 -0.468 . . . . 72.22 111.123 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.217 -0.447 . . . . 75.21 110.856 -179.972 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.4 mtp . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.805 0.336 . . . . 74.23 110.899 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.3 m 53.59 -172.79 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.222 -0.445 . . . . 74.4 110.857 -179.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 53.7 mttt -90.03 45.85 1.31 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.12 -0.491 . . . . 75.5 110.915 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 11.5 p -63.79 -31.99 73.35 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.248 -0.433 . . . . 71.42 111.155 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -167.01 137.1 4.46 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.764 -0.731 . . . . 61.51 112.501 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.439 ' OG1' ' HB1' ' A' ' 85' ' ' ALA . 20.0 p -82.35 138.84 34.39 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.89 0.376 . . . . 74.01 111.105 -179.833 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.453 ' N ' ' HE1' ' A' ' 47' ' ' TRP . 2.9 tttt -124.91 134.66 52.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.232 -0.44 . . . . 74.32 110.878 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.503 HD13 ' CE1' ' A' ' 10' ' ' PHE . 15.4 tt -136.56 149.2 26.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.21 -0.45 . . . . 74.15 111.189 179.833 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.492 HG21 ' CE2' ' A' ' 11' ' ' TYR . 10.3 m -130.87 141.35 50.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.184 -0.462 . . . . 70.24 111.145 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.503 ' CE1' HD13 ' A' ' 8' ' ' ILE . 0.9 OUTLIER -128.83 128.36 43.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.275 -0.421 . . . . 72.3 110.845 -179.981 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.528 ' CG ' ' HA ' ' A' ' 16' ' ' PHE . 22.9 m-85 -114.28 132.12 56.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.102 -0.499 . . . . 60.34 110.927 -179.862 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.445 ' HG2' ' HB2' ' A' ' 36' ' ' ARG . 0.0 OUTLIER -60.01 -23.47 63.7 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.145 -0.479 . . . . 64.12 110.888 -179.98 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 65.6 m-20 -128.58 152.41 48.35 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.142 -0.481 . . . . 73.33 110.869 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.43 ' N ' ' HB3' ' A' ' 38' ' ' ASN . 31.8 mtmt -55.67 -175.18 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.166 -0.47 . . . . 75.31 110.897 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 17.8 m120 46.43 33.58 1.98 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.237 -0.438 . . . . 63.13 110.84 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.528 ' HA ' ' CG ' ' A' ' 11' ' ' TYR . 4.0 m-85 48.95 57.97 5.86 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.181 -0.463 . . . . 71.24 110.899 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 -132.81 158.56 42.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.153 -0.476 . . . . 72.12 110.931 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 94.7 -150.52 19.76 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.746 -0.74 . . . . 53.03 112.447 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.457 ' O ' ' CD1' ' A' ' 34' ' ' LEU . 0.0 OUTLIER -69.6 80.45 0.41 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.794 0.33 . . . . 74.43 110.875 -179.838 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.445 ' HB2' ' CE1' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -79.11 128.5 33.36 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.188 -0.46 . . . . 73.51 110.835 -179.927 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.471 ' CD2' ' CD2' ' A' ' 30' ' ' PHE . 71.2 t80 -124.49 125.36 44.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.15 -0.477 . . . . 74.45 110.921 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.461 ' CG ' HG23 ' A' ' 9' ' ' THR . 1.2 m-20 -119.48 132.61 55.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.128 -0.487 . . . . 73.01 110.91 179.899 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 10.4 t -157.09 130.25 7.83 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.195 -0.457 . . . . 65.21 110.907 -179.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.402 ' HA ' ' HA ' ' A' ' 7' ' ' LYS . 3.9 p30 -99.4 5.76 46.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.214 -0.448 . . . . 74.31 110.866 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 47.1 t -117.68 161.46 19.63 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.208 -0.451 . . . . 74.44 110.9 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 31.5 m-20 -45.12 120.51 2.44 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.176 -0.465 . . . . 72.1 110.887 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.579 ' HB2' ' HB3' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -114.27 43.87 1.8 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.185 -0.461 . . . . 64.1 110.869 -179.909 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.543 ' O ' ' HA ' ' A' ' 82' ' ' SER . . . -49.67 -21.53 1.07 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 72.42 111.105 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 60.2 t0 -129.58 40.99 3.51 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.222 -0.445 . . . . 73.44 110.862 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.795 ' O ' ' CD2' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -81.48 17.79 1.31 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.211 -0.449 . . . . 72.42 110.907 -179.934 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.548 ' HB2' ' HB3' ' A' ' 81' ' ' SER . 40.7 t60 -81.98 -33.56 30.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.166 -0.47 . . . . 65.41 110.845 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.0 t -66.96 -5.67 13.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.194 -0.457 . . . . 73.13 111.114 -179.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -108.29 -27.68 9.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.231 -0.44 . . . . 74.42 110.92 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.457 ' CD1' ' O ' ' A' ' 19' ' ' ARG . 23.3 tp -141.51 145.99 35.85 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.111 -0.495 . . . . 75.14 110.95 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.3 m -112.66 -34.93 5.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.181 -0.463 . . . . 73.1 110.806 -179.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.494 ' NH2' HD22 ' A' ' 38' ' ' ASN . 2.0 mtp85 -115.79 142.09 47.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.148 -0.478 . . . . 74.22 110.842 -179.877 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.62 ' SG ' ' HB2' ' A' ' 80' ' ' LEU . 6.3 p -120.02 64.81 0.82 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.139 -0.482 . . . . 74.31 110.899 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.494 HD22 ' NH2' ' A' ' 36' ' ' ARG . 3.0 m120 -63.66 -66.64 0.51 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.17 -0.468 . . . . 74.41 110.893 -179.885 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 5.0 p -113.81 127.31 55.95 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.113 -0.494 . . . . 75.43 110.881 -179.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.67 ' O ' ' HB2' ' A' ' 67' ' ' TYR . 18.7 mt -120.95 149.37 23.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.131 -0.486 . . . . 71.32 111.146 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.483 ' N ' HG23 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -143.5 119.3 10.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.189 -0.459 . . . . 71.01 110.902 179.874 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.601 HG22 ' HB2' ' A' ' 47' ' ' TRP . 1.0 OUTLIER -106.06 118.07 52.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.245 -0.434 . . . . 74.23 111.152 179.877 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -114.76 76.73 1.01 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.178 -0.465 . . . . 65.24 110.888 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 140.87 90.13 0.17 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.788 -0.72 . . . . 74.45 112.524 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 58.46 172.36 0.36 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.75 -0.738 . . . . 45.42 112.484 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.526 HG21 ' HA ' ' A' ' 63' ' ' PRO . 0.2 OUTLIER -66.01 172.35 3.79 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.828 0.347 . . . . 73.31 111.132 -179.867 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.601 ' HB2' HG22 ' A' ' 42' ' ' VAL . 6.6 m95 -146.97 129.55 15.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.2 -0.454 . . . . 73.11 110.948 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.602 ' O ' ' N ' ' A' ' 84' ' ' ARG . . . -91.13 127.7 36.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.263 -0.426 . . . . 75.04 111.092 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.559 HG11 ' CD1' ' A' ' 80' ' ' LEU . 21.1 m -125.86 145.0 34.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.215 -0.448 . . . . 74.34 111.115 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.88 ' HB3' ' CB ' ' A' ' 56' ' ' ALA . 6.7 m-85 -122.84 143.68 49.7 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.212 -0.449 . . . . 75.52 110.925 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.603 ' HG2' ' N ' ' A' ' 52' ' ' ARG . 0.5 OUTLIER -49.46 -84.04 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.176 -0.465 . . . . 63.4 110.871 179.987 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.728 ' H ' ' HA ' ' A' ' 56' ' ' ALA . 0.8 OUTLIER -81.91 136.43 47.59 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.586 0.707 . . . . 75.11 110.866 -179.89 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.625 ' HB3' ' HB3' ' A' ' 81' ' ' SER . 53.4 Cg_endo -69.74 135.79 31.41 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.668 2.245 . . . . 71.43 112.326 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.445 ' HB3' ' CE2' ' A' ' 55' ' ' PHE . 7.1 t-20 72.17 -6.15 1.59 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.174 -0.466 . . . . 74.34 110.945 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.445 ' CE2' ' HB3' ' A' ' 54' ' ' ASN . 0.1 OUTLIER -144.46 -75.36 0.24 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.136 -0.484 . . . . 72.31 110.877 -179.996 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.88 ' CB ' ' HB3' ' A' ' 50' ' ' TYR . . . 47.58 82.55 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.132 -0.485 . . . . 63.25 111.059 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . 0.61 ' O ' ' CD2' ' A' ' 58' ' ' TYR . 28.5 m0 -64.41 31.08 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.254 -0.43 . . . . 75.25 110.938 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.665 ' H ' ' C ' ' A' ' 56' ' ' ALA . 3.8 m-85 -160.29 115.6 2.3 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.264 -0.426 . . . . 73.25 110.935 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -82.39 136.59 34.94 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.128 -0.487 . . . . 75.42 110.85 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.616 ' HA ' ' OE1' ' A' ' 149' ' ' GLN . 5.4 t80 -146.39 124.86 12.37 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.243 -0.435 . . . . 75.12 110.9 -179.899 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.605 ' N ' ' CD1' ' A' ' 61' ' ' ILE . 1.0 OUTLIER -109.21 116.95 53.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.13 -0.486 . . . . 74.14 111.164 179.883 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -89.34 129.17 48.48 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.635 0.731 . . . . 64.32 110.909 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.526 ' HA ' HG21 ' A' ' 46' ' ' THR . 53.5 Cg_endo -69.8 -175.28 1.11 Allowed 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.664 2.242 . . . . 72.52 112.323 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.48 162.7 15.58 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.216 -0.447 . . . . 73.23 110.897 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 112.34 -171.56 14.15 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.797 -0.716 . . . . 73.45 112.533 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -103.5 150.96 23.4 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.871 0.367 . . . . 74.14 110.885 -179.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.67 ' HB2' ' O ' ' A' ' 40' ' ' ILE . 19.7 m-85 -139.26 85.34 15.59 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.669 0.747 . . . . 74.22 110.923 -179.853 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.442 ' HD2' ' HG3' ' A' ' 72' ' ' ARG . 53.9 Cg_endo -69.72 -0.01 6.26 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.687 2.258 . . . . 72.04 112.373 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.518 ' HB2' ' HG2' ' A' ' 72' ' ' ARG . 49.3 mt-10 -155.81 142.18 18.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.177 -0.465 . . . . 63.43 110.855 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.726 ' HA ' ' NE1' ' A' ' 73' ' ' TRP . 30.0 p90 -54.85 -20.52 8.9 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.158 -0.473 . . . . 72.22 110.918 -179.857 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -80.41 -18.72 48.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.144 -0.48 . . . . 74.11 110.945 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.518 ' HG2' ' HB2' ' A' ' 69' ' ' GLU . 26.5 mmt180 -69.9 -7.35 39.62 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.466 . . . . 72.34 110.887 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . 0.726 ' NE1' ' HA ' ' A' ' 70' ' ' TYR . 0.0 OUTLIER -139.28 18.49 2.58 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.176 -0.465 . . . . 72.23 110.929 -179.957 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' MET . . . . . 0.461 ' C ' ' O ' ' A' ' 73' ' ' TRP . 0.0 OUTLIER 33.54 43.98 0.06 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.212 -0.449 . . . . 73.23 110.863 179.95 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -53.31 125.44 31.43 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.784 -0.722 . . . . 63.24 112.472 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.2 mt -52.85 -53.98 40.98 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.862 0.363 . . . . 72.23 110.9 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 -130.68 151.66 50.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.198 -0.456 . . . . 71.21 110.866 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -84.22 13.29 5.38 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.201 -0.454 . . . . 62.33 110.864 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.6 67.72 0.91 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 74.14 110.87 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.62 ' HB2' ' SG ' ' A' ' 37' ' ' CYS . 0.1 OUTLIER -72.0 132.9 44.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.225 -0.443 . . . . 73.05 110.919 -179.98 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.625 ' HB3' ' HB3' ' A' ' 53' ' ' PRO . 1.3 m -151.09 -122.48 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.193 -0.458 . . . . 73.21 110.841 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.56 ' O ' ' N ' ' A' ' 50' ' ' TYR . 0.1 OUTLIER -38.33 106.06 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.136 -0.484 . . . . 74.23 110.844 -179.782 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . 0.493 ' SG ' ' HB2' ' A' ' 27' ' ' CYS . 9.3 p -134.38 131.34 38.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.15 -0.477 . . . . 75.04 110.904 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.602 ' N ' ' O ' ' A' ' 48' ' ' ALA . 2.9 mmt-85 -113.76 164.75 13.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 74.25 110.874 -179.835 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.439 ' HB1' ' OG1' ' A' ' 6' ' ' THR . . . -79.82 130.31 35.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.219 -0.446 . . . . 70.33 111.084 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 54.3 t -116.07 136.05 54.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.195 -0.457 . . . . 75.34 111.162 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . 0.463 ' O ' ' CG2' ' A' ' 136' ' ' VAL . 45.8 m80 -114.92 105.8 13.42 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.183 -0.462 . . . . 74.12 110.854 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.451 ' C ' ' O ' ' A' ' 87' ' ' HIS . 0.0 OUTLIER -34.02 146.55 0.13 Allowed Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.56 0.695 . . . . 75.04 110.926 -179.976 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.556 ' HB3' ' H ' ' A' ' 136' ' ' VAL . 53.5 Cg_endo -69.77 109.99 2.45 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.669 2.246 . . . . 75.12 112.356 179.843 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -106.83 158.84 16.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.236 -0.438 . . . . 74.23 110.841 -179.818 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 49.7 79.52 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.743 -0.742 . . . . 64.53 112.488 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 124.64 11.19 4.59 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.725 -0.75 . . . . 62.41 112.492 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.438 ' O ' ' HG2' ' A' ' 134' ' ' GLU . 14.8 pt20 38.02 -122.84 0.25 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.824 0.345 . . . . 72.44 110.923 -179.833 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.488 ' O ' ' HA ' ' A' ' 112' ' ' THR . 0.2 OUTLIER -124.19 101.97 7.47 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.209 -0.45 . . . . 74.2 110.903 -179.876 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.428 ' H ' ' HG2' ' A' ' 134' ' ' GLU . 47.4 tptt -110.89 126.55 54.82 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.07 -0.514 . . . . 75.44 110.893 179.886 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.436 HG21 HD13 ' A' ' 96' ' ' ILE . 0.0 OUTLIER -149.38 138.04 14.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.262 -0.426 . . . . 71.15 111.146 179.808 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.457 ' HB2' ' O ' ' A' ' 131' ' ' LYS . 2.2 mt-30 -105.52 121.23 43.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.182 -0.463 . . . . 73.44 110.889 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 23.0 mm -97.75 131.23 45.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.15 -0.477 . . . . 73.44 111.125 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.665 ' CB ' ' HB2' ' A' ' 129' ' ' SER . 37.6 m-85 -120.96 140.54 51.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.181 -0.463 . . . . 75.13 110.868 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 59.6 tt0 -75.79 -61.7 1.84 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.15 -0.477 . . . . 73.13 110.907 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 39.9 mttt -96.6 171.42 8.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.128 -0.487 . . . . 71.25 110.898 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.428 ' HA2' ' OG ' ' A' ' 129' ' ' SER . . . -70.5 153.46 51.68 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.719 -0.753 . . . . 72.12 112.493 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.439 ' HA ' ' HB2' ' A' ' 158' ' ' ARG . 26.8 t0 65.27 46.11 2.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.802 0.334 . . . . 74.11 110.861 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.593 ' N ' ' CD2' ' A' ' 104' ' ' PHE . 0.1 OUTLIER 47.54 33.18 2.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.227 -0.442 . . . . 75.12 110.853 -179.948 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 57.8 m -96.13 159.45 14.95 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.168 -0.469 . . . . 64.44 110.847 -179.774 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 84.92 -137.29 15.4 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.748 -0.739 . . . . 74.21 112.504 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 30.1 tp60 -88.84 114.2 25.2 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.805 0.336 . . . . 71.42 110.94 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 1.5 ttp -101.36 144.12 30.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.185 -0.461 . . . . 72.33 110.9 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -149.47 136.01 19.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.218 -0.446 . . . . 75.02 110.899 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -117.36 102.49 9.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.107 -0.497 . . . . 65.32 110.867 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 11.9 t -113.05 129.15 56.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.166 -0.47 . . . . 61.23 111.134 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.488 ' HA ' ' O ' ' A' ' 94' ' ' TYR . 1.5 t -96.74 22.52 8.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.224 -0.443 . . . . 74.53 111.199 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -151.2 137.56 18.53 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.155 -0.475 . . . . 74.15 110.848 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 30.7 p30 -53.89 178.27 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.16 -0.473 . . . . 74.42 110.882 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . 0.498 ' O ' ' HB2' ' A' ' 172' ' ' SER . 0.8 OUTLIER -155.65 151.31 21.89 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.57 0.7 . . . . 70.1 110.888 -179.92 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.453 ' O ' ' C ' ' A' ' 143' ' ' PRO . 54.1 Cg_endo -69.77 -33.94 15.54 Favored 'Trans proline' 0 C--O 1.231 0.134 0 C-N-CA 122.659 2.24 . . . . 73.25 112.383 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.615 ' HB3' ' CB ' ' A' ' 120' ' ' GLU . 0.1 OUTLIER -148.3 109.55 4.35 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 64.41 110.83 -179.821 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.601 ' HB ' ' O ' ' A' ' 171' ' ' GLN . 4.3 tt -60.45 -30.0 45.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.156 -0.475 . . . . 72.54 111.125 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' MET . . . . . 0.604 ' O ' ' HA ' ' A' ' 123' ' ' HIS . 5.0 ttt -86.14 -41.91 14.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.227 -0.442 . . . . 74.34 110.835 179.873 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.615 ' CB ' ' HB3' ' A' ' 117' ' ' SER . 10.0 tp10 -68.03 -14.11 62.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.229 -0.441 . . . . 71.24 110.913 -179.924 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 6.9 tp-100 -115.17 -48.27 2.82 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.092 -0.503 . . . . 72.23 110.91 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . 0.522 ' HB2' ' O ' ' A' ' 118' ' ' ILE . 53.4 m-85 -103.34 -20.4 14.1 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.198 -0.455 . . . . 75.12 110.879 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . 0.604 ' HA ' ' O ' ' A' ' 119' ' ' MET . 0.1 OUTLIER 71.33 29.87 2.68 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.104 -0.498 . . . . 63.04 110.859 -179.997 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.409 ' O ' HG22 ' A' ' 118' ' ' ILE . 4.5 mtt -107.85 86.34 2.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.256 -0.429 . . . . 74.11 110.892 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 1.9 ptp85 -51.97 -40.44 60.89 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.239 -0.437 . . . . 72.3 110.886 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.462 ' HB3' ' HG2' ' A' ' 168' ' ' PRO . 12.9 mt-10 -137.51 133.51 34.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.191 -0.458 . . . . 73.51 110.907 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.457 ' CG2' ' O ' ' A' ' 129' ' ' SER . 3.7 mm -93.48 101.57 12.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.135 -0.484 . . . . 71.41 111.149 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 11.8 m80 -69.9 -34.16 73.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.2 -0.455 . . . . 74.21 110.855 179.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.665 ' HB2' ' CB ' ' A' ' 99' ' ' PHE . 8.3 m -134.02 154.3 51.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.231 -0.44 . . . . 60.13 110.838 -179.756 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . 0.571 ' HB3' ' HD2' ' A' ' 154' ' ' LYS . 0.1 OUTLIER -155.13 118.54 4.46 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.154 -0.475 . . . . 75.43 110.886 -179.929 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.522 ' HA ' ' HA ' ' A' ' 156' ' ' GLU . 7.7 mtpp -112.86 154.0 27.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.201 -0.454 . . . . 55.34 110.912 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.52 ' HB ' ' O ' ' A' ' 131' ' ' LYS . 15.2 t 87.17 162.57 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.218 -0.446 . . . . 72.22 111.127 179.9 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.431 ' HB3' ' HA ' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -179.65 125.63 0.08 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.161 -0.472 . . . . 72.22 110.895 179.939 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.438 ' HG2' ' O ' ' A' ' 93' ' ' GLN . 0.0 OUTLIER -93.71 176.9 6.19 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.186 -0.461 . . . . 71.44 110.867 179.953 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . 0.492 ' HA3' ' HA ' ' A' ' 89' ' ' PRO . . . -37.26 -67.41 0.45 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.768 -0.73 . . . . 65.14 112.488 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.712 ' HA ' HD13 ' A' ' 152' ' ' LEU . 13.4 t -140.65 145.24 25.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.913 0.387 . . . . 74.21 111.073 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . 0.548 ' H ' ' CD1' ' A' ' 152' ' ' LEU . 0.1 OUTLIER -147.51 168.68 21.33 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.117 -0.492 . . . . 73.35 110.898 179.988 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.556 ' CG2' ' HB2' ' A' ' 149' ' ' GLN . 63.0 mt -138.13 133.72 44.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.219 -0.446 . . . . 73.32 111.153 179.879 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.469 ' HB2' ' HB2' ' A' ' 150' ' ' TYR . 83.6 m-85 -98.4 179.92 4.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.191 -0.459 . . . . 72.34 110.855 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . 0.424 ' CE2' ' HD2' ' A' ' 174' ' ' ARG . 0.4 OUTLIER -153.54 126.0 8.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.145 -0.479 . . . . 74.13 110.936 -179.829 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . 0.585 ' O ' ' HB2' ' A' ' 171' ' ' GLN . 27.0 tt0 -62.85 -28.1 69.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.125 -0.489 . . . . 74.44 110.926 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.733 ' HB3' ' HD2' ' A' ' 143' ' ' PRO . 9.4 mp -115.88 173.5 2.96 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.565 0.698 . . . . 73.03 110.928 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . 0.733 ' HD2' ' HB3' ' A' ' 142' ' ' LEU . 54.0 Cg_endo -69.73 -90.92 0.01 OUTLIER 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.653 2.235 . . . . 71.43 112.373 179.836 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . 0.727 ' O ' ' N ' ' A' ' 146' ' ' ARG . 1.6 m-80 -54.05 96.69 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 75.33 110.881 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . 0.652 ' C ' ' O ' ' A' ' 144' ' ' ASN . 5.8 m-85 11.87 53.1 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.157 -0.474 . . . . 74.32 110.895 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . 0.727 ' N ' ' O ' ' A' ' 144' ' ' ASN . 19.5 mtt-85 -116.8 170.41 8.63 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.113 -0.494 . . . . 74.13 110.88 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 70.39 -172.08 42.41 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.747 -0.74 . . . . 75.11 112.481 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.75 132.62 34.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.761 0.315 . . . . 73.42 110.897 -179.851 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . 0.616 ' OE1' ' HA ' ' A' ' 60' ' ' TYR . 0.8 OUTLIER -88.53 157.73 18.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.204 -0.453 . . . . 72.45 110.928 -179.922 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . 0.469 ' HB2' ' HB2' ' A' ' 139' ' ' PHE . 12.6 m-85 -122.84 141.48 51.82 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.187 -0.46 . . . . 71.14 110.891 -179.83 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.433 ' CA ' HD12 ' A' ' 61' ' ' ILE . 7.8 tp -76.16 123.65 26.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.105 -0.498 . . . . 75.33 110.858 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.712 HD13 ' HA ' ' A' ' 136' ' ' VAL . 0.0 OUTLIER -50.9 135.5 24.24 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.179 -0.464 . . . . 74.11 110.911 179.847 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -165.4 27.68 0.05 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.193 -0.458 . . . . 72.53 110.882 179.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.766 ' O ' ' HG3' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -114.88 -175.23 2.64 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.224 -0.444 . . . . 61.24 110.874 -179.993 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.766 ' HG3' ' O ' ' A' ' 154' ' ' LYS . 0.0 OUTLIER -161.02 -127.54 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.202 -0.454 . . . . 71.41 110.887 179.878 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.577 ' HG2' ' O ' ' A' ' 156' ' ' GLU . 2.9 tm-20 -68.54 6.0 0.92 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.245 -0.434 . . . . 74.15 110.895 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . 0.762 ' CE1' ' HA ' ' A' ' 154' ' ' LYS . 20.4 m-30 -34.61 152.85 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.141 -0.481 . . . . 75.21 110.869 -179.828 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . 0.458 ' O ' ' OG ' ' A' ' 129' ' ' SER . 0.0 OUTLIER -125.76 -35.74 2.48 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.132 -0.486 . . . . 73.32 110.865 -179.99 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -86.72 151.23 52.32 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.563 0.697 . . . . 73.32 110.866 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . 0.438 ' HB2' ' HD3' ' A' ' 168' ' ' PRO . 53.6 Cg_endo -69.74 -28.01 25.85 Favored 'Trans proline' 0 C--O 1.232 0.207 0 C-N-CA 122.658 2.238 . . . . 71.35 112.316 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.552 HD11 ' H ' ' A' ' 161' ' ' ILE . 3.6 mp -64.08 -11.75 10.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.258 -0.428 . . . . 73.11 111.133 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . 0.639 ' HB3' ' CD1' ' A' ' 157' ' ' TYR . 0.3 OUTLIER -75.32 -13.42 60.42 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.152 -0.477 . . . . 72.22 110.896 179.813 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' TRP . . . . . 0.44 ' CH2' ' CE1' ' A' ' 139' ' ' PHE . 3.4 m95 -87.16 0.16 55.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.227 -0.442 . . . . 72.05 110.93 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 91.64 -35.68 3.89 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.743 -0.741 . . . . 71.33 112.461 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -82.05 130.75 35.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.798 0.332 . . . . 61.53 111.144 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -39.01 -38.42 0.45 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.244 -0.435 . . . . 72.33 111.069 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' SER . . . . . 0.523 ' C ' ' H ' ' A' ' 169' ' ' ALA . 0.3 OUTLIER -128.35 156.35 76.99 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.666 0.746 . . . . 73.51 110.858 -179.765 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . 0.462 ' HG2' ' HB3' ' A' ' 126' ' ' GLU . 54.1 Cg_endo -69.72 27.86 0.18 Allowed 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.715 2.277 . . . . 75.34 112.332 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . 0.523 ' H ' ' C ' ' A' ' 167' ' ' SER . . . -68.27 104.61 1.89 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.246 -0.434 . . . . 74.42 111.111 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 3.4 t -152.94 164.37 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.188 -0.46 . . . . 72.54 111.149 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' GLN . . . . . 0.666 ' OE1' ' HB3' ' A' ' 143' ' ' PRO . 1.7 mm-40 -113.88 -85.79 0.59 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.244 -0.435 . . . . 74.11 110.867 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' SER . . . . . 0.72 ' OG ' ' O ' ' A' ' 143' ' ' PRO . 33.6 p -127.05 -179.53 4.89 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.198 -0.456 . . . . 73.52 110.863 -179.815 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -145.49 170.89 15.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.077 -0.511 . . . . 75.24 110.875 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . 0.424 ' HD2' ' CE2' ' A' ' 140' ' ' TYR . 0.0 OUTLIER -136.09 157.58 46.49 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.152 -0.477 . . . . 74.55 110.865 -179.89 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . 0.47 ' HD2' ' CE2' ' A' ' 94' ' ' TYR . 1.8 ptt180 -98.86 -171.93 2.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.142 -0.481 . . . . 74.42 110.905 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 3.5 mt -125.33 130.99 72.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.223 -0.444 . . . . 75.05 111.085 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 9.1 p -53.84 137.67 14.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.182 -0.463 . . . . 72.24 111.135 179.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.203 -0.453 . . . . 73.23 110.883 -179.951 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.796 0.331 . . . . 74.1 110.881 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.9 p -60.83 -68.6 0.29 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.196 -0.456 . . . . 63.43 110.87 -179.812 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 48.24 60.99 3.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.105 -0.498 . . . . 75.51 110.931 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 29.0 p -53.0 174.53 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.216 -0.447 . . . . 65.21 111.139 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -68.68 123.32 15.7 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.783 -0.723 . . . . 70.31 112.491 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.453 ' OG1' ' HB1' ' A' ' 85' ' ' ALA . 26.2 p -81.54 136.48 35.6 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.85 0.357 . . . . 74.43 111.165 -179.876 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 2.6 tttt -124.67 136.96 54.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.228 -0.442 . . . . 73.3 110.919 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.556 HD13 ' CE1' ' A' ' 10' ' ' PHE . 16.0 tt -136.98 148.98 26.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.219 -0.446 . . . . 71.44 111.168 179.862 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.502 HG21 ' CE2' ' A' ' 11' ' ' TYR . 19.0 m -132.58 137.36 47.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.218 -0.446 . . . . 72.31 111.184 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.556 ' CE1' HD13 ' A' ' 8' ' ' ILE . 0.5 OUTLIER -125.46 128.06 47.47 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.183 -0.462 . . . . 75.35 110.874 -179.982 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.553 ' CG ' ' HA ' ' A' ' 16' ' ' PHE . 17.0 m-85 -113.16 131.98 55.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.103 -0.499 . . . . 73.42 110.937 -179.831 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.44 ' HB2' ' HB2' ' A' ' 19' ' ' ARG . 0.0 OUTLIER -61.71 -14.53 32.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.162 -0.472 . . . . 74.33 110.852 -179.958 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.419 ' HB2' ' O ' ' A' ' 17' ' ' GLN . 77.4 m-20 -135.41 149.56 49.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.138 -0.483 . . . . 73.12 110.89 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.517 ' N ' ' HB3' ' A' ' 38' ' ' ASN . 30.3 mtmm -54.61 -176.68 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.224 -0.444 . . . . 73.5 110.874 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 16.5 m120 46.99 30.58 1.29 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.185 -0.461 . . . . 74.3 110.908 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.553 ' HA ' ' CG ' ' A' ' 11' ' ' TYR . 3.6 m-85 51.24 65.38 1.5 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.152 -0.477 . . . . 75.41 110.867 -180.0 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.419 ' O ' ' HB2' ' A' ' 13' ' ' ASP . 16.9 mt-30 -140.26 160.87 38.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.113 -0.494 . . . . 75.42 110.899 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 90.98 -147.99 19.16 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.736 -0.745 . . . . 73.42 112.519 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.44 ' HB2' ' HB2' ' A' ' 12' ' ' GLU . 0.0 OUTLIER -68.9 77.47 0.32 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.83 0.348 . . . . 71.11 110.908 -179.893 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.437 ' HB2' ' CE1' ' A' ' 11' ' ' TYR . 0.7 OUTLIER -77.83 127.82 33.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.148 -0.478 . . . . 75.1 110.846 -179.892 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.496 ' O ' ' HA ' ' A' ' 9' ' ' THR . 88.2 t80 -122.01 124.0 42.97 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.199 -0.455 . . . . 75.13 110.922 -179.889 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.498 ' CG ' HG23 ' A' ' 9' ' ' THR . 1.2 m-20 -120.19 134.37 55.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.1 -0.5 . . . . 74.23 110.86 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -167.49 134.32 2.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.199 -0.455 . . . . 70.0 110.889 -179.887 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -102.2 5.45 40.2 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.174 -0.466 . . . . 74.14 110.857 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 11.7 t -107.79 169.38 8.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.171 -0.468 . . . . 71.21 110.932 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -64.96 117.15 7.19 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.198 -0.455 . . . . 52.35 110.875 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.431 ' HB2' ' HB3' ' A' ' 30' ' ' PHE . 4.4 m -116.95 53.65 0.89 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.178 -0.465 . . . . 73.24 110.876 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.525 ' C ' ' HA ' ' A' ' 82' ' ' SER . . . -46.44 -20.72 0.13 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.176 -0.465 . . . . 74.25 111.126 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 57.0 t0 -128.3 42.71 3.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.21 -0.45 . . . . 72.31 110.877 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.76 ' O ' ' CD2' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -80.0 14.44 1.83 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.187 -0.461 . . . . 74.42 110.92 -179.905 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.511 ' HB2' ' HB3' ' A' ' 81' ' ' SER . 28.3 t60 -77.61 -40.13 43.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.104 -0.498 . . . . 74.23 110.853 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.6 t -56.15 -14.98 3.08 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.215 -0.448 . . . . 63.55 111.129 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -99.07 -27.23 13.93 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.258 -0.428 . . . . 65.22 110.896 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.415 ' CD1' ' O ' ' A' ' 19' ' ' ARG . 17.4 tp -141.97 135.84 29.75 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.146 -0.479 . . . . 74.3 110.909 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 20.5 m -99.36 -42.62 6.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 74.42 110.876 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -118.15 141.48 48.45 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.104 -0.498 . . . . 75.14 110.849 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.635 ' SG ' ' HB2' ' A' ' 80' ' ' LEU . 4.6 p -110.73 86.77 2.38 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.148 -0.478 . . . . 71.31 110.877 -179.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.517 ' HB3' ' N ' ' A' ' 14' ' ' LYS . 0.2 OUTLIER -77.97 -66.29 0.86 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.175 -0.466 . . . . 75.1 110.851 -179.863 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 6.1 p -117.08 123.11 46.01 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.201 -0.454 . . . . 63.22 110.84 -179.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.644 ' O ' ' HB2' ' A' ' 67' ' ' TYR . 27.2 mt -116.27 150.2 18.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.092 -0.503 . . . . 72.3 111.107 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.467 ' HD2' ' CE2' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -145.63 118.51 8.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.211 -0.45 . . . . 73.04 110.901 179.832 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.48 HG23 ' CB ' ' A' ' 8' ' ' ILE . 1.3 t -104.87 115.7 47.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.244 -0.435 . . . . 75.15 111.172 179.836 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -110.84 77.82 1.07 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.164 -0.471 . . . . 73.21 110.901 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.404 ' O ' ' HA ' ' A' ' 6' ' ' THR . . . 135.28 101.98 0.69 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.768 -0.729 . . . . 73.31 112.493 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 53.74 179.17 0.12 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.747 -0.739 . . . . 73.01 112.515 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.481 HG21 ' HA ' ' A' ' 63' ' ' PRO . 0.6 OUTLIER -79.67 172.61 13.56 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.819 0.342 . . . . 74.12 111.121 -179.885 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.518 ' CD1' ' HB ' ' A' ' 8' ' ' ILE . 14.8 m95 -144.07 130.2 19.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 73.54 110.906 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.516 ' O ' ' HA ' ' A' ' 83' ' ' CYS . . . -97.18 112.0 23.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.288 -0.415 . . . . 74.02 111.158 179.858 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.424 ' HA ' ' HA ' ' A' ' 83' ' ' CYS . 3.6 m -113.12 129.73 68.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.227 -0.442 . . . . 72.05 111.117 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.676 ' HB3' ' HA ' ' A' ' 56' ' ' ALA . 33.0 m-85 -95.78 148.59 22.42 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.156 -0.475 . . . . 74.44 110.92 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.636 ' OE1' ' HB3' ' A' ' 57' ' ' TRP . 35.1 tt0 -45.43 -80.85 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.099 -0.501 . . . . 73.35 110.885 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.615 ' HB3' ' CD2' ' A' ' 55' ' ' PHE . 0.3 OUTLIER -90.54 146.38 34.22 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.621 0.724 . . . . 74.5 110.88 -179.891 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.692 ' HA ' ' OG ' ' A' ' 82' ' ' SER . 54.2 Cg_endo -69.71 134.71 28.74 Favored 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.701 2.267 . . . . 74.5 112.38 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 1.5 t30 65.63 -9.84 0.23 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.214 -0.448 . . . . 75.15 110.884 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.615 ' CD2' ' HB3' ' A' ' 52' ' ' ARG . 4.7 m-30 -98.75 -24.16 15.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.173 -0.467 . . . . 75.22 110.914 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.676 ' HA ' ' HB3' ' A' ' 50' ' ' TYR . . . 56.62 20.83 5.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.102 -0.499 . . . . 72.12 111.141 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . 0.636 ' HB3' ' OE1' ' A' ' 51' ' ' GLU . 0.1 OUTLIER -50.7 -166.11 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.167 -0.47 . . . . 71.45 110.93 -179.958 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.633 ' HB2' ' CD ' ' A' ' 51' ' ' GLU . 6.9 m-30 -13.08 101.87 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.251 -0.431 . . . . 74.14 110.877 -179.866 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.73 154.24 42.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.12 -0.491 . . . . 75.22 110.883 179.881 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.422 ' CE2' ' HB3' ' A' ' 76' ' ' LEU . 5.1 t80 -173.72 102.13 0.11 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.213 -0.449 . . . . 73.34 110.906 -179.895 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.449 HD11 ' HA ' ' A' ' 151' ' ' LEU . 4.8 mp -88.21 118.71 34.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.093 -0.503 . . . . 73.21 111.076 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -83.61 129.59 59.21 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.603 0.716 . . . . 64.24 110.856 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.481 ' HA ' HG21 ' A' ' 46' ' ' THR . 53.3 Cg_endo -69.87 -172.34 0.58 Allowed 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.652 2.234 . . . . 65.44 112.288 179.878 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -88.74 161.9 16.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 73.4 110.911 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 112.07 -167.74 12.5 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.778 -0.725 . . . . 75.25 112.511 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -109.08 154.45 22.24 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.901 0.381 . . . . 71.21 110.862 -179.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.644 ' HB2' ' O ' ' A' ' 40' ' ' ILE . 14.6 m-85 -142.05 84.96 11.3 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.667 0.746 . . . . 74.02 110.925 -179.893 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.469 ' HD2' ' HG3' ' A' ' 72' ' ' ARG . 53.8 Cg_endo -69.73 -0.06 6.34 Favored 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.682 2.254 . . . . 64.01 112.335 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.537 ' HB2' ' HG2' ' A' ' 72' ' ' ARG . 47.9 mt-10 -156.5 143.53 18.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.226 -0.443 . . . . 71.12 110.891 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.73 ' HA ' ' NE1' ' A' ' 73' ' ' TRP . 35.9 p90 -54.43 -22.35 12.35 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.161 -0.472 . . . . 74.21 110.915 -179.836 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -79.55 -18.05 52.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.121 -0.491 . . . . 74.42 110.907 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.537 ' HG2' ' HB2' ' A' ' 69' ' ' GLU . 28.2 mmt180 -69.28 -7.75 39.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.453 . . . . 65.52 110.883 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . 0.73 ' NE1' ' HA ' ' A' ' 70' ' ' TYR . 0.0 OUTLIER -138.6 15.82 2.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.183 -0.462 . . . . 64.24 110.925 -179.971 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' MET . . . . . 0.431 ' C ' ' O ' ' A' ' 73' ' ' TRP . 0.0 OUTLIER 36.0 43.84 0.22 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.213 -0.449 . . . . 73.42 110.894 179.93 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -51.93 123.92 22.31 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.763 -0.732 . . . . 43.3 112.506 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.422 ' HB3' ' CE2' ' A' ' 60' ' ' TYR . 1.1 pt? -59.09 -33.2 70.56 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.803 0.335 . . . . 73.23 110.864 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.413 ' C ' ' H ' ' A' ' 79' ' ' ARG . 17.7 t-20 -147.49 139.43 24.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.239 -0.437 . . . . 75.41 110.902 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -78.12 18.51 0.51 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.168 -0.469 . . . . 75.01 110.896 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.413 ' H ' ' C ' ' A' ' 77' ' ' ASN . 0.1 OUTLIER -107.17 73.28 0.92 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.186 -0.461 . . . . 74.45 110.873 -179.895 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.635 ' HB2' ' SG ' ' A' ' 37' ' ' CYS . 0.0 OUTLIER -82.31 133.98 35.25 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.228 -0.442 . . . . 71.21 110.871 -179.955 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.576 ' OG ' ' HD3' ' A' ' 53' ' ' PRO . 0.9 OUTLIER -147.56 -126.34 0.06 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.173 -0.467 . . . . 71.41 110.889 -179.942 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.692 ' OG ' ' HA ' ' A' ' 53' ' ' PRO . 0.4 OUTLIER -29.88 123.34 0.17 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.148 -0.478 . . . . 72.5 110.866 -179.844 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . 0.516 ' HA ' ' O ' ' A' ' 48' ' ' ALA . 9.2 p -133.42 141.56 47.91 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.149 -0.478 . . . . 73.54 110.873 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.466 ' N ' ' O ' ' A' ' 48' ' ' ALA . 1.5 mmt85 -138.44 130.22 28.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.204 -0.453 . . . . 75.11 110.886 -179.872 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.453 ' HB1' ' OG1' ' A' ' 6' ' ' THR . . . -50.87 128.84 22.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.21 -0.45 . . . . 74.35 111.095 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.507 ' CG2' ' CB ' ' A' ' 48' ' ' ALA . 54.3 t -114.61 130.64 68.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.19 -0.459 . . . . 74.02 111.16 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . 0.458 ' O ' ' C ' ' A' ' 88' ' ' LEU . 72.1 m-70 -114.67 119.03 35.33 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.154 -0.475 . . . . 71.31 110.881 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.458 ' C ' ' O ' ' A' ' 87' ' ' HIS . 0.0 OUTLIER -33.64 146.1 0.12 Allowed Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.556 0.693 . . . . 74.51 110.915 -179.956 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.708 ' HA ' ' HA3' ' A' ' 135' ' ' GLY . 53.4 Cg_endo -69.74 -79.29 0.01 OUTLIER 'Trans proline' 0 C--O 1.231 0.151 0 C-N-CA 122.721 2.281 . . . . 74.43 112.306 179.879 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.48 ' H ' ' HG2' ' A' ' 89' ' ' PRO . 67.2 m -109.07 -178.56 3.61 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.183 -0.462 . . . . 74.11 110.893 -179.827 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -100.94 4.15 55.96 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.794 -0.717 . . . . 43.11 112.488 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -125.19 -55.43 0.17 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.744 -0.741 . . . . 73.35 112.523 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.493 ' HG3' ' OG1' ' A' ' 112' ' ' THR . 11.5 pt20 -165.88 -170.05 1.66 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.837 0.351 . . . . 74.22 110.888 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.774 ' CD2' ' HB2' ' A' ' 134' ' ' GLU . 38.8 t80 -116.43 106.07 13.21 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.199 -0.455 . . . . 74.34 110.919 -179.859 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.457 ' HA ' ' HB ' ' A' ' 112' ' ' THR . 36.7 tptt -74.95 126.2 30.49 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.131 -0.486 . . . . 74.3 110.913 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -149.1 140.92 17.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.228 -0.442 . . . . 75.12 111.122 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.433 ' HB2' ' O ' ' A' ' 131' ' ' LYS . 1.3 mt-30 -109.63 125.84 53.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.197 -0.456 . . . . 73.14 110.888 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 2.3 mp -106.05 132.86 52.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.153 -0.476 . . . . 72.51 111.15 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.711 ' HB2' ' HB2' ' A' ' 129' ' ' SER . 46.3 m-85 -119.38 150.45 40.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.18 -0.464 . . . . 73.4 110.925 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.544 ' HA ' ' CE ' ' A' ' 124' ' ' MET . 62.9 tt0 -85.15 -52.18 6.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.177 -0.465 . . . . 62.13 110.892 -179.873 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 40.7 mttt -105.48 166.47 10.41 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.099 -0.501 . . . . 75.13 110.868 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.409 ' HA2' ' OG ' ' A' ' 129' ' ' SER . . . -67.12 152.46 52.75 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.722 -0.751 . . . . 73.31 112.522 179.885 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.419 ' HA ' ' HB2' ' A' ' 158' ' ' ARG . 42.3 t0 66.78 46.16 1.76 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.829 0.347 . . . . 72.01 110.885 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.546 ' CD2' ' N ' ' A' ' 104' ' ' PHE . 0.3 OUTLIER 48.3 33.08 3.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.208 -0.451 . . . . 74.2 110.866 -179.904 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 57.8 m -96.5 160.82 14.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.16 -0.473 . . . . 72.4 110.846 -179.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 81.97 -143.74 23.39 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.712 -0.756 . . . . 61.44 112.479 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 38.1 tp60 -80.13 120.45 24.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.755 0.312 . . . . 73.43 110.877 -179.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 5.7 ttp -108.84 134.17 51.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.212 -0.449 . . . . 62.13 110.886 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -139.22 135.5 34.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.205 -0.452 . . . . 70.21 110.925 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -114.83 94.52 4.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.061 -0.518 . . . . 75.24 110.872 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 5.7 t -114.77 144.13 43.98 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.148 -0.478 . . . . 75.15 111.165 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.493 ' OG1' ' HG3' ' A' ' 93' ' ' GLN . 6.6 t -129.66 47.28 2.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.234 -0.439 . . . . 73.11 111.112 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -151.54 157.92 42.89 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.221 -0.445 . . . . 73.51 110.882 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.405 ' OD1' ' HG3' ' A' ' 175' ' ' ARG . 2.6 m-20 -56.2 148.46 18.21 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.112 -0.494 . . . . 75.01 110.874 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . 0.742 ' O ' ' HB2' ' A' ' 172' ' ' SER . 42.7 t -139.23 124.3 11.69 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.616 0.722 . . . . 71.31 110.899 -179.907 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.532 ' O ' ' C ' ' A' ' 143' ' ' PRO . 53.6 Cg_endo -69.78 -30.44 22.16 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.688 2.259 . . . . 75.43 112.322 -179.89 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.613 ' HB3' ' CB ' ' A' ' 120' ' ' GLU . 0.1 OUTLIER -149.18 106.72 3.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.201 -0.454 . . . . 42.13 110.853 -179.877 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.57 ' HB ' ' O ' ' A' ' 171' ' ' GLN . 3.9 tt -61.7 -30.48 48.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.127 -0.488 . . . . 74.42 111.1 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' MET . . . . . 0.701 ' O ' ' HA ' ' A' ' 123' ' ' HIS . 0.1 OUTLIER -91.02 -42.01 10.77 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.186 -0.461 . . . . 75.35 110.949 179.819 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.613 ' CB ' ' HB3' ' A' ' 117' ' ' SER . 2.9 tp10 -70.26 -11.79 61.15 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.201 -0.454 . . . . 74.44 110.861 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 29.8 mm100 -112.93 -52.14 2.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.183 -0.462 . . . . 63.12 110.966 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 30.9 m-85 -102.75 14.18 32.59 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.194 -0.457 . . . . 64.54 110.88 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . 0.701 ' HA ' ' O ' ' A' ' 119' ' ' MET . 21.5 m-70 47.13 25.11 0.48 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.118 -0.492 . . . . 74.43 110.835 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.544 ' CE ' ' HA ' ' A' ' 100' ' ' GLU . 0.0 OUTLIER -100.78 124.93 47.13 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.239 -0.437 . . . . 74.42 110.892 179.953 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 3.0 ptp85 -96.71 -35.05 11.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.257 -0.428 . . . . 74.2 110.838 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.463 ' HB3' ' HG2' ' A' ' 168' ' ' PRO . 34.8 mt-10 -145.54 115.52 7.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.18 -0.464 . . . . 64.13 110.859 -179.905 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.411 HD11 HD13 ' A' ' 118' ' ' ILE . 3.1 mm -74.13 100.45 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.121 -0.49 . . . . 74.44 111.11 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . 0.41 ' CD2' ' HG3' ' A' ' 168' ' ' PRO . 12.9 m170 -69.04 -36.21 77.46 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.138 -0.483 . . . . 75.1 110.867 179.85 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.711 ' HB2' ' HB2' ' A' ' 99' ' ' PHE . 19.3 m -134.03 144.18 48.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.193 -0.458 . . . . 74.31 110.875 -179.795 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . 0.629 ' O ' ' O ' ' A' ' 155' ' ' LYS . 1.4 m -140.31 114.65 9.24 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.124 -0.489 . . . . 74.33 110.925 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.513 ' HA ' ' O ' ' A' ' 155' ' ' LYS . 5.5 mtpp -110.22 150.63 28.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.178 -0.465 . . . . 72.44 110.92 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.47 ' HB ' ' O ' ' A' ' 131' ' ' LYS . 12.6 t 81.2 158.49 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.233 -0.44 . . . . 73.01 111.164 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.487 ' CD2' ' HG2' ' A' ' 155' ' ' LYS . 0.1 OUTLIER 176.27 124.29 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.213 -0.449 . . . . 72.35 110.96 179.957 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.774 ' HB2' ' CD2' ' A' ' 94' ' ' TYR . 3.7 mm-40 -86.8 -167.82 2.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.196 -0.456 . . . . 65.45 110.884 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . 0.708 ' HA3' ' HA ' ' A' ' 89' ' ' PRO . . . -48.77 -92.85 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.759 -0.734 . . . . 75.5 112.465 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.584 ' HA ' HD13 ' A' ' 152' ' ' LEU . 2.3 t -103.21 148.26 8.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.779 0.323 . . . . 73.24 111.17 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . 0.625 ' CD1' ' C ' ' A' ' 137' ' ' TRP . 0.0 OUTLIER -156.73 158.84 37.64 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.227 -0.442 . . . . 75.01 110.932 179.919 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.46 ' N ' ' CG ' ' A' ' 137' ' ' TRP . 5.0 mt -134.25 136.44 53.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.262 -0.426 . . . . 74.12 111.145 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.42 ' HB2' ' HB2' ' A' ' 150' ' ' TYR . 0.1 OUTLIER -102.15 160.36 14.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.157 -0.474 . . . . 72.31 110.848 179.983 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -129.33 115.51 17.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.124 -0.489 . . . . 70.11 110.908 -179.846 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . 0.578 ' O ' ' HB2' ' A' ' 171' ' ' GLN . 0.6 OUTLIER -54.91 -33.39 62.04 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.128 -0.487 . . . . 75.03 110.841 -179.983 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.725 ' HB3' ' HD2' ' A' ' 143' ' ' PRO . 8.8 mp -113.36 172.81 3.25 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.643 0.735 . . . . 74.02 110.914 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . 0.792 ' O ' ' OG ' ' A' ' 172' ' ' SER . 53.1 Cg_endo -69.78 -93.15 0.01 OUTLIER 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.7 2.266 . . . . 65.23 112.355 179.882 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . 0.745 ' O ' ' N ' ' A' ' 146' ' ' ARG . 0.3 OUTLIER -50.18 99.05 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.22 -0.445 . . . . 75.44 110.906 179.971 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . 0.643 ' C ' ' O ' ' A' ' 144' ' ' ASN . 34.5 m-85 11.59 52.23 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.199 -0.455 . . . . 75.43 110.942 -179.905 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . 0.745 ' N ' ' O ' ' A' ' 144' ' ' ASN . 12.4 mtp85 -117.86 172.14 7.59 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.128 -0.487 . . . . 73.33 110.892 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 80.11 -170.27 53.58 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.747 -0.739 . . . . 60.45 112.448 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -92.54 152.62 19.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.767 0.318 . . . . 75.05 110.881 -179.84 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 -88.25 150.34 23.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.256 -0.429 . . . . 73.24 110.893 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . 0.42 ' HB2' ' HB2' ' A' ' 139' ' ' PHE . 96.2 m-85 -130.5 122.42 27.62 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.164 -0.471 . . . . 75.52 110.906 -179.876 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.449 ' HA ' HD11 ' A' ' 61' ' ' ILE . 33.9 tp -62.49 134.51 56.51 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.098 -0.501 . . . . 75.32 110.946 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.621 ' CB ' ' HB3' ' A' ' 137' ' ' TRP . 0.0 OUTLIER -63.8 133.24 53.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.17 -0.468 . . . . 75.45 110.878 179.991 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -165.76 25.21 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.174 -0.466 . . . . 75.35 110.875 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.793 ' HA ' ' CE1' ' A' ' 157' ' ' TYR . 0.2 OUTLIER -106.65 -156.62 0.58 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.182 -0.463 . . . . 75.22 110.876 179.991 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.629 ' O ' ' O ' ' A' ' 130' ' ' CYS . 0.0 OUTLIER 168.9 -132.95 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.179 -0.464 . . . . 74.31 110.868 179.888 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.548 ' H ' ' HB3' ' A' ' 155' ' ' LYS . 2.6 tm-20 -61.57 3.29 0.14 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.176 -0.465 . . . . 64.42 110.886 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . 0.793 ' CE1' ' HA ' ' A' ' 154' ' ' LYS . 15.1 m-30 -34.37 150.22 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.184 -0.462 . . . . 64.23 110.865 -179.831 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . 0.537 ' O ' ' OG ' ' A' ' 129' ' ' SER . 0.0 OUTLIER -126.31 -38.69 2.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.073 -0.512 . . . . 74.34 110.84 -179.961 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . 0.432 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 0.3 OUTLIER -85.12 150.8 55.9 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.538 0.685 . . . . 73.15 110.915 179.969 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . 0.508 ' HB3' ' HB3' ' A' ' 168' ' ' PRO . 53.5 Cg_endo -69.78 -23.29 30.87 Favored 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.726 2.284 . . . . 65.33 112.339 179.892 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.473 HD11 ' H ' ' A' ' 161' ' ' ILE . 4.0 mp -75.47 -3.24 4.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.179 -0.464 . . . . 75.24 111.117 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . 0.687 ' HB3' ' CD1' ' A' ' 157' ' ' TYR . 0.3 OUTLIER -76.53 -14.44 60.02 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.164 -0.471 . . . . 74.1 110.838 179.911 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 11.4 t90 -94.61 2.24 55.62 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.226 -0.443 . . . . 74.54 110.875 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 90.42 -36.21 3.64 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.752 -0.737 . . . . 75.04 112.526 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -71.77 128.12 34.75 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.766 0.317 . . . . 70.14 111.137 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -42.16 -34.89 0.82 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.198 -0.456 . . . . 44.33 111.086 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' SER . . . . . 0.519 ' C ' ' H ' ' A' ' 169' ' ' ALA . 0.3 OUTLIER -131.25 157.84 76.96 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.663 0.744 . . . . 75.25 110.861 -179.771 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . 0.508 ' HB3' ' HB3' ' A' ' 160' ' ' PRO . 54.3 Cg_endo -69.69 21.46 0.17 Allowed 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.699 2.266 . . . . 74.21 112.406 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . 0.519 ' H ' ' C ' ' A' ' 167' ' ' SER . . . -62.47 102.05 0.29 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.181 -0.463 . . . . 74.53 111.129 179.881 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 2.8 t -154.12 155.63 5.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.188 -0.46 . . . . 74.15 111.129 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' GLN . . . . . 0.578 ' HB2' ' O ' ' A' ' 141' ' ' GLU . 1.5 tm0? -116.75 -134.71 0.34 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.162 -0.472 . . . . 75.33 110.935 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' SER . . . . . 0.792 ' OG ' ' O ' ' A' ' 143' ' ' PRO . 12.1 p -64.46 171.87 2.94 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.246 -0.434 . . . . 73.03 110.896 -179.843 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . 0.466 ' CG ' ' HH2' ' A' ' 137' ' ' TRP . 2.3 p90 -147.43 175.57 10.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.111 -0.495 . . . . 72.13 110.881 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . 0.437 ' HG2' ' O ' ' A' ' 174' ' ' ARG . 1.7 ptm180 -140.32 136.62 33.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.166 -0.47 . . . . 73.44 110.897 -179.912 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . 0.425 ' HB2' ' HB3' ' A' ' 94' ' ' TYR . 0.0 OUTLIER -105.56 138.26 42.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.18 -0.464 . . . . 73.21 110.881 -179.913 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . 0.447 HD11 ' C ' ' A' ' 136' ' ' VAL . 1.9 mt -79.44 144.93 10.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.194 -0.457 . . . . 75.04 111.138 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 4.6 p -136.19 156.28 36.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.175 -0.466 . . . . 72.12 111.135 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.146 -0.479 . . . . 74.44 110.884 -179.944 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.356 0 N-CA-C 112.531 -0.228 . . . . 73.129999999999995 112.531 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.494 ' C ' ' HE1' ' A' ' 47' ' ' TRP . 4.6 p -82.09 135.1 35.36 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.828 0.347 . . . . 73.430000000000007 111.151 -179.822 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 3.4 tttt -121.56 135.94 54.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.223 -0.444 . . . . 74.5 110.894 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.615 ' HB ' ' CD1' ' A' ' 47' ' ' TRP . 15.9 tt -136.78 153.39 30.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.208 -0.451 . . . . 51.539999999999999 111.127 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.524 ' HA ' ' O ' ' A' ' 21' ' ' TYR . 17.9 m -134.01 143.89 48.38 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.193 -0.458 . . . . 71.129999999999995 111.14 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.721 ' HB2' HD22 ' A' ' 34' ' ' LEU . 0.8 OUTLIER -131.28 127.9 38.71 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.203 -0.453 . . . . 71.430000000000007 110.894 -179.983 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.545 ' CG ' ' HA ' ' A' ' 16' ' ' PHE . 11.1 m-85 -113.19 132.51 55.46 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.161 -0.472 . . . . 71.120000000000005 110.868 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.424 ' HB2' ' HB2' ' A' ' 19' ' ' ARG . 0.0 OUTLIER -60.11 -16.07 28.89 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.102 -0.499 . . . . 73.420000000000002 110.876 179.998 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.437 ' HB2' ' O ' ' A' ' 17' ' ' GLN . 72.2 m-20 -134.68 150.54 50.64 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.174 -0.467 . . . . 71.109999999999999 110.847 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.489 ' N ' ' HB3' ' A' ' 38' ' ' ASN . 38.7 mtmt -55.25 -176.12 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.181 -0.463 . . . . 75.420000000000002 110.873 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 18.8 m120 46.54 32.48 1.65 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.193 -0.458 . . . . 70.329999999999998 110.869 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.545 ' HA ' ' CG ' ' A' ' 11' ' ' TYR . 3.0 m-85 49.68 63.94 1.96 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.174 -0.466 . . . . 72.540000000000006 110.887 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.437 ' O ' ' HB2' ' A' ' 13' ' ' ASP . 3.8 mt-30 -138.76 158.59 43.94 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.132 -0.485 . . . . 74.439999999999998 110.892 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 92.86 -148.86 19.25 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.716 -0.754 . . . . 32.350000000000001 112.473 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.75 ' O ' HD13 ' A' ' 34' ' ' LEU . 0.3 OUTLIER -69.04 78.06 0.33 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.767 0.318 . . . . 73.400000000000006 110.911 -179.861 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.486 ' HB2' ' CE1' ' A' ' 11' ' ' TYR . 0.6 OUTLIER -77.14 130.11 36.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.456 . . . . 73.430000000000007 110.891 -179.905 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.524 ' O ' ' HA ' ' A' ' 9' ' ' THR . 90.7 t80 -124.02 124.87 43.51 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.169 -0.469 . . . . 71.349999999999994 110.93 -179.845 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.446 ' CG ' HG23 ' A' ' 9' ' ' THR . 1.1 m-20 -121.9 134.45 54.86 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.109 -0.496 . . . . 64.349999999999994 110.833 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -167.86 135.81 2.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.167 -0.47 . . . . 73.530000000000001 110.882 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -101.27 0.04 36.62 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.212 -0.449 . . . . 73.120000000000005 110.863 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 16.5 t -104.37 164.88 11.42 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.172 -0.467 . . . . 64.540000000000006 110.914 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 35.6 m-20 -58.24 120.84 9.4 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.209 -0.451 . . . . 72.329999999999998 110.879 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.566 ' HB2' ' HB3' ' A' ' 30' ' ' PHE . 1.8 m -115.95 51.94 0.93 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.208 -0.451 . . . . 61.340000000000003 110.886 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.501 ' C ' ' HA ' ' A' ' 82' ' ' SER . . . -47.33 -21.27 0.27 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.223 -0.444 . . . . 74.140000000000001 111.083 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 56.8 t0 -128.54 42.33 3.34 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.223 -0.444 . . . . 63.420000000000002 110.866 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.785 ' CD2' ' O ' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -80.99 15.33 1.87 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.217 -0.447 . . . . 73.510000000000005 110.858 -179.852 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.48 ' HB2' ' HB3' ' A' ' 81' ' ' SER . 28.5 t60 -80.01 -39.57 29.68 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.142 -0.481 . . . . 74.209999999999994 110.885 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.7 t -57.93 -13.94 5.39 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.202 -0.454 . . . . 75.150000000000006 111.119 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -99.96 -27.14 13.73 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.27 -0.423 . . . . 73.329999999999998 110.907 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.75 HD13 ' O ' ' A' ' 19' ' ' ARG . 18.0 tp -142.65 136.31 28.97 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.162 -0.472 . . . . 70.219999999999999 110.916 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 23.8 m -98.81 -42.42 7.19 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.174 -0.467 . . . . 62.130000000000003 110.861 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -118.54 141.37 48.64 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.135 -0.484 . . . . 63.119999999999997 110.861 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.547 ' HB3' ' HB2' ' A' ' 80' ' ' LEU . 3.1 p -109.95 83.97 1.85 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.188 -0.46 . . . . 71.329999999999998 110.858 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.489 ' HB3' ' N ' ' A' ' 14' ' ' LYS . 0.2 OUTLIER -75.33 -70.64 0.41 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.157 -0.474 . . . . 52.119999999999997 110.872 -179.911 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 5.0 p -111.77 124.38 52.21 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.192 -0.458 . . . . 72.430000000000007 110.836 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.724 HD12 ' CH2' ' A' ' 73' ' ' TRP . 45.1 mt -117.67 148.36 20.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.123 -0.489 . . . . 72.510000000000005 111.149 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.464 ' HB3' ' HE2' ' A' ' 41' ' ' LYS . 0.0 OUTLIER -143.49 120.57 11.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.181 -0.463 . . . . 53.310000000000002 110.9 179.85 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.534 HG22 ' HB ' ' A' ' 8' ' ' ILE . 1.9 t -104.98 115.53 47.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.22 -0.446 . . . . 71.219999999999999 111.096 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -110.35 80.27 1.29 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.227 -0.442 . . . . 61.43 110.872 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.467 ' O ' ' HA ' ' A' ' 6' ' ' THR . . . 127.89 106.85 1.37 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.736 -0.745 . . . . 74.319999999999993 112.485 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 51.95 177.98 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.738 -0.744 . . . . 71.239999999999995 112.494 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.74 HG23 ' HA ' ' A' ' 63' ' ' PRO . 1.9 m -80.91 165.79 21.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.813 0.34 . . . . 61.210000000000001 111.112 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' TRP . . . . . 0.615 ' CD1' ' HB ' ' A' ' 8' ' ' ILE . 3.3 m95 -138.91 130.05 26.75 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.449 . . . . 74.150000000000006 110.901 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.802 ' HB2' ' CG2' ' A' ' 86' ' ' VAL . . . -94.09 129.66 40.56 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.214 -0.448 . . . . 64.329999999999998 111.103 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.63 HG11 ' CD1' ' A' ' 80' ' ' LEU . 12.5 m -126.86 131.32 71.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.259 -0.428 . . . . 74.099999999999994 111.121 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.777 ' HB3' ' HA ' ' A' ' 56' ' ' ALA . 42.1 m-85 -97.28 147.73 23.84 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.182 -0.463 . . . . 73.209999999999994 110.928 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.617 ' OE1' ' HB3' ' A' ' 57' ' ' TRP . 47.3 tt0 -49.97 -78.12 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.094 -0.503 . . . . 73.329999999999998 110.867 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.572 ' HB2' ' HB2' ' A' ' 57' ' ' TRP . 1.2 mtp180 -93.5 143.99 27.52 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.609 0.719 . . . . 75.430000000000007 110.875 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.748 ' HA ' ' OG ' ' A' ' 82' ' ' SER . 54.2 Cg_endo -69.71 141.11 44.54 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.754 2.303 . . . . 65.209999999999994 112.366 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 63.42 -11.13 0.1 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.238 -0.437 . . . . 71.239999999999995 110.903 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.6 ' H ' ' C ' ' A' ' 53' ' ' PRO . 2.5 m-30 -104.7 -20.58 13.59 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.168 -0.469 . . . . 64.319999999999993 110.899 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.777 ' HA ' ' HB3' ' A' ' 50' ' ' TYR . . . 50.29 25.58 1.9 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.134 -0.485 . . . . 71.299999999999997 111.09 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' TRP . . . . . 0.632 ' O ' ' C ' ' A' ' 58' ' ' TYR . 0.1 OUTLIER -49.21 -164.92 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.234 -0.439 . . . . 54.329999999999998 110.952 -179.929 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.632 ' C ' ' O ' ' A' ' 57' ' ' TRP . 7.0 m-30 -13.27 101.69 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.274 -0.421 . . . . 72.409999999999997 110.948 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.601 ' HB2' ' HA ' ' A' ' 150' ' ' TYR . 1.9 mpt? -65.45 157.56 29.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.136 -0.483 . . . . 74.439999999999998 110.936 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.795 ' CD2' HD12 ' A' ' 76' ' ' LEU . 3.2 t80 -175.01 101.37 0.08 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.255 -0.43 . . . . 71.430000000000007 110.927 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.708 HD11 ' HA ' ' A' ' 151' ' ' LEU . 4.4 mp -88.24 116.21 29.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.163 -0.471 . . . . 62.439999999999998 111.121 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.816 HD23 ' HD2' ' A' ' 63' ' ' PRO . 0.3 OUTLIER -80.33 128.24 73.57 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.605 0.717 . . . . 55.409999999999997 110.958 179.898 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.816 ' HD2' HD23 ' A' ' 62' ' ' LEU . 53.3 Cg_endo -69.78 -173.41 0.71 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.678 2.252 . . . . 65.040000000000006 112.357 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -88.44 161.6 16.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.265 -0.425 . . . . 74.239999999999995 110.924 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 112.64 -168.44 12.65 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.734 -0.746 . . . . 74.299999999999997 112.47 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -108.09 153.92 22.43 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.873 0.368 . . . . 74.140000000000001 110.915 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.613 ' HB2' ' O ' ' A' ' 40' ' ' ILE . 10.2 m-85 -143.48 83.83 10.51 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.625 0.726 . . . . 74.530000000000001 110.934 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.44 ' HD2' ' HG3' ' A' ' 72' ' ' ARG . 53.8 Cg_endo -69.77 0.78 5.16 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.679 2.253 . . . . 62.520000000000003 112.354 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.544 ' HB2' ' HG2' ' A' ' 72' ' ' ARG . 46.2 mt-10 -156.09 143.84 19.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.197 -0.456 . . . . 73.519999999999996 110.878 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.732 ' HA ' ' NE1' ' A' ' 73' ' ' TRP . 32.4 p90 -55.34 -21.98 17.37 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.157 -0.474 . . . . 74.150000000000006 110.944 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -79.14 -17.56 54.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.134 -0.484 . . . . 63.229999999999997 110.898 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.544 ' HG2' ' HB2' ' A' ' 69' ' ' GLU . 27.8 mmt180 -69.34 -8.11 43.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.185 -0.461 . . . . 71.329999999999998 110.889 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' TRP . . . . . 0.732 ' NE1' ' HA ' ' A' ' 70' ' ' TYR . 0.0 OUTLIER -136.94 18.99 3.01 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.169 -0.469 . . . . 75.140000000000001 110.876 -179.973 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 74' ' ' MET . . . . . 0.481 ' C ' ' O ' ' A' ' 73' ' ' TRP . 0.0 OUTLIER 32.11 47.71 0.09 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.255 -0.43 . . . . 74.099999999999994 110.835 179.921 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -59.92 120.38 22.48 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.71 -0.757 . . . . 75.340000000000003 112.531 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 1.043 HD13 ' N ' ' A' ' 77' ' ' ASN . 0.0 OUTLIER -63.56 -15.42 57.98 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.809 0.338 . . . . 73.420000000000002 110.937 -179.91 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 1.043 ' N ' HD13 ' A' ' 76' ' ' LEU . 35.5 t-20 -156.38 134.62 11.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.185 -0.461 . . . . 72.530000000000001 110.896 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -83.27 23.06 0.93 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.17 -0.468 . . . . 64.219999999999999 110.839 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 4.1 ttm-85 -110.16 80.77 1.34 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.232 -0.44 . . . . 74.540000000000006 110.886 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.63 ' CD1' HG11 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -87.91 133.99 33.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.224 -0.443 . . . . 73.310000000000002 110.871 -179.932 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.63 ' HB3' ' HB3' ' A' ' 53' ' ' PRO . 1.0 OUTLIER -150.32 -124.94 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.188 -0.46 . . . . 61.219999999999999 110.83 -179.96 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.748 ' OG ' ' HA ' ' A' ' 53' ' ' PRO . 0.1 OUTLIER -36.15 104.89 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.145 -0.48 . . . . 63.439999999999998 110.86 -179.784 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 83' ' ' CYS . . . . . 0.611 ' HB3' HG12 ' A' ' 49' ' ' VAL . 19.5 p -121.32 135.3 55.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.096 -0.502 . . . . 71.430000000000007 110.935 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.587 ' N ' ' O ' ' A' ' 48' ' ' ALA . 9.4 mmt85 -120.62 138.46 53.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.254 -0.43 . . . . 72.510000000000005 110.883 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.434 ' N ' ' CZ3' ' A' ' 47' ' ' TRP . . . -59.42 129.02 39.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.196 -0.457 . . . . 64.540000000000006 111.115 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.894 ' CG1' HG11 ' A' ' 136' ' ' VAL . 40.9 t -113.24 129.9 68.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.239 -0.437 . . . . 64.230000000000004 111.085 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' HIS . . . . . 0.552 ' O ' HG23 ' A' ' 136' ' ' VAL . 82.9 m-70 -111.52 107.46 16.65 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.154 -0.476 . . . . 73.140000000000001 110.892 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.488 ' H ' HD23 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -32.66 141.86 0.18 Allowed Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.645 0.736 . . . . 64.209999999999994 110.904 -179.92 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.471 ' HB3' ' H ' ' A' ' 136' ' ' VAL . 53.4 Cg_endo -69.79 98.02 0.67 Allowed 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.693 2.262 . . . . 63.509999999999998 112.329 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -100.76 138.72 37.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.231 -0.441 . . . . 70.439999999999998 110.831 -179.808 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 105.1 115.81 4.13 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.707 -0.759 . . . . 74.230000000000004 112.51 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 52.31 48.33 54.2 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.684 -0.769 . . . . 42.200000000000003 112.514 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 24.7 pt20 38.95 -153.31 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.778 0.323 . . . . 75.239999999999995 110.924 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.62 ' HA ' ' CG ' ' A' ' 134' ' ' GLU . 33.0 t80 -106.23 104.08 13.7 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.229 -0.441 . . . . 73.120000000000005 110.903 -179.845 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.467 ' H ' ' CG ' ' A' ' 134' ' ' GLU . 33.5 tptt -96.92 132.23 42.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.153 -0.476 . . . . 70.329999999999998 110.906 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.415 HD12 ' OH ' ' A' ' 94' ' ' TYR . 0.2 OUTLIER -149.42 135.91 12.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.197 -0.456 . . . . 72.129999999999995 111.166 179.891 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.587 ' HB2' HG23 ' A' ' 132' ' ' VAL . 0.8 OUTLIER -107.31 132.5 53.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.195 -0.457 . . . . 75.430000000000007 110.898 179.983 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.581 HD13 HD11 ' A' ' 118' ' ' ILE . 2.8 mt -118.18 130.84 72.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.234 -0.439 . . . . 75.219999999999999 111.149 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.688 ' HB2' ' HB2' ' A' ' 129' ' ' SER . 5.7 m-85 -120.21 152.59 37.49 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.141 -0.481 . . . . 72.340000000000003 110.948 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 70.7 tt0 -81.06 -68.83 0.65 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.206 -0.452 . . . . 61.200000000000003 110.865 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.526 ' C ' ' HB2' ' A' ' 128' ' ' HIS . 33.1 mttt -89.19 166.3 13.9 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.186 -0.461 . . . . 63.350000000000001 110.888 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -80.25 160.99 44.72 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.746 -0.74 . . . . 64.109999999999999 112.504 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.444 ' HA ' ' HB2' ' A' ' 158' ' ' ARG . 41.1 t0 66.08 52.05 1.23 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.81 0.338 . . . . 74.109999999999999 110.878 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.639 ' CE1' ' HD2' ' A' ' 131' ' ' LYS . 6.9 m-85 48.19 33.23 3.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.2 -0.455 . . . . 73.430000000000007 110.862 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.461 ' C ' ' HB2' ' A' ' 101' ' ' LYS . 43.8 m -108.97 155.53 20.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.125 -0.489 . . . . 61.5 110.875 -179.8 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 89.52 -163.83 31.4 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.776 -0.726 . . . . 72.430000000000007 112.488 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -76.36 123.49 26.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.794 0.33 . . . . 54.210000000000001 110.931 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 3.5 ttp -107.71 131.42 54.44 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.187 -0.46 . . . . 71.030000000000001 110.897 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -133.79 137.02 44.88 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.208 -0.451 . . . . 73.450000000000003 110.95 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -117.04 107.47 14.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.143 -0.48 . . . . 62.439999999999998 110.841 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 10.1 t -123.04 155.98 35.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.133 -0.485 . . . . 75.239999999999995 111.104 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.423 ' HA ' ' O ' ' A' ' 94' ' ' TYR . 1.7 t -135.47 45.68 2.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.208 -0.451 . . . . 73.219999999999999 111.132 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -152.72 158.66 42.64 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.229 -0.441 . . . . 73.540000000000006 110.87 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -51.33 156.4 1.2 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.126 -0.488 . . . . 62.140000000000001 110.862 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' CYS . . . . . 0.526 ' O ' ' HB2' ' A' ' 172' ' ' SER . 39.7 t -146.42 113.28 4.4 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.632 0.729 . . . . 52.020000000000003 110.862 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.419 ' O ' ' C ' ' A' ' 143' ' ' PRO . 53.4 Cg_endo -69.74 -30.71 21.93 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.665 2.243 . . . . 75.129999999999995 112.333 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.653 ' HB3' ' CB ' ' A' ' 120' ' ' GLU . 0.1 OUTLIER -149.57 101.35 3.08 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.211 -0.449 . . . . 75.329999999999998 110.848 -179.815 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.639 HD13 HD11 ' A' ' 127' ' ' ILE . 3.0 tt -54.66 -29.74 21.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.175 -0.466 . . . . 74.219999999999999 111.163 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' MET . . . . . 0.581 ' O ' ' HA ' ' A' ' 123' ' ' HIS . 0.6 OUTLIER -86.53 -45.08 11.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.145 -0.48 . . . . 72.329999999999998 110.899 179.817 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.653 ' CB ' ' HB3' ' A' ' 117' ' ' SER . 6.6 tp10 -65.78 -12.87 57.55 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.245 -0.434 . . . . 70.340000000000003 110.887 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 27.8 tp60 -114.51 -51.17 2.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.176 -0.466 . . . . 75.540000000000006 110.872 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.459 ' HB2' ' O ' ' A' ' 118' ' ' ILE . 44.0 m-85 -102.89 -19.65 14.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.197 -0.456 . . . . 73.200000000000003 110.872 -179.884 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' HIS . . . . . 0.581 ' HA ' ' O ' ' A' ' 119' ' ' MET . 29.6 m-70 71.72 28.63 2.69 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.16 -0.473 . . . . 73.219999999999999 110.896 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.412 ' HB3' ' CD1' ' A' ' 127' ' ' ILE . 10.7 mtt -103.95 85.94 2.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.234 -0.439 . . . . 63.049999999999997 110.91 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 4.0 ptp180 -51.44 -38.11 52.01 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.205 -0.452 . . . . 72.439999999999998 110.859 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.473 ' HG2' ' HA ' ' A' ' 169' ' ' ALA . 13.2 mt-10 -142.23 133.03 25.61 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.17 -0.468 . . . . 73.129999999999995 110.858 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.639 HD11 HD13 ' A' ' 118' ' ' ILE . 3.8 mm -92.08 97.07 6.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.155 -0.475 . . . . 70.239999999999995 111.13 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' HIS . . . . . 0.526 ' HB2' ' C ' ' A' ' 101' ' ' LYS . 0.6 OUTLIER -67.75 -34.04 76.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.133 -0.485 . . . . 73.120000000000005 110.891 179.857 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 129' ' ' SER . . . . . 0.688 ' HB2' ' HB2' ' A' ' 99' ' ' PHE . 58.2 m -129.43 136.61 50.15 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.184 -0.462 . . . . 75.239999999999995 110.868 -179.822 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' CYS . . . . . 0.526 ' O ' ' O ' ' A' ' 155' ' ' LYS . 3.4 m -131.74 119.93 22.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.128 -0.487 . . . . 64.299999999999997 110.894 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.693 ' HA ' ' HA ' ' A' ' 156' ' ' GLU . 2.0 mtpp -115.45 150.71 36.02 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.179 -0.464 . . . . 72.329999999999998 110.911 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.587 HG23 ' HB2' ' A' ' 97' ' ' GLN . 16.4 t 83.59 163.42 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.198 -0.456 . . . . 51.310000000000002 111.137 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.822 HD13 ' O ' ' A' ' 154' ' ' LYS . 0.0 OUTLIER -174.86 123.67 0.25 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.163 -0.471 . . . . 75.319999999999993 110.899 179.994 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.62 ' CG ' ' HA ' ' A' ' 94' ' ' TYR . 0.0 OUTLIER -91.86 172.85 8.19 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.231 -0.441 . . . . 73.439999999999998 110.894 179.923 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -41.96 -47.25 5.2 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.696 -0.764 . . . . 73.340000000000003 112.466 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.894 HG11 ' CG1' ' A' ' 86' ' ' VAL . 5.2 t -148.87 142.54 18.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.819 0.342 . . . . 75.120000000000005 111.093 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 137' ' ' TRP . . . . . 0.712 ' HB3' ' CB ' ' A' ' 152' ' ' LEU . 25.0 t90 -149.43 148.17 29.13 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.142 -0.481 . . . . 73.25 110.925 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.683 HG12 HD13 ' A' ' 61' ' ' ILE . 20.3 mt -125.75 132.5 70.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.224 -0.444 . . . . 75.340000000000003 111.175 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.673 ' CE1' HG11 ' A' ' 170' ' ' VAL . 0.1 OUTLIER -100.84 152.98 19.87 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.169 -0.468 . . . . 63.049999999999997 110.866 179.981 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 140' ' ' TYR . . . . . 0.502 ' CD2' ' HA ' ' A' ' 145' ' ' TYR . 0.8 OUTLIER -129.14 127.16 40.85 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.146 -0.479 . . . . 74.209999999999994 110.922 -179.832 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 141' ' ' GLU . . . . . 0.632 ' O ' ' HB2' ' A' ' 171' ' ' GLN . 0.6 OUTLIER -61.63 -25.86 67.63 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.14 -0.482 . . . . 63.0 110.884 179.998 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.711 ' HB3' ' HD2' ' A' ' 143' ' ' PRO . 9.3 mp -114.64 173.07 3.09 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.659 0.742 . . . . 71.340000000000003 110.891 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 143' ' ' PRO . . . . . 0.735 ' O ' ' OG ' ' A' ' 172' ' ' SER . 53.8 Cg_endo -69.77 -90.34 0.0 OUTLIER 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.665 2.243 . . . . 73.319999999999993 112.349 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 144' ' ' ASN . . . . . 0.697 ' O ' ' N ' ' A' ' 146' ' ' ARG . 1.0 OUTLIER -51.88 97.73 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.247 -0.433 . . . . 73.299999999999997 110.903 179.993 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 145' ' ' TYR . . . . . 0.636 ' C ' ' O ' ' A' ' 144' ' ' ASN . 0.1 OUTLIER 12.46 53.19 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.215 -0.448 . . . . 74.120000000000005 110.883 -179.941 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 146' ' ' ARG . . . . . 0.697 ' N ' ' O ' ' A' ' 144' ' ' ASN . 20.7 mtt180 -120.4 173.54 7.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.175 -0.466 . . . . 72.400000000000006 110.851 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 79.83 179.51 52.42 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.712 -0.756 . . . . 74.340000000000003 112.49 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -74.02 146.58 43.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.799 0.333 . . . . 73.200000000000003 110.894 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 149' ' ' GLN . . . . . 0.644 ' CD ' HG21 ' A' ' 138' ' ' ILE . 16.8 mt-30 -85.92 153.86 21.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.455 . . . . 74.299999999999997 110.895 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 150' ' ' TYR . . . . . 0.601 ' HA ' ' HB2' ' A' ' 59' ' ' MET . 76.8 m-85 -135.12 122.3 21.51 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.191 -0.458 . . . . 72.439999999999998 110.964 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.708 ' HA ' HD11 ' A' ' 61' ' ' ILE . 33.5 tp -66.55 135.94 54.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.067 -0.515 . . . . 70.200000000000003 110.935 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.944 HD13 ' O ' ' A' ' 152' ' ' LEU . 0.0 OUTLIER -70.08 133.97 47.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.223 -0.444 . . . . 75.430000000000007 110.878 179.906 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -163.21 25.42 0.09 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.167 -0.469 . . . . 75.219999999999999 110.853 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.822 ' O ' HD13 ' A' ' 133' ' ' LEU . 0.1 OUTLIER -113.03 -169.42 1.48 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.15 -0.477 . . . . 74.409999999999997 110.888 179.993 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.809 ' CG ' HD22 ' A' ' 133' ' ' LEU . 0.6 OUTLIER -167.25 -122.06 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.245 -0.434 . . . . 74.219999999999999 110.925 179.866 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.693 ' HA ' ' HA ' ' A' ' 131' ' ' LYS . 0.7 OUTLIER -73.03 -1.26 16.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.241 -0.436 . . . . 75.150000000000006 110.832 179.976 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 157' ' ' TYR . . . . . 0.723 ' CE1' ' HA ' ' A' ' 154' ' ' LYS . 20.1 m-30 -27.26 141.03 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.195 -0.457 . . . . 73.409999999999997 110.892 -179.799 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 158' ' ' ARG . . . . . 0.561 ' O ' ' OG ' ' A' ' 129' ' ' SER . 9.9 ptp180 -107.62 -41.14 5.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.129 -0.487 . . . . 51.350000000000001 110.868 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -87.43 150.34 48.73 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.562 0.696 . . . . 55.310000000000002 110.902 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 160' ' ' PRO . . . . . 0.494 ' HB3' ' HB3' ' A' ' 168' ' ' PRO . 53.7 Cg_endo -69.8 -24.17 29.8 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.64 2.227 . . . . 75.219999999999999 112.371 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.613 HD12 ' H ' ' A' ' 161' ' ' ILE . 3.6 mp -69.25 -10.82 14.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.23 -0.441 . . . . 72.530000000000001 111.107 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.644 ' HB3' ' CD1' ' A' ' 157' ' ' TYR . 0.5 OUTLIER -75.79 -14.11 60.3 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.19 -0.459 . . . . 65.540000000000006 110.869 179.879 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 163' ' ' TRP . . . . . 0.43 ' CE3' ' HB3' ' A' ' 165' ' ' ALA . 24.8 t90 -88.69 -12.7 41.6 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.189 -0.459 . . . . 72.310000000000002 110.933 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 106.66 -37.03 4.03 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.751 -0.738 . . . . 42.520000000000003 112.487 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.43 ' HB3' ' CE3' ' A' ' 163' ' ' TRP . . . -77.1 126.77 31.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.796 0.331 . . . . 63.229999999999997 111.062 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 166' ' ' ALA . . . . . 0.4 ' C ' ' O ' ' A' ' 165' ' ' ALA . . . -37.56 -41.36 0.46 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 74.430000000000007 111.101 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 167' ' ' SER . . . . . 0.489 ' C ' ' H ' ' A' ' 169' ' ' ALA . 0.3 OUTLIER -130.28 155.64 80.6 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.66 0.743 . . . . 75.549999999999997 110.82 -179.778 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 168' ' ' PRO . . . . . 0.494 ' HB3' ' HB3' ' A' ' 160' ' ' PRO . 53.6 Cg_endo -69.78 27.29 0.18 Allowed 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.674 2.249 . . . . 72.140000000000001 112.312 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 0.489 ' H ' ' C ' ' A' ' 167' ' ' SER . . . -65.63 104.6 1.06 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.213 -0.449 . . . . 70.299999999999997 111.147 179.839 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.673 HG11 ' CE1' ' A' ' 139' ' ' PHE . 2.8 t -151.75 161.97 3.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.21 -0.45 . . . . 72.109999999999999 111.127 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 171' ' ' GLN . . . . . 0.632 ' HB2' ' O ' ' A' ' 141' ' ' GLU . 1.8 tm0? -109.4 -82.08 0.57 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.213 -0.449 . . . . 75.519999999999996 110.91 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 172' ' ' SER . . . . . 0.735 ' OG ' ' O ' ' A' ' 143' ' ' PRO . 21.6 p -130.87 176.22 8.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.208 -0.451 . . . . 52.399999999999999 110.831 -179.786 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 173' ' ' PHE . . . . . 0.469 ' HB3' ' CD1' ' A' ' 139' ' ' PHE . 32.2 p90 -144.31 173.78 11.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.114 -0.494 . . . . 74.439999999999998 110.885 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 174' ' ' ARG . . . . . 0.443 ' HG2' ' CE2' ' A' ' 140' ' ' TYR . 0.0 OUTLIER -147.4 141.36 25.9 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.152 -0.476 . . . . 75.140000000000001 110.88 -179.883 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 175' ' ' ARG . . . . . 0.494 HH12 HG12 ' A' ' 177' ' ' VAL . 0.0 OUTLIER -86.32 -177.23 6.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.18 -0.464 . . . . 73.230000000000004 110.909 -179.945 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 176' ' ' ILE . . . . . 0.483 HD11 HG13 ' A' ' 138' ' ' ILE . 2.9 mt -132.51 139.09 50.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.215 -0.448 . . . . 61.450000000000003 111.11 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.494 HG12 HH12 ' A' ' 175' ' ' ARG . 2.1 p -149.32 155.4 8.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.185 -0.461 . . . . 64.400000000000006 111.173 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.2 -0.455 . . . . 74.230000000000004 110.859 -179.96 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.318 0 N-CA-C 112.492 -0.243 . . . . 63.020000000000003 112.492 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.439 ' HB ' ' O ' ' A' ' 44' ' ' GLY . 12.2 p -82.23 133.11 35.24 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.839 0.352 . . . . 71.109999999999999 111.134 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 3.1 tttt -122.37 138.33 54.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.241 -0.436 . . . . 71.340000000000003 110.888 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.593 ' HB ' ' CD1' ' A' ' 47' ' ' TRP . 12.5 tt -136.64 149.75 26.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.233 -0.44 . . . . 70.310000000000002 111.142 179.883 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.521 HG22 ' CE2' ' A' ' 11' ' ' TYR . 24.8 m -133.62 129.13 36.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.181 -0.463 . . . . 71.200000000000003 111.139 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.867 ' HB2' HD22 ' A' ' 34' ' ' LEU . 0.4 OUTLIER -117.3 131.89 56.72 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.208 -0.451 . . . . 75.299999999999997 110.845 -179.977 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.538 ' CG ' ' HA ' ' A' ' 16' ' ' PHE . 44.1 m-85 -114.95 132.35 56.6 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.138 -0.483 . . . . 74.25 110.94 -179.834 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.477 ' HG2' ' HB2' ' A' ' 36' ' ' ARG . 0.0 OUTLIER -61.98 -24.63 67.14 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.162 -0.472 . . . . 70.540000000000006 110.876 -179.949 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 65.7 m-20 -126.12 150.42 48.25 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.16 -0.473 . . . . 72.310000000000002 110.836 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.537 ' N ' ' HB3' ' A' ' 38' ' ' ASN . 4.6 mtmm -55.04 -179.83 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.189 -0.46 . . . . 75.519999999999996 110.866 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 52.0 m-80 49.38 38.46 14.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.233 -0.44 . . . . 53.25 110.889 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.538 ' HA ' ' CG ' ' A' ' 11' ' ' TYR . 3.4 m-85 45.14 60.17 3.13 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.17 -0.468 . . . . 63.520000000000003 110.859 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -136.46 160.06 39.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.142 -0.481 . . . . 63.43 110.906 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 92.84 -150.99 20.26 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.751 -0.738 . . . . 50.200000000000003 112.518 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.767 ' O ' HD13 ' A' ' 34' ' ' LEU . 0.0 OUTLIER -67.49 79.62 0.17 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.812 0.339 . . . . 71.230000000000004 110.905 -179.888 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.44 ' HB2' ' CE1' ' A' ' 11' ' ' TYR . 0.7 OUTLIER -78.95 125.9 29.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 63.409999999999997 110.857 -179.897 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.483 ' CD2' ' CD2' ' A' ' 30' ' ' PHE . 82.4 t80 -121.18 124.35 44.5 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.182 -0.463 . . . . 75.140000000000001 110.905 -179.841 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.441 ' CG ' HG23 ' A' ' 9' ' ' THR . 1.0 OUTLIER -119.22 134.62 55.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.131 -0.486 . . . . 70.540000000000006 110.885 179.877 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -166.75 135.71 2.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.231 -0.44 . . . . 72.510000000000005 110.851 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -105.07 5.72 32.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.187 -0.461 . . . . 72.140000000000001 110.882 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 12.1 t -108.73 168.38 9.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.168 -0.469 . . . . 53.43 110.886 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 78.8 m-20 -64.64 116.72 6.5 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.232 -0.44 . . . . 74.340000000000003 110.887 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.477 ' HB2' ' HB3' ' A' ' 30' ' ' PHE . 7.4 m -119.42 54.4 0.99 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.203 -0.453 . . . . 74.510000000000005 110.872 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.539 ' C ' ' HA ' ' A' ' 82' ' ' SER . . . -45.88 -20.28 0.08 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.183 -0.462 . . . . 72.329999999999998 111.095 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.406 ' N ' ' C ' ' A' ' 27' ' ' CYS . 59.7 t0 -128.32 43.56 3.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.224 -0.444 . . . . 75.409999999999997 110.879 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.776 ' CD2' ' O ' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -80.97 14.72 2.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.174 -0.466 . . . . 74.019999999999996 110.884 -179.873 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.489 ' HB2' ' HB3' ' A' ' 53' ' ' PRO . 27.6 t60 -77.72 -38.66 46.7 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.159 -0.473 . . . . 74.230000000000004 110.845 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.6 t -58.22 -12.57 3.73 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.208 -0.451 . . . . 73.230000000000004 111.121 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -101.48 -28.37 12.6 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.18 -0.464 . . . . 75.450000000000003 110.941 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.867 HD22 ' HB2' ' A' ' 10' ' ' PHE . 16.0 tp -141.15 141.7 34.12 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.149 -0.478 . . . . 72.010000000000005 110.927 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -111.57 -31.11 7.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.187 -0.46 . . . . 70.209999999999994 110.908 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.485 ' O ' HD21 ' A' ' 34' ' ' LEU . 1.6 mtp85 -116.78 142.41 46.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.092 -0.504 . . . . 74.219999999999999 110.845 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.643 ' SG ' ' HB2' ' A' ' 80' ' ' LEU . 1.8 p -118.99 51.44 1.12 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.188 -0.46 . . . . 72.340000000000003 110.864 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.537 ' HB3' ' N ' ' A' ' 14' ' ' LYS . 1.9 m-80 -52.35 -62.68 1.48 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.165 -0.471 . . . . 54.140000000000001 110.896 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.433 ' HB2' ' HA ' ' A' ' 68' ' ' PRO . 9.3 p -121.8 127.78 50.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.201 -0.454 . . . . 75.010000000000005 110.809 -179.815 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.592 HG21 HD13 ' A' ' 62' ' ' LEU . 4.5 mt -127.15 148.59 31.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.124 -0.489 . . . . 65.010000000000005 111.135 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.46 122.0 15.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.17 -0.468 . . . . 74.129999999999995 110.863 179.84 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.585 ' CG2' HD12 ' A' ' 8' ' ' ILE . 0.9 OUTLIER -103.92 117.43 49.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.189 -0.459 . . . . 62.43 111.145 179.876 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -112.44 81.14 1.43 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.223 -0.444 . . . . 73.239999999999995 110.89 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.439 ' O ' ' HB ' ' A' ' 6' ' ' THR . . . 130.63 100.02 0.86 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.736 -0.745 . . . . 71.129999999999995 112.534 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 55.21 175.85 0.14 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.712 -0.756 . . . . 64.420000000000002 112.491 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.75 HG23 ' HA ' ' A' ' 63' ' ' PRO . 5.9 m -80.29 165.99 21.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.812 0.339 . . . . 65.540000000000006 111.137 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' TRP . . . . . 0.593 ' CD1' ' HB ' ' A' ' 8' ' ' ILE . 14.6 m95 -136.76 129.94 31.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.208 -0.451 . . . . 62.409999999999997 110.909 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.656 ' HB2' ' CG2' ' A' ' 86' ' ' VAL . . . -97.46 114.06 25.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.456 . . . . 72.019999999999996 111.111 179.843 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.921 HG11 HD11 ' A' ' 80' ' ' LEU . 5.1 m -116.8 134.04 61.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.243 -0.435 . . . . 70.140000000000001 111.151 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.741 ' HB3' ' HA ' ' A' ' 56' ' ' ALA . 35.1 m-85 -97.07 151.86 19.33 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.185 -0.461 . . . . 72.319999999999993 110.954 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.59 ' HB2' ' O ' ' A' ' 58' ' ' TYR . 8.8 tt0 -47.76 -78.84 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.143 -0.48 . . . . 55.0 110.892 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.618 ' HB3' ' CD1' ' A' ' 55' ' ' PHE . 4.7 mtp180 -90.25 143.95 30.33 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.656 0.741 . . . . 64.099999999999994 110.826 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.756 ' HA ' ' OG ' ' A' ' 82' ' ' SER . 53.9 Cg_endo -69.75 134.56 28.29 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.66 2.24 . . . . 62.509999999999998 112.372 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 66.2 -8.55 0.34 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.233 -0.439 . . . . 74.209999999999994 110.847 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.618 ' CD1' ' HB3' ' A' ' 52' ' ' ARG . 4.6 m-30 -101.75 -26.81 13.35 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.216 -0.447 . . . . 54.329999999999998 110.919 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.741 ' HA ' ' HB3' ' A' ' 50' ' ' TYR . . . 58.71 22.87 10.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.145 -0.479 . . . . 75.239999999999995 111.109 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' TRP . . . . . 0.645 ' O ' ' C ' ' A' ' 58' ' ' TYR . 2.4 m95 -52.17 -165.89 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.251 -0.432 . . . . 64.530000000000001 110.925 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.645 ' C ' ' O ' ' A' ' 57' ' ' TRP . 6.5 m-30 -12.46 103.62 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.231 -0.441 . . . . 74.310000000000002 110.936 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.523 ' HB2' ' O ' ' A' ' 149' ' ' GLN . 2.5 mpt? -62.29 147.48 47.99 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.128 -0.487 . . . . 73.040000000000006 110.903 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.617 ' O ' HG23 ' A' ' 49' ' ' VAL . 0.3 OUTLIER -164.29 92.27 0.64 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.236 -0.438 . . . . 74.209999999999994 110.865 -179.88 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.716 ' N ' HD12 ' A' ' 61' ' ' ILE . 1.6 mp -85.06 120.2 35.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.154 -0.475 . . . . 61.539999999999999 111.117 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.817 HD23 ' HD2' ' A' ' 63' ' ' PRO . 0.3 OUTLIER -87.55 126.15 62.96 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-O 121.658 0.742 . . . . 72.450000000000003 110.878 179.91 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.817 ' HD2' HD23 ' A' ' 62' ' ' LEU . 53.5 Cg_endo -69.83 -168.03 0.26 Allowed 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.684 2.256 . . . . 70.430000000000007 112.307 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.05 161.12 14.57 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.24 -0.437 . . . . 62.549999999999997 110.931 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 111.66 -157.52 14.9 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.775 -0.726 . . . . 64.409999999999997 112.507 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 5.3 mp0 -115.0 158.75 21.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.85 0.357 . . . . 64.400000000000006 110.904 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.472 ' N ' ' O ' ' A' ' 40' ' ' ILE . 7.2 m-85 -149.52 79.73 7.93 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 121.676 0.75 . . . . 75.230000000000004 110.976 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.532 ' HD2' ' HG3' ' A' ' 72' ' ' ARG . 53.6 Cg_endo -69.81 1.11 4.77 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.7 2.266 . . . . 65.439999999999998 112.29 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 86.3 mt-10 -159.15 154.36 25.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.25 -0.432 . . . . 74.329999999999998 110.903 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.836 ' O ' ' CD1' ' A' ' 73' ' ' TRP . 25.6 p90 -65.39 -12.19 49.75 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.135 -0.484 . . . . 75.519999999999996 110.949 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -86.75 -13.65 44.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.127 -0.488 . . . . 64.239999999999995 110.878 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.532 ' HG3' ' HD2' ' A' ' 68' ' ' PRO . 24.1 mmt180 -73.58 -27.09 61.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.221 -0.445 . . . . 74.219999999999999 110.919 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' TRP . . . . . 0.836 ' CD1' ' O ' ' A' ' 70' ' ' TYR . 0.6 OUTLIER -105.97 11.22 31.9 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.157 -0.474 . . . . 75.239999999999995 110.957 179.979 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 74' ' ' MET . . . . . 0.506 ' C ' ' O ' ' A' ' 73' ' ' TRP . 0.4 OUTLIER 29.19 56.76 0.13 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.212 -0.449 . . . . 74.219999999999999 110.849 179.909 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.609 ' HA3' ' OH ' ' A' ' 60' ' ' TYR . . . -96.92 -140.27 11.19 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.733 -0.746 . . . . 63.130000000000003 112.51 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.758 HD21 ' HA ' ' A' ' 148' ' ' ARG . 0.0 OUTLIER -141.95 -84.1 0.19 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.831 0.348 . . . . 71.450000000000003 110.905 -179.946 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 -77.47 145.85 36.81 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.465 . . . . 63.109999999999999 110.915 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 -101.44 33.29 2.98 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.198 -0.456 . . . . 51.409999999999997 110.858 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -104.78 72.13 1.01 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.208 -0.451 . . . . 63.130000000000003 110.874 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.921 HD11 HG11 ' A' ' 49' ' ' VAL . 0.1 OUTLIER -77.83 130.25 36.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.162 -0.472 . . . . 74.540000000000006 110.906 -179.955 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.609 ' HB3' ' HB3' ' A' ' 53' ' ' PRO . 0.9 OUTLIER -146.92 -127.93 0.06 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.218 -0.446 . . . . 63.030000000000001 110.874 -179.929 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.756 ' OG ' ' HA ' ' A' ' 53' ' ' PRO . 0.7 OUTLIER -27.58 123.49 0.1 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.117 -0.492 . . . . 75.439999999999998 110.872 -179.845 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 83' ' ' CYS . . . . . 0.53 ' CB ' HG12 ' A' ' 49' ' ' VAL . 5.4 p -131.14 143.06 50.35 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.146 -0.479 . . . . 74.25 110.87 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.483 ' N ' ' O ' ' A' ' 48' ' ' ALA . 5.7 mmt85 -140.59 131.37 25.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.189 -0.459 . . . . 62.420000000000002 110.9 -179.843 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.412 ' N ' ' CZ3' ' A' ' 47' ' ' TRP . . . -56.27 123.88 16.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.22 -0.446 . . . . 74.319999999999993 111.043 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.965 HG11 HG11 ' A' ' 136' ' ' VAL . 1.9 t -115.93 143.31 26.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.21 -0.45 . . . . 62.409999999999997 111.113 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' HIS . . . . . 0.572 ' O ' ' CG2' ' A' ' 136' ' ' VAL . 34.9 m80 -111.23 106.45 15.44 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.184 -0.462 . . . . 73.409999999999997 110.878 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.501 ' H ' HD23 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -31.64 150.17 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.659 0.742 . . . . 73.439999999999998 110.909 -179.975 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.58 ' HB3' ' H ' ' A' ' 136' ' ' VAL . 53.5 Cg_endo -69.77 83.39 0.7 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.674 2.249 . . . . 53.210000000000001 112.326 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -88.76 -173.35 4.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.188 -0.46 . . . . 73.329999999999998 110.832 -179.834 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 51.26 58.49 9.69 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.761 -0.733 . . . . 73.120000000000005 112.439 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 117.68 26.22 2.89 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.724 -0.751 . . . . 73.030000000000001 112.454 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 27.5 pt20 39.56 -148.57 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.826 0.346 . . . . 73.409999999999997 110.916 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.506 ' HA ' ' HG2' ' A' ' 134' ' ' GLU . 8.2 t80 -98.79 101.02 12.29 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.26 -0.427 . . . . 75.549999999999997 110.906 -179.838 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.429 ' HG3' HG11 ' A' ' 132' ' ' VAL . 38.2 tptt -107.91 130.34 55.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.126 -0.488 . . . . 62.299999999999997 110.896 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 4.2 tt -147.36 137.72 17.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.238 -0.437 . . . . 73.219999999999999 111.131 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.517 ' HB2' HG23 ' A' ' 132' ' ' VAL . 0.5 OUTLIER -109.92 113.35 26.01 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.211 -0.449 . . . . 74.010000000000005 110.942 179.905 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.578 HD11 HG22 ' A' ' 111' ' ' THR . 2.7 mp -93.66 136.17 26.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.163 -0.471 . . . . 75.0 111.15 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.646 ' HB2' ' HB2' ' A' ' 129' ' ' SER . 53.2 m-85 -124.73 140.1 53.24 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.194 -0.457 . . . . 70.519999999999996 110.855 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 64.6 tt0 -69.68 -75.17 0.12 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.148 -0.478 . . . . 70.140000000000001 110.889 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 16.5 mttt -84.51 170.41 13.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.138 -0.483 . . . . 73.349999999999994 110.893 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.441 ' CA ' ' HB3' ' A' ' 128' ' ' HIS . . . -73.73 159.62 53.1 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.724 -0.75 . . . . 72.010000000000005 112.478 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.486 ' HA ' ' HB2' ' A' ' 158' ' ' ARG . 60.9 t0 64.17 37.18 9.04 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.819 0.342 . . . . 73.409999999999997 110.844 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.57 ' CZ ' ' HB3' ' A' ' 158' ' ' ARG . 5.0 m-85 51.66 45.19 28.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.192 -0.458 . . . . 73.239999999999995 110.89 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 5.1 m -112.45 148.87 33.48 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.112 -0.495 . . . . 64.299999999999997 110.865 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 95.34 -132.5 11.13 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.776 -0.726 . . . . 63.030000000000001 112.519 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 6.9 tp-100 -91.68 126.11 36.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.813 0.339 . . . . 61.240000000000002 110.948 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' MET . . . . . 0.459 ' HB2' ' CE1' ' A' ' 99' ' ' PHE . 4.8 ttt -113.55 131.56 56.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.168 -0.469 . . . . 71.439999999999998 110.849 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -136.26 136.38 39.79 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.215 -0.448 . . . . 64.120000000000005 110.93 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -118.37 109.2 16.0 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.115 -0.493 . . . . 65.319999999999993 110.896 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.578 HG22 HD11 ' A' ' 98' ' ' ILE . 14.1 t -123.46 145.68 48.63 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.132 -0.486 . . . . 65.439999999999998 111.18 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.474 ' O ' ' OG1' ' A' ' 112' ' ' THR . 0.8 OUTLIER -118.2 38.31 3.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.249 -0.432 . . . . 54.450000000000003 111.133 -179.944 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -150.94 170.43 19.35 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.228 -0.442 . . . . 72.019999999999996 110.898 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 -65.79 176.11 1.7 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.201 -0.454 . . . . 71.329999999999998 110.868 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 46.6 t -156.01 122.62 2.64 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.599 0.714 . . . . 52.539999999999999 110.891 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.475 ' C ' ' OG ' ' A' ' 172' ' ' SER . 54.0 Cg_endo -69.79 -31.24 20.76 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.646 2.23 . . . . 52.229999999999997 112.338 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.662 ' HB3' ' CB ' ' A' ' 120' ' ' GLU . 0.1 OUTLIER -152.99 92.97 1.69 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.222 -0.445 . . . . 43.439999999999998 110.872 -179.86 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.679 ' HB ' ' O ' ' A' ' 171' ' ' GLN . 5.0 tt -49.01 -28.78 2.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.157 -0.474 . . . . 74.019999999999996 111.155 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' MET . . . . . 0.581 ' O ' ' HA ' ' A' ' 123' ' ' HIS . 15.7 ttp -86.36 -45.19 11.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.186 -0.461 . . . . 74.549999999999997 110.848 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.662 ' CB ' ' HB3' ' A' ' 117' ' ' SER . 10.1 tp10 -66.75 -13.37 61.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.232 -0.44 . . . . 61.5 110.875 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -114.52 -51.9 2.73 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.185 -0.461 . . . . 74.140000000000001 110.897 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.48 ' HB2' ' O ' ' A' ' 118' ' ' ILE . 14.6 m-85 -101.89 -18.67 15.6 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.24 -0.437 . . . . 73.329999999999998 110.935 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' HIS . . . . . 0.581 ' HA ' ' O ' ' A' ' 119' ' ' MET . 16.6 m80 68.42 32.72 4.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.078 -0.51 . . . . 74.140000000000001 110.892 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.483 ' SD ' HG22 ' A' ' 98' ' ' ILE . 9.3 mtt -111.04 84.62 1.96 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.183 -0.462 . . . . 63.32 110.819 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 3.9 ptp180 -52.93 -34.87 57.41 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.23 -0.441 . . . . 63.329999999999998 110.884 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.475 ' HG2' ' HA ' ' A' ' 169' ' ' ALA . 35.0 mt-10 -142.34 128.77 20.1 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.192 -0.458 . . . . 74.040000000000006 110.864 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.545 HD11 HD13 ' A' ' 118' ' ' ILE . 4.1 mm -87.89 101.16 11.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.146 -0.479 . . . . 74.129999999999995 111.159 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 128' ' ' HIS . . . . . 0.441 ' HB3' ' CA ' ' A' ' 102' ' ' GLY . 22.3 m80 -69.65 -35.24 75.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.165 -0.471 . . . . 72.450000000000003 110.861 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 129' ' ' SER . . . . . 0.646 ' HB2' ' HB2' ' A' ' 99' ' ' PHE . 6.2 m -135.4 152.2 51.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.255 -0.43 . . . . 72.109999999999999 110.87 -179.803 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 130' ' ' CYS . . . . . 0.498 ' HB2' ' CH2' ' A' ' 163' ' ' TRP . 0.0 OUTLIER -156.22 118.24 3.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.144 -0.48 . . . . 70.049999999999997 110.901 -179.934 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.523 ' C ' HG23 ' A' ' 132' ' ' VAL . 3.7 mtpp -105.66 161.2 14.59 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.182 -0.463 . . . . 74.5 110.875 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.572 HG12 ' N ' ' A' ' 133' ' ' LEU . 16.0 t 86.03 165.97 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.469 . . . . 21.52 111.154 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.657 HD13 ' CE ' ' A' ' 155' ' ' LYS . 1.0 OUTLIER -166.2 131.19 2.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.182 -0.463 . . . . 74.109999999999999 110.895 179.941 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.506 ' HG2' ' HA ' ' A' ' 94' ' ' TYR . 0.8 OUTLIER -105.29 147.72 27.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.192 -0.458 . . . . 72.230000000000004 110.9 179.921 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 135' ' ' GLY . . . . . 0.483 ' C ' ' O ' ' A' ' 134' ' ' GLU . . . -31.37 -45.63 0.14 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.746 -0.74 . . . . 25.32 112.508 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.982 ' HB ' HD12 ' A' ' 176' ' ' ILE . 0.7 OUTLIER -149.94 135.6 11.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.823 0.344 . . . . 75.310000000000002 111.116 -179.98 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 137' ' ' TRP . . . . . 0.647 ' HB3' ' CB ' ' A' ' 152' ' ' LEU . 24.0 t90 -150.14 149.59 30.46 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.131 -0.486 . . . . 72.409999999999997 110.92 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.415 ' HA ' ' O ' ' A' ' 150' ' ' TYR . 16.6 mt -124.17 132.04 71.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.275 -0.421 . . . . 71.510000000000005 111.118 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.759 ' CE2' HG11 ' A' ' 170' ' ' VAL . 0.1 OUTLIER -99.09 139.13 35.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.167 -0.47 . . . . 74.329999999999998 110.884 179.966 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 140' ' ' TYR . . . . . 0.495 ' CD2' ' HA ' ' A' ' 145' ' ' TYR . 0.1 OUTLIER -110.59 126.86 54.89 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.159 -0.473 . . . . 74.230000000000004 110.914 -179.843 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 141' ' ' GLU . . . . . 0.564 ' O ' ' HB2' ' A' ' 171' ' ' GLN . 26.6 tt0 -66.08 -27.83 68.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.101 -0.5 . . . . 71.239999999999995 110.886 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.601 ' HB3' ' HD2' ' A' ' 143' ' ' PRO . 9.9 mp -109.73 169.71 6.13 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.632 0.729 . . . . 73.450000000000003 110.929 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 143' ' ' PRO . . . . . 0.718 ' O ' ' HB2' ' A' ' 172' ' ' SER . 53.5 Cg_endo -69.73 -89.15 0.0 OUTLIER 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.713 2.276 . . . . 72.409999999999997 112.338 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 144' ' ' ASN . . . . . 0.73 ' O ' ' N ' ' A' ' 146' ' ' ARG . 1.1 m-20 -48.43 96.43 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.218 -0.446 . . . . 75.129999999999995 110.924 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 145' ' ' TYR . . . . . 0.636 ' C ' ' O ' ' A' ' 144' ' ' ASN . 20.1 m-85 12.54 51.6 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.191 -0.459 . . . . 72.409999999999997 110.905 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 146' ' ' ARG . . . . . 0.73 ' N ' ' O ' ' A' ' 144' ' ' ASN . 11.4 mtp85 -127.01 178.62 5.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.132 -0.485 . . . . 72.310000000000002 110.876 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 86.78 167.16 43.39 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.73 -0.747 . . . . 61.350000000000001 112.469 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.758 ' HA ' HD21 ' A' ' 76' ' ' LEU . 2.8 mpt_? -65.48 142.18 58.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.796 0.331 . . . . 71.120000000000005 110.86 -179.857 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 149' ' ' GLN . . . . . 0.523 ' O ' ' HB2' ' A' ' 59' ' ' MET . 51.4 mt-30 -81.29 155.57 25.98 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.173 -0.467 . . . . 64.140000000000001 110.907 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 150' ' ' TYR . . . . . 0.524 ' HB2' ' CB ' ' A' ' 139' ' ' PHE . 95.9 m-85 -138.29 123.01 18.71 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.231 -0.44 . . . . 74.420000000000002 110.924 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.559 ' HB2' HD11 ' A' ' 61' ' ' ILE . 21.3 tp -64.66 132.7 50.42 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.101 -0.499 . . . . 64.109999999999999 110.97 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.918 HD13 ' O ' ' A' ' 152' ' ' LEU . 0.0 OUTLIER -68.45 133.29 48.41 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.218 -0.446 . . . . 73.239999999999995 110.906 179.912 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -163.28 25.95 0.09 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.147 -0.479 . . . . 74.450000000000003 110.907 179.843 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.743 ' HA ' ' CE1' ' A' ' 157' ' ' TYR . 0.0 OUTLIER -108.89 -173.86 2.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.148 -0.478 . . . . 71.129999999999995 110.872 -179.99 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.657 ' CE ' HD13 ' A' ' 133' ' ' LEU . 4.0 mptt -164.93 -124.43 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.218 -0.446 . . . . 74.349999999999994 110.911 179.827 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.504 ' HA ' ' HA ' ' A' ' 131' ' ' LYS . 4.4 tm-20 -71.5 1.37 6.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.223 -0.444 . . . . 71.519999999999996 110.851 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 157' ' ' TYR . . . . . 0.743 ' CE1' ' HA ' ' A' ' 154' ' ' LYS . 21.3 m-30 -31.23 143.81 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.191 -0.459 . . . . 70.25 110.938 -179.836 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 158' ' ' ARG . . . . . 0.57 ' HB3' ' CZ ' ' A' ' 104' ' ' PHE . 0.0 OUTLIER -115.35 -40.68 3.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.128 -0.487 . . . . 54.32 110.897 -179.989 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 159' ' ' LYS . . . . . 0.472 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 0.2 OUTLIER -81.01 150.89 69.59 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.553 0.692 . . . . 73.340000000000003 110.918 179.966 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 160' ' ' PRO . . . . . 0.565 ' HA ' ' NE1' ' A' ' 163' ' ' TRP . 53.5 Cg_endo -69.78 -27.47 26.35 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.655 2.237 . . . . 74.310000000000002 112.346 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.65 HD12 ' H ' ' A' ' 161' ' ' ILE . 3.8 mp -67.21 -3.5 2.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.236 -0.438 . . . . 73.540000000000006 111.114 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.654 ' HB3' ' CD1' ' A' ' 157' ' ' TYR . 0.3 OUTLIER -76.61 -23.21 53.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.215 -0.448 . . . . 71.329999999999998 110.876 179.818 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 163' ' ' TRP . . . . . 0.565 ' NE1' ' HA ' ' A' ' 160' ' ' PRO . 1.7 m95 -79.96 -1.37 39.19 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.198 -0.455 . . . . 74.239999999999995 110.931 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 92.46 -35.22 4.12 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.728 -0.749 . . . . 74.25 112.475 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.415 ' O ' ' C ' ' A' ' 166' ' ' ALA . . . -77.37 129.2 35.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.826 0.346 . . . . 71.310000000000002 111.091 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 166' ' ' ALA . . . . . 0.415 ' C ' ' O ' ' A' ' 165' ' ' ALA . . . -37.08 -40.08 0.28 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.224 -0.443 . . . . 65.120000000000005 111.117 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 167' ' ' SER . . . . . 0.479 ' C ' ' H ' ' A' ' 169' ' ' ALA . 0.3 OUTLIER -129.29 157.32 76.53 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.61 0.719 . . . . 74.150000000000006 110.867 -179.767 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 168' ' ' PRO . . . . . 0.517 ' HD3' ' HB2' ' A' ' 160' ' ' PRO . 53.4 Cg_endo -69.73 29.07 0.18 Allowed 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.667 2.245 . . . . 34.219999999999999 112.324 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 0.479 ' H ' ' C ' ' A' ' 167' ' ' SER . . . -66.01 106.58 1.63 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.244 -0.435 . . . . 62.119999999999997 111.094 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.759 HG11 ' CE2' ' A' ' 139' ' ' PHE . 3.3 t -152.08 165.92 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.224 -0.444 . . . . 72.430000000000007 111.083 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 171' ' ' GLN . . . . . 0.679 ' O ' ' HB ' ' A' ' 118' ' ' ILE . 2.6 mm-40 -123.72 -87.11 0.63 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.142 -0.481 . . . . 63.25 110.884 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 172' ' ' SER . . . . . 0.718 ' HB2' ' O ' ' A' ' 143' ' ' PRO . 3.1 m -111.11 175.65 5.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.174 -0.466 . . . . 61.340000000000003 110.897 -179.804 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 173' ' ' PHE . . . . . 0.452 ' HB3' ' CD2' ' A' ' 139' ' ' PHE . 1.8 p90 -147.94 158.58 44.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.168 -0.469 . . . . 71.420000000000002 110.899 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 174' ' ' ARG . . . . . 0.429 ' HG2' ' CD2' ' A' ' 140' ' ' TYR . 0.0 OUTLIER -133.93 139.75 46.34 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.12 -0.491 . . . . 73.340000000000003 110.837 -179.857 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -95.38 -170.08 2.1 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.177 -0.465 . . . . 70.519999999999996 110.851 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 176' ' ' ILE . . . . . 0.982 HD12 ' HB ' ' A' ' 136' ' ' VAL . 3.3 mt -139.21 135.79 41.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.145 -0.479 . . . . 72.439999999999998 111.16 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 25.9 t -148.8 150.11 14.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.192 -0.458 . . . . 70.329999999999998 111.1 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.259 0 CA-C-N 116.134 -0.484 . . . . 74.120000000000005 110.936 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.312 0 N-CA-C 112.462 -0.255 . . . . 71.319999999999993 112.462 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.515 ' C ' ' HE1' ' A' ' 47' ' ' TRP . 11.2 p -82.58 133.1 35.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.882 0.372 . . . . 62.130000000000003 111.122 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 3.5 tttt -121.15 137.65 54.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.242 -0.435 . . . . 65.25 110.895 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.617 HD12 ' CG2' ' A' ' 42' ' ' VAL . 11.6 tt -137.33 149.41 25.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.209 -0.451 . . . . 71.099999999999994 111.166 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.525 HG22 ' CE2' ' A' ' 11' ' ' TYR . 24.5 m -131.74 129.02 40.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.178 -0.464 . . . . 61.340000000000003 111.133 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.818 ' HB2' HD22 ' A' ' 34' ' ' LEU . 0.6 OUTLIER -116.15 132.35 56.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.16 -0.473 . . . . 71.340000000000003 110.875 -179.957 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.556 ' CG ' ' HA ' ' A' ' 16' ' ' PHE . 49.1 m-85 -116.01 131.92 56.8 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.16 -0.473 . . . . 73.230000000000004 110.966 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.481 ' HG2' ' HB2' ' A' ' 36' ' ' ARG . 0.0 OUTLIER -60.7 -25.73 66.61 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 74.340000000000003 110.92 179.987 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 -125.96 151.23 47.28 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.114 -0.494 . . . . 75.099999999999994 110.855 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.441 ' HG3' ' HB3' ' A' ' 38' ' ' ASN . 19.7 mtmt -54.94 -178.21 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 62.240000000000002 110.936 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 24.7 m-20 47.68 38.72 8.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.256 -0.429 . . . . 62.409999999999997 110.894 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.556 ' HA ' ' CG ' ' A' ' 11' ' ' TYR . 3.0 m-85 44.71 60.48 2.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.15 -0.477 . . . . 60.32 110.885 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -135.97 158.78 43.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.088 -0.505 . . . . 74.120000000000005 110.882 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 93.47 -151.51 20.39 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.76 -0.733 . . . . 73.450000000000003 112.491 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.787 ' O ' HD13 ' A' ' 34' ' ' LEU . 0.3 OUTLIER -67.27 80.85 0.14 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.794 0.331 . . . . 74.239999999999995 110.937 -179.869 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.43 ' HA ' ' O ' ' A' ' 10' ' ' PHE . 0.7 OUTLIER -79.38 126.31 30.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.209 -0.45 . . . . 72.340000000000003 110.911 -179.89 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.478 ' CD2' ' CD2' ' A' ' 30' ' ' PHE . 85.9 t80 -121.46 124.03 43.47 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.221 -0.445 . . . . 74.409999999999997 110.909 -179.827 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.456 ' CG ' HG23 ' A' ' 9' ' ' THR . 1.0 OUTLIER -119.14 134.84 54.97 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.134 -0.485 . . . . 70.299999999999997 110.835 179.934 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -166.94 135.81 2.78 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.156 -0.474 . . . . 73.230000000000004 110.899 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -104.53 5.75 34.19 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 72.25 110.844 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 13.9 t -110.71 164.49 12.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.193 -0.458 . . . . 73.239999999999995 110.868 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -60.82 117.54 5.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.186 -0.461 . . . . 65.25 110.86 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.465 ' HB2' ' SG ' ' A' ' 83' ' ' CYS . 18.7 m -117.48 55.51 0.85 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.245 -0.434 . . . . 54.509999999999998 110.864 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.526 ' C ' ' HA ' ' A' ' 82' ' ' SER . . . -46.64 -19.14 0.08 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.208 -0.451 . . . . 53.520000000000003 111.158 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.402 ' N ' ' C ' ' A' ' 27' ' ' CYS . 52.4 t0 -128.71 42.14 3.37 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.212 -0.449 . . . . 65.140000000000001 110.872 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.805 ' CD2' ' O ' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -80.45 15.75 1.54 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.459 . . . . 74.150000000000006 110.864 -179.893 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.501 ' HB2' ' HB3' ' A' ' 81' ' ' SER . 33.2 t60 -80.65 -38.15 29.67 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.163 -0.471 . . . . 75.450000000000003 110.785 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.7 t -60.16 -12.52 8.77 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.245 -0.434 . . . . 62.020000000000003 111.137 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -101.34 -27.6 13.08 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.246 -0.434 . . . . 72.450000000000003 110.925 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.818 HD22 ' HB2' ' A' ' 10' ' ' PHE . 19.1 tp -141.94 140.53 32.8 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.133 -0.485 . . . . 71.310000000000002 110.888 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.1 m -109.07 -31.95 7.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.221 -0.445 . . . . 55.299999999999997 110.883 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.561 ' NH2' HD21 ' A' ' 38' ' ' ASN . 1.8 mtp85 -116.82 142.0 47.49 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.128 -0.487 . . . . 70.25 110.872 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.582 ' HB3' ' HB2' ' A' ' 80' ' ' LEU . 0.9 OUTLIER -118.37 52.09 1.05 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.22 -0.445 . . . . 61.450000000000003 110.869 -179.957 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.561 HD21 ' NH2' ' A' ' 36' ' ' ARG . 3.0 m120 -53.01 -70.78 0.08 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.203 -0.453 . . . . 73.409999999999997 110.866 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 8.7 p -112.86 128.42 56.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.203 -0.453 . . . . 74.239999999999995 110.887 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.659 HG21 HD13 ' A' ' 62' ' ' LEU . 5.4 mt -127.41 150.1 32.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.097 -0.501 . . . . 71.310000000000002 111.131 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.47 122.75 14.83 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.17 -0.468 . . . . 75.209999999999994 110.892 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.617 ' CG2' HD12 ' A' ' 8' ' ' ILE . 1.4 t -104.43 116.59 48.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.23 -0.441 . . . . 70.349999999999994 111.176 179.84 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -111.55 80.97 1.37 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.161 -0.472 . . . . 74.25 110.866 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.411 ' O ' ' HA ' ' A' ' 6' ' ' THR . . . 128.75 103.69 1.13 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.745 -0.74 . . . . 64.219999999999999 112.527 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.464 ' HA2' HD21 ' A' ' 88' ' ' LEU . . . 53.97 178.09 0.12 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.75 -0.738 . . . . 71.430000000000007 112.464 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.762 HG23 ' HA ' ' A' ' 63' ' ' PRO . 3.1 m -81.36 165.66 21.14 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.729 0.299 . . . . 74.310000000000002 111.177 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' TRP . . . . . 0.598 ' CD1' ' HB ' ' A' ' 8' ' ' ILE . 6.2 m95 -139.86 130.09 25.22 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.216 -0.447 . . . . 73.510000000000005 110.925 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.842 ' HB2' ' CG2' ' A' ' 86' ' ' VAL . . . -95.12 129.01 42.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.203 -0.453 . . . . 65.540000000000006 111.152 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.788 HG12 ' HB3' ' A' ' 83' ' ' CYS . 14.1 m -127.47 127.27 68.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.233 -0.439 . . . . 74.510000000000005 111.115 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.756 ' HB3' ' HA ' ' A' ' 56' ' ' ALA . 45.8 m-85 -93.36 147.51 22.87 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.137 -0.483 . . . . 74.430000000000007 110.927 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.655 ' OE1' ' HB3' ' A' ' 57' ' ' TRP . 54.7 tt0 -48.5 -78.48 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.113 -0.494 . . . . 75.209999999999994 110.862 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.544 ' HB3' ' CD1' ' A' ' 55' ' ' PHE . 0.0 OUTLIER -92.98 143.81 27.41 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.652 0.739 . . . . 72.140000000000001 110.878 -179.907 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.769 ' HA ' ' OG ' ' A' ' 82' ' ' SER . 53.8 Cg_endo -69.75 141.59 45.67 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.688 2.259 . . . . 62.409999999999997 112.34 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 62.53 -10.98 0.08 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.19 -0.459 . . . . 74.310000000000002 110.876 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.614 ' H ' ' C ' ' A' ' 53' ' ' PRO . 2.6 m-30 -104.34 -20.19 13.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.455 . . . . 74.430000000000007 110.869 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.756 ' HA ' ' HB3' ' A' ' 50' ' ' TYR . . . 48.55 26.44 1.19 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.168 -0.469 . . . . 72.549999999999997 111.117 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' TRP . . . . . 0.655 ' HB3' ' OE1' ' A' ' 51' ' ' GLU . 0.0 OUTLIER -50.7 -159.98 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.233 -0.44 . . . . 72.329999999999998 110.919 -179.978 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.627 ' C ' ' O ' ' A' ' 57' ' ' TRP . 6.0 m-30 -15.5 103.84 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.213 -0.448 . . . . 71.409999999999997 110.914 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.468 ' HB2' ' O ' ' A' ' 149' ' ' GLN . 0.8 OUTLIER -62.44 145.14 54.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.124 -0.489 . . . . 73.140000000000001 110.892 179.891 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.646 ' O ' ' O ' ' A' ' 49' ' ' VAL . 0.4 OUTLIER -160.76 100.12 1.27 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.218 -0.447 . . . . 74.129999999999995 110.945 -179.89 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.796 ' N ' HD12 ' A' ' 61' ' ' ILE . 1.3 mp -94.22 117.17 37.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.101 -0.5 . . . . 54.43 111.157 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.741 HD23 ' HD2' ' A' ' 63' ' ' PRO . 0.4 OUTLIER -84.21 125.84 71.25 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.618 0.723 . . . . 61.240000000000002 110.92 179.928 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.762 ' HA ' HG23 ' A' ' 46' ' ' THR . 53.7 Cg_endo -69.68 -165.58 0.16 Allowed 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.68 2.253 . . . . 54.009999999999998 112.381 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.22 159.86 14.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.238 -0.437 . . . . 63.009999999999998 110.885 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 113.62 -149.95 18.58 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.791 -0.719 . . . . 60.420000000000002 112.495 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -122.94 160.36 26.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.859 0.362 . . . . 75.230000000000004 110.93 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.551 ' CE1' HD22 ' A' ' 62' ' ' LEU . 5.9 m-85 -150.05 79.1 7.78 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.668 0.747 . . . . 65.340000000000003 110.924 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.498 ' HD2' ' HG3' ' A' ' 72' ' ' ARG . 53.4 Cg_endo -69.81 0.48 5.62 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.721 2.281 . . . . 74.439999999999998 112.305 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 76.3 mt-10 -157.31 156.17 31.92 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.247 -0.433 . . . . 75.319999999999993 110.906 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.832 ' O ' ' CD1' ' A' ' 73' ' ' TRP . 11.7 p90 -68.35 -6.87 26.69 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.248 -0.433 . . . . 75.230000000000004 110.895 -179.851 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -87.12 -13.48 44.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.141 -0.481 . . . . 70.430000000000007 110.891 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.498 ' HG3' ' HD2' ' A' ' 68' ' ' PRO . 21.2 mmt180 -73.5 -24.64 60.2 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.224 -0.444 . . . . 70.209999999999994 110.891 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' TRP . . . . . 0.832 ' CD1' ' O ' ' A' ' 70' ' ' TYR . 0.5 OUTLIER -111.8 25.13 11.93 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.179 -0.464 . . . . 75.299999999999997 110.934 -179.975 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 74' ' ' MET . . . . . 0.552 ' CB ' ' O ' ' A' ' 73' ' ' TRP . 2.0 mmt 87.38 -38.47 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.248 -0.433 . . . . 75.140000000000001 110.927 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 88.93 45.83 4.7 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.724 -0.751 . . . . 53.32 112.495 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.595 HD21 ' HA ' ' A' ' 148' ' ' ARG . 0.4 OUTLIER -67.08 -74.95 0.1 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.837 0.351 . . . . 61.350000000000001 110.94 -179.957 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -129.28 136.13 49.66 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.188 -0.46 . . . . 71.530000000000001 110.859 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.424 ' C ' ' SG ' ' A' ' 37' ' ' CYS . 24.4 m-20 -90.35 18.54 6.0 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.187 -0.46 . . . . 72.310000000000002 110.858 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.406 ' HD2' ' HG2' ' A' ' 51' ' ' GLU . 0.6 OUTLIER -112.33 86.45 2.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.199 -0.455 . . . . 73.319999999999993 110.874 -179.914 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.806 HD12 ' CD1' ' A' ' 10' ' ' PHE . 0.0 OUTLIER -89.86 133.24 34.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.216 -0.447 . . . . 72.430000000000007 110.947 -179.992 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.641 ' HB3' ' HB3' ' A' ' 53' ' ' PRO . 0.8 OUTLIER -151.23 -127.93 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.203 -0.453 . . . . 62.409999999999997 110.875 -179.923 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.769 ' OG ' ' HA ' ' A' ' 53' ' ' PRO . 0.1 OUTLIER -33.98 102.16 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 62.509999999999998 110.847 -179.845 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 83' ' ' CYS . . . . . 0.788 ' HB3' HG12 ' A' ' 49' ' ' VAL . 30.2 p -118.82 133.35 55.9 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.125 -0.488 . . . . 75.299999999999997 110.882 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.599 ' N ' ' O ' ' A' ' 48' ' ' ALA . 13.7 mmt85 -119.94 144.25 47.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.228 -0.442 . . . . 73.019999999999996 110.862 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.419 ' N ' ' CZ3' ' A' ' 47' ' ' TRP . . . -63.61 127.66 32.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.178 -0.465 . . . . 64.120000000000005 111.095 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.842 ' CG2' ' HB2' ' A' ' 48' ' ' ALA . 46.7 t -115.78 137.86 48.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 74.120000000000005 111.113 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' HIS . . . . . 0.558 ' O ' HG23 ' A' ' 136' ' ' VAL . 34.0 m80 -111.58 112.82 24.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.205 -0.452 . . . . 74.219999999999999 110.825 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.471 ' H ' HD23 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -35.82 143.23 0.27 Allowed Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.594 0.712 . . . . 61.450000000000003 110.872 -179.967 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.58 ' HB3' ' H ' ' A' ' 136' ' ' VAL . 53.9 Cg_endo -69.81 78.62 1.01 Allowed 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.695 2.263 . . . . 64.150000000000006 112.334 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -78.03 -177.01 4.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.223 -0.444 . . . . 73.239999999999995 110.852 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 74.8 -97.46 1.0 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.736 -0.745 . . . . 60.229999999999997 112.466 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.411 ' O ' ' C ' ' A' ' 93' ' ' GLN . . . -90.29 44.61 2.94 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.779 -0.724 . . . . 72.239999999999995 112.496 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.469 ' O ' ' HG2' ' A' ' 134' ' ' GLU . 13.7 pt20 37.19 -122.17 0.19 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.876 0.37 . . . . 72.120000000000005 110.917 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.558 ' OH ' HG22 ' A' ' 177' ' ' VAL . 0.1 OUTLIER -121.41 103.59 9.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.196 -0.456 . . . . 72.140000000000001 110.934 -179.9 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.559 ' HG3' HG11 ' A' ' 132' ' ' VAL . 41.4 tptt -114.83 126.15 54.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.114 -0.494 . . . . 73.319999999999993 110.862 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 8.2 tt -147.57 137.94 17.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.23 -0.441 . . . . 74.120000000000005 111.127 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.487 ' HB2' HG23 ' A' ' 132' ' ' VAL . 0.6 OUTLIER -108.7 131.67 54.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.182 -0.463 . . . . 74.310000000000002 110.877 179.937 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.805 HG23 HG13 ' A' ' 127' ' ' ILE . 1.1 mp -115.64 134.5 58.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.455 . . . . 72.219999999999999 111.136 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.607 ' HB2' ' CB ' ' A' ' 129' ' ' SER . 7.1 m-85 -122.66 155.15 36.99 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.197 -0.456 . . . . 71.420000000000002 110.855 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.534 ' HA ' ' CE ' ' A' ' 124' ' ' MET . 56.6 tt0 -84.75 -44.0 13.74 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.183 -0.462 . . . . 71.239999999999995 110.854 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.468 ' HB2' ' C ' ' A' ' 105' ' ' SER . 55.9 mttt -117.61 155.0 30.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.182 -0.463 . . . . 62.039999999999999 110.894 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -73.82 169.48 53.57 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.757 -0.735 . . . . 73.530000000000001 112.436 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.44 ' HA ' ' HB2' ' A' ' 158' ' ' ARG . 36.9 t70 63.25 40.3 8.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.798 0.333 . . . . 65.439999999999998 110.814 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.623 ' CE1' ' HD2' ' A' ' 131' ' ' LYS . 11.6 m-85 54.89 49.27 18.16 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.25 -0.432 . . . . 54.140000000000001 110.867 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.468 ' C ' ' HB2' ' A' ' 101' ' ' LYS . 69.5 m -127.93 161.85 28.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.169 -0.469 . . . . 73.439999999999998 110.841 -179.825 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 83.04 -172.48 51.5 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.715 -0.755 . . . . 71.219999999999999 112.472 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 -67.62 120.59 14.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.78 0.324 . . . . 71.200000000000003 110.921 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 5.6 ttp -106.65 132.01 53.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.191 -0.459 . . . . 75.219999999999999 110.89 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -137.12 137.45 39.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.274 -0.421 . . . . 75.430000000000007 110.909 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -114.66 112.76 23.38 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.092 -0.504 . . . . 72.129999999999995 110.903 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 13.9 t -121.28 132.18 54.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.168 -0.469 . . . . 74.340000000000003 111.168 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.51 ' HA ' ' O ' ' A' ' 94' ' ' TYR . 1.8 t -112.29 37.1 3.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.246 -0.434 . . . . 72.150000000000006 111.129 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -151.03 165.43 33.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.229 -0.441 . . . . 63.409999999999997 110.857 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -53.11 161.22 0.88 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.142 -0.481 . . . . 74.349999999999994 110.83 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' CYS . . . . . 0.606 ' O ' ' HB2' ' A' ' 172' ' ' SER . 20.4 t -146.9 110.92 4.11 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.651 0.738 . . . . 75.099999999999994 110.882 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.512 ' O ' ' C ' ' A' ' 143' ' ' PRO . 53.6 Cg_endo -69.82 -38.6 7.45 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.647 2.231 . . . . 74.400000000000006 112.309 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.617 ' HB3' ' CB ' ' A' ' 120' ' ' GLU . 0.1 OUTLIER -147.28 105.41 3.75 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.238 -0.437 . . . . 75.230000000000004 110.839 -179.839 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.614 ' HB ' ' O ' ' A' ' 171' ' ' GLN . 3.4 tt -58.07 -27.94 32.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.125 -0.489 . . . . 54.219999999999999 111.118 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' MET . . . . . 0.684 ' O ' ' HA ' ' A' ' 123' ' ' HIS . 8.6 ttp -86.77 -40.57 14.86 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.17 -0.468 . . . . 73.329999999999998 110.875 179.852 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.617 ' CB ' ' HB3' ' A' ' 117' ' ' SER . 14.7 tp10 -70.52 -13.52 62.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.264 -0.426 . . . . 72.310000000000002 110.879 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 7.6 tp-100 -116.25 -50.71 2.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.152 -0.477 . . . . 73.150000000000006 110.944 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.482 ' HB2' ' O ' ' A' ' 118' ' ' ILE . 46.8 m-85 -101.26 -13.85 17.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.222 -0.445 . . . . 74.530000000000001 110.917 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' HIS . . . . . 0.684 ' HA ' ' O ' ' A' ' 119' ' ' MET . 27.9 m-70 69.16 24.86 5.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.125 -0.488 . . . . 64.239999999999995 110.828 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.534 ' CE ' ' HA ' ' A' ' 100' ' ' GLU . 0.9 OUTLIER -96.47 145.24 25.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.248 -0.433 . . . . 71.329999999999998 110.891 179.975 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 5.1 ptp180 -110.62 -40.91 4.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.249 -0.432 . . . . 74.310000000000002 110.862 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.442 ' HB3' ' HG2' ' A' ' 168' ' ' PRO . 17.6 mt-10 -141.05 116.13 9.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.205 -0.452 . . . . 70.510000000000005 110.864 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.805 HG13 HG23 ' A' ' 98' ' ' ILE . 1.0 OUTLIER -74.8 99.78 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.149 -0.478 . . . . 61.030000000000001 111.126 179.954 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 128' ' ' HIS . . . . . 0.434 ' CD2' ' HA ' ' A' ' 101' ' ' LYS . 1.0 OUTLIER -73.33 -28.13 61.9 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.113 -0.494 . . . . 72.519999999999996 110.884 179.831 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 129' ' ' SER . . . . . 0.607 ' CB ' ' HB2' ' A' ' 99' ' ' PHE . 0.5 OUTLIER -132.31 136.93 47.24 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.225 -0.443 . . . . 74.239999999999995 110.872 -179.741 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 130' ' ' CYS . . . . . 0.614 ' SG ' HG21 ' A' ' 127' ' ' ILE . 0.1 OUTLIER -135.09 118.15 16.43 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.218 -0.446 . . . . 64.030000000000001 110.881 -179.977 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.65 ' HA ' ' HA ' ' A' ' 156' ' ' GLU . 6.0 mtpp -118.59 152.53 35.85 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.153 -0.476 . . . . 61.43 110.859 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.559 HG11 ' HG3' ' A' ' 95' ' ' LYS . 16.6 t 82.74 163.4 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.217 -0.447 . . . . 51.299999999999997 111.108 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.829 HD13 ' O ' ' A' ' 154' ' ' LYS . 0.0 OUTLIER -179.73 123.57 0.07 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.17 -0.468 . . . . 71.549999999999997 110.911 179.942 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.516 ' O ' ' C ' ' A' ' 135' ' ' GLY . 0.1 OUTLIER -94.27 167.1 11.75 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.153 -0.476 . . . . 65.120000000000005 110.915 179.908 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 135' ' ' GLY . . . . . 0.516 ' C ' ' O ' ' A' ' 134' ' ' GLU . . . -27.93 -57.82 0.12 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.745 -0.74 . . . . 51.109999999999999 112.463 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.689 HG21 HG13 ' A' ' 86' ' ' VAL . 2.8 t -145.66 144.44 21.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.809 0.338 . . . . 74.109999999999999 111.167 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 137' ' ' TRP . . . . . 0.588 ' HB3' ' HB3' ' A' ' 152' ' ' LEU . 7.4 t-105 -143.52 152.98 42.13 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.22 -0.445 . . . . 75.450000000000003 110.974 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.493 ' CD1' ' HB ' ' A' ' 61' ' ' ILE . 2.8 mm -119.21 132.02 70.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.271 -0.422 . . . . 64.420000000000002 111.156 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.707 ' CE2' HG11 ' A' ' 170' ' ' VAL . 0.2 OUTLIER -111.41 146.37 37.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.187 -0.46 . . . . 72.519999999999996 110.858 179.951 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 140' ' ' TYR . . . . . 0.422 ' CD2' ' HA ' ' A' ' 145' ' ' TYR . 3.4 m-85 -127.79 130.01 47.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.069 -0.514 . . . . 74.230000000000004 110.889 -179.858 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 141' ' ' GLU . . . . . 0.613 ' O ' ' HB2' ' A' ' 171' ' ' GLN . 0.2 OUTLIER -60.34 -25.78 66.08 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.081 -0.509 . . . . 75.219999999999999 110.877 -179.984 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.748 ' HB3' ' HD2' ' A' ' 143' ' ' PRO . 9.7 mp -114.66 173.88 2.66 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.657 0.742 . . . . 70.299999999999997 110.88 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 143' ' ' PRO . . . . . 0.751 ' O ' ' OG ' ' A' ' 172' ' ' SER . 53.7 Cg_endo -69.77 -91.62 0.01 OUTLIER 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.726 2.284 . . . . 75.450000000000003 112.281 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 144' ' ' ASN . . . . . 0.71 ' O ' ' N ' ' A' ' 146' ' ' ARG . 0.9 OUTLIER -50.98 97.89 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.154 -0.476 . . . . 52.340000000000003 110.858 -179.926 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 145' ' ' TYR . . . . . 0.641 ' C ' ' O ' ' A' ' 144' ' ' ASN . 0.1 OUTLIER 12.1 53.09 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.143 -0.48 . . . . 72.129999999999995 110.923 -179.924 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 146' ' ' ARG . . . . . 0.71 ' N ' ' O ' ' A' ' 144' ' ' ASN . 11.3 mtp85 -118.76 174.71 6.12 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.095 -0.502 . . . . 75.040000000000006 110.844 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 80.84 -173.0 54.62 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.733 -0.746 . . . . 41.329999999999998 112.495 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.595 ' HA ' HD21 ' A' ' 76' ' ' LEU . 0.8 OUTLIER -80.58 150.46 29.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.749 0.309 . . . . 61.539999999999999 110.893 -179.906 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 149' ' ' GLN . . . . . 0.468 ' O ' ' HB2' ' A' ' 59' ' ' MET . 8.4 mt-30 -81.73 153.62 26.45 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.185 -0.461 . . . . 74.340000000000003 110.889 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 150' ' ' TYR . . . . . 0.585 ' HB2' ' CB ' ' A' ' 139' ' ' PHE . 98.3 m-85 -139.28 129.44 25.26 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.218 -0.446 . . . . 44.030000000000001 110.945 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.602 ' HB2' HD11 ' A' ' 61' ' ' ILE . 13.3 tp -81.78 121.72 26.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.092 -0.504 . . . . 43.229999999999997 110.911 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 1.02 HD13 ' O ' ' A' ' 152' ' ' LEU . 0.0 OUTLIER -53.77 135.86 40.82 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.191 -0.459 . . . . 73.319999999999993 110.948 179.886 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -164.07 27.75 0.08 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.206 -0.452 . . . . 74.150000000000006 110.828 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.829 ' O ' HD13 ' A' ' 133' ' ' LEU . 0.0 OUTLIER -116.71 -172.74 2.25 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.214 -0.448 . . . . 74.549999999999997 110.889 179.969 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.804 ' HG3' HD22 ' A' ' 133' ' ' LEU . 0.0 OUTLIER -162.39 -128.92 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.221 -0.445 . . . . 42.119999999999997 110.908 179.875 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.65 ' HA ' ' HA ' ' A' ' 131' ' ' LYS . 0.2 OUTLIER -68.0 1.13 2.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.213 -0.449 . . . . 74.140000000000001 110.936 179.956 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 157' ' ' TYR . . . . . 0.746 ' CE1' ' HA ' ' A' ' 154' ' ' LYS . 20.3 m-30 -28.78 143.47 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.094 -0.503 . . . . 75.25 110.933 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 158' ' ' ARG . . . . . 0.44 ' HB2' ' HA ' ' A' ' 103' ' ' ASP . 9.5 ptp180 -110.91 -43.4 3.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.158 -0.474 . . . . 71.540000000000006 110.921 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -82.45 151.24 65.16 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.519 0.676 . . . . 70.530000000000001 110.93 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 160' ' ' PRO . . . . . 0.541 ' HB3' ' HB3' ' A' ' 168' ' ' PRO . 54.0 Cg_endo -69.74 -26.67 27.45 Favored 'Trans proline' 0 C--O 1.231 0.136 0 C-N-CA 122.7 2.266 . . . . 75.150000000000006 112.347 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.598 HD12 ' H ' ' A' ' 161' ' ' ILE . 3.6 mp -65.44 -11.78 12.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.224 -0.444 . . . . 74.040000000000006 111.074 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.67 ' HB3' ' CD1' ' A' ' 157' ' ' TYR . 0.3 OUTLIER -75.0 -18.88 60.29 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.151 -0.477 . . . . 74.540000000000006 110.837 179.936 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 13.3 t90 -82.06 0.23 41.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.197 -0.456 . . . . 73.450000000000003 110.938 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 91.91 -36.2 3.74 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.75 -0.738 . . . . 65.540000000000006 112.507 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -79.68 128.39 33.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.777 0.322 . . . . 74.540000000000006 111.099 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -39.41 -38.28 0.54 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.194 -0.457 . . . . 50.020000000000003 111.101 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 167' ' ' SER . . . . . 0.496 ' C ' ' H ' ' A' ' 169' ' ' ALA . 0.5 OUTLIER -128.18 154.26 78.77 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.642 0.734 . . . . 64.310000000000002 110.892 -179.822 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 168' ' ' PRO . . . . . 0.541 ' HB3' ' HB3' ' A' ' 160' ' ' PRO . 54.4 Cg_endo -69.74 25.13 0.17 Allowed 'Trans proline' 0 C--O 1.231 0.147 0 C-N-CA 122.742 2.294 . . . . 73.540000000000006 112.352 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 0.496 ' H ' ' C ' ' A' ' 167' ' ' SER . . . -65.89 103.65 0.96 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.223 -0.444 . . . . 72.129999999999995 111.11 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.707 HG11 ' CE2' ' A' ' 139' ' ' PHE . 2.6 t -152.14 163.43 2.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.225 -0.443 . . . . 63.219999999999999 111.145 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 171' ' ' GLN . . . . . 0.64 ' OE1' ' HB3' ' A' ' 143' ' ' PRO . 1.8 mm-40 -114.26 -89.57 0.54 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.19 -0.459 . . . . 74.420000000000002 110.914 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 172' ' ' SER . . . . . 0.751 ' OG ' ' O ' ' A' ' 143' ' ' PRO . 12.6 p -126.9 177.05 6.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.194 -0.457 . . . . 61.100000000000001 110.852 -179.829 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 173' ' ' PHE . . . . . 0.604 ' CE1' HD11 ' A' ' 98' ' ' ILE . 1.4 p90 -145.8 174.38 11.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.105 -0.498 . . . . 72.420000000000002 110.883 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.18 154.61 46.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.179 -0.464 . . . . 73.010000000000005 110.88 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.15 -169.91 2.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.16 -0.473 . . . . 72.340000000000003 110.864 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 176' ' ' ILE . . . . . 0.422 HD12 ' HB ' ' A' ' 136' ' ' VAL . 4.5 mt -134.51 136.85 52.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.21 -0.45 . . . . 74.239999999999995 111.173 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.558 HG22 ' OH ' ' A' ' 94' ' ' TYR . 10.7 t -140.31 153.43 22.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.218 -0.446 . . . . 65.439999999999998 111.142 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 178' ' ' GLU . . . . . 0.445 ' HB3' HD13 ' A' ' 88' ' ' LEU . 10.6 pt-20 . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 116.133 -0.485 . . . . 61.219999999999999 110.855 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.376 0 N-CA-C 112.489 -0.245 . . . . 64.430000000000007 112.489 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.514 ' C ' ' HE1' ' A' ' 47' ' ' TRP . 6.9 p -82.8 135.81 34.85 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.908 0.385 . . . . 75.430000000000007 111.117 -179.86 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 3.6 tttt -122.54 135.24 54.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 72.420000000000002 110.937 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.591 ' HB ' HG22 ' A' ' 42' ' ' VAL . 15.2 tt -136.75 150.61 27.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.21 -0.45 . . . . 52.140000000000001 111.125 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.496 HG23 ' CG ' ' A' ' 22' ' ' ASP . 13.6 m -127.4 146.29 50.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.187 -0.461 . . . . 74.420000000000002 111.164 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.795 ' HB2' HD22 ' A' ' 34' ' ' LEU . 0.2 OUTLIER -134.07 127.17 31.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.206 -0.452 . . . . 71.430000000000007 110.888 179.999 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.551 ' CG ' ' HA ' ' A' ' 16' ' ' PHE . 26.2 m-85 -113.41 131.82 55.86 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.149 -0.478 . . . . 71.109999999999999 110.923 -179.858 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.458 ' N ' HD11 ' A' ' 34' ' ' LEU . 0.0 OUTLIER -60.26 -15.43 24.79 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.121 -0.49 . . . . 65.140000000000001 110.9 179.987 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.449 ' HB2' ' O ' ' A' ' 17' ' ' GLN . 71.2 m-20 -134.89 150.57 50.45 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.156 -0.475 . . . . 70.019999999999996 110.873 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.504 ' N ' ' HB3' ' A' ' 38' ' ' ASN . 39.4 mtmt -55.7 -177.78 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.182 -0.463 . . . . 74.129999999999995 110.857 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 22.7 m-20 48.14 33.26 3.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.17 -0.468 . . . . 75.299999999999997 110.888 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.551 ' HA ' ' CG ' ' A' ' 11' ' ' TYR . 3.3 m-85 49.22 64.3 1.79 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.164 -0.471 . . . . 71.439999999999998 110.853 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.449 ' O ' ' HB2' ' A' ' 13' ' ' ASP . 15.6 mt-30 -140.07 158.07 44.63 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.146 -0.479 . . . . 71.319999999999993 110.934 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 93.28 -150.63 20.0 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.775 -0.726 . . . . 74.430000000000007 112.476 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.715 ' O ' HD13 ' A' ' 34' ' ' LEU . 0.2 OUTLIER -66.72 78.51 0.11 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.754 0.311 . . . . 73.25 110.851 -179.829 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.475 ' HB2' ' CE1' ' A' ' 11' ' ' TYR . 0.7 OUTLIER -77.04 128.88 35.27 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.232 -0.44 . . . . 74.430000000000007 110.876 -179.921 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.475 ' O ' ' HA ' ' A' ' 9' ' ' THR . 88.1 t80 -123.06 125.72 45.73 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.21 -0.45 . . . . 73.140000000000001 110.943 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.496 ' CG ' HG23 ' A' ' 9' ' ' THR . 1.3 m-20 -123.33 132.63 54.05 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.156 -0.474 . . . . 72.310000000000002 110.857 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -166.0 138.33 3.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 65.340000000000003 110.927 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -104.72 4.48 32.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.195 -0.457 . . . . 73.120000000000005 110.846 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 14.9 t -108.55 164.2 12.56 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.21 -0.45 . . . . 64.349999999999994 110.882 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -60.25 117.49 5.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.173 -0.467 . . . . 73.310000000000002 110.832 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.469 ' HB3' ' CB ' ' A' ' 30' ' ' PHE . 16.6 m -117.07 54.05 0.88 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.173 -0.467 . . . . 61.030000000000001 110.894 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.525 ' O ' ' HA ' ' A' ' 82' ' ' SER . . . -47.67 -18.84 0.17 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 30.239999999999998 111.06 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 58.3 t0 -127.26 40.07 3.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.236 -0.438 . . . . 75.430000000000007 110.845 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.779 ' CD2' ' O ' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -80.77 14.12 2.3 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.224 -0.444 . . . . 72.450000000000003 110.896 -179.927 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.508 ' HB2' ' HB3' ' A' ' 53' ' ' PRO . 36.2 t60 -78.47 -37.75 42.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.121 -0.49 . . . . 71.319999999999993 110.893 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.5 t -58.19 -15.18 8.89 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.199 -0.455 . . . . 71.519999999999996 111.149 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -98.53 -27.97 13.8 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.243 -0.435 . . . . 73.439999999999998 110.899 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.795 HD22 ' HB2' ' A' ' 10' ' ' PHE . 15.6 tp -140.87 134.92 30.78 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.129 -0.487 . . . . 74.540000000000006 110.878 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 23.3 m -99.74 -41.49 7.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.187 -0.46 . . . . 73.0 110.866 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -119.14 143.08 47.4 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.13 -0.486 . . . . 73.430000000000007 110.865 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.64 ' SG ' ' HB2' ' A' ' 80' ' ' LEU . 1.8 p -115.65 89.75 3.17 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.193 -0.458 . . . . 74.510000000000005 110.919 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.504 ' HB3' ' N ' ' A' ' 14' ' ' LYS . 3.6 m-20 -85.46 -54.01 4.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.193 -0.458 . . . . 64.340000000000003 110.87 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 9.7 p -125.32 128.12 47.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 51.420000000000002 110.854 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.741 HG21 HD13 ' A' ' 62' ' ' LEU . 11.0 mt -127.05 152.08 34.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.11 -0.495 . . . . 74.25 111.123 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.435 ' N ' ' CG2' ' A' ' 40' ' ' ILE . 0.0 OUTLIER -142.78 118.33 10.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.188 -0.46 . . . . 74.549999999999997 110.877 179.852 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.591 HG22 ' HB ' ' A' ' 8' ' ' ILE . 1.9 t -101.2 115.15 42.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.187 -0.46 . . . . 72.219999999999999 111.111 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -111.28 79.96 1.26 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.181 -0.463 . . . . 72.209999999999994 110.889 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.454 ' O ' ' HA ' ' A' ' 6' ' ' THR . . . 129.44 103.33 1.07 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.72 -0.752 . . . . 74.439999999999998 112.467 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.475 ' HA2' HD21 ' A' ' 88' ' ' LEU . . . 52.84 178.1 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.704 -0.76 . . . . 63.130000000000003 112.49 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.758 HG23 ' HA ' ' A' ' 63' ' ' PRO . 3.0 m -79.65 164.78 23.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.794 0.331 . . . . 61.520000000000003 111.119 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' TRP . . . . . 0.575 ' CD1' ' HB ' ' A' ' 8' ' ' ILE . 2.7 m95 -137.69 130.02 29.34 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.155 -0.475 . . . . 74.549999999999997 110.857 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.805 ' HB2' ' CG2' ' A' ' 86' ' ' VAL . . . -92.77 131.26 37.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.227 -0.442 . . . . 74.209999999999994 111.151 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.907 HG11 HD11 ' A' ' 80' ' ' LEU . 19.6 m -132.56 127.51 56.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.241 -0.436 . . . . 73.239999999999995 111.105 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.75 ' HB3' ' HA ' ' A' ' 56' ' ' ALA . 38.9 m-85 -94.75 148.3 22.43 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.218 -0.447 . . . . 62.420000000000002 110.92 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.544 ' HB2' ' O ' ' A' ' 58' ' ' TYR . 7.1 tt0 -50.91 -76.55 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.148 -0.478 . . . . 43.240000000000002 110.855 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.571 ' HB3' ' CD1' ' A' ' 55' ' ' PHE . 19.2 mmm-85 -89.92 140.7 27.73 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.64 0.733 . . . . 72.200000000000003 110.846 -179.873 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.789 ' HA ' ' OG ' ' A' ' 82' ' ' SER . 54.1 Cg_endo -69.75 137.8 36.35 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.733 2.289 . . . . 71.450000000000003 112.322 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 65.32 -11.18 0.17 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.246 -0.434 . . . . 73.129999999999995 110.897 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.571 ' CD1' ' HB3' ' A' ' 52' ' ' ARG . 4.9 m-30 -100.85 -32.19 10.79 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.159 -0.473 . . . . 62.530000000000001 110.876 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.75 ' HA ' ' HB3' ' A' ' 50' ' ' TYR . . . 63.42 22.44 13.25 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.185 -0.461 . . . . 73.540000000000006 111.107 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' TRP . . . . . 0.629 ' O ' ' C ' ' A' ' 58' ' ' TYR . 1.2 t90 -51.4 -159.69 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.216 -0.447 . . . . 73.109999999999999 110.923 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.629 ' C ' ' O ' ' A' ' 57' ' ' TRP . 5.8 m-30 -13.72 101.43 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.278 -0.419 . . . . 71.540000000000006 110.929 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.407 ' HB2' ' HA ' ' A' ' 150' ' ' TYR . 2.1 mpt? -59.67 149.28 31.02 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.067 -0.515 . . . . 53.439999999999998 110.886 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.811 ' CE2' HD12 ' A' ' 76' ' ' LEU . 0.4 OUTLIER -163.93 105.08 0.91 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.232 -0.44 . . . . 72.109999999999999 110.923 -179.876 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.81 ' N ' HD12 ' A' ' 61' ' ' ILE . 0.9 OUTLIER -98.86 115.72 40.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.114 -0.494 . . . . 74.430000000000007 111.114 179.904 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.778 HD23 ' HD2' ' A' ' 63' ' ' PRO . 0.4 OUTLIER -83.64 123.71 76.07 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.6 0.714 . . . . 32.530000000000001 110.939 179.877 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.778 ' HD2' HD23 ' A' ' 62' ' ' LEU . 54.3 Cg_endo -69.74 -165.21 0.15 Allowed 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.73 2.286 . . . . 73.430000000000007 112.341 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.64 159.57 14.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.233 -0.44 . . . . 73.329999999999998 110.907 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 112.88 -155.52 16.23 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.715 -0.755 . . . . 62.539999999999999 112.448 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -114.81 160.42 19.47 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.877 0.37 . . . . 74.109999999999999 110.859 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.446 ' N ' ' O ' ' A' ' 40' ' ' ILE . 10.8 m-85 -149.58 83.81 6.27 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.71 0.766 . . . . 74.319999999999993 110.919 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.8 -4.73 14.65 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.65 2.234 . . . . 71.430000000000007 112.325 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -156.89 148.23 22.2 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.244 -0.435 . . . . 75.329999999999998 110.919 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.99 ' O ' ' CD1' ' A' ' 73' ' ' TRP . 44.6 p90 -57.44 -42.44 82.45 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.164 -0.471 . . . . 70.439999999999998 110.936 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -51.94 -15.79 0.6 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.102 -0.499 . . . . 63.420000000000002 110.89 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 28.7 mmt180 -69.16 -9.22 51.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.179 -0.464 . . . . 75.25 110.902 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' TRP . . . . . 0.99 ' CD1' ' O ' ' A' ' 70' ' ' TYR . 0.5 OUTLIER -128.8 21.63 5.9 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.18 -0.463 . . . . 71.319999999999993 110.905 -179.946 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 74' ' ' MET . . . . . 0.623 ' O ' ' C ' ' A' ' 75' ' ' GLY . 24.1 mmt 79.54 27.44 0.36 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.276 -0.42 . . . . 72.230000000000004 110.878 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.623 ' C ' ' O ' ' A' ' 74' ' ' MET . . . 15.74 61.94 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.698 -0.763 . . . . 33.149999999999999 112.514 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.811 HD12 ' CE2' ' A' ' 60' ' ' TYR . 59.9 mt -58.89 -80.34 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.843 0.354 . . . . 73.549999999999997 110.902 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.589 ' O ' ' CB ' ' A' ' 78' ' ' ASP . 3.8 t-20 -113.56 -41.84 3.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.193 -0.458 . . . . 50.329999999999998 110.898 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.589 ' CB ' ' O ' ' A' ' 77' ' ' ASN . 2.6 t70 91.04 16.38 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.18 -0.464 . . . . 74.129999999999995 110.891 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.451 ' NE ' ' HD3' ' A' ' 52' ' ' ARG . 4.9 ttm105 -110.92 97.66 6.99 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.143 -0.481 . . . . 73.409999999999997 110.845 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.907 HD11 HG11 ' A' ' 49' ' ' VAL . 0.1 OUTLIER -95.6 131.7 41.53 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.18 -0.463 . . . . 71.109999999999999 110.912 -179.985 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.671 ' HB3' ' HB3' ' A' ' 53' ' ' PRO . 1.2 m -153.03 -123.58 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.208 -0.451 . . . . 65.340000000000003 110.877 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.789 ' OG ' ' HA ' ' A' ' 53' ' ' PRO . 0.0 OUTLIER -41.65 101.86 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.138 -0.483 . . . . 73.239999999999995 110.797 -179.757 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 83' ' ' CYS . . . . . 0.711 ' CB ' HG12 ' A' ' 49' ' ' VAL . 21.3 p -117.43 136.15 53.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.109 -0.496 . . . . 74.200000000000003 110.857 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.585 ' N ' ' O ' ' A' ' 48' ' ' ALA . 6.6 mmt85 -123.43 138.38 54.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.149 -0.478 . . . . 71.040000000000006 110.865 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.448 ' N ' ' CZ3' ' A' ' 47' ' ' TRP . . . -57.71 128.67 38.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.202 -0.454 . . . . 74.109999999999999 111.044 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.832 HG13 HG21 ' A' ' 136' ' ' VAL . 12.3 t -111.71 139.6 35.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.18 -0.463 . . . . 60.200000000000003 111.113 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' HIS . . . . . 0.637 ' O ' HG23 ' A' ' 136' ' ' VAL . 29.8 m80 -111.84 106.01 14.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.173 -0.467 . . . . 75.109999999999999 110.854 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.73 HD13 ' HA ' ' A' ' 178' ' ' GLU . 0.0 OUTLIER -31.9 143.22 0.13 Allowed Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.619 0.723 . . . . 71.030000000000001 110.888 -179.949 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.529 ' HB3' ' H ' ' A' ' 136' ' ' VAL . 53.7 Cg_endo -69.82 105.73 1.55 Allowed 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.652 2.235 . . . . 64.120000000000005 112.291 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.03 177.35 4.88 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.206 -0.452 . . . . 72.319999999999993 110.805 -179.835 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 50.12 63.16 4.48 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.741 -0.742 . . . . 35.229999999999997 112.486 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.424 ' O ' ' C ' ' A' ' 93' ' ' GLN . . . 124.25 21.72 2.24 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.754 -0.736 . . . . 61.32 112.454 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.471 ' O ' ' HG2' ' A' ' 134' ' ' GLU . 13.5 pt20 36.59 -121.29 0.16 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.815 0.341 . . . . 73.430000000000007 110.859 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.535 ' O ' ' HA ' ' A' ' 112' ' ' THR . 0.1 OUTLIER -120.92 100.8 7.29 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.141 -0.482 . . . . 65.530000000000001 110.911 -179.853 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.533 ' HG3' HG11 ' A' ' 132' ' ' VAL . 45.6 tptt -110.82 128.27 55.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.112 -0.494 . . . . 71.0 110.907 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.472 HG21 ' CH2' ' A' ' 137' ' ' TRP . 0.0 OUTLIER -149.11 142.38 18.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.253 -0.431 . . . . 70.299999999999997 111.12 179.82 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.532 ' HB2' HG23 ' A' ' 132' ' ' VAL . 2.8 mt-30 -112.1 126.94 55.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.137 -0.483 . . . . 74.420000000000002 110.911 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.625 HD13 ' HE1' ' A' ' 122' ' ' PHE . 4.9 mp -108.33 131.26 59.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.237 -0.438 . . . . 44.210000000000001 111.115 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.672 ' HB2' ' HB2' ' A' ' 129' ' ' SER . 6.4 m-85 -120.15 148.19 43.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.172 -0.467 . . . . 75.430000000000007 110.883 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -74.88 -75.59 0.16 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.159 -0.473 . . . . 73.400000000000006 110.912 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.439 ' C ' ' HB3' ' A' ' 128' ' ' HIS . 36.7 mttt -83.14 176.19 9.39 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.168 -0.469 . . . . 72.450000000000003 110.926 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -88.79 160.41 29.98 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.764 -0.731 . . . . 64.340000000000003 112.476 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.432 ' HA ' ' HB2' ' A' ' 158' ' ' ARG . 27.8 t0 65.15 53.42 1.35 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.883 0.373 . . . . 73.230000000000004 110.893 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.63 ' CE1' ' HD2' ' A' ' 131' ' ' LYS . 6.1 m-85 48.38 33.74 4.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.457 . . . . 64.109999999999999 110.876 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.419 ' HB2' ' HB2' ' A' ' 101' ' ' LYS . 45.4 m -109.47 151.61 26.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.101 -0.499 . . . . 74.25 110.848 -179.795 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 91.35 -164.4 29.44 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.675 -0.774 . . . . 71.25 112.467 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 5.0 tp-100 -75.41 129.65 37.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.805 0.336 . . . . 71.010000000000005 110.945 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 3.8 ttp -112.47 144.96 41.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.197 -0.456 . . . . 65.319999999999993 110.887 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 -148.84 141.73 24.72 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.212 -0.449 . . . . 70.510000000000005 110.949 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -123.78 108.66 12.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.1 -0.5 . . . . 73.340000000000003 110.938 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 5.0 t -121.47 145.69 47.68 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.175 -0.466 . . . . 64.340000000000003 111.132 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.535 ' HA ' ' O ' ' A' ' 94' ' ' TYR . 4.4 t -120.96 41.91 3.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.245 -0.434 . . . . 64.120000000000005 111.152 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -151.19 157.08 42.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.224 -0.444 . . . . 73.310000000000002 110.904 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -53.85 157.86 2.23 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.145 -0.479 . . . . 73.409999999999997 110.823 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' CYS . . . . . 0.671 ' O ' ' HB2' ' A' ' 172' ' ' SER . 73.2 m -146.89 115.2 4.36 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-O 121.626 0.727 . . . . 73.319999999999993 110.898 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.455 ' O ' ' C ' ' A' ' 143' ' ' PRO . 53.3 Cg_endo -69.82 -30.3 22.24 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.648 2.232 . . . . 73.319999999999993 112.328 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.634 ' HB3' ' CB ' ' A' ' 120' ' ' GLU . 0.1 OUTLIER -148.26 99.82 3.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.251 -0.431 . . . . 64.329999999999998 110.814 -179.854 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.642 HD13 HD11 ' A' ' 127' ' ' ILE . 5.6 tt -52.86 -26.56 11.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.12 -0.491 . . . . 45.310000000000002 111.124 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' MET . . . . . 0.602 ' O ' ' HA ' ' A' ' 123' ' ' HIS . 14.4 ttp -86.75 -41.26 14.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.198 -0.455 . . . . 73.129999999999995 110.89 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.634 ' CB ' ' HB3' ' A' ' 117' ' ' SER . 34.5 tp10 -64.33 -12.98 47.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.215 -0.448 . . . . 73.230000000000004 110.854 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' GLN . . . . . 0.404 ' H ' ' HG3' ' A' ' 121' ' ' GLN . 0.0 OUTLIER -114.62 -51.56 2.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.189 -0.46 . . . . 71.510000000000005 110.946 -179.96 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.625 ' HE1' HD13 ' A' ' 98' ' ' ILE . 12.1 m-30 -101.22 -18.17 16.27 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.217 -0.447 . . . . 44.340000000000003 110.935 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' HIS . . . . . 0.602 ' HA ' ' O ' ' A' ' 119' ' ' MET . 11.8 m80 74.39 21.29 2.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.135 -0.484 . . . . 73.310000000000002 110.901 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.56 ' SD ' HG22 ' A' ' 98' ' ' ILE . 6.5 mtt -94.27 131.91 39.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.188 -0.46 . . . . 65.340000000000003 110.873 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 4.9 ptp180 -95.23 -38.55 10.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.181 -0.463 . . . . 65.219999999999999 110.877 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.464 ' HG2' ' HA ' ' A' ' 169' ' ' ALA . 25.2 mt-10 -141.25 118.62 11.45 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.159 -0.473 . . . . 64.140000000000001 110.875 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.642 HD11 HD13 ' A' ' 118' ' ' ILE . 3.0 mm -80.08 101.09 4.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.163 -0.471 . . . . 75.450000000000003 111.138 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 128' ' ' HIS . . . . . 0.439 ' HB3' ' C ' ' A' ' 101' ' ' LYS . 0.4 OUTLIER -73.19 -32.58 64.9 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.171 -0.468 . . . . 72.450000000000003 110.846 179.888 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 129' ' ' SER . . . . . 0.672 ' HB2' ' HB2' ' A' ' 99' ' ' PHE . 66.5 m -128.47 138.89 52.51 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.193 -0.458 . . . . 65.019999999999996 110.83 -179.719 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 130' ' ' CYS . . . . . 0.573 ' O ' ' O ' ' A' ' 155' ' ' LYS . 3.8 m -136.05 120.43 18.02 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.149 -0.478 . . . . 61.409999999999997 110.865 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.67 ' HA ' ' HA ' ' A' ' 156' ' ' GLU . 3.6 mtpp -116.35 152.21 34.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.131 -0.486 . . . . 71.5 110.892 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.539 ' HB ' ' O ' ' A' ' 131' ' ' LYS . 19.4 t 85.6 162.46 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.226 -0.443 . . . . 75.310000000000002 111.145 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.812 HD22 ' CG ' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -177.33 124.59 0.14 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.223 -0.444 . . . . 64.239999999999995 110.929 179.933 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.501 ' O ' ' C ' ' A' ' 135' ' ' GLY . 0.1 OUTLIER -98.26 168.23 10.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.162 -0.472 . . . . 72.120000000000005 110.895 179.936 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 135' ' ' GLY . . . . . 0.501 ' C ' ' O ' ' A' ' 134' ' ' GLU . . . -29.17 -70.04 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.751 -0.738 . . . . 72.129999999999995 112.447 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.832 HG21 HG13 ' A' ' 86' ' ' VAL . 3.0 t -133.82 145.43 33.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.834 0.349 . . . . 73.549999999999997 111.109 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 137' ' ' TRP . . . . . 0.616 ' H ' HD12 ' A' ' 152' ' ' LEU . 0.1 OUTLIER -150.1 162.8 39.7 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.187 -0.461 . . . . 73.150000000000006 110.866 -179.975 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.456 HD12 HH11 ' A' ' 174' ' ' ARG . 22.6 mt -138.48 134.03 43.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.208 -0.451 . . . . 75.409999999999997 111.136 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.676 ' CE1' HG11 ' A' ' 170' ' ' VAL . 0.2 OUTLIER -103.68 159.16 15.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.176 -0.465 . . . . 73.329999999999998 110.884 179.957 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 140' ' ' TYR . . . . . 0.481 ' CD2' ' HA ' ' A' ' 145' ' ' TYR . 0.5 OUTLIER -131.61 128.46 39.18 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.123 -0.49 . . . . 75.430000000000007 110.905 -179.875 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 141' ' ' GLU . . . . . 0.576 ' O ' ' HB2' ' A' ' 171' ' ' GLN . 7.0 tt0 -60.76 -27.75 68.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.089 -0.505 . . . . 61.520000000000003 110.858 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.743 ' HB3' ' HD2' ' A' ' 143' ' ' PRO . 10.1 mp -114.97 173.46 2.89 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.588 0.709 . . . . 74.450000000000003 110.938 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 143' ' ' PRO . . . . . 0.758 ' O ' ' OG ' ' A' ' 172' ' ' SER . 53.2 Cg_endo -69.77 -90.61 0.0 OUTLIER 'Trans proline' 0 C--N 1.34 0.129 0 C-N-CA 122.694 2.263 . . . . 44.299999999999997 112.327 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 144' ' ' ASN . . . . . 0.723 ' O ' ' N ' ' A' ' 146' ' ' ARG . 2.4 m-20 -50.73 98.57 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.181 -0.463 . . . . 74.329999999999998 110.87 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 145' ' ' TYR . . . . . 0.638 ' C ' ' O ' ' A' ' 144' ' ' ASN . 0.1 OUTLIER 12.67 51.77 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.163 -0.471 . . . . 72.25 110.945 -179.959 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 146' ' ' ARG . . . . . 0.723 ' N ' ' O ' ' A' ' 144' ' ' ASN . 22.3 mtt-85 -119.46 173.43 6.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.132 -0.486 . . . . 75.340000000000003 110.921 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 79.84 172.27 43.6 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.737 -0.744 . . . . 62.049999999999997 112.462 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 19.3 mtp180 -68.55 150.61 47.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.755 0.312 . . . . 73.420000000000002 110.888 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 149' ' ' GLN . . . . . 0.688 ' HG3' HD11 ' A' ' 76' ' ' LEU . 55.4 mt-30 -86.02 153.21 22.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.236 -0.438 . . . . 75.400000000000006 110.932 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 150' ' ' TYR . . . . . 0.482 ' HB2' ' HB2' ' A' ' 139' ' ' PHE . 76.1 m-85 -133.91 123.02 23.98 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.222 -0.445 . . . . 74.129999999999995 110.934 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.663 HD23 ' OH ' ' A' ' 50' ' ' TYR . 12.1 tp -70.32 125.24 26.24 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.144 -0.48 . . . . 52.0 110.909 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 1.003 HD13 ' O ' ' A' ' 152' ' ' LEU . 0.0 OUTLIER -59.94 132.58 54.4 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.177 -0.465 . . . . 72.430000000000007 110.871 179.948 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -163.56 24.98 0.08 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.138 -0.483 . . . . 75.329999999999998 110.862 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.785 ' O ' HD13 ' A' ' 133' ' ' LEU . 0.1 OUTLIER -112.41 -171.1 1.79 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.186 -0.461 . . . . 70.25 110.923 179.954 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.812 ' CG ' HD22 ' A' ' 133' ' ' LEU . 0.2 OUTLIER -165.67 -122.39 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.207 -0.452 . . . . 75.329999999999998 110.858 179.87 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.67 ' HA ' ' HA ' ' A' ' 131' ' ' LYS . 0.4 OUTLIER -71.39 0.42 8.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.232 -0.44 . . . . 73.319999999999993 110.913 -179.99 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 157' ' ' TYR . . . . . 0.661 ' CE1' ' HA ' ' A' ' 154' ' ' LYS . 16.8 m-30 -28.49 142.49 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.128 -0.487 . . . . 74.319999999999993 110.938 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 158' ' ' ARG . . . . . 0.432 ' HB2' ' HA ' ' A' ' 103' ' ' ASP . 11.1 ptp180 -112.18 -33.74 6.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.126 -0.488 . . . . 65.109999999999999 110.862 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -101.1 152.28 37.85 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.541 0.686 . . . . 72.010000000000005 110.914 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.73 -22.64 31.92 Favored 'Trans proline' 0 C--O 1.232 0.206 0 C-N-CA 122.694 2.262 . . . . 65.340000000000003 112.354 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.656 HD12 ' H ' ' A' ' 161' ' ' ILE . 4.0 mp -76.67 -2.89 4.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.226 -0.443 . . . . 62.520000000000003 111.146 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.657 ' HB3' ' CD1' ' A' ' 157' ' ' TYR . 1.4 t0 -72.47 -17.34 61.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.19 -0.459 . . . . 74.310000000000002 110.878 179.839 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 163' ' ' TRP . . . . . 0.52 ' CG ' ' O ' ' A' ' 163' ' ' TRP . 6.2 t-105 -109.99 10.21 24.24 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.168 -0.469 . . . . 62.409999999999997 110.934 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 87.71 -31.63 4.53 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.69 -0.767 . . . . 64.420000000000002 112.503 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -54.35 119.35 5.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.799 0.333 . . . . 71.319999999999993 111.103 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -49.1 -26.14 2.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.202 -0.454 . . . . 63.0 111.1 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 167' ' ' SER . . . . . 0.461 ' C ' ' H ' ' A' ' 169' ' ' ALA . 0.3 OUTLIER -154.98 159.36 31.89 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.635 0.731 . . . . 63.030000000000001 110.855 -179.794 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 168' ' ' PRO . . . . . 0.502 ' HB3' ' O ' ' A' ' 127' ' ' ILE . 53.5 Cg_endo -69.81 19.21 0.19 Allowed 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.679 2.253 . . . . 75.510000000000005 112.32 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 0.464 ' HA ' ' HG2' ' A' ' 126' ' ' GLU . . . -63.01 102.58 0.38 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.236 -0.438 . . . . 72.230000000000004 111.083 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.676 HG11 ' CE1' ' A' ' 139' ' ' PHE . 3.4 t -153.09 162.15 2.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.223 -0.444 . . . . 53.329999999999998 111.147 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 171' ' ' GLN . . . . . 0.669 ' OE1' ' HB3' ' A' ' 143' ' ' PRO . 1.7 mm-40 -112.21 -88.38 0.53 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.209 -0.45 . . . . 71.310000000000002 110.93 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 172' ' ' SER . . . . . 0.758 ' OG ' ' O ' ' A' ' 143' ' ' PRO . 45.7 p -121.67 177.92 5.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.156 -0.475 . . . . 64.099999999999994 110.882 -179.801 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 2.0 p90 -141.97 168.34 19.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.161 -0.472 . . . . 71.0 110.861 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 174' ' ' ARG . . . . . 0.456 HH11 HD12 ' A' ' 138' ' ' ILE . 0.0 OUTLIER -135.21 156.16 49.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.11 -0.496 . . . . 60.039999999999999 110.911 -179.937 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 175' ' ' ARG . . . . . 0.404 ' HD2' ' CE2' ' A' ' 94' ' ' TYR . 0.0 OUTLIER -100.68 -164.48 1.12 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.178 -0.464 . . . . 73.040000000000006 110.868 -179.922 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 176' ' ' ILE . . . . . 0.768 HD12 ' HB ' ' A' ' 136' ' ' VAL . 5.6 mt -137.0 130.5 45.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.164 -0.471 . . . . 74.099999999999994 111.09 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 7.4 p -98.43 155.84 3.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.198 -0.456 . . . . 74.109999999999999 111.103 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 178' ' ' GLU . . . . . 0.73 ' HA ' HD13 ' A' ' 88' ' ' LEU . 3.4 mt-10 . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.174 -0.467 . . . . 73.340000000000003 110.877 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.352 0 N-CA-C 112.511 -0.235 . . . . 65.239999999999995 112.511 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.485 ' C ' ' HE1' ' A' ' 47' ' ' TRP . 9.9 p -82.67 133.78 35.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.871 0.367 . . . . 71.340000000000003 111.149 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 3.0 tttt -122.08 137.08 54.94 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.176 -0.465 . . . . 74.439999999999998 110.856 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.585 ' HB ' ' CD1' ' A' ' 47' ' ' TRP . 14.3 tt -137.16 152.94 28.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.197 -0.456 . . . . 60.240000000000002 111.148 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.492 ' HA ' ' O ' ' A' ' 21' ' ' TYR . 23.0 m -136.63 136.95 39.6 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.208 -0.451 . . . . 74.299999999999997 111.14 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.732 ' HB2' HD22 ' A' ' 34' ' ' LEU . 0.2 OUTLIER -125.23 129.3 49.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.225 -0.443 . . . . 71.209999999999994 110.883 -179.992 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.545 ' CG ' ' HA ' ' A' ' 16' ' ' PHE . 33.9 m-85 -112.38 131.93 55.28 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.138 -0.483 . . . . 72.299999999999997 110.953 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.443 ' HB2' ' HB2' ' A' ' 19' ' ' ARG . 0.1 OUTLIER -62.2 -16.45 53.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.147 -0.479 . . . . 74.209999999999994 110.89 -179.985 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.42 ' HB2' ' O ' ' A' ' 17' ' ' GLN . 70.7 m-20 -133.83 148.8 51.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.13 -0.487 . . . . 52.109999999999999 110.886 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.615 ' N ' ' HB3' ' A' ' 38' ' ' ASN . 3.5 mtmm -54.53 -179.19 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.217 -0.447 . . . . 71.239999999999995 110.927 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 22.3 m-20 49.64 32.87 5.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.259 -0.428 . . . . 74.219999999999999 110.906 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.545 ' HA ' ' CG ' ' A' ' 11' ' ' TYR . 4.0 m-85 49.79 62.45 2.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.137 -0.483 . . . . 75.239999999999995 110.919 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.42 ' O ' ' HB2' ' A' ' 13' ' ' ASP . 4.1 mt-30 -138.85 161.89 36.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.115 -0.493 . . . . 75.439999999999998 110.894 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 91.78 -149.76 19.93 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.771 -0.728 . . . . 52.310000000000002 112.493 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.734 ' O ' HD13 ' A' ' 34' ' ' LEU . 0.0 OUTLIER -69.41 77.58 0.39 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.812 0.339 . . . . 73.439999999999998 110.889 -179.845 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.433 ' HB2' ' CE1' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -75.79 129.11 36.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.181 -0.463 . . . . 74.230000000000004 110.871 -179.907 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.492 ' O ' ' HA ' ' A' ' 9' ' ' THR . 90.6 t80 -123.03 124.4 43.03 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.172 -0.467 . . . . 62.020000000000003 110.922 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.47 ' CG ' HG23 ' A' ' 9' ' ' THR . 1.1 m-20 -121.02 133.52 55.26 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.143 -0.481 . . . . 72.439999999999998 110.851 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -166.77 133.94 2.5 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.168 -0.469 . . . . 73.340000000000003 110.924 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -99.76 2.18 43.92 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.189 -0.459 . . . . 73.340000000000003 110.935 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 18.6 t -106.46 164.96 11.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.17 -0.468 . . . . 53.219999999999999 110.881 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -56.93 120.78 8.52 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.201 -0.454 . . . . 74.010000000000005 110.866 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.623 ' HB2' ' HB3' ' A' ' 30' ' ' PHE . 0.6 OUTLIER -115.64 50.14 1.03 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.212 -0.449 . . . . 70.230000000000004 110.875 -179.894 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.508 ' O ' ' HA ' ' A' ' 82' ' ' SER . . . -47.69 -21.43 0.37 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.163 -0.471 . . . . 63.329999999999998 111.093 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 58.5 t0 -128.68 42.11 3.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.235 -0.439 . . . . 72.200000000000003 110.89 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.731 ' CD2' ' O ' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -81.45 13.98 2.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.166 -0.47 . . . . 74.140000000000001 110.925 -179.932 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.454 ' HB2' ' HB3' ' A' ' 53' ' ' PRO . 29.7 t60 -78.19 -39.05 41.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.138 -0.483 . . . . 74.219999999999999 110.824 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.7 t -57.93 -14.93 7.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.221 -0.445 . . . . 73.400000000000006 111.139 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -99.6 -26.26 14.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.233 -0.44 . . . . 73.420000000000002 110.928 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.734 HD13 ' O ' ' A' ' 19' ' ' ARG . 15.5 tp -142.89 133.12 24.58 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.129 -0.487 . . . . 72.409999999999997 110.923 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 22.3 m -97.51 -43.28 7.32 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.169 -0.469 . . . . 71.239999999999995 110.865 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 1.6 tmm_? -117.27 142.57 46.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.146 -0.479 . . . . 72.409999999999997 110.886 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.658 ' SG ' ' HB2' ' A' ' 80' ' ' LEU . 1.5 p -111.65 89.19 2.99 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.204 -0.453 . . . . 63.140000000000001 110.893 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.615 ' HB3' ' N ' ' A' ' 14' ' ' LYS . 0.3 OUTLIER -81.73 -61.99 1.77 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.176 -0.465 . . . . 64.150000000000006 110.89 -179.906 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 10.4 p -124.17 125.93 45.29 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.196 -0.457 . . . . 74.439999999999998 110.847 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.603 HG21 HD13 ' A' ' 62' ' ' LEU . 2.6 mt -124.06 151.55 29.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.13 -0.486 . . . . 73.409999999999997 111.139 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.413 ' N ' ' CG2' ' A' ' 40' ' ' ILE . 0.0 OUTLIER -142.32 121.97 13.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.145 -0.479 . . . . 74.400000000000006 110.862 179.887 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.497 ' HA ' ' HA ' ' A' ' 8' ' ' ILE . 1.0 OUTLIER -104.82 118.84 52.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.22 -0.445 . . . . 54.25 111.118 179.876 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -114.07 77.73 1.09 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.146 -0.479 . . . . 61.100000000000001 110.836 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.403 ' O ' ' HA ' ' A' ' 6' ' ' THR . . . 135.46 99.14 0.58 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.714 -0.755 . . . . 42.240000000000002 112.476 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 54.75 176.8 0.14 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.733 -0.746 . . . . 72.219999999999999 112.473 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.773 HG23 ' HA ' ' A' ' 63' ' ' PRO . 1.9 m -75.82 169.24 18.53 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.789 0.328 . . . . 72.420000000000002 111.156 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' TRP . . . . . 0.585 ' CD1' ' HB ' ' A' ' 8' ' ' ILE . 6.0 m95 -143.02 129.35 19.94 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.251 -0.431 . . . . 73.439999999999998 110.907 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.879 ' HB2' ' CG2' ' A' ' 86' ' ' VAL . . . -90.98 129.19 37.01 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.206 -0.452 . . . . 75.019999999999996 111.143 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.862 HG11 HD11 ' A' ' 80' ' ' LEU . 17.3 m -129.34 125.66 62.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.277 -0.419 . . . . 65.340000000000003 111.107 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.796 ' HB3' ' HA ' ' A' ' 56' ' ' ALA . 44.0 m-85 -93.73 148.38 22.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.182 -0.463 . . . . 64.510000000000005 110.926 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.573 ' HB2' ' O ' ' A' ' 58' ' ' TYR . 7.0 tt0 -48.72 -79.89 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.152 -0.476 . . . . 75.439999999999998 110.877 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.541 ' HB3' ' CD1' ' A' ' 55' ' ' PHE . 0.0 OUTLIER -92.75 145.15 29.77 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.617 0.723 . . . . 63.219999999999999 110.845 -179.908 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.781 ' HA ' ' OG ' ' A' ' 82' ' ' SER . 53.9 Cg_endo -69.79 140.78 43.41 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.678 2.252 . . . . 73.329999999999998 112.381 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 62.9 -11.03 0.09 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.227 -0.442 . . . . 74.209999999999994 110.924 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.606 ' H ' ' C ' ' A' ' 53' ' ' PRO . 2.6 m-30 -104.0 -21.37 13.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.162 -0.472 . . . . 65.239999999999995 110.913 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.796 ' HA ' ' HB3' ' A' ' 50' ' ' TYR . . . 50.05 25.98 1.9 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.135 -0.484 . . . . 74.230000000000004 111.063 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' TRP . . . . . 0.637 ' O ' ' C ' ' A' ' 58' ' ' TYR . 0.0 OUTLIER -50.07 -161.36 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.233 -0.44 . . . . 73.319999999999993 110.941 -179.997 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.637 ' C ' ' O ' ' A' ' 57' ' ' TRP . 6.3 m-30 -14.24 101.59 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.227 -0.442 . . . . 72.019999999999996 110.926 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.467 ' HB2' ' HA ' ' A' ' 150' ' ' TYR . 0.5 OUTLIER -58.41 146.15 35.93 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.087 -0.506 . . . . 63.5 110.905 179.903 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.78 ' O ' ' O ' ' A' ' 49' ' ' VAL . 0.3 OUTLIER -159.07 112.28 2.29 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.253 -0.43 . . . . 74.230000000000004 110.885 -179.863 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.829 ' N ' HD12 ' A' ' 61' ' ' ILE . 1.0 OUTLIER -104.95 114.84 45.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.097 -0.502 . . . . 74.439999999999998 111.15 179.898 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.765 HD23 ' HD2' ' A' ' 63' ' ' PRO . 0.4 OUTLIER -84.95 124.86 71.97 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.617 0.722 . . . . 74.409999999999997 110.934 179.916 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.773 ' HA ' HG23 ' A' ' 46' ' ' THR . 53.7 Cg_endo -69.75 -165.29 0.15 Allowed 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.647 2.232 . . . . 75.349999999999994 112.357 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.42 160.37 14.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.223 -0.444 . . . . 65.409999999999997 110.887 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 112.91 -152.11 18.05 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.697 -0.763 . . . . 62.130000000000003 112.486 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 11.2 mp0 -118.69 159.44 23.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.844 0.354 . . . . 75.0 110.937 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.508 ' HB2' ' O ' ' A' ' 40' ' ' ILE . 13.0 m-85 -147.94 82.43 7.84 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.655 0.741 . . . . 52.420000000000002 110.924 -179.854 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.7 -3.67 12.44 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.731 2.288 . . . . 74.319999999999993 112.355 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -157.72 147.68 20.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.178 -0.464 . . . . 75.25 110.856 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.882 ' O ' ' CD1' ' A' ' 73' ' ' TRP . 44.6 p90 -57.53 -41.47 80.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.121 -0.49 . . . . 72.200000000000003 110.927 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -53.35 -17.1 1.63 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.138 -0.483 . . . . 72.0 110.945 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 29.3 mmt180 -63.62 -36.29 83.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 71.319999999999993 110.852 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' TRP . . . . . 0.882 ' CD1' ' O ' ' A' ' 70' ' ' TYR . 0.3 OUTLIER -98.61 25.41 6.47 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.243 -0.435 . . . . 63.43 110.907 -179.958 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 74' ' ' MET . . . . . 0.566 ' O ' ' C ' ' A' ' 75' ' ' GLY . 1.6 mtp 75.53 26.87 1.08 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.264 -0.425 . . . . 62.25 110.886 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.566 ' C ' ' O ' ' A' ' 74' ' ' MET . . . 23.51 54.57 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.763 -0.732 . . . . 63.119999999999997 112.481 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.51 ' HB2' ' CE2' ' A' ' 60' ' ' TYR . 0.2 OUTLIER -56.69 -74.46 0.05 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.781 0.324 . . . . 63.020000000000003 110.918 -179.917 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.766 ' O ' ' CB ' ' A' ' 78' ' ' ASP . 28.0 t-20 -113.75 -80.55 0.59 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.214 -0.448 . . . . 73.439999999999998 110.897 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.766 ' CB ' ' O ' ' A' ' 77' ' ' ASN . 27.8 t70 129.45 5.38 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.182 -0.463 . . . . 75.219999999999999 110.911 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -107.3 92.28 4.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.211 -0.45 . . . . 71.549999999999997 110.893 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.862 HD11 HG11 ' A' ' 49' ' ' VAL . 0.2 OUTLIER -90.7 129.5 36.79 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.186 -0.461 . . . . 72.219999999999999 110.923 -179.959 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.6 ' HB3' ' HB3' ' A' ' 53' ' ' PRO . 0.9 OUTLIER -153.66 -123.42 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.23 -0.441 . . . . 74.409999999999997 110.897 -179.945 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.781 ' OG ' ' HA ' ' A' ' 53' ' ' PRO . 0.0 OUTLIER -41.46 101.91 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.168 -0.469 . . . . 71.120000000000005 110.877 -179.824 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 83' ' ' CYS . . . . . 0.705 ' HB3' HG12 ' A' ' 49' ' ' VAL . 31.5 p -121.16 135.38 55.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.095 -0.502 . . . . 70.109999999999999 110.887 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.585 ' N ' ' O ' ' A' ' 48' ' ' ALA . 10.9 mmt85 -119.62 150.94 39.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.2 -0.455 . . . . 44.119999999999997 110.832 -179.86 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -66.65 127.14 31.24 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.176 -0.465 . . . . 73.239999999999995 111.102 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.879 ' CG2' ' HB2' ' A' ' 48' ' ' ALA . 52.9 t -116.94 137.56 50.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.245 -0.434 . . . . 61.229999999999997 111.127 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' HIS . . . . . 0.438 ' O ' ' CG2' ' A' ' 136' ' ' VAL . 29.4 m80 -111.17 126.54 54.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.124 -0.489 . . . . 75.450000000000003 110.88 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.416 HD13 ' CB ' ' A' ' 178' ' ' GLU . 0.3 OUTLIER -39.63 137.99 1.03 Allowed Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.598 0.713 . . . . 62.340000000000003 110.899 -179.961 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.448 ' HB3' ' H ' ' A' ' 136' ' ' VAL . 53.8 Cg_endo -69.79 80.71 0.87 Allowed 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.713 2.275 . . . . 52.43 112.329 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -90.58 -177.12 4.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 64.409999999999997 110.838 -179.835 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 67.41 117.52 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.756 -0.735 . . . . 74.230000000000004 112.496 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 50.02 40.23 35.17 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.747 -0.74 . . . . 53.340000000000003 112.536 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.444 ' HB2' ' H ' ' A' ' 94' ' ' TYR . 12.8 pt20 40.21 -156.65 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.802 0.334 . . . . 75.019999999999996 110.901 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.634 ' OH ' HG23 ' A' ' 177' ' ' VAL . 0.1 OUTLIER -97.47 104.81 16.87 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.204 -0.453 . . . . 71.230000000000004 110.909 -179.875 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.496 ' HG3' HG11 ' A' ' 132' ' ' VAL . 45.7 tptt -105.99 131.34 53.4 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.132 -0.485 . . . . 74.140000000000001 110.885 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -150.23 137.38 13.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.252 -0.431 . . . . 75.150000000000006 111.141 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.446 ' HB2' ' O ' ' A' ' 131' ' ' LYS . 0.8 OUTLIER -112.77 135.6 53.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.205 -0.452 . . . . 74.019999999999996 110.93 179.935 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.635 HD13 HD11 ' A' ' 118' ' ' ILE . 1.5 mt -114.52 142.62 26.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.166 -0.47 . . . . 62.32 111.13 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.625 ' HB2' ' HB2' ' A' ' 129' ' ' SER . 57.1 m-85 -131.29 134.28 46.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.182 -0.463 . . . . 74.209999999999994 110.832 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 64.2 tt0 -63.59 -74.46 0.1 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.126 -0.488 . . . . 73.200000000000003 110.869 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.459 ' C ' ' HB3' ' A' ' 128' ' ' HIS . 9.7 mttt -83.11 177.45 8.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.142 -0.481 . . . . 74.239999999999995 110.854 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.427 ' HA2' ' HB3' ' A' ' 128' ' ' HIS . . . -83.61 161.1 38.34 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.732 -0.747 . . . . 75.319999999999993 112.49 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.444 ' HA ' ' HB2' ' A' ' 158' ' ' ARG . 30.4 t0 61.76 32.86 18.12 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.851 0.357 . . . . 71.349999999999994 110.885 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.576 ' HA ' ' CD2' ' A' ' 99' ' ' PHE . 21.1 m-85 59.35 48.88 9.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.191 -0.458 . . . . 75.150000000000006 110.924 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 4.4 m -114.25 150.06 34.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 55.520000000000003 110.85 -179.794 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 89.81 -127.73 8.88 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.721 -0.752 . . . . 43.520000000000003 112.506 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 -99.18 139.41 34.87 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.806 0.336 . . . . 73.430000000000007 110.885 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 4.4 ttp -128.74 146.17 50.97 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.183 -0.462 . . . . 73.430000000000007 110.862 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 18.9 m-85 -148.25 136.79 21.5 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.267 -0.424 . . . . 74.420000000000002 110.918 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -115.3 99.26 7.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.097 -0.501 . . . . 64.319999999999993 110.912 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 13.6 t -112.58 132.03 55.33 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.135 -0.484 . . . . 60.43 111.156 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.413 ' O ' ' OG1' ' A' ' 112' ' ' THR . 1.7 t -97.4 33.3 2.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.177 -0.465 . . . . 60.240000000000002 111.128 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -149.88 -176.05 5.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.199 -0.455 . . . . 64.129999999999995 110.917 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.509 ' CB ' ' HA ' ' A' ' 174' ' ' ARG . 5.3 p30 -103.45 171.29 7.45 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.184 -0.462 . . . . 74.010000000000005 110.895 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' CYS . . . . . 0.484 ' O ' ' HB2' ' A' ' 172' ' ' SER . 16.7 p -152.02 146.14 18.31 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.602 0.715 . . . . 64.200000000000003 110.908 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.417 ' O ' ' CA ' ' A' ' 143' ' ' PRO . 53.2 Cg_endo -69.8 -28.5 24.98 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.665 2.243 . . . . 62.030000000000001 112.305 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.633 ' HB3' ' CB ' ' A' ' 120' ' ' GLU . 0.1 OUTLIER -147.59 105.85 3.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.25 -0.432 . . . . 73.540000000000006 110.862 -179.858 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.737 HD13 HD11 ' A' ' 127' ' ' ILE . 3.6 tt -58.09 -29.77 37.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.165 -0.471 . . . . 53.439999999999998 111.146 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' MET . . . . . 0.596 ' O ' ' HA ' ' A' ' 123' ' ' HIS . 27.0 ttp -86.4 -43.72 12.61 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.458 . . . . 55.310000000000002 110.91 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.633 ' CB ' ' HB3' ' A' ' 117' ' ' SER . 9.4 tp10 -66.49 -13.21 60.56 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.223 -0.444 . . . . 74.209999999999994 110.857 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -114.62 -49.97 2.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.194 -0.457 . . . . 74.430000000000007 110.954 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.463 ' HB2' ' O ' ' A' ' 118' ' ' ILE . 63.2 m-85 -103.03 -20.37 14.22 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.2 -0.455 . . . . 74.420000000000002 110.874 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' HIS . . . . . 0.596 ' HA ' ' O ' ' A' ' 119' ' ' MET . 28.3 m-70 72.75 26.88 2.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.136 -0.484 . . . . 73.519999999999996 110.851 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.405 ' HB3' ' CD1' ' A' ' 127' ' ' ILE . 16.9 mtt -102.06 88.75 3.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.196 -0.456 . . . . 71.299999999999997 110.885 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 2.0 ptp85 -52.04 -42.86 63.43 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.26 -0.427 . . . . 74.109999999999999 110.869 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.465 ' HG2' ' HA ' ' A' ' 169' ' ' ALA . 13.4 mt-10 -137.2 130.75 31.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.213 -0.449 . . . . 71.25 110.902 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.737 HD11 HD13 ' A' ' 118' ' ' ILE . 3.4 mm -89.48 87.68 2.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.173 -0.467 . . . . 52.439999999999998 111.147 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 128' ' ' HIS . . . . . 0.459 ' HB3' ' C ' ' A' ' 101' ' ' LYS . 0.7 OUTLIER -62.4 -31.98 72.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.201 -0.454 . . . . 62.310000000000002 110.871 179.911 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 129' ' ' SER . . . . . 0.625 ' HB2' ' HB2' ' A' ' 99' ' ' PHE . 0.4 OUTLIER -134.35 142.38 47.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.172 -0.467 . . . . 65.25 110.801 -179.747 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 130' ' ' CYS . . . . . 0.624 ' O ' ' O ' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -143.17 117.61 9.69 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.151 -0.477 . . . . 73.310000000000002 110.882 -179.987 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.732 ' HA ' ' HA ' ' A' ' 156' ' ' GLU . 4.6 mtpp -106.67 150.86 25.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.217 -0.447 . . . . 61.130000000000003 110.915 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.496 HG11 ' HG3' ' A' ' 95' ' ' LYS . 3.4 t 74.27 165.84 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.234 -0.439 . . . . 74.239999999999995 111.11 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.674 HD12 ' O ' ' A' ' 154' ' ' LYS . 0.2 OUTLIER 172.77 128.84 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.136 -0.484 . . . . 45.329999999999998 110.936 179.929 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.584 ' CG ' ' HA ' ' A' ' 94' ' ' TYR . 0.7 OUTLIER -79.83 163.1 24.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.213 -0.449 . . . . 71.310000000000002 110.876 179.944 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 135' ' ' GLY . . . . . 0.441 ' C ' ' O ' ' A' ' 134' ' ' GLU . . . -34.71 -42.98 0.36 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.777 -0.725 . . . . 74.409999999999997 112.455 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.665 HG11 ' CG1' ' A' ' 86' ' ' VAL . 2.1 t -146.61 137.74 18.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.825 0.345 . . . . 74.400000000000006 111.148 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 137' ' ' TRP . . . . . 0.6 ' HB3' ' HB3' ' A' ' 152' ' ' LEU . 9.9 t-105 -138.46 157.12 46.82 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.151 -0.477 . . . . 73.209999999999994 110.886 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.464 HG12 HG13 ' A' ' 176' ' ' ILE . 18.2 mm -121.44 132.31 70.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.206 -0.452 . . . . 73.349999999999994 111.142 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.575 ' CB ' ' HB2' ' A' ' 150' ' ' TYR . 0.1 OUTLIER -118.87 137.61 53.32 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.163 -0.471 . . . . 70.019999999999996 110.92 179.945 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 140' ' ' TYR . . . . . 0.477 ' CD2' ' HA ' ' A' ' 145' ' ' TYR . 3.4 m-85 -119.37 132.05 55.79 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.13 -0.486 . . . . 71.400000000000006 110.923 -179.836 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 141' ' ' GLU . . . . . 0.674 ' O ' ' HB2' ' A' ' 171' ' ' GLN . 10.9 tt0 -60.04 -27.61 67.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.096 -0.502 . . . . 73.530000000000001 110.895 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.746 ' HB3' ' HD2' ' A' ' 143' ' ' PRO . 10.0 mp -112.85 173.74 2.69 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-O 121.614 0.721 . . . . 51.340000000000003 110.899 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 143' ' ' PRO . . . . . 0.747 ' O ' ' OG ' ' A' ' 172' ' ' SER . 53.9 Cg_endo -69.79 -88.8 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.71 2.273 . . . . 73.120000000000005 112.312 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 144' ' ' ASN . . . . . 0.686 ' O ' ' N ' ' A' ' 146' ' ' ARG . 1.4 m-20 -52.91 96.56 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.26 -0.427 . . . . 74.200000000000003 110.861 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 145' ' ' TYR . . . . . 0.633 ' C ' ' O ' ' A' ' 144' ' ' ASN . 0.1 OUTLIER 13.12 52.9 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.144 -0.48 . . . . 62.350000000000001 110.935 -179.94 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 146' ' ' ARG . . . . . 0.686 ' N ' ' O ' ' A' ' 144' ' ' ASN . 8.8 mtp85 -119.38 179.36 4.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.141 -0.481 . . . . 73.430000000000007 110.89 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 147' ' ' GLY . . . . . 0.428 ' O ' HD21 ' A' ' 76' ' ' LEU . . . 77.02 -177.69 52.06 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.726 -0.749 . . . . 74.109999999999999 112.486 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.409 ' HG2' ' CD1' ' A' ' 58' ' ' TYR . 5.7 mtp180 -74.11 156.23 37.62 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.756 0.312 . . . . 64.540000000000006 110.913 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 149' ' ' GLN . . . . . 0.527 ' NE2' ' CD1' ' A' ' 60' ' ' TYR . 2.1 mt-30 -85.67 151.24 24.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.256 -0.429 . . . . 73.329999999999998 110.909 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 150' ' ' TYR . . . . . 0.575 ' HB2' ' CB ' ' A' ' 139' ' ' PHE . 73.8 m-85 -137.67 122.8 19.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.209 -0.45 . . . . 73.400000000000006 110.914 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.638 ' HB2' HD11 ' A' ' 61' ' ' ILE . 10.5 tp -81.56 121.9 26.89 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.147 -0.479 . . . . 74.420000000000002 110.932 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.98 HD13 ' O ' ' A' ' 152' ' ' LEU . 0.0 OUTLIER -51.71 139.33 21.4 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.162 -0.472 . . . . 75.140000000000001 110.925 179.916 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 153' ' ' ASP . . . . . 0.434 ' N ' HD22 ' A' ' 152' ' ' LEU . 1.1 t70 -162.68 26.45 0.1 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.208 -0.451 . . . . 64.430000000000007 110.822 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.935 ' HB2' ' CD1' ' A' ' 157' ' ' TYR . 2.9 ptmt -127.44 -173.49 2.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.162 -0.472 . . . . 70.430000000000007 110.906 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.733 ' HD2' ' C ' ' A' ' 154' ' ' LYS . 0.8 OUTLIER -161.58 -117.17 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.187 -0.46 . . . . 63.32 110.882 179.812 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.732 ' HA ' ' HA ' ' A' ' 131' ' ' LYS . 3.2 tm-20 -71.15 0.44 7.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.224 -0.444 . . . . 64.549999999999997 110.918 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 157' ' ' TYR . . . . . 0.935 ' CD1' ' HB2' ' A' ' 154' ' ' LYS . 13.6 m-30 -32.93 147.05 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.146 -0.479 . . . . 75.25 110.922 -179.836 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 158' ' ' ARG . . . . . 0.534 ' HB3' ' CZ ' ' A' ' 104' ' ' PHE . 9.8 ptp180 -113.0 -33.54 6.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.106 -0.497 . . . . 74.140000000000001 110.887 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 7.0 ptpt -99.04 151.86 37.55 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.597 0.713 . . . . 70.219999999999999 110.859 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.79 -25.71 28.16 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.716 2.278 . . . . 75.239999999999995 112.298 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.686 HD12 ' H ' ' A' ' 161' ' ' ILE . 3.8 mp -73.83 -6.03 7.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.251 -0.431 . . . . 51.439999999999998 111.111 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.676 ' HB3' ' CD1' ' A' ' 157' ' ' TYR . 1.7 t0 -73.04 -15.73 61.51 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.194 -0.457 . . . . 73.109999999999999 110.913 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 4.8 t90 -109.94 12.65 23.71 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.197 -0.456 . . . . 75.310000000000002 110.95 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 85.6 -34.51 3.31 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.753 -0.736 . . . . 55.310000000000002 112.493 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -55.31 119.86 6.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.772 0.32 . . . . 73.340000000000003 111.118 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -49.93 -26.69 4.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.216 -0.447 . . . . 73.0 111.098 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 167' ' ' SER . . . . . 0.479 ' C ' ' H ' ' A' ' 169' ' ' ALA . 0.3 OUTLIER -154.55 158.18 32.25 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.688 0.756 . . . . 52.100000000000001 110.819 -179.772 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 168' ' ' PRO . . . . . 0.41 ' HG3' ' CD2' ' A' ' 128' ' ' HIS . 53.9 Cg_endo -69.7 18.5 0.19 Allowed 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.752 2.301 . . . . 61.210000000000001 112.321 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 0.479 ' H ' ' C ' ' A' ' 167' ' ' SER . . . -63.45 102.97 0.47 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.235 -0.439 . . . . 43.310000000000002 111.13 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.47 HG11 ' CD1' ' A' ' 139' ' ' PHE . 3.1 t -153.37 163.61 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.173 -0.467 . . . . 72.150000000000006 111.105 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 171' ' ' GLN . . . . . 0.674 ' HB2' ' O ' ' A' ' 141' ' ' GLU . 1.9 mm-40 -110.23 -87.07 0.53 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.146 -0.479 . . . . 73.120000000000005 110.898 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 172' ' ' SER . . . . . 0.747 ' OG ' ' O ' ' A' ' 143' ' ' PRO . 47.0 p -125.48 172.92 9.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.213 -0.449 . . . . 71.030000000000001 110.857 -179.777 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 5.9 p90 -145.77 164.69 31.09 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.142 -0.481 . . . . 74.549999999999997 110.828 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 174' ' ' ARG . . . . . 0.509 ' HA ' ' CB ' ' A' ' 114' ' ' ASP . 0.0 OUTLIER -135.56 151.28 50.15 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.091 -0.504 . . . . 74.129999999999995 110.834 -179.909 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 175' ' ' ARG . . . . . 0.489 ' H ' ' HG3' ' A' ' 175' ' ' ARG . 0.0 OUTLIER -104.62 139.51 39.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.195 -0.457 . . . . 71.040000000000006 110.863 -179.911 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 176' ' ' ILE . . . . . 0.464 HG13 HG12 ' A' ' 138' ' ' ILE . 1.2 mt -77.25 132.45 32.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.17 -0.468 . . . . 61.109999999999999 111.172 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.634 HG23 ' OH ' ' A' ' 94' ' ' TYR . 7.7 p -118.21 155.73 20.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.189 -0.46 . . . . 73.040000000000006 111.103 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 178' ' ' GLU . . . . . 0.416 ' CB ' HD13 ' A' ' 88' ' ' LEU . 1.3 mp0 . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.14 -0.482 . . . . 71.25 110.88 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.304 0 N-CA-C 112.466 -0.254 . . . . 63.329999999999998 112.466 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.502 ' C ' ' HE1' ' A' ' 47' ' ' TRP . 5.7 p -82.1 136.03 35.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.886 0.374 . . . . 74.299999999999997 111.098 -179.845 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.407 ' HA ' ' HA ' ' A' ' 24' ' ' ASP . 3.2 tttt -122.24 136.11 54.85 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.178 -0.464 . . . . 75.510000000000005 110.899 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.627 ' HB ' ' CD1' ' A' ' 47' ' ' TRP . 15.4 tt -136.84 151.49 27.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.2 -0.454 . . . . 61.329999999999998 111.102 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.503 ' HA ' ' O ' ' A' ' 21' ' ' TYR . 17.1 m -132.81 140.07 47.8 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.161 -0.472 . . . . 62.229999999999997 111.165 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.718 ' HB2' HD22 ' A' ' 34' ' ' LEU . 1.0 OUTLIER -127.99 127.7 43.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.17 -0.468 . . . . 75.409999999999997 110.873 -179.947 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.539 ' CG ' ' HA ' ' A' ' 16' ' ' PHE . 14.1 m-85 -112.72 132.4 55.23 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.202 -0.454 . . . . 71.219999999999999 110.91 -179.831 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.445 ' HB2' ' HB2' ' A' ' 19' ' ' ARG . 0.0 OUTLIER -61.04 -14.71 25.3 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.125 -0.489 . . . . 74.219999999999999 110.924 179.991 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.438 ' HB2' ' O ' ' A' ' 17' ' ' GLN . 74.4 m-20 -135.93 150.43 49.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.137 -0.483 . . . . 73.150000000000006 110.868 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.486 ' N ' ' HB3' ' A' ' 38' ' ' ASN . 40.8 mtmt -55.25 -176.17 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.152 -0.476 . . . . 64.109999999999999 110.89 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 16.1 m120 46.43 32.43 1.58 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.227 -0.442 . . . . 71.439999999999998 110.939 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.539 ' HA ' ' CG ' ' A' ' 11' ' ' TYR . 3.6 m-85 49.67 64.33 1.81 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.154 -0.476 . . . . 73.340000000000003 110.877 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.438 ' O ' ' HB2' ' A' ' 13' ' ' ASP . 9.9 mt-30 -139.32 159.78 41.35 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.145 -0.48 . . . . 74.109999999999999 110.891 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 92.35 -148.19 19.03 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.786 -0.721 . . . . 71.430000000000007 112.455 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.759 ' O ' HD13 ' A' ' 34' ' ' LEU . 0.0 OUTLIER -70.02 77.78 0.49 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.859 0.361 . . . . 73.340000000000003 110.834 -179.795 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.469 ' HB2' ' CE1' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -76.87 129.1 35.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.163 -0.471 . . . . 74.109999999999999 110.877 -179.956 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.503 ' O ' ' HA ' ' A' ' 9' ' ' THR . 90.7 t80 -123.01 124.39 43.02 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.182 -0.463 . . . . 74.439999999999998 110.925 -179.842 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.472 ' CG ' HG23 ' A' ' 9' ' ' THR . 1.3 m-20 -121.06 133.99 55.26 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.142 -0.481 . . . . 74.310000000000002 110.856 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -168.13 135.59 2.17 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.213 -0.449 . . . . 55.210000000000001 110.908 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.407 ' HA ' ' HA ' ' A' ' 7' ' ' LYS . 4.8 p-10 -100.94 -2.6 31.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.193 -0.458 . . . . 61.25 110.871 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 15.6 t -100.9 165.68 11.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.201 -0.454 . . . . 72.0 110.904 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -59.14 120.26 8.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.2 -0.455 . . . . 74.510000000000005 110.855 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.578 ' HB2' ' HB3' ' A' ' 30' ' ' PHE . 1.7 m -115.29 51.0 0.94 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.204 -0.453 . . . . 52.439999999999998 110.879 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.495 ' C ' ' HA ' ' A' ' 82' ' ' SER . . . -46.43 -22.16 0.24 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.178 -0.464 . . . . 72.010000000000005 111.081 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 55.5 t0 -127.94 42.83 3.25 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.194 -0.457 . . . . 73.150000000000006 110.885 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.777 ' CD2' ' O ' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -81.17 15.68 1.83 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.459 . . . . 73.530000000000001 110.869 -179.929 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.495 ' HB2' ' HB3' ' A' ' 81' ' ' SER . 29.7 t60 -80.3 -39.26 29.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 74.219999999999999 110.889 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.7 t -58.43 -13.8 6.27 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.204 -0.453 . . . . 53.210000000000001 111.166 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -100.07 -26.95 13.79 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.236 -0.438 . . . . 74.209999999999994 110.947 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.759 HD13 ' O ' ' A' ' 19' ' ' ARG . 18.0 tp -142.79 135.11 27.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.144 -0.48 . . . . 64.329999999999998 110.93 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 25.3 m -97.63 -42.51 7.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.165 -0.47 . . . . 73.420000000000002 110.849 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -118.77 141.83 48.27 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.077 -0.511 . . . . 74.040000000000006 110.84 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.554 ' HB3' ' HB2' ' A' ' 80' ' ' LEU . 3.3 p -110.17 84.86 2.0 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.197 -0.456 . . . . 55.039999999999999 110.861 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.486 ' HB3' ' N ' ' A' ' 14' ' ' LYS . 0.2 OUTLIER -76.07 -71.1 0.4 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.238 -0.437 . . . . 73.430000000000007 110.871 -179.934 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 5.2 p -111.53 124.07 51.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.184 -0.462 . . . . 65.219999999999999 110.903 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.747 HD12 ' CH2' ' A' ' 73' ' ' TRP . 43.0 mt -117.25 149.32 19.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.151 -0.477 . . . . 73.439999999999998 111.113 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.465 ' HD2' ' CE2' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -144.67 120.36 10.49 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.126 -0.488 . . . . 65.439999999999998 110.93 179.812 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.497 ' CG2' HD12 ' A' ' 8' ' ' ILE . 1.5 t -105.25 116.32 48.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.216 -0.447 . . . . 61.009999999999998 111.123 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -111.11 79.22 1.18 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.174 -0.467 . . . . 73.430000000000007 110.897 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.468 ' O ' ' HA ' ' A' ' 6' ' ' THR . . . 129.9 104.31 1.08 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.74 -0.743 . . . . 54.229999999999997 112.513 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 53.08 175.18 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.681 -0.771 . . . . 63.420000000000002 112.526 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.733 HG23 ' HA ' ' A' ' 63' ' ' PRO . 1.0 OUTLIER -76.84 169.03 19.07 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.74 0.305 . . . . 71.340000000000003 111.148 -179.856 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 47' ' ' TRP . . . . . 0.627 ' CD1' ' HB ' ' A' ' 8' ' ' ILE . 3.6 m95 -141.68 130.18 22.58 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.238 -0.437 . . . . 73.140000000000001 110.917 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.835 ' HB2' ' CG2' ' A' ' 86' ' ' VAL . . . -94.16 127.12 39.81 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.212 -0.449 . . . . 54.030000000000001 111.066 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.625 HG11 ' CD1' ' A' ' 80' ' ' LEU . 12.2 m -125.33 131.01 72.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.203 -0.453 . . . . 73.409999999999997 111.119 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.771 ' HB3' ' HA ' ' A' ' 56' ' ' ALA . 43.1 m-85 -98.32 147.3 24.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.174 -0.466 . . . . 75.409999999999997 110.937 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.644 ' OE1' ' HB3' ' A' ' 57' ' ' TRP . 46.9 tt0 -48.93 -79.68 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.13 -0.487 . . . . 73.019999999999996 110.865 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.551 ' HB2' ' HB2' ' A' ' 57' ' ' TRP . 0.0 OUTLIER -92.24 143.82 28.05 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.599 0.714 . . . . 70.010000000000005 110.853 -179.856 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.754 ' HA ' ' OG ' ' A' ' 82' ' ' SER . 53.7 Cg_endo -69.73 141.38 45.2 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.694 2.263 . . . . 71.510000000000005 112.381 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 63.54 -11.22 0.11 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.261 -0.427 . . . . 74.319999999999993 110.85 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.596 ' H ' ' C ' ' A' ' 53' ' ' PRO . 2.6 m-30 -104.45 -21.47 13.46 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.228 -0.442 . . . . 73.340000000000003 110.863 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.771 ' HA ' ' HB3' ' A' ' 50' ' ' TYR . . . 51.35 25.85 2.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.116 -0.493 . . . . 31.329999999999998 111.108 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' TRP . . . . . 0.644 ' HB3' ' OE1' ' A' ' 51' ' ' GLU . 0.0 OUTLIER -49.48 -163.1 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.215 -0.448 . . . . 65.519999999999996 110.948 179.995 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.638 ' C ' ' O ' ' A' ' 57' ' ' TRP . 6.1 m-30 -13.41 102.6 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.219 -0.446 . . . . 74.219999999999999 110.992 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.433 ' HB2' ' O ' ' A' ' 149' ' ' GLN . 2.0 mpt? -67.85 148.26 51.42 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.13 -0.486 . . . . 75.439999999999998 110.872 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.766 ' CD2' HD12 ' A' ' 76' ' ' LEU . 3.0 t80 -164.7 108.17 0.89 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.211 -0.449 . . . . 71.430000000000007 110.905 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.765 ' N ' HD12 ' A' ' 61' ' ' ILE . 1.4 mp -93.67 116.88 35.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.131 -0.486 . . . . 63.539999999999999 111.089 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.83 HD23 ' HD2' ' A' ' 63' ' ' PRO . 0.3 OUTLIER -83.95 127.96 64.95 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.559 0.695 . . . . 74.349999999999994 110.901 179.891 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.83 ' HD2' HD23 ' A' ' 62' ' ' LEU . 53.6 Cg_endo -69.76 -172.85 0.62 Allowed 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.652 2.235 . . . . 75.420000000000002 112.344 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.35 161.79 16.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.225 -0.443 . . . . 73.450000000000003 110.864 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 112.83 -165.61 12.06 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.702 -0.761 . . . . 44.439999999999998 112.459 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -109.93 154.36 23.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.901 0.382 . . . . 74.0 110.881 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.604 ' HB2' ' O ' ' A' ' 40' ' ' ILE . 10.7 m-85 -143.88 83.75 10.19 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.699 0.762 . . . . 71.409999999999997 110.944 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.449 ' HD2' ' HG3' ' A' ' 72' ' ' ARG . 53.8 Cg_endo -69.74 0.79 5.11 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.709 2.272 . . . . 73.439999999999998 112.344 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.544 ' HB2' ' HG2' ' A' ' 72' ' ' ARG . 41.3 mt-10 -155.88 144.11 19.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.457 . . . . 64.0 110.929 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.724 ' HA ' ' NE1' ' A' ' 73' ' ' TRP . 32.3 p90 -55.92 -21.65 21.67 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.172 -0.467 . . . . 72.530000000000001 110.883 -179.813 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -79.78 -16.47 55.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.144 -0.48 . . . . 71.340000000000003 110.921 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.544 ' HG2' ' HB2' ' A' ' 69' ' ' GLU . 28.1 mmt180 -69.47 -9.17 52.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.161 -0.472 . . . . 74.150000000000006 110.848 -179.895 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' TRP . . . . . 0.747 ' CH2' HD12 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -134.49 16.52 3.68 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.197 -0.456 . . . . 74.439999999999998 110.911 -179.966 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 74' ' ' MET . . . . . 0.406 ' C ' ' O ' ' A' ' 73' ' ' TRP . 0.0 OUTLIER 37.75 42.91 0.43 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.284 -0.416 . . . . 73.310000000000002 110.866 179.911 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -58.03 120.59 22.46 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.753 -0.737 . . . . 72.5 112.515 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.981 HD13 ' N ' ' A' ' 77' ' ' ASN . 0.0 OUTLIER -70.05 -10.7 59.56 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.787 0.327 . . . . 71.140000000000001 110.872 -179.898 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.981 ' N ' HD13 ' A' ' 76' ' ' LEU . 30.2 t-20 -156.36 131.24 9.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.199 -0.455 . . . . 72.200000000000003 110.904 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -83.95 23.06 1.06 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.186 -0.461 . . . . 63.219999999999999 110.868 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -109.92 78.47 1.13 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.195 -0.457 . . . . 61.210000000000001 110.891 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.625 ' CD1' HG11 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -85.77 133.51 33.99 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.167 -0.47 . . . . 73.319999999999993 110.929 -179.999 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.594 ' HB3' ' HB3' ' A' ' 53' ' ' PRO . 0.9 OUTLIER -150.03 -125.04 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.184 -0.462 . . . . 54.43 110.912 -179.947 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.754 ' OG ' ' HA ' ' A' ' 53' ' ' PRO . 0.0 OUTLIER -35.03 103.81 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.12 -0.491 . . . . 62.450000000000003 110.832 -179.833 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 83' ' ' CYS . . . . . 0.614 ' HB3' HG12 ' A' ' 49' ' ' VAL . 19.8 p -121.88 134.45 54.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.152 -0.476 . . . . 74.310000000000002 110.854 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.595 ' N ' ' O ' ' A' ' 48' ' ' ALA . 11.6 mmt85 -120.4 139.51 52.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.184 -0.462 . . . . 74.519999999999996 110.871 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.431 ' N ' ' CZ3' ' A' ' 47' ' ' TRP . . . -58.15 129.17 40.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 73.510000000000005 111.111 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.835 ' CG2' ' HB2' ' A' ' 48' ' ' ALA . 55.5 t -113.23 133.74 58.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.194 -0.457 . . . . 64.219999999999999 111.093 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' HIS . . . . . 0.628 ' O ' HG23 ' A' ' 136' ' ' VAL . 23.1 m80 -114.43 111.21 21.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.113 -0.494 . . . . 72.120000000000005 110.827 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.469 ' H ' HD23 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -33.39 140.13 0.24 Allowed Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.564 0.697 . . . . 72.439999999999998 110.937 -179.986 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.558 ' HB3' ' H ' ' A' ' 136' ' ' VAL . 53.7 Cg_endo -69.79 105.13 1.44 Allowed 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.718 2.278 . . . . 64.209999999999994 112.331 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -106.16 -177.97 3.52 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.201 -0.454 . . . . 74.310000000000002 110.833 -179.815 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 45.45 63.22 2.82 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.74 -0.743 . . . . 23.039999999999999 112.476 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.41 ' O ' ' C ' ' A' ' 93' ' ' GLN . . . 123.82 20.65 2.53 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.716 -0.754 . . . . 64.540000000000006 112.493 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.478 ' O ' ' HG2' ' A' ' 134' ' ' GLU . 2.0 pt20 37.47 -120.67 0.2 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.839 0.352 . . . . 70.340000000000003 110.901 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.466 ' O ' ' HA ' ' A' ' 112' ' ' THR . 0.0 OUTLIER -124.87 100.78 6.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.19 -0.459 . . . . 73.349999999999994 110.945 -179.86 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.512 ' HG3' HG11 ' A' ' 132' ' ' VAL . 31.3 tptt -110.69 126.53 54.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.173 -0.467 . . . . 73.299999999999997 110.929 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 8.0 tt -147.54 136.17 15.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.198 -0.456 . . . . 74.239999999999995 111.108 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.428 ' HB2' ' O ' ' A' ' 131' ' ' LYS . 1.2 mt-30 -107.82 131.56 54.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.203 -0.453 . . . . 74.120000000000005 110.925 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.58 HD11 ' CD1' ' A' ' 122' ' ' PHE . 13.1 pt -111.41 136.79 46.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.192 -0.458 . . . . 71.299999999999997 111.117 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.575 ' HB2' ' CB ' ' A' ' 129' ' ' SER . 62.4 m-85 -124.82 136.9 54.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.196 -0.456 . . . . 62.219999999999999 110.895 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -68.95 -58.3 4.31 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.099 -0.501 . . . . 55.439999999999998 110.905 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 21.0 mttt -101.59 149.46 24.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.126 -0.488 . . . . 75.230000000000004 110.942 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -57.8 163.72 7.94 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.755 -0.736 . . . . 74.120000000000005 112.469 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.523 ' HA ' ' HB2' ' A' ' 158' ' ' ARG . 42.1 t0 64.13 29.0 14.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.853 0.359 . . . . 71.409999999999997 110.912 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.68 ' CZ ' ' HB3' ' A' ' 158' ' ' ARG . 5.1 m-85 57.51 46.07 18.48 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.174 -0.466 . . . . 75.010000000000005 110.888 -179.873 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 2.3 m -114.08 158.02 21.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.181 -0.463 . . . . 70.109999999999999 110.871 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 86.88 -137.09 14.52 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.711 -0.756 . . . . 53.509999999999998 112.488 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 38.1 tp60 -90.39 126.6 35.93 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.812 0.339 . . . . 71.200000000000003 110.934 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' MET . . . . . 0.445 ' HB2' ' CE1' ' A' ' 99' ' ' PHE . 19.1 ttp -113.17 146.3 39.49 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.215 -0.448 . . . . 73.340000000000003 110.875 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -152.6 137.19 16.87 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.192 -0.458 . . . . 52.219999999999999 110.95 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -119.31 113.8 21.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.161 -0.472 . . . . 74.209999999999994 110.905 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 14.6 t -124.24 145.9 49.07 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.163 -0.471 . . . . 61.049999999999997 111.108 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.466 ' HA ' ' O ' ' A' ' 94' ' ' TYR . 1.5 t -122.92 41.64 3.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.205 -0.452 . . . . 54.119999999999997 111.129 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -150.59 -172.74 4.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.262 -0.426 . . . . 72.230000000000004 110.888 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -84.39 164.57 18.83 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.159 -0.473 . . . . 74.200000000000003 110.836 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 8.2 t -157.89 129.14 3.77 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.64 0.733 . . . . 73.099999999999994 110.914 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.724 ' O ' ' HB2' ' A' ' 172' ' ' SER . 53.9 Cg_endo -69.75 -44.15 2.25 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.718 2.279 . . . . 61.219999999999999 112.384 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.636 ' HB3' ' CB ' ' A' ' 120' ' ' GLU . 0.1 OUTLIER -138.8 102.78 4.65 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.172 -0.467 . . . . 74.329999999999998 110.874 -179.859 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.615 ' HB ' ' O ' ' A' ' 171' ' ' GLN . 3.0 tt -51.13 -30.08 9.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.101 -0.5 . . . . 74.099999999999994 111.144 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' MET . . . . . 0.56 ' O ' ' HA ' ' A' ' 123' ' ' HIS . 3.6 ttt -85.32 -46.19 11.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.159 -0.473 . . . . 72.549999999999997 110.867 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.636 ' CB ' ' HB3' ' A' ' 117' ' ' SER . 14.1 tp10 -63.42 -13.6 41.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.183 -0.462 . . . . 73.510000000000005 110.866 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 26.3 tp60 -114.7 -52.91 2.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.156 -0.475 . . . . 72.340000000000003 110.931 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.58 ' CD1' HD11 ' A' ' 98' ' ' ILE . 86.7 m-85 -99.33 -22.44 15.58 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.456 . . . . 74.430000000000007 110.864 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' HIS . . . . . 0.56 ' HA ' ' O ' ' A' ' 119' ' ' MET . 0.5 OUTLIER 76.67 24.6 0.96 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.176 -0.466 . . . . 70.25 110.87 179.984 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.469 ' O ' ' CG2' ' A' ' 118' ' ' ILE . 9.4 mtt -103.38 81.79 1.97 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.186 -0.461 . . . . 74.420000000000002 110.865 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 2.1 ptp85 -46.82 -40.99 14.8 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.251 -0.431 . . . . 74.420000000000002 110.854 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.498 ' HB3' ' HG2' ' A' ' 168' ' ' PRO . 32.7 mt-10 -142.67 130.43 21.54 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.162 -0.472 . . . . 74.219999999999999 110.9 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.603 HG22 ' O ' ' A' ' 127' ' ' ILE . 1.3 mp -87.69 97.1 6.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.219 -0.446 . . . . 63.009999999999998 111.13 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 128' ' ' HIS . . . . . 0.452 ' HA ' ' HB3' ' A' ' 160' ' ' PRO . 0.3 OUTLIER -69.67 -25.99 64.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.218 -0.446 . . . . 74.540000000000006 110.908 179.854 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 129' ' ' SER . . . . . 0.575 ' CB ' ' HB2' ' A' ' 99' ' ' PHE . 0.0 OUTLIER -136.68 139.02 41.67 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.158 -0.474 . . . . 75.25 110.828 -179.788 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 130' ' ' CYS . . . . . 0.598 ' O ' ' O ' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -138.17 119.52 14.76 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.108 -0.497 . . . . 62.539999999999999 110.846 -179.975 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.646 ' HA ' ' HA ' ' A' ' 156' ' ' GLU . 4.4 mtpp -113.08 152.31 29.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.15 -0.477 . . . . 61.399999999999999 110.897 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.552 HG23 ' C ' ' A' ' 131' ' ' LYS . 10.8 t 84.15 163.58 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.183 -0.462 . . . . 72.530000000000001 111.13 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.746 HD22 ' CG ' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -177.45 124.58 0.13 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.198 -0.456 . . . . 71.400000000000006 110.973 179.943 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.542 ' O ' ' C ' ' A' ' 135' ' ' GLY . 0.2 OUTLIER -99.58 167.09 10.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.165 -0.471 . . . . 75.129999999999995 110.887 179.965 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 135' ' ' GLY . . . . . 0.542 ' C ' ' O ' ' A' ' 134' ' ' GLU . . . -24.93 -74.03 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.698 -0.763 . . . . 72.439999999999998 112.528 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.729 ' HB ' HD12 ' A' ' 176' ' ' ILE . 3.1 t -135.01 147.97 29.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.84 0.353 . . . . 72.129999999999995 111.127 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 137' ' ' TRP . . . . . 0.717 ' H ' HD12 ' A' ' 152' ' ' LEU . 0.0 OUTLIER -152.03 162.41 41.13 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.202 -0.454 . . . . 71.329999999999998 110.929 179.977 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.515 HG21 ' HD2' ' A' ' 174' ' ' ARG . 19.4 mt -135.15 137.69 49.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.234 -0.439 . . . . 74.040000000000006 111.1 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.562 ' CD2' HG11 ' A' ' 170' ' ' VAL . 0.2 OUTLIER -110.93 146.12 37.14 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.154 -0.475 . . . . 72.450000000000003 110.892 179.914 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 140' ' ' TYR . . . . . 0.714 ' CE2' ' HA ' ' A' ' 145' ' ' TYR . 0.6 OUTLIER -107.08 131.14 54.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.13 -0.486 . . . . 71.329999999999998 110.912 -179.831 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 141' ' ' GLU . . . . . 0.596 ' O ' ' NE2' ' A' ' 171' ' ' GLN . 7.5 tt0 -70.66 -27.3 63.93 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.086 -0.507 . . . . 73.219999999999999 110.9 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.574 ' O ' ' HB3' ' A' ' 172' ' ' SER . 5.8 mp -113.37 147.15 36.82 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.58 0.705 . . . . 73.430000000000007 110.931 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 143' ' ' PRO . . . . . 0.698 ' CD ' ' HG2' ' A' ' 171' ' ' GLN . 53.9 Cg_endo -69.7 43.68 0.38 Allowed 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.694 2.262 . . . . 74.049999999999997 112.349 179.834 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 144' ' ' ASN . . . . . 1.093 ' O ' ' N ' ' A' ' 146' ' ' ARG . 0.4 OUTLIER 177.87 111.49 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.209 -0.45 . . . . 71.420000000000002 110.888 179.96 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 145' ' ' TYR . . . . . 0.714 ' HA ' ' CE2' ' A' ' 140' ' ' TYR . 0.1 OUTLIER -6.59 52.18 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.156 -0.475 . . . . 73.150000000000006 110.876 -179.892 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 146' ' ' ARG . . . . . 1.093 ' N ' ' O ' ' A' ' 144' ' ' ASN . 40.7 mtt180 -140.16 170.52 15.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.121 -0.49 . . . . 72.519999999999996 110.885 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 81.0 -167.61 49.92 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.706 -0.759 . . . . 61.130000000000003 112.464 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.424 ' HG2' ' CD1' ' A' ' 58' ' ' TYR . 0.5 OUTLIER -88.58 142.98 27.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.778 0.323 . . . . 62.32 110.901 -179.935 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 149' ' ' GLN . . . . . 0.433 ' O ' ' HB2' ' A' ' 59' ' ' MET . 74.0 mt-30 -84.07 162.83 20.2 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.157 -0.474 . . . . 63.509999999999998 110.931 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 150' ' ' TYR . . . . . 0.412 ' HB2' ' HB2' ' A' ' 139' ' ' PHE . 92.8 m-85 -134.96 116.73 15.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.238 -0.437 . . . . 74.299999999999997 110.985 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.668 HD23 ' OH ' ' A' ' 50' ' ' TYR . 9.9 tp -68.6 119.09 12.48 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.129 -0.487 . . . . 74.25 110.877 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 1.055 HD13 ' O ' ' A' ' 152' ' ' LEU . 0.0 OUTLIER -51.4 135.45 27.22 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.18 -0.464 . . . . 61.549999999999997 110.903 179.899 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -163.37 24.84 0.08 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.177 -0.465 . . . . 75.430000000000007 110.848 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.783 ' HB2' ' CD1' ' A' ' 157' ' ' TYR . 0.0 OUTLIER -115.47 -173.54 2.35 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.252 -0.431 . . . . 73.450000000000003 110.913 -179.996 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.746 ' CG ' HD22 ' A' ' 133' ' ' LEU . 0.8 OUTLIER -161.48 -124.56 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.264 -0.425 . . . . 73.329999999999998 110.904 179.907 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.646 ' HA ' ' HA ' ' A' ' 131' ' ' LYS . 1.7 tm-20 -70.43 2.74 3.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 73.439999999999998 110.876 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 157' ' ' TYR . . . . . 0.783 ' CD1' ' HB2' ' A' ' 154' ' ' LYS . 18.4 m-30 -32.79 147.04 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.167 -0.469 . . . . 72.140000000000001 110.904 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 158' ' ' ARG . . . . . 0.68 ' HB3' ' CZ ' ' A' ' 104' ' ' PHE . 8.2 ptp180 -113.5 -37.45 4.63 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.097 -0.501 . . . . 73.299999999999997 110.844 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -89.01 152.54 48.44 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.576 0.703 . . . . 55.149999999999999 110.869 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 160' ' ' PRO . . . . . 0.544 ' HB3' ' HB3' ' A' ' 168' ' ' PRO . 54.3 Cg_endo -69.74 -29.29 24.2 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.658 2.239 . . . . 71.109999999999999 112.369 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.684 HD12 ' H ' ' A' ' 161' ' ' ILE . 4.3 mp -66.37 -10.5 11.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.216 -0.447 . . . . 74.319999999999993 111.161 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.671 ' HB3' ' CD1' ' A' ' 157' ' ' TYR . 0.5 OUTLIER -77.0 -13.94 59.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.143 -0.481 . . . . 74.040000000000006 110.853 179.848 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 163' ' ' TRP . . . . . 0.447 ' CE3' ' HB3' ' A' ' 165' ' ' ALA . 26.3 t90 -87.95 -7.68 56.78 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.245 -0.434 . . . . 63.020000000000003 110.921 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 99.3 -36.82 3.81 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.755 -0.736 . . . . 24.109999999999999 112.454 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.447 ' HB3' ' CE3' ' A' ' 163' ' ' TRP . . . -76.88 126.7 31.42 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.8 0.333 . . . . 72.230000000000004 111.149 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -37.27 -42.83 0.49 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.229 -0.441 . . . . 62.299999999999997 111.053 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 167' ' ' SER . . . . . 0.491 ' C ' ' H ' ' A' ' 169' ' ' ALA . 0.5 OUTLIER -127.64 152.34 76.65 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.68 0.752 . . . . 71.450000000000003 110.835 -179.786 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 168' ' ' PRO . . . . . 0.544 ' HB3' ' HB3' ' A' ' 160' ' ' PRO . 53.7 Cg_endo -69.76 27.97 0.18 Allowed 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.689 2.259 . . . . 71.019999999999996 112.379 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 0.491 ' H ' ' C ' ' A' ' 167' ' ' SER . . . -67.6 99.98 0.83 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.215 -0.448 . . . . 55.32 111.149 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.582 HG12 ' H ' ' A' ' 171' ' ' GLN . 1.4 t -155.41 173.62 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.195 -0.457 . . . . 62.420000000000002 111.108 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 171' ' ' GLN . . . . . 0.698 ' HG2' ' CD ' ' A' ' 143' ' ' PRO . 0.0 OUTLIER -159.17 -97.55 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.165 -0.47 . . . . 75.430000000000007 110.91 -179.998 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 172' ' ' SER . . . . . 0.724 ' HB2' ' O ' ' A' ' 116' ' ' PRO . 0.0 OUTLIER -64.62 153.77 38.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.23 -0.441 . . . . 51.109999999999999 110.851 -179.791 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 173' ' ' PHE . . . . . 0.404 ' HB3' ' CD2' ' A' ' 139' ' ' PHE . 1.2 p90 -151.96 158.21 42.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.146 -0.479 . . . . 71.349999999999994 110.888 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 174' ' ' ARG . . . . . 0.515 ' HD2' HG21 ' A' ' 138' ' ' ILE . 1.3 ptp180 -130.22 142.39 50.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.17 -0.468 . . . . 73.439999999999998 110.935 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 175' ' ' ARG . . . . . 0.432 ' HD2' ' CE2' ' A' ' 94' ' ' TYR . 0.0 OUTLIER -98.19 -169.21 1.77 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.21 -0.45 . . . . 72.049999999999997 110.902 -179.882 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 176' ' ' ILE . . . . . 0.729 HD12 ' HB ' ' A' ' 136' ' ' VAL . 4.1 mt -139.05 132.03 38.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.222 -0.444 . . . . 53.130000000000003 111.17 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 4.8 p -144.62 155.83 14.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.208 -0.451 . . . . 75.340000000000003 111.085 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.125 -0.488 . . . . 72.040000000000006 110.933 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.287 0 N-CA-C 112.475 -0.25 . . . . 73.200000000000003 112.475 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.429 ' HA ' ' O ' ' A' ' 44' ' ' GLY . 10.9 p -82.33 136.11 35.07 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.898 0.38 . . . . 63.009999999999998 111.122 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.472 ' N ' ' HE1' ' A' ' 47' ' ' TRP . 2.6 tttt -127.91 138.12 52.54 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.203 -0.453 . . . . 62.240000000000002 110.852 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.514 HD12 ' CG2' ' A' ' 42' ' ' VAL . 16.0 tt -136.68 150.89 27.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.165 -0.47 . . . . 74.340000000000003 111.084 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.484 HG22 ' CE2' ' A' ' 11' ' ' TYR . 9.3 m -132.55 140.94 48.51 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.159 -0.473 . . . . 62.32 111.111 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.722 ' HB2' HD22 ' A' ' 34' ' ' LEU . 1.6 m-85 -129.2 131.68 47.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.228 -0.442 . . . . 72.409999999999997 110.924 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.54 ' CG ' ' HA ' ' A' ' 16' ' ' PHE . 6.2 m-85 -117.41 134.09 55.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.142 -0.481 . . . . 74.349999999999994 110.915 -179.825 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.46 ' HB2' ' H ' ' A' ' 19' ' ' ARG . 0.0 OUTLIER -56.83 -28.56 61.74 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.129 -0.487 . . . . 60.420000000000002 110.848 -179.968 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 49.4 m-20 -123.29 155.42 37.26 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.201 -0.454 . . . . 44.109999999999999 110.855 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 7.9 mtmm -57.41 -173.35 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 54.130000000000003 110.884 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 23.3 m-20 44.34 34.76 1.11 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.2 -0.454 . . . . 75.25 110.851 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.54 ' HA ' ' CG ' ' A' ' 11' ' ' TYR . 2.6 m-85 47.7 59.8 3.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.227 -0.442 . . . . 60.109999999999999 110.878 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 10.6 mt-30 -133.23 154.14 50.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.172 -0.467 . . . . 73.319999999999993 110.918 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 95.67 -154.43 20.96 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.768 -0.73 . . . . 42.140000000000001 112.446 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.752 ' O ' HD13 ' A' ' 34' ' ' LEU . 0.6 OUTLIER -63.65 81.7 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.857 0.361 . . . . 71.329999999999998 110.86 -179.838 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.516 ' HB2' ' CE1' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -81.05 127.52 32.69 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.193 -0.458 . . . . 75.040000000000006 110.859 -179.918 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.449 ' CZ ' ' CD1' ' A' ' 33' ' ' TYR . 82.8 t80 -124.23 125.71 44.86 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.217 -0.447 . . . . 65.230000000000004 110.903 -179.865 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -111.25 131.45 55.13 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.11 -0.495 . . . . 74.230000000000004 110.876 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -142.58 143.12 32.31 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.19 -0.459 . . . . 54.549999999999997 110.856 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -125.64 5.09 7.5 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.191 -0.459 . . . . 74.230000000000004 110.894 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 50.6 t -129.71 159.19 37.25 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.137 -0.483 . . . . 64.099999999999994 110.91 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -42.87 108.48 0.1 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.177 -0.465 . . . . 50.439999999999998 110.878 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.608 ' HB3' ' HB3' ' A' ' 30' ' ' PHE . 0.1 OUTLIER -119.8 51.38 1.18 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.202 -0.453 . . . . 52.130000000000003 110.887 -179.92 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.546 ' C ' ' HA ' ' A' ' 82' ' ' SER . . . -50.61 -14.61 0.2 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.209 -0.451 . . . . 65.530000000000001 111.08 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 63.6 t0 -127.3 42.21 3.37 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.227 -0.442 . . . . 64.510000000000005 110.88 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.819 ' CD2' ' O ' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -82.28 14.34 3.0 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.192 -0.458 . . . . 73.439999999999998 110.849 -179.885 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.536 ' HB2' ' HB3' ' A' ' 53' ' ' PRO . 31.3 t60 -76.8 -44.4 32.82 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.158 -0.474 . . . . 65.420000000000002 110.854 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.428 HG23 ' CD2' ' A' ' 33' ' ' TYR . 9.7 t -54.7 -13.57 1.06 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.156 -0.475 . . . . 73.519999999999996 111.147 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.498 ' CD1' ' HA ' ' A' ' 30' ' ' PHE . 12.3 m-85 -97.27 -29.65 13.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.224 -0.444 . . . . 71.299999999999997 110.91 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.752 HD13 ' O ' ' A' ' 19' ' ' ARG . 31.7 tp -137.85 140.35 40.41 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.101 -0.5 . . . . 71.409999999999997 110.907 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 2.6 m -104.16 -38.71 6.8 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.155 -0.475 . . . . 60.310000000000002 110.861 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.491 ' O ' HD21 ' A' ' 34' ' ' LEU . 0.2 OUTLIER -111.18 140.85 45.4 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.172 -0.467 . . . . 63.32 110.839 -179.928 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.471 ' SG ' ' CB ' ' A' ' 80' ' ' LEU . 2.0 m -122.46 76.35 1.32 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.157 -0.474 . . . . 71.540000000000006 110.871 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -80.15 -71.11 0.47 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.142 -0.481 . . . . 73.099999999999994 110.842 -179.846 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 4.8 p -104.52 134.54 47.53 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.157 -0.474 . . . . 73.150000000000006 110.869 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.744 HD12 ' CH2' ' A' ' 73' ' ' TRP . 19.4 mt -126.86 151.69 33.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.124 -0.489 . . . . 73.409999999999997 111.147 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.475 ' HD2' ' CE2' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -146.59 122.12 10.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.201 -0.454 . . . . 74.409999999999997 110.856 179.894 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.528 HG12 ' O ' ' A' ' 42' ' ' VAL . 1.4 t -108.41 114.63 47.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.259 -0.428 . . . . 74.299999999999997 111.134 179.824 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.407 ' N ' ' O ' ' A' ' 7' ' ' LYS . 1.5 mm-40 -109.79 79.06 1.17 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.193 -0.458 . . . . 72.409999999999997 110.827 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.429 ' O ' ' HA ' ' A' ' 6' ' ' THR . . . 134.2 102.72 0.76 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.794 -0.717 . . . . 55.009999999999998 112.524 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 52.21 -178.26 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.723 -0.751 . . . . 72.230000000000004 112.471 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.737 HG23 ' HA ' ' A' ' 63' ' ' PRO . 0.6 OUTLIER -81.57 172.19 13.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.809 0.338 . . . . 55.399999999999999 111.117 -179.846 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 47' ' ' TRP . . . . . 0.558 ' H ' HG22 ' A' ' 46' ' ' THR . 13.2 m95 -142.59 130.04 21.23 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.214 -0.448 . . . . 70.310000000000002 110.898 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.841 ' HB2' ' CG2' ' A' ' 86' ' ' VAL . . . -97.39 108.89 21.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.234 -0.439 . . . . 71.430000000000007 111.109 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.849 HG11 HD11 ' A' ' 80' ' ' LEU . 4.2 m -111.45 130.96 64.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.215 -0.448 . . . . 73.140000000000001 111.13 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.663 ' HB3' ' HA ' ' A' ' 56' ' ' ALA . 56.6 m-85 -93.88 148.56 22.02 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.177 -0.465 . . . . 73.040000000000006 110.947 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.651 ' HB2' ' HB2' ' A' ' 58' ' ' TYR . 39.1 tt0 -45.38 -78.22 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.103 -0.499 . . . . 63.5 110.892 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.645 ' HB3' ' CD2' ' A' ' 55' ' ' PHE . 0.2 OUTLIER -90.78 144.77 30.81 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.574 0.702 . . . . 71.329999999999998 110.906 -179.924 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.745 ' HA ' ' OG ' ' A' ' 82' ' ' SER . 54.0 Cg_endo -69.79 131.38 21.08 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.688 2.259 . . . . 73.25 112.35 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 67.8 -8.2 0.54 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.218 -0.446 . . . . 72.299999999999997 110.891 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.645 ' CD2' ' HB3' ' A' ' 52' ' ' ARG . 6.2 m-30 -98.43 -27.73 13.94 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.181 -0.463 . . . . 73.140000000000001 110.884 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.663 ' HA ' ' HB3' ' A' ' 50' ' ' TYR . . . 62.79 16.42 9.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.173 -0.467 . . . . 64.319999999999993 111.153 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' TRP . . . . . 0.646 ' O ' ' C ' ' A' ' 58' ' ' TYR . 0.1 OUTLIER -49.02 -167.94 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.176 -0.465 . . . . 70.430000000000007 110.923 -179.958 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.651 ' HB2' ' HB2' ' A' ' 51' ' ' GLU . 8.1 m-30 -13.06 103.08 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.217 -0.447 . . . . 72.340000000000003 110.908 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.432 ' HB2' ' O ' ' A' ' 149' ' ' GLN . 1.9 mpt? -68.54 148.66 50.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.148 -0.478 . . . . 71.319999999999993 110.844 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.79 ' CD2' HD12 ' A' ' 76' ' ' LEU . 3.3 t80 -163.66 108.77 1.05 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.232 -0.44 . . . . 65.450000000000003 110.943 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.789 ' N ' HD12 ' A' ' 61' ' ' ILE . 1.5 mp -95.02 116.13 35.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.081 -0.508 . . . . 74.099999999999994 111.121 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.77 HD23 ' HD2' ' A' ' 63' ' ' PRO . 0.2 OUTLIER -84.07 128.78 61.23 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.611 0.719 . . . . 75.409999999999997 110.932 179.888 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.77 ' HD2' HD23 ' A' ' 62' ' ' LEU . 53.8 Cg_endo -69.74 -172.74 0.61 Allowed 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.705 2.27 . . . . 74.129999999999995 112.368 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -88.12 161.96 17.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.246 -0.434 . . . . 75.25 110.877 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 112.2 -167.94 12.55 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.719 -0.753 . . . . 42.109999999999999 112.457 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -108.05 156.44 19.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.855 0.359 . . . . 73.209999999999994 110.862 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.622 ' HB2' ' O ' ' A' ' 40' ' ' ILE . 15.7 m-85 -144.19 84.39 9.5 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.684 0.754 . . . . 73.209999999999994 110.904 -179.869 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.419 ' HD2' ' HG3' ' A' ' 72' ' ' ARG . 53.2 Cg_endo -69.83 2.83 3.21 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.7 2.267 . . . . 71.299999999999997 112.344 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.608 ' HB2' ' HG2' ' A' ' 72' ' ' ARG . 52.6 mt-10 -157.38 143.45 17.7 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.199 -0.455 . . . . 75.299999999999997 110.889 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.741 ' HA ' ' NE1' ' A' ' 73' ' ' TRP . 30.6 p90 -55.35 -21.39 14.99 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.161 -0.472 . . . . 40.530000000000001 110.916 -179.86 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -81.25 -17.15 50.48 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.099 -0.501 . . . . 74.019999999999996 110.876 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.608 ' HG2' ' HB2' ' A' ' 69' ' ' GLU . 33.0 mmt180 -68.32 -10.61 56.06 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.233 -0.439 . . . . 74.349999999999994 110.853 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' TRP . . . . . 0.744 ' CH2' HD12 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -133.13 17.7 4.1 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.182 -0.463 . . . . 74.430000000000007 110.869 -179.953 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 40.56 37.45 0.47 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.275 -0.42 . . . . 73.329999999999998 110.868 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -52.06 114.22 3.08 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.738 -0.744 . . . . 64.400000000000006 112.521 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 1.016 HD13 ' N ' ' A' ' 77' ' ' ASN . 0.0 OUTLIER -63.82 -16.7 61.93 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.781 0.324 . . . . 74.319999999999993 110.87 -179.889 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 1.016 ' N ' HD13 ' A' ' 76' ' ' LEU . 57.8 t-20 -157.87 130.53 7.32 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.194 -0.457 . . . . 73.409999999999997 110.936 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -77.5 9.17 3.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.174 -0.466 . . . . 62.149999999999999 110.879 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.416 ' HG2' ' O ' ' A' ' 79' ' ' ARG . 24.1 ttt85 -88.9 38.38 0.88 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.205 -0.452 . . . . 65.540000000000006 110.889 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.849 HD11 HG11 ' A' ' 49' ' ' VAL . 0.1 OUTLIER -56.7 126.84 28.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.143 -0.481 . . . . 51.329999999999998 110.87 -179.931 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.655 ' HB3' ' HB3' ' A' ' 53' ' ' PRO . 4.4 m -142.8 -117.55 0.1 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.191 -0.459 . . . . 73.340000000000003 110.889 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.745 ' OG ' ' HA ' ' A' ' 53' ' ' PRO . 0.4 OUTLIER -30.38 130.36 0.1 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.127 -0.488 . . . . 75.400000000000006 110.844 -179.848 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 83' ' ' CYS . . . . . 0.545 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 11.0 p -138.74 144.43 39.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.176 -0.466 . . . . 73.120000000000005 110.855 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.508 ' N ' ' O ' ' A' ' 48' ' ' ALA . 0.6 OUTLIER -141.31 128.17 20.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.165 -0.47 . . . . 72.239999999999995 110.905 -179.865 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.429 ' N ' ' CZ3' ' A' ' 47' ' ' TRP . . . -49.64 126.89 14.61 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.24 -0.437 . . . . 51.32 111.126 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.841 ' CG2' ' HB2' ' A' ' 48' ' ' ALA . 48.4 t -114.17 132.9 61.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.214 -0.448 . . . . 64.409999999999997 111.126 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' HIS . . . . . 0.769 ' O ' HG23 ' A' ' 136' ' ' VAL . 20.3 m-70 -108.15 105.18 14.8 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.16 -0.473 . . . . 62.140000000000001 110.872 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.627 HD12 ' HB3' ' A' ' 178' ' ' GLU . 0.0 OUTLIER -35.55 144.29 0.24 Allowed Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.566 0.698 . . . . 72.310000000000002 110.931 179.993 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.472 ' HA ' ' HA3' ' A' ' 135' ' ' GLY . 54.1 Cg_endo -69.76 87.67 0.55 Allowed 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.684 2.256 . . . . 53.340000000000003 112.323 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -105.92 -177.57 3.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.265 -0.425 . . . . 51.520000000000003 110.846 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 60.88 23.94 61.96 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.74 -0.743 . . . . 73.329999999999998 112.5 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.413 ' O ' ' C ' ' A' ' 93' ' ' GLN . . . 153.24 34.33 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.735 -0.745 . . . . 44.409999999999997 112.452 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.492 ' O ' ' CG ' ' A' ' 134' ' ' GLU . 23.6 pt20 36.37 -135.07 0.05 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.811 0.339 . . . . 62.149999999999999 110.916 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.465 ' O ' ' HA ' ' A' ' 112' ' ' THR . 13.9 t80 -119.71 106.8 12.49 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.184 -0.462 . . . . 70.349999999999994 110.907 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.541 ' HG3' HG11 ' A' ' 132' ' ' VAL . 36.3 tptt -108.65 128.69 55.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.107 -0.497 . . . . 75.299999999999997 110.922 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.425 HD12 ' OH ' ' A' ' 94' ' ' TYR . 6.8 tt -148.39 144.17 18.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.231 -0.44 . . . . 70.530000000000001 111.116 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.589 ' O ' ' HA ' ' A' ' 130' ' ' CYS . 1.3 mt-30 -115.97 111.57 20.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.153 -0.476 . . . . 74.530000000000001 110.897 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.563 ' CG2' HD12 ' A' ' 127' ' ' ILE . 2.7 mm -86.49 140.97 15.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.222 -0.445 . . . . 75.420000000000002 111.11 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.565 ' HB2' ' HB2' ' A' ' 129' ' ' SER . 57.4 m-85 -130.91 133.16 45.6 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.201 -0.454 . . . . 72.030000000000001 110.878 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 60.6 tt0 -61.4 -80.14 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.189 -0.459 . . . . 55.210000000000001 110.878 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 12.2 mttt -85.51 162.44 18.92 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.145 -0.479 . . . . 63.130000000000003 110.898 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -67.86 162.28 48.55 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.691 -0.766 . . . . 62.450000000000003 112.512 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.516 ' HA ' ' HB2' ' A' ' 158' ' ' ARG . 36.5 t70 64.46 27.16 13.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.861 0.362 . . . . 75.150000000000006 110.876 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.54 ' CZ ' ' HB3' ' A' ' 158' ' ' ARG . 8.8 m-85 59.57 48.14 9.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.153 -0.476 . . . . 74.420000000000002 110.915 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 2.9 m -113.45 143.92 43.68 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.148 -0.478 . . . . 75.319999999999993 110.85 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 96.41 -124.15 7.98 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.74 -0.743 . . . . 74.140000000000001 112.447 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 4.9 tp-100 -102.77 143.62 32.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.799 0.333 . . . . 74.25 110.841 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 2.9 ttp -130.33 146.43 51.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.182 -0.463 . . . . 73.540000000000006 110.84 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 11.8 m-85 -148.13 137.5 22.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.174 -0.466 . . . . 75.230000000000004 110.925 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -118.63 101.24 7.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.121 -0.49 . . . . 75.299999999999997 110.88 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 8.1 t -118.24 153.21 34.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 64.409999999999997 111.177 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.465 ' HA ' ' O ' ' A' ' 94' ' ' TYR . 1.4 t -125.45 47.25 2.22 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.223 -0.444 . . . . 65.150000000000006 111.116 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 75.0 mm-40 -148.32 -175.2 4.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.264 -0.426 . . . . 60.420000000000002 110.863 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -101.94 150.96 22.67 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.134 -0.485 . . . . 71.049999999999997 110.884 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 11.1 m -143.03 136.83 14.37 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.638 0.732 . . . . 74.209999999999994 110.857 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.765 ' O ' ' HB2' ' A' ' 172' ' ' SER . 53.9 Cg_endo -69.72 -34.34 14.9 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.752 2.301 . . . . 73.230000000000004 112.354 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.64 ' HB3' ' CB ' ' A' ' 120' ' ' GLU . 0.1 OUTLIER -140.79 97.96 3.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.178 -0.464 . . . . 74.109999999999999 110.839 -179.831 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.782 HD13 HD11 ' A' ' 127' ' ' ILE . 5.0 tt -49.54 -28.33 3.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.146 -0.479 . . . . 63.530000000000001 111.132 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' MET . . . . . 0.568 ' O ' ' HA ' ' A' ' 123' ' ' HIS . 7.2 ttt -84.71 -42.61 15.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.157 -0.474 . . . . 65.340000000000003 110.89 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.64 ' CB ' ' HB3' ' A' ' 117' ' ' SER . 24.3 tp10 -62.5 -13.22 28.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.218 -0.446 . . . . 63.219999999999999 110.907 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' GLN . . . . . 0.485 ' NE2' ' CG ' ' A' ' 122' ' ' PHE . 0.5 OUTLIER -113.92 -52.93 2.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.152 -0.476 . . . . 73.120000000000005 110.931 -179.961 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.485 ' CG ' ' NE2' ' A' ' 121' ' ' GLN . 12.0 m-30 -101.93 -18.93 15.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.205 -0.452 . . . . 64.319999999999993 110.885 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' HIS . . . . . 0.568 ' HA ' ' O ' ' A' ' 119' ' ' MET . 10.7 m80 74.5 24.62 1.74 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.136 -0.484 . . . . 74.109999999999999 110.86 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.465 ' SD ' HG22 ' A' ' 98' ' ' ILE . 8.6 mtt -100.39 83.31 2.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.223 -0.444 . . . . 75.319999999999993 110.921 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 3.6 ptp180 -49.5 -33.05 13.5 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.186 -0.461 . . . . 72.230000000000004 110.888 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.536 ' HB3' ' HG2' ' A' ' 168' ' ' PRO . 16.0 mt-10 -145.44 129.23 17.26 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.122 -0.49 . . . . 75.430000000000007 110.886 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.782 HD11 HD13 ' A' ' 118' ' ' ILE . 3.0 mm -87.33 91.13 3.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.147 -0.479 . . . . 72.430000000000007 111.122 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -61.9 -34.45 76.07 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.187 -0.461 . . . . 70.519999999999996 110.865 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 129' ' ' SER . . . . . 0.565 ' HB2' ' HB2' ' A' ' 99' ' ' PHE . 0.6 OUTLIER -135.05 152.13 51.41 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.224 -0.444 . . . . 74.420000000000002 110.887 -179.751 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 130' ' ' CYS . . . . . 0.597 ' O ' ' O ' ' A' ' 155' ' ' LYS . 0.1 OUTLIER -155.25 121.04 5.07 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.157 -0.474 . . . . 54.399999999999999 110.852 -179.94 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.657 ' HA ' ' HA ' ' A' ' 156' ' ' GLU . 8.7 mtpp -108.57 153.85 22.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.191 -0.459 . . . . 71.230000000000004 110.88 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.57 HG23 ' C ' ' A' ' 131' ' ' LYS . 11.3 t 85.76 164.7 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.197 -0.456 . . . . 72.5 111.14 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.747 HD22 ' CG ' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -176.93 122.76 0.14 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.189 -0.46 . . . . 63.409999999999997 110.921 179.918 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.614 ' O ' ' C ' ' A' ' 135' ' ' GLY . 0.0 OUTLIER -98.75 159.12 15.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.13 -0.486 . . . . 73.019999999999996 110.873 179.95 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 135' ' ' GLY . . . . . 0.614 ' C ' ' O ' ' A' ' 134' ' ' GLU . . . -13.57 -75.63 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.769 -0.729 . . . . 63.439999999999998 112.497 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.821 HG21 HG13 ' A' ' 86' ' ' VAL . 5.6 t -136.1 148.81 27.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.821 0.343 . . . . 75.540000000000006 111.129 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 137' ' ' TRP . . . . . 0.631 ' HB3' ' HB3' ' A' ' 152' ' ' LEU . 22.8 t90 -146.2 148.65 32.74 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.157 -0.474 . . . . 71.510000000000005 110.934 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.46 HD13 ' HB ' ' A' ' 61' ' ' ILE . 0.4 OUTLIER -118.05 135.11 59.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.245 -0.434 . . . . 41.229999999999997 111.123 179.953 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.533 ' CZ ' HG11 ' A' ' 170' ' ' VAL . 0.1 OUTLIER -110.07 147.51 33.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.173 -0.467 . . . . 74.25 110.863 179.977 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 140' ' ' TYR . . . . . 0.711 ' HB2' ' O ' ' A' ' 172' ' ' SER . 0.8 OUTLIER -115.32 129.67 56.67 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.18 -0.464 . . . . 74.329999999999998 110.898 -179.855 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 141' ' ' GLU . . . . . 0.625 ' O ' ' NE2' ' A' ' 171' ' ' GLN . 8.1 tt0 -69.34 -28.6 66.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.126 -0.488 . . . . 73.439999999999998 110.926 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.775 ' O ' ' HB3' ' A' ' 172' ' ' SER . 5.9 mp -113.41 148.48 39.73 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.629 0.728 . . . . 71.340000000000003 110.876 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 143' ' ' PRO . . . . . 0.684 ' CD ' ' HG2' ' A' ' 171' ' ' GLN . 53.5 Cg_endo -69.74 43.95 0.39 Allowed 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.695 2.263 . . . . 73.340000000000003 112.328 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 144' ' ' ASN . . . . . 1.093 ' O ' ' N ' ' A' ' 146' ' ' ARG . 0.4 OUTLIER 177.47 111.23 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.261 -0.427 . . . . 75.420000000000002 110.928 179.996 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 145' ' ' TYR . . . . . 0.66 ' HA ' ' CE2' ' A' ' 140' ' ' TYR . 0.2 OUTLIER -6.36 52.37 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.159 -0.473 . . . . 72.439999999999998 110.911 -179.895 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 146' ' ' ARG . . . . . 1.093 ' N ' ' O ' ' A' ' 144' ' ' ASN . 26.9 mtt180 -138.85 167.12 22.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.11 -0.495 . . . . 73.239999999999995 110.858 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 83.89 -165.35 41.79 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.692 -0.766 . . . . 64.439999999999998 112.5 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -88.07 146.45 25.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.751 0.31 . . . . 72.019999999999996 110.912 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 149' ' ' GLN . . . . . 0.432 ' O ' ' HB2' ' A' ' 59' ' ' MET . 28.2 mt-30 -88.59 161.91 16.66 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.239 -0.437 . . . . 75.219999999999999 110.903 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 150' ' ' TYR . . . . . 0.465 ' HB2' ' CB ' ' A' ' 139' ' ' PHE . 85.9 m-85 -135.72 130.87 34.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.162 -0.472 . . . . 73.200000000000003 110.932 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.649 HD23 ' OH ' ' A' ' 50' ' ' TYR . 9.2 tp -82.87 120.34 25.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.152 -0.476 . . . . 72.519999999999996 110.914 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.935 HD13 ' O ' ' A' ' 152' ' ' LEU . 0.0 OUTLIER -51.62 136.77 26.17 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.208 -0.451 . . . . 75.129999999999995 110.888 179.877 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -164.53 24.93 0.06 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.207 -0.451 . . . . 75.519999999999996 110.834 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.843 ' HB2' ' CD1' ' A' ' 157' ' ' TYR . 0.0 OUTLIER -119.42 -176.57 3.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.239 -0.437 . . . . 75.340000000000003 110.936 179.968 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.747 ' CG ' HD22 ' A' ' 133' ' ' LEU . 1.1 mptt -159.09 -121.72 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.216 -0.447 . . . . 74.439999999999998 110.912 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.657 ' HA ' ' HA ' ' A' ' 131' ' ' LYS . 2.9 tm-20 -68.93 0.09 4.91 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.175 -0.466 . . . . 52.539999999999999 110.881 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 157' ' ' TYR . . . . . 0.843 ' CD1' ' HB2' ' A' ' 154' ' ' LYS . 16.5 m-30 -32.01 147.5 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.151 -0.477 . . . . 72.120000000000005 110.968 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 158' ' ' ARG . . . . . 0.54 ' HB3' ' CZ ' ' A' ' 104' ' ' PHE . 6.8 ptp180 -112.5 -41.78 3.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.145 -0.479 . . . . 74.129999999999995 110.85 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -85.95 150.57 53.11 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.56 0.695 . . . . 75.340000000000003 110.906 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 160' ' ' PRO . . . . . 0.52 ' HB3' ' HB3' ' A' ' 168' ' ' PRO . 54.1 Cg_endo -69.74 -31.57 20.36 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.719 2.279 . . . . 71.019999999999996 112.364 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.761 HD12 ' H ' ' A' ' 161' ' ' ILE . 3.5 mp -62.25 -12.75 8.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.236 -0.438 . . . . 72.0 111.115 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.587 ' HB3' ' CD1' ' A' ' 157' ' ' TYR . 0.5 OUTLIER -70.44 -12.26 61.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.216 -0.447 . . . . 55.200000000000003 110.874 179.842 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 75.4 t-105 -90.95 -12.96 34.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.23 -0.441 . . . . 74.5 110.928 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 93.03 -35.25 4.17 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.769 -0.729 . . . . 43.329999999999998 112.487 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -79.84 123.24 27.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.818 0.342 . . . . 61.229999999999997 111.076 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -49.38 122.6 6.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.167 -0.469 . . . . 42.020000000000003 111.094 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 167' ' ' SER . . . . . 0.469 ' C ' ' H ' ' A' ' 169' ' ' ALA . 0.5 OUTLIER 64.89 140.86 0.06 OUTLIER Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.637 0.732 . . . . 71.319999999999993 110.909 -179.768 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 168' ' ' PRO . . . . . 0.536 ' HG2' ' HB3' ' A' ' 126' ' ' GLU . 53.5 Cg_endo -69.8 33.6 0.2 Allowed 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.717 2.278 . . . . 64.049999999999997 112.317 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 0.473 ' O ' HG22 ' A' ' 170' ' ' VAL . . . -67.19 98.28 0.59 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.233 -0.44 . . . . 71.230000000000004 111.148 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.597 HG12 ' H ' ' A' ' 171' ' ' GLN . 1.1 t -156.97 175.32 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.221 -0.445 . . . . 65.25 111.13 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 171' ' ' GLN . . . . . 0.701 ' N ' ' CD ' ' A' ' 171' ' ' GLN . 0.0 OUTLIER -160.66 -99.93 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.146 -0.479 . . . . 54.299999999999997 110.911 -179.957 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 172' ' ' SER . . . . . 0.775 ' HB3' ' O ' ' A' ' 142' ' ' LEU . 0.1 OUTLIER -52.46 140.61 22.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.168 -0.469 . . . . 34.229999999999997 110.868 -179.793 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 173' ' ' PHE . . . . . 0.484 ' HB3' ' CE1' ' A' ' 139' ' ' PHE . 18.9 p90 -156.44 149.84 24.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.114 -0.494 . . . . 64.540000000000006 110.89 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 174' ' ' ARG . . . . . 0.478 ' HD3' ' CE2' ' A' ' 140' ' ' TYR . 0.0 OUTLIER -149.21 157.58 43.48 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.128 -0.487 . . . . 70.530000000000001 110.851 -179.899 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 175' ' ' ARG . . . . . 0.415 ' H ' ' HD2' ' A' ' 175' ' ' ARG . 0.0 OUTLIER -106.29 172.08 7.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.221 -0.445 . . . . 73.129999999999995 110.854 -179.938 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 176' ' ' ILE . . . . . 0.806 HD12 ' HB ' ' A' ' 136' ' ' VAL . 6.5 mt -97.78 143.38 12.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.175 -0.466 . . . . 72.209999999999994 111.132 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 67.8 t -48.36 140.72 2.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.164 -0.471 . . . . 73.400000000000006 111.128 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 178' ' ' GLU . . . . . 0.627 ' HB3' HD12 ' A' ' 88' ' ' LEU . 1.2 mm-40 . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 116.213 -0.448 . . . . 74.239999999999995 110.907 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.322 0 N-CA-C 112.468 -0.253 . . . . 34.229999999999997 112.468 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.503 ' C ' ' HE1' ' A' ' 47' ' ' TRP . 5.2 p -82.41 134.3 35.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.906 0.384 . . . . 64.310000000000002 111.105 -179.832 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 3.9 tttt -120.06 135.87 54.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.176 -0.465 . . . . 73.310000000000002 110.906 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.616 ' HB ' ' CD1' ' A' ' 47' ' ' TRP . 15.5 tt -137.14 151.88 27.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.231 -0.44 . . . . 61.310000000000002 111.159 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.499 ' HA ' ' O ' ' A' ' 21' ' ' TYR . 18.1 m -132.86 142.45 48.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.192 -0.458 . . . . 61.43 111.153 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.722 ' HB2' HD22 ' A' ' 34' ' ' LEU . 0.8 OUTLIER -130.08 129.03 43.07 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.25 -0.432 . . . . 73.420000000000002 110.875 -179.965 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.547 ' CG ' ' HA ' ' A' ' 16' ' ' PHE . 12.5 m-85 -114.4 131.65 56.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.136 -0.484 . . . . 53.509999999999998 110.93 -179.867 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.438 ' HB2' ' HB2' ' A' ' 19' ' ' ARG . 0.1 OUTLIER -59.5 -16.49 24.83 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.117 -0.492 . . . . 72.430000000000007 110.864 -179.97 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.443 ' HB2' ' O ' ' A' ' 17' ' ' GLN . 72.2 m-20 -134.14 150.56 51.12 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.167 -0.469 . . . . 71.120000000000005 110.885 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.469 ' N ' ' HB3' ' A' ' 38' ' ' ASN . 34.2 mtmt -55.61 -176.58 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.196 -0.456 . . . . 64.299999999999997 110.864 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 20.2 m120 47.22 32.45 2.1 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.194 -0.457 . . . . 50.310000000000002 110.908 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.547 ' HA ' ' CG ' ' A' ' 11' ' ' TYR . 3.3 m-85 49.74 62.66 2.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 72.200000000000003 110.916 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.443 ' O ' ' HB2' ' A' ' 13' ' ' ASP . 18.3 mt-30 -137.75 159.22 42.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.116 -0.493 . . . . 71.120000000000005 110.895 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 92.7 -148.49 19.11 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.765 -0.731 . . . . 74.140000000000001 112.482 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.757 ' O ' HD13 ' A' ' 34' ' ' LEU . 0.3 OUTLIER -69.75 78.43 0.45 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.797 0.332 . . . . 75.540000000000006 110.844 -179.8 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.487 ' HB2' ' CE1' ' A' ' 11' ' ' TYR . 0.6 OUTLIER -76.88 130.35 37.46 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.188 -0.46 . . . . 65.129999999999995 110.845 -179.91 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.499 ' O ' ' HA ' ' A' ' 9' ' ' THR . 89.2 t80 -124.33 123.65 40.67 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.193 -0.458 . . . . 74.25 110.895 -179.829 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.471 ' CG ' HG23 ' A' ' 9' ' ' THR . 1.2 m-20 -121.14 133.78 55.21 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.089 -0.505 . . . . 73.400000000000006 110.856 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -168.31 136.67 2.26 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.196 -0.457 . . . . 62.049999999999997 110.916 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -101.93 -0.69 33.46 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.185 -0.461 . . . . 74.299999999999997 110.839 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 16.8 t -102.85 164.34 11.68 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.226 -0.443 . . . . 71.239999999999995 110.911 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -57.68 120.86 9.1 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.238 -0.437 . . . . 70.420000000000002 110.894 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.55 ' HB2' ' HB3' ' A' ' 30' ' ' PHE . 1.8 m -116.63 51.13 1.0 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.185 -0.461 . . . . 72.420000000000002 110.853 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.495 ' C ' ' HA ' ' A' ' 82' ' ' SER . . . -47.07 -21.1 0.2 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.226 -0.443 . . . . 73.019999999999996 111.099 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 55.0 t0 -128.17 41.77 3.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.202 -0.454 . . . . 74.420000000000002 110.862 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.773 ' CD2' ' O ' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -81.35 13.18 3.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.184 -0.462 . . . . 73.040000000000006 110.851 -179.881 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.479 ' HB2' ' HB3' ' A' ' 53' ' ' PRO . 28.8 t60 -78.75 -40.44 33.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.143 -0.48 . . . . 73.099999999999994 110.803 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.7 t -56.33 -16.14 5.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.197 -0.456 . . . . 74.109999999999999 111.126 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -98.26 -25.95 14.69 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.21 -0.45 . . . . 64.019999999999996 110.932 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.757 HD13 ' O ' ' A' ' 19' ' ' ARG . 16.3 tp -144.13 131.58 20.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.076 -0.511 . . . . 43.299999999999997 110.901 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 24.5 m -93.81 -42.88 8.88 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.193 -0.458 . . . . 63.420000000000002 110.839 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 1.1 tmm_? -118.41 140.64 49.54 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.163 -0.471 . . . . 72.099999999999994 110.861 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.493 ' HB3' ' HB2' ' A' ' 80' ' ' LEU . 4.0 p -108.71 81.08 1.4 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.164 -0.471 . . . . 74.430000000000007 110.913 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.469 ' HB3' ' N ' ' A' ' 14' ' ' LYS . 0.2 OUTLIER -70.4 -73.26 0.17 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.17 -0.468 . . . . 75.109999999999999 110.879 -179.882 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 4.3 p -109.21 125.03 51.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.208 -0.451 . . . . 74.109999999999999 110.841 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.756 HG21 HD13 ' A' ' 62' ' ' LEU . 45.3 mt -118.05 148.83 20.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.127 -0.488 . . . . 73.420000000000002 111.11 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.468 ' HD2' ' CE2' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -144.69 119.26 9.73 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.207 -0.451 . . . . 64.420000000000002 110.847 179.868 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.535 HG22 ' HB ' ' A' ' 8' ' ' ILE . 2.0 t -104.04 115.66 46.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.186 -0.461 . . . . 72.140000000000001 111.121 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -110.27 79.39 1.2 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.202 -0.454 . . . . 71.010000000000005 110.884 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.438 ' O ' ' HA ' ' A' ' 6' ' ' THR . . . 129.31 106.89 1.25 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.704 -0.76 . . . . 70.420000000000002 112.501 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 51.89 -178.75 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.764 -0.732 . . . . 54.32 112.463 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.705 HG23 ' HA ' ' A' ' 63' ' ' PRO . 1.2 m -83.23 168.29 16.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.749 0.309 . . . . 73.439999999999998 111.137 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' TRP . . . . . 0.616 ' CD1' ' HB ' ' A' ' 8' ' ' ILE . 3.4 m95 -141.04 130.19 23.44 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.276 -0.42 . . . . 74.010000000000005 110.918 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.882 ' HB2' ' CG2' ' A' ' 86' ' ' VAL . . . -93.52 129.27 39.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.275 -0.42 . . . . 74.329999999999998 111.102 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.665 HG11 ' CD1' ' A' ' 80' ' ' LEU . 15.5 m -129.02 125.83 63.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.206 -0.452 . . . . 75.209999999999994 111.108 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.73 ' HB3' ' HA ' ' A' ' 56' ' ' ALA . 42.8 m-85 -92.16 150.11 21.1 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.16 -0.473 . . . . 72.430000000000007 110.929 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.648 ' OE1' ' HB3' ' A' ' 57' ' ' TRP . 54.2 tt0 -49.99 -78.94 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.099 -0.5 . . . . 55.240000000000002 110.865 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.544 ' HB3' ' CD2' ' A' ' 55' ' ' PHE . 0.0 OUTLIER -93.66 144.68 28.58 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.626 0.727 . . . . 74.349999999999994 110.848 -179.867 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.772 ' HA ' ' OG ' ' A' ' 82' ' ' SER . 53.8 Cg_endo -69.78 141.76 46.01 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.702 2.268 . . . . 64.310000000000002 112.346 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 63.38 -11.89 0.09 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.226 -0.443 . . . . 75.209999999999994 110.878 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.61 ' H ' ' C ' ' A' ' 53' ' ' PRO . 2.5 m-30 -104.01 -19.13 14.31 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.148 -0.478 . . . . 73.120000000000005 110.893 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.73 ' HA ' ' HB3' ' A' ' 50' ' ' TYR . . . 49.47 25.46 1.37 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.138 -0.483 . . . . 71.299999999999997 111.09 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' TRP . . . . . 0.648 ' HB3' ' OE1' ' A' ' 51' ' ' GLU . 0.0 OUTLIER -50.01 -166.06 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.243 -0.435 . . . . 74.549999999999997 110.982 -179.988 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.636 ' C ' ' O ' ' A' ' 57' ' ' TRP . 10.0 m-30 -14.1 101.32 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.267 -0.424 . . . . 75.340000000000003 110.913 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.482 ' HB2' ' HA ' ' A' ' 150' ' ' TYR . 1.6 mpt? -64.14 157.57 25.22 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.089 -0.505 . . . . 73.340000000000003 110.879 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.723 ' CD2' HD12 ' A' ' 76' ' ' LEU . 2.6 t80 -170.48 103.98 0.27 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.259 -0.428 . . . . 64.319999999999993 110.925 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.625 HD11 ' HB2' ' A' ' 151' ' ' LEU . 0.8 OUTLIER -91.23 115.09 29.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.115 -0.493 . . . . 64.299999999999997 111.113 179.904 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.79 HD23 ' HD2' ' A' ' 63' ' ' PRO . 0.3 OUTLIER -81.84 126.32 75.65 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.595 0.712 . . . . 73.230000000000004 110.949 179.861 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.79 ' HD2' HD23 ' A' ' 62' ' ' LEU . 53.9 Cg_endo -69.71 -176.1 1.36 Allowed 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.729 2.286 . . . . 71.049999999999997 112.348 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -84.51 161.66 20.16 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.238 -0.437 . . . . 73.5 110.899 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 113.64 -162.47 12.37 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.74 -0.743 . . . . 55.539999999999999 112.491 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -115.68 156.45 25.89 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.899 0.38 . . . . 74.349999999999994 110.847 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.554 ' HB2' ' O ' ' A' ' 40' ' ' ILE . 9.4 m-85 -145.17 83.72 9.07 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.669 0.747 . . . . 74.540000000000006 110.943 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.409 ' HD2' ' HG3' ' A' ' 72' ' ' ARG . 53.8 Cg_endo -69.77 0.67 5.32 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.686 2.257 . . . . 54.329999999999998 112.326 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.483 ' HB2' ' HG2' ' A' ' 72' ' ' ARG . 42.4 mt-10 -155.79 142.72 18.99 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.268 -0.424 . . . . 74.310000000000002 110.922 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.693 ' HA ' ' NE1' ' A' ' 73' ' ' TRP . 24.1 p90 -56.11 -21.38 21.97 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.205 -0.452 . . . . 72.239999999999995 110.899 -179.838 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -78.2 -18.42 55.51 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.094 -0.503 . . . . 62.149999999999999 110.894 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.483 ' HG2' ' HB2' ' A' ' 69' ' ' GLU . 29.4 mmt180 -67.52 -9.25 40.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.213 -0.449 . . . . 71.299999999999997 110.919 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' TRP . . . . . 0.714 ' CD1' ' N ' ' A' ' 73' ' ' TRP . 0.0 OUTLIER -135.51 5.89 3.22 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.175 -0.466 . . . . 74.040000000000006 110.93 -179.979 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 11.6 mtp 45.42 68.64 0.54 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.234 -0.439 . . . . 64.420000000000002 110.934 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -60.66 120.79 24.33 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.749 -0.739 . . . . 71.230000000000004 112.47 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.876 HD13 ' N ' ' A' ' 77' ' ' ASN . 0.0 OUTLIER -70.75 -8.79 54.82 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.805 0.336 . . . . 71.420000000000002 110.897 -179.954 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.876 ' N ' HD13 ' A' ' 76' ' ' LEU . 10.7 t-20 -151.46 -41.83 0.12 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.217 -0.447 . . . . 73.219999999999999 110.885 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.581 ' CB ' ' O ' ' A' ' 77' ' ' ASN . 1.8 t70 89.88 7.68 0.1 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.186 -0.461 . . . . 72.510000000000005 110.872 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -105.81 91.43 3.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.181 -0.463 . . . . 73.519999999999996 110.888 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.665 ' CD1' HG11 ' A' ' 49' ' ' VAL . 0.1 OUTLIER -90.28 135.54 33.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.172 -0.467 . . . . 65.109999999999999 110.965 -180.0 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.631 ' HB3' ' HB3' ' A' ' 53' ' ' PRO . 1.2 m -151.94 -118.66 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.198 -0.455 . . . . 75.099999999999994 110.884 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.772 ' OG ' ' HA ' ' A' ' 53' ' ' PRO . 0.2 OUTLIER -44.57 101.8 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.142 -0.481 . . . . 70.129999999999995 110.851 -179.824 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 83' ' ' CYS . . . . . 0.601 ' HB3' HG12 ' A' ' 49' ' ' VAL . 15.9 p -115.77 141.43 48.11 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.133 -0.485 . . . . 75.409999999999997 110.887 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.6 ' N ' ' O ' ' A' ' 48' ' ' ALA . 13.8 mmt85 -128.38 134.7 48.88 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.218 -0.447 . . . . 63.240000000000002 110.884 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.465 ' N ' ' CZ3' ' A' ' 47' ' ' TRP . . . -53.06 127.44 24.05 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.456 . . . . 45.420000000000002 111.08 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.882 ' CG2' ' HB2' ' A' ' 48' ' ' ALA . 73.7 t -115.05 135.43 55.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.238 -0.437 . . . . 71.129999999999995 111.136 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 28.7 m-70 -112.08 120.2 41.03 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.15 -0.477 . . . . 74.349999999999994 110.859 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.763 HD13 ' HB3' ' A' ' 178' ' ' GLU . 0.1 OUTLIER -40.04 137.65 1.18 Allowed Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.62 0.724 . . . . 72.099999999999994 110.942 -179.961 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.65 ' HB3' ' H ' ' A' ' 136' ' ' VAL . 53.9 Cg_endo -69.72 81.17 0.83 Allowed 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.7 2.266 . . . . 75.519999999999996 112.363 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -98.72 119.15 36.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.242 -0.435 . . . . 72.120000000000005 110.881 -179.856 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 130.51 85.98 0.39 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.755 -0.735 . . . . 53.130000000000003 112.496 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 88.1 35.63 8.81 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.782 -0.723 . . . . 73.519999999999996 112.471 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.46 ' O ' ' HG3' ' A' ' 134' ' ' GLU . 12.4 pt20 39.47 -154.18 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.832 0.349 . . . . 73.400000000000006 110.917 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.596 ' O ' ' HA ' ' A' ' 112' ' ' THR . 28.0 m-85 -96.17 102.35 14.12 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.199 -0.455 . . . . 71.340000000000003 110.919 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.506 ' H ' ' CG ' ' A' ' 134' ' ' GLU . 35.4 tptt -109.58 126.18 53.33 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.139 -0.482 . . . . 72.439999999999998 110.895 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 5.3 tt -150.6 137.19 12.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.189 -0.46 . . . . 74.340000000000003 111.119 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -108.14 135.11 50.04 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.17 -0.468 . . . . 72.120000000000005 110.917 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.582 ' CG2' HD12 ' A' ' 127' ' ' ILE . 26.0 mm -115.37 134.7 57.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.231 -0.44 . . . . 72.420000000000002 111.113 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.589 ' HB2' ' HB2' ' A' ' 129' ' ' SER . 61.7 m-85 -123.13 140.07 53.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 74.329999999999998 110.885 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.551 ' HA ' ' CE ' ' A' ' 124' ' ' MET . 58.6 tt0 -75.06 -52.64 10.54 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.161 -0.472 . . . . 72.340000000000003 110.922 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 40.8 mttt -106.8 155.29 19.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.136 -0.484 . . . . 63.450000000000003 110.932 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.406 ' N ' ' HB3' ' A' ' 128' ' ' HIS . . . -62.24 157.3 36.6 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.772 -0.728 . . . . 65.120000000000005 112.467 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.55 ' HA ' ' HB2' ' A' ' 158' ' ' ARG . 12.8 t70 69.48 39.92 1.52 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.896 0.379 . . . . 63.439999999999998 110.878 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.526 ' HA ' ' CD1' ' A' ' 99' ' ' PHE . 2.1 m-85 55.32 25.13 7.16 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.176 -0.465 . . . . 74.120000000000005 110.886 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 68.0 m -92.94 166.83 12.19 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.18 -0.464 . . . . 70.129999999999995 110.831 -179.776 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 79.18 -157.66 43.16 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.75 -0.738 . . . . 72.049999999999997 112.511 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 4.3 tp-100 -75.08 119.58 19.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.794 0.33 . . . . 73.239999999999995 110.931 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' MET . . . . . 0.462 ' HB2' ' CE1' ' A' ' 99' ' ' PHE . 18.8 ttp -104.36 145.46 30.22 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.23 -0.441 . . . . 74.099999999999994 110.864 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -148.66 134.84 19.29 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.195 -0.457 . . . . 70.400000000000006 110.926 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -113.38 89.28 3.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 74.340000000000003 110.907 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 15.0 t -101.04 130.55 47.07 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.115 -0.493 . . . . 72.340000000000003 111.163 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.596 ' HA ' ' O ' ' A' ' 94' ' ' TYR . 0.6 OUTLIER -104.83 30.68 5.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.229 -0.441 . . . . 71.329999999999998 111.148 -179.974 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -154.05 133.12 12.49 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.216 -0.447 . . . . 75.519999999999996 110.876 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.4 ' HB2' ' HA ' ' A' ' 174' ' ' ARG . 39.1 p30 -51.3 170.24 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.141 -0.481 . . . . 74.340000000000003 110.864 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' CYS . . . . . 0.486 ' O ' ' HB2' ' A' ' 172' ' ' SER . 14.1 p -152.37 144.24 16.44 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.594 0.711 . . . . 71.409999999999997 110.915 -179.898 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.434 ' O ' ' C ' ' A' ' 143' ' ' PRO . 53.6 Cg_endo -69.76 -31.16 21.08 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.712 2.275 . . . . 71.439999999999998 112.385 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.634 ' HB3' ' CB ' ' A' ' 120' ' ' GLU . 0.1 OUTLIER -147.41 106.66 3.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.193 -0.458 . . . . 50.530000000000001 110.88 -179.875 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.656 ' HB ' ' O ' ' A' ' 171' ' ' GLN . 4.0 tt -58.14 -28.18 33.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.131 -0.486 . . . . 75.120000000000005 111.088 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' MET . . . . . 0.695 ' O ' ' HA ' ' A' ' 123' ' ' HIS . 27.1 ttp -87.46 -41.47 13.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.185 -0.462 . . . . 74.510000000000005 110.915 179.831 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.634 ' CB ' ' HB3' ' A' ' 117' ' ' SER . 15.5 tp10 -68.65 -12.33 61.23 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.223 -0.444 . . . . 72.450000000000003 110.876 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 18.6 tp60 -115.94 -48.46 2.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.167 -0.469 . . . . 62.399999999999999 110.917 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.477 ' HB2' ' O ' ' A' ' 118' ' ' ILE . 44.6 m-85 -103.99 -13.78 16.19 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.189 -0.46 . . . . 73.409999999999997 110.897 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' HIS . . . . . 0.695 ' HA ' ' O ' ' A' ' 119' ' ' MET . 10.8 m80 71.46 20.18 4.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.106 -0.497 . . . . 74.099999999999994 110.825 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.551 ' CE ' ' HA ' ' A' ' 100' ' ' GLU . 0.0 OUTLIER -93.42 139.59 30.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.208 -0.451 . . . . 74.129999999999995 110.854 179.97 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 5.3 ptp180 -102.36 -44.92 5.25 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.188 -0.46 . . . . 72.540000000000006 110.827 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.451 ' HG2' ' HA ' ' A' ' 169' ' ' ALA . 10.8 mt-10 -138.17 117.23 12.54 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.209 -0.45 . . . . 72.040000000000006 110.858 -179.89 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.645 HG21 ' SG ' ' A' ' 130' ' ' CYS . 2.5 mm -77.41 93.93 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.131 -0.486 . . . . 72.25 111.087 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 128' ' ' HIS . . . . . 0.406 ' HB3' ' N ' ' A' ' 102' ' ' GLY . 0.6 OUTLIER -63.78 -36.08 82.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.467 . . . . 74.120000000000005 110.877 179.849 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 129' ' ' SER . . . . . 0.589 ' HB2' ' HB2' ' A' ' 99' ' ' PHE . 0.6 OUTLIER -132.32 146.21 51.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.205 -0.452 . . . . 72.409999999999997 110.851 -179.756 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 130' ' ' CYS . . . . . 0.645 ' SG ' HG21 ' A' ' 127' ' ' ILE . 0.5 OUTLIER -145.27 120.49 10.18 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.15 -0.477 . . . . 73.329999999999998 110.849 -179.937 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.653 ' HA ' ' HA ' ' A' ' 156' ' ' GLU . 1.3 mtpt -107.39 153.93 22.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.152 -0.477 . . . . 74.349999999999994 110.894 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.592 HG23 ' C ' ' A' ' 131' ' ' LYS . 4.8 t 82.71 165.27 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.207 -0.451 . . . . 74.400000000000006 111.119 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.795 HD13 ' O ' ' A' ' 154' ' ' LYS . 0.0 OUTLIER -176.47 126.02 0.18 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.187 -0.46 . . . . 52.229999999999997 110.884 179.988 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.506 ' CG ' ' H ' ' A' ' 95' ' ' LYS . 0.0 OUTLIER -94.39 159.23 15.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.172 -0.467 . . . . 75.099999999999994 110.893 179.95 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 135' ' ' GLY . . . . . 0.485 ' C ' ' O ' ' A' ' 134' ' ' GLU . . . -31.05 -48.82 0.2 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.764 -0.732 . . . . 72.409999999999997 112.451 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.799 ' HB ' HD12 ' A' ' 176' ' ' ILE . 2.3 t -150.99 133.5 6.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.814 0.34 . . . . 74.209999999999994 111.105 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 137' ' ' TRP . . . . . 0.596 ' H ' ' CG ' ' A' ' 152' ' ' LEU . 3.6 t-105 -133.5 150.7 51.7 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.173 -0.467 . . . . 74.450000000000003 110.88 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.721 HG23 ' NE2' ' A' ' 149' ' ' GLN . 22.1 mm -114.12 128.77 70.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.18 -0.463 . . . . 73.540000000000006 111.139 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.518 ' CB ' ' HB2' ' A' ' 150' ' ' TYR . 0.5 OUTLIER -114.91 149.59 36.99 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.217 -0.447 . . . . 74.239999999999995 110.875 179.953 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 140' ' ' TYR . . . . . 0.492 ' CD2' ' HA ' ' A' ' 145' ' ' TYR . 2.3 m-85 -134.98 133.17 39.2 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.131 -0.486 . . . . 60.350000000000001 110.902 -179.86 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 141' ' ' GLU . . . . . 0.69 ' O ' ' HB2' ' A' ' 171' ' ' GLN . 0.8 OUTLIER -59.93 -26.49 65.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.147 -0.478 . . . . 63.109999999999999 110.911 179.966 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.728 ' HB3' ' HD2' ' A' ' 143' ' ' PRO . 9.7 mp -112.15 173.13 3.03 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.595 0.712 . . . . 65.310000000000002 110.883 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 143' ' ' PRO . . . . . 0.728 ' HD2' ' HB3' ' A' ' 142' ' ' LEU . 53.8 Cg_endo -69.76 -89.68 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.645 2.23 . . . . 74.299999999999997 112.357 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 144' ' ' ASN . . . . . 0.686 ' O ' ' N ' ' A' ' 146' ' ' ARG . 2.3 m-20 -52.81 97.0 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.183 -0.462 . . . . 71.140000000000001 110.923 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 145' ' ' TYR . . . . . 0.64 ' C ' ' O ' ' A' ' 144' ' ' ASN . 0.1 OUTLIER 12.78 53.25 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.18 -0.463 . . . . 74.340000000000003 110.962 -179.899 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 146' ' ' ARG . . . . . 0.686 ' N ' ' O ' ' A' ' 144' ' ' ASN . 38.1 mtt85 -119.46 179.1 4.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.1 -0.5 . . . . 74.450000000000003 110.865 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 73.98 -174.05 49.59 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.723 -0.751 . . . . 70.329999999999998 112.509 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.427 ' HG2' ' CD1' ' A' ' 58' ' ' TYR . 0.2 OUTLIER -75.91 151.75 37.27 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.758 0.313 . . . . 72.209999999999994 110.868 -179.883 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 149' ' ' GLN . . . . . 0.721 ' NE2' HG23 ' A' ' 138' ' ' ILE . 0.0 OUTLIER -88.5 149.82 23.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.186 -0.461 . . . . 74.109999999999999 110.946 -179.979 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 150' ' ' TYR . . . . . 0.518 ' HB2' ' CB ' ' A' ' 139' ' ' PHE . 82.4 m-85 -134.07 129.5 36.12 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.205 -0.452 . . . . 72.310000000000002 110.9 -179.847 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.625 ' HB2' HD11 ' A' ' 61' ' ' ILE . 16.8 tp -81.67 122.72 27.99 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.129 -0.487 . . . . 65.420000000000002 110.882 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.921 HD13 ' O ' ' A' ' 152' ' ' LEU . 0.0 OUTLIER -54.54 135.36 46.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.2 -0.455 . . . . 72.530000000000001 110.915 179.871 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -163.25 25.74 0.09 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.183 -0.462 . . . . 62.329999999999998 110.9 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.795 ' O ' HD13 ' A' ' 133' ' ' LEU . 0.0 OUTLIER -117.27 -173.7 2.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.133 -0.485 . . . . 71.420000000000002 110.874 179.984 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.753 ' CG ' HD22 ' A' ' 133' ' ' LEU . 0.5 OUTLIER -161.87 -124.77 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.18 -0.464 . . . . 73.409999999999997 110.901 179.886 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.653 ' HA ' ' HA ' ' A' ' 131' ' ' LYS . 0.7 OUTLIER -69.09 -0.41 5.79 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.226 -0.443 . . . . 74.200000000000003 110.921 179.928 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 157' ' ' TYR . . . . . 0.785 ' CE1' ' HA ' ' A' ' 154' ' ' LYS . 18.5 m-30 -31.08 146.95 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.122 -0.49 . . . . 72.019999999999996 110.93 -179.822 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 158' ' ' ARG . . . . . 0.55 ' HB2' ' HA ' ' A' ' 103' ' ' ASP . 8.5 ptp180 -112.29 -39.49 4.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.117 -0.492 . . . . 70.239999999999995 110.867 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 159' ' ' LYS . . . . . 0.457 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 2.6 ptpp? -92.01 150.96 41.43 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.602 0.715 . . . . 72.430000000000007 110.881 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 160' ' ' PRO . . . . . 0.423 ' HA ' ' CZ2' ' A' ' 163' ' ' TRP . 53.9 Cg_endo -69.7 -23.05 31.49 Favored 'Trans proline' 0 C--O 1.232 0.214 0 C-N-CA 122.717 2.278 . . . . 72.409999999999997 112.352 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.674 HD12 ' H ' ' A' ' 161' ' ' ILE . 3.9 mp -76.62 2.32 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.226 -0.443 . . . . 63.32 111.105 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.667 ' HB3' ' CD1' ' A' ' 157' ' ' TYR . 0.6 OUTLIER -73.07 -19.86 61.08 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.176 -0.465 . . . . 74.200000000000003 110.855 179.855 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 163' ' ' TRP . . . . . 0.605 ' N ' ' CD1' ' A' ' 163' ' ' TRP . 0.0 OUTLIER -109.13 13.92 24.21 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.182 -0.463 . . . . 74.219999999999999 110.928 -179.965 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 85.04 -30.53 3.93 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.75 -0.738 . . . . 74.430000000000007 112.496 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -54.19 120.1 6.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.742 0.306 . . . . 71.019999999999996 111.1 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -49.67 -25.65 3.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.214 -0.448 . . . . 51.299999999999997 111.136 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 167' ' ' SER . . . . . 0.477 ' C ' ' H ' ' A' ' 169' ' ' ALA . 0.3 OUTLIER -155.61 160.13 31.09 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.708 0.766 . . . . 55.100000000000001 110.85 -179.804 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 168' ' ' PRO . . . . . 0.437 ' HB3' ' O ' ' A' ' 127' ' ' ILE . 53.8 Cg_endo -69.78 20.36 0.18 Allowed 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.717 2.278 . . . . 64.329999999999998 112.296 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 0.477 ' H ' ' C ' ' A' ' 167' ' ' SER . . . -63.18 103.64 0.5 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.245 -0.434 . . . . 71.409999999999997 111.124 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.425 HG12 ' N ' ' A' ' 171' ' ' GLN . 3.4 t -152.91 160.87 2.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.24 -0.436 . . . . 73.219999999999999 111.15 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 171' ' ' GLN . . . . . 0.69 ' HB2' ' O ' ' A' ' 141' ' ' GLU . 1.9 mm-40 -109.73 -88.03 0.5 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.215 -0.448 . . . . 73.540000000000006 110.913 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 172' ' ' SER . . . . . 0.699 ' OG ' ' O ' ' A' ' 143' ' ' PRO . 15.4 p -130.6 178.39 6.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.177 -0.465 . . . . 73.239999999999995 110.817 -179.789 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -143.79 168.07 20.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.107 -0.497 . . . . 74.230000000000004 110.864 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 174' ' ' ARG . . . . . 0.676 ' NE ' HG21 ' A' ' 138' ' ' ILE . 2.1 ppt_? -133.39 156.66 47.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.163 -0.471 . . . . 74.25 110.913 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 175' ' ' ARG . . . . . 0.43 ' HB2' ' CE1' ' A' ' 94' ' ' TYR . 6.2 ptt85 -98.18 150.72 21.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.259 -0.428 . . . . 61.549999999999997 110.869 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 176' ' ' ILE . . . . . 0.799 HD12 ' HB ' ' A' ' 136' ' ' VAL . 15.4 mt -83.1 152.31 3.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.217 -0.447 . . . . 53.109999999999999 111.116 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 7.5 p -126.29 147.2 31.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.129 -0.487 . . . . 63.219999999999999 111.132 179.826 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 178' ' ' GLU . . . . . 0.763 ' HB3' HD13 ' A' ' 88' ' ' LEU . 1.6 pt-20 . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.215 -0.448 . . . . 63.530000000000001 110.933 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.304 0 N-CA-C 112.444 -0.262 . . . . 55.25 112.444 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.439 ' C ' ' HE1' ' A' ' 47' ' ' TRP . 9.8 p -82.68 135.61 34.98 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.837 0.351 . . . . 41.100000000000001 111.158 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.422 ' HA ' ' HA ' ' A' ' 24' ' ' ASP . 2.8 tttt -123.47 135.75 54.23 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.217 -0.447 . . . . 65.209999999999994 110.9 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.498 ' HA ' ' HA ' ' A' ' 42' ' ' VAL . 14.5 tt -136.71 152.05 28.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.25 -0.432 . . . . 54.140000000000001 111.148 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.478 HG23 ' CG ' ' A' ' 22' ' ' ASP . 15.3 m -133.98 142.66 47.75 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.19 -0.459 . . . . 60.340000000000003 111.129 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.551 ' HD1' HD11 ' A' ' 40' ' ' ILE . 0.3 OUTLIER -130.01 128.72 42.59 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.226 -0.443 . . . . 73.439999999999998 110.92 179.997 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.544 ' CG ' ' HA ' ' A' ' 16' ' ' PHE . 24.1 m-85 -113.54 131.96 55.88 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.164 -0.471 . . . . 72.340000000000003 110.973 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.434 ' HA ' ' O ' ' A' ' 36' ' ' ARG . 0.0 OUTLIER -61.08 -13.63 18.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.123 -0.489 . . . . 63.299999999999997 110.914 -179.955 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.437 ' HB2' ' O ' ' A' ' 17' ' ' GLN . 77.1 m-20 -136.95 150.78 48.38 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.124 -0.489 . . . . 60.539999999999999 110.868 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 4.8 mtmm -55.22 -175.95 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.198 -0.456 . . . . 53.530000000000001 110.852 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 20.2 m-20 45.53 33.25 1.3 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.156 -0.475 . . . . 74.400000000000006 110.885 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.544 ' HA ' ' CG ' ' A' ' 11' ' ' TYR . 2.7 m-85 49.22 64.77 1.6 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.169 -0.469 . . . . 71.010000000000005 110.896 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.437 ' O ' ' HB2' ' A' ' 13' ' ' ASP . 8.0 mt-30 -139.46 159.96 40.96 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.154 -0.476 . . . . 70.25 110.886 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 92.7 -150.03 19.84 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.78 -0.724 . . . . 55.109999999999999 112.521 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.741 ' O ' HD13 ' A' ' 34' ' ' LEU . 0.3 OUTLIER -69.9 78.79 0.47 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.803 0.335 . . . . 72.549999999999997 110.89 -179.885 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.456 ' HA ' ' O ' ' A' ' 10' ' ' PHE . 0.0 OUTLIER -76.24 129.51 36.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.205 -0.452 . . . . 72.219999999999999 110.856 -179.871 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.469 ' CD2' ' CD2' ' A' ' 30' ' ' PHE . 69.2 t80 -124.26 125.31 44.16 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.184 -0.462 . . . . 65.219999999999999 110.903 -179.858 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.478 ' CG ' HG23 ' A' ' 9' ' ' THR . 1.2 m-20 -118.83 134.54 55.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.113 -0.494 . . . . 65.219999999999999 110.925 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 8.8 t -161.17 129.66 4.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.23 -0.441 . . . . 74.510000000000005 110.897 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.422 ' HA ' ' HA ' ' A' ' 7' ' ' LYS . 14.1 p-10 -97.33 4.39 50.81 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.178 -0.465 . . . . 70.209999999999994 110.89 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 46.9 t -113.52 159.66 19.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.179 -0.464 . . . . 74.099999999999994 110.855 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -42.67 119.67 1.51 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.162 -0.472 . . . . 71.329999999999998 110.854 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.558 ' HB2' ' HB3' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -114.6 40.55 2.54 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.187 -0.461 . . . . 74.329999999999998 110.9 -179.913 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.563 ' O ' ' HA ' ' A' ' 82' ' ' SER . . . -51.12 -21.22 1.81 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.15 -0.477 . . . . 71.439999999999998 111.119 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 59.9 t0 -128.86 38.32 3.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.168 -0.469 . . . . 75.310000000000002 110.888 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.773 ' CD2' ' O ' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -80.27 13.92 2.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.186 -0.461 . . . . 64.129999999999995 110.878 -179.885 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.437 ' CG ' ' HG3' ' A' ' 53' ' ' PRO . 36.2 t60 -77.65 -36.81 51.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.147 -0.479 . . . . 65.420000000000002 110.875 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.7 t -59.81 -14.52 15.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.196 -0.456 . . . . 65.319999999999993 111.156 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -100.99 -24.97 14.23 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.202 -0.454 . . . . 71.129999999999995 110.877 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.741 HD13 ' O ' ' A' ' 19' ' ' ARG . 23.9 tp -141.62 123.93 15.67 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.125 -0.489 . . . . 51.109999999999999 110.943 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 27.0 m -82.83 -49.32 9.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.211 -0.45 . . . . 74.019999999999996 110.829 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.434 ' O ' ' HA ' ' A' ' 12' ' ' GLU . 0.1 OUTLIER -114.04 143.25 45.07 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.131 -0.486 . . . . 72.019999999999996 110.834 -179.925 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.586 ' HB2' ' HB2' ' A' ' 80' ' ' LEU . 57.6 m -122.93 104.76 9.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.174 -0.466 . . . . 74.209999999999994 110.906 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 10.9 m-20 -97.49 -67.15 0.86 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.226 -0.443 . . . . 71.519999999999996 110.892 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 10.6 p -105.68 133.66 50.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.207 -0.451 . . . . 74.310000000000002 110.895 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.666 HD12 ' HZ3' ' A' ' 73' ' ' TRP . 6.9 mt -130.01 149.53 33.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.135 -0.484 . . . . 65.400000000000006 111.114 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.426 ' HD2' ' CE2' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -142.51 119.07 11.0 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.155 -0.475 . . . . 75.010000000000005 110.906 179.853 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.613 HG21 ' HB2' ' A' ' 47' ' ' TRP . 1.0 OUTLIER -104.76 117.47 50.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.268 -0.424 . . . . 61.229999999999997 111.098 179.908 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -112.55 76.67 0.99 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.155 -0.475 . . . . 74.439999999999998 110.896 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.427 ' O ' ' HA ' ' A' ' 6' ' ' THR . . . 139.21 99.61 0.45 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.723 -0.751 . . . . 54.039999999999999 112.479 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.415 ' HA2' HD21 ' A' ' 88' ' ' LEU . . . 55.59 177.78 0.25 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.743 -0.741 . . . . 75.109999999999999 112.479 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.725 HG23 ' HA ' ' A' ' 63' ' ' PRO . 2.2 m -76.46 168.7 19.61 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.719 0.295 . . . . 75.340000000000003 111.18 -179.863 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' TRP . . . . . 0.613 ' HB2' HG21 ' A' ' 42' ' ' VAL . 7.7 m95 -143.32 128.36 18.54 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.261 -0.427 . . . . 74.409999999999997 110.93 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.778 ' HB2' ' CG2' ' A' ' 86' ' ' VAL . . . -89.83 127.62 36.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.221 -0.445 . . . . 63.0 111.093 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.826 HG11 HD11 ' A' ' 80' ' ' LEU . 26.9 m -127.62 141.72 45.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.181 -0.463 . . . . 43.020000000000003 111.144 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.804 ' HB3' ' CB ' ' A' ' 56' ' ' ALA . 5.0 m-85 -122.53 155.44 36.22 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.189 -0.459 . . . . 74.099999999999994 110.903 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.685 ' N ' ' HB1' ' A' ' 56' ' ' ALA . 35.3 mp0 -53.19 -94.8 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.081 -0.509 . . . . 75.519999999999996 110.928 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.839 ' O ' ' HB2' ' A' ' 56' ' ' ALA . 3.4 mtp180 -72.0 136.46 82.31 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.556 0.693 . . . . 75.25 110.863 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.643 ' HA ' ' OG ' ' A' ' 82' ' ' SER . 53.8 Cg_endo -69.79 131.64 21.62 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.676 2.251 . . . . 72.230000000000004 112.321 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.458 ' H ' ' HB3' ' A' ' 82' ' ' SER . 10.1 t30 77.07 -5.35 2.19 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.169 -0.469 . . . . 75.120000000000005 110.916 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.414 ' HE1' HD21 ' A' ' 54' ' ' ASN . 0.1 OUTLIER -144.73 -73.4 0.25 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.158 -0.474 . . . . 74.010000000000005 110.852 -179.981 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.839 ' HB2' ' O ' ' A' ' 52' ' ' ARG . . . 37.96 80.29 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.177 -0.465 . . . . 75.230000000000004 111.107 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' TRP . . . . . 0.458 ' O ' ' CG ' ' A' ' 58' ' ' TYR . 31.4 m95 -64.96 53.07 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.215 -0.448 . . . . 72.120000000000005 110.903 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.575 ' CB ' ' OE1' ' A' ' 51' ' ' GLU . 0.5 OUTLIER -177.19 124.39 0.14 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.252 -0.431 . . . . 74.239999999999995 110.911 -179.921 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.526 ' HG3' ' CE2' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -81.79 139.71 34.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.136 -0.484 . . . . 70.420000000000002 110.874 179.903 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.715 ' OH ' ' O ' ' A' ' 73' ' ' TRP . 1.0 OUTLIER -154.7 86.24 1.13 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.248 -0.433 . . . . 55.210000000000001 110.906 -179.876 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.782 HD11 ' HA ' ' A' ' 151' ' ' LEU . 1.6 mp -80.42 118.88 28.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.145 -0.48 . . . . 63.32 111.109 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.783 HD23 ' HD2' ' A' ' 63' ' ' PRO . 0.3 OUTLIER -87.06 127.86 57.83 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.615 0.721 . . . . 74.519999999999996 110.929 179.853 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.783 ' HD2' HD23 ' A' ' 62' ' ' LEU . 53.4 Cg_endo -69.81 -174.24 0.88 Allowed 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.701 2.268 . . . . 71.540000000000006 112.34 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -87.02 162.89 17.37 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.203 -0.453 . . . . 60.219999999999999 110.943 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 113.37 -161.03 12.82 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.767 -0.73 . . . . 73.219999999999999 112.469 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -111.99 160.24 17.65 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.862 0.363 . . . . 72.140000000000001 110.906 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.479 ' N ' ' O ' ' A' ' 40' ' ' ILE . 20.6 m-85 -149.16 81.6 7.39 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.646 0.736 . . . . 74.439999999999998 110.898 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.475 ' HD2' ' HG3' ' A' ' 72' ' ' ARG . 53.8 Cg_endo -69.7 -3.57 12.24 Favored 'Trans proline' 0 C--O 1.231 0.155 0 C-N-CA 122.706 2.271 . . . . 50.219999999999999 112.345 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -157.77 149.36 21.75 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.224 -0.443 . . . . 75.219999999999999 110.927 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.778 ' O ' ' CD1' ' A' ' 73' ' ' TRP . 35.4 p90 -55.28 -41.27 72.06 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.163 -0.471 . . . . 71.310000000000002 110.979 -179.845 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -51.66 -21.89 2.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.099 -0.5 . . . . 64.340000000000003 110.938 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.475 ' HG3' ' HD2' ' A' ' 68' ' ' PRO . 28.9 mmt180 -61.8 -39.74 92.8 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.189 -0.46 . . . . 74.340000000000003 110.891 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' TRP . . . . . 0.778 ' CD1' ' O ' ' A' ' 70' ' ' TYR . 0.3 OUTLIER -92.88 34.17 1.11 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.168 -0.469 . . . . 64.0 110.934 -179.999 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 34.5 mmm 75.19 17.66 2.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.258 -0.428 . . . . 65.549999999999997 110.913 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.427 ' N ' ' HD1' ' A' ' 73' ' ' TRP . . . 42.98 44.0 5.6 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.759 -0.734 . . . . 71.310000000000002 112.484 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.462 ' CB ' ' CE2' ' A' ' 60' ' ' TYR . 0.5 OUTLIER -67.45 -74.12 0.12 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.877 0.37 . . . . 72.519999999999996 110.933 -179.907 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 12.6 t-20 -154.02 138.96 17.22 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.164 -0.471 . . . . 75.299999999999997 110.879 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -87.61 13.61 10.0 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.164 -0.471 . . . . 73.25 110.87 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.511 ' HD3' ' HB3' ' A' ' 51' ' ' GLU . 38.7 ttt85 -84.29 44.97 1.06 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.182 -0.463 . . . . 71.340000000000003 110.866 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.826 HD11 HG11 ' A' ' 49' ' ' VAL . 0.1 OUTLIER -66.12 125.59 25.99 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.2 -0.454 . . . . 62.310000000000002 110.928 -179.995 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.56 ' HB3' ' HB3' ' A' ' 53' ' ' PRO . 3.7 m -151.07 -109.2 0.06 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.186 -0.461 . . . . 73.519999999999996 110.879 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.643 ' OG ' ' HA ' ' A' ' 53' ' ' PRO . 0.0 OUTLIER -51.32 102.23 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.147 -0.479 . . . . 74.530000000000001 110.869 -179.827 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 83' ' ' CYS . . . . . 0.819 ' HB3' HG12 ' A' ' 49' ' ' VAL . 14.6 p -126.55 135.33 51.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.155 -0.475 . . . . 65.040000000000006 110.855 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.598 ' N ' ' O ' ' A' ' 48' ' ' ALA . 2.1 mmt85 -118.29 159.87 22.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.162 -0.472 . . . . 72.129999999999995 110.863 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -74.3 125.96 29.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.208 -0.451 . . . . 73.299999999999997 111.067 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.778 ' CG2' ' HB2' ' A' ' 48' ' ' ALA . 18.0 t -120.31 145.31 26.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.202 -0.454 . . . . 41.5 111.102 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' HIS . . . . . 0.558 ' O ' HG23 ' A' ' 136' ' ' VAL . 70.0 m-70 -110.78 112.36 24.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.176 -0.465 . . . . 74.340000000000003 110.905 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.467 ' H ' HD23 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -37.91 152.28 0.15 Allowed Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 121.626 0.727 . . . . 51.030000000000001 110.887 -179.956 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.529 ' HB3' ' H ' ' A' ' 136' ' ' VAL . 54.3 Cg_endo -69.67 83.15 0.69 Allowed 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.673 2.248 . . . . 72.340000000000003 112.361 179.809 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.2 t -90.23 -177.34 5.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.275 -0.42 . . . . 72.049999999999997 110.846 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 70.35 -81.94 0.37 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.702 -0.761 . . . . 65.140000000000001 112.489 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.41 ' O ' ' C ' ' A' ' 93' ' ' GLN . . . -92.58 34.16 4.63 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.739 -0.743 . . . . 54.399999999999999 112.53 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.459 ' O ' ' HG2' ' A' ' 134' ' ' GLU . 14.6 pt20 37.54 -121.58 0.21 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.868 0.366 . . . . 75.430000000000007 110.903 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.684 ' CZ ' ' HA ' ' A' ' 175' ' ' ARG . 1.4 t80 -121.91 99.29 6.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.228 -0.442 . . . . 74.239999999999995 110.945 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.559 ' HG3' HG11 ' A' ' 132' ' ' VAL . 23.8 tptt -119.27 127.14 52.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.153 -0.476 . . . . 63.340000000000003 110.846 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.589 HD13 ' H ' ' A' ' 97' ' ' GLN . 0.4 OUTLIER -150.1 138.61 14.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.189 -0.46 . . . . 73.209999999999994 111.099 179.901 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.589 ' H ' HD13 ' A' ' 96' ' ' ILE . 0.7 OUTLIER -110.38 124.3 51.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.175 -0.466 . . . . 63.43 110.916 179.904 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.545 HG22 ' SD ' ' A' ' 124' ' ' MET . 29.6 mm -107.19 133.23 52.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.172 -0.467 . . . . 71.439999999999998 111.168 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.66 ' HB2' ' HB2' ' A' ' 129' ' ' SER . 7.7 m-85 -123.41 144.76 49.28 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.199 -0.455 . . . . 72.200000000000003 110.896 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 71.7 tt0 -72.85 -74.43 0.17 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.16 -0.473 . . . . 74.430000000000007 110.923 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.503 ' C ' ' HB2' ' A' ' 128' ' ' HIS . 31.9 mttt -85.2 167.12 15.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.09 -0.505 . . . . 63.439999999999998 110.887 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.424 ' HA2' ' OG ' ' A' ' 129' ' ' SER . . . -80.9 158.03 40.17 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.77 -0.729 . . . . 31.050000000000001 112.495 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.48 ' HA ' ' HB2' ' A' ' 158' ' ' ARG . 33.2 t70 68.1 54.27 0.6 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.799 0.333 . . . . 72.510000000000005 110.833 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.697 ' CE1' ' HD2' ' A' ' 131' ' ' LYS . 7.2 m-85 47.39 29.99 1.45 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.197 -0.456 . . . . 62.439999999999998 110.905 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.446 ' C ' ' HB2' ' A' ' 101' ' ' LYS . 48.0 m -105.47 152.11 23.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.103 -0.499 . . . . 75.439999999999998 110.889 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 89.42 -165.2 32.36 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.723 -0.751 . . . . 30.43 112.441 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 5.9 tp-100 -73.43 129.09 37.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.827 0.346 . . . . 73.439999999999998 110.867 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 1.6 ttt -114.76 131.39 56.8 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.215 -0.448 . . . . 54.130000000000003 110.89 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -134.94 137.2 42.89 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.229 -0.441 . . . . 74.299999999999997 110.918 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -110.8 94.48 5.02 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.119 -0.491 . . . . 65.340000000000003 110.884 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 9.1 t -102.38 130.29 49.09 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.14 -0.482 . . . . 72.109999999999999 111.111 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.54 ' O ' ' OG1' ' A' ' 112' ' ' THR . 0.0 OUTLIER -109.84 37.3 2.7 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.206 -0.452 . . . . 64.230000000000004 111.103 -179.952 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -151.78 -176.36 5.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.22 -0.446 . . . . 51.200000000000003 110.853 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -80.49 179.58 7.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.107 -0.497 . . . . 71.430000000000007 110.839 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' CYS . . . . . 0.567 ' O ' ' HB2' ' A' ' 172' ' ' SER . 45.7 t -167.3 125.02 0.97 Allowed Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.549 0.69 . . . . 75.319999999999993 110.903 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.72 -30.37 22.58 Favored 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.657 2.238 . . . . 73.420000000000002 112.33 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.629 ' HB3' ' CB ' ' A' ' 120' ' ' GLU . 0.1 OUTLIER -150.19 101.93 3.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.202 -0.454 . . . . 71.340000000000003 110.86 -179.843 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.7 HD13 HD11 ' A' ' 127' ' ' ILE . 4.0 tt -52.56 -29.67 13.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.145 -0.48 . . . . 73.140000000000001 111.1 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' MET . . . . . 0.578 ' O ' ' HA ' ' A' ' 123' ' ' HIS . 0.8 OUTLIER -85.55 -45.11 12.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.184 -0.462 . . . . 75.230000000000004 110.848 179.906 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.629 ' CB ' ' HB3' ' A' ' 117' ' ' SER . 8.4 tp10 -65.45 -13.75 59.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.262 -0.427 . . . . 62.009999999999998 110.859 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -114.22 -51.97 2.75 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.169 -0.469 . . . . 74.519999999999996 110.896 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.45 ' HB2' ' O ' ' A' ' 118' ' ' ILE . 54.1 m-85 -101.24 -20.3 15.32 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.195 -0.457 . . . . 73.420000000000002 110.902 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' HIS . . . . . 0.578 ' HA ' ' O ' ' A' ' 119' ' ' MET . 12.6 m80 71.24 30.61 2.58 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.132 -0.485 . . . . 62.399999999999999 110.869 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.545 ' SD ' HG22 ' A' ' 98' ' ' ILE . 5.2 mtt -108.99 86.42 2.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.224 -0.444 . . . . 61.450000000000003 110.902 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 2.0 ptp85 -51.94 -35.57 46.4 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.209 -0.45 . . . . 75.25 110.877 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.502 ' HB3' ' HG2' ' A' ' 168' ' ' PRO . 28.9 mt-10 -142.39 131.7 23.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.201 -0.454 . . . . 72.319999999999993 110.896 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.7 HD11 HD13 ' A' ' 118' ' ' ILE . 3.5 mm -91.38 91.46 3.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.17 -0.468 . . . . 74.409999999999997 111.14 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' HIS . . . . . 0.503 ' HB2' ' C ' ' A' ' 101' ' ' LYS . 0.5 OUTLIER -60.58 -35.43 76.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.183 -0.462 . . . . 74.209999999999994 110.86 179.882 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 129' ' ' SER . . . . . 0.66 ' HB2' ' HB2' ' A' ' 99' ' ' PHE . 66.5 m -131.09 140.08 49.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.222 -0.444 . . . . 65.450000000000003 110.829 -179.763 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 130' ' ' CYS . . . . . 0.616 ' O ' ' O ' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -139.18 121.59 16.09 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.134 -0.484 . . . . 70.439999999999998 110.855 179.999 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.697 ' HD2' ' CE1' ' A' ' 104' ' ' PHE . 6.3 mtpp -115.33 153.15 31.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.153 -0.476 . . . . 74.030000000000001 110.925 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.562 HG12 ' N ' ' A' ' 133' ' ' LEU . 16.1 t 84.34 164.57 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.242 -0.435 . . . . 61.109999999999999 111.126 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.728 HD22 ' CG ' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -178.44 121.98 0.1 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.136 -0.484 . . . . 44.530000000000001 110.91 179.976 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.513 ' O ' ' C ' ' A' ' 135' ' ' GLY . 0.1 OUTLIER -94.03 167.02 11.86 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.186 -0.461 . . . . 71.200000000000003 110.89 179.922 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 135' ' ' GLY . . . . . 0.513 ' C ' ' O ' ' A' ' 134' ' ' GLU . . . -27.8 -55.89 0.12 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.717 -0.754 . . . . 74.310000000000002 112.517 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.602 HG21 ' CG1' ' A' ' 86' ' ' VAL . 3.2 t -144.51 137.36 22.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.806 0.336 . . . . 71.420000000000002 111.12 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 137' ' ' TRP . . . . . 0.715 ' CB ' ' HB3' ' A' ' 152' ' ' LEU . 0.0 OUTLIER -129.82 142.46 50.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.157 -0.474 . . . . 73.049999999999997 110.92 179.914 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.766 HD13 HD13 ' A' ' 61' ' ' ILE . 11.4 mm -114.99 134.35 58.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.195 -0.457 . . . . 64.439999999999998 111.12 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.54 ' CD1' HG11 ' A' ' 170' ' ' VAL . 0.8 OUTLIER -123.33 145.38 48.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.172 -0.467 . . . . 61.340000000000003 110.881 179.932 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 140' ' ' TYR . . . . . 0.483 ' CE2' ' CD ' ' A' ' 174' ' ' ARG . 0.3 OUTLIER -126.99 133.85 50.48 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.164 -0.471 . . . . 64.430000000000007 110.93 -179.899 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 141' ' ' GLU . . . . . 0.654 ' O ' ' HB2' ' A' ' 171' ' ' GLN . 0.2 OUTLIER -59.97 -27.2 66.63 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.105 -0.498 . . . . 61.200000000000003 110.89 -179.979 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.686 ' HB3' ' HD2' ' A' ' 143' ' ' PRO . 9.7 mp -112.91 171.79 4.04 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.617 0.722 . . . . 72.439999999999998 110.897 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 143' ' ' PRO . . . . . 0.757 ' O ' ' OG ' ' A' ' 172' ' ' SER . 54.0 Cg_endo -69.74 -92.71 0.01 OUTLIER 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.737 2.291 . . . . 74.439999999999998 112.323 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 144' ' ' ASN . . . . . 0.732 ' O ' ' N ' ' A' ' 146' ' ' ARG . 0.8 OUTLIER -49.99 99.21 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.217 -0.447 . . . . 64.439999999999998 110.913 -179.984 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 145' ' ' TYR . . . . . 0.641 ' C ' ' O ' ' A' ' 144' ' ' ASN . 19.8 m-85 11.64 52.44 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.218 -0.446 . . . . 74.329999999999998 110.928 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 146' ' ' ARG . . . . . 0.732 ' N ' ' O ' ' A' ' 144' ' ' ASN . 21.1 mtt180 -118.6 173.28 6.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.098 -0.501 . . . . 72.420000000000002 110.875 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 78.97 -176.1 54.82 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.713 -0.756 . . . . 51.340000000000003 112.52 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -80.64 144.01 32.65 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.746 0.308 . . . . 74.030000000000001 110.87 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 149' ' ' GLN . . . . . 0.402 ' HB3' ' HA ' ' A' ' 60' ' ' TYR . 2.8 mt-30 -71.63 162.93 28.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.218 -0.446 . . . . 64.219999999999999 110.904 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 150' ' ' TYR . . . . . 0.531 ' HB2' ' CB ' ' A' ' 139' ' ' PHE . 78.9 m-85 -145.89 128.19 15.82 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.202 -0.454 . . . . 64.420000000000002 110.945 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.782 ' HA ' HD11 ' A' ' 61' ' ' ILE . 15.1 tp -85.94 123.21 31.02 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.161 -0.472 . . . . 64.200000000000003 110.89 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.989 HD13 ' O ' ' A' ' 152' ' ' LEU . 0.0 OUTLIER -58.33 142.23 48.72 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.183 -0.462 . . . . 64.310000000000002 110.903 179.887 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 153' ' ' ASP . . . . . 0.469 ' N ' HD22 ' A' ' 152' ' ' LEU . 5.4 t70 -162.99 25.44 0.09 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.156 -0.474 . . . . 64.030000000000001 110.88 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.926 ' HB2' ' CD1' ' A' ' 157' ' ' TYR . 3.1 ptmt -123.17 -172.38 2.49 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.189 -0.459 . . . . 73.349999999999994 110.874 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.728 ' CG ' HD22 ' A' ' 133' ' ' LEU . 0.4 OUTLIER -159.8 -123.79 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.236 -0.438 . . . . 73.019999999999996 110.903 179.91 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.655 ' HA ' ' HA ' ' A' ' 131' ' ' LYS . 0.8 OUTLIER -66.02 -3.74 5.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.208 -0.451 . . . . 64.420000000000002 110.897 179.96 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 157' ' ' TYR . . . . . 0.926 ' CD1' ' HB2' ' A' ' 154' ' ' LYS . 13.3 m-30 -27.62 140.01 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.158 -0.473 . . . . 73.140000000000001 110.946 -179.847 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 158' ' ' ARG . . . . . 0.543 ' O ' ' OG ' ' A' ' 129' ' ' SER . 8.2 ptp180 -103.8 -46.18 4.57 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.159 -0.473 . . . . 75.409999999999997 110.853 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 2.4 ptpp? -81.68 149.25 63.78 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.546 0.688 . . . . 71.140000000000001 110.87 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 160' ' ' PRO . . . . . 0.439 ' CB ' ' HD3' ' A' ' 168' ' ' PRO . 53.7 Cg_endo -69.74 -26.74 27.38 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.703 2.269 . . . . 71.209999999999994 112.34 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.705 HD12 ' H ' ' A' ' 161' ' ' ILE . 4.1 mp -69.95 -10.62 13.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.215 -0.448 . . . . 70.299999999999997 111.152 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.598 ' HB3' ' CD1' ' A' ' 157' ' ' TYR . 1.0 OUTLIER -70.65 -12.79 61.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 73.329999999999998 110.859 179.865 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 163' ' ' TRP . . . . . 0.551 ' CD1' ' HB3' ' A' ' 165' ' ' ALA . 11.5 t-105 -90.13 -19.65 24.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.193 -0.458 . . . . 72.230000000000004 110.879 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 103.21 -37.11 3.89 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.772 -0.727 . . . . 75.129999999999995 112.536 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.551 ' HB3' ' CD1' ' A' ' 163' ' ' TRP . . . -78.29 123.1 26.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.843 0.354 . . . . 73.010000000000005 111.03 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -49.79 121.46 5.3 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.192 -0.458 . . . . 71.439999999999998 111.133 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 167' ' ' SER . . . . . 0.472 ' C ' ' H ' ' A' ' 169' ' ' ALA . 0.4 OUTLIER 64.94 143.81 0.08 OUTLIER Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.623 0.725 . . . . 72.549999999999997 110.886 -179.781 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 168' ' ' PRO . . . . . 0.502 ' HG2' ' HB3' ' A' ' 126' ' ' GLU . 53.8 Cg_endo -69.74 33.12 0.19 Allowed 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.675 2.25 . . . . 55.210000000000001 112.319 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 0.474 ' HA ' ' HG2' ' A' ' 126' ' ' GLU . . . -67.32 105.17 1.69 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.27 -0.423 . . . . 74.310000000000002 111.077 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.54 HG11 ' CD1' ' A' ' 139' ' ' PHE . 3.3 t -153.5 163.4 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.203 -0.453 . . . . 73.25 111.176 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 171' ' ' GLN . . . . . 0.654 ' HB2' ' O ' ' A' ' 141' ' ' GLU . 2.0 mm-40 -111.77 -90.21 0.5 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.192 -0.458 . . . . 74.319999999999993 110.913 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 172' ' ' SER . . . . . 0.757 ' OG ' ' O ' ' A' ' 143' ' ' PRO . 36.2 p -122.19 -179.72 4.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.187 -0.46 . . . . 63.409999999999997 110.851 -179.82 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -146.54 174.78 11.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.113 -0.494 . . . . 72.0 110.898 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 174' ' ' ARG . . . . . 0.52 ' HG2' ' HB ' ' A' ' 138' ' ' ILE . 0.0 OUTLIER -147.01 158.05 43.8 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.144 -0.48 . . . . 63.350000000000001 110.911 -179.933 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 175' ' ' ARG . . . . . 0.684 ' HA ' ' CZ ' ' A' ' 94' ' ' TYR . 0.0 OUTLIER -95.14 -179.95 4.99 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.198 -0.455 . . . . 75.319999999999993 110.847 -179.908 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 176' ' ' ILE . . . . . 0.476 ' CD1' ' HB ' ' A' ' 136' ' ' VAL . 1.8 mt -126.45 132.45 70.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.161 -0.472 . . . . 73.209999999999994 111.119 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 42.2 t -126.09 150.08 31.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.199 -0.455 . . . . 74.129999999999995 111.156 179.842 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.193 -0.458 . . . . 73.420000000000002 110.935 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.326 0 N-CA-C 112.49 -0.244 . . . . 14.140000000000001 112.49 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.475 ' C ' ' HE1' ' A' ' 47' ' ' TRP . 2.8 p -82.83 135.15 35.04 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.858 0.361 . . . . 65.129999999999995 111.17 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 3.9 tttt -121.2 137.12 54.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.244 -0.434 . . . . 74.329999999999998 110.89 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.614 ' HB ' HG22 ' A' ' 42' ' ' VAL . 13.3 tt -137.32 147.07 26.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.214 -0.448 . . . . 73.25 111.145 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.502 HG22 ' CE2' ' A' ' 11' ' ' TYR . 13.8 m -126.5 129.16 48.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.168 -0.469 . . . . 52.43 111.132 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.779 ' HB2' HD22 ' A' ' 34' ' ' LEU . 1.5 m-85 -114.69 130.15 56.78 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.245 -0.434 . . . . 74.219999999999999 110.906 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.52 ' CG ' ' HA ' ' A' ' 16' ' ' PHE . 41.4 m-85 -115.67 130.86 57.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.156 -0.475 . . . . 75.140000000000001 110.938 -179.839 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.493 ' HG2' ' HB2' ' A' ' 36' ' ' ARG . 0.0 OUTLIER -60.24 -26.52 66.5 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.172 -0.467 . . . . 74.540000000000006 110.871 -179.976 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 68.9 m-20 -124.32 151.22 44.55 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.119 -0.491 . . . . 74.030000000000001 110.872 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.53 ' N ' ' HB3' ' A' ' 38' ' ' ASN . 35.0 mtmt -56.26 -178.58 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.162 -0.472 . . . . 63.310000000000002 110.885 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 28.1 m-20 49.78 35.41 9.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.239 -0.437 . . . . 75.230000000000004 110.893 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.52 ' HA ' ' CG ' ' A' ' 11' ' ' TYR . 3.8 m-85 48.05 57.6 5.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.17 -0.468 . . . . 74.209999999999994 110.894 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -134.46 160.26 38.55 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.125 -0.488 . . . . 75.129999999999995 110.943 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 94.0 -151.47 20.27 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.776 -0.726 . . . . 55.229999999999997 112.501 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.775 ' O ' HD13 ' A' ' 34' ' ' LEU . 0.0 OUTLIER -68.71 80.0 0.29 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.813 0.34 . . . . 75.120000000000005 110.864 -179.874 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.466 ' HA ' ' O ' ' A' ' 10' ' ' PHE . 0.5 OUTLIER -78.28 124.89 28.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.169 -0.468 . . . . 73.319999999999993 110.879 -179.922 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.424 ' CD2' ' CD2' ' A' ' 30' ' ' PHE . 86.9 t80 -122.42 124.87 44.65 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.194 -0.457 . . . . 72.530000000000001 110.917 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -109.94 130.33 55.54 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.146 -0.479 . . . . 73.129999999999995 110.852 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.409 ' HB3' ' CE2' ' A' ' 21' ' ' TYR . 0.1 OUTLIER -142.0 145.96 35.03 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.173 -0.467 . . . . 64.430000000000007 110.868 -179.892 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -130.73 5.7 4.66 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.178 -0.465 . . . . 53.530000000000001 110.905 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.42 ' O ' ' C ' ' A' ' 26' ' ' ASP . 38.2 t -132.15 160.41 36.12 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.151 -0.477 . . . . 75.099999999999994 110.897 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.42 ' C ' ' O ' ' A' ' 25' ' ' CYS . 6.2 m-20 -35.59 108.88 0.08 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.168 -0.469 . . . . 54.409999999999997 110.853 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.713 ' HB3' ' HB3' ' A' ' 30' ' ' PHE . 0.5 OUTLIER -119.24 45.82 2.03 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.167 -0.469 . . . . 71.430000000000007 110.883 -179.892 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.592 ' O ' ' HA ' ' A' ' 82' ' ' SER . . . -55.08 -11.14 0.62 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.204 -0.453 . . . . 61.310000000000002 111.143 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 60.6 t0 -130.81 39.13 3.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.219 -0.446 . . . . 71.120000000000005 110.831 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.833 ' CD2' ' O ' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -82.8 16.55 2.19 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.232 -0.44 . . . . 70.200000000000003 110.897 -179.916 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.475 ' HB2' ' HB3' ' A' ' 81' ' ' SER . 46.5 t60 -81.78 -29.61 32.66 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.172 -0.467 . . . . 73.019999999999996 110.851 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.7 t -68.66 -7.07 29.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.218 -0.446 . . . . 53.130000000000003 111.14 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -107.01 -29.44 9.42 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.197 -0.456 . . . . 75.120000000000005 110.925 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.779 HD22 ' HB2' ' A' ' 10' ' ' PHE . 24.0 tp -138.26 145.32 41.18 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.139 -0.482 . . . . 74.239999999999995 110.903 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.2 m -113.37 -32.51 6.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.158 -0.474 . . . . 72.319999999999993 110.837 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.521 ' O ' HD21 ' A' ' 34' ' ' LEU . 1.4 mtp85 -116.22 142.37 46.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.162 -0.472 . . . . 71.140000000000001 110.869 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.632 ' SG ' ' HB2' ' A' ' 80' ' ' LEU . 1.7 p -119.91 54.94 1.0 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.184 -0.462 . . . . 72.519999999999996 110.917 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.53 ' HB3' ' N ' ' A' ' 14' ' ' LYS . 1.8 m-80 -55.59 -64.96 0.68 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.156 -0.474 . . . . 73.340000000000003 110.871 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 5.9 p -116.95 130.94 57.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.261 -0.427 . . . . 73.230000000000004 110.863 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.618 HG21 HD13 ' A' ' 62' ' ' LEU . 12.1 mt -126.87 149.15 31.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.164 -0.471 . . . . 64.420000000000002 111.066 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.405 ' HE3' ' CD1' ' A' ' 16' ' ' PHE . 0.0 OUTLIER -143.73 120.7 11.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.125 -0.488 . . . . 65.209999999999994 110.884 179.83 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.614 HG22 ' HB ' ' A' ' 8' ' ' ILE . 2.1 t -102.85 115.04 44.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.21 -0.45 . . . . 75.0 111.133 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -109.47 81.05 1.38 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.203 -0.453 . . . . 65.420000000000002 110.895 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.438 ' O ' ' HB ' ' A' ' 6' ' ' THR . . . 127.32 108.52 1.51 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.776 -0.726 . . . . 62.409999999999997 112.478 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 50.78 -179.54 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.72 -0.753 . . . . 72.329999999999998 112.511 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.715 HG23 ' HA ' ' A' ' 63' ' ' PRO . 15.3 m -84.47 159.64 20.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.736 0.303 . . . . 62.450000000000003 111.203 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' TRP . . . . . 0.598 ' CD1' ' HB ' ' A' ' 8' ' ' ILE . 3.3 m95 -131.92 130.24 41.31 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.264 -0.426 . . . . 65.540000000000006 110.914 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.727 ' HB2' ' CG2' ' A' ' 86' ' ' VAL . . . -91.4 124.6 35.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.236 -0.438 . . . . 41.0 111.103 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.754 HG11 HD11 ' A' ' 80' ' ' LEU . 13.7 m -126.87 131.35 71.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.204 -0.453 . . . . 63.439999999999998 111.133 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.971 ' HB3' ' CB ' ' A' ' 56' ' ' ALA . 4.6 m-85 -106.68 145.37 32.07 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.141 -0.481 . . . . 72.439999999999998 110.864 -179.874 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.451 ' N ' ' HB1' ' A' ' 56' ' ' ALA . 0.8 OUTLIER -50.51 -86.41 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.079 -0.509 . . . . 61.43 110.829 -179.936 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.874 ' O ' ' HB2' ' A' ' 56' ' ' ALA . 7.7 mmm180 -77.63 138.34 62.77 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.608 0.718 . . . . 72.340000000000003 110.84 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.741 ' HA ' ' OG ' ' A' ' 82' ' ' SER . 53.7 Cg_endo -69.81 136.41 32.8 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.702 2.268 . . . . 53.310000000000002 112.352 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.427 ' C ' ' CD1' ' A' ' 55' ' ' PHE . 1.3 m120 64.99 -4.92 0.44 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.201 -0.454 . . . . 63.0 110.889 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.485 ' H ' ' C ' ' A' ' 53' ' ' PRO . 0.1 OUTLIER -137.86 -70.39 0.44 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.153 -0.476 . . . . 71.230000000000004 110.878 -179.989 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.971 ' CB ' ' HB3' ' A' ' 50' ' ' TYR . . . 38.87 74.9 0.08 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.168 -0.469 . . . . 62.109999999999999 111.088 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' TRP . . . . . 0.415 ' O ' ' CD2' ' A' ' 58' ' ' TYR . 9.8 m0 -63.6 30.59 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.174 -0.466 . . . . 65.400000000000006 110.924 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.639 ' H ' ' C ' ' A' ' 56' ' ' ALA . 1.2 m-30 -163.13 109.5 1.16 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.233 -0.439 . . . . 74.129999999999995 110.898 -179.867 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.437 ' HG3' ' CE2' ' A' ' 50' ' ' TYR . 0.3 OUTLIER -68.79 140.24 55.28 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.166 -0.47 . . . . 73.420000000000002 110.88 179.879 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.626 ' O ' HG23 ' A' ' 49' ' ' VAL . 0.9 OUTLIER -150.47 81.97 1.35 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.221 -0.445 . . . . 74.540000000000006 110.879 -179.875 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.524 HD11 HD22 ' A' ' 151' ' ' LEU . 1.1 mp -75.14 115.5 16.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.139 -0.482 . . . . 72.219999999999999 111.107 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.776 HD23 ' HD2' ' A' ' 63' ' ' PRO . 0.3 OUTLIER -82.4 124.05 78.4 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.579 0.704 . . . . 73.129999999999995 110.88 179.911 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.776 ' HD2' HD23 ' A' ' 62' ' ' LEU . 53.2 Cg_endo -69.82 -174.04 0.84 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.604 2.203 . . . . 73.129999999999995 112.373 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.0 163.33 18.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.26 -0.427 . . . . 74.129999999999995 110.925 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 113.05 -160.41 13.14 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.75 -0.738 . . . . 41.149999999999999 112.509 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -115.13 158.25 22.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.858 0.361 . . . . 74.530000000000001 110.869 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.464 ' N ' ' O ' ' A' ' 40' ' ' ILE . 11.2 m-85 -148.21 83.24 7.29 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.671 0.748 . . . . 74.5 110.878 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.414 ' HD2' ' HG3' ' A' ' 72' ' ' ARG . 53.5 Cg_endo -69.77 -4.98 15.12 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.728 2.285 . . . . 73.019999999999996 112.324 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -157.58 141.14 15.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.202 -0.454 . . . . 75.430000000000007 110.94 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.896 ' O ' ' CD1' ' A' ' 73' ' ' TRP . 44.9 p90 -51.55 -41.24 60.95 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.177 -0.465 . . . . 72.049999999999997 110.896 -179.834 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -52.02 -20.05 2.2 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.156 -0.474 . . . . 74.540000000000006 110.917 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.414 ' HG3' ' HD2' ' A' ' 68' ' ' PRO . 28.2 mmt180 -64.03 -30.24 71.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.188 -0.46 . . . . 65.010000000000005 110.872 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' TRP . . . . . 0.896 ' CD1' ' O ' ' A' ' 70' ' ' TYR . 0.5 OUTLIER -103.88 30.66 4.97 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.192 -0.458 . . . . 73.530000000000001 110.951 179.983 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 74' ' ' MET . . . . . 0.439 ' O ' ' C ' ' A' ' 75' ' ' GLY . 0.0 OUTLIER 74.64 23.82 1.79 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.225 -0.443 . . . . 63.520000000000003 110.88 179.918 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.449 ' N ' ' HD1' ' A' ' 73' ' ' TRP . . . 33.03 49.37 0.43 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.697 -0.763 . . . . 23.219999999999999 112.525 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.764 HD21 ' HA ' ' A' ' 148' ' ' ARG . 0.6 OUTLIER -65.46 -77.61 0.06 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.806 0.336 . . . . 73.230000000000004 110.909 -179.908 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -135.79 134.17 38.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.161 -0.472 . . . . 63.409999999999997 110.888 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -90.09 17.0 7.42 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.122 -0.49 . . . . 74.219999999999999 110.88 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 6.0 ttm105 -107.36 77.18 1.12 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.174 -0.466 . . . . 72.430000000000007 110.844 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.754 HD11 HG11 ' A' ' 49' ' ' VAL . 0.1 OUTLIER -82.32 134.43 35.26 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.172 -0.467 . . . . 51.439999999999998 110.928 -179.99 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.702 ' HB3' ' HB3' ' A' ' 53' ' ' PRO . 1.5 m -154.32 -124.38 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.196 -0.456 . . . . 63.229999999999997 110.866 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.741 ' OG ' ' HA ' ' A' ' 53' ' ' PRO . 0.0 OUTLIER -36.28 106.88 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 72.329999999999998 110.891 -179.846 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 83' ' ' CYS . . . . . 0.691 ' HB3' HG12 ' A' ' 49' ' ' VAL . 27.9 p -130.13 132.78 46.24 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.147 -0.479 . . . . 75.409999999999997 110.881 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.565 ' N ' ' O ' ' A' ' 48' ' ' ALA . 4.1 mmt180 -123.41 146.46 47.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.205 -0.452 . . . . 72.319999999999993 110.876 -179.839 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -64.99 124.97 23.46 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.244 -0.434 . . . . 61.420000000000002 111.11 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.727 ' CG2' ' HB2' ' A' ' 48' ' ' ALA . 2.7 t -118.67 146.67 22.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.185 -0.461 . . . . 63.119999999999997 111.127 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' HIS . . . . . 0.558 ' O ' HG23 ' A' ' 136' ' ' VAL . 22.3 m-70 -110.11 112.5 24.53 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.189 -0.459 . . . . 71.420000000000002 110.92 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.533 HD13 ' HB3' ' A' ' 178' ' ' GLU . 0.0 OUTLIER -38.04 151.27 0.16 Allowed Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.647 0.737 . . . . 72.030000000000001 110.875 -179.944 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.552 ' HB3' ' H ' ' A' ' 136' ' ' VAL . 53.8 Cg_endo -69.76 98.78 0.7 Allowed 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.644 2.23 . . . . 61.299999999999997 112.354 179.816 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -105.56 -178.44 3.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.199 -0.455 . . . . 60.240000000000002 110.826 -179.822 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 48.9 84.89 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.764 -0.731 . . . . 41.109999999999999 112.443 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 100.72 29.45 6.55 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.777 -0.725 . . . . 73.510000000000005 112.475 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.473 ' O ' ' HG2' ' A' ' 134' ' ' GLU . 18.6 pt20 38.35 -129.6 0.22 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.852 0.358 . . . . 74.329999999999998 110.912 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.64 ' HA ' ' HG2' ' A' ' 134' ' ' GLU . 0.4 OUTLIER -117.13 103.73 10.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.211 -0.45 . . . . 72.310000000000002 110.943 -179.878 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.554 ' HG3' HG11 ' A' ' 132' ' ' VAL . 38.9 tptt -110.8 125.77 53.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.129 -0.487 . . . . 75.150000000000006 110.886 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.721 HD13 ' N ' ' A' ' 97' ' ' GLN . 0.0 OUTLIER -149.84 136.96 13.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.238 -0.437 . . . . 73.5 111.149 179.829 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.721 ' N ' HD13 ' A' ' 96' ' ' ILE . 2.4 mt-30 -107.86 132.7 53.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.183 -0.462 . . . . 74.109999999999999 110.917 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.769 HD11 HG22 ' A' ' 111' ' ' THR . 1.2 mp -111.29 140.8 28.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.176 -0.466 . . . . 62.229999999999997 111.158 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.634 ' HB2' ' HB2' ' A' ' 129' ' ' SER . 47.5 m-85 -130.97 134.65 46.92 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.192 -0.458 . . . . 73.310000000000002 110.868 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 51.1 tt0 -62.82 -78.86 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.15 -0.477 . . . . 74.030000000000001 110.907 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 6.6 mttt -83.97 162.68 20.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.117 -0.492 . . . . 73.209999999999994 110.851 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.419 ' CA ' ' HB3' ' A' ' 128' ' ' HIS . . . -70.4 163.2 53.09 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.726 -0.75 . . . . 72.430000000000007 112.466 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.497 ' HA ' ' HB2' ' A' ' 158' ' ' ARG . 33.4 t0 63.62 26.29 14.58 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.842 0.353 . . . . 45.109999999999999 110.888 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.48 ' CZ ' ' HB3' ' A' ' 158' ' ' ARG . 14.8 m-85 61.49 48.48 5.84 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.207 -0.451 . . . . 54.229999999999997 110.831 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 2.3 m -113.67 148.04 37.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.16 -0.473 . . . . 73.540000000000006 110.807 -179.79 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 92.27 -121.81 6.6 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.692 -0.766 . . . . 74.409999999999997 112.452 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 7.5 tp-100 -104.88 147.21 27.99 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.822 0.344 . . . . 64.409999999999997 110.916 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 3.7 ttp -136.65 136.79 39.42 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.205 -0.452 . . . . 75.430000000000007 110.919 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' TYR . . . . . 0.473 ' O ' HD12 ' A' ' 98' ' ' ILE . 12.9 m-85 -143.95 137.41 27.76 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.249 -0.432 . . . . 72.340000000000003 110.959 -179.838 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -114.93 111.14 20.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.153 -0.476 . . . . 75.450000000000003 110.933 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.769 HG22 HD11 ' A' ' 98' ' ' ILE . 11.7 t -118.1 139.46 51.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.157 -0.474 . . . . 70.319999999999993 111.122 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.556 ' HA ' ' O ' ' A' ' 94' ' ' TYR . 2.1 t -117.66 40.49 3.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.177 -0.465 . . . . 45.32 111.152 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -153.15 163.31 40.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.227 -0.442 . . . . 65.439999999999998 110.887 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -51.34 159.3 0.7 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.182 -0.463 . . . . 72.150000000000006 110.855 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' CYS . . . . . 0.607 ' O ' ' HB2' ' A' ' 172' ' ' SER . 41.9 t -147.85 111.34 3.86 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.589 0.709 . . . . 62.210000000000001 110.892 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.456 ' O ' ' C ' ' A' ' 143' ' ' PRO . 53.7 Cg_endo -69.8 -31.98 19.3 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.663 2.242 . . . . 74.319999999999993 112.303 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.641 ' HB3' ' CB ' ' A' ' 120' ' ' GLU . 0.2 OUTLIER -149.06 105.5 3.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.238 -0.437 . . . . 62.210000000000001 110.865 -179.819 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.656 HD13 HD11 ' A' ' 127' ' ' ILE . 3.7 tt -61.93 -30.52 48.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.15 -0.477 . . . . 63.210000000000001 111.153 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' MET . . . . . 0.628 ' O ' ' HA ' ' A' ' 123' ' ' HIS . 38.5 ttp -86.68 -38.6 16.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 73.230000000000004 110.894 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.641 ' CB ' ' HB3' ' A' ' 117' ' ' SER . 5.3 tp10 -72.71 -13.44 61.34 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.222 -0.445 . . . . 73.510000000000005 110.89 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 28.1 tp60 -114.8 -41.18 3.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.126 -0.488 . . . . 72.230000000000004 110.914 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.511 ' HB2' ' O ' ' A' ' 118' ' ' ILE . 51.8 m-85 -112.05 -20.61 11.89 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.216 -0.447 . . . . 65.439999999999998 110.913 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' HIS . . . . . 0.628 ' HA ' ' O ' ' A' ' 119' ' ' MET . 13.0 m80 72.8 27.02 2.25 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.124 -0.489 . . . . 72.010000000000005 110.856 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.454 ' SD ' HG22 ' A' ' 98' ' ' ILE . 9.3 mtt -101.31 90.75 4.22 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.183 -0.462 . . . . 65.109999999999999 110.861 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 4.1 ptp180 -53.49 -43.94 68.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.268 -0.424 . . . . 64.230000000000004 110.912 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.472 ' HG2' ' HA ' ' A' ' 169' ' ' ALA . 8.7 mt-10 -137.59 130.55 30.34 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.146 -0.479 . . . . 75.109999999999999 110.883 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.656 HD11 HD13 ' A' ' 118' ' ' ILE . 3.5 mm -88.79 91.48 3.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.104 -0.498 . . . . 74.230000000000004 111.165 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 128' ' ' HIS . . . . . 0.544 ' CD2' ' HG3' ' A' ' 168' ' ' PRO . 52.4 m80 -65.51 -30.16 70.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.147 -0.478 . . . . 74.019999999999996 110.857 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 129' ' ' SER . . . . . 0.634 ' HB2' ' HB2' ' A' ' 99' ' ' PHE . 0.4 OUTLIER -135.08 144.42 47.2 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.205 -0.452 . . . . 75.530000000000001 110.865 -179.765 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 130' ' ' CYS . . . . . 0.662 ' O ' ' O ' ' A' ' 155' ' ' LYS . 0.1 OUTLIER -146.53 119.71 8.89 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.138 -0.483 . . . . 72.219999999999999 110.858 -179.934 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.653 ' HA ' ' HA ' ' A' ' 156' ' ' GLU . 6.0 mtpp -107.38 153.54 22.63 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.172 -0.467 . . . . 64.129999999999995 110.859 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.554 HG11 ' HG3' ' A' ' 95' ' ' LYS . 9.8 t 82.28 165.54 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.239 -0.437 . . . . 61.409999999999997 111.133 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.768 HD22 ' CG ' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -176.91 124.2 0.15 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.17 -0.468 . . . . 63.32 110.934 179.956 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.64 ' HG2' ' HA ' ' A' ' 94' ' ' TYR . 0.0 OUTLIER -97.44 164.02 12.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.227 -0.442 . . . . 64.099999999999994 110.924 179.919 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 135' ' ' GLY . . . . . 0.544 ' C ' ' O ' ' A' ' 134' ' ' GLU . . . -24.7 -61.18 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.746 -0.74 . . . . 62.210000000000001 112.451 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.707 HG21 ' CG1' ' A' ' 86' ' ' VAL . 1.7 t -147.44 154.19 11.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.817 0.341 . . . . 62.100000000000001 111.15 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 137' ' ' TRP . . . . . 0.943 ' H ' HD12 ' A' ' 152' ' ' LEU . 0.7 OUTLIER -152.09 149.05 28.39 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.188 -0.46 . . . . 72.010000000000005 110.887 -179.994 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.485 ' CD1' ' HB ' ' A' ' 61' ' ' ILE . 5.6 mm -116.55 135.42 56.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.21 -0.45 . . . . 65.219999999999999 111.163 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.515 ' HB2' ' HB2' ' A' ' 150' ' ' TYR . 1.4 m-85 -112.25 165.02 12.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.209 -0.451 . . . . 72.329999999999998 110.866 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 140' ' ' TYR . . . . . 0.461 ' HB3' ' O ' ' A' ' 146' ' ' ARG . 5.2 m-85 -144.8 132.03 20.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.147 -0.479 . . . . 75.219999999999999 110.887 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 141' ' ' GLU . . . . . 0.641 ' O ' ' HB2' ' A' ' 171' ' ' GLN . 0.0 OUTLIER -57.92 -27.79 63.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.091 -0.504 . . . . 55.240000000000002 110.876 -179.997 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.727 ' HB3' ' HD2' ' A' ' 143' ' ' PRO . 9.5 mp -114.1 173.28 2.96 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.614 0.721 . . . . 74.340000000000003 110.94 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 143' ' ' PRO . . . . . 0.734 ' O ' ' OG ' ' A' ' 172' ' ' SER . 53.3 Cg_endo -69.8 -90.46 0.0 OUTLIER 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.697 2.264 . . . . 71.420000000000002 112.324 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 144' ' ' ASN . . . . . 0.721 ' O ' ' N ' ' A' ' 146' ' ' ARG . 0.6 OUTLIER -50.79 97.81 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.213 -0.449 . . . . 75.239999999999995 110.937 179.985 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 145' ' ' TYR . . . . . 0.653 ' C ' ' O ' ' A' ' 144' ' ' ASN . 0.2 OUTLIER 11.46 53.34 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.173 -0.467 . . . . 64.140000000000001 110.937 -179.875 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 146' ' ' ARG . . . . . 0.721 ' N ' ' O ' ' A' ' 144' ' ' ASN . 22.5 mtt180 -121.5 160.2 24.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.148 -0.478 . . . . 74.420000000000002 110.859 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 93.26 -172.4 33.33 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.696 -0.764 . . . . 33.420000000000002 112.493 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.764 ' HA ' HD21 ' A' ' 76' ' ' LEU . 4.1 mpt_? -79.65 155.05 28.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.79 0.328 . . . . 73.540000000000006 110.88 -179.878 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 149' ' ' GLN . . . . . 0.403 ' HB3' ' HA ' ' A' ' 60' ' ' TYR . 0.4 OUTLIER -81.56 151.83 27.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.213 -0.449 . . . . 71.310000000000002 110.919 -179.941 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 150' ' ' TYR . . . . . 0.515 ' HB2' ' HB2' ' A' ' 139' ' ' PHE . 69.4 m-85 -151.96 103.11 2.87 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.178 -0.464 . . . . 73.109999999999999 110.893 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.524 HD22 HD11 ' A' ' 61' ' ' ILE . 0.1 OUTLIER -69.92 137.33 51.48 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.096 -0.502 . . . . 73.040000000000006 110.892 179.988 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 1.022 HD13 ' O ' ' A' ' 152' ' ' LEU . 0.0 OUTLIER -72.7 151.87 41.97 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.189 -0.46 . . . . 70.299999999999997 110.905 179.898 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 153' ' ' ASP . . . . . 0.743 ' N ' HD22 ' A' ' 152' ' ' LEU . 6.0 t0 -162.66 24.34 0.1 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.165 -0.471 . . . . 74.340000000000003 110.859 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 1.029 ' HB2' ' CD1' ' A' ' 157' ' ' TYR . 6.1 ptmt -115.29 -166.79 1.16 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.187 -0.461 . . . . 70.25 110.895 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.768 ' CG ' HD22 ' A' ' 133' ' ' LEU . 0.9 OUTLIER -158.47 -122.42 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.238 -0.437 . . . . 74.129999999999995 110.914 179.852 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.653 ' HA ' ' HA ' ' A' ' 131' ' ' LYS . 2.4 tm-20 -68.56 -0.33 4.99 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.222 -0.445 . . . . 75.329999999999998 110.943 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 157' ' ' TYR . . . . . 1.029 ' CD1' ' HB2' ' A' ' 154' ' ' LYS . 9.5 m-30 -32.55 146.15 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.12 -0.491 . . . . 54.539999999999999 110.901 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 158' ' ' ARG . . . . . 0.497 ' HB2' ' HA ' ' A' ' 103' ' ' ASP . 7.5 ptp180 -110.13 -39.7 4.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.107 -0.497 . . . . 74.540000000000006 110.902 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 2.4 ptpp? -91.39 151.2 42.49 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.58 0.705 . . . . 73.109999999999999 110.896 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 -25.73 28.28 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.734 2.289 . . . . 74.219999999999999 112.295 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.668 HD12 ' H ' ' A' ' 161' ' ' ILE . 4.0 mp -73.98 -6.16 7.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.265 -0.425 . . . . 71.040000000000006 111.129 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.594 ' HB3' ' CD1' ' A' ' 157' ' ' TYR . 1.6 t0 -72.54 -13.45 61.41 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.197 -0.456 . . . . 54.310000000000002 110.868 179.842 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 82.2 t90 -107.14 -3.43 19.91 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.189 -0.46 . . . . 72.140000000000001 110.917 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 100.12 -35.35 4.84 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.753 -0.737 . . . . 71.129999999999995 112.475 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -57.1 121.07 9.16 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.812 0.339 . . . . 63.100000000000001 111.098 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -46.99 -30.48 2.62 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.224 -0.444 . . . . 74.040000000000006 111.087 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 167' ' ' SER . . . . . 0.486 ' C ' ' H ' ' A' ' 169' ' ' ALA . 0.5 OUTLIER -151.49 154.41 33.4 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.697 0.76 . . . . 35.420000000000002 110.826 -179.74 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 168' ' ' PRO . . . . . 0.544 ' HG3' ' CD2' ' A' ' 128' ' ' HIS . 53.5 Cg_endo -69.73 22.53 0.17 Allowed 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.639 2.226 . . . . 63.439999999999998 112.399 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 0.486 ' H ' ' C ' ' A' ' 167' ' ' SER . . . -65.65 101.25 0.6 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.201 -0.454 . . . . 73.120000000000005 111.121 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.482 HG11 ' CD1' ' A' ' 139' ' ' PHE . 2.4 t -153.59 163.77 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.235 -0.439 . . . . 71.310000000000002 111.133 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 171' ' ' GLN . . . . . 0.641 ' HB2' ' O ' ' A' ' 141' ' ' GLU . 1.8 mm-40 -111.23 -87.2 0.54 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.21 -0.45 . . . . 71.420000000000002 110.941 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 172' ' ' SER . . . . . 0.734 ' OG ' ' O ' ' A' ' 143' ' ' PRO . 24.8 p -125.97 175.53 7.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.218 -0.446 . . . . 71.0 110.86 -179.792 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 10.7 p90 -144.14 168.25 20.47 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.166 -0.47 . . . . 75.420000000000002 110.889 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.32 156.6 48.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.133 -0.485 . . . . 75.25 110.862 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 175' ' ' ARG . . . . . 0.451 ' HD2' ' CE2' ' A' ' 94' ' ' TYR . 0.8 OUTLIER -88.68 -175.76 5.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.194 -0.457 . . . . 73.439999999999998 110.838 -179.916 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 176' ' ' ILE . . . . . 0.506 HD12 ' C ' ' A' ' 136' ' ' VAL . 5.6 mt -129.7 131.69 66.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.151 -0.477 . . . . 65.319999999999993 111.127 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 18.9 t -125.38 153.22 32.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.177 -0.465 . . . . 64.430000000000007 111.149 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 178' ' ' GLU . . . . . 0.533 ' HB3' HD13 ' A' ' 88' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.218 -0.446 . . . . 75.140000000000001 110.847 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.266 0 N-CA-C 112.465 -0.254 . . . . 53.149999999999999 112.465 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.457 ' C ' ' HE1' ' A' ' 47' ' ' TRP . 14.7 p -81.85 137.32 35.28 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.852 0.358 . . . . 72.109999999999999 111.143 -179.878 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.435 ' HA ' ' HA ' ' A' ' 24' ' ' ASP . 2.4 tttt -125.69 135.62 52.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.238 -0.437 . . . . 73.5 110.887 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.516 ' HA ' ' HA ' ' A' ' 42' ' ' VAL . 14.6 tt -135.98 153.78 32.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.216 -0.447 . . . . 74.319999999999993 111.094 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.481 HG23 ' CG ' ' A' ' 22' ' ' ASP . 12.9 m -135.77 145.91 47.06 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.151 -0.477 . . . . 65.209999999999994 111.143 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.567 ' CE1' HD12 ' A' ' 80' ' ' LEU . 0.3 OUTLIER -133.6 128.52 35.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.208 -0.451 . . . . 75.129999999999995 110.835 -179.954 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.556 ' CG ' ' HA ' ' A' ' 16' ' ' PHE . 22.1 m-85 -113.65 132.54 55.73 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.182 -0.463 . . . . 61.409999999999997 110.914 -179.869 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.409 ' HA ' ' O ' ' A' ' 36' ' ' ARG . 0.0 OUTLIER -60.71 -14.38 20.68 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.108 -0.496 . . . . 72.239999999999995 110.883 -179.989 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.447 ' HB2' ' O ' ' A' ' 17' ' ' GLN . 78.1 m-20 -136.38 150.96 49.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.146 -0.479 . . . . 72.340000000000003 110.852 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.441 ' HG3' ' HB3' ' A' ' 38' ' ' ASN . 4.5 mtmm -55.25 -176.2 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.165 -0.471 . . . . 74.439999999999998 110.919 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 19.4 m120 45.31 34.18 1.42 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.234 -0.439 . . . . 70.239999999999995 110.849 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.556 ' HA ' ' CG ' ' A' ' 11' ' ' TYR . 2.2 m-85 48.39 67.32 0.87 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.211 -0.449 . . . . 74.519999999999996 110.905 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.447 ' O ' ' HB2' ' A' ' 13' ' ' ASP . 4.7 mt-30 -141.78 158.13 44.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.145 -0.48 . . . . 75.030000000000001 110.876 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 92.85 -150.29 19.92 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.759 -0.734 . . . . 24.030000000000001 112.497 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.732 ' O ' HD13 ' A' ' 34' ' ' LEU . 2.2 mtt180 -68.74 79.9 0.29 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.827 0.346 . . . . 64.329999999999998 110.872 -179.855 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.478 ' HA ' ' O ' ' A' ' 10' ' ' PHE . 0.5 OUTLIER -77.96 129.13 34.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.199 -0.455 . . . . 61.329999999999998 110.89 -179.953 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.428 ' O ' ' HA ' ' A' ' 9' ' ' THR . 70.3 t80 -123.86 125.98 45.61 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.177 -0.465 . . . . 64.200000000000003 110.948 -179.87 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.481 ' CG ' HG23 ' A' ' 9' ' ' THR . 1.3 m-20 -119.41 134.81 55.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.109 -0.496 . . . . 74.150000000000006 110.85 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 9.4 t -160.44 129.4 4.87 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.177 -0.465 . . . . 62.409999999999997 110.858 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.435 ' HA ' ' HA ' ' A' ' 7' ' ' LYS . 2.5 p30 -97.65 5.36 49.48 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.157 -0.474 . . . . 64.439999999999998 110.841 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 47.5 t -114.91 160.65 19.27 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.186 -0.461 . . . . 63.109999999999999 110.892 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 87.4 m-20 -43.06 120.11 1.72 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.202 -0.453 . . . . 71.340000000000003 110.904 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.572 ' CB ' ' HB3' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -114.37 40.35 2.55 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.21 -0.45 . . . . 73.120000000000005 110.862 -179.907 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.564 ' O ' ' HB3' ' A' ' 82' ' ' SER . . . -50.47 -21.76 1.62 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.239 -0.437 . . . . 54.329999999999998 111.126 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 60.8 t0 -130.5 40.02 3.56 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.212 -0.449 . . . . 72.200000000000003 110.871 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.762 ' CD2' ' O ' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -80.04 14.54 1.8 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.15 -0.477 . . . . 62.340000000000003 110.911 -179.914 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.427 ' CG ' ' HG3' ' A' ' 53' ' ' PRO . 40.7 t60 -77.63 -35.11 52.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.138 -0.483 . . . . 64.319999999999993 110.842 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.6 t -61.95 -12.23 17.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.254 -0.43 . . . . 74.310000000000002 111.119 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -102.29 -26.56 13.27 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.265 -0.425 . . . . 73.129999999999995 110.894 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.732 HD13 ' O ' ' A' ' 19' ' ' ARG . 28.0 tp -139.33 130.43 26.54 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.146 -0.479 . . . . 72.140000000000001 110.944 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 21.1 m -91.24 -44.73 9.04 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.167 -0.469 . . . . 71.209999999999994 110.866 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.409 ' O ' ' HA ' ' A' ' 12' ' ' GLU . 0.0 OUTLIER -114.28 145.49 41.68 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.103 -0.499 . . . . 65.239999999999995 110.893 -179.918 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.576 ' SG ' ' CB ' ' A' ' 80' ' ' LEU . 3.5 m -126.76 106.35 9.3 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.184 -0.462 . . . . 63.329999999999998 110.861 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.441 ' HB3' ' HG3' ' A' ' 14' ' ' LYS . 11.3 m-20 -104.07 -62.43 1.31 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.174 -0.466 . . . . 74.439999999999998 110.905 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 9.7 p -111.96 133.19 54.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.46 . . . . 70.219999999999999 110.903 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.628 HD12 ' HZ3' ' A' ' 73' ' ' TRP . 8.9 mt -129.19 151.56 35.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.14 -0.482 . . . . 64.319999999999993 111.122 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.431 ' HE3' ' CD1' ' A' ' 16' ' ' PHE . 0.0 OUTLIER -143.05 121.03 12.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.149 -0.478 . . . . 75.409999999999997 110.862 179.84 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.654 HG21 ' HB2' ' A' ' 47' ' ' TRP . 1.3 t -107.62 116.79 51.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.212 -0.449 . . . . 75.049999999999997 111.148 179.833 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -112.18 76.5 0.98 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.177 -0.465 . . . . 72.329999999999998 110.932 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.421 ' O ' ' HA ' ' A' ' 6' ' ' THR . . . 142.37 94.09 0.21 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.738 -0.744 . . . . 54.210000000000001 112.441 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 56.49 174.26 0.21 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.763 -0.732 . . . . 43.219999999999999 112.49 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.708 HG23 ' HA ' ' A' ' 63' ' ' PRO . 1.2 m -69.09 169.99 10.84 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.793 0.33 . . . . 74.430000000000007 111.126 -179.867 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' TRP . . . . . 0.654 ' HB2' HG21 ' A' ' 42' ' ' VAL . 5.3 m95 -145.53 128.91 16.88 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.208 -0.451 . . . . 74.409999999999997 110.924 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.903 ' HB2' ' CG2' ' A' ' 86' ' ' VAL . . . -88.54 126.62 35.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.234 -0.439 . . . . 73.209999999999994 111.105 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.785 HG11 HD11 ' A' ' 80' ' ' LEU . 27.2 m -126.77 139.58 51.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.211 -0.45 . . . . 74.310000000000002 111.177 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.895 ' HB3' ' CB ' ' A' ' 56' ' ' ALA . 5.0 m-85 -116.55 144.47 44.33 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.17 -0.468 . . . . 73.120000000000005 110.949 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.555 ' HG2' ' N ' ' A' ' 52' ' ' ARG . 0.3 OUTLIER -48.61 -84.67 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.141 -0.481 . . . . 73.519999999999996 110.867 -179.971 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.896 ' O ' ' HB2' ' A' ' 56' ' ' ALA . 0.2 OUTLIER -81.46 136.72 48.78 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.573 0.701 . . . . 73.519999999999996 110.915 -179.935 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.654 ' HB3' ' HB3' ' A' ' 81' ' ' SER . 53.8 Cg_endo -69.7 137.89 36.7 Favored 'Trans proline' 0 C--N 1.341 0.14 0 C-N-CA 122.681 2.254 . . . . 74.140000000000001 112.376 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.468 ' C ' ' CD2' ' A' ' 55' ' ' PHE . 2.0 m120 69.22 -5.87 1.03 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.277 -0.419 . . . . 62.530000000000001 110.885 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.468 ' CD2' ' C ' ' A' ' 54' ' ' ASN . 0.1 OUTLIER -143.51 -75.43 0.26 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.131 -0.486 . . . . 75.530000000000001 110.875 -179.913 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.896 ' HB2' ' O ' ' A' ' 52' ' ' ARG . . . 45.87 81.27 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.14 -0.482 . . . . 72.340000000000003 111.09 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' TRP . . . . . 0.455 ' O ' ' CD2' ' A' ' 58' ' ' TYR . 18.9 m0 -65.32 35.48 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.227 -0.442 . . . . 74.530000000000001 110.908 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.586 ' H ' ' C ' ' A' ' 56' ' ' ALA . 1.2 m-30 -165.06 117.26 1.18 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.257 -0.429 . . . . 74.549999999999997 110.913 -179.844 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.453 ' HB2' ' HA ' ' A' ' 150' ' ' TYR . 1.0 OUTLIER -78.7 130.66 36.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.105 -0.498 . . . . 71.219999999999999 110.899 179.925 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.909 ' CD2' HD12 ' A' ' 76' ' ' LEU . 13.8 t80 -139.51 98.17 3.43 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.262 -0.427 . . . . 72.109999999999999 110.922 -179.864 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.584 ' H ' HD12 ' A' ' 61' ' ' ILE . 4.0 mp -83.56 111.16 19.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.1 -0.5 . . . . 74.409999999999997 111.15 179.873 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.874 HD23 ' HD2' ' A' ' 63' ' ' PRO . 0.3 OUTLIER -79.88 127.05 78.68 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.608 0.718 . . . . 71.040000000000006 110.923 179.898 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.874 ' HD2' HD23 ' A' ' 62' ' ' LEU . 53.7 Cg_endo -69.76 -165.04 0.14 Allowed 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.688 2.259 . . . . 72.310000000000002 112.348 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.91 160.68 14.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.236 -0.438 . . . . 75.129999999999995 110.928 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 112.61 -151.92 18.03 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.71 -0.757 . . . . 62.32 112.498 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -116.05 161.57 18.69 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.863 0.363 . . . . 74.030000000000001 110.884 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.498 ' N ' ' O ' ' A' ' 40' ' ' ILE . 13.6 m-85 -149.56 82.38 6.81 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.69 0.757 . . . . 71.439999999999998 110.929 -179.857 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.437 ' HD2' ' HG3' ' A' ' 72' ' ' ARG . 53.9 Cg_endo -69.74 -0.3 6.7 Favored 'Trans proline' 0 N--CA 1.465 -0.19 0 C-N-CA 122.72 2.28 . . . . 61.340000000000003 112.379 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -157.99 155.39 29.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.181 -0.463 . . . . 73.430000000000007 110.867 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.594 ' O ' ' CD1' ' A' ' 73' ' ' TRP . 24.9 p90 -62.18 -37.46 85.34 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.152 -0.476 . . . . 63.210000000000001 110.915 -179.854 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.585 ' HA ' ' CA ' ' A' ' 75' ' ' GLY . 6.6 pt20 -61.25 -10.6 7.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.12 -0.491 . . . . 64.299999999999997 110.922 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.437 ' HG3' ' HD2' ' A' ' 68' ' ' PRO . 25.2 mmt180 -65.82 -45.11 83.53 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.186 -0.461 . . . . 71.200000000000003 110.872 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' TRP . . . . . 0.757 ' O ' ' CB ' ' A' ' 74' ' ' MET . 0.4 OUTLIER -81.11 -5.45 57.68 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.182 -0.463 . . . . 74.519999999999996 110.902 -179.944 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 74' ' ' MET . . . . . 0.757 ' CB ' ' O ' ' A' ' 73' ' ' TRP . 8.4 mmm 131.21 -3.98 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.207 -0.451 . . . . 73.219999999999999 110.889 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.585 ' CA ' ' HA ' ' A' ' 71' ' ' GLN . . . 76.2 17.22 80.14 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.7 -0.762 . . . . 62.549999999999997 112.451 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.909 HD12 ' CD2' ' A' ' 60' ' ' TYR . 0.0 OUTLIER -63.45 -154.25 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.787 0.327 . . . . 65.439999999999998 110.963 -179.905 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.473 ' H ' HD13 ' A' ' 76' ' ' LEU . 2.9 t-20 -65.06 131.71 47.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.275 -0.421 . . . . 73.540000000000006 110.87 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -87.93 11.91 14.58 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.178 -0.465 . . . . 63.119999999999997 110.878 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.539 ' O ' ' O ' ' A' ' 51' ' ' GLU . 0.0 OUTLIER -87.95 49.44 1.8 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.169 -0.469 . . . . 61.329999999999998 110.852 -179.872 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.785 HD11 HG11 ' A' ' 49' ' ' VAL . 0.1 OUTLIER -59.89 127.08 30.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.191 -0.458 . . . . 62.409999999999997 110.891 -179.943 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.654 ' HB3' ' HB3' ' A' ' 53' ' ' PRO . 5.3 m -149.83 -114.99 0.06 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.188 -0.46 . . . . 53.200000000000003 110.897 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.626 ' OG ' ' HA ' ' A' ' 53' ' ' PRO . 0.1 OUTLIER -42.43 102.48 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.155 -0.475 . . . . 71.519999999999996 110.849 -179.776 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 83' ' ' CYS . . . . . 0.721 ' HB3' HG12 ' A' ' 49' ' ' VAL . 8.7 p -130.42 134.02 46.8 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.133 -0.485 . . . . 71.510000000000005 110.865 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.627 ' N ' ' O ' ' A' ' 48' ' ' ALA . 0.9 OUTLIER -117.33 158.44 24.39 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.16 -0.473 . . . . 65.510000000000005 110.854 -179.862 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -70.58 131.77 44.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.2 -0.454 . . . . 63.329999999999998 111.075 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.903 ' CG2' ' HB2' ' A' ' 48' ' ' ALA . 71.3 t -117.06 129.07 74.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.162 -0.472 . . . . 62.229999999999997 111.142 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' HIS . . . . . 0.664 ' O ' HG23 ' A' ' 136' ' ' VAL . 16.9 m80 -113.79 107.39 15.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.179 -0.464 . . . . 74.310000000000002 110.824 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.479 ' H ' HD23 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -31.69 148.67 0.05 OUTLIER Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.574 0.702 . . . . 73.239999999999995 110.955 -179.999 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.548 ' HB3' ' H ' ' A' ' 136' ' ' VAL . 53.4 Cg_endo -69.8 93.23 0.52 Allowed 'Trans proline' 0 C--O 1.231 0.136 0 C-N-CA 122.689 2.259 . . . . 73.219999999999999 112.323 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -104.61 -174.22 2.49 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.205 -0.452 . . . . 73.010000000000005 110.881 -179.872 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 49.55 64.18 3.6 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.755 -0.736 . . . . 53.340000000000003 112.464 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 122.6 24.22 2.17 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.751 -0.738 . . . . 71.209999999999994 112.515 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 41.5 -158.73 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.822 0.344 . . . . 53.219999999999999 110.892 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.506 ' HA ' ' HG2' ' A' ' 134' ' ' GLU . 31.5 t80 -99.77 102.78 14.33 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.187 -0.46 . . . . 74.450000000000003 110.905 -179.837 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.498 ' HG3' HG11 ' A' ' 132' ' ' VAL . 42.8 tptt -112.61 130.03 56.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.132 -0.485 . . . . 72.140000000000001 110.887 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.478 ' HB ' ' OE1' ' A' ' 134' ' ' GLU . 0.0 OUTLIER -148.83 137.44 15.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.232 -0.44 . . . . 75.140000000000001 111.127 179.888 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.474 ' N ' HD13 ' A' ' 96' ' ' ILE . 0.9 OUTLIER -111.16 132.2 54.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.15 -0.477 . . . . 72.310000000000002 110.905 179.935 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.571 ' CG2' HD12 ' A' ' 127' ' ' ILE . 3.1 mp -113.17 135.54 52.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.211 -0.45 . . . . 54.039999999999999 111.094 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.653 ' HB2' ' HB2' ' A' ' 129' ' ' SER . 48.7 m-85 -126.48 136.34 52.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.148 -0.478 . . . . 74.519999999999996 110.835 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 51.9 tt0 -65.6 -75.29 0.09 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.101 -0.499 . . . . 70.519999999999996 110.883 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.429 ' C ' ' HB2' ' A' ' 128' ' ' HIS . 6.0 mttt -85.64 158.6 20.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.143 -0.481 . . . . 71.409999999999997 110.939 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -66.54 164.4 41.93 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.782 -0.723 . . . . 71.439999999999998 112.512 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.426 ' HA ' ' HB2' ' A' ' 158' ' ' ARG . 38.7 t70 61.67 27.89 17.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.88 0.371 . . . . 65.319999999999993 110.843 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.506 ' HA ' ' CD2' ' A' ' 99' ' ' PHE . 14.9 m-85 59.52 52.68 5.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.193 -0.458 . . . . 74.510000000000005 110.916 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.2 m -118.13 148.9 41.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.102 -0.499 . . . . 62.329999999999998 110.827 -179.755 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 90.8 -125.19 7.86 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.724 -0.75 . . . . 74.299999999999997 112.532 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -98.85 139.55 34.36 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.756 0.312 . . . . 72.439999999999998 110.958 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 1.3 ttp -130.99 137.0 49.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.214 -0.448 . . . . 74.120000000000005 110.857 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 13.3 m-85 -141.29 136.56 31.72 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.244 -0.434 . . . . 75.049999999999997 110.953 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -117.74 103.85 10.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.146 -0.479 . . . . 70.319999999999993 110.874 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 13.1 t -117.33 140.69 49.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.166 -0.47 . . . . 60.350000000000001 111.166 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.522 ' O ' ' OG1' ' A' ' 112' ' ' THR . 0.1 OUTLIER -101.52 27.72 6.1 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.209 -0.45 . . . . 64.540000000000006 111.142 -179.962 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -143.67 -174.96 4.39 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.213 -0.449 . . . . 72.430000000000007 110.852 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.48 ' CB ' ' HA ' ' A' ' 174' ' ' ARG . 9.2 p30 -107.96 177.43 4.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.146 -0.479 . . . . 74.200000000000003 110.899 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' CYS . . . . . 0.434 ' O ' ' HB2' ' A' ' 172' ' ' SER . 18.4 p -155.98 148.86 18.14 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 121.578 0.704 . . . . 74.200000000000003 110.916 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 -25.65 28.36 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.68 2.253 . . . . 72.349999999999994 112.364 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.626 ' HB3' ' CB ' ' A' ' 120' ' ' GLU . 0.1 OUTLIER -150.77 107.4 3.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.192 -0.458 . . . . 72.120000000000005 110.879 -179.861 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.659 HD13 HD11 ' A' ' 127' ' ' ILE . 4.0 tt -59.08 -29.81 42.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.142 -0.481 . . . . 72.310000000000002 111.152 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 119' ' ' MET . . . . . 0.596 ' O ' ' HA ' ' A' ' 123' ' ' HIS . 54.8 ttp -86.39 -42.66 13.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.168 -0.469 . . . . 73.310000000000002 110.877 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.626 ' CB ' ' HB3' ' A' ' 117' ' ' SER . 8.5 tp10 -67.59 -13.14 61.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.24 -0.437 . . . . 75.340000000000003 110.9 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 22.2 tp60 -114.53 -48.11 2.88 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.158 -0.473 . . . . 64.510000000000005 110.944 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.443 ' HB2' ' O ' ' A' ' 118' ' ' ILE . 47.6 m-85 -105.68 -20.1 13.56 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.217 -0.447 . . . . 71.129999999999995 110.878 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 123' ' ' HIS . . . . . 0.596 ' HA ' ' O ' ' A' ' 119' ' ' MET . 10.7 m80 72.61 28.14 2.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.201 -0.454 . . . . 63.530000000000001 110.83 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.533 ' SD ' HG22 ' A' ' 98' ' ' ILE . 4.6 mtt -105.44 84.49 2.1 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.222 -0.444 . . . . 70.450000000000003 110.873 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 3.7 ptp180 -50.98 -34.81 30.6 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.196 -0.456 . . . . 75.010000000000005 110.885 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.51 ' HG2' ' HA ' ' A' ' 169' ' ' ALA . 18.4 mt-10 -144.8 135.27 24.39 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.16 -0.473 . . . . 73.430000000000007 110.872 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.659 HD11 HD13 ' A' ' 118' ' ' ILE . 3.7 mm -96.04 100.71 11.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.147 -0.478 . . . . 74.230000000000004 111.122 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 128' ' ' HIS . . . . . 0.429 ' HB2' ' C ' ' A' ' 101' ' ' LYS . 0.3 OUTLIER -71.34 -30.77 66.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.194 -0.457 . . . . 62.130000000000003 110.879 179.874 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 129' ' ' SER . . . . . 0.653 ' HB2' ' HB2' ' A' ' 99' ' ' PHE . 0.4 OUTLIER -133.85 140.08 46.64 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.158 -0.473 . . . . 73.140000000000001 110.87 -179.778 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 130' ' ' CYS . . . . . 0.573 ' O ' ' O ' ' A' ' 155' ' ' LYS . 2.7 m -140.45 117.59 11.24 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.112 -0.494 . . . . 64.420000000000002 110.846 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.697 ' HA ' ' HA ' ' A' ' 156' ' ' GLU . 2.9 mtpp -106.44 154.55 20.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.196 -0.456 . . . . 64.230000000000004 110.872 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.537 HG23 ' C ' ' A' ' 131' ' ' LYS . 4.8 t 79.59 166.38 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.203 -0.453 . . . . 75.120000000000005 111.115 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.676 HD22 ' CG ' ' A' ' 155' ' ' LYS . 0.1 OUTLIER -171.19 128.52 0.71 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.159 -0.473 . . . . 72.400000000000006 110.905 179.992 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.536 ' CD ' ' H ' ' A' ' 134' ' ' GLU . 0.3 OUTLIER -97.3 155.98 16.64 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.181 -0.463 . . . . 75.530000000000001 110.877 179.905 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 135' ' ' GLY . . . . . 0.519 ' HA3' ' HA ' ' A' ' 89' ' ' PRO . . . -30.53 -48.42 0.16 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.75 -0.738 . . . . 65.209999999999994 112.488 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.816 HG11 ' CG1' ' A' ' 86' ' ' VAL . 3.1 t -150.18 137.68 13.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.842 0.353 . . . . 62.340000000000003 111.136 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 137' ' ' TRP . . . . . 0.729 ' HB3' ' CB ' ' A' ' 152' ' ' LEU . 16.5 t90 -144.3 137.63 27.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.19 -0.459 . . . . 75.150000000000006 110.897 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.544 ' CG2' ' HB2' ' A' ' 149' ' ' GLN . 34.2 mt -111.69 132.05 61.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.212 -0.449 . . . . 72.450000000000003 111.097 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.561 ' CD2' ' HB3' ' A' ' 173' ' ' PHE . 0.1 OUTLIER -96.88 178.25 5.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.181 -0.463 . . . . 73.140000000000001 110.844 179.994 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 140' ' ' TYR . . . . . 0.527 ' CE2' ' HG2' ' A' ' 174' ' ' ARG . 0.3 OUTLIER -155.07 124.06 6.21 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.143 -0.48 . . . . 71.430000000000007 110.921 -179.836 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 141' ' ' GLU . . . . . 0.612 ' O ' ' HB2' ' A' ' 171' ' ' GLN . 0.1 OUTLIER -61.44 -29.71 70.12 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.158 -0.474 . . . . 62.299999999999997 110.859 -179.982 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.704 ' HB3' ' HD2' ' A' ' 143' ' ' PRO . 9.1 mp -114.54 172.89 3.22 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.562 0.696 . . . . 53.140000000000001 110.94 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 143' ' ' PRO . . . . . 0.74 ' O ' ' OG ' ' A' ' 172' ' ' SER . 53.4 Cg_endo -69.76 -90.73 0.01 OUTLIER 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.669 2.246 . . . . 72.510000000000005 112.324 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 144' ' ' ASN . . . . . 0.698 ' O ' ' N ' ' A' ' 146' ' ' ARG . 1.6 m-20 -54.21 95.79 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.201 -0.454 . . . . 61.140000000000001 110.907 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 145' ' ' TYR . . . . . 0.649 ' C ' ' O ' ' A' ' 144' ' ' ASN . 0.1 OUTLIER 12.08 53.94 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.175 -0.466 . . . . 72.430000000000007 110.95 -179.876 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 146' ' ' ARG . . . . . 0.698 ' N ' ' O ' ' A' ' 144' ' ' ASN . 8.8 mtp85 -116.38 163.03 16.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.098 -0.501 . . . . 73.239999999999995 110.851 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 74.31 -172.67 51.86 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.722 -0.752 . . . . 50.020000000000003 112.481 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 4.7 mpt_? -86.7 134.02 33.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.764 0.316 . . . . 63.140000000000001 110.88 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 149' ' ' GLN . . . . . 0.641 ' OE1' ' HA ' ' A' ' 60' ' ' TYR . 0.3 OUTLIER -87.76 163.42 16.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.163 -0.471 . . . . 74.049999999999997 110.957 -179.952 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 150' ' ' TYR . . . . . 0.459 ' HB2' ' HB2' ' A' ' 139' ' ' PHE . 5.2 m-85 -126.8 151.42 48.3 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.234 -0.439 . . . . 75.299999999999997 110.958 -179.896 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.409 HD12 ' H ' ' A' ' 152' ' ' LEU . 29.7 tp -85.65 140.08 30.86 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.125 -0.489 . . . . 74.420000000000002 110.868 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.973 HD13 ' O ' ' A' ' 152' ' ' LEU . 0.0 OUTLIER -69.96 138.24 52.14 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.167 -0.47 . . . . 71.349999999999994 110.893 179.883 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -165.84 27.53 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.216 -0.447 . . . . 72.099999999999994 110.872 179.783 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.826 ' HB2' ' CD1' ' A' ' 157' ' ' TYR . 0.0 OUTLIER -118.61 -172.42 2.28 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.177 -0.465 . . . . 71.319999999999993 110.931 179.952 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.742 ' HD2' ' C ' ' A' ' 154' ' ' LYS . 1.0 OUTLIER -161.63 -123.2 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.236 -0.438 . . . . 73.540000000000006 110.855 179.844 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.697 ' HA ' ' HA ' ' A' ' 131' ' ' LYS . 2.7 tm-20 -71.65 2.63 4.95 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.207 -0.451 . . . . 74.219999999999999 110.911 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 157' ' ' TYR . . . . . 0.826 ' CD1' ' HB2' ' A' ' 154' ' ' LYS . 18.5 m-30 -32.33 147.3 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.14 -0.482 . . . . 74.530000000000001 110.91 -179.836 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 158' ' ' ARG . . . . . 0.491 ' HB3' ' CZ ' ' A' ' 104' ' ' PHE . 8.7 ptp180 -113.64 -35.76 5.1 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.133 -0.485 . . . . 75.510000000000005 110.885 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -92.27 152.94 42.9 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.551 0.691 . . . . 51.509999999999998 110.905 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 160' ' ' PRO . . . . . 0.477 ' HB3' ' HB3' ' A' ' 168' ' ' PRO . 53.7 Cg_endo -69.75 -35.0 13.49 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.679 2.252 . . . . 65.209999999999994 112.35 179.893 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.706 HD12 ' H ' ' A' ' 161' ' ' ILE . 3.2 mp -57.56 -15.85 4.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.444 . . . . 75.219999999999999 111.125 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.643 ' HB3' ' CD1' ' A' ' 157' ' ' TYR . 0.4 OUTLIER -71.69 -13.74 61.83 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.206 -0.452 . . . . 51.130000000000003 110.829 179.884 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 163' ' ' TRP . . . . . 0.475 ' CE3' ' HB3' ' A' ' 165' ' ' ALA . 22.3 t90 -87.98 -16.28 34.2 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.192 -0.458 . . . . 71.219999999999999 110.881 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 109.82 -37.36 3.81 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.758 -0.734 . . . . 54.310000000000002 112.483 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.475 ' HB3' ' CE3' ' A' ' 163' ' ' TRP . . . -78.92 127.17 31.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.797 0.332 . . . . 61.520000000000003 111.066 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 166' ' ' ALA . . . . . 0.424 ' C ' ' O ' ' A' ' 165' ' ' ALA . . . -35.94 -42.18 0.27 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.231 -0.44 . . . . 72.040000000000006 111.11 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 167' ' ' SER . . . . . 0.486 ' C ' ' H ' ' A' ' 169' ' ' ALA . 0.5 OUTLIER -129.78 153.57 80.88 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.654 0.74 . . . . 75.219999999999999 110.864 -179.811 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 168' ' ' PRO . . . . . 0.49 ' HB3' ' O ' ' A' ' 127' ' ' ILE . 53.9 Cg_endo -69.72 29.04 0.18 Allowed 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.691 2.261 . . . . 75.230000000000004 112.357 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 0.51 ' HA ' ' HG2' ' A' ' 126' ' ' GLU . . . -66.28 103.95 1.1 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.236 -0.438 . . . . 43.43 111.09 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.543 HG11 ' CE2' ' A' ' 139' ' ' PHE . 2.6 t -151.57 163.33 2.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.459 . . . . 63.340000000000003 111.127 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 171' ' ' GLN . . . . . 0.652 ' OE1' ' HB3' ' A' ' 143' ' ' PRO . 1.6 tm0? -112.26 -83.31 0.59 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.157 -0.474 . . . . 75.219999999999999 110.897 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 172' ' ' SER . . . . . 0.74 ' OG ' ' O ' ' A' ' 143' ' ' PRO . 54.4 p -124.55 174.91 7.51 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.203 -0.453 . . . . 70.420000000000002 110.805 -179.788 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 173' ' ' PHE . . . . . 0.561 ' HB3' ' CD2' ' A' ' 139' ' ' PHE . 39.6 p90 -148.76 164.83 33.25 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.101 -0.5 . . . . 74.430000000000007 110.919 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 174' ' ' ARG . . . . . 0.527 ' HG2' ' CE2' ' A' ' 140' ' ' TYR . 0.0 OUTLIER -136.16 142.75 44.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.209 -0.45 . . . . 64.439999999999998 110.906 -179.921 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 175' ' ' ARG . . . . . 0.405 ' HG3' ' OD1' ' A' ' 114' ' ' ASP . 0.0 OUTLIER -90.59 -176.62 4.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.199 -0.455 . . . . 73.040000000000006 110.838 -179.911 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 176' ' ' ILE . . . . . 0.704 HD12 ' HB ' ' A' ' 136' ' ' VAL . 2.4 mt -133.84 132.21 56.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.174 -0.467 . . . . 71.430000000000007 111.112 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 83.1 t -150.04 140.56 16.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.213 -0.449 . . . . 61.219999999999999 111.138 179.799 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.163 -0.471 . . . . 71.310000000000002 110.894 -179.986 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.293 0 N-CA-C 112.491 -0.244 . . . . 53.5 112.491 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.478 ' C ' ' HE1' ' A' ' 47' ' ' TRP . 6.6 p -81.94 133.61 35.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.833 0.349 . . . . 61.539999999999999 111.151 -179.88 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 2.7 tttt -120.94 136.93 54.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.262 -0.426 . . . . 74.109999999999999 110.912 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.577 ' HB ' ' CD1' ' A' ' 47' ' ' TRP . 13.7 tt -136.92 152.18 28.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.236 -0.438 . . . . 65.109999999999999 111.153 179.821 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.498 HG23 ' CG ' ' A' ' 22' ' ' ASP . 15.5 m -134.0 138.15 45.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.192 -0.458 . . . . 74.200000000000003 111.113 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.716 ' HB2' HD22 ' A' ' 34' ' ' LEU . 0.2 OUTLIER -126.74 128.53 46.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.2 -0.455 . . . . 43.140000000000001 110.882 179.995 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.549 ' CG ' ' HA ' ' A' ' 16' ' ' PHE . 26.3 m-85 -113.45 132.0 55.82 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.118 -0.492 . . . . 71.349999999999994 110.876 -179.833 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.441 ' HB2' ' HB2' ' A' ' 19' ' ' ARG . 0.1 OUTLIER -61.69 -15.14 37.71 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.107 -0.497 . . . . 73.430000000000007 110.89 179.99 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.435 ' HB2' ' O ' ' A' ' 17' ' ' GLN . 72.5 m-20 -134.91 150.42 50.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.142 -0.481 . . . . 64.319999999999993 110.865 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.546 ' N ' ' HB3' ' A' ' 38' ' ' ASN . 36.7 mtmt -56.16 -178.77 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.224 -0.443 . . . . 63.109999999999999 110.914 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 25.4 m-20 49.44 31.52 4.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.212 -0.449 . . . . 62.32 110.898 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.549 ' HA ' ' CG ' ' A' ' 11' ' ' TYR . 3.7 m-85 50.9 63.54 2.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.179 -0.464 . . . . 73.230000000000004 110.922 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.435 ' O ' ' HB2' ' A' ' 13' ' ' ASP . 24.6 mt-30 -139.52 160.85 38.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.15 -0.477 . . . . 74.040000000000006 110.898 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 92.0 -149.29 19.62 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.8 -0.714 . . . . 64.340000000000003 112.485 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.721 ' O ' HD13 ' A' ' 34' ' ' LEU . 0.0 OUTLIER -69.21 77.8 0.36 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.756 0.312 . . . . 74.140000000000001 110.852 -179.865 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.46 ' HB2' ' CE1' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -76.3 129.01 36.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 72.109999999999999 110.882 -179.919 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.485 ' O ' ' HA ' ' A' ' 9' ' ' THR . 91.4 t80 -122.95 125.57 45.55 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.213 -0.449 . . . . 71.540000000000006 110.888 -179.81 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.498 ' CG ' HG23 ' A' ' 9' ' ' THR . 1.4 m-20 -121.73 133.51 54.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.121 -0.49 . . . . 75.530000000000001 110.866 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -166.99 135.43 2.67 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.217 -0.447 . . . . 72.109999999999999 110.878 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -103.22 5.55 37.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.17 -0.468 . . . . 50.149999999999999 110.815 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 49.7 t -110.08 158.85 17.86 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.231 -0.44 . . . . 72.019999999999996 110.864 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -43.3 120.17 1.8 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.172 -0.467 . . . . 70.329999999999998 110.83 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.632 ' HB2' ' HB3' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -115.6 42.33 2.31 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.204 -0.453 . . . . 53.409999999999997 110.868 -179.951 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.563 ' O ' ' HA ' ' A' ' 82' ' ' SER . . . -51.12 -20.11 1.37 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.229 -0.441 . . . . 74.109999999999999 111.126 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 63.2 t0 -128.5 37.57 4.1 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.218 -0.446 . . . . 65.519999999999996 110.864 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.763 ' CD2' ' O ' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -80.97 15.68 1.74 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.198 -0.456 . . . . 64.040000000000006 110.857 -179.892 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.412 ' CG ' ' HG3' ' A' ' 53' ' ' PRO . 39.3 t60 -80.02 -34.0 38.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.189 -0.459 . . . . 71.030000000000001 110.864 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.6 t -63.24 -10.84 17.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.216 -0.447 . . . . 71.519999999999996 111.136 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -103.32 -28.87 11.6 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.193 -0.458 . . . . 74.209999999999994 110.925 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.721 HD13 ' O ' ' A' ' 19' ' ' ARG . 16.0 tp -139.02 141.25 38.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.133 -0.485 . . . . 74.400000000000006 110.89 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 20.7 m -105.35 -42.05 5.36 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.174 -0.466 . . . . 64.430000000000007 110.863 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -118.49 143.0 47.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.178 -0.464 . . . . 73.540000000000006 110.907 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.683 ' SG ' ' HB2' ' A' ' 80' ' ' LEU . 3.9 p -115.05 87.22 2.61 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.204 -0.453 . . . . 72.239999999999995 110.9 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.546 ' HB3' ' N ' ' A' ' 14' ' ' LYS . 3.3 m-20 -82.76 -50.85 8.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 62.409999999999997 110.852 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.403 ' OG ' ' HB2' ' A' ' 11' ' ' TYR . 9.8 p -129.4 127.14 40.37 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.163 -0.472 . . . . 74.109999999999999 110.821 -179.815 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.538 HG21 HD13 ' A' ' 62' ' ' LEU . 13.5 mt -125.44 152.1 31.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.103 -0.499 . . . . 71.340000000000003 111.15 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.426 ' N ' ' CG2' ' A' ' 40' ' ' ILE . 0.0 OUTLIER -144.85 118.55 9.2 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.201 -0.454 . . . . 64.010000000000005 110.932 179.845 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.513 ' HA ' ' HA ' ' A' ' 8' ' ' ILE . 1.3 t -104.02 116.7 48.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.259 -0.428 . . . . 64.510000000000005 111.175 179.85 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -111.54 77.65 1.06 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.197 -0.456 . . . . 63.539999999999999 110.887 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.432 ' O ' ' HA ' ' A' ' 6' ' ' THR . . . 135.4 101.87 0.68 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.762 -0.732 . . . . 51.240000000000002 112.512 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.501 ' HA2' HD21 ' A' ' 88' ' ' LEU . . . 53.91 179.65 0.14 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.767 -0.73 . . . . 74.200000000000003 112.493 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.748 HG23 ' HA ' ' A' ' 63' ' ' PRO . 1.4 m -80.25 169.28 18.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.797 0.332 . . . . 43.210000000000001 111.12 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' TRP . . . . . 0.577 ' CD1' ' HB ' ' A' ' 8' ' ' ILE . 5.7 m95 -141.18 130.1 23.13 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.194 -0.457 . . . . 65.109999999999999 110.945 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.948 ' HB2' ' CG2' ' A' ' 86' ' ' VAL . . . -90.58 127.02 36.13 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.222 -0.445 . . . . 64.540000000000006 111.125 179.892 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.871 HG11 HD11 ' A' ' 80' ' ' LEU . 35.7 m -128.84 124.48 61.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.213 -0.449 . . . . 63.439999999999998 111.135 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.73 ' HB3' ' HA ' ' A' ' 56' ' ' ALA . 49.5 m-85 -94.51 150.15 20.53 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.21 -0.45 . . . . 70.549999999999997 110.901 -179.91 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.675 ' OE1' ' HB3' ' A' ' 57' ' ' TRP . 58.1 tt0 -49.27 -79.51 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.106 -0.497 . . . . 74.099999999999994 110.901 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.57 ' HB2' ' HB2' ' A' ' 57' ' ' TRP . 0.0 OUTLIER -92.54 143.77 27.73 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.607 0.718 . . . . 74.430000000000007 110.893 -179.951 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.69 ' HA ' ' OG ' ' A' ' 82' ' ' SER . 53.3 Cg_endo -69.82 142.41 47.57 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.739 2.293 . . . . 44.509999999999998 112.301 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 61.95 -9.75 0.08 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.236 -0.438 . . . . 73.519999999999996 110.89 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.611 ' H ' ' C ' ' A' ' 53' ' ' PRO . 2.7 m-30 -105.92 -20.4 13.44 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.184 -0.462 . . . . 73.430000000000007 110.901 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.73 ' HA ' ' HB3' ' A' ' 50' ' ' TYR . . . 50.02 27.15 2.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.168 -0.469 . . . . 72.099999999999994 111.068 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' TRP . . . . . 0.675 ' HB3' ' OE1' ' A' ' 51' ' ' GLU . 0.1 OUTLIER -50.69 -163.69 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.23 -0.441 . . . . 74.040000000000006 110.907 -179.959 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.636 ' C ' ' O ' ' A' ' 57' ' ' TRP . 5.4 m-30 -13.1 101.2 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.235 -0.439 . . . . 64.530000000000001 110.954 -179.841 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.43 142.89 36.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.072 -0.513 . . . . 73.319999999999993 110.873 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.788 ' O ' ' O ' ' A' ' 49' ' ' VAL . 0.3 OUTLIER -153.4 112.41 3.75 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.255 -0.43 . . . . 71.450000000000003 110.938 -179.896 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.81 ' N ' HD12 ' A' ' 61' ' ' ILE . 1.1 mp -102.82 114.19 41.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.13 -0.486 . . . . 64.209999999999994 111.153 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.849 HD23 ' HD2' ' A' ' 63' ' ' PRO . 0.6 OUTLIER -85.41 122.46 73.56 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 121.632 0.73 . . . . 72.409999999999997 110.89 179.962 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.849 ' HD2' HD23 ' A' ' 62' ' ' LEU . 54.1 Cg_endo -69.7 -166.34 0.18 Allowed 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.699 2.266 . . . . 75.010000000000005 112.339 179.868 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.44 160.96 14.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.164 -0.471 . . . . 75.030000000000001 110.896 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 113.48 -152.7 17.93 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.743 -0.741 . . . . 52.439999999999998 112.517 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -118.4 159.26 23.76 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.867 0.365 . . . . 74.150000000000006 110.891 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.479 ' N ' ' O ' ' A' ' 40' ' ' ILE . 11.5 m-85 -147.32 84.02 7.47 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.665 0.745 . . . . 73.340000000000003 110.942 -179.85 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 -4.68 14.51 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.655 2.237 . . . . 65.310000000000002 112.393 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 89.3 mt-10 -157.49 147.84 20.88 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.158 -0.474 . . . . 75.329999999999998 110.889 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.941 ' O ' ' CD1' ' A' ' 73' ' ' TRP . 44.4 p90 -57.97 -41.07 82.16 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.181 -0.463 . . . . 73.430000000000007 110.911 -179.882 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -52.8 -15.69 0.8 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.098 -0.501 . . . . 71.530000000000001 110.948 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 29.2 mmt180 -65.77 -17.6 64.74 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.189 -0.46 . . . . 72.400000000000006 110.845 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' TRP . . . . . 0.941 ' CD1' ' O ' ' A' ' 70' ' ' TYR . 0.4 OUTLIER -121.14 22.39 10.95 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.2 -0.455 . . . . 64.340000000000003 110.896 -179.948 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 74' ' ' MET . . . . . 0.594 ' O ' ' C ' ' A' ' 75' ' ' GLY . 0.0 OUTLIER 75.67 30.22 0.8 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.278 -0.419 . . . . 72.099999999999994 110.9 179.943 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.594 ' C ' ' O ' ' A' ' 74' ' ' MET . . . 17.11 59.06 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.678 -0.773 . . . . 61.350000000000001 112.508 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.727 HD12 HE21 ' A' ' 149' ' ' GLN . 0.0 OUTLIER -55.01 -72.38 0.07 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.836 0.35 . . . . 72.519999999999996 110.944 -179.955 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.498 ' O ' ' CB ' ' A' ' 78' ' ' ASP . 16.3 t-20 -121.16 -37.93 2.88 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.172 -0.467 . . . . 73.409999999999997 110.857 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.498 ' CB ' ' O ' ' A' ' 77' ' ' ASN . 0.0 OUTLIER 83.83 10.35 0.47 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.206 -0.452 . . . . 64.010000000000005 110.882 179.925 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -105.74 86.89 2.47 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.186 -0.461 . . . . 71.230000000000004 110.88 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.871 HD11 HG11 ' A' ' 49' ' ' VAL . 0.1 OUTLIER -86.95 131.38 34.11 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.182 -0.463 . . . . 70.310000000000002 110.886 -179.965 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.645 ' HB3' ' HB3' ' A' ' 53' ' ' PRO . 1.4 m -153.82 -119.23 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.158 -0.473 . . . . 74.400000000000006 110.843 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.69 ' OG ' ' HA ' ' A' ' 53' ' ' PRO . 0.1 OUTLIER -46.38 97.76 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.142 -0.481 . . . . 71.510000000000005 110.871 -179.814 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 83' ' ' CYS . . . . . 0.786 ' CB ' HG12 ' A' ' 49' ' ' VAL . 9.7 p -122.78 134.96 54.41 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.186 -0.461 . . . . 74.010000000000005 110.86 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.613 ' N ' ' O ' ' A' ' 48' ' ' ALA . 2.2 mmt85 -117.66 156.57 27.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.176 -0.466 . . . . 73.409999999999997 110.87 -179.843 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -68.42 129.05 38.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 72.150000000000006 111.119 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.948 ' CG2' ' HB2' ' A' ' 48' ' ' ALA . 38.3 t -115.56 139.17 43.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.24 -0.437 . . . . 64.239999999999995 111.114 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' HIS . . . . . 0.682 ' O ' HG23 ' A' ' 136' ' ' VAL . 9.2 m170 -114.12 108.59 17.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.161 -0.472 . . . . 62.130000000000003 110.892 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.56 HD13 ' HB3' ' A' ' 178' ' ' GLU . 0.0 OUTLIER -32.79 148.15 0.06 OUTLIER Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.577 0.703 . . . . 65.120000000000005 110.908 -179.972 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.582 ' HA ' ' HA3' ' A' ' 135' ' ' GLY . 53.3 Cg_endo -69.82 100.38 0.82 Allowed 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.658 2.239 . . . . 65.140000000000001 112.303 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -105.72 -175.65 2.85 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.194 -0.457 . . . . 73.230000000000004 110.867 -179.855 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 46.36 57.91 6.17 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.7 -0.762 . . . . 72.099999999999994 112.509 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 125.44 26.63 1.29 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.763 -0.732 . . . . 73.329999999999998 112.49 -179.88 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.518 ' O ' ' CG ' ' A' ' 134' ' ' GLU . 15.0 pt20 38.27 -124.49 0.27 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.792 0.33 . . . . 71.129999999999995 110.935 -179.861 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.589 ' HA ' ' HG2' ' A' ' 134' ' ' GLU . 0.0 OUTLIER -125.76 103.38 7.78 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.173 -0.467 . . . . 75.329999999999998 110.888 -179.857 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.538 ' HG3' HG11 ' A' ' 132' ' ' VAL . 12.6 tptp -113.34 130.96 56.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.079 -0.51 . . . . 71.150000000000006 110.875 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.717 HD11 ' NZ ' ' A' ' 154' ' ' LYS . 7.6 tt -149.05 138.25 15.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.185 -0.461 . . . . 71.120000000000005 111.13 179.864 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.488 ' HB2' ' O ' ' A' ' 131' ' ' LYS . 0.9 OUTLIER -110.52 139.38 45.81 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.153 -0.476 . . . . 73.329999999999998 110.878 179.962 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.649 HD12 ' O ' ' A' ' 109' ' ' TYR . 1.2 mp -116.74 148.58 19.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 53.520000000000003 111.102 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.62 ' HB2' ' HB2' ' A' ' 129' ' ' SER . 38.6 m-85 -134.1 133.94 41.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.205 -0.452 . . . . 75.230000000000004 110.848 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 77.2 tt0 -65.26 -61.25 2.24 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.159 -0.473 . . . . 72.200000000000003 110.878 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 35.4 mttt -99.79 162.21 13.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.134 -0.485 . . . . 73.129999999999995 110.872 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -68.16 159.83 51.18 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.73 -0.747 . . . . 72.150000000000006 112.48 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.513 ' HA ' ' HB2' ' A' ' 158' ' ' ARG . 25.7 t0 67.22 39.0 3.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.855 0.359 . . . . 44.329999999999998 110.888 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.597 ' CZ ' ' HB3' ' A' ' 158' ' ' ARG . 3.6 m-85 58.06 19.65 6.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.202 -0.454 . . . . 74.25 110.894 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 70.4 m -88.23 161.55 17.15 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.15 -0.477 . . . . 74.549999999999997 110.88 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 82.26 -159.0 38.65 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.726 -0.75 . . . . 40.32 112.454 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 4.1 tp-100 -82.86 129.19 34.97 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.786 0.327 . . . . 73.010000000000005 110.887 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' MET . . . . . 0.474 ' HB2' ' CD1' ' A' ' 99' ' ' PHE . 0.0 OUTLIER -118.69 160.39 21.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.195 -0.457 . . . . 43.450000000000003 110.862 179.954 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 109' ' ' TYR . . . . . 0.649 ' O ' HD12 ' A' ' 98' ' ' ILE . 29.9 m-85 -154.72 135.87 13.94 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.205 -0.452 . . . . 75.450000000000003 110.911 -179.851 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -110.98 102.0 10.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.139 -0.482 . . . . 73.200000000000003 110.906 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.405 HG22 HD11 ' A' ' 98' ' ' ILE . 9.0 t -113.38 128.56 56.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.148 -0.478 . . . . 52.399999999999999 111.14 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.42 ' HA ' ' HA ' ' A' ' 95' ' ' LYS . 1.8 t -93.4 32.6 1.33 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.222 -0.444 . . . . 74.319999999999993 111.162 -180.0 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -153.79 -174.85 5.11 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.211 -0.449 . . . . 71.129999999999995 110.895 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -90.16 -175.18 4.45 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.154 -0.475 . . . . 63.130000000000003 110.839 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 115' ' ' CYS . . . . . 0.654 ' O ' ' HB2' ' A' ' 172' ' ' SER . 39.0 t -161.19 136.17 5.53 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.606 0.717 . . . . 75.299999999999997 110.854 -179.893 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.497 ' O ' ' C ' ' A' ' 143' ' ' PRO . 53.4 Cg_endo -69.81 -34.51 14.28 Favored 'Trans proline' 0 C--N 1.341 0.134 0 C-N-CA 122.669 2.246 . . . . 62.140000000000001 112.324 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.635 ' HB3' ' CB ' ' A' ' 120' ' ' GLU . 0.1 OUTLIER -147.04 97.28 2.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.228 -0.442 . . . . 65.430000000000007 110.88 -179.844 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.696 HD13 HD11 ' A' ' 127' ' ' ILE . 3.7 tt -50.81 -28.8 6.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.158 -0.473 . . . . 71.219999999999999 111.107 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 119' ' ' MET . . . . . 0.571 ' O ' ' HA ' ' A' ' 123' ' ' HIS . 21.7 ttp -85.95 -44.96 11.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.169 -0.469 . . . . 72.439999999999998 110.896 179.848 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.635 ' CB ' ' HB3' ' A' ' 117' ' ' SER . 17.5 tp10 -66.17 -14.14 61.36 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.242 -0.435 . . . . 74.129999999999995 110.9 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 7.1 tp-100 -113.69 -51.49 2.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.121 -0.491 . . . . 63.240000000000002 110.882 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.483 ' HB2' ' O ' ' A' ' 118' ' ' ILE . 77.2 m-85 -101.81 -21.53 14.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.187 -0.46 . . . . 51.329999999999998 110.845 -179.912 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 123' ' ' HIS . . . . . 0.571 ' HA ' ' O ' ' A' ' 119' ' ' MET . 29.3 m-70 71.87 30.83 2.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.155 -0.475 . . . . 72.409999999999997 110.91 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 4.1 mtt -106.79 88.65 2.8 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.174 -0.466 . . . . 73.420000000000002 110.829 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 4.0 ptp180 -53.34 -38.44 63.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.252 -0.431 . . . . 74.530000000000001 110.864 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.476 ' HB3' ' HG2' ' A' ' 168' ' ' PRO . 18.2 mt-10 -140.2 130.58 25.31 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.166 -0.47 . . . . 75.230000000000004 110.87 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.696 HD11 HD13 ' A' ' 118' ' ' ILE . 3.0 mm -87.57 96.88 6.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.173 -0.467 . . . . 73.019999999999996 111.09 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 128' ' ' HIS . . . . . 0.443 ' HA ' ' HB3' ' A' ' 160' ' ' PRO . 17.0 m170 -66.03 -35.93 81.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.132 -0.485 . . . . 63.329999999999998 110.867 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 129' ' ' SER . . . . . 0.62 ' HB2' ' HB2' ' A' ' 99' ' ' PHE . 0.6 OUTLIER -135.54 147.45 48.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.225 -0.443 . . . . 64.010000000000005 110.884 -179.809 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 130' ' ' CYS . . . . . 0.553 ' O ' ' O ' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -144.78 120.39 10.43 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.192 -0.458 . . . . 64.450000000000003 110.924 -179.989 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.64 ' HA ' ' HA ' ' A' ' 156' ' ' GLU . 4.4 mtpt -111.25 154.32 24.62 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.156 -0.475 . . . . 65.329999999999998 110.938 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.538 HG11 ' HG3' ' A' ' 95' ' ' LYS . 13.0 t 83.32 163.59 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 71.120000000000005 111.131 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.847 HD13 ' O ' ' A' ' 154' ' ' LYS . 0.0 OUTLIER -178.86 122.2 0.09 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.176 -0.465 . . . . 64.219999999999999 110.898 179.95 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.589 ' HG2' ' HA ' ' A' ' 94' ' ' TYR . 0.1 OUTLIER -96.13 166.6 11.67 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.165 -0.47 . . . . 63.439999999999998 110.895 179.923 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 135' ' ' GLY . . . . . 0.582 ' HA3' ' HA ' ' A' ' 89' ' ' PRO . . . -24.42 -73.71 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.691 -0.766 . . . . 53.009999999999998 112.532 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.744 HG21 HG13 ' A' ' 86' ' ' VAL . 4.7 t -132.45 146.97 32.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.833 0.349 . . . . 72.439999999999998 111.126 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 137' ' ' TRP . . . . . 0.616 ' HB3' ' HB3' ' A' ' 152' ' ' LEU . 2.6 t-105 -149.6 141.98 24.25 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.17 -0.468 . . . . 75.109999999999999 110.924 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.573 HG13 HD11 ' A' ' 176' ' ' ILE . 59.5 mt -115.59 132.34 65.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.258 -0.428 . . . . 74.040000000000006 111.177 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.473 ' CD2' HG11 ' A' ' 170' ' ' VAL . 0.3 OUTLIER -99.74 179.58 4.49 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.166 -0.47 . . . . 64.099999999999994 110.878 179.99 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 140' ' ' TYR . . . . . 0.553 ' CE1' ' HB3' ' A' ' 149' ' ' GLN . 1.4 m-85 -152.39 126.08 8.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.136 -0.483 . . . . 74.530000000000001 110.905 -179.867 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 141' ' ' GLU . . . . . 0.606 ' O ' ' HB2' ' A' ' 171' ' ' GLN . 3.2 tt0 -61.05 -26.49 67.66 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.142 -0.481 . . . . 70.319999999999993 110.907 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.709 ' HB3' ' HD2' ' A' ' 143' ' ' PRO . 8.4 mp -116.24 173.29 3.12 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.59 0.709 . . . . 74.219999999999999 110.892 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 143' ' ' PRO . . . . . 0.747 ' O ' ' OG ' ' A' ' 172' ' ' SER . 54.0 Cg_endo -69.73 -89.68 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.145 0 C-N-CA 122.724 2.283 . . . . 64.439999999999998 112.373 179.813 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 144' ' ' ASN . . . . . 0.704 ' O ' ' N ' ' A' ' 146' ' ' ARG . 1.0 OUTLIER -54.69 95.7 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.232 -0.44 . . . . 72.120000000000005 110.931 179.957 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 145' ' ' TYR . . . . . 0.646 ' C ' ' O ' ' A' ' 144' ' ' ASN . 0.1 OUTLIER 12.69 53.01 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.17 -0.468 . . . . 74.310000000000002 110.89 -179.913 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 146' ' ' ARG . . . . . 0.704 ' N ' ' O ' ' A' ' 144' ' ' ASN . 10.1 mtp85 -118.69 172.46 7.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.159 -0.473 . . . . 73.120000000000005 110.862 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 70.59 -175.34 37.41 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.713 -0.756 . . . . 72.340000000000003 112.479 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.436 ' HA ' HD11 ' A' ' 76' ' ' LEU . 3.9 mtp180 -83.28 130.7 35.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.776 0.322 . . . . 62.210000000000001 110.87 -179.867 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 149' ' ' GLN . . . . . 0.735 ' OE1' ' HA ' ' A' ' 60' ' ' TYR . 0.3 OUTLIER -85.79 158.7 19.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.178 -0.464 . . . . 74.200000000000003 110.9 -179.926 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -123.59 158.27 31.84 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.206 -0.452 . . . . 72.430000000000007 110.957 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.64 ' HB2' HD11 ' A' ' 61' ' ' ILE . 13.4 tp -92.01 134.65 34.62 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.108 -0.496 . . . . 63.32 110.917 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 1.041 HD13 ' O ' ' A' ' 152' ' ' LEU . 0.0 OUTLIER -63.94 132.59 51.17 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.218 -0.446 . . . . 75.310000000000002 110.895 179.884 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -163.69 26.04 0.08 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.174 -0.467 . . . . 62.399999999999999 110.854 179.802 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.847 ' O ' HD13 ' A' ' 133' ' ' LEU . 5.6 pttt -116.13 -173.03 2.28 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.167 -0.469 . . . . 54.399999999999999 110.854 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.838 ' HG3' HD22 ' A' ' 133' ' ' LEU . 0.1 OUTLIER -161.75 -124.53 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.183 -0.462 . . . . 65.430000000000007 110.898 179.867 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.64 ' HA ' ' HA ' ' A' ' 131' ' ' LYS . 0.3 OUTLIER -71.42 2.2 5.27 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.228 -0.442 . . . . 64.420000000000002 110.904 179.976 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 157' ' ' TYR . . . . . 0.795 ' CD1' ' HB2' ' A' ' 154' ' ' LYS . 20.5 m-30 -30.17 144.85 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.153 -0.476 . . . . 70.219999999999999 110.93 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 158' ' ' ARG . . . . . 0.597 ' HB3' ' CZ ' ' A' ' 104' ' ' PHE . 9.4 ptp180 -112.67 -44.13 3.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.128 -0.487 . . . . 73.540000000000006 110.881 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -80.48 152.17 72.65 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.596 0.712 . . . . 74.420000000000002 110.865 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 160' ' ' PRO . . . . . 0.443 ' HB3' ' HA ' ' A' ' 128' ' ' HIS . 54.2 Cg_endo -69.76 -32.83 17.8 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.693 2.262 . . . . 71.420000000000002 112.335 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.61 HD12 ' H ' ' A' ' 161' ' ' ILE . 3.6 mp -55.34 -19.04 4.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.224 -0.444 . . . . 74.239999999999995 111.143 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.654 ' HB3' ' CD1' ' A' ' 157' ' ' TYR . 0.3 OUTLIER -73.57 -23.0 59.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.202 -0.454 . . . . 70.329999999999998 110.891 179.826 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 163' ' ' TRP . . . . . 0.407 ' HB3' ' O ' ' A' ' 160' ' ' PRO . 2.1 t-105 -67.53 -17.7 64.76 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.2 -0.455 . . . . 73.319999999999993 110.963 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 114.3 -38.63 3.09 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.689 -0.767 . . . . 72.349999999999994 112.473 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -90.91 140.68 29.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.81 0.338 . . . . 63.140000000000001 111.063 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -40.97 -35.13 0.48 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.196 -0.456 . . . . 54.340000000000003 111.09 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 167' ' ' SER . . . . . 0.498 ' C ' ' H ' ' A' ' 169' ' ' ALA . 0.3 OUTLIER -129.51 156.82 78.02 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.665 0.745 . . . . 75.549999999999997 110.9 -179.803 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 168' ' ' PRO . . . . . 0.476 ' HG2' ' HB3' ' A' ' 126' ' ' GLU . 53.9 Cg_endo -69.76 25.27 0.17 Allowed 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.697 2.264 . . . . 74.409999999999997 112.356 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 0.498 ' H ' ' C ' ' A' ' 167' ' ' SER . . . -64.3 103.88 0.69 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.197 -0.456 . . . . 62.140000000000001 111.149 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.473 HG11 ' CD2' ' A' ' 139' ' ' PHE . 3.5 t -153.66 162.17 2.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.238 -0.437 . . . . 51.240000000000002 111.122 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 171' ' ' GLN . . . . . 0.647 ' O ' ' HB ' ' A' ' 118' ' ' ILE . 1.9 mm-40 -112.54 -85.19 0.58 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.15 -0.477 . . . . 62.32 110.926 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 172' ' ' SER . . . . . 0.747 ' OG ' ' O ' ' A' ' 143' ' ' PRO . 32.0 p -129.54 178.78 6.22 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.204 -0.453 . . . . 74.140000000000001 110.87 -179.84 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -145.91 176.44 9.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.092 -0.504 . . . . 72.129999999999995 110.894 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 174' ' ' ARG . . . . . 0.434 ' HG2' ' HB ' ' A' ' 138' ' ' ILE . 0.2 OUTLIER -134.47 151.15 50.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.179 -0.464 . . . . 72.420000000000002 110.86 -179.903 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 175' ' ' ARG . . . . . 0.553 ' HD2' ' CE1' ' A' ' 94' ' ' TYR . 1.7 ptt180 -102.34 147.98 26.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.186 -0.461 . . . . 74.340000000000003 110.835 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 176' ' ' ILE . . . . . 0.573 HD11 HG13 ' A' ' 138' ' ' ILE . 3.9 mt -100.34 126.66 53.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.16 -0.473 . . . . 75.329999999999998 111.126 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 9.6 p -127.38 153.09 36.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.161 -0.472 . . . . 53.210000000000001 111.083 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 178' ' ' GLU . . . . . 0.56 ' HB3' HD13 ' A' ' 88' ' ' LEU . 1.5 pt-20 . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.142 -0.481 . . . . 75.099999999999994 110.904 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.314 0 N-CA-C 112.508 -0.237 . . . . 73.349999999999994 112.508 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.431 ' C ' ' HE1' ' A' ' 47' ' ' TRP . 5.3 p -82.23 134.05 35.28 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.872 0.367 . . . . 72.319999999999993 111.126 -179.832 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 2.8 tttt -121.44 136.44 54.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.26 -0.427 . . . . 63.509999999999998 110.899 179.893 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.583 ' HB ' ' CD1' ' A' ' 47' ' ' TRP . 12.7 tt -136.69 147.49 27.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.271 -0.422 . . . . 75.140000000000001 111.156 179.827 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.552 HG22 ' CE2' ' A' ' 11' ' ' TYR . 15.9 m -130.01 129.95 44.36 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.175 -0.466 . . . . 75.030000000000001 111.106 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.799 ' HB2' HD22 ' A' ' 34' ' ' LEU . 0.4 OUTLIER -117.05 131.1 57.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.171 -0.468 . . . . 61.439999999999998 110.896 -179.988 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.552 ' CE2' HG22 ' A' ' 9' ' ' THR . 43.5 m-85 -116.46 131.21 57.01 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.179 -0.464 . . . . 42.210000000000001 110.916 -179.86 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.516 ' HG2' ' HB2' ' A' ' 36' ' ' ARG . 0.0 OUTLIER -60.91 -23.94 65.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.092 -0.504 . . . . 73.349999999999994 110.899 -179.999 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 68.6 m-20 -127.87 152.48 47.79 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.187 -0.46 . . . . 73.439999999999998 110.848 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.48 ' N ' ' HB3' ' A' ' 38' ' ' ASN . 4.2 mtmm -56.05 -176.98 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.175 -0.466 . . . . 75.109999999999999 110.893 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 69.9 m-20 46.99 37.74 5.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.209 -0.45 . . . . 73.030000000000001 110.896 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.535 ' HA ' ' CG ' ' A' ' 11' ' ' TYR . 4.3 m-85 45.91 56.59 5.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.145 -0.48 . . . . 72.329999999999998 110.93 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 4.1 mt-30 -132.16 159.91 37.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.142 -0.481 . . . . 74.340000000000003 110.928 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 93.81 -150.93 20.05 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.722 -0.752 . . . . 71.409999999999997 112.449 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.768 ' O ' HD13 ' A' ' 34' ' ' LEU . 0.0 OUTLIER -68.9 80.02 0.3 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.81 0.338 . . . . 75.540000000000006 110.843 -179.811 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.478 ' HB2' ' CE1' ' A' ' 11' ' ' TYR . 0.8 OUTLIER -77.99 127.99 33.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.203 -0.453 . . . . 73.150000000000006 110.862 -179.891 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.411 ' CD2' ' CD2' ' A' ' 30' ' ' PHE . 90.5 t80 -124.25 125.59 44.65 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.223 -0.444 . . . . 53.450000000000003 110.957 -179.883 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.46 ' CG ' HG23 ' A' ' 9' ' ' THR . 1.5 m-20 -118.99 132.49 56.07 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.14 -0.482 . . . . 70.420000000000002 110.865 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 12.6 t -161.3 131.01 4.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.208 -0.451 . . . . 65.409999999999997 110.888 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -102.12 4.17 39.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 71.239999999999995 110.888 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 48.7 t -112.9 159.46 19.04 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.46 . . . . 71.109999999999999 110.893 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -42.24 119.97 1.51 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.165 -0.47 . . . . 64.040000000000006 110.847 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.636 ' HB2' ' HB3' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -114.83 43.32 1.98 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.18 -0.464 . . . . 71.230000000000004 110.895 -179.925 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.532 ' O ' ' HA ' ' A' ' 82' ' ' SER . . . -49.97 -21.22 1.13 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.179 -0.464 . . . . 65.030000000000001 111.093 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 64.7 t0 -129.47 40.63 3.57 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.224 -0.444 . . . . 75.109999999999999 110.867 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.763 ' CD2' ' O ' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -82.06 16.39 1.95 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.207 -0.451 . . . . 75.5 110.833 -179.904 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.432 ' HB2' ' HB3' ' A' ' 81' ' ' SER . 34.4 t60 -78.62 -40.82 33.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.213 -0.449 . . . . 75.519999999999996 110.891 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.43 HG23 ' CD2' ' A' ' 33' ' ' TYR . 10.0 t -61.73 -10.65 9.24 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.201 -0.454 . . . . 73.420000000000002 111.12 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.501 ' CD1' ' HA ' ' A' ' 30' ' ' PHE . 12.2 m-85 -99.43 -30.77 12.0 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.217 -0.447 . . . . 74.019999999999996 110.95 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.799 HD22 ' HB2' ' A' ' 10' ' ' PHE . 16.7 tp -141.54 146.15 36.0 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.126 -0.488 . . . . 65.409999999999997 110.933 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.2 m -112.09 -34.65 5.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.154 -0.475 . . . . 61.219999999999999 110.847 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.579 ' O ' HD21 ' A' ' 34' ' ' LEU . 1.8 mtp85 -115.6 140.87 48.77 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.119 -0.491 . . . . 75.510000000000005 110.884 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.595 ' SG ' ' HB2' ' A' ' 80' ' ' LEU . 1.6 p -116.86 54.45 0.86 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.184 -0.462 . . . . 73.109999999999999 110.899 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.48 ' HB3' ' N ' ' A' ' 14' ' ' LYS . 1.9 m-80 -55.02 -65.71 0.53 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.182 -0.463 . . . . 73.409999999999997 110.91 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.406 ' HB2' ' HA ' ' A' ' 68' ' ' PRO . 7.6 p -116.27 128.15 55.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.181 -0.463 . . . . 71.420000000000002 110.832 -179.857 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.593 HD12 ' CZ3' ' A' ' 73' ' ' TRP . 12.0 mt -124.67 147.47 29.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.088 -0.505 . . . . 72.439999999999998 111.13 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.423 ' HD2' ' CE2' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -141.67 118.7 11.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.149 -0.478 . . . . 73.450000000000003 110.884 179.86 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.504 HG12 ' O ' ' A' ' 42' ' ' VAL . 1.0 OUTLIER -104.35 117.46 49.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.461 . . . . 64.439999999999998 111.088 179.908 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -112.34 77.68 1.06 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.173 -0.467 . . . . 51.409999999999997 110.868 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.417 ' O ' ' HA ' ' A' ' 6' ' ' THR . . . 136.88 98.31 0.51 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.73 -0.748 . . . . 70.209999999999994 112.468 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.447 ' HA2' HD21 ' A' ' 88' ' ' LEU . . . 55.36 177.86 0.22 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.725 -0.75 . . . . 65.349999999999994 112.426 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.735 HG23 ' HA ' ' A' ' 63' ' ' PRO . 1.0 OUTLIER -76.32 171.13 15.08 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.77 0.319 . . . . 73.040000000000006 111.166 -179.901 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 47' ' ' TRP . . . . . 0.583 ' CD1' ' HB ' ' A' ' 8' ' ' ILE . 6.1 m95 -143.47 128.77 18.85 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.251 -0.431 . . . . 43.439999999999998 110.921 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.888 ' HB2' ' CG2' ' A' ' 86' ' ' VAL . . . -90.88 126.33 36.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.191 -0.459 . . . . 54.32 111.096 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.823 HG11 HD11 ' A' ' 80' ' ' LEU . 26.9 m -126.32 130.1 71.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.202 -0.454 . . . . 75.329999999999998 111.083 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.8 ' HB3' ' HA ' ' A' ' 56' ' ' ALA . 52.4 m-85 -100.41 148.02 25.19 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.161 -0.472 . . . . 74.209999999999994 110.973 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.568 ' HB3' ' HB3' ' A' ' 57' ' ' TRP . 58.4 tt0 -49.75 -78.07 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.105 -0.498 . . . . 73.219999999999999 110.873 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.484 ' HB3' ' CD1' ' A' ' 55' ' ' PHE . 0.1 OUTLIER -93.36 141.57 24.13 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.614 0.721 . . . . 71.540000000000006 110.859 -179.878 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.661 ' HB3' ' HB3' ' A' ' 81' ' ' SER . 53.7 Cg_endo -69.76 145.25 56.6 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.691 2.261 . . . . 61.210000000000001 112.341 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 61.9 -11.02 0.07 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.201 -0.454 . . . . 74.329999999999998 110.925 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.625 ' H ' ' C ' ' A' ' 53' ' ' PRO . 1.8 m-30 -108.16 -21.29 12.85 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.163 -0.472 . . . . 74.010000000000005 110.831 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.8 ' HA ' ' HB3' ' A' ' 50' ' ' TYR . . . 50.96 26.77 2.85 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.183 -0.462 . . . . 43.43 111.069 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' TRP . . . . . 0.641 ' O ' ' C ' ' A' ' 58' ' ' TYR . 0.8 OUTLIER -48.63 -164.5 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.245 -0.434 . . . . 73.0 110.899 -179.967 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.641 ' C ' ' O ' ' A' ' 57' ' ' TRP . 5.3 m-30 -11.76 100.15 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.236 -0.438 . . . . 73.209999999999994 110.933 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.475 ' HB2' ' HA ' ' A' ' 150' ' ' TYR . 0.0 OUTLIER -60.41 153.36 23.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.154 -0.476 . . . . 62.439999999999998 110.869 179.911 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.659 ' CE2' HD12 ' A' ' 76' ' ' LEU . 2.1 t80 -168.65 107.95 0.48 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.193 -0.458 . . . . 74.420000000000002 110.914 -179.871 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.865 HD13 HG23 ' A' ' 138' ' ' ILE . 4.9 mp -95.73 118.65 42.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.148 -0.478 . . . . 64.040000000000006 111.131 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.848 HD23 ' HD2' ' A' ' 63' ' ' PRO . 0.3 OUTLIER -87.45 126.0 63.64 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.587 0.708 . . . . 73.140000000000001 110.927 179.904 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.848 ' HD2' HD23 ' A' ' 62' ' ' LEU . 54.0 Cg_endo -69.76 -172.81 0.62 Allowed 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.662 2.241 . . . . 63.210000000000001 112.346 179.871 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.67 161.71 15.96 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.209 -0.451 . . . . 75.109999999999999 110.917 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 112.87 -159.49 13.64 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.707 -0.758 . . . . 72.120000000000005 112.5 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -114.71 158.5 21.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.865 0.364 . . . . 72.329999999999998 110.913 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.493 ' N ' ' O ' ' A' ' 40' ' ' ILE . 7.2 m-85 -149.44 80.42 7.69 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.681 0.753 . . . . 74.019999999999996 110.895 -179.837 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.573 ' HD2' ' HG3' ' A' ' 72' ' ' ARG . 53.7 Cg_endo -69.78 1.13 4.73 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.682 2.255 . . . . 75.120000000000005 112.321 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -157.91 155.1 28.96 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.24 -0.436 . . . . 75.340000000000003 110.873 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.807 ' O ' ' CD1' ' A' ' 73' ' ' TRP . 18.9 p90 -66.97 -7.97 26.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.164 -0.471 . . . . 74.200000000000003 110.947 -179.883 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -90.44 -16.32 29.23 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.102 -0.499 . . . . 63.229999999999997 110.909 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.573 ' HG3' ' HD2' ' A' ' 68' ' ' PRO . 25.5 mmt180 -75.01 -22.87 58.23 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.203 -0.453 . . . . 72.329999999999998 110.919 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' TRP . . . . . 0.807 ' CD1' ' O ' ' A' ' 70' ' ' TYR . 0.5 OUTLIER -109.39 8.22 25.35 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.148 -0.478 . . . . 65.430000000000007 110.927 -179.967 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 74' ' ' MET . . . . . 0.504 ' C ' ' O ' ' A' ' 73' ' ' TRP . 0.0 OUTLIER 30.23 55.48 0.17 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.205 -0.452 . . . . 71.129999999999995 110.903 179.954 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.527 ' CA ' ' OH ' ' A' ' 60' ' ' TYR . . . -91.77 -170.14 41.65 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.781 -0.723 . . . . 72.109999999999999 112.469 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.671 HD21 ' HA ' ' A' ' 148' ' ' ARG . 0.1 OUTLIER -107.87 -74.28 0.66 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.834 0.35 . . . . 74.030000000000001 110.915 -179.936 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -96.84 147.01 24.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.146 -0.479 . . . . 74.239999999999995 110.914 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.406 ' O ' ' SG ' ' A' ' 37' ' ' CYS . 15.8 p30 -95.71 34.05 1.56 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.203 -0.453 . . . . 41.340000000000003 110.877 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 4.3 ttm-85 -105.69 79.47 1.44 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 72.030000000000001 110.851 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.823 HD11 HG11 ' A' ' 49' ' ' VAL . 0.1 OUTLIER -82.82 130.3 35.11 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.179 -0.464 . . . . 73.019999999999996 110.955 179.976 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.661 ' HB3' ' HB3' ' A' ' 53' ' ' PRO . 1.3 m -152.24 -123.51 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.22 -0.446 . . . . 64.230000000000004 110.858 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.619 ' OG ' ' HA ' ' A' ' 53' ' ' PRO . 0.2 OUTLIER -41.0 99.98 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.118 -0.492 . . . . 60.329999999999998 110.855 -179.82 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 83' ' ' CYS . . . . . 0.72 ' HB3' HG12 ' A' ' 49' ' ' VAL . 8.9 p -127.0 134.38 50.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.131 -0.486 . . . . 64.299999999999997 110.863 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.617 ' N ' ' O ' ' A' ' 48' ' ' ALA . 4.5 mmt85 -115.47 158.32 22.72 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.194 -0.457 . . . . 64.510000000000005 110.902 -179.879 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -72.08 129.61 38.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.46 . . . . 72.450000000000003 111.104 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.888 ' CG2' ' HB2' ' A' ' 48' ' ' ALA . 61.5 t -116.02 136.23 53.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.213 -0.449 . . . . 62.32 111.142 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' HIS . . . . . 0.587 ' O ' HG23 ' A' ' 136' ' ' VAL . 40.2 m80 -113.89 108.09 16.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.162 -0.472 . . . . 74.129999999999995 110.872 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.465 ' H ' HD23 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -35.39 144.94 0.22 Allowed Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.621 0.724 . . . . 75.329999999999998 110.91 -179.971 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.475 ' HB3' ' H ' ' A' ' 136' ' ' VAL . 53.9 Cg_endo -69.73 104.24 1.28 Allowed 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.678 2.252 . . . . 74.040000000000006 112.317 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -103.16 165.68 10.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.231 -0.441 . . . . 65.450000000000003 110.859 -179.836 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 66.65 129.02 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.737 -0.744 . . . . 73.129999999999995 112.535 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.417 ' C ' ' HG2' ' A' ' 93' ' ' GLN . . . 51.1 33.92 30.78 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.721 -0.752 . . . . 43.009999999999998 112.495 -179.893 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.453 ' O ' ' CG ' ' A' ' 134' ' ' GLU . 27.7 pt20 39.07 -154.72 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.848 0.356 . . . . 71.239999999999995 110.911 -179.883 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.48 ' HA ' ' CG ' ' A' ' 134' ' ' GLU . 25.2 t80 -95.19 108.26 20.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.178 -0.464 . . . . 73.439999999999998 110.935 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.527 ' HG3' HG11 ' A' ' 132' ' ' VAL . 11.7 tptt -107.88 127.94 54.18 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.111 -0.495 . . . . 72.129999999999995 110.89 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.585 HD13 ' H ' ' A' ' 97' ' ' GLN . 0.4 OUTLIER -152.25 134.37 5.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.186 -0.461 . . . . 71.099999999999994 111.138 179.85 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.585 ' H ' HD13 ' A' ' 96' ' ' ILE . 1.2 mt-30 -109.08 124.63 51.07 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.169 -0.469 . . . . 61.530000000000001 110.913 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.767 HD13 HD11 ' A' ' 118' ' ' ILE . 7.9 mt -101.19 140.64 19.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.2 -0.455 . . . . 70.439999999999998 111.136 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.522 ' CD2' ' HA ' ' A' ' 104' ' ' PHE . 48.1 m-85 -129.0 146.02 51.09 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 64.219999999999999 110.835 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -80.19 -28.65 38.67 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.095 -0.502 . . . . 71.400000000000006 110.866 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 29.5 mttt -122.11 166.26 14.82 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.152 -0.476 . . . . 64.010000000000005 110.908 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.472 ' HA2' ' HB3' ' A' ' 129' ' ' SER . . . -68.48 178.98 22.13 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.751 -0.738 . . . . 41.520000000000003 112.473 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.403 ' C ' ' CG ' ' A' ' 104' ' ' PHE . 38.4 t70 40.91 36.26 0.41 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.845 0.355 . . . . 73.409999999999997 110.865 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.672 ' N ' ' CD2' ' A' ' 104' ' ' PHE . 0.0 OUTLIER 50.95 73.13 0.31 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.171 -0.468 . . . . 74.120000000000005 110.918 -179.877 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 1.2 m -139.52 161.04 38.46 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.119 -0.491 . . . . 35.149999999999999 110.879 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 79.79 -142.2 24.28 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.78 -0.724 . . . . 74.239999999999995 112.49 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 3.1 tp-100 -71.03 111.76 6.65 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.749 0.309 . . . . 71.019999999999996 110.933 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' MET . . . . . 0.495 ' HB2' ' CE2' ' A' ' 99' ' ' PHE . 5.9 ttp -106.62 149.12 27.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.254 -0.43 . . . . 73.129999999999995 110.894 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -153.19 135.15 14.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.227 -0.442 . . . . 73.409999999999997 110.891 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -110.19 97.55 7.0 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.117 -0.492 . . . . 74.129999999999995 110.888 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 9.7 t -110.3 132.19 54.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.141 -0.481 . . . . 71.540000000000006 111.134 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.445 ' O ' ' OG1' ' A' ' 112' ' ' THR . 1.1 t -119.37 36.43 4.48 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.182 -0.463 . . . . 74.140000000000001 111.162 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 53.5 mt-10 -151.34 165.59 33.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.241 -0.436 . . . . 63.310000000000002 110.891 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -56.25 164.24 1.38 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.136 -0.484 . . . . 52.32 110.856 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 115' ' ' CYS . . . . . 0.494 ' O ' ' HB2' ' A' ' 172' ' ' SER . 18.4 t -153.12 117.59 2.84 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.617 0.722 . . . . 62.030000000000001 110.886 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.426 ' O ' ' C ' ' A' ' 143' ' ' PRO . 53.4 Cg_endo -69.75 -31.97 19.52 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.716 2.277 . . . . 73.219999999999999 112.311 -179.906 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.642 ' HB3' ' CB ' ' A' ' 120' ' ' GLU . 0.1 OUTLIER -148.82 104.51 3.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.23 -0.441 . . . . 54.119999999999997 110.914 -179.834 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.767 HD11 HD13 ' A' ' 98' ' ' ILE . 2.9 tt -57.84 -29.46 35.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.131 -0.486 . . . . 61.340000000000003 111.129 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 119' ' ' MET . . . . . 0.598 ' O ' ' HA ' ' A' ' 123' ' ' HIS . 11.6 ttp -86.77 -42.96 12.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 64.510000000000005 110.835 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.642 ' CB ' ' HB3' ' A' ' 117' ' ' SER . 6.7 tp10 -67.66 -13.23 61.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.271 -0.422 . . . . 71.030000000000001 110.856 -179.916 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 28.3 tp60 -115.48 -48.72 2.78 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.151 -0.477 . . . . 72.430000000000007 110.894 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.5 ' HB2' ' O ' ' A' ' 118' ' ' ILE . 33.8 m-85 -103.69 -20.28 14.03 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.253 -0.431 . . . . 75.129999999999995 110.912 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 123' ' ' HIS . . . . . 0.598 ' HA ' ' O ' ' A' ' 119' ' ' MET . 0.2 OUTLIER 71.9 26.41 2.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.114 -0.493 . . . . 71.329999999999998 110.854 -179.977 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.463 ' SD ' HG22 ' A' ' 98' ' ' ILE . 7.1 mtt -102.56 83.99 2.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.214 -0.448 . . . . 72.109999999999999 110.868 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 1.8 ptp85 -52.12 -29.94 24.11 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.264 -0.426 . . . . 72.400000000000006 110.852 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.504 ' HG2' ' HA ' ' A' ' 169' ' ' ALA . 20.9 mt-10 -146.22 130.73 17.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.215 -0.448 . . . . 63.549999999999997 110.921 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.653 HD11 HD13 ' A' ' 118' ' ' ILE . 4.4 mm -91.37 103.92 14.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.15 -0.477 . . . . 71.129999999999995 111.137 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 128' ' ' HIS . . . . . 0.421 ' HB3' ' N ' ' A' ' 102' ' ' GLY . 2.3 m170 -71.53 -29.61 64.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.169 -0.469 . . . . 75.129999999999995 110.865 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 129' ' ' SER . . . . . 0.472 ' HB3' ' HA2' ' A' ' 102' ' ' GLY . 0.3 OUTLIER -153.55 152.74 31.26 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.182 -0.463 . . . . 73.530000000000001 110.824 -179.819 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 130' ' ' CYS . . . . . 0.72 ' O ' ' HB2' ' A' ' 157' ' ' TYR . 0.0 OUTLIER -146.57 112.12 5.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.085 -0.507 . . . . 51.539999999999999 110.885 -179.942 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.765 ' HA ' ' HA ' ' A' ' 156' ' ' GLU . 13.4 mtpt -90.78 147.74 23.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 73.140000000000001 110.908 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.553 HG12 ' N ' ' A' ' 133' ' ' LEU . 11.3 t 85.03 165.33 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.283 -0.417 . . . . 52.130000000000003 111.149 179.875 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.774 HD22 ' HA ' ' A' ' 155' ' ' LYS . 0.3 OUTLIER -179.1 127.79 0.1 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.176 -0.466 . . . . 71.430000000000007 110.876 179.959 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.48 ' CG ' ' HA ' ' A' ' 94' ' ' TYR . 0.0 OUTLIER -89.14 -171.51 3.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.116 -0.493 . . . . 60.210000000000001 110.881 179.94 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -48.79 -52.83 19.7 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.77 -0.729 . . . . 50.32 112.463 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.81 ' HB ' HD12 ' A' ' 176' ' ' ILE . 3.6 t -147.48 146.92 17.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.841 0.353 . . . . 53.32 111.1 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 137' ' ' TRP . . . . . 0.667 ' HB3' ' CB ' ' A' ' 152' ' ' LEU . 23.0 t90 -147.04 143.13 28.14 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.196 -0.457 . . . . 73.219999999999999 110.932 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.865 HG23 HD13 ' A' ' 61' ' ' ILE . 14.0 mt -123.53 133.69 68.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.244 -0.434 . . . . 60.409999999999997 111.119 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.517 ' CE1' ' HB3' ' A' ' 173' ' ' PHE . 0.1 OUTLIER -99.41 166.42 11.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.173 -0.467 . . . . 73.019999999999996 110.918 179.936 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -142.17 125.96 17.05 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.159 -0.473 . . . . 62.219999999999999 110.925 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 141' ' ' GLU . . . . . 0.623 ' O ' ' HB2' ' A' ' 171' ' ' GLN . 0.5 OUTLIER -58.77 -25.22 62.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.119 -0.492 . . . . 72.409999999999997 110.928 179.977 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.742 ' HB3' ' HD2' ' A' ' 143' ' ' PRO . 9.3 mp -115.65 173.67 2.84 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.635 0.731 . . . . 73.120000000000005 110.898 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 143' ' ' PRO . . . . . 0.805 ' O ' ' OG ' ' A' ' 172' ' ' SER . 54.3 Cg_endo -69.74 -87.59 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.667 2.245 . . . . 62.5 112.325 179.826 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 144' ' ' ASN . . . . . 0.699 ' O ' ' N ' ' A' ' 146' ' ' ARG . 1.1 m-20 -53.71 96.23 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.205 -0.452 . . . . 54.439999999999998 110.889 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 145' ' ' TYR . . . . . 0.641 ' C ' ' O ' ' A' ' 144' ' ' ASN . 0.0 OUTLIER 13.23 52.6 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.136 -0.484 . . . . 74.549999999999997 110.933 -179.933 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 146' ' ' ARG . . . . . 0.699 ' N ' ' O ' ' A' ' 144' ' ' ASN . 10.6 mtp85 -119.49 174.66 6.25 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.108 -0.496 . . . . 74.299999999999997 110.843 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 79.64 -179.96 52.71 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.754 -0.736 . . . . 74.310000000000002 112.469 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.671 ' HA ' HD21 ' A' ' 76' ' ' LEU . 17.2 mtt180 -71.67 144.41 49.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.808 0.337 . . . . 71.129999999999995 110.896 -179.893 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 149' ' ' GLN . . . . . 0.536 ' HB2' ' HA ' ' A' ' 60' ' ' TYR . 49.5 mt-30 -83.28 148.51 27.33 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.158 -0.474 . . . . 74.430000000000007 110.937 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 150' ' ' TYR . . . . . 0.496 ' HB2' ' HB2' ' A' ' 139' ' ' PHE . 87.3 m-85 -132.81 118.92 19.59 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.221 -0.445 . . . . 74.200000000000003 110.902 -179.824 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.756 ' CA ' HD11 ' A' ' 61' ' ' ILE . 18.7 tp -69.91 136.37 50.53 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.095 -0.502 . . . . 71.230000000000004 110.951 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 1.055 HD13 ' O ' ' A' ' 152' ' ' LEU . 0.0 OUTLIER -74.02 135.81 43.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.208 -0.451 . . . . 74.349999999999994 110.945 179.873 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 153' ' ' ASP . . . . . 0.93 ' O ' ' HB2' ' A' ' 154' ' ' LYS . 54.5 t0 -161.39 109.65 1.51 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.21 -0.45 . . . . 65.409999999999997 110.877 179.852 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.93 ' HB2' ' O ' ' A' ' 153' ' ' ASP . 0.4 OUTLIER 156.07 -133.29 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.235 -0.439 . . . . 74.430000000000007 110.913 179.996 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.774 ' HA ' HD22 ' A' ' 133' ' ' LEU . 0.4 OUTLIER -164.98 -94.78 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.185 -0.461 . . . . 75.400000000000006 110.868 179.861 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.765 ' HA ' ' HA ' ' A' ' 131' ' ' LYS . 0.3 OUTLIER -89.76 9.34 27.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.262 -0.426 . . . . 74.25 110.908 179.927 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 157' ' ' TYR . . . . . 0.813 ' CZ ' ' HB3' ' A' ' 154' ' ' LYS . 1.9 m-85 20.4 108.14 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.124 -0.489 . . . . 65.049999999999997 110.945 -179.859 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.35 -34.03 8.9 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.151 -0.477 . . . . 74.019999999999996 110.856 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 159' ' ' LYS . . . . . 0.4 ' HB2' ' HD2' ' A' ' 160' ' ' PRO . 2.8 ptpt -108.92 158.72 33.43 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.654 0.74 . . . . 71.450000000000003 110.862 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 160' ' ' PRO . . . . . 0.463 ' HB2' ' HD3' ' A' ' 168' ' ' PRO . 53.9 Cg_endo -69.73 -21.57 33.43 Favored 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.7 2.267 . . . . 60.420000000000002 112.322 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.624 HD12 ' H ' ' A' ' 161' ' ' ILE . 3.4 mp -82.5 3.75 2.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.244 -0.435 . . . . 53.439999999999998 111.149 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.402 ' HB3' ' CD1' ' A' ' 157' ' ' TYR . 3.7 m-20 -64.58 -12.85 49.47 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.163 -0.471 . . . . 65.510000000000005 110.839 179.896 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 163' ' ' TRP . . . . . 0.492 ' CZ2' ' HB2' ' A' ' 130' ' ' CYS . 19.7 m-90 -105.47 -16.24 14.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.217 -0.447 . . . . 72.109999999999999 110.957 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 112.13 -35.33 4.72 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.743 -0.741 . . . . 44.039999999999999 112.491 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -62.68 126.58 27.81 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.759 0.314 . . . . 52.329999999999998 111.126 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -41.01 -37.5 0.83 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.217 -0.447 . . . . 74.040000000000006 111.135 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 167' ' ' SER . . . . . 0.483 ' C ' ' H ' ' A' ' 169' ' ' ALA . 0.3 OUTLIER -130.66 157.33 78.0 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.665 0.745 . . . . 64.349999999999994 110.863 -179.811 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 168' ' ' PRO . . . . . 0.463 ' HD3' ' HB2' ' A' ' 160' ' ' PRO . 53.6 Cg_endo -69.74 24.0 0.17 Allowed 'Trans proline' 0 C--N 1.341 0.137 0 C-N-CA 122.642 2.228 . . . . 75.409999999999997 112.397 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 0.504 ' HA ' ' HG2' ' A' ' 126' ' ' GLU . . . -65.57 107.02 1.58 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.204 -0.453 . . . . 75.200000000000003 111.097 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.441 HG11 ' CE1' ' A' ' 139' ' ' PHE . 3.3 t -152.94 159.83 3.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.195 -0.457 . . . . 74.209999999999994 111.155 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 171' ' ' GLN . . . . . 0.623 ' HB2' ' O ' ' A' ' 141' ' ' GLU . 1.7 tm0? -105.7 -81.19 0.54 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.202 -0.454 . . . . 74.310000000000002 110.933 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 172' ' ' SER . . . . . 0.805 ' OG ' ' O ' ' A' ' 143' ' ' PRO . 51.6 p -127.2 -178.23 4.36 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 55.119999999999997 110.88 -179.817 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 173' ' ' PHE . . . . . 0.517 ' HB3' ' CE1' ' A' ' 139' ' ' PHE . 27.5 p90 -142.66 167.07 22.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.181 -0.463 . . . . 74.450000000000003 110.871 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.88 130.1 19.74 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.127 -0.488 . . . . 62.140000000000001 110.852 -179.876 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.47 -169.96 1.62 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.179 -0.464 . . . . 73.540000000000006 110.849 -179.896 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 176' ' ' ILE . . . . . 0.81 HD12 ' HB ' ' A' ' 136' ' ' VAL . 3.7 mt -137.12 134.19 47.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 65.340000000000003 111.141 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 95.3 t -150.45 142.37 16.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.181 -0.463 . . . . 74.349999999999994 111.121 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 178' ' ' GLU . . . . . 0.432 ' HB3' HD13 ' A' ' 88' ' ' LEU . 5.3 pt-20 . . . . . 0 C--N 1.33 -0.261 0 CA-C-N 116.175 -0.466 . . . . 72.030000000000001 110.922 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.317 0 N-CA-C 112.49 -0.244 . . . . 71.219999999999999 112.49 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.446 ' HB ' ' O ' ' A' ' 44' ' ' GLY . 12.8 p -82.56 133.18 35.19 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.847 0.356 . . . . 72.25 111.132 -179.844 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 3.0 tttt -122.4 137.74 54.76 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.214 -0.448 . . . . 73.540000000000006 110.908 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.587 ' HB ' ' CD1' ' A' ' 47' ' ' TRP . 15.1 tt -138.38 149.48 24.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.181 -0.463 . . . . 71.329999999999998 111.168 179.871 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.497 HG23 ' CG ' ' A' ' 22' ' ' ASP . 15.3 m -129.22 140.4 51.49 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.174 -0.466 . . . . 54.549999999999997 111.105 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.82 ' HB2' HD22 ' A' ' 34' ' ' LEU . 0.7 OUTLIER -126.56 130.86 51.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.183 -0.462 . . . . 65.109999999999999 110.855 -179.973 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.547 ' CG ' ' HA ' ' A' ' 16' ' ' PHE . 44.5 m-85 -117.41 129.82 56.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.114 -0.494 . . . . 71.140000000000001 110.926 -179.877 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.498 ' HG2' ' HB2' ' A' ' 36' ' ' ARG . 0.0 OUTLIER -59.04 -23.95 62.44 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.105 -0.498 . . . . 75.140000000000001 110.864 -179.951 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 -127.54 152.67 47.31 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.144 -0.48 . . . . 71.519999999999996 110.853 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.436 ' N ' ' HB3' ' A' ' 38' ' ' ASN . 4.2 mtmp? -56.02 -175.36 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.16 -0.473 . . . . 61.219999999999999 110.916 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 22.0 m-20 46.02 36.08 2.83 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.242 -0.435 . . . . 73.540000000000006 110.879 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.547 ' HA ' ' CG ' ' A' ' 11' ' ' TYR . 4.4 m-85 47.12 57.7 5.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.218 -0.446 . . . . 74.340000000000003 110.901 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -132.85 159.91 38.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.141 -0.481 . . . . 74.150000000000006 110.879 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 93.41 -151.39 20.34 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.74 -0.743 . . . . 63.450000000000003 112.486 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.786 ' O ' HD13 ' A' ' 34' ' ' LEU . 0.0 OUTLIER -67.95 80.92 0.21 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.788 0.327 . . . . 74.409999999999997 110.854 -179.84 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.494 ' HA ' ' O ' ' A' ' 10' ' ' PHE . 0.0 OUTLIER -78.83 128.91 33.99 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.222 -0.445 . . . . 75.299999999999997 110.864 -179.926 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.511 ' CD2' ' CD2' ' A' ' 30' ' ' PHE . 81.3 t80 -124.57 123.6 40.44 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.174 -0.466 . . . . 73.430000000000007 110.876 -179.825 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.497 ' CG ' HG23 ' A' ' 9' ' ' THR . 1.3 m-20 -119.17 134.02 55.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.116 -0.493 . . . . 74.450000000000003 110.871 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -165.95 136.61 3.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.234 -0.439 . . . . 64.239999999999995 110.887 -179.886 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -105.1 4.82 31.84 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.202 -0.454 . . . . 74.400000000000006 110.85 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 13.4 t -108.14 165.98 11.08 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.22 -0.445 . . . . 55.240000000000002 110.916 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -62.67 116.75 5.45 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.195 -0.457 . . . . 62.32 110.857 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.476 ' HB2' ' HB3' ' A' ' 30' ' ' PHE . 7.9 m -118.11 53.93 0.94 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.194 -0.457 . . . . 74.140000000000001 110.87 -179.924 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.53 ' C ' ' HA ' ' A' ' 82' ' ' SER . . . -45.83 -19.72 0.07 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.156 -0.474 . . . . 54.210000000000001 111.106 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 53.1 t0 -128.46 42.01 3.39 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.246 -0.433 . . . . 54.509999999999998 110.853 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.784 ' CD2' ' O ' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -80.63 13.98 2.3 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.214 -0.448 . . . . 61.43 110.87 -179.899 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.493 ' HB2' ' HB3' ' A' ' 53' ' ' PRO . 29.0 t60 -78.74 -37.18 41.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.157 -0.474 . . . . 75.099999999999994 110.852 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.5 t -59.27 -13.17 6.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.182 -0.463 . . . . 75.430000000000007 111.095 -179.878 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -101.39 -26.41 13.6 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.263 -0.426 . . . . 74.030000000000001 110.95 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.82 HD22 ' HB2' ' A' ' 10' ' ' PHE . 16.6 tp -142.87 139.96 31.05 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.073 -0.512 . . . . 72.25 110.966 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.1 m -109.05 -32.16 7.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.201 -0.454 . . . . 74.120000000000005 110.859 -179.877 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.498 ' HB2' ' HG2' ' A' ' 12' ' ' GLU . 1.9 mtp85 -115.59 140.36 49.25 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.102 -0.499 . . . . 74.420000000000002 110.905 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.543 ' SG ' ' O ' ' A' ' 78' ' ' ASP . 1.3 p -117.65 54.23 0.91 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.249 -0.432 . . . . 71.430000000000007 110.866 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.436 ' HB3' ' N ' ' A' ' 14' ' ' LYS . 1.9 m-80 -54.29 -70.09 0.11 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.465 . . . . 74.200000000000003 110.9 -179.889 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 6.4 p -111.83 129.53 56.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.175 -0.466 . . . . 74.230000000000004 110.85 -179.868 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.649 HG21 HD13 ' A' ' 62' ' ' LEU . 20.1 mt -126.08 151.35 32.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.104 -0.498 . . . . 61.140000000000001 111.09 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.421 ' N ' ' CG2' ' A' ' 40' ' ' ILE . 0.0 OUTLIER -143.74 119.33 10.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.147 -0.479 . . . . 72.420000000000002 110.894 179.825 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.534 HG22 ' HB ' ' A' ' 8' ' ' ILE . 1.2 t -103.98 116.13 47.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.227 -0.442 . . . . 62.310000000000002 111.134 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -112.36 80.53 1.35 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.199 -0.455 . . . . 70.400000000000006 110.894 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.446 ' O ' ' HB ' ' A' ' 6' ' ' THR . . . 130.34 102.06 0.95 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.727 -0.749 . . . . 73.120000000000005 112.493 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 54.35 178.36 0.14 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.763 -0.732 . . . . 72.030000000000001 112.523 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.728 HG23 ' HA ' ' A' ' 63' ' ' PRO . 1.3 m -81.99 171.47 14.37 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.725 0.297 . . . . 62.310000000000002 111.153 -179.886 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' TRP . . . . . 0.597 ' H ' HG22 ' A' ' 46' ' ' THR . 15.9 m95 -141.92 130.0 22.04 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.217 -0.447 . . . . 74.219999999999999 110.915 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.905 ' HB2' ' CG2' ' A' ' 86' ' ' VAL . . . -95.37 111.99 23.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.231 -0.44 . . . . 70.430000000000007 111.113 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.626 HG11 HD13 ' A' ' 80' ' ' LEU . 5.6 m -115.0 129.55 71.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.218 -0.447 . . . . 73.010000000000005 111.153 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.771 ' HB3' ' HA ' ' A' ' 56' ' ' ALA . 35.7 m-85 -95.61 150.6 20.16 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.148 -0.478 . . . . 73.310000000000002 110.89 -179.876 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.626 ' HB2' ' O ' ' A' ' 58' ' ' TYR . 7.1 tt0 -46.51 -77.77 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.104 -0.498 . . . . 74.549999999999997 110.889 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.622 ' HB3' ' CD1' ' A' ' 55' ' ' PHE . 1.6 mtp180 -93.44 145.95 30.93 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.567 0.699 . . . . 70.400000000000006 110.877 -179.853 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.731 ' HA ' ' OG ' ' A' ' 82' ' ' SER . 53.7 Cg_endo -69.76 134.12 27.22 Favored 'Trans proline' 0 C--N 1.34 0.126 0 C-N-CA 122.715 2.276 . . . . 74.019999999999996 112.329 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 66.38 -9.88 0.29 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.267 -0.424 . . . . 71.310000000000002 110.899 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.622 ' CD1' ' HB3' ' A' ' 52' ' ' ARG . 4.2 m-30 -100.22 -25.92 14.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.176 -0.465 . . . . 73.400000000000006 110.868 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.771 ' HA ' ' HB3' ' A' ' 50' ' ' TYR . . . 57.09 23.0 7.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.17 -0.468 . . . . 75.349999999999994 111.092 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' TRP . . . . . 0.643 ' O ' ' C ' ' A' ' 58' ' ' TYR . 3.4 m0 -52.49 -165.0 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.21 -0.45 . . . . 72.439999999999998 110.897 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.643 ' C ' ' O ' ' A' ' 57' ' ' TRP . 5.4 m-30 -12.1 103.84 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.246 -0.434 . . . . 73.349999999999994 110.917 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.52 ' HB2' ' HA ' ' A' ' 150' ' ' TYR . 2.0 mpt? -61.52 148.12 43.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.138 -0.483 . . . . 73.319999999999993 110.848 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.617 ' O ' HG23 ' A' ' 49' ' ' VAL . 0.3 OUTLIER -161.01 97.66 1.15 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.204 -0.453 . . . . 74.239999999999995 110.919 -179.834 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.745 HD11 ' HA ' ' A' ' 151' ' ' LEU . 4.6 mp -89.18 114.52 27.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.14 -0.482 . . . . 74.129999999999995 111.101 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.832 HD23 ' HD2' ' A' ' 63' ' ' PRO . 0.6 OUTLIER -85.16 122.21 73.96 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.598 0.713 . . . . 72.120000000000005 110.927 179.906 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.832 ' HD2' HD23 ' A' ' 62' ' ' LEU . 54.0 Cg_endo -69.71 -167.49 0.23 Allowed 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.736 2.291 . . . . 71.209999999999994 112.324 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.55 160.98 14.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.205 -0.452 . . . . 72.0 110.941 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 114.93 -146.57 18.83 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.714 -0.755 . . . . 73.329999999999998 112.516 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -128.3 158.37 38.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.876 0.369 . . . . 72.299999999999997 110.912 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.508 ' N ' ' O ' ' A' ' 40' ' ' ILE . 5.7 m-85 -146.78 81.62 9.06 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.648 0.737 . . . . 72.420000000000002 110.911 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.468 ' HD2' ' HG3' ' A' ' 72' ' ' ARG . 53.8 Cg_endo -69.81 1.4 4.51 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.643 2.229 . . . . 74.230000000000004 112.344 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.413 ' HA ' ' HG2' ' A' ' 14' ' ' LYS . 86.2 mt-10 -156.9 155.08 30.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.212 -0.449 . . . . 62.32 110.891 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.82 ' O ' ' CD1' ' A' ' 73' ' ' TRP . 8.9 p90 -70.6 -1.93 12.67 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.161 -0.472 . . . . 74.109999999999999 110.954 -179.907 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -91.22 -13.82 32.12 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.132 -0.485 . . . . 72.540000000000006 110.968 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.468 ' HG3' ' HD2' ' A' ' 68' ' ' PRO . 23.2 mmt180 -73.7 -5.35 40.04 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.162 -0.472 . . . . 75.299999999999997 110.902 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' TRP . . . . . 0.82 ' CD1' ' O ' ' A' ' 70' ' ' TYR . 0.4 OUTLIER -134.71 4.93 3.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.165 -0.47 . . . . 73.409999999999997 110.877 -179.933 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 74' ' ' MET . . . . . 0.466 ' CB ' ' O ' ' A' ' 73' ' ' TRP . 0.0 OUTLIER 81.13 -17.89 0.53 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.263 -0.426 . . . . 61.520000000000003 110.893 179.956 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.458 ' N ' ' CD1' ' A' ' 73' ' ' TRP . . . 40.32 57.66 2.59 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.757 -0.735 . . . . 64.540000000000006 112.461 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.577 ' HG ' ' CE2' ' A' ' 60' ' ' TYR . 3.1 pp -50.85 -36.84 39.73 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.787 0.327 . . . . 43.350000000000001 110.878 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.562 ' O ' ' CB ' ' A' ' 78' ' ' ASP . 23.7 t-20 -121.82 -47.13 2.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.202 -0.454 . . . . 74.120000000000005 110.864 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.562 ' CB ' ' O ' ' A' ' 77' ' ' ASN . 6.3 t0 89.61 5.3 0.14 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.193 -0.458 . . . . 52.130000000000003 110.862 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 1.2 ttm-85 -110.46 102.29 10.92 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.176 -0.465 . . . . 74.409999999999997 110.898 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.626 HD13 HG11 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -101.12 134.68 43.77 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.225 -0.443 . . . . 73.519999999999996 110.93 -179.996 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.578 ' HB3' ' HB3' ' A' ' 53' ' ' PRO . 1.2 m -151.15 -119.35 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.212 -0.449 . . . . 74.540000000000006 110.859 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.731 ' OG ' ' HA ' ' A' ' 53' ' ' PRO . 0.5 OUTLIER -38.31 107.65 0.07 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.168 -0.469 . . . . 52.310000000000002 110.882 -179.789 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 83' ' ' CYS . . . . . 0.529 ' HA ' ' O ' ' A' ' 48' ' ' ALA . 8.3 p -115.96 146.66 41.92 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.164 -0.471 . . . . 73.140000000000001 110.859 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.54 ' N ' ' O ' ' A' ' 48' ' ' ALA . 0.1 OUTLIER -144.59 128.95 17.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.192 -0.458 . . . . 71.209999999999994 110.866 -179.834 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.46 ' N ' ' CZ3' ' A' ' 47' ' ' TRP . . . -48.47 127.81 13.76 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.209 -0.45 . . . . 60.030000000000001 111.101 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.905 ' CG2' ' HB2' ' A' ' 48' ' ' ALA . 25.0 t -115.17 139.02 43.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.2 -0.454 . . . . 60.439999999999998 111.14 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' HIS . . . . . 0.556 ' O ' ' CG2' ' A' ' 136' ' ' VAL . 11.8 m170 -112.41 107.11 15.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.164 -0.471 . . . . 74.299999999999997 110.835 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.472 ' C ' ' O ' ' A' ' 87' ' ' HIS . 0.0 OUTLIER -32.57 152.96 0.04 OUTLIER Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.619 0.723 . . . . 73.129999999999995 110.906 -179.996 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.557 ' HB3' ' H ' ' A' ' 136' ' ' VAL . 53.6 Cg_endo -69.79 84.72 0.65 Allowed 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.689 2.26 . . . . 74.230000000000004 112.335 179.845 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -83.27 -171.29 3.49 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.228 -0.442 . . . . 72.120000000000005 110.832 -179.842 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 72.05 68.03 1.7 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.754 -0.736 . . . . 73.209999999999994 112.442 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 97.03 -69.88 0.79 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.764 -0.731 . . . . 71.109999999999999 112.513 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.417 ' HB2' ' H ' ' A' ' 94' ' ' TYR . 14.6 pt20 171.39 -148.88 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.774 0.321 . . . . 65.129999999999995 110.933 -179.9 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.504 ' O ' ' HA ' ' A' ' 112' ' ' THR . 0.0 OUTLIER -107.53 101.78 11.09 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.184 -0.462 . . . . 74.409999999999997 110.918 -179.865 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.442 ' HG3' HG11 ' A' ' 132' ' ' VAL . 28.2 tptt -102.07 130.0 48.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.096 -0.502 . . . . 63.409999999999997 110.917 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -149.29 135.26 11.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.238 -0.437 . . . . 54.219999999999999 111.158 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.426 ' HB2' HG23 ' A' ' 132' ' ' VAL . 1.6 mt-30 -107.87 131.59 54.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.156 -0.474 . . . . 62.340000000000003 110.915 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.529 ' CG2' HD12 ' A' ' 127' ' ' ILE . 1.5 mp -113.46 131.31 65.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.186 -0.461 . . . . 72.150000000000006 111.104 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.605 ' HB2' ' HB2' ' A' ' 129' ' ' SER . 74.0 m-85 -122.19 136.87 54.97 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.162 -0.472 . . . . 73.140000000000001 110.895 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 57.3 tt0 -67.31 -73.94 0.13 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.167 -0.469 . . . . 75.319999999999993 110.867 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.518 ' C ' ' HB2' ' A' ' 128' ' ' HIS . 5.1 mttt -84.54 165.73 17.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.193 -0.458 . . . . 74.200000000000003 110.954 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -72.23 160.58 54.1 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.757 -0.735 . . . . 40.030000000000001 112.461 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.443 ' HA ' ' HB2' ' A' ' 158' ' ' ARG . 29.5 t70 62.56 32.68 16.35 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.819 0.343 . . . . 74.25 110.878 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.508 ' CZ ' ' HB3' ' A' ' 158' ' ' ARG . 13.5 m-85 56.98 49.16 14.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.185 -0.461 . . . . 72.030000000000001 110.866 -179.892 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.1 m -113.62 150.97 32.37 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.206 -0.452 . . . . 74.040000000000006 110.85 -179.783 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 89.24 -123.67 6.98 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.762 -0.733 . . . . 72.439999999999998 112.471 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 7.6 tp-100 -101.21 141.26 34.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.79 0.329 . . . . 74.439999999999998 110.877 -179.823 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 3.2 ttp -131.5 131.52 43.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.211 -0.45 . . . . 74.349999999999994 110.876 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 10.0 m-85 -136.81 137.31 39.64 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.451 . . . . 70.430000000000007 110.958 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -118.91 112.71 19.98 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.12 -0.491 . . . . 61.350000000000001 110.891 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.471 HG22 HD11 ' A' ' 98' ' ' ILE . 11.9 t -125.51 150.41 47.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.152 -0.476 . . . . 72.019999999999996 111.104 -179.872 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.504 ' HA ' ' O ' ' A' ' 94' ' ' TYR . 1.4 t -124.49 47.76 2.06 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.177 -0.465 . . . . 74.310000000000002 111.112 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -152.58 -178.21 6.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.227 -0.442 . . . . 63.5 110.893 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -73.86 164.98 25.93 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.165 -0.47 . . . . 63.240000000000002 110.849 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 115' ' ' CYS . . . . . 0.536 ' O ' ' HB2' ' A' ' 172' ' ' SER . 4.8 t -154.33 113.69 2.47 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.591 0.71 . . . . 63.350000000000001 110.889 -179.924 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.41 ' O ' ' CA ' ' A' ' 143' ' ' PRO . 53.1 Cg_endo -69.81 -30.2 22.4 Favored 'Trans proline' 0 C--O 1.231 0.15 0 C-N-CA 122.686 2.257 . . . . 51.549999999999997 112.328 -179.895 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.653 ' HB3' ' CB ' ' A' ' 120' ' ' GLU . 0.1 OUTLIER -149.97 98.02 2.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.19 -0.459 . . . . 73.120000000000005 110.898 -179.857 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.646 HD13 HD11 ' A' ' 127' ' ' ILE . 3.0 tt -50.55 -29.16 6.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.132 -0.486 . . . . 43.240000000000002 111.099 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 119' ' ' MET . . . . . 0.572 ' O ' ' HA ' ' A' ' 123' ' ' HIS . 0.0 OUTLIER -86.39 -45.94 10.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.198 -0.456 . . . . 74.340000000000003 110.876 179.866 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.653 ' CB ' ' HB3' ' A' ' 117' ' ' SER . 16.5 tp10 -64.87 -12.94 54.34 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.222 -0.445 . . . . 73.140000000000001 110.868 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -113.25 -51.88 2.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.184 -0.462 . . . . 73.019999999999996 110.968 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.417 ' HB2' ' O ' ' A' ' 118' ' ' ILE . 93.8 m-85 -103.4 -20.05 14.21 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.155 -0.475 . . . . 73.230000000000004 110.905 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 123' ' ' HIS . . . . . 0.572 ' HA ' ' O ' ' A' ' 119' ' ' MET . 10.9 m80 73.26 26.62 2.06 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.177 -0.465 . . . . 63.119999999999997 110.867 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.479 ' SD ' HG22 ' A' ' 98' ' ' ILE . 6.0 mtt -101.16 85.55 2.85 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.221 -0.445 . . . . 70.120000000000005 110.862 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 1.7 ptp85 -51.33 -34.11 32.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.254 -0.43 . . . . 74.219999999999999 110.89 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.528 ' C ' HD13 ' A' ' 127' ' ' ILE . 40.7 mt-10 -144.34 138.07 27.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.19 -0.459 . . . . 64.530000000000001 110.883 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.646 HD11 HD13 ' A' ' 118' ' ' ILE . 3.4 mm -99.88 96.6 5.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.115 -0.493 . . . . 71.329999999999998 111.129 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 128' ' ' HIS . . . . . 0.518 ' HB2' ' C ' ' A' ' 101' ' ' LYS . 0.6 OUTLIER -69.43 -31.69 70.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.232 -0.44 . . . . 72.299999999999997 110.831 179.922 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 129' ' ' SER . . . . . 0.605 ' HB2' ' HB2' ' A' ' 99' ' ' PHE . 0.3 OUTLIER -132.65 145.34 51.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.247 -0.433 . . . . 73.120000000000005 110.854 -179.778 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 130' ' ' CYS . . . . . 0.609 ' SG ' HG21 ' A' ' 127' ' ' ILE . 0.3 OUTLIER -147.25 119.1 8.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.149 -0.478 . . . . 34.009999999999998 110.874 -179.931 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.604 ' C ' HG23 ' A' ' 132' ' ' VAL . 6.9 mtpp -108.14 157.83 17.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.176 -0.466 . . . . 73.239999999999995 110.924 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.604 HG23 ' C ' ' A' ' 131' ' ' LYS . 3.5 t 81.58 169.06 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.237 -0.438 . . . . 75.340000000000003 111.089 179.836 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.972 HD23 ' HG3' ' A' ' 155' ' ' LYS . 0.2 OUTLIER -165.85 128.18 2.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.138 -0.483 . . . . 74.530000000000001 110.912 179.927 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.516 ' O ' ' C ' ' A' ' 135' ' ' GLY . 1.4 mp0 -98.15 141.26 31.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.456 . . . . 62.5 110.888 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 135' ' ' GLY . . . . . 0.55 ' HA3' ' HA ' ' A' ' 89' ' ' PRO . . . -27.25 -44.79 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.735 -0.745 . . . . 62.0 112.479 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.871 ' HB ' HD12 ' A' ' 176' ' ' ILE . 2.0 t -149.85 127.88 2.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.834 0.349 . . . . 75.329999999999998 111.157 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 137' ' ' TRP . . . . . 0.673 ' HB3' ' CB ' ' A' ' 152' ' ' LEU . 26.1 t90 -142.08 145.53 34.42 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.173 -0.467 . . . . 73.530000000000001 110.893 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.61 HG23 HD13 ' A' ' 61' ' ' ILE . 7.1 mt -123.19 130.01 74.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.252 -0.431 . . . . 74.129999999999995 111.11 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.623 ' CE1' HG11 ' A' ' 170' ' ' VAL . 0.1 OUTLIER -97.36 147.36 24.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.155 -0.475 . . . . 72.239999999999995 110.897 179.965 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 140' ' ' TYR . . . . . 0.446 ' CD2' ' HA ' ' A' ' 145' ' ' TYR . 8.6 m-85 -124.26 124.69 42.97 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.124 -0.489 . . . . 74.25 110.895 -179.846 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 141' ' ' GLU . . . . . 0.56 ' O ' ' HB2' ' A' ' 171' ' ' GLN . 0.0 OUTLIER -58.96 -25.24 63.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.133 -0.485 . . . . 72.209999999999994 110.909 179.996 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.823 ' HB3' ' HD2' ' A' ' 143' ' ' PRO . 9.1 mp -118.06 175.9 1.87 Allowed Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.603 0.716 . . . . 74.120000000000005 110.886 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 143' ' ' PRO . . . . . 0.823 ' HD2' ' HB3' ' A' ' 142' ' ' LEU . 54.0 Cg_endo -69.74 -90.98 0.01 OUTLIER 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.66 2.24 . . . . 73.150000000000006 112.378 179.836 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 144' ' ' ASN . . . . . 0.981 ' O ' ' HG2' ' A' ' 146' ' ' ARG . 0.0 OUTLIER -49.6 86.26 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.175 -0.466 . . . . 74.420000000000002 110.872 -179.968 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 145' ' ' TYR . . . . . 0.59 ' C ' ' O ' ' A' ' 144' ' ' ASN . 2.6 m-85 19.73 43.03 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.185 -0.461 . . . . 70.209999999999994 110.897 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 146' ' ' ARG . . . . . 0.981 ' HG2' ' O ' ' A' ' 144' ' ' ASN . 12.8 mmm-85 -101.21 178.49 4.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.092 -0.504 . . . . 75.230000000000004 110.853 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 73.51 -166.31 54.65 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.735 -0.745 . . . . 55.549999999999997 112.467 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -86.25 159.81 19.34 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.77 0.319 . . . . 72.109999999999999 110.848 -179.806 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 149' ' ' GLN . . . . . 0.511 ' HB2' ' HA ' ' A' ' 60' ' ' TYR . 50.3 mt-30 -94.41 153.16 18.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.163 -0.471 . . . . 74.040000000000006 110.874 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 150' ' ' TYR . . . . . 0.562 ' HB2' ' CB ' ' A' ' 139' ' ' PHE . 95.9 m-85 -135.11 119.2 17.55 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.183 -0.462 . . . . 71.409999999999997 110.976 -179.899 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.745 ' HA ' HD11 ' A' ' 61' ' ' ILE . 22.8 tp -65.11 136.8 57.14 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.09 -0.505 . . . . 61.149999999999999 110.894 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.931 HD13 ' O ' ' A' ' 152' ' ' LEU . 0.0 OUTLIER -73.03 134.23 44.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.222 -0.445 . . . . 54.439999999999998 110.945 179.85 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -165.27 30.88 0.06 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.212 -0.449 . . . . 54.329999999999998 110.908 179.85 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.754 ' O ' ' HG3' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -111.76 -172.27 2.01 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.16 -0.473 . . . . 70.019999999999996 110.945 179.947 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.972 ' HG3' HD23 ' A' ' 133' ' ' LEU . 0.0 OUTLIER -159.86 -129.43 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.239 -0.437 . . . . 73.430000000000007 110.869 179.849 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.579 ' HA ' ' HA ' ' A' ' 131' ' ' LYS . 2.1 tm-20 -70.27 4.94 1.92 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.215 -0.448 . . . . 74.239999999999995 110.883 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 157' ' ' TYR . . . . . 0.783 ' CD1' ' HB3' ' A' ' 162' ' ' ASP . 21.2 m-30 -30.7 148.19 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.135 -0.484 . . . . 72.0 110.895 -179.818 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 158' ' ' ARG . . . . . 0.508 ' HB3' ' CZ ' ' A' ' 104' ' ' PHE . 10.4 ptp180 -118.54 -31.87 4.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.065 -0.516 . . . . 75.299999999999997 110.841 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 159' ' ' LYS . . . . . 0.53 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 2.1 ptpp? -99.64 153.22 37.89 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.584 0.707 . . . . 72.040000000000006 110.889 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 160' ' ' PRO . . . . . 0.473 ' HB3' ' HB3' ' A' ' 168' ' ' PRO . 53.4 Cg_endo -69.82 -25.23 28.54 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.693 2.262 . . . . 75.310000000000002 112.312 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.681 HD12 ' H ' ' A' ' 161' ' ' ILE . 3.8 mp -75.46 4.19 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.229 -0.441 . . . . 73.040000000000006 111.131 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.783 ' HB3' ' CD1' ' A' ' 157' ' ' TYR . 0.2 OUTLIER -72.63 -21.12 61.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.151 -0.477 . . . . 72.230000000000004 110.831 179.856 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 163' ' ' TRP . . . . . 0.51 ' CD1' ' N ' ' A' ' 163' ' ' TRP . 0.0 OUTLIER -108.65 13.47 25.16 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.238 -0.437 . . . . 73.140000000000001 110.92 -179.934 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 84.94 -29.21 4.26 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.724 -0.75 . . . . 13.42 112.502 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -53.65 118.95 4.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.798 0.332 . . . . 61.020000000000003 111.092 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -48.78 -26.1 2.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.249 -0.432 . . . . 70.099999999999994 111.123 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 167' ' ' SER . . . . . 0.484 ' C ' ' H ' ' A' ' 169' ' ' ALA . 0.3 OUTLIER -155.71 157.19 31.4 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.69 0.757 . . . . 71.230000000000004 110.791 -179.779 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 168' ' ' PRO . . . . . 0.473 ' HB3' ' HB3' ' A' ' 160' ' ' PRO . 54.0 Cg_endo -69.78 22.24 0.17 Allowed 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.666 2.244 . . . . 73.319999999999993 112.353 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 0.494 ' HA ' ' HG2' ' A' ' 126' ' ' GLU . . . -64.66 103.76 0.73 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.239 -0.437 . . . . 52.119999999999997 111.071 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.623 HG11 ' CE1' ' A' ' 139' ' ' PHE . 2.9 t -152.59 160.91 2.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.169 -0.469 . . . . 74.409999999999997 111.11 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 171' ' ' GLN . . . . . 0.619 ' OE1' ' HB3' ' A' ' 143' ' ' PRO . 1.7 tm0? -108.13 -81.66 0.56 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.194 -0.457 . . . . 71.430000000000007 110.877 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 172' ' ' SER . . . . . 0.702 ' OG ' ' O ' ' A' ' 143' ' ' PRO . 24.9 p -129.8 179.48 5.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 65.400000000000006 110.834 -179.795 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 173' ' ' PHE . . . . . 0.405 ' HB3' ' CD1' ' A' ' 139' ' ' PHE . 27.4 p90 -144.2 167.81 21.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.14 -0.482 . . . . 65.519999999999996 110.853 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 174' ' ' ARG . . . . . 0.408 ' CD ' HD12 ' A' ' 138' ' ' ILE . 0.1 OUTLIER -139.13 135.98 34.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.139 -0.482 . . . . 73.239999999999995 110.876 -179.918 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 175' ' ' ARG . . . . . 0.486 ' HD2' ' CE2' ' A' ' 94' ' ' TYR . 0.1 OUTLIER -82.93 -167.04 1.5 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.196 -0.456 . . . . 64.150000000000006 110.879 -179.937 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 176' ' ' ILE . . . . . 0.871 HD12 ' HB ' ' A' ' 136' ' ' VAL . 4.2 mt -139.75 132.72 35.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.194 -0.457 . . . . 75.310000000000002 111.151 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 11.5 t -132.77 147.68 31.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.159 -0.473 . . . . 52.240000000000002 111.08 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 178' ' ' GLU . . . . . 0.417 ' HB3' HD13 ' A' ' 88' ' ' LEU . 3.6 pt-20 . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.178 -0.464 . . . . 73.140000000000001 110.852 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.315 0 N-CA-C 112.554 -0.218 . . . . 65.319999999999993 112.554 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.497 ' C ' ' HE1' ' A' ' 47' ' ' TRP . 6.3 p -81.76 135.72 35.46 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.859 0.361 . . . . 53.210000000000001 111.135 -179.884 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.408 ' HA ' ' HA ' ' A' ' 24' ' ' ASP . 3.2 tttt -121.93 135.84 54.89 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.198 -0.455 . . . . 70.140000000000001 110.911 179.869 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.604 ' HB ' ' CD1' ' A' ' 47' ' ' TRP . 15.1 tt -136.91 150.54 26.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.232 -0.44 . . . . 74.519999999999996 111.132 179.839 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.492 HG23 ' CG ' ' A' ' 22' ' ' ASP . 9.9 m -131.01 142.05 50.29 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.162 -0.472 . . . . 61.439999999999998 111.158 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.774 ' HB2' HD22 ' A' ' 34' ' ' LEU . 1.2 m-85 -128.48 129.95 46.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 74.150000000000006 110.863 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.533 ' CG ' ' HA ' ' A' ' 16' ' ' PHE . 18.9 m-85 -116.23 131.4 56.95 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.188 -0.46 . . . . 74.230000000000004 110.886 -179.832 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.495 ' HG2' ' HB2' ' A' ' 36' ' ' ARG . 0.0 OUTLIER -58.24 -25.41 61.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.141 -0.481 . . . . 73.409999999999997 110.897 179.978 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 59.5 m-20 -127.16 152.57 47.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.144 -0.48 . . . . 71.340000000000003 110.905 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.49 ' N ' ' HB3' ' A' ' 38' ' ' ASN . 34.8 mtmt -56.08 -175.35 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.266 -0.424 . . . . 41.439999999999998 110.938 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 18.6 m120 46.96 34.13 2.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.233 -0.44 . . . . 75.299999999999997 110.882 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.533 ' HA ' ' CG ' ' A' ' 11' ' ' TYR . 4.2 m-85 48.51 57.18 6.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.217 -0.447 . . . . 73.200000000000003 110.867 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 14.7 mt-30 -131.98 157.24 44.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.12 -0.491 . . . . 71.439999999999998 110.92 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 95.5 -150.79 19.78 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.775 -0.726 . . . . 45.119999999999997 112.537 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.805 ' O ' HD13 ' A' ' 34' ' ' LEU . 0.1 OUTLIER -69.45 81.08 0.39 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.746 0.308 . . . . 73.230000000000004 110.889 -179.878 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.477 ' HB2' ' CE1' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -79.21 128.67 33.59 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.203 -0.453 . . . . 74.450000000000003 110.862 -179.884 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.47 ' CD2' ' CD2' ' A' ' 30' ' ' PHE . 75.6 t80 -124.41 125.06 43.65 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.181 -0.463 . . . . 65.019999999999996 110.944 -179.849 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.492 ' CG ' HG23 ' A' ' 9' ' ' THR . 1.4 m-20 -119.08 133.7 55.65 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.136 -0.484 . . . . 71.319999999999993 110.83 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 10.1 t -161.33 133.05 5.61 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 63.140000000000001 110.885 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.408 ' HA ' ' HA ' ' A' ' 7' ' ' LYS . 12.3 p-10 -100.86 -3.07 30.47 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.16 -0.473 . . . . 73.420000000000002 110.875 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 34.3 t -106.61 160.99 15.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.456 . . . . 71.450000000000003 110.905 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -48.16 120.38 3.52 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.216 -0.447 . . . . 73.510000000000005 110.828 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.67 ' HB2' ' HB3' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -115.54 46.61 1.46 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.218 -0.446 . . . . 70.109999999999999 110.832 -179.884 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.563 ' O ' ' HA ' ' A' ' 82' ' ' SER . . . -49.12 -21.01 0.65 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.191 -0.458 . . . . 62.32 111.1 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 60.8 t0 -128.56 40.86 3.59 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.224 -0.444 . . . . 72.0 110.889 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.792 ' CD2' ' O ' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -81.46 16.92 1.51 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.177 -0.465 . . . . 75.319999999999993 110.842 -179.874 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.501 ' HB2' ' HB3' ' A' ' 81' ' ' SER . 37.6 t60 -81.45 -35.14 30.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.158 -0.474 . . . . 73.519999999999996 110.9 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.8 t -64.52 -7.93 11.98 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.169 -0.469 . . . . 72.209999999999994 111.152 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -106.09 -28.21 10.64 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.215 -0.448 . . . . 65.409999999999997 110.895 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.805 HD13 ' O ' ' A' ' 19' ' ' ARG . 19.1 tp -141.36 144.83 34.75 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.121 -0.49 . . . . 73.140000000000001 110.882 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.1 m -111.29 -33.79 6.33 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.138 -0.483 . . . . 73.340000000000003 110.842 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.542 ' O ' HD21 ' A' ' 34' ' ' LEU . 2.3 mtp85 -116.66 140.64 49.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.095 -0.502 . . . . 74.25 110.903 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.626 ' HB3' ' HB2' ' A' ' 80' ' ' LEU . 6.3 p -117.37 59.08 0.78 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.199 -0.455 . . . . 74.040000000000006 110.873 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.49 ' HB3' ' N ' ' A' ' 14' ' ' LYS . 1.3 m-80 -57.38 -72.55 0.08 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.224 -0.443 . . . . 62.329999999999998 110.849 -179.859 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 4.5 p -108.08 127.06 53.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.204 -0.453 . . . . 63.520000000000003 110.901 -179.868 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.765 HD12 ' CH2' ' A' ' 73' ' ' TRP . 23.3 mt -120.55 149.18 23.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.187 -0.46 . . . . 74.219999999999999 111.127 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.446 ' HD2' ' CE2' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -143.73 121.55 11.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.122 -0.49 . . . . 60.009999999999998 110.89 179.842 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.524 HG22 ' HB ' ' A' ' 8' ' ' ILE . 1.5 t -107.04 115.65 48.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.203 -0.453 . . . . 64.040000000000006 111.074 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -111.36 79.26 1.19 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.116 -0.493 . . . . 74.329999999999998 110.908 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.429 ' O ' ' HB ' ' A' ' 6' ' ' THR . . . 132.75 102.12 0.81 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.737 -0.744 . . . . 44.420000000000002 112.508 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 53.2 178.12 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.761 -0.733 . . . . 72.230000000000004 112.469 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.718 HG23 ' HA ' ' A' ' 63' ' ' PRO . 0.7 OUTLIER -76.78 170.63 16.11 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.729 0.3 . . . . 45.350000000000001 111.168 -179.875 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 47' ' ' TRP . . . . . 0.604 ' CD1' ' HB ' ' A' ' 8' ' ' ILE . 4.0 m95 -144.66 129.98 18.75 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.215 -0.448 . . . . 74.129999999999995 110.938 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.804 ' HB2' ' CG2' ' A' ' 86' ' ' VAL . . . -93.2 126.1 38.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.243 -0.435 . . . . 60.039999999999999 111.136 179.893 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.702 HG12 ' HB3' ' A' ' 83' ' ' CYS . 17.2 m -124.58 142.18 42.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.22 -0.446 . . . . 71.319999999999993 111.113 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.925 ' HB3' ' CB ' ' A' ' 56' ' ' ALA . 7.0 m-85 -116.92 143.53 45.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.127 -0.488 . . . . 73.230000000000004 110.977 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.554 ' HG2' ' N ' ' A' ' 52' ' ' ARG . 0.3 OUTLIER -49.47 -83.63 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.154 -0.475 . . . . 70.0 110.865 -179.976 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.903 ' O ' ' HB2' ' A' ' 56' ' ' ALA . 1.2 mtp180 -81.67 138.58 47.26 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.562 0.696 . . . . 75.230000000000004 110.914 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.746 ' HA ' ' OG ' ' A' ' 82' ' ' SER . 53.8 Cg_endo -69.75 138.14 37.17 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.672 2.248 . . . . 53.340000000000003 112.366 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.467 ' C ' ' CD2' ' A' ' 55' ' ' PHE . 6.3 m-20 66.67 -6.75 0.5 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.245 -0.434 . . . . 65.030000000000001 110.87 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.473 ' H ' ' C ' ' A' ' 53' ' ' PRO . 0.0 OUTLIER -139.86 -75.82 0.34 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.223 -0.444 . . . . 74.230000000000004 110.885 -179.966 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.925 ' CB ' ' HB3' ' A' ' 50' ' ' TYR . . . 45.71 79.98 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.19 -0.459 . . . . 74.310000000000002 111.044 179.906 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' TRP . . . . . 0.546 ' O ' ' CD2' ' A' ' 58' ' ' TYR . 54.1 m95 -64.72 33.71 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.257 -0.429 . . . . 71.299999999999997 110.901 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.603 ' H ' ' C ' ' A' ' 56' ' ' ALA . 1.4 m-30 -163.25 120.61 1.88 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.22 -0.446 . . . . 72.349999999999994 110.91 -179.927 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.496 ' HB2' ' HA ' ' A' ' 150' ' ' TYR . 1.0 OUTLIER -85.74 138.84 31.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.099 -0.5 . . . . 65.040000000000006 110.873 179.895 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.519 ' CE2' ' HG ' ' A' ' 76' ' ' LEU . 2.8 t80 -153.28 101.68 2.55 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.223 -0.444 . . . . 74.439999999999998 110.92 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.747 ' N ' HD12 ' A' ' 61' ' ' ILE . 1.8 mp -90.25 116.98 32.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.134 -0.485 . . . . 74.430000000000007 111.156 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.76 HD23 ' HD2' ' A' ' 63' ' ' PRO . 0.2 OUTLIER -82.74 130.88 56.46 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 121.554 0.693 . . . . 75.319999999999993 110.962 179.917 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.76 ' HD2' HD23 ' A' ' 62' ' ' LEU . 53.9 Cg_endo -69.72 -171.94 0.52 Allowed 'Trans proline' 0 C--N 1.341 0.132 0 C-N-CA 122.663 2.242 . . . . 74.120000000000005 112.359 179.887 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.92 162.53 14.73 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.219 -0.446 . . . . 63.210000000000001 110.937 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 112.3 -168.47 12.7 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.78 -0.724 . . . . 64.349999999999994 112.498 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -107.47 152.29 24.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.893 0.378 . . . . 72.310000000000002 110.89 -179.882 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.62 ' HB2' ' O ' ' A' ' 40' ' ' ILE . 11.2 m-85 -141.25 84.95 12.29 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.716 0.77 . . . . 70.549999999999997 110.935 -179.864 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.427 ' HD2' ' HG3' ' A' ' 72' ' ' ARG . 53.8 Cg_endo -69.79 0.17 6.06 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.701 2.267 . . . . 64.310000000000002 112.353 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.524 ' HB2' ' HG2' ' A' ' 72' ' ' ARG . 51.7 mt-10 -155.47 142.43 19.1 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.21 -0.45 . . . . 75.120000000000005 110.917 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.703 ' HA ' ' CE2' ' A' ' 73' ' ' TRP . 26.8 p90 -55.75 -20.06 13.38 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.145 -0.48 . . . . 73.120000000000005 110.963 -179.878 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -80.97 -16.01 54.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.093 -0.503 . . . . 73.5 110.9 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.524 ' HG2' ' HB2' ' A' ' 69' ' ' GLU . 27.9 mmt180 -69.88 -9.26 54.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.212 -0.449 . . . . 74.150000000000006 110.894 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' TRP . . . . . 0.765 ' CH2' HD12 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -133.74 17.53 3.9 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.187 -0.46 . . . . 71.430000000000007 110.919 -179.976 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 74' ' ' MET . . . . . 0.443 ' C ' ' O ' ' A' ' 73' ' ' TRP . 19.8 ptp 34.82 47.64 0.26 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.232 -0.44 . . . . 70.010000000000005 110.882 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -66.75 117.75 9.72 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.701 -0.761 . . . . 65.120000000000005 112.49 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.519 ' HG ' ' CE2' ' A' ' 60' ' ' TYR . 0.7 OUTLIER -61.08 -34.78 75.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.824 0.345 . . . . 65.409999999999997 110.927 -179.936 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.427 ' HB2' HD12 ' A' ' 76' ' ' LEU . 13.5 t-20 -125.57 134.12 52.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.183 -0.462 . . . . 70.420000000000002 110.889 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -88.4 16.36 6.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.181 -0.463 . . . . 54.439999999999998 110.886 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.4 ' HD3' ' HA ' ' A' ' 52' ' ' ARG . 0.9 OUTLIER -108.51 80.19 1.32 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.16 -0.473 . . . . 75.219999999999999 110.834 -179.895 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.626 ' HB2' ' HB3' ' A' ' 37' ' ' CYS . 0.0 OUTLIER -81.39 134.36 35.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 74.510000000000005 110.905 179.992 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.662 ' HB3' ' HB3' ' A' ' 53' ' ' PRO . 1.5 m -150.74 -118.89 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.188 -0.46 . . . . 74.519999999999996 110.86 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.746 ' OG ' ' HA ' ' A' ' 53' ' ' PRO . 0.0 OUTLIER -41.19 103.03 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.151 -0.477 . . . . 73.549999999999997 110.872 -179.815 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 83' ' ' CYS . . . . . 0.702 ' HB3' HG12 ' A' ' 49' ' ' VAL . 24.7 p -126.83 131.67 51.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.138 -0.483 . . . . 43.240000000000002 110.883 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.596 ' N ' ' O ' ' A' ' 48' ' ' ALA . 8.9 mmt85 -113.63 151.21 32.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.181 -0.463 . . . . 75.549999999999997 110.852 -179.86 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -68.41 128.34 36.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.19 -0.459 . . . . 63.140000000000001 111.095 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.885 ' CG1' HG11 ' A' ' 136' ' ' VAL . 90.4 t -115.63 128.46 72.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.225 -0.443 . . . . 55.229999999999997 111.126 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' HIS . . . . . 0.523 ' O ' HG23 ' A' ' 136' ' ' VAL . 62.3 m80 -108.34 121.71 45.49 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.143 -0.48 . . . . 74.319999999999993 110.831 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.411 ' C ' ' O ' ' A' ' 87' ' ' HIS . 0.2 OUTLIER -37.47 138.01 0.62 Allowed Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.578 0.704 . . . . 75.310000000000002 110.904 -179.979 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.706 ' HB3' ' H ' ' A' ' 136' ' ' VAL . 53.7 Cg_endo -69.76 98.53 0.69 Allowed 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.662 2.241 . . . . 63.009999999999998 112.352 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -101.19 -176.29 3.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.204 -0.453 . . . . 61.210000000000001 110.868 -179.854 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 53.98 51.49 49.48 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.742 -0.742 . . . . 52.210000000000001 112.505 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.428 ' O ' ' C ' ' A' ' 93' ' ' GLN . . . 126.41 28.24 1.01 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.752 -0.737 . . . . 71.540000000000006 112.476 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.507 ' O ' ' HG2' ' A' ' 134' ' ' GLU . 11.4 pt20 36.25 -117.92 0.13 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.839 0.352 . . . . 75.319999999999993 110.893 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.53 ' O ' ' HA ' ' A' ' 112' ' ' THR . 0.0 OUTLIER -123.57 99.75 6.46 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.159 -0.473 . . . . 73.120000000000005 110.881 -179.863 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.526 ' HG3' HG11 ' A' ' 132' ' ' VAL . 46.2 tptt -111.07 128.32 55.84 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.118 -0.492 . . . . 64.340000000000003 110.915 179.863 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.485 HD13 ' N ' ' A' ' 97' ' ' GLN . 0.0 OUTLIER -150.55 141.36 16.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.229 -0.441 . . . . 72.310000000000002 111.157 179.831 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.528 ' HB2' HG23 ' A' ' 132' ' ' VAL . 2.2 mt-30 -108.44 130.93 55.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.214 -0.448 . . . . 71.430000000000007 110.874 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.679 HD11 HG22 ' A' ' 111' ' ' THR . 1.3 mp -111.25 135.38 50.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.162 -0.472 . . . . 63.439999999999998 111.146 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.652 ' HB2' ' HB2' ' A' ' 129' ' ' SER . 8.3 m-85 -125.15 144.27 50.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.199 -0.455 . . . . 72.510000000000005 110.934 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 78.5 tt0 -71.36 -75.92 0.12 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.2 -0.454 . . . . 75.019999999999996 110.892 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.474 ' C ' ' HB3' ' A' ' 128' ' ' HIS . 41.4 mttt -82.35 175.06 10.55 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.178 -0.464 . . . . 65.340000000000003 110.906 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.438 ' N ' ' HB3' ' A' ' 128' ' ' HIS . . . -88.24 158.24 28.8 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.736 -0.745 . . . . 13.130000000000001 112.497 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.466 ' HA ' ' HB2' ' A' ' 158' ' ' ARG . 27.9 t0 67.2 54.42 0.73 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.819 0.342 . . . . 71.519999999999996 110.82 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.66 ' CE1' ' HD2' ' A' ' 131' ' ' LYS . 6.8 m-85 48.19 31.64 2.68 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.202 -0.454 . . . . 64.409999999999997 110.912 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.418 ' C ' ' HB2' ' A' ' 101' ' ' LYS . 49.2 m -107.36 150.62 26.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.159 -0.473 . . . . 73.519999999999996 110.873 -179.796 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 91.32 -164.65 29.63 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.69 -0.767 . . . . 50.340000000000003 112.441 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -74.67 130.27 39.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.802 0.334 . . . . 71.109999999999999 110.938 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -115.76 131.82 56.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.207 -0.451 . . . . 63.409999999999997 110.904 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -137.63 138.09 39.12 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.222 -0.444 . . . . 72.439999999999998 110.932 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -114.86 111.66 21.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.145 -0.48 . . . . 65.450000000000003 110.937 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.679 HG22 HD11 ' A' ' 98' ' ' ILE . 12.2 t -122.06 142.2 50.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.165 -0.47 . . . . 74.25 111.115 -179.899 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.53 ' HA ' ' O ' ' A' ' 94' ' ' TYR . 3.8 t -119.02 39.14 3.62 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.182 -0.463 . . . . 75.200000000000003 111.125 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -151.29 156.32 40.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.233 -0.44 . . . . 74.549999999999997 110.912 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -53.7 159.68 1.53 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.131 -0.486 . . . . 73.510000000000005 110.914 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 115' ' ' CYS . . . . . 0.549 ' O ' ' HB2' ' A' ' 172' ' ' SER . 29.4 t -146.32 120.17 5.23 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-O 121.6 0.714 . . . . 74.209999999999994 110.918 -179.884 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.452 ' O ' ' C ' ' A' ' 143' ' ' PRO . 53.7 Cg_endo -69.67 -32.76 18.31 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.668 2.245 . . . . 71.25 112.361 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.65 ' HB3' ' CB ' ' A' ' 120' ' ' GLU . 0.1 OUTLIER -148.63 101.72 3.24 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.186 -0.461 . . . . 71.439999999999998 110.842 -179.772 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.713 HD13 HD11 ' A' ' 127' ' ' ILE . 3.3 tt -54.47 -29.57 20.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.123 -0.49 . . . . 63.240000000000002 111.156 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 119' ' ' MET . . . . . 0.591 ' O ' ' HA ' ' A' ' 123' ' ' HIS . 49.2 ttp -86.2 -44.29 12.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 63.009999999999998 110.902 179.819 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.65 ' CB ' ' HB3' ' A' ' 117' ' ' SER . 12.6 tp10 -66.48 -12.47 57.53 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.223 -0.444 . . . . 73.0 110.865 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 25.0 tp60 -114.64 -49.06 2.83 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.156 -0.474 . . . . 72.340000000000003 110.934 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.437 ' HB2' ' O ' ' A' ' 118' ' ' ILE . 86.1 m-85 -105.23 -19.15 13.9 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.197 -0.456 . . . . 71.140000000000001 110.865 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 123' ' ' HIS . . . . . 0.591 ' HA ' ' O ' ' A' ' 119' ' ' MET . 11.4 m80 72.18 26.94 2.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.154 -0.475 . . . . 73.340000000000003 110.875 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.473 ' SD ' HG22 ' A' ' 98' ' ' ILE . 8.9 mtt -102.2 86.44 2.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.182 -0.463 . . . . 72.329999999999998 110.876 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 1.7 ptp85 -51.59 -34.54 37.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.245 -0.434 . . . . 70.439999999999998 110.913 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.486 ' HG2' ' HA ' ' A' ' 169' ' ' ALA . 35.9 mt-10 -144.89 133.57 22.19 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.152 -0.476 . . . . 73.430000000000007 110.897 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.713 HD11 HD13 ' A' ' 118' ' ' ILE . 3.5 mm -94.73 89.77 2.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.147 -0.478 . . . . 72.140000000000001 111.15 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 128' ' ' HIS . . . . . 0.474 ' HB3' ' C ' ' A' ' 101' ' ' LYS . 0.6 OUTLIER -62.58 -33.27 74.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.2 -0.455 . . . . 63.420000000000002 110.846 179.862 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 129' ' ' SER . . . . . 0.652 ' HB2' ' HB2' ' A' ' 99' ' ' PHE . 69.9 m -130.58 141.53 50.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 63.43 110.871 -179.747 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 130' ' ' CYS . . . . . 0.614 ' O ' ' O ' ' A' ' 155' ' ' LYS . 0.1 OUTLIER -142.84 122.31 13.19 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.178 -0.464 . . . . 62.240000000000002 110.91 -179.959 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.66 ' HD2' ' CE1' ' A' ' 104' ' ' PHE . 7.1 mtpp -115.74 155.61 27.46 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.169 -0.469 . . . . 63.240000000000002 110.861 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.546 HG12 ' N ' ' A' ' 133' ' ' LEU . 18.1 t 84.92 163.72 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.242 -0.435 . . . . 72.420000000000002 111.114 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.731 HD22 ' CG ' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -178.95 122.86 0.09 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.162 -0.472 . . . . 73.140000000000001 110.898 180.0 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.507 ' HG2' ' O ' ' A' ' 93' ' ' GLN . 0.0 OUTLIER -92.49 171.23 9.17 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.225 -0.443 . . . . 63.32 110.912 179.863 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 135' ' ' GLY . . . . . 0.455 ' C ' ' O ' ' A' ' 134' ' ' GLU . . . -32.67 -53.08 0.47 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.754 -0.736 . . . . 50.009999999999998 112.482 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.885 HG11 ' CG1' ' A' ' 86' ' ' VAL . 4.1 t -148.81 146.13 17.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.858 0.361 . . . . 63.509999999999998 111.109 -179.944 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 137' ' ' TRP . . . . . 0.65 ' H ' HD12 ' A' ' 152' ' ' LEU . 0.7 OUTLIER -150.01 163.34 38.4 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.146 -0.479 . . . . 74.420000000000002 110.893 179.975 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.557 HD12 HH11 ' A' ' 174' ' ' ARG . 4.7 mt -143.18 136.65 25.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.186 -0.461 . . . . 60.439999999999998 111.109 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.689 ' CD1' HG11 ' A' ' 170' ' ' VAL . 0.2 OUTLIER -102.55 168.79 9.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.204 -0.453 . . . . 73.329999999999998 110.882 179.989 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 140' ' ' TYR . . . . . 0.47 ' CD2' ' HA ' ' A' ' 145' ' ' TYR . 0.5 OUTLIER -139.88 127.65 21.91 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.131 -0.486 . . . . 51.439999999999998 110.959 -179.85 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 141' ' ' GLU . . . . . 0.602 ' O ' ' HB2' ' A' ' 171' ' ' GLN . 0.7 OUTLIER -60.79 -28.41 68.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.134 -0.484 . . . . 75.420000000000002 110.893 -179.986 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.736 ' HB3' ' HD2' ' A' ' 143' ' ' PRO . 9.2 mp -115.06 173.63 2.81 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.621 0.724 . . . . 73.319999999999993 110.909 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 143' ' ' PRO . . . . . 0.742 ' O ' ' OG ' ' A' ' 172' ' ' SER . 53.8 Cg_endo -69.76 -89.59 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.603 2.202 . . . . 62.210000000000001 112.363 179.852 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 144' ' ' ASN . . . . . 0.711 ' O ' ' N ' ' A' ' 146' ' ' ARG . 1.3 m-20 -53.13 97.63 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.203 -0.453 . . . . 72.409999999999997 110.911 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 145' ' ' TYR . . . . . 0.637 ' C ' ' O ' ' A' ' 144' ' ' ASN . 33.1 m-85 12.51 52.36 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.169 -0.469 . . . . 72.150000000000006 110.932 -179.882 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 146' ' ' ARG . . . . . 0.711 ' N ' ' O ' ' A' ' 144' ' ' ASN . 19.5 mtt-85 -117.85 172.6 7.28 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.095 -0.502 . . . . 63.219999999999999 110.91 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 77.55 -176.86 53.35 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.759 -0.734 . . . . 54.340000000000003 112.523 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -78.08 149.62 33.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.76 0.314 . . . . 72.219999999999999 110.895 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 63.3 mt-30 -85.71 157.24 20.34 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.217 -0.447 . . . . 75.519999999999996 110.945 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 150' ' ' TYR . . . . . 0.509 ' HB2' ' HB2' ' A' ' 139' ' ' PHE . 88.8 m-85 -137.78 109.78 7.22 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.229 -0.441 . . . . 74.030000000000001 110.905 -179.837 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.637 ' HB2' HD11 ' A' ' 61' ' ' ILE . 20.2 tp -59.76 136.11 57.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.097 -0.502 . . . . 73.519999999999996 110.924 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 1.045 HD13 ' O ' ' A' ' 152' ' ' LEU . 0.0 OUTLIER -68.93 137.17 53.57 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.18 -0.464 . . . . 71.510000000000005 110.905 179.881 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 153' ' ' ASP . . . . . 0.442 ' N ' HD22 ' A' ' 152' ' ' LEU . 1.3 t70 -164.15 24.94 0.07 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.223 -0.444 . . . . 73.239999999999995 110.922 179.814 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.924 ' HB2' ' CD1' ' A' ' 157' ' ' TYR . 2.2 ptmt -122.0 -174.62 2.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.131 -0.486 . . . . 44.009999999999998 110.872 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.731 ' CG ' HD22 ' A' ' 133' ' ' LEU . 0.0 OUTLIER -158.66 -124.8 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.243 -0.435 . . . . 74.140000000000001 110.891 179.871 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.629 ' HA ' ' HA ' ' A' ' 131' ' ' LYS . 0.5 OUTLIER -64.75 -4.67 4.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.45 . . . . 74.430000000000007 110.89 179.943 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 157' ' ' TYR . . . . . 0.924 ' CD1' ' HB2' ' A' ' 154' ' ' LYS . 14.2 m-30 -26.42 141.33 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.143 -0.48 . . . . 54.32 110.899 -179.854 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 158' ' ' ARG . . . . . 0.466 ' HB2' ' HA ' ' A' ' 103' ' ' ASP . 8.2 ptp180 -105.17 -46.04 4.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.158 -0.474 . . . . 74.540000000000006 110.843 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 159' ' ' LYS . . . . . 0.485 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 3.3 ptpp? -84.59 150.42 56.63 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.537 0.684 . . . . 71.140000000000001 110.92 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 160' ' ' PRO . . . . . 0.654 ' O ' ' CD1' ' A' ' 163' ' ' TRP . 54.0 Cg_endo -69.77 -29.49 23.72 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.692 2.261 . . . . 73.209999999999994 112.33 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.746 HD12 ' H ' ' A' ' 161' ' ' ILE . 2.0 mp -71.96 6.85 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.197 -0.456 . . . . 71.219999999999999 111.169 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.602 ' HB3' ' CD1' ' A' ' 157' ' ' TYR . 0.9 OUTLIER -76.99 -18.05 58.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.109 -0.496 . . . . 73.150000000000006 110.838 179.896 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 163' ' ' TRP . . . . . 0.835 ' NE1' ' HB3' ' A' ' 165' ' ' ALA . 0.4 OUTLIER -109.21 12.83 24.73 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.25 -0.432 . . . . 73.120000000000005 110.955 -179.941 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 81.25 -44.08 2.99 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.706 -0.759 . . . . 71.239999999999995 112.488 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.835 ' HB3' ' NE1' ' A' ' 163' ' ' TRP . . . -52.3 121.49 7.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.813 0.339 . . . . 61.520000000000003 111.095 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -64.67 122.14 16.15 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.208 -0.451 . . . . 65.0 111.126 179.893 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 167' ' ' SER . . . . . 0.488 ' C ' ' H ' ' A' ' 169' ' ' ALA . 0.4 OUTLIER 63.23 146.46 0.09 OUTLIER Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 121.673 0.749 . . . . 54.229999999999997 110.866 -179.786 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 168' ' ' PRO . . . . . 0.489 ' HB2' ' N ' ' A' ' 127' ' ' ILE . 53.5 Cg_endo -69.81 23.75 0.17 Allowed 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.664 2.243 . . . . 72.219999999999999 112.37 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 0.488 ' H ' ' C ' ' A' ' 167' ' ' SER . . . -62.39 102.75 0.34 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.189 -0.46 . . . . 50.409999999999997 111.086 179.848 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.689 HG11 ' CD1' ' A' ' 139' ' ' PHE . 3.4 t -154.87 162.49 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.208 -0.451 . . . . 72.25 111.112 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 171' ' ' GLN . . . . . 0.653 ' OE1' ' HB3' ' A' ' 143' ' ' PRO . 1.6 tm0? -109.93 -83.05 0.57 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.156 -0.474 . . . . 64.230000000000004 110.925 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 172' ' ' SER . . . . . 0.742 ' OG ' ' O ' ' A' ' 143' ' ' PRO . 52.5 p -123.83 177.14 5.88 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.234 -0.439 . . . . 64.329999999999998 110.878 -179.858 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -140.45 168.0 20.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.136 -0.484 . . . . 73.120000000000005 110.893 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 174' ' ' ARG . . . . . 0.557 HH11 HD12 ' A' ' 138' ' ' ILE . 0.1 OUTLIER -134.66 152.64 51.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.112 -0.494 . . . . 74.530000000000001 110.866 -179.904 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.29 167.77 10.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.184 -0.462 . . . . 55.329999999999998 110.886 -179.911 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 2.6 mt -116.63 141.52 34.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.165 -0.47 . . . . 53.329999999999998 111.16 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 3.2 p -149.97 155.85 7.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.195 -0.457 . . . . 70.400000000000006 111.108 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 116.143 -0.48 . . . . 64.400000000000006 110.895 179.996 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.305 0 N-CA-C 112.466 -0.254 . . . . 65.400000000000006 112.466 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.496 ' C ' ' HE1' ' A' ' 47' ' ' TRP . 7.2 p -82.46 136.72 34.86 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.867 0.365 . . . . 75.129999999999995 111.153 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.447 ' N ' ' HE1' ' A' ' 47' ' ' TRP . 2.5 tttt -126.93 136.76 52.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.236 -0.438 . . . . 64.310000000000002 110.907 179.878 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.517 ' HA ' ' HA ' ' A' ' 42' ' ' VAL . 16.5 tt -136.5 154.56 32.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.22 -0.445 . . . . 73.239999999999995 111.129 179.881 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.488 HG23 ' CG ' ' A' ' 22' ' ' ASP . 13.7 m -134.55 151.41 51.08 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.162 -0.472 . . . . 61.130000000000003 111.157 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.662 ' HB2' HD22 ' A' ' 34' ' ' LEU . 1.2 m-85 -140.45 129.59 23.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.454 . . . . 75.040000000000006 110.863 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.55 ' CG ' ' HA ' ' A' ' 16' ' ' PHE . 8.2 m-85 -115.36 133.15 56.3 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.154 -0.475 . . . . 74.340000000000003 110.942 -179.872 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.454 ' HG2' ' HB2' ' A' ' 36' ' ' ARG . 0.0 OUTLIER -56.6 -25.0 51.6 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.181 -0.463 . . . . 72.540000000000006 110.89 -179.974 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.413 ' HB2' ' O ' ' A' ' 17' ' ' GLN . 62.8 m-20 -126.38 155.8 41.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.159 -0.473 . . . . 74.409999999999997 110.91 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.412 ' HG2' ' HA ' ' A' ' 69' ' ' GLU . 11.2 mtmt -57.99 -173.58 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.206 -0.452 . . . . 72.019999999999996 110.899 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 23.9 m-20 43.95 34.41 0.92 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.244 -0.435 . . . . 64.25 110.867 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.55 ' HA ' ' CG ' ' A' ' 11' ' ' TYR . 3.1 m-85 48.05 62.9 2.27 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.21 -0.45 . . . . 73.409999999999997 110.829 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.413 ' O ' ' HB2' ' A' ' 13' ' ' ASP . 10.6 mt-30 -136.55 154.68 50.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.181 -0.463 . . . . 71.209999999999994 110.902 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 95.28 -152.94 20.6 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.711 -0.757 . . . . 60.100000000000001 112.485 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.795 ' O ' HD13 ' A' ' 34' ' ' LEU . 0.0 OUTLIER -65.21 81.13 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.844 0.354 . . . . 73.109999999999999 110.891 -179.867 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.466 ' HB2' ' CE1' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -79.97 128.92 34.04 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.189 -0.46 . . . . 70.310000000000002 110.835 -179.859 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.471 ' CD2' ' CD2' ' A' ' 30' ' ' PHE . 72.2 t80 -123.53 126.12 46.11 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.221 -0.445 . . . . 70.420000000000002 110.944 -179.854 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.488 ' CG ' HG23 ' A' ' 9' ' ' THR . 1.1 m-20 -121.71 134.41 54.95 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.17 -0.468 . . . . 40.119999999999997 110.874 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 6.7 t -163.02 134.39 4.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.165 -0.471 . . . . 52.350000000000001 110.922 -179.879 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.417 ' HA ' ' HA ' ' A' ' 7' ' ' LYS . 5.0 p-10 -101.96 3.56 39.11 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.203 -0.453 . . . . 72.209999999999994 110.875 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 42.2 t -110.62 158.79 18.2 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.197 -0.456 . . . . 53.200000000000003 110.893 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -40.7 119.75 1.16 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.234 -0.439 . . . . 70.230000000000004 110.889 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.567 ' HB2' ' HB3' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -114.51 39.95 2.68 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.175 -0.466 . . . . 73.340000000000003 110.879 -179.896 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.583 ' O ' ' HB3' ' A' ' 82' ' ' SER . . . -50.86 -21.35 1.65 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.218 -0.447 . . . . 63.420000000000002 111.078 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 58.1 t0 -130.45 39.44 3.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.215 -0.448 . . . . 75.0 110.843 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.81 ' CD2' ' O ' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -81.09 15.27 1.94 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.213 -0.449 . . . . 71.209999999999994 110.885 -179.876 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.419 ' CG ' ' HG3' ' A' ' 53' ' ' PRO . 44.5 t60 -80.57 -35.02 34.86 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.157 -0.474 . . . . 73.299999999999997 110.867 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.7 t -62.96 -10.65 14.46 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.169 -0.469 . . . . 75.5 111.154 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -103.53 -27.29 12.45 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.231 -0.44 . . . . 64.120000000000005 110.92 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.795 HD13 ' O ' ' A' ' 19' ' ' ARG . 30.4 tp -138.17 138.73 38.88 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.137 -0.483 . . . . 75.239999999999995 110.905 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.5 m -104.11 -36.15 7.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.169 -0.469 . . . . 62.43 110.824 -179.88 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.458 ' O ' HD21 ' A' ' 34' ' ' LEU . 0.7 OUTLIER -112.98 139.86 48.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.131 -0.486 . . . . 72.340000000000003 110.863 -179.92 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.476 ' SG ' ' CB ' ' A' ' 80' ' ' LEU . 2.2 m -121.41 69.87 0.92 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.193 -0.458 . . . . 73.349999999999994 110.93 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -72.04 -71.86 0.26 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.214 -0.448 . . . . 70.019999999999996 110.889 -179.864 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 4.9 p -104.54 134.61 47.43 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.165 -0.47 . . . . 61.219999999999999 110.867 -179.846 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.576 HD12 ' CH2' ' A' ' 73' ' ' TRP . 20.8 mt -126.51 151.65 33.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.135 -0.484 . . . . 74.340000000000003 111.124 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.481 ' HD2' ' CE2' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -145.0 124.75 13.34 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.155 -0.475 . . . . 62.130000000000003 110.918 179.834 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.517 ' HA ' ' HA ' ' A' ' 8' ' ' ILE . 1.2 t -111.99 116.03 51.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.214 -0.448 . . . . 72.340000000000003 111.16 179.882 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -112.95 77.63 1.06 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.217 -0.447 . . . . 73.140000000000001 110.886 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.415 ' O ' ' HB ' ' A' ' 6' ' ' THR . . . 139.08 97.49 0.38 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.685 -0.769 . . . . 72.519999999999996 112.464 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.419 ' HA2' HD21 ' A' ' 88' ' ' LEU . . . 52.52 -179.9 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.729 -0.748 . . . . 63.549999999999997 112.476 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.7 HG23 ' HA ' ' A' ' 63' ' ' PRO . 1.4 m -74.52 170.05 16.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.75 0.31 . . . . 74.409999999999997 111.162 -179.886 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' TRP . . . . . 0.57 ' H ' HG22 ' A' ' 46' ' ' THR . 4.5 m95 -142.92 130.03 20.77 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.245 -0.434 . . . . 74.040000000000006 110.887 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.891 ' HB2' ' CG2' ' A' ' 86' ' ' VAL . . . -87.36 127.09 35.2 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.225 -0.443 . . . . 75.439999999999998 111.115 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.908 HG11 HD11 ' A' ' 80' ' ' LEU . 34.5 m -129.7 131.71 66.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.263 -0.426 . . . . 64.310000000000002 111.127 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.726 ' HB3' ' HA ' ' A' ' 56' ' ' ALA . 58.8 m-85 -103.01 147.92 26.34 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.192 -0.458 . . . . 71.310000000000002 110.913 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.651 ' OE1' ' HB3' ' A' ' 57' ' ' TRP . 63.7 tt0 -50.19 -78.99 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.133 -0.485 . . . . 64.540000000000006 110.858 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.598 ' HB3' ' HB2' ' A' ' 55' ' ' PHE . 0.5 OUTLIER -91.04 138.01 26.22 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.618 0.723 . . . . 73.109999999999999 110.869 -179.908 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.739 ' HB3' ' HB3' ' A' ' 81' ' ' SER . 53.7 Cg_endo -69.82 145.98 58.43 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.655 2.237 . . . . 35.530000000000001 112.349 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 63.15 -7.67 0.15 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.239 -0.437 . . . . 73.25 110.917 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.614 ' CD1' ' O ' ' A' ' 53' ' ' PRO . 30.8 m-85 -113.72 -20.32 11.21 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.173 -0.467 . . . . 72.209999999999994 110.864 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.726 ' HA ' ' HB3' ' A' ' 50' ' ' TYR . . . 52.37 27.27 4.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.188 -0.46 . . . . 63.229999999999997 111.105 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' TRP . . . . . 0.651 ' HB3' ' OE1' ' A' ' 51' ' ' GLU . 0.0 OUTLIER -49.28 -164.36 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.225 -0.443 . . . . 74.409999999999997 110.888 -179.956 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.637 ' C ' ' O ' ' A' ' 57' ' ' TRP . 4.7 m-30 -12.55 101.39 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.182 -0.463 . . . . 73.230000000000004 110.951 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.451 ' HB2' ' O ' ' A' ' 149' ' ' GLN . 2.3 mpt? -60.74 155.93 18.1 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.17 -0.468 . . . . 63.509999999999998 110.856 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.68 ' O ' ' O ' ' A' ' 49' ' ' VAL . 2.7 t80 -170.74 120.63 0.56 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.202 -0.454 . . . . 72.140000000000001 110.972 -179.872 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.854 ' N ' HD12 ' A' ' 61' ' ' ILE . 1.0 OUTLIER -106.2 114.24 44.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.165 -0.47 . . . . 62.219999999999999 111.15 179.923 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.614 HD23 ' HD2' ' A' ' 63' ' ' PRO . 0.3 OUTLIER -83.75 124.65 74.82 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.583 0.706 . . . . 75.239999999999995 110.933 179.943 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.7 ' HA ' HG23 ' A' ' 46' ' ' THR . 53.3 Cg_endo -69.75 -171.3 0.46 Allowed 'Trans proline' 0 C--O 1.231 0.141 0 C-N-CA 122.706 2.271 . . . . 74.340000000000003 112.295 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.79 163.2 15.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.189 -0.459 . . . . 72.099999999999994 110.908 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 114.35 -158.42 14.33 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.795 -0.717 . . . . 73.450000000000003 112.472 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -118.28 154.3 32.53 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.871 0.367 . . . . 74.040000000000006 110.868 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.55 ' HB2' ' O ' ' A' ' 40' ' ' ILE . 17.5 m-85 -140.94 84.14 13.47 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.691 0.758 . . . . 72.340000000000003 110.959 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.409 ' HD2' ' HG3' ' A' ' 72' ' ' ARG . 53.1 Cg_endo -69.84 2.79 3.25 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.643 2.229 . . . . 72.540000000000006 112.35 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.603 ' HB2' ' HG2' ' A' ' 72' ' ' ARG . 48.4 mt-10 -157.56 144.21 17.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.183 -0.462 . . . . 74.030000000000001 110.893 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.707 ' HA ' ' NE1' ' A' ' 73' ' ' TRP . 35.4 p90 -55.78 -25.97 43.74 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.127 -0.488 . . . . 71.25 110.896 -179.801 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -76.51 -15.81 59.79 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.154 -0.475 . . . . 64.430000000000007 110.931 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.603 ' HG2' ' HB2' ' A' ' 69' ' ' GLU . 32.0 mmt180 -67.27 -15.98 64.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.201 -0.454 . . . . 75.219999999999999 110.874 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' TRP . . . . . 0.745 ' CD1' ' N ' ' A' ' 73' ' ' TRP . 0.0 OUTLIER -125.14 21.88 7.99 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.202 -0.454 . . . . 72.450000000000003 110.939 -179.959 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 74' ' ' MET . . . . . 0.574 ' O ' ' C ' ' A' ' 75' ' ' GLY . 2.1 ttm 75.87 -16.4 0.6 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.258 -0.428 . . . . 51.420000000000002 110.88 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.574 ' C ' ' O ' ' A' ' 74' ' ' MET . . . 21.93 57.5 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.762 -0.732 . . . . 51.210000000000001 112.496 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.93 HD13 ' N ' ' A' ' 77' ' ' ASN . 0.0 OUTLIER -56.48 -10.93 1.07 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.835 0.35 . . . . 65.340000000000003 110.927 -179.935 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.93 ' N ' HD13 ' A' ' 76' ' ' LEU . 37.0 t-20 -149.33 -48.67 0.14 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.219 -0.446 . . . . 74.319999999999993 110.853 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.556 ' CB ' ' O ' ' A' ' 77' ' ' ASN . 5.2 t0 87.22 -7.73 0.64 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.192 -0.458 . . . . 72.400000000000006 110.901 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.457 ' HG2' ' O ' ' A' ' 79' ' ' ARG . 8.7 ttt85 -85.39 50.15 1.9 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.178 -0.464 . . . . 60.100000000000001 110.874 -179.897 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.908 HD11 HG11 ' A' ' 49' ' ' VAL . 0.1 OUTLIER -59.36 130.65 47.95 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.195 -0.457 . . . . 61.030000000000001 110.937 179.998 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.739 ' HB3' ' HB3' ' A' ' 53' ' ' PRO . 12.3 m -151.6 -111.77 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.182 -0.463 . . . . 73.430000000000007 110.849 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.601 ' OG ' ' HA ' ' A' ' 53' ' ' PRO . 1.0 OUTLIER -47.87 97.12 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.155 -0.475 . . . . 52.530000000000001 110.851 -179.802 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 83' ' ' CYS . . . . . 0.784 ' CB ' HG12 ' A' ' 49' ' ' VAL . 7.6 p -123.89 135.23 53.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.167 -0.469 . . . . 61.229999999999997 110.858 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.633 ' N ' ' O ' ' A' ' 48' ' ' ALA . 0.9 OUTLIER -115.12 154.82 28.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.154 -0.475 . . . . 74.319999999999993 110.89 -179.9 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -68.17 130.06 41.77 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.191 -0.458 . . . . 72.450000000000003 111.048 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.891 ' CG2' ' HB2' ' A' ' 48' ' ' ALA . 37.7 t -115.03 133.34 61.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.208 -0.451 . . . . 62.109999999999999 111.179 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' HIS . . . . . 0.646 ' O ' HG23 ' A' ' 136' ' ' VAL . 39.9 m80 -111.26 108.48 18.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.202 -0.454 . . . . 72.310000000000002 110.87 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.477 ' H ' HD23 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -33.4 147.04 0.1 OUTLIER Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.566 0.698 . . . . 74.340000000000003 110.943 -179.96 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.521 ' HB3' ' H ' ' A' ' 136' ' ' VAL . 53.6 Cg_endo -69.78 95.52 0.56 Allowed 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.68 2.253 . . . . 62.020000000000003 112.328 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -88.89 -174.87 4.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.225 -0.443 . . . . 72.120000000000005 110.844 -179.847 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 64.0 108.48 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.766 -0.731 . . . . 65.349999999999994 112.525 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 69.41 -84.34 0.26 Allowed Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.695 -0.764 . . . . 74.439999999999998 112.481 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.446 ' O ' ' HG2' ' A' ' 134' ' ' GLU . 19.5 pt20 178.74 -136.79 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.842 0.353 . . . . 63.450000000000003 110.945 -179.863 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.671 ' HA ' ' HG2' ' A' ' 134' ' ' GLU . 0.0 OUTLIER -113.86 103.2 10.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.202 -0.454 . . . . 74.430000000000007 110.96 -179.877 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.492 ' HG3' HG11 ' A' ' 132' ' ' VAL . 29.1 tptt -107.41 128.79 54.79 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.127 -0.488 . . . . 73.439999999999998 110.896 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.528 HD13 ' N ' ' A' ' 97' ' ' GLN . 0.1 OUTLIER -151.08 133.97 6.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.194 -0.457 . . . . 74.319999999999993 111.136 179.828 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.528 ' N ' HD13 ' A' ' 96' ' ' ILE . 0.3 OUTLIER -105.76 126.61 52.37 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.142 -0.481 . . . . 74.340000000000003 110.911 179.948 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.626 HD13 HD11 ' A' ' 118' ' ' ILE . 13.0 mt -105.08 138.51 29.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.186 -0.461 . . . . 72.519999999999996 111.103 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.663 ' HB2' ' HB2' ' A' ' 129' ' ' SER . 46.7 m-85 -125.75 139.9 53.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.166 -0.47 . . . . 51.219999999999999 110.87 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 79.0 tt0 -71.89 -70.8 0.31 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.119 -0.491 . . . . 70.239999999999995 110.875 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 41.4 mttt -87.9 171.02 10.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.157 -0.474 . . . . 71.519999999999996 110.858 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -75.47 155.05 46.58 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.801 -0.714 . . . . 72.400000000000006 112.481 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.615 ' HA ' ' HB2' ' A' ' 158' ' ' ARG . 16.1 t0 68.03 45.26 1.35 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.85 0.357 . . . . 63.119999999999997 110.863 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.441 ' HA ' ' CD1' ' A' ' 99' ' ' PHE . 0.7 OUTLIER 50.7 29.17 4.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.183 -0.462 . . . . 70.510000000000005 110.89 -179.905 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 71.2 m -96.82 159.06 15.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.149 -0.478 . . . . 74.049999999999997 110.911 -179.821 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 87.1 -145.06 19.64 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.774 -0.727 . . . . 75.129999999999995 112.493 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 3.8 tp-100 -87.66 125.01 34.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.8 0.333 . . . . 70.409999999999997 110.906 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' MET . . . . . 0.48 ' HB2' ' CE1' ' A' ' 99' ' ' PHE . 23.4 ttp -107.64 144.35 34.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.198 -0.455 . . . . 74.510000000000005 110.889 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -149.51 135.5 18.85 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.275 -0.421 . . . . 75.400000000000006 110.884 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -114.93 102.68 10.19 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.102 -0.499 . . . . 62.409999999999997 110.909 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 14.6 t -114.07 144.19 43.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 74.319999999999993 111.102 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.479 ' O ' ' OG1' ' A' ' 112' ' ' THR . 0.8 OUTLIER -124.4 36.35 4.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.252 -0.431 . . . . 51.340000000000003 111.135 -179.988 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -143.84 -172.52 3.76 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.232 -0.44 . . . . 73.0 110.867 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -86.31 162.54 18.18 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.112 -0.494 . . . . 74.430000000000007 110.88 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 115' ' ' CYS . . . . . 0.419 ' HB3' ' CE2' ' A' ' 173' ' ' PHE . 0.8 OUTLIER -157.25 120.76 2.21 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-O 121.585 0.707 . . . . 73.519999999999996 110.92 -179.918 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.586 ' O ' ' OG ' ' A' ' 172' ' ' SER . 54.1 Cg_endo -69.73 -33.5 16.6 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.642 2.228 . . . . 63.130000000000003 112.401 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.669 ' HB3' ' CB ' ' A' ' 120' ' ' GLU . 0.2 OUTLIER -138.68 103.57 4.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.22 -0.445 . . . . 71.510000000000005 110.846 -179.862 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.674 ' HB ' ' O ' ' A' ' 171' ' ' GLN . 4.9 tt -57.91 -29.87 36.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.135 -0.484 . . . . 51.439999999999998 111.148 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 119' ' ' MET . . . . . 0.594 ' O ' ' HA ' ' A' ' 123' ' ' HIS . 2.8 ttt -87.89 -45.62 10.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.165 -0.47 . . . . 63.439999999999998 110.864 179.873 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.669 ' CB ' ' HB3' ' A' ' 117' ' ' SER . 6.7 tp10 -62.86 -13.5 34.7 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.235 -0.439 . . . . 75.239999999999995 110.89 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 7.8 tp-100 -114.64 -50.09 2.8 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.186 -0.461 . . . . 74.400000000000006 110.963 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.569 ' HB2' ' O ' ' A' ' 118' ' ' ILE . 96.1 m-85 -100.07 -20.64 15.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.165 -0.47 . . . . 54.039999999999999 110.881 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 123' ' ' HIS . . . . . 0.594 ' HA ' ' O ' ' A' ' 119' ' ' MET . 13.4 m-70 76.42 22.07 1.3 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.17 -0.468 . . . . 74.25 110.888 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.506 ' O ' HG23 ' A' ' 118' ' ' ILE . 3.5 mtt -97.67 118.74 34.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.174 -0.466 . . . . 64.530000000000001 110.856 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 5.8 ptp180 -79.58 -45.79 18.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.203 -0.453 . . . . 65.530000000000001 110.863 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.44 ' HB3' ' HG2' ' A' ' 168' ' ' PRO . 19.9 mt-10 -140.45 117.36 11.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.181 -0.463 . . . . 71.420000000000002 110.836 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.642 HG21 ' SG ' ' A' ' 130' ' ' CYS . 3.2 mm -73.52 92.49 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.128 -0.487 . . . . 74.120000000000005 111.112 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -64.89 -34.0 77.35 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.156 -0.475 . . . . 72.129999999999995 110.868 179.874 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 129' ' ' SER . . . . . 0.663 ' HB2' ' HB2' ' A' ' 99' ' ' PHE . 4.7 m -133.97 155.03 50.68 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.207 -0.452 . . . . 62.43 110.845 -179.802 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 130' ' ' CYS . . . . . 0.663 ' O ' ' O ' ' A' ' 155' ' ' LYS . 0.1 OUTLIER -156.59 123.04 5.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.112 -0.494 . . . . 60.140000000000001 110.844 -179.951 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.636 ' HA ' ' HA ' ' A' ' 156' ' ' GLU . 1.9 mtpt -108.22 154.21 22.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.16 -0.473 . . . . 71.510000000000005 110.885 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.553 HG23 ' C ' ' A' ' 131' ' ' LYS . 8.3 t 83.45 165.03 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.215 -0.448 . . . . 74.310000000000002 111.136 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.789 HD22 ' CG ' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -178.49 123.69 0.1 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.125 -0.489 . . . . 55.219999999999999 110.905 179.977 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.671 ' HG2' ' HA ' ' A' ' 94' ' ' TYR . 0.1 OUTLIER -98.64 164.41 12.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.21 -0.45 . . . . 73.530000000000001 110.856 179.928 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 135' ' ' GLY . . . . . 0.557 ' C ' ' O ' ' A' ' 134' ' ' GLU . . . -23.06 -63.1 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.736 -0.745 . . . . 42.5 112.487 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.795 ' HB ' HD12 ' A' ' 176' ' ' ILE . 3.1 t -144.44 146.34 20.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.804 0.335 . . . . 72.329999999999998 111.126 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 137' ' ' TRP . . . . . 0.645 ' HB3' ' HB3' ' A' ' 152' ' ' LEU . 6.3 t-105 -143.19 149.56 38.17 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.164 -0.471 . . . . 74.099999999999994 110.945 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.412 HD12 ' HB ' ' A' ' 61' ' ' ILE . 3.5 mm -114.59 134.73 56.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.285 -0.416 . . . . 61.409999999999997 111.161 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.524 ' CD1' HG11 ' A' ' 170' ' ' VAL . 0.1 OUTLIER -117.23 142.65 46.79 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.204 -0.453 . . . . 72.340000000000003 110.846 -179.989 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 140' ' ' TYR . . . . . 0.512 ' CE2' ' HA ' ' A' ' 145' ' ' TYR . 3.9 m-85 -120.79 130.4 53.98 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.14 -0.482 . . . . 73.510000000000005 110.932 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 141' ' ' GLU . . . . . 0.452 ' O ' ' HB2' ' A' ' 171' ' ' GLN . 2.9 tt0 -61.77 -47.62 84.35 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.121 -0.49 . . . . 75.409999999999997 110.885 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 1.057 ' O ' ' HB2' ' A' ' 172' ' ' SER . 7.1 mp -97.41 152.56 38.29 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.588 0.709 . . . . 74.510000000000005 110.922 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 143' ' ' PRO . . . . . 0.684 ' HB3' ' OE1' ' A' ' 171' ' ' GLN . 54.3 Cg_endo -69.68 44.76 0.42 Allowed 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.709 2.273 . . . . 54.310000000000002 112.379 179.854 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 144' ' ' ASN . . . . . 1.084 ' O ' ' N ' ' A' ' 146' ' ' ARG . 0.1 OUTLIER 179.06 106.62 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.228 -0.442 . . . . 74.340000000000003 110.885 -179.989 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 145' ' ' TYR . . . . . 0.668 ' C ' ' O ' ' A' ' 144' ' ' ASN . 0.0 OUTLIER -3.51 51.25 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.204 -0.453 . . . . 64.0 110.938 -179.948 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 146' ' ' ARG . . . . . 1.084 ' N ' ' O ' ' A' ' 144' ' ' ASN . 36.7 mtt180 -131.47 163.27 28.33 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.118 -0.492 . . . . 63.509999999999998 110.881 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 82.8 -162.69 41.34 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.75 -0.738 . . . . 73.5 112.472 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -84.97 148.96 25.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.753 0.311 . . . . 74.329999999999998 110.84 -179.848 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 149' ' ' GLN . . . . . 0.451 ' O ' ' HB2' ' A' ' 59' ' ' MET . 19.3 mt-30 -95.73 135.09 37.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.159 -0.473 . . . . 70.120000000000005 110.901 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 150' ' ' TYR . . . . . 0.471 ' HB2' ' HB2' ' A' ' 139' ' ' PHE . 41.6 m-85 -109.95 127.06 54.54 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.164 -0.471 . . . . 73.140000000000001 110.856 -179.841 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.509 ' HB2' HD11 ' A' ' 61' ' ' ILE . 6.8 tp -83.01 120.89 26.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.088 -0.505 . . . . 52.219999999999999 110.947 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 1.043 HD13 ' O ' ' A' ' 152' ' ' LEU . 0.0 OUTLIER -50.46 133.11 25.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.2 -0.454 . . . . 73.549999999999997 110.962 179.887 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -162.09 23.16 0.11 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.216 -0.447 . . . . 52.310000000000002 110.868 179.817 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.83 ' HB2' ' CD1' ' A' ' 157' ' ' TYR . 3.2 ptmt -119.97 -174.02 2.67 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.191 -0.459 . . . . 43.409999999999997 110.91 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.789 ' CG ' HD22 ' A' ' 133' ' ' LEU . 1.7 mptt -158.4 -119.43 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.249 -0.432 . . . . 75.349999999999994 110.934 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.636 ' HA ' ' HA ' ' A' ' 131' ' ' LYS . 1.2 tm-20 -72.47 0.74 9.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.201 -0.454 . . . . 73.5 110.931 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 157' ' ' TYR . . . . . 0.83 ' CD1' ' HB2' ' A' ' 154' ' ' LYS . 12.9 m-30 -34.97 154.11 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.106 -0.497 . . . . 75.420000000000002 110.929 -179.868 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 158' ' ' ARG . . . . . 0.615 ' HB2' ' HA ' ' A' ' 103' ' ' ASP . 8.0 ptp180 -116.7 -44.22 2.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.074 -0.512 . . . . 71.109999999999999 110.883 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 159' ' ' LYS . . . . . 0.42 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 3.1 ptpp? -86.25 150.13 51.3 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.6 0.714 . . . . 73.439999999999998 110.854 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 160' ' ' PRO . . . . . 0.445 ' HA ' ' HE1' ' A' ' 163' ' ' TRP . 54.2 Cg_endo -69.78 -23.49 30.66 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.64 2.227 . . . . 74.120000000000005 112.377 179.86 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.648 HD12 ' H ' ' A' ' 161' ' ' ILE . 3.5 mp -78.71 4.09 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.212 -0.449 . . . . 73.140000000000001 111.138 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.529 ' HB3' ' CD1' ' A' ' 157' ' ' TYR . 1.0 OUTLIER -72.96 -16.91 61.52 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.19 -0.459 . . . . 71.5 110.819 179.853 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 163' ' ' TRP . . . . . 0.673 ' N ' ' CD1' ' A' ' 163' ' ' TRP . 0.0 OUTLIER -115.82 13.54 16.11 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.217 -0.447 . . . . 75.450000000000003 110.864 -179.943 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 88.64 -31.88 4.74 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.762 -0.732 . . . . 75.030000000000001 112.489 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -51.53 118.55 3.4 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.783 0.325 . . . . 62.409999999999997 111.1 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -50.73 -31.5 16.81 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.248 -0.433 . . . . 72.230000000000004 111.114 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 167' ' ' SER . . . . . 0.493 ' C ' ' H ' ' A' ' 169' ' ' ALA . 0.3 OUTLIER -149.98 156.44 38.01 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.701 0.763 . . . . 52.149999999999999 110.835 -179.826 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 168' ' ' PRO . . . . . 0.444 ' HB3' ' O ' ' A' ' 127' ' ' ILE . 53.9 Cg_endo -69.73 24.95 0.17 Allowed 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.727 2.285 . . . . 60.5 112.312 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 0.493 ' H ' ' C ' ' A' ' 167' ' ' SER . . . -65.55 100.93 0.55 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.265 -0.425 . . . . 64.420000000000002 111.082 179.91 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.524 HG11 ' CD1' ' A' ' 139' ' ' PHE . 1.9 t -154.42 165.35 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.213 -0.449 . . . . 74.439999999999998 111.12 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 171' ' ' GLN . . . . . 0.684 ' OE1' ' HB3' ' A' ' 143' ' ' PRO . 2.2 mm-40 -147.53 -101.2 0.09 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.128 -0.487 . . . . 75.439999999999998 110.876 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 172' ' ' SER . . . . . 1.057 ' HB2' ' O ' ' A' ' 142' ' ' LEU . 0.3 OUTLIER -56.31 143.73 33.03 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.196 -0.456 . . . . 44.240000000000002 110.902 -179.8 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 173' ' ' PHE . . . . . 0.419 ' CE2' ' HB3' ' A' ' 115' ' ' CYS . 31.2 p90 -152.1 132.79 13.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.184 -0.462 . . . . 72.120000000000005 110.92 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.51 165.47 23.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.186 -0.461 . . . . 75.340000000000003 110.861 -179.878 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 175' ' ' ARG . . . . . 0.404 ' HG3' ' CZ ' ' A' ' 94' ' ' TYR . 0.0 OUTLIER -104.12 -161.28 0.82 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.209 -0.45 . . . . 71.140000000000001 110.877 -179.943 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 176' ' ' ILE . . . . . 0.795 HD12 ' HB ' ' A' ' 136' ' ' VAL . 3.5 mt -139.3 138.79 40.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 63.240000000000002 111.144 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 5.0 p -145.34 152.34 14.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.188 -0.46 . . . . 72.0 111.106 179.875 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.149 -0.478 . . . . 72.109999999999999 110.896 -179.961 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.366 0 N-CA-C 112.497 -0.241 . . . . 72.099999999999994 112.497 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.518 ' C ' ' HE1' ' A' ' 47' ' ' TRP . 8.0 p -82.98 135.87 34.73 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.867 0.365 . . . . 71.25 111.155 -179.862 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.408 ' HA ' ' HA ' ' A' ' 24' ' ' ASP . 3.2 tttt -123.94 136.17 54.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.189 -0.459 . . . . 70.140000000000001 110.9 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.576 ' HB ' ' CD1' ' A' ' 47' ' ' TRP . 16.2 tt -137.47 150.89 25.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.223 -0.444 . . . . 75.209999999999994 111.151 179.861 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.481 HG23 ' CG ' ' A' ' 22' ' ' ASP . 10.1 m -130.21 146.08 51.8 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.196 -0.456 . . . . 72.340000000000003 111.163 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.792 ' HB2' HD22 ' A' ' 34' ' ' LEU . 1.5 m-85 -132.33 129.1 39.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.205 -0.452 . . . . 64.349999999999994 110.865 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.544 ' CG ' ' HA ' ' A' ' 16' ' ' PHE . 18.4 m-85 -115.65 132.13 56.73 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.135 -0.484 . . . . 73.030000000000001 110.974 -179.894 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.475 ' HG2' ' HB2' ' A' ' 36' ' ' ARG . 0.0 OUTLIER -58.6 -24.36 60.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.123 -0.49 . . . . 74.329999999999998 110.891 -179.976 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 64.9 m-20 -127.63 152.73 47.3 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.113 -0.494 . . . . 64.519999999999996 110.89 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.429 ' N ' ' HB3' ' A' ' 38' ' ' ASN . 32.5 mtmt -56.09 -175.25 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 75.120000000000005 110.922 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 25.7 m-20 46.51 33.6 2.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.258 -0.428 . . . . 64.109999999999999 110.897 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.544 ' HA ' ' CG ' ' A' ' 11' ' ' TYR . 3.4 m-85 48.91 58.9 4.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.147 -0.478 . . . . 75.010000000000005 110.842 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -133.49 157.78 44.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 53.310000000000002 110.905 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 94.25 -149.88 19.57 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.679 -0.772 . . . . 72.329999999999998 112.474 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.79 ' O ' HD13 ' A' ' 34' ' ' LEU . 0.1 OUTLIER -69.06 81.59 0.32 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.833 0.349 . . . . 74.239999999999995 110.881 -179.832 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.49 ' HB2' ' CE1' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -79.63 129.6 34.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.201 -0.454 . . . . 72.209999999999994 110.874 -179.898 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.444 ' O ' ' HA ' ' A' ' 9' ' ' THR . 88.8 t80 -125.54 125.32 43.03 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.204 -0.453 . . . . 73.420000000000002 110.899 -179.842 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.481 ' CG ' HG23 ' A' ' 9' ' ' THR . 1.4 m-20 -119.9 134.47 55.23 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.121 -0.491 . . . . 62.119999999999997 110.895 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 11.3 t -162.98 135.19 5.31 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.158 -0.474 . . . . 63.229999999999997 110.915 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.408 ' HA ' ' HA ' ' A' ' 7' ' ' LYS . 5.5 p-10 -102.66 -5.19 24.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.188 -0.46 . . . . 74.340000000000003 110.928 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.448 ' O ' ' SG ' ' A' ' 27' ' ' CYS . 20.0 t -102.54 165.08 11.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.14 -0.482 . . . . 71.420000000000002 110.851 -179.908 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -55.26 120.95 7.83 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.155 -0.475 . . . . 62.310000000000002 110.878 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.639 ' HB2' ' HB3' ' A' ' 30' ' ' PHE . 0.2 OUTLIER -116.39 49.97 1.09 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.225 -0.443 . . . . 62.520000000000003 110.924 -179.93 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.527 ' O ' ' HA ' ' A' ' 82' ' ' SER . . . -46.86 -22.23 0.29 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.191 -0.458 . . . . 72.430000000000007 111.096 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 63.3 t0 -129.19 42.76 3.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.189 -0.46 . . . . 64.409999999999997 110.85 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.775 ' CD2' ' O ' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -79.13 15.82 1.08 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.192 -0.458 . . . . 64.230000000000004 110.887 -179.936 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.448 ' HB2' ' HB3' ' A' ' 53' ' ' PRO . 27.1 t60 -77.2 -45.67 25.84 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.161 -0.472 . . . . 75.450000000000003 110.841 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.444 HG23 ' CD2' ' A' ' 33' ' ' TYR . 8.9 t -55.69 -14.5 2.27 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.191 -0.458 . . . . 70.329999999999998 111.175 -179.91 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.506 ' CD1' ' HA ' ' A' ' 30' ' ' PHE . 11.4 m-85 -96.1 -30.26 13.64 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.197 -0.456 . . . . 70.430000000000007 110.865 -179.907 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.792 HD22 ' HB2' ' A' ' 10' ' ' PHE . 19.3 tp -143.5 143.12 31.42 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.178 -0.464 . . . . 71.299999999999997 110.94 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.2 m -108.52 -34.73 6.66 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.185 -0.461 . . . . 61.229999999999997 110.883 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.545 ' O ' HD21 ' A' ' 34' ' ' LEU . 1.8 mtp85 -115.89 139.8 49.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.13 -0.486 . . . . 75.439999999999998 110.86 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.61 ' HB3' ' HB2' ' A' ' 80' ' ' LEU . 5.2 p -117.28 61.31 0.75 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.144 -0.48 . . . . 74.329999999999998 110.894 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.504 HD21 ' NH2' ' A' ' 36' ' ' ARG . 3.0 m120 -60.26 -69.62 0.21 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.133 -0.485 . . . . 73.140000000000001 110.869 -179.874 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 5.0 p -110.67 127.28 55.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.18 -0.463 . . . . 73.129999999999995 110.873 -179.869 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.757 HD12 ' CH2' ' A' ' 73' ' ' TRP . 29.9 mt -121.01 148.49 24.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.134 -0.485 . . . . 72.310000000000002 111.126 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.453 ' HD2' ' CE2' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -142.27 121.99 13.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 71.219999999999999 110.902 179.823 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.546 HG22 ' HB ' ' A' ' 8' ' ' ILE . 1.5 t -106.64 115.27 47.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.22 -0.445 . . . . 52.310000000000002 111.114 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -111.58 79.93 1.26 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.165 -0.47 . . . . 63.43 110.895 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.434 ' O ' ' HA ' ' A' ' 6' ' ' THR . . . 132.13 100.63 0.8 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.75 -0.738 . . . . 55.0 112.531 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.481 ' HA2' HD21 ' A' ' 88' ' ' LEU . . . 53.47 178.36 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.724 -0.75 . . . . 64.439999999999998 112.467 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.715 HG23 ' HA ' ' A' ' 63' ' ' PRO . 0.8 OUTLIER -76.74 168.06 20.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.774 0.321 . . . . 73.340000000000003 111.11 -179.831 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 47' ' ' TRP . . . . . 0.576 ' CD1' ' HB ' ' A' ' 8' ' ' ILE . 3.6 m95 -142.87 129.42 20.19 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.191 -0.459 . . . . 73.129999999999995 110.897 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.83 ' HB2' ' CG2' ' A' ' 86' ' ' VAL . . . -92.69 126.84 37.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.191 -0.459 . . . . 55.530000000000001 111.086 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.639 HG12 ' HB3' ' A' ' 83' ' ' CYS . 15.1 m -124.49 145.73 31.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.231 -0.44 . . . . 44.149999999999999 111.105 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.926 ' HB3' ' CB ' ' A' ' 56' ' ' ALA . 6.8 m-85 -119.31 141.35 49.07 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.125 -0.489 . . . . 63.240000000000002 110.925 -179.905 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.531 ' HG2' ' N ' ' A' ' 52' ' ' ARG . 0.3 OUTLIER -48.87 -82.18 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.166 -0.47 . . . . 74.540000000000006 110.903 179.99 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.904 ' O ' ' HB2' ' A' ' 56' ' ' ALA . 2.1 mtp180 -82.92 137.58 43.48 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.607 0.718 . . . . 61.399999999999999 110.88 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.746 ' HA ' ' OG ' ' A' ' 82' ' ' SER . 54.1 Cg_endo -69.76 137.53 35.69 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.703 2.269 . . . . 74.239999999999995 112.33 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.462 ' C ' ' CD2' ' A' ' 55' ' ' PHE . 0.9 OUTLIER 67.16 -6.27 0.61 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.241 -0.436 . . . . 75.340000000000003 110.904 179.994 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.463 ' H ' ' C ' ' A' ' 53' ' ' PRO . 0.0 OUTLIER -140.22 -74.91 0.34 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.165 -0.47 . . . . 73.420000000000002 110.905 -179.962 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.926 ' CB ' ' HB3' ' A' ' 50' ' ' TYR . . . 45.16 78.91 0.05 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.117 -0.492 . . . . 43.039999999999999 111.128 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' TRP . . . . . 0.557 ' O ' ' CD2' ' A' ' 58' ' ' TYR . 24.9 t-105 -64.18 31.55 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.279 -0.418 . . . . 74.109999999999999 110.939 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.623 ' H ' ' C ' ' A' ' 56' ' ' ALA . 1.9 m-30 -162.57 116.75 1.76 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.189 -0.46 . . . . 65.239999999999995 110.929 -179.848 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.548 ' HB2' ' HA ' ' A' ' 150' ' ' TYR . 1.8 mpt? -81.9 143.51 31.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.085 -0.507 . . . . 72.109999999999999 110.884 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.831 ' CD2' HD12 ' A' ' 76' ' ' LEU . 3.1 t80 -156.95 107.15 2.28 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.223 -0.444 . . . . 74.129999999999995 110.963 -179.861 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.811 ' N ' HD12 ' A' ' 61' ' ' ILE . 1.3 mp -94.57 116.66 36.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.096 -0.502 . . . . 72.209999999999994 111.102 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.798 HD23 ' HD2' ' A' ' 63' ' ' PRO . 0.2 OUTLIER -82.73 130.17 59.29 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.569 0.699 . . . . 71.129999999999995 110.92 179.915 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.798 ' HD2' HD23 ' A' ' 62' ' ' LEU . 53.7 Cg_endo -69.71 -173.64 0.75 Allowed 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.645 2.23 . . . . 72.209999999999994 112.38 179.869 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.21 162.17 16.04 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.221 -0.445 . . . . 72.400000000000006 110.903 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 112.01 -168.69 12.81 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.752 -0.737 . . . . 72.040000000000006 112.512 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 8.7 mp0 -107.07 152.97 23.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.842 0.353 . . . . 72.109999999999999 110.898 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.639 ' HB2' ' O ' ' A' ' 40' ' ' ILE . 12.9 m-85 -141.84 84.72 11.76 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.75 0.785 . . . . 74.200000000000003 110.914 -179.864 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.423 ' HD2' ' HG3' ' A' ' 72' ' ' ARG . 53.7 Cg_endo -69.75 0.48 5.58 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.693 2.262 . . . . 74.430000000000007 112.341 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.524 ' HB2' ' HG2' ' A' ' 72' ' ' ARG . 48.6 mt-10 -155.37 142.49 19.26 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.231 -0.441 . . . . 70.109999999999999 110.88 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.708 ' HA ' ' NE1' ' A' ' 73' ' ' TRP . 28.4 p90 -55.7 -20.27 13.75 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.169 -0.468 . . . . 73.120000000000005 110.956 -179.887 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -80.41 -16.93 53.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.121 -0.49 . . . . 73.239999999999995 110.908 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.524 ' HG2' ' HB2' ' A' ' 69' ' ' GLU . 31.3 mmt180 -69.49 -8.76 49.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.229 -0.442 . . . . 72.530000000000001 110.876 -179.915 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' TRP . . . . . 0.757 ' CH2' HD12 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -135.35 16.79 3.41 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.208 -0.451 . . . . 72.109999999999999 110.893 -179.95 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 74' ' ' MET . . . . . 0.411 ' C ' ' O ' ' A' ' 73' ' ' TRP . 15.8 mtm 36.95 43.95 0.33 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.266 -0.425 . . . . 63.149999999999999 110.896 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -56.51 119.14 13.61 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.741 -0.742 . . . . 33.350000000000001 112.451 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.903 HD13 ' N ' ' A' ' 77' ' ' ASN . 0.0 OUTLIER -68.69 -8.7 44.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.792 0.33 . . . . 74.329999999999998 110.913 -179.911 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.903 ' N ' HD13 ' A' ' 76' ' ' LEU . 12.8 t-20 -152.77 138.15 17.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.189 -0.46 . . . . 71.310000000000002 110.884 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -89.67 13.15 14.9 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.185 -0.461 . . . . 63.310000000000002 110.85 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.426 ' HD3' ' HA ' ' A' ' 52' ' ' ARG . 1.2 ttm-85 -110.95 81.64 1.46 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.217 -0.447 . . . . 74.129999999999995 110.85 -179.869 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.61 ' HB2' ' HB3' ' A' ' 37' ' ' CYS . 0.0 OUTLIER -83.77 134.65 34.72 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.198 -0.456 . . . . 51.030000000000001 110.935 179.993 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.643 ' HB3' ' HB3' ' A' ' 53' ' ' PRO . 1.3 m -150.38 -123.79 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.173 -0.467 . . . . 72.239999999999995 110.832 -179.907 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.746 ' OG ' ' HA ' ' A' ' 53' ' ' PRO . 0.0 OUTLIER -34.28 105.79 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.172 -0.467 . . . . 55.299999999999997 110.841 -179.826 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 83' ' ' CYS . . . . . 0.639 ' HB3' HG12 ' A' ' 49' ' ' VAL . 31.7 p -128.2 132.4 48.83 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.149 -0.478 . . . . 32.25 110.89 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.603 ' N ' ' O ' ' A' ' 48' ' ' ALA . 10.7 mmt85 -116.61 149.39 39.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.188 -0.46 . . . . 74.340000000000003 110.918 -179.894 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -66.33 129.37 39.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.253 -0.431 . . . . 44.030000000000001 111.094 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.83 ' CG2' ' HB2' ' A' ' 48' ' ' ALA . 76.2 t -114.76 135.65 53.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.211 -0.45 . . . . 55.420000000000002 111.167 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' HIS . . . . . 0.659 ' O ' HG23 ' A' ' 136' ' ' VAL . 6.1 m-70 -111.8 113.03 25.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 74.219999999999999 110.836 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.481 HD21 ' HA2' ' A' ' 45' ' ' GLY . 0.0 OUTLIER -38.07 141.12 0.53 Allowed Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.587 0.708 . . . . 61.539999999999999 110.939 -179.966 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.59 ' HB3' ' H ' ' A' ' 136' ' ' VAL . 53.6 Cg_endo -69.79 79.95 0.92 Allowed 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.654 2.236 . . . . 74.549999999999997 112.365 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -91.55 -177.15 4.72 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.174 -0.467 . . . . 70.5 110.855 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 61.15 38.87 96.31 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.717 -0.754 . . . . 71.0 112.487 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.415 ' O ' ' C ' ' A' ' 93' ' ' GLN . . . 134.14 33.55 0.32 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.728 -0.749 . . . . 64.329999999999998 112.48 -179.914 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.596 ' O ' ' HG3' ' A' ' 134' ' ' GLU . 21.6 pt20 37.26 -131.38 0.13 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.846 0.355 . . . . 70.340000000000003 110.89 -179.874 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.575 ' HA ' ' HG3' ' A' ' 134' ' ' GLU . 0.1 OUTLIER -117.37 112.1 20.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.45 . . . . 74.409999999999997 110.9 -179.831 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.571 ' H ' ' CG ' ' A' ' 134' ' ' GLU . 31.8 tptt -119.16 128.66 54.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.134 -0.484 . . . . 71.049999999999997 110.886 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.429 HG13 ' CZ3' ' A' ' 137' ' ' TRP . 0.0 OUTLIER -152.26 139.54 13.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.24 -0.436 . . . . 64.540000000000006 111.111 179.865 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -105.85 122.8 46.84 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.159 -0.473 . . . . 71.319999999999993 110.947 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.532 HG22 ' SD ' ' A' ' 124' ' ' MET . 2.6 mt -101.93 130.61 51.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.232 -0.44 . . . . 72.400000000000006 111.127 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.69 ' HB2' ' HB2' ' A' ' 129' ' ' SER . 43.9 m-85 -118.46 147.84 43.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.18 -0.463 . . . . 73.319999999999993 110.87 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 56.5 tt0 -81.69 -56.15 4.18 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.13 -0.486 . . . . 74.409999999999997 110.906 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 45.9 mttt -101.92 172.32 7.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.134 -0.485 . . . . 72.319999999999993 110.921 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.407 ' HA2' ' OG ' ' A' ' 129' ' ' SER . . . -71.52 153.09 50.19 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.703 -0.761 . . . . 62.299999999999997 112.467 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.47 ' HA ' ' HB2' ' A' ' 158' ' ' ARG . 41.0 t0 65.42 46.22 2.61 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.894 0.378 . . . . 64.519999999999996 110.892 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.576 ' N ' ' CD2' ' A' ' 104' ' ' PHE . 0.2 OUTLIER 47.66 32.1 2.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.184 -0.462 . . . . 73.120000000000005 110.864 -179.898 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 57.7 m -94.03 164.04 13.24 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.179 -0.464 . . . . 74.140000000000001 110.879 -179.78 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 80.57 -136.29 16.31 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.763 -0.732 . . . . 72.420000000000002 112.52 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -90.89 121.07 32.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.784 0.325 . . . . 71.239999999999995 110.895 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 4.6 ttp -106.57 134.97 48.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.218 -0.446 . . . . 62.009999999999998 110.929 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -141.39 136.67 31.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.252 -0.431 . . . . 64.540000000000006 110.952 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -117.3 111.55 19.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.115 -0.493 . . . . 74.019999999999996 110.847 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.458 HG22 ' CD1' ' A' ' 98' ' ' ILE . 11.8 t -119.96 147.62 44.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.195 -0.457 . . . . 61.140000000000001 111.185 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.478 ' O ' ' OG1' ' A' ' 112' ' ' THR . 0.6 OUTLIER -128.38 27.73 5.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.242 -0.436 . . . . 65.439999999999998 111.153 179.982 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -141.06 156.64 45.97 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.249 -0.432 . . . . 74.239999999999995 110.933 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -50.32 162.35 0.23 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.179 -0.464 . . . . 73.25 110.881 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 115' ' ' CYS . . . . . 0.538 ' O ' ' HB2' ' A' ' 172' ' ' SER . 52.6 t -153.18 120.31 3.0 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.647 0.737 . . . . 75.040000000000006 110.816 -179.884 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.41 ' O ' ' CA ' ' A' ' 143' ' ' PRO . 53.3 Cg_endo -69.83 -30.85 21.33 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.708 2.272 . . . . 32.25 112.315 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.655 ' HB3' ' CB ' ' A' ' 120' ' ' GLU . 0.1 OUTLIER -149.58 112.8 4.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.254 -0.43 . . . . 71.409999999999997 110.828 -179.836 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.673 HD13 HD11 ' A' ' 127' ' ' ILE . 3.9 tt -64.54 -31.6 54.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.129 -0.487 . . . . 62.240000000000002 111.116 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 119' ' ' MET . . . . . 0.642 ' O ' ' HA ' ' A' ' 123' ' ' HIS . 0.0 OUTLIER -86.33 -39.2 16.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.206 -0.452 . . . . 54.119999999999997 110.928 179.807 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.655 ' CB ' ' HB3' ' A' ' 117' ' ' SER . 4.7 tp10 -70.79 -13.88 62.21 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.212 -0.449 . . . . 71.129999999999995 110.924 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 25.2 tp60 -114.72 -46.26 2.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.114 -0.493 . . . . 73.319999999999993 110.926 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.469 ' HB2' ' O ' ' A' ' 118' ' ' ILE . 74.5 m-85 -106.98 -19.08 13.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.189 -0.459 . . . . 73.409999999999997 110.9 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 123' ' ' HIS . . . . . 0.642 ' HA ' ' O ' ' A' ' 119' ' ' MET . 30.4 m-70 72.35 26.87 2.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.11 -0.496 . . . . 75.439999999999998 110.8 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.532 ' SD ' HG22 ' A' ' 98' ' ' ILE . 7.6 mtt -108.93 74.76 0.92 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.243 -0.435 . . . . 62.219999999999999 110.878 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 1.7 ptp85 -49.96 -26.31 4.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.229 -0.442 . . . . 74.25 110.849 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.431 ' C ' HD13 ' A' ' 127' ' ' ILE . 24.7 mt-10 -144.01 130.38 19.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.149 -0.478 . . . . 54.43 110.878 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.673 HD11 HD13 ' A' ' 118' ' ' ILE . 4.0 mm -96.45 104.76 16.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.072 -0.513 . . . . 65.299999999999997 111.107 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 8.2 m80 -72.22 -33.0 67.24 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.201 -0.454 . . . . 74.530000000000001 110.872 179.833 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' SER . . . . . 0.69 ' HB2' ' HB2' ' A' ' 99' ' ' PHE . 16.8 m -134.77 144.04 47.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.225 -0.443 . . . . 63.020000000000003 110.857 -179.81 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 130' ' ' CYS . . . . . 0.565 ' O ' ' O ' ' A' ' 155' ' ' LYS . 1.1 m -142.52 115.04 8.51 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.129 -0.487 . . . . 45.109999999999999 110.885 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.58 ' HA ' ' HA ' ' A' ' 156' ' ' GLU . 7.2 mtpp -109.62 153.57 24.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.166 -0.47 . . . . 62.130000000000003 110.914 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.528 HG12 ' N ' ' A' ' 133' ' ' LEU . 16.2 t 85.25 162.87 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.247 -0.433 . . . . 73.310000000000002 111.1 179.855 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.784 HD22 ' CG ' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -175.77 126.61 0.23 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.134 -0.485 . . . . 74.400000000000006 110.897 179.944 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.596 ' HG3' ' O ' ' A' ' 93' ' ' GLN . 10.1 mm-40 -99.99 164.38 12.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.186 -0.461 . . . . 72.319999999999993 110.881 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 135' ' ' GLY . . . . . 0.552 ' C ' ' O ' ' A' ' 134' ' ' GLU . . . -23.91 -63.07 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.746 -0.74 . . . . 73.219999999999999 112.467 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.718 HG21 HG13 ' A' ' 86' ' ' VAL . 10.4 t -144.45 145.99 20.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.858 0.361 . . . . 61.539999999999999 111.089 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 137' ' ' TRP . . . . . 0.617 ' HB3' ' HB3' ' A' ' 152' ' ' LEU . 4.7 t90 -140.12 156.64 46.47 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.161 -0.472 . . . . 73.109999999999999 110.929 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.425 HD12 ' HB ' ' A' ' 61' ' ' ILE . 6.4 mm -122.37 134.98 63.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.242 -0.435 . . . . 75.310000000000002 111.14 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.556 ' CE2' HG11 ' A' ' 170' ' ' VAL . 0.0 OUTLIER -112.73 151.97 29.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.156 -0.474 . . . . 64.430000000000007 110.878 179.922 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 140' ' ' TYR . . . . . 0.42 ' CD2' ' HA ' ' A' ' 145' ' ' TYR . 5.5 m-85 -133.7 129.79 37.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.111 -0.495 . . . . 75.420000000000002 110.912 -179.85 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 141' ' ' GLU . . . . . 0.698 ' O ' ' HB2' ' A' ' 171' ' ' GLN . 0.8 OUTLIER -63.03 -30.43 71.59 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.102 -0.499 . . . . 64.140000000000001 110.849 -179.949 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.696 ' HB3' ' HD2' ' A' ' 143' ' ' PRO . 8.9 mp -112.02 172.93 3.15 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.637 0.732 . . . . 72.040000000000006 110.909 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 143' ' ' PRO . . . . . 0.721 ' O ' ' OG ' ' A' ' 172' ' ' SER . 53.9 Cg_endo -69.77 -90.51 0.0 OUTLIER 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.701 2.267 . . . . 75.209999999999994 112.337 179.857 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 144' ' ' ASN . . . . . 0.705 ' O ' ' N ' ' A' ' 146' ' ' ARG . 1.0 OUTLIER -53.48 96.21 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.215 -0.448 . . . . 61.119999999999997 110.881 -179.976 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 145' ' ' TYR . . . . . 0.642 ' C ' ' O ' ' A' ' 144' ' ' ASN . 0.0 OUTLIER 13.33 51.97 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.115 -0.493 . . . . 73.120000000000005 110.934 -179.911 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 146' ' ' ARG . . . . . 0.705 ' N ' ' O ' ' A' ' 144' ' ' ASN . 21.2 mtt180 -117.84 163.87 15.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.108 -0.496 . . . . 74.129999999999995 110.893 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 84.85 -171.6 47.05 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.742 -0.742 . . . . 50.020000000000003 112.482 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -82.05 155.02 25.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.741 0.305 . . . . 74.219999999999999 110.87 -179.869 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -92.81 159.99 15.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.15 -0.477 . . . . 70.129999999999995 110.897 -179.896 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 150' ' ' TYR . . . . . 0.548 ' HA ' ' HB2' ' A' ' 59' ' ' MET . 79.8 m-85 -140.85 130.76 24.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.182 -0.463 . . . . 73.430000000000007 110.903 -179.835 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.665 ' HB2' HD11 ' A' ' 61' ' ' ILE . 20.2 tp -78.9 123.95 27.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.104 -0.498 . . . . 61.549999999999997 110.89 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 1.01 HD13 ' O ' ' A' ' 152' ' ' LEU . 0.0 OUTLIER -53.82 137.06 39.26 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.222 -0.445 . . . . 74.099999999999994 110.951 179.832 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 153' ' ' ASP . . . . . 0.439 ' N ' HD22 ' A' ' 152' ' ' LEU . 11.3 t0 -161.09 25.92 0.14 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.173 -0.467 . . . . 72.329999999999998 110.851 179.876 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.797 ' HB2' ' CD1' ' A' ' 157' ' ' TYR . 0.0 OUTLIER -118.06 -177.32 3.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.207 -0.451 . . . . 52.229999999999997 110.852 -179.971 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.784 ' CG ' HD22 ' A' ' 133' ' ' LEU . 0.3 OUTLIER -161.23 -124.39 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.197 -0.456 . . . . 64.140000000000001 110.924 179.834 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.58 ' HA ' ' HA ' ' A' ' 131' ' ' LYS . 3.0 tm-20 -67.27 4.19 1.02 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.184 -0.462 . . . . 73.230000000000004 110.866 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 157' ' ' TYR . . . . . 0.797 ' CD1' ' HB2' ' A' ' 154' ' ' LYS . 18.0 m-30 -35.08 151.33 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.168 -0.469 . . . . 74.420000000000002 110.918 -179.856 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 158' ' ' ARG . . . . . 0.47 ' HB2' ' HA ' ' A' ' 103' ' ' ASP . 0.0 OUTLIER -122.93 -35.53 3.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.109 -0.496 . . . . 75.209999999999994 110.916 179.985 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -88.44 150.93 47.63 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.553 0.692 . . . . 61.450000000000003 110.891 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 -26.32 27.69 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.648 2.232 . . . . 72.540000000000006 112.36 179.869 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.655 HD12 ' H ' ' A' ' 161' ' ' ILE . 4.2 mp -70.46 -8.81 11.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.232 -0.44 . . . . 72.349999999999994 111.139 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.644 ' HB3' ' CD1' ' A' ' 157' ' ' TYR . 0.4 OUTLIER -75.81 -14.26 60.29 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.173 -0.467 . . . . 62.350000000000001 110.852 179.829 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 28.1 t-105 -89.63 -9.44 49.64 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.233 -0.44 . . . . 74.239999999999995 110.97 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 101.88 -36.51 4.19 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.707 -0.759 . . . . 73.0 112.509 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -75.46 127.69 33.67 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.816 0.341 . . . . 72.409999999999997 111.117 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -38.1 -39.96 0.45 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.249 -0.432 . . . . 50.520000000000003 111.105 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 167' ' ' SER . . . . . 0.496 ' C ' ' H ' ' A' ' 169' ' ' ALA . 0.3 OUTLIER -132.11 157.71 77.5 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.673 0.749 . . . . 73.409999999999997 110.824 -179.775 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 168' ' ' PRO . . . . . 0.501 ' HB3' ' O ' ' A' ' 127' ' ' ILE . 54.0 Cg_endo -69.75 28.43 0.18 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.668 2.245 . . . . 63.5 112.372 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 0.496 ' H ' ' C ' ' A' ' 167' ' ' SER . . . -68.84 106.58 2.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.217 -0.447 . . . . 54.539999999999999 111.069 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.556 HG11 ' CE2' ' A' ' 139' ' ' PHE . 2.6 t -153.43 164.63 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.233 -0.439 . . . . 55.130000000000003 111.143 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 171' ' ' GLN . . . . . 0.698 ' HB2' ' O ' ' A' ' 141' ' ' GLU . 2.1 mm-40 -112.85 -86.81 0.56 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.162 -0.472 . . . . 64.25 110.9 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 172' ' ' SER . . . . . 0.721 ' OG ' ' O ' ' A' ' 143' ' ' PRO . 56.7 p -124.41 176.91 6.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.465 . . . . 70.299999999999997 110.85 -179.8 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 173' ' ' PHE . . . . . 0.407 ' HB3' ' CD1' ' A' ' 139' ' ' PHE . 0.5 OUTLIER -144.81 168.83 19.29 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.103 -0.498 . . . . 74.420000000000002 110.911 -179.974 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 7.8 mtp85 -138.73 139.25 38.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.144 -0.48 . . . . 54.530000000000001 110.882 -179.872 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 175' ' ' ARG . . . . . 0.402 ' HB2' ' CG ' ' A' ' 94' ' ' TYR . 0.0 OUTLIER -95.7 154.73 17.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.19 -0.459 . . . . 75.129999999999995 110.885 -179.951 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 176' ' ' ILE . . . . . 0.525 HD12 ' O ' ' A' ' 136' ' ' VAL . 2.2 mt -96.0 132.83 39.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.197 -0.456 . . . . 74.019999999999996 111.143 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 11.5 p -51.62 147.38 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.224 -0.444 . . . . 73.030000000000001 111.104 179.823 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.167 -0.47 . . . . 75.450000000000003 110.847 179.947 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.345 0 N-CA-C 112.468 -0.253 . . . . 74.349999999999994 112.468 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.44 ' C ' ' HE1' ' A' ' 47' ' ' TRP . 19.3 p -82.66 133.73 35.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.864 0.364 . . . . 75.120000000000005 111.135 -179.865 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 2.9 tttt -123.44 136.94 54.87 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.213 -0.449 . . . . 74.120000000000005 110.918 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.654 ' HB ' ' CD1' ' A' ' 47' ' ' TRP . 16.9 tt -137.48 152.1 26.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.199 -0.455 . . . . 71.340000000000003 111.101 179.908 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.53 ' HA ' ' O ' ' A' ' 21' ' ' TYR . 13.5 m -132.74 145.13 50.77 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.149 -0.478 . . . . 72.239999999999995 111.144 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.756 ' HB2' HD22 ' A' ' 34' ' ' LEU . 1.1 m-85 -132.42 126.03 32.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.214 -0.448 . . . . 72.329999999999998 110.831 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.551 ' CG ' ' HA ' ' A' ' 16' ' ' PHE . 12.8 m-85 -112.01 132.83 54.56 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.132 -0.486 . . . . 54.130000000000003 110.935 -179.877 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.47 ' HB2' ' HB2' ' A' ' 19' ' ' ARG . 0.0 OUTLIER -61.92 -15.04 40.04 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.115 -0.493 . . . . 71.340000000000003 110.935 179.96 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.452 ' HB2' ' O ' ' A' ' 17' ' ' GLN . 71.4 m-20 -134.67 149.01 50.46 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.125 -0.489 . . . . 72.319999999999993 110.901 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.557 ' N ' ' HB3' ' A' ' 38' ' ' ASN . 5.8 mtmt -54.26 -176.94 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.198 -0.456 . . . . 55.399999999999999 110.911 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 16.6 m120 47.52 30.99 1.81 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.255 -0.43 . . . . 64.340000000000003 110.919 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.551 ' HA ' ' CG ' ' A' ' 11' ' ' TYR . 3.3 m-85 51.05 64.51 1.81 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.175 -0.466 . . . . 74.219999999999999 110.862 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.452 ' O ' ' HB2' ' A' ' 13' ' ' ASP . 14.2 mt-30 -139.76 158.92 43.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.141 -0.482 . . . . 75.120000000000005 110.89 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 92.61 -148.79 19.26 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.729 -0.748 . . . . 35.210000000000001 112.51 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.704 ' O ' HD13 ' A' ' 34' ' ' LEU . 0.0 OUTLIER -68.12 77.65 0.24 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.852 0.358 . . . . 71.549999999999997 110.879 -179.834 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.474 ' HB2' ' CE1' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -77.86 129.36 35.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.178 -0.465 . . . . 73.200000000000003 110.863 -179.882 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.53 ' O ' ' HA ' ' A' ' 9' ' ' THR . 90.8 t80 -123.49 123.99 41.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 62.32 110.888 -179.823 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.481 ' CG ' HG23 ' A' ' 9' ' ' THR . 1.3 m-20 -120.57 133.96 55.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.141 -0.481 . . . . 74.540000000000006 110.885 179.873 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -167.72 136.79 2.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.168 -0.469 . . . . 72.349999999999994 110.86 -179.912 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -105.37 5.18 31.57 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.157 -0.474 . . . . 72.349999999999994 110.919 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 11.7 t -107.1 169.35 8.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.183 -0.462 . . . . 54.240000000000002 110.897 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -64.66 116.89 6.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.172 -0.467 . . . . 74.230000000000004 110.874 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.46 ' HB2' ' HB3' ' A' ' 30' ' ' PHE . 4.7 m -118.06 53.67 0.95 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.198 -0.456 . . . . 74.25 110.852 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.529 ' C ' ' HA ' ' A' ' 82' ' ' SER . . . -46.28 -21.05 0.13 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.157 -0.474 . . . . 63.420000000000002 111.099 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -127.71 43.61 3.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.209 -0.45 . . . . 74.310000000000002 110.895 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.777 ' CD2' ' O ' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -81.11 15.51 1.86 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.19 -0.459 . . . . 64.019999999999996 110.837 -179.885 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.535 ' HB2' ' HB3' ' A' ' 81' ' ' SER . 30.7 t60 -78.86 -39.3 35.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.145 -0.48 . . . . 71.340000000000003 110.826 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.6 t -56.83 -13.89 2.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.229 -0.441 . . . . 65.239999999999995 111.155 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -99.61 -28.08 13.37 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.216 -0.447 . . . . 61.310000000000002 110.906 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.756 HD22 ' HB2' ' A' ' 10' ' ' PHE . 18.2 tp -141.12 137.25 32.64 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.157 -0.474 . . . . 64.5 110.916 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 30.6 m -101.07 -43.06 6.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.184 -0.462 . . . . 60.039999999999999 110.867 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -118.0 140.97 48.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.118 -0.492 . . . . 64.319999999999993 110.854 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.702 ' SG ' ' HB2' ' A' ' 80' ' ' LEU . 5.6 p -110.21 87.4 2.51 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.225 -0.443 . . . . 63.229999999999997 110.904 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.557 ' HB3' ' N ' ' A' ' 14' ' ' LYS . 0.2 OUTLIER -78.62 -65.17 1.02 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.186 -0.461 . . . . 75.310000000000002 110.881 -179.878 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 5.0 p -118.41 123.9 46.36 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.157 -0.474 . . . . 42.100000000000001 110.856 -179.834 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.908 HD12 ' CH2' ' A' ' 73' ' ' TRP . 25.6 mt -117.27 150.62 19.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.13 -0.486 . . . . 64.099999999999994 111.094 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.458 ' HD2' ' CE2' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -145.53 119.22 9.18 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.108 -0.497 . . . . 73.150000000000006 110.877 179.871 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.511 ' CG2' HD12 ' A' ' 8' ' ' ILE . 1.4 t -103.54 116.21 46.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.238 -0.437 . . . . 64.439999999999998 111.14 179.89 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -111.04 79.94 1.25 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.233 -0.44 . . . . 74.420000000000002 110.884 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.436 ' O ' ' HA ' ' A' ' 6' ' ' THR . . . 127.17 108.84 1.55 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.793 -0.717 . . . . 43.310000000000002 112.476 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.418 ' HA3' HG22 ' A' ' 6' ' ' THR . . . 52.44 179.79 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.706 -0.759 . . . . 74.420000000000002 112.491 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.753 HG23 ' HA ' ' A' ' 63' ' ' PRO . 1.3 m -86.39 169.89 12.5 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.78 0.324 . . . . 60.049999999999997 111.154 -179.887 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' TRP . . . . . 0.654 ' CD1' ' HB ' ' A' ' 8' ' ' ILE . 17.8 m95 -140.86 130.8 24.51 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.203 -0.453 . . . . 75.409999999999997 110.913 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.909 ' HB2' ' CG2' ' A' ' 86' ' ' VAL . . . -100.28 107.53 19.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.257 -0.429 . . . . 50.119999999999997 111.099 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.756 HG11 HD11 ' A' ' 80' ' ' LEU . 4.9 m -107.7 125.52 64.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.205 -0.452 . . . . 54.43 111.157 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.734 ' HB3' ' HA ' ' A' ' 56' ' ' ALA . 39.9 m-85 -89.05 148.12 23.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.222 -0.445 . . . . 74.310000000000002 110.899 -179.89 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.567 ' HB2' ' HB2' ' A' ' 58' ' ' TYR . 59.6 tt0 -48.06 -77.85 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.134 -0.485 . . . . 72.409999999999997 110.889 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.579 ' HB3' ' HB2' ' A' ' 55' ' ' PHE . 0.2 OUTLIER -89.76 141.37 28.32 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.623 0.725 . . . . 73.510000000000005 110.868 -179.914 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.75 ' HA ' ' OG ' ' A' ' 82' ' ' SER . 53.6 Cg_endo -69.78 138.17 37.11 Favored 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.675 2.25 . . . . 60.43 112.356 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 2.3 t30 65.15 -10.0 0.19 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.264 -0.426 . . . . 73.129999999999995 110.884 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.579 ' HB2' ' HB3' ' A' ' 52' ' ' ARG . 3.3 m-30 -103.19 -23.32 13.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.175 -0.466 . . . . 72.530000000000001 110.856 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.734 ' HA ' ' HB3' ' A' ' 50' ' ' TYR . . . 55.61 23.36 6.02 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.194 -0.457 . . . . 63.43 111.095 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' TRP . . . . . 0.63 ' O ' ' C ' ' A' ' 58' ' ' TYR . 0.7 OUTLIER -51.67 -165.79 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.236 -0.438 . . . . 74.409999999999997 110.887 -179.975 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.63 ' C ' ' O ' ' A' ' 57' ' ' TRP . 11.1 m-30 -14.08 100.57 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.281 -0.418 . . . . 54.030000000000001 110.886 -179.85 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.515 ' HB2' ' HA ' ' A' ' 150' ' ' TYR . 0.0 OUTLIER -58.7 158.87 7.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.151 -0.477 . . . . 75.040000000000006 110.876 179.91 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.608 ' OH ' ' O ' ' A' ' 73' ' ' TRP . 0.4 OUTLIER -172.23 97.3 0.16 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.257 -0.429 . . . . 72.120000000000005 110.906 -179.843 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.776 HD11 ' HB2' ' A' ' 151' ' ' LEU . 2.5 mp -94.32 119.01 41.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.103 -0.498 . . . . 71.340000000000003 111.129 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.849 HD13 HG21 ' A' ' 40' ' ' ILE . 0.3 OUTLIER -88.06 128.92 51.96 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-O 121.557 0.694 . . . . 75.219999999999999 110.938 179.912 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.787 ' HD2' HD23 ' A' ' 62' ' ' LEU . 53.5 Cg_endo -69.72 -170.53 0.4 Allowed 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.688 2.259 . . . . 64.430000000000007 112.358 179.885 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -88.69 161.36 16.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.244 -0.435 . . . . 65.040000000000006 110.892 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 112.58 -166.37 12.16 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.759 -0.734 . . . . 53.43 112.534 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -111.04 150.99 28.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.913 0.387 . . . . 73.450000000000003 110.867 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.636 ' HB2' ' O ' ' A' ' 40' ' ' ILE . 10.0 m-85 -140.13 84.44 14.82 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.707 0.765 . . . . 61.310000000000002 110.911 -179.874 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 -1.06 7.83 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.739 2.293 . . . . 42.509999999999998 112.329 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.495 ' HB2' ' HG2' ' A' ' 72' ' ' ARG . 80.7 mt-10 -154.63 142.6 20.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.23 -0.441 . . . . 75.140000000000001 110.905 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.743 ' HA ' ' NE1' ' A' ' 73' ' ' TRP . 35.9 p90 -55.13 -23.79 22.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.464 . . . . 73.319999999999993 110.93 -179.865 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -76.43 -16.53 59.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.166 -0.47 . . . . 74.420000000000002 110.93 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.495 ' HG2' ' HB2' ' A' ' 69' ' ' GLU . 28.3 mmt180 -70.64 -6.36 36.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.209 -0.45 . . . . 73.120000000000005 110.879 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' TRP . . . . . 0.908 ' CH2' HD12 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -139.35 26.58 2.37 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.181 -0.463 . . . . 72.420000000000002 110.933 -179.951 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 74' ' ' MET . . . . . 0.463 ' HB2' ' O ' ' A' ' 73' ' ' TRP . 0.0 OUTLIER 75.84 -11.0 1.18 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.23 -0.441 . . . . 72.230000000000004 110.891 179.954 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.413 ' C ' ' O ' ' A' ' 74' ' ' MET . . . 37.27 46.55 1.38 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.76 -0.733 . . . . 41.310000000000002 112.456 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.731 HD12 ' HG3' ' A' ' 149' ' ' GLN . 0.1 OUTLIER -45.83 -63.25 1.01 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.819 0.342 . . . . 54.210000000000001 110.92 -179.927 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -127.32 126.11 42.01 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.208 -0.451 . . . . 42.310000000000002 110.873 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -76.03 1.69 14.78 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.187 -0.461 . . . . 65.239999999999995 110.889 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -99.89 73.85 1.79 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.176 -0.465 . . . . 74.530000000000001 110.837 -179.873 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.756 HD11 HG11 ' A' ' 49' ' ' VAL . 0.1 OUTLIER -81.87 133.08 35.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.155 -0.475 . . . . 74.120000000000005 110.874 -179.977 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.622 ' HB3' ' HB3' ' A' ' 53' ' ' PRO . 0.9 OUTLIER -148.31 -130.45 0.06 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.193 -0.458 . . . . 73.209999999999994 110.921 -179.957 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.75 ' OG ' ' HA ' ' A' ' 53' ' ' PRO . 0.6 OUTLIER -25.78 131.4 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.124 -0.489 . . . . 65.049999999999997 110.893 -179.851 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 83' ' ' CYS . . . . . 0.512 ' HA ' ' O ' ' A' ' 48' ' ' ALA . 6.9 p -138.1 140.87 40.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.141 -0.482 . . . . 62.409999999999997 110.87 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.521 ' N ' ' O ' ' A' ' 48' ' ' ALA . 6.4 mmt85 -139.78 128.36 23.01 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.225 -0.443 . . . . 70.140000000000001 110.851 -179.823 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.449 ' N ' ' CZ3' ' A' ' 47' ' ' TRP . . . -50.56 129.59 22.6 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.195 -0.457 . . . . 64.420000000000002 111.096 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.909 ' CG2' ' HB2' ' A' ' 48' ' ' ALA . 25.5 t -114.51 142.04 28.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.276 -0.42 . . . . 75.200000000000003 111.09 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' HIS . . . . . 0.59 ' O ' HG23 ' A' ' 136' ' ' VAL . 6.7 m-70 -112.24 110.56 20.88 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.161 -0.472 . . . . 74.230000000000004 110.851 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.595 HD13 ' HB3' ' A' ' 178' ' ' GLU . 0.0 OUTLIER -35.95 144.13 0.26 Allowed Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.646 0.736 . . . . 60.299999999999997 110.9 -179.959 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.534 ' HB3' ' H ' ' A' ' 136' ' ' VAL . 53.7 Cg_endo -69.7 98.66 0.69 Allowed 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.671 2.247 . . . . 70.120000000000005 112.357 179.857 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -104.51 -175.35 2.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.263 -0.426 . . . . 74.019999999999996 110.878 -179.84 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 50.95 58.84 8.8 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.757 -0.735 . . . . 71.310000000000002 112.523 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.412 ' O ' ' C ' ' A' ' 93' ' ' GLN . . . 123.46 26.07 1.68 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.747 -0.74 . . . . 70.510000000000005 112.488 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.45 ' O ' ' HG2' ' A' ' 134' ' ' GLU . 14.6 pt20 37.32 -123.05 0.21 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.834 0.35 . . . . 75.530000000000001 110.905 -179.856 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.541 ' HA ' ' HG2' ' A' ' 134' ' ' GLU . 0.1 OUTLIER -123.75 104.41 8.96 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.172 -0.467 . . . . 73.209999999999994 110.907 -179.852 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.562 ' HG3' HG11 ' A' ' 132' ' ' VAL . 34.1 tptt -114.37 127.78 56.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.099 -0.5 . . . . 62.149999999999999 110.895 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.584 HG21 ' HE2' ' A' ' 173' ' ' PHE . 6.3 tt -149.45 136.93 13.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.221 -0.445 . . . . 73.430000000000007 111.073 179.898 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.461 ' HB2' ' O ' ' A' ' 131' ' ' LYS . 0.7 OUTLIER -107.25 123.91 48.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.15 -0.477 . . . . 74.239999999999995 110.907 179.949 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.437 ' CG2' HD12 ' A' ' 127' ' ' ILE . 43.9 mm -105.39 131.06 55.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.193 -0.458 . . . . 70.120000000000005 111.121 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.7 ' HB2' ' HB2' ' A' ' 129' ' ' SER . 45.9 m-85 -118.79 150.39 39.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.152 -0.476 . . . . 74.340000000000003 110.897 179.911 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 50.8 tt0 -85.76 -56.08 3.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.187 -0.461 . . . . 71.099999999999994 110.852 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 47.6 mttt -101.01 164.93 11.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.167 -0.47 . . . . 65.140000000000001 110.89 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.402 ' HA2' ' OG ' ' A' ' 129' ' ' SER . . . -65.53 152.4 51.51 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.768 -0.73 . . . . 73.120000000000005 112.49 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.425 ' HA ' ' HB2' ' A' ' 158' ' ' ARG . 27.8 t0 65.76 45.37 2.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.831 0.348 . . . . 75.140000000000001 110.852 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.576 ' N ' ' CD2' ' A' ' 104' ' ' PHE . 0.1 OUTLIER 47.48 33.81 3.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.233 -0.44 . . . . 75.239999999999995 110.912 -179.881 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 53.3 m -96.35 159.61 14.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.164 -0.471 . . . . 75.040000000000006 110.861 -179.785 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 83.91 -135.67 14.01 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.695 -0.764 . . . . 70.25 112.49 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 5.9 tp-100 -88.65 120.67 30.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.783 0.325 . . . . 61.140000000000001 110.879 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 3.5 ttp -108.25 132.8 53.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.154 -0.475 . . . . 72.109999999999999 110.862 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -137.72 137.09 37.97 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.221 -0.445 . . . . 70.239999999999995 110.925 -179.846 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -119.33 104.43 10.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.097 -0.501 . . . . 75.420000000000002 110.854 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 8.9 t -112.82 133.38 54.85 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.183 -0.462 . . . . 54.409999999999997 111.152 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.475 ' HA ' ' O ' ' A' ' 94' ' ' TYR . 1.6 t -115.5 32.49 6.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.22 -0.446 . . . . 72.340000000000003 111.131 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -142.38 -173.91 3.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.219 -0.446 . . . . 75.329999999999998 110.88 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -72.08 150.66 43.71 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.117 -0.492 . . . . 75.129999999999995 110.837 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 115' ' ' CYS . . . . . 0.424 ' O ' ' HB2' ' A' ' 172' ' ' SER . 57.4 m -140.99 107.16 6.27 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-O 121.631 0.729 . . . . 71.340000000000003 110.884 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.618 ' O ' ' CB ' ' A' ' 172' ' ' SER . 53.3 Cg_endo -69.74 -35.97 11.73 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.657 2.238 . . . . 71.25 112.311 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.611 ' HB3' ' CB ' ' A' ' 120' ' ' GLU . 0.1 OUTLIER -142.0 112.37 7.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.228 -0.442 . . . . 60.450000000000003 110.865 -179.78 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.54 ' HB ' ' O ' ' A' ' 171' ' ' GLN . 5.4 tt -67.24 -32.87 59.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.18 -0.463 . . . . 72.530000000000001 111.104 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 119' ' ' MET . . . . . 0.643 ' O ' ' HA ' ' A' ' 123' ' ' HIS . 0.0 OUTLIER -87.28 -38.99 15.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.178 -0.464 . . . . 72.109999999999999 110.897 179.855 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.611 ' CB ' ' HB3' ' A' ' 117' ' ' SER . 3.9 tp10 -72.18 -15.43 61.96 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.218 -0.446 . . . . 55.520000000000003 110.896 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 13.0 mm100 -114.44 -45.82 3.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.123 -0.49 . . . . 75.049999999999997 110.925 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.538 ' HB2' ' O ' ' A' ' 118' ' ' ILE . 47.4 m-85 -106.23 -19.71 13.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.195 -0.457 . . . . 74.310000000000002 110.879 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 123' ' ' HIS . . . . . 0.643 ' HA ' ' O ' ' A' ' 119' ' ' MET . 12.3 m80 70.58 29.21 3.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.137 -0.483 . . . . 73.140000000000001 110.889 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.403 ' SD ' HG22 ' A' ' 98' ' ' ILE . 4.0 mtt -107.19 83.42 1.82 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.208 -0.451 . . . . 71.430000000000007 110.838 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 4.0 ptp180 -50.58 -35.43 30.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.239 -0.437 . . . . 65.030000000000001 110.86 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.462 ' HB3' ' HG2' ' A' ' 168' ' ' PRO . 18.8 mt-10 -142.42 136.14 29.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.231 -0.44 . . . . 75.150000000000006 110.899 -179.915 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.529 HD11 HD13 ' A' ' 118' ' ' ILE . 3.9 mm -96.3 104.47 15.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.174 -0.466 . . . . 64.540000000000006 111.076 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 12.6 m170 -70.79 -34.95 72.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.157 -0.474 . . . . 72.340000000000003 110.833 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' SER . . . . . 0.7 ' HB2' ' HB2' ' A' ' 99' ' ' PHE . 13.7 m -133.75 149.85 51.47 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.204 -0.453 . . . . 53.229999999999997 110.883 -179.822 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 130' ' ' CYS . . . . . 0.496 ' O ' ' HE3' ' A' ' 154' ' ' LYS . 0.1 OUTLIER -148.68 117.92 6.85 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.151 -0.477 . . . . 74.129999999999995 110.865 -179.913 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.501 ' HG2' ' HG2' ' A' ' 156' ' ' GLU . 11.2 mtpt -113.87 155.56 25.53 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.21 -0.45 . . . . 70.310000000000002 110.892 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.562 HG11 ' HG3' ' A' ' 95' ' ' LYS . 15.5 t 83.43 160.91 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.221 -0.445 . . . . 54.439999999999998 111.104 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.863 HD22 ' O ' ' A' ' 133' ' ' LEU . 0.0 OUTLIER -177.79 127.3 0.13 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.166 -0.47 . . . . 70.5 110.923 179.911 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.541 ' HG2' ' HA ' ' A' ' 94' ' ' TYR . 0.1 OUTLIER -97.8 171.34 8.37 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.162 -0.472 . . . . 70.040000000000006 110.898 179.938 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 135' ' ' GLY . . . . . 0.493 ' C ' ' O ' ' A' ' 134' ' ' GLU . . . -30.41 -78.84 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.741 -0.742 . . . . 72.430000000000007 112.468 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.79 HG21 HG13 ' A' ' 86' ' ' VAL . 2.8 t -128.53 144.91 36.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.781 0.324 . . . . 72.129999999999995 111.158 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 137' ' ' TRP . . . . . 0.65 ' HB3' ' CB ' ' A' ' 152' ' ' LEU . 60.2 t-105 -146.14 163.94 33.77 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.214 -0.448 . . . . 74.530000000000001 110.897 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.511 ' CD1' ' HB ' ' A' ' 61' ' ' ILE . 5.8 mm -132.74 138.07 52.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.231 -0.441 . . . . 64.510000000000005 111.091 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.748 ' HB2' ' HB2' ' A' ' 150' ' ' TYR . 69.7 m-85 -114.49 152.48 31.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.139 -0.482 . . . . 64.239999999999995 110.855 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 140' ' ' TYR . . . . . 0.734 ' CD2' ' HA ' ' A' ' 145' ' ' TYR . 13.7 m-85 -128.34 144.19 51.1 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.149 -0.478 . . . . 74.439999999999998 110.878 -179.874 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 141' ' ' GLU . . . . . 0.57 ' C ' ' HB2' ' A' ' 171' ' ' GLN . 27.4 tt0 -84.77 -7.96 59.0 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.106 -0.497 . . . . 75.219999999999999 110.864 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.476 ' C ' ' H ' ' A' ' 144' ' ' ASN . 7.2 mp -120.05 149.07 48.29 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.579 0.704 . . . . 74.010000000000005 110.954 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 143' ' ' PRO . . . . . 0.709 ' HD3' ' CD ' ' A' ' 171' ' ' GLN . 54.0 Cg_endo -69.71 32.75 0.19 Allowed 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.695 2.264 . . . . 73.129999999999995 112.375 179.857 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 144' ' ' ASN . . . . . 1.007 ' O ' ' N ' ' A' ' 146' ' ' ARG . 0.0 OUTLIER -169.34 101.91 0.35 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.201 -0.454 . . . . 73.430000000000007 110.923 -179.961 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 145' ' ' TYR . . . . . 0.734 ' HA ' ' CD2' ' A' ' 140' ' ' TYR . 0.3 OUTLIER 3.59 48.39 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.155 -0.475 . . . . 74.400000000000006 110.945 -179.866 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 146' ' ' ARG . . . . . 1.007 ' N ' ' O ' ' A' ' 144' ' ' ASN . 1.1 mtp85 -136.16 178.02 7.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.069 -0.514 . . . . 61.340000000000003 110.835 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 147' ' ' GLY . . . . . 0.445 ' O ' HD11 ' A' ' 76' ' ' LEU . . . 83.04 -175.48 53.01 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.764 -0.731 . . . . 44.140000000000001 112.482 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 53.3 mtt180 -62.45 146.22 52.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.705 0.288 . . . . 73.409999999999997 110.852 -179.84 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 149' ' ' GLN . . . . . 0.731 ' HG3' HD12 ' A' ' 76' ' ' LEU . 1.4 mt-30 -98.22 135.39 39.92 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.202 -0.454 . . . . 74.019999999999996 110.933 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 150' ' ' TYR . . . . . 0.748 ' HB2' ' HB2' ' A' ' 139' ' ' PHE . 54.5 m-85 -121.46 125.43 46.84 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.23 -0.441 . . . . 73.510000000000005 110.888 -179.863 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.776 ' HB2' HD11 ' A' ' 61' ' ' ILE . 19.8 tp -76.89 122.71 25.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.113 -0.494 . . . . 70.310000000000002 110.908 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 1.034 HD13 ' O ' ' A' ' 152' ' ' LEU . 0.0 OUTLIER -50.74 130.71 25.19 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.156 -0.475 . . . . 60.420000000000002 110.893 179.893 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -163.86 26.48 0.08 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.21 -0.45 . . . . 75.209999999999994 110.837 179.864 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.826 ' O ' ' HG3' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -108.09 -174.76 2.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.191 -0.458 . . . . 62.130000000000003 110.865 -179.999 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.826 ' HG3' ' O ' ' A' ' 154' ' ' LYS . 1.5 mptt -162.44 -127.74 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.195 -0.457 . . . . 54.409999999999997 110.936 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.569 ' HG2' ' O ' ' A' ' 156' ' ' GLU . 2.2 tm-20 -70.46 6.91 1.2 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.247 -0.433 . . . . 74.510000000000005 110.835 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 157' ' ' TYR . . . . . 0.701 ' CE1' ' HA ' ' A' ' 154' ' ' LYS . 18.9 m-30 -32.44 149.97 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.176 -0.466 . . . . 71.109999999999999 110.894 -179.835 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 158' ' ' ARG . . . . . 0.442 ' HB3' ' CE2' ' A' ' 104' ' ' PHE . 0.0 OUTLIER -126.5 -34.73 2.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.108 -0.496 . . . . 73.5 110.864 -179.992 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -89.07 151.69 47.22 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.638 0.732 . . . . 71.349999999999994 110.892 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 160' ' ' PRO . . . . . 0.485 ' HB2' ' HD3' ' A' ' 168' ' ' PRO . 54.1 Cg_endo -69.72 -24.11 30.2 Favored 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 122.645 2.23 . . . . 75.549999999999997 112.401 179.896 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.6 HD12 ' H ' ' A' ' 161' ' ' ILE . 3.7 mp -69.41 -9.39 12.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.189 -0.459 . . . . 63.399999999999999 111.131 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.67 ' HB3' ' CD1' ' A' ' 157' ' ' TYR . 0.3 OUTLIER -77.2 -13.38 59.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.14 -0.482 . . . . 72.420000000000002 110.87 179.88 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -87.64 3.17 48.78 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.186 -0.461 . . . . 73.219999999999999 110.968 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 88.42 -36.15 3.47 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.713 -0.756 . . . . 72.230000000000004 112.516 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -80.76 129.86 34.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.795 0.331 . . . . 61.329999999999998 111.086 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -37.95 -38.33 0.3 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.218 -0.447 . . . . 74.299999999999997 111.121 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 167' ' ' SER . . . . . 0.485 ' C ' ' H ' ' A' ' 169' ' ' ALA . 0.3 OUTLIER -127.12 158.88 67.67 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.647 0.737 . . . . 74.099999999999994 110.857 -179.785 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 168' ' ' PRO . . . . . 0.485 ' HD3' ' HB2' ' A' ' 160' ' ' PRO . 54.5 Cg_endo -69.7 26.3 0.17 Allowed 'Trans proline' 0 C--N 1.341 0.132 0 C-N-CA 122.715 2.277 . . . . 75.329999999999998 112.355 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 0.485 ' H ' ' C ' ' A' ' 167' ' ' SER . . . -65.95 107.81 1.98 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.25 -0.432 . . . . 70.400000000000006 111.129 179.909 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.505 HG12 ' N ' ' A' ' 171' ' ' GLN . 19.2 t -151.15 160.52 3.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.215 -0.448 . . . . 64.230000000000004 111.141 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 171' ' ' GLN . . . . . 0.709 ' CD ' ' HD3' ' A' ' 143' ' ' PRO . 6.5 mm-40 -109.41 -91.85 0.44 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.175 -0.466 . . . . 74.409999999999997 110.922 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 172' ' ' SER . . . . . 0.618 ' CB ' ' O ' ' A' ' 116' ' ' PRO . 60.1 p -127.98 168.91 14.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.199 -0.455 . . . . 72.230000000000004 110.873 -179.821 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 173' ' ' PHE . . . . . 0.612 ' CD1' ' N ' ' A' ' 173' ' ' PHE . 0.1 OUTLIER -146.75 165.79 28.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.146 -0.479 . . . . 70.450000000000003 110.918 -179.953 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 174' ' ' ARG . . . . . 0.414 ' HG2' ' HE2' ' A' ' 140' ' ' TYR . 0.7 OUTLIER -146.33 169.93 17.82 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.185 -0.462 . . . . 74.129999999999995 110.852 -179.916 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 175' ' ' ARG . . . . . 0.507 ' HB3' ' CZ3' ' A' ' 137' ' ' TRP . 0.0 OUTLIER -89.1 -162.26 0.85 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.12 -0.491 . . . . 73.430000000000007 110.86 -179.913 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 176' ' ' ILE . . . . . 0.489 HD11 HG12 ' A' ' 136' ' ' VAL . 27.4 mt -124.68 141.82 43.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.157 -0.474 . . . . 73.040000000000006 111.133 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 44.1 t -75.25 140.88 16.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.171 -0.468 . . . . 54.149999999999999 111.123 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 178' ' ' GLU . . . . . 0.595 ' HB3' HD13 ' A' ' 88' ' ' LEU . 35.8 mt-10 . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.217 -0.447 . . . . 75.209999999999994 110.856 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.339 0 N-CA-C 112.501 -0.239 . . . . 61.509999999999998 112.501 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.451 ' C ' ' HE1' ' A' ' 47' ' ' TRP . 20.0 p -82.35 138.84 34.39 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.89 0.376 . . . . 71.530000000000001 111.105 -179.833 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.492 ' N ' ' HE1' ' A' ' 47' ' ' TRP . 2.9 tttt -124.91 134.66 52.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.232 -0.44 . . . . 74.319999999999993 110.878 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.483 HG13 HG23 ' A' ' 42' ' ' VAL . 15.4 tt -136.56 149.2 26.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.21 -0.45 . . . . 74.150000000000006 111.189 179.833 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.51 HG23 ' CG ' ' A' ' 22' ' ' ASP . 10.3 m -130.87 141.35 50.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.184 -0.462 . . . . 63.32 111.145 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.781 ' HB2' HD22 ' A' ' 34' ' ' LEU . 0.9 OUTLIER -128.83 128.36 43.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.275 -0.421 . . . . 72.299999999999997 110.845 -179.981 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.539 ' CG ' ' HA ' ' A' ' 16' ' ' PHE . 22.9 m-85 -114.28 132.12 56.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.102 -0.499 . . . . 60.340000000000003 110.927 -179.862 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.458 ' HG2' ' HB2' ' A' ' 36' ' ' ARG . 0.0 OUTLIER -60.01 -23.47 63.7 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.145 -0.479 . . . . 64.120000000000005 110.888 -179.98 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 65.6 m-20 -128.58 152.41 48.35 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.142 -0.481 . . . . 73.329999999999998 110.869 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.445 ' N ' ' HB3' ' A' ' 38' ' ' ASN . 31.8 mtmt -55.67 -175.18 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.166 -0.47 . . . . 75.310000000000002 110.897 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 17.8 m120 46.43 33.58 1.98 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.237 -0.438 . . . . 63.130000000000003 110.84 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.539 ' HA ' ' CG ' ' A' ' 11' ' ' TYR . 4.0 m-85 48.95 57.97 5.86 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.181 -0.463 . . . . 71.239999999999995 110.899 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 -132.81 158.56 42.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.153 -0.476 . . . . 64.430000000000007 110.931 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 94.7 -150.52 19.76 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.746 -0.74 . . . . 53.030000000000001 112.447 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.796 ' O ' HD13 ' A' ' 34' ' ' LEU . 0.0 OUTLIER -69.6 80.45 0.41 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.794 0.33 . . . . 74.430000000000007 110.875 -179.838 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.466 ' HB2' ' CE1' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -79.11 128.5 33.36 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.188 -0.46 . . . . 73.510000000000005 110.835 -179.927 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.471 ' CD2' ' CD2' ' A' ' 30' ' ' PHE . 71.2 t80 -124.49 125.36 44.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.15 -0.477 . . . . 74.450000000000003 110.921 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.51 ' CG ' HG23 ' A' ' 9' ' ' THR . 1.2 m-20 -119.48 132.61 55.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.128 -0.487 . . . . 72.010000000000005 110.91 179.899 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 10.4 t -157.09 130.25 7.83 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.195 -0.457 . . . . 54.32 110.907 -179.899 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.415 ' HA ' ' HA ' ' A' ' 7' ' ' LYS . 3.9 p30 -99.4 5.76 46.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.214 -0.448 . . . . 60.020000000000003 110.866 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 47.1 t -117.68 161.46 19.63 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.208 -0.451 . . . . 74.439999999999998 110.9 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 31.5 m-20 -45.12 120.51 2.44 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.176 -0.465 . . . . 72.099999999999994 110.887 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.62 ' HB2' ' HB3' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -114.27 43.87 1.8 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.185 -0.461 . . . . 61.219999999999999 110.869 -179.909 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.546 ' O ' ' HA ' ' A' ' 82' ' ' SER . . . -49.67 -21.53 1.07 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 35.039999999999999 111.105 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 60.2 t0 -129.58 40.99 3.51 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.222 -0.445 . . . . 73.439999999999998 110.862 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.795 ' CD2' ' O ' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -81.48 17.79 1.31 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.211 -0.449 . . . . 63.140000000000001 110.907 -179.934 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.54 ' HB2' ' HB3' ' A' ' 81' ' ' SER . 40.7 t60 -81.98 -33.56 30.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.166 -0.47 . . . . 50.310000000000002 110.845 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.0 t -66.96 -5.67 13.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.194 -0.457 . . . . 50.100000000000001 111.114 -179.874 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -108.29 -27.68 9.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.231 -0.44 . . . . 74.420000000000002 110.92 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.796 HD13 ' O ' ' A' ' 19' ' ' ARG . 23.3 tp -141.51 145.99 35.85 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.111 -0.495 . . . . 72.150000000000006 110.95 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.3 m -112.66 -34.93 5.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.181 -0.463 . . . . 45.329999999999998 110.806 -179.879 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.51 ' NH2' HD21 ' A' ' 38' ' ' ASN . 2.0 mtp85 -115.79 142.09 47.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.148 -0.478 . . . . 72.040000000000006 110.842 -179.877 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.616 ' SG ' ' HB2' ' A' ' 80' ' ' LEU . 6.3 p -120.02 64.81 0.82 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.139 -0.482 . . . . 74.310000000000002 110.899 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.51 HD21 ' NH2' ' A' ' 36' ' ' ARG . 3.0 m120 -63.66 -66.64 0.51 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.17 -0.468 . . . . 74.409999999999997 110.893 -179.885 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 5.0 p -113.81 127.31 55.95 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.113 -0.494 . . . . 71.209999999999994 110.881 -179.854 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.797 HD12 ' CH2' ' A' ' 73' ' ' TRP . 18.7 mt -120.95 149.37 23.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.131 -0.486 . . . . 70.209999999999994 111.146 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.462 ' HD2' ' CE2' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -143.5 119.3 10.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.189 -0.459 . . . . 71.010000000000005 110.902 179.874 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.571 HG21 ' HB2' ' A' ' 47' ' ' TRP . 1.0 OUTLIER -106.06 118.07 52.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.245 -0.434 . . . . 74.230000000000004 111.152 179.877 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -114.76 76.73 1.01 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.178 -0.465 . . . . 62.210000000000001 110.888 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.4 ' O ' ' HB ' ' A' ' 6' ' ' THR . . . 140.87 90.13 0.17 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.788 -0.72 . . . . 74.450000000000003 112.524 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 58.46 172.36 0.36 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.75 -0.738 . . . . 45.420000000000002 112.484 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.749 HG23 ' HA ' ' A' ' 63' ' ' PRO . 0.2 OUTLIER -66.01 172.35 3.79 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.828 0.347 . . . . 73.310000000000002 111.132 -179.867 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 47' ' ' TRP . . . . . 0.571 ' HB2' HG21 ' A' ' 42' ' ' VAL . 6.6 m95 -146.97 129.55 15.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.2 -0.454 . . . . 73.109999999999999 110.948 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.798 ' HB2' ' CG2' ' A' ' 86' ' ' VAL . . . -91.13 127.7 36.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.263 -0.426 . . . . 75.040000000000006 111.092 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.729 HG11 HD11 ' A' ' 80' ' ' LEU . 21.1 m -125.86 145.0 34.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.215 -0.448 . . . . 72.019999999999996 111.115 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.895 ' HB3' ' CB ' ' A' ' 56' ' ' ALA . 6.7 m-85 -122.84 143.68 49.7 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.212 -0.449 . . . . 75.519999999999996 110.925 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.584 ' HG2' ' N ' ' A' ' 52' ' ' ARG . 0.5 OUTLIER -49.46 -84.04 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.176 -0.465 . . . . 55.100000000000001 110.871 179.987 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.862 ' O ' ' HB2' ' A' ' 56' ' ' ALA . 0.8 OUTLIER -81.91 136.43 47.59 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.586 0.707 . . . . 75.109999999999999 110.866 -179.89 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.635 ' HB3' ' HB3' ' A' ' 81' ' ' SER . 53.4 Cg_endo -69.74 135.79 31.41 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.668 2.245 . . . . 71.430000000000007 112.326 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.437 ' HB3' ' CE2' ' A' ' 55' ' ' PHE . 7.1 t-20 72.17 -6.15 1.59 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.174 -0.466 . . . . 74.340000000000003 110.945 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.437 ' CE2' ' HB3' ' A' ' 54' ' ' ASN . 0.1 OUTLIER -144.46 -75.36 0.24 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.136 -0.484 . . . . 72.310000000000002 110.877 -179.996 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.895 ' CB ' ' HB3' ' A' ' 50' ' ' TYR . . . 47.58 82.55 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.132 -0.485 . . . . 63.25 111.059 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' TRP . . . . . 0.61 ' O ' ' CD2' ' A' ' 58' ' ' TYR . 28.5 m0 -64.41 31.08 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.254 -0.43 . . . . 73.420000000000002 110.938 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.635 ' H ' ' C ' ' A' ' 56' ' ' ALA . 3.8 m-85 -160.29 115.6 2.3 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.264 -0.426 . . . . 73.25 110.935 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -82.39 136.59 34.94 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.128 -0.487 . . . . 63.340000000000003 110.85 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.629 ' HA ' ' OE1' ' A' ' 149' ' ' GLN . 5.4 t80 -146.39 124.86 12.37 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.243 -0.435 . . . . 74.430000000000007 110.9 -179.899 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.847 ' N ' HD12 ' A' ' 61' ' ' ILE . 1.0 OUTLIER -109.21 116.95 53.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.13 -0.486 . . . . 74.140000000000001 111.164 179.883 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.804 HD23 ' HD2' ' A' ' 63' ' ' PRO . 0.3 OUTLIER -89.34 129.17 48.48 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.635 0.731 . . . . 64.319999999999993 110.909 179.93 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.804 ' HD2' HD23 ' A' ' 62' ' ' LEU . 53.5 Cg_endo -69.8 -175.28 1.11 Allowed 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.664 2.242 . . . . 72.519999999999996 112.323 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.48 162.7 15.58 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.216 -0.447 . . . . 73.230000000000004 110.897 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 112.34 -171.56 14.15 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.797 -0.716 . . . . 73.450000000000003 112.533 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -103.5 150.96 23.4 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.871 0.367 . . . . 74.140000000000001 110.885 -179.874 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.662 ' HB2' ' O ' ' A' ' 40' ' ' ILE . 19.7 m-85 -139.26 85.34 15.59 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.669 0.747 . . . . 74.219999999999999 110.923 -179.853 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 -0.01 6.26 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.687 2.258 . . . . 64.349999999999994 112.373 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.553 ' HB2' ' HG2' ' A' ' 72' ' ' ARG . 49.3 mt-10 -155.81 142.18 18.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.177 -0.465 . . . . 63.340000000000003 110.855 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.737 ' HA ' ' NE1' ' A' ' 73' ' ' TRP . 30.0 p90 -54.85 -20.52 8.9 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.158 -0.473 . . . . 72.219999999999999 110.918 -179.857 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -80.41 -18.72 48.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.144 -0.48 . . . . 72.430000000000007 110.945 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.553 ' HG2' ' HB2' ' A' ' 69' ' ' GLU . 26.5 mmt180 -69.9 -7.35 39.62 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.466 . . . . 71.0 110.887 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' TRP . . . . . 0.797 ' CH2' HD12 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -139.28 18.49 2.58 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.176 -0.465 . . . . 71.510000000000005 110.929 -179.957 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 74' ' ' MET . . . . . 0.461 ' C ' ' O ' ' A' ' 73' ' ' TRP . 0.0 OUTLIER 33.54 43.98 0.06 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.212 -0.449 . . . . 73.230000000000004 110.863 179.95 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -53.31 125.44 31.43 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.784 -0.722 . . . . 53.439999999999998 112.472 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.499 HD11 ' HA ' ' A' ' 148' ' ' ARG . 6.2 mt -52.85 -53.98 40.98 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.862 0.363 . . . . 72.230000000000004 110.9 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 -130.68 151.66 50.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.198 -0.456 . . . . 64.430000000000007 110.866 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -84.22 13.29 5.38 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.201 -0.454 . . . . 62.329999999999998 110.864 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.406 ' HD2' ' HG2' ' A' ' 51' ' ' GLU . 0.0 OUTLIER -103.6 67.72 0.91 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 73.519999999999996 110.87 -179.904 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.729 HD11 HG11 ' A' ' 49' ' ' VAL . 0.1 OUTLIER -72.0 132.9 44.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.225 -0.443 . . . . 72.230000000000004 110.919 -179.98 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.635 ' HB3' ' HB3' ' A' ' 53' ' ' PRO . 1.3 m -151.09 -122.48 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.193 -0.458 . . . . 73.209999999999994 110.841 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.606 ' OG ' ' HA ' ' A' ' 53' ' ' PRO . 0.1 OUTLIER -38.33 106.06 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.136 -0.484 . . . . 74.230000000000004 110.844 -179.782 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 83' ' ' CYS . . . . . 0.67 ' HB3' HG12 ' A' ' 49' ' ' VAL . 9.3 p -134.38 131.34 38.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.15 -0.477 . . . . 72.319999999999993 110.904 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.602 ' N ' ' O ' ' A' ' 48' ' ' ALA . 2.9 mmt-85 -113.76 164.75 13.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 60.32 110.874 -179.835 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -79.82 130.31 35.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.219 -0.446 . . . . 53.329999999999998 111.084 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.798 ' CG2' ' HB2' ' A' ' 48' ' ' ALA . 54.3 t -116.07 136.05 54.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.195 -0.457 . . . . 75.340000000000003 111.162 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' HIS . . . . . 0.641 ' O ' HG23 ' A' ' 136' ' ' VAL . 45.8 m80 -114.92 105.8 13.42 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.183 -0.462 . . . . 64.150000000000006 110.854 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.577 HD13 ' HB3' ' A' ' 178' ' ' GLU . 0.0 OUTLIER -34.02 146.55 0.13 Allowed Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.56 0.695 . . . . 63.229999999999997 110.926 -179.976 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.548 ' HB3' ' H ' ' A' ' 136' ' ' VAL . 53.5 Cg_endo -69.77 109.99 2.45 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.669 2.246 . . . . 71.030000000000001 112.356 179.843 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -106.83 158.84 16.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.236 -0.438 . . . . 74.230000000000004 110.841 -179.818 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 49.7 79.52 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.743 -0.742 . . . . 40.340000000000003 112.488 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 124.64 11.19 4.59 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.725 -0.75 . . . . 54.450000000000003 112.492 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.46 ' O ' ' HG2' ' A' ' 134' ' ' GLU . 14.8 pt20 38.02 -122.84 0.25 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.824 0.345 . . . . 72.439999999999998 110.923 -179.833 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.475 ' CE2' ' HD2' ' A' ' 175' ' ' ARG . 0.2 OUTLIER -124.19 101.97 7.47 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.209 -0.45 . . . . 74.200000000000003 110.903 -179.876 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.505 ' HG3' HG11 ' A' ' 132' ' ' VAL . 47.4 tptt -110.89 126.55 54.82 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.07 -0.514 . . . . 75.439999999999998 110.893 179.886 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.75 HD13 ' N ' ' A' ' 97' ' ' GLN . 0.0 OUTLIER -149.38 138.04 14.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.262 -0.426 . . . . 52.140000000000001 111.146 179.808 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.75 ' N ' HD13 ' A' ' 96' ' ' ILE . 2.2 mt-30 -105.52 121.23 43.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.182 -0.463 . . . . 64.010000000000005 110.889 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.59 ' CD1' HD12 ' A' ' 96' ' ' ILE . 23.0 mm -97.75 131.23 45.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.15 -0.477 . . . . 71.329999999999998 111.125 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.675 ' CB ' ' HB2' ' A' ' 129' ' ' SER . 37.6 m-85 -120.96 140.54 51.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.181 -0.463 . . . . 75.129999999999995 110.868 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 59.6 tt0 -75.79 -61.7 1.84 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.15 -0.477 . . . . 73.129999999999995 110.907 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 39.9 mttt -96.6 171.42 8.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.128 -0.487 . . . . 71.129999999999995 110.898 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.424 ' HA2' ' OG ' ' A' ' 129' ' ' SER . . . -70.5 153.46 51.68 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.719 -0.753 . . . . 71.519999999999996 112.493 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.461 ' HA ' ' HB2' ' A' ' 158' ' ' ARG . 26.8 t0 65.27 46.11 2.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.802 0.334 . . . . 73.129999999999995 110.861 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.593 ' N ' ' CD2' ' A' ' 104' ' ' PHE . 0.1 OUTLIER 47.54 33.18 2.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.227 -0.442 . . . . 75.120000000000005 110.853 -179.948 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 57.8 m -96.13 159.45 14.95 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.168 -0.469 . . . . 51.420000000000002 110.847 -179.774 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 84.92 -137.29 15.4 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.748 -0.739 . . . . 74.209999999999994 112.504 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 30.1 tp60 -88.84 114.2 25.2 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.805 0.336 . . . . 64.109999999999999 110.94 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 1.5 ttp -101.36 144.12 30.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.185 -0.461 . . . . 64.349999999999994 110.9 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -149.47 136.01 19.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.218 -0.446 . . . . 75.019999999999996 110.899 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -117.36 102.49 9.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.107 -0.497 . . . . 65.319999999999993 110.867 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 11.9 t -113.05 129.15 56.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.166 -0.47 . . . . 61.229999999999997 111.134 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.474 ' HA ' ' O ' ' A' ' 94' ' ' TYR . 1.5 t -96.74 22.52 8.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.224 -0.443 . . . . 74.530000000000001 111.199 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -151.2 137.56 18.53 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.155 -0.475 . . . . 74.150000000000006 110.848 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 30.7 p30 -53.89 178.27 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.16 -0.473 . . . . 64.129999999999995 110.882 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' CYS . . . . . 0.498 ' O ' ' HB2' ' A' ' 172' ' ' SER . 0.8 OUTLIER -155.65 151.31 21.89 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.57 0.7 . . . . 64.450000000000003 110.888 -179.92 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.453 ' O ' ' C ' ' A' ' 143' ' ' PRO . 54.1 Cg_endo -69.77 -33.94 15.54 Favored 'Trans proline' 0 C--O 1.231 0.134 0 C-N-CA 122.659 2.24 . . . . 64.349999999999994 112.383 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.632 ' HB3' ' CB ' ' A' ' 120' ' ' GLU . 0.1 OUTLIER -148.3 109.55 4.35 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 64.409999999999997 110.83 -179.821 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.636 HD13 HD11 ' A' ' 127' ' ' ILE . 4.3 tt -60.45 -30.0 45.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.156 -0.475 . . . . 72.329999999999998 111.125 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 119' ' ' MET . . . . . 0.603 ' O ' ' HA ' ' A' ' 123' ' ' HIS . 5.0 ttt -86.14 -41.91 14.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.227 -0.442 . . . . 74.340000000000003 110.835 179.873 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.632 ' CB ' ' HB3' ' A' ' 117' ' ' SER . 10.0 tp10 -68.03 -14.11 62.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.229 -0.441 . . . . 63.109999999999999 110.913 -179.924 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 6.9 tp-100 -115.17 -48.27 2.82 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.092 -0.503 . . . . 71.450000000000003 110.91 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.516 ' HB2' ' O ' ' A' ' 118' ' ' ILE . 53.4 m-85 -103.34 -20.4 14.1 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.198 -0.455 . . . . 75.120000000000005 110.879 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 123' ' ' HIS . . . . . 0.603 ' HA ' ' O ' ' A' ' 119' ' ' MET . 0.1 OUTLIER 71.33 29.87 2.68 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.104 -0.498 . . . . 63.039999999999999 110.859 -179.997 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.557 ' SD ' HG22 ' A' ' 98' ' ' ILE . 4.5 mtt -107.85 86.34 2.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.256 -0.429 . . . . 62.409999999999997 110.892 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 1.9 ptp85 -51.97 -40.44 60.89 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.239 -0.437 . . . . 72.299999999999997 110.886 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.469 ' HB3' ' HG2' ' A' ' 168' ' ' PRO . 12.9 mt-10 -137.51 133.51 34.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.191 -0.458 . . . . 73.510000000000005 110.907 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.636 HD11 HD13 ' A' ' 118' ' ' ILE . 3.7 mm -93.48 101.57 12.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.135 -0.484 . . . . 65.230000000000004 111.149 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 11.8 m80 -69.9 -34.16 73.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.2 -0.455 . . . . 74.209999999999994 110.855 179.848 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' SER . . . . . 0.675 ' HB2' ' CB ' ' A' ' 99' ' ' PHE . 8.3 m -134.02 154.3 51.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.231 -0.44 . . . . 34.149999999999999 110.838 -179.756 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 130' ' ' CYS . . . . . 0.615 ' SG ' HD11 ' A' ' 96' ' ' ILE . 0.1 OUTLIER -155.13 118.54 4.46 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.154 -0.475 . . . . 75.430000000000007 110.886 -179.929 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.561 ' C ' HG23 ' A' ' 132' ' ' VAL . 7.7 mtpp -112.86 154.0 27.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.201 -0.454 . . . . 55.340000000000003 110.912 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.561 HG23 ' C ' ' A' ' 131' ' ' LYS . 15.2 t 87.17 162.57 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.218 -0.446 . . . . 54.229999999999997 111.127 179.9 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.819 HD22 ' HG3' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -179.65 125.63 0.08 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.161 -0.472 . . . . 70.010000000000005 110.895 179.939 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.46 ' HG2' ' O ' ' A' ' 93' ' ' GLN . 0.0 OUTLIER -93.71 176.9 6.19 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.186 -0.461 . . . . 71.439999999999998 110.867 179.953 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 135' ' ' GLY . . . . . 0.452 ' HA3' ' HA ' ' A' ' 89' ' ' PRO . . . -37.26 -67.41 0.45 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.768 -0.73 . . . . 65.140000000000001 112.488 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.789 HG11 ' CG1' ' A' ' 86' ' ' VAL . 13.4 t -140.65 145.24 25.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.913 0.387 . . . . 74.209999999999994 111.073 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 137' ' ' TRP . . . . . 0.679 ' H ' HD12 ' A' ' 152' ' ' LEU . 0.1 OUTLIER -147.51 168.68 21.33 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.117 -0.492 . . . . 52.229999999999997 110.898 179.988 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.574 ' CG2' ' HB2' ' A' ' 149' ' ' GLN . 63.0 mt -138.13 133.72 44.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.219 -0.446 . . . . 73.319999999999993 111.153 179.879 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.466 ' HB2' ' HB2' ' A' ' 150' ' ' TYR . 83.6 m-85 -98.4 179.92 4.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.191 -0.459 . . . . 72.340000000000003 110.855 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 140' ' ' TYR . . . . . 0.42 ' CD2' ' HA ' ' A' ' 145' ' ' TYR . 0.4 OUTLIER -153.54 126.0 8.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.145 -0.479 . . . . 73.439999999999998 110.936 -179.829 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 141' ' ' GLU . . . . . 0.59 ' O ' ' HB2' ' A' ' 171' ' ' GLN . 27.0 tt0 -62.85 -28.1 69.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.125 -0.489 . . . . 61.420000000000002 110.926 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.726 ' HB3' ' HD2' ' A' ' 143' ' ' PRO . 9.4 mp -115.88 173.5 2.96 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.565 0.698 . . . . 71.239999999999995 110.928 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 143' ' ' PRO . . . . . 0.726 ' HD2' ' HB3' ' A' ' 142' ' ' LEU . 54.0 Cg_endo -69.73 -90.92 0.01 OUTLIER 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.653 2.235 . . . . 71.430000000000007 112.373 179.836 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 144' ' ' ASN . . . . . 0.727 ' O ' ' N ' ' A' ' 146' ' ' ARG . 1.6 m-80 -54.05 96.69 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 62.0 110.881 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 145' ' ' TYR . . . . . 0.652 ' C ' ' O ' ' A' ' 144' ' ' ASN . 5.8 m-85 11.87 53.1 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.157 -0.474 . . . . 52.229999999999997 110.895 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 146' ' ' ARG . . . . . 0.727 ' N ' ' O ' ' A' ' 144' ' ' ASN . 19.5 mtt-85 -116.8 170.41 8.63 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.113 -0.494 . . . . 73.239999999999995 110.88 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 70.39 -172.08 42.41 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.747 -0.74 . . . . 75.109999999999999 112.481 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.499 ' HA ' HD11 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -87.75 132.62 34.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.761 0.315 . . . . 72.409999999999997 110.897 -179.851 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 149' ' ' GLN . . . . . 0.629 ' OE1' ' HA ' ' A' ' 60' ' ' TYR . 0.8 OUTLIER -88.53 157.73 18.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.204 -0.453 . . . . 71.239999999999995 110.928 -179.922 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 150' ' ' TYR . . . . . 0.466 ' HB2' ' HB2' ' A' ' 139' ' ' PHE . 12.6 m-85 -122.84 141.48 51.82 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.187 -0.46 . . . . 64.299999999999997 110.891 -179.83 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.579 ' HB2' HD11 ' A' ' 61' ' ' ILE . 7.8 tp -76.16 123.65 26.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.105 -0.498 . . . . 75.329999999999998 110.858 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 1.08 HD13 ' O ' ' A' ' 152' ' ' LEU . 0.0 OUTLIER -50.9 135.5 24.24 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.179 -0.464 . . . . 74.109999999999999 110.911 179.847 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 153' ' ' ASP . . . . . 0.46 ' N ' HD22 ' A' ' 152' ' ' LEU . 7.9 t0 -165.4 27.68 0.05 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.193 -0.458 . . . . 72.530000000000001 110.882 179.845 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.817 ' O ' HD13 ' A' ' 133' ' ' LEU . 0.0 OUTLIER -114.88 -175.23 2.64 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.224 -0.444 . . . . 60.240000000000002 110.874 -179.993 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.819 ' HG3' HD22 ' A' ' 133' ' ' LEU . 0.0 OUTLIER -161.02 -127.54 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.202 -0.454 . . . . 64.439999999999998 110.887 179.878 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.562 ' HG2' ' O ' ' A' ' 156' ' ' GLU . 2.9 tm-20 -68.54 6.0 0.92 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.245 -0.434 . . . . 74.150000000000006 110.895 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 157' ' ' TYR . . . . . 0.769 ' CE1' ' HA ' ' A' ' 154' ' ' LYS . 20.4 m-30 -34.61 152.85 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.141 -0.481 . . . . 75.209999999999994 110.869 -179.828 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 158' ' ' ARG . . . . . 0.461 ' HB2' ' HA ' ' A' ' 103' ' ' ASP . 0.0 OUTLIER -125.76 -35.74 2.48 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.132 -0.486 . . . . 65.25 110.865 -179.99 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -86.72 151.23 52.32 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.563 0.697 . . . . 63.140000000000001 110.866 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 160' ' ' PRO . . . . . 0.455 ' HB2' ' HD3' ' A' ' 168' ' ' PRO . 53.6 Cg_endo -69.74 -28.01 25.85 Favored 'Trans proline' 0 C--O 1.232 0.207 0 C-N-CA 122.658 2.238 . . . . 71.349999999999994 112.316 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.622 HD12 ' H ' ' A' ' 161' ' ' ILE . 3.6 mp -64.08 -11.75 10.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.258 -0.428 . . . . 62.399999999999999 111.133 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.635 ' HB3' ' CD1' ' A' ' 157' ' ' TYR . 0.3 OUTLIER -75.32 -13.42 60.42 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.152 -0.477 . . . . 72.219999999999999 110.896 179.813 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 163' ' ' TRP . . . . . 0.44 ' CH2' ' CE1' ' A' ' 139' ' ' PHE . 3.4 m95 -87.16 0.16 55.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.227 -0.442 . . . . 71.219999999999999 110.93 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 91.64 -35.68 3.89 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.743 -0.741 . . . . 55.039999999999999 112.461 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -82.05 130.75 35.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.798 0.332 . . . . 61.530000000000001 111.144 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -39.01 -38.42 0.45 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.244 -0.435 . . . . 72.329999999999998 111.069 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 167' ' ' SER . . . . . 0.487 ' C ' ' H ' ' A' ' 169' ' ' ALA . 0.3 OUTLIER -128.35 156.35 76.99 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.666 0.746 . . . . 64.150000000000006 110.858 -179.765 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 168' ' ' PRO . . . . . 0.469 ' HG2' ' HB3' ' A' ' 126' ' ' GLU . 54.1 Cg_endo -69.72 27.86 0.18 Allowed 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.715 2.277 . . . . 64.099999999999994 112.332 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 0.487 ' H ' ' C ' ' A' ' 167' ' ' SER . . . -68.27 104.61 1.89 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.246 -0.434 . . . . 74.420000000000002 111.111 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.472 HG12 ' N ' ' A' ' 171' ' ' GLN . 3.4 t -152.94 164.37 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.188 -0.46 . . . . 72.540000000000006 111.149 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 171' ' ' GLN . . . . . 0.65 ' OE1' ' HB3' ' A' ' 143' ' ' PRO . 1.7 mm-40 -113.88 -85.79 0.59 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.244 -0.435 . . . . 71.510000000000005 110.867 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 172' ' ' SER . . . . . 0.706 ' OG ' ' O ' ' A' ' 143' ' ' PRO . 33.6 p -127.05 -179.53 4.89 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.198 -0.456 . . . . 73.519999999999996 110.863 -179.815 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -145.49 170.89 15.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.077 -0.511 . . . . 75.239999999999995 110.875 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 174' ' ' ARG . . . . . 0.419 ' HD2' ' CE2' ' A' ' 140' ' ' TYR . 0.0 OUTLIER -136.09 157.58 46.49 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.152 -0.477 . . . . 74.549999999999997 110.865 -179.89 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 175' ' ' ARG . . . . . 0.475 ' HD2' ' CE2' ' A' ' 94' ' ' TYR . 1.8 ptt180 -98.86 -171.93 2.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.142 -0.481 . . . . 74.420000000000002 110.905 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 176' ' ' ILE . . . . . 0.556 HD11 HG12 ' A' ' 136' ' ' VAL . 3.5 mt -125.33 130.99 72.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.223 -0.444 . . . . 75.049999999999997 111.085 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 9.1 p -53.84 137.67 14.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.182 -0.463 . . . . 72.239999999999995 111.135 179.826 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 178' ' ' GLU . . . . . 0.577 ' HB3' HD13 ' A' ' 88' ' ' LEU . 1.8 mm-40 . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.203 -0.453 . . . . 73.230000000000004 110.883 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.323 0 N-CA-C 112.491 -0.244 . . . . 70.310000000000002 112.491 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.404 ' HB ' ' O ' ' A' ' 44' ' ' GLY . 26.2 p -81.54 136.48 35.6 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.85 0.357 . . . . 74.430000000000007 111.165 -179.876 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.425 ' N ' ' HE1' ' A' ' 47' ' ' TRP . 2.6 tttt -124.67 136.96 54.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.228 -0.442 . . . . 54.439999999999998 110.919 179.912 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.524 ' HB ' ' CD1' ' A' ' 47' ' ' TRP . 16.0 tt -136.98 148.98 26.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.219 -0.446 . . . . 71.439999999999998 111.168 179.862 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.548 HG22 ' CE2' ' A' ' 11' ' ' TYR . 19.0 m -132.58 137.36 47.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.218 -0.446 . . . . 64.099999999999994 111.184 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.771 ' HB2' HD22 ' A' ' 34' ' ' LEU . 0.5 OUTLIER -125.46 128.06 47.47 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.183 -0.462 . . . . 75.349999999999994 110.874 -179.982 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.564 ' CG ' ' HA ' ' A' ' 16' ' ' PHE . 17.0 m-85 -113.16 131.98 55.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.103 -0.499 . . . . 73.420000000000002 110.937 -179.831 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.464 ' HB2' ' HB2' ' A' ' 19' ' ' ARG . 0.0 OUTLIER -61.71 -14.53 32.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.162 -0.472 . . . . 74.329999999999998 110.852 -179.958 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.424 ' HB2' ' O ' ' A' ' 17' ' ' GLN . 77.4 m-20 -135.41 149.56 49.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.138 -0.483 . . . . 63.520000000000003 110.89 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.526 ' N ' ' HB3' ' A' ' 38' ' ' ASN . 30.3 mtmm -54.61 -176.68 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.224 -0.444 . . . . 72.219999999999999 110.874 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 16.5 m120 46.99 30.58 1.29 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.185 -0.461 . . . . 71.329999999999998 110.908 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.564 ' HA ' ' CG ' ' A' ' 11' ' ' TYR . 3.6 m-85 51.24 65.38 1.5 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.152 -0.477 . . . . 62.310000000000002 110.867 -180.0 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.424 ' O ' ' HB2' ' A' ' 13' ' ' ASP . 16.9 mt-30 -140.26 160.87 38.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.113 -0.494 . . . . 72.219999999999999 110.899 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 90.98 -147.99 19.16 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.736 -0.745 . . . . 73.420000000000002 112.519 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.709 ' O ' HD13 ' A' ' 34' ' ' LEU . 0.0 OUTLIER -68.9 77.47 0.32 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.83 0.348 . . . . 65.230000000000004 110.908 -179.893 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.457 ' HB2' ' CE1' ' A' ' 11' ' ' TYR . 0.7 OUTLIER -77.83 127.82 33.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.148 -0.478 . . . . 75.099999999999994 110.846 -179.892 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.491 ' O ' ' HA ' ' A' ' 9' ' ' THR . 88.2 t80 -122.01 124.0 42.97 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.199 -0.455 . . . . 72.319999999999993 110.922 -179.889 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.473 ' CG ' HG23 ' A' ' 9' ' ' THR . 1.2 m-20 -120.19 134.37 55.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.1 -0.5 . . . . 74.230000000000004 110.86 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -167.49 134.32 2.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.199 -0.455 . . . . 70.0 110.889 -179.887 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.406 ' HA ' ' HA ' ' A' ' 7' ' ' LYS . 6.1 p-10 -102.2 5.45 40.2 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.174 -0.466 . . . . 73.030000000000001 110.857 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 11.7 t -107.79 169.38 8.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.171 -0.468 . . . . 71.209999999999994 110.932 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -64.96 117.15 7.19 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.198 -0.455 . . . . 51.100000000000001 110.875 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.473 ' HB2' ' HB3' ' A' ' 30' ' ' PHE . 4.4 m -116.95 53.65 0.89 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.178 -0.465 . . . . 73.239999999999995 110.876 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.533 ' C ' ' HA ' ' A' ' 82' ' ' SER . . . -46.44 -20.72 0.13 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.176 -0.465 . . . . 70.420000000000002 111.126 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 57.0 t0 -128.3 42.71 3.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.21 -0.45 . . . . 72.310000000000002 110.877 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.76 ' CD2' ' O ' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -80.0 14.44 1.83 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.187 -0.461 . . . . 74.420000000000002 110.92 -179.905 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.503 ' HB2' ' HB3' ' A' ' 81' ' ' SER . 28.3 t60 -77.61 -40.13 43.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.104 -0.498 . . . . 71.209999999999994 110.853 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.6 t -56.15 -14.98 3.08 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.215 -0.448 . . . . 63.549999999999997 111.129 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -99.07 -27.23 13.93 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.258 -0.428 . . . . 65.219999999999999 110.896 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.771 HD22 ' HB2' ' A' ' 10' ' ' PHE . 17.4 tp -141.97 135.84 29.75 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.146 -0.479 . . . . 74.299999999999997 110.909 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 20.5 m -99.36 -42.62 6.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 74.420000000000002 110.876 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -118.15 141.48 48.45 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.104 -0.498 . . . . 73.340000000000003 110.849 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.633 ' SG ' ' HB2' ' A' ' 80' ' ' LEU . 4.6 p -110.73 86.77 2.38 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.148 -0.478 . . . . 71.310000000000002 110.877 -179.92 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.526 ' HB3' ' N ' ' A' ' 14' ' ' LYS . 0.2 OUTLIER -77.97 -66.29 0.86 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.175 -0.466 . . . . 75.099999999999994 110.851 -179.863 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 6.1 p -117.08 123.11 46.01 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.201 -0.454 . . . . 63.219999999999999 110.84 -179.865 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.767 HD12 ' CH2' ' A' ' 73' ' ' TRP . 27.2 mt -116.27 150.2 18.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.092 -0.503 . . . . 72.299999999999997 111.107 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.486 ' HD2' ' CE2' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -145.63 118.51 8.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.211 -0.45 . . . . 64.209999999999994 110.901 179.832 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.503 HG12 ' O ' ' A' ' 42' ' ' VAL . 1.3 t -104.87 115.7 47.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.244 -0.435 . . . . 75.150000000000006 111.172 179.836 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -110.84 77.82 1.07 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.164 -0.471 . . . . 71.310000000000002 110.901 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.404 ' O ' ' HB ' ' A' ' 6' ' ' THR . . . 135.28 101.98 0.69 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.768 -0.729 . . . . 55.329999999999998 112.493 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 53.74 179.17 0.12 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.747 -0.739 . . . . 73.010000000000005 112.515 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.747 HG23 ' HA ' ' A' ' 63' ' ' PRO . 0.6 OUTLIER -79.67 172.61 13.56 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.819 0.342 . . . . 64.200000000000003 111.121 -179.885 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 47' ' ' TRP . . . . . 0.586 ' H ' HG22 ' A' ' 46' ' ' THR . 14.8 m95 -144.07 130.2 19.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 73.540000000000006 110.906 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.883 ' HB2' ' CG2' ' A' ' 86' ' ' VAL . . . -97.18 112.0 23.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.288 -0.415 . . . . 74.019999999999996 111.158 179.858 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.564 HG11 ' CD1' ' A' ' 80' ' ' LEU . 3.6 m -113.12 129.73 68.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.227 -0.442 . . . . 71.140000000000001 111.117 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.692 ' HB3' ' HA ' ' A' ' 56' ' ' ALA . 33.0 m-85 -95.78 148.59 22.42 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.156 -0.475 . . . . 74.439999999999998 110.92 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.659 ' HB2' ' HB2' ' A' ' 58' ' ' TYR . 35.1 tt0 -45.43 -80.85 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.099 -0.501 . . . . 73.349999999999994 110.885 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.622 ' HB3' ' CD2' ' A' ' 55' ' ' PHE . 0.3 OUTLIER -90.54 146.38 34.22 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.621 0.724 . . . . 74.5 110.88 -179.891 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.751 ' HA ' ' OG ' ' A' ' 82' ' ' SER . 54.2 Cg_endo -69.71 134.71 28.74 Favored 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.701 2.267 . . . . 74.340000000000003 112.38 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 1.5 t30 65.63 -9.84 0.23 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.214 -0.448 . . . . 75.150000000000006 110.884 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.622 ' CD2' ' HB3' ' A' ' 52' ' ' ARG . 4.7 m-30 -98.75 -24.16 15.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.173 -0.467 . . . . 73.329999999999998 110.914 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.692 ' HA ' ' HB3' ' A' ' 50' ' ' TYR . . . 56.62 20.83 5.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.102 -0.499 . . . . 62.439999999999998 111.141 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' TRP . . . . . 0.634 ' HB3' ' OE1' ' A' ' 51' ' ' GLU . 0.1 OUTLIER -50.7 -166.11 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.167 -0.47 . . . . 71.409999999999997 110.93 -179.958 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.775 ' HB3' HD11 ' A' ' 76' ' ' LEU . 6.9 m-30 -13.08 101.87 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.251 -0.431 . . . . 71.5 110.877 -179.866 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.41 ' HB2' ' HA ' ' A' ' 150' ' ' TYR . 0.0 OUTLIER -68.73 154.24 42.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.12 -0.491 . . . . 62.009999999999998 110.883 179.881 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.89 ' CD2' HD22 ' A' ' 76' ' ' LEU . 5.1 t80 -173.72 102.13 0.11 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.213 -0.449 . . . . 73.340000000000003 110.906 -179.895 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.74 HD13 HG12 ' A' ' 138' ' ' ILE . 4.8 mp -88.21 118.71 34.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.093 -0.503 . . . . 73.209999999999994 111.076 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.775 HD23 ' HD2' ' A' ' 63' ' ' PRO . 0.2 OUTLIER -83.61 129.59 59.21 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.603 0.716 . . . . 61.210000000000001 110.856 179.924 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.775 ' HD2' HD23 ' A' ' 62' ' ' LEU . 53.3 Cg_endo -69.87 -172.34 0.58 Allowed 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.652 2.234 . . . . 65.439999999999998 112.288 179.878 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -88.74 161.9 16.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 73.400000000000006 110.911 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 112.07 -167.74 12.5 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.778 -0.725 . . . . 74.140000000000001 112.511 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -109.08 154.45 22.24 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.901 0.381 . . . . 71.209999999999994 110.862 -179.863 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.632 ' HB2' ' O ' ' A' ' 40' ' ' ILE . 14.6 m-85 -142.05 84.96 11.3 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.667 0.746 . . . . 74.019999999999996 110.925 -179.893 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.438 ' HD2' ' HG3' ' A' ' 72' ' ' ARG . 53.8 Cg_endo -69.73 -0.06 6.34 Favored 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.682 2.254 . . . . 54.210000000000001 112.335 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.564 ' HB2' ' HG2' ' A' ' 72' ' ' ARG . 47.9 mt-10 -156.5 143.53 18.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.226 -0.443 . . . . 64.239999999999995 110.891 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.739 ' HA ' ' NE1' ' A' ' 73' ' ' TRP . 35.9 p90 -54.43 -22.35 12.35 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.161 -0.472 . . . . 74.109999999999999 110.915 -179.836 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -79.55 -18.05 52.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.121 -0.491 . . . . 74.420000000000002 110.907 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.564 ' HG2' ' HB2' ' A' ' 69' ' ' GLU . 28.2 mmt180 -69.28 -7.75 39.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.453 . . . . 65.519999999999996 110.883 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' TRP . . . . . 0.767 ' CH2' HD12 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -138.6 15.82 2.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.183 -0.462 . . . . 64.120000000000005 110.925 -179.971 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 74' ' ' MET . . . . . 0.431 ' C ' ' O ' ' A' ' 73' ' ' TRP . 0.0 OUTLIER 36.0 43.84 0.22 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.213 -0.449 . . . . 72.329999999999998 110.894 179.93 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -51.93 123.92 22.31 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.763 -0.732 . . . . 32.0 112.506 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.89 HD22 ' CD2' ' A' ' 60' ' ' TYR . 1.1 pt? -59.09 -33.2 70.56 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.803 0.335 . . . . 73.230000000000004 110.864 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.704 ' H ' HD23 ' A' ' 76' ' ' LEU . 17.7 t-20 -147.49 139.43 24.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.239 -0.437 . . . . 74.400000000000006 110.902 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -78.12 18.51 0.51 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.168 -0.469 . . . . 75.010000000000005 110.896 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -107.17 73.28 0.92 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.186 -0.461 . . . . 64.530000000000001 110.873 -179.895 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.633 ' HB2' ' SG ' ' A' ' 37' ' ' CYS . 0.0 OUTLIER -82.31 133.98 35.25 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.228 -0.442 . . . . 71.209999999999994 110.871 -179.955 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.575 ' HB3' ' HB3' ' A' ' 53' ' ' PRO . 0.9 OUTLIER -147.56 -126.34 0.06 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.173 -0.467 . . . . 71.409999999999997 110.889 -179.942 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.751 ' OG ' ' HA ' ' A' ' 53' ' ' PRO . 0.4 OUTLIER -29.88 123.34 0.17 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.148 -0.478 . . . . 72.230000000000004 110.866 -179.844 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 83' ' ' CYS . . . . . 0.528 ' HA ' ' O ' ' A' ' 48' ' ' ALA . 9.2 p -133.42 141.56 47.91 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.149 -0.478 . . . . 72.349999999999994 110.873 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.466 ' N ' ' O ' ' A' ' 48' ' ' ALA . 1.5 mmt85 -138.44 130.22 28.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.204 -0.453 . . . . 74.140000000000001 110.886 -179.872 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.451 ' N ' ' CZ3' ' A' ' 47' ' ' TRP . . . -50.87 128.84 22.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.21 -0.45 . . . . 74.349999999999994 111.095 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.883 ' CG2' ' HB2' ' A' ' 48' ' ' ALA . 54.3 t -114.61 130.64 68.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.19 -0.459 . . . . 63.439999999999998 111.16 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' HIS . . . . . 0.483 ' O ' HG23 ' A' ' 136' ' ' VAL . 72.1 m-70 -114.67 119.03 35.33 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.154 -0.475 . . . . 71.310000000000002 110.881 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.731 HD13 ' HA ' ' A' ' 178' ' ' GLU . 0.0 OUTLIER -33.64 146.1 0.12 Allowed Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.556 0.693 . . . . 74.019999999999996 110.915 -179.956 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.676 ' HA ' ' HA3' ' A' ' 135' ' ' GLY . 53.4 Cg_endo -69.74 -79.29 0.01 OUTLIER 'Trans proline' 0 C--O 1.231 0.151 0 C-N-CA 122.721 2.281 . . . . 74.430000000000007 112.306 179.879 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.452 ' H ' ' HG2' ' A' ' 89' ' ' PRO . 67.2 m -109.07 -178.56 3.61 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.183 -0.462 . . . . 73.239999999999995 110.893 -179.827 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -100.94 4.15 55.96 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.794 -0.717 . . . . 31.039999999999999 112.488 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -125.19 -55.43 0.17 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.744 -0.741 . . . . 62.130000000000003 112.523 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.485 ' HG3' ' OG1' ' A' ' 112' ' ' THR . 11.5 pt20 -165.88 -170.05 1.66 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.837 0.351 . . . . 74.219999999999999 110.888 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.774 ' CD2' ' HB2' ' A' ' 134' ' ' GLU . 38.8 t80 -116.43 106.07 13.21 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.199 -0.455 . . . . 74.340000000000003 110.919 -179.859 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.467 ' HA ' ' HB ' ' A' ' 112' ' ' THR . 36.7 tptt -74.95 126.2 30.49 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.131 -0.486 . . . . 74.299999999999997 110.913 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.54 HD13 ' N ' ' A' ' 97' ' ' GLN . 0.0 OUTLIER -149.1 140.92 17.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.228 -0.442 . . . . 74.420000000000002 111.122 179.896 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.54 ' N ' HD13 ' A' ' 96' ' ' ILE . 1.3 mt-30 -109.63 125.84 53.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.197 -0.456 . . . . 73.140000000000001 110.888 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.55 ' CG2' HD12 ' A' ' 127' ' ' ILE . 2.3 mp -106.05 132.86 52.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.153 -0.476 . . . . 72.510000000000005 111.15 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.715 ' HB2' ' HB2' ' A' ' 129' ' ' SER . 46.3 m-85 -119.38 150.45 40.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.18 -0.464 . . . . 73.400000000000006 110.925 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.554 ' HA ' ' CE ' ' A' ' 124' ' ' MET . 62.9 tt0 -85.15 -52.18 6.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.177 -0.465 . . . . 61.210000000000001 110.892 -179.873 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 40.7 mttt -105.48 166.47 10.41 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.099 -0.501 . . . . 75.129999999999995 110.868 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.404 ' HA2' ' OG ' ' A' ' 129' ' ' SER . . . -67.12 152.46 52.75 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.722 -0.751 . . . . 73.310000000000002 112.522 179.885 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.44 ' HA ' ' HB2' ' A' ' 158' ' ' ARG . 42.3 t0 66.78 46.16 1.76 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.829 0.347 . . . . 72.010000000000005 110.885 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.546 ' N ' ' CD2' ' A' ' 104' ' ' PHE . 0.3 OUTLIER 48.3 33.08 3.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.208 -0.451 . . . . 74.200000000000003 110.866 -179.904 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 57.8 m -96.5 160.82 14.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.16 -0.473 . . . . 72.400000000000006 110.846 -179.802 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 81.97 -143.74 23.39 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.712 -0.756 . . . . 61.439999999999998 112.479 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -80.13 120.45 24.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.755 0.312 . . . . 32.350000000000001 110.877 -179.837 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 5.7 ttp -108.84 134.17 51.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.212 -0.449 . . . . 62.130000000000003 110.886 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -139.22 135.5 34.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.205 -0.452 . . . . 60.200000000000003 110.925 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -114.83 94.52 4.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.061 -0.518 . . . . 75.239999999999995 110.872 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.502 HG22 ' CD1' ' A' ' 98' ' ' ILE . 5.7 t -114.77 144.13 43.98 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.148 -0.478 . . . . 70.319999999999993 111.165 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.485 ' OG1' ' HG3' ' A' ' 93' ' ' GLN . 6.6 t -129.66 47.28 2.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.234 -0.439 . . . . 51.119999999999997 111.112 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -151.54 157.92 42.89 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.221 -0.445 . . . . 73.510000000000005 110.882 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.404 ' OD1' ' HG3' ' A' ' 175' ' ' ARG . 2.6 m-20 -56.2 148.46 18.21 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.112 -0.494 . . . . 75.010000000000005 110.874 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 115' ' ' CYS . . . . . 0.741 ' O ' ' HB2' ' A' ' 172' ' ' SER . 42.7 t -139.23 124.3 11.69 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.616 0.722 . . . . 63.420000000000002 110.899 -179.907 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.532 ' O ' ' C ' ' A' ' 143' ' ' PRO . 53.6 Cg_endo -69.78 -30.44 22.16 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.688 2.259 . . . . 72.530000000000001 112.322 -179.89 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.623 ' HB3' ' CB ' ' A' ' 120' ' ' GLU . 0.1 OUTLIER -149.18 106.72 3.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.201 -0.454 . . . . 42.130000000000003 110.853 -179.877 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.609 HD13 HD11 ' A' ' 127' ' ' ILE . 3.9 tt -61.7 -30.48 48.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.127 -0.488 . . . . 62.130000000000003 111.1 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 119' ' ' MET . . . . . 0.702 ' O ' ' HA ' ' A' ' 123' ' ' HIS . 0.1 OUTLIER -91.02 -42.01 10.77 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.186 -0.461 . . . . 75.349999999999994 110.949 179.819 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.623 ' CB ' ' HB3' ' A' ' 117' ' ' SER . 2.9 tp10 -70.26 -11.79 61.15 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.201 -0.454 . . . . 63.420000000000002 110.861 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 29.8 mm100 -112.93 -52.14 2.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.183 -0.462 . . . . 63.119999999999997 110.966 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 30.9 m-85 -102.75 14.18 32.59 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.194 -0.457 . . . . 64.540000000000006 110.88 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' HIS . . . . . 0.702 ' HA ' ' O ' ' A' ' 119' ' ' MET . 21.5 m-70 47.13 25.11 0.48 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.118 -0.492 . . . . 74.430000000000007 110.835 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.606 ' HE2' HD13 ' A' ' 127' ' ' ILE . 0.0 OUTLIER -100.78 124.93 47.13 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.239 -0.437 . . . . 74.420000000000002 110.892 179.953 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 3.0 ptp85 -96.71 -35.05 11.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.257 -0.428 . . . . 74.200000000000003 110.838 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.473 ' HB3' ' HG2' ' A' ' 168' ' ' PRO . 34.8 mt-10 -145.54 115.52 7.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.18 -0.464 . . . . 64.129999999999995 110.859 -179.905 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.609 HD11 HD13 ' A' ' 118' ' ' ILE . 3.1 mm -74.13 100.45 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.121 -0.49 . . . . 74.439999999999998 111.11 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 128' ' ' HIS . . . . . 0.436 ' CD2' ' HG3' ' A' ' 168' ' ' PRO . 12.9 m170 -69.04 -36.21 77.46 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.138 -0.483 . . . . 72.120000000000005 110.867 179.85 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 129' ' ' SER . . . . . 0.715 ' HB2' ' HB2' ' A' ' 99' ' ' PHE . 19.3 m -134.03 144.18 48.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.193 -0.458 . . . . 73.120000000000005 110.875 -179.795 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 130' ' ' CYS . . . . . 0.629 ' O ' ' O ' ' A' ' 155' ' ' LYS . 1.4 m -140.31 114.65 9.24 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.124 -0.489 . . . . 63.020000000000003 110.925 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.523 ' HA ' ' O ' ' A' ' 155' ' ' LYS . 5.5 mtpp -110.22 150.63 28.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.178 -0.465 . . . . 72.439999999999998 110.92 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.471 ' HB ' ' O ' ' A' ' 131' ' ' LYS . 12.6 t 81.2 158.49 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.233 -0.44 . . . . 73.010000000000005 111.164 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.855 HD22 ' HG2' ' A' ' 155' ' ' LYS . 0.1 OUTLIER 176.27 124.29 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.213 -0.449 . . . . 62.119999999999997 110.96 179.957 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.774 ' HB2' ' CD2' ' A' ' 94' ' ' TYR . 3.7 mm-40 -86.8 -167.82 2.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.196 -0.456 . . . . 62.509999999999998 110.884 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 135' ' ' GLY . . . . . 0.676 ' HA3' ' HA ' ' A' ' 89' ' ' PRO . . . -48.77 -92.85 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.759 -0.734 . . . . 45.109999999999999 112.465 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.933 ' HB ' HD12 ' A' ' 176' ' ' ILE . 2.3 t -103.21 148.26 8.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.779 0.323 . . . . 54.25 111.17 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 137' ' ' TRP . . . . . 0.641 ' HB2' ' CE2' ' A' ' 94' ' ' TYR . 0.0 OUTLIER -156.73 158.84 37.64 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.227 -0.442 . . . . 75.010000000000005 110.932 179.919 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.74 HG12 HD13 ' A' ' 61' ' ' ILE . 5.0 mt -134.25 136.44 53.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.262 -0.426 . . . . 74.120000000000005 111.145 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.464 ' HB2' ' HB2' ' A' ' 150' ' ' TYR . 0.1 OUTLIER -102.15 160.36 14.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.157 -0.474 . . . . 72.310000000000002 110.848 179.983 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -129.33 115.51 17.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.124 -0.489 . . . . 64.25 110.908 -179.846 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 141' ' ' GLU . . . . . 0.589 ' O ' ' HB2' ' A' ' 171' ' ' GLN . 0.6 OUTLIER -54.91 -33.39 62.04 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.128 -0.487 . . . . 61.109999999999999 110.841 -179.983 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.696 ' HB3' ' HD2' ' A' ' 143' ' ' PRO . 8.8 mp -113.36 172.81 3.25 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.643 0.735 . . . . 63.32 110.914 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 143' ' ' PRO . . . . . 0.792 ' O ' ' OG ' ' A' ' 172' ' ' SER . 53.1 Cg_endo -69.78 -93.15 0.01 OUTLIER 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.7 2.266 . . . . 65.230000000000004 112.355 179.882 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 144' ' ' ASN . . . . . 0.745 ' O ' ' N ' ' A' ' 146' ' ' ARG . 0.3 OUTLIER -50.18 99.05 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.22 -0.445 . . . . 75.439999999999998 110.906 179.971 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 145' ' ' TYR . . . . . 0.643 ' C ' ' O ' ' A' ' 144' ' ' ASN . 34.5 m-85 11.59 52.23 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.199 -0.455 . . . . 75.430000000000007 110.942 -179.905 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 146' ' ' ARG . . . . . 0.745 ' N ' ' O ' ' A' ' 144' ' ' ASN . 12.4 mtp85 -117.86 172.14 7.59 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.128 -0.487 . . . . 73.329999999999998 110.892 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 80.11 -170.27 53.58 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.747 -0.739 . . . . 53.310000000000002 112.448 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.63 ' CG ' HD12 ' A' ' 76' ' ' LEU . 0.6 OUTLIER -92.54 152.62 19.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.767 0.318 . . . . 72.209999999999994 110.881 -179.84 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 149' ' ' GLN . . . . . 0.488 ' CD ' HG21 ' A' ' 138' ' ' ILE . 47.2 mt-30 -88.25 150.34 23.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.256 -0.429 . . . . 73.239999999999995 110.893 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 150' ' ' TYR . . . . . 0.464 ' HB2' ' HB2' ' A' ' 139' ' ' PHE . 96.2 m-85 -130.5 122.42 27.62 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.164 -0.471 . . . . 75.519999999999996 110.906 -179.876 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.492 HD23 ' OH ' ' A' ' 50' ' ' TYR . 33.9 tp -62.49 134.51 56.51 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.098 -0.501 . . . . 75.319999999999993 110.946 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.952 HD13 ' O ' ' A' ' 152' ' ' LEU . 0.0 OUTLIER -63.8 133.24 53.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.17 -0.468 . . . . 75.450000000000003 110.878 179.991 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -165.76 25.21 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.174 -0.466 . . . . 71.319999999999993 110.875 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.802 ' HA ' ' CE1' ' A' ' 157' ' ' TYR . 0.2 OUTLIER -106.65 -156.62 0.58 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.182 -0.463 . . . . 71.519999999999996 110.876 179.991 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.855 ' HG2' HD22 ' A' ' 133' ' ' LEU . 0.0 OUTLIER 168.9 -132.95 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.179 -0.464 . . . . 74.310000000000002 110.868 179.888 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.478 ' HA ' ' HA ' ' A' ' 131' ' ' LYS . 2.6 tm-20 -61.57 3.29 0.14 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.176 -0.465 . . . . 55.299999999999997 110.886 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 157' ' ' TYR . . . . . 0.802 ' CE1' ' HA ' ' A' ' 154' ' ' LYS . 15.1 m-30 -34.37 150.22 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.184 -0.462 . . . . 64.230000000000004 110.865 -179.831 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 158' ' ' ARG . . . . . 0.518 ' O ' ' OG ' ' A' ' 129' ' ' SER . 0.0 OUTLIER -126.31 -38.69 2.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.073 -0.512 . . . . 65.420000000000002 110.84 -179.961 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 159' ' ' LYS . . . . . 0.446 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 0.3 OUTLIER -85.12 150.8 55.9 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.538 0.685 . . . . 73.150000000000006 110.915 179.969 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 160' ' ' PRO . . . . . 0.52 ' HB3' ' HB3' ' A' ' 168' ' ' PRO . 53.5 Cg_endo -69.78 -23.29 30.87 Favored 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.726 2.284 . . . . 65.329999999999998 112.339 179.892 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.65 HD12 ' H ' ' A' ' 161' ' ' ILE . 4.0 mp -75.47 -3.24 4.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.179 -0.464 . . . . 65.439999999999998 111.117 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.68 ' HB3' ' CD1' ' A' ' 157' ' ' TYR . 0.3 OUTLIER -76.53 -14.44 60.02 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.164 -0.471 . . . . 74.099999999999994 110.838 179.911 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 11.4 t90 -94.61 2.24 55.62 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.226 -0.443 . . . . 74.540000000000006 110.875 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 90.42 -36.21 3.64 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.752 -0.737 . . . . 74.409999999999997 112.526 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -71.77 128.12 34.75 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.766 0.317 . . . . 63.5 111.137 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -42.16 -34.89 0.82 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.198 -0.456 . . . . 44.329999999999998 111.086 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 167' ' ' SER . . . . . 0.486 ' C ' ' H ' ' A' ' 169' ' ' ALA . 0.3 OUTLIER -131.25 157.84 76.96 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.663 0.744 . . . . 75.25 110.861 -179.771 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 168' ' ' PRO . . . . . 0.52 ' HB3' ' HB3' ' A' ' 160' ' ' PRO . 54.3 Cg_endo -69.69 21.46 0.17 Allowed 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.699 2.266 . . . . 74.209999999999994 112.406 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 0.486 ' H ' ' C ' ' A' ' 167' ' ' SER . . . -62.47 102.05 0.29 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.181 -0.463 . . . . 55.210000000000001 111.129 179.881 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 2.8 t -154.12 155.63 5.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.188 -0.46 . . . . 53.520000000000003 111.129 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 171' ' ' GLN . . . . . 0.589 ' HB2' ' O ' ' A' ' 141' ' ' GLU . 1.5 tm0? -116.75 -134.71 0.34 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.162 -0.472 . . . . 75.329999999999998 110.935 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 172' ' ' SER . . . . . 0.792 ' OG ' ' O ' ' A' ' 143' ' ' PRO . 12.1 p -64.46 171.87 2.94 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.246 -0.434 . . . . 71.109999999999999 110.896 -179.843 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 173' ' ' PHE . . . . . 0.467 ' CG ' ' HH2' ' A' ' 137' ' ' TRP . 2.3 p90 -147.43 175.57 10.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.111 -0.495 . . . . 72.129999999999995 110.881 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 174' ' ' ARG . . . . . 0.45 ' HG2' ' O ' ' A' ' 174' ' ' ARG . 1.7 ptm180 -140.32 136.62 33.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.166 -0.47 . . . . 73.439999999999998 110.897 -179.912 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 175' ' ' ARG . . . . . 0.469 ' HB2' ' HB3' ' A' ' 94' ' ' TYR . 0.0 OUTLIER -105.56 138.26 42.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.18 -0.464 . . . . 70.120000000000005 110.881 -179.913 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 176' ' ' ILE . . . . . 0.933 HD12 ' HB ' ' A' ' 136' ' ' VAL . 1.9 mt -79.44 144.93 10.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.194 -0.457 . . . . 75.040000000000006 111.138 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 4.6 p -136.19 156.28 36.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.175 -0.466 . . . . 72.120000000000005 111.135 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 178' ' ' GLU . . . . . 0.731 ' HA ' HD13 ' A' ' 88' ' ' LEU . 1.1 mp0 . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.146 -0.479 . . . . 74.439999999999998 110.884 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 38.9 mtm . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.764 0.316 . . . . 72.340000000000003 110.871 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -60.71 -66.32 0.55 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.234 -0.439 . . . . 73.109999999999999 110.867 -179.786 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 51.48 34.32 11.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.148 -0.478 . . . . 74.219999999999999 110.951 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 4.0 t -71.24 -32.26 68.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.172 -0.467 . . . . 54.450000000000003 111.182 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 160.32 125.45 0.78 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.781 -0.724 . . . . 73.129999999999995 112.531 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.494 ' C ' ' HE1' ' A' ' 47' ' ' TRP . 4.6 p -82.09 135.1 35.36 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.828 0.347 . . . . 73.430000000000007 111.151 -179.822 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 3.4 tttt -121.56 135.94 54.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.223 -0.444 . . . . 74.5 110.894 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.615 ' HB ' ' CD1' ' A' ' 47' ' ' TRP . 15.9 tt -136.78 153.39 30.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.208 -0.451 . . . . 51.539999999999999 111.127 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.524 ' HA ' ' O ' ' A' ' 21' ' ' TYR . 17.9 m -134.01 143.89 48.38 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.193 -0.458 . . . . 71.129999999999995 111.14 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.721 ' HB2' HD22 ' A' ' 34' ' ' LEU . 0.8 OUTLIER -131.28 127.9 38.71 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.203 -0.453 . . . . 71.430000000000007 110.894 -179.983 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.545 ' CG ' ' HA ' ' A' ' 16' ' ' PHE . 11.1 m-85 -113.19 132.51 55.46 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.161 -0.472 . . . . 71.120000000000005 110.868 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.424 ' HB2' ' HB2' ' A' ' 19' ' ' ARG . 0.0 OUTLIER -60.11 -16.07 28.89 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.102 -0.499 . . . . 73.420000000000002 110.876 179.998 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.437 ' HB2' ' O ' ' A' ' 17' ' ' GLN . 72.2 m-20 -134.68 150.54 50.64 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.174 -0.467 . . . . 71.109999999999999 110.847 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.489 ' N ' ' HB3' ' A' ' 38' ' ' ASN . 38.7 mtmt -55.25 -176.12 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.181 -0.463 . . . . 75.420000000000002 110.873 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 18.8 m120 46.54 32.48 1.65 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.193 -0.458 . . . . 70.329999999999998 110.869 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.545 ' HA ' ' CG ' ' A' ' 11' ' ' TYR . 3.0 m-85 49.68 63.94 1.96 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.174 -0.466 . . . . 72.540000000000006 110.887 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.437 ' O ' ' HB2' ' A' ' 13' ' ' ASP . 3.8 mt-30 -138.76 158.59 43.94 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.132 -0.485 . . . . 74.439999999999998 110.892 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 92.86 -148.86 19.25 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.716 -0.754 . . . . 32.350000000000001 112.473 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.75 ' O ' HD13 ' A' ' 34' ' ' LEU . 0.3 OUTLIER -69.04 78.06 0.33 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.767 0.318 . . . . 73.400000000000006 110.911 -179.861 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.486 ' HB2' ' CE1' ' A' ' 11' ' ' TYR . 0.6 OUTLIER -77.14 130.11 36.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.456 . . . . 73.430000000000007 110.891 -179.905 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.524 ' O ' ' HA ' ' A' ' 9' ' ' THR . 90.7 t80 -124.02 124.87 43.51 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.169 -0.469 . . . . 71.349999999999994 110.93 -179.845 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.446 ' CG ' HG23 ' A' ' 9' ' ' THR . 1.1 m-20 -121.9 134.45 54.86 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.109 -0.496 . . . . 64.349999999999994 110.833 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -167.86 135.81 2.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.167 -0.47 . . . . 73.530000000000001 110.882 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -101.27 0.04 36.62 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.212 -0.449 . . . . 73.120000000000005 110.863 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 16.5 t -104.37 164.88 11.42 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.172 -0.467 . . . . 64.540000000000006 110.914 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 35.6 m-20 -58.24 120.84 9.4 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.209 -0.451 . . . . 72.329999999999998 110.879 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.566 ' HB2' ' HB3' ' A' ' 30' ' ' PHE . 1.8 m -115.95 51.94 0.93 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.208 -0.451 . . . . 61.340000000000003 110.886 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.501 ' C ' ' HA ' ' A' ' 82' ' ' SER . . . -47.33 -21.27 0.27 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.223 -0.444 . . . . 74.140000000000001 111.083 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 56.8 t0 -128.54 42.33 3.34 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.223 -0.444 . . . . 63.420000000000002 110.866 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.785 ' CD2' ' O ' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -80.99 15.33 1.87 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.217 -0.447 . . . . 73.510000000000005 110.858 -179.852 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.48 ' HB2' ' HB3' ' A' ' 81' ' ' SER . 28.5 t60 -80.01 -39.57 29.68 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.142 -0.481 . . . . 74.209999999999994 110.885 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.7 t -57.93 -13.94 5.39 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.202 -0.454 . . . . 75.150000000000006 111.119 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -99.96 -27.14 13.73 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.27 -0.423 . . . . 73.329999999999998 110.907 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.75 HD13 ' O ' ' A' ' 19' ' ' ARG . 18.0 tp -142.65 136.31 28.97 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.162 -0.472 . . . . 70.219999999999999 110.916 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 23.8 m -98.81 -42.42 7.19 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.174 -0.467 . . . . 62.130000000000003 110.861 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -118.54 141.37 48.64 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.135 -0.484 . . . . 63.119999999999997 110.861 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.547 ' HB3' ' HB2' ' A' ' 80' ' ' LEU . 3.1 p -109.95 83.97 1.85 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.188 -0.46 . . . . 71.329999999999998 110.858 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.489 ' HB3' ' N ' ' A' ' 14' ' ' LYS . 0.2 OUTLIER -75.33 -70.64 0.41 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.157 -0.474 . . . . 52.119999999999997 110.872 -179.911 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 5.0 p -111.77 124.38 52.21 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.192 -0.458 . . . . 72.430000000000007 110.836 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.724 HD12 ' CH2' ' A' ' 73' ' ' TRP . 45.1 mt -117.67 148.36 20.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.123 -0.489 . . . . 72.510000000000005 111.149 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.464 ' HB3' ' HE2' ' A' ' 41' ' ' LYS . 0.0 OUTLIER -143.49 120.57 11.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.181 -0.463 . . . . 53.310000000000002 110.9 179.85 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.534 HG22 ' HB ' ' A' ' 8' ' ' ILE . 1.9 t -104.98 115.53 47.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.22 -0.446 . . . . 71.219999999999999 111.096 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -110.35 80.27 1.29 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.227 -0.442 . . . . 61.43 110.872 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.467 ' O ' ' HA ' ' A' ' 6' ' ' THR . . . 127.89 106.85 1.37 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.736 -0.745 . . . . 74.319999999999993 112.485 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 51.95 177.98 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.738 -0.744 . . . . 71.239999999999995 112.494 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.74 HG23 ' HA ' ' A' ' 63' ' ' PRO . 1.9 m -80.91 165.79 21.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.813 0.34 . . . . 61.210000000000001 111.112 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.615 ' CD1' ' HB ' ' A' ' 8' ' ' ILE . 3.3 m95 -138.91 130.05 26.75 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.449 . . . . 74.150000000000006 110.901 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.802 ' HB2' ' CG2' ' A' ' 86' ' ' VAL . . . -94.09 129.66 40.56 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.214 -0.448 . . . . 64.329999999999998 111.103 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.63 HG11 ' CD1' ' A' ' 80' ' ' LEU . 12.5 m -126.86 131.32 71.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.259 -0.428 . . . . 74.099999999999994 111.121 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.777 ' HB3' ' HA ' ' A' ' 56' ' ' ALA . 42.1 m-85 -97.28 147.73 23.84 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.182 -0.463 . . . . 73.209999999999994 110.928 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.617 ' OE1' ' HB3' ' A' ' 57' ' ' TRP . 47.3 tt0 -49.97 -78.12 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.094 -0.503 . . . . 73.329999999999998 110.867 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.572 ' HB2' ' HB2' ' A' ' 57' ' ' TRP . 1.2 mtp180 -93.5 143.99 27.52 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.609 0.719 . . . . 75.430000000000007 110.875 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.748 ' HA ' ' OG ' ' A' ' 82' ' ' SER . 54.2 Cg_endo -69.71 141.11 44.54 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.754 2.303 . . . . 65.209999999999994 112.366 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 63.42 -11.13 0.1 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.238 -0.437 . . . . 71.239999999999995 110.903 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.6 ' H ' ' C ' ' A' ' 53' ' ' PRO . 2.5 m-30 -104.7 -20.58 13.59 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.168 -0.469 . . . . 64.319999999999993 110.899 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.777 ' HA ' ' HB3' ' A' ' 50' ' ' TYR . . . 50.29 25.58 1.9 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.134 -0.485 . . . . 71.299999999999997 111.09 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' TRP . . . . . 0.632 ' O ' ' C ' ' A' ' 58' ' ' TYR . 0.1 OUTLIER -49.21 -164.92 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.234 -0.439 . . . . 54.329999999999998 110.952 -179.929 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.632 ' C ' ' O ' ' A' ' 57' ' ' TRP . 7.0 m-30 -13.27 101.69 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.274 -0.421 . . . . 72.409999999999997 110.948 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.601 ' HB2' ' HA ' ' A' ' 150' ' ' TYR . 1.9 mpt? -65.45 157.56 29.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.136 -0.483 . . . . 74.439999999999998 110.936 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.795 ' CD2' HD12 ' A' ' 76' ' ' LEU . 3.2 t80 -175.01 101.37 0.08 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.255 -0.43 . . . . 71.430000000000007 110.927 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.708 HD11 ' HA ' ' A' ' 151' ' ' LEU . 4.4 mp -88.24 116.21 29.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.163 -0.471 . . . . 62.439999999999998 111.121 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.816 HD23 ' HD2' ' A' ' 63' ' ' PRO . 0.3 OUTLIER -80.33 128.24 73.57 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.605 0.717 . . . . 55.409999999999997 110.958 179.898 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.816 ' HD2' HD23 ' A' ' 62' ' ' LEU . 53.3 Cg_endo -69.78 -173.41 0.71 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.678 2.252 . . . . 65.040000000000006 112.357 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -88.44 161.6 16.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.265 -0.425 . . . . 74.239999999999995 110.924 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 112.64 -168.44 12.65 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.734 -0.746 . . . . 74.299999999999997 112.47 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -108.09 153.92 22.43 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.873 0.368 . . . . 74.140000000000001 110.915 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.613 ' HB2' ' O ' ' A' ' 40' ' ' ILE . 10.2 m-85 -143.48 83.83 10.51 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.625 0.726 . . . . 74.530000000000001 110.934 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.44 ' HD2' ' HG3' ' A' ' 72' ' ' ARG . 53.8 Cg_endo -69.77 0.78 5.16 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.679 2.253 . . . . 62.520000000000003 112.354 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.544 ' HB2' ' HG2' ' A' ' 72' ' ' ARG . 46.2 mt-10 -156.09 143.84 19.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.197 -0.456 . . . . 73.519999999999996 110.878 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.732 ' HA ' ' NE1' ' A' ' 73' ' ' TRP . 32.4 p90 -55.34 -21.98 17.37 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.157 -0.474 . . . . 74.150000000000006 110.944 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -79.14 -17.56 54.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.134 -0.484 . . . . 63.229999999999997 110.898 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.544 ' HG2' ' HB2' ' A' ' 69' ' ' GLU . 27.8 mmt180 -69.34 -8.11 43.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.185 -0.461 . . . . 71.329999999999998 110.889 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' TRP . . . . . 0.732 ' NE1' ' HA ' ' A' ' 70' ' ' TYR . 0.0 OUTLIER -136.94 18.99 3.01 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.169 -0.469 . . . . 75.140000000000001 110.876 -179.973 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.481 ' C ' ' O ' ' A' ' 73' ' ' TRP . 0.0 OUTLIER 32.11 47.71 0.09 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.255 -0.43 . . . . 74.099999999999994 110.835 179.921 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -59.92 120.38 22.48 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.71 -0.757 . . . . 75.340000000000003 112.531 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 1.043 HD13 ' N ' ' A' ' 77' ' ' ASN . 0.0 OUTLIER -63.56 -15.42 57.98 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.809 0.338 . . . . 73.420000000000002 110.937 -179.91 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 1.043 ' N ' HD13 ' A' ' 76' ' ' LEU . 35.5 t-20 -156.38 134.62 11.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.185 -0.461 . . . . 72.530000000000001 110.896 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -83.27 23.06 0.93 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.17 -0.468 . . . . 64.219999999999999 110.839 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 4.1 ttm-85 -110.16 80.77 1.34 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.232 -0.44 . . . . 74.540000000000006 110.886 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.63 ' CD1' HG11 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -87.91 133.99 33.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.224 -0.443 . . . . 73.310000000000002 110.871 -179.932 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.63 ' HB3' ' HB3' ' A' ' 53' ' ' PRO . 1.0 OUTLIER -150.32 -124.94 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.188 -0.46 . . . . 61.219999999999999 110.83 -179.96 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.748 ' OG ' ' HA ' ' A' ' 53' ' ' PRO . 0.1 OUTLIER -36.15 104.89 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.145 -0.48 . . . . 63.439999999999998 110.86 -179.784 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 83' ' ' CYS . . . . . 0.611 ' HB3' HG12 ' A' ' 49' ' ' VAL . 19.5 p -121.32 135.3 55.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.096 -0.502 . . . . 71.430000000000007 110.935 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.587 ' N ' ' O ' ' A' ' 48' ' ' ALA . 9.4 mmt85 -120.62 138.46 53.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.254 -0.43 . . . . 72.510000000000005 110.883 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.434 ' N ' ' CZ3' ' A' ' 47' ' ' TRP . . . -59.42 129.02 39.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.196 -0.457 . . . . 64.540000000000006 111.115 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.894 ' CG1' HG11 ' A' ' 136' ' ' VAL . 40.9 t -113.24 129.9 68.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.239 -0.437 . . . . 64.230000000000004 111.085 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' HIS . . . . . 0.552 ' O ' HG23 ' A' ' 136' ' ' VAL . 82.9 m-70 -111.52 107.46 16.65 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.154 -0.476 . . . . 73.140000000000001 110.892 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.488 ' H ' HD23 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -32.66 141.86 0.18 Allowed Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.645 0.736 . . . . 64.209999999999994 110.904 -179.92 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.471 ' HB3' ' H ' ' A' ' 136' ' ' VAL . 53.4 Cg_endo -69.79 98.02 0.67 Allowed 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.693 2.262 . . . . 63.509999999999998 112.329 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -100.76 138.72 37.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.231 -0.441 . . . . 70.439999999999998 110.831 -179.808 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 105.1 115.81 4.13 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.707 -0.759 . . . . 74.230000000000004 112.51 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 52.31 48.33 54.2 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.684 -0.769 . . . . 42.200000000000003 112.514 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 24.7 pt20 38.95 -153.31 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.778 0.323 . . . . 75.239999999999995 110.924 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.62 ' HA ' ' CG ' ' A' ' 134' ' ' GLU . 33.0 t80 -106.23 104.08 13.7 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.229 -0.441 . . . . 73.120000000000005 110.903 -179.845 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.467 ' H ' ' CG ' ' A' ' 134' ' ' GLU . 33.5 tptt -96.92 132.23 42.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.153 -0.476 . . . . 70.329999999999998 110.906 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.415 HD12 ' OH ' ' A' ' 94' ' ' TYR . 0.2 OUTLIER -149.42 135.91 12.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.197 -0.456 . . . . 72.129999999999995 111.166 179.891 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.587 ' HB2' HG23 ' A' ' 132' ' ' VAL . 0.8 OUTLIER -107.31 132.5 53.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.195 -0.457 . . . . 75.430000000000007 110.898 179.983 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.581 HD13 HD11 ' A' ' 118' ' ' ILE . 2.8 mt -118.18 130.84 72.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.234 -0.439 . . . . 75.219999999999999 111.149 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.688 ' HB2' ' HB2' ' A' ' 129' ' ' SER . 5.7 m-85 -120.21 152.59 37.49 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.141 -0.481 . . . . 72.340000000000003 110.948 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 70.7 tt0 -81.06 -68.83 0.65 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.206 -0.452 . . . . 61.200000000000003 110.865 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.526 ' C ' ' HB2' ' A' ' 128' ' ' HIS . 33.1 mttt -89.19 166.3 13.9 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.186 -0.461 . . . . 63.350000000000001 110.888 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -80.25 160.99 44.72 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.746 -0.74 . . . . 64.109999999999999 112.504 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.444 ' HA ' ' HB2' ' A' ' 158' ' ' ARG . 41.1 t0 66.08 52.05 1.23 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.81 0.338 . . . . 74.109999999999999 110.878 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.639 ' CE1' ' HD2' ' A' ' 131' ' ' LYS . 6.9 m-85 48.19 33.23 3.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.2 -0.455 . . . . 73.430000000000007 110.862 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.461 ' C ' ' HB2' ' A' ' 101' ' ' LYS . 43.8 m -108.97 155.53 20.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.125 -0.489 . . . . 61.5 110.875 -179.8 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 89.52 -163.83 31.4 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.776 -0.726 . . . . 72.430000000000007 112.488 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -76.36 123.49 26.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.794 0.33 . . . . 54.210000000000001 110.931 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 3.5 ttp -107.71 131.42 54.44 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.187 -0.46 . . . . 71.030000000000001 110.897 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -133.79 137.02 44.88 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.208 -0.451 . . . . 73.450000000000003 110.95 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -117.04 107.47 14.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.143 -0.48 . . . . 62.439999999999998 110.841 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 10.1 t -123.04 155.98 35.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.133 -0.485 . . . . 75.239999999999995 111.104 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.423 ' HA ' ' O ' ' A' ' 94' ' ' TYR . 1.7 t -135.47 45.68 2.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.208 -0.451 . . . . 73.219999999999999 111.132 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -152.72 158.66 42.64 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.229 -0.441 . . . . 73.540000000000006 110.87 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -51.33 156.4 1.2 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.126 -0.488 . . . . 62.140000000000001 110.862 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' CYS . . . . . 0.526 ' O ' ' HB2' ' A' ' 172' ' ' SER . 39.7 t -146.42 113.28 4.4 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.632 0.729 . . . . 52.020000000000003 110.862 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.419 ' O ' ' C ' ' A' ' 143' ' ' PRO . 53.4 Cg_endo -69.74 -30.71 21.93 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.665 2.243 . . . . 75.129999999999995 112.333 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.653 ' HB3' ' CB ' ' A' ' 120' ' ' GLU . 0.1 OUTLIER -149.57 101.35 3.08 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.211 -0.449 . . . . 75.329999999999998 110.848 -179.815 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.639 HD13 HD11 ' A' ' 127' ' ' ILE . 3.0 tt -54.66 -29.74 21.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.175 -0.466 . . . . 74.219999999999999 111.163 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' MET . . . . . 0.581 ' O ' ' HA ' ' A' ' 123' ' ' HIS . 0.6 OUTLIER -86.53 -45.08 11.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.145 -0.48 . . . . 72.329999999999998 110.899 179.817 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.653 ' CB ' ' HB3' ' A' ' 117' ' ' SER . 6.6 tp10 -65.78 -12.87 57.55 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.245 -0.434 . . . . 70.340000000000003 110.887 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 27.8 tp60 -114.51 -51.17 2.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.176 -0.466 . . . . 75.540000000000006 110.872 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.459 ' HB2' ' O ' ' A' ' 118' ' ' ILE . 44.0 m-85 -102.89 -19.65 14.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.197 -0.456 . . . . 73.200000000000003 110.872 -179.884 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' HIS . . . . . 0.581 ' HA ' ' O ' ' A' ' 119' ' ' MET . 29.6 m-70 71.72 28.63 2.69 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.16 -0.473 . . . . 73.219999999999999 110.896 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.412 ' HB3' ' CD1' ' A' ' 127' ' ' ILE . 10.7 mtt -103.95 85.94 2.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.234 -0.439 . . . . 63.049999999999997 110.91 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 4.0 ptp180 -51.44 -38.11 52.01 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.205 -0.452 . . . . 72.439999999999998 110.859 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.473 ' HG2' ' HA ' ' A' ' 169' ' ' ALA . 13.2 mt-10 -142.23 133.03 25.61 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.17 -0.468 . . . . 73.129999999999995 110.858 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.639 HD11 HD13 ' A' ' 118' ' ' ILE . 3.8 mm -92.08 97.07 6.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.155 -0.475 . . . . 70.239999999999995 111.13 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' HIS . . . . . 0.526 ' HB2' ' C ' ' A' ' 101' ' ' LYS . 0.6 OUTLIER -67.75 -34.04 76.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.133 -0.485 . . . . 73.120000000000005 110.891 179.857 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.688 ' HB2' ' HB2' ' A' ' 99' ' ' PHE . 58.2 m -129.43 136.61 50.15 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.184 -0.462 . . . . 75.239999999999995 110.868 -179.822 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' CYS . . . . . 0.526 ' O ' ' O ' ' A' ' 155' ' ' LYS . 3.4 m -131.74 119.93 22.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.128 -0.487 . . . . 64.299999999999997 110.894 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.693 ' HA ' ' HA ' ' A' ' 156' ' ' GLU . 2.0 mtpp -115.45 150.71 36.02 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.179 -0.464 . . . . 72.329999999999998 110.911 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.587 HG23 ' HB2' ' A' ' 97' ' ' GLN . 16.4 t 83.59 163.42 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.198 -0.456 . . . . 51.310000000000002 111.137 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.822 HD13 ' O ' ' A' ' 154' ' ' LYS . 0.0 OUTLIER -174.86 123.67 0.25 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.163 -0.471 . . . . 75.319999999999993 110.899 179.994 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.62 ' CG ' ' HA ' ' A' ' 94' ' ' TYR . 0.0 OUTLIER -91.86 172.85 8.19 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.231 -0.441 . . . . 73.439999999999998 110.894 179.923 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -41.96 -47.25 5.2 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.696 -0.764 . . . . 73.340000000000003 112.466 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.894 HG11 ' CG1' ' A' ' 86' ' ' VAL . 5.2 t -148.87 142.54 18.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.819 0.342 . . . . 75.120000000000005 111.093 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' TRP . . . . . 0.712 ' HB3' ' CB ' ' A' ' 152' ' ' LEU . 25.0 t90 -149.43 148.17 29.13 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.142 -0.481 . . . . 73.25 110.925 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.683 HG12 HD13 ' A' ' 61' ' ' ILE . 20.3 mt -125.75 132.5 70.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.224 -0.444 . . . . 75.340000000000003 111.175 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.673 ' CE1' HG11 ' A' ' 170' ' ' VAL . 0.1 OUTLIER -100.84 152.98 19.87 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.169 -0.468 . . . . 63.049999999999997 110.866 179.981 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 0.502 ' CD2' ' HA ' ' A' ' 145' ' ' TYR . 0.8 OUTLIER -129.14 127.16 40.85 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.146 -0.479 . . . . 74.209999999999994 110.922 -179.832 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.632 ' O ' ' HB2' ' A' ' 171' ' ' GLN . 0.6 OUTLIER -61.63 -25.86 67.63 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.14 -0.482 . . . . 63.0 110.884 179.998 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.711 ' HB3' ' HD2' ' A' ' 143' ' ' PRO . 9.3 mp -114.64 173.07 3.09 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.659 0.742 . . . . 71.340000000000003 110.891 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' PRO . . . . . 0.735 ' O ' ' OG ' ' A' ' 172' ' ' SER . 53.8 Cg_endo -69.77 -90.34 0.0 OUTLIER 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.665 2.243 . . . . 73.319999999999993 112.349 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' ASN . . . . . 0.697 ' O ' ' N ' ' A' ' 146' ' ' ARG . 1.0 OUTLIER -51.88 97.73 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.247 -0.433 . . . . 73.299999999999997 110.903 179.993 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 145' ' ' TYR . . . . . 0.636 ' C ' ' O ' ' A' ' 144' ' ' ASN . 0.1 OUTLIER 12.46 53.19 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.215 -0.448 . . . . 74.120000000000005 110.883 -179.941 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 146' ' ' ARG . . . . . 0.697 ' N ' ' O ' ' A' ' 144' ' ' ASN . 20.7 mtt180 -120.4 173.54 7.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.175 -0.466 . . . . 72.400000000000006 110.851 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 79.83 179.51 52.42 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.712 -0.756 . . . . 74.340000000000003 112.49 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -74.02 146.58 43.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.799 0.333 . . . . 73.200000000000003 110.894 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 149' ' ' GLN . . . . . 0.644 ' CD ' HG21 ' A' ' 138' ' ' ILE . 16.8 mt-30 -85.92 153.86 21.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.455 . . . . 74.299999999999997 110.895 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' TYR . . . . . 0.601 ' HA ' ' HB2' ' A' ' 59' ' ' MET . 76.8 m-85 -135.12 122.3 21.51 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.191 -0.458 . . . . 72.439999999999998 110.964 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.708 ' HA ' HD11 ' A' ' 61' ' ' ILE . 33.5 tp -66.55 135.94 54.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.067 -0.515 . . . . 70.200000000000003 110.935 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.944 HD13 ' O ' ' A' ' 152' ' ' LEU . 0.0 OUTLIER -70.08 133.97 47.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.223 -0.444 . . . . 75.430000000000007 110.878 179.906 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -163.21 25.42 0.09 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.167 -0.469 . . . . 75.219999999999999 110.853 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.822 ' O ' HD13 ' A' ' 133' ' ' LEU . 0.1 OUTLIER -113.03 -169.42 1.48 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.15 -0.477 . . . . 74.409999999999997 110.888 179.993 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.809 ' CG ' HD22 ' A' ' 133' ' ' LEU . 0.6 OUTLIER -167.25 -122.06 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.245 -0.434 . . . . 74.219999999999999 110.925 179.866 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.693 ' HA ' ' HA ' ' A' ' 131' ' ' LYS . 0.7 OUTLIER -73.03 -1.26 16.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.241 -0.436 . . . . 75.150000000000006 110.832 179.976 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 157' ' ' TYR . . . . . 0.723 ' CE1' ' HA ' ' A' ' 154' ' ' LYS . 20.1 m-30 -27.26 141.03 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.195 -0.457 . . . . 73.409999999999997 110.892 -179.799 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 158' ' ' ARG . . . . . 0.561 ' O ' ' OG ' ' A' ' 129' ' ' SER . 9.9 ptp180 -107.62 -41.14 5.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.129 -0.487 . . . . 51.350000000000001 110.868 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -87.43 150.34 48.73 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.562 0.696 . . . . 55.310000000000002 110.902 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 160' ' ' PRO . . . . . 0.494 ' HB3' ' HB3' ' A' ' 168' ' ' PRO . 53.7 Cg_endo -69.8 -24.17 29.8 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.64 2.227 . . . . 75.219999999999999 112.371 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.613 HD12 ' H ' ' A' ' 161' ' ' ILE . 3.6 mp -69.25 -10.82 14.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.23 -0.441 . . . . 72.530000000000001 111.107 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.644 ' HB3' ' CD1' ' A' ' 157' ' ' TYR . 0.5 OUTLIER -75.79 -14.11 60.3 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.19 -0.459 . . . . 65.540000000000006 110.869 179.879 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 163' ' ' TRP . . . . . 0.43 ' CE3' ' HB3' ' A' ' 165' ' ' ALA . 24.8 t90 -88.69 -12.7 41.6 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.189 -0.459 . . . . 72.310000000000002 110.933 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 106.66 -37.03 4.03 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.751 -0.738 . . . . 42.520000000000003 112.487 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.43 ' HB3' ' CE3' ' A' ' 163' ' ' TRP . . . -77.1 126.77 31.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.796 0.331 . . . . 63.229999999999997 111.062 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 166' ' ' ALA . . . . . 0.4 ' C ' ' O ' ' A' ' 165' ' ' ALA . . . -37.56 -41.36 0.46 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 74.430000000000007 111.101 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 167' ' ' SER . . . . . 0.489 ' C ' ' H ' ' A' ' 169' ' ' ALA . 0.3 OUTLIER -130.28 155.64 80.6 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.66 0.743 . . . . 75.549999999999997 110.82 -179.778 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 168' ' ' PRO . . . . . 0.494 ' HB3' ' HB3' ' A' ' 160' ' ' PRO . 53.6 Cg_endo -69.78 27.29 0.18 Allowed 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.674 2.249 . . . . 72.140000000000001 112.312 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.489 ' H ' ' C ' ' A' ' 167' ' ' SER . . . -65.63 104.6 1.06 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.213 -0.449 . . . . 70.299999999999997 111.147 179.839 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.673 HG11 ' CE1' ' A' ' 139' ' ' PHE . 2.8 t -151.75 161.97 3.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.21 -0.45 . . . . 72.109999999999999 111.127 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 171' ' ' GLN . . . . . 0.632 ' HB2' ' O ' ' A' ' 141' ' ' GLU . 1.8 tm0? -109.4 -82.08 0.57 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.213 -0.449 . . . . 75.519999999999996 110.91 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 172' ' ' SER . . . . . 0.735 ' OG ' ' O ' ' A' ' 143' ' ' PRO . 21.6 p -130.87 176.22 8.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.208 -0.451 . . . . 52.399999999999999 110.831 -179.786 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 173' ' ' PHE . . . . . 0.469 ' HB3' ' CD1' ' A' ' 139' ' ' PHE . 32.2 p90 -144.31 173.78 11.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.114 -0.494 . . . . 74.439999999999998 110.885 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 174' ' ' ARG . . . . . 0.443 ' HG2' ' CE2' ' A' ' 140' ' ' TYR . 0.0 OUTLIER -147.4 141.36 25.9 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.152 -0.476 . . . . 75.140000000000001 110.88 -179.883 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 175' ' ' ARG . . . . . 0.494 HH12 HG12 ' A' ' 177' ' ' VAL . 0.0 OUTLIER -86.32 -177.23 6.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.18 -0.464 . . . . 73.230000000000004 110.909 -179.945 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 176' ' ' ILE . . . . . 0.483 HD11 HG13 ' A' ' 138' ' ' ILE . 2.9 mt -132.51 139.09 50.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.215 -0.448 . . . . 61.450000000000003 111.11 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.494 HG12 HH12 ' A' ' 175' ' ' ARG . 2.1 p -149.32 155.4 8.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.185 -0.461 . . . . 64.400000000000006 111.173 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.2 -0.455 . . . . 74.230000000000004 110.859 -179.96 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.817 0.342 . . . . 73.420000000000002 110.902 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 57.1 p -167.37 148.44 5.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.254 -0.43 . . . . 53.119999999999997 110.896 -179.788 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.493 ' HE2' HD11 ' A' ' 88' ' ' LEU . 29.7 mmtp -99.43 36.49 1.75 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.15 -0.477 . . . . 73.150000000000006 110.87 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 5.0 t -147.34 122.86 10.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.25 -0.432 . . . . 51.409999999999997 111.137 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 61.24 92.7 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.733 -0.746 . . . . 63.020000000000003 112.492 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.439 ' HB ' ' O ' ' A' ' 44' ' ' GLY . 12.2 p -82.23 133.11 35.24 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.839 0.352 . . . . 71.109999999999999 111.134 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 3.1 tttt -122.37 138.33 54.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.241 -0.436 . . . . 71.340000000000003 110.888 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.593 ' HB ' ' CD1' ' A' ' 47' ' ' TRP . 12.5 tt -136.64 149.75 26.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.233 -0.44 . . . . 70.310000000000002 111.142 179.883 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.521 HG22 ' CE2' ' A' ' 11' ' ' TYR . 24.8 m -133.62 129.13 36.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.181 -0.463 . . . . 71.200000000000003 111.139 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.867 ' HB2' HD22 ' A' ' 34' ' ' LEU . 0.4 OUTLIER -117.3 131.89 56.72 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.208 -0.451 . . . . 75.299999999999997 110.845 -179.977 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.538 ' CG ' ' HA ' ' A' ' 16' ' ' PHE . 44.1 m-85 -114.95 132.35 56.6 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.138 -0.483 . . . . 74.25 110.94 -179.834 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.477 ' HG2' ' HB2' ' A' ' 36' ' ' ARG . 0.0 OUTLIER -61.98 -24.63 67.14 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.162 -0.472 . . . . 70.540000000000006 110.876 -179.949 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 65.7 m-20 -126.12 150.42 48.25 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.16 -0.473 . . . . 72.310000000000002 110.836 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.537 ' N ' ' HB3' ' A' ' 38' ' ' ASN . 4.6 mtmm -55.04 -179.83 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.189 -0.46 . . . . 75.519999999999996 110.866 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 52.0 m-80 49.38 38.46 14.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.233 -0.44 . . . . 53.25 110.889 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.538 ' HA ' ' CG ' ' A' ' 11' ' ' TYR . 3.4 m-85 45.14 60.17 3.13 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.17 -0.468 . . . . 63.520000000000003 110.859 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -136.46 160.06 39.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.142 -0.481 . . . . 63.43 110.906 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 92.84 -150.99 20.26 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.751 -0.738 . . . . 50.200000000000003 112.518 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.767 ' O ' HD13 ' A' ' 34' ' ' LEU . 0.0 OUTLIER -67.49 79.62 0.17 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.812 0.339 . . . . 71.230000000000004 110.905 -179.888 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.44 ' HB2' ' CE1' ' A' ' 11' ' ' TYR . 0.7 OUTLIER -78.95 125.9 29.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 63.409999999999997 110.857 -179.897 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.483 ' CD2' ' CD2' ' A' ' 30' ' ' PHE . 82.4 t80 -121.18 124.35 44.5 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.182 -0.463 . . . . 75.140000000000001 110.905 -179.841 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.441 ' CG ' HG23 ' A' ' 9' ' ' THR . 1.0 OUTLIER -119.22 134.62 55.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.131 -0.486 . . . . 70.540000000000006 110.885 179.877 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -166.75 135.71 2.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.231 -0.44 . . . . 72.510000000000005 110.851 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -105.07 5.72 32.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.187 -0.461 . . . . 72.140000000000001 110.882 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 12.1 t -108.73 168.38 9.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.168 -0.469 . . . . 53.43 110.886 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 78.8 m-20 -64.64 116.72 6.5 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.232 -0.44 . . . . 74.340000000000003 110.887 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.477 ' HB2' ' HB3' ' A' ' 30' ' ' PHE . 7.4 m -119.42 54.4 0.99 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.203 -0.453 . . . . 74.510000000000005 110.872 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.539 ' C ' ' HA ' ' A' ' 82' ' ' SER . . . -45.88 -20.28 0.08 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.183 -0.462 . . . . 72.329999999999998 111.095 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.406 ' N ' ' C ' ' A' ' 27' ' ' CYS . 59.7 t0 -128.32 43.56 3.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.224 -0.444 . . . . 75.409999999999997 110.879 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.776 ' CD2' ' O ' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -80.97 14.72 2.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.174 -0.466 . . . . 74.019999999999996 110.884 -179.873 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.489 ' HB2' ' HB3' ' A' ' 53' ' ' PRO . 27.6 t60 -77.72 -38.66 46.7 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.159 -0.473 . . . . 74.230000000000004 110.845 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.6 t -58.22 -12.57 3.73 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.208 -0.451 . . . . 73.230000000000004 111.121 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -101.48 -28.37 12.6 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.18 -0.464 . . . . 75.450000000000003 110.941 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.867 HD22 ' HB2' ' A' ' 10' ' ' PHE . 16.0 tp -141.15 141.7 34.12 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.149 -0.478 . . . . 72.010000000000005 110.927 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -111.57 -31.11 7.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.187 -0.46 . . . . 70.209999999999994 110.908 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.485 ' O ' HD21 ' A' ' 34' ' ' LEU . 1.6 mtp85 -116.78 142.41 46.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.092 -0.504 . . . . 74.219999999999999 110.845 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.643 ' SG ' ' HB2' ' A' ' 80' ' ' LEU . 1.8 p -118.99 51.44 1.12 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.188 -0.46 . . . . 72.340000000000003 110.864 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.537 ' HB3' ' N ' ' A' ' 14' ' ' LYS . 1.9 m-80 -52.35 -62.68 1.48 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.165 -0.471 . . . . 54.140000000000001 110.896 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.433 ' HB2' ' HA ' ' A' ' 68' ' ' PRO . 9.3 p -121.8 127.78 50.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.201 -0.454 . . . . 75.010000000000005 110.809 -179.815 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.592 HG21 HD13 ' A' ' 62' ' ' LEU . 4.5 mt -127.15 148.59 31.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.124 -0.489 . . . . 65.010000000000005 111.135 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.46 122.0 15.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.17 -0.468 . . . . 74.129999999999995 110.863 179.84 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.585 ' CG2' HD12 ' A' ' 8' ' ' ILE . 0.9 OUTLIER -103.92 117.43 49.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.189 -0.459 . . . . 62.43 111.145 179.876 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -112.44 81.14 1.43 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.223 -0.444 . . . . 73.239999999999995 110.89 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.439 ' O ' ' HB ' ' A' ' 6' ' ' THR . . . 130.63 100.02 0.86 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.736 -0.745 . . . . 71.129999999999995 112.534 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 55.21 175.85 0.14 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.712 -0.756 . . . . 64.420000000000002 112.491 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.75 HG23 ' HA ' ' A' ' 63' ' ' PRO . 5.9 m -80.29 165.99 21.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.812 0.339 . . . . 65.540000000000006 111.137 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.593 ' CD1' ' HB ' ' A' ' 8' ' ' ILE . 14.6 m95 -136.76 129.94 31.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.208 -0.451 . . . . 62.409999999999997 110.909 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.656 ' HB2' ' CG2' ' A' ' 86' ' ' VAL . . . -97.46 114.06 25.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.456 . . . . 72.019999999999996 111.111 179.843 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.921 HG11 HD11 ' A' ' 80' ' ' LEU . 5.1 m -116.8 134.04 61.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.243 -0.435 . . . . 70.140000000000001 111.151 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.741 ' HB3' ' HA ' ' A' ' 56' ' ' ALA . 35.1 m-85 -97.07 151.86 19.33 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.185 -0.461 . . . . 72.319999999999993 110.954 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.59 ' HB2' ' O ' ' A' ' 58' ' ' TYR . 8.8 tt0 -47.76 -78.84 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.143 -0.48 . . . . 55.0 110.892 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.618 ' HB3' ' CD1' ' A' ' 55' ' ' PHE . 4.7 mtp180 -90.25 143.95 30.33 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.656 0.741 . . . . 64.099999999999994 110.826 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.756 ' HA ' ' OG ' ' A' ' 82' ' ' SER . 53.9 Cg_endo -69.75 134.56 28.29 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.66 2.24 . . . . 62.509999999999998 112.372 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 66.2 -8.55 0.34 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.233 -0.439 . . . . 74.209999999999994 110.847 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.618 ' CD1' ' HB3' ' A' ' 52' ' ' ARG . 4.6 m-30 -101.75 -26.81 13.35 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.216 -0.447 . . . . 54.329999999999998 110.919 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.741 ' HA ' ' HB3' ' A' ' 50' ' ' TYR . . . 58.71 22.87 10.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.145 -0.479 . . . . 75.239999999999995 111.109 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' TRP . . . . . 0.645 ' O ' ' C ' ' A' ' 58' ' ' TYR . 2.4 m95 -52.17 -165.89 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.251 -0.432 . . . . 64.530000000000001 110.925 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.645 ' C ' ' O ' ' A' ' 57' ' ' TRP . 6.5 m-30 -12.46 103.62 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.231 -0.441 . . . . 74.310000000000002 110.936 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.523 ' HB2' ' O ' ' A' ' 149' ' ' GLN . 2.5 mpt? -62.29 147.48 47.99 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.128 -0.487 . . . . 73.040000000000006 110.903 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.617 ' O ' HG23 ' A' ' 49' ' ' VAL . 0.3 OUTLIER -164.29 92.27 0.64 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.236 -0.438 . . . . 74.209999999999994 110.865 -179.88 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.716 ' N ' HD12 ' A' ' 61' ' ' ILE . 1.6 mp -85.06 120.2 35.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.154 -0.475 . . . . 61.539999999999999 111.117 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.817 HD23 ' HD2' ' A' ' 63' ' ' PRO . 0.3 OUTLIER -87.55 126.15 62.96 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-O 121.658 0.742 . . . . 72.450000000000003 110.878 179.91 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.817 ' HD2' HD23 ' A' ' 62' ' ' LEU . 53.5 Cg_endo -69.83 -168.03 0.26 Allowed 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.684 2.256 . . . . 70.430000000000007 112.307 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.05 161.12 14.57 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.24 -0.437 . . . . 62.549999999999997 110.931 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 111.66 -157.52 14.9 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.775 -0.726 . . . . 64.409999999999997 112.507 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 5.3 mp0 -115.0 158.75 21.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.85 0.357 . . . . 64.400000000000006 110.904 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.472 ' N ' ' O ' ' A' ' 40' ' ' ILE . 7.2 m-85 -149.52 79.73 7.93 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 121.676 0.75 . . . . 75.230000000000004 110.976 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.532 ' HD2' ' HG3' ' A' ' 72' ' ' ARG . 53.6 Cg_endo -69.81 1.11 4.77 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.7 2.266 . . . . 65.439999999999998 112.29 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 86.3 mt-10 -159.15 154.36 25.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.25 -0.432 . . . . 74.329999999999998 110.903 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.836 ' O ' ' CD1' ' A' ' 73' ' ' TRP . 25.6 p90 -65.39 -12.19 49.75 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.135 -0.484 . . . . 75.519999999999996 110.949 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -86.75 -13.65 44.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.127 -0.488 . . . . 64.239999999999995 110.878 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.532 ' HG3' ' HD2' ' A' ' 68' ' ' PRO . 24.1 mmt180 -73.58 -27.09 61.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.221 -0.445 . . . . 74.219999999999999 110.919 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' TRP . . . . . 0.836 ' CD1' ' O ' ' A' ' 70' ' ' TYR . 0.6 OUTLIER -105.97 11.22 31.9 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.157 -0.474 . . . . 75.239999999999995 110.957 179.979 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.506 ' C ' ' O ' ' A' ' 73' ' ' TRP . 0.4 OUTLIER 29.19 56.76 0.13 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.212 -0.449 . . . . 74.219999999999999 110.849 179.909 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.609 ' HA3' ' OH ' ' A' ' 60' ' ' TYR . . . -96.92 -140.27 11.19 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.733 -0.746 . . . . 63.130000000000003 112.51 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.758 HD21 ' HA ' ' A' ' 148' ' ' ARG . 0.0 OUTLIER -141.95 -84.1 0.19 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.831 0.348 . . . . 71.450000000000003 110.905 -179.946 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 -77.47 145.85 36.81 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.465 . . . . 63.109999999999999 110.915 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 -101.44 33.29 2.98 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.198 -0.456 . . . . 51.409999999999997 110.858 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -104.78 72.13 1.01 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.208 -0.451 . . . . 63.130000000000003 110.874 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.921 HD11 HG11 ' A' ' 49' ' ' VAL . 0.1 OUTLIER -77.83 130.25 36.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.162 -0.472 . . . . 74.540000000000006 110.906 -179.955 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.609 ' HB3' ' HB3' ' A' ' 53' ' ' PRO . 0.9 OUTLIER -146.92 -127.93 0.06 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.218 -0.446 . . . . 63.030000000000001 110.874 -179.929 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.756 ' OG ' ' HA ' ' A' ' 53' ' ' PRO . 0.7 OUTLIER -27.58 123.49 0.1 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.117 -0.492 . . . . 75.439999999999998 110.872 -179.845 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 83' ' ' CYS . . . . . 0.53 ' CB ' HG12 ' A' ' 49' ' ' VAL . 5.4 p -131.14 143.06 50.35 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.146 -0.479 . . . . 74.25 110.87 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.483 ' N ' ' O ' ' A' ' 48' ' ' ALA . 5.7 mmt85 -140.59 131.37 25.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.189 -0.459 . . . . 62.420000000000002 110.9 -179.843 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.412 ' N ' ' CZ3' ' A' ' 47' ' ' TRP . . . -56.27 123.88 16.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.22 -0.446 . . . . 74.319999999999993 111.043 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.965 HG11 HG11 ' A' ' 136' ' ' VAL . 1.9 t -115.93 143.31 26.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.21 -0.45 . . . . 62.409999999999997 111.113 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' HIS . . . . . 0.572 ' O ' ' CG2' ' A' ' 136' ' ' VAL . 34.9 m80 -111.23 106.45 15.44 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.184 -0.462 . . . . 73.409999999999997 110.878 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.501 ' H ' HD23 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -31.64 150.17 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.659 0.742 . . . . 73.439999999999998 110.909 -179.975 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.58 ' HB3' ' H ' ' A' ' 136' ' ' VAL . 53.5 Cg_endo -69.77 83.39 0.7 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.674 2.249 . . . . 53.210000000000001 112.326 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -88.76 -173.35 4.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.188 -0.46 . . . . 73.329999999999998 110.832 -179.834 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 51.26 58.49 9.69 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.761 -0.733 . . . . 73.120000000000005 112.439 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 117.68 26.22 2.89 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.724 -0.751 . . . . 73.030000000000001 112.454 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 27.5 pt20 39.56 -148.57 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.826 0.346 . . . . 73.409999999999997 110.916 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.506 ' HA ' ' HG2' ' A' ' 134' ' ' GLU . 8.2 t80 -98.79 101.02 12.29 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.26 -0.427 . . . . 75.549999999999997 110.906 -179.838 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.429 ' HG3' HG11 ' A' ' 132' ' ' VAL . 38.2 tptt -107.91 130.34 55.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.126 -0.488 . . . . 62.299999999999997 110.896 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 4.2 tt -147.36 137.72 17.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.238 -0.437 . . . . 73.219999999999999 111.131 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.517 ' HB2' HG23 ' A' ' 132' ' ' VAL . 0.5 OUTLIER -109.92 113.35 26.01 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.211 -0.449 . . . . 74.010000000000005 110.942 179.905 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.578 HD11 HG22 ' A' ' 111' ' ' THR . 2.7 mp -93.66 136.17 26.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.163 -0.471 . . . . 75.0 111.15 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.646 ' HB2' ' HB2' ' A' ' 129' ' ' SER . 53.2 m-85 -124.73 140.1 53.24 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.194 -0.457 . . . . 70.519999999999996 110.855 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 64.6 tt0 -69.68 -75.17 0.12 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.148 -0.478 . . . . 70.140000000000001 110.889 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 16.5 mttt -84.51 170.41 13.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.138 -0.483 . . . . 73.349999999999994 110.893 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.441 ' CA ' ' HB3' ' A' ' 128' ' ' HIS . . . -73.73 159.62 53.1 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.724 -0.75 . . . . 72.010000000000005 112.478 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.486 ' HA ' ' HB2' ' A' ' 158' ' ' ARG . 60.9 t0 64.17 37.18 9.04 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.819 0.342 . . . . 73.409999999999997 110.844 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.57 ' CZ ' ' HB3' ' A' ' 158' ' ' ARG . 5.0 m-85 51.66 45.19 28.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.192 -0.458 . . . . 73.239999999999995 110.89 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 5.1 m -112.45 148.87 33.48 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.112 -0.495 . . . . 64.299999999999997 110.865 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 95.34 -132.5 11.13 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.776 -0.726 . . . . 63.030000000000001 112.519 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 6.9 tp-100 -91.68 126.11 36.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.813 0.339 . . . . 61.240000000000002 110.948 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' MET . . . . . 0.459 ' HB2' ' CE1' ' A' ' 99' ' ' PHE . 4.8 ttt -113.55 131.56 56.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.168 -0.469 . . . . 71.439999999999998 110.849 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -136.26 136.38 39.79 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.215 -0.448 . . . . 64.120000000000005 110.93 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -118.37 109.2 16.0 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.115 -0.493 . . . . 65.319999999999993 110.896 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.578 HG22 HD11 ' A' ' 98' ' ' ILE . 14.1 t -123.46 145.68 48.63 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.132 -0.486 . . . . 65.439999999999998 111.18 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.474 ' O ' ' OG1' ' A' ' 112' ' ' THR . 0.8 OUTLIER -118.2 38.31 3.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.249 -0.432 . . . . 54.450000000000003 111.133 -179.944 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -150.94 170.43 19.35 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.228 -0.442 . . . . 72.019999999999996 110.898 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 -65.79 176.11 1.7 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.201 -0.454 . . . . 71.329999999999998 110.868 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 46.6 t -156.01 122.62 2.64 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.599 0.714 . . . . 52.539999999999999 110.891 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.475 ' C ' ' OG ' ' A' ' 172' ' ' SER . 54.0 Cg_endo -69.79 -31.24 20.76 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.646 2.23 . . . . 52.229999999999997 112.338 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.662 ' HB3' ' CB ' ' A' ' 120' ' ' GLU . 0.1 OUTLIER -152.99 92.97 1.69 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.222 -0.445 . . . . 43.439999999999998 110.872 -179.86 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.679 ' HB ' ' O ' ' A' ' 171' ' ' GLN . 5.0 tt -49.01 -28.78 2.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.157 -0.474 . . . . 74.019999999999996 111.155 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' MET . . . . . 0.581 ' O ' ' HA ' ' A' ' 123' ' ' HIS . 15.7 ttp -86.36 -45.19 11.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.186 -0.461 . . . . 74.549999999999997 110.848 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.662 ' CB ' ' HB3' ' A' ' 117' ' ' SER . 10.1 tp10 -66.75 -13.37 61.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.232 -0.44 . . . . 61.5 110.875 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -114.52 -51.9 2.73 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.185 -0.461 . . . . 74.140000000000001 110.897 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.48 ' HB2' ' O ' ' A' ' 118' ' ' ILE . 14.6 m-85 -101.89 -18.67 15.6 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.24 -0.437 . . . . 73.329999999999998 110.935 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' HIS . . . . . 0.581 ' HA ' ' O ' ' A' ' 119' ' ' MET . 16.6 m80 68.42 32.72 4.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.078 -0.51 . . . . 74.140000000000001 110.892 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.483 ' SD ' HG22 ' A' ' 98' ' ' ILE . 9.3 mtt -111.04 84.62 1.96 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.183 -0.462 . . . . 63.32 110.819 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 3.9 ptp180 -52.93 -34.87 57.41 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.23 -0.441 . . . . 63.329999999999998 110.884 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.475 ' HG2' ' HA ' ' A' ' 169' ' ' ALA . 35.0 mt-10 -142.34 128.77 20.1 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.192 -0.458 . . . . 74.040000000000006 110.864 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.545 HD11 HD13 ' A' ' 118' ' ' ILE . 4.1 mm -87.89 101.16 11.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.146 -0.479 . . . . 74.129999999999995 111.159 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' HIS . . . . . 0.441 ' HB3' ' CA ' ' A' ' 102' ' ' GLY . 22.3 m80 -69.65 -35.24 75.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.165 -0.471 . . . . 72.450000000000003 110.861 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.646 ' HB2' ' HB2' ' A' ' 99' ' ' PHE . 6.2 m -135.4 152.2 51.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.255 -0.43 . . . . 72.109999999999999 110.87 -179.803 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' CYS . . . . . 0.498 ' HB2' ' CH2' ' A' ' 163' ' ' TRP . 0.0 OUTLIER -156.22 118.24 3.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.144 -0.48 . . . . 70.049999999999997 110.901 -179.934 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.523 ' C ' HG23 ' A' ' 132' ' ' VAL . 3.7 mtpp -105.66 161.2 14.59 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.182 -0.463 . . . . 74.5 110.875 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.572 HG12 ' N ' ' A' ' 133' ' ' LEU . 16.0 t 86.03 165.97 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.469 . . . . 21.52 111.154 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.657 HD13 ' CE ' ' A' ' 155' ' ' LYS . 1.0 OUTLIER -166.2 131.19 2.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.182 -0.463 . . . . 74.109999999999999 110.895 179.941 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.506 ' HG2' ' HA ' ' A' ' 94' ' ' TYR . 0.8 OUTLIER -105.29 147.72 27.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.192 -0.458 . . . . 72.230000000000004 110.9 179.921 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.483 ' C ' ' O ' ' A' ' 134' ' ' GLU . . . -31.37 -45.63 0.14 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.746 -0.74 . . . . 25.32 112.508 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.982 ' HB ' HD12 ' A' ' 176' ' ' ILE . 0.7 OUTLIER -149.94 135.6 11.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.823 0.344 . . . . 75.310000000000002 111.116 -179.98 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 137' ' ' TRP . . . . . 0.647 ' HB3' ' CB ' ' A' ' 152' ' ' LEU . 24.0 t90 -150.14 149.59 30.46 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.131 -0.486 . . . . 72.409999999999997 110.92 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.415 ' HA ' ' O ' ' A' ' 150' ' ' TYR . 16.6 mt -124.17 132.04 71.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.275 -0.421 . . . . 71.510000000000005 111.118 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.759 ' CE2' HG11 ' A' ' 170' ' ' VAL . 0.1 OUTLIER -99.09 139.13 35.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.167 -0.47 . . . . 74.329999999999998 110.884 179.966 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 0.495 ' CD2' ' HA ' ' A' ' 145' ' ' TYR . 0.1 OUTLIER -110.59 126.86 54.89 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.159 -0.473 . . . . 74.230000000000004 110.914 -179.843 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.564 ' O ' ' HB2' ' A' ' 171' ' ' GLN . 26.6 tt0 -66.08 -27.83 68.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.101 -0.5 . . . . 71.239999999999995 110.886 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.601 ' HB3' ' HD2' ' A' ' 143' ' ' PRO . 9.9 mp -109.73 169.71 6.13 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.632 0.729 . . . . 73.450000000000003 110.929 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 143' ' ' PRO . . . . . 0.718 ' O ' ' HB2' ' A' ' 172' ' ' SER . 53.5 Cg_endo -69.73 -89.15 0.0 OUTLIER 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.713 2.276 . . . . 72.409999999999997 112.338 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 144' ' ' ASN . . . . . 0.73 ' O ' ' N ' ' A' ' 146' ' ' ARG . 1.1 m-20 -48.43 96.43 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.218 -0.446 . . . . 75.129999999999995 110.924 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' TYR . . . . . 0.636 ' C ' ' O ' ' A' ' 144' ' ' ASN . 20.1 m-85 12.54 51.6 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.191 -0.459 . . . . 72.409999999999997 110.905 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 146' ' ' ARG . . . . . 0.73 ' N ' ' O ' ' A' ' 144' ' ' ASN . 11.4 mtp85 -127.01 178.62 5.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.132 -0.485 . . . . 72.310000000000002 110.876 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 86.78 167.16 43.39 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.73 -0.747 . . . . 61.350000000000001 112.469 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.758 ' HA ' HD21 ' A' ' 76' ' ' LEU . 2.8 mpt_? -65.48 142.18 58.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.796 0.331 . . . . 71.120000000000005 110.86 -179.857 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 149' ' ' GLN . . . . . 0.523 ' O ' ' HB2' ' A' ' 59' ' ' MET . 51.4 mt-30 -81.29 155.57 25.98 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.173 -0.467 . . . . 64.140000000000001 110.907 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 150' ' ' TYR . . . . . 0.524 ' HB2' ' CB ' ' A' ' 139' ' ' PHE . 95.9 m-85 -138.29 123.01 18.71 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.231 -0.44 . . . . 74.420000000000002 110.924 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.559 ' HB2' HD11 ' A' ' 61' ' ' ILE . 21.3 tp -64.66 132.7 50.42 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.101 -0.499 . . . . 64.109999999999999 110.97 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.918 HD13 ' O ' ' A' ' 152' ' ' LEU . 0.0 OUTLIER -68.45 133.29 48.41 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.218 -0.446 . . . . 73.239999999999995 110.906 179.912 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -163.28 25.95 0.09 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.147 -0.479 . . . . 74.450000000000003 110.907 179.843 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.743 ' HA ' ' CE1' ' A' ' 157' ' ' TYR . 0.0 OUTLIER -108.89 -173.86 2.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.148 -0.478 . . . . 71.129999999999995 110.872 -179.99 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.657 ' CE ' HD13 ' A' ' 133' ' ' LEU . 4.0 mptt -164.93 -124.43 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.218 -0.446 . . . . 74.349999999999994 110.911 179.827 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.504 ' HA ' ' HA ' ' A' ' 131' ' ' LYS . 4.4 tm-20 -71.5 1.37 6.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.223 -0.444 . . . . 71.519999999999996 110.851 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 157' ' ' TYR . . . . . 0.743 ' CE1' ' HA ' ' A' ' 154' ' ' LYS . 21.3 m-30 -31.23 143.81 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.191 -0.459 . . . . 70.25 110.938 -179.836 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 158' ' ' ARG . . . . . 0.57 ' HB3' ' CZ ' ' A' ' 104' ' ' PHE . 0.0 OUTLIER -115.35 -40.68 3.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.128 -0.487 . . . . 54.32 110.897 -179.989 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 159' ' ' LYS . . . . . 0.472 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 0.2 OUTLIER -81.01 150.89 69.59 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.553 0.692 . . . . 73.340000000000003 110.918 179.966 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 160' ' ' PRO . . . . . 0.565 ' HA ' ' NE1' ' A' ' 163' ' ' TRP . 53.5 Cg_endo -69.78 -27.47 26.35 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.655 2.237 . . . . 74.310000000000002 112.346 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.65 HD12 ' H ' ' A' ' 161' ' ' ILE . 3.8 mp -67.21 -3.5 2.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.236 -0.438 . . . . 73.540000000000006 111.114 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.654 ' HB3' ' CD1' ' A' ' 157' ' ' TYR . 0.3 OUTLIER -76.61 -23.21 53.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.215 -0.448 . . . . 71.329999999999998 110.876 179.818 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 163' ' ' TRP . . . . . 0.565 ' NE1' ' HA ' ' A' ' 160' ' ' PRO . 1.7 m95 -79.96 -1.37 39.19 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.198 -0.455 . . . . 74.239999999999995 110.931 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 92.46 -35.22 4.12 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.728 -0.749 . . . . 74.25 112.475 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.415 ' O ' ' C ' ' A' ' 166' ' ' ALA . . . -77.37 129.2 35.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.826 0.346 . . . . 71.310000000000002 111.091 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 166' ' ' ALA . . . . . 0.415 ' C ' ' O ' ' A' ' 165' ' ' ALA . . . -37.08 -40.08 0.28 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.224 -0.443 . . . . 65.120000000000005 111.117 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 167' ' ' SER . . . . . 0.479 ' C ' ' H ' ' A' ' 169' ' ' ALA . 0.3 OUTLIER -129.29 157.32 76.53 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.61 0.719 . . . . 74.150000000000006 110.867 -179.767 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 168' ' ' PRO . . . . . 0.517 ' HD3' ' HB2' ' A' ' 160' ' ' PRO . 53.4 Cg_endo -69.73 29.07 0.18 Allowed 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.667 2.245 . . . . 34.219999999999999 112.324 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.479 ' H ' ' C ' ' A' ' 167' ' ' SER . . . -66.01 106.58 1.63 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.244 -0.435 . . . . 62.119999999999997 111.094 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.759 HG11 ' CE2' ' A' ' 139' ' ' PHE . 3.3 t -152.08 165.92 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.224 -0.444 . . . . 72.430000000000007 111.083 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 171' ' ' GLN . . . . . 0.679 ' O ' ' HB ' ' A' ' 118' ' ' ILE . 2.6 mm-40 -123.72 -87.11 0.63 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.142 -0.481 . . . . 63.25 110.884 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 172' ' ' SER . . . . . 0.718 ' HB2' ' O ' ' A' ' 143' ' ' PRO . 3.1 m -111.11 175.65 5.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.174 -0.466 . . . . 61.340000000000003 110.897 -179.804 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 173' ' ' PHE . . . . . 0.452 ' HB3' ' CD2' ' A' ' 139' ' ' PHE . 1.8 p90 -147.94 158.58 44.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.168 -0.469 . . . . 71.420000000000002 110.899 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 174' ' ' ARG . . . . . 0.429 ' HG2' ' CD2' ' A' ' 140' ' ' TYR . 0.0 OUTLIER -133.93 139.75 46.34 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.12 -0.491 . . . . 73.340000000000003 110.837 -179.857 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -95.38 -170.08 2.1 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.177 -0.465 . . . . 70.519999999999996 110.851 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 176' ' ' ILE . . . . . 0.982 HD12 ' HB ' ' A' ' 136' ' ' VAL . 3.3 mt -139.21 135.79 41.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.145 -0.479 . . . . 72.439999999999998 111.16 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 25.9 t -148.8 150.11 14.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.192 -0.458 . . . . 70.329999999999998 111.1 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.259 0 CA-C-N 116.134 -0.484 . . . . 74.120000000000005 110.936 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.79 0.329 . . . . 74.420000000000002 110.903 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -169.96 175.83 4.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.231 -0.441 . . . . 53.0 110.879 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 3.0 mtpm? -73.84 -36.75 64.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.151 -0.477 . . . . 74.109999999999999 110.879 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 8.8 t -51.83 -36.2 47.28 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.265 -0.425 . . . . 75.0 111.131 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -118.44 101.51 0.9 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.75 -0.738 . . . . 71.319999999999993 112.462 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.515 ' C ' ' HE1' ' A' ' 47' ' ' TRP . 11.2 p -82.58 133.1 35.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.882 0.372 . . . . 62.130000000000003 111.122 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 3.5 tttt -121.15 137.65 54.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.242 -0.435 . . . . 65.25 110.895 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.617 HD12 ' CG2' ' A' ' 42' ' ' VAL . 11.6 tt -137.33 149.41 25.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.209 -0.451 . . . . 71.099999999999994 111.166 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.525 HG22 ' CE2' ' A' ' 11' ' ' TYR . 24.5 m -131.74 129.02 40.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.178 -0.464 . . . . 61.340000000000003 111.133 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.818 ' HB2' HD22 ' A' ' 34' ' ' LEU . 0.6 OUTLIER -116.15 132.35 56.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.16 -0.473 . . . . 71.340000000000003 110.875 -179.957 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.556 ' CG ' ' HA ' ' A' ' 16' ' ' PHE . 49.1 m-85 -116.01 131.92 56.8 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.16 -0.473 . . . . 73.230000000000004 110.966 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.481 ' HG2' ' HB2' ' A' ' 36' ' ' ARG . 0.0 OUTLIER -60.7 -25.73 66.61 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 74.340000000000003 110.92 179.987 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 -125.96 151.23 47.28 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.114 -0.494 . . . . 75.099999999999994 110.855 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.441 ' HG3' ' HB3' ' A' ' 38' ' ' ASN . 19.7 mtmt -54.94 -178.21 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 62.240000000000002 110.936 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 24.7 m-20 47.68 38.72 8.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.256 -0.429 . . . . 62.409999999999997 110.894 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.556 ' HA ' ' CG ' ' A' ' 11' ' ' TYR . 3.0 m-85 44.71 60.48 2.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.15 -0.477 . . . . 60.32 110.885 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -135.97 158.78 43.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.088 -0.505 . . . . 74.120000000000005 110.882 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 93.47 -151.51 20.39 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.76 -0.733 . . . . 73.450000000000003 112.491 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.787 ' O ' HD13 ' A' ' 34' ' ' LEU . 0.3 OUTLIER -67.27 80.85 0.14 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.794 0.331 . . . . 74.239999999999995 110.937 -179.869 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.43 ' HA ' ' O ' ' A' ' 10' ' ' PHE . 0.7 OUTLIER -79.38 126.31 30.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.209 -0.45 . . . . 72.340000000000003 110.911 -179.89 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.478 ' CD2' ' CD2' ' A' ' 30' ' ' PHE . 85.9 t80 -121.46 124.03 43.47 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.221 -0.445 . . . . 74.409999999999997 110.909 -179.827 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.456 ' CG ' HG23 ' A' ' 9' ' ' THR . 1.0 OUTLIER -119.14 134.84 54.97 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.134 -0.485 . . . . 70.299999999999997 110.835 179.934 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -166.94 135.81 2.78 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.156 -0.474 . . . . 73.230000000000004 110.899 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -104.53 5.75 34.19 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 72.25 110.844 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 13.9 t -110.71 164.49 12.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.193 -0.458 . . . . 73.239999999999995 110.868 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -60.82 117.54 5.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.186 -0.461 . . . . 65.25 110.86 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.465 ' HB2' ' SG ' ' A' ' 83' ' ' CYS . 18.7 m -117.48 55.51 0.85 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.245 -0.434 . . . . 54.509999999999998 110.864 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.526 ' C ' ' HA ' ' A' ' 82' ' ' SER . . . -46.64 -19.14 0.08 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.208 -0.451 . . . . 53.520000000000003 111.158 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.402 ' N ' ' C ' ' A' ' 27' ' ' CYS . 52.4 t0 -128.71 42.14 3.37 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.212 -0.449 . . . . 65.140000000000001 110.872 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.805 ' CD2' ' O ' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -80.45 15.75 1.54 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.459 . . . . 74.150000000000006 110.864 -179.893 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.501 ' HB2' ' HB3' ' A' ' 81' ' ' SER . 33.2 t60 -80.65 -38.15 29.67 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.163 -0.471 . . . . 75.450000000000003 110.785 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.7 t -60.16 -12.52 8.77 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.245 -0.434 . . . . 62.020000000000003 111.137 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -101.34 -27.6 13.08 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.246 -0.434 . . . . 72.450000000000003 110.925 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.818 HD22 ' HB2' ' A' ' 10' ' ' PHE . 19.1 tp -141.94 140.53 32.8 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.133 -0.485 . . . . 71.310000000000002 110.888 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.1 m -109.07 -31.95 7.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.221 -0.445 . . . . 55.299999999999997 110.883 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.561 ' NH2' HD21 ' A' ' 38' ' ' ASN . 1.8 mtp85 -116.82 142.0 47.49 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.128 -0.487 . . . . 70.25 110.872 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.582 ' HB3' ' HB2' ' A' ' 80' ' ' LEU . 0.9 OUTLIER -118.37 52.09 1.05 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.22 -0.445 . . . . 61.450000000000003 110.869 -179.957 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.561 HD21 ' NH2' ' A' ' 36' ' ' ARG . 3.0 m120 -53.01 -70.78 0.08 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.203 -0.453 . . . . 73.409999999999997 110.866 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 8.7 p -112.86 128.42 56.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.203 -0.453 . . . . 74.239999999999995 110.887 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.659 HG21 HD13 ' A' ' 62' ' ' LEU . 5.4 mt -127.41 150.1 32.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.097 -0.501 . . . . 71.310000000000002 111.131 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.47 122.75 14.83 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.17 -0.468 . . . . 75.209999999999994 110.892 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.617 ' CG2' HD12 ' A' ' 8' ' ' ILE . 1.4 t -104.43 116.59 48.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.23 -0.441 . . . . 70.349999999999994 111.176 179.84 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -111.55 80.97 1.37 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.161 -0.472 . . . . 74.25 110.866 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.411 ' O ' ' HA ' ' A' ' 6' ' ' THR . . . 128.75 103.69 1.13 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.745 -0.74 . . . . 64.219999999999999 112.527 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.464 ' HA2' HD21 ' A' ' 88' ' ' LEU . . . 53.97 178.09 0.12 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.75 -0.738 . . . . 71.430000000000007 112.464 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.762 HG23 ' HA ' ' A' ' 63' ' ' PRO . 3.1 m -81.36 165.66 21.14 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.729 0.299 . . . . 74.310000000000002 111.177 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.598 ' CD1' ' HB ' ' A' ' 8' ' ' ILE . 6.2 m95 -139.86 130.09 25.22 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.216 -0.447 . . . . 73.510000000000005 110.925 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.842 ' HB2' ' CG2' ' A' ' 86' ' ' VAL . . . -95.12 129.01 42.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.203 -0.453 . . . . 65.540000000000006 111.152 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.788 HG12 ' HB3' ' A' ' 83' ' ' CYS . 14.1 m -127.47 127.27 68.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.233 -0.439 . . . . 74.510000000000005 111.115 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.756 ' HB3' ' HA ' ' A' ' 56' ' ' ALA . 45.8 m-85 -93.36 147.51 22.87 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.137 -0.483 . . . . 74.430000000000007 110.927 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.655 ' OE1' ' HB3' ' A' ' 57' ' ' TRP . 54.7 tt0 -48.5 -78.48 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.113 -0.494 . . . . 75.209999999999994 110.862 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.544 ' HB3' ' CD1' ' A' ' 55' ' ' PHE . 0.0 OUTLIER -92.98 143.81 27.41 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.652 0.739 . . . . 72.140000000000001 110.878 -179.907 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.769 ' HA ' ' OG ' ' A' ' 82' ' ' SER . 53.8 Cg_endo -69.75 141.59 45.67 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.688 2.259 . . . . 62.409999999999997 112.34 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 62.53 -10.98 0.08 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.19 -0.459 . . . . 74.310000000000002 110.876 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.614 ' H ' ' C ' ' A' ' 53' ' ' PRO . 2.6 m-30 -104.34 -20.19 13.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.455 . . . . 74.430000000000007 110.869 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.756 ' HA ' ' HB3' ' A' ' 50' ' ' TYR . . . 48.55 26.44 1.19 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.168 -0.469 . . . . 72.549999999999997 111.117 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' TRP . . . . . 0.655 ' HB3' ' OE1' ' A' ' 51' ' ' GLU . 0.0 OUTLIER -50.7 -159.98 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.233 -0.44 . . . . 72.329999999999998 110.919 -179.978 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.627 ' C ' ' O ' ' A' ' 57' ' ' TRP . 6.0 m-30 -15.5 103.84 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.213 -0.448 . . . . 71.409999999999997 110.914 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.468 ' HB2' ' O ' ' A' ' 149' ' ' GLN . 0.8 OUTLIER -62.44 145.14 54.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.124 -0.489 . . . . 73.140000000000001 110.892 179.891 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.646 ' O ' ' O ' ' A' ' 49' ' ' VAL . 0.4 OUTLIER -160.76 100.12 1.27 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.218 -0.447 . . . . 74.129999999999995 110.945 -179.89 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.796 ' N ' HD12 ' A' ' 61' ' ' ILE . 1.3 mp -94.22 117.17 37.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.101 -0.5 . . . . 54.43 111.157 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.741 HD23 ' HD2' ' A' ' 63' ' ' PRO . 0.4 OUTLIER -84.21 125.84 71.25 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.618 0.723 . . . . 61.240000000000002 110.92 179.928 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.762 ' HA ' HG23 ' A' ' 46' ' ' THR . 53.7 Cg_endo -69.68 -165.58 0.16 Allowed 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.68 2.253 . . . . 54.009999999999998 112.381 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.22 159.86 14.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.238 -0.437 . . . . 63.009999999999998 110.885 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 113.62 -149.95 18.58 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.791 -0.719 . . . . 60.420000000000002 112.495 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -122.94 160.36 26.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.859 0.362 . . . . 75.230000000000004 110.93 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.551 ' CE1' HD22 ' A' ' 62' ' ' LEU . 5.9 m-85 -150.05 79.1 7.78 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.668 0.747 . . . . 65.340000000000003 110.924 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.498 ' HD2' ' HG3' ' A' ' 72' ' ' ARG . 53.4 Cg_endo -69.81 0.48 5.62 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.721 2.281 . . . . 74.439999999999998 112.305 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 76.3 mt-10 -157.31 156.17 31.92 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.247 -0.433 . . . . 75.319999999999993 110.906 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.832 ' O ' ' CD1' ' A' ' 73' ' ' TRP . 11.7 p90 -68.35 -6.87 26.69 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.248 -0.433 . . . . 75.230000000000004 110.895 -179.851 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -87.12 -13.48 44.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.141 -0.481 . . . . 70.430000000000007 110.891 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.498 ' HG3' ' HD2' ' A' ' 68' ' ' PRO . 21.2 mmt180 -73.5 -24.64 60.2 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.224 -0.444 . . . . 70.209999999999994 110.891 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' TRP . . . . . 0.832 ' CD1' ' O ' ' A' ' 70' ' ' TYR . 0.5 OUTLIER -111.8 25.13 11.93 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.179 -0.464 . . . . 75.299999999999997 110.934 -179.975 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.552 ' CB ' ' O ' ' A' ' 73' ' ' TRP . 2.0 mmt 87.38 -38.47 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.248 -0.433 . . . . 75.140000000000001 110.927 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 88.93 45.83 4.7 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.724 -0.751 . . . . 53.32 112.495 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.595 HD21 ' HA ' ' A' ' 148' ' ' ARG . 0.4 OUTLIER -67.08 -74.95 0.1 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.837 0.351 . . . . 61.350000000000001 110.94 -179.957 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -129.28 136.13 49.66 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.188 -0.46 . . . . 71.530000000000001 110.859 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.424 ' C ' ' SG ' ' A' ' 37' ' ' CYS . 24.4 m-20 -90.35 18.54 6.0 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.187 -0.46 . . . . 72.310000000000002 110.858 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.406 ' HD2' ' HG2' ' A' ' 51' ' ' GLU . 0.6 OUTLIER -112.33 86.45 2.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.199 -0.455 . . . . 73.319999999999993 110.874 -179.914 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.806 HD12 ' CD1' ' A' ' 10' ' ' PHE . 0.0 OUTLIER -89.86 133.24 34.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.216 -0.447 . . . . 72.430000000000007 110.947 -179.992 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.641 ' HB3' ' HB3' ' A' ' 53' ' ' PRO . 0.8 OUTLIER -151.23 -127.93 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.203 -0.453 . . . . 62.409999999999997 110.875 -179.923 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.769 ' OG ' ' HA ' ' A' ' 53' ' ' PRO . 0.1 OUTLIER -33.98 102.16 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 62.509999999999998 110.847 -179.845 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 83' ' ' CYS . . . . . 0.788 ' HB3' HG12 ' A' ' 49' ' ' VAL . 30.2 p -118.82 133.35 55.9 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.125 -0.488 . . . . 75.299999999999997 110.882 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.599 ' N ' ' O ' ' A' ' 48' ' ' ALA . 13.7 mmt85 -119.94 144.25 47.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.228 -0.442 . . . . 73.019999999999996 110.862 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.419 ' N ' ' CZ3' ' A' ' 47' ' ' TRP . . . -63.61 127.66 32.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.178 -0.465 . . . . 64.120000000000005 111.095 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.842 ' CG2' ' HB2' ' A' ' 48' ' ' ALA . 46.7 t -115.78 137.86 48.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 74.120000000000005 111.113 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' HIS . . . . . 0.558 ' O ' HG23 ' A' ' 136' ' ' VAL . 34.0 m80 -111.58 112.82 24.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.205 -0.452 . . . . 74.219999999999999 110.825 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.471 ' H ' HD23 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -35.82 143.23 0.27 Allowed Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.594 0.712 . . . . 61.450000000000003 110.872 -179.967 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.58 ' HB3' ' H ' ' A' ' 136' ' ' VAL . 53.9 Cg_endo -69.81 78.62 1.01 Allowed 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.695 2.263 . . . . 64.150000000000006 112.334 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -78.03 -177.01 4.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.223 -0.444 . . . . 73.239999999999995 110.852 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 74.8 -97.46 1.0 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.736 -0.745 . . . . 60.229999999999997 112.466 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.411 ' O ' ' C ' ' A' ' 93' ' ' GLN . . . -90.29 44.61 2.94 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.779 -0.724 . . . . 72.239999999999995 112.496 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.469 ' O ' ' HG2' ' A' ' 134' ' ' GLU . 13.7 pt20 37.19 -122.17 0.19 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.876 0.37 . . . . 72.120000000000005 110.917 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.558 ' OH ' HG22 ' A' ' 177' ' ' VAL . 0.1 OUTLIER -121.41 103.59 9.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.196 -0.456 . . . . 72.140000000000001 110.934 -179.9 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.559 ' HG3' HG11 ' A' ' 132' ' ' VAL . 41.4 tptt -114.83 126.15 54.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.114 -0.494 . . . . 73.319999999999993 110.862 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 8.2 tt -147.57 137.94 17.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.23 -0.441 . . . . 74.120000000000005 111.127 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.487 ' HB2' HG23 ' A' ' 132' ' ' VAL . 0.6 OUTLIER -108.7 131.67 54.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.182 -0.463 . . . . 74.310000000000002 110.877 179.937 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.805 HG23 HG13 ' A' ' 127' ' ' ILE . 1.1 mp -115.64 134.5 58.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.455 . . . . 72.219999999999999 111.136 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.607 ' HB2' ' CB ' ' A' ' 129' ' ' SER . 7.1 m-85 -122.66 155.15 36.99 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.197 -0.456 . . . . 71.420000000000002 110.855 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.534 ' HA ' ' CE ' ' A' ' 124' ' ' MET . 56.6 tt0 -84.75 -44.0 13.74 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.183 -0.462 . . . . 71.239999999999995 110.854 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.468 ' HB2' ' C ' ' A' ' 105' ' ' SER . 55.9 mttt -117.61 155.0 30.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.182 -0.463 . . . . 62.039999999999999 110.894 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -73.82 169.48 53.57 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.757 -0.735 . . . . 73.530000000000001 112.436 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.44 ' HA ' ' HB2' ' A' ' 158' ' ' ARG . 36.9 t70 63.25 40.3 8.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.798 0.333 . . . . 65.439999999999998 110.814 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.623 ' CE1' ' HD2' ' A' ' 131' ' ' LYS . 11.6 m-85 54.89 49.27 18.16 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.25 -0.432 . . . . 54.140000000000001 110.867 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.468 ' C ' ' HB2' ' A' ' 101' ' ' LYS . 69.5 m -127.93 161.85 28.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.169 -0.469 . . . . 73.439999999999998 110.841 -179.825 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 83.04 -172.48 51.5 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.715 -0.755 . . . . 71.219999999999999 112.472 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 -67.62 120.59 14.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.78 0.324 . . . . 71.200000000000003 110.921 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 5.6 ttp -106.65 132.01 53.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.191 -0.459 . . . . 75.219999999999999 110.89 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -137.12 137.45 39.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.274 -0.421 . . . . 75.430000000000007 110.909 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -114.66 112.76 23.38 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.092 -0.504 . . . . 72.129999999999995 110.903 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 13.9 t -121.28 132.18 54.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.168 -0.469 . . . . 74.340000000000003 111.168 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.51 ' HA ' ' O ' ' A' ' 94' ' ' TYR . 1.8 t -112.29 37.1 3.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.246 -0.434 . . . . 72.150000000000006 111.129 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -151.03 165.43 33.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.229 -0.441 . . . . 63.409999999999997 110.857 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -53.11 161.22 0.88 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.142 -0.481 . . . . 74.349999999999994 110.83 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' CYS . . . . . 0.606 ' O ' ' HB2' ' A' ' 172' ' ' SER . 20.4 t -146.9 110.92 4.11 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.651 0.738 . . . . 75.099999999999994 110.882 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.512 ' O ' ' C ' ' A' ' 143' ' ' PRO . 53.6 Cg_endo -69.82 -38.6 7.45 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.647 2.231 . . . . 74.400000000000006 112.309 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.617 ' HB3' ' CB ' ' A' ' 120' ' ' GLU . 0.1 OUTLIER -147.28 105.41 3.75 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.238 -0.437 . . . . 75.230000000000004 110.839 -179.839 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.614 ' HB ' ' O ' ' A' ' 171' ' ' GLN . 3.4 tt -58.07 -27.94 32.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.125 -0.489 . . . . 54.219999999999999 111.118 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' MET . . . . . 0.684 ' O ' ' HA ' ' A' ' 123' ' ' HIS . 8.6 ttp -86.77 -40.57 14.86 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.17 -0.468 . . . . 73.329999999999998 110.875 179.852 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.617 ' CB ' ' HB3' ' A' ' 117' ' ' SER . 14.7 tp10 -70.52 -13.52 62.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.264 -0.426 . . . . 72.310000000000002 110.879 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 7.6 tp-100 -116.25 -50.71 2.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.152 -0.477 . . . . 73.150000000000006 110.944 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.482 ' HB2' ' O ' ' A' ' 118' ' ' ILE . 46.8 m-85 -101.26 -13.85 17.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.222 -0.445 . . . . 74.530000000000001 110.917 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' HIS . . . . . 0.684 ' HA ' ' O ' ' A' ' 119' ' ' MET . 27.9 m-70 69.16 24.86 5.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.125 -0.488 . . . . 64.239999999999995 110.828 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.534 ' CE ' ' HA ' ' A' ' 100' ' ' GLU . 0.9 OUTLIER -96.47 145.24 25.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.248 -0.433 . . . . 71.329999999999998 110.891 179.975 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 5.1 ptp180 -110.62 -40.91 4.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.249 -0.432 . . . . 74.310000000000002 110.862 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.442 ' HB3' ' HG2' ' A' ' 168' ' ' PRO . 17.6 mt-10 -141.05 116.13 9.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.205 -0.452 . . . . 70.510000000000005 110.864 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.805 HG13 HG23 ' A' ' 98' ' ' ILE . 1.0 OUTLIER -74.8 99.78 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.149 -0.478 . . . . 61.030000000000001 111.126 179.954 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 128' ' ' HIS . . . . . 0.434 ' CD2' ' HA ' ' A' ' 101' ' ' LYS . 1.0 OUTLIER -73.33 -28.13 61.9 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.113 -0.494 . . . . 72.519999999999996 110.884 179.831 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.607 ' CB ' ' HB2' ' A' ' 99' ' ' PHE . 0.5 OUTLIER -132.31 136.93 47.24 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.225 -0.443 . . . . 74.239999999999995 110.872 -179.741 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 130' ' ' CYS . . . . . 0.614 ' SG ' HG21 ' A' ' 127' ' ' ILE . 0.1 OUTLIER -135.09 118.15 16.43 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.218 -0.446 . . . . 64.030000000000001 110.881 -179.977 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.65 ' HA ' ' HA ' ' A' ' 156' ' ' GLU . 6.0 mtpp -118.59 152.53 35.85 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.153 -0.476 . . . . 61.43 110.859 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.559 HG11 ' HG3' ' A' ' 95' ' ' LYS . 16.6 t 82.74 163.4 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.217 -0.447 . . . . 51.299999999999997 111.108 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.829 HD13 ' O ' ' A' ' 154' ' ' LYS . 0.0 OUTLIER -179.73 123.57 0.07 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.17 -0.468 . . . . 71.549999999999997 110.911 179.942 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.516 ' O ' ' C ' ' A' ' 135' ' ' GLY . 0.1 OUTLIER -94.27 167.1 11.75 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.153 -0.476 . . . . 65.120000000000005 110.915 179.908 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.516 ' C ' ' O ' ' A' ' 134' ' ' GLU . . . -27.93 -57.82 0.12 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.745 -0.74 . . . . 51.109999999999999 112.463 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.689 HG21 HG13 ' A' ' 86' ' ' VAL . 2.8 t -145.66 144.44 21.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.809 0.338 . . . . 74.109999999999999 111.167 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' TRP . . . . . 0.588 ' HB3' ' HB3' ' A' ' 152' ' ' LEU . 7.4 t-105 -143.52 152.98 42.13 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.22 -0.445 . . . . 75.450000000000003 110.974 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.493 ' CD1' ' HB ' ' A' ' 61' ' ' ILE . 2.8 mm -119.21 132.02 70.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.271 -0.422 . . . . 64.420000000000002 111.156 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.707 ' CE2' HG11 ' A' ' 170' ' ' VAL . 0.2 OUTLIER -111.41 146.37 37.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.187 -0.46 . . . . 72.519999999999996 110.858 179.951 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 0.422 ' CD2' ' HA ' ' A' ' 145' ' ' TYR . 3.4 m-85 -127.79 130.01 47.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.069 -0.514 . . . . 74.230000000000004 110.889 -179.858 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.613 ' O ' ' HB2' ' A' ' 171' ' ' GLN . 0.2 OUTLIER -60.34 -25.78 66.08 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.081 -0.509 . . . . 75.219999999999999 110.877 -179.984 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.748 ' HB3' ' HD2' ' A' ' 143' ' ' PRO . 9.7 mp -114.66 173.88 2.66 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.657 0.742 . . . . 70.299999999999997 110.88 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' PRO . . . . . 0.751 ' O ' ' OG ' ' A' ' 172' ' ' SER . 53.7 Cg_endo -69.77 -91.62 0.01 OUTLIER 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.726 2.284 . . . . 75.450000000000003 112.281 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 144' ' ' ASN . . . . . 0.71 ' O ' ' N ' ' A' ' 146' ' ' ARG . 0.9 OUTLIER -50.98 97.89 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.154 -0.476 . . . . 52.340000000000003 110.858 -179.926 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 145' ' ' TYR . . . . . 0.641 ' C ' ' O ' ' A' ' 144' ' ' ASN . 0.1 OUTLIER 12.1 53.09 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.143 -0.48 . . . . 72.129999999999995 110.923 -179.924 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 146' ' ' ARG . . . . . 0.71 ' N ' ' O ' ' A' ' 144' ' ' ASN . 11.3 mtp85 -118.76 174.71 6.12 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.095 -0.502 . . . . 75.040000000000006 110.844 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 80.84 -173.0 54.62 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.733 -0.746 . . . . 41.329999999999998 112.495 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.595 ' HA ' HD21 ' A' ' 76' ' ' LEU . 0.8 OUTLIER -80.58 150.46 29.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.749 0.309 . . . . 61.539999999999999 110.893 -179.906 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 149' ' ' GLN . . . . . 0.468 ' O ' ' HB2' ' A' ' 59' ' ' MET . 8.4 mt-30 -81.73 153.62 26.45 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.185 -0.461 . . . . 74.340000000000003 110.889 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 150' ' ' TYR . . . . . 0.585 ' HB2' ' CB ' ' A' ' 139' ' ' PHE . 98.3 m-85 -139.28 129.44 25.26 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.218 -0.446 . . . . 44.030000000000001 110.945 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.602 ' HB2' HD11 ' A' ' 61' ' ' ILE . 13.3 tp -81.78 121.72 26.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.092 -0.504 . . . . 43.229999999999997 110.911 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 1.02 HD13 ' O ' ' A' ' 152' ' ' LEU . 0.0 OUTLIER -53.77 135.86 40.82 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.191 -0.459 . . . . 73.319999999999993 110.948 179.886 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -164.07 27.75 0.08 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.206 -0.452 . . . . 74.150000000000006 110.828 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.829 ' O ' HD13 ' A' ' 133' ' ' LEU . 0.0 OUTLIER -116.71 -172.74 2.25 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.214 -0.448 . . . . 74.549999999999997 110.889 179.969 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.804 ' HG3' HD22 ' A' ' 133' ' ' LEU . 0.0 OUTLIER -162.39 -128.92 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.221 -0.445 . . . . 42.119999999999997 110.908 179.875 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.65 ' HA ' ' HA ' ' A' ' 131' ' ' LYS . 0.2 OUTLIER -68.0 1.13 2.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.213 -0.449 . . . . 74.140000000000001 110.936 179.956 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 157' ' ' TYR . . . . . 0.746 ' CE1' ' HA ' ' A' ' 154' ' ' LYS . 20.3 m-30 -28.78 143.47 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.094 -0.503 . . . . 75.25 110.933 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 158' ' ' ARG . . . . . 0.44 ' HB2' ' HA ' ' A' ' 103' ' ' ASP . 9.5 ptp180 -110.91 -43.4 3.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.158 -0.474 . . . . 71.540000000000006 110.921 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -82.45 151.24 65.16 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.519 0.676 . . . . 70.530000000000001 110.93 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 160' ' ' PRO . . . . . 0.541 ' HB3' ' HB3' ' A' ' 168' ' ' PRO . 54.0 Cg_endo -69.74 -26.67 27.45 Favored 'Trans proline' 0 C--O 1.231 0.136 0 C-N-CA 122.7 2.266 . . . . 75.150000000000006 112.347 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.598 HD12 ' H ' ' A' ' 161' ' ' ILE . 3.6 mp -65.44 -11.78 12.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.224 -0.444 . . . . 74.040000000000006 111.074 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.67 ' HB3' ' CD1' ' A' ' 157' ' ' TYR . 0.3 OUTLIER -75.0 -18.88 60.29 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.151 -0.477 . . . . 74.540000000000006 110.837 179.936 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 13.3 t90 -82.06 0.23 41.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.197 -0.456 . . . . 73.450000000000003 110.938 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 91.91 -36.2 3.74 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.75 -0.738 . . . . 65.540000000000006 112.507 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -79.68 128.39 33.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.777 0.322 . . . . 74.540000000000006 111.099 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -39.41 -38.28 0.54 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.194 -0.457 . . . . 50.020000000000003 111.101 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 167' ' ' SER . . . . . 0.496 ' C ' ' H ' ' A' ' 169' ' ' ALA . 0.5 OUTLIER -128.18 154.26 78.77 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.642 0.734 . . . . 64.310000000000002 110.892 -179.822 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 168' ' ' PRO . . . . . 0.541 ' HB3' ' HB3' ' A' ' 160' ' ' PRO . 54.4 Cg_endo -69.74 25.13 0.17 Allowed 'Trans proline' 0 C--O 1.231 0.147 0 C-N-CA 122.742 2.294 . . . . 73.540000000000006 112.352 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.496 ' H ' ' C ' ' A' ' 167' ' ' SER . . . -65.89 103.65 0.96 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.223 -0.444 . . . . 72.129999999999995 111.11 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.707 HG11 ' CE2' ' A' ' 139' ' ' PHE . 2.6 t -152.14 163.43 2.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.225 -0.443 . . . . 63.219999999999999 111.145 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 171' ' ' GLN . . . . . 0.64 ' OE1' ' HB3' ' A' ' 143' ' ' PRO . 1.8 mm-40 -114.26 -89.57 0.54 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.19 -0.459 . . . . 74.420000000000002 110.914 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 172' ' ' SER . . . . . 0.751 ' OG ' ' O ' ' A' ' 143' ' ' PRO . 12.6 p -126.9 177.05 6.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.194 -0.457 . . . . 61.100000000000001 110.852 -179.829 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 173' ' ' PHE . . . . . 0.604 ' CE1' HD11 ' A' ' 98' ' ' ILE . 1.4 p90 -145.8 174.38 11.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.105 -0.498 . . . . 72.420000000000002 110.883 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.18 154.61 46.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.179 -0.464 . . . . 73.010000000000005 110.88 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.15 -169.91 2.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.16 -0.473 . . . . 72.340000000000003 110.864 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 176' ' ' ILE . . . . . 0.422 HD12 ' HB ' ' A' ' 136' ' ' VAL . 4.5 mt -134.51 136.85 52.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.21 -0.45 . . . . 74.239999999999995 111.173 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.558 HG22 ' OH ' ' A' ' 94' ' ' TYR . 10.7 t -140.31 153.43 22.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.218 -0.446 . . . . 65.439999999999998 111.142 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 178' ' ' GLU . . . . . 0.445 ' HB3' HD13 ' A' ' 88' ' ' LEU . 10.6 pt-20 . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 116.133 -0.485 . . . . 61.219999999999999 110.855 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.81 0.338 . . . . 71.310000000000002 110.857 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.8 m -156.84 176.55 12.6 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.215 -0.448 . . . . 72.129999999999995 110.816 -179.733 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -73.01 -37.21 67.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.14 -0.482 . . . . 72.409999999999997 110.925 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER 51.98 -172.42 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.216 -0.447 . . . . 71.430000000000007 111.116 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -79.61 146.6 28.77 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.765 -0.731 . . . . 64.430000000000007 112.489 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.514 ' C ' ' HE1' ' A' ' 47' ' ' TRP . 6.9 p -82.8 135.81 34.85 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.908 0.385 . . . . 75.430000000000007 111.117 -179.86 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 3.6 tttt -122.54 135.24 54.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 72.420000000000002 110.937 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.591 ' HB ' HG22 ' A' ' 42' ' ' VAL . 15.2 tt -136.75 150.61 27.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.21 -0.45 . . . . 52.140000000000001 111.125 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.496 HG23 ' CG ' ' A' ' 22' ' ' ASP . 13.6 m -127.4 146.29 50.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.187 -0.461 . . . . 74.420000000000002 111.164 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.795 ' HB2' HD22 ' A' ' 34' ' ' LEU . 0.2 OUTLIER -134.07 127.17 31.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.206 -0.452 . . . . 71.430000000000007 110.888 179.999 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.551 ' CG ' ' HA ' ' A' ' 16' ' ' PHE . 26.2 m-85 -113.41 131.82 55.86 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.149 -0.478 . . . . 71.109999999999999 110.923 -179.858 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.458 ' N ' HD11 ' A' ' 34' ' ' LEU . 0.0 OUTLIER -60.26 -15.43 24.79 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.121 -0.49 . . . . 65.140000000000001 110.9 179.987 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.449 ' HB2' ' O ' ' A' ' 17' ' ' GLN . 71.2 m-20 -134.89 150.57 50.45 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.156 -0.475 . . . . 70.019999999999996 110.873 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.504 ' N ' ' HB3' ' A' ' 38' ' ' ASN . 39.4 mtmt -55.7 -177.78 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.182 -0.463 . . . . 74.129999999999995 110.857 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 22.7 m-20 48.14 33.26 3.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.17 -0.468 . . . . 75.299999999999997 110.888 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.551 ' HA ' ' CG ' ' A' ' 11' ' ' TYR . 3.3 m-85 49.22 64.3 1.79 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.164 -0.471 . . . . 71.439999999999998 110.853 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.449 ' O ' ' HB2' ' A' ' 13' ' ' ASP . 15.6 mt-30 -140.07 158.07 44.63 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.146 -0.479 . . . . 71.319999999999993 110.934 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 93.28 -150.63 20.0 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.775 -0.726 . . . . 74.430000000000007 112.476 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.715 ' O ' HD13 ' A' ' 34' ' ' LEU . 0.2 OUTLIER -66.72 78.51 0.11 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.754 0.311 . . . . 73.25 110.851 -179.829 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.475 ' HB2' ' CE1' ' A' ' 11' ' ' TYR . 0.7 OUTLIER -77.04 128.88 35.27 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.232 -0.44 . . . . 74.430000000000007 110.876 -179.921 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.475 ' O ' ' HA ' ' A' ' 9' ' ' THR . 88.1 t80 -123.06 125.72 45.73 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.21 -0.45 . . . . 73.140000000000001 110.943 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.496 ' CG ' HG23 ' A' ' 9' ' ' THR . 1.3 m-20 -123.33 132.63 54.05 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.156 -0.474 . . . . 72.310000000000002 110.857 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -166.0 138.33 3.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 65.340000000000003 110.927 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -104.72 4.48 32.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.195 -0.457 . . . . 73.120000000000005 110.846 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 14.9 t -108.55 164.2 12.56 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.21 -0.45 . . . . 64.349999999999994 110.882 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -60.25 117.49 5.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.173 -0.467 . . . . 73.310000000000002 110.832 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.469 ' HB3' ' CB ' ' A' ' 30' ' ' PHE . 16.6 m -117.07 54.05 0.88 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.173 -0.467 . . . . 61.030000000000001 110.894 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.525 ' O ' ' HA ' ' A' ' 82' ' ' SER . . . -47.67 -18.84 0.17 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 30.239999999999998 111.06 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 58.3 t0 -127.26 40.07 3.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.236 -0.438 . . . . 75.430000000000007 110.845 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.779 ' CD2' ' O ' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -80.77 14.12 2.3 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.224 -0.444 . . . . 72.450000000000003 110.896 -179.927 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.508 ' HB2' ' HB3' ' A' ' 53' ' ' PRO . 36.2 t60 -78.47 -37.75 42.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.121 -0.49 . . . . 71.319999999999993 110.893 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.5 t -58.19 -15.18 8.89 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.199 -0.455 . . . . 71.519999999999996 111.149 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -98.53 -27.97 13.8 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.243 -0.435 . . . . 73.439999999999998 110.899 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.795 HD22 ' HB2' ' A' ' 10' ' ' PHE . 15.6 tp -140.87 134.92 30.78 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.129 -0.487 . . . . 74.540000000000006 110.878 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 23.3 m -99.74 -41.49 7.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.187 -0.46 . . . . 73.0 110.866 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -119.14 143.08 47.4 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.13 -0.486 . . . . 73.430000000000007 110.865 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.64 ' SG ' ' HB2' ' A' ' 80' ' ' LEU . 1.8 p -115.65 89.75 3.17 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.193 -0.458 . . . . 74.510000000000005 110.919 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.504 ' HB3' ' N ' ' A' ' 14' ' ' LYS . 3.6 m-20 -85.46 -54.01 4.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.193 -0.458 . . . . 64.340000000000003 110.87 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 9.7 p -125.32 128.12 47.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 51.420000000000002 110.854 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.741 HG21 HD13 ' A' ' 62' ' ' LEU . 11.0 mt -127.05 152.08 34.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.11 -0.495 . . . . 74.25 111.123 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.435 ' N ' ' CG2' ' A' ' 40' ' ' ILE . 0.0 OUTLIER -142.78 118.33 10.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.188 -0.46 . . . . 74.549999999999997 110.877 179.852 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.591 HG22 ' HB ' ' A' ' 8' ' ' ILE . 1.9 t -101.2 115.15 42.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.187 -0.46 . . . . 72.219999999999999 111.111 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -111.28 79.96 1.26 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.181 -0.463 . . . . 72.209999999999994 110.889 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.454 ' O ' ' HA ' ' A' ' 6' ' ' THR . . . 129.44 103.33 1.07 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.72 -0.752 . . . . 74.439999999999998 112.467 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.475 ' HA2' HD21 ' A' ' 88' ' ' LEU . . . 52.84 178.1 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.704 -0.76 . . . . 63.130000000000003 112.49 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.758 HG23 ' HA ' ' A' ' 63' ' ' PRO . 3.0 m -79.65 164.78 23.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.794 0.331 . . . . 61.520000000000003 111.119 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.575 ' CD1' ' HB ' ' A' ' 8' ' ' ILE . 2.7 m95 -137.69 130.02 29.34 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.155 -0.475 . . . . 74.549999999999997 110.857 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.805 ' HB2' ' CG2' ' A' ' 86' ' ' VAL . . . -92.77 131.26 37.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.227 -0.442 . . . . 74.209999999999994 111.151 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.907 HG11 HD11 ' A' ' 80' ' ' LEU . 19.6 m -132.56 127.51 56.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.241 -0.436 . . . . 73.239999999999995 111.105 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.75 ' HB3' ' HA ' ' A' ' 56' ' ' ALA . 38.9 m-85 -94.75 148.3 22.43 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.218 -0.447 . . . . 62.420000000000002 110.92 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.544 ' HB2' ' O ' ' A' ' 58' ' ' TYR . 7.1 tt0 -50.91 -76.55 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.148 -0.478 . . . . 43.240000000000002 110.855 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.571 ' HB3' ' CD1' ' A' ' 55' ' ' PHE . 19.2 mmm-85 -89.92 140.7 27.73 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.64 0.733 . . . . 72.200000000000003 110.846 -179.873 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.789 ' HA ' ' OG ' ' A' ' 82' ' ' SER . 54.1 Cg_endo -69.75 137.8 36.35 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.733 2.289 . . . . 71.450000000000003 112.322 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 65.32 -11.18 0.17 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.246 -0.434 . . . . 73.129999999999995 110.897 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.571 ' CD1' ' HB3' ' A' ' 52' ' ' ARG . 4.9 m-30 -100.85 -32.19 10.79 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.159 -0.473 . . . . 62.530000000000001 110.876 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.75 ' HA ' ' HB3' ' A' ' 50' ' ' TYR . . . 63.42 22.44 13.25 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.185 -0.461 . . . . 73.540000000000006 111.107 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' TRP . . . . . 0.629 ' O ' ' C ' ' A' ' 58' ' ' TYR . 1.2 t90 -51.4 -159.69 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.216 -0.447 . . . . 73.109999999999999 110.923 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.629 ' C ' ' O ' ' A' ' 57' ' ' TRP . 5.8 m-30 -13.72 101.43 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.278 -0.419 . . . . 71.540000000000006 110.929 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.407 ' HB2' ' HA ' ' A' ' 150' ' ' TYR . 2.1 mpt? -59.67 149.28 31.02 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.067 -0.515 . . . . 53.439999999999998 110.886 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.811 ' CE2' HD12 ' A' ' 76' ' ' LEU . 0.4 OUTLIER -163.93 105.08 0.91 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.232 -0.44 . . . . 72.109999999999999 110.923 -179.876 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.81 ' N ' HD12 ' A' ' 61' ' ' ILE . 0.9 OUTLIER -98.86 115.72 40.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.114 -0.494 . . . . 74.430000000000007 111.114 179.904 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.778 HD23 ' HD2' ' A' ' 63' ' ' PRO . 0.4 OUTLIER -83.64 123.71 76.07 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.6 0.714 . . . . 32.530000000000001 110.939 179.877 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.778 ' HD2' HD23 ' A' ' 62' ' ' LEU . 54.3 Cg_endo -69.74 -165.21 0.15 Allowed 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.73 2.286 . . . . 73.430000000000007 112.341 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.64 159.57 14.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.233 -0.44 . . . . 73.329999999999998 110.907 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 112.88 -155.52 16.23 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.715 -0.755 . . . . 62.539999999999999 112.448 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -114.81 160.42 19.47 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.877 0.37 . . . . 74.109999999999999 110.859 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.446 ' N ' ' O ' ' A' ' 40' ' ' ILE . 10.8 m-85 -149.58 83.81 6.27 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.71 0.766 . . . . 74.319999999999993 110.919 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.8 -4.73 14.65 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.65 2.234 . . . . 71.430000000000007 112.325 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -156.89 148.23 22.2 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.244 -0.435 . . . . 75.329999999999998 110.919 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.99 ' O ' ' CD1' ' A' ' 73' ' ' TRP . 44.6 p90 -57.44 -42.44 82.45 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.164 -0.471 . . . . 70.439999999999998 110.936 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -51.94 -15.79 0.6 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.102 -0.499 . . . . 63.420000000000002 110.89 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 28.7 mmt180 -69.16 -9.22 51.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.179 -0.464 . . . . 75.25 110.902 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' TRP . . . . . 0.99 ' CD1' ' O ' ' A' ' 70' ' ' TYR . 0.5 OUTLIER -128.8 21.63 5.9 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.18 -0.463 . . . . 71.319999999999993 110.905 -179.946 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.623 ' O ' ' C ' ' A' ' 75' ' ' GLY . 24.1 mmt 79.54 27.44 0.36 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.276 -0.42 . . . . 72.230000000000004 110.878 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.623 ' C ' ' O ' ' A' ' 74' ' ' MET . . . 15.74 61.94 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.698 -0.763 . . . . 33.149999999999999 112.514 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.811 HD12 ' CE2' ' A' ' 60' ' ' TYR . 59.9 mt -58.89 -80.34 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.843 0.354 . . . . 73.549999999999997 110.902 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.589 ' O ' ' CB ' ' A' ' 78' ' ' ASP . 3.8 t-20 -113.56 -41.84 3.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.193 -0.458 . . . . 50.329999999999998 110.898 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.589 ' CB ' ' O ' ' A' ' 77' ' ' ASN . 2.6 t70 91.04 16.38 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.18 -0.464 . . . . 74.129999999999995 110.891 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.451 ' NE ' ' HD3' ' A' ' 52' ' ' ARG . 4.9 ttm105 -110.92 97.66 6.99 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.143 -0.481 . . . . 73.409999999999997 110.845 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.907 HD11 HG11 ' A' ' 49' ' ' VAL . 0.1 OUTLIER -95.6 131.7 41.53 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.18 -0.463 . . . . 71.109999999999999 110.912 -179.985 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.671 ' HB3' ' HB3' ' A' ' 53' ' ' PRO . 1.2 m -153.03 -123.58 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.208 -0.451 . . . . 65.340000000000003 110.877 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.789 ' OG ' ' HA ' ' A' ' 53' ' ' PRO . 0.0 OUTLIER -41.65 101.86 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.138 -0.483 . . . . 73.239999999999995 110.797 -179.757 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 83' ' ' CYS . . . . . 0.711 ' CB ' HG12 ' A' ' 49' ' ' VAL . 21.3 p -117.43 136.15 53.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.109 -0.496 . . . . 74.200000000000003 110.857 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.585 ' N ' ' O ' ' A' ' 48' ' ' ALA . 6.6 mmt85 -123.43 138.38 54.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.149 -0.478 . . . . 71.040000000000006 110.865 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.448 ' N ' ' CZ3' ' A' ' 47' ' ' TRP . . . -57.71 128.67 38.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.202 -0.454 . . . . 74.109999999999999 111.044 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.832 HG13 HG21 ' A' ' 136' ' ' VAL . 12.3 t -111.71 139.6 35.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.18 -0.463 . . . . 60.200000000000003 111.113 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' HIS . . . . . 0.637 ' O ' HG23 ' A' ' 136' ' ' VAL . 29.8 m80 -111.84 106.01 14.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.173 -0.467 . . . . 75.109999999999999 110.854 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.73 HD13 ' HA ' ' A' ' 178' ' ' GLU . 0.0 OUTLIER -31.9 143.22 0.13 Allowed Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.619 0.723 . . . . 71.030000000000001 110.888 -179.949 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.529 ' HB3' ' H ' ' A' ' 136' ' ' VAL . 53.7 Cg_endo -69.82 105.73 1.55 Allowed 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.652 2.235 . . . . 64.120000000000005 112.291 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.03 177.35 4.88 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.206 -0.452 . . . . 72.319999999999993 110.805 -179.835 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 50.12 63.16 4.48 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.741 -0.742 . . . . 35.229999999999997 112.486 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.424 ' O ' ' C ' ' A' ' 93' ' ' GLN . . . 124.25 21.72 2.24 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.754 -0.736 . . . . 61.32 112.454 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.471 ' O ' ' HG2' ' A' ' 134' ' ' GLU . 13.5 pt20 36.59 -121.29 0.16 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.815 0.341 . . . . 73.430000000000007 110.859 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.535 ' O ' ' HA ' ' A' ' 112' ' ' THR . 0.1 OUTLIER -120.92 100.8 7.29 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.141 -0.482 . . . . 65.530000000000001 110.911 -179.853 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.533 ' HG3' HG11 ' A' ' 132' ' ' VAL . 45.6 tptt -110.82 128.27 55.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.112 -0.494 . . . . 71.0 110.907 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.472 HG21 ' CH2' ' A' ' 137' ' ' TRP . 0.0 OUTLIER -149.11 142.38 18.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.253 -0.431 . . . . 70.299999999999997 111.12 179.82 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.532 ' HB2' HG23 ' A' ' 132' ' ' VAL . 2.8 mt-30 -112.1 126.94 55.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.137 -0.483 . . . . 74.420000000000002 110.911 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.625 HD13 ' HE1' ' A' ' 122' ' ' PHE . 4.9 mp -108.33 131.26 59.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.237 -0.438 . . . . 44.210000000000001 111.115 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.672 ' HB2' ' HB2' ' A' ' 129' ' ' SER . 6.4 m-85 -120.15 148.19 43.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.172 -0.467 . . . . 75.430000000000007 110.883 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -74.88 -75.59 0.16 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.159 -0.473 . . . . 73.400000000000006 110.912 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.439 ' C ' ' HB3' ' A' ' 128' ' ' HIS . 36.7 mttt -83.14 176.19 9.39 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.168 -0.469 . . . . 72.450000000000003 110.926 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -88.79 160.41 29.98 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.764 -0.731 . . . . 64.340000000000003 112.476 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.432 ' HA ' ' HB2' ' A' ' 158' ' ' ARG . 27.8 t0 65.15 53.42 1.35 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.883 0.373 . . . . 73.230000000000004 110.893 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.63 ' CE1' ' HD2' ' A' ' 131' ' ' LYS . 6.1 m-85 48.38 33.74 4.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.457 . . . . 64.109999999999999 110.876 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.419 ' HB2' ' HB2' ' A' ' 101' ' ' LYS . 45.4 m -109.47 151.61 26.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.101 -0.499 . . . . 74.25 110.848 -179.795 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 91.35 -164.4 29.44 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.675 -0.774 . . . . 71.25 112.467 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 5.0 tp-100 -75.41 129.65 37.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.805 0.336 . . . . 71.010000000000005 110.945 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 3.8 ttp -112.47 144.96 41.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.197 -0.456 . . . . 65.319999999999993 110.887 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 -148.84 141.73 24.72 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.212 -0.449 . . . . 70.510000000000005 110.949 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -123.78 108.66 12.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.1 -0.5 . . . . 73.340000000000003 110.938 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 5.0 t -121.47 145.69 47.68 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.175 -0.466 . . . . 64.340000000000003 111.132 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.535 ' HA ' ' O ' ' A' ' 94' ' ' TYR . 4.4 t -120.96 41.91 3.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.245 -0.434 . . . . 64.120000000000005 111.152 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -151.19 157.08 42.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.224 -0.444 . . . . 73.310000000000002 110.904 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -53.85 157.86 2.23 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.145 -0.479 . . . . 73.409999999999997 110.823 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' CYS . . . . . 0.671 ' O ' ' HB2' ' A' ' 172' ' ' SER . 73.2 m -146.89 115.2 4.36 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-O 121.626 0.727 . . . . 73.319999999999993 110.898 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.455 ' O ' ' C ' ' A' ' 143' ' ' PRO . 53.3 Cg_endo -69.82 -30.3 22.24 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.648 2.232 . . . . 73.319999999999993 112.328 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.634 ' HB3' ' CB ' ' A' ' 120' ' ' GLU . 0.1 OUTLIER -148.26 99.82 3.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.251 -0.431 . . . . 64.329999999999998 110.814 -179.854 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.642 HD13 HD11 ' A' ' 127' ' ' ILE . 5.6 tt -52.86 -26.56 11.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.12 -0.491 . . . . 45.310000000000002 111.124 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' MET . . . . . 0.602 ' O ' ' HA ' ' A' ' 123' ' ' HIS . 14.4 ttp -86.75 -41.26 14.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.198 -0.455 . . . . 73.129999999999995 110.89 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.634 ' CB ' ' HB3' ' A' ' 117' ' ' SER . 34.5 tp10 -64.33 -12.98 47.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.215 -0.448 . . . . 73.230000000000004 110.854 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.404 ' H ' ' HG3' ' A' ' 121' ' ' GLN . 0.0 OUTLIER -114.62 -51.56 2.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.189 -0.46 . . . . 71.510000000000005 110.946 -179.96 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.625 ' HE1' HD13 ' A' ' 98' ' ' ILE . 12.1 m-30 -101.22 -18.17 16.27 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.217 -0.447 . . . . 44.340000000000003 110.935 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' HIS . . . . . 0.602 ' HA ' ' O ' ' A' ' 119' ' ' MET . 11.8 m80 74.39 21.29 2.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.135 -0.484 . . . . 73.310000000000002 110.901 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.56 ' SD ' HG22 ' A' ' 98' ' ' ILE . 6.5 mtt -94.27 131.91 39.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.188 -0.46 . . . . 65.340000000000003 110.873 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 4.9 ptp180 -95.23 -38.55 10.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.181 -0.463 . . . . 65.219999999999999 110.877 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.464 ' HG2' ' HA ' ' A' ' 169' ' ' ALA . 25.2 mt-10 -141.25 118.62 11.45 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.159 -0.473 . . . . 64.140000000000001 110.875 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.642 HD11 HD13 ' A' ' 118' ' ' ILE . 3.0 mm -80.08 101.09 4.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.163 -0.471 . . . . 75.450000000000003 111.138 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' HIS . . . . . 0.439 ' HB3' ' C ' ' A' ' 101' ' ' LYS . 0.4 OUTLIER -73.19 -32.58 64.9 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.171 -0.468 . . . . 72.450000000000003 110.846 179.888 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.672 ' HB2' ' HB2' ' A' ' 99' ' ' PHE . 66.5 m -128.47 138.89 52.51 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.193 -0.458 . . . . 65.019999999999996 110.83 -179.719 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' CYS . . . . . 0.573 ' O ' ' O ' ' A' ' 155' ' ' LYS . 3.8 m -136.05 120.43 18.02 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.149 -0.478 . . . . 61.409999999999997 110.865 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.67 ' HA ' ' HA ' ' A' ' 156' ' ' GLU . 3.6 mtpp -116.35 152.21 34.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.131 -0.486 . . . . 71.5 110.892 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.539 ' HB ' ' O ' ' A' ' 131' ' ' LYS . 19.4 t 85.6 162.46 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.226 -0.443 . . . . 75.310000000000002 111.145 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.812 HD22 ' CG ' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -177.33 124.59 0.14 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.223 -0.444 . . . . 64.239999999999995 110.929 179.933 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.501 ' O ' ' C ' ' A' ' 135' ' ' GLY . 0.1 OUTLIER -98.26 168.23 10.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.162 -0.472 . . . . 72.120000000000005 110.895 179.936 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.501 ' C ' ' O ' ' A' ' 134' ' ' GLU . . . -29.17 -70.04 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.751 -0.738 . . . . 72.129999999999995 112.447 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.832 HG21 HG13 ' A' ' 86' ' ' VAL . 3.0 t -133.82 145.43 33.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.834 0.349 . . . . 73.549999999999997 111.109 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 137' ' ' TRP . . . . . 0.616 ' H ' HD12 ' A' ' 152' ' ' LEU . 0.1 OUTLIER -150.1 162.8 39.7 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.187 -0.461 . . . . 73.150000000000006 110.866 -179.975 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.456 HD12 HH11 ' A' ' 174' ' ' ARG . 22.6 mt -138.48 134.03 43.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.208 -0.451 . . . . 75.409999999999997 111.136 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.676 ' CE1' HG11 ' A' ' 170' ' ' VAL . 0.2 OUTLIER -103.68 159.16 15.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.176 -0.465 . . . . 73.329999999999998 110.884 179.957 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 0.481 ' CD2' ' HA ' ' A' ' 145' ' ' TYR . 0.5 OUTLIER -131.61 128.46 39.18 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.123 -0.49 . . . . 75.430000000000007 110.905 -179.875 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.576 ' O ' ' HB2' ' A' ' 171' ' ' GLN . 7.0 tt0 -60.76 -27.75 68.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.089 -0.505 . . . . 61.520000000000003 110.858 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.743 ' HB3' ' HD2' ' A' ' 143' ' ' PRO . 10.1 mp -114.97 173.46 2.89 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.588 0.709 . . . . 74.450000000000003 110.938 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 143' ' ' PRO . . . . . 0.758 ' O ' ' OG ' ' A' ' 172' ' ' SER . 53.2 Cg_endo -69.77 -90.61 0.0 OUTLIER 'Trans proline' 0 C--N 1.34 0.129 0 C-N-CA 122.694 2.263 . . . . 44.299999999999997 112.327 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 144' ' ' ASN . . . . . 0.723 ' O ' ' N ' ' A' ' 146' ' ' ARG . 2.4 m-20 -50.73 98.57 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.181 -0.463 . . . . 74.329999999999998 110.87 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 145' ' ' TYR . . . . . 0.638 ' C ' ' O ' ' A' ' 144' ' ' ASN . 0.1 OUTLIER 12.67 51.77 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.163 -0.471 . . . . 72.25 110.945 -179.959 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 146' ' ' ARG . . . . . 0.723 ' N ' ' O ' ' A' ' 144' ' ' ASN . 22.3 mtt-85 -119.46 173.43 6.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.132 -0.486 . . . . 75.340000000000003 110.921 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 79.84 172.27 43.6 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.737 -0.744 . . . . 62.049999999999997 112.462 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 19.3 mtp180 -68.55 150.61 47.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.755 0.312 . . . . 73.420000000000002 110.888 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' GLN . . . . . 0.688 ' HG3' HD11 ' A' ' 76' ' ' LEU . 55.4 mt-30 -86.02 153.21 22.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.236 -0.438 . . . . 75.400000000000006 110.932 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 150' ' ' TYR . . . . . 0.482 ' HB2' ' HB2' ' A' ' 139' ' ' PHE . 76.1 m-85 -133.91 123.02 23.98 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.222 -0.445 . . . . 74.129999999999995 110.934 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.663 HD23 ' OH ' ' A' ' 50' ' ' TYR . 12.1 tp -70.32 125.24 26.24 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.144 -0.48 . . . . 52.0 110.909 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 1.003 HD13 ' O ' ' A' ' 152' ' ' LEU . 0.0 OUTLIER -59.94 132.58 54.4 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.177 -0.465 . . . . 72.430000000000007 110.871 179.948 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -163.56 24.98 0.08 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.138 -0.483 . . . . 75.329999999999998 110.862 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.785 ' O ' HD13 ' A' ' 133' ' ' LEU . 0.1 OUTLIER -112.41 -171.1 1.79 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.186 -0.461 . . . . 70.25 110.923 179.954 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.812 ' CG ' HD22 ' A' ' 133' ' ' LEU . 0.2 OUTLIER -165.67 -122.39 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.207 -0.452 . . . . 75.329999999999998 110.858 179.87 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.67 ' HA ' ' HA ' ' A' ' 131' ' ' LYS . 0.4 OUTLIER -71.39 0.42 8.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.232 -0.44 . . . . 73.319999999999993 110.913 -179.99 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 157' ' ' TYR . . . . . 0.661 ' CE1' ' HA ' ' A' ' 154' ' ' LYS . 16.8 m-30 -28.49 142.49 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.128 -0.487 . . . . 74.319999999999993 110.938 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 158' ' ' ARG . . . . . 0.432 ' HB2' ' HA ' ' A' ' 103' ' ' ASP . 11.1 ptp180 -112.18 -33.74 6.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.126 -0.488 . . . . 65.109999999999999 110.862 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -101.1 152.28 37.85 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.541 0.686 . . . . 72.010000000000005 110.914 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.73 -22.64 31.92 Favored 'Trans proline' 0 C--O 1.232 0.206 0 C-N-CA 122.694 2.262 . . . . 65.340000000000003 112.354 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.656 HD12 ' H ' ' A' ' 161' ' ' ILE . 4.0 mp -76.67 -2.89 4.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.226 -0.443 . . . . 62.520000000000003 111.146 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.657 ' HB3' ' CD1' ' A' ' 157' ' ' TYR . 1.4 t0 -72.47 -17.34 61.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.19 -0.459 . . . . 74.310000000000002 110.878 179.839 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 163' ' ' TRP . . . . . 0.52 ' CG ' ' O ' ' A' ' 163' ' ' TRP . 6.2 t-105 -109.99 10.21 24.24 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.168 -0.469 . . . . 62.409999999999997 110.934 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 87.71 -31.63 4.53 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.69 -0.767 . . . . 64.420000000000002 112.503 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -54.35 119.35 5.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.799 0.333 . . . . 71.319999999999993 111.103 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -49.1 -26.14 2.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.202 -0.454 . . . . 63.0 111.1 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 167' ' ' SER . . . . . 0.461 ' C ' ' H ' ' A' ' 169' ' ' ALA . 0.3 OUTLIER -154.98 159.36 31.89 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.635 0.731 . . . . 63.030000000000001 110.855 -179.794 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 168' ' ' PRO . . . . . 0.502 ' HB3' ' O ' ' A' ' 127' ' ' ILE . 53.5 Cg_endo -69.81 19.21 0.19 Allowed 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.679 2.253 . . . . 75.510000000000005 112.32 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.464 ' HA ' ' HG2' ' A' ' 126' ' ' GLU . . . -63.01 102.58 0.38 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.236 -0.438 . . . . 72.230000000000004 111.083 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.676 HG11 ' CE1' ' A' ' 139' ' ' PHE . 3.4 t -153.09 162.15 2.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.223 -0.444 . . . . 53.329999999999998 111.147 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 171' ' ' GLN . . . . . 0.669 ' OE1' ' HB3' ' A' ' 143' ' ' PRO . 1.7 mm-40 -112.21 -88.38 0.53 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.209 -0.45 . . . . 71.310000000000002 110.93 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 172' ' ' SER . . . . . 0.758 ' OG ' ' O ' ' A' ' 143' ' ' PRO . 45.7 p -121.67 177.92 5.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.156 -0.475 . . . . 64.099999999999994 110.882 -179.801 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 2.0 p90 -141.97 168.34 19.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.161 -0.472 . . . . 71.0 110.861 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 174' ' ' ARG . . . . . 0.456 HH11 HD12 ' A' ' 138' ' ' ILE . 0.0 OUTLIER -135.21 156.16 49.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.11 -0.496 . . . . 60.039999999999999 110.911 -179.937 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 175' ' ' ARG . . . . . 0.404 ' HD2' ' CE2' ' A' ' 94' ' ' TYR . 0.0 OUTLIER -100.68 -164.48 1.12 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.178 -0.464 . . . . 73.040000000000006 110.868 -179.922 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 176' ' ' ILE . . . . . 0.768 HD12 ' HB ' ' A' ' 136' ' ' VAL . 5.6 mt -137.0 130.5 45.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.164 -0.471 . . . . 74.099999999999994 111.09 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 7.4 p -98.43 155.84 3.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.198 -0.456 . . . . 74.109999999999999 111.103 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 178' ' ' GLU . . . . . 0.73 ' HA ' HD13 ' A' ' 88' ' ' LEU . 3.4 mt-10 . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.174 -0.467 . . . . 73.340000000000003 110.877 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.78 0.324 . . . . 72.519999999999996 110.869 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.8 m -149.51 -175.96 5.21 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.216 -0.447 . . . . 50.210000000000001 110.864 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -99.17 36.41 1.73 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.15 -0.477 . . . . 72.109999999999999 110.889 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 15.2 t -94.94 35.5 1.26 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.235 -0.439 . . . . 73.349999999999994 111.168 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 141.83 117.11 1.28 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.729 -0.748 . . . . 65.239999999999995 112.511 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.485 ' C ' ' HE1' ' A' ' 47' ' ' TRP . 9.9 p -82.67 133.78 35.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.871 0.367 . . . . 71.340000000000003 111.149 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 3.0 tttt -122.08 137.08 54.94 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.176 -0.465 . . . . 74.439999999999998 110.856 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.585 ' HB ' ' CD1' ' A' ' 47' ' ' TRP . 14.3 tt -137.16 152.94 28.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.197 -0.456 . . . . 60.240000000000002 111.148 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.492 ' HA ' ' O ' ' A' ' 21' ' ' TYR . 23.0 m -136.63 136.95 39.6 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.208 -0.451 . . . . 74.299999999999997 111.14 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.732 ' HB2' HD22 ' A' ' 34' ' ' LEU . 0.2 OUTLIER -125.23 129.3 49.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.225 -0.443 . . . . 71.209999999999994 110.883 -179.992 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.545 ' CG ' ' HA ' ' A' ' 16' ' ' PHE . 33.9 m-85 -112.38 131.93 55.28 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.138 -0.483 . . . . 72.299999999999997 110.953 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.443 ' HB2' ' HB2' ' A' ' 19' ' ' ARG . 0.1 OUTLIER -62.2 -16.45 53.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.147 -0.479 . . . . 74.209999999999994 110.89 -179.985 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.42 ' HB2' ' O ' ' A' ' 17' ' ' GLN . 70.7 m-20 -133.83 148.8 51.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.13 -0.487 . . . . 52.109999999999999 110.886 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.615 ' N ' ' HB3' ' A' ' 38' ' ' ASN . 3.5 mtmm -54.53 -179.19 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.217 -0.447 . . . . 71.239999999999995 110.927 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 22.3 m-20 49.64 32.87 5.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.259 -0.428 . . . . 74.219999999999999 110.906 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.545 ' HA ' ' CG ' ' A' ' 11' ' ' TYR . 4.0 m-85 49.79 62.45 2.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.137 -0.483 . . . . 75.239999999999995 110.919 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.42 ' O ' ' HB2' ' A' ' 13' ' ' ASP . 4.1 mt-30 -138.85 161.89 36.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.115 -0.493 . . . . 75.439999999999998 110.894 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 91.78 -149.76 19.93 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.771 -0.728 . . . . 52.310000000000002 112.493 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.734 ' O ' HD13 ' A' ' 34' ' ' LEU . 0.0 OUTLIER -69.41 77.58 0.39 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.812 0.339 . . . . 73.439999999999998 110.889 -179.845 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.433 ' HB2' ' CE1' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -75.79 129.11 36.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.181 -0.463 . . . . 74.230000000000004 110.871 -179.907 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.492 ' O ' ' HA ' ' A' ' 9' ' ' THR . 90.6 t80 -123.03 124.4 43.03 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.172 -0.467 . . . . 62.020000000000003 110.922 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.47 ' CG ' HG23 ' A' ' 9' ' ' THR . 1.1 m-20 -121.02 133.52 55.26 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.143 -0.481 . . . . 72.439999999999998 110.851 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -166.77 133.94 2.5 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.168 -0.469 . . . . 73.340000000000003 110.924 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -99.76 2.18 43.92 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.189 -0.459 . . . . 73.340000000000003 110.935 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 18.6 t -106.46 164.96 11.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.17 -0.468 . . . . 53.219999999999999 110.881 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -56.93 120.78 8.52 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.201 -0.454 . . . . 74.010000000000005 110.866 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.623 ' HB2' ' HB3' ' A' ' 30' ' ' PHE . 0.6 OUTLIER -115.64 50.14 1.03 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.212 -0.449 . . . . 70.230000000000004 110.875 -179.894 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.508 ' O ' ' HA ' ' A' ' 82' ' ' SER . . . -47.69 -21.43 0.37 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.163 -0.471 . . . . 63.329999999999998 111.093 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 58.5 t0 -128.68 42.11 3.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.235 -0.439 . . . . 72.200000000000003 110.89 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.731 ' CD2' ' O ' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -81.45 13.98 2.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.166 -0.47 . . . . 74.140000000000001 110.925 -179.932 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.454 ' HB2' ' HB3' ' A' ' 53' ' ' PRO . 29.7 t60 -78.19 -39.05 41.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.138 -0.483 . . . . 74.219999999999999 110.824 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.7 t -57.93 -14.93 7.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.221 -0.445 . . . . 73.400000000000006 111.139 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -99.6 -26.26 14.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.233 -0.44 . . . . 73.420000000000002 110.928 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.734 HD13 ' O ' ' A' ' 19' ' ' ARG . 15.5 tp -142.89 133.12 24.58 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.129 -0.487 . . . . 72.409999999999997 110.923 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 22.3 m -97.51 -43.28 7.32 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.169 -0.469 . . . . 71.239999999999995 110.865 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 1.6 tmm_? -117.27 142.57 46.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.146 -0.479 . . . . 72.409999999999997 110.886 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.658 ' SG ' ' HB2' ' A' ' 80' ' ' LEU . 1.5 p -111.65 89.19 2.99 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.204 -0.453 . . . . 63.140000000000001 110.893 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.615 ' HB3' ' N ' ' A' ' 14' ' ' LYS . 0.3 OUTLIER -81.73 -61.99 1.77 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.176 -0.465 . . . . 64.150000000000006 110.89 -179.906 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 10.4 p -124.17 125.93 45.29 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.196 -0.457 . . . . 74.439999999999998 110.847 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.603 HG21 HD13 ' A' ' 62' ' ' LEU . 2.6 mt -124.06 151.55 29.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.13 -0.486 . . . . 73.409999999999997 111.139 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.413 ' N ' ' CG2' ' A' ' 40' ' ' ILE . 0.0 OUTLIER -142.32 121.97 13.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.145 -0.479 . . . . 74.400000000000006 110.862 179.887 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.497 ' HA ' ' HA ' ' A' ' 8' ' ' ILE . 1.0 OUTLIER -104.82 118.84 52.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.22 -0.445 . . . . 54.25 111.118 179.876 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -114.07 77.73 1.09 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.146 -0.479 . . . . 61.100000000000001 110.836 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.403 ' O ' ' HA ' ' A' ' 6' ' ' THR . . . 135.46 99.14 0.58 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.714 -0.755 . . . . 42.240000000000002 112.476 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 54.75 176.8 0.14 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.733 -0.746 . . . . 72.219999999999999 112.473 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.773 HG23 ' HA ' ' A' ' 63' ' ' PRO . 1.9 m -75.82 169.24 18.53 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.789 0.328 . . . . 72.420000000000002 111.156 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.585 ' CD1' ' HB ' ' A' ' 8' ' ' ILE . 6.0 m95 -143.02 129.35 19.94 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.251 -0.431 . . . . 73.439999999999998 110.907 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.879 ' HB2' ' CG2' ' A' ' 86' ' ' VAL . . . -90.98 129.19 37.01 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.206 -0.452 . . . . 75.019999999999996 111.143 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.862 HG11 HD11 ' A' ' 80' ' ' LEU . 17.3 m -129.34 125.66 62.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.277 -0.419 . . . . 65.340000000000003 111.107 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.796 ' HB3' ' HA ' ' A' ' 56' ' ' ALA . 44.0 m-85 -93.73 148.38 22.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.182 -0.463 . . . . 64.510000000000005 110.926 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.573 ' HB2' ' O ' ' A' ' 58' ' ' TYR . 7.0 tt0 -48.72 -79.89 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.152 -0.476 . . . . 75.439999999999998 110.877 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.541 ' HB3' ' CD1' ' A' ' 55' ' ' PHE . 0.0 OUTLIER -92.75 145.15 29.77 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.617 0.723 . . . . 63.219999999999999 110.845 -179.908 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.781 ' HA ' ' OG ' ' A' ' 82' ' ' SER . 53.9 Cg_endo -69.79 140.78 43.41 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.678 2.252 . . . . 73.329999999999998 112.381 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 62.9 -11.03 0.09 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.227 -0.442 . . . . 74.209999999999994 110.924 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.606 ' H ' ' C ' ' A' ' 53' ' ' PRO . 2.6 m-30 -104.0 -21.37 13.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.162 -0.472 . . . . 65.239999999999995 110.913 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.796 ' HA ' ' HB3' ' A' ' 50' ' ' TYR . . . 50.05 25.98 1.9 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.135 -0.484 . . . . 74.230000000000004 111.063 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' TRP . . . . . 0.637 ' O ' ' C ' ' A' ' 58' ' ' TYR . 0.0 OUTLIER -50.07 -161.36 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.233 -0.44 . . . . 73.319999999999993 110.941 -179.997 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.637 ' C ' ' O ' ' A' ' 57' ' ' TRP . 6.3 m-30 -14.24 101.59 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.227 -0.442 . . . . 72.019999999999996 110.926 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.467 ' HB2' ' HA ' ' A' ' 150' ' ' TYR . 0.5 OUTLIER -58.41 146.15 35.93 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.087 -0.506 . . . . 63.5 110.905 179.903 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.78 ' O ' ' O ' ' A' ' 49' ' ' VAL . 0.3 OUTLIER -159.07 112.28 2.29 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.253 -0.43 . . . . 74.230000000000004 110.885 -179.863 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.829 ' N ' HD12 ' A' ' 61' ' ' ILE . 1.0 OUTLIER -104.95 114.84 45.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.097 -0.502 . . . . 74.439999999999998 111.15 179.898 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.765 HD23 ' HD2' ' A' ' 63' ' ' PRO . 0.4 OUTLIER -84.95 124.86 71.97 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.617 0.722 . . . . 74.409999999999997 110.934 179.916 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.773 ' HA ' HG23 ' A' ' 46' ' ' THR . 53.7 Cg_endo -69.75 -165.29 0.15 Allowed 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.647 2.232 . . . . 75.349999999999994 112.357 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.42 160.37 14.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.223 -0.444 . . . . 65.409999999999997 110.887 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 112.91 -152.11 18.05 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.697 -0.763 . . . . 62.130000000000003 112.486 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 11.2 mp0 -118.69 159.44 23.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.844 0.354 . . . . 75.0 110.937 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.508 ' HB2' ' O ' ' A' ' 40' ' ' ILE . 13.0 m-85 -147.94 82.43 7.84 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.655 0.741 . . . . 52.420000000000002 110.924 -179.854 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.7 -3.67 12.44 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.731 2.288 . . . . 74.319999999999993 112.355 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -157.72 147.68 20.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.178 -0.464 . . . . 75.25 110.856 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.882 ' O ' ' CD1' ' A' ' 73' ' ' TRP . 44.6 p90 -57.53 -41.47 80.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.121 -0.49 . . . . 72.200000000000003 110.927 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -53.35 -17.1 1.63 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.138 -0.483 . . . . 72.0 110.945 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 29.3 mmt180 -63.62 -36.29 83.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 71.319999999999993 110.852 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' TRP . . . . . 0.882 ' CD1' ' O ' ' A' ' 70' ' ' TYR . 0.3 OUTLIER -98.61 25.41 6.47 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.243 -0.435 . . . . 63.43 110.907 -179.958 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.566 ' O ' ' C ' ' A' ' 75' ' ' GLY . 1.6 mtp 75.53 26.87 1.08 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.264 -0.425 . . . . 62.25 110.886 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.566 ' C ' ' O ' ' A' ' 74' ' ' MET . . . 23.51 54.57 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.763 -0.732 . . . . 63.119999999999997 112.481 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.51 ' HB2' ' CE2' ' A' ' 60' ' ' TYR . 0.2 OUTLIER -56.69 -74.46 0.05 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.781 0.324 . . . . 63.020000000000003 110.918 -179.917 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.766 ' O ' ' CB ' ' A' ' 78' ' ' ASP . 28.0 t-20 -113.75 -80.55 0.59 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.214 -0.448 . . . . 73.439999999999998 110.897 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.766 ' CB ' ' O ' ' A' ' 77' ' ' ASN . 27.8 t70 129.45 5.38 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.182 -0.463 . . . . 75.219999999999999 110.911 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -107.3 92.28 4.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.211 -0.45 . . . . 71.549999999999997 110.893 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.862 HD11 HG11 ' A' ' 49' ' ' VAL . 0.2 OUTLIER -90.7 129.5 36.79 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.186 -0.461 . . . . 72.219999999999999 110.923 -179.959 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.6 ' HB3' ' HB3' ' A' ' 53' ' ' PRO . 0.9 OUTLIER -153.66 -123.42 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.23 -0.441 . . . . 74.409999999999997 110.897 -179.945 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.781 ' OG ' ' HA ' ' A' ' 53' ' ' PRO . 0.0 OUTLIER -41.46 101.91 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.168 -0.469 . . . . 71.120000000000005 110.877 -179.824 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 83' ' ' CYS . . . . . 0.705 ' HB3' HG12 ' A' ' 49' ' ' VAL . 31.5 p -121.16 135.38 55.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.095 -0.502 . . . . 70.109999999999999 110.887 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.585 ' N ' ' O ' ' A' ' 48' ' ' ALA . 10.9 mmt85 -119.62 150.94 39.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.2 -0.455 . . . . 44.119999999999997 110.832 -179.86 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -66.65 127.14 31.24 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.176 -0.465 . . . . 73.239999999999995 111.102 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.879 ' CG2' ' HB2' ' A' ' 48' ' ' ALA . 52.9 t -116.94 137.56 50.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.245 -0.434 . . . . 61.229999999999997 111.127 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' HIS . . . . . 0.438 ' O ' ' CG2' ' A' ' 136' ' ' VAL . 29.4 m80 -111.17 126.54 54.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.124 -0.489 . . . . 75.450000000000003 110.88 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.416 HD13 ' CB ' ' A' ' 178' ' ' GLU . 0.3 OUTLIER -39.63 137.99 1.03 Allowed Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.598 0.713 . . . . 62.340000000000003 110.899 -179.961 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.448 ' HB3' ' H ' ' A' ' 136' ' ' VAL . 53.8 Cg_endo -69.79 80.71 0.87 Allowed 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.713 2.275 . . . . 52.43 112.329 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -90.58 -177.12 4.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 64.409999999999997 110.838 -179.835 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 67.41 117.52 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.756 -0.735 . . . . 74.230000000000004 112.496 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 50.02 40.23 35.17 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.747 -0.74 . . . . 53.340000000000003 112.536 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.444 ' HB2' ' H ' ' A' ' 94' ' ' TYR . 12.8 pt20 40.21 -156.65 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.802 0.334 . . . . 75.019999999999996 110.901 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.634 ' OH ' HG23 ' A' ' 177' ' ' VAL . 0.1 OUTLIER -97.47 104.81 16.87 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.204 -0.453 . . . . 71.230000000000004 110.909 -179.875 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.496 ' HG3' HG11 ' A' ' 132' ' ' VAL . 45.7 tptt -105.99 131.34 53.4 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.132 -0.485 . . . . 74.140000000000001 110.885 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -150.23 137.38 13.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.252 -0.431 . . . . 75.150000000000006 111.141 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.446 ' HB2' ' O ' ' A' ' 131' ' ' LYS . 0.8 OUTLIER -112.77 135.6 53.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.205 -0.452 . . . . 74.019999999999996 110.93 179.935 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.635 HD13 HD11 ' A' ' 118' ' ' ILE . 1.5 mt -114.52 142.62 26.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.166 -0.47 . . . . 62.32 111.13 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.625 ' HB2' ' HB2' ' A' ' 129' ' ' SER . 57.1 m-85 -131.29 134.28 46.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.182 -0.463 . . . . 74.209999999999994 110.832 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 64.2 tt0 -63.59 -74.46 0.1 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.126 -0.488 . . . . 73.200000000000003 110.869 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.459 ' C ' ' HB3' ' A' ' 128' ' ' HIS . 9.7 mttt -83.11 177.45 8.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.142 -0.481 . . . . 74.239999999999995 110.854 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.427 ' HA2' ' HB3' ' A' ' 128' ' ' HIS . . . -83.61 161.1 38.34 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.732 -0.747 . . . . 75.319999999999993 112.49 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.444 ' HA ' ' HB2' ' A' ' 158' ' ' ARG . 30.4 t0 61.76 32.86 18.12 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.851 0.357 . . . . 71.349999999999994 110.885 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.576 ' HA ' ' CD2' ' A' ' 99' ' ' PHE . 21.1 m-85 59.35 48.88 9.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.191 -0.458 . . . . 75.150000000000006 110.924 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 4.4 m -114.25 150.06 34.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 55.520000000000003 110.85 -179.794 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 89.81 -127.73 8.88 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.721 -0.752 . . . . 43.520000000000003 112.506 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 -99.18 139.41 34.87 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.806 0.336 . . . . 73.430000000000007 110.885 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 4.4 ttp -128.74 146.17 50.97 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.183 -0.462 . . . . 73.430000000000007 110.862 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 18.9 m-85 -148.25 136.79 21.5 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.267 -0.424 . . . . 74.420000000000002 110.918 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -115.3 99.26 7.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.097 -0.501 . . . . 64.319999999999993 110.912 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 13.6 t -112.58 132.03 55.33 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.135 -0.484 . . . . 60.43 111.156 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.413 ' O ' ' OG1' ' A' ' 112' ' ' THR . 1.7 t -97.4 33.3 2.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.177 -0.465 . . . . 60.240000000000002 111.128 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -149.88 -176.05 5.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.199 -0.455 . . . . 64.129999999999995 110.917 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.509 ' CB ' ' HA ' ' A' ' 174' ' ' ARG . 5.3 p30 -103.45 171.29 7.45 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.184 -0.462 . . . . 74.010000000000005 110.895 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' CYS . . . . . 0.484 ' O ' ' HB2' ' A' ' 172' ' ' SER . 16.7 p -152.02 146.14 18.31 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.602 0.715 . . . . 64.200000000000003 110.908 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.417 ' O ' ' CA ' ' A' ' 143' ' ' PRO . 53.2 Cg_endo -69.8 -28.5 24.98 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.665 2.243 . . . . 62.030000000000001 112.305 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.633 ' HB3' ' CB ' ' A' ' 120' ' ' GLU . 0.1 OUTLIER -147.59 105.85 3.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.25 -0.432 . . . . 73.540000000000006 110.862 -179.858 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.737 HD13 HD11 ' A' ' 127' ' ' ILE . 3.6 tt -58.09 -29.77 37.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.165 -0.471 . . . . 53.439999999999998 111.146 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' MET . . . . . 0.596 ' O ' ' HA ' ' A' ' 123' ' ' HIS . 27.0 ttp -86.4 -43.72 12.61 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.458 . . . . 55.310000000000002 110.91 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.633 ' CB ' ' HB3' ' A' ' 117' ' ' SER . 9.4 tp10 -66.49 -13.21 60.56 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.223 -0.444 . . . . 74.209999999999994 110.857 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -114.62 -49.97 2.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.194 -0.457 . . . . 74.430000000000007 110.954 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.463 ' HB2' ' O ' ' A' ' 118' ' ' ILE . 63.2 m-85 -103.03 -20.37 14.22 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.2 -0.455 . . . . 74.420000000000002 110.874 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' HIS . . . . . 0.596 ' HA ' ' O ' ' A' ' 119' ' ' MET . 28.3 m-70 72.75 26.88 2.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.136 -0.484 . . . . 73.519999999999996 110.851 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.405 ' HB3' ' CD1' ' A' ' 127' ' ' ILE . 16.9 mtt -102.06 88.75 3.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.196 -0.456 . . . . 71.299999999999997 110.885 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 2.0 ptp85 -52.04 -42.86 63.43 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.26 -0.427 . . . . 74.109999999999999 110.869 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.465 ' HG2' ' HA ' ' A' ' 169' ' ' ALA . 13.4 mt-10 -137.2 130.75 31.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.213 -0.449 . . . . 71.25 110.902 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.737 HD11 HD13 ' A' ' 118' ' ' ILE . 3.4 mm -89.48 87.68 2.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.173 -0.467 . . . . 52.439999999999998 111.147 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' HIS . . . . . 0.459 ' HB3' ' C ' ' A' ' 101' ' ' LYS . 0.7 OUTLIER -62.4 -31.98 72.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.201 -0.454 . . . . 62.310000000000002 110.871 179.911 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.625 ' HB2' ' HB2' ' A' ' 99' ' ' PHE . 0.4 OUTLIER -134.35 142.38 47.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.172 -0.467 . . . . 65.25 110.801 -179.747 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 130' ' ' CYS . . . . . 0.624 ' O ' ' O ' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -143.17 117.61 9.69 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.151 -0.477 . . . . 73.310000000000002 110.882 -179.987 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.732 ' HA ' ' HA ' ' A' ' 156' ' ' GLU . 4.6 mtpp -106.67 150.86 25.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.217 -0.447 . . . . 61.130000000000003 110.915 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.496 HG11 ' HG3' ' A' ' 95' ' ' LYS . 3.4 t 74.27 165.84 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.234 -0.439 . . . . 74.239999999999995 111.11 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.674 HD12 ' O ' ' A' ' 154' ' ' LYS . 0.2 OUTLIER 172.77 128.84 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.136 -0.484 . . . . 45.329999999999998 110.936 179.929 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.584 ' CG ' ' HA ' ' A' ' 94' ' ' TYR . 0.7 OUTLIER -79.83 163.1 24.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.213 -0.449 . . . . 71.310000000000002 110.876 179.944 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.441 ' C ' ' O ' ' A' ' 134' ' ' GLU . . . -34.71 -42.98 0.36 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.777 -0.725 . . . . 74.409999999999997 112.455 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.665 HG11 ' CG1' ' A' ' 86' ' ' VAL . 2.1 t -146.61 137.74 18.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.825 0.345 . . . . 74.400000000000006 111.148 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' TRP . . . . . 0.6 ' HB3' ' HB3' ' A' ' 152' ' ' LEU . 9.9 t-105 -138.46 157.12 46.82 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.151 -0.477 . . . . 73.209999999999994 110.886 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.464 HG12 HG13 ' A' ' 176' ' ' ILE . 18.2 mm -121.44 132.31 70.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.206 -0.452 . . . . 73.349999999999994 111.142 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.575 ' CB ' ' HB2' ' A' ' 150' ' ' TYR . 0.1 OUTLIER -118.87 137.61 53.32 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.163 -0.471 . . . . 70.019999999999996 110.92 179.945 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 0.477 ' CD2' ' HA ' ' A' ' 145' ' ' TYR . 3.4 m-85 -119.37 132.05 55.79 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.13 -0.486 . . . . 71.400000000000006 110.923 -179.836 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.674 ' O ' ' HB2' ' A' ' 171' ' ' GLN . 10.9 tt0 -60.04 -27.61 67.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.096 -0.502 . . . . 73.530000000000001 110.895 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.746 ' HB3' ' HD2' ' A' ' 143' ' ' PRO . 10.0 mp -112.85 173.74 2.69 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-O 121.614 0.721 . . . . 51.340000000000003 110.899 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 143' ' ' PRO . . . . . 0.747 ' O ' ' OG ' ' A' ' 172' ' ' SER . 53.9 Cg_endo -69.79 -88.8 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.71 2.273 . . . . 73.120000000000005 112.312 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 144' ' ' ASN . . . . . 0.686 ' O ' ' N ' ' A' ' 146' ' ' ARG . 1.4 m-20 -52.91 96.56 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.26 -0.427 . . . . 74.200000000000003 110.861 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 145' ' ' TYR . . . . . 0.633 ' C ' ' O ' ' A' ' 144' ' ' ASN . 0.1 OUTLIER 13.12 52.9 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.144 -0.48 . . . . 62.350000000000001 110.935 -179.94 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 146' ' ' ARG . . . . . 0.686 ' N ' ' O ' ' A' ' 144' ' ' ASN . 8.8 mtp85 -119.38 179.36 4.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.141 -0.481 . . . . 73.430000000000007 110.89 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 147' ' ' GLY . . . . . 0.428 ' O ' HD21 ' A' ' 76' ' ' LEU . . . 77.02 -177.69 52.06 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.726 -0.749 . . . . 74.109999999999999 112.486 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.409 ' HG2' ' CD1' ' A' ' 58' ' ' TYR . 5.7 mtp180 -74.11 156.23 37.62 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.756 0.312 . . . . 64.540000000000006 110.913 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 149' ' ' GLN . . . . . 0.527 ' NE2' ' CD1' ' A' ' 60' ' ' TYR . 2.1 mt-30 -85.67 151.24 24.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.256 -0.429 . . . . 73.329999999999998 110.909 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 150' ' ' TYR . . . . . 0.575 ' HB2' ' CB ' ' A' ' 139' ' ' PHE . 73.8 m-85 -137.67 122.8 19.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.209 -0.45 . . . . 73.400000000000006 110.914 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.638 ' HB2' HD11 ' A' ' 61' ' ' ILE . 10.5 tp -81.56 121.9 26.89 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.147 -0.479 . . . . 74.420000000000002 110.932 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.98 HD13 ' O ' ' A' ' 152' ' ' LEU . 0.0 OUTLIER -51.71 139.33 21.4 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.162 -0.472 . . . . 75.140000000000001 110.925 179.916 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 153' ' ' ASP . . . . . 0.434 ' N ' HD22 ' A' ' 152' ' ' LEU . 1.1 t70 -162.68 26.45 0.1 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.208 -0.451 . . . . 64.430000000000007 110.822 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.935 ' HB2' ' CD1' ' A' ' 157' ' ' TYR . 2.9 ptmt -127.44 -173.49 2.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.162 -0.472 . . . . 70.430000000000007 110.906 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.733 ' HD2' ' C ' ' A' ' 154' ' ' LYS . 0.8 OUTLIER -161.58 -117.17 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.187 -0.46 . . . . 63.32 110.882 179.812 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.732 ' HA ' ' HA ' ' A' ' 131' ' ' LYS . 3.2 tm-20 -71.15 0.44 7.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.224 -0.444 . . . . 64.549999999999997 110.918 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 157' ' ' TYR . . . . . 0.935 ' CD1' ' HB2' ' A' ' 154' ' ' LYS . 13.6 m-30 -32.93 147.05 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.146 -0.479 . . . . 75.25 110.922 -179.836 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 158' ' ' ARG . . . . . 0.534 ' HB3' ' CZ ' ' A' ' 104' ' ' PHE . 9.8 ptp180 -113.0 -33.54 6.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.106 -0.497 . . . . 74.140000000000001 110.887 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 7.0 ptpt -99.04 151.86 37.55 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.597 0.713 . . . . 70.219999999999999 110.859 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.79 -25.71 28.16 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.716 2.278 . . . . 75.239999999999995 112.298 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.686 HD12 ' H ' ' A' ' 161' ' ' ILE . 3.8 mp -73.83 -6.03 7.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.251 -0.431 . . . . 51.439999999999998 111.111 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.676 ' HB3' ' CD1' ' A' ' 157' ' ' TYR . 1.7 t0 -73.04 -15.73 61.51 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.194 -0.457 . . . . 73.109999999999999 110.913 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 4.8 t90 -109.94 12.65 23.71 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.197 -0.456 . . . . 75.310000000000002 110.95 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 85.6 -34.51 3.31 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.753 -0.736 . . . . 55.310000000000002 112.493 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -55.31 119.86 6.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.772 0.32 . . . . 73.340000000000003 111.118 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -49.93 -26.69 4.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.216 -0.447 . . . . 73.0 111.098 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 167' ' ' SER . . . . . 0.479 ' C ' ' H ' ' A' ' 169' ' ' ALA . 0.3 OUTLIER -154.55 158.18 32.25 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.688 0.756 . . . . 52.100000000000001 110.819 -179.772 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 168' ' ' PRO . . . . . 0.41 ' HG3' ' CD2' ' A' ' 128' ' ' HIS . 53.9 Cg_endo -69.7 18.5 0.19 Allowed 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.752 2.301 . . . . 61.210000000000001 112.321 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.479 ' H ' ' C ' ' A' ' 167' ' ' SER . . . -63.45 102.97 0.47 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.235 -0.439 . . . . 43.310000000000002 111.13 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.47 HG11 ' CD1' ' A' ' 139' ' ' PHE . 3.1 t -153.37 163.61 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.173 -0.467 . . . . 72.150000000000006 111.105 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 171' ' ' GLN . . . . . 0.674 ' HB2' ' O ' ' A' ' 141' ' ' GLU . 1.9 mm-40 -110.23 -87.07 0.53 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.146 -0.479 . . . . 73.120000000000005 110.898 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 172' ' ' SER . . . . . 0.747 ' OG ' ' O ' ' A' ' 143' ' ' PRO . 47.0 p -125.48 172.92 9.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.213 -0.449 . . . . 71.030000000000001 110.857 -179.777 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 5.9 p90 -145.77 164.69 31.09 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.142 -0.481 . . . . 74.549999999999997 110.828 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 174' ' ' ARG . . . . . 0.509 ' HA ' ' CB ' ' A' ' 114' ' ' ASP . 0.0 OUTLIER -135.56 151.28 50.15 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.091 -0.504 . . . . 74.129999999999995 110.834 -179.909 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 175' ' ' ARG . . . . . 0.489 ' H ' ' HG3' ' A' ' 175' ' ' ARG . 0.0 OUTLIER -104.62 139.51 39.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.195 -0.457 . . . . 71.040000000000006 110.863 -179.911 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 176' ' ' ILE . . . . . 0.464 HG13 HG12 ' A' ' 138' ' ' ILE . 1.2 mt -77.25 132.45 32.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.17 -0.468 . . . . 61.109999999999999 111.172 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.634 HG23 ' OH ' ' A' ' 94' ' ' TYR . 7.7 p -118.21 155.73 20.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.189 -0.46 . . . . 73.040000000000006 111.103 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 178' ' ' GLU . . . . . 0.416 ' CB ' HD13 ' A' ' 88' ' ' LEU . 1.3 mp0 . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.14 -0.482 . . . . 71.25 110.88 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.757 0.313 . . . . 74.430000000000007 110.842 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.8 m -157.7 -174.64 4.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.262 -0.426 . . . . 73.010000000000005 110.854 -179.805 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 12.6 mttt -77.21 59.59 1.79 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.117 -0.492 . . . . 74.129999999999995 110.891 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 3.2 t -127.64 64.48 1.35 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.237 -0.438 . . . . 71.219999999999999 111.155 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -162.71 57.78 0.29 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.751 -0.737 . . . . 63.329999999999998 112.466 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.502 ' C ' ' HE1' ' A' ' 47' ' ' TRP . 5.7 p -82.1 136.03 35.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.886 0.374 . . . . 74.299999999999997 111.098 -179.845 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.407 ' HA ' ' HA ' ' A' ' 24' ' ' ASP . 3.2 tttt -122.24 136.11 54.85 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.178 -0.464 . . . . 75.510000000000005 110.899 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.627 ' HB ' ' CD1' ' A' ' 47' ' ' TRP . 15.4 tt -136.84 151.49 27.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.2 -0.454 . . . . 61.329999999999998 111.102 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.503 ' HA ' ' O ' ' A' ' 21' ' ' TYR . 17.1 m -132.81 140.07 47.8 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.161 -0.472 . . . . 62.229999999999997 111.165 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.718 ' HB2' HD22 ' A' ' 34' ' ' LEU . 1.0 OUTLIER -127.99 127.7 43.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.17 -0.468 . . . . 75.409999999999997 110.873 -179.947 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.539 ' CG ' ' HA ' ' A' ' 16' ' ' PHE . 14.1 m-85 -112.72 132.4 55.23 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.202 -0.454 . . . . 71.219999999999999 110.91 -179.831 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.445 ' HB2' ' HB2' ' A' ' 19' ' ' ARG . 0.0 OUTLIER -61.04 -14.71 25.3 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.125 -0.489 . . . . 74.219999999999999 110.924 179.991 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.438 ' HB2' ' O ' ' A' ' 17' ' ' GLN . 74.4 m-20 -135.93 150.43 49.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.137 -0.483 . . . . 73.150000000000006 110.868 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.486 ' N ' ' HB3' ' A' ' 38' ' ' ASN . 40.8 mtmt -55.25 -176.17 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.152 -0.476 . . . . 64.109999999999999 110.89 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 16.1 m120 46.43 32.43 1.58 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.227 -0.442 . . . . 71.439999999999998 110.939 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.539 ' HA ' ' CG ' ' A' ' 11' ' ' TYR . 3.6 m-85 49.67 64.33 1.81 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.154 -0.476 . . . . 73.340000000000003 110.877 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.438 ' O ' ' HB2' ' A' ' 13' ' ' ASP . 9.9 mt-30 -139.32 159.78 41.35 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.145 -0.48 . . . . 74.109999999999999 110.891 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 92.35 -148.19 19.03 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.786 -0.721 . . . . 71.430000000000007 112.455 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.759 ' O ' HD13 ' A' ' 34' ' ' LEU . 0.0 OUTLIER -70.02 77.78 0.49 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.859 0.361 . . . . 73.340000000000003 110.834 -179.795 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.469 ' HB2' ' CE1' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -76.87 129.1 35.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.163 -0.471 . . . . 74.109999999999999 110.877 -179.956 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.503 ' O ' ' HA ' ' A' ' 9' ' ' THR . 90.7 t80 -123.01 124.39 43.02 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.182 -0.463 . . . . 74.439999999999998 110.925 -179.842 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.472 ' CG ' HG23 ' A' ' 9' ' ' THR . 1.3 m-20 -121.06 133.99 55.26 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.142 -0.481 . . . . 74.310000000000002 110.856 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -168.13 135.59 2.17 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.213 -0.449 . . . . 55.210000000000001 110.908 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.407 ' HA ' ' HA ' ' A' ' 7' ' ' LYS . 4.8 p-10 -100.94 -2.6 31.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.193 -0.458 . . . . 61.25 110.871 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 15.6 t -100.9 165.68 11.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.201 -0.454 . . . . 72.0 110.904 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -59.14 120.26 8.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.2 -0.455 . . . . 74.510000000000005 110.855 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.578 ' HB2' ' HB3' ' A' ' 30' ' ' PHE . 1.7 m -115.29 51.0 0.94 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.204 -0.453 . . . . 52.439999999999998 110.879 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.495 ' C ' ' HA ' ' A' ' 82' ' ' SER . . . -46.43 -22.16 0.24 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.178 -0.464 . . . . 72.010000000000005 111.081 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 55.5 t0 -127.94 42.83 3.25 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.194 -0.457 . . . . 73.150000000000006 110.885 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.777 ' CD2' ' O ' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -81.17 15.68 1.83 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.459 . . . . 73.530000000000001 110.869 -179.929 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.495 ' HB2' ' HB3' ' A' ' 81' ' ' SER . 29.7 t60 -80.3 -39.26 29.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 74.219999999999999 110.889 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.7 t -58.43 -13.8 6.27 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.204 -0.453 . . . . 53.210000000000001 111.166 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -100.07 -26.95 13.79 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.236 -0.438 . . . . 74.209999999999994 110.947 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.759 HD13 ' O ' ' A' ' 19' ' ' ARG . 18.0 tp -142.79 135.11 27.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.144 -0.48 . . . . 64.329999999999998 110.93 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 25.3 m -97.63 -42.51 7.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.165 -0.47 . . . . 73.420000000000002 110.849 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -118.77 141.83 48.27 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.077 -0.511 . . . . 74.040000000000006 110.84 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.554 ' HB3' ' HB2' ' A' ' 80' ' ' LEU . 3.3 p -110.17 84.86 2.0 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.197 -0.456 . . . . 55.039999999999999 110.861 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.486 ' HB3' ' N ' ' A' ' 14' ' ' LYS . 0.2 OUTLIER -76.07 -71.1 0.4 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.238 -0.437 . . . . 73.430000000000007 110.871 -179.934 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 5.2 p -111.53 124.07 51.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.184 -0.462 . . . . 65.219999999999999 110.903 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.747 HD12 ' CH2' ' A' ' 73' ' ' TRP . 43.0 mt -117.25 149.32 19.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.151 -0.477 . . . . 73.439999999999998 111.113 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.465 ' HD2' ' CE2' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -144.67 120.36 10.49 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.126 -0.488 . . . . 65.439999999999998 110.93 179.812 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.497 ' CG2' HD12 ' A' ' 8' ' ' ILE . 1.5 t -105.25 116.32 48.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.216 -0.447 . . . . 61.009999999999998 111.123 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -111.11 79.22 1.18 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.174 -0.467 . . . . 73.430000000000007 110.897 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.468 ' O ' ' HA ' ' A' ' 6' ' ' THR . . . 129.9 104.31 1.08 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.74 -0.743 . . . . 54.229999999999997 112.513 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 53.08 175.18 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.681 -0.771 . . . . 63.420000000000002 112.526 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.733 HG23 ' HA ' ' A' ' 63' ' ' PRO . 1.0 OUTLIER -76.84 169.03 19.07 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.74 0.305 . . . . 71.340000000000003 111.148 -179.856 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.627 ' CD1' ' HB ' ' A' ' 8' ' ' ILE . 3.6 m95 -141.68 130.18 22.58 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.238 -0.437 . . . . 73.140000000000001 110.917 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.835 ' HB2' ' CG2' ' A' ' 86' ' ' VAL . . . -94.16 127.12 39.81 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.212 -0.449 . . . . 54.030000000000001 111.066 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.625 HG11 ' CD1' ' A' ' 80' ' ' LEU . 12.2 m -125.33 131.01 72.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.203 -0.453 . . . . 73.409999999999997 111.119 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.771 ' HB3' ' HA ' ' A' ' 56' ' ' ALA . 43.1 m-85 -98.32 147.3 24.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.174 -0.466 . . . . 75.409999999999997 110.937 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.644 ' OE1' ' HB3' ' A' ' 57' ' ' TRP . 46.9 tt0 -48.93 -79.68 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.13 -0.487 . . . . 73.019999999999996 110.865 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.551 ' HB2' ' HB2' ' A' ' 57' ' ' TRP . 0.0 OUTLIER -92.24 143.82 28.05 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.599 0.714 . . . . 70.010000000000005 110.853 -179.856 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.754 ' HA ' ' OG ' ' A' ' 82' ' ' SER . 53.7 Cg_endo -69.73 141.38 45.2 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.694 2.263 . . . . 71.510000000000005 112.381 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 63.54 -11.22 0.11 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.261 -0.427 . . . . 74.319999999999993 110.85 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.596 ' H ' ' C ' ' A' ' 53' ' ' PRO . 2.6 m-30 -104.45 -21.47 13.46 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.228 -0.442 . . . . 73.340000000000003 110.863 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.771 ' HA ' ' HB3' ' A' ' 50' ' ' TYR . . . 51.35 25.85 2.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.116 -0.493 . . . . 31.329999999999998 111.108 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' TRP . . . . . 0.644 ' HB3' ' OE1' ' A' ' 51' ' ' GLU . 0.0 OUTLIER -49.48 -163.1 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.215 -0.448 . . . . 65.519999999999996 110.948 179.995 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.638 ' C ' ' O ' ' A' ' 57' ' ' TRP . 6.1 m-30 -13.41 102.6 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.219 -0.446 . . . . 74.219999999999999 110.992 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.433 ' HB2' ' O ' ' A' ' 149' ' ' GLN . 2.0 mpt? -67.85 148.26 51.42 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.13 -0.486 . . . . 75.439999999999998 110.872 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.766 ' CD2' HD12 ' A' ' 76' ' ' LEU . 3.0 t80 -164.7 108.17 0.89 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.211 -0.449 . . . . 71.430000000000007 110.905 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.765 ' N ' HD12 ' A' ' 61' ' ' ILE . 1.4 mp -93.67 116.88 35.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.131 -0.486 . . . . 63.539999999999999 111.089 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.83 HD23 ' HD2' ' A' ' 63' ' ' PRO . 0.3 OUTLIER -83.95 127.96 64.95 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.559 0.695 . . . . 74.349999999999994 110.901 179.891 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.83 ' HD2' HD23 ' A' ' 62' ' ' LEU . 53.6 Cg_endo -69.76 -172.85 0.62 Allowed 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.652 2.235 . . . . 75.420000000000002 112.344 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.35 161.79 16.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.225 -0.443 . . . . 73.450000000000003 110.864 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 112.83 -165.61 12.06 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.702 -0.761 . . . . 44.439999999999998 112.459 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -109.93 154.36 23.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.901 0.382 . . . . 74.0 110.881 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.604 ' HB2' ' O ' ' A' ' 40' ' ' ILE . 10.7 m-85 -143.88 83.75 10.19 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.699 0.762 . . . . 71.409999999999997 110.944 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.449 ' HD2' ' HG3' ' A' ' 72' ' ' ARG . 53.8 Cg_endo -69.74 0.79 5.11 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.709 2.272 . . . . 73.439999999999998 112.344 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.544 ' HB2' ' HG2' ' A' ' 72' ' ' ARG . 41.3 mt-10 -155.88 144.11 19.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.457 . . . . 64.0 110.929 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.724 ' HA ' ' NE1' ' A' ' 73' ' ' TRP . 32.3 p90 -55.92 -21.65 21.67 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.172 -0.467 . . . . 72.530000000000001 110.883 -179.813 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -79.78 -16.47 55.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.144 -0.48 . . . . 71.340000000000003 110.921 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.544 ' HG2' ' HB2' ' A' ' 69' ' ' GLU . 28.1 mmt180 -69.47 -9.17 52.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.161 -0.472 . . . . 74.150000000000006 110.848 -179.895 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' TRP . . . . . 0.747 ' CH2' HD12 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -134.49 16.52 3.68 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.197 -0.456 . . . . 74.439999999999998 110.911 -179.966 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.406 ' C ' ' O ' ' A' ' 73' ' ' TRP . 0.0 OUTLIER 37.75 42.91 0.43 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.284 -0.416 . . . . 73.310000000000002 110.866 179.911 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -58.03 120.59 22.46 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.753 -0.737 . . . . 72.5 112.515 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.981 HD13 ' N ' ' A' ' 77' ' ' ASN . 0.0 OUTLIER -70.05 -10.7 59.56 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.787 0.327 . . . . 71.140000000000001 110.872 -179.898 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.981 ' N ' HD13 ' A' ' 76' ' ' LEU . 30.2 t-20 -156.36 131.24 9.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.199 -0.455 . . . . 72.200000000000003 110.904 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -83.95 23.06 1.06 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.186 -0.461 . . . . 63.219999999999999 110.868 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -109.92 78.47 1.13 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.195 -0.457 . . . . 61.210000000000001 110.891 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.625 ' CD1' HG11 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -85.77 133.51 33.99 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.167 -0.47 . . . . 73.319999999999993 110.929 -179.999 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.594 ' HB3' ' HB3' ' A' ' 53' ' ' PRO . 0.9 OUTLIER -150.03 -125.04 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.184 -0.462 . . . . 54.43 110.912 -179.947 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.754 ' OG ' ' HA ' ' A' ' 53' ' ' PRO . 0.0 OUTLIER -35.03 103.81 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.12 -0.491 . . . . 62.450000000000003 110.832 -179.833 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 83' ' ' CYS . . . . . 0.614 ' HB3' HG12 ' A' ' 49' ' ' VAL . 19.8 p -121.88 134.45 54.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.152 -0.476 . . . . 74.310000000000002 110.854 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.595 ' N ' ' O ' ' A' ' 48' ' ' ALA . 11.6 mmt85 -120.4 139.51 52.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.184 -0.462 . . . . 74.519999999999996 110.871 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.431 ' N ' ' CZ3' ' A' ' 47' ' ' TRP . . . -58.15 129.17 40.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 73.510000000000005 111.111 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.835 ' CG2' ' HB2' ' A' ' 48' ' ' ALA . 55.5 t -113.23 133.74 58.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.194 -0.457 . . . . 64.219999999999999 111.093 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' HIS . . . . . 0.628 ' O ' HG23 ' A' ' 136' ' ' VAL . 23.1 m80 -114.43 111.21 21.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.113 -0.494 . . . . 72.120000000000005 110.827 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.469 ' H ' HD23 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -33.39 140.13 0.24 Allowed Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.564 0.697 . . . . 72.439999999999998 110.937 -179.986 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.558 ' HB3' ' H ' ' A' ' 136' ' ' VAL . 53.7 Cg_endo -69.79 105.13 1.44 Allowed 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.718 2.278 . . . . 64.209999999999994 112.331 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -106.16 -177.97 3.52 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.201 -0.454 . . . . 74.310000000000002 110.833 -179.815 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 45.45 63.22 2.82 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.74 -0.743 . . . . 23.039999999999999 112.476 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.41 ' O ' ' C ' ' A' ' 93' ' ' GLN . . . 123.82 20.65 2.53 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.716 -0.754 . . . . 64.540000000000006 112.493 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.478 ' O ' ' HG2' ' A' ' 134' ' ' GLU . 2.0 pt20 37.47 -120.67 0.2 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.839 0.352 . . . . 70.340000000000003 110.901 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.466 ' O ' ' HA ' ' A' ' 112' ' ' THR . 0.0 OUTLIER -124.87 100.78 6.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.19 -0.459 . . . . 73.349999999999994 110.945 -179.86 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.512 ' HG3' HG11 ' A' ' 132' ' ' VAL . 31.3 tptt -110.69 126.53 54.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.173 -0.467 . . . . 73.299999999999997 110.929 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 8.0 tt -147.54 136.17 15.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.198 -0.456 . . . . 74.239999999999995 111.108 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.428 ' HB2' ' O ' ' A' ' 131' ' ' LYS . 1.2 mt-30 -107.82 131.56 54.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.203 -0.453 . . . . 74.120000000000005 110.925 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.58 HD11 ' CD1' ' A' ' 122' ' ' PHE . 13.1 pt -111.41 136.79 46.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.192 -0.458 . . . . 71.299999999999997 111.117 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.575 ' HB2' ' CB ' ' A' ' 129' ' ' SER . 62.4 m-85 -124.82 136.9 54.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.196 -0.456 . . . . 62.219999999999999 110.895 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -68.95 -58.3 4.31 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.099 -0.501 . . . . 55.439999999999998 110.905 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 21.0 mttt -101.59 149.46 24.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.126 -0.488 . . . . 75.230000000000004 110.942 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -57.8 163.72 7.94 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.755 -0.736 . . . . 74.120000000000005 112.469 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.523 ' HA ' ' HB2' ' A' ' 158' ' ' ARG . 42.1 t0 64.13 29.0 14.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.853 0.359 . . . . 71.409999999999997 110.912 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.68 ' CZ ' ' HB3' ' A' ' 158' ' ' ARG . 5.1 m-85 57.51 46.07 18.48 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.174 -0.466 . . . . 75.010000000000005 110.888 -179.873 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 2.3 m -114.08 158.02 21.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.181 -0.463 . . . . 70.109999999999999 110.871 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 86.88 -137.09 14.52 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.711 -0.756 . . . . 53.509999999999998 112.488 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 38.1 tp60 -90.39 126.6 35.93 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.812 0.339 . . . . 71.200000000000003 110.934 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' MET . . . . . 0.445 ' HB2' ' CE1' ' A' ' 99' ' ' PHE . 19.1 ttp -113.17 146.3 39.49 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.215 -0.448 . . . . 73.340000000000003 110.875 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -152.6 137.19 16.87 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.192 -0.458 . . . . 52.219999999999999 110.95 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -119.31 113.8 21.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.161 -0.472 . . . . 74.209999999999994 110.905 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 14.6 t -124.24 145.9 49.07 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.163 -0.471 . . . . 61.049999999999997 111.108 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.466 ' HA ' ' O ' ' A' ' 94' ' ' TYR . 1.5 t -122.92 41.64 3.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.205 -0.452 . . . . 54.119999999999997 111.129 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -150.59 -172.74 4.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.262 -0.426 . . . . 72.230000000000004 110.888 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -84.39 164.57 18.83 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.159 -0.473 . . . . 74.200000000000003 110.836 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 8.2 t -157.89 129.14 3.77 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.64 0.733 . . . . 73.099999999999994 110.914 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.724 ' O ' ' HB2' ' A' ' 172' ' ' SER . 53.9 Cg_endo -69.75 -44.15 2.25 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.718 2.279 . . . . 61.219999999999999 112.384 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.636 ' HB3' ' CB ' ' A' ' 120' ' ' GLU . 0.1 OUTLIER -138.8 102.78 4.65 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.172 -0.467 . . . . 74.329999999999998 110.874 -179.859 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.615 ' HB ' ' O ' ' A' ' 171' ' ' GLN . 3.0 tt -51.13 -30.08 9.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.101 -0.5 . . . . 74.099999999999994 111.144 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' MET . . . . . 0.56 ' O ' ' HA ' ' A' ' 123' ' ' HIS . 3.6 ttt -85.32 -46.19 11.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.159 -0.473 . . . . 72.549999999999997 110.867 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.636 ' CB ' ' HB3' ' A' ' 117' ' ' SER . 14.1 tp10 -63.42 -13.6 41.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.183 -0.462 . . . . 73.510000000000005 110.866 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 26.3 tp60 -114.7 -52.91 2.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.156 -0.475 . . . . 72.340000000000003 110.931 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.58 ' CD1' HD11 ' A' ' 98' ' ' ILE . 86.7 m-85 -99.33 -22.44 15.58 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.456 . . . . 74.430000000000007 110.864 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' HIS . . . . . 0.56 ' HA ' ' O ' ' A' ' 119' ' ' MET . 0.5 OUTLIER 76.67 24.6 0.96 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.176 -0.466 . . . . 70.25 110.87 179.984 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.469 ' O ' ' CG2' ' A' ' 118' ' ' ILE . 9.4 mtt -103.38 81.79 1.97 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.186 -0.461 . . . . 74.420000000000002 110.865 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 2.1 ptp85 -46.82 -40.99 14.8 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.251 -0.431 . . . . 74.420000000000002 110.854 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.498 ' HB3' ' HG2' ' A' ' 168' ' ' PRO . 32.7 mt-10 -142.67 130.43 21.54 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.162 -0.472 . . . . 74.219999999999999 110.9 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.603 HG22 ' O ' ' A' ' 127' ' ' ILE . 1.3 mp -87.69 97.1 6.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.219 -0.446 . . . . 63.009999999999998 111.13 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' HIS . . . . . 0.452 ' HA ' ' HB3' ' A' ' 160' ' ' PRO . 0.3 OUTLIER -69.67 -25.99 64.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.218 -0.446 . . . . 74.540000000000006 110.908 179.854 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.575 ' CB ' ' HB2' ' A' ' 99' ' ' PHE . 0.0 OUTLIER -136.68 139.02 41.67 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.158 -0.474 . . . . 75.25 110.828 -179.788 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 130' ' ' CYS . . . . . 0.598 ' O ' ' O ' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -138.17 119.52 14.76 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.108 -0.497 . . . . 62.539999999999999 110.846 -179.975 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.646 ' HA ' ' HA ' ' A' ' 156' ' ' GLU . 4.4 mtpp -113.08 152.31 29.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.15 -0.477 . . . . 61.399999999999999 110.897 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.552 HG23 ' C ' ' A' ' 131' ' ' LYS . 10.8 t 84.15 163.58 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.183 -0.462 . . . . 72.530000000000001 111.13 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.746 HD22 ' CG ' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -177.45 124.58 0.13 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.198 -0.456 . . . . 71.400000000000006 110.973 179.943 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.542 ' O ' ' C ' ' A' ' 135' ' ' GLY . 0.2 OUTLIER -99.58 167.09 10.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.165 -0.471 . . . . 75.129999999999995 110.887 179.965 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.542 ' C ' ' O ' ' A' ' 134' ' ' GLU . . . -24.93 -74.03 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.698 -0.763 . . . . 72.439999999999998 112.528 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.729 ' HB ' HD12 ' A' ' 176' ' ' ILE . 3.1 t -135.01 147.97 29.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.84 0.353 . . . . 72.129999999999995 111.127 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' TRP . . . . . 0.717 ' H ' HD12 ' A' ' 152' ' ' LEU . 0.0 OUTLIER -152.03 162.41 41.13 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.202 -0.454 . . . . 71.329999999999998 110.929 179.977 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.515 HG21 ' HD2' ' A' ' 174' ' ' ARG . 19.4 mt -135.15 137.69 49.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.234 -0.439 . . . . 74.040000000000006 111.1 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.562 ' CD2' HG11 ' A' ' 170' ' ' VAL . 0.2 OUTLIER -110.93 146.12 37.14 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.154 -0.475 . . . . 72.450000000000003 110.892 179.914 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 0.714 ' CE2' ' HA ' ' A' ' 145' ' ' TYR . 0.6 OUTLIER -107.08 131.14 54.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.13 -0.486 . . . . 71.329999999999998 110.912 -179.831 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.596 ' O ' ' NE2' ' A' ' 171' ' ' GLN . 7.5 tt0 -70.66 -27.3 63.93 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.086 -0.507 . . . . 73.219999999999999 110.9 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.574 ' O ' ' HB3' ' A' ' 172' ' ' SER . 5.8 mp -113.37 147.15 36.82 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.58 0.705 . . . . 73.430000000000007 110.931 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 143' ' ' PRO . . . . . 0.698 ' CD ' ' HG2' ' A' ' 171' ' ' GLN . 53.9 Cg_endo -69.7 43.68 0.38 Allowed 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.694 2.262 . . . . 74.049999999999997 112.349 179.834 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 144' ' ' ASN . . . . . 1.093 ' O ' ' N ' ' A' ' 146' ' ' ARG . 0.4 OUTLIER 177.87 111.49 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.209 -0.45 . . . . 71.420000000000002 110.888 179.96 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 145' ' ' TYR . . . . . 0.714 ' HA ' ' CE2' ' A' ' 140' ' ' TYR . 0.1 OUTLIER -6.59 52.18 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.156 -0.475 . . . . 73.150000000000006 110.876 -179.892 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 146' ' ' ARG . . . . . 1.093 ' N ' ' O ' ' A' ' 144' ' ' ASN . 40.7 mtt180 -140.16 170.52 15.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.121 -0.49 . . . . 72.519999999999996 110.885 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 81.0 -167.61 49.92 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.706 -0.759 . . . . 61.130000000000003 112.464 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.424 ' HG2' ' CD1' ' A' ' 58' ' ' TYR . 0.5 OUTLIER -88.58 142.98 27.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.778 0.323 . . . . 62.32 110.901 -179.935 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 149' ' ' GLN . . . . . 0.433 ' O ' ' HB2' ' A' ' 59' ' ' MET . 74.0 mt-30 -84.07 162.83 20.2 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.157 -0.474 . . . . 63.509999999999998 110.931 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 150' ' ' TYR . . . . . 0.412 ' HB2' ' HB2' ' A' ' 139' ' ' PHE . 92.8 m-85 -134.96 116.73 15.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.238 -0.437 . . . . 74.299999999999997 110.985 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.668 HD23 ' OH ' ' A' ' 50' ' ' TYR . 9.9 tp -68.6 119.09 12.48 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.129 -0.487 . . . . 74.25 110.877 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 1.055 HD13 ' O ' ' A' ' 152' ' ' LEU . 0.0 OUTLIER -51.4 135.45 27.22 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.18 -0.464 . . . . 61.549999999999997 110.903 179.899 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -163.37 24.84 0.08 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.177 -0.465 . . . . 75.430000000000007 110.848 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.783 ' HB2' ' CD1' ' A' ' 157' ' ' TYR . 0.0 OUTLIER -115.47 -173.54 2.35 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.252 -0.431 . . . . 73.450000000000003 110.913 -179.996 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.746 ' CG ' HD22 ' A' ' 133' ' ' LEU . 0.8 OUTLIER -161.48 -124.56 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.264 -0.425 . . . . 73.329999999999998 110.904 179.907 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.646 ' HA ' ' HA ' ' A' ' 131' ' ' LYS . 1.7 tm-20 -70.43 2.74 3.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 73.439999999999998 110.876 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 157' ' ' TYR . . . . . 0.783 ' CD1' ' HB2' ' A' ' 154' ' ' LYS . 18.4 m-30 -32.79 147.04 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.167 -0.469 . . . . 72.140000000000001 110.904 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 158' ' ' ARG . . . . . 0.68 ' HB3' ' CZ ' ' A' ' 104' ' ' PHE . 8.2 ptp180 -113.5 -37.45 4.63 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.097 -0.501 . . . . 73.299999999999997 110.844 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -89.01 152.54 48.44 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.576 0.703 . . . . 55.149999999999999 110.869 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 160' ' ' PRO . . . . . 0.544 ' HB3' ' HB3' ' A' ' 168' ' ' PRO . 54.3 Cg_endo -69.74 -29.29 24.2 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.658 2.239 . . . . 71.109999999999999 112.369 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.684 HD12 ' H ' ' A' ' 161' ' ' ILE . 4.3 mp -66.37 -10.5 11.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.216 -0.447 . . . . 74.319999999999993 111.161 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.671 ' HB3' ' CD1' ' A' ' 157' ' ' TYR . 0.5 OUTLIER -77.0 -13.94 59.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.143 -0.481 . . . . 74.040000000000006 110.853 179.848 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 163' ' ' TRP . . . . . 0.447 ' CE3' ' HB3' ' A' ' 165' ' ' ALA . 26.3 t90 -87.95 -7.68 56.78 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.245 -0.434 . . . . 63.020000000000003 110.921 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 99.3 -36.82 3.81 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.755 -0.736 . . . . 24.109999999999999 112.454 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.447 ' HB3' ' CE3' ' A' ' 163' ' ' TRP . . . -76.88 126.7 31.42 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.8 0.333 . . . . 72.230000000000004 111.149 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -37.27 -42.83 0.49 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.229 -0.441 . . . . 62.299999999999997 111.053 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 167' ' ' SER . . . . . 0.491 ' C ' ' H ' ' A' ' 169' ' ' ALA . 0.5 OUTLIER -127.64 152.34 76.65 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.68 0.752 . . . . 71.450000000000003 110.835 -179.786 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 168' ' ' PRO . . . . . 0.544 ' HB3' ' HB3' ' A' ' 160' ' ' PRO . 53.7 Cg_endo -69.76 27.97 0.18 Allowed 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.689 2.259 . . . . 71.019999999999996 112.379 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.491 ' H ' ' C ' ' A' ' 167' ' ' SER . . . -67.6 99.98 0.83 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.215 -0.448 . . . . 55.32 111.149 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.582 HG12 ' H ' ' A' ' 171' ' ' GLN . 1.4 t -155.41 173.62 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.195 -0.457 . . . . 62.420000000000002 111.108 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 171' ' ' GLN . . . . . 0.698 ' HG2' ' CD ' ' A' ' 143' ' ' PRO . 0.0 OUTLIER -159.17 -97.55 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.165 -0.47 . . . . 75.430000000000007 110.91 -179.998 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 172' ' ' SER . . . . . 0.724 ' HB2' ' O ' ' A' ' 116' ' ' PRO . 0.0 OUTLIER -64.62 153.77 38.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.23 -0.441 . . . . 51.109999999999999 110.851 -179.791 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 173' ' ' PHE . . . . . 0.404 ' HB3' ' CD2' ' A' ' 139' ' ' PHE . 1.2 p90 -151.96 158.21 42.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.146 -0.479 . . . . 71.349999999999994 110.888 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 174' ' ' ARG . . . . . 0.515 ' HD2' HG21 ' A' ' 138' ' ' ILE . 1.3 ptp180 -130.22 142.39 50.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.17 -0.468 . . . . 73.439999999999998 110.935 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 175' ' ' ARG . . . . . 0.432 ' HD2' ' CE2' ' A' ' 94' ' ' TYR . 0.0 OUTLIER -98.19 -169.21 1.77 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.21 -0.45 . . . . 72.049999999999997 110.902 -179.882 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 176' ' ' ILE . . . . . 0.729 HD12 ' HB ' ' A' ' 136' ' ' VAL . 4.1 mt -139.05 132.03 38.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.222 -0.444 . . . . 53.130000000000003 111.17 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 4.8 p -144.62 155.83 14.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.208 -0.451 . . . . 75.340000000000003 111.085 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.125 -0.488 . . . . 72.040000000000006 110.933 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.066 0 CA-C-O 120.829 0.347 . . . . 70.120000000000005 110.903 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.4 p -95.24 73.81 3.36 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.206 -0.452 . . . . 65.129999999999995 110.839 -179.775 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.51 61.09 3.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.115 -0.493 . . . . 61.439999999999998 110.911 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 27.1 p -53.98 -35.79 62.2 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.178 -0.464 . . . . 64.340000000000003 111.142 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 159.8 128.27 0.96 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.727 -0.749 . . . . 73.200000000000003 112.475 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.429 ' HA ' ' O ' ' A' ' 44' ' ' GLY . 10.9 p -82.33 136.11 35.07 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.898 0.38 . . . . 63.009999999999998 111.122 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.472 ' N ' ' HE1' ' A' ' 47' ' ' TRP . 2.6 tttt -127.91 138.12 52.54 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.203 -0.453 . . . . 62.240000000000002 110.852 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.514 HD12 ' CG2' ' A' ' 42' ' ' VAL . 16.0 tt -136.68 150.89 27.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.165 -0.47 . . . . 74.340000000000003 111.084 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.484 HG22 ' CE2' ' A' ' 11' ' ' TYR . 9.3 m -132.55 140.94 48.51 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.159 -0.473 . . . . 62.32 111.111 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.722 ' HB2' HD22 ' A' ' 34' ' ' LEU . 1.6 m-85 -129.2 131.68 47.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.228 -0.442 . . . . 72.409999999999997 110.924 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.54 ' CG ' ' HA ' ' A' ' 16' ' ' PHE . 6.2 m-85 -117.41 134.09 55.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.142 -0.481 . . . . 74.349999999999994 110.915 -179.825 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.46 ' HB2' ' H ' ' A' ' 19' ' ' ARG . 0.0 OUTLIER -56.83 -28.56 61.74 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.129 -0.487 . . . . 60.420000000000002 110.848 -179.968 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 49.4 m-20 -123.29 155.42 37.26 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.201 -0.454 . . . . 44.109999999999999 110.855 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 7.9 mtmm -57.41 -173.35 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 54.130000000000003 110.884 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 23.3 m-20 44.34 34.76 1.11 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.2 -0.454 . . . . 75.25 110.851 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.54 ' HA ' ' CG ' ' A' ' 11' ' ' TYR . 2.6 m-85 47.7 59.8 3.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.227 -0.442 . . . . 60.109999999999999 110.878 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 10.6 mt-30 -133.23 154.14 50.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.172 -0.467 . . . . 73.319999999999993 110.918 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 95.67 -154.43 20.96 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.768 -0.73 . . . . 42.140000000000001 112.446 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.752 ' O ' HD13 ' A' ' 34' ' ' LEU . 0.6 OUTLIER -63.65 81.7 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.857 0.361 . . . . 71.329999999999998 110.86 -179.838 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.516 ' HB2' ' CE1' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -81.05 127.52 32.69 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.193 -0.458 . . . . 75.040000000000006 110.859 -179.918 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.449 ' CZ ' ' CD1' ' A' ' 33' ' ' TYR . 82.8 t80 -124.23 125.71 44.86 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.217 -0.447 . . . . 65.230000000000004 110.903 -179.865 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -111.25 131.45 55.13 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.11 -0.495 . . . . 74.230000000000004 110.876 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -142.58 143.12 32.31 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.19 -0.459 . . . . 54.549999999999997 110.856 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -125.64 5.09 7.5 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.191 -0.459 . . . . 74.230000000000004 110.894 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 50.6 t -129.71 159.19 37.25 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.137 -0.483 . . . . 64.099999999999994 110.91 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -42.87 108.48 0.1 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.177 -0.465 . . . . 50.439999999999998 110.878 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.608 ' HB3' ' HB3' ' A' ' 30' ' ' PHE . 0.1 OUTLIER -119.8 51.38 1.18 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.202 -0.453 . . . . 52.130000000000003 110.887 -179.92 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.546 ' C ' ' HA ' ' A' ' 82' ' ' SER . . . -50.61 -14.61 0.2 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.209 -0.451 . . . . 65.530000000000001 111.08 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 63.6 t0 -127.3 42.21 3.37 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.227 -0.442 . . . . 64.510000000000005 110.88 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.819 ' CD2' ' O ' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -82.28 14.34 3.0 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.192 -0.458 . . . . 73.439999999999998 110.849 -179.885 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.536 ' HB2' ' HB3' ' A' ' 53' ' ' PRO . 31.3 t60 -76.8 -44.4 32.82 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.158 -0.474 . . . . 65.420000000000002 110.854 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.428 HG23 ' CD2' ' A' ' 33' ' ' TYR . 9.7 t -54.7 -13.57 1.06 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.156 -0.475 . . . . 73.519999999999996 111.147 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.498 ' CD1' ' HA ' ' A' ' 30' ' ' PHE . 12.3 m-85 -97.27 -29.65 13.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.224 -0.444 . . . . 71.299999999999997 110.91 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.752 HD13 ' O ' ' A' ' 19' ' ' ARG . 31.7 tp -137.85 140.35 40.41 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.101 -0.5 . . . . 71.409999999999997 110.907 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 2.6 m -104.16 -38.71 6.8 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.155 -0.475 . . . . 60.310000000000002 110.861 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.491 ' O ' HD21 ' A' ' 34' ' ' LEU . 0.2 OUTLIER -111.18 140.85 45.4 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.172 -0.467 . . . . 63.32 110.839 -179.928 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.471 ' SG ' ' CB ' ' A' ' 80' ' ' LEU . 2.0 m -122.46 76.35 1.32 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.157 -0.474 . . . . 71.540000000000006 110.871 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -80.15 -71.11 0.47 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.142 -0.481 . . . . 73.099999999999994 110.842 -179.846 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 4.8 p -104.52 134.54 47.53 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.157 -0.474 . . . . 73.150000000000006 110.869 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.744 HD12 ' CH2' ' A' ' 73' ' ' TRP . 19.4 mt -126.86 151.69 33.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.124 -0.489 . . . . 73.409999999999997 111.147 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.475 ' HD2' ' CE2' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -146.59 122.12 10.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.201 -0.454 . . . . 74.409999999999997 110.856 179.894 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.528 HG12 ' O ' ' A' ' 42' ' ' VAL . 1.4 t -108.41 114.63 47.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.259 -0.428 . . . . 74.299999999999997 111.134 179.824 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.407 ' N ' ' O ' ' A' ' 7' ' ' LYS . 1.5 mm-40 -109.79 79.06 1.17 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.193 -0.458 . . . . 72.409999999999997 110.827 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.429 ' O ' ' HA ' ' A' ' 6' ' ' THR . . . 134.2 102.72 0.76 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.794 -0.717 . . . . 55.009999999999998 112.524 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 52.21 -178.26 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.723 -0.751 . . . . 72.230000000000004 112.471 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.737 HG23 ' HA ' ' A' ' 63' ' ' PRO . 0.6 OUTLIER -81.57 172.19 13.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.809 0.338 . . . . 55.399999999999999 111.117 -179.846 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.558 ' H ' HG22 ' A' ' 46' ' ' THR . 13.2 m95 -142.59 130.04 21.23 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.214 -0.448 . . . . 70.310000000000002 110.898 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.841 ' HB2' ' CG2' ' A' ' 86' ' ' VAL . . . -97.39 108.89 21.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.234 -0.439 . . . . 71.430000000000007 111.109 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.849 HG11 HD11 ' A' ' 80' ' ' LEU . 4.2 m -111.45 130.96 64.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.215 -0.448 . . . . 73.140000000000001 111.13 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.663 ' HB3' ' HA ' ' A' ' 56' ' ' ALA . 56.6 m-85 -93.88 148.56 22.02 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.177 -0.465 . . . . 73.040000000000006 110.947 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.651 ' HB2' ' HB2' ' A' ' 58' ' ' TYR . 39.1 tt0 -45.38 -78.22 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.103 -0.499 . . . . 63.5 110.892 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.645 ' HB3' ' CD2' ' A' ' 55' ' ' PHE . 0.2 OUTLIER -90.78 144.77 30.81 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.574 0.702 . . . . 71.329999999999998 110.906 -179.924 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.745 ' HA ' ' OG ' ' A' ' 82' ' ' SER . 54.0 Cg_endo -69.79 131.38 21.08 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.688 2.259 . . . . 73.25 112.35 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 67.8 -8.2 0.54 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.218 -0.446 . . . . 72.299999999999997 110.891 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.645 ' CD2' ' HB3' ' A' ' 52' ' ' ARG . 6.2 m-30 -98.43 -27.73 13.94 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.181 -0.463 . . . . 73.140000000000001 110.884 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.663 ' HA ' ' HB3' ' A' ' 50' ' ' TYR . . . 62.79 16.42 9.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.173 -0.467 . . . . 64.319999999999993 111.153 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' TRP . . . . . 0.646 ' O ' ' C ' ' A' ' 58' ' ' TYR . 0.1 OUTLIER -49.02 -167.94 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.176 -0.465 . . . . 70.430000000000007 110.923 -179.958 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.651 ' HB2' ' HB2' ' A' ' 51' ' ' GLU . 8.1 m-30 -13.06 103.08 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.217 -0.447 . . . . 72.340000000000003 110.908 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.432 ' HB2' ' O ' ' A' ' 149' ' ' GLN . 1.9 mpt? -68.54 148.66 50.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.148 -0.478 . . . . 71.319999999999993 110.844 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.79 ' CD2' HD12 ' A' ' 76' ' ' LEU . 3.3 t80 -163.66 108.77 1.05 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.232 -0.44 . . . . 65.450000000000003 110.943 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.789 ' N ' HD12 ' A' ' 61' ' ' ILE . 1.5 mp -95.02 116.13 35.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.081 -0.508 . . . . 74.099999999999994 111.121 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.77 HD23 ' HD2' ' A' ' 63' ' ' PRO . 0.2 OUTLIER -84.07 128.78 61.23 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.611 0.719 . . . . 75.409999999999997 110.932 179.888 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.77 ' HD2' HD23 ' A' ' 62' ' ' LEU . 53.8 Cg_endo -69.74 -172.74 0.61 Allowed 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.705 2.27 . . . . 74.129999999999995 112.368 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -88.12 161.96 17.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.246 -0.434 . . . . 75.25 110.877 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 112.2 -167.94 12.55 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.719 -0.753 . . . . 42.109999999999999 112.457 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -108.05 156.44 19.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.855 0.359 . . . . 73.209999999999994 110.862 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.622 ' HB2' ' O ' ' A' ' 40' ' ' ILE . 15.7 m-85 -144.19 84.39 9.5 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.684 0.754 . . . . 73.209999999999994 110.904 -179.869 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.419 ' HD2' ' HG3' ' A' ' 72' ' ' ARG . 53.2 Cg_endo -69.83 2.83 3.21 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.7 2.267 . . . . 71.299999999999997 112.344 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.608 ' HB2' ' HG2' ' A' ' 72' ' ' ARG . 52.6 mt-10 -157.38 143.45 17.7 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.199 -0.455 . . . . 75.299999999999997 110.889 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.741 ' HA ' ' NE1' ' A' ' 73' ' ' TRP . 30.6 p90 -55.35 -21.39 14.99 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.161 -0.472 . . . . 40.530000000000001 110.916 -179.86 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -81.25 -17.15 50.48 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.099 -0.501 . . . . 74.019999999999996 110.876 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.608 ' HG2' ' HB2' ' A' ' 69' ' ' GLU . 33.0 mmt180 -68.32 -10.61 56.06 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.233 -0.439 . . . . 74.349999999999994 110.853 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' TRP . . . . . 0.744 ' CH2' HD12 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -133.13 17.7 4.1 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.182 -0.463 . . . . 74.430000000000007 110.869 -179.953 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 40.56 37.45 0.47 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.275 -0.42 . . . . 73.329999999999998 110.868 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -52.06 114.22 3.08 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.738 -0.744 . . . . 64.400000000000006 112.521 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 1.016 HD13 ' N ' ' A' ' 77' ' ' ASN . 0.0 OUTLIER -63.82 -16.7 61.93 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.781 0.324 . . . . 74.319999999999993 110.87 -179.889 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 1.016 ' N ' HD13 ' A' ' 76' ' ' LEU . 57.8 t-20 -157.87 130.53 7.32 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.194 -0.457 . . . . 73.409999999999997 110.936 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -77.5 9.17 3.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.174 -0.466 . . . . 62.149999999999999 110.879 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.416 ' HG2' ' O ' ' A' ' 79' ' ' ARG . 24.1 ttt85 -88.9 38.38 0.88 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.205 -0.452 . . . . 65.540000000000006 110.889 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.849 HD11 HG11 ' A' ' 49' ' ' VAL . 0.1 OUTLIER -56.7 126.84 28.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.143 -0.481 . . . . 51.329999999999998 110.87 -179.931 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.655 ' HB3' ' HB3' ' A' ' 53' ' ' PRO . 4.4 m -142.8 -117.55 0.1 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.191 -0.459 . . . . 73.340000000000003 110.889 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.745 ' OG ' ' HA ' ' A' ' 53' ' ' PRO . 0.4 OUTLIER -30.38 130.36 0.1 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.127 -0.488 . . . . 75.400000000000006 110.844 -179.848 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 83' ' ' CYS . . . . . 0.545 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 11.0 p -138.74 144.43 39.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.176 -0.466 . . . . 73.120000000000005 110.855 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.508 ' N ' ' O ' ' A' ' 48' ' ' ALA . 0.6 OUTLIER -141.31 128.17 20.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.165 -0.47 . . . . 72.239999999999995 110.905 -179.865 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.429 ' N ' ' CZ3' ' A' ' 47' ' ' TRP . . . -49.64 126.89 14.61 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.24 -0.437 . . . . 51.32 111.126 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.841 ' CG2' ' HB2' ' A' ' 48' ' ' ALA . 48.4 t -114.17 132.9 61.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.214 -0.448 . . . . 64.409999999999997 111.126 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' HIS . . . . . 0.769 ' O ' HG23 ' A' ' 136' ' ' VAL . 20.3 m-70 -108.15 105.18 14.8 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.16 -0.473 . . . . 62.140000000000001 110.872 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.627 HD12 ' HB3' ' A' ' 178' ' ' GLU . 0.0 OUTLIER -35.55 144.29 0.24 Allowed Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.566 0.698 . . . . 72.310000000000002 110.931 179.993 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.472 ' HA ' ' HA3' ' A' ' 135' ' ' GLY . 54.1 Cg_endo -69.76 87.67 0.55 Allowed 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.684 2.256 . . . . 53.340000000000003 112.323 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -105.92 -177.57 3.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.265 -0.425 . . . . 51.520000000000003 110.846 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 60.88 23.94 61.96 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.74 -0.743 . . . . 73.329999999999998 112.5 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.413 ' O ' ' C ' ' A' ' 93' ' ' GLN . . . 153.24 34.33 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.735 -0.745 . . . . 44.409999999999997 112.452 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.492 ' O ' ' CG ' ' A' ' 134' ' ' GLU . 23.6 pt20 36.37 -135.07 0.05 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.811 0.339 . . . . 62.149999999999999 110.916 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.465 ' O ' ' HA ' ' A' ' 112' ' ' THR . 13.9 t80 -119.71 106.8 12.49 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.184 -0.462 . . . . 70.349999999999994 110.907 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.541 ' HG3' HG11 ' A' ' 132' ' ' VAL . 36.3 tptt -108.65 128.69 55.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.107 -0.497 . . . . 75.299999999999997 110.922 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.425 HD12 ' OH ' ' A' ' 94' ' ' TYR . 6.8 tt -148.39 144.17 18.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.231 -0.44 . . . . 70.530000000000001 111.116 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.589 ' O ' ' HA ' ' A' ' 130' ' ' CYS . 1.3 mt-30 -115.97 111.57 20.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.153 -0.476 . . . . 74.530000000000001 110.897 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.563 ' CG2' HD12 ' A' ' 127' ' ' ILE . 2.7 mm -86.49 140.97 15.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.222 -0.445 . . . . 75.420000000000002 111.11 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.565 ' HB2' ' HB2' ' A' ' 129' ' ' SER . 57.4 m-85 -130.91 133.16 45.6 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.201 -0.454 . . . . 72.030000000000001 110.878 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 60.6 tt0 -61.4 -80.14 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.189 -0.459 . . . . 55.210000000000001 110.878 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 12.2 mttt -85.51 162.44 18.92 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.145 -0.479 . . . . 63.130000000000003 110.898 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -67.86 162.28 48.55 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.691 -0.766 . . . . 62.450000000000003 112.512 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.516 ' HA ' ' HB2' ' A' ' 158' ' ' ARG . 36.5 t70 64.46 27.16 13.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.861 0.362 . . . . 75.150000000000006 110.876 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.54 ' CZ ' ' HB3' ' A' ' 158' ' ' ARG . 8.8 m-85 59.57 48.14 9.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.153 -0.476 . . . . 74.420000000000002 110.915 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 2.9 m -113.45 143.92 43.68 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.148 -0.478 . . . . 75.319999999999993 110.85 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 96.41 -124.15 7.98 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.74 -0.743 . . . . 74.140000000000001 112.447 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 4.9 tp-100 -102.77 143.62 32.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.799 0.333 . . . . 74.25 110.841 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 2.9 ttp -130.33 146.43 51.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.182 -0.463 . . . . 73.540000000000006 110.84 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 11.8 m-85 -148.13 137.5 22.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.174 -0.466 . . . . 75.230000000000004 110.925 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -118.63 101.24 7.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.121 -0.49 . . . . 75.299999999999997 110.88 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 8.1 t -118.24 153.21 34.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 64.409999999999997 111.177 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.465 ' HA ' ' O ' ' A' ' 94' ' ' TYR . 1.4 t -125.45 47.25 2.22 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.223 -0.444 . . . . 65.150000000000006 111.116 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 75.0 mm-40 -148.32 -175.2 4.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.264 -0.426 . . . . 60.420000000000002 110.863 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -101.94 150.96 22.67 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.134 -0.485 . . . . 71.049999999999997 110.884 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 11.1 m -143.03 136.83 14.37 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.638 0.732 . . . . 74.209999999999994 110.857 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.765 ' O ' ' HB2' ' A' ' 172' ' ' SER . 53.9 Cg_endo -69.72 -34.34 14.9 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.752 2.301 . . . . 73.230000000000004 112.354 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.64 ' HB3' ' CB ' ' A' ' 120' ' ' GLU . 0.1 OUTLIER -140.79 97.96 3.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.178 -0.464 . . . . 74.109999999999999 110.839 -179.831 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.782 HD13 HD11 ' A' ' 127' ' ' ILE . 5.0 tt -49.54 -28.33 3.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.146 -0.479 . . . . 63.530000000000001 111.132 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' MET . . . . . 0.568 ' O ' ' HA ' ' A' ' 123' ' ' HIS . 7.2 ttt -84.71 -42.61 15.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.157 -0.474 . . . . 65.340000000000003 110.89 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.64 ' CB ' ' HB3' ' A' ' 117' ' ' SER . 24.3 tp10 -62.5 -13.22 28.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.218 -0.446 . . . . 63.219999999999999 110.907 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.485 ' NE2' ' CG ' ' A' ' 122' ' ' PHE . 0.5 OUTLIER -113.92 -52.93 2.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.152 -0.476 . . . . 73.120000000000005 110.931 -179.961 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.485 ' CG ' ' NE2' ' A' ' 121' ' ' GLN . 12.0 m-30 -101.93 -18.93 15.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.205 -0.452 . . . . 64.319999999999993 110.885 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' HIS . . . . . 0.568 ' HA ' ' O ' ' A' ' 119' ' ' MET . 10.7 m80 74.5 24.62 1.74 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.136 -0.484 . . . . 74.109999999999999 110.86 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.465 ' SD ' HG22 ' A' ' 98' ' ' ILE . 8.6 mtt -100.39 83.31 2.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.223 -0.444 . . . . 75.319999999999993 110.921 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 3.6 ptp180 -49.5 -33.05 13.5 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.186 -0.461 . . . . 72.230000000000004 110.888 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.536 ' HB3' ' HG2' ' A' ' 168' ' ' PRO . 16.0 mt-10 -145.44 129.23 17.26 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.122 -0.49 . . . . 75.430000000000007 110.886 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.782 HD11 HD13 ' A' ' 118' ' ' ILE . 3.0 mm -87.33 91.13 3.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.147 -0.479 . . . . 72.430000000000007 111.122 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -61.9 -34.45 76.07 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.187 -0.461 . . . . 70.519999999999996 110.865 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.565 ' HB2' ' HB2' ' A' ' 99' ' ' PHE . 0.6 OUTLIER -135.05 152.13 51.41 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.224 -0.444 . . . . 74.420000000000002 110.887 -179.751 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 130' ' ' CYS . . . . . 0.597 ' O ' ' O ' ' A' ' 155' ' ' LYS . 0.1 OUTLIER -155.25 121.04 5.07 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.157 -0.474 . . . . 54.399999999999999 110.852 -179.94 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.657 ' HA ' ' HA ' ' A' ' 156' ' ' GLU . 8.7 mtpp -108.57 153.85 22.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.191 -0.459 . . . . 71.230000000000004 110.88 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.57 HG23 ' C ' ' A' ' 131' ' ' LYS . 11.3 t 85.76 164.7 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.197 -0.456 . . . . 72.5 111.14 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.747 HD22 ' CG ' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -176.93 122.76 0.14 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.189 -0.46 . . . . 63.409999999999997 110.921 179.918 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.614 ' O ' ' C ' ' A' ' 135' ' ' GLY . 0.0 OUTLIER -98.75 159.12 15.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.13 -0.486 . . . . 73.019999999999996 110.873 179.95 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.614 ' C ' ' O ' ' A' ' 134' ' ' GLU . . . -13.57 -75.63 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.769 -0.729 . . . . 63.439999999999998 112.497 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.821 HG21 HG13 ' A' ' 86' ' ' VAL . 5.6 t -136.1 148.81 27.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.821 0.343 . . . . 75.540000000000006 111.129 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' TRP . . . . . 0.631 ' HB3' ' HB3' ' A' ' 152' ' ' LEU . 22.8 t90 -146.2 148.65 32.74 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.157 -0.474 . . . . 71.510000000000005 110.934 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.46 HD13 ' HB ' ' A' ' 61' ' ' ILE . 0.4 OUTLIER -118.05 135.11 59.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.245 -0.434 . . . . 41.229999999999997 111.123 179.953 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.533 ' CZ ' HG11 ' A' ' 170' ' ' VAL . 0.1 OUTLIER -110.07 147.51 33.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.173 -0.467 . . . . 74.25 110.863 179.977 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 0.711 ' HB2' ' O ' ' A' ' 172' ' ' SER . 0.8 OUTLIER -115.32 129.67 56.67 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.18 -0.464 . . . . 74.329999999999998 110.898 -179.855 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.625 ' O ' ' NE2' ' A' ' 171' ' ' GLN . 8.1 tt0 -69.34 -28.6 66.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.126 -0.488 . . . . 73.439999999999998 110.926 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.775 ' O ' ' HB3' ' A' ' 172' ' ' SER . 5.9 mp -113.41 148.48 39.73 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.629 0.728 . . . . 71.340000000000003 110.876 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' PRO . . . . . 0.684 ' CD ' ' HG2' ' A' ' 171' ' ' GLN . 53.5 Cg_endo -69.74 43.95 0.39 Allowed 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.695 2.263 . . . . 73.340000000000003 112.328 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 144' ' ' ASN . . . . . 1.093 ' O ' ' N ' ' A' ' 146' ' ' ARG . 0.4 OUTLIER 177.47 111.23 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.261 -0.427 . . . . 75.420000000000002 110.928 179.996 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 145' ' ' TYR . . . . . 0.66 ' HA ' ' CE2' ' A' ' 140' ' ' TYR . 0.2 OUTLIER -6.36 52.37 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.159 -0.473 . . . . 72.439999999999998 110.911 -179.895 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 146' ' ' ARG . . . . . 1.093 ' N ' ' O ' ' A' ' 144' ' ' ASN . 26.9 mtt180 -138.85 167.12 22.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.11 -0.495 . . . . 73.239999999999995 110.858 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 83.89 -165.35 41.79 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.692 -0.766 . . . . 64.439999999999998 112.5 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -88.07 146.45 25.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.751 0.31 . . . . 72.019999999999996 110.912 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' GLN . . . . . 0.432 ' O ' ' HB2' ' A' ' 59' ' ' MET . 28.2 mt-30 -88.59 161.91 16.66 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.239 -0.437 . . . . 75.219999999999999 110.903 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 150' ' ' TYR . . . . . 0.465 ' HB2' ' CB ' ' A' ' 139' ' ' PHE . 85.9 m-85 -135.72 130.87 34.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.162 -0.472 . . . . 73.200000000000003 110.932 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.649 HD23 ' OH ' ' A' ' 50' ' ' TYR . 9.2 tp -82.87 120.34 25.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.152 -0.476 . . . . 72.519999999999996 110.914 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.935 HD13 ' O ' ' A' ' 152' ' ' LEU . 0.0 OUTLIER -51.62 136.77 26.17 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.208 -0.451 . . . . 75.129999999999995 110.888 179.877 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -164.53 24.93 0.06 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.207 -0.451 . . . . 75.519999999999996 110.834 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.843 ' HB2' ' CD1' ' A' ' 157' ' ' TYR . 0.0 OUTLIER -119.42 -176.57 3.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.239 -0.437 . . . . 75.340000000000003 110.936 179.968 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.747 ' CG ' HD22 ' A' ' 133' ' ' LEU . 1.1 mptt -159.09 -121.72 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.216 -0.447 . . . . 74.439999999999998 110.912 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.657 ' HA ' ' HA ' ' A' ' 131' ' ' LYS . 2.9 tm-20 -68.93 0.09 4.91 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.175 -0.466 . . . . 52.539999999999999 110.881 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 157' ' ' TYR . . . . . 0.843 ' CD1' ' HB2' ' A' ' 154' ' ' LYS . 16.5 m-30 -32.01 147.5 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.151 -0.477 . . . . 72.120000000000005 110.968 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 158' ' ' ARG . . . . . 0.54 ' HB3' ' CZ ' ' A' ' 104' ' ' PHE . 6.8 ptp180 -112.5 -41.78 3.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.145 -0.479 . . . . 74.129999999999995 110.85 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -85.95 150.57 53.11 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.56 0.695 . . . . 75.340000000000003 110.906 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 160' ' ' PRO . . . . . 0.52 ' HB3' ' HB3' ' A' ' 168' ' ' PRO . 54.1 Cg_endo -69.74 -31.57 20.36 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.719 2.279 . . . . 71.019999999999996 112.364 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.761 HD12 ' H ' ' A' ' 161' ' ' ILE . 3.5 mp -62.25 -12.75 8.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.236 -0.438 . . . . 72.0 111.115 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.587 ' HB3' ' CD1' ' A' ' 157' ' ' TYR . 0.5 OUTLIER -70.44 -12.26 61.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.216 -0.447 . . . . 55.200000000000003 110.874 179.842 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 75.4 t-105 -90.95 -12.96 34.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.23 -0.441 . . . . 74.5 110.928 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 93.03 -35.25 4.17 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.769 -0.729 . . . . 43.329999999999998 112.487 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -79.84 123.24 27.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.818 0.342 . . . . 61.229999999999997 111.076 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -49.38 122.6 6.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.167 -0.469 . . . . 42.020000000000003 111.094 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 167' ' ' SER . . . . . 0.469 ' C ' ' H ' ' A' ' 169' ' ' ALA . 0.5 OUTLIER 64.89 140.86 0.06 OUTLIER Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.637 0.732 . . . . 71.319999999999993 110.909 -179.768 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 168' ' ' PRO . . . . . 0.536 ' HG2' ' HB3' ' A' ' 126' ' ' GLU . 53.5 Cg_endo -69.8 33.6 0.2 Allowed 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.717 2.278 . . . . 64.049999999999997 112.317 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.473 ' O ' HG22 ' A' ' 170' ' ' VAL . . . -67.19 98.28 0.59 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.233 -0.44 . . . . 71.230000000000004 111.148 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.597 HG12 ' H ' ' A' ' 171' ' ' GLN . 1.1 t -156.97 175.32 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.221 -0.445 . . . . 65.25 111.13 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 171' ' ' GLN . . . . . 0.701 ' N ' ' CD ' ' A' ' 171' ' ' GLN . 0.0 OUTLIER -160.66 -99.93 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.146 -0.479 . . . . 54.299999999999997 110.911 -179.957 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 172' ' ' SER . . . . . 0.775 ' HB3' ' O ' ' A' ' 142' ' ' LEU . 0.1 OUTLIER -52.46 140.61 22.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.168 -0.469 . . . . 34.229999999999997 110.868 -179.793 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 173' ' ' PHE . . . . . 0.484 ' HB3' ' CE1' ' A' ' 139' ' ' PHE . 18.9 p90 -156.44 149.84 24.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.114 -0.494 . . . . 64.540000000000006 110.89 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 174' ' ' ARG . . . . . 0.478 ' HD3' ' CE2' ' A' ' 140' ' ' TYR . 0.0 OUTLIER -149.21 157.58 43.48 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.128 -0.487 . . . . 70.530000000000001 110.851 -179.899 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 175' ' ' ARG . . . . . 0.415 ' H ' ' HD2' ' A' ' 175' ' ' ARG . 0.0 OUTLIER -106.29 172.08 7.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.221 -0.445 . . . . 73.129999999999995 110.854 -179.938 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 176' ' ' ILE . . . . . 0.806 HD12 ' HB ' ' A' ' 136' ' ' VAL . 6.5 mt -97.78 143.38 12.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.175 -0.466 . . . . 72.209999999999994 111.132 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 67.8 t -48.36 140.72 2.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.164 -0.471 . . . . 73.400000000000006 111.128 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 178' ' ' GLU . . . . . 0.627 ' HB3' HD12 ' A' ' 88' ' ' LEU . 1.2 mm-40 . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 116.213 -0.448 . . . . 74.239999999999995 110.907 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.066 0 CA-C-O 120.803 0.335 . . . . 71.25 110.846 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.7 p -65.36 -61.34 2.17 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.206 -0.452 . . . . 71.519999999999996 110.847 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 52.29 59.66 4.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.103 -0.499 . . . . 64.140000000000001 110.935 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 6.9 p -83.68 53.4 2.53 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.174 -0.466 . . . . 74.340000000000003 111.114 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 68.05 125.81 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.798 -0.715 . . . . 34.229999999999997 112.468 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.503 ' C ' ' HE1' ' A' ' 47' ' ' TRP . 5.2 p -82.41 134.3 35.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.906 0.384 . . . . 64.310000000000002 111.105 -179.832 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 3.9 tttt -120.06 135.87 54.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.176 -0.465 . . . . 73.310000000000002 110.906 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.616 ' HB ' ' CD1' ' A' ' 47' ' ' TRP . 15.5 tt -137.14 151.88 27.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.231 -0.44 . . . . 61.310000000000002 111.159 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.499 ' HA ' ' O ' ' A' ' 21' ' ' TYR . 18.1 m -132.86 142.45 48.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.192 -0.458 . . . . 61.43 111.153 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.722 ' HB2' HD22 ' A' ' 34' ' ' LEU . 0.8 OUTLIER -130.08 129.03 43.07 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.25 -0.432 . . . . 73.420000000000002 110.875 -179.965 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.547 ' CG ' ' HA ' ' A' ' 16' ' ' PHE . 12.5 m-85 -114.4 131.65 56.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.136 -0.484 . . . . 53.509999999999998 110.93 -179.867 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.438 ' HB2' ' HB2' ' A' ' 19' ' ' ARG . 0.1 OUTLIER -59.5 -16.49 24.83 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.117 -0.492 . . . . 72.430000000000007 110.864 -179.97 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.443 ' HB2' ' O ' ' A' ' 17' ' ' GLN . 72.2 m-20 -134.14 150.56 51.12 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.167 -0.469 . . . . 71.120000000000005 110.885 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.469 ' N ' ' HB3' ' A' ' 38' ' ' ASN . 34.2 mtmt -55.61 -176.58 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.196 -0.456 . . . . 64.299999999999997 110.864 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 20.2 m120 47.22 32.45 2.1 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.194 -0.457 . . . . 50.310000000000002 110.908 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.547 ' HA ' ' CG ' ' A' ' 11' ' ' TYR . 3.3 m-85 49.74 62.66 2.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 72.200000000000003 110.916 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.443 ' O ' ' HB2' ' A' ' 13' ' ' ASP . 18.3 mt-30 -137.75 159.22 42.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.116 -0.493 . . . . 71.120000000000005 110.895 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 92.7 -148.49 19.11 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.765 -0.731 . . . . 74.140000000000001 112.482 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.757 ' O ' HD13 ' A' ' 34' ' ' LEU . 0.3 OUTLIER -69.75 78.43 0.45 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.797 0.332 . . . . 75.540000000000006 110.844 -179.8 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.487 ' HB2' ' CE1' ' A' ' 11' ' ' TYR . 0.6 OUTLIER -76.88 130.35 37.46 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.188 -0.46 . . . . 65.129999999999995 110.845 -179.91 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.499 ' O ' ' HA ' ' A' ' 9' ' ' THR . 89.2 t80 -124.33 123.65 40.67 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.193 -0.458 . . . . 74.25 110.895 -179.829 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.471 ' CG ' HG23 ' A' ' 9' ' ' THR . 1.2 m-20 -121.14 133.78 55.21 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.089 -0.505 . . . . 73.400000000000006 110.856 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -168.31 136.67 2.26 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.196 -0.457 . . . . 62.049999999999997 110.916 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -101.93 -0.69 33.46 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.185 -0.461 . . . . 74.299999999999997 110.839 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 16.8 t -102.85 164.34 11.68 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.226 -0.443 . . . . 71.239999999999995 110.911 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -57.68 120.86 9.1 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.238 -0.437 . . . . 70.420000000000002 110.894 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.55 ' HB2' ' HB3' ' A' ' 30' ' ' PHE . 1.8 m -116.63 51.13 1.0 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.185 -0.461 . . . . 72.420000000000002 110.853 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.495 ' C ' ' HA ' ' A' ' 82' ' ' SER . . . -47.07 -21.1 0.2 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.226 -0.443 . . . . 73.019999999999996 111.099 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 55.0 t0 -128.17 41.77 3.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.202 -0.454 . . . . 74.420000000000002 110.862 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.773 ' CD2' ' O ' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -81.35 13.18 3.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.184 -0.462 . . . . 73.040000000000006 110.851 -179.881 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.479 ' HB2' ' HB3' ' A' ' 53' ' ' PRO . 28.8 t60 -78.75 -40.44 33.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.143 -0.48 . . . . 73.099999999999994 110.803 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.7 t -56.33 -16.14 5.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.197 -0.456 . . . . 74.109999999999999 111.126 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -98.26 -25.95 14.69 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.21 -0.45 . . . . 64.019999999999996 110.932 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.757 HD13 ' O ' ' A' ' 19' ' ' ARG . 16.3 tp -144.13 131.58 20.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.076 -0.511 . . . . 43.299999999999997 110.901 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 24.5 m -93.81 -42.88 8.88 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.193 -0.458 . . . . 63.420000000000002 110.839 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 1.1 tmm_? -118.41 140.64 49.54 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.163 -0.471 . . . . 72.099999999999994 110.861 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.493 ' HB3' ' HB2' ' A' ' 80' ' ' LEU . 4.0 p -108.71 81.08 1.4 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.164 -0.471 . . . . 74.430000000000007 110.913 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.469 ' HB3' ' N ' ' A' ' 14' ' ' LYS . 0.2 OUTLIER -70.4 -73.26 0.17 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.17 -0.468 . . . . 75.109999999999999 110.879 -179.882 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 4.3 p -109.21 125.03 51.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.208 -0.451 . . . . 74.109999999999999 110.841 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.756 HG21 HD13 ' A' ' 62' ' ' LEU . 45.3 mt -118.05 148.83 20.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.127 -0.488 . . . . 73.420000000000002 111.11 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.468 ' HD2' ' CE2' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -144.69 119.26 9.73 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.207 -0.451 . . . . 64.420000000000002 110.847 179.868 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.535 HG22 ' HB ' ' A' ' 8' ' ' ILE . 2.0 t -104.04 115.66 46.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.186 -0.461 . . . . 72.140000000000001 111.121 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -110.27 79.39 1.2 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.202 -0.454 . . . . 71.010000000000005 110.884 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.438 ' O ' ' HA ' ' A' ' 6' ' ' THR . . . 129.31 106.89 1.25 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.704 -0.76 . . . . 70.420000000000002 112.501 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 51.89 -178.75 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.764 -0.732 . . . . 54.32 112.463 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.705 HG23 ' HA ' ' A' ' 63' ' ' PRO . 1.2 m -83.23 168.29 16.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.749 0.309 . . . . 73.439999999999998 111.137 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.616 ' CD1' ' HB ' ' A' ' 8' ' ' ILE . 3.4 m95 -141.04 130.19 23.44 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.276 -0.42 . . . . 74.010000000000005 110.918 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.882 ' HB2' ' CG2' ' A' ' 86' ' ' VAL . . . -93.52 129.27 39.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.275 -0.42 . . . . 74.329999999999998 111.102 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.665 HG11 ' CD1' ' A' ' 80' ' ' LEU . 15.5 m -129.02 125.83 63.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.206 -0.452 . . . . 75.209999999999994 111.108 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.73 ' HB3' ' HA ' ' A' ' 56' ' ' ALA . 42.8 m-85 -92.16 150.11 21.1 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.16 -0.473 . . . . 72.430000000000007 110.929 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.648 ' OE1' ' HB3' ' A' ' 57' ' ' TRP . 54.2 tt0 -49.99 -78.94 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.099 -0.5 . . . . 55.240000000000002 110.865 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.544 ' HB3' ' CD2' ' A' ' 55' ' ' PHE . 0.0 OUTLIER -93.66 144.68 28.58 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.626 0.727 . . . . 74.349999999999994 110.848 -179.867 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.772 ' HA ' ' OG ' ' A' ' 82' ' ' SER . 53.8 Cg_endo -69.78 141.76 46.01 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.702 2.268 . . . . 64.310000000000002 112.346 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 63.38 -11.89 0.09 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.226 -0.443 . . . . 75.209999999999994 110.878 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.61 ' H ' ' C ' ' A' ' 53' ' ' PRO . 2.5 m-30 -104.01 -19.13 14.31 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.148 -0.478 . . . . 73.120000000000005 110.893 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.73 ' HA ' ' HB3' ' A' ' 50' ' ' TYR . . . 49.47 25.46 1.37 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.138 -0.483 . . . . 71.299999999999997 111.09 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' TRP . . . . . 0.648 ' HB3' ' OE1' ' A' ' 51' ' ' GLU . 0.0 OUTLIER -50.01 -166.06 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.243 -0.435 . . . . 74.549999999999997 110.982 -179.988 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.636 ' C ' ' O ' ' A' ' 57' ' ' TRP . 10.0 m-30 -14.1 101.32 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.267 -0.424 . . . . 75.340000000000003 110.913 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.482 ' HB2' ' HA ' ' A' ' 150' ' ' TYR . 1.6 mpt? -64.14 157.57 25.22 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.089 -0.505 . . . . 73.340000000000003 110.879 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.723 ' CD2' HD12 ' A' ' 76' ' ' LEU . 2.6 t80 -170.48 103.98 0.27 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.259 -0.428 . . . . 64.319999999999993 110.925 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.625 HD11 ' HB2' ' A' ' 151' ' ' LEU . 0.8 OUTLIER -91.23 115.09 29.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.115 -0.493 . . . . 64.299999999999997 111.113 179.904 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.79 HD23 ' HD2' ' A' ' 63' ' ' PRO . 0.3 OUTLIER -81.84 126.32 75.65 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.595 0.712 . . . . 73.230000000000004 110.949 179.861 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.79 ' HD2' HD23 ' A' ' 62' ' ' LEU . 53.9 Cg_endo -69.71 -176.1 1.36 Allowed 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.729 2.286 . . . . 71.049999999999997 112.348 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -84.51 161.66 20.16 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.238 -0.437 . . . . 73.5 110.899 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 113.64 -162.47 12.37 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.74 -0.743 . . . . 55.539999999999999 112.491 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -115.68 156.45 25.89 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.899 0.38 . . . . 74.349999999999994 110.847 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.554 ' HB2' ' O ' ' A' ' 40' ' ' ILE . 9.4 m-85 -145.17 83.72 9.07 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.669 0.747 . . . . 74.540000000000006 110.943 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.409 ' HD2' ' HG3' ' A' ' 72' ' ' ARG . 53.8 Cg_endo -69.77 0.67 5.32 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.686 2.257 . . . . 54.329999999999998 112.326 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.483 ' HB2' ' HG2' ' A' ' 72' ' ' ARG . 42.4 mt-10 -155.79 142.72 18.99 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.268 -0.424 . . . . 74.310000000000002 110.922 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.693 ' HA ' ' NE1' ' A' ' 73' ' ' TRP . 24.1 p90 -56.11 -21.38 21.97 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.205 -0.452 . . . . 72.239999999999995 110.899 -179.838 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -78.2 -18.42 55.51 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.094 -0.503 . . . . 62.149999999999999 110.894 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.483 ' HG2' ' HB2' ' A' ' 69' ' ' GLU . 29.4 mmt180 -67.52 -9.25 40.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.213 -0.449 . . . . 71.299999999999997 110.919 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' TRP . . . . . 0.714 ' CD1' ' N ' ' A' ' 73' ' ' TRP . 0.0 OUTLIER -135.51 5.89 3.22 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.175 -0.466 . . . . 74.040000000000006 110.93 -179.979 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 11.6 mtp 45.42 68.64 0.54 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.234 -0.439 . . . . 64.420000000000002 110.934 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -60.66 120.79 24.33 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.749 -0.739 . . . . 71.230000000000004 112.47 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.876 HD13 ' N ' ' A' ' 77' ' ' ASN . 0.0 OUTLIER -70.75 -8.79 54.82 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.805 0.336 . . . . 71.420000000000002 110.897 -179.954 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.876 ' N ' HD13 ' A' ' 76' ' ' LEU . 10.7 t-20 -151.46 -41.83 0.12 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.217 -0.447 . . . . 73.219999999999999 110.885 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.581 ' CB ' ' O ' ' A' ' 77' ' ' ASN . 1.8 t70 89.88 7.68 0.1 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.186 -0.461 . . . . 72.510000000000005 110.872 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -105.81 91.43 3.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.181 -0.463 . . . . 73.519999999999996 110.888 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.665 ' CD1' HG11 ' A' ' 49' ' ' VAL . 0.1 OUTLIER -90.28 135.54 33.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.172 -0.467 . . . . 65.109999999999999 110.965 -180.0 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.631 ' HB3' ' HB3' ' A' ' 53' ' ' PRO . 1.2 m -151.94 -118.66 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.198 -0.455 . . . . 75.099999999999994 110.884 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.772 ' OG ' ' HA ' ' A' ' 53' ' ' PRO . 0.2 OUTLIER -44.57 101.8 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.142 -0.481 . . . . 70.129999999999995 110.851 -179.824 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 83' ' ' CYS . . . . . 0.601 ' HB3' HG12 ' A' ' 49' ' ' VAL . 15.9 p -115.77 141.43 48.11 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.133 -0.485 . . . . 75.409999999999997 110.887 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.6 ' N ' ' O ' ' A' ' 48' ' ' ALA . 13.8 mmt85 -128.38 134.7 48.88 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.218 -0.447 . . . . 63.240000000000002 110.884 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.465 ' N ' ' CZ3' ' A' ' 47' ' ' TRP . . . -53.06 127.44 24.05 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.456 . . . . 45.420000000000002 111.08 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.882 ' CG2' ' HB2' ' A' ' 48' ' ' ALA . 73.7 t -115.05 135.43 55.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.238 -0.437 . . . . 71.129999999999995 111.136 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 28.7 m-70 -112.08 120.2 41.03 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.15 -0.477 . . . . 74.349999999999994 110.859 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.763 HD13 ' HB3' ' A' ' 178' ' ' GLU . 0.1 OUTLIER -40.04 137.65 1.18 Allowed Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.62 0.724 . . . . 72.099999999999994 110.942 -179.961 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.65 ' HB3' ' H ' ' A' ' 136' ' ' VAL . 53.9 Cg_endo -69.72 81.17 0.83 Allowed 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.7 2.266 . . . . 75.519999999999996 112.363 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -98.72 119.15 36.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.242 -0.435 . . . . 72.120000000000005 110.881 -179.856 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 130.51 85.98 0.39 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.755 -0.735 . . . . 53.130000000000003 112.496 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 88.1 35.63 8.81 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.782 -0.723 . . . . 73.519999999999996 112.471 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.46 ' O ' ' HG3' ' A' ' 134' ' ' GLU . 12.4 pt20 39.47 -154.18 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.832 0.349 . . . . 73.400000000000006 110.917 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.596 ' O ' ' HA ' ' A' ' 112' ' ' THR . 28.0 m-85 -96.17 102.35 14.12 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.199 -0.455 . . . . 71.340000000000003 110.919 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.506 ' H ' ' CG ' ' A' ' 134' ' ' GLU . 35.4 tptt -109.58 126.18 53.33 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.139 -0.482 . . . . 72.439999999999998 110.895 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 5.3 tt -150.6 137.19 12.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.189 -0.46 . . . . 74.340000000000003 111.119 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -108.14 135.11 50.04 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.17 -0.468 . . . . 72.120000000000005 110.917 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.582 ' CG2' HD12 ' A' ' 127' ' ' ILE . 26.0 mm -115.37 134.7 57.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.231 -0.44 . . . . 72.420000000000002 111.113 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.589 ' HB2' ' HB2' ' A' ' 129' ' ' SER . 61.7 m-85 -123.13 140.07 53.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 74.329999999999998 110.885 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.551 ' HA ' ' CE ' ' A' ' 124' ' ' MET . 58.6 tt0 -75.06 -52.64 10.54 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.161 -0.472 . . . . 72.340000000000003 110.922 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 40.8 mttt -106.8 155.29 19.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.136 -0.484 . . . . 63.450000000000003 110.932 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.406 ' N ' ' HB3' ' A' ' 128' ' ' HIS . . . -62.24 157.3 36.6 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.772 -0.728 . . . . 65.120000000000005 112.467 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.55 ' HA ' ' HB2' ' A' ' 158' ' ' ARG . 12.8 t70 69.48 39.92 1.52 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.896 0.379 . . . . 63.439999999999998 110.878 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.526 ' HA ' ' CD1' ' A' ' 99' ' ' PHE . 2.1 m-85 55.32 25.13 7.16 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.176 -0.465 . . . . 74.120000000000005 110.886 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 68.0 m -92.94 166.83 12.19 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.18 -0.464 . . . . 70.129999999999995 110.831 -179.776 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 79.18 -157.66 43.16 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.75 -0.738 . . . . 72.049999999999997 112.511 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 4.3 tp-100 -75.08 119.58 19.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.794 0.33 . . . . 73.239999999999995 110.931 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' MET . . . . . 0.462 ' HB2' ' CE1' ' A' ' 99' ' ' PHE . 18.8 ttp -104.36 145.46 30.22 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.23 -0.441 . . . . 74.099999999999994 110.864 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -148.66 134.84 19.29 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.195 -0.457 . . . . 70.400000000000006 110.926 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -113.38 89.28 3.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 74.340000000000003 110.907 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 15.0 t -101.04 130.55 47.07 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.115 -0.493 . . . . 72.340000000000003 111.163 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.596 ' HA ' ' O ' ' A' ' 94' ' ' TYR . 0.6 OUTLIER -104.83 30.68 5.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.229 -0.441 . . . . 71.329999999999998 111.148 -179.974 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -154.05 133.12 12.49 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.216 -0.447 . . . . 75.519999999999996 110.876 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.4 ' HB2' ' HA ' ' A' ' 174' ' ' ARG . 39.1 p30 -51.3 170.24 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.141 -0.481 . . . . 74.340000000000003 110.864 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' CYS . . . . . 0.486 ' O ' ' HB2' ' A' ' 172' ' ' SER . 14.1 p -152.37 144.24 16.44 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.594 0.711 . . . . 71.409999999999997 110.915 -179.898 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.434 ' O ' ' C ' ' A' ' 143' ' ' PRO . 53.6 Cg_endo -69.76 -31.16 21.08 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.712 2.275 . . . . 71.439999999999998 112.385 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.634 ' HB3' ' CB ' ' A' ' 120' ' ' GLU . 0.1 OUTLIER -147.41 106.66 3.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.193 -0.458 . . . . 50.530000000000001 110.88 -179.875 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.656 ' HB ' ' O ' ' A' ' 171' ' ' GLN . 4.0 tt -58.14 -28.18 33.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.131 -0.486 . . . . 75.120000000000005 111.088 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' MET . . . . . 0.695 ' O ' ' HA ' ' A' ' 123' ' ' HIS . 27.1 ttp -87.46 -41.47 13.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.185 -0.462 . . . . 74.510000000000005 110.915 179.831 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.634 ' CB ' ' HB3' ' A' ' 117' ' ' SER . 15.5 tp10 -68.65 -12.33 61.23 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.223 -0.444 . . . . 72.450000000000003 110.876 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 18.6 tp60 -115.94 -48.46 2.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.167 -0.469 . . . . 62.399999999999999 110.917 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.477 ' HB2' ' O ' ' A' ' 118' ' ' ILE . 44.6 m-85 -103.99 -13.78 16.19 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.189 -0.46 . . . . 73.409999999999997 110.897 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' HIS . . . . . 0.695 ' HA ' ' O ' ' A' ' 119' ' ' MET . 10.8 m80 71.46 20.18 4.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.106 -0.497 . . . . 74.099999999999994 110.825 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.551 ' CE ' ' HA ' ' A' ' 100' ' ' GLU . 0.0 OUTLIER -93.42 139.59 30.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.208 -0.451 . . . . 74.129999999999995 110.854 179.97 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 5.3 ptp180 -102.36 -44.92 5.25 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.188 -0.46 . . . . 72.540000000000006 110.827 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.451 ' HG2' ' HA ' ' A' ' 169' ' ' ALA . 10.8 mt-10 -138.17 117.23 12.54 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.209 -0.45 . . . . 72.040000000000006 110.858 -179.89 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.645 HG21 ' SG ' ' A' ' 130' ' ' CYS . 2.5 mm -77.41 93.93 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.131 -0.486 . . . . 72.25 111.087 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' HIS . . . . . 0.406 ' HB3' ' N ' ' A' ' 102' ' ' GLY . 0.6 OUTLIER -63.78 -36.08 82.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.467 . . . . 74.120000000000005 110.877 179.849 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.589 ' HB2' ' HB2' ' A' ' 99' ' ' PHE . 0.6 OUTLIER -132.32 146.21 51.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.205 -0.452 . . . . 72.409999999999997 110.851 -179.756 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 130' ' ' CYS . . . . . 0.645 ' SG ' HG21 ' A' ' 127' ' ' ILE . 0.5 OUTLIER -145.27 120.49 10.18 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.15 -0.477 . . . . 73.329999999999998 110.849 -179.937 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.653 ' HA ' ' HA ' ' A' ' 156' ' ' GLU . 1.3 mtpt -107.39 153.93 22.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.152 -0.477 . . . . 74.349999999999994 110.894 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.592 HG23 ' C ' ' A' ' 131' ' ' LYS . 4.8 t 82.71 165.27 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.207 -0.451 . . . . 74.400000000000006 111.119 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.795 HD13 ' O ' ' A' ' 154' ' ' LYS . 0.0 OUTLIER -176.47 126.02 0.18 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.187 -0.46 . . . . 52.229999999999997 110.884 179.988 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.506 ' CG ' ' H ' ' A' ' 95' ' ' LYS . 0.0 OUTLIER -94.39 159.23 15.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.172 -0.467 . . . . 75.099999999999994 110.893 179.95 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.485 ' C ' ' O ' ' A' ' 134' ' ' GLU . . . -31.05 -48.82 0.2 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.764 -0.732 . . . . 72.409999999999997 112.451 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.799 ' HB ' HD12 ' A' ' 176' ' ' ILE . 2.3 t -150.99 133.5 6.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.814 0.34 . . . . 74.209999999999994 111.105 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' TRP . . . . . 0.596 ' H ' ' CG ' ' A' ' 152' ' ' LEU . 3.6 t-105 -133.5 150.7 51.7 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.173 -0.467 . . . . 74.450000000000003 110.88 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.721 HG23 ' NE2' ' A' ' 149' ' ' GLN . 22.1 mm -114.12 128.77 70.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.18 -0.463 . . . . 73.540000000000006 111.139 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.518 ' CB ' ' HB2' ' A' ' 150' ' ' TYR . 0.5 OUTLIER -114.91 149.59 36.99 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.217 -0.447 . . . . 74.239999999999995 110.875 179.953 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 0.492 ' CD2' ' HA ' ' A' ' 145' ' ' TYR . 2.3 m-85 -134.98 133.17 39.2 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.131 -0.486 . . . . 60.350000000000001 110.902 -179.86 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.69 ' O ' ' HB2' ' A' ' 171' ' ' GLN . 0.8 OUTLIER -59.93 -26.49 65.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.147 -0.478 . . . . 63.109999999999999 110.911 179.966 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.728 ' HB3' ' HD2' ' A' ' 143' ' ' PRO . 9.7 mp -112.15 173.13 3.03 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.595 0.712 . . . . 65.310000000000002 110.883 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 143' ' ' PRO . . . . . 0.728 ' HD2' ' HB3' ' A' ' 142' ' ' LEU . 53.8 Cg_endo -69.76 -89.68 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.645 2.23 . . . . 74.299999999999997 112.357 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 144' ' ' ASN . . . . . 0.686 ' O ' ' N ' ' A' ' 146' ' ' ARG . 2.3 m-20 -52.81 97.0 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.183 -0.462 . . . . 71.140000000000001 110.923 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 145' ' ' TYR . . . . . 0.64 ' C ' ' O ' ' A' ' 144' ' ' ASN . 0.1 OUTLIER 12.78 53.25 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.18 -0.463 . . . . 74.340000000000003 110.962 -179.899 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 146' ' ' ARG . . . . . 0.686 ' N ' ' O ' ' A' ' 144' ' ' ASN . 38.1 mtt85 -119.46 179.1 4.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.1 -0.5 . . . . 74.450000000000003 110.865 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 73.98 -174.05 49.59 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.723 -0.751 . . . . 70.329999999999998 112.509 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.427 ' HG2' ' CD1' ' A' ' 58' ' ' TYR . 0.2 OUTLIER -75.91 151.75 37.27 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.758 0.313 . . . . 72.209999999999994 110.868 -179.883 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 149' ' ' GLN . . . . . 0.721 ' NE2' HG23 ' A' ' 138' ' ' ILE . 0.0 OUTLIER -88.5 149.82 23.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.186 -0.461 . . . . 74.109999999999999 110.946 -179.979 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 150' ' ' TYR . . . . . 0.518 ' HB2' ' CB ' ' A' ' 139' ' ' PHE . 82.4 m-85 -134.07 129.5 36.12 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.205 -0.452 . . . . 72.310000000000002 110.9 -179.847 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.625 ' HB2' HD11 ' A' ' 61' ' ' ILE . 16.8 tp -81.67 122.72 27.99 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.129 -0.487 . . . . 65.420000000000002 110.882 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.921 HD13 ' O ' ' A' ' 152' ' ' LEU . 0.0 OUTLIER -54.54 135.36 46.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.2 -0.455 . . . . 72.530000000000001 110.915 179.871 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -163.25 25.74 0.09 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.183 -0.462 . . . . 62.329999999999998 110.9 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.795 ' O ' HD13 ' A' ' 133' ' ' LEU . 0.0 OUTLIER -117.27 -173.7 2.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.133 -0.485 . . . . 71.420000000000002 110.874 179.984 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.753 ' CG ' HD22 ' A' ' 133' ' ' LEU . 0.5 OUTLIER -161.87 -124.77 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.18 -0.464 . . . . 73.409999999999997 110.901 179.886 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.653 ' HA ' ' HA ' ' A' ' 131' ' ' LYS . 0.7 OUTLIER -69.09 -0.41 5.79 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.226 -0.443 . . . . 74.200000000000003 110.921 179.928 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 157' ' ' TYR . . . . . 0.785 ' CE1' ' HA ' ' A' ' 154' ' ' LYS . 18.5 m-30 -31.08 146.95 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.122 -0.49 . . . . 72.019999999999996 110.93 -179.822 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 158' ' ' ARG . . . . . 0.55 ' HB2' ' HA ' ' A' ' 103' ' ' ASP . 8.5 ptp180 -112.29 -39.49 4.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.117 -0.492 . . . . 70.239999999999995 110.867 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 159' ' ' LYS . . . . . 0.457 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 2.6 ptpp? -92.01 150.96 41.43 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.602 0.715 . . . . 72.430000000000007 110.881 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 160' ' ' PRO . . . . . 0.423 ' HA ' ' CZ2' ' A' ' 163' ' ' TRP . 53.9 Cg_endo -69.7 -23.05 31.49 Favored 'Trans proline' 0 C--O 1.232 0.214 0 C-N-CA 122.717 2.278 . . . . 72.409999999999997 112.352 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.674 HD12 ' H ' ' A' ' 161' ' ' ILE . 3.9 mp -76.62 2.32 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.226 -0.443 . . . . 63.32 111.105 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.667 ' HB3' ' CD1' ' A' ' 157' ' ' TYR . 0.6 OUTLIER -73.07 -19.86 61.08 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.176 -0.465 . . . . 74.200000000000003 110.855 179.855 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 163' ' ' TRP . . . . . 0.605 ' N ' ' CD1' ' A' ' 163' ' ' TRP . 0.0 OUTLIER -109.13 13.92 24.21 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.182 -0.463 . . . . 74.219999999999999 110.928 -179.965 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 85.04 -30.53 3.93 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.75 -0.738 . . . . 74.430000000000007 112.496 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -54.19 120.1 6.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.742 0.306 . . . . 71.019999999999996 111.1 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -49.67 -25.65 3.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.214 -0.448 . . . . 51.299999999999997 111.136 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 167' ' ' SER . . . . . 0.477 ' C ' ' H ' ' A' ' 169' ' ' ALA . 0.3 OUTLIER -155.61 160.13 31.09 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.708 0.766 . . . . 55.100000000000001 110.85 -179.804 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 168' ' ' PRO . . . . . 0.437 ' HB3' ' O ' ' A' ' 127' ' ' ILE . 53.8 Cg_endo -69.78 20.36 0.18 Allowed 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.717 2.278 . . . . 64.329999999999998 112.296 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.477 ' H ' ' C ' ' A' ' 167' ' ' SER . . . -63.18 103.64 0.5 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.245 -0.434 . . . . 71.409999999999997 111.124 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.425 HG12 ' N ' ' A' ' 171' ' ' GLN . 3.4 t -152.91 160.87 2.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.24 -0.436 . . . . 73.219999999999999 111.15 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 171' ' ' GLN . . . . . 0.69 ' HB2' ' O ' ' A' ' 141' ' ' GLU . 1.9 mm-40 -109.73 -88.03 0.5 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.215 -0.448 . . . . 73.540000000000006 110.913 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 172' ' ' SER . . . . . 0.699 ' OG ' ' O ' ' A' ' 143' ' ' PRO . 15.4 p -130.6 178.39 6.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.177 -0.465 . . . . 73.239999999999995 110.817 -179.789 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -143.79 168.07 20.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.107 -0.497 . . . . 74.230000000000004 110.864 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 174' ' ' ARG . . . . . 0.676 ' NE ' HG21 ' A' ' 138' ' ' ILE . 2.1 ppt_? -133.39 156.66 47.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.163 -0.471 . . . . 74.25 110.913 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 175' ' ' ARG . . . . . 0.43 ' HB2' ' CE1' ' A' ' 94' ' ' TYR . 6.2 ptt85 -98.18 150.72 21.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.259 -0.428 . . . . 61.549999999999997 110.869 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 176' ' ' ILE . . . . . 0.799 HD12 ' HB ' ' A' ' 136' ' ' VAL . 15.4 mt -83.1 152.31 3.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.217 -0.447 . . . . 53.109999999999999 111.116 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 7.5 p -126.29 147.2 31.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.129 -0.487 . . . . 63.219999999999999 111.132 179.826 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 178' ' ' GLU . . . . . 0.763 ' HB3' HD13 ' A' ' 88' ' ' LEU . 1.6 pt-20 . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.215 -0.448 . . . . 63.530000000000001 110.933 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.788 0.328 . . . . 71.310000000000002 110.849 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.9 m -140.48 -176.49 4.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.245 -0.434 . . . . 74.420000000000002 110.878 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 31.7 mttt -101.53 41.63 1.19 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.138 -0.483 . . . . 72.430000000000007 110.897 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 3.3 t -102.11 65.7 0.98 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.239 -0.437 . . . . 65.219999999999999 111.157 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 111.46 114.0 3.41 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.754 -0.736 . . . . 55.25 112.444 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.439 ' C ' ' HE1' ' A' ' 47' ' ' TRP . 9.8 p -82.68 135.61 34.98 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.837 0.351 . . . . 41.100000000000001 111.158 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.422 ' HA ' ' HA ' ' A' ' 24' ' ' ASP . 2.8 tttt -123.47 135.75 54.23 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.217 -0.447 . . . . 65.209999999999994 110.9 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.498 ' HA ' ' HA ' ' A' ' 42' ' ' VAL . 14.5 tt -136.71 152.05 28.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.25 -0.432 . . . . 54.140000000000001 111.148 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.478 HG23 ' CG ' ' A' ' 22' ' ' ASP . 15.3 m -133.98 142.66 47.75 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.19 -0.459 . . . . 60.340000000000003 111.129 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.551 ' HD1' HD11 ' A' ' 40' ' ' ILE . 0.3 OUTLIER -130.01 128.72 42.59 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.226 -0.443 . . . . 73.439999999999998 110.92 179.997 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.544 ' CG ' ' HA ' ' A' ' 16' ' ' PHE . 24.1 m-85 -113.54 131.96 55.88 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.164 -0.471 . . . . 72.340000000000003 110.973 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.434 ' HA ' ' O ' ' A' ' 36' ' ' ARG . 0.0 OUTLIER -61.08 -13.63 18.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.123 -0.489 . . . . 63.299999999999997 110.914 -179.955 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.437 ' HB2' ' O ' ' A' ' 17' ' ' GLN . 77.1 m-20 -136.95 150.78 48.38 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.124 -0.489 . . . . 60.539999999999999 110.868 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 4.8 mtmm -55.22 -175.95 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.198 -0.456 . . . . 53.530000000000001 110.852 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 20.2 m-20 45.53 33.25 1.3 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.156 -0.475 . . . . 74.400000000000006 110.885 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.544 ' HA ' ' CG ' ' A' ' 11' ' ' TYR . 2.7 m-85 49.22 64.77 1.6 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.169 -0.469 . . . . 71.010000000000005 110.896 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.437 ' O ' ' HB2' ' A' ' 13' ' ' ASP . 8.0 mt-30 -139.46 159.96 40.96 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.154 -0.476 . . . . 70.25 110.886 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 92.7 -150.03 19.84 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.78 -0.724 . . . . 55.109999999999999 112.521 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.741 ' O ' HD13 ' A' ' 34' ' ' LEU . 0.3 OUTLIER -69.9 78.79 0.47 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.803 0.335 . . . . 72.549999999999997 110.89 -179.885 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.456 ' HA ' ' O ' ' A' ' 10' ' ' PHE . 0.0 OUTLIER -76.24 129.51 36.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.205 -0.452 . . . . 72.219999999999999 110.856 -179.871 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.469 ' CD2' ' CD2' ' A' ' 30' ' ' PHE . 69.2 t80 -124.26 125.31 44.16 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.184 -0.462 . . . . 65.219999999999999 110.903 -179.858 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.478 ' CG ' HG23 ' A' ' 9' ' ' THR . 1.2 m-20 -118.83 134.54 55.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.113 -0.494 . . . . 65.219999999999999 110.925 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 8.8 t -161.17 129.66 4.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.23 -0.441 . . . . 74.510000000000005 110.897 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.422 ' HA ' ' HA ' ' A' ' 7' ' ' LYS . 14.1 p-10 -97.33 4.39 50.81 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.178 -0.465 . . . . 70.209999999999994 110.89 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 46.9 t -113.52 159.66 19.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.179 -0.464 . . . . 74.099999999999994 110.855 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -42.67 119.67 1.51 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.162 -0.472 . . . . 71.329999999999998 110.854 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.558 ' HB2' ' HB3' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -114.6 40.55 2.54 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.187 -0.461 . . . . 74.329999999999998 110.9 -179.913 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.563 ' O ' ' HA ' ' A' ' 82' ' ' SER . . . -51.12 -21.22 1.81 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.15 -0.477 . . . . 71.439999999999998 111.119 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 59.9 t0 -128.86 38.32 3.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.168 -0.469 . . . . 75.310000000000002 110.888 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.773 ' CD2' ' O ' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -80.27 13.92 2.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.186 -0.461 . . . . 64.129999999999995 110.878 -179.885 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.437 ' CG ' ' HG3' ' A' ' 53' ' ' PRO . 36.2 t60 -77.65 -36.81 51.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.147 -0.479 . . . . 65.420000000000002 110.875 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.7 t -59.81 -14.52 15.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.196 -0.456 . . . . 65.319999999999993 111.156 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -100.99 -24.97 14.23 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.202 -0.454 . . . . 71.129999999999995 110.877 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.741 HD13 ' O ' ' A' ' 19' ' ' ARG . 23.9 tp -141.62 123.93 15.67 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.125 -0.489 . . . . 51.109999999999999 110.943 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 27.0 m -82.83 -49.32 9.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.211 -0.45 . . . . 74.019999999999996 110.829 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.434 ' O ' ' HA ' ' A' ' 12' ' ' GLU . 0.1 OUTLIER -114.04 143.25 45.07 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.131 -0.486 . . . . 72.019999999999996 110.834 -179.925 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.586 ' HB2' ' HB2' ' A' ' 80' ' ' LEU . 57.6 m -122.93 104.76 9.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.174 -0.466 . . . . 74.209999999999994 110.906 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 10.9 m-20 -97.49 -67.15 0.86 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.226 -0.443 . . . . 71.519999999999996 110.892 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 10.6 p -105.68 133.66 50.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.207 -0.451 . . . . 74.310000000000002 110.895 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.666 HD12 ' HZ3' ' A' ' 73' ' ' TRP . 6.9 mt -130.01 149.53 33.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.135 -0.484 . . . . 65.400000000000006 111.114 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.426 ' HD2' ' CE2' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -142.51 119.07 11.0 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.155 -0.475 . . . . 75.010000000000005 110.906 179.853 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.613 HG21 ' HB2' ' A' ' 47' ' ' TRP . 1.0 OUTLIER -104.76 117.47 50.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.268 -0.424 . . . . 61.229999999999997 111.098 179.908 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -112.55 76.67 0.99 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.155 -0.475 . . . . 74.439999999999998 110.896 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.427 ' O ' ' HA ' ' A' ' 6' ' ' THR . . . 139.21 99.61 0.45 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.723 -0.751 . . . . 54.039999999999999 112.479 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.415 ' HA2' HD21 ' A' ' 88' ' ' LEU . . . 55.59 177.78 0.25 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.743 -0.741 . . . . 75.109999999999999 112.479 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.725 HG23 ' HA ' ' A' ' 63' ' ' PRO . 2.2 m -76.46 168.7 19.61 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.719 0.295 . . . . 75.340000000000003 111.18 -179.863 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.613 ' HB2' HG21 ' A' ' 42' ' ' VAL . 7.7 m95 -143.32 128.36 18.54 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.261 -0.427 . . . . 74.409999999999997 110.93 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.778 ' HB2' ' CG2' ' A' ' 86' ' ' VAL . . . -89.83 127.62 36.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.221 -0.445 . . . . 63.0 111.093 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.826 HG11 HD11 ' A' ' 80' ' ' LEU . 26.9 m -127.62 141.72 45.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.181 -0.463 . . . . 43.020000000000003 111.144 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.804 ' HB3' ' CB ' ' A' ' 56' ' ' ALA . 5.0 m-85 -122.53 155.44 36.22 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.189 -0.459 . . . . 74.099999999999994 110.903 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.685 ' N ' ' HB1' ' A' ' 56' ' ' ALA . 35.3 mp0 -53.19 -94.8 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.081 -0.509 . . . . 75.519999999999996 110.928 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.839 ' O ' ' HB2' ' A' ' 56' ' ' ALA . 3.4 mtp180 -72.0 136.46 82.31 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.556 0.693 . . . . 75.25 110.863 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.643 ' HA ' ' OG ' ' A' ' 82' ' ' SER . 53.8 Cg_endo -69.79 131.64 21.62 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.676 2.251 . . . . 72.230000000000004 112.321 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.458 ' H ' ' HB3' ' A' ' 82' ' ' SER . 10.1 t30 77.07 -5.35 2.19 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.169 -0.469 . . . . 75.120000000000005 110.916 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.414 ' HE1' HD21 ' A' ' 54' ' ' ASN . 0.1 OUTLIER -144.73 -73.4 0.25 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.158 -0.474 . . . . 74.010000000000005 110.852 -179.981 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.839 ' HB2' ' O ' ' A' ' 52' ' ' ARG . . . 37.96 80.29 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.177 -0.465 . . . . 75.230000000000004 111.107 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' TRP . . . . . 0.458 ' O ' ' CG ' ' A' ' 58' ' ' TYR . 31.4 m95 -64.96 53.07 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.215 -0.448 . . . . 72.120000000000005 110.903 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.575 ' CB ' ' OE1' ' A' ' 51' ' ' GLU . 0.5 OUTLIER -177.19 124.39 0.14 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.252 -0.431 . . . . 74.239999999999995 110.911 -179.921 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.526 ' HG3' ' CE2' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -81.79 139.71 34.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.136 -0.484 . . . . 70.420000000000002 110.874 179.903 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.715 ' OH ' ' O ' ' A' ' 73' ' ' TRP . 1.0 OUTLIER -154.7 86.24 1.13 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.248 -0.433 . . . . 55.210000000000001 110.906 -179.876 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.782 HD11 ' HA ' ' A' ' 151' ' ' LEU . 1.6 mp -80.42 118.88 28.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.145 -0.48 . . . . 63.32 111.109 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.783 HD23 ' HD2' ' A' ' 63' ' ' PRO . 0.3 OUTLIER -87.06 127.86 57.83 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.615 0.721 . . . . 74.519999999999996 110.929 179.853 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.783 ' HD2' HD23 ' A' ' 62' ' ' LEU . 53.4 Cg_endo -69.81 -174.24 0.88 Allowed 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.701 2.268 . . . . 71.540000000000006 112.34 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -87.02 162.89 17.37 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.203 -0.453 . . . . 60.219999999999999 110.943 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 113.37 -161.03 12.82 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.767 -0.73 . . . . 73.219999999999999 112.469 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -111.99 160.24 17.65 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.862 0.363 . . . . 72.140000000000001 110.906 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.479 ' N ' ' O ' ' A' ' 40' ' ' ILE . 20.6 m-85 -149.16 81.6 7.39 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.646 0.736 . . . . 74.439999999999998 110.898 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.475 ' HD2' ' HG3' ' A' ' 72' ' ' ARG . 53.8 Cg_endo -69.7 -3.57 12.24 Favored 'Trans proline' 0 C--O 1.231 0.155 0 C-N-CA 122.706 2.271 . . . . 50.219999999999999 112.345 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -157.77 149.36 21.75 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.224 -0.443 . . . . 75.219999999999999 110.927 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.778 ' O ' ' CD1' ' A' ' 73' ' ' TRP . 35.4 p90 -55.28 -41.27 72.06 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.163 -0.471 . . . . 71.310000000000002 110.979 -179.845 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -51.66 -21.89 2.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.099 -0.5 . . . . 64.340000000000003 110.938 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.475 ' HG3' ' HD2' ' A' ' 68' ' ' PRO . 28.9 mmt180 -61.8 -39.74 92.8 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.189 -0.46 . . . . 74.340000000000003 110.891 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' TRP . . . . . 0.778 ' CD1' ' O ' ' A' ' 70' ' ' TYR . 0.3 OUTLIER -92.88 34.17 1.11 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.168 -0.469 . . . . 64.0 110.934 -179.999 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 34.5 mmm 75.19 17.66 2.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.258 -0.428 . . . . 65.549999999999997 110.913 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.427 ' N ' ' HD1' ' A' ' 73' ' ' TRP . . . 42.98 44.0 5.6 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.759 -0.734 . . . . 71.310000000000002 112.484 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.462 ' CB ' ' CE2' ' A' ' 60' ' ' TYR . 0.5 OUTLIER -67.45 -74.12 0.12 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.877 0.37 . . . . 72.519999999999996 110.933 -179.907 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 12.6 t-20 -154.02 138.96 17.22 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.164 -0.471 . . . . 75.299999999999997 110.879 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -87.61 13.61 10.0 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.164 -0.471 . . . . 73.25 110.87 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.511 ' HD3' ' HB3' ' A' ' 51' ' ' GLU . 38.7 ttt85 -84.29 44.97 1.06 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.182 -0.463 . . . . 71.340000000000003 110.866 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.826 HD11 HG11 ' A' ' 49' ' ' VAL . 0.1 OUTLIER -66.12 125.59 25.99 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.2 -0.454 . . . . 62.310000000000002 110.928 -179.995 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.56 ' HB3' ' HB3' ' A' ' 53' ' ' PRO . 3.7 m -151.07 -109.2 0.06 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.186 -0.461 . . . . 73.519999999999996 110.879 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.643 ' OG ' ' HA ' ' A' ' 53' ' ' PRO . 0.0 OUTLIER -51.32 102.23 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.147 -0.479 . . . . 74.530000000000001 110.869 -179.827 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 83' ' ' CYS . . . . . 0.819 ' HB3' HG12 ' A' ' 49' ' ' VAL . 14.6 p -126.55 135.33 51.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.155 -0.475 . . . . 65.040000000000006 110.855 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.598 ' N ' ' O ' ' A' ' 48' ' ' ALA . 2.1 mmt85 -118.29 159.87 22.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.162 -0.472 . . . . 72.129999999999995 110.863 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -74.3 125.96 29.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.208 -0.451 . . . . 73.299999999999997 111.067 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.778 ' CG2' ' HB2' ' A' ' 48' ' ' ALA . 18.0 t -120.31 145.31 26.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.202 -0.454 . . . . 41.5 111.102 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' HIS . . . . . 0.558 ' O ' HG23 ' A' ' 136' ' ' VAL . 70.0 m-70 -110.78 112.36 24.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.176 -0.465 . . . . 74.340000000000003 110.905 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.467 ' H ' HD23 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -37.91 152.28 0.15 Allowed Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 121.626 0.727 . . . . 51.030000000000001 110.887 -179.956 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.529 ' HB3' ' H ' ' A' ' 136' ' ' VAL . 54.3 Cg_endo -69.67 83.15 0.69 Allowed 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.673 2.248 . . . . 72.340000000000003 112.361 179.809 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.2 t -90.23 -177.34 5.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.275 -0.42 . . . . 72.049999999999997 110.846 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 70.35 -81.94 0.37 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.702 -0.761 . . . . 65.140000000000001 112.489 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.41 ' O ' ' C ' ' A' ' 93' ' ' GLN . . . -92.58 34.16 4.63 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.739 -0.743 . . . . 54.399999999999999 112.53 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.459 ' O ' ' HG2' ' A' ' 134' ' ' GLU . 14.6 pt20 37.54 -121.58 0.21 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.868 0.366 . . . . 75.430000000000007 110.903 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.684 ' CZ ' ' HA ' ' A' ' 175' ' ' ARG . 1.4 t80 -121.91 99.29 6.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.228 -0.442 . . . . 74.239999999999995 110.945 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.559 ' HG3' HG11 ' A' ' 132' ' ' VAL . 23.8 tptt -119.27 127.14 52.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.153 -0.476 . . . . 63.340000000000003 110.846 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.589 HD13 ' H ' ' A' ' 97' ' ' GLN . 0.4 OUTLIER -150.1 138.61 14.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.189 -0.46 . . . . 73.209999999999994 111.099 179.901 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.589 ' H ' HD13 ' A' ' 96' ' ' ILE . 0.7 OUTLIER -110.38 124.3 51.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.175 -0.466 . . . . 63.43 110.916 179.904 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.545 HG22 ' SD ' ' A' ' 124' ' ' MET . 29.6 mm -107.19 133.23 52.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.172 -0.467 . . . . 71.439999999999998 111.168 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.66 ' HB2' ' HB2' ' A' ' 129' ' ' SER . 7.7 m-85 -123.41 144.76 49.28 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.199 -0.455 . . . . 72.200000000000003 110.896 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 71.7 tt0 -72.85 -74.43 0.17 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.16 -0.473 . . . . 74.430000000000007 110.923 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.503 ' C ' ' HB2' ' A' ' 128' ' ' HIS . 31.9 mttt -85.2 167.12 15.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.09 -0.505 . . . . 63.439999999999998 110.887 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.424 ' HA2' ' OG ' ' A' ' 129' ' ' SER . . . -80.9 158.03 40.17 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.77 -0.729 . . . . 31.050000000000001 112.495 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.48 ' HA ' ' HB2' ' A' ' 158' ' ' ARG . 33.2 t70 68.1 54.27 0.6 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.799 0.333 . . . . 72.510000000000005 110.833 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.697 ' CE1' ' HD2' ' A' ' 131' ' ' LYS . 7.2 m-85 47.39 29.99 1.45 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.197 -0.456 . . . . 62.439999999999998 110.905 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.446 ' C ' ' HB2' ' A' ' 101' ' ' LYS . 48.0 m -105.47 152.11 23.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.103 -0.499 . . . . 75.439999999999998 110.889 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 89.42 -165.2 32.36 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.723 -0.751 . . . . 30.43 112.441 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 5.9 tp-100 -73.43 129.09 37.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.827 0.346 . . . . 73.439999999999998 110.867 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 1.6 ttt -114.76 131.39 56.8 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.215 -0.448 . . . . 54.130000000000003 110.89 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -134.94 137.2 42.89 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.229 -0.441 . . . . 74.299999999999997 110.918 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -110.8 94.48 5.02 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.119 -0.491 . . . . 65.340000000000003 110.884 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 9.1 t -102.38 130.29 49.09 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.14 -0.482 . . . . 72.109999999999999 111.111 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.54 ' O ' ' OG1' ' A' ' 112' ' ' THR . 0.0 OUTLIER -109.84 37.3 2.7 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.206 -0.452 . . . . 64.230000000000004 111.103 -179.952 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -151.78 -176.36 5.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.22 -0.446 . . . . 51.200000000000003 110.853 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -80.49 179.58 7.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.107 -0.497 . . . . 71.430000000000007 110.839 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' CYS . . . . . 0.567 ' O ' ' HB2' ' A' ' 172' ' ' SER . 45.7 t -167.3 125.02 0.97 Allowed Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.549 0.69 . . . . 75.319999999999993 110.903 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.72 -30.37 22.58 Favored 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.657 2.238 . . . . 73.420000000000002 112.33 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.629 ' HB3' ' CB ' ' A' ' 120' ' ' GLU . 0.1 OUTLIER -150.19 101.93 3.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.202 -0.454 . . . . 71.340000000000003 110.86 -179.843 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.7 HD13 HD11 ' A' ' 127' ' ' ILE . 4.0 tt -52.56 -29.67 13.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.145 -0.48 . . . . 73.140000000000001 111.1 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' MET . . . . . 0.578 ' O ' ' HA ' ' A' ' 123' ' ' HIS . 0.8 OUTLIER -85.55 -45.11 12.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.184 -0.462 . . . . 75.230000000000004 110.848 179.906 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.629 ' CB ' ' HB3' ' A' ' 117' ' ' SER . 8.4 tp10 -65.45 -13.75 59.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.262 -0.427 . . . . 62.009999999999998 110.859 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -114.22 -51.97 2.75 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.169 -0.469 . . . . 74.519999999999996 110.896 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.45 ' HB2' ' O ' ' A' ' 118' ' ' ILE . 54.1 m-85 -101.24 -20.3 15.32 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.195 -0.457 . . . . 73.420000000000002 110.902 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' HIS . . . . . 0.578 ' HA ' ' O ' ' A' ' 119' ' ' MET . 12.6 m80 71.24 30.61 2.58 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.132 -0.485 . . . . 62.399999999999999 110.869 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.545 ' SD ' HG22 ' A' ' 98' ' ' ILE . 5.2 mtt -108.99 86.42 2.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.224 -0.444 . . . . 61.450000000000003 110.902 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 2.0 ptp85 -51.94 -35.57 46.4 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.209 -0.45 . . . . 75.25 110.877 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.502 ' HB3' ' HG2' ' A' ' 168' ' ' PRO . 28.9 mt-10 -142.39 131.7 23.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.201 -0.454 . . . . 72.319999999999993 110.896 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.7 HD11 HD13 ' A' ' 118' ' ' ILE . 3.5 mm -91.38 91.46 3.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.17 -0.468 . . . . 74.409999999999997 111.14 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' HIS . . . . . 0.503 ' HB2' ' C ' ' A' ' 101' ' ' LYS . 0.5 OUTLIER -60.58 -35.43 76.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.183 -0.462 . . . . 74.209999999999994 110.86 179.882 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.66 ' HB2' ' HB2' ' A' ' 99' ' ' PHE . 66.5 m -131.09 140.08 49.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.222 -0.444 . . . . 65.450000000000003 110.829 -179.763 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' CYS . . . . . 0.616 ' O ' ' O ' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -139.18 121.59 16.09 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.134 -0.484 . . . . 70.439999999999998 110.855 179.999 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.697 ' HD2' ' CE1' ' A' ' 104' ' ' PHE . 6.3 mtpp -115.33 153.15 31.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.153 -0.476 . . . . 74.030000000000001 110.925 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.562 HG12 ' N ' ' A' ' 133' ' ' LEU . 16.1 t 84.34 164.57 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.242 -0.435 . . . . 61.109999999999999 111.126 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.728 HD22 ' CG ' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -178.44 121.98 0.1 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.136 -0.484 . . . . 44.530000000000001 110.91 179.976 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.513 ' O ' ' C ' ' A' ' 135' ' ' GLY . 0.1 OUTLIER -94.03 167.02 11.86 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.186 -0.461 . . . . 71.200000000000003 110.89 179.922 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.513 ' C ' ' O ' ' A' ' 134' ' ' GLU . . . -27.8 -55.89 0.12 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.717 -0.754 . . . . 74.310000000000002 112.517 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.602 HG21 ' CG1' ' A' ' 86' ' ' VAL . 3.2 t -144.51 137.36 22.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.806 0.336 . . . . 71.420000000000002 111.12 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 137' ' ' TRP . . . . . 0.715 ' CB ' ' HB3' ' A' ' 152' ' ' LEU . 0.0 OUTLIER -129.82 142.46 50.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.157 -0.474 . . . . 73.049999999999997 110.92 179.914 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.766 HD13 HD13 ' A' ' 61' ' ' ILE . 11.4 mm -114.99 134.35 58.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.195 -0.457 . . . . 64.439999999999998 111.12 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.54 ' CD1' HG11 ' A' ' 170' ' ' VAL . 0.8 OUTLIER -123.33 145.38 48.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.172 -0.467 . . . . 61.340000000000003 110.881 179.932 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 0.483 ' CE2' ' CD ' ' A' ' 174' ' ' ARG . 0.3 OUTLIER -126.99 133.85 50.48 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.164 -0.471 . . . . 64.430000000000007 110.93 -179.899 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.654 ' O ' ' HB2' ' A' ' 171' ' ' GLN . 0.2 OUTLIER -59.97 -27.2 66.63 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.105 -0.498 . . . . 61.200000000000003 110.89 -179.979 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.686 ' HB3' ' HD2' ' A' ' 143' ' ' PRO . 9.7 mp -112.91 171.79 4.04 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.617 0.722 . . . . 72.439999999999998 110.897 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 143' ' ' PRO . . . . . 0.757 ' O ' ' OG ' ' A' ' 172' ' ' SER . 54.0 Cg_endo -69.74 -92.71 0.01 OUTLIER 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.737 2.291 . . . . 74.439999999999998 112.323 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 144' ' ' ASN . . . . . 0.732 ' O ' ' N ' ' A' ' 146' ' ' ARG . 0.8 OUTLIER -49.99 99.21 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.217 -0.447 . . . . 64.439999999999998 110.913 -179.984 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 145' ' ' TYR . . . . . 0.641 ' C ' ' O ' ' A' ' 144' ' ' ASN . 19.8 m-85 11.64 52.44 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.218 -0.446 . . . . 74.329999999999998 110.928 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 146' ' ' ARG . . . . . 0.732 ' N ' ' O ' ' A' ' 144' ' ' ASN . 21.1 mtt180 -118.6 173.28 6.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.098 -0.501 . . . . 72.420000000000002 110.875 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 78.97 -176.1 54.82 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.713 -0.756 . . . . 51.340000000000003 112.52 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -80.64 144.01 32.65 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.746 0.308 . . . . 74.030000000000001 110.87 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 149' ' ' GLN . . . . . 0.402 ' HB3' ' HA ' ' A' ' 60' ' ' TYR . 2.8 mt-30 -71.63 162.93 28.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.218 -0.446 . . . . 64.219999999999999 110.904 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 150' ' ' TYR . . . . . 0.531 ' HB2' ' CB ' ' A' ' 139' ' ' PHE . 78.9 m-85 -145.89 128.19 15.82 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.202 -0.454 . . . . 64.420000000000002 110.945 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.782 ' HA ' HD11 ' A' ' 61' ' ' ILE . 15.1 tp -85.94 123.21 31.02 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.161 -0.472 . . . . 64.200000000000003 110.89 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.989 HD13 ' O ' ' A' ' 152' ' ' LEU . 0.0 OUTLIER -58.33 142.23 48.72 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.183 -0.462 . . . . 64.310000000000002 110.903 179.887 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 153' ' ' ASP . . . . . 0.469 ' N ' HD22 ' A' ' 152' ' ' LEU . 5.4 t70 -162.99 25.44 0.09 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.156 -0.474 . . . . 64.030000000000001 110.88 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.926 ' HB2' ' CD1' ' A' ' 157' ' ' TYR . 3.1 ptmt -123.17 -172.38 2.49 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.189 -0.459 . . . . 73.349999999999994 110.874 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.728 ' CG ' HD22 ' A' ' 133' ' ' LEU . 0.4 OUTLIER -159.8 -123.79 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.236 -0.438 . . . . 73.019999999999996 110.903 179.91 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.655 ' HA ' ' HA ' ' A' ' 131' ' ' LYS . 0.8 OUTLIER -66.02 -3.74 5.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.208 -0.451 . . . . 64.420000000000002 110.897 179.96 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 157' ' ' TYR . . . . . 0.926 ' CD1' ' HB2' ' A' ' 154' ' ' LYS . 13.3 m-30 -27.62 140.01 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.158 -0.473 . . . . 73.140000000000001 110.946 -179.847 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 158' ' ' ARG . . . . . 0.543 ' O ' ' OG ' ' A' ' 129' ' ' SER . 8.2 ptp180 -103.8 -46.18 4.57 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.159 -0.473 . . . . 75.409999999999997 110.853 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 2.4 ptpp? -81.68 149.25 63.78 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.546 0.688 . . . . 71.140000000000001 110.87 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' PRO . . . . . 0.439 ' CB ' ' HD3' ' A' ' 168' ' ' PRO . 53.7 Cg_endo -69.74 -26.74 27.38 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.703 2.269 . . . . 71.209999999999994 112.34 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.705 HD12 ' H ' ' A' ' 161' ' ' ILE . 4.1 mp -69.95 -10.62 13.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.215 -0.448 . . . . 70.299999999999997 111.152 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.598 ' HB3' ' CD1' ' A' ' 157' ' ' TYR . 1.0 OUTLIER -70.65 -12.79 61.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 73.329999999999998 110.859 179.865 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 163' ' ' TRP . . . . . 0.551 ' CD1' ' HB3' ' A' ' 165' ' ' ALA . 11.5 t-105 -90.13 -19.65 24.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.193 -0.458 . . . . 72.230000000000004 110.879 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 103.21 -37.11 3.89 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.772 -0.727 . . . . 75.129999999999995 112.536 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.551 ' HB3' ' CD1' ' A' ' 163' ' ' TRP . . . -78.29 123.1 26.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.843 0.354 . . . . 73.010000000000005 111.03 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -49.79 121.46 5.3 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.192 -0.458 . . . . 71.439999999999998 111.133 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 167' ' ' SER . . . . . 0.472 ' C ' ' H ' ' A' ' 169' ' ' ALA . 0.4 OUTLIER 64.94 143.81 0.08 OUTLIER Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.623 0.725 . . . . 72.549999999999997 110.886 -179.781 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 168' ' ' PRO . . . . . 0.502 ' HG2' ' HB3' ' A' ' 126' ' ' GLU . 53.8 Cg_endo -69.74 33.12 0.19 Allowed 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.675 2.25 . . . . 55.210000000000001 112.319 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.474 ' HA ' ' HG2' ' A' ' 126' ' ' GLU . . . -67.32 105.17 1.69 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.27 -0.423 . . . . 74.310000000000002 111.077 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.54 HG11 ' CD1' ' A' ' 139' ' ' PHE . 3.3 t -153.5 163.4 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.203 -0.453 . . . . 73.25 111.176 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 171' ' ' GLN . . . . . 0.654 ' HB2' ' O ' ' A' ' 141' ' ' GLU . 2.0 mm-40 -111.77 -90.21 0.5 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.192 -0.458 . . . . 74.319999999999993 110.913 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 172' ' ' SER . . . . . 0.757 ' OG ' ' O ' ' A' ' 143' ' ' PRO . 36.2 p -122.19 -179.72 4.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.187 -0.46 . . . . 63.409999999999997 110.851 -179.82 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -146.54 174.78 11.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.113 -0.494 . . . . 72.0 110.898 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 174' ' ' ARG . . . . . 0.52 ' HG2' ' HB ' ' A' ' 138' ' ' ILE . 0.0 OUTLIER -147.01 158.05 43.8 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.144 -0.48 . . . . 63.350000000000001 110.911 -179.933 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 175' ' ' ARG . . . . . 0.684 ' HA ' ' CZ ' ' A' ' 94' ' ' TYR . 0.0 OUTLIER -95.14 -179.95 4.99 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.198 -0.455 . . . . 75.319999999999993 110.847 -179.908 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 176' ' ' ILE . . . . . 0.476 ' CD1' ' HB ' ' A' ' 136' ' ' VAL . 1.8 mt -126.45 132.45 70.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.161 -0.472 . . . . 73.209999999999994 111.119 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 42.2 t -126.09 150.08 31.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.199 -0.455 . . . . 74.129999999999995 111.156 179.842 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.193 -0.458 . . . . 73.420000000000002 110.935 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.0 mtm . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.769 0.319 . . . . 62.530000000000001 110.894 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -152.11 129.44 11.3 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.227 -0.442 . . . . 74.319999999999993 110.835 -179.774 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.426 ' O ' ' C ' ' A' ' 4' ' ' THR . 0.0 OUTLIER -75.3 -65.85 0.84 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.098 -0.501 . . . . 74.239999999999995 110.947 179.913 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.426 ' C ' ' O ' ' A' ' 3' ' ' LYS . 7.4 t 36.15 48.6 0.56 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.229 -0.441 . . . . 72.010000000000005 111.13 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 70.67 125.57 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.765 -0.731 . . . . 14.140000000000001 112.49 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.475 ' C ' ' HE1' ' A' ' 47' ' ' TRP . 2.8 p -82.83 135.15 35.04 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.858 0.361 . . . . 65.129999999999995 111.17 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 3.9 tttt -121.2 137.12 54.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.244 -0.434 . . . . 74.329999999999998 110.89 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.614 ' HB ' HG22 ' A' ' 42' ' ' VAL . 13.3 tt -137.32 147.07 26.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.214 -0.448 . . . . 73.25 111.145 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.502 HG22 ' CE2' ' A' ' 11' ' ' TYR . 13.8 m -126.5 129.16 48.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.168 -0.469 . . . . 52.43 111.132 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.779 ' HB2' HD22 ' A' ' 34' ' ' LEU . 1.5 m-85 -114.69 130.15 56.78 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.245 -0.434 . . . . 74.219999999999999 110.906 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.52 ' CG ' ' HA ' ' A' ' 16' ' ' PHE . 41.4 m-85 -115.67 130.86 57.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.156 -0.475 . . . . 75.140000000000001 110.938 -179.839 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.493 ' HG2' ' HB2' ' A' ' 36' ' ' ARG . 0.0 OUTLIER -60.24 -26.52 66.5 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.172 -0.467 . . . . 74.540000000000006 110.871 -179.976 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 68.9 m-20 -124.32 151.22 44.55 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.119 -0.491 . . . . 74.030000000000001 110.872 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.53 ' N ' ' HB3' ' A' ' 38' ' ' ASN . 35.0 mtmt -56.26 -178.58 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.162 -0.472 . . . . 63.310000000000002 110.885 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 28.1 m-20 49.78 35.41 9.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.239 -0.437 . . . . 75.230000000000004 110.893 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.52 ' HA ' ' CG ' ' A' ' 11' ' ' TYR . 3.8 m-85 48.05 57.6 5.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.17 -0.468 . . . . 74.209999999999994 110.894 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -134.46 160.26 38.55 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.125 -0.488 . . . . 75.129999999999995 110.943 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 94.0 -151.47 20.27 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.776 -0.726 . . . . 55.229999999999997 112.501 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.775 ' O ' HD13 ' A' ' 34' ' ' LEU . 0.0 OUTLIER -68.71 80.0 0.29 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.813 0.34 . . . . 75.120000000000005 110.864 -179.874 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.466 ' HA ' ' O ' ' A' ' 10' ' ' PHE . 0.5 OUTLIER -78.28 124.89 28.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.169 -0.468 . . . . 73.319999999999993 110.879 -179.922 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.424 ' CD2' ' CD2' ' A' ' 30' ' ' PHE . 86.9 t80 -122.42 124.87 44.65 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.194 -0.457 . . . . 72.530000000000001 110.917 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -109.94 130.33 55.54 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.146 -0.479 . . . . 73.129999999999995 110.852 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.409 ' HB3' ' CE2' ' A' ' 21' ' ' TYR . 0.1 OUTLIER -142.0 145.96 35.03 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.173 -0.467 . . . . 64.430000000000007 110.868 -179.892 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -130.73 5.7 4.66 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.178 -0.465 . . . . 53.530000000000001 110.905 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.42 ' O ' ' C ' ' A' ' 26' ' ' ASP . 38.2 t -132.15 160.41 36.12 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.151 -0.477 . . . . 75.099999999999994 110.897 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.42 ' C ' ' O ' ' A' ' 25' ' ' CYS . 6.2 m-20 -35.59 108.88 0.08 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.168 -0.469 . . . . 54.409999999999997 110.853 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.713 ' HB3' ' HB3' ' A' ' 30' ' ' PHE . 0.5 OUTLIER -119.24 45.82 2.03 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.167 -0.469 . . . . 71.430000000000007 110.883 -179.892 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.592 ' O ' ' HA ' ' A' ' 82' ' ' SER . . . -55.08 -11.14 0.62 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.204 -0.453 . . . . 61.310000000000002 111.143 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 60.6 t0 -130.81 39.13 3.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.219 -0.446 . . . . 71.120000000000005 110.831 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.833 ' CD2' ' O ' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -82.8 16.55 2.19 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.232 -0.44 . . . . 70.200000000000003 110.897 -179.916 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.475 ' HB2' ' HB3' ' A' ' 81' ' ' SER . 46.5 t60 -81.78 -29.61 32.66 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.172 -0.467 . . . . 73.019999999999996 110.851 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.7 t -68.66 -7.07 29.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.218 -0.446 . . . . 53.130000000000003 111.14 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -107.01 -29.44 9.42 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.197 -0.456 . . . . 75.120000000000005 110.925 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.779 HD22 ' HB2' ' A' ' 10' ' ' PHE . 24.0 tp -138.26 145.32 41.18 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.139 -0.482 . . . . 74.239999999999995 110.903 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.2 m -113.37 -32.51 6.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.158 -0.474 . . . . 72.319999999999993 110.837 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.521 ' O ' HD21 ' A' ' 34' ' ' LEU . 1.4 mtp85 -116.22 142.37 46.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.162 -0.472 . . . . 71.140000000000001 110.869 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.632 ' SG ' ' HB2' ' A' ' 80' ' ' LEU . 1.7 p -119.91 54.94 1.0 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.184 -0.462 . . . . 72.519999999999996 110.917 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.53 ' HB3' ' N ' ' A' ' 14' ' ' LYS . 1.8 m-80 -55.59 -64.96 0.68 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.156 -0.474 . . . . 73.340000000000003 110.871 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 5.9 p -116.95 130.94 57.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.261 -0.427 . . . . 73.230000000000004 110.863 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.618 HG21 HD13 ' A' ' 62' ' ' LEU . 12.1 mt -126.87 149.15 31.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.164 -0.471 . . . . 64.420000000000002 111.066 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.405 ' HE3' ' CD1' ' A' ' 16' ' ' PHE . 0.0 OUTLIER -143.73 120.7 11.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.125 -0.488 . . . . 65.209999999999994 110.884 179.83 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.614 HG22 ' HB ' ' A' ' 8' ' ' ILE . 2.1 t -102.85 115.04 44.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.21 -0.45 . . . . 75.0 111.133 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -109.47 81.05 1.38 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.203 -0.453 . . . . 65.420000000000002 110.895 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.438 ' O ' ' HB ' ' A' ' 6' ' ' THR . . . 127.32 108.52 1.51 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.776 -0.726 . . . . 62.409999999999997 112.478 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 50.78 -179.54 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.72 -0.753 . . . . 72.329999999999998 112.511 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.715 HG23 ' HA ' ' A' ' 63' ' ' PRO . 15.3 m -84.47 159.64 20.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.736 0.303 . . . . 62.450000000000003 111.203 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.598 ' CD1' ' HB ' ' A' ' 8' ' ' ILE . 3.3 m95 -131.92 130.24 41.31 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.264 -0.426 . . . . 65.540000000000006 110.914 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.727 ' HB2' ' CG2' ' A' ' 86' ' ' VAL . . . -91.4 124.6 35.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.236 -0.438 . . . . 41.0 111.103 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.754 HG11 HD11 ' A' ' 80' ' ' LEU . 13.7 m -126.87 131.35 71.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.204 -0.453 . . . . 63.439999999999998 111.133 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.971 ' HB3' ' CB ' ' A' ' 56' ' ' ALA . 4.6 m-85 -106.68 145.37 32.07 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.141 -0.481 . . . . 72.439999999999998 110.864 -179.874 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.451 ' N ' ' HB1' ' A' ' 56' ' ' ALA . 0.8 OUTLIER -50.51 -86.41 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.079 -0.509 . . . . 61.43 110.829 -179.936 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.874 ' O ' ' HB2' ' A' ' 56' ' ' ALA . 7.7 mmm180 -77.63 138.34 62.77 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.608 0.718 . . . . 72.340000000000003 110.84 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.741 ' HA ' ' OG ' ' A' ' 82' ' ' SER . 53.7 Cg_endo -69.81 136.41 32.8 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.702 2.268 . . . . 53.310000000000002 112.352 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.427 ' C ' ' CD1' ' A' ' 55' ' ' PHE . 1.3 m120 64.99 -4.92 0.44 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.201 -0.454 . . . . 63.0 110.889 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.485 ' H ' ' C ' ' A' ' 53' ' ' PRO . 0.1 OUTLIER -137.86 -70.39 0.44 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.153 -0.476 . . . . 71.230000000000004 110.878 -179.989 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.971 ' CB ' ' HB3' ' A' ' 50' ' ' TYR . . . 38.87 74.9 0.08 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.168 -0.469 . . . . 62.109999999999999 111.088 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' TRP . . . . . 0.415 ' O ' ' CD2' ' A' ' 58' ' ' TYR . 9.8 m0 -63.6 30.59 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.174 -0.466 . . . . 65.400000000000006 110.924 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.639 ' H ' ' C ' ' A' ' 56' ' ' ALA . 1.2 m-30 -163.13 109.5 1.16 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.233 -0.439 . . . . 74.129999999999995 110.898 -179.867 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.437 ' HG3' ' CE2' ' A' ' 50' ' ' TYR . 0.3 OUTLIER -68.79 140.24 55.28 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.166 -0.47 . . . . 73.420000000000002 110.88 179.879 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.626 ' O ' HG23 ' A' ' 49' ' ' VAL . 0.9 OUTLIER -150.47 81.97 1.35 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.221 -0.445 . . . . 74.540000000000006 110.879 -179.875 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.524 HD11 HD22 ' A' ' 151' ' ' LEU . 1.1 mp -75.14 115.5 16.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.139 -0.482 . . . . 72.219999999999999 111.107 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.776 HD23 ' HD2' ' A' ' 63' ' ' PRO . 0.3 OUTLIER -82.4 124.05 78.4 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.579 0.704 . . . . 73.129999999999995 110.88 179.911 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.776 ' HD2' HD23 ' A' ' 62' ' ' LEU . 53.2 Cg_endo -69.82 -174.04 0.84 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.604 2.203 . . . . 73.129999999999995 112.373 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.0 163.33 18.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.26 -0.427 . . . . 74.129999999999995 110.925 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 113.05 -160.41 13.14 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.75 -0.738 . . . . 41.149999999999999 112.509 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -115.13 158.25 22.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.858 0.361 . . . . 74.530000000000001 110.869 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.464 ' N ' ' O ' ' A' ' 40' ' ' ILE . 11.2 m-85 -148.21 83.24 7.29 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.671 0.748 . . . . 74.5 110.878 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.414 ' HD2' ' HG3' ' A' ' 72' ' ' ARG . 53.5 Cg_endo -69.77 -4.98 15.12 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.728 2.285 . . . . 73.019999999999996 112.324 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -157.58 141.14 15.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.202 -0.454 . . . . 75.430000000000007 110.94 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.896 ' O ' ' CD1' ' A' ' 73' ' ' TRP . 44.9 p90 -51.55 -41.24 60.95 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.177 -0.465 . . . . 72.049999999999997 110.896 -179.834 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -52.02 -20.05 2.2 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.156 -0.474 . . . . 74.540000000000006 110.917 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.414 ' HG3' ' HD2' ' A' ' 68' ' ' PRO . 28.2 mmt180 -64.03 -30.24 71.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.188 -0.46 . . . . 65.010000000000005 110.872 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' TRP . . . . . 0.896 ' CD1' ' O ' ' A' ' 70' ' ' TYR . 0.5 OUTLIER -103.88 30.66 4.97 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.192 -0.458 . . . . 73.530000000000001 110.951 179.983 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.439 ' O ' ' C ' ' A' ' 75' ' ' GLY . 0.0 OUTLIER 74.64 23.82 1.79 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.225 -0.443 . . . . 63.520000000000003 110.88 179.918 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.449 ' N ' ' HD1' ' A' ' 73' ' ' TRP . . . 33.03 49.37 0.43 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.697 -0.763 . . . . 23.219999999999999 112.525 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.764 HD21 ' HA ' ' A' ' 148' ' ' ARG . 0.6 OUTLIER -65.46 -77.61 0.06 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.806 0.336 . . . . 73.230000000000004 110.909 -179.908 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -135.79 134.17 38.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.161 -0.472 . . . . 63.409999999999997 110.888 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -90.09 17.0 7.42 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.122 -0.49 . . . . 74.219999999999999 110.88 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 6.0 ttm105 -107.36 77.18 1.12 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.174 -0.466 . . . . 72.430000000000007 110.844 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.754 HD11 HG11 ' A' ' 49' ' ' VAL . 0.1 OUTLIER -82.32 134.43 35.26 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.172 -0.467 . . . . 51.439999999999998 110.928 -179.99 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.702 ' HB3' ' HB3' ' A' ' 53' ' ' PRO . 1.5 m -154.32 -124.38 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.196 -0.456 . . . . 63.229999999999997 110.866 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.741 ' OG ' ' HA ' ' A' ' 53' ' ' PRO . 0.0 OUTLIER -36.28 106.88 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 72.329999999999998 110.891 -179.846 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 83' ' ' CYS . . . . . 0.691 ' HB3' HG12 ' A' ' 49' ' ' VAL . 27.9 p -130.13 132.78 46.24 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.147 -0.479 . . . . 75.409999999999997 110.881 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.565 ' N ' ' O ' ' A' ' 48' ' ' ALA . 4.1 mmt180 -123.41 146.46 47.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.205 -0.452 . . . . 72.319999999999993 110.876 -179.839 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -64.99 124.97 23.46 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.244 -0.434 . . . . 61.420000000000002 111.11 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.727 ' CG2' ' HB2' ' A' ' 48' ' ' ALA . 2.7 t -118.67 146.67 22.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.185 -0.461 . . . . 63.119999999999997 111.127 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' HIS . . . . . 0.558 ' O ' HG23 ' A' ' 136' ' ' VAL . 22.3 m-70 -110.11 112.5 24.53 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.189 -0.459 . . . . 71.420000000000002 110.92 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.533 HD13 ' HB3' ' A' ' 178' ' ' GLU . 0.0 OUTLIER -38.04 151.27 0.16 Allowed Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.647 0.737 . . . . 72.030000000000001 110.875 -179.944 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.552 ' HB3' ' H ' ' A' ' 136' ' ' VAL . 53.8 Cg_endo -69.76 98.78 0.7 Allowed 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.644 2.23 . . . . 61.299999999999997 112.354 179.816 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -105.56 -178.44 3.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.199 -0.455 . . . . 60.240000000000002 110.826 -179.822 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 48.9 84.89 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.764 -0.731 . . . . 41.109999999999999 112.443 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 100.72 29.45 6.55 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.777 -0.725 . . . . 73.510000000000005 112.475 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.473 ' O ' ' HG2' ' A' ' 134' ' ' GLU . 18.6 pt20 38.35 -129.6 0.22 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.852 0.358 . . . . 74.329999999999998 110.912 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.64 ' HA ' ' HG2' ' A' ' 134' ' ' GLU . 0.4 OUTLIER -117.13 103.73 10.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.211 -0.45 . . . . 72.310000000000002 110.943 -179.878 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.554 ' HG3' HG11 ' A' ' 132' ' ' VAL . 38.9 tptt -110.8 125.77 53.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.129 -0.487 . . . . 75.150000000000006 110.886 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.721 HD13 ' N ' ' A' ' 97' ' ' GLN . 0.0 OUTLIER -149.84 136.96 13.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.238 -0.437 . . . . 73.5 111.149 179.829 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.721 ' N ' HD13 ' A' ' 96' ' ' ILE . 2.4 mt-30 -107.86 132.7 53.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.183 -0.462 . . . . 74.109999999999999 110.917 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.769 HD11 HG22 ' A' ' 111' ' ' THR . 1.2 mp -111.29 140.8 28.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.176 -0.466 . . . . 62.229999999999997 111.158 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.634 ' HB2' ' HB2' ' A' ' 129' ' ' SER . 47.5 m-85 -130.97 134.65 46.92 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.192 -0.458 . . . . 73.310000000000002 110.868 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 51.1 tt0 -62.82 -78.86 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.15 -0.477 . . . . 74.030000000000001 110.907 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 6.6 mttt -83.97 162.68 20.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.117 -0.492 . . . . 73.209999999999994 110.851 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.419 ' CA ' ' HB3' ' A' ' 128' ' ' HIS . . . -70.4 163.2 53.09 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.726 -0.75 . . . . 72.430000000000007 112.466 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.497 ' HA ' ' HB2' ' A' ' 158' ' ' ARG . 33.4 t0 63.62 26.29 14.58 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.842 0.353 . . . . 45.109999999999999 110.888 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.48 ' CZ ' ' HB3' ' A' ' 158' ' ' ARG . 14.8 m-85 61.49 48.48 5.84 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.207 -0.451 . . . . 54.229999999999997 110.831 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 2.3 m -113.67 148.04 37.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.16 -0.473 . . . . 73.540000000000006 110.807 -179.79 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 92.27 -121.81 6.6 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.692 -0.766 . . . . 74.409999999999997 112.452 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 7.5 tp-100 -104.88 147.21 27.99 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.822 0.344 . . . . 64.409999999999997 110.916 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 3.7 ttp -136.65 136.79 39.42 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.205 -0.452 . . . . 75.430000000000007 110.919 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' TYR . . . . . 0.473 ' O ' HD12 ' A' ' 98' ' ' ILE . 12.9 m-85 -143.95 137.41 27.76 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.249 -0.432 . . . . 72.340000000000003 110.959 -179.838 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -114.93 111.14 20.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.153 -0.476 . . . . 75.450000000000003 110.933 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.769 HG22 HD11 ' A' ' 98' ' ' ILE . 11.7 t -118.1 139.46 51.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.157 -0.474 . . . . 70.319999999999993 111.122 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.556 ' HA ' ' O ' ' A' ' 94' ' ' TYR . 2.1 t -117.66 40.49 3.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.177 -0.465 . . . . 45.32 111.152 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -153.15 163.31 40.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.227 -0.442 . . . . 65.439999999999998 110.887 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -51.34 159.3 0.7 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.182 -0.463 . . . . 72.150000000000006 110.855 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' CYS . . . . . 0.607 ' O ' ' HB2' ' A' ' 172' ' ' SER . 41.9 t -147.85 111.34 3.86 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.589 0.709 . . . . 62.210000000000001 110.892 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.456 ' O ' ' C ' ' A' ' 143' ' ' PRO . 53.7 Cg_endo -69.8 -31.98 19.3 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.663 2.242 . . . . 74.319999999999993 112.303 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.641 ' HB3' ' CB ' ' A' ' 120' ' ' GLU . 0.2 OUTLIER -149.06 105.5 3.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.238 -0.437 . . . . 62.210000000000001 110.865 -179.819 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.656 HD13 HD11 ' A' ' 127' ' ' ILE . 3.7 tt -61.93 -30.52 48.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.15 -0.477 . . . . 63.210000000000001 111.153 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' MET . . . . . 0.628 ' O ' ' HA ' ' A' ' 123' ' ' HIS . 38.5 ttp -86.68 -38.6 16.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 73.230000000000004 110.894 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.641 ' CB ' ' HB3' ' A' ' 117' ' ' SER . 5.3 tp10 -72.71 -13.44 61.34 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.222 -0.445 . . . . 73.510000000000005 110.89 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 28.1 tp60 -114.8 -41.18 3.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.126 -0.488 . . . . 72.230000000000004 110.914 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.511 ' HB2' ' O ' ' A' ' 118' ' ' ILE . 51.8 m-85 -112.05 -20.61 11.89 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.216 -0.447 . . . . 65.439999999999998 110.913 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' HIS . . . . . 0.628 ' HA ' ' O ' ' A' ' 119' ' ' MET . 13.0 m80 72.8 27.02 2.25 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.124 -0.489 . . . . 72.010000000000005 110.856 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.454 ' SD ' HG22 ' A' ' 98' ' ' ILE . 9.3 mtt -101.31 90.75 4.22 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.183 -0.462 . . . . 65.109999999999999 110.861 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 4.1 ptp180 -53.49 -43.94 68.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.268 -0.424 . . . . 64.230000000000004 110.912 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.472 ' HG2' ' HA ' ' A' ' 169' ' ' ALA . 8.7 mt-10 -137.59 130.55 30.34 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.146 -0.479 . . . . 75.109999999999999 110.883 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.656 HD11 HD13 ' A' ' 118' ' ' ILE . 3.5 mm -88.79 91.48 3.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.104 -0.498 . . . . 74.230000000000004 111.165 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' HIS . . . . . 0.544 ' CD2' ' HG3' ' A' ' 168' ' ' PRO . 52.4 m80 -65.51 -30.16 70.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.147 -0.478 . . . . 74.019999999999996 110.857 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.634 ' HB2' ' HB2' ' A' ' 99' ' ' PHE . 0.4 OUTLIER -135.08 144.42 47.2 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.205 -0.452 . . . . 75.530000000000001 110.865 -179.765 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 130' ' ' CYS . . . . . 0.662 ' O ' ' O ' ' A' ' 155' ' ' LYS . 0.1 OUTLIER -146.53 119.71 8.89 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.138 -0.483 . . . . 72.219999999999999 110.858 -179.934 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.653 ' HA ' ' HA ' ' A' ' 156' ' ' GLU . 6.0 mtpp -107.38 153.54 22.63 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.172 -0.467 . . . . 64.129999999999995 110.859 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.554 HG11 ' HG3' ' A' ' 95' ' ' LYS . 9.8 t 82.28 165.54 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.239 -0.437 . . . . 61.409999999999997 111.133 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.768 HD22 ' CG ' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -176.91 124.2 0.15 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.17 -0.468 . . . . 63.32 110.934 179.956 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.64 ' HG2' ' HA ' ' A' ' 94' ' ' TYR . 0.0 OUTLIER -97.44 164.02 12.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.227 -0.442 . . . . 64.099999999999994 110.924 179.919 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.544 ' C ' ' O ' ' A' ' 134' ' ' GLU . . . -24.7 -61.18 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.746 -0.74 . . . . 62.210000000000001 112.451 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.707 HG21 ' CG1' ' A' ' 86' ' ' VAL . 1.7 t -147.44 154.19 11.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.817 0.341 . . . . 62.100000000000001 111.15 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' TRP . . . . . 0.943 ' H ' HD12 ' A' ' 152' ' ' LEU . 0.7 OUTLIER -152.09 149.05 28.39 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.188 -0.46 . . . . 72.010000000000005 110.887 -179.994 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.485 ' CD1' ' HB ' ' A' ' 61' ' ' ILE . 5.6 mm -116.55 135.42 56.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.21 -0.45 . . . . 65.219999999999999 111.163 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.515 ' HB2' ' HB2' ' A' ' 150' ' ' TYR . 1.4 m-85 -112.25 165.02 12.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.209 -0.451 . . . . 72.329999999999998 110.866 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 0.461 ' HB3' ' O ' ' A' ' 146' ' ' ARG . 5.2 m-85 -144.8 132.03 20.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.147 -0.479 . . . . 75.219999999999999 110.887 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.641 ' O ' ' HB2' ' A' ' 171' ' ' GLN . 0.0 OUTLIER -57.92 -27.79 63.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.091 -0.504 . . . . 55.240000000000002 110.876 -179.997 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.727 ' HB3' ' HD2' ' A' ' 143' ' ' PRO . 9.5 mp -114.1 173.28 2.96 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.614 0.721 . . . . 74.340000000000003 110.94 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 143' ' ' PRO . . . . . 0.734 ' O ' ' OG ' ' A' ' 172' ' ' SER . 53.3 Cg_endo -69.8 -90.46 0.0 OUTLIER 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.697 2.264 . . . . 71.420000000000002 112.324 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 144' ' ' ASN . . . . . 0.721 ' O ' ' N ' ' A' ' 146' ' ' ARG . 0.6 OUTLIER -50.79 97.81 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.213 -0.449 . . . . 75.239999999999995 110.937 179.985 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 145' ' ' TYR . . . . . 0.653 ' C ' ' O ' ' A' ' 144' ' ' ASN . 0.2 OUTLIER 11.46 53.34 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.173 -0.467 . . . . 64.140000000000001 110.937 -179.875 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 146' ' ' ARG . . . . . 0.721 ' N ' ' O ' ' A' ' 144' ' ' ASN . 22.5 mtt180 -121.5 160.2 24.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.148 -0.478 . . . . 74.420000000000002 110.859 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 93.26 -172.4 33.33 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.696 -0.764 . . . . 33.420000000000002 112.493 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.764 ' HA ' HD21 ' A' ' 76' ' ' LEU . 4.1 mpt_? -79.65 155.05 28.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.79 0.328 . . . . 73.540000000000006 110.88 -179.878 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 149' ' ' GLN . . . . . 0.403 ' HB3' ' HA ' ' A' ' 60' ' ' TYR . 0.4 OUTLIER -81.56 151.83 27.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.213 -0.449 . . . . 71.310000000000002 110.919 -179.941 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 150' ' ' TYR . . . . . 0.515 ' HB2' ' HB2' ' A' ' 139' ' ' PHE . 69.4 m-85 -151.96 103.11 2.87 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.178 -0.464 . . . . 73.109999999999999 110.893 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.524 HD22 HD11 ' A' ' 61' ' ' ILE . 0.1 OUTLIER -69.92 137.33 51.48 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.096 -0.502 . . . . 73.040000000000006 110.892 179.988 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 1.022 HD13 ' O ' ' A' ' 152' ' ' LEU . 0.0 OUTLIER -72.7 151.87 41.97 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.189 -0.46 . . . . 70.299999999999997 110.905 179.898 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 153' ' ' ASP . . . . . 0.743 ' N ' HD22 ' A' ' 152' ' ' LEU . 6.0 t0 -162.66 24.34 0.1 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.165 -0.471 . . . . 74.340000000000003 110.859 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 1.029 ' HB2' ' CD1' ' A' ' 157' ' ' TYR . 6.1 ptmt -115.29 -166.79 1.16 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.187 -0.461 . . . . 70.25 110.895 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.768 ' CG ' HD22 ' A' ' 133' ' ' LEU . 0.9 OUTLIER -158.47 -122.42 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.238 -0.437 . . . . 74.129999999999995 110.914 179.852 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.653 ' HA ' ' HA ' ' A' ' 131' ' ' LYS . 2.4 tm-20 -68.56 -0.33 4.99 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.222 -0.445 . . . . 75.329999999999998 110.943 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 157' ' ' TYR . . . . . 1.029 ' CD1' ' HB2' ' A' ' 154' ' ' LYS . 9.5 m-30 -32.55 146.15 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.12 -0.491 . . . . 54.539999999999999 110.901 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 158' ' ' ARG . . . . . 0.497 ' HB2' ' HA ' ' A' ' 103' ' ' ASP . 7.5 ptp180 -110.13 -39.7 4.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.107 -0.497 . . . . 74.540000000000006 110.902 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 2.4 ptpp? -91.39 151.2 42.49 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.58 0.705 . . . . 73.109999999999999 110.896 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 -25.73 28.28 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.734 2.289 . . . . 74.219999999999999 112.295 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.668 HD12 ' H ' ' A' ' 161' ' ' ILE . 4.0 mp -73.98 -6.16 7.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.265 -0.425 . . . . 71.040000000000006 111.129 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.594 ' HB3' ' CD1' ' A' ' 157' ' ' TYR . 1.6 t0 -72.54 -13.45 61.41 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.197 -0.456 . . . . 54.310000000000002 110.868 179.842 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 82.2 t90 -107.14 -3.43 19.91 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.189 -0.46 . . . . 72.140000000000001 110.917 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 100.12 -35.35 4.84 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.753 -0.737 . . . . 71.129999999999995 112.475 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -57.1 121.07 9.16 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.812 0.339 . . . . 63.100000000000001 111.098 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -46.99 -30.48 2.62 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.224 -0.444 . . . . 74.040000000000006 111.087 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 167' ' ' SER . . . . . 0.486 ' C ' ' H ' ' A' ' 169' ' ' ALA . 0.5 OUTLIER -151.49 154.41 33.4 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.697 0.76 . . . . 35.420000000000002 110.826 -179.74 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 168' ' ' PRO . . . . . 0.544 ' HG3' ' CD2' ' A' ' 128' ' ' HIS . 53.5 Cg_endo -69.73 22.53 0.17 Allowed 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.639 2.226 . . . . 63.439999999999998 112.399 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.486 ' H ' ' C ' ' A' ' 167' ' ' SER . . . -65.65 101.25 0.6 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.201 -0.454 . . . . 73.120000000000005 111.121 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.482 HG11 ' CD1' ' A' ' 139' ' ' PHE . 2.4 t -153.59 163.77 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.235 -0.439 . . . . 71.310000000000002 111.133 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 171' ' ' GLN . . . . . 0.641 ' HB2' ' O ' ' A' ' 141' ' ' GLU . 1.8 mm-40 -111.23 -87.2 0.54 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.21 -0.45 . . . . 71.420000000000002 110.941 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 172' ' ' SER . . . . . 0.734 ' OG ' ' O ' ' A' ' 143' ' ' PRO . 24.8 p -125.97 175.53 7.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.218 -0.446 . . . . 71.0 110.86 -179.792 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 10.7 p90 -144.14 168.25 20.47 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.166 -0.47 . . . . 75.420000000000002 110.889 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.32 156.6 48.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.133 -0.485 . . . . 75.25 110.862 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 175' ' ' ARG . . . . . 0.451 ' HD2' ' CE2' ' A' ' 94' ' ' TYR . 0.8 OUTLIER -88.68 -175.76 5.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.194 -0.457 . . . . 73.439999999999998 110.838 -179.916 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 176' ' ' ILE . . . . . 0.506 HD12 ' C ' ' A' ' 136' ' ' VAL . 5.6 mt -129.7 131.69 66.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.151 -0.477 . . . . 65.319999999999993 111.127 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 18.9 t -125.38 153.22 32.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.177 -0.465 . . . . 64.430000000000007 111.149 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 178' ' ' GLU . . . . . 0.533 ' HB3' HD13 ' A' ' 88' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.218 -0.446 . . . . 75.140000000000001 110.847 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.9 mtt . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.79 0.328 . . . . 64.430000000000007 110.919 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 11.2 m -137.21 37.57 2.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.214 -0.448 . . . . 61.130000000000003 110.888 -179.79 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 52.79 39.3 28.52 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.112 -0.494 . . . . 54.340000000000003 110.92 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.8 t -114.65 -35.98 4.69 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.206 -0.452 . . . . 72.409999999999997 111.135 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -166.26 122.3 1.05 Allowed Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.727 -0.749 . . . . 53.149999999999999 112.465 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.457 ' C ' ' HE1' ' A' ' 47' ' ' TRP . 14.7 p -81.85 137.32 35.28 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.852 0.358 . . . . 72.109999999999999 111.143 -179.878 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.435 ' HA ' ' HA ' ' A' ' 24' ' ' ASP . 2.4 tttt -125.69 135.62 52.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.238 -0.437 . . . . 73.5 110.887 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.516 ' HA ' ' HA ' ' A' ' 42' ' ' VAL . 14.6 tt -135.98 153.78 32.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.216 -0.447 . . . . 74.319999999999993 111.094 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.481 HG23 ' CG ' ' A' ' 22' ' ' ASP . 12.9 m -135.77 145.91 47.06 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.151 -0.477 . . . . 65.209999999999994 111.143 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.567 ' CE1' HD12 ' A' ' 80' ' ' LEU . 0.3 OUTLIER -133.6 128.52 35.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.208 -0.451 . . . . 75.129999999999995 110.835 -179.954 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.556 ' CG ' ' HA ' ' A' ' 16' ' ' PHE . 22.1 m-85 -113.65 132.54 55.73 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.182 -0.463 . . . . 61.409999999999997 110.914 -179.869 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.409 ' HA ' ' O ' ' A' ' 36' ' ' ARG . 0.0 OUTLIER -60.71 -14.38 20.68 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.108 -0.496 . . . . 72.239999999999995 110.883 -179.989 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.447 ' HB2' ' O ' ' A' ' 17' ' ' GLN . 78.1 m-20 -136.38 150.96 49.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.146 -0.479 . . . . 72.340000000000003 110.852 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.441 ' HG3' ' HB3' ' A' ' 38' ' ' ASN . 4.5 mtmm -55.25 -176.2 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.165 -0.471 . . . . 74.439999999999998 110.919 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 19.4 m120 45.31 34.18 1.42 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.234 -0.439 . . . . 70.239999999999995 110.849 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.556 ' HA ' ' CG ' ' A' ' 11' ' ' TYR . 2.2 m-85 48.39 67.32 0.87 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.211 -0.449 . . . . 74.519999999999996 110.905 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.447 ' O ' ' HB2' ' A' ' 13' ' ' ASP . 4.7 mt-30 -141.78 158.13 44.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.145 -0.48 . . . . 75.030000000000001 110.876 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 92.85 -150.29 19.92 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.759 -0.734 . . . . 24.030000000000001 112.497 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.732 ' O ' HD13 ' A' ' 34' ' ' LEU . 2.2 mtt180 -68.74 79.9 0.29 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.827 0.346 . . . . 64.329999999999998 110.872 -179.855 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.478 ' HA ' ' O ' ' A' ' 10' ' ' PHE . 0.5 OUTLIER -77.96 129.13 34.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.199 -0.455 . . . . 61.329999999999998 110.89 -179.953 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.428 ' O ' ' HA ' ' A' ' 9' ' ' THR . 70.3 t80 -123.86 125.98 45.61 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.177 -0.465 . . . . 64.200000000000003 110.948 -179.87 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.481 ' CG ' HG23 ' A' ' 9' ' ' THR . 1.3 m-20 -119.41 134.81 55.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.109 -0.496 . . . . 74.150000000000006 110.85 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 9.4 t -160.44 129.4 4.87 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.177 -0.465 . . . . 62.409999999999997 110.858 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.435 ' HA ' ' HA ' ' A' ' 7' ' ' LYS . 2.5 p30 -97.65 5.36 49.48 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.157 -0.474 . . . . 64.439999999999998 110.841 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 47.5 t -114.91 160.65 19.27 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.186 -0.461 . . . . 63.109999999999999 110.892 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 87.4 m-20 -43.06 120.11 1.72 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.202 -0.453 . . . . 71.340000000000003 110.904 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.572 ' CB ' ' HB3' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -114.37 40.35 2.55 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.21 -0.45 . . . . 73.120000000000005 110.862 -179.907 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.564 ' O ' ' HB3' ' A' ' 82' ' ' SER . . . -50.47 -21.76 1.62 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.239 -0.437 . . . . 54.329999999999998 111.126 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 60.8 t0 -130.5 40.02 3.56 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.212 -0.449 . . . . 72.200000000000003 110.871 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.762 ' CD2' ' O ' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -80.04 14.54 1.8 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.15 -0.477 . . . . 62.340000000000003 110.911 -179.914 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.427 ' CG ' ' HG3' ' A' ' 53' ' ' PRO . 40.7 t60 -77.63 -35.11 52.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.138 -0.483 . . . . 64.319999999999993 110.842 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.6 t -61.95 -12.23 17.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.254 -0.43 . . . . 74.310000000000002 111.119 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -102.29 -26.56 13.27 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.265 -0.425 . . . . 73.129999999999995 110.894 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.732 HD13 ' O ' ' A' ' 19' ' ' ARG . 28.0 tp -139.33 130.43 26.54 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.146 -0.479 . . . . 72.140000000000001 110.944 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 21.1 m -91.24 -44.73 9.04 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.167 -0.469 . . . . 71.209999999999994 110.866 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.409 ' O ' ' HA ' ' A' ' 12' ' ' GLU . 0.0 OUTLIER -114.28 145.49 41.68 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.103 -0.499 . . . . 65.239999999999995 110.893 -179.918 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.576 ' SG ' ' CB ' ' A' ' 80' ' ' LEU . 3.5 m -126.76 106.35 9.3 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.184 -0.462 . . . . 63.329999999999998 110.861 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.441 ' HB3' ' HG3' ' A' ' 14' ' ' LYS . 11.3 m-20 -104.07 -62.43 1.31 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.174 -0.466 . . . . 74.439999999999998 110.905 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 9.7 p -111.96 133.19 54.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.46 . . . . 70.219999999999999 110.903 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.628 HD12 ' HZ3' ' A' ' 73' ' ' TRP . 8.9 mt -129.19 151.56 35.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.14 -0.482 . . . . 64.319999999999993 111.122 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.431 ' HE3' ' CD1' ' A' ' 16' ' ' PHE . 0.0 OUTLIER -143.05 121.03 12.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.149 -0.478 . . . . 75.409999999999997 110.862 179.84 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.654 HG21 ' HB2' ' A' ' 47' ' ' TRP . 1.3 t -107.62 116.79 51.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.212 -0.449 . . . . 75.049999999999997 111.148 179.833 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -112.18 76.5 0.98 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.177 -0.465 . . . . 72.329999999999998 110.932 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.421 ' O ' ' HA ' ' A' ' 6' ' ' THR . . . 142.37 94.09 0.21 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.738 -0.744 . . . . 54.210000000000001 112.441 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 56.49 174.26 0.21 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.763 -0.732 . . . . 43.219999999999999 112.49 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.708 HG23 ' HA ' ' A' ' 63' ' ' PRO . 1.2 m -69.09 169.99 10.84 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.793 0.33 . . . . 74.430000000000007 111.126 -179.867 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.654 ' HB2' HG21 ' A' ' 42' ' ' VAL . 5.3 m95 -145.53 128.91 16.88 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.208 -0.451 . . . . 74.409999999999997 110.924 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.903 ' HB2' ' CG2' ' A' ' 86' ' ' VAL . . . -88.54 126.62 35.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.234 -0.439 . . . . 73.209999999999994 111.105 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.785 HG11 HD11 ' A' ' 80' ' ' LEU . 27.2 m -126.77 139.58 51.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.211 -0.45 . . . . 74.310000000000002 111.177 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.895 ' HB3' ' CB ' ' A' ' 56' ' ' ALA . 5.0 m-85 -116.55 144.47 44.33 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.17 -0.468 . . . . 73.120000000000005 110.949 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.555 ' HG2' ' N ' ' A' ' 52' ' ' ARG . 0.3 OUTLIER -48.61 -84.67 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.141 -0.481 . . . . 73.519999999999996 110.867 -179.971 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.896 ' O ' ' HB2' ' A' ' 56' ' ' ALA . 0.2 OUTLIER -81.46 136.72 48.78 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.573 0.701 . . . . 73.519999999999996 110.915 -179.935 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.654 ' HB3' ' HB3' ' A' ' 81' ' ' SER . 53.8 Cg_endo -69.7 137.89 36.7 Favored 'Trans proline' 0 C--N 1.341 0.14 0 C-N-CA 122.681 2.254 . . . . 74.140000000000001 112.376 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.468 ' C ' ' CD2' ' A' ' 55' ' ' PHE . 2.0 m120 69.22 -5.87 1.03 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.277 -0.419 . . . . 62.530000000000001 110.885 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.468 ' CD2' ' C ' ' A' ' 54' ' ' ASN . 0.1 OUTLIER -143.51 -75.43 0.26 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.131 -0.486 . . . . 75.530000000000001 110.875 -179.913 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.896 ' HB2' ' O ' ' A' ' 52' ' ' ARG . . . 45.87 81.27 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.14 -0.482 . . . . 72.340000000000003 111.09 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' TRP . . . . . 0.455 ' O ' ' CD2' ' A' ' 58' ' ' TYR . 18.9 m0 -65.32 35.48 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.227 -0.442 . . . . 74.530000000000001 110.908 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.586 ' H ' ' C ' ' A' ' 56' ' ' ALA . 1.2 m-30 -165.06 117.26 1.18 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.257 -0.429 . . . . 74.549999999999997 110.913 -179.844 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.453 ' HB2' ' HA ' ' A' ' 150' ' ' TYR . 1.0 OUTLIER -78.7 130.66 36.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.105 -0.498 . . . . 71.219999999999999 110.899 179.925 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.909 ' CD2' HD12 ' A' ' 76' ' ' LEU . 13.8 t80 -139.51 98.17 3.43 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.262 -0.427 . . . . 72.109999999999999 110.922 -179.864 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.584 ' H ' HD12 ' A' ' 61' ' ' ILE . 4.0 mp -83.56 111.16 19.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.1 -0.5 . . . . 74.409999999999997 111.15 179.873 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.874 HD23 ' HD2' ' A' ' 63' ' ' PRO . 0.3 OUTLIER -79.88 127.05 78.68 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.608 0.718 . . . . 71.040000000000006 110.923 179.898 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.874 ' HD2' HD23 ' A' ' 62' ' ' LEU . 53.7 Cg_endo -69.76 -165.04 0.14 Allowed 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.688 2.259 . . . . 72.310000000000002 112.348 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.91 160.68 14.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.236 -0.438 . . . . 75.129999999999995 110.928 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 112.61 -151.92 18.03 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.71 -0.757 . . . . 62.32 112.498 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -116.05 161.57 18.69 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.863 0.363 . . . . 74.030000000000001 110.884 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.498 ' N ' ' O ' ' A' ' 40' ' ' ILE . 13.6 m-85 -149.56 82.38 6.81 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.69 0.757 . . . . 71.439999999999998 110.929 -179.857 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.437 ' HD2' ' HG3' ' A' ' 72' ' ' ARG . 53.9 Cg_endo -69.74 -0.3 6.7 Favored 'Trans proline' 0 N--CA 1.465 -0.19 0 C-N-CA 122.72 2.28 . . . . 61.340000000000003 112.379 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -157.99 155.39 29.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.181 -0.463 . . . . 73.430000000000007 110.867 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.594 ' O ' ' CD1' ' A' ' 73' ' ' TRP . 24.9 p90 -62.18 -37.46 85.34 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.152 -0.476 . . . . 63.210000000000001 110.915 -179.854 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.585 ' HA ' ' CA ' ' A' ' 75' ' ' GLY . 6.6 pt20 -61.25 -10.6 7.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.12 -0.491 . . . . 64.299999999999997 110.922 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.437 ' HG3' ' HD2' ' A' ' 68' ' ' PRO . 25.2 mmt180 -65.82 -45.11 83.53 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.186 -0.461 . . . . 71.200000000000003 110.872 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' TRP . . . . . 0.757 ' O ' ' CB ' ' A' ' 74' ' ' MET . 0.4 OUTLIER -81.11 -5.45 57.68 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.182 -0.463 . . . . 74.519999999999996 110.902 -179.944 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.757 ' CB ' ' O ' ' A' ' 73' ' ' TRP . 8.4 mmm 131.21 -3.98 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.207 -0.451 . . . . 73.219999999999999 110.889 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.585 ' CA ' ' HA ' ' A' ' 71' ' ' GLN . . . 76.2 17.22 80.14 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.7 -0.762 . . . . 62.549999999999997 112.451 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.909 HD12 ' CD2' ' A' ' 60' ' ' TYR . 0.0 OUTLIER -63.45 -154.25 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.787 0.327 . . . . 65.439999999999998 110.963 -179.905 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.473 ' H ' HD13 ' A' ' 76' ' ' LEU . 2.9 t-20 -65.06 131.71 47.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.275 -0.421 . . . . 73.540000000000006 110.87 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -87.93 11.91 14.58 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.178 -0.465 . . . . 63.119999999999997 110.878 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.539 ' O ' ' O ' ' A' ' 51' ' ' GLU . 0.0 OUTLIER -87.95 49.44 1.8 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.169 -0.469 . . . . 61.329999999999998 110.852 -179.872 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.785 HD11 HG11 ' A' ' 49' ' ' VAL . 0.1 OUTLIER -59.89 127.08 30.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.191 -0.458 . . . . 62.409999999999997 110.891 -179.943 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.654 ' HB3' ' HB3' ' A' ' 53' ' ' PRO . 5.3 m -149.83 -114.99 0.06 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.188 -0.46 . . . . 53.200000000000003 110.897 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.626 ' OG ' ' HA ' ' A' ' 53' ' ' PRO . 0.1 OUTLIER -42.43 102.48 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.155 -0.475 . . . . 71.519999999999996 110.849 -179.776 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 83' ' ' CYS . . . . . 0.721 ' HB3' HG12 ' A' ' 49' ' ' VAL . 8.7 p -130.42 134.02 46.8 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.133 -0.485 . . . . 71.510000000000005 110.865 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.627 ' N ' ' O ' ' A' ' 48' ' ' ALA . 0.9 OUTLIER -117.33 158.44 24.39 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.16 -0.473 . . . . 65.510000000000005 110.854 -179.862 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -70.58 131.77 44.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.2 -0.454 . . . . 63.329999999999998 111.075 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.903 ' CG2' ' HB2' ' A' ' 48' ' ' ALA . 71.3 t -117.06 129.07 74.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.162 -0.472 . . . . 62.229999999999997 111.142 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' HIS . . . . . 0.664 ' O ' HG23 ' A' ' 136' ' ' VAL . 16.9 m80 -113.79 107.39 15.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.179 -0.464 . . . . 74.310000000000002 110.824 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.479 ' H ' HD23 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -31.69 148.67 0.05 OUTLIER Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.574 0.702 . . . . 73.239999999999995 110.955 -179.999 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.548 ' HB3' ' H ' ' A' ' 136' ' ' VAL . 53.4 Cg_endo -69.8 93.23 0.52 Allowed 'Trans proline' 0 C--O 1.231 0.136 0 C-N-CA 122.689 2.259 . . . . 73.219999999999999 112.323 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -104.61 -174.22 2.49 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.205 -0.452 . . . . 73.010000000000005 110.881 -179.872 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 49.55 64.18 3.6 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.755 -0.736 . . . . 53.340000000000003 112.464 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 122.6 24.22 2.17 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.751 -0.738 . . . . 71.209999999999994 112.515 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 41.5 -158.73 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.822 0.344 . . . . 53.219999999999999 110.892 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.506 ' HA ' ' HG2' ' A' ' 134' ' ' GLU . 31.5 t80 -99.77 102.78 14.33 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.187 -0.46 . . . . 74.450000000000003 110.905 -179.837 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.498 ' HG3' HG11 ' A' ' 132' ' ' VAL . 42.8 tptt -112.61 130.03 56.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.132 -0.485 . . . . 72.140000000000001 110.887 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.478 ' HB ' ' OE1' ' A' ' 134' ' ' GLU . 0.0 OUTLIER -148.83 137.44 15.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.232 -0.44 . . . . 75.140000000000001 111.127 179.888 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.474 ' N ' HD13 ' A' ' 96' ' ' ILE . 0.9 OUTLIER -111.16 132.2 54.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.15 -0.477 . . . . 72.310000000000002 110.905 179.935 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.571 ' CG2' HD12 ' A' ' 127' ' ' ILE . 3.1 mp -113.17 135.54 52.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.211 -0.45 . . . . 54.039999999999999 111.094 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.653 ' HB2' ' HB2' ' A' ' 129' ' ' SER . 48.7 m-85 -126.48 136.34 52.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.148 -0.478 . . . . 74.519999999999996 110.835 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 51.9 tt0 -65.6 -75.29 0.09 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.101 -0.499 . . . . 70.519999999999996 110.883 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.429 ' C ' ' HB2' ' A' ' 128' ' ' HIS . 6.0 mttt -85.64 158.6 20.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.143 -0.481 . . . . 71.409999999999997 110.939 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -66.54 164.4 41.93 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.782 -0.723 . . . . 71.439999999999998 112.512 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.426 ' HA ' ' HB2' ' A' ' 158' ' ' ARG . 38.7 t70 61.67 27.89 17.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.88 0.371 . . . . 65.319999999999993 110.843 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.506 ' HA ' ' CD2' ' A' ' 99' ' ' PHE . 14.9 m-85 59.52 52.68 5.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.193 -0.458 . . . . 74.510000000000005 110.916 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.2 m -118.13 148.9 41.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.102 -0.499 . . . . 62.329999999999998 110.827 -179.755 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 90.8 -125.19 7.86 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.724 -0.75 . . . . 74.299999999999997 112.532 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -98.85 139.55 34.36 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.756 0.312 . . . . 72.439999999999998 110.958 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 1.3 ttp -130.99 137.0 49.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.214 -0.448 . . . . 74.120000000000005 110.857 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 13.3 m-85 -141.29 136.56 31.72 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.244 -0.434 . . . . 75.049999999999997 110.953 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -117.74 103.85 10.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.146 -0.479 . . . . 70.319999999999993 110.874 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 13.1 t -117.33 140.69 49.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.166 -0.47 . . . . 60.350000000000001 111.166 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.522 ' O ' ' OG1' ' A' ' 112' ' ' THR . 0.1 OUTLIER -101.52 27.72 6.1 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.209 -0.45 . . . . 64.540000000000006 111.142 -179.962 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -143.67 -174.96 4.39 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.213 -0.449 . . . . 72.430000000000007 110.852 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.48 ' CB ' ' HA ' ' A' ' 174' ' ' ARG . 9.2 p30 -107.96 177.43 4.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.146 -0.479 . . . . 74.200000000000003 110.899 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' CYS . . . . . 0.434 ' O ' ' HB2' ' A' ' 172' ' ' SER . 18.4 p -155.98 148.86 18.14 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 121.578 0.704 . . . . 74.200000000000003 110.916 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 -25.65 28.36 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.68 2.253 . . . . 72.349999999999994 112.364 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.626 ' HB3' ' CB ' ' A' ' 120' ' ' GLU . 0.1 OUTLIER -150.77 107.4 3.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.192 -0.458 . . . . 72.120000000000005 110.879 -179.861 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.659 HD13 HD11 ' A' ' 127' ' ' ILE . 4.0 tt -59.08 -29.81 42.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.142 -0.481 . . . . 72.310000000000002 111.152 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' MET . . . . . 0.596 ' O ' ' HA ' ' A' ' 123' ' ' HIS . 54.8 ttp -86.39 -42.66 13.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.168 -0.469 . . . . 73.310000000000002 110.877 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.626 ' CB ' ' HB3' ' A' ' 117' ' ' SER . 8.5 tp10 -67.59 -13.14 61.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.24 -0.437 . . . . 75.340000000000003 110.9 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 22.2 tp60 -114.53 -48.11 2.88 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.158 -0.473 . . . . 64.510000000000005 110.944 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.443 ' HB2' ' O ' ' A' ' 118' ' ' ILE . 47.6 m-85 -105.68 -20.1 13.56 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.217 -0.447 . . . . 71.129999999999995 110.878 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' HIS . . . . . 0.596 ' HA ' ' O ' ' A' ' 119' ' ' MET . 10.7 m80 72.61 28.14 2.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.201 -0.454 . . . . 63.530000000000001 110.83 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.533 ' SD ' HG22 ' A' ' 98' ' ' ILE . 4.6 mtt -105.44 84.49 2.1 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.222 -0.444 . . . . 70.450000000000003 110.873 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 3.7 ptp180 -50.98 -34.81 30.6 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.196 -0.456 . . . . 75.010000000000005 110.885 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.51 ' HG2' ' HA ' ' A' ' 169' ' ' ALA . 18.4 mt-10 -144.8 135.27 24.39 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.16 -0.473 . . . . 73.430000000000007 110.872 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.659 HD11 HD13 ' A' ' 118' ' ' ILE . 3.7 mm -96.04 100.71 11.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.147 -0.478 . . . . 74.230000000000004 111.122 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 128' ' ' HIS . . . . . 0.429 ' HB2' ' C ' ' A' ' 101' ' ' LYS . 0.3 OUTLIER -71.34 -30.77 66.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.194 -0.457 . . . . 62.130000000000003 110.879 179.874 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.653 ' HB2' ' HB2' ' A' ' 99' ' ' PHE . 0.4 OUTLIER -133.85 140.08 46.64 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.158 -0.473 . . . . 73.140000000000001 110.87 -179.778 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 130' ' ' CYS . . . . . 0.573 ' O ' ' O ' ' A' ' 155' ' ' LYS . 2.7 m -140.45 117.59 11.24 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.112 -0.494 . . . . 64.420000000000002 110.846 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.697 ' HA ' ' HA ' ' A' ' 156' ' ' GLU . 2.9 mtpp -106.44 154.55 20.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.196 -0.456 . . . . 64.230000000000004 110.872 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.537 HG23 ' C ' ' A' ' 131' ' ' LYS . 4.8 t 79.59 166.38 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.203 -0.453 . . . . 75.120000000000005 111.115 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.676 HD22 ' CG ' ' A' ' 155' ' ' LYS . 0.1 OUTLIER -171.19 128.52 0.71 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.159 -0.473 . . . . 72.400000000000006 110.905 179.992 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.536 ' CD ' ' H ' ' A' ' 134' ' ' GLU . 0.3 OUTLIER -97.3 155.98 16.64 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.181 -0.463 . . . . 75.530000000000001 110.877 179.905 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.519 ' HA3' ' HA ' ' A' ' 89' ' ' PRO . . . -30.53 -48.42 0.16 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.75 -0.738 . . . . 65.209999999999994 112.488 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.816 HG11 ' CG1' ' A' ' 86' ' ' VAL . 3.1 t -150.18 137.68 13.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.842 0.353 . . . . 62.340000000000003 111.136 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 137' ' ' TRP . . . . . 0.729 ' HB3' ' CB ' ' A' ' 152' ' ' LEU . 16.5 t90 -144.3 137.63 27.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.19 -0.459 . . . . 75.150000000000006 110.897 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.544 ' CG2' ' HB2' ' A' ' 149' ' ' GLN . 34.2 mt -111.69 132.05 61.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.212 -0.449 . . . . 72.450000000000003 111.097 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.561 ' CD2' ' HB3' ' A' ' 173' ' ' PHE . 0.1 OUTLIER -96.88 178.25 5.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.181 -0.463 . . . . 73.140000000000001 110.844 179.994 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 0.527 ' CE2' ' HG2' ' A' ' 174' ' ' ARG . 0.3 OUTLIER -155.07 124.06 6.21 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.143 -0.48 . . . . 71.430000000000007 110.921 -179.836 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.612 ' O ' ' HB2' ' A' ' 171' ' ' GLN . 0.1 OUTLIER -61.44 -29.71 70.12 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.158 -0.474 . . . . 62.299999999999997 110.859 -179.982 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.704 ' HB3' ' HD2' ' A' ' 143' ' ' PRO . 9.1 mp -114.54 172.89 3.22 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.562 0.696 . . . . 53.140000000000001 110.94 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 143' ' ' PRO . . . . . 0.74 ' O ' ' OG ' ' A' ' 172' ' ' SER . 53.4 Cg_endo -69.76 -90.73 0.01 OUTLIER 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.669 2.246 . . . . 72.510000000000005 112.324 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 144' ' ' ASN . . . . . 0.698 ' O ' ' N ' ' A' ' 146' ' ' ARG . 1.6 m-20 -54.21 95.79 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.201 -0.454 . . . . 61.140000000000001 110.907 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 145' ' ' TYR . . . . . 0.649 ' C ' ' O ' ' A' ' 144' ' ' ASN . 0.1 OUTLIER 12.08 53.94 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.175 -0.466 . . . . 72.430000000000007 110.95 -179.876 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 146' ' ' ARG . . . . . 0.698 ' N ' ' O ' ' A' ' 144' ' ' ASN . 8.8 mtp85 -116.38 163.03 16.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.098 -0.501 . . . . 73.239999999999995 110.851 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 74.31 -172.67 51.86 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.722 -0.752 . . . . 50.020000000000003 112.481 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 4.7 mpt_? -86.7 134.02 33.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.764 0.316 . . . . 63.140000000000001 110.88 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' GLN . . . . . 0.641 ' OE1' ' HA ' ' A' ' 60' ' ' TYR . 0.3 OUTLIER -87.76 163.42 16.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.163 -0.471 . . . . 74.049999999999997 110.957 -179.952 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 150' ' ' TYR . . . . . 0.459 ' HB2' ' HB2' ' A' ' 139' ' ' PHE . 5.2 m-85 -126.8 151.42 48.3 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.234 -0.439 . . . . 75.299999999999997 110.958 -179.896 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.409 HD12 ' H ' ' A' ' 152' ' ' LEU . 29.7 tp -85.65 140.08 30.86 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.125 -0.489 . . . . 74.420000000000002 110.868 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.973 HD13 ' O ' ' A' ' 152' ' ' LEU . 0.0 OUTLIER -69.96 138.24 52.14 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.167 -0.47 . . . . 71.349999999999994 110.893 179.883 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -165.84 27.53 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.216 -0.447 . . . . 72.099999999999994 110.872 179.783 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.826 ' HB2' ' CD1' ' A' ' 157' ' ' TYR . 0.0 OUTLIER -118.61 -172.42 2.28 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.177 -0.465 . . . . 71.319999999999993 110.931 179.952 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.742 ' HD2' ' C ' ' A' ' 154' ' ' LYS . 1.0 OUTLIER -161.63 -123.2 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.236 -0.438 . . . . 73.540000000000006 110.855 179.844 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.697 ' HA ' ' HA ' ' A' ' 131' ' ' LYS . 2.7 tm-20 -71.65 2.63 4.95 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.207 -0.451 . . . . 74.219999999999999 110.911 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 157' ' ' TYR . . . . . 0.826 ' CD1' ' HB2' ' A' ' 154' ' ' LYS . 18.5 m-30 -32.33 147.3 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.14 -0.482 . . . . 74.530000000000001 110.91 -179.836 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 158' ' ' ARG . . . . . 0.491 ' HB3' ' CZ ' ' A' ' 104' ' ' PHE . 8.7 ptp180 -113.64 -35.76 5.1 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.133 -0.485 . . . . 75.510000000000005 110.885 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -92.27 152.94 42.9 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.551 0.691 . . . . 51.509999999999998 110.905 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 160' ' ' PRO . . . . . 0.477 ' HB3' ' HB3' ' A' ' 168' ' ' PRO . 53.7 Cg_endo -69.75 -35.0 13.49 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.679 2.252 . . . . 65.209999999999994 112.35 179.893 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.706 HD12 ' H ' ' A' ' 161' ' ' ILE . 3.2 mp -57.56 -15.85 4.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.444 . . . . 75.219999999999999 111.125 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.643 ' HB3' ' CD1' ' A' ' 157' ' ' TYR . 0.4 OUTLIER -71.69 -13.74 61.83 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.206 -0.452 . . . . 51.130000000000003 110.829 179.884 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 163' ' ' TRP . . . . . 0.475 ' CE3' ' HB3' ' A' ' 165' ' ' ALA . 22.3 t90 -87.98 -16.28 34.2 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.192 -0.458 . . . . 71.219999999999999 110.881 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 109.82 -37.36 3.81 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.758 -0.734 . . . . 54.310000000000002 112.483 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.475 ' HB3' ' CE3' ' A' ' 163' ' ' TRP . . . -78.92 127.17 31.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.797 0.332 . . . . 61.520000000000003 111.066 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 166' ' ' ALA . . . . . 0.424 ' C ' ' O ' ' A' ' 165' ' ' ALA . . . -35.94 -42.18 0.27 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.231 -0.44 . . . . 72.040000000000006 111.11 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 167' ' ' SER . . . . . 0.486 ' C ' ' H ' ' A' ' 169' ' ' ALA . 0.5 OUTLIER -129.78 153.57 80.88 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.654 0.74 . . . . 75.219999999999999 110.864 -179.811 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 168' ' ' PRO . . . . . 0.49 ' HB3' ' O ' ' A' ' 127' ' ' ILE . 53.9 Cg_endo -69.72 29.04 0.18 Allowed 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.691 2.261 . . . . 75.230000000000004 112.357 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.51 ' HA ' ' HG2' ' A' ' 126' ' ' GLU . . . -66.28 103.95 1.1 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.236 -0.438 . . . . 43.43 111.09 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.543 HG11 ' CE2' ' A' ' 139' ' ' PHE . 2.6 t -151.57 163.33 2.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.459 . . . . 63.340000000000003 111.127 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 171' ' ' GLN . . . . . 0.652 ' OE1' ' HB3' ' A' ' 143' ' ' PRO . 1.6 tm0? -112.26 -83.31 0.59 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.157 -0.474 . . . . 75.219999999999999 110.897 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 172' ' ' SER . . . . . 0.74 ' OG ' ' O ' ' A' ' 143' ' ' PRO . 54.4 p -124.55 174.91 7.51 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.203 -0.453 . . . . 70.420000000000002 110.805 -179.788 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 173' ' ' PHE . . . . . 0.561 ' HB3' ' CD2' ' A' ' 139' ' ' PHE . 39.6 p90 -148.76 164.83 33.25 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.101 -0.5 . . . . 74.430000000000007 110.919 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 174' ' ' ARG . . . . . 0.527 ' HG2' ' CE2' ' A' ' 140' ' ' TYR . 0.0 OUTLIER -136.16 142.75 44.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.209 -0.45 . . . . 64.439999999999998 110.906 -179.921 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 175' ' ' ARG . . . . . 0.405 ' HG3' ' OD1' ' A' ' 114' ' ' ASP . 0.0 OUTLIER -90.59 -176.62 4.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.199 -0.455 . . . . 73.040000000000006 110.838 -179.911 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 176' ' ' ILE . . . . . 0.704 HD12 ' HB ' ' A' ' 136' ' ' VAL . 2.4 mt -133.84 132.21 56.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.174 -0.467 . . . . 71.430000000000007 111.112 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 83.1 t -150.04 140.56 16.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.213 -0.449 . . . . 61.219999999999999 111.138 179.799 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.163 -0.471 . . . . 71.310000000000002 110.894 -179.986 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.793 0.33 . . . . 64.129999999999995 110.881 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.4 m -152.54 -170.93 3.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.253 -0.43 . . . . 63.109999999999999 110.864 -179.791 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -90.88 63.5 5.26 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.129 -0.487 . . . . 74.010000000000005 110.913 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 8.1 t -167.18 -37.6 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.161 -0.472 . . . . 62.229999999999997 111.148 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -84.43 78.14 2.04 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.747 -0.739 . . . . 53.5 112.491 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.478 ' C ' ' HE1' ' A' ' 47' ' ' TRP . 6.6 p -81.94 133.61 35.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.833 0.349 . . . . 61.539999999999999 111.151 -179.88 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 2.7 tttt -120.94 136.93 54.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.262 -0.426 . . . . 74.109999999999999 110.912 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.577 ' HB ' ' CD1' ' A' ' 47' ' ' TRP . 13.7 tt -136.92 152.18 28.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.236 -0.438 . . . . 65.109999999999999 111.153 179.821 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.498 HG23 ' CG ' ' A' ' 22' ' ' ASP . 15.5 m -134.0 138.15 45.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.192 -0.458 . . . . 74.200000000000003 111.113 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.716 ' HB2' HD22 ' A' ' 34' ' ' LEU . 0.2 OUTLIER -126.74 128.53 46.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.2 -0.455 . . . . 43.140000000000001 110.882 179.995 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.549 ' CG ' ' HA ' ' A' ' 16' ' ' PHE . 26.3 m-85 -113.45 132.0 55.82 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.118 -0.492 . . . . 71.349999999999994 110.876 -179.833 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.441 ' HB2' ' HB2' ' A' ' 19' ' ' ARG . 0.1 OUTLIER -61.69 -15.14 37.71 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.107 -0.497 . . . . 73.430000000000007 110.89 179.99 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.435 ' HB2' ' O ' ' A' ' 17' ' ' GLN . 72.5 m-20 -134.91 150.42 50.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.142 -0.481 . . . . 64.319999999999993 110.865 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.546 ' N ' ' HB3' ' A' ' 38' ' ' ASN . 36.7 mtmt -56.16 -178.77 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.224 -0.443 . . . . 63.109999999999999 110.914 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 25.4 m-20 49.44 31.52 4.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.212 -0.449 . . . . 62.32 110.898 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.549 ' HA ' ' CG ' ' A' ' 11' ' ' TYR . 3.7 m-85 50.9 63.54 2.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.179 -0.464 . . . . 73.230000000000004 110.922 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.435 ' O ' ' HB2' ' A' ' 13' ' ' ASP . 24.6 mt-30 -139.52 160.85 38.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.15 -0.477 . . . . 74.040000000000006 110.898 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 92.0 -149.29 19.62 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.8 -0.714 . . . . 64.340000000000003 112.485 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.721 ' O ' HD13 ' A' ' 34' ' ' LEU . 0.0 OUTLIER -69.21 77.8 0.36 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.756 0.312 . . . . 74.140000000000001 110.852 -179.865 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.46 ' HB2' ' CE1' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -76.3 129.01 36.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 72.109999999999999 110.882 -179.919 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.485 ' O ' ' HA ' ' A' ' 9' ' ' THR . 91.4 t80 -122.95 125.57 45.55 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.213 -0.449 . . . . 71.540000000000006 110.888 -179.81 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.498 ' CG ' HG23 ' A' ' 9' ' ' THR . 1.4 m-20 -121.73 133.51 54.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.121 -0.49 . . . . 75.530000000000001 110.866 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -166.99 135.43 2.67 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.217 -0.447 . . . . 72.109999999999999 110.878 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -103.22 5.55 37.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.17 -0.468 . . . . 50.149999999999999 110.815 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 49.7 t -110.08 158.85 17.86 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.231 -0.44 . . . . 72.019999999999996 110.864 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -43.3 120.17 1.8 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.172 -0.467 . . . . 70.329999999999998 110.83 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.632 ' HB2' ' HB3' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -115.6 42.33 2.31 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.204 -0.453 . . . . 53.409999999999997 110.868 -179.951 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.563 ' O ' ' HA ' ' A' ' 82' ' ' SER . . . -51.12 -20.11 1.37 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.229 -0.441 . . . . 74.109999999999999 111.126 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 63.2 t0 -128.5 37.57 4.1 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.218 -0.446 . . . . 65.519999999999996 110.864 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.763 ' CD2' ' O ' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -80.97 15.68 1.74 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.198 -0.456 . . . . 64.040000000000006 110.857 -179.892 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.412 ' CG ' ' HG3' ' A' ' 53' ' ' PRO . 39.3 t60 -80.02 -34.0 38.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.189 -0.459 . . . . 71.030000000000001 110.864 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.6 t -63.24 -10.84 17.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.216 -0.447 . . . . 71.519999999999996 111.136 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -103.32 -28.87 11.6 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.193 -0.458 . . . . 74.209999999999994 110.925 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.721 HD13 ' O ' ' A' ' 19' ' ' ARG . 16.0 tp -139.02 141.25 38.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.133 -0.485 . . . . 74.400000000000006 110.89 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 20.7 m -105.35 -42.05 5.36 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.174 -0.466 . . . . 64.430000000000007 110.863 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -118.49 143.0 47.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.178 -0.464 . . . . 73.540000000000006 110.907 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.683 ' SG ' ' HB2' ' A' ' 80' ' ' LEU . 3.9 p -115.05 87.22 2.61 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.204 -0.453 . . . . 72.239999999999995 110.9 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.546 ' HB3' ' N ' ' A' ' 14' ' ' LYS . 3.3 m-20 -82.76 -50.85 8.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 62.409999999999997 110.852 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.403 ' OG ' ' HB2' ' A' ' 11' ' ' TYR . 9.8 p -129.4 127.14 40.37 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.163 -0.472 . . . . 74.109999999999999 110.821 -179.815 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.538 HG21 HD13 ' A' ' 62' ' ' LEU . 13.5 mt -125.44 152.1 31.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.103 -0.499 . . . . 71.340000000000003 111.15 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.426 ' N ' ' CG2' ' A' ' 40' ' ' ILE . 0.0 OUTLIER -144.85 118.55 9.2 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.201 -0.454 . . . . 64.010000000000005 110.932 179.845 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.513 ' HA ' ' HA ' ' A' ' 8' ' ' ILE . 1.3 t -104.02 116.7 48.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.259 -0.428 . . . . 64.510000000000005 111.175 179.85 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -111.54 77.65 1.06 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.197 -0.456 . . . . 63.539999999999999 110.887 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.432 ' O ' ' HA ' ' A' ' 6' ' ' THR . . . 135.4 101.87 0.68 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.762 -0.732 . . . . 51.240000000000002 112.512 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.501 ' HA2' HD21 ' A' ' 88' ' ' LEU . . . 53.91 179.65 0.14 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.767 -0.73 . . . . 74.200000000000003 112.493 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.748 HG23 ' HA ' ' A' ' 63' ' ' PRO . 1.4 m -80.25 169.28 18.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.797 0.332 . . . . 43.210000000000001 111.12 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.577 ' CD1' ' HB ' ' A' ' 8' ' ' ILE . 5.7 m95 -141.18 130.1 23.13 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.194 -0.457 . . . . 65.109999999999999 110.945 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.948 ' HB2' ' CG2' ' A' ' 86' ' ' VAL . . . -90.58 127.02 36.13 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.222 -0.445 . . . . 64.540000000000006 111.125 179.892 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.871 HG11 HD11 ' A' ' 80' ' ' LEU . 35.7 m -128.84 124.48 61.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.213 -0.449 . . . . 63.439999999999998 111.135 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.73 ' HB3' ' HA ' ' A' ' 56' ' ' ALA . 49.5 m-85 -94.51 150.15 20.53 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.21 -0.45 . . . . 70.549999999999997 110.901 -179.91 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.675 ' OE1' ' HB3' ' A' ' 57' ' ' TRP . 58.1 tt0 -49.27 -79.51 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.106 -0.497 . . . . 74.099999999999994 110.901 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.57 ' HB2' ' HB2' ' A' ' 57' ' ' TRP . 0.0 OUTLIER -92.54 143.77 27.73 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.607 0.718 . . . . 74.430000000000007 110.893 -179.951 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.69 ' HA ' ' OG ' ' A' ' 82' ' ' SER . 53.3 Cg_endo -69.82 142.41 47.57 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.739 2.293 . . . . 44.509999999999998 112.301 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 61.95 -9.75 0.08 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.236 -0.438 . . . . 73.519999999999996 110.89 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.611 ' H ' ' C ' ' A' ' 53' ' ' PRO . 2.7 m-30 -105.92 -20.4 13.44 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.184 -0.462 . . . . 73.430000000000007 110.901 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.73 ' HA ' ' HB3' ' A' ' 50' ' ' TYR . . . 50.02 27.15 2.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.168 -0.469 . . . . 72.099999999999994 111.068 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' TRP . . . . . 0.675 ' HB3' ' OE1' ' A' ' 51' ' ' GLU . 0.1 OUTLIER -50.69 -163.69 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.23 -0.441 . . . . 74.040000000000006 110.907 -179.959 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.636 ' C ' ' O ' ' A' ' 57' ' ' TRP . 5.4 m-30 -13.1 101.2 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.235 -0.439 . . . . 64.530000000000001 110.954 -179.841 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.43 142.89 36.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.072 -0.513 . . . . 73.319999999999993 110.873 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.788 ' O ' ' O ' ' A' ' 49' ' ' VAL . 0.3 OUTLIER -153.4 112.41 3.75 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.255 -0.43 . . . . 71.450000000000003 110.938 -179.896 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.81 ' N ' HD12 ' A' ' 61' ' ' ILE . 1.1 mp -102.82 114.19 41.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.13 -0.486 . . . . 64.209999999999994 111.153 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.849 HD23 ' HD2' ' A' ' 63' ' ' PRO . 0.6 OUTLIER -85.41 122.46 73.56 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 121.632 0.73 . . . . 72.409999999999997 110.89 179.962 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.849 ' HD2' HD23 ' A' ' 62' ' ' LEU . 54.1 Cg_endo -69.7 -166.34 0.18 Allowed 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.699 2.266 . . . . 75.010000000000005 112.339 179.868 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.44 160.96 14.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.164 -0.471 . . . . 75.030000000000001 110.896 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 113.48 -152.7 17.93 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.743 -0.741 . . . . 52.439999999999998 112.517 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -118.4 159.26 23.76 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.867 0.365 . . . . 74.150000000000006 110.891 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.479 ' N ' ' O ' ' A' ' 40' ' ' ILE . 11.5 m-85 -147.32 84.02 7.47 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.665 0.745 . . . . 73.340000000000003 110.942 -179.85 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 -4.68 14.51 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.655 2.237 . . . . 65.310000000000002 112.393 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 89.3 mt-10 -157.49 147.84 20.88 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.158 -0.474 . . . . 75.329999999999998 110.889 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.941 ' O ' ' CD1' ' A' ' 73' ' ' TRP . 44.4 p90 -57.97 -41.07 82.16 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.181 -0.463 . . . . 73.430000000000007 110.911 -179.882 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -52.8 -15.69 0.8 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.098 -0.501 . . . . 71.530000000000001 110.948 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 29.2 mmt180 -65.77 -17.6 64.74 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.189 -0.46 . . . . 72.400000000000006 110.845 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' TRP . . . . . 0.941 ' CD1' ' O ' ' A' ' 70' ' ' TYR . 0.4 OUTLIER -121.14 22.39 10.95 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.2 -0.455 . . . . 64.340000000000003 110.896 -179.948 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.594 ' O ' ' C ' ' A' ' 75' ' ' GLY . 0.0 OUTLIER 75.67 30.22 0.8 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.278 -0.419 . . . . 72.099999999999994 110.9 179.943 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.594 ' C ' ' O ' ' A' ' 74' ' ' MET . . . 17.11 59.06 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.678 -0.773 . . . . 61.350000000000001 112.508 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.727 HD12 HE21 ' A' ' 149' ' ' GLN . 0.0 OUTLIER -55.01 -72.38 0.07 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.836 0.35 . . . . 72.519999999999996 110.944 -179.955 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.498 ' O ' ' CB ' ' A' ' 78' ' ' ASP . 16.3 t-20 -121.16 -37.93 2.88 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.172 -0.467 . . . . 73.409999999999997 110.857 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.498 ' CB ' ' O ' ' A' ' 77' ' ' ASN . 0.0 OUTLIER 83.83 10.35 0.47 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.206 -0.452 . . . . 64.010000000000005 110.882 179.925 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -105.74 86.89 2.47 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.186 -0.461 . . . . 71.230000000000004 110.88 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.871 HD11 HG11 ' A' ' 49' ' ' VAL . 0.1 OUTLIER -86.95 131.38 34.11 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.182 -0.463 . . . . 70.310000000000002 110.886 -179.965 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.645 ' HB3' ' HB3' ' A' ' 53' ' ' PRO . 1.4 m -153.82 -119.23 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.158 -0.473 . . . . 74.400000000000006 110.843 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.69 ' OG ' ' HA ' ' A' ' 53' ' ' PRO . 0.1 OUTLIER -46.38 97.76 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.142 -0.481 . . . . 71.510000000000005 110.871 -179.814 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 83' ' ' CYS . . . . . 0.786 ' CB ' HG12 ' A' ' 49' ' ' VAL . 9.7 p -122.78 134.96 54.41 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.186 -0.461 . . . . 74.010000000000005 110.86 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.613 ' N ' ' O ' ' A' ' 48' ' ' ALA . 2.2 mmt85 -117.66 156.57 27.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.176 -0.466 . . . . 73.409999999999997 110.87 -179.843 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -68.42 129.05 38.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 72.150000000000006 111.119 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.948 ' CG2' ' HB2' ' A' ' 48' ' ' ALA . 38.3 t -115.56 139.17 43.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.24 -0.437 . . . . 64.239999999999995 111.114 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' HIS . . . . . 0.682 ' O ' HG23 ' A' ' 136' ' ' VAL . 9.2 m170 -114.12 108.59 17.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.161 -0.472 . . . . 62.130000000000003 110.892 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.56 HD13 ' HB3' ' A' ' 178' ' ' GLU . 0.0 OUTLIER -32.79 148.15 0.06 OUTLIER Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.577 0.703 . . . . 65.120000000000005 110.908 -179.972 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.582 ' HA ' ' HA3' ' A' ' 135' ' ' GLY . 53.3 Cg_endo -69.82 100.38 0.82 Allowed 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.658 2.239 . . . . 65.140000000000001 112.303 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -105.72 -175.65 2.85 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.194 -0.457 . . . . 73.230000000000004 110.867 -179.855 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 46.36 57.91 6.17 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.7 -0.762 . . . . 72.099999999999994 112.509 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 125.44 26.63 1.29 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.763 -0.732 . . . . 73.329999999999998 112.49 -179.88 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.518 ' O ' ' CG ' ' A' ' 134' ' ' GLU . 15.0 pt20 38.27 -124.49 0.27 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.792 0.33 . . . . 71.129999999999995 110.935 -179.861 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.589 ' HA ' ' HG2' ' A' ' 134' ' ' GLU . 0.0 OUTLIER -125.76 103.38 7.78 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.173 -0.467 . . . . 75.329999999999998 110.888 -179.857 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.538 ' HG3' HG11 ' A' ' 132' ' ' VAL . 12.6 tptp -113.34 130.96 56.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.079 -0.51 . . . . 71.150000000000006 110.875 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.717 HD11 ' NZ ' ' A' ' 154' ' ' LYS . 7.6 tt -149.05 138.25 15.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.185 -0.461 . . . . 71.120000000000005 111.13 179.864 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.488 ' HB2' ' O ' ' A' ' 131' ' ' LYS . 0.9 OUTLIER -110.52 139.38 45.81 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.153 -0.476 . . . . 73.329999999999998 110.878 179.962 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.649 HD12 ' O ' ' A' ' 109' ' ' TYR . 1.2 mp -116.74 148.58 19.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 53.520000000000003 111.102 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.62 ' HB2' ' HB2' ' A' ' 129' ' ' SER . 38.6 m-85 -134.1 133.94 41.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.205 -0.452 . . . . 75.230000000000004 110.848 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 77.2 tt0 -65.26 -61.25 2.24 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.159 -0.473 . . . . 72.200000000000003 110.878 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 35.4 mttt -99.79 162.21 13.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.134 -0.485 . . . . 73.129999999999995 110.872 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -68.16 159.83 51.18 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.73 -0.747 . . . . 72.150000000000006 112.48 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.513 ' HA ' ' HB2' ' A' ' 158' ' ' ARG . 25.7 t0 67.22 39.0 3.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.855 0.359 . . . . 44.329999999999998 110.888 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.597 ' CZ ' ' HB3' ' A' ' 158' ' ' ARG . 3.6 m-85 58.06 19.65 6.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.202 -0.454 . . . . 74.25 110.894 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 70.4 m -88.23 161.55 17.15 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.15 -0.477 . . . . 74.549999999999997 110.88 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 82.26 -159.0 38.65 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.726 -0.75 . . . . 40.32 112.454 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 4.1 tp-100 -82.86 129.19 34.97 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.786 0.327 . . . . 73.010000000000005 110.887 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' MET . . . . . 0.474 ' HB2' ' CD1' ' A' ' 99' ' ' PHE . 0.0 OUTLIER -118.69 160.39 21.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.195 -0.457 . . . . 43.450000000000003 110.862 179.954 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 109' ' ' TYR . . . . . 0.649 ' O ' HD12 ' A' ' 98' ' ' ILE . 29.9 m-85 -154.72 135.87 13.94 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.205 -0.452 . . . . 75.450000000000003 110.911 -179.851 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -110.98 102.0 10.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.139 -0.482 . . . . 73.200000000000003 110.906 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.405 HG22 HD11 ' A' ' 98' ' ' ILE . 9.0 t -113.38 128.56 56.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.148 -0.478 . . . . 52.399999999999999 111.14 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.42 ' HA ' ' HA ' ' A' ' 95' ' ' LYS . 1.8 t -93.4 32.6 1.33 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.222 -0.444 . . . . 74.319999999999993 111.162 -180.0 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -153.79 -174.85 5.11 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.211 -0.449 . . . . 71.129999999999995 110.895 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -90.16 -175.18 4.45 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.154 -0.475 . . . . 63.130000000000003 110.839 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' CYS . . . . . 0.654 ' O ' ' HB2' ' A' ' 172' ' ' SER . 39.0 t -161.19 136.17 5.53 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.606 0.717 . . . . 75.299999999999997 110.854 -179.893 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.497 ' O ' ' C ' ' A' ' 143' ' ' PRO . 53.4 Cg_endo -69.81 -34.51 14.28 Favored 'Trans proline' 0 C--N 1.341 0.134 0 C-N-CA 122.669 2.246 . . . . 62.140000000000001 112.324 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.635 ' HB3' ' CB ' ' A' ' 120' ' ' GLU . 0.1 OUTLIER -147.04 97.28 2.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.228 -0.442 . . . . 65.430000000000007 110.88 -179.844 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.696 HD13 HD11 ' A' ' 127' ' ' ILE . 3.7 tt -50.81 -28.8 6.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.158 -0.473 . . . . 71.219999999999999 111.107 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' MET . . . . . 0.571 ' O ' ' HA ' ' A' ' 123' ' ' HIS . 21.7 ttp -85.95 -44.96 11.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.169 -0.469 . . . . 72.439999999999998 110.896 179.848 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.635 ' CB ' ' HB3' ' A' ' 117' ' ' SER . 17.5 tp10 -66.17 -14.14 61.36 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.242 -0.435 . . . . 74.129999999999995 110.9 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 7.1 tp-100 -113.69 -51.49 2.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.121 -0.491 . . . . 63.240000000000002 110.882 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.483 ' HB2' ' O ' ' A' ' 118' ' ' ILE . 77.2 m-85 -101.81 -21.53 14.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.187 -0.46 . . . . 51.329999999999998 110.845 -179.912 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' HIS . . . . . 0.571 ' HA ' ' O ' ' A' ' 119' ' ' MET . 29.3 m-70 71.87 30.83 2.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.155 -0.475 . . . . 72.409999999999997 110.91 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 4.1 mtt -106.79 88.65 2.8 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.174 -0.466 . . . . 73.420000000000002 110.829 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 4.0 ptp180 -53.34 -38.44 63.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.252 -0.431 . . . . 74.530000000000001 110.864 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.476 ' HB3' ' HG2' ' A' ' 168' ' ' PRO . 18.2 mt-10 -140.2 130.58 25.31 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.166 -0.47 . . . . 75.230000000000004 110.87 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.696 HD11 HD13 ' A' ' 118' ' ' ILE . 3.0 mm -87.57 96.88 6.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.173 -0.467 . . . . 73.019999999999996 111.09 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 128' ' ' HIS . . . . . 0.443 ' HA ' ' HB3' ' A' ' 160' ' ' PRO . 17.0 m170 -66.03 -35.93 81.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.132 -0.485 . . . . 63.329999999999998 110.867 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.62 ' HB2' ' HB2' ' A' ' 99' ' ' PHE . 0.6 OUTLIER -135.54 147.45 48.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.225 -0.443 . . . . 64.010000000000005 110.884 -179.809 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 130' ' ' CYS . . . . . 0.553 ' O ' ' O ' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -144.78 120.39 10.43 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.192 -0.458 . . . . 64.450000000000003 110.924 -179.989 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.64 ' HA ' ' HA ' ' A' ' 156' ' ' GLU . 4.4 mtpt -111.25 154.32 24.62 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.156 -0.475 . . . . 65.329999999999998 110.938 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.538 HG11 ' HG3' ' A' ' 95' ' ' LYS . 13.0 t 83.32 163.59 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 71.120000000000005 111.131 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.847 HD13 ' O ' ' A' ' 154' ' ' LYS . 0.0 OUTLIER -178.86 122.2 0.09 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.176 -0.465 . . . . 64.219999999999999 110.898 179.95 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.589 ' HG2' ' HA ' ' A' ' 94' ' ' TYR . 0.1 OUTLIER -96.13 166.6 11.67 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.165 -0.47 . . . . 63.439999999999998 110.895 179.923 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.582 ' HA3' ' HA ' ' A' ' 89' ' ' PRO . . . -24.42 -73.71 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.691 -0.766 . . . . 53.009999999999998 112.532 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.744 HG21 HG13 ' A' ' 86' ' ' VAL . 4.7 t -132.45 146.97 32.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.833 0.349 . . . . 72.439999999999998 111.126 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 137' ' ' TRP . . . . . 0.616 ' HB3' ' HB3' ' A' ' 152' ' ' LEU . 2.6 t-105 -149.6 141.98 24.25 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.17 -0.468 . . . . 75.109999999999999 110.924 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.573 HG13 HD11 ' A' ' 176' ' ' ILE . 59.5 mt -115.59 132.34 65.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.258 -0.428 . . . . 74.040000000000006 111.177 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.473 ' CD2' HG11 ' A' ' 170' ' ' VAL . 0.3 OUTLIER -99.74 179.58 4.49 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.166 -0.47 . . . . 64.099999999999994 110.878 179.99 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 0.553 ' CE1' ' HB3' ' A' ' 149' ' ' GLN . 1.4 m-85 -152.39 126.08 8.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.136 -0.483 . . . . 74.530000000000001 110.905 -179.867 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.606 ' O ' ' HB2' ' A' ' 171' ' ' GLN . 3.2 tt0 -61.05 -26.49 67.66 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.142 -0.481 . . . . 70.319999999999993 110.907 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.709 ' HB3' ' HD2' ' A' ' 143' ' ' PRO . 8.4 mp -116.24 173.29 3.12 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.59 0.709 . . . . 74.219999999999999 110.892 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 143' ' ' PRO . . . . . 0.747 ' O ' ' OG ' ' A' ' 172' ' ' SER . 54.0 Cg_endo -69.73 -89.68 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.145 0 C-N-CA 122.724 2.283 . . . . 64.439999999999998 112.373 179.813 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 144' ' ' ASN . . . . . 0.704 ' O ' ' N ' ' A' ' 146' ' ' ARG . 1.0 OUTLIER -54.69 95.7 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.232 -0.44 . . . . 72.120000000000005 110.931 179.957 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 145' ' ' TYR . . . . . 0.646 ' C ' ' O ' ' A' ' 144' ' ' ASN . 0.1 OUTLIER 12.69 53.01 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.17 -0.468 . . . . 74.310000000000002 110.89 -179.913 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 146' ' ' ARG . . . . . 0.704 ' N ' ' O ' ' A' ' 144' ' ' ASN . 10.1 mtp85 -118.69 172.46 7.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.159 -0.473 . . . . 73.120000000000005 110.862 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 70.59 -175.34 37.41 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.713 -0.756 . . . . 72.340000000000003 112.479 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.436 ' HA ' HD11 ' A' ' 76' ' ' LEU . 3.9 mtp180 -83.28 130.7 35.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.776 0.322 . . . . 62.210000000000001 110.87 -179.867 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 149' ' ' GLN . . . . . 0.735 ' OE1' ' HA ' ' A' ' 60' ' ' TYR . 0.3 OUTLIER -85.79 158.7 19.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.178 -0.464 . . . . 74.200000000000003 110.9 -179.926 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -123.59 158.27 31.84 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.206 -0.452 . . . . 72.430000000000007 110.957 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.64 ' HB2' HD11 ' A' ' 61' ' ' ILE . 13.4 tp -92.01 134.65 34.62 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.108 -0.496 . . . . 63.32 110.917 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 1.041 HD13 ' O ' ' A' ' 152' ' ' LEU . 0.0 OUTLIER -63.94 132.59 51.17 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.218 -0.446 . . . . 75.310000000000002 110.895 179.884 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -163.69 26.04 0.08 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.174 -0.467 . . . . 62.399999999999999 110.854 179.802 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.847 ' O ' HD13 ' A' ' 133' ' ' LEU . 5.6 pttt -116.13 -173.03 2.28 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.167 -0.469 . . . . 54.399999999999999 110.854 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.838 ' HG3' HD22 ' A' ' 133' ' ' LEU . 0.1 OUTLIER -161.75 -124.53 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.183 -0.462 . . . . 65.430000000000007 110.898 179.867 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.64 ' HA ' ' HA ' ' A' ' 131' ' ' LYS . 0.3 OUTLIER -71.42 2.2 5.27 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.228 -0.442 . . . . 64.420000000000002 110.904 179.976 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 157' ' ' TYR . . . . . 0.795 ' CD1' ' HB2' ' A' ' 154' ' ' LYS . 20.5 m-30 -30.17 144.85 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.153 -0.476 . . . . 70.219999999999999 110.93 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 158' ' ' ARG . . . . . 0.597 ' HB3' ' CZ ' ' A' ' 104' ' ' PHE . 9.4 ptp180 -112.67 -44.13 3.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.128 -0.487 . . . . 73.540000000000006 110.881 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -80.48 152.17 72.65 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.596 0.712 . . . . 74.420000000000002 110.865 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 160' ' ' PRO . . . . . 0.443 ' HB3' ' HA ' ' A' ' 128' ' ' HIS . 54.2 Cg_endo -69.76 -32.83 17.8 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.693 2.262 . . . . 71.420000000000002 112.335 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.61 HD12 ' H ' ' A' ' 161' ' ' ILE . 3.6 mp -55.34 -19.04 4.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.224 -0.444 . . . . 74.239999999999995 111.143 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.654 ' HB3' ' CD1' ' A' ' 157' ' ' TYR . 0.3 OUTLIER -73.57 -23.0 59.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.202 -0.454 . . . . 70.329999999999998 110.891 179.826 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 163' ' ' TRP . . . . . 0.407 ' HB3' ' O ' ' A' ' 160' ' ' PRO . 2.1 t-105 -67.53 -17.7 64.76 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.2 -0.455 . . . . 73.319999999999993 110.963 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 114.3 -38.63 3.09 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.689 -0.767 . . . . 72.349999999999994 112.473 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -90.91 140.68 29.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.81 0.338 . . . . 63.140000000000001 111.063 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -40.97 -35.13 0.48 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.196 -0.456 . . . . 54.340000000000003 111.09 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 167' ' ' SER . . . . . 0.498 ' C ' ' H ' ' A' ' 169' ' ' ALA . 0.3 OUTLIER -129.51 156.82 78.02 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.665 0.745 . . . . 75.549999999999997 110.9 -179.803 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 168' ' ' PRO . . . . . 0.476 ' HG2' ' HB3' ' A' ' 126' ' ' GLU . 53.9 Cg_endo -69.76 25.27 0.17 Allowed 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.697 2.264 . . . . 74.409999999999997 112.356 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.498 ' H ' ' C ' ' A' ' 167' ' ' SER . . . -64.3 103.88 0.69 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.197 -0.456 . . . . 62.140000000000001 111.149 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.473 HG11 ' CD2' ' A' ' 139' ' ' PHE . 3.5 t -153.66 162.17 2.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.238 -0.437 . . . . 51.240000000000002 111.122 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 171' ' ' GLN . . . . . 0.647 ' O ' ' HB ' ' A' ' 118' ' ' ILE . 1.9 mm-40 -112.54 -85.19 0.58 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.15 -0.477 . . . . 62.32 110.926 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 172' ' ' SER . . . . . 0.747 ' OG ' ' O ' ' A' ' 143' ' ' PRO . 32.0 p -129.54 178.78 6.22 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.204 -0.453 . . . . 74.140000000000001 110.87 -179.84 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -145.91 176.44 9.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.092 -0.504 . . . . 72.129999999999995 110.894 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 174' ' ' ARG . . . . . 0.434 ' HG2' ' HB ' ' A' ' 138' ' ' ILE . 0.2 OUTLIER -134.47 151.15 50.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.179 -0.464 . . . . 72.420000000000002 110.86 -179.903 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 175' ' ' ARG . . . . . 0.553 ' HD2' ' CE1' ' A' ' 94' ' ' TYR . 1.7 ptt180 -102.34 147.98 26.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.186 -0.461 . . . . 74.340000000000003 110.835 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 176' ' ' ILE . . . . . 0.573 HD11 HG13 ' A' ' 138' ' ' ILE . 3.9 mt -100.34 126.66 53.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.16 -0.473 . . . . 75.329999999999998 111.126 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 9.6 p -127.38 153.09 36.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.161 -0.472 . . . . 53.210000000000001 111.083 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 178' ' ' GLU . . . . . 0.56 ' HB3' HD13 ' A' ' 88' ' ' LEU . 1.5 pt-20 . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.142 -0.481 . . . . 75.099999999999994 110.904 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.23 0.06 0 CA-C-O 120.811 0.339 . . . . 74.530000000000001 110.866 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -86.5 151.86 23.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.222 -0.445 . . . . 72.310000000000002 110.86 -179.803 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 20.8 mttt -90.84 64.18 5.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.149 -0.478 . . . . 75.25 110.933 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.0 t -116.32 70.43 0.76 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.225 -0.443 . . . . 71.310000000000002 111.165 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 101.71 117.65 4.26 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.748 -0.739 . . . . 73.349999999999994 112.508 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.431 ' C ' ' HE1' ' A' ' 47' ' ' TRP . 5.3 p -82.23 134.05 35.28 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.872 0.367 . . . . 72.319999999999993 111.126 -179.832 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 2.8 tttt -121.44 136.44 54.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.26 -0.427 . . . . 63.509999999999998 110.899 179.893 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.583 ' HB ' ' CD1' ' A' ' 47' ' ' TRP . 12.7 tt -136.69 147.49 27.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.271 -0.422 . . . . 75.140000000000001 111.156 179.827 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.552 HG22 ' CE2' ' A' ' 11' ' ' TYR . 15.9 m -130.01 129.95 44.36 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.175 -0.466 . . . . 75.030000000000001 111.106 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.799 ' HB2' HD22 ' A' ' 34' ' ' LEU . 0.4 OUTLIER -117.05 131.1 57.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.171 -0.468 . . . . 61.439999999999998 110.896 -179.988 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.552 ' CE2' HG22 ' A' ' 9' ' ' THR . 43.5 m-85 -116.46 131.21 57.01 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.179 -0.464 . . . . 42.210000000000001 110.916 -179.86 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.516 ' HG2' ' HB2' ' A' ' 36' ' ' ARG . 0.0 OUTLIER -60.91 -23.94 65.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.092 -0.504 . . . . 73.349999999999994 110.899 -179.999 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 68.6 m-20 -127.87 152.48 47.79 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.187 -0.46 . . . . 73.439999999999998 110.848 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.48 ' N ' ' HB3' ' A' ' 38' ' ' ASN . 4.2 mtmm -56.05 -176.98 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.175 -0.466 . . . . 75.109999999999999 110.893 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 69.9 m-20 46.99 37.74 5.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.209 -0.45 . . . . 73.030000000000001 110.896 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.535 ' HA ' ' CG ' ' A' ' 11' ' ' TYR . 4.3 m-85 45.91 56.59 5.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.145 -0.48 . . . . 72.329999999999998 110.93 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 4.1 mt-30 -132.16 159.91 37.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.142 -0.481 . . . . 74.340000000000003 110.928 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 93.81 -150.93 20.05 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.722 -0.752 . . . . 71.409999999999997 112.449 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.768 ' O ' HD13 ' A' ' 34' ' ' LEU . 0.0 OUTLIER -68.9 80.02 0.3 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.81 0.338 . . . . 75.540000000000006 110.843 -179.811 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.478 ' HB2' ' CE1' ' A' ' 11' ' ' TYR . 0.8 OUTLIER -77.99 127.99 33.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.203 -0.453 . . . . 73.150000000000006 110.862 -179.891 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.411 ' CD2' ' CD2' ' A' ' 30' ' ' PHE . 90.5 t80 -124.25 125.59 44.65 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.223 -0.444 . . . . 53.450000000000003 110.957 -179.883 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.46 ' CG ' HG23 ' A' ' 9' ' ' THR . 1.5 m-20 -118.99 132.49 56.07 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.14 -0.482 . . . . 70.420000000000002 110.865 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 12.6 t -161.3 131.01 4.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.208 -0.451 . . . . 65.409999999999997 110.888 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -102.12 4.17 39.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 71.239999999999995 110.888 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 48.7 t -112.9 159.46 19.04 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.46 . . . . 71.109999999999999 110.893 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -42.24 119.97 1.51 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.165 -0.47 . . . . 64.040000000000006 110.847 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.636 ' HB2' ' HB3' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -114.83 43.32 1.98 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.18 -0.464 . . . . 71.230000000000004 110.895 -179.925 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.532 ' O ' ' HA ' ' A' ' 82' ' ' SER . . . -49.97 -21.22 1.13 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.179 -0.464 . . . . 65.030000000000001 111.093 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 64.7 t0 -129.47 40.63 3.57 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.224 -0.444 . . . . 75.109999999999999 110.867 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.763 ' CD2' ' O ' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -82.06 16.39 1.95 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.207 -0.451 . . . . 75.5 110.833 -179.904 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.432 ' HB2' ' HB3' ' A' ' 81' ' ' SER . 34.4 t60 -78.62 -40.82 33.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.213 -0.449 . . . . 75.519999999999996 110.891 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.43 HG23 ' CD2' ' A' ' 33' ' ' TYR . 10.0 t -61.73 -10.65 9.24 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.201 -0.454 . . . . 73.420000000000002 111.12 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.501 ' CD1' ' HA ' ' A' ' 30' ' ' PHE . 12.2 m-85 -99.43 -30.77 12.0 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.217 -0.447 . . . . 74.019999999999996 110.95 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.799 HD22 ' HB2' ' A' ' 10' ' ' PHE . 16.7 tp -141.54 146.15 36.0 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.126 -0.488 . . . . 65.409999999999997 110.933 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.2 m -112.09 -34.65 5.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.154 -0.475 . . . . 61.219999999999999 110.847 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.579 ' O ' HD21 ' A' ' 34' ' ' LEU . 1.8 mtp85 -115.6 140.87 48.77 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.119 -0.491 . . . . 75.510000000000005 110.884 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.595 ' SG ' ' HB2' ' A' ' 80' ' ' LEU . 1.6 p -116.86 54.45 0.86 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.184 -0.462 . . . . 73.109999999999999 110.899 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.48 ' HB3' ' N ' ' A' ' 14' ' ' LYS . 1.9 m-80 -55.02 -65.71 0.53 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.182 -0.463 . . . . 73.409999999999997 110.91 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.406 ' HB2' ' HA ' ' A' ' 68' ' ' PRO . 7.6 p -116.27 128.15 55.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.181 -0.463 . . . . 71.420000000000002 110.832 -179.857 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.593 HD12 ' CZ3' ' A' ' 73' ' ' TRP . 12.0 mt -124.67 147.47 29.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.088 -0.505 . . . . 72.439999999999998 111.13 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.423 ' HD2' ' CE2' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -141.67 118.7 11.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.149 -0.478 . . . . 73.450000000000003 110.884 179.86 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.504 HG12 ' O ' ' A' ' 42' ' ' VAL . 1.0 OUTLIER -104.35 117.46 49.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.461 . . . . 64.439999999999998 111.088 179.908 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -112.34 77.68 1.06 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.173 -0.467 . . . . 51.409999999999997 110.868 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.417 ' O ' ' HA ' ' A' ' 6' ' ' THR . . . 136.88 98.31 0.51 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.73 -0.748 . . . . 70.209999999999994 112.468 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.447 ' HA2' HD21 ' A' ' 88' ' ' LEU . . . 55.36 177.86 0.22 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.725 -0.75 . . . . 65.349999999999994 112.426 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.735 HG23 ' HA ' ' A' ' 63' ' ' PRO . 1.0 OUTLIER -76.32 171.13 15.08 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.77 0.319 . . . . 73.040000000000006 111.166 -179.901 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.583 ' CD1' ' HB ' ' A' ' 8' ' ' ILE . 6.1 m95 -143.47 128.77 18.85 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.251 -0.431 . . . . 43.439999999999998 110.921 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.888 ' HB2' ' CG2' ' A' ' 86' ' ' VAL . . . -90.88 126.33 36.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.191 -0.459 . . . . 54.32 111.096 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.823 HG11 HD11 ' A' ' 80' ' ' LEU . 26.9 m -126.32 130.1 71.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.202 -0.454 . . . . 75.329999999999998 111.083 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.8 ' HB3' ' HA ' ' A' ' 56' ' ' ALA . 52.4 m-85 -100.41 148.02 25.19 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.161 -0.472 . . . . 74.209999999999994 110.973 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.568 ' HB3' ' HB3' ' A' ' 57' ' ' TRP . 58.4 tt0 -49.75 -78.07 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.105 -0.498 . . . . 73.219999999999999 110.873 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.484 ' HB3' ' CD1' ' A' ' 55' ' ' PHE . 0.1 OUTLIER -93.36 141.57 24.13 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.614 0.721 . . . . 71.540000000000006 110.859 -179.878 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.661 ' HB3' ' HB3' ' A' ' 81' ' ' SER . 53.7 Cg_endo -69.76 145.25 56.6 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.691 2.261 . . . . 61.210000000000001 112.341 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 61.9 -11.02 0.07 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.201 -0.454 . . . . 74.329999999999998 110.925 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.625 ' H ' ' C ' ' A' ' 53' ' ' PRO . 1.8 m-30 -108.16 -21.29 12.85 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.163 -0.472 . . . . 74.010000000000005 110.831 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.8 ' HA ' ' HB3' ' A' ' 50' ' ' TYR . . . 50.96 26.77 2.85 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.183 -0.462 . . . . 43.43 111.069 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' TRP . . . . . 0.641 ' O ' ' C ' ' A' ' 58' ' ' TYR . 0.8 OUTLIER -48.63 -164.5 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.245 -0.434 . . . . 73.0 110.899 -179.967 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.641 ' C ' ' O ' ' A' ' 57' ' ' TRP . 5.3 m-30 -11.76 100.15 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.236 -0.438 . . . . 73.209999999999994 110.933 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.475 ' HB2' ' HA ' ' A' ' 150' ' ' TYR . 0.0 OUTLIER -60.41 153.36 23.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.154 -0.476 . . . . 62.439999999999998 110.869 179.911 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.659 ' CE2' HD12 ' A' ' 76' ' ' LEU . 2.1 t80 -168.65 107.95 0.48 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.193 -0.458 . . . . 74.420000000000002 110.914 -179.871 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.865 HD13 HG23 ' A' ' 138' ' ' ILE . 4.9 mp -95.73 118.65 42.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.148 -0.478 . . . . 64.040000000000006 111.131 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.848 HD23 ' HD2' ' A' ' 63' ' ' PRO . 0.3 OUTLIER -87.45 126.0 63.64 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.587 0.708 . . . . 73.140000000000001 110.927 179.904 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.848 ' HD2' HD23 ' A' ' 62' ' ' LEU . 54.0 Cg_endo -69.76 -172.81 0.62 Allowed 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.662 2.241 . . . . 63.210000000000001 112.346 179.871 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.67 161.71 15.96 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.209 -0.451 . . . . 75.109999999999999 110.917 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 112.87 -159.49 13.64 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.707 -0.758 . . . . 72.120000000000005 112.5 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -114.71 158.5 21.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.865 0.364 . . . . 72.329999999999998 110.913 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.493 ' N ' ' O ' ' A' ' 40' ' ' ILE . 7.2 m-85 -149.44 80.42 7.69 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.681 0.753 . . . . 74.019999999999996 110.895 -179.837 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.573 ' HD2' ' HG3' ' A' ' 72' ' ' ARG . 53.7 Cg_endo -69.78 1.13 4.73 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.682 2.255 . . . . 75.120000000000005 112.321 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -157.91 155.1 28.96 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.24 -0.436 . . . . 75.340000000000003 110.873 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.807 ' O ' ' CD1' ' A' ' 73' ' ' TRP . 18.9 p90 -66.97 -7.97 26.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.164 -0.471 . . . . 74.200000000000003 110.947 -179.883 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -90.44 -16.32 29.23 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.102 -0.499 . . . . 63.229999999999997 110.909 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.573 ' HG3' ' HD2' ' A' ' 68' ' ' PRO . 25.5 mmt180 -75.01 -22.87 58.23 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.203 -0.453 . . . . 72.329999999999998 110.919 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' TRP . . . . . 0.807 ' CD1' ' O ' ' A' ' 70' ' ' TYR . 0.5 OUTLIER -109.39 8.22 25.35 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.148 -0.478 . . . . 65.430000000000007 110.927 -179.967 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.504 ' C ' ' O ' ' A' ' 73' ' ' TRP . 0.0 OUTLIER 30.23 55.48 0.17 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.205 -0.452 . . . . 71.129999999999995 110.903 179.954 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.527 ' CA ' ' OH ' ' A' ' 60' ' ' TYR . . . -91.77 -170.14 41.65 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.781 -0.723 . . . . 72.109999999999999 112.469 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.671 HD21 ' HA ' ' A' ' 148' ' ' ARG . 0.1 OUTLIER -107.87 -74.28 0.66 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.834 0.35 . . . . 74.030000000000001 110.915 -179.936 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -96.84 147.01 24.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.146 -0.479 . . . . 74.239999999999995 110.914 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.406 ' O ' ' SG ' ' A' ' 37' ' ' CYS . 15.8 p30 -95.71 34.05 1.56 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.203 -0.453 . . . . 41.340000000000003 110.877 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 4.3 ttm-85 -105.69 79.47 1.44 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 72.030000000000001 110.851 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.823 HD11 HG11 ' A' ' 49' ' ' VAL . 0.1 OUTLIER -82.82 130.3 35.11 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.179 -0.464 . . . . 73.019999999999996 110.955 179.976 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.661 ' HB3' ' HB3' ' A' ' 53' ' ' PRO . 1.3 m -152.24 -123.51 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.22 -0.446 . . . . 64.230000000000004 110.858 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.619 ' OG ' ' HA ' ' A' ' 53' ' ' PRO . 0.2 OUTLIER -41.0 99.98 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.118 -0.492 . . . . 60.329999999999998 110.855 -179.82 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 83' ' ' CYS . . . . . 0.72 ' HB3' HG12 ' A' ' 49' ' ' VAL . 8.9 p -127.0 134.38 50.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.131 -0.486 . . . . 64.299999999999997 110.863 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.617 ' N ' ' O ' ' A' ' 48' ' ' ALA . 4.5 mmt85 -115.47 158.32 22.72 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.194 -0.457 . . . . 64.510000000000005 110.902 -179.879 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -72.08 129.61 38.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.46 . . . . 72.450000000000003 111.104 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.888 ' CG2' ' HB2' ' A' ' 48' ' ' ALA . 61.5 t -116.02 136.23 53.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.213 -0.449 . . . . 62.32 111.142 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' HIS . . . . . 0.587 ' O ' HG23 ' A' ' 136' ' ' VAL . 40.2 m80 -113.89 108.09 16.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.162 -0.472 . . . . 74.129999999999995 110.872 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.465 ' H ' HD23 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -35.39 144.94 0.22 Allowed Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.621 0.724 . . . . 75.329999999999998 110.91 -179.971 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.475 ' HB3' ' H ' ' A' ' 136' ' ' VAL . 53.9 Cg_endo -69.73 104.24 1.28 Allowed 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.678 2.252 . . . . 74.040000000000006 112.317 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -103.16 165.68 10.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.231 -0.441 . . . . 65.450000000000003 110.859 -179.836 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 66.65 129.02 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.737 -0.744 . . . . 73.129999999999995 112.535 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.417 ' C ' ' HG2' ' A' ' 93' ' ' GLN . . . 51.1 33.92 30.78 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.721 -0.752 . . . . 43.009999999999998 112.495 -179.893 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.453 ' O ' ' CG ' ' A' ' 134' ' ' GLU . 27.7 pt20 39.07 -154.72 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.848 0.356 . . . . 71.239999999999995 110.911 -179.883 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.48 ' HA ' ' CG ' ' A' ' 134' ' ' GLU . 25.2 t80 -95.19 108.26 20.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.178 -0.464 . . . . 73.439999999999998 110.935 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.527 ' HG3' HG11 ' A' ' 132' ' ' VAL . 11.7 tptt -107.88 127.94 54.18 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.111 -0.495 . . . . 72.129999999999995 110.89 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.585 HD13 ' H ' ' A' ' 97' ' ' GLN . 0.4 OUTLIER -152.25 134.37 5.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.186 -0.461 . . . . 71.099999999999994 111.138 179.85 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.585 ' H ' HD13 ' A' ' 96' ' ' ILE . 1.2 mt-30 -109.08 124.63 51.07 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.169 -0.469 . . . . 61.530000000000001 110.913 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.767 HD13 HD11 ' A' ' 118' ' ' ILE . 7.9 mt -101.19 140.64 19.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.2 -0.455 . . . . 70.439999999999998 111.136 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.522 ' CD2' ' HA ' ' A' ' 104' ' ' PHE . 48.1 m-85 -129.0 146.02 51.09 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 64.219999999999999 110.835 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -80.19 -28.65 38.67 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.095 -0.502 . . . . 71.400000000000006 110.866 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 29.5 mttt -122.11 166.26 14.82 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.152 -0.476 . . . . 64.010000000000005 110.908 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.472 ' HA2' ' HB3' ' A' ' 129' ' ' SER . . . -68.48 178.98 22.13 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.751 -0.738 . . . . 41.520000000000003 112.473 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.403 ' C ' ' CG ' ' A' ' 104' ' ' PHE . 38.4 t70 40.91 36.26 0.41 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.845 0.355 . . . . 73.409999999999997 110.865 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.672 ' N ' ' CD2' ' A' ' 104' ' ' PHE . 0.0 OUTLIER 50.95 73.13 0.31 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.171 -0.468 . . . . 74.120000000000005 110.918 -179.877 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 1.2 m -139.52 161.04 38.46 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.119 -0.491 . . . . 35.149999999999999 110.879 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 79.79 -142.2 24.28 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.78 -0.724 . . . . 74.239999999999995 112.49 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 3.1 tp-100 -71.03 111.76 6.65 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.749 0.309 . . . . 71.019999999999996 110.933 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' MET . . . . . 0.495 ' HB2' ' CE2' ' A' ' 99' ' ' PHE . 5.9 ttp -106.62 149.12 27.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.254 -0.43 . . . . 73.129999999999995 110.894 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -153.19 135.15 14.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.227 -0.442 . . . . 73.409999999999997 110.891 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -110.19 97.55 7.0 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.117 -0.492 . . . . 74.129999999999995 110.888 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 9.7 t -110.3 132.19 54.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.141 -0.481 . . . . 71.540000000000006 111.134 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.445 ' O ' ' OG1' ' A' ' 112' ' ' THR . 1.1 t -119.37 36.43 4.48 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.182 -0.463 . . . . 74.140000000000001 111.162 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 53.5 mt-10 -151.34 165.59 33.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.241 -0.436 . . . . 63.310000000000002 110.891 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -56.25 164.24 1.38 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.136 -0.484 . . . . 52.32 110.856 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' CYS . . . . . 0.494 ' O ' ' HB2' ' A' ' 172' ' ' SER . 18.4 t -153.12 117.59 2.84 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.617 0.722 . . . . 62.030000000000001 110.886 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.426 ' O ' ' C ' ' A' ' 143' ' ' PRO . 53.4 Cg_endo -69.75 -31.97 19.52 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.716 2.277 . . . . 73.219999999999999 112.311 -179.906 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.642 ' HB3' ' CB ' ' A' ' 120' ' ' GLU . 0.1 OUTLIER -148.82 104.51 3.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.23 -0.441 . . . . 54.119999999999997 110.914 -179.834 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.767 HD11 HD13 ' A' ' 98' ' ' ILE . 2.9 tt -57.84 -29.46 35.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.131 -0.486 . . . . 61.340000000000003 111.129 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' MET . . . . . 0.598 ' O ' ' HA ' ' A' ' 123' ' ' HIS . 11.6 ttp -86.77 -42.96 12.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 64.510000000000005 110.835 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.642 ' CB ' ' HB3' ' A' ' 117' ' ' SER . 6.7 tp10 -67.66 -13.23 61.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.271 -0.422 . . . . 71.030000000000001 110.856 -179.916 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 28.3 tp60 -115.48 -48.72 2.78 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.151 -0.477 . . . . 72.430000000000007 110.894 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.5 ' HB2' ' O ' ' A' ' 118' ' ' ILE . 33.8 m-85 -103.69 -20.28 14.03 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.253 -0.431 . . . . 75.129999999999995 110.912 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' HIS . . . . . 0.598 ' HA ' ' O ' ' A' ' 119' ' ' MET . 0.2 OUTLIER 71.9 26.41 2.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.114 -0.493 . . . . 71.329999999999998 110.854 -179.977 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.463 ' SD ' HG22 ' A' ' 98' ' ' ILE . 7.1 mtt -102.56 83.99 2.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.214 -0.448 . . . . 72.109999999999999 110.868 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 1.8 ptp85 -52.12 -29.94 24.11 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.264 -0.426 . . . . 72.400000000000006 110.852 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.504 ' HG2' ' HA ' ' A' ' 169' ' ' ALA . 20.9 mt-10 -146.22 130.73 17.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.215 -0.448 . . . . 63.549999999999997 110.921 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.653 HD11 HD13 ' A' ' 118' ' ' ILE . 4.4 mm -91.37 103.92 14.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.15 -0.477 . . . . 71.129999999999995 111.137 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 128' ' ' HIS . . . . . 0.421 ' HB3' ' N ' ' A' ' 102' ' ' GLY . 2.3 m170 -71.53 -29.61 64.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.169 -0.469 . . . . 75.129999999999995 110.865 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.472 ' HB3' ' HA2' ' A' ' 102' ' ' GLY . 0.3 OUTLIER -153.55 152.74 31.26 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.182 -0.463 . . . . 73.530000000000001 110.824 -179.819 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 130' ' ' CYS . . . . . 0.72 ' O ' ' HB2' ' A' ' 157' ' ' TYR . 0.0 OUTLIER -146.57 112.12 5.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.085 -0.507 . . . . 51.539999999999999 110.885 -179.942 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.765 ' HA ' ' HA ' ' A' ' 156' ' ' GLU . 13.4 mtpt -90.78 147.74 23.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 73.140000000000001 110.908 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.553 HG12 ' N ' ' A' ' 133' ' ' LEU . 11.3 t 85.03 165.33 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.283 -0.417 . . . . 52.130000000000003 111.149 179.875 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.774 HD22 ' HA ' ' A' ' 155' ' ' LYS . 0.3 OUTLIER -179.1 127.79 0.1 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.176 -0.466 . . . . 71.430000000000007 110.876 179.959 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.48 ' CG ' ' HA ' ' A' ' 94' ' ' TYR . 0.0 OUTLIER -89.14 -171.51 3.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.116 -0.493 . . . . 60.210000000000001 110.881 179.94 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -48.79 -52.83 19.7 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.77 -0.729 . . . . 50.32 112.463 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.81 ' HB ' HD12 ' A' ' 176' ' ' ILE . 3.6 t -147.48 146.92 17.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.841 0.353 . . . . 53.32 111.1 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 137' ' ' TRP . . . . . 0.667 ' HB3' ' CB ' ' A' ' 152' ' ' LEU . 23.0 t90 -147.04 143.13 28.14 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.196 -0.457 . . . . 73.219999999999999 110.932 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.865 HG23 HD13 ' A' ' 61' ' ' ILE . 14.0 mt -123.53 133.69 68.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.244 -0.434 . . . . 60.409999999999997 111.119 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.517 ' CE1' ' HB3' ' A' ' 173' ' ' PHE . 0.1 OUTLIER -99.41 166.42 11.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.173 -0.467 . . . . 73.019999999999996 110.918 179.936 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -142.17 125.96 17.05 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.159 -0.473 . . . . 62.219999999999999 110.925 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.623 ' O ' ' HB2' ' A' ' 171' ' ' GLN . 0.5 OUTLIER -58.77 -25.22 62.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.119 -0.492 . . . . 72.409999999999997 110.928 179.977 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.742 ' HB3' ' HD2' ' A' ' 143' ' ' PRO . 9.3 mp -115.65 173.67 2.84 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.635 0.731 . . . . 73.120000000000005 110.898 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 143' ' ' PRO . . . . . 0.805 ' O ' ' OG ' ' A' ' 172' ' ' SER . 54.3 Cg_endo -69.74 -87.59 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.667 2.245 . . . . 62.5 112.325 179.826 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 144' ' ' ASN . . . . . 0.699 ' O ' ' N ' ' A' ' 146' ' ' ARG . 1.1 m-20 -53.71 96.23 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.205 -0.452 . . . . 54.439999999999998 110.889 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 145' ' ' TYR . . . . . 0.641 ' C ' ' O ' ' A' ' 144' ' ' ASN . 0.0 OUTLIER 13.23 52.6 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.136 -0.484 . . . . 74.549999999999997 110.933 -179.933 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 146' ' ' ARG . . . . . 0.699 ' N ' ' O ' ' A' ' 144' ' ' ASN . 10.6 mtp85 -119.49 174.66 6.25 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.108 -0.496 . . . . 74.299999999999997 110.843 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 79.64 -179.96 52.71 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.754 -0.736 . . . . 74.310000000000002 112.469 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.671 ' HA ' HD21 ' A' ' 76' ' ' LEU . 17.2 mtt180 -71.67 144.41 49.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.808 0.337 . . . . 71.129999999999995 110.896 -179.893 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 149' ' ' GLN . . . . . 0.536 ' HB2' ' HA ' ' A' ' 60' ' ' TYR . 49.5 mt-30 -83.28 148.51 27.33 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.158 -0.474 . . . . 74.430000000000007 110.937 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 150' ' ' TYR . . . . . 0.496 ' HB2' ' HB2' ' A' ' 139' ' ' PHE . 87.3 m-85 -132.81 118.92 19.59 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.221 -0.445 . . . . 74.200000000000003 110.902 -179.824 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.756 ' CA ' HD11 ' A' ' 61' ' ' ILE . 18.7 tp -69.91 136.37 50.53 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.095 -0.502 . . . . 71.230000000000004 110.951 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 1.055 HD13 ' O ' ' A' ' 152' ' ' LEU . 0.0 OUTLIER -74.02 135.81 43.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.208 -0.451 . . . . 74.349999999999994 110.945 179.873 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 153' ' ' ASP . . . . . 0.93 ' O ' ' HB2' ' A' ' 154' ' ' LYS . 54.5 t0 -161.39 109.65 1.51 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.21 -0.45 . . . . 65.409999999999997 110.877 179.852 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.93 ' HB2' ' O ' ' A' ' 153' ' ' ASP . 0.4 OUTLIER 156.07 -133.29 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.235 -0.439 . . . . 74.430000000000007 110.913 179.996 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.774 ' HA ' HD22 ' A' ' 133' ' ' LEU . 0.4 OUTLIER -164.98 -94.78 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.185 -0.461 . . . . 75.400000000000006 110.868 179.861 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.765 ' HA ' ' HA ' ' A' ' 131' ' ' LYS . 0.3 OUTLIER -89.76 9.34 27.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.262 -0.426 . . . . 74.25 110.908 179.927 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 157' ' ' TYR . . . . . 0.813 ' CZ ' ' HB3' ' A' ' 154' ' ' LYS . 1.9 m-85 20.4 108.14 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.124 -0.489 . . . . 65.049999999999997 110.945 -179.859 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.35 -34.03 8.9 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.151 -0.477 . . . . 74.019999999999996 110.856 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 159' ' ' LYS . . . . . 0.4 ' HB2' ' HD2' ' A' ' 160' ' ' PRO . 2.8 ptpt -108.92 158.72 33.43 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.654 0.74 . . . . 71.450000000000003 110.862 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 160' ' ' PRO . . . . . 0.463 ' HB2' ' HD3' ' A' ' 168' ' ' PRO . 53.9 Cg_endo -69.73 -21.57 33.43 Favored 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.7 2.267 . . . . 60.420000000000002 112.322 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.624 HD12 ' H ' ' A' ' 161' ' ' ILE . 3.4 mp -82.5 3.75 2.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.244 -0.435 . . . . 53.439999999999998 111.149 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.402 ' HB3' ' CD1' ' A' ' 157' ' ' TYR . 3.7 m-20 -64.58 -12.85 49.47 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.163 -0.471 . . . . 65.510000000000005 110.839 179.896 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 163' ' ' TRP . . . . . 0.492 ' CZ2' ' HB2' ' A' ' 130' ' ' CYS . 19.7 m-90 -105.47 -16.24 14.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.217 -0.447 . . . . 72.109999999999999 110.957 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 112.13 -35.33 4.72 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.743 -0.741 . . . . 44.039999999999999 112.491 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -62.68 126.58 27.81 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.759 0.314 . . . . 52.329999999999998 111.126 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -41.01 -37.5 0.83 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.217 -0.447 . . . . 74.040000000000006 111.135 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 167' ' ' SER . . . . . 0.483 ' C ' ' H ' ' A' ' 169' ' ' ALA . 0.3 OUTLIER -130.66 157.33 78.0 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.665 0.745 . . . . 64.349999999999994 110.863 -179.811 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 168' ' ' PRO . . . . . 0.463 ' HD3' ' HB2' ' A' ' 160' ' ' PRO . 53.6 Cg_endo -69.74 24.0 0.17 Allowed 'Trans proline' 0 C--N 1.341 0.137 0 C-N-CA 122.642 2.228 . . . . 75.409999999999997 112.397 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.504 ' HA ' ' HG2' ' A' ' 126' ' ' GLU . . . -65.57 107.02 1.58 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.204 -0.453 . . . . 75.200000000000003 111.097 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.441 HG11 ' CE1' ' A' ' 139' ' ' PHE . 3.3 t -152.94 159.83 3.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.195 -0.457 . . . . 74.209999999999994 111.155 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 171' ' ' GLN . . . . . 0.623 ' HB2' ' O ' ' A' ' 141' ' ' GLU . 1.7 tm0? -105.7 -81.19 0.54 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.202 -0.454 . . . . 74.310000000000002 110.933 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 172' ' ' SER . . . . . 0.805 ' OG ' ' O ' ' A' ' 143' ' ' PRO . 51.6 p -127.2 -178.23 4.36 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 55.119999999999997 110.88 -179.817 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 173' ' ' PHE . . . . . 0.517 ' HB3' ' CE1' ' A' ' 139' ' ' PHE . 27.5 p90 -142.66 167.07 22.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.181 -0.463 . . . . 74.450000000000003 110.871 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.88 130.1 19.74 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.127 -0.488 . . . . 62.140000000000001 110.852 -179.876 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.47 -169.96 1.62 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.179 -0.464 . . . . 73.540000000000006 110.849 -179.896 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 176' ' ' ILE . . . . . 0.81 HD12 ' HB ' ' A' ' 136' ' ' VAL . 3.7 mt -137.12 134.19 47.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 65.340000000000003 111.141 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 95.3 t -150.45 142.37 16.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.181 -0.463 . . . . 74.349999999999994 111.121 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 178' ' ' GLU . . . . . 0.432 ' HB3' HD13 ' A' ' 88' ' ' LEU . 5.3 pt-20 . . . . . 0 C--N 1.33 -0.261 0 CA-C-N 116.175 -0.466 . . . . 72.030000000000001 110.922 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.753 0.311 . . . . 74.200000000000003 110.895 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -116.47 -62.57 1.57 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.226 -0.443 . . . . 73.219999999999999 110.816 -179.767 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 39.5 mmtm 51.35 34.73 12.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.142 -0.481 . . . . 74.129999999999995 110.894 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 6.7 t -74.23 -33.74 63.45 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.212 -0.449 . . . . 60.420000000000002 111.162 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 177.23 117.91 0.53 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.712 -0.756 . . . . 71.219999999999999 112.49 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.446 ' HB ' ' O ' ' A' ' 44' ' ' GLY . 12.8 p -82.56 133.18 35.19 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.847 0.356 . . . . 72.25 111.132 -179.844 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 3.0 tttt -122.4 137.74 54.76 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.214 -0.448 . . . . 73.540000000000006 110.908 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.587 ' HB ' ' CD1' ' A' ' 47' ' ' TRP . 15.1 tt -138.38 149.48 24.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.181 -0.463 . . . . 71.329999999999998 111.168 179.871 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.497 HG23 ' CG ' ' A' ' 22' ' ' ASP . 15.3 m -129.22 140.4 51.49 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.174 -0.466 . . . . 54.549999999999997 111.105 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.82 ' HB2' HD22 ' A' ' 34' ' ' LEU . 0.7 OUTLIER -126.56 130.86 51.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.183 -0.462 . . . . 65.109999999999999 110.855 -179.973 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.547 ' CG ' ' HA ' ' A' ' 16' ' ' PHE . 44.5 m-85 -117.41 129.82 56.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.114 -0.494 . . . . 71.140000000000001 110.926 -179.877 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.498 ' HG2' ' HB2' ' A' ' 36' ' ' ARG . 0.0 OUTLIER -59.04 -23.95 62.44 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.105 -0.498 . . . . 75.140000000000001 110.864 -179.951 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 -127.54 152.67 47.31 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.144 -0.48 . . . . 71.519999999999996 110.853 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.436 ' N ' ' HB3' ' A' ' 38' ' ' ASN . 4.2 mtmp? -56.02 -175.36 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.16 -0.473 . . . . 61.219999999999999 110.916 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 22.0 m-20 46.02 36.08 2.83 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.242 -0.435 . . . . 73.540000000000006 110.879 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.547 ' HA ' ' CG ' ' A' ' 11' ' ' TYR . 4.4 m-85 47.12 57.7 5.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.218 -0.446 . . . . 74.340000000000003 110.901 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -132.85 159.91 38.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.141 -0.481 . . . . 74.150000000000006 110.879 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 93.41 -151.39 20.34 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.74 -0.743 . . . . 63.450000000000003 112.486 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.786 ' O ' HD13 ' A' ' 34' ' ' LEU . 0.0 OUTLIER -67.95 80.92 0.21 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.788 0.327 . . . . 74.409999999999997 110.854 -179.84 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.494 ' HA ' ' O ' ' A' ' 10' ' ' PHE . 0.0 OUTLIER -78.83 128.91 33.99 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.222 -0.445 . . . . 75.299999999999997 110.864 -179.926 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.511 ' CD2' ' CD2' ' A' ' 30' ' ' PHE . 81.3 t80 -124.57 123.6 40.44 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.174 -0.466 . . . . 73.430000000000007 110.876 -179.825 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.497 ' CG ' HG23 ' A' ' 9' ' ' THR . 1.3 m-20 -119.17 134.02 55.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.116 -0.493 . . . . 74.450000000000003 110.871 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -165.95 136.61 3.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.234 -0.439 . . . . 64.239999999999995 110.887 -179.886 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -105.1 4.82 31.84 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.202 -0.454 . . . . 74.400000000000006 110.85 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 13.4 t -108.14 165.98 11.08 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.22 -0.445 . . . . 55.240000000000002 110.916 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -62.67 116.75 5.45 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.195 -0.457 . . . . 62.32 110.857 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.476 ' HB2' ' HB3' ' A' ' 30' ' ' PHE . 7.9 m -118.11 53.93 0.94 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.194 -0.457 . . . . 74.140000000000001 110.87 -179.924 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.53 ' C ' ' HA ' ' A' ' 82' ' ' SER . . . -45.83 -19.72 0.07 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.156 -0.474 . . . . 54.210000000000001 111.106 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 53.1 t0 -128.46 42.01 3.39 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.246 -0.433 . . . . 54.509999999999998 110.853 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.784 ' CD2' ' O ' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -80.63 13.98 2.3 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.214 -0.448 . . . . 61.43 110.87 -179.899 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.493 ' HB2' ' HB3' ' A' ' 53' ' ' PRO . 29.0 t60 -78.74 -37.18 41.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.157 -0.474 . . . . 75.099999999999994 110.852 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.5 t -59.27 -13.17 6.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.182 -0.463 . . . . 75.430000000000007 111.095 -179.878 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -101.39 -26.41 13.6 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.263 -0.426 . . . . 74.030000000000001 110.95 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.82 HD22 ' HB2' ' A' ' 10' ' ' PHE . 16.6 tp -142.87 139.96 31.05 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.073 -0.512 . . . . 72.25 110.966 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.1 m -109.05 -32.16 7.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.201 -0.454 . . . . 74.120000000000005 110.859 -179.877 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.498 ' HB2' ' HG2' ' A' ' 12' ' ' GLU . 1.9 mtp85 -115.59 140.36 49.25 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.102 -0.499 . . . . 74.420000000000002 110.905 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.543 ' SG ' ' O ' ' A' ' 78' ' ' ASP . 1.3 p -117.65 54.23 0.91 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.249 -0.432 . . . . 71.430000000000007 110.866 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.436 ' HB3' ' N ' ' A' ' 14' ' ' LYS . 1.9 m-80 -54.29 -70.09 0.11 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.465 . . . . 74.200000000000003 110.9 -179.889 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 6.4 p -111.83 129.53 56.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.175 -0.466 . . . . 74.230000000000004 110.85 -179.868 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.649 HG21 HD13 ' A' ' 62' ' ' LEU . 20.1 mt -126.08 151.35 32.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.104 -0.498 . . . . 61.140000000000001 111.09 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.421 ' N ' ' CG2' ' A' ' 40' ' ' ILE . 0.0 OUTLIER -143.74 119.33 10.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.147 -0.479 . . . . 72.420000000000002 110.894 179.825 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.534 HG22 ' HB ' ' A' ' 8' ' ' ILE . 1.2 t -103.98 116.13 47.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.227 -0.442 . . . . 62.310000000000002 111.134 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -112.36 80.53 1.35 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.199 -0.455 . . . . 70.400000000000006 110.894 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.446 ' O ' ' HB ' ' A' ' 6' ' ' THR . . . 130.34 102.06 0.95 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.727 -0.749 . . . . 73.120000000000005 112.493 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 54.35 178.36 0.14 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.763 -0.732 . . . . 72.030000000000001 112.523 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.728 HG23 ' HA ' ' A' ' 63' ' ' PRO . 1.3 m -81.99 171.47 14.37 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.725 0.297 . . . . 62.310000000000002 111.153 -179.886 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.597 ' H ' HG22 ' A' ' 46' ' ' THR . 15.9 m95 -141.92 130.0 22.04 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.217 -0.447 . . . . 74.219999999999999 110.915 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.905 ' HB2' ' CG2' ' A' ' 86' ' ' VAL . . . -95.37 111.99 23.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.231 -0.44 . . . . 70.430000000000007 111.113 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.626 HG11 HD13 ' A' ' 80' ' ' LEU . 5.6 m -115.0 129.55 71.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.218 -0.447 . . . . 73.010000000000005 111.153 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.771 ' HB3' ' HA ' ' A' ' 56' ' ' ALA . 35.7 m-85 -95.61 150.6 20.16 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.148 -0.478 . . . . 73.310000000000002 110.89 -179.876 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.626 ' HB2' ' O ' ' A' ' 58' ' ' TYR . 7.1 tt0 -46.51 -77.77 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.104 -0.498 . . . . 74.549999999999997 110.889 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.622 ' HB3' ' CD1' ' A' ' 55' ' ' PHE . 1.6 mtp180 -93.44 145.95 30.93 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.567 0.699 . . . . 70.400000000000006 110.877 -179.853 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.731 ' HA ' ' OG ' ' A' ' 82' ' ' SER . 53.7 Cg_endo -69.76 134.12 27.22 Favored 'Trans proline' 0 C--N 1.34 0.126 0 C-N-CA 122.715 2.276 . . . . 74.019999999999996 112.329 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 66.38 -9.88 0.29 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.267 -0.424 . . . . 71.310000000000002 110.899 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.622 ' CD1' ' HB3' ' A' ' 52' ' ' ARG . 4.2 m-30 -100.22 -25.92 14.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.176 -0.465 . . . . 73.400000000000006 110.868 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.771 ' HA ' ' HB3' ' A' ' 50' ' ' TYR . . . 57.09 23.0 7.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.17 -0.468 . . . . 75.349999999999994 111.092 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' TRP . . . . . 0.643 ' O ' ' C ' ' A' ' 58' ' ' TYR . 3.4 m0 -52.49 -165.0 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.21 -0.45 . . . . 72.439999999999998 110.897 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.643 ' C ' ' O ' ' A' ' 57' ' ' TRP . 5.4 m-30 -12.1 103.84 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.246 -0.434 . . . . 73.349999999999994 110.917 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.52 ' HB2' ' HA ' ' A' ' 150' ' ' TYR . 2.0 mpt? -61.52 148.12 43.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.138 -0.483 . . . . 73.319999999999993 110.848 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.617 ' O ' HG23 ' A' ' 49' ' ' VAL . 0.3 OUTLIER -161.01 97.66 1.15 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.204 -0.453 . . . . 74.239999999999995 110.919 -179.834 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.745 HD11 ' HA ' ' A' ' 151' ' ' LEU . 4.6 mp -89.18 114.52 27.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.14 -0.482 . . . . 74.129999999999995 111.101 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.832 HD23 ' HD2' ' A' ' 63' ' ' PRO . 0.6 OUTLIER -85.16 122.21 73.96 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.598 0.713 . . . . 72.120000000000005 110.927 179.906 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.832 ' HD2' HD23 ' A' ' 62' ' ' LEU . 54.0 Cg_endo -69.71 -167.49 0.23 Allowed 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.736 2.291 . . . . 71.209999999999994 112.324 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.55 160.98 14.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.205 -0.452 . . . . 72.0 110.941 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 114.93 -146.57 18.83 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.714 -0.755 . . . . 73.329999999999998 112.516 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -128.3 158.37 38.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.876 0.369 . . . . 72.299999999999997 110.912 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.508 ' N ' ' O ' ' A' ' 40' ' ' ILE . 5.7 m-85 -146.78 81.62 9.06 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.648 0.737 . . . . 72.420000000000002 110.911 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.468 ' HD2' ' HG3' ' A' ' 72' ' ' ARG . 53.8 Cg_endo -69.81 1.4 4.51 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.643 2.229 . . . . 74.230000000000004 112.344 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.413 ' HA ' ' HG2' ' A' ' 14' ' ' LYS . 86.2 mt-10 -156.9 155.08 30.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.212 -0.449 . . . . 62.32 110.891 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.82 ' O ' ' CD1' ' A' ' 73' ' ' TRP . 8.9 p90 -70.6 -1.93 12.67 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.161 -0.472 . . . . 74.109999999999999 110.954 -179.907 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -91.22 -13.82 32.12 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.132 -0.485 . . . . 72.540000000000006 110.968 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.468 ' HG3' ' HD2' ' A' ' 68' ' ' PRO . 23.2 mmt180 -73.7 -5.35 40.04 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.162 -0.472 . . . . 75.299999999999997 110.902 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' TRP . . . . . 0.82 ' CD1' ' O ' ' A' ' 70' ' ' TYR . 0.4 OUTLIER -134.71 4.93 3.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.165 -0.47 . . . . 73.409999999999997 110.877 -179.933 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.466 ' CB ' ' O ' ' A' ' 73' ' ' TRP . 0.0 OUTLIER 81.13 -17.89 0.53 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.263 -0.426 . . . . 61.520000000000003 110.893 179.956 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.458 ' N ' ' CD1' ' A' ' 73' ' ' TRP . . . 40.32 57.66 2.59 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.757 -0.735 . . . . 64.540000000000006 112.461 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.577 ' HG ' ' CE2' ' A' ' 60' ' ' TYR . 3.1 pp -50.85 -36.84 39.73 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.787 0.327 . . . . 43.350000000000001 110.878 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.562 ' O ' ' CB ' ' A' ' 78' ' ' ASP . 23.7 t-20 -121.82 -47.13 2.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.202 -0.454 . . . . 74.120000000000005 110.864 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.562 ' CB ' ' O ' ' A' ' 77' ' ' ASN . 6.3 t0 89.61 5.3 0.14 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.193 -0.458 . . . . 52.130000000000003 110.862 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 1.2 ttm-85 -110.46 102.29 10.92 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.176 -0.465 . . . . 74.409999999999997 110.898 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.626 HD13 HG11 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -101.12 134.68 43.77 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.225 -0.443 . . . . 73.519999999999996 110.93 -179.996 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.578 ' HB3' ' HB3' ' A' ' 53' ' ' PRO . 1.2 m -151.15 -119.35 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.212 -0.449 . . . . 74.540000000000006 110.859 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.731 ' OG ' ' HA ' ' A' ' 53' ' ' PRO . 0.5 OUTLIER -38.31 107.65 0.07 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.168 -0.469 . . . . 52.310000000000002 110.882 -179.789 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 83' ' ' CYS . . . . . 0.529 ' HA ' ' O ' ' A' ' 48' ' ' ALA . 8.3 p -115.96 146.66 41.92 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.164 -0.471 . . . . 73.140000000000001 110.859 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.54 ' N ' ' O ' ' A' ' 48' ' ' ALA . 0.1 OUTLIER -144.59 128.95 17.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.192 -0.458 . . . . 71.209999999999994 110.866 -179.834 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.46 ' N ' ' CZ3' ' A' ' 47' ' ' TRP . . . -48.47 127.81 13.76 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.209 -0.45 . . . . 60.030000000000001 111.101 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.905 ' CG2' ' HB2' ' A' ' 48' ' ' ALA . 25.0 t -115.17 139.02 43.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.2 -0.454 . . . . 60.439999999999998 111.14 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' HIS . . . . . 0.556 ' O ' ' CG2' ' A' ' 136' ' ' VAL . 11.8 m170 -112.41 107.11 15.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.164 -0.471 . . . . 74.299999999999997 110.835 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.472 ' C ' ' O ' ' A' ' 87' ' ' HIS . 0.0 OUTLIER -32.57 152.96 0.04 OUTLIER Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.619 0.723 . . . . 73.129999999999995 110.906 -179.996 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.557 ' HB3' ' H ' ' A' ' 136' ' ' VAL . 53.6 Cg_endo -69.79 84.72 0.65 Allowed 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.689 2.26 . . . . 74.230000000000004 112.335 179.845 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -83.27 -171.29 3.49 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.228 -0.442 . . . . 72.120000000000005 110.832 -179.842 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 72.05 68.03 1.7 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.754 -0.736 . . . . 73.209999999999994 112.442 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 97.03 -69.88 0.79 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.764 -0.731 . . . . 71.109999999999999 112.513 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.417 ' HB2' ' H ' ' A' ' 94' ' ' TYR . 14.6 pt20 171.39 -148.88 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.774 0.321 . . . . 65.129999999999995 110.933 -179.9 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.504 ' O ' ' HA ' ' A' ' 112' ' ' THR . 0.0 OUTLIER -107.53 101.78 11.09 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.184 -0.462 . . . . 74.409999999999997 110.918 -179.865 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.442 ' HG3' HG11 ' A' ' 132' ' ' VAL . 28.2 tptt -102.07 130.0 48.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.096 -0.502 . . . . 63.409999999999997 110.917 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -149.29 135.26 11.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.238 -0.437 . . . . 54.219999999999999 111.158 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.426 ' HB2' HG23 ' A' ' 132' ' ' VAL . 1.6 mt-30 -107.87 131.59 54.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.156 -0.474 . . . . 62.340000000000003 110.915 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.529 ' CG2' HD12 ' A' ' 127' ' ' ILE . 1.5 mp -113.46 131.31 65.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.186 -0.461 . . . . 72.150000000000006 111.104 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.605 ' HB2' ' HB2' ' A' ' 129' ' ' SER . 74.0 m-85 -122.19 136.87 54.97 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.162 -0.472 . . . . 73.140000000000001 110.895 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 57.3 tt0 -67.31 -73.94 0.13 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.167 -0.469 . . . . 75.319999999999993 110.867 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.518 ' C ' ' HB2' ' A' ' 128' ' ' HIS . 5.1 mttt -84.54 165.73 17.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.193 -0.458 . . . . 74.200000000000003 110.954 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -72.23 160.58 54.1 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.757 -0.735 . . . . 40.030000000000001 112.461 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.443 ' HA ' ' HB2' ' A' ' 158' ' ' ARG . 29.5 t70 62.56 32.68 16.35 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.819 0.343 . . . . 74.25 110.878 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.508 ' CZ ' ' HB3' ' A' ' 158' ' ' ARG . 13.5 m-85 56.98 49.16 14.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.185 -0.461 . . . . 72.030000000000001 110.866 -179.892 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.1 m -113.62 150.97 32.37 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.206 -0.452 . . . . 74.040000000000006 110.85 -179.783 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 89.24 -123.67 6.98 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.762 -0.733 . . . . 72.439999999999998 112.471 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 7.6 tp-100 -101.21 141.26 34.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.79 0.329 . . . . 74.439999999999998 110.877 -179.823 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 3.2 ttp -131.5 131.52 43.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.211 -0.45 . . . . 74.349999999999994 110.876 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 10.0 m-85 -136.81 137.31 39.64 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.451 . . . . 70.430000000000007 110.958 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -118.91 112.71 19.98 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.12 -0.491 . . . . 61.350000000000001 110.891 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.471 HG22 HD11 ' A' ' 98' ' ' ILE . 11.9 t -125.51 150.41 47.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.152 -0.476 . . . . 72.019999999999996 111.104 -179.872 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.504 ' HA ' ' O ' ' A' ' 94' ' ' TYR . 1.4 t -124.49 47.76 2.06 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.177 -0.465 . . . . 74.310000000000002 111.112 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -152.58 -178.21 6.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.227 -0.442 . . . . 63.5 110.893 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -73.86 164.98 25.93 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.165 -0.47 . . . . 63.240000000000002 110.849 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' CYS . . . . . 0.536 ' O ' ' HB2' ' A' ' 172' ' ' SER . 4.8 t -154.33 113.69 2.47 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.591 0.71 . . . . 63.350000000000001 110.889 -179.924 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.41 ' O ' ' CA ' ' A' ' 143' ' ' PRO . 53.1 Cg_endo -69.81 -30.2 22.4 Favored 'Trans proline' 0 C--O 1.231 0.15 0 C-N-CA 122.686 2.257 . . . . 51.549999999999997 112.328 -179.895 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.653 ' HB3' ' CB ' ' A' ' 120' ' ' GLU . 0.1 OUTLIER -149.97 98.02 2.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.19 -0.459 . . . . 73.120000000000005 110.898 -179.857 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.646 HD13 HD11 ' A' ' 127' ' ' ILE . 3.0 tt -50.55 -29.16 6.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.132 -0.486 . . . . 43.240000000000002 111.099 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' MET . . . . . 0.572 ' O ' ' HA ' ' A' ' 123' ' ' HIS . 0.0 OUTLIER -86.39 -45.94 10.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.198 -0.456 . . . . 74.340000000000003 110.876 179.866 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.653 ' CB ' ' HB3' ' A' ' 117' ' ' SER . 16.5 tp10 -64.87 -12.94 54.34 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.222 -0.445 . . . . 73.140000000000001 110.868 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -113.25 -51.88 2.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.184 -0.462 . . . . 73.019999999999996 110.968 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.417 ' HB2' ' O ' ' A' ' 118' ' ' ILE . 93.8 m-85 -103.4 -20.05 14.21 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.155 -0.475 . . . . 73.230000000000004 110.905 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' HIS . . . . . 0.572 ' HA ' ' O ' ' A' ' 119' ' ' MET . 10.9 m80 73.26 26.62 2.06 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.177 -0.465 . . . . 63.119999999999997 110.867 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.479 ' SD ' HG22 ' A' ' 98' ' ' ILE . 6.0 mtt -101.16 85.55 2.85 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.221 -0.445 . . . . 70.120000000000005 110.862 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 1.7 ptp85 -51.33 -34.11 32.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.254 -0.43 . . . . 74.219999999999999 110.89 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.528 ' C ' HD13 ' A' ' 127' ' ' ILE . 40.7 mt-10 -144.34 138.07 27.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.19 -0.459 . . . . 64.530000000000001 110.883 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.646 HD11 HD13 ' A' ' 118' ' ' ILE . 3.4 mm -99.88 96.6 5.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.115 -0.493 . . . . 71.329999999999998 111.129 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 128' ' ' HIS . . . . . 0.518 ' HB2' ' C ' ' A' ' 101' ' ' LYS . 0.6 OUTLIER -69.43 -31.69 70.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.232 -0.44 . . . . 72.299999999999997 110.831 179.922 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.605 ' HB2' ' HB2' ' A' ' 99' ' ' PHE . 0.3 OUTLIER -132.65 145.34 51.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.247 -0.433 . . . . 73.120000000000005 110.854 -179.778 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 130' ' ' CYS . . . . . 0.609 ' SG ' HG21 ' A' ' 127' ' ' ILE . 0.3 OUTLIER -147.25 119.1 8.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.149 -0.478 . . . . 34.009999999999998 110.874 -179.931 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.604 ' C ' HG23 ' A' ' 132' ' ' VAL . 6.9 mtpp -108.14 157.83 17.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.176 -0.466 . . . . 73.239999999999995 110.924 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.604 HG23 ' C ' ' A' ' 131' ' ' LYS . 3.5 t 81.58 169.06 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.237 -0.438 . . . . 75.340000000000003 111.089 179.836 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.972 HD23 ' HG3' ' A' ' 155' ' ' LYS . 0.2 OUTLIER -165.85 128.18 2.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.138 -0.483 . . . . 74.530000000000001 110.912 179.927 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.516 ' O ' ' C ' ' A' ' 135' ' ' GLY . 1.4 mp0 -98.15 141.26 31.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.456 . . . . 62.5 110.888 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.55 ' HA3' ' HA ' ' A' ' 89' ' ' PRO . . . -27.25 -44.79 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.735 -0.745 . . . . 62.0 112.479 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.871 ' HB ' HD12 ' A' ' 176' ' ' ILE . 2.0 t -149.85 127.88 2.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.834 0.349 . . . . 75.329999999999998 111.157 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 137' ' ' TRP . . . . . 0.673 ' HB3' ' CB ' ' A' ' 152' ' ' LEU . 26.1 t90 -142.08 145.53 34.42 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.173 -0.467 . . . . 73.530000000000001 110.893 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.61 HG23 HD13 ' A' ' 61' ' ' ILE . 7.1 mt -123.19 130.01 74.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.252 -0.431 . . . . 74.129999999999995 111.11 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.623 ' CE1' HG11 ' A' ' 170' ' ' VAL . 0.1 OUTLIER -97.36 147.36 24.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.155 -0.475 . . . . 72.239999999999995 110.897 179.965 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 0.446 ' CD2' ' HA ' ' A' ' 145' ' ' TYR . 8.6 m-85 -124.26 124.69 42.97 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.124 -0.489 . . . . 74.25 110.895 -179.846 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.56 ' O ' ' HB2' ' A' ' 171' ' ' GLN . 0.0 OUTLIER -58.96 -25.24 63.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.133 -0.485 . . . . 72.209999999999994 110.909 179.996 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.823 ' HB3' ' HD2' ' A' ' 143' ' ' PRO . 9.1 mp -118.06 175.9 1.87 Allowed Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.603 0.716 . . . . 74.120000000000005 110.886 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 143' ' ' PRO . . . . . 0.823 ' HD2' ' HB3' ' A' ' 142' ' ' LEU . 54.0 Cg_endo -69.74 -90.98 0.01 OUTLIER 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.66 2.24 . . . . 73.150000000000006 112.378 179.836 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 144' ' ' ASN . . . . . 0.981 ' O ' ' HG2' ' A' ' 146' ' ' ARG . 0.0 OUTLIER -49.6 86.26 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.175 -0.466 . . . . 74.420000000000002 110.872 -179.968 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 145' ' ' TYR . . . . . 0.59 ' C ' ' O ' ' A' ' 144' ' ' ASN . 2.6 m-85 19.73 43.03 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.185 -0.461 . . . . 70.209999999999994 110.897 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 146' ' ' ARG . . . . . 0.981 ' HG2' ' O ' ' A' ' 144' ' ' ASN . 12.8 mmm-85 -101.21 178.49 4.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.092 -0.504 . . . . 75.230000000000004 110.853 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 73.51 -166.31 54.65 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.735 -0.745 . . . . 55.549999999999997 112.467 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -86.25 159.81 19.34 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.77 0.319 . . . . 72.109999999999999 110.848 -179.806 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 149' ' ' GLN . . . . . 0.511 ' HB2' ' HA ' ' A' ' 60' ' ' TYR . 50.3 mt-30 -94.41 153.16 18.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.163 -0.471 . . . . 74.040000000000006 110.874 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 150' ' ' TYR . . . . . 0.562 ' HB2' ' CB ' ' A' ' 139' ' ' PHE . 95.9 m-85 -135.11 119.2 17.55 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.183 -0.462 . . . . 71.409999999999997 110.976 -179.899 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.745 ' HA ' HD11 ' A' ' 61' ' ' ILE . 22.8 tp -65.11 136.8 57.14 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.09 -0.505 . . . . 61.149999999999999 110.894 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.931 HD13 ' O ' ' A' ' 152' ' ' LEU . 0.0 OUTLIER -73.03 134.23 44.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.222 -0.445 . . . . 54.439999999999998 110.945 179.85 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -165.27 30.88 0.06 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.212 -0.449 . . . . 54.329999999999998 110.908 179.85 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.754 ' O ' ' HG3' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -111.76 -172.27 2.01 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.16 -0.473 . . . . 70.019999999999996 110.945 179.947 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.972 ' HG3' HD23 ' A' ' 133' ' ' LEU . 0.0 OUTLIER -159.86 -129.43 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.239 -0.437 . . . . 73.430000000000007 110.869 179.849 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.579 ' HA ' ' HA ' ' A' ' 131' ' ' LYS . 2.1 tm-20 -70.27 4.94 1.92 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.215 -0.448 . . . . 74.239999999999995 110.883 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 157' ' ' TYR . . . . . 0.783 ' CD1' ' HB3' ' A' ' 162' ' ' ASP . 21.2 m-30 -30.7 148.19 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.135 -0.484 . . . . 72.0 110.895 -179.818 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 158' ' ' ARG . . . . . 0.508 ' HB3' ' CZ ' ' A' ' 104' ' ' PHE . 10.4 ptp180 -118.54 -31.87 4.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.065 -0.516 . . . . 75.299999999999997 110.841 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 159' ' ' LYS . . . . . 0.53 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 2.1 ptpp? -99.64 153.22 37.89 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.584 0.707 . . . . 72.040000000000006 110.889 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 160' ' ' PRO . . . . . 0.473 ' HB3' ' HB3' ' A' ' 168' ' ' PRO . 53.4 Cg_endo -69.82 -25.23 28.54 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.693 2.262 . . . . 75.310000000000002 112.312 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.681 HD12 ' H ' ' A' ' 161' ' ' ILE . 3.8 mp -75.46 4.19 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.229 -0.441 . . . . 73.040000000000006 111.131 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.783 ' HB3' ' CD1' ' A' ' 157' ' ' TYR . 0.2 OUTLIER -72.63 -21.12 61.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.151 -0.477 . . . . 72.230000000000004 110.831 179.856 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 163' ' ' TRP . . . . . 0.51 ' CD1' ' N ' ' A' ' 163' ' ' TRP . 0.0 OUTLIER -108.65 13.47 25.16 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.238 -0.437 . . . . 73.140000000000001 110.92 -179.934 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 84.94 -29.21 4.26 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.724 -0.75 . . . . 13.42 112.502 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -53.65 118.95 4.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.798 0.332 . . . . 61.020000000000003 111.092 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -48.78 -26.1 2.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.249 -0.432 . . . . 70.099999999999994 111.123 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 167' ' ' SER . . . . . 0.484 ' C ' ' H ' ' A' ' 169' ' ' ALA . 0.3 OUTLIER -155.71 157.19 31.4 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.69 0.757 . . . . 71.230000000000004 110.791 -179.779 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 168' ' ' PRO . . . . . 0.473 ' HB3' ' HB3' ' A' ' 160' ' ' PRO . 54.0 Cg_endo -69.78 22.24 0.17 Allowed 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.666 2.244 . . . . 73.319999999999993 112.353 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.494 ' HA ' ' HG2' ' A' ' 126' ' ' GLU . . . -64.66 103.76 0.73 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.239 -0.437 . . . . 52.119999999999997 111.071 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.623 HG11 ' CE1' ' A' ' 139' ' ' PHE . 2.9 t -152.59 160.91 2.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.169 -0.469 . . . . 74.409999999999997 111.11 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 171' ' ' GLN . . . . . 0.619 ' OE1' ' HB3' ' A' ' 143' ' ' PRO . 1.7 tm0? -108.13 -81.66 0.56 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.194 -0.457 . . . . 71.430000000000007 110.877 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 172' ' ' SER . . . . . 0.702 ' OG ' ' O ' ' A' ' 143' ' ' PRO . 24.9 p -129.8 179.48 5.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 65.400000000000006 110.834 -179.795 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 173' ' ' PHE . . . . . 0.405 ' HB3' ' CD1' ' A' ' 139' ' ' PHE . 27.4 p90 -144.2 167.81 21.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.14 -0.482 . . . . 65.519999999999996 110.853 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 174' ' ' ARG . . . . . 0.408 ' CD ' HD12 ' A' ' 138' ' ' ILE . 0.1 OUTLIER -139.13 135.98 34.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.139 -0.482 . . . . 73.239999999999995 110.876 -179.918 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 175' ' ' ARG . . . . . 0.486 ' HD2' ' CE2' ' A' ' 94' ' ' TYR . 0.1 OUTLIER -82.93 -167.04 1.5 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.196 -0.456 . . . . 64.150000000000006 110.879 -179.937 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 176' ' ' ILE . . . . . 0.871 HD12 ' HB ' ' A' ' 136' ' ' VAL . 4.2 mt -139.75 132.72 35.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.194 -0.457 . . . . 75.310000000000002 111.151 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 11.5 t -132.77 147.68 31.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.159 -0.473 . . . . 52.240000000000002 111.08 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 178' ' ' GLU . . . . . 0.417 ' HB3' HD13 ' A' ' 88' ' ' LEU . 3.6 pt-20 . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.178 -0.464 . . . . 73.140000000000001 110.852 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.2 mtm . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.839 0.352 . . . . 74.439999999999998 110.905 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -150.9 153.23 34.91 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.198 -0.456 . . . . 74.299999999999997 110.843 -179.796 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 30.8 mmtp -101.67 58.68 0.85 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.149 -0.478 . . . . 74.010000000000005 110.876 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 25.9 p -53.68 -39.77 65.4 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.255 -0.429 . . . . 61.039999999999999 111.126 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 161.83 145.99 4.51 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.747 -0.739 . . . . 65.319999999999993 112.554 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.497 ' C ' ' HE1' ' A' ' 47' ' ' TRP . 6.3 p -81.76 135.72 35.46 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.859 0.361 . . . . 53.210000000000001 111.135 -179.884 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.408 ' HA ' ' HA ' ' A' ' 24' ' ' ASP . 3.2 tttt -121.93 135.84 54.89 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.198 -0.455 . . . . 70.140000000000001 110.911 179.869 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.604 ' HB ' ' CD1' ' A' ' 47' ' ' TRP . 15.1 tt -136.91 150.54 26.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.232 -0.44 . . . . 74.519999999999996 111.132 179.839 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.492 HG23 ' CG ' ' A' ' 22' ' ' ASP . 9.9 m -131.01 142.05 50.29 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.162 -0.472 . . . . 61.439999999999998 111.158 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.774 ' HB2' HD22 ' A' ' 34' ' ' LEU . 1.2 m-85 -128.48 129.95 46.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 74.150000000000006 110.863 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.533 ' CG ' ' HA ' ' A' ' 16' ' ' PHE . 18.9 m-85 -116.23 131.4 56.95 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.188 -0.46 . . . . 74.230000000000004 110.886 -179.832 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.495 ' HG2' ' HB2' ' A' ' 36' ' ' ARG . 0.0 OUTLIER -58.24 -25.41 61.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.141 -0.481 . . . . 73.409999999999997 110.897 179.978 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 59.5 m-20 -127.16 152.57 47.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.144 -0.48 . . . . 71.340000000000003 110.905 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.49 ' N ' ' HB3' ' A' ' 38' ' ' ASN . 34.8 mtmt -56.08 -175.35 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.266 -0.424 . . . . 41.439999999999998 110.938 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 18.6 m120 46.96 34.13 2.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.233 -0.44 . . . . 75.299999999999997 110.882 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.533 ' HA ' ' CG ' ' A' ' 11' ' ' TYR . 4.2 m-85 48.51 57.18 6.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.217 -0.447 . . . . 73.200000000000003 110.867 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 14.7 mt-30 -131.98 157.24 44.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.12 -0.491 . . . . 71.439999999999998 110.92 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 95.5 -150.79 19.78 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.775 -0.726 . . . . 45.119999999999997 112.537 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.805 ' O ' HD13 ' A' ' 34' ' ' LEU . 0.1 OUTLIER -69.45 81.08 0.39 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.746 0.308 . . . . 73.230000000000004 110.889 -179.878 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.477 ' HB2' ' CE1' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -79.21 128.67 33.59 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.203 -0.453 . . . . 74.450000000000003 110.862 -179.884 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.47 ' CD2' ' CD2' ' A' ' 30' ' ' PHE . 75.6 t80 -124.41 125.06 43.65 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.181 -0.463 . . . . 65.019999999999996 110.944 -179.849 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.492 ' CG ' HG23 ' A' ' 9' ' ' THR . 1.4 m-20 -119.08 133.7 55.65 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.136 -0.484 . . . . 71.319999999999993 110.83 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 10.1 t -161.33 133.05 5.61 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 63.140000000000001 110.885 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.408 ' HA ' ' HA ' ' A' ' 7' ' ' LYS . 12.3 p-10 -100.86 -3.07 30.47 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.16 -0.473 . . . . 73.420000000000002 110.875 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 34.3 t -106.61 160.99 15.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.456 . . . . 71.450000000000003 110.905 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -48.16 120.38 3.52 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.216 -0.447 . . . . 73.510000000000005 110.828 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.67 ' HB2' ' HB3' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -115.54 46.61 1.46 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.218 -0.446 . . . . 70.109999999999999 110.832 -179.884 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.563 ' O ' ' HA ' ' A' ' 82' ' ' SER . . . -49.12 -21.01 0.65 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.191 -0.458 . . . . 62.32 111.1 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 60.8 t0 -128.56 40.86 3.59 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.224 -0.444 . . . . 72.0 110.889 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.792 ' CD2' ' O ' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -81.46 16.92 1.51 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.177 -0.465 . . . . 75.319999999999993 110.842 -179.874 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.501 ' HB2' ' HB3' ' A' ' 81' ' ' SER . 37.6 t60 -81.45 -35.14 30.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.158 -0.474 . . . . 73.519999999999996 110.9 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.8 t -64.52 -7.93 11.98 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.169 -0.469 . . . . 72.209999999999994 111.152 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -106.09 -28.21 10.64 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.215 -0.448 . . . . 65.409999999999997 110.895 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.805 HD13 ' O ' ' A' ' 19' ' ' ARG . 19.1 tp -141.36 144.83 34.75 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.121 -0.49 . . . . 73.140000000000001 110.882 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.1 m -111.29 -33.79 6.33 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.138 -0.483 . . . . 73.340000000000003 110.842 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.542 ' O ' HD21 ' A' ' 34' ' ' LEU . 2.3 mtp85 -116.66 140.64 49.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.095 -0.502 . . . . 74.25 110.903 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.626 ' HB3' ' HB2' ' A' ' 80' ' ' LEU . 6.3 p -117.37 59.08 0.78 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.199 -0.455 . . . . 74.040000000000006 110.873 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.49 ' HB3' ' N ' ' A' ' 14' ' ' LYS . 1.3 m-80 -57.38 -72.55 0.08 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.224 -0.443 . . . . 62.329999999999998 110.849 -179.859 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 4.5 p -108.08 127.06 53.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.204 -0.453 . . . . 63.520000000000003 110.901 -179.868 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.765 HD12 ' CH2' ' A' ' 73' ' ' TRP . 23.3 mt -120.55 149.18 23.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.187 -0.46 . . . . 74.219999999999999 111.127 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.446 ' HD2' ' CE2' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -143.73 121.55 11.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.122 -0.49 . . . . 60.009999999999998 110.89 179.842 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.524 HG22 ' HB ' ' A' ' 8' ' ' ILE . 1.5 t -107.04 115.65 48.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.203 -0.453 . . . . 64.040000000000006 111.074 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -111.36 79.26 1.19 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.116 -0.493 . . . . 74.329999999999998 110.908 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.429 ' O ' ' HB ' ' A' ' 6' ' ' THR . . . 132.75 102.12 0.81 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.737 -0.744 . . . . 44.420000000000002 112.508 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 53.2 178.12 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.761 -0.733 . . . . 72.230000000000004 112.469 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.718 HG23 ' HA ' ' A' ' 63' ' ' PRO . 0.7 OUTLIER -76.78 170.63 16.11 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.729 0.3 . . . . 45.350000000000001 111.168 -179.875 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.604 ' CD1' ' HB ' ' A' ' 8' ' ' ILE . 4.0 m95 -144.66 129.98 18.75 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.215 -0.448 . . . . 74.129999999999995 110.938 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.804 ' HB2' ' CG2' ' A' ' 86' ' ' VAL . . . -93.2 126.1 38.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.243 -0.435 . . . . 60.039999999999999 111.136 179.893 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.702 HG12 ' HB3' ' A' ' 83' ' ' CYS . 17.2 m -124.58 142.18 42.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.22 -0.446 . . . . 71.319999999999993 111.113 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.925 ' HB3' ' CB ' ' A' ' 56' ' ' ALA . 7.0 m-85 -116.92 143.53 45.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.127 -0.488 . . . . 73.230000000000004 110.977 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.554 ' HG2' ' N ' ' A' ' 52' ' ' ARG . 0.3 OUTLIER -49.47 -83.63 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.154 -0.475 . . . . 70.0 110.865 -179.976 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.903 ' O ' ' HB2' ' A' ' 56' ' ' ALA . 1.2 mtp180 -81.67 138.58 47.26 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.562 0.696 . . . . 75.230000000000004 110.914 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.746 ' HA ' ' OG ' ' A' ' 82' ' ' SER . 53.8 Cg_endo -69.75 138.14 37.17 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.672 2.248 . . . . 53.340000000000003 112.366 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.467 ' C ' ' CD2' ' A' ' 55' ' ' PHE . 6.3 m-20 66.67 -6.75 0.5 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.245 -0.434 . . . . 65.030000000000001 110.87 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.473 ' H ' ' C ' ' A' ' 53' ' ' PRO . 0.0 OUTLIER -139.86 -75.82 0.34 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.223 -0.444 . . . . 74.230000000000004 110.885 -179.966 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.925 ' CB ' ' HB3' ' A' ' 50' ' ' TYR . . . 45.71 79.98 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.19 -0.459 . . . . 74.310000000000002 111.044 179.906 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' TRP . . . . . 0.546 ' O ' ' CD2' ' A' ' 58' ' ' TYR . 54.1 m95 -64.72 33.71 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.257 -0.429 . . . . 71.299999999999997 110.901 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.603 ' H ' ' C ' ' A' ' 56' ' ' ALA . 1.4 m-30 -163.25 120.61 1.88 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.22 -0.446 . . . . 72.349999999999994 110.91 -179.927 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.496 ' HB2' ' HA ' ' A' ' 150' ' ' TYR . 1.0 OUTLIER -85.74 138.84 31.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.099 -0.5 . . . . 65.040000000000006 110.873 179.895 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.519 ' CE2' ' HG ' ' A' ' 76' ' ' LEU . 2.8 t80 -153.28 101.68 2.55 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.223 -0.444 . . . . 74.439999999999998 110.92 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.747 ' N ' HD12 ' A' ' 61' ' ' ILE . 1.8 mp -90.25 116.98 32.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.134 -0.485 . . . . 74.430000000000007 111.156 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.76 HD23 ' HD2' ' A' ' 63' ' ' PRO . 0.2 OUTLIER -82.74 130.88 56.46 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 121.554 0.693 . . . . 75.319999999999993 110.962 179.917 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.76 ' HD2' HD23 ' A' ' 62' ' ' LEU . 53.9 Cg_endo -69.72 -171.94 0.52 Allowed 'Trans proline' 0 C--N 1.341 0.132 0 C-N-CA 122.663 2.242 . . . . 74.120000000000005 112.359 179.887 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.92 162.53 14.73 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.219 -0.446 . . . . 63.210000000000001 110.937 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 112.3 -168.47 12.7 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.78 -0.724 . . . . 64.349999999999994 112.498 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -107.47 152.29 24.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.893 0.378 . . . . 72.310000000000002 110.89 -179.882 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.62 ' HB2' ' O ' ' A' ' 40' ' ' ILE . 11.2 m-85 -141.25 84.95 12.29 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.716 0.77 . . . . 70.549999999999997 110.935 -179.864 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.427 ' HD2' ' HG3' ' A' ' 72' ' ' ARG . 53.8 Cg_endo -69.79 0.17 6.06 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.701 2.267 . . . . 64.310000000000002 112.353 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.524 ' HB2' ' HG2' ' A' ' 72' ' ' ARG . 51.7 mt-10 -155.47 142.43 19.1 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.21 -0.45 . . . . 75.120000000000005 110.917 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.703 ' HA ' ' CE2' ' A' ' 73' ' ' TRP . 26.8 p90 -55.75 -20.06 13.38 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.145 -0.48 . . . . 73.120000000000005 110.963 -179.878 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -80.97 -16.01 54.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.093 -0.503 . . . . 73.5 110.9 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.524 ' HG2' ' HB2' ' A' ' 69' ' ' GLU . 27.9 mmt180 -69.88 -9.26 54.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.212 -0.449 . . . . 74.150000000000006 110.894 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' TRP . . . . . 0.765 ' CH2' HD12 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -133.74 17.53 3.9 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.187 -0.46 . . . . 71.430000000000007 110.919 -179.976 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.443 ' C ' ' O ' ' A' ' 73' ' ' TRP . 19.8 ptp 34.82 47.64 0.26 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.232 -0.44 . . . . 70.010000000000005 110.882 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -66.75 117.75 9.72 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.701 -0.761 . . . . 65.120000000000005 112.49 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.519 ' HG ' ' CE2' ' A' ' 60' ' ' TYR . 0.7 OUTLIER -61.08 -34.78 75.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.824 0.345 . . . . 65.409999999999997 110.927 -179.936 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.427 ' HB2' HD12 ' A' ' 76' ' ' LEU . 13.5 t-20 -125.57 134.12 52.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.183 -0.462 . . . . 70.420000000000002 110.889 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -88.4 16.36 6.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.181 -0.463 . . . . 54.439999999999998 110.886 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.4 ' HD3' ' HA ' ' A' ' 52' ' ' ARG . 0.9 OUTLIER -108.51 80.19 1.32 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.16 -0.473 . . . . 75.219999999999999 110.834 -179.895 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.626 ' HB2' ' HB3' ' A' ' 37' ' ' CYS . 0.0 OUTLIER -81.39 134.36 35.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 74.510000000000005 110.905 179.992 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.662 ' HB3' ' HB3' ' A' ' 53' ' ' PRO . 1.5 m -150.74 -118.89 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.188 -0.46 . . . . 74.519999999999996 110.86 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.746 ' OG ' ' HA ' ' A' ' 53' ' ' PRO . 0.0 OUTLIER -41.19 103.03 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.151 -0.477 . . . . 73.549999999999997 110.872 -179.815 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 83' ' ' CYS . . . . . 0.702 ' HB3' HG12 ' A' ' 49' ' ' VAL . 24.7 p -126.83 131.67 51.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.138 -0.483 . . . . 43.240000000000002 110.883 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.596 ' N ' ' O ' ' A' ' 48' ' ' ALA . 8.9 mmt85 -113.63 151.21 32.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.181 -0.463 . . . . 75.549999999999997 110.852 -179.86 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -68.41 128.34 36.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.19 -0.459 . . . . 63.140000000000001 111.095 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.885 ' CG1' HG11 ' A' ' 136' ' ' VAL . 90.4 t -115.63 128.46 72.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.225 -0.443 . . . . 55.229999999999997 111.126 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' HIS . . . . . 0.523 ' O ' HG23 ' A' ' 136' ' ' VAL . 62.3 m80 -108.34 121.71 45.49 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.143 -0.48 . . . . 74.319999999999993 110.831 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.411 ' C ' ' O ' ' A' ' 87' ' ' HIS . 0.2 OUTLIER -37.47 138.01 0.62 Allowed Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.578 0.704 . . . . 75.310000000000002 110.904 -179.979 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.706 ' HB3' ' H ' ' A' ' 136' ' ' VAL . 53.7 Cg_endo -69.76 98.53 0.69 Allowed 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.662 2.241 . . . . 63.009999999999998 112.352 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -101.19 -176.29 3.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.204 -0.453 . . . . 61.210000000000001 110.868 -179.854 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 53.98 51.49 49.48 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.742 -0.742 . . . . 52.210000000000001 112.505 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.428 ' O ' ' C ' ' A' ' 93' ' ' GLN . . . 126.41 28.24 1.01 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.752 -0.737 . . . . 71.540000000000006 112.476 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.507 ' O ' ' HG2' ' A' ' 134' ' ' GLU . 11.4 pt20 36.25 -117.92 0.13 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.839 0.352 . . . . 75.319999999999993 110.893 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.53 ' O ' ' HA ' ' A' ' 112' ' ' THR . 0.0 OUTLIER -123.57 99.75 6.46 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.159 -0.473 . . . . 73.120000000000005 110.881 -179.863 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.526 ' HG3' HG11 ' A' ' 132' ' ' VAL . 46.2 tptt -111.07 128.32 55.84 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.118 -0.492 . . . . 64.340000000000003 110.915 179.863 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.485 HD13 ' N ' ' A' ' 97' ' ' GLN . 0.0 OUTLIER -150.55 141.36 16.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.229 -0.441 . . . . 72.310000000000002 111.157 179.831 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.528 ' HB2' HG23 ' A' ' 132' ' ' VAL . 2.2 mt-30 -108.44 130.93 55.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.214 -0.448 . . . . 71.430000000000007 110.874 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.679 HD11 HG22 ' A' ' 111' ' ' THR . 1.3 mp -111.25 135.38 50.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.162 -0.472 . . . . 63.439999999999998 111.146 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.652 ' HB2' ' HB2' ' A' ' 129' ' ' SER . 8.3 m-85 -125.15 144.27 50.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.199 -0.455 . . . . 72.510000000000005 110.934 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 78.5 tt0 -71.36 -75.92 0.12 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.2 -0.454 . . . . 75.019999999999996 110.892 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.474 ' C ' ' HB3' ' A' ' 128' ' ' HIS . 41.4 mttt -82.35 175.06 10.55 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.178 -0.464 . . . . 65.340000000000003 110.906 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.438 ' N ' ' HB3' ' A' ' 128' ' ' HIS . . . -88.24 158.24 28.8 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.736 -0.745 . . . . 13.130000000000001 112.497 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.466 ' HA ' ' HB2' ' A' ' 158' ' ' ARG . 27.9 t0 67.2 54.42 0.73 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.819 0.342 . . . . 71.519999999999996 110.82 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.66 ' CE1' ' HD2' ' A' ' 131' ' ' LYS . 6.8 m-85 48.19 31.64 2.68 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.202 -0.454 . . . . 64.409999999999997 110.912 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.418 ' C ' ' HB2' ' A' ' 101' ' ' LYS . 49.2 m -107.36 150.62 26.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.159 -0.473 . . . . 73.519999999999996 110.873 -179.796 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 91.32 -164.65 29.63 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.69 -0.767 . . . . 50.340000000000003 112.441 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -74.67 130.27 39.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.802 0.334 . . . . 71.109999999999999 110.938 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -115.76 131.82 56.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.207 -0.451 . . . . 63.409999999999997 110.904 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -137.63 138.09 39.12 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.222 -0.444 . . . . 72.439999999999998 110.932 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -114.86 111.66 21.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.145 -0.48 . . . . 65.450000000000003 110.937 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.679 HG22 HD11 ' A' ' 98' ' ' ILE . 12.2 t -122.06 142.2 50.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.165 -0.47 . . . . 74.25 111.115 -179.899 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.53 ' HA ' ' O ' ' A' ' 94' ' ' TYR . 3.8 t -119.02 39.14 3.62 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.182 -0.463 . . . . 75.200000000000003 111.125 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -151.29 156.32 40.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.233 -0.44 . . . . 74.549999999999997 110.912 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -53.7 159.68 1.53 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.131 -0.486 . . . . 73.510000000000005 110.914 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' CYS . . . . . 0.549 ' O ' ' HB2' ' A' ' 172' ' ' SER . 29.4 t -146.32 120.17 5.23 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-O 121.6 0.714 . . . . 74.209999999999994 110.918 -179.884 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.452 ' O ' ' C ' ' A' ' 143' ' ' PRO . 53.7 Cg_endo -69.67 -32.76 18.31 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.668 2.245 . . . . 71.25 112.361 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.65 ' HB3' ' CB ' ' A' ' 120' ' ' GLU . 0.1 OUTLIER -148.63 101.72 3.24 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.186 -0.461 . . . . 71.439999999999998 110.842 -179.772 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.713 HD13 HD11 ' A' ' 127' ' ' ILE . 3.3 tt -54.47 -29.57 20.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.123 -0.49 . . . . 63.240000000000002 111.156 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' MET . . . . . 0.591 ' O ' ' HA ' ' A' ' 123' ' ' HIS . 49.2 ttp -86.2 -44.29 12.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 63.009999999999998 110.902 179.819 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.65 ' CB ' ' HB3' ' A' ' 117' ' ' SER . 12.6 tp10 -66.48 -12.47 57.53 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.223 -0.444 . . . . 73.0 110.865 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 25.0 tp60 -114.64 -49.06 2.83 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.156 -0.474 . . . . 72.340000000000003 110.934 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.437 ' HB2' ' O ' ' A' ' 118' ' ' ILE . 86.1 m-85 -105.23 -19.15 13.9 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.197 -0.456 . . . . 71.140000000000001 110.865 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 123' ' ' HIS . . . . . 0.591 ' HA ' ' O ' ' A' ' 119' ' ' MET . 11.4 m80 72.18 26.94 2.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.154 -0.475 . . . . 73.340000000000003 110.875 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.473 ' SD ' HG22 ' A' ' 98' ' ' ILE . 8.9 mtt -102.2 86.44 2.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.182 -0.463 . . . . 72.329999999999998 110.876 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 1.7 ptp85 -51.59 -34.54 37.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.245 -0.434 . . . . 70.439999999999998 110.913 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.486 ' HG2' ' HA ' ' A' ' 169' ' ' ALA . 35.9 mt-10 -144.89 133.57 22.19 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.152 -0.476 . . . . 73.430000000000007 110.897 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.713 HD11 HD13 ' A' ' 118' ' ' ILE . 3.5 mm -94.73 89.77 2.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.147 -0.478 . . . . 72.140000000000001 111.15 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 128' ' ' HIS . . . . . 0.474 ' HB3' ' C ' ' A' ' 101' ' ' LYS . 0.6 OUTLIER -62.58 -33.27 74.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.2 -0.455 . . . . 63.420000000000002 110.846 179.862 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.652 ' HB2' ' HB2' ' A' ' 99' ' ' PHE . 69.9 m -130.58 141.53 50.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 63.43 110.871 -179.747 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 130' ' ' CYS . . . . . 0.614 ' O ' ' O ' ' A' ' 155' ' ' LYS . 0.1 OUTLIER -142.84 122.31 13.19 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.178 -0.464 . . . . 62.240000000000002 110.91 -179.959 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.66 ' HD2' ' CE1' ' A' ' 104' ' ' PHE . 7.1 mtpp -115.74 155.61 27.46 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.169 -0.469 . . . . 63.240000000000002 110.861 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.546 HG12 ' N ' ' A' ' 133' ' ' LEU . 18.1 t 84.92 163.72 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.242 -0.435 . . . . 72.420000000000002 111.114 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.731 HD22 ' CG ' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -178.95 122.86 0.09 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.162 -0.472 . . . . 73.140000000000001 110.898 180.0 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.507 ' HG2' ' O ' ' A' ' 93' ' ' GLN . 0.0 OUTLIER -92.49 171.23 9.17 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.225 -0.443 . . . . 63.32 110.912 179.863 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.455 ' C ' ' O ' ' A' ' 134' ' ' GLU . . . -32.67 -53.08 0.47 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.754 -0.736 . . . . 50.009999999999998 112.482 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.885 HG11 ' CG1' ' A' ' 86' ' ' VAL . 4.1 t -148.81 146.13 17.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.858 0.361 . . . . 63.509999999999998 111.109 -179.944 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 137' ' ' TRP . . . . . 0.65 ' H ' HD12 ' A' ' 152' ' ' LEU . 0.7 OUTLIER -150.01 163.34 38.4 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.146 -0.479 . . . . 74.420000000000002 110.893 179.975 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.557 HD12 HH11 ' A' ' 174' ' ' ARG . 4.7 mt -143.18 136.65 25.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.186 -0.461 . . . . 60.439999999999998 111.109 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.689 ' CD1' HG11 ' A' ' 170' ' ' VAL . 0.2 OUTLIER -102.55 168.79 9.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.204 -0.453 . . . . 73.329999999999998 110.882 179.989 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 0.47 ' CD2' ' HA ' ' A' ' 145' ' ' TYR . 0.5 OUTLIER -139.88 127.65 21.91 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.131 -0.486 . . . . 51.439999999999998 110.959 -179.85 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.602 ' O ' ' HB2' ' A' ' 171' ' ' GLN . 0.7 OUTLIER -60.79 -28.41 68.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.134 -0.484 . . . . 75.420000000000002 110.893 -179.986 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.736 ' HB3' ' HD2' ' A' ' 143' ' ' PRO . 9.2 mp -115.06 173.63 2.81 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.621 0.724 . . . . 73.319999999999993 110.909 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 143' ' ' PRO . . . . . 0.742 ' O ' ' OG ' ' A' ' 172' ' ' SER . 53.8 Cg_endo -69.76 -89.59 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.603 2.202 . . . . 62.210000000000001 112.363 179.852 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 144' ' ' ASN . . . . . 0.711 ' O ' ' N ' ' A' ' 146' ' ' ARG . 1.3 m-20 -53.13 97.63 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.203 -0.453 . . . . 72.409999999999997 110.911 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 145' ' ' TYR . . . . . 0.637 ' C ' ' O ' ' A' ' 144' ' ' ASN . 33.1 m-85 12.51 52.36 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.169 -0.469 . . . . 72.150000000000006 110.932 -179.882 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 146' ' ' ARG . . . . . 0.711 ' N ' ' O ' ' A' ' 144' ' ' ASN . 19.5 mtt-85 -117.85 172.6 7.28 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.095 -0.502 . . . . 63.219999999999999 110.91 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 77.55 -176.86 53.35 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.759 -0.734 . . . . 54.340000000000003 112.523 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -78.08 149.62 33.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.76 0.314 . . . . 72.219999999999999 110.895 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 63.3 mt-30 -85.71 157.24 20.34 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.217 -0.447 . . . . 75.519999999999996 110.945 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' TYR . . . . . 0.509 ' HB2' ' HB2' ' A' ' 139' ' ' PHE . 88.8 m-85 -137.78 109.78 7.22 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.229 -0.441 . . . . 74.030000000000001 110.905 -179.837 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.637 ' HB2' HD11 ' A' ' 61' ' ' ILE . 20.2 tp -59.76 136.11 57.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.097 -0.502 . . . . 73.519999999999996 110.924 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 1.045 HD13 ' O ' ' A' ' 152' ' ' LEU . 0.0 OUTLIER -68.93 137.17 53.57 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.18 -0.464 . . . . 71.510000000000005 110.905 179.881 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 153' ' ' ASP . . . . . 0.442 ' N ' HD22 ' A' ' 152' ' ' LEU . 1.3 t70 -164.15 24.94 0.07 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.223 -0.444 . . . . 73.239999999999995 110.922 179.814 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.924 ' HB2' ' CD1' ' A' ' 157' ' ' TYR . 2.2 ptmt -122.0 -174.62 2.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.131 -0.486 . . . . 44.009999999999998 110.872 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.731 ' CG ' HD22 ' A' ' 133' ' ' LEU . 0.0 OUTLIER -158.66 -124.8 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.243 -0.435 . . . . 74.140000000000001 110.891 179.871 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.629 ' HA ' ' HA ' ' A' ' 131' ' ' LYS . 0.5 OUTLIER -64.75 -4.67 4.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.45 . . . . 74.430000000000007 110.89 179.943 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 157' ' ' TYR . . . . . 0.924 ' CD1' ' HB2' ' A' ' 154' ' ' LYS . 14.2 m-30 -26.42 141.33 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.143 -0.48 . . . . 54.32 110.899 -179.854 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 158' ' ' ARG . . . . . 0.466 ' HB2' ' HA ' ' A' ' 103' ' ' ASP . 8.2 ptp180 -105.17 -46.04 4.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.158 -0.474 . . . . 74.540000000000006 110.843 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 159' ' ' LYS . . . . . 0.485 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 3.3 ptpp? -84.59 150.42 56.63 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.537 0.684 . . . . 71.140000000000001 110.92 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 160' ' ' PRO . . . . . 0.654 ' O ' ' CD1' ' A' ' 163' ' ' TRP . 54.0 Cg_endo -69.77 -29.49 23.72 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.692 2.261 . . . . 73.209999999999994 112.33 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.746 HD12 ' H ' ' A' ' 161' ' ' ILE . 2.0 mp -71.96 6.85 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.197 -0.456 . . . . 71.219999999999999 111.169 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.602 ' HB3' ' CD1' ' A' ' 157' ' ' TYR . 0.9 OUTLIER -76.99 -18.05 58.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.109 -0.496 . . . . 73.150000000000006 110.838 179.896 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 163' ' ' TRP . . . . . 0.835 ' NE1' ' HB3' ' A' ' 165' ' ' ALA . 0.4 OUTLIER -109.21 12.83 24.73 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.25 -0.432 . . . . 73.120000000000005 110.955 -179.941 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 81.25 -44.08 2.99 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.706 -0.759 . . . . 71.239999999999995 112.488 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.835 ' HB3' ' NE1' ' A' ' 163' ' ' TRP . . . -52.3 121.49 7.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.813 0.339 . . . . 61.520000000000003 111.095 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -64.67 122.14 16.15 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.208 -0.451 . . . . 65.0 111.126 179.893 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 167' ' ' SER . . . . . 0.488 ' C ' ' H ' ' A' ' 169' ' ' ALA . 0.4 OUTLIER 63.23 146.46 0.09 OUTLIER Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 121.673 0.749 . . . . 54.229999999999997 110.866 -179.786 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 168' ' ' PRO . . . . . 0.489 ' HB2' ' N ' ' A' ' 127' ' ' ILE . 53.5 Cg_endo -69.81 23.75 0.17 Allowed 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.664 2.243 . . . . 72.219999999999999 112.37 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.488 ' H ' ' C ' ' A' ' 167' ' ' SER . . . -62.39 102.75 0.34 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.189 -0.46 . . . . 50.409999999999997 111.086 179.848 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.689 HG11 ' CD1' ' A' ' 139' ' ' PHE . 3.4 t -154.87 162.49 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.208 -0.451 . . . . 72.25 111.112 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 171' ' ' GLN . . . . . 0.653 ' OE1' ' HB3' ' A' ' 143' ' ' PRO . 1.6 tm0? -109.93 -83.05 0.57 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.156 -0.474 . . . . 64.230000000000004 110.925 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 172' ' ' SER . . . . . 0.742 ' OG ' ' O ' ' A' ' 143' ' ' PRO . 52.5 p -123.83 177.14 5.88 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.234 -0.439 . . . . 64.329999999999998 110.878 -179.858 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -140.45 168.0 20.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.136 -0.484 . . . . 73.120000000000005 110.893 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 174' ' ' ARG . . . . . 0.557 HH11 HD12 ' A' ' 138' ' ' ILE . 0.1 OUTLIER -134.66 152.64 51.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.112 -0.494 . . . . 74.530000000000001 110.866 -179.904 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.29 167.77 10.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.184 -0.462 . . . . 55.329999999999998 110.886 -179.911 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 2.6 mt -116.63 141.52 34.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.165 -0.47 . . . . 53.329999999999998 111.16 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 3.2 p -149.97 155.85 7.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.195 -0.457 . . . . 70.400000000000006 111.108 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 116.143 -0.48 . . . . 64.400000000000006 110.895 179.996 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.786 0.327 . . . . 64.129999999999995 110.881 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -144.29 109.28 5.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.225 -0.443 . . . . 65.25 110.833 -179.775 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 9.1 mmtp -95.34 36.08 1.27 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.164 -0.471 . . . . 75.540000000000006 110.931 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.9 t -62.68 -33.66 75.54 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.254 -0.43 . . . . 61.399999999999999 111.156 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 160.97 139.76 2.73 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.768 -0.729 . . . . 65.400000000000006 112.466 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.496 ' C ' ' HE1' ' A' ' 47' ' ' TRP . 7.2 p -82.46 136.72 34.86 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.867 0.365 . . . . 75.129999999999995 111.153 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.447 ' N ' ' HE1' ' A' ' 47' ' ' TRP . 2.5 tttt -126.93 136.76 52.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.236 -0.438 . . . . 64.310000000000002 110.907 179.878 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.517 ' HA ' ' HA ' ' A' ' 42' ' ' VAL . 16.5 tt -136.5 154.56 32.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.22 -0.445 . . . . 73.239999999999995 111.129 179.881 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.488 HG23 ' CG ' ' A' ' 22' ' ' ASP . 13.7 m -134.55 151.41 51.08 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.162 -0.472 . . . . 61.130000000000003 111.157 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.662 ' HB2' HD22 ' A' ' 34' ' ' LEU . 1.2 m-85 -140.45 129.59 23.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.454 . . . . 75.040000000000006 110.863 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.55 ' CG ' ' HA ' ' A' ' 16' ' ' PHE . 8.2 m-85 -115.36 133.15 56.3 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.154 -0.475 . . . . 74.340000000000003 110.942 -179.872 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.454 ' HG2' ' HB2' ' A' ' 36' ' ' ARG . 0.0 OUTLIER -56.6 -25.0 51.6 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.181 -0.463 . . . . 72.540000000000006 110.89 -179.974 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.413 ' HB2' ' O ' ' A' ' 17' ' ' GLN . 62.8 m-20 -126.38 155.8 41.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.159 -0.473 . . . . 74.409999999999997 110.91 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.412 ' HG2' ' HA ' ' A' ' 69' ' ' GLU . 11.2 mtmt -57.99 -173.58 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.206 -0.452 . . . . 72.019999999999996 110.899 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 23.9 m-20 43.95 34.41 0.92 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.244 -0.435 . . . . 64.25 110.867 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.55 ' HA ' ' CG ' ' A' ' 11' ' ' TYR . 3.1 m-85 48.05 62.9 2.27 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.21 -0.45 . . . . 73.409999999999997 110.829 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.413 ' O ' ' HB2' ' A' ' 13' ' ' ASP . 10.6 mt-30 -136.55 154.68 50.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.181 -0.463 . . . . 71.209999999999994 110.902 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 95.28 -152.94 20.6 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.711 -0.757 . . . . 60.100000000000001 112.485 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.795 ' O ' HD13 ' A' ' 34' ' ' LEU . 0.0 OUTLIER -65.21 81.13 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.844 0.354 . . . . 73.109999999999999 110.891 -179.867 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.466 ' HB2' ' CE1' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -79.97 128.92 34.04 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.189 -0.46 . . . . 70.310000000000002 110.835 -179.859 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.471 ' CD2' ' CD2' ' A' ' 30' ' ' PHE . 72.2 t80 -123.53 126.12 46.11 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.221 -0.445 . . . . 70.420000000000002 110.944 -179.854 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.488 ' CG ' HG23 ' A' ' 9' ' ' THR . 1.1 m-20 -121.71 134.41 54.95 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.17 -0.468 . . . . 40.119999999999997 110.874 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 6.7 t -163.02 134.39 4.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.165 -0.471 . . . . 52.350000000000001 110.922 -179.879 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.417 ' HA ' ' HA ' ' A' ' 7' ' ' LYS . 5.0 p-10 -101.96 3.56 39.11 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.203 -0.453 . . . . 72.209999999999994 110.875 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 42.2 t -110.62 158.79 18.2 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.197 -0.456 . . . . 53.200000000000003 110.893 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -40.7 119.75 1.16 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.234 -0.439 . . . . 70.230000000000004 110.889 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.567 ' HB2' ' HB3' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -114.51 39.95 2.68 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.175 -0.466 . . . . 73.340000000000003 110.879 -179.896 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.583 ' O ' ' HB3' ' A' ' 82' ' ' SER . . . -50.86 -21.35 1.65 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.218 -0.447 . . . . 63.420000000000002 111.078 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 58.1 t0 -130.45 39.44 3.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.215 -0.448 . . . . 75.0 110.843 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.81 ' CD2' ' O ' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -81.09 15.27 1.94 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.213 -0.449 . . . . 71.209999999999994 110.885 -179.876 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.419 ' CG ' ' HG3' ' A' ' 53' ' ' PRO . 44.5 t60 -80.57 -35.02 34.86 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.157 -0.474 . . . . 73.299999999999997 110.867 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.7 t -62.96 -10.65 14.46 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.169 -0.469 . . . . 75.5 111.154 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -103.53 -27.29 12.45 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.231 -0.44 . . . . 64.120000000000005 110.92 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.795 HD13 ' O ' ' A' ' 19' ' ' ARG . 30.4 tp -138.17 138.73 38.88 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.137 -0.483 . . . . 75.239999999999995 110.905 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.5 m -104.11 -36.15 7.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.169 -0.469 . . . . 62.43 110.824 -179.88 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.458 ' O ' HD21 ' A' ' 34' ' ' LEU . 0.7 OUTLIER -112.98 139.86 48.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.131 -0.486 . . . . 72.340000000000003 110.863 -179.92 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.476 ' SG ' ' CB ' ' A' ' 80' ' ' LEU . 2.2 m -121.41 69.87 0.92 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.193 -0.458 . . . . 73.349999999999994 110.93 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -72.04 -71.86 0.26 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.214 -0.448 . . . . 70.019999999999996 110.889 -179.864 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 4.9 p -104.54 134.61 47.43 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.165 -0.47 . . . . 61.219999999999999 110.867 -179.846 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.576 HD12 ' CH2' ' A' ' 73' ' ' TRP . 20.8 mt -126.51 151.65 33.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.135 -0.484 . . . . 74.340000000000003 111.124 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.481 ' HD2' ' CE2' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -145.0 124.75 13.34 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.155 -0.475 . . . . 62.130000000000003 110.918 179.834 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.517 ' HA ' ' HA ' ' A' ' 8' ' ' ILE . 1.2 t -111.99 116.03 51.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.214 -0.448 . . . . 72.340000000000003 111.16 179.882 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -112.95 77.63 1.06 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.217 -0.447 . . . . 73.140000000000001 110.886 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.415 ' O ' ' HB ' ' A' ' 6' ' ' THR . . . 139.08 97.49 0.38 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.685 -0.769 . . . . 72.519999999999996 112.464 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.419 ' HA2' HD21 ' A' ' 88' ' ' LEU . . . 52.52 -179.9 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.729 -0.748 . . . . 63.549999999999997 112.476 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.7 HG23 ' HA ' ' A' ' 63' ' ' PRO . 1.4 m -74.52 170.05 16.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.75 0.31 . . . . 74.409999999999997 111.162 -179.886 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.57 ' H ' HG22 ' A' ' 46' ' ' THR . 4.5 m95 -142.92 130.03 20.77 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.245 -0.434 . . . . 74.040000000000006 110.887 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.891 ' HB2' ' CG2' ' A' ' 86' ' ' VAL . . . -87.36 127.09 35.2 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.225 -0.443 . . . . 75.439999999999998 111.115 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.908 HG11 HD11 ' A' ' 80' ' ' LEU . 34.5 m -129.7 131.71 66.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.263 -0.426 . . . . 64.310000000000002 111.127 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.726 ' HB3' ' HA ' ' A' ' 56' ' ' ALA . 58.8 m-85 -103.01 147.92 26.34 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.192 -0.458 . . . . 71.310000000000002 110.913 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.651 ' OE1' ' HB3' ' A' ' 57' ' ' TRP . 63.7 tt0 -50.19 -78.99 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.133 -0.485 . . . . 64.540000000000006 110.858 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.598 ' HB3' ' HB2' ' A' ' 55' ' ' PHE . 0.5 OUTLIER -91.04 138.01 26.22 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.618 0.723 . . . . 73.109999999999999 110.869 -179.908 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.739 ' HB3' ' HB3' ' A' ' 81' ' ' SER . 53.7 Cg_endo -69.82 145.98 58.43 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.655 2.237 . . . . 35.530000000000001 112.349 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 63.15 -7.67 0.15 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.239 -0.437 . . . . 73.25 110.917 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.614 ' CD1' ' O ' ' A' ' 53' ' ' PRO . 30.8 m-85 -113.72 -20.32 11.21 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.173 -0.467 . . . . 72.209999999999994 110.864 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.726 ' HA ' ' HB3' ' A' ' 50' ' ' TYR . . . 52.37 27.27 4.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.188 -0.46 . . . . 63.229999999999997 111.105 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' TRP . . . . . 0.651 ' HB3' ' OE1' ' A' ' 51' ' ' GLU . 0.0 OUTLIER -49.28 -164.36 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.225 -0.443 . . . . 74.409999999999997 110.888 -179.956 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.637 ' C ' ' O ' ' A' ' 57' ' ' TRP . 4.7 m-30 -12.55 101.39 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.182 -0.463 . . . . 73.230000000000004 110.951 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.451 ' HB2' ' O ' ' A' ' 149' ' ' GLN . 2.3 mpt? -60.74 155.93 18.1 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.17 -0.468 . . . . 63.509999999999998 110.856 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.68 ' O ' ' O ' ' A' ' 49' ' ' VAL . 2.7 t80 -170.74 120.63 0.56 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.202 -0.454 . . . . 72.140000000000001 110.972 -179.872 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.854 ' N ' HD12 ' A' ' 61' ' ' ILE . 1.0 OUTLIER -106.2 114.24 44.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.165 -0.47 . . . . 62.219999999999999 111.15 179.923 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.614 HD23 ' HD2' ' A' ' 63' ' ' PRO . 0.3 OUTLIER -83.75 124.65 74.82 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.583 0.706 . . . . 75.239999999999995 110.933 179.943 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.7 ' HA ' HG23 ' A' ' 46' ' ' THR . 53.3 Cg_endo -69.75 -171.3 0.46 Allowed 'Trans proline' 0 C--O 1.231 0.141 0 C-N-CA 122.706 2.271 . . . . 74.340000000000003 112.295 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.79 163.2 15.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.189 -0.459 . . . . 72.099999999999994 110.908 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 114.35 -158.42 14.33 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.795 -0.717 . . . . 73.450000000000003 112.472 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -118.28 154.3 32.53 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.871 0.367 . . . . 74.040000000000006 110.868 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.55 ' HB2' ' O ' ' A' ' 40' ' ' ILE . 17.5 m-85 -140.94 84.14 13.47 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.691 0.758 . . . . 72.340000000000003 110.959 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.409 ' HD2' ' HG3' ' A' ' 72' ' ' ARG . 53.1 Cg_endo -69.84 2.79 3.25 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.643 2.229 . . . . 72.540000000000006 112.35 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.603 ' HB2' ' HG2' ' A' ' 72' ' ' ARG . 48.4 mt-10 -157.56 144.21 17.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.183 -0.462 . . . . 74.030000000000001 110.893 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.707 ' HA ' ' NE1' ' A' ' 73' ' ' TRP . 35.4 p90 -55.78 -25.97 43.74 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.127 -0.488 . . . . 71.25 110.896 -179.801 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -76.51 -15.81 59.79 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.154 -0.475 . . . . 64.430000000000007 110.931 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.603 ' HG2' ' HB2' ' A' ' 69' ' ' GLU . 32.0 mmt180 -67.27 -15.98 64.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.201 -0.454 . . . . 75.219999999999999 110.874 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' TRP . . . . . 0.745 ' CD1' ' N ' ' A' ' 73' ' ' TRP . 0.0 OUTLIER -125.14 21.88 7.99 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.202 -0.454 . . . . 72.450000000000003 110.939 -179.959 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.574 ' O ' ' C ' ' A' ' 75' ' ' GLY . 2.1 ttm 75.87 -16.4 0.6 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.258 -0.428 . . . . 51.420000000000002 110.88 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.574 ' C ' ' O ' ' A' ' 74' ' ' MET . . . 21.93 57.5 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.762 -0.732 . . . . 51.210000000000001 112.496 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.93 HD13 ' N ' ' A' ' 77' ' ' ASN . 0.0 OUTLIER -56.48 -10.93 1.07 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.835 0.35 . . . . 65.340000000000003 110.927 -179.935 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.93 ' N ' HD13 ' A' ' 76' ' ' LEU . 37.0 t-20 -149.33 -48.67 0.14 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.219 -0.446 . . . . 74.319999999999993 110.853 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.556 ' CB ' ' O ' ' A' ' 77' ' ' ASN . 5.2 t0 87.22 -7.73 0.64 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.192 -0.458 . . . . 72.400000000000006 110.901 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.457 ' HG2' ' O ' ' A' ' 79' ' ' ARG . 8.7 ttt85 -85.39 50.15 1.9 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.178 -0.464 . . . . 60.100000000000001 110.874 -179.897 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.908 HD11 HG11 ' A' ' 49' ' ' VAL . 0.1 OUTLIER -59.36 130.65 47.95 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.195 -0.457 . . . . 61.030000000000001 110.937 179.998 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.739 ' HB3' ' HB3' ' A' ' 53' ' ' PRO . 12.3 m -151.6 -111.77 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.182 -0.463 . . . . 73.430000000000007 110.849 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.601 ' OG ' ' HA ' ' A' ' 53' ' ' PRO . 1.0 OUTLIER -47.87 97.12 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.155 -0.475 . . . . 52.530000000000001 110.851 -179.802 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 83' ' ' CYS . . . . . 0.784 ' CB ' HG12 ' A' ' 49' ' ' VAL . 7.6 p -123.89 135.23 53.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.167 -0.469 . . . . 61.229999999999997 110.858 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.633 ' N ' ' O ' ' A' ' 48' ' ' ALA . 0.9 OUTLIER -115.12 154.82 28.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.154 -0.475 . . . . 74.319999999999993 110.89 -179.9 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -68.17 130.06 41.77 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.191 -0.458 . . . . 72.450000000000003 111.048 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.891 ' CG2' ' HB2' ' A' ' 48' ' ' ALA . 37.7 t -115.03 133.34 61.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.208 -0.451 . . . . 62.109999999999999 111.179 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' HIS . . . . . 0.646 ' O ' HG23 ' A' ' 136' ' ' VAL . 39.9 m80 -111.26 108.48 18.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.202 -0.454 . . . . 72.310000000000002 110.87 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.477 ' H ' HD23 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -33.4 147.04 0.1 OUTLIER Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.566 0.698 . . . . 74.340000000000003 110.943 -179.96 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.521 ' HB3' ' H ' ' A' ' 136' ' ' VAL . 53.6 Cg_endo -69.78 95.52 0.56 Allowed 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.68 2.253 . . . . 62.020000000000003 112.328 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -88.89 -174.87 4.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.225 -0.443 . . . . 72.120000000000005 110.844 -179.847 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 64.0 108.48 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.766 -0.731 . . . . 65.349999999999994 112.525 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 69.41 -84.34 0.26 Allowed Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.695 -0.764 . . . . 74.439999999999998 112.481 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.446 ' O ' ' HG2' ' A' ' 134' ' ' GLU . 19.5 pt20 178.74 -136.79 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.842 0.353 . . . . 63.450000000000003 110.945 -179.863 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.671 ' HA ' ' HG2' ' A' ' 134' ' ' GLU . 0.0 OUTLIER -113.86 103.2 10.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.202 -0.454 . . . . 74.430000000000007 110.96 -179.877 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.492 ' HG3' HG11 ' A' ' 132' ' ' VAL . 29.1 tptt -107.41 128.79 54.79 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.127 -0.488 . . . . 73.439999999999998 110.896 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.528 HD13 ' N ' ' A' ' 97' ' ' GLN . 0.1 OUTLIER -151.08 133.97 6.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.194 -0.457 . . . . 74.319999999999993 111.136 179.828 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.528 ' N ' HD13 ' A' ' 96' ' ' ILE . 0.3 OUTLIER -105.76 126.61 52.37 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.142 -0.481 . . . . 74.340000000000003 110.911 179.948 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.626 HD13 HD11 ' A' ' 118' ' ' ILE . 13.0 mt -105.08 138.51 29.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.186 -0.461 . . . . 72.519999999999996 111.103 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.663 ' HB2' ' HB2' ' A' ' 129' ' ' SER . 46.7 m-85 -125.75 139.9 53.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.166 -0.47 . . . . 51.219999999999999 110.87 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 79.0 tt0 -71.89 -70.8 0.31 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.119 -0.491 . . . . 70.239999999999995 110.875 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 41.4 mttt -87.9 171.02 10.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.157 -0.474 . . . . 71.519999999999996 110.858 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -75.47 155.05 46.58 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.801 -0.714 . . . . 72.400000000000006 112.481 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.615 ' HA ' ' HB2' ' A' ' 158' ' ' ARG . 16.1 t0 68.03 45.26 1.35 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.85 0.357 . . . . 63.119999999999997 110.863 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.441 ' HA ' ' CD1' ' A' ' 99' ' ' PHE . 0.7 OUTLIER 50.7 29.17 4.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.183 -0.462 . . . . 70.510000000000005 110.89 -179.905 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 71.2 m -96.82 159.06 15.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.149 -0.478 . . . . 74.049999999999997 110.911 -179.821 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 87.1 -145.06 19.64 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.774 -0.727 . . . . 75.129999999999995 112.493 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 3.8 tp-100 -87.66 125.01 34.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.8 0.333 . . . . 70.409999999999997 110.906 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' MET . . . . . 0.48 ' HB2' ' CE1' ' A' ' 99' ' ' PHE . 23.4 ttp -107.64 144.35 34.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.198 -0.455 . . . . 74.510000000000005 110.889 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -149.51 135.5 18.85 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.275 -0.421 . . . . 75.400000000000006 110.884 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -114.93 102.68 10.19 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.102 -0.499 . . . . 62.409999999999997 110.909 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 14.6 t -114.07 144.19 43.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 74.319999999999993 111.102 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.479 ' O ' ' OG1' ' A' ' 112' ' ' THR . 0.8 OUTLIER -124.4 36.35 4.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.252 -0.431 . . . . 51.340000000000003 111.135 -179.988 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -143.84 -172.52 3.76 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.232 -0.44 . . . . 73.0 110.867 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -86.31 162.54 18.18 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.112 -0.494 . . . . 74.430000000000007 110.88 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' CYS . . . . . 0.419 ' HB3' ' CE2' ' A' ' 173' ' ' PHE . 0.8 OUTLIER -157.25 120.76 2.21 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-O 121.585 0.707 . . . . 73.519999999999996 110.92 -179.918 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.586 ' O ' ' OG ' ' A' ' 172' ' ' SER . 54.1 Cg_endo -69.73 -33.5 16.6 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.642 2.228 . . . . 63.130000000000003 112.401 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.669 ' HB3' ' CB ' ' A' ' 120' ' ' GLU . 0.2 OUTLIER -138.68 103.57 4.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.22 -0.445 . . . . 71.510000000000005 110.846 -179.862 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.674 ' HB ' ' O ' ' A' ' 171' ' ' GLN . 4.9 tt -57.91 -29.87 36.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.135 -0.484 . . . . 51.439999999999998 111.148 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' MET . . . . . 0.594 ' O ' ' HA ' ' A' ' 123' ' ' HIS . 2.8 ttt -87.89 -45.62 10.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.165 -0.47 . . . . 63.439999999999998 110.864 179.873 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.669 ' CB ' ' HB3' ' A' ' 117' ' ' SER . 6.7 tp10 -62.86 -13.5 34.7 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.235 -0.439 . . . . 75.239999999999995 110.89 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 7.8 tp-100 -114.64 -50.09 2.8 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.186 -0.461 . . . . 74.400000000000006 110.963 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.569 ' HB2' ' O ' ' A' ' 118' ' ' ILE . 96.1 m-85 -100.07 -20.64 15.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.165 -0.47 . . . . 54.039999999999999 110.881 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 123' ' ' HIS . . . . . 0.594 ' HA ' ' O ' ' A' ' 119' ' ' MET . 13.4 m-70 76.42 22.07 1.3 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.17 -0.468 . . . . 74.25 110.888 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.506 ' O ' HG23 ' A' ' 118' ' ' ILE . 3.5 mtt -97.67 118.74 34.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.174 -0.466 . . . . 64.530000000000001 110.856 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 5.8 ptp180 -79.58 -45.79 18.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.203 -0.453 . . . . 65.530000000000001 110.863 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.44 ' HB3' ' HG2' ' A' ' 168' ' ' PRO . 19.9 mt-10 -140.45 117.36 11.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.181 -0.463 . . . . 71.420000000000002 110.836 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.642 HG21 ' SG ' ' A' ' 130' ' ' CYS . 3.2 mm -73.52 92.49 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.128 -0.487 . . . . 74.120000000000005 111.112 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -64.89 -34.0 77.35 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.156 -0.475 . . . . 72.129999999999995 110.868 179.874 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.663 ' HB2' ' HB2' ' A' ' 99' ' ' PHE . 4.7 m -133.97 155.03 50.68 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.207 -0.452 . . . . 62.43 110.845 -179.802 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 130' ' ' CYS . . . . . 0.663 ' O ' ' O ' ' A' ' 155' ' ' LYS . 0.1 OUTLIER -156.59 123.04 5.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.112 -0.494 . . . . 60.140000000000001 110.844 -179.951 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.636 ' HA ' ' HA ' ' A' ' 156' ' ' GLU . 1.9 mtpt -108.22 154.21 22.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.16 -0.473 . . . . 71.510000000000005 110.885 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.553 HG23 ' C ' ' A' ' 131' ' ' LYS . 8.3 t 83.45 165.03 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.215 -0.448 . . . . 74.310000000000002 111.136 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.789 HD22 ' CG ' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -178.49 123.69 0.1 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.125 -0.489 . . . . 55.219999999999999 110.905 179.977 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.671 ' HG2' ' HA ' ' A' ' 94' ' ' TYR . 0.1 OUTLIER -98.64 164.41 12.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.21 -0.45 . . . . 73.530000000000001 110.856 179.928 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.557 ' C ' ' O ' ' A' ' 134' ' ' GLU . . . -23.06 -63.1 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.736 -0.745 . . . . 42.5 112.487 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.795 ' HB ' HD12 ' A' ' 176' ' ' ILE . 3.1 t -144.44 146.34 20.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.804 0.335 . . . . 72.329999999999998 111.126 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 137' ' ' TRP . . . . . 0.645 ' HB3' ' HB3' ' A' ' 152' ' ' LEU . 6.3 t-105 -143.19 149.56 38.17 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.164 -0.471 . . . . 74.099999999999994 110.945 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.412 HD12 ' HB ' ' A' ' 61' ' ' ILE . 3.5 mm -114.59 134.73 56.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.285 -0.416 . . . . 61.409999999999997 111.161 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.524 ' CD1' HG11 ' A' ' 170' ' ' VAL . 0.1 OUTLIER -117.23 142.65 46.79 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.204 -0.453 . . . . 72.340000000000003 110.846 -179.989 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 0.512 ' CE2' ' HA ' ' A' ' 145' ' ' TYR . 3.9 m-85 -120.79 130.4 53.98 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.14 -0.482 . . . . 73.510000000000005 110.932 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.452 ' O ' ' HB2' ' A' ' 171' ' ' GLN . 2.9 tt0 -61.77 -47.62 84.35 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.121 -0.49 . . . . 75.409999999999997 110.885 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 1.057 ' O ' ' HB2' ' A' ' 172' ' ' SER . 7.1 mp -97.41 152.56 38.29 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.588 0.709 . . . . 74.510000000000005 110.922 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 143' ' ' PRO . . . . . 0.684 ' HB3' ' OE1' ' A' ' 171' ' ' GLN . 54.3 Cg_endo -69.68 44.76 0.42 Allowed 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.709 2.273 . . . . 54.310000000000002 112.379 179.854 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 144' ' ' ASN . . . . . 1.084 ' O ' ' N ' ' A' ' 146' ' ' ARG . 0.1 OUTLIER 179.06 106.62 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.228 -0.442 . . . . 74.340000000000003 110.885 -179.989 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 145' ' ' TYR . . . . . 0.668 ' C ' ' O ' ' A' ' 144' ' ' ASN . 0.0 OUTLIER -3.51 51.25 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.204 -0.453 . . . . 64.0 110.938 -179.948 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 146' ' ' ARG . . . . . 1.084 ' N ' ' O ' ' A' ' 144' ' ' ASN . 36.7 mtt180 -131.47 163.27 28.33 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.118 -0.492 . . . . 63.509999999999998 110.881 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 82.8 -162.69 41.34 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.75 -0.738 . . . . 73.5 112.472 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -84.97 148.96 25.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.753 0.311 . . . . 74.329999999999998 110.84 -179.848 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' GLN . . . . . 0.451 ' O ' ' HB2' ' A' ' 59' ' ' MET . 19.3 mt-30 -95.73 135.09 37.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.159 -0.473 . . . . 70.120000000000005 110.901 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 150' ' ' TYR . . . . . 0.471 ' HB2' ' HB2' ' A' ' 139' ' ' PHE . 41.6 m-85 -109.95 127.06 54.54 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.164 -0.471 . . . . 73.140000000000001 110.856 -179.841 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.509 ' HB2' HD11 ' A' ' 61' ' ' ILE . 6.8 tp -83.01 120.89 26.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.088 -0.505 . . . . 52.219999999999999 110.947 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 1.043 HD13 ' O ' ' A' ' 152' ' ' LEU . 0.0 OUTLIER -50.46 133.11 25.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.2 -0.454 . . . . 73.549999999999997 110.962 179.887 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -162.09 23.16 0.11 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.216 -0.447 . . . . 52.310000000000002 110.868 179.817 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.83 ' HB2' ' CD1' ' A' ' 157' ' ' TYR . 3.2 ptmt -119.97 -174.02 2.67 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.191 -0.459 . . . . 43.409999999999997 110.91 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.789 ' CG ' HD22 ' A' ' 133' ' ' LEU . 1.7 mptt -158.4 -119.43 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.249 -0.432 . . . . 75.349999999999994 110.934 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.636 ' HA ' ' HA ' ' A' ' 131' ' ' LYS . 1.2 tm-20 -72.47 0.74 9.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.201 -0.454 . . . . 73.5 110.931 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 157' ' ' TYR . . . . . 0.83 ' CD1' ' HB2' ' A' ' 154' ' ' LYS . 12.9 m-30 -34.97 154.11 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.106 -0.497 . . . . 75.420000000000002 110.929 -179.868 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 158' ' ' ARG . . . . . 0.615 ' HB2' ' HA ' ' A' ' 103' ' ' ASP . 8.0 ptp180 -116.7 -44.22 2.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.074 -0.512 . . . . 71.109999999999999 110.883 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 159' ' ' LYS . . . . . 0.42 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 3.1 ptpp? -86.25 150.13 51.3 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.6 0.714 . . . . 73.439999999999998 110.854 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 160' ' ' PRO . . . . . 0.445 ' HA ' ' HE1' ' A' ' 163' ' ' TRP . 54.2 Cg_endo -69.78 -23.49 30.66 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.64 2.227 . . . . 74.120000000000005 112.377 179.86 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.648 HD12 ' H ' ' A' ' 161' ' ' ILE . 3.5 mp -78.71 4.09 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.212 -0.449 . . . . 73.140000000000001 111.138 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.529 ' HB3' ' CD1' ' A' ' 157' ' ' TYR . 1.0 OUTLIER -72.96 -16.91 61.52 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.19 -0.459 . . . . 71.5 110.819 179.853 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 163' ' ' TRP . . . . . 0.673 ' N ' ' CD1' ' A' ' 163' ' ' TRP . 0.0 OUTLIER -115.82 13.54 16.11 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.217 -0.447 . . . . 75.450000000000003 110.864 -179.943 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 88.64 -31.88 4.74 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.762 -0.732 . . . . 75.030000000000001 112.489 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -51.53 118.55 3.4 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.783 0.325 . . . . 62.409999999999997 111.1 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -50.73 -31.5 16.81 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.248 -0.433 . . . . 72.230000000000004 111.114 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 167' ' ' SER . . . . . 0.493 ' C ' ' H ' ' A' ' 169' ' ' ALA . 0.3 OUTLIER -149.98 156.44 38.01 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.701 0.763 . . . . 52.149999999999999 110.835 -179.826 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 168' ' ' PRO . . . . . 0.444 ' HB3' ' O ' ' A' ' 127' ' ' ILE . 53.9 Cg_endo -69.73 24.95 0.17 Allowed 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.727 2.285 . . . . 60.5 112.312 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.493 ' H ' ' C ' ' A' ' 167' ' ' SER . . . -65.55 100.93 0.55 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.265 -0.425 . . . . 64.420000000000002 111.082 179.91 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.524 HG11 ' CD1' ' A' ' 139' ' ' PHE . 1.9 t -154.42 165.35 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.213 -0.449 . . . . 74.439999999999998 111.12 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 171' ' ' GLN . . . . . 0.684 ' OE1' ' HB3' ' A' ' 143' ' ' PRO . 2.2 mm-40 -147.53 -101.2 0.09 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.128 -0.487 . . . . 75.439999999999998 110.876 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 172' ' ' SER . . . . . 1.057 ' HB2' ' O ' ' A' ' 142' ' ' LEU . 0.3 OUTLIER -56.31 143.73 33.03 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.196 -0.456 . . . . 44.240000000000002 110.902 -179.8 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 173' ' ' PHE . . . . . 0.419 ' CE2' ' HB3' ' A' ' 115' ' ' CYS . 31.2 p90 -152.1 132.79 13.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.184 -0.462 . . . . 72.120000000000005 110.92 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.51 165.47 23.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.186 -0.461 . . . . 75.340000000000003 110.861 -179.878 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 175' ' ' ARG . . . . . 0.404 ' HG3' ' CZ ' ' A' ' 94' ' ' TYR . 0.0 OUTLIER -104.12 -161.28 0.82 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.209 -0.45 . . . . 71.140000000000001 110.877 -179.943 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 176' ' ' ILE . . . . . 0.795 HD12 ' HB ' ' A' ' 136' ' ' VAL . 3.5 mt -139.3 138.79 40.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 63.240000000000002 111.144 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 5.0 p -145.34 152.34 14.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.188 -0.46 . . . . 72.0 111.106 179.875 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.149 -0.478 . . . . 72.109999999999999 110.896 -179.961 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.7 mmt . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.76 0.315 . . . . 74.340000000000003 110.859 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.1 m -159.4 -171.5 3.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.212 -0.449 . . . . 65.5 110.892 -179.805 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.5 mmmp? -77.88 60.82 2.38 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.156 -0.475 . . . . 72.209999999999994 110.886 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.7 t -130.88 77.51 1.79 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.224 -0.444 . . . . 62.210000000000001 111.19 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -177.35 47.27 0.1 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.714 -0.755 . . . . 72.099999999999994 112.497 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.518 ' C ' ' HE1' ' A' ' 47' ' ' TRP . 8.0 p -82.98 135.87 34.73 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.867 0.365 . . . . 71.25 111.155 -179.862 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.408 ' HA ' ' HA ' ' A' ' 24' ' ' ASP . 3.2 tttt -123.94 136.17 54.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.189 -0.459 . . . . 70.140000000000001 110.9 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.576 ' HB ' ' CD1' ' A' ' 47' ' ' TRP . 16.2 tt -137.47 150.89 25.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.223 -0.444 . . . . 75.209999999999994 111.151 179.861 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.481 HG23 ' CG ' ' A' ' 22' ' ' ASP . 10.1 m -130.21 146.08 51.8 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.196 -0.456 . . . . 72.340000000000003 111.163 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.792 ' HB2' HD22 ' A' ' 34' ' ' LEU . 1.5 m-85 -132.33 129.1 39.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.205 -0.452 . . . . 64.349999999999994 110.865 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.544 ' CG ' ' HA ' ' A' ' 16' ' ' PHE . 18.4 m-85 -115.65 132.13 56.73 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.135 -0.484 . . . . 73.030000000000001 110.974 -179.894 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.475 ' HG2' ' HB2' ' A' ' 36' ' ' ARG . 0.0 OUTLIER -58.6 -24.36 60.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.123 -0.49 . . . . 74.329999999999998 110.891 -179.976 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 64.9 m-20 -127.63 152.73 47.3 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.113 -0.494 . . . . 64.519999999999996 110.89 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.429 ' N ' ' HB3' ' A' ' 38' ' ' ASN . 32.5 mtmt -56.09 -175.25 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 75.120000000000005 110.922 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 25.7 m-20 46.51 33.6 2.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.258 -0.428 . . . . 64.109999999999999 110.897 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.544 ' HA ' ' CG ' ' A' ' 11' ' ' TYR . 3.4 m-85 48.91 58.9 4.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.147 -0.478 . . . . 75.010000000000005 110.842 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -133.49 157.78 44.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 53.310000000000002 110.905 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 94.25 -149.88 19.57 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.679 -0.772 . . . . 72.329999999999998 112.474 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.79 ' O ' HD13 ' A' ' 34' ' ' LEU . 0.1 OUTLIER -69.06 81.59 0.32 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.833 0.349 . . . . 74.239999999999995 110.881 -179.832 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.49 ' HB2' ' CE1' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -79.63 129.6 34.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.201 -0.454 . . . . 72.209999999999994 110.874 -179.898 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.444 ' O ' ' HA ' ' A' ' 9' ' ' THR . 88.8 t80 -125.54 125.32 43.03 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.204 -0.453 . . . . 73.420000000000002 110.899 -179.842 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.481 ' CG ' HG23 ' A' ' 9' ' ' THR . 1.4 m-20 -119.9 134.47 55.23 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.121 -0.491 . . . . 62.119999999999997 110.895 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 11.3 t -162.98 135.19 5.31 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.158 -0.474 . . . . 63.229999999999997 110.915 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.408 ' HA ' ' HA ' ' A' ' 7' ' ' LYS . 5.5 p-10 -102.66 -5.19 24.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.188 -0.46 . . . . 74.340000000000003 110.928 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.448 ' O ' ' SG ' ' A' ' 27' ' ' CYS . 20.0 t -102.54 165.08 11.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.14 -0.482 . . . . 71.420000000000002 110.851 -179.908 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -55.26 120.95 7.83 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.155 -0.475 . . . . 62.310000000000002 110.878 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.639 ' HB2' ' HB3' ' A' ' 30' ' ' PHE . 0.2 OUTLIER -116.39 49.97 1.09 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.225 -0.443 . . . . 62.520000000000003 110.924 -179.93 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.527 ' O ' ' HA ' ' A' ' 82' ' ' SER . . . -46.86 -22.23 0.29 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.191 -0.458 . . . . 72.430000000000007 111.096 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 63.3 t0 -129.19 42.76 3.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.189 -0.46 . . . . 64.409999999999997 110.85 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.775 ' CD2' ' O ' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -79.13 15.82 1.08 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.192 -0.458 . . . . 64.230000000000004 110.887 -179.936 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.448 ' HB2' ' HB3' ' A' ' 53' ' ' PRO . 27.1 t60 -77.2 -45.67 25.84 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.161 -0.472 . . . . 75.450000000000003 110.841 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.444 HG23 ' CD2' ' A' ' 33' ' ' TYR . 8.9 t -55.69 -14.5 2.27 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.191 -0.458 . . . . 70.329999999999998 111.175 -179.91 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.506 ' CD1' ' HA ' ' A' ' 30' ' ' PHE . 11.4 m-85 -96.1 -30.26 13.64 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.197 -0.456 . . . . 70.430000000000007 110.865 -179.907 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.792 HD22 ' HB2' ' A' ' 10' ' ' PHE . 19.3 tp -143.5 143.12 31.42 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.178 -0.464 . . . . 71.299999999999997 110.94 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.2 m -108.52 -34.73 6.66 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.185 -0.461 . . . . 61.229999999999997 110.883 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.545 ' O ' HD21 ' A' ' 34' ' ' LEU . 1.8 mtp85 -115.89 139.8 49.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.13 -0.486 . . . . 75.439999999999998 110.86 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.61 ' HB3' ' HB2' ' A' ' 80' ' ' LEU . 5.2 p -117.28 61.31 0.75 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.144 -0.48 . . . . 74.329999999999998 110.894 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.504 HD21 ' NH2' ' A' ' 36' ' ' ARG . 3.0 m120 -60.26 -69.62 0.21 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.133 -0.485 . . . . 73.140000000000001 110.869 -179.874 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 5.0 p -110.67 127.28 55.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.18 -0.463 . . . . 73.129999999999995 110.873 -179.869 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.757 HD12 ' CH2' ' A' ' 73' ' ' TRP . 29.9 mt -121.01 148.49 24.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.134 -0.485 . . . . 72.310000000000002 111.126 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.453 ' HD2' ' CE2' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -142.27 121.99 13.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 71.219999999999999 110.902 179.823 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.546 HG22 ' HB ' ' A' ' 8' ' ' ILE . 1.5 t -106.64 115.27 47.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.22 -0.445 . . . . 52.310000000000002 111.114 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -111.58 79.93 1.26 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.165 -0.47 . . . . 63.43 110.895 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.434 ' O ' ' HA ' ' A' ' 6' ' ' THR . . . 132.13 100.63 0.8 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.75 -0.738 . . . . 55.0 112.531 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.481 ' HA2' HD21 ' A' ' 88' ' ' LEU . . . 53.47 178.36 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.724 -0.75 . . . . 64.439999999999998 112.467 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.715 HG23 ' HA ' ' A' ' 63' ' ' PRO . 0.8 OUTLIER -76.74 168.06 20.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.774 0.321 . . . . 73.340000000000003 111.11 -179.831 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.576 ' CD1' ' HB ' ' A' ' 8' ' ' ILE . 3.6 m95 -142.87 129.42 20.19 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.191 -0.459 . . . . 73.129999999999995 110.897 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.83 ' HB2' ' CG2' ' A' ' 86' ' ' VAL . . . -92.69 126.84 37.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.191 -0.459 . . . . 55.530000000000001 111.086 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.639 HG12 ' HB3' ' A' ' 83' ' ' CYS . 15.1 m -124.49 145.73 31.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.231 -0.44 . . . . 44.149999999999999 111.105 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.926 ' HB3' ' CB ' ' A' ' 56' ' ' ALA . 6.8 m-85 -119.31 141.35 49.07 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.125 -0.489 . . . . 63.240000000000002 110.925 -179.905 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.531 ' HG2' ' N ' ' A' ' 52' ' ' ARG . 0.3 OUTLIER -48.87 -82.18 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.166 -0.47 . . . . 74.540000000000006 110.903 179.99 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.904 ' O ' ' HB2' ' A' ' 56' ' ' ALA . 2.1 mtp180 -82.92 137.58 43.48 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.607 0.718 . . . . 61.399999999999999 110.88 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.746 ' HA ' ' OG ' ' A' ' 82' ' ' SER . 54.1 Cg_endo -69.76 137.53 35.69 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.703 2.269 . . . . 74.239999999999995 112.33 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.462 ' C ' ' CD2' ' A' ' 55' ' ' PHE . 0.9 OUTLIER 67.16 -6.27 0.61 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.241 -0.436 . . . . 75.340000000000003 110.904 179.994 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.463 ' H ' ' C ' ' A' ' 53' ' ' PRO . 0.0 OUTLIER -140.22 -74.91 0.34 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.165 -0.47 . . . . 73.420000000000002 110.905 -179.962 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.926 ' CB ' ' HB3' ' A' ' 50' ' ' TYR . . . 45.16 78.91 0.05 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.117 -0.492 . . . . 43.039999999999999 111.128 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' TRP . . . . . 0.557 ' O ' ' CD2' ' A' ' 58' ' ' TYR . 24.9 t-105 -64.18 31.55 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.279 -0.418 . . . . 74.109999999999999 110.939 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.623 ' H ' ' C ' ' A' ' 56' ' ' ALA . 1.9 m-30 -162.57 116.75 1.76 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.189 -0.46 . . . . 65.239999999999995 110.929 -179.848 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.548 ' HB2' ' HA ' ' A' ' 150' ' ' TYR . 1.8 mpt? -81.9 143.51 31.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.085 -0.507 . . . . 72.109999999999999 110.884 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.831 ' CD2' HD12 ' A' ' 76' ' ' LEU . 3.1 t80 -156.95 107.15 2.28 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.223 -0.444 . . . . 74.129999999999995 110.963 -179.861 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.811 ' N ' HD12 ' A' ' 61' ' ' ILE . 1.3 mp -94.57 116.66 36.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.096 -0.502 . . . . 72.209999999999994 111.102 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.798 HD23 ' HD2' ' A' ' 63' ' ' PRO . 0.2 OUTLIER -82.73 130.17 59.29 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.569 0.699 . . . . 71.129999999999995 110.92 179.915 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.798 ' HD2' HD23 ' A' ' 62' ' ' LEU . 53.7 Cg_endo -69.71 -173.64 0.75 Allowed 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.645 2.23 . . . . 72.209999999999994 112.38 179.869 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.21 162.17 16.04 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.221 -0.445 . . . . 72.400000000000006 110.903 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 112.01 -168.69 12.81 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.752 -0.737 . . . . 72.040000000000006 112.512 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 8.7 mp0 -107.07 152.97 23.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.842 0.353 . . . . 72.109999999999999 110.898 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.639 ' HB2' ' O ' ' A' ' 40' ' ' ILE . 12.9 m-85 -141.84 84.72 11.76 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.75 0.785 . . . . 74.200000000000003 110.914 -179.864 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.423 ' HD2' ' HG3' ' A' ' 72' ' ' ARG . 53.7 Cg_endo -69.75 0.48 5.58 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.693 2.262 . . . . 74.430000000000007 112.341 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.524 ' HB2' ' HG2' ' A' ' 72' ' ' ARG . 48.6 mt-10 -155.37 142.49 19.26 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.231 -0.441 . . . . 70.109999999999999 110.88 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.708 ' HA ' ' NE1' ' A' ' 73' ' ' TRP . 28.4 p90 -55.7 -20.27 13.75 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.169 -0.468 . . . . 73.120000000000005 110.956 -179.887 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -80.41 -16.93 53.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.121 -0.49 . . . . 73.239999999999995 110.908 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.524 ' HG2' ' HB2' ' A' ' 69' ' ' GLU . 31.3 mmt180 -69.49 -8.76 49.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.229 -0.442 . . . . 72.530000000000001 110.876 -179.915 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' TRP . . . . . 0.757 ' CH2' HD12 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -135.35 16.79 3.41 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.208 -0.451 . . . . 72.109999999999999 110.893 -179.95 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.411 ' C ' ' O ' ' A' ' 73' ' ' TRP . 15.8 mtm 36.95 43.95 0.33 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.266 -0.425 . . . . 63.149999999999999 110.896 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -56.51 119.14 13.61 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.741 -0.742 . . . . 33.350000000000001 112.451 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.903 HD13 ' N ' ' A' ' 77' ' ' ASN . 0.0 OUTLIER -68.69 -8.7 44.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.792 0.33 . . . . 74.329999999999998 110.913 -179.911 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.903 ' N ' HD13 ' A' ' 76' ' ' LEU . 12.8 t-20 -152.77 138.15 17.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.189 -0.46 . . . . 71.310000000000002 110.884 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -89.67 13.15 14.9 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.185 -0.461 . . . . 63.310000000000002 110.85 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.426 ' HD3' ' HA ' ' A' ' 52' ' ' ARG . 1.2 ttm-85 -110.95 81.64 1.46 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.217 -0.447 . . . . 74.129999999999995 110.85 -179.869 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.61 ' HB2' ' HB3' ' A' ' 37' ' ' CYS . 0.0 OUTLIER -83.77 134.65 34.72 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.198 -0.456 . . . . 51.030000000000001 110.935 179.993 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.643 ' HB3' ' HB3' ' A' ' 53' ' ' PRO . 1.3 m -150.38 -123.79 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.173 -0.467 . . . . 72.239999999999995 110.832 -179.907 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.746 ' OG ' ' HA ' ' A' ' 53' ' ' PRO . 0.0 OUTLIER -34.28 105.79 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.172 -0.467 . . . . 55.299999999999997 110.841 -179.826 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 83' ' ' CYS . . . . . 0.639 ' HB3' HG12 ' A' ' 49' ' ' VAL . 31.7 p -128.2 132.4 48.83 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.149 -0.478 . . . . 32.25 110.89 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.603 ' N ' ' O ' ' A' ' 48' ' ' ALA . 10.7 mmt85 -116.61 149.39 39.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.188 -0.46 . . . . 74.340000000000003 110.918 -179.894 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -66.33 129.37 39.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.253 -0.431 . . . . 44.030000000000001 111.094 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.83 ' CG2' ' HB2' ' A' ' 48' ' ' ALA . 76.2 t -114.76 135.65 53.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.211 -0.45 . . . . 55.420000000000002 111.167 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' HIS . . . . . 0.659 ' O ' HG23 ' A' ' 136' ' ' VAL . 6.1 m-70 -111.8 113.03 25.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 74.219999999999999 110.836 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.481 HD21 ' HA2' ' A' ' 45' ' ' GLY . 0.0 OUTLIER -38.07 141.12 0.53 Allowed Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.587 0.708 . . . . 61.539999999999999 110.939 -179.966 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.59 ' HB3' ' H ' ' A' ' 136' ' ' VAL . 53.6 Cg_endo -69.79 79.95 0.92 Allowed 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.654 2.236 . . . . 74.549999999999997 112.365 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -91.55 -177.15 4.72 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.174 -0.467 . . . . 70.5 110.855 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 61.15 38.87 96.31 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.717 -0.754 . . . . 71.0 112.487 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.415 ' O ' ' C ' ' A' ' 93' ' ' GLN . . . 134.14 33.55 0.32 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.728 -0.749 . . . . 64.329999999999998 112.48 -179.914 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.596 ' O ' ' HG3' ' A' ' 134' ' ' GLU . 21.6 pt20 37.26 -131.38 0.13 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.846 0.355 . . . . 70.340000000000003 110.89 -179.874 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.575 ' HA ' ' HG3' ' A' ' 134' ' ' GLU . 0.1 OUTLIER -117.37 112.1 20.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.45 . . . . 74.409999999999997 110.9 -179.831 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.571 ' H ' ' CG ' ' A' ' 134' ' ' GLU . 31.8 tptt -119.16 128.66 54.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.134 -0.484 . . . . 71.049999999999997 110.886 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.429 HG13 ' CZ3' ' A' ' 137' ' ' TRP . 0.0 OUTLIER -152.26 139.54 13.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.24 -0.436 . . . . 64.540000000000006 111.111 179.865 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -105.85 122.8 46.84 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.159 -0.473 . . . . 71.319999999999993 110.947 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.532 HG22 ' SD ' ' A' ' 124' ' ' MET . 2.6 mt -101.93 130.61 51.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.232 -0.44 . . . . 72.400000000000006 111.127 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.69 ' HB2' ' HB2' ' A' ' 129' ' ' SER . 43.9 m-85 -118.46 147.84 43.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.18 -0.463 . . . . 73.319999999999993 110.87 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 56.5 tt0 -81.69 -56.15 4.18 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.13 -0.486 . . . . 74.409999999999997 110.906 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 45.9 mttt -101.92 172.32 7.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.134 -0.485 . . . . 72.319999999999993 110.921 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.407 ' HA2' ' OG ' ' A' ' 129' ' ' SER . . . -71.52 153.09 50.19 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.703 -0.761 . . . . 62.299999999999997 112.467 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.47 ' HA ' ' HB2' ' A' ' 158' ' ' ARG . 41.0 t0 65.42 46.22 2.61 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.894 0.378 . . . . 64.519999999999996 110.892 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.576 ' N ' ' CD2' ' A' ' 104' ' ' PHE . 0.2 OUTLIER 47.66 32.1 2.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.184 -0.462 . . . . 73.120000000000005 110.864 -179.898 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 57.7 m -94.03 164.04 13.24 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.179 -0.464 . . . . 74.140000000000001 110.879 -179.78 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 80.57 -136.29 16.31 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.763 -0.732 . . . . 72.420000000000002 112.52 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -90.89 121.07 32.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.784 0.325 . . . . 71.239999999999995 110.895 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 4.6 ttp -106.57 134.97 48.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.218 -0.446 . . . . 62.009999999999998 110.929 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -141.39 136.67 31.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.252 -0.431 . . . . 64.540000000000006 110.952 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -117.3 111.55 19.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.115 -0.493 . . . . 74.019999999999996 110.847 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.458 HG22 ' CD1' ' A' ' 98' ' ' ILE . 11.8 t -119.96 147.62 44.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.195 -0.457 . . . . 61.140000000000001 111.185 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.478 ' O ' ' OG1' ' A' ' 112' ' ' THR . 0.6 OUTLIER -128.38 27.73 5.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.242 -0.436 . . . . 65.439999999999998 111.153 179.982 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -141.06 156.64 45.97 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.249 -0.432 . . . . 74.239999999999995 110.933 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -50.32 162.35 0.23 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.179 -0.464 . . . . 73.25 110.881 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' CYS . . . . . 0.538 ' O ' ' HB2' ' A' ' 172' ' ' SER . 52.6 t -153.18 120.31 3.0 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.647 0.737 . . . . 75.040000000000006 110.816 -179.884 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.41 ' O ' ' CA ' ' A' ' 143' ' ' PRO . 53.3 Cg_endo -69.83 -30.85 21.33 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.708 2.272 . . . . 32.25 112.315 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.655 ' HB3' ' CB ' ' A' ' 120' ' ' GLU . 0.1 OUTLIER -149.58 112.8 4.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.254 -0.43 . . . . 71.409999999999997 110.828 -179.836 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.673 HD13 HD11 ' A' ' 127' ' ' ILE . 3.9 tt -64.54 -31.6 54.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.129 -0.487 . . . . 62.240000000000002 111.116 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 119' ' ' MET . . . . . 0.642 ' O ' ' HA ' ' A' ' 123' ' ' HIS . 0.0 OUTLIER -86.33 -39.2 16.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.206 -0.452 . . . . 54.119999999999997 110.928 179.807 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.655 ' CB ' ' HB3' ' A' ' 117' ' ' SER . 4.7 tp10 -70.79 -13.88 62.21 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.212 -0.449 . . . . 71.129999999999995 110.924 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 25.2 tp60 -114.72 -46.26 2.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.114 -0.493 . . . . 73.319999999999993 110.926 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.469 ' HB2' ' O ' ' A' ' 118' ' ' ILE . 74.5 m-85 -106.98 -19.08 13.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.189 -0.459 . . . . 73.409999999999997 110.9 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 123' ' ' HIS . . . . . 0.642 ' HA ' ' O ' ' A' ' 119' ' ' MET . 30.4 m-70 72.35 26.87 2.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.11 -0.496 . . . . 75.439999999999998 110.8 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.532 ' SD ' HG22 ' A' ' 98' ' ' ILE . 7.6 mtt -108.93 74.76 0.92 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.243 -0.435 . . . . 62.219999999999999 110.878 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 1.7 ptp85 -49.96 -26.31 4.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.229 -0.442 . . . . 74.25 110.849 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.431 ' C ' HD13 ' A' ' 127' ' ' ILE . 24.7 mt-10 -144.01 130.38 19.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.149 -0.478 . . . . 54.43 110.878 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.673 HD11 HD13 ' A' ' 118' ' ' ILE . 4.0 mm -96.45 104.76 16.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.072 -0.513 . . . . 65.299999999999997 111.107 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 8.2 m80 -72.22 -33.0 67.24 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.201 -0.454 . . . . 74.530000000000001 110.872 179.833 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.69 ' HB2' ' HB2' ' A' ' 99' ' ' PHE . 16.8 m -134.77 144.04 47.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.225 -0.443 . . . . 63.020000000000003 110.857 -179.81 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 130' ' ' CYS . . . . . 0.565 ' O ' ' O ' ' A' ' 155' ' ' LYS . 1.1 m -142.52 115.04 8.51 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.129 -0.487 . . . . 45.109999999999999 110.885 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.58 ' HA ' ' HA ' ' A' ' 156' ' ' GLU . 7.2 mtpp -109.62 153.57 24.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.166 -0.47 . . . . 62.130000000000003 110.914 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.528 HG12 ' N ' ' A' ' 133' ' ' LEU . 16.2 t 85.25 162.87 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.247 -0.433 . . . . 73.310000000000002 111.1 179.855 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.784 HD22 ' CG ' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -175.77 126.61 0.23 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.134 -0.485 . . . . 74.400000000000006 110.897 179.944 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.596 ' HG3' ' O ' ' A' ' 93' ' ' GLN . 10.1 mm-40 -99.99 164.38 12.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.186 -0.461 . . . . 72.319999999999993 110.881 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.552 ' C ' ' O ' ' A' ' 134' ' ' GLU . . . -23.91 -63.07 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.746 -0.74 . . . . 73.219999999999999 112.467 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.718 HG21 HG13 ' A' ' 86' ' ' VAL . 10.4 t -144.45 145.99 20.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.858 0.361 . . . . 61.539999999999999 111.089 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 137' ' ' TRP . . . . . 0.617 ' HB3' ' HB3' ' A' ' 152' ' ' LEU . 4.7 t90 -140.12 156.64 46.47 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.161 -0.472 . . . . 73.109999999999999 110.929 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.425 HD12 ' HB ' ' A' ' 61' ' ' ILE . 6.4 mm -122.37 134.98 63.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.242 -0.435 . . . . 75.310000000000002 111.14 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.556 ' CE2' HG11 ' A' ' 170' ' ' VAL . 0.0 OUTLIER -112.73 151.97 29.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.156 -0.474 . . . . 64.430000000000007 110.878 179.922 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 0.42 ' CD2' ' HA ' ' A' ' 145' ' ' TYR . 5.5 m-85 -133.7 129.79 37.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.111 -0.495 . . . . 75.420000000000002 110.912 -179.85 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.698 ' O ' ' HB2' ' A' ' 171' ' ' GLN . 0.8 OUTLIER -63.03 -30.43 71.59 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.102 -0.499 . . . . 64.140000000000001 110.849 -179.949 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.696 ' HB3' ' HD2' ' A' ' 143' ' ' PRO . 8.9 mp -112.02 172.93 3.15 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.637 0.732 . . . . 72.040000000000006 110.909 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 143' ' ' PRO . . . . . 0.721 ' O ' ' OG ' ' A' ' 172' ' ' SER . 53.9 Cg_endo -69.77 -90.51 0.0 OUTLIER 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.701 2.267 . . . . 75.209999999999994 112.337 179.857 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 144' ' ' ASN . . . . . 0.705 ' O ' ' N ' ' A' ' 146' ' ' ARG . 1.0 OUTLIER -53.48 96.21 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.215 -0.448 . . . . 61.119999999999997 110.881 -179.976 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 145' ' ' TYR . . . . . 0.642 ' C ' ' O ' ' A' ' 144' ' ' ASN . 0.0 OUTLIER 13.33 51.97 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.115 -0.493 . . . . 73.120000000000005 110.934 -179.911 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 146' ' ' ARG . . . . . 0.705 ' N ' ' O ' ' A' ' 144' ' ' ASN . 21.2 mtt180 -117.84 163.87 15.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.108 -0.496 . . . . 74.129999999999995 110.893 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 84.85 -171.6 47.05 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.742 -0.742 . . . . 50.020000000000003 112.482 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -82.05 155.02 25.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.741 0.305 . . . . 74.219999999999999 110.87 -179.869 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -92.81 159.99 15.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.15 -0.477 . . . . 70.129999999999995 110.897 -179.896 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 150' ' ' TYR . . . . . 0.548 ' HA ' ' HB2' ' A' ' 59' ' ' MET . 79.8 m-85 -140.85 130.76 24.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.182 -0.463 . . . . 73.430000000000007 110.903 -179.835 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.665 ' HB2' HD11 ' A' ' 61' ' ' ILE . 20.2 tp -78.9 123.95 27.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.104 -0.498 . . . . 61.549999999999997 110.89 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 1.01 HD13 ' O ' ' A' ' 152' ' ' LEU . 0.0 OUTLIER -53.82 137.06 39.26 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.222 -0.445 . . . . 74.099999999999994 110.951 179.832 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 153' ' ' ASP . . . . . 0.439 ' N ' HD22 ' A' ' 152' ' ' LEU . 11.3 t0 -161.09 25.92 0.14 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.173 -0.467 . . . . 72.329999999999998 110.851 179.876 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.797 ' HB2' ' CD1' ' A' ' 157' ' ' TYR . 0.0 OUTLIER -118.06 -177.32 3.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.207 -0.451 . . . . 52.229999999999997 110.852 -179.971 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.784 ' CG ' HD22 ' A' ' 133' ' ' LEU . 0.3 OUTLIER -161.23 -124.39 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.197 -0.456 . . . . 64.140000000000001 110.924 179.834 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.58 ' HA ' ' HA ' ' A' ' 131' ' ' LYS . 3.0 tm-20 -67.27 4.19 1.02 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.184 -0.462 . . . . 73.230000000000004 110.866 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 157' ' ' TYR . . . . . 0.797 ' CD1' ' HB2' ' A' ' 154' ' ' LYS . 18.0 m-30 -35.08 151.33 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.168 -0.469 . . . . 74.420000000000002 110.918 -179.856 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 158' ' ' ARG . . . . . 0.47 ' HB2' ' HA ' ' A' ' 103' ' ' ASP . 0.0 OUTLIER -122.93 -35.53 3.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.109 -0.496 . . . . 75.209999999999994 110.916 179.985 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -88.44 150.93 47.63 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.553 0.692 . . . . 61.450000000000003 110.891 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 -26.32 27.69 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.648 2.232 . . . . 72.540000000000006 112.36 179.869 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.655 HD12 ' H ' ' A' ' 161' ' ' ILE . 4.2 mp -70.46 -8.81 11.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.232 -0.44 . . . . 72.349999999999994 111.139 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.644 ' HB3' ' CD1' ' A' ' 157' ' ' TYR . 0.4 OUTLIER -75.81 -14.26 60.29 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.173 -0.467 . . . . 62.350000000000001 110.852 179.829 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 28.1 t-105 -89.63 -9.44 49.64 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.233 -0.44 . . . . 74.239999999999995 110.97 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 101.88 -36.51 4.19 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.707 -0.759 . . . . 73.0 112.509 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -75.46 127.69 33.67 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.816 0.341 . . . . 72.409999999999997 111.117 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -38.1 -39.96 0.45 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.249 -0.432 . . . . 50.520000000000003 111.105 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 167' ' ' SER . . . . . 0.496 ' C ' ' H ' ' A' ' 169' ' ' ALA . 0.3 OUTLIER -132.11 157.71 77.5 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.673 0.749 . . . . 73.409999999999997 110.824 -179.775 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 168' ' ' PRO . . . . . 0.501 ' HB3' ' O ' ' A' ' 127' ' ' ILE . 54.0 Cg_endo -69.75 28.43 0.18 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.668 2.245 . . . . 63.5 112.372 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.496 ' H ' ' C ' ' A' ' 167' ' ' SER . . . -68.84 106.58 2.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.217 -0.447 . . . . 54.539999999999999 111.069 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.556 HG11 ' CE2' ' A' ' 139' ' ' PHE . 2.6 t -153.43 164.63 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.233 -0.439 . . . . 55.130000000000003 111.143 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 171' ' ' GLN . . . . . 0.698 ' HB2' ' O ' ' A' ' 141' ' ' GLU . 2.1 mm-40 -112.85 -86.81 0.56 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.162 -0.472 . . . . 64.25 110.9 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 172' ' ' SER . . . . . 0.721 ' OG ' ' O ' ' A' ' 143' ' ' PRO . 56.7 p -124.41 176.91 6.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.465 . . . . 70.299999999999997 110.85 -179.8 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 173' ' ' PHE . . . . . 0.407 ' HB3' ' CD1' ' A' ' 139' ' ' PHE . 0.5 OUTLIER -144.81 168.83 19.29 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.103 -0.498 . . . . 74.420000000000002 110.911 -179.974 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 7.8 mtp85 -138.73 139.25 38.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.144 -0.48 . . . . 54.530000000000001 110.882 -179.872 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 175' ' ' ARG . . . . . 0.402 ' HB2' ' CG ' ' A' ' 94' ' ' TYR . 0.0 OUTLIER -95.7 154.73 17.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.19 -0.459 . . . . 75.129999999999995 110.885 -179.951 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 176' ' ' ILE . . . . . 0.525 HD12 ' O ' ' A' ' 136' ' ' VAL . 2.2 mt -96.0 132.83 39.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.197 -0.456 . . . . 74.019999999999996 111.143 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 11.5 p -51.62 147.38 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.224 -0.444 . . . . 73.030000000000001 111.104 179.823 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.167 -0.47 . . . . 75.450000000000003 110.847 179.947 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.4 mtt . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.778 0.323 . . . . 62.450000000000003 110.864 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.5 m -160.5 -173.54 4.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.253 -0.431 . . . . 73.109999999999999 110.908 -179.812 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 20.0 mtpt -84.67 54.02 2.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.164 -0.471 . . . . 75.310000000000002 110.898 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.0 t -116.38 -33.68 4.86 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.213 -0.449 . . . . 73.109999999999999 111.129 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -76.13 71.12 2.02 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.781 -0.723 . . . . 74.349999999999994 112.468 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.44 ' C ' ' HE1' ' A' ' 47' ' ' TRP . 19.3 p -82.66 133.73 35.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.864 0.364 . . . . 75.120000000000005 111.135 -179.865 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 2.9 tttt -123.44 136.94 54.87 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.213 -0.449 . . . . 74.120000000000005 110.918 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.654 ' HB ' ' CD1' ' A' ' 47' ' ' TRP . 16.9 tt -137.48 152.1 26.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.199 -0.455 . . . . 71.340000000000003 111.101 179.908 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.53 ' HA ' ' O ' ' A' ' 21' ' ' TYR . 13.5 m -132.74 145.13 50.77 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.149 -0.478 . . . . 72.239999999999995 111.144 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.756 ' HB2' HD22 ' A' ' 34' ' ' LEU . 1.1 m-85 -132.42 126.03 32.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.214 -0.448 . . . . 72.329999999999998 110.831 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.551 ' CG ' ' HA ' ' A' ' 16' ' ' PHE . 12.8 m-85 -112.01 132.83 54.56 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.132 -0.486 . . . . 54.130000000000003 110.935 -179.877 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.47 ' HB2' ' HB2' ' A' ' 19' ' ' ARG . 0.0 OUTLIER -61.92 -15.04 40.04 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.115 -0.493 . . . . 71.340000000000003 110.935 179.96 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.452 ' HB2' ' O ' ' A' ' 17' ' ' GLN . 71.4 m-20 -134.67 149.01 50.46 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.125 -0.489 . . . . 72.319999999999993 110.901 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.557 ' N ' ' HB3' ' A' ' 38' ' ' ASN . 5.8 mtmt -54.26 -176.94 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.198 -0.456 . . . . 55.399999999999999 110.911 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 16.6 m120 47.52 30.99 1.81 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.255 -0.43 . . . . 64.340000000000003 110.919 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.551 ' HA ' ' CG ' ' A' ' 11' ' ' TYR . 3.3 m-85 51.05 64.51 1.81 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.175 -0.466 . . . . 74.219999999999999 110.862 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.452 ' O ' ' HB2' ' A' ' 13' ' ' ASP . 14.2 mt-30 -139.76 158.92 43.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.141 -0.482 . . . . 75.120000000000005 110.89 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 92.61 -148.79 19.26 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.729 -0.748 . . . . 35.210000000000001 112.51 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.704 ' O ' HD13 ' A' ' 34' ' ' LEU . 0.0 OUTLIER -68.12 77.65 0.24 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.852 0.358 . . . . 71.549999999999997 110.879 -179.834 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.474 ' HB2' ' CE1' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -77.86 129.36 35.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.178 -0.465 . . . . 73.200000000000003 110.863 -179.882 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.53 ' O ' ' HA ' ' A' ' 9' ' ' THR . 90.8 t80 -123.49 123.99 41.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 62.32 110.888 -179.823 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.481 ' CG ' HG23 ' A' ' 9' ' ' THR . 1.3 m-20 -120.57 133.96 55.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.141 -0.481 . . . . 74.540000000000006 110.885 179.873 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -167.72 136.79 2.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.168 -0.469 . . . . 72.349999999999994 110.86 -179.912 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -105.37 5.18 31.57 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.157 -0.474 . . . . 72.349999999999994 110.919 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 11.7 t -107.1 169.35 8.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.183 -0.462 . . . . 54.240000000000002 110.897 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -64.66 116.89 6.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.172 -0.467 . . . . 74.230000000000004 110.874 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.46 ' HB2' ' HB3' ' A' ' 30' ' ' PHE . 4.7 m -118.06 53.67 0.95 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.198 -0.456 . . . . 74.25 110.852 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.529 ' C ' ' HA ' ' A' ' 82' ' ' SER . . . -46.28 -21.05 0.13 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.157 -0.474 . . . . 63.420000000000002 111.099 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -127.71 43.61 3.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.209 -0.45 . . . . 74.310000000000002 110.895 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.777 ' CD2' ' O ' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -81.11 15.51 1.86 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.19 -0.459 . . . . 64.019999999999996 110.837 -179.885 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.535 ' HB2' ' HB3' ' A' ' 81' ' ' SER . 30.7 t60 -78.86 -39.3 35.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.145 -0.48 . . . . 71.340000000000003 110.826 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.6 t -56.83 -13.89 2.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.229 -0.441 . . . . 65.239999999999995 111.155 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -99.61 -28.08 13.37 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.216 -0.447 . . . . 61.310000000000002 110.906 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.756 HD22 ' HB2' ' A' ' 10' ' ' PHE . 18.2 tp -141.12 137.25 32.64 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.157 -0.474 . . . . 64.5 110.916 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 30.6 m -101.07 -43.06 6.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.184 -0.462 . . . . 60.039999999999999 110.867 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -118.0 140.97 48.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.118 -0.492 . . . . 64.319999999999993 110.854 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.702 ' SG ' ' HB2' ' A' ' 80' ' ' LEU . 5.6 p -110.21 87.4 2.51 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.225 -0.443 . . . . 63.229999999999997 110.904 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.557 ' HB3' ' N ' ' A' ' 14' ' ' LYS . 0.2 OUTLIER -78.62 -65.17 1.02 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.186 -0.461 . . . . 75.310000000000002 110.881 -179.878 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 5.0 p -118.41 123.9 46.36 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.157 -0.474 . . . . 42.100000000000001 110.856 -179.834 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.908 HD12 ' CH2' ' A' ' 73' ' ' TRP . 25.6 mt -117.27 150.62 19.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.13 -0.486 . . . . 64.099999999999994 111.094 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.458 ' HD2' ' CE2' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -145.53 119.22 9.18 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.108 -0.497 . . . . 73.150000000000006 110.877 179.871 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.511 ' CG2' HD12 ' A' ' 8' ' ' ILE . 1.4 t -103.54 116.21 46.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.238 -0.437 . . . . 64.439999999999998 111.14 179.89 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -111.04 79.94 1.25 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.233 -0.44 . . . . 74.420000000000002 110.884 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.436 ' O ' ' HA ' ' A' ' 6' ' ' THR . . . 127.17 108.84 1.55 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.793 -0.717 . . . . 43.310000000000002 112.476 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.418 ' HA3' HG22 ' A' ' 6' ' ' THR . . . 52.44 179.79 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.706 -0.759 . . . . 74.420000000000002 112.491 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.753 HG23 ' HA ' ' A' ' 63' ' ' PRO . 1.3 m -86.39 169.89 12.5 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.78 0.324 . . . . 60.049999999999997 111.154 -179.887 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.654 ' CD1' ' HB ' ' A' ' 8' ' ' ILE . 17.8 m95 -140.86 130.8 24.51 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.203 -0.453 . . . . 75.409999999999997 110.913 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.909 ' HB2' ' CG2' ' A' ' 86' ' ' VAL . . . -100.28 107.53 19.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.257 -0.429 . . . . 50.119999999999997 111.099 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.756 HG11 HD11 ' A' ' 80' ' ' LEU . 4.9 m -107.7 125.52 64.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.205 -0.452 . . . . 54.43 111.157 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.734 ' HB3' ' HA ' ' A' ' 56' ' ' ALA . 39.9 m-85 -89.05 148.12 23.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.222 -0.445 . . . . 74.310000000000002 110.899 -179.89 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.567 ' HB2' ' HB2' ' A' ' 58' ' ' TYR . 59.6 tt0 -48.06 -77.85 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.134 -0.485 . . . . 72.409999999999997 110.889 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.579 ' HB3' ' HB2' ' A' ' 55' ' ' PHE . 0.2 OUTLIER -89.76 141.37 28.32 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.623 0.725 . . . . 73.510000000000005 110.868 -179.914 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.75 ' HA ' ' OG ' ' A' ' 82' ' ' SER . 53.6 Cg_endo -69.78 138.17 37.11 Favored 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.675 2.25 . . . . 60.43 112.356 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 2.3 t30 65.15 -10.0 0.19 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.264 -0.426 . . . . 73.129999999999995 110.884 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.579 ' HB2' ' HB3' ' A' ' 52' ' ' ARG . 3.3 m-30 -103.19 -23.32 13.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.175 -0.466 . . . . 72.530000000000001 110.856 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.734 ' HA ' ' HB3' ' A' ' 50' ' ' TYR . . . 55.61 23.36 6.02 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.194 -0.457 . . . . 63.43 111.095 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' TRP . . . . . 0.63 ' O ' ' C ' ' A' ' 58' ' ' TYR . 0.7 OUTLIER -51.67 -165.79 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.236 -0.438 . . . . 74.409999999999997 110.887 -179.975 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.63 ' C ' ' O ' ' A' ' 57' ' ' TRP . 11.1 m-30 -14.08 100.57 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.281 -0.418 . . . . 54.030000000000001 110.886 -179.85 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.515 ' HB2' ' HA ' ' A' ' 150' ' ' TYR . 0.0 OUTLIER -58.7 158.87 7.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.151 -0.477 . . . . 75.040000000000006 110.876 179.91 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.608 ' OH ' ' O ' ' A' ' 73' ' ' TRP . 0.4 OUTLIER -172.23 97.3 0.16 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.257 -0.429 . . . . 72.120000000000005 110.906 -179.843 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.776 HD11 ' HB2' ' A' ' 151' ' ' LEU . 2.5 mp -94.32 119.01 41.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.103 -0.498 . . . . 71.340000000000003 111.129 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.849 HD13 HG21 ' A' ' 40' ' ' ILE . 0.3 OUTLIER -88.06 128.92 51.96 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-O 121.557 0.694 . . . . 75.219999999999999 110.938 179.912 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.787 ' HD2' HD23 ' A' ' 62' ' ' LEU . 53.5 Cg_endo -69.72 -170.53 0.4 Allowed 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.688 2.259 . . . . 64.430000000000007 112.358 179.885 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -88.69 161.36 16.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.244 -0.435 . . . . 65.040000000000006 110.892 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 112.58 -166.37 12.16 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.759 -0.734 . . . . 53.43 112.534 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -111.04 150.99 28.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.913 0.387 . . . . 73.450000000000003 110.867 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.636 ' HB2' ' O ' ' A' ' 40' ' ' ILE . 10.0 m-85 -140.13 84.44 14.82 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.707 0.765 . . . . 61.310000000000002 110.911 -179.874 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 -1.06 7.83 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.739 2.293 . . . . 42.509999999999998 112.329 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.495 ' HB2' ' HG2' ' A' ' 72' ' ' ARG . 80.7 mt-10 -154.63 142.6 20.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.23 -0.441 . . . . 75.140000000000001 110.905 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.743 ' HA ' ' NE1' ' A' ' 73' ' ' TRP . 35.9 p90 -55.13 -23.79 22.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.464 . . . . 73.319999999999993 110.93 -179.865 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -76.43 -16.53 59.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.166 -0.47 . . . . 74.420000000000002 110.93 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.495 ' HG2' ' HB2' ' A' ' 69' ' ' GLU . 28.3 mmt180 -70.64 -6.36 36.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.209 -0.45 . . . . 73.120000000000005 110.879 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' TRP . . . . . 0.908 ' CH2' HD12 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -139.35 26.58 2.37 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.181 -0.463 . . . . 72.420000000000002 110.933 -179.951 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.463 ' HB2' ' O ' ' A' ' 73' ' ' TRP . 0.0 OUTLIER 75.84 -11.0 1.18 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.23 -0.441 . . . . 72.230000000000004 110.891 179.954 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.413 ' C ' ' O ' ' A' ' 74' ' ' MET . . . 37.27 46.55 1.38 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.76 -0.733 . . . . 41.310000000000002 112.456 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.731 HD12 ' HG3' ' A' ' 149' ' ' GLN . 0.1 OUTLIER -45.83 -63.25 1.01 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.819 0.342 . . . . 54.210000000000001 110.92 -179.927 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -127.32 126.11 42.01 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.208 -0.451 . . . . 42.310000000000002 110.873 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -76.03 1.69 14.78 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.187 -0.461 . . . . 65.239999999999995 110.889 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -99.89 73.85 1.79 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.176 -0.465 . . . . 74.530000000000001 110.837 -179.873 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.756 HD11 HG11 ' A' ' 49' ' ' VAL . 0.1 OUTLIER -81.87 133.08 35.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.155 -0.475 . . . . 74.120000000000005 110.874 -179.977 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.622 ' HB3' ' HB3' ' A' ' 53' ' ' PRO . 0.9 OUTLIER -148.31 -130.45 0.06 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.193 -0.458 . . . . 73.209999999999994 110.921 -179.957 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.75 ' OG ' ' HA ' ' A' ' 53' ' ' PRO . 0.6 OUTLIER -25.78 131.4 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.124 -0.489 . . . . 65.049999999999997 110.893 -179.851 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 83' ' ' CYS . . . . . 0.512 ' HA ' ' O ' ' A' ' 48' ' ' ALA . 6.9 p -138.1 140.87 40.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.141 -0.482 . . . . 62.409999999999997 110.87 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.521 ' N ' ' O ' ' A' ' 48' ' ' ALA . 6.4 mmt85 -139.78 128.36 23.01 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.225 -0.443 . . . . 70.140000000000001 110.851 -179.823 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.449 ' N ' ' CZ3' ' A' ' 47' ' ' TRP . . . -50.56 129.59 22.6 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.195 -0.457 . . . . 64.420000000000002 111.096 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.909 ' CG2' ' HB2' ' A' ' 48' ' ' ALA . 25.5 t -114.51 142.04 28.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.276 -0.42 . . . . 75.200000000000003 111.09 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' HIS . . . . . 0.59 ' O ' HG23 ' A' ' 136' ' ' VAL . 6.7 m-70 -112.24 110.56 20.88 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.161 -0.472 . . . . 74.230000000000004 110.851 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.595 HD13 ' HB3' ' A' ' 178' ' ' GLU . 0.0 OUTLIER -35.95 144.13 0.26 Allowed Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.646 0.736 . . . . 60.299999999999997 110.9 -179.959 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.534 ' HB3' ' H ' ' A' ' 136' ' ' VAL . 53.7 Cg_endo -69.7 98.66 0.69 Allowed 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.671 2.247 . . . . 70.120000000000005 112.357 179.857 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -104.51 -175.35 2.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.263 -0.426 . . . . 74.019999999999996 110.878 -179.84 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 50.95 58.84 8.8 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.757 -0.735 . . . . 71.310000000000002 112.523 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.412 ' O ' ' C ' ' A' ' 93' ' ' GLN . . . 123.46 26.07 1.68 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.747 -0.74 . . . . 70.510000000000005 112.488 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.45 ' O ' ' HG2' ' A' ' 134' ' ' GLU . 14.6 pt20 37.32 -123.05 0.21 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.834 0.35 . . . . 75.530000000000001 110.905 -179.856 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.541 ' HA ' ' HG2' ' A' ' 134' ' ' GLU . 0.1 OUTLIER -123.75 104.41 8.96 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.172 -0.467 . . . . 73.209999999999994 110.907 -179.852 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.562 ' HG3' HG11 ' A' ' 132' ' ' VAL . 34.1 tptt -114.37 127.78 56.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.099 -0.5 . . . . 62.149999999999999 110.895 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.584 HG21 ' HE2' ' A' ' 173' ' ' PHE . 6.3 tt -149.45 136.93 13.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.221 -0.445 . . . . 73.430000000000007 111.073 179.898 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.461 ' HB2' ' O ' ' A' ' 131' ' ' LYS . 0.7 OUTLIER -107.25 123.91 48.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.15 -0.477 . . . . 74.239999999999995 110.907 179.949 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.437 ' CG2' HD12 ' A' ' 127' ' ' ILE . 43.9 mm -105.39 131.06 55.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.193 -0.458 . . . . 70.120000000000005 111.121 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.7 ' HB2' ' HB2' ' A' ' 129' ' ' SER . 45.9 m-85 -118.79 150.39 39.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.152 -0.476 . . . . 74.340000000000003 110.897 179.911 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 50.8 tt0 -85.76 -56.08 3.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.187 -0.461 . . . . 71.099999999999994 110.852 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 47.6 mttt -101.01 164.93 11.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.167 -0.47 . . . . 65.140000000000001 110.89 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.402 ' HA2' ' OG ' ' A' ' 129' ' ' SER . . . -65.53 152.4 51.51 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.768 -0.73 . . . . 73.120000000000005 112.49 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.425 ' HA ' ' HB2' ' A' ' 158' ' ' ARG . 27.8 t0 65.76 45.37 2.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.831 0.348 . . . . 75.140000000000001 110.852 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.576 ' N ' ' CD2' ' A' ' 104' ' ' PHE . 0.1 OUTLIER 47.48 33.81 3.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.233 -0.44 . . . . 75.239999999999995 110.912 -179.881 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 53.3 m -96.35 159.61 14.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.164 -0.471 . . . . 75.040000000000006 110.861 -179.785 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 83.91 -135.67 14.01 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.695 -0.764 . . . . 70.25 112.49 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 5.9 tp-100 -88.65 120.67 30.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.783 0.325 . . . . 61.140000000000001 110.879 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 3.5 ttp -108.25 132.8 53.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.154 -0.475 . . . . 72.109999999999999 110.862 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -137.72 137.09 37.97 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.221 -0.445 . . . . 70.239999999999995 110.925 -179.846 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -119.33 104.43 10.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.097 -0.501 . . . . 75.420000000000002 110.854 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 8.9 t -112.82 133.38 54.85 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.183 -0.462 . . . . 54.409999999999997 111.152 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.475 ' HA ' ' O ' ' A' ' 94' ' ' TYR . 1.6 t -115.5 32.49 6.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.22 -0.446 . . . . 72.340000000000003 111.131 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -142.38 -173.91 3.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.219 -0.446 . . . . 75.329999999999998 110.88 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -72.08 150.66 43.71 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.117 -0.492 . . . . 75.129999999999995 110.837 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' CYS . . . . . 0.424 ' O ' ' HB2' ' A' ' 172' ' ' SER . 57.4 m -140.99 107.16 6.27 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-O 121.631 0.729 . . . . 71.340000000000003 110.884 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.618 ' O ' ' CB ' ' A' ' 172' ' ' SER . 53.3 Cg_endo -69.74 -35.97 11.73 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.657 2.238 . . . . 71.25 112.311 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.611 ' HB3' ' CB ' ' A' ' 120' ' ' GLU . 0.1 OUTLIER -142.0 112.37 7.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.228 -0.442 . . . . 60.450000000000003 110.865 -179.78 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.54 ' HB ' ' O ' ' A' ' 171' ' ' GLN . 5.4 tt -67.24 -32.87 59.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.18 -0.463 . . . . 72.530000000000001 111.104 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 119' ' ' MET . . . . . 0.643 ' O ' ' HA ' ' A' ' 123' ' ' HIS . 0.0 OUTLIER -87.28 -38.99 15.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.178 -0.464 . . . . 72.109999999999999 110.897 179.855 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.611 ' CB ' ' HB3' ' A' ' 117' ' ' SER . 3.9 tp10 -72.18 -15.43 61.96 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.218 -0.446 . . . . 55.520000000000003 110.896 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 13.0 mm100 -114.44 -45.82 3.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.123 -0.49 . . . . 75.049999999999997 110.925 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.538 ' HB2' ' O ' ' A' ' 118' ' ' ILE . 47.4 m-85 -106.23 -19.71 13.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.195 -0.457 . . . . 74.310000000000002 110.879 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 123' ' ' HIS . . . . . 0.643 ' HA ' ' O ' ' A' ' 119' ' ' MET . 12.3 m80 70.58 29.21 3.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.137 -0.483 . . . . 73.140000000000001 110.889 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.403 ' SD ' HG22 ' A' ' 98' ' ' ILE . 4.0 mtt -107.19 83.42 1.82 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.208 -0.451 . . . . 71.430000000000007 110.838 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 4.0 ptp180 -50.58 -35.43 30.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.239 -0.437 . . . . 65.030000000000001 110.86 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.462 ' HB3' ' HG2' ' A' ' 168' ' ' PRO . 18.8 mt-10 -142.42 136.14 29.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.231 -0.44 . . . . 75.150000000000006 110.899 -179.915 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.529 HD11 HD13 ' A' ' 118' ' ' ILE . 3.9 mm -96.3 104.47 15.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.174 -0.466 . . . . 64.540000000000006 111.076 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 12.6 m170 -70.79 -34.95 72.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.157 -0.474 . . . . 72.340000000000003 110.833 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.7 ' HB2' ' HB2' ' A' ' 99' ' ' PHE . 13.7 m -133.75 149.85 51.47 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.204 -0.453 . . . . 53.229999999999997 110.883 -179.822 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 130' ' ' CYS . . . . . 0.496 ' O ' ' HE3' ' A' ' 154' ' ' LYS . 0.1 OUTLIER -148.68 117.92 6.85 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.151 -0.477 . . . . 74.129999999999995 110.865 -179.913 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.501 ' HG2' ' HG2' ' A' ' 156' ' ' GLU . 11.2 mtpt -113.87 155.56 25.53 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.21 -0.45 . . . . 70.310000000000002 110.892 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.562 HG11 ' HG3' ' A' ' 95' ' ' LYS . 15.5 t 83.43 160.91 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.221 -0.445 . . . . 54.439999999999998 111.104 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.863 HD22 ' O ' ' A' ' 133' ' ' LEU . 0.0 OUTLIER -177.79 127.3 0.13 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.166 -0.47 . . . . 70.5 110.923 179.911 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.541 ' HG2' ' HA ' ' A' ' 94' ' ' TYR . 0.1 OUTLIER -97.8 171.34 8.37 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.162 -0.472 . . . . 70.040000000000006 110.898 179.938 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.493 ' C ' ' O ' ' A' ' 134' ' ' GLU . . . -30.41 -78.84 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.741 -0.742 . . . . 72.430000000000007 112.468 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.79 HG21 HG13 ' A' ' 86' ' ' VAL . 2.8 t -128.53 144.91 36.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.781 0.324 . . . . 72.129999999999995 111.158 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 137' ' ' TRP . . . . . 0.65 ' HB3' ' CB ' ' A' ' 152' ' ' LEU . 60.2 t-105 -146.14 163.94 33.77 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.214 -0.448 . . . . 74.530000000000001 110.897 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.511 ' CD1' ' HB ' ' A' ' 61' ' ' ILE . 5.8 mm -132.74 138.07 52.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.231 -0.441 . . . . 64.510000000000005 111.091 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.748 ' HB2' ' HB2' ' A' ' 150' ' ' TYR . 69.7 m-85 -114.49 152.48 31.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.139 -0.482 . . . . 64.239999999999995 110.855 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 0.734 ' CD2' ' HA ' ' A' ' 145' ' ' TYR . 13.7 m-85 -128.34 144.19 51.1 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.149 -0.478 . . . . 74.439999999999998 110.878 -179.874 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.57 ' C ' ' HB2' ' A' ' 171' ' ' GLN . 27.4 tt0 -84.77 -7.96 59.0 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.106 -0.497 . . . . 75.219999999999999 110.864 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.476 ' C ' ' H ' ' A' ' 144' ' ' ASN . 7.2 mp -120.05 149.07 48.29 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.579 0.704 . . . . 74.010000000000005 110.954 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 143' ' ' PRO . . . . . 0.709 ' HD3' ' CD ' ' A' ' 171' ' ' GLN . 54.0 Cg_endo -69.71 32.75 0.19 Allowed 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.695 2.264 . . . . 73.129999999999995 112.375 179.857 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 144' ' ' ASN . . . . . 1.007 ' O ' ' N ' ' A' ' 146' ' ' ARG . 0.0 OUTLIER -169.34 101.91 0.35 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.201 -0.454 . . . . 73.430000000000007 110.923 -179.961 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 145' ' ' TYR . . . . . 0.734 ' HA ' ' CD2' ' A' ' 140' ' ' TYR . 0.3 OUTLIER 3.59 48.39 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.155 -0.475 . . . . 74.400000000000006 110.945 -179.866 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 146' ' ' ARG . . . . . 1.007 ' N ' ' O ' ' A' ' 144' ' ' ASN . 1.1 mtp85 -136.16 178.02 7.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.069 -0.514 . . . . 61.340000000000003 110.835 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 147' ' ' GLY . . . . . 0.445 ' O ' HD11 ' A' ' 76' ' ' LEU . . . 83.04 -175.48 53.01 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.764 -0.731 . . . . 44.140000000000001 112.482 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 53.3 mtt180 -62.45 146.22 52.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.705 0.288 . . . . 73.409999999999997 110.852 -179.84 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 149' ' ' GLN . . . . . 0.731 ' HG3' HD12 ' A' ' 76' ' ' LEU . 1.4 mt-30 -98.22 135.39 39.92 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.202 -0.454 . . . . 74.019999999999996 110.933 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 150' ' ' TYR . . . . . 0.748 ' HB2' ' HB2' ' A' ' 139' ' ' PHE . 54.5 m-85 -121.46 125.43 46.84 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.23 -0.441 . . . . 73.510000000000005 110.888 -179.863 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.776 ' HB2' HD11 ' A' ' 61' ' ' ILE . 19.8 tp -76.89 122.71 25.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.113 -0.494 . . . . 70.310000000000002 110.908 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 1.034 HD13 ' O ' ' A' ' 152' ' ' LEU . 0.0 OUTLIER -50.74 130.71 25.19 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.156 -0.475 . . . . 60.420000000000002 110.893 179.893 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -163.86 26.48 0.08 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.21 -0.45 . . . . 75.209999999999994 110.837 179.864 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.826 ' O ' ' HG3' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -108.09 -174.76 2.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.191 -0.458 . . . . 62.130000000000003 110.865 -179.999 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.826 ' HG3' ' O ' ' A' ' 154' ' ' LYS . 1.5 mptt -162.44 -127.74 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.195 -0.457 . . . . 54.409999999999997 110.936 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.569 ' HG2' ' O ' ' A' ' 156' ' ' GLU . 2.2 tm-20 -70.46 6.91 1.2 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.247 -0.433 . . . . 74.510000000000005 110.835 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 157' ' ' TYR . . . . . 0.701 ' CE1' ' HA ' ' A' ' 154' ' ' LYS . 18.9 m-30 -32.44 149.97 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.176 -0.466 . . . . 71.109999999999999 110.894 -179.835 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 158' ' ' ARG . . . . . 0.442 ' HB3' ' CE2' ' A' ' 104' ' ' PHE . 0.0 OUTLIER -126.5 -34.73 2.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.108 -0.496 . . . . 73.5 110.864 -179.992 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -89.07 151.69 47.22 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.638 0.732 . . . . 71.349999999999994 110.892 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 160' ' ' PRO . . . . . 0.485 ' HB2' ' HD3' ' A' ' 168' ' ' PRO . 54.1 Cg_endo -69.72 -24.11 30.2 Favored 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 122.645 2.23 . . . . 75.549999999999997 112.401 179.896 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.6 HD12 ' H ' ' A' ' 161' ' ' ILE . 3.7 mp -69.41 -9.39 12.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.189 -0.459 . . . . 63.399999999999999 111.131 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.67 ' HB3' ' CD1' ' A' ' 157' ' ' TYR . 0.3 OUTLIER -77.2 -13.38 59.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.14 -0.482 . . . . 72.420000000000002 110.87 179.88 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -87.64 3.17 48.78 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.186 -0.461 . . . . 73.219999999999999 110.968 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 88.42 -36.15 3.47 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.713 -0.756 . . . . 72.230000000000004 112.516 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -80.76 129.86 34.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.795 0.331 . . . . 61.329999999999998 111.086 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -37.95 -38.33 0.3 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.218 -0.447 . . . . 74.299999999999997 111.121 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 167' ' ' SER . . . . . 0.485 ' C ' ' H ' ' A' ' 169' ' ' ALA . 0.3 OUTLIER -127.12 158.88 67.67 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.647 0.737 . . . . 74.099999999999994 110.857 -179.785 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 168' ' ' PRO . . . . . 0.485 ' HD3' ' HB2' ' A' ' 160' ' ' PRO . 54.5 Cg_endo -69.7 26.3 0.17 Allowed 'Trans proline' 0 C--N 1.341 0.132 0 C-N-CA 122.715 2.277 . . . . 75.329999999999998 112.355 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.485 ' H ' ' C ' ' A' ' 167' ' ' SER . . . -65.95 107.81 1.98 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.25 -0.432 . . . . 70.400000000000006 111.129 179.909 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.505 HG12 ' N ' ' A' ' 171' ' ' GLN . 19.2 t -151.15 160.52 3.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.215 -0.448 . . . . 64.230000000000004 111.141 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 171' ' ' GLN . . . . . 0.709 ' CD ' ' HD3' ' A' ' 143' ' ' PRO . 6.5 mm-40 -109.41 -91.85 0.44 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.175 -0.466 . . . . 74.409999999999997 110.922 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 172' ' ' SER . . . . . 0.618 ' CB ' ' O ' ' A' ' 116' ' ' PRO . 60.1 p -127.98 168.91 14.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.199 -0.455 . . . . 72.230000000000004 110.873 -179.821 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 173' ' ' PHE . . . . . 0.612 ' CD1' ' N ' ' A' ' 173' ' ' PHE . 0.1 OUTLIER -146.75 165.79 28.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.146 -0.479 . . . . 70.450000000000003 110.918 -179.953 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 174' ' ' ARG . . . . . 0.414 ' HG2' ' HE2' ' A' ' 140' ' ' TYR . 0.7 OUTLIER -146.33 169.93 17.82 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.185 -0.462 . . . . 74.129999999999995 110.852 -179.916 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 175' ' ' ARG . . . . . 0.507 ' HB3' ' CZ3' ' A' ' 137' ' ' TRP . 0.0 OUTLIER -89.1 -162.26 0.85 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.12 -0.491 . . . . 73.430000000000007 110.86 -179.913 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 176' ' ' ILE . . . . . 0.489 HD11 HG12 ' A' ' 136' ' ' VAL . 27.4 mt -124.68 141.82 43.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.157 -0.474 . . . . 73.040000000000006 111.133 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 44.1 t -75.25 140.88 16.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.171 -0.468 . . . . 54.149999999999999 111.123 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 178' ' ' GLU . . . . . 0.595 ' HB3' HD13 ' A' ' 88' ' ' LEU . 35.8 mt-10 . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.217 -0.447 . . . . 75.209999999999994 110.856 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.4 mtp . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.805 0.336 . . . . 31.32 110.899 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.3 m 53.59 -172.79 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.222 -0.445 . . . . 63.200000000000003 110.857 -179.78 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 53.7 mttt -90.03 45.85 1.31 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.12 -0.491 . . . . 62.140000000000001 110.915 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 11.5 p -63.79 -31.99 73.35 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.248 -0.433 . . . . 64.310000000000002 111.155 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -167.01 137.1 4.46 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.764 -0.731 . . . . 61.509999999999998 112.501 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.451 ' C ' ' HE1' ' A' ' 47' ' ' TRP . 20.0 p -82.35 138.84 34.39 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.89 0.376 . . . . 71.530000000000001 111.105 -179.833 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.492 ' N ' ' HE1' ' A' ' 47' ' ' TRP . 2.9 tttt -124.91 134.66 52.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.232 -0.44 . . . . 74.319999999999993 110.878 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.483 HG13 HG23 ' A' ' 42' ' ' VAL . 15.4 tt -136.56 149.2 26.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.21 -0.45 . . . . 74.150000000000006 111.189 179.833 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.51 HG23 ' CG ' ' A' ' 22' ' ' ASP . 10.3 m -130.87 141.35 50.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.184 -0.462 . . . . 63.32 111.145 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.781 ' HB2' HD22 ' A' ' 34' ' ' LEU . 0.9 OUTLIER -128.83 128.36 43.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.275 -0.421 . . . . 72.299999999999997 110.845 -179.981 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.539 ' CG ' ' HA ' ' A' ' 16' ' ' PHE . 22.9 m-85 -114.28 132.12 56.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.102 -0.499 . . . . 60.340000000000003 110.927 -179.862 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.458 ' HG2' ' HB2' ' A' ' 36' ' ' ARG . 0.0 OUTLIER -60.01 -23.47 63.7 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.145 -0.479 . . . . 64.120000000000005 110.888 -179.98 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 65.6 m-20 -128.58 152.41 48.35 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.142 -0.481 . . . . 73.329999999999998 110.869 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.445 ' N ' ' HB3' ' A' ' 38' ' ' ASN . 31.8 mtmt -55.67 -175.18 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.166 -0.47 . . . . 75.310000000000002 110.897 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 17.8 m120 46.43 33.58 1.98 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.237 -0.438 . . . . 63.130000000000003 110.84 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.539 ' HA ' ' CG ' ' A' ' 11' ' ' TYR . 4.0 m-85 48.95 57.97 5.86 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.181 -0.463 . . . . 71.239999999999995 110.899 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 -132.81 158.56 42.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.153 -0.476 . . . . 64.430000000000007 110.931 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 94.7 -150.52 19.76 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.746 -0.74 . . . . 53.030000000000001 112.447 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.796 ' O ' HD13 ' A' ' 34' ' ' LEU . 0.0 OUTLIER -69.6 80.45 0.41 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.794 0.33 . . . . 74.430000000000007 110.875 -179.838 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.466 ' HB2' ' CE1' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -79.11 128.5 33.36 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.188 -0.46 . . . . 73.510000000000005 110.835 -179.927 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.471 ' CD2' ' CD2' ' A' ' 30' ' ' PHE . 71.2 t80 -124.49 125.36 44.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.15 -0.477 . . . . 74.450000000000003 110.921 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.51 ' CG ' HG23 ' A' ' 9' ' ' THR . 1.2 m-20 -119.48 132.61 55.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.128 -0.487 . . . . 72.010000000000005 110.91 179.899 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 10.4 t -157.09 130.25 7.83 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.195 -0.457 . . . . 54.32 110.907 -179.899 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.415 ' HA ' ' HA ' ' A' ' 7' ' ' LYS . 3.9 p30 -99.4 5.76 46.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.214 -0.448 . . . . 60.020000000000003 110.866 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 47.1 t -117.68 161.46 19.63 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.208 -0.451 . . . . 74.439999999999998 110.9 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 31.5 m-20 -45.12 120.51 2.44 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.176 -0.465 . . . . 72.099999999999994 110.887 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.62 ' HB2' ' HB3' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -114.27 43.87 1.8 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.185 -0.461 . . . . 61.219999999999999 110.869 -179.909 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.546 ' O ' ' HA ' ' A' ' 82' ' ' SER . . . -49.67 -21.53 1.07 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 35.039999999999999 111.105 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 60.2 t0 -129.58 40.99 3.51 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.222 -0.445 . . . . 73.439999999999998 110.862 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.795 ' CD2' ' O ' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -81.48 17.79 1.31 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.211 -0.449 . . . . 63.140000000000001 110.907 -179.934 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.54 ' HB2' ' HB3' ' A' ' 81' ' ' SER . 40.7 t60 -81.98 -33.56 30.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.166 -0.47 . . . . 50.310000000000002 110.845 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.0 t -66.96 -5.67 13.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.194 -0.457 . . . . 50.100000000000001 111.114 -179.874 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -108.29 -27.68 9.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.231 -0.44 . . . . 74.420000000000002 110.92 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.796 HD13 ' O ' ' A' ' 19' ' ' ARG . 23.3 tp -141.51 145.99 35.85 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.111 -0.495 . . . . 72.150000000000006 110.95 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.3 m -112.66 -34.93 5.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.181 -0.463 . . . . 45.329999999999998 110.806 -179.879 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.51 ' NH2' HD21 ' A' ' 38' ' ' ASN . 2.0 mtp85 -115.79 142.09 47.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.148 -0.478 . . . . 72.040000000000006 110.842 -179.877 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.616 ' SG ' ' HB2' ' A' ' 80' ' ' LEU . 6.3 p -120.02 64.81 0.82 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.139 -0.482 . . . . 74.310000000000002 110.899 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.51 HD21 ' NH2' ' A' ' 36' ' ' ARG . 3.0 m120 -63.66 -66.64 0.51 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.17 -0.468 . . . . 74.409999999999997 110.893 -179.885 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 5.0 p -113.81 127.31 55.95 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.113 -0.494 . . . . 71.209999999999994 110.881 -179.854 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.797 HD12 ' CH2' ' A' ' 73' ' ' TRP . 18.7 mt -120.95 149.37 23.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.131 -0.486 . . . . 70.209999999999994 111.146 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.462 ' HD2' ' CE2' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -143.5 119.3 10.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.189 -0.459 . . . . 71.010000000000005 110.902 179.874 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.571 HG21 ' HB2' ' A' ' 47' ' ' TRP . 1.0 OUTLIER -106.06 118.07 52.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.245 -0.434 . . . . 74.230000000000004 111.152 179.877 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -114.76 76.73 1.01 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.178 -0.465 . . . . 62.210000000000001 110.888 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.4 ' O ' ' HB ' ' A' ' 6' ' ' THR . . . 140.87 90.13 0.17 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.788 -0.72 . . . . 74.450000000000003 112.524 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 58.46 172.36 0.36 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.75 -0.738 . . . . 45.420000000000002 112.484 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.749 HG23 ' HA ' ' A' ' 63' ' ' PRO . 0.2 OUTLIER -66.01 172.35 3.79 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.828 0.347 . . . . 73.310000000000002 111.132 -179.867 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.571 ' HB2' HG21 ' A' ' 42' ' ' VAL . 6.6 m95 -146.97 129.55 15.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.2 -0.454 . . . . 73.109999999999999 110.948 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.798 ' HB2' ' CG2' ' A' ' 86' ' ' VAL . . . -91.13 127.7 36.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.263 -0.426 . . . . 75.040000000000006 111.092 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.729 HG11 HD11 ' A' ' 80' ' ' LEU . 21.1 m -125.86 145.0 34.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.215 -0.448 . . . . 72.019999999999996 111.115 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.895 ' HB3' ' CB ' ' A' ' 56' ' ' ALA . 6.7 m-85 -122.84 143.68 49.7 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.212 -0.449 . . . . 75.519999999999996 110.925 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.584 ' HG2' ' N ' ' A' ' 52' ' ' ARG . 0.5 OUTLIER -49.46 -84.04 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.176 -0.465 . . . . 55.100000000000001 110.871 179.987 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.862 ' O ' ' HB2' ' A' ' 56' ' ' ALA . 0.8 OUTLIER -81.91 136.43 47.59 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.586 0.707 . . . . 75.109999999999999 110.866 -179.89 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.635 ' HB3' ' HB3' ' A' ' 81' ' ' SER . 53.4 Cg_endo -69.74 135.79 31.41 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.668 2.245 . . . . 71.430000000000007 112.326 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.437 ' HB3' ' CE2' ' A' ' 55' ' ' PHE . 7.1 t-20 72.17 -6.15 1.59 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.174 -0.466 . . . . 74.340000000000003 110.945 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.437 ' CE2' ' HB3' ' A' ' 54' ' ' ASN . 0.1 OUTLIER -144.46 -75.36 0.24 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.136 -0.484 . . . . 72.310000000000002 110.877 -179.996 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.895 ' CB ' ' HB3' ' A' ' 50' ' ' TYR . . . 47.58 82.55 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.132 -0.485 . . . . 63.25 111.059 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' TRP . . . . . 0.61 ' O ' ' CD2' ' A' ' 58' ' ' TYR . 28.5 m0 -64.41 31.08 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.254 -0.43 . . . . 73.420000000000002 110.938 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.635 ' H ' ' C ' ' A' ' 56' ' ' ALA . 3.8 m-85 -160.29 115.6 2.3 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.264 -0.426 . . . . 73.25 110.935 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -82.39 136.59 34.94 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.128 -0.487 . . . . 63.340000000000003 110.85 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.629 ' HA ' ' OE1' ' A' ' 149' ' ' GLN . 5.4 t80 -146.39 124.86 12.37 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.243 -0.435 . . . . 74.430000000000007 110.9 -179.899 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.847 ' N ' HD12 ' A' ' 61' ' ' ILE . 1.0 OUTLIER -109.21 116.95 53.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.13 -0.486 . . . . 74.140000000000001 111.164 179.883 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.804 HD23 ' HD2' ' A' ' 63' ' ' PRO . 0.3 OUTLIER -89.34 129.17 48.48 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.635 0.731 . . . . 64.319999999999993 110.909 179.93 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.804 ' HD2' HD23 ' A' ' 62' ' ' LEU . 53.5 Cg_endo -69.8 -175.28 1.11 Allowed 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.664 2.242 . . . . 72.519999999999996 112.323 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.48 162.7 15.58 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.216 -0.447 . . . . 73.230000000000004 110.897 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 112.34 -171.56 14.15 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.797 -0.716 . . . . 73.450000000000003 112.533 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -103.5 150.96 23.4 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.871 0.367 . . . . 74.140000000000001 110.885 -179.874 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.662 ' HB2' ' O ' ' A' ' 40' ' ' ILE . 19.7 m-85 -139.26 85.34 15.59 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.669 0.747 . . . . 74.219999999999999 110.923 -179.853 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 -0.01 6.26 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.687 2.258 . . . . 64.349999999999994 112.373 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.553 ' HB2' ' HG2' ' A' ' 72' ' ' ARG . 49.3 mt-10 -155.81 142.18 18.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.177 -0.465 . . . . 63.340000000000003 110.855 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.737 ' HA ' ' NE1' ' A' ' 73' ' ' TRP . 30.0 p90 -54.85 -20.52 8.9 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.158 -0.473 . . . . 72.219999999999999 110.918 -179.857 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -80.41 -18.72 48.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.144 -0.48 . . . . 72.430000000000007 110.945 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.553 ' HG2' ' HB2' ' A' ' 69' ' ' GLU . 26.5 mmt180 -69.9 -7.35 39.62 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.466 . . . . 71.0 110.887 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' TRP . . . . . 0.797 ' CH2' HD12 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -139.28 18.49 2.58 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.176 -0.465 . . . . 71.510000000000005 110.929 -179.957 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.461 ' C ' ' O ' ' A' ' 73' ' ' TRP . 0.0 OUTLIER 33.54 43.98 0.06 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.212 -0.449 . . . . 73.230000000000004 110.863 179.95 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -53.31 125.44 31.43 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.784 -0.722 . . . . 53.439999999999998 112.472 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.499 HD11 ' HA ' ' A' ' 148' ' ' ARG . 6.2 mt -52.85 -53.98 40.98 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.862 0.363 . . . . 72.230000000000004 110.9 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 -130.68 151.66 50.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.198 -0.456 . . . . 64.430000000000007 110.866 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -84.22 13.29 5.38 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.201 -0.454 . . . . 62.329999999999998 110.864 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.406 ' HD2' ' HG2' ' A' ' 51' ' ' GLU . 0.0 OUTLIER -103.6 67.72 0.91 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 73.519999999999996 110.87 -179.904 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.729 HD11 HG11 ' A' ' 49' ' ' VAL . 0.1 OUTLIER -72.0 132.9 44.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.225 -0.443 . . . . 72.230000000000004 110.919 -179.98 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.635 ' HB3' ' HB3' ' A' ' 53' ' ' PRO . 1.3 m -151.09 -122.48 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.193 -0.458 . . . . 73.209999999999994 110.841 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.606 ' OG ' ' HA ' ' A' ' 53' ' ' PRO . 0.1 OUTLIER -38.33 106.06 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.136 -0.484 . . . . 74.230000000000004 110.844 -179.782 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 83' ' ' CYS . . . . . 0.67 ' HB3' HG12 ' A' ' 49' ' ' VAL . 9.3 p -134.38 131.34 38.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.15 -0.477 . . . . 72.319999999999993 110.904 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.602 ' N ' ' O ' ' A' ' 48' ' ' ALA . 2.9 mmt-85 -113.76 164.75 13.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 60.32 110.874 -179.835 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -79.82 130.31 35.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.219 -0.446 . . . . 53.329999999999998 111.084 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.798 ' CG2' ' HB2' ' A' ' 48' ' ' ALA . 54.3 t -116.07 136.05 54.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.195 -0.457 . . . . 75.340000000000003 111.162 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' HIS . . . . . 0.641 ' O ' HG23 ' A' ' 136' ' ' VAL . 45.8 m80 -114.92 105.8 13.42 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.183 -0.462 . . . . 64.150000000000006 110.854 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.577 HD13 ' HB3' ' A' ' 178' ' ' GLU . 0.0 OUTLIER -34.02 146.55 0.13 Allowed Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.56 0.695 . . . . 63.229999999999997 110.926 -179.976 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.548 ' HB3' ' H ' ' A' ' 136' ' ' VAL . 53.5 Cg_endo -69.77 109.99 2.45 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.669 2.246 . . . . 71.030000000000001 112.356 179.843 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -106.83 158.84 16.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.236 -0.438 . . . . 74.230000000000004 110.841 -179.818 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 49.7 79.52 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.743 -0.742 . . . . 40.340000000000003 112.488 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 124.64 11.19 4.59 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.725 -0.75 . . . . 54.450000000000003 112.492 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.46 ' O ' ' HG2' ' A' ' 134' ' ' GLU . 14.8 pt20 38.02 -122.84 0.25 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.824 0.345 . . . . 72.439999999999998 110.923 -179.833 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.475 ' CE2' ' HD2' ' A' ' 175' ' ' ARG . 0.2 OUTLIER -124.19 101.97 7.47 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.209 -0.45 . . . . 74.200000000000003 110.903 -179.876 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.505 ' HG3' HG11 ' A' ' 132' ' ' VAL . 47.4 tptt -110.89 126.55 54.82 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.07 -0.514 . . . . 75.439999999999998 110.893 179.886 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.75 HD13 ' N ' ' A' ' 97' ' ' GLN . 0.0 OUTLIER -149.38 138.04 14.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.262 -0.426 . . . . 52.140000000000001 111.146 179.808 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.75 ' N ' HD13 ' A' ' 96' ' ' ILE . 2.2 mt-30 -105.52 121.23 43.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.182 -0.463 . . . . 64.010000000000005 110.889 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.59 ' CD1' HD12 ' A' ' 96' ' ' ILE . 23.0 mm -97.75 131.23 45.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.15 -0.477 . . . . 71.329999999999998 111.125 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.675 ' CB ' ' HB2' ' A' ' 129' ' ' SER . 37.6 m-85 -120.96 140.54 51.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.181 -0.463 . . . . 75.129999999999995 110.868 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 59.6 tt0 -75.79 -61.7 1.84 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.15 -0.477 . . . . 73.129999999999995 110.907 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 39.9 mttt -96.6 171.42 8.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.128 -0.487 . . . . 71.129999999999995 110.898 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.424 ' HA2' ' OG ' ' A' ' 129' ' ' SER . . . -70.5 153.46 51.68 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.719 -0.753 . . . . 71.519999999999996 112.493 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.461 ' HA ' ' HB2' ' A' ' 158' ' ' ARG . 26.8 t0 65.27 46.11 2.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.802 0.334 . . . . 73.129999999999995 110.861 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.593 ' N ' ' CD2' ' A' ' 104' ' ' PHE . 0.1 OUTLIER 47.54 33.18 2.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.227 -0.442 . . . . 75.120000000000005 110.853 -179.948 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 57.8 m -96.13 159.45 14.95 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.168 -0.469 . . . . 51.420000000000002 110.847 -179.774 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 84.92 -137.29 15.4 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.748 -0.739 . . . . 74.209999999999994 112.504 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 30.1 tp60 -88.84 114.2 25.2 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.805 0.336 . . . . 64.109999999999999 110.94 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 1.5 ttp -101.36 144.12 30.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.185 -0.461 . . . . 64.349999999999994 110.9 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -149.47 136.01 19.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.218 -0.446 . . . . 75.019999999999996 110.899 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -117.36 102.49 9.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.107 -0.497 . . . . 65.319999999999993 110.867 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 11.9 t -113.05 129.15 56.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.166 -0.47 . . . . 61.229999999999997 111.134 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.474 ' HA ' ' O ' ' A' ' 94' ' ' TYR . 1.5 t -96.74 22.52 8.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.224 -0.443 . . . . 74.530000000000001 111.199 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -151.2 137.56 18.53 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.155 -0.475 . . . . 74.150000000000006 110.848 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 30.7 p30 -53.89 178.27 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.16 -0.473 . . . . 64.129999999999995 110.882 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' CYS . . . . . 0.498 ' O ' ' HB2' ' A' ' 172' ' ' SER . 0.8 OUTLIER -155.65 151.31 21.89 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.57 0.7 . . . . 64.450000000000003 110.888 -179.92 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.453 ' O ' ' C ' ' A' ' 143' ' ' PRO . 54.1 Cg_endo -69.77 -33.94 15.54 Favored 'Trans proline' 0 C--O 1.231 0.134 0 C-N-CA 122.659 2.24 . . . . 64.349999999999994 112.383 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.632 ' HB3' ' CB ' ' A' ' 120' ' ' GLU . 0.1 OUTLIER -148.3 109.55 4.35 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 64.409999999999997 110.83 -179.821 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.636 HD13 HD11 ' A' ' 127' ' ' ILE . 4.3 tt -60.45 -30.0 45.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.156 -0.475 . . . . 72.329999999999998 111.125 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 119' ' ' MET . . . . . 0.603 ' O ' ' HA ' ' A' ' 123' ' ' HIS . 5.0 ttt -86.14 -41.91 14.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.227 -0.442 . . . . 74.340000000000003 110.835 179.873 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.632 ' CB ' ' HB3' ' A' ' 117' ' ' SER . 10.0 tp10 -68.03 -14.11 62.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.229 -0.441 . . . . 63.109999999999999 110.913 -179.924 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 6.9 tp-100 -115.17 -48.27 2.82 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.092 -0.503 . . . . 71.450000000000003 110.91 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.516 ' HB2' ' O ' ' A' ' 118' ' ' ILE . 53.4 m-85 -103.34 -20.4 14.1 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.198 -0.455 . . . . 75.120000000000005 110.879 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 123' ' ' HIS . . . . . 0.603 ' HA ' ' O ' ' A' ' 119' ' ' MET . 0.1 OUTLIER 71.33 29.87 2.68 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.104 -0.498 . . . . 63.039999999999999 110.859 -179.997 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.557 ' SD ' HG22 ' A' ' 98' ' ' ILE . 4.5 mtt -107.85 86.34 2.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.256 -0.429 . . . . 62.409999999999997 110.892 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 1.9 ptp85 -51.97 -40.44 60.89 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.239 -0.437 . . . . 72.299999999999997 110.886 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.469 ' HB3' ' HG2' ' A' ' 168' ' ' PRO . 12.9 mt-10 -137.51 133.51 34.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.191 -0.458 . . . . 73.510000000000005 110.907 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.636 HD11 HD13 ' A' ' 118' ' ' ILE . 3.7 mm -93.48 101.57 12.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.135 -0.484 . . . . 65.230000000000004 111.149 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 11.8 m80 -69.9 -34.16 73.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.2 -0.455 . . . . 74.209999999999994 110.855 179.848 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.675 ' HB2' ' CB ' ' A' ' 99' ' ' PHE . 8.3 m -134.02 154.3 51.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.231 -0.44 . . . . 34.149999999999999 110.838 -179.756 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 130' ' ' CYS . . . . . 0.615 ' SG ' HD11 ' A' ' 96' ' ' ILE . 0.1 OUTLIER -155.13 118.54 4.46 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.154 -0.475 . . . . 75.430000000000007 110.886 -179.929 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.561 ' C ' HG23 ' A' ' 132' ' ' VAL . 7.7 mtpp -112.86 154.0 27.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.201 -0.454 . . . . 55.340000000000003 110.912 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.561 HG23 ' C ' ' A' ' 131' ' ' LYS . 15.2 t 87.17 162.57 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.218 -0.446 . . . . 54.229999999999997 111.127 179.9 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.819 HD22 ' HG3' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -179.65 125.63 0.08 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.161 -0.472 . . . . 70.010000000000005 110.895 179.939 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.46 ' HG2' ' O ' ' A' ' 93' ' ' GLN . 0.0 OUTLIER -93.71 176.9 6.19 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.186 -0.461 . . . . 71.439999999999998 110.867 179.953 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.452 ' HA3' ' HA ' ' A' ' 89' ' ' PRO . . . -37.26 -67.41 0.45 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.768 -0.73 . . . . 65.140000000000001 112.488 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.789 HG11 ' CG1' ' A' ' 86' ' ' VAL . 13.4 t -140.65 145.24 25.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.913 0.387 . . . . 74.209999999999994 111.073 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 137' ' ' TRP . . . . . 0.679 ' H ' HD12 ' A' ' 152' ' ' LEU . 0.1 OUTLIER -147.51 168.68 21.33 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.117 -0.492 . . . . 52.229999999999997 110.898 179.988 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.574 ' CG2' ' HB2' ' A' ' 149' ' ' GLN . 63.0 mt -138.13 133.72 44.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.219 -0.446 . . . . 73.319999999999993 111.153 179.879 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.466 ' HB2' ' HB2' ' A' ' 150' ' ' TYR . 83.6 m-85 -98.4 179.92 4.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.191 -0.459 . . . . 72.340000000000003 110.855 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 0.42 ' CD2' ' HA ' ' A' ' 145' ' ' TYR . 0.4 OUTLIER -153.54 126.0 8.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.145 -0.479 . . . . 73.439999999999998 110.936 -179.829 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.59 ' O ' ' HB2' ' A' ' 171' ' ' GLN . 27.0 tt0 -62.85 -28.1 69.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.125 -0.489 . . . . 61.420000000000002 110.926 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.726 ' HB3' ' HD2' ' A' ' 143' ' ' PRO . 9.4 mp -115.88 173.5 2.96 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.565 0.698 . . . . 71.239999999999995 110.928 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 143' ' ' PRO . . . . . 0.726 ' HD2' ' HB3' ' A' ' 142' ' ' LEU . 54.0 Cg_endo -69.73 -90.92 0.01 OUTLIER 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.653 2.235 . . . . 71.430000000000007 112.373 179.836 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 144' ' ' ASN . . . . . 0.727 ' O ' ' N ' ' A' ' 146' ' ' ARG . 1.6 m-80 -54.05 96.69 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 62.0 110.881 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 145' ' ' TYR . . . . . 0.652 ' C ' ' O ' ' A' ' 144' ' ' ASN . 5.8 m-85 11.87 53.1 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.157 -0.474 . . . . 52.229999999999997 110.895 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 146' ' ' ARG . . . . . 0.727 ' N ' ' O ' ' A' ' 144' ' ' ASN . 19.5 mtt-85 -116.8 170.41 8.63 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.113 -0.494 . . . . 73.239999999999995 110.88 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 70.39 -172.08 42.41 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.747 -0.74 . . . . 75.109999999999999 112.481 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.499 ' HA ' HD11 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -87.75 132.62 34.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.761 0.315 . . . . 72.409999999999997 110.897 -179.851 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 149' ' ' GLN . . . . . 0.629 ' OE1' ' HA ' ' A' ' 60' ' ' TYR . 0.8 OUTLIER -88.53 157.73 18.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.204 -0.453 . . . . 71.239999999999995 110.928 -179.922 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 150' ' ' TYR . . . . . 0.466 ' HB2' ' HB2' ' A' ' 139' ' ' PHE . 12.6 m-85 -122.84 141.48 51.82 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.187 -0.46 . . . . 64.299999999999997 110.891 -179.83 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.579 ' HB2' HD11 ' A' ' 61' ' ' ILE . 7.8 tp -76.16 123.65 26.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.105 -0.498 . . . . 75.329999999999998 110.858 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 1.08 HD13 ' O ' ' A' ' 152' ' ' LEU . 0.0 OUTLIER -50.9 135.5 24.24 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.179 -0.464 . . . . 74.109999999999999 110.911 179.847 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 153' ' ' ASP . . . . . 0.46 ' N ' HD22 ' A' ' 152' ' ' LEU . 7.9 t0 -165.4 27.68 0.05 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.193 -0.458 . . . . 72.530000000000001 110.882 179.845 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.817 ' O ' HD13 ' A' ' 133' ' ' LEU . 0.0 OUTLIER -114.88 -175.23 2.64 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.224 -0.444 . . . . 60.240000000000002 110.874 -179.993 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.819 ' HG3' HD22 ' A' ' 133' ' ' LEU . 0.0 OUTLIER -161.02 -127.54 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.202 -0.454 . . . . 64.439999999999998 110.887 179.878 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.562 ' HG2' ' O ' ' A' ' 156' ' ' GLU . 2.9 tm-20 -68.54 6.0 0.92 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.245 -0.434 . . . . 74.150000000000006 110.895 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 157' ' ' TYR . . . . . 0.769 ' CE1' ' HA ' ' A' ' 154' ' ' LYS . 20.4 m-30 -34.61 152.85 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.141 -0.481 . . . . 75.209999999999994 110.869 -179.828 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 158' ' ' ARG . . . . . 0.461 ' HB2' ' HA ' ' A' ' 103' ' ' ASP . 0.0 OUTLIER -125.76 -35.74 2.48 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.132 -0.486 . . . . 65.25 110.865 -179.99 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -86.72 151.23 52.32 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.563 0.697 . . . . 63.140000000000001 110.866 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 160' ' ' PRO . . . . . 0.455 ' HB2' ' HD3' ' A' ' 168' ' ' PRO . 53.6 Cg_endo -69.74 -28.01 25.85 Favored 'Trans proline' 0 C--O 1.232 0.207 0 C-N-CA 122.658 2.238 . . . . 71.349999999999994 112.316 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.622 HD12 ' H ' ' A' ' 161' ' ' ILE . 3.6 mp -64.08 -11.75 10.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.258 -0.428 . . . . 62.399999999999999 111.133 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.635 ' HB3' ' CD1' ' A' ' 157' ' ' TYR . 0.3 OUTLIER -75.32 -13.42 60.42 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.152 -0.477 . . . . 72.219999999999999 110.896 179.813 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 163' ' ' TRP . . . . . 0.44 ' CH2' ' CE1' ' A' ' 139' ' ' PHE . 3.4 m95 -87.16 0.16 55.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.227 -0.442 . . . . 71.219999999999999 110.93 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 91.64 -35.68 3.89 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.743 -0.741 . . . . 55.039999999999999 112.461 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -82.05 130.75 35.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.798 0.332 . . . . 61.530000000000001 111.144 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -39.01 -38.42 0.45 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.244 -0.435 . . . . 72.329999999999998 111.069 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 167' ' ' SER . . . . . 0.487 ' C ' ' H ' ' A' ' 169' ' ' ALA . 0.3 OUTLIER -128.35 156.35 76.99 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.666 0.746 . . . . 64.150000000000006 110.858 -179.765 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 168' ' ' PRO . . . . . 0.469 ' HG2' ' HB3' ' A' ' 126' ' ' GLU . 54.1 Cg_endo -69.72 27.86 0.18 Allowed 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.715 2.277 . . . . 64.099999999999994 112.332 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.487 ' H ' ' C ' ' A' ' 167' ' ' SER . . . -68.27 104.61 1.89 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.246 -0.434 . . . . 74.420000000000002 111.111 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.472 HG12 ' N ' ' A' ' 171' ' ' GLN . 3.4 t -152.94 164.37 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.188 -0.46 . . . . 72.540000000000006 111.149 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 171' ' ' GLN . . . . . 0.65 ' OE1' ' HB3' ' A' ' 143' ' ' PRO . 1.7 mm-40 -113.88 -85.79 0.59 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.244 -0.435 . . . . 71.510000000000005 110.867 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 172' ' ' SER . . . . . 0.706 ' OG ' ' O ' ' A' ' 143' ' ' PRO . 33.6 p -127.05 -179.53 4.89 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.198 -0.456 . . . . 73.519999999999996 110.863 -179.815 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -145.49 170.89 15.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.077 -0.511 . . . . 75.239999999999995 110.875 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 174' ' ' ARG . . . . . 0.419 ' HD2' ' CE2' ' A' ' 140' ' ' TYR . 0.0 OUTLIER -136.09 157.58 46.49 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.152 -0.477 . . . . 74.549999999999997 110.865 -179.89 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 175' ' ' ARG . . . . . 0.475 ' HD2' ' CE2' ' A' ' 94' ' ' TYR . 1.8 ptt180 -98.86 -171.93 2.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.142 -0.481 . . . . 74.420000000000002 110.905 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 176' ' ' ILE . . . . . 0.556 HD11 HG12 ' A' ' 136' ' ' VAL . 3.5 mt -125.33 130.99 72.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.223 -0.444 . . . . 75.049999999999997 111.085 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 9.1 p -53.84 137.67 14.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.182 -0.463 . . . . 72.239999999999995 111.135 179.826 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 178' ' ' GLU . . . . . 0.577 ' HB3' HD13 ' A' ' 88' ' ' LEU . 1.8 mm-40 . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.203 -0.453 . . . . 73.230000000000004 110.883 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.796 0.331 . . . . 63.200000000000003 110.881 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.9 p -60.83 -68.6 0.29 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.196 -0.456 . . . . 63.43 110.87 -179.812 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 48.24 60.99 3.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.105 -0.498 . . . . 75.510000000000005 110.931 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 29.0 p -53.0 174.53 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.216 -0.447 . . . . 65.209999999999994 111.139 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -68.68 123.32 15.7 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.783 -0.723 . . . . 70.310000000000002 112.491 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.404 ' HB ' ' O ' ' A' ' 44' ' ' GLY . 26.2 p -81.54 136.48 35.6 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.85 0.357 . . . . 74.430000000000007 111.165 -179.876 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.425 ' N ' ' HE1' ' A' ' 47' ' ' TRP . 2.6 tttt -124.67 136.96 54.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.228 -0.442 . . . . 54.439999999999998 110.919 179.912 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.524 ' HB ' ' CD1' ' A' ' 47' ' ' TRP . 16.0 tt -136.98 148.98 26.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.219 -0.446 . . . . 71.439999999999998 111.168 179.862 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.548 HG22 ' CE2' ' A' ' 11' ' ' TYR . 19.0 m -132.58 137.36 47.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.218 -0.446 . . . . 64.099999999999994 111.184 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.771 ' HB2' HD22 ' A' ' 34' ' ' LEU . 0.5 OUTLIER -125.46 128.06 47.47 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.183 -0.462 . . . . 75.349999999999994 110.874 -179.982 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.564 ' CG ' ' HA ' ' A' ' 16' ' ' PHE . 17.0 m-85 -113.16 131.98 55.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.103 -0.499 . . . . 73.420000000000002 110.937 -179.831 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.464 ' HB2' ' HB2' ' A' ' 19' ' ' ARG . 0.0 OUTLIER -61.71 -14.53 32.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.162 -0.472 . . . . 74.329999999999998 110.852 -179.958 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.424 ' HB2' ' O ' ' A' ' 17' ' ' GLN . 77.4 m-20 -135.41 149.56 49.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.138 -0.483 . . . . 63.520000000000003 110.89 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.526 ' N ' ' HB3' ' A' ' 38' ' ' ASN . 30.3 mtmm -54.61 -176.68 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.224 -0.444 . . . . 72.219999999999999 110.874 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 16.5 m120 46.99 30.58 1.29 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.185 -0.461 . . . . 71.329999999999998 110.908 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.564 ' HA ' ' CG ' ' A' ' 11' ' ' TYR . 3.6 m-85 51.24 65.38 1.5 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.152 -0.477 . . . . 62.310000000000002 110.867 -180.0 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.424 ' O ' ' HB2' ' A' ' 13' ' ' ASP . 16.9 mt-30 -140.26 160.87 38.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.113 -0.494 . . . . 72.219999999999999 110.899 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 90.98 -147.99 19.16 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.736 -0.745 . . . . 73.420000000000002 112.519 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.709 ' O ' HD13 ' A' ' 34' ' ' LEU . 0.0 OUTLIER -68.9 77.47 0.32 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.83 0.348 . . . . 65.230000000000004 110.908 -179.893 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.457 ' HB2' ' CE1' ' A' ' 11' ' ' TYR . 0.7 OUTLIER -77.83 127.82 33.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.148 -0.478 . . . . 75.099999999999994 110.846 -179.892 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.491 ' O ' ' HA ' ' A' ' 9' ' ' THR . 88.2 t80 -122.01 124.0 42.97 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.199 -0.455 . . . . 72.319999999999993 110.922 -179.889 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.473 ' CG ' HG23 ' A' ' 9' ' ' THR . 1.2 m-20 -120.19 134.37 55.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.1 -0.5 . . . . 74.230000000000004 110.86 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -167.49 134.32 2.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.199 -0.455 . . . . 70.0 110.889 -179.887 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.406 ' HA ' ' HA ' ' A' ' 7' ' ' LYS . 6.1 p-10 -102.2 5.45 40.2 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.174 -0.466 . . . . 73.030000000000001 110.857 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 11.7 t -107.79 169.38 8.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.171 -0.468 . . . . 71.209999999999994 110.932 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -64.96 117.15 7.19 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.198 -0.455 . . . . 51.100000000000001 110.875 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.473 ' HB2' ' HB3' ' A' ' 30' ' ' PHE . 4.4 m -116.95 53.65 0.89 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.178 -0.465 . . . . 73.239999999999995 110.876 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.533 ' C ' ' HA ' ' A' ' 82' ' ' SER . . . -46.44 -20.72 0.13 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.176 -0.465 . . . . 70.420000000000002 111.126 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 57.0 t0 -128.3 42.71 3.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.21 -0.45 . . . . 72.310000000000002 110.877 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.76 ' CD2' ' O ' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -80.0 14.44 1.83 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.187 -0.461 . . . . 74.420000000000002 110.92 -179.905 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.503 ' HB2' ' HB3' ' A' ' 81' ' ' SER . 28.3 t60 -77.61 -40.13 43.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.104 -0.498 . . . . 71.209999999999994 110.853 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.6 t -56.15 -14.98 3.08 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.215 -0.448 . . . . 63.549999999999997 111.129 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -99.07 -27.23 13.93 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.258 -0.428 . . . . 65.219999999999999 110.896 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.771 HD22 ' HB2' ' A' ' 10' ' ' PHE . 17.4 tp -141.97 135.84 29.75 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.146 -0.479 . . . . 74.299999999999997 110.909 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 20.5 m -99.36 -42.62 6.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 74.420000000000002 110.876 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -118.15 141.48 48.45 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.104 -0.498 . . . . 73.340000000000003 110.849 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.633 ' SG ' ' HB2' ' A' ' 80' ' ' LEU . 4.6 p -110.73 86.77 2.38 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.148 -0.478 . . . . 71.310000000000002 110.877 -179.92 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.526 ' HB3' ' N ' ' A' ' 14' ' ' LYS . 0.2 OUTLIER -77.97 -66.29 0.86 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.175 -0.466 . . . . 75.099999999999994 110.851 -179.863 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 6.1 p -117.08 123.11 46.01 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.201 -0.454 . . . . 63.219999999999999 110.84 -179.865 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.767 HD12 ' CH2' ' A' ' 73' ' ' TRP . 27.2 mt -116.27 150.2 18.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.092 -0.503 . . . . 72.299999999999997 111.107 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.486 ' HD2' ' CE2' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -145.63 118.51 8.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.211 -0.45 . . . . 64.209999999999994 110.901 179.832 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.503 HG12 ' O ' ' A' ' 42' ' ' VAL . 1.3 t -104.87 115.7 47.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.244 -0.435 . . . . 75.150000000000006 111.172 179.836 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -110.84 77.82 1.07 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.164 -0.471 . . . . 71.310000000000002 110.901 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.404 ' O ' ' HB ' ' A' ' 6' ' ' THR . . . 135.28 101.98 0.69 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.768 -0.729 . . . . 55.329999999999998 112.493 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 53.74 179.17 0.12 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.747 -0.739 . . . . 73.010000000000005 112.515 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.747 HG23 ' HA ' ' A' ' 63' ' ' PRO . 0.6 OUTLIER -79.67 172.61 13.56 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.819 0.342 . . . . 64.200000000000003 111.121 -179.885 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.586 ' H ' HG22 ' A' ' 46' ' ' THR . 14.8 m95 -144.07 130.2 19.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 73.540000000000006 110.906 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.883 ' HB2' ' CG2' ' A' ' 86' ' ' VAL . . . -97.18 112.0 23.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.288 -0.415 . . . . 74.019999999999996 111.158 179.858 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.564 HG11 ' CD1' ' A' ' 80' ' ' LEU . 3.6 m -113.12 129.73 68.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.227 -0.442 . . . . 71.140000000000001 111.117 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.692 ' HB3' ' HA ' ' A' ' 56' ' ' ALA . 33.0 m-85 -95.78 148.59 22.42 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.156 -0.475 . . . . 74.439999999999998 110.92 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.659 ' HB2' ' HB2' ' A' ' 58' ' ' TYR . 35.1 tt0 -45.43 -80.85 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.099 -0.501 . . . . 73.349999999999994 110.885 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.622 ' HB3' ' CD2' ' A' ' 55' ' ' PHE . 0.3 OUTLIER -90.54 146.38 34.22 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.621 0.724 . . . . 74.5 110.88 -179.891 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.751 ' HA ' ' OG ' ' A' ' 82' ' ' SER . 54.2 Cg_endo -69.71 134.71 28.74 Favored 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.701 2.267 . . . . 74.340000000000003 112.38 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 1.5 t30 65.63 -9.84 0.23 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.214 -0.448 . . . . 75.150000000000006 110.884 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.622 ' CD2' ' HB3' ' A' ' 52' ' ' ARG . 4.7 m-30 -98.75 -24.16 15.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.173 -0.467 . . . . 73.329999999999998 110.914 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.692 ' HA ' ' HB3' ' A' ' 50' ' ' TYR . . . 56.62 20.83 5.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.102 -0.499 . . . . 62.439999999999998 111.141 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' TRP . . . . . 0.634 ' HB3' ' OE1' ' A' ' 51' ' ' GLU . 0.1 OUTLIER -50.7 -166.11 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.167 -0.47 . . . . 71.409999999999997 110.93 -179.958 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.775 ' HB3' HD11 ' A' ' 76' ' ' LEU . 6.9 m-30 -13.08 101.87 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.251 -0.431 . . . . 71.5 110.877 -179.866 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.41 ' HB2' ' HA ' ' A' ' 150' ' ' TYR . 0.0 OUTLIER -68.73 154.24 42.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.12 -0.491 . . . . 62.009999999999998 110.883 179.881 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.89 ' CD2' HD22 ' A' ' 76' ' ' LEU . 5.1 t80 -173.72 102.13 0.11 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.213 -0.449 . . . . 73.340000000000003 110.906 -179.895 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.74 HD13 HG12 ' A' ' 138' ' ' ILE . 4.8 mp -88.21 118.71 34.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.093 -0.503 . . . . 73.209999999999994 111.076 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.775 HD23 ' HD2' ' A' ' 63' ' ' PRO . 0.2 OUTLIER -83.61 129.59 59.21 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.603 0.716 . . . . 61.210000000000001 110.856 179.924 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.775 ' HD2' HD23 ' A' ' 62' ' ' LEU . 53.3 Cg_endo -69.87 -172.34 0.58 Allowed 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.652 2.234 . . . . 65.439999999999998 112.288 179.878 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -88.74 161.9 16.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 73.400000000000006 110.911 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 112.07 -167.74 12.5 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.778 -0.725 . . . . 74.140000000000001 112.511 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -109.08 154.45 22.24 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.901 0.381 . . . . 71.209999999999994 110.862 -179.863 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.632 ' HB2' ' O ' ' A' ' 40' ' ' ILE . 14.6 m-85 -142.05 84.96 11.3 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.667 0.746 . . . . 74.019999999999996 110.925 -179.893 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.438 ' HD2' ' HG3' ' A' ' 72' ' ' ARG . 53.8 Cg_endo -69.73 -0.06 6.34 Favored 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.682 2.254 . . . . 54.210000000000001 112.335 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.564 ' HB2' ' HG2' ' A' ' 72' ' ' ARG . 47.9 mt-10 -156.5 143.53 18.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.226 -0.443 . . . . 64.239999999999995 110.891 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.739 ' HA ' ' NE1' ' A' ' 73' ' ' TRP . 35.9 p90 -54.43 -22.35 12.35 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.161 -0.472 . . . . 74.109999999999999 110.915 -179.836 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -79.55 -18.05 52.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.121 -0.491 . . . . 74.420000000000002 110.907 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.564 ' HG2' ' HB2' ' A' ' 69' ' ' GLU . 28.2 mmt180 -69.28 -7.75 39.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.453 . . . . 65.519999999999996 110.883 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' TRP . . . . . 0.767 ' CH2' HD12 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -138.6 15.82 2.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.183 -0.462 . . . . 64.120000000000005 110.925 -179.971 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.431 ' C ' ' O ' ' A' ' 73' ' ' TRP . 0.0 OUTLIER 36.0 43.84 0.22 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.213 -0.449 . . . . 72.329999999999998 110.894 179.93 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -51.93 123.92 22.31 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.763 -0.732 . . . . 32.0 112.506 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.89 HD22 ' CD2' ' A' ' 60' ' ' TYR . 1.1 pt? -59.09 -33.2 70.56 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.803 0.335 . . . . 73.230000000000004 110.864 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.704 ' H ' HD23 ' A' ' 76' ' ' LEU . 17.7 t-20 -147.49 139.43 24.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.239 -0.437 . . . . 74.400000000000006 110.902 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -78.12 18.51 0.51 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.168 -0.469 . . . . 75.010000000000005 110.896 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -107.17 73.28 0.92 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.186 -0.461 . . . . 64.530000000000001 110.873 -179.895 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.633 ' HB2' ' SG ' ' A' ' 37' ' ' CYS . 0.0 OUTLIER -82.31 133.98 35.25 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.228 -0.442 . . . . 71.209999999999994 110.871 -179.955 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.575 ' HB3' ' HB3' ' A' ' 53' ' ' PRO . 0.9 OUTLIER -147.56 -126.34 0.06 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.173 -0.467 . . . . 71.409999999999997 110.889 -179.942 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.751 ' OG ' ' HA ' ' A' ' 53' ' ' PRO . 0.4 OUTLIER -29.88 123.34 0.17 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.148 -0.478 . . . . 72.230000000000004 110.866 -179.844 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 83' ' ' CYS . . . . . 0.528 ' HA ' ' O ' ' A' ' 48' ' ' ALA . 9.2 p -133.42 141.56 47.91 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.149 -0.478 . . . . 72.349999999999994 110.873 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.466 ' N ' ' O ' ' A' ' 48' ' ' ALA . 1.5 mmt85 -138.44 130.22 28.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.204 -0.453 . . . . 74.140000000000001 110.886 -179.872 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.451 ' N ' ' CZ3' ' A' ' 47' ' ' TRP . . . -50.87 128.84 22.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.21 -0.45 . . . . 74.349999999999994 111.095 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.883 ' CG2' ' HB2' ' A' ' 48' ' ' ALA . 54.3 t -114.61 130.64 68.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.19 -0.459 . . . . 63.439999999999998 111.16 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' HIS . . . . . 0.483 ' O ' HG23 ' A' ' 136' ' ' VAL . 72.1 m-70 -114.67 119.03 35.33 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.154 -0.475 . . . . 71.310000000000002 110.881 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.731 HD13 ' HA ' ' A' ' 178' ' ' GLU . 0.0 OUTLIER -33.64 146.1 0.12 Allowed Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.556 0.693 . . . . 74.019999999999996 110.915 -179.956 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.676 ' HA ' ' HA3' ' A' ' 135' ' ' GLY . 53.4 Cg_endo -69.74 -79.29 0.01 OUTLIER 'Trans proline' 0 C--O 1.231 0.151 0 C-N-CA 122.721 2.281 . . . . 74.430000000000007 112.306 179.879 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.452 ' H ' ' HG2' ' A' ' 89' ' ' PRO . 67.2 m -109.07 -178.56 3.61 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.183 -0.462 . . . . 73.239999999999995 110.893 -179.827 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -100.94 4.15 55.96 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.794 -0.717 . . . . 31.039999999999999 112.488 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -125.19 -55.43 0.17 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.744 -0.741 . . . . 62.130000000000003 112.523 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.485 ' HG3' ' OG1' ' A' ' 112' ' ' THR . 11.5 pt20 -165.88 -170.05 1.66 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.837 0.351 . . . . 74.219999999999999 110.888 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.774 ' CD2' ' HB2' ' A' ' 134' ' ' GLU . 38.8 t80 -116.43 106.07 13.21 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.199 -0.455 . . . . 74.340000000000003 110.919 -179.859 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.467 ' HA ' ' HB ' ' A' ' 112' ' ' THR . 36.7 tptt -74.95 126.2 30.49 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.131 -0.486 . . . . 74.299999999999997 110.913 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.54 HD13 ' N ' ' A' ' 97' ' ' GLN . 0.0 OUTLIER -149.1 140.92 17.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.228 -0.442 . . . . 74.420000000000002 111.122 179.896 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.54 ' N ' HD13 ' A' ' 96' ' ' ILE . 1.3 mt-30 -109.63 125.84 53.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.197 -0.456 . . . . 73.140000000000001 110.888 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.55 ' CG2' HD12 ' A' ' 127' ' ' ILE . 2.3 mp -106.05 132.86 52.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.153 -0.476 . . . . 72.510000000000005 111.15 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.715 ' HB2' ' HB2' ' A' ' 129' ' ' SER . 46.3 m-85 -119.38 150.45 40.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.18 -0.464 . . . . 73.400000000000006 110.925 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.554 ' HA ' ' CE ' ' A' ' 124' ' ' MET . 62.9 tt0 -85.15 -52.18 6.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.177 -0.465 . . . . 61.210000000000001 110.892 -179.873 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 40.7 mttt -105.48 166.47 10.41 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.099 -0.501 . . . . 75.129999999999995 110.868 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.404 ' HA2' ' OG ' ' A' ' 129' ' ' SER . . . -67.12 152.46 52.75 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.722 -0.751 . . . . 73.310000000000002 112.522 179.885 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.44 ' HA ' ' HB2' ' A' ' 158' ' ' ARG . 42.3 t0 66.78 46.16 1.76 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.829 0.347 . . . . 72.010000000000005 110.885 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.546 ' N ' ' CD2' ' A' ' 104' ' ' PHE . 0.3 OUTLIER 48.3 33.08 3.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.208 -0.451 . . . . 74.200000000000003 110.866 -179.904 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 57.8 m -96.5 160.82 14.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.16 -0.473 . . . . 72.400000000000006 110.846 -179.802 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 81.97 -143.74 23.39 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.712 -0.756 . . . . 61.439999999999998 112.479 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -80.13 120.45 24.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.755 0.312 . . . . 32.350000000000001 110.877 -179.837 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 5.7 ttp -108.84 134.17 51.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.212 -0.449 . . . . 62.130000000000003 110.886 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -139.22 135.5 34.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.205 -0.452 . . . . 60.200000000000003 110.925 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -114.83 94.52 4.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.061 -0.518 . . . . 75.239999999999995 110.872 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.502 HG22 ' CD1' ' A' ' 98' ' ' ILE . 5.7 t -114.77 144.13 43.98 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.148 -0.478 . . . . 70.319999999999993 111.165 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.485 ' OG1' ' HG3' ' A' ' 93' ' ' GLN . 6.6 t -129.66 47.28 2.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.234 -0.439 . . . . 51.119999999999997 111.112 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -151.54 157.92 42.89 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.221 -0.445 . . . . 73.510000000000005 110.882 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.404 ' OD1' ' HG3' ' A' ' 175' ' ' ARG . 2.6 m-20 -56.2 148.46 18.21 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.112 -0.494 . . . . 75.010000000000005 110.874 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 115' ' ' CYS . . . . . 0.741 ' O ' ' HB2' ' A' ' 172' ' ' SER . 42.7 t -139.23 124.3 11.69 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.616 0.722 . . . . 63.420000000000002 110.899 -179.907 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.532 ' O ' ' C ' ' A' ' 143' ' ' PRO . 53.6 Cg_endo -69.78 -30.44 22.16 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.688 2.259 . . . . 72.530000000000001 112.322 -179.89 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.623 ' HB3' ' CB ' ' A' ' 120' ' ' GLU . 0.1 OUTLIER -149.18 106.72 3.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.201 -0.454 . . . . 42.130000000000003 110.853 -179.877 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.609 HD13 HD11 ' A' ' 127' ' ' ILE . 3.9 tt -61.7 -30.48 48.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.127 -0.488 . . . . 62.130000000000003 111.1 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 119' ' ' MET . . . . . 0.702 ' O ' ' HA ' ' A' ' 123' ' ' HIS . 0.1 OUTLIER -91.02 -42.01 10.77 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.186 -0.461 . . . . 75.349999999999994 110.949 179.819 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.623 ' CB ' ' HB3' ' A' ' 117' ' ' SER . 2.9 tp10 -70.26 -11.79 61.15 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.201 -0.454 . . . . 63.420000000000002 110.861 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 29.8 mm100 -112.93 -52.14 2.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.183 -0.462 . . . . 63.119999999999997 110.966 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 30.9 m-85 -102.75 14.18 32.59 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.194 -0.457 . . . . 64.540000000000006 110.88 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' HIS . . . . . 0.702 ' HA ' ' O ' ' A' ' 119' ' ' MET . 21.5 m-70 47.13 25.11 0.48 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.118 -0.492 . . . . 74.430000000000007 110.835 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.606 ' HE2' HD13 ' A' ' 127' ' ' ILE . 0.0 OUTLIER -100.78 124.93 47.13 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.239 -0.437 . . . . 74.420000000000002 110.892 179.953 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 3.0 ptp85 -96.71 -35.05 11.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.257 -0.428 . . . . 74.200000000000003 110.838 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.473 ' HB3' ' HG2' ' A' ' 168' ' ' PRO . 34.8 mt-10 -145.54 115.52 7.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.18 -0.464 . . . . 64.129999999999995 110.859 -179.905 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.609 HD11 HD13 ' A' ' 118' ' ' ILE . 3.1 mm -74.13 100.45 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.121 -0.49 . . . . 74.439999999999998 111.11 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 128' ' ' HIS . . . . . 0.436 ' CD2' ' HG3' ' A' ' 168' ' ' PRO . 12.9 m170 -69.04 -36.21 77.46 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.138 -0.483 . . . . 72.120000000000005 110.867 179.85 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.715 ' HB2' ' HB2' ' A' ' 99' ' ' PHE . 19.3 m -134.03 144.18 48.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.193 -0.458 . . . . 73.120000000000005 110.875 -179.795 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 130' ' ' CYS . . . . . 0.629 ' O ' ' O ' ' A' ' 155' ' ' LYS . 1.4 m -140.31 114.65 9.24 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.124 -0.489 . . . . 63.020000000000003 110.925 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.523 ' HA ' ' O ' ' A' ' 155' ' ' LYS . 5.5 mtpp -110.22 150.63 28.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.178 -0.465 . . . . 72.439999999999998 110.92 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.471 ' HB ' ' O ' ' A' ' 131' ' ' LYS . 12.6 t 81.2 158.49 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.233 -0.44 . . . . 73.010000000000005 111.164 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.855 HD22 ' HG2' ' A' ' 155' ' ' LYS . 0.1 OUTLIER 176.27 124.29 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.213 -0.449 . . . . 62.119999999999997 110.96 179.957 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.774 ' HB2' ' CD2' ' A' ' 94' ' ' TYR . 3.7 mm-40 -86.8 -167.82 2.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.196 -0.456 . . . . 62.509999999999998 110.884 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.676 ' HA3' ' HA ' ' A' ' 89' ' ' PRO . . . -48.77 -92.85 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.759 -0.734 . . . . 45.109999999999999 112.465 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.933 ' HB ' HD12 ' A' ' 176' ' ' ILE . 2.3 t -103.21 148.26 8.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.779 0.323 . . . . 54.25 111.17 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 137' ' ' TRP . . . . . 0.641 ' HB2' ' CE2' ' A' ' 94' ' ' TYR . 0.0 OUTLIER -156.73 158.84 37.64 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.227 -0.442 . . . . 75.010000000000005 110.932 179.919 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.74 HG12 HD13 ' A' ' 61' ' ' ILE . 5.0 mt -134.25 136.44 53.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.262 -0.426 . . . . 74.120000000000005 111.145 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.464 ' HB2' ' HB2' ' A' ' 150' ' ' TYR . 0.1 OUTLIER -102.15 160.36 14.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.157 -0.474 . . . . 72.310000000000002 110.848 179.983 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -129.33 115.51 17.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.124 -0.489 . . . . 64.25 110.908 -179.846 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.589 ' O ' ' HB2' ' A' ' 171' ' ' GLN . 0.6 OUTLIER -54.91 -33.39 62.04 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.128 -0.487 . . . . 61.109999999999999 110.841 -179.983 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.696 ' HB3' ' HD2' ' A' ' 143' ' ' PRO . 8.8 mp -113.36 172.81 3.25 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.643 0.735 . . . . 63.32 110.914 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 143' ' ' PRO . . . . . 0.792 ' O ' ' OG ' ' A' ' 172' ' ' SER . 53.1 Cg_endo -69.78 -93.15 0.01 OUTLIER 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.7 2.266 . . . . 65.230000000000004 112.355 179.882 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 144' ' ' ASN . . . . . 0.745 ' O ' ' N ' ' A' ' 146' ' ' ARG . 0.3 OUTLIER -50.18 99.05 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.22 -0.445 . . . . 75.439999999999998 110.906 179.971 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 145' ' ' TYR . . . . . 0.643 ' C ' ' O ' ' A' ' 144' ' ' ASN . 34.5 m-85 11.59 52.23 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.199 -0.455 . . . . 75.430000000000007 110.942 -179.905 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 146' ' ' ARG . . . . . 0.745 ' N ' ' O ' ' A' ' 144' ' ' ASN . 12.4 mtp85 -117.86 172.14 7.59 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.128 -0.487 . . . . 73.329999999999998 110.892 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 80.11 -170.27 53.58 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.747 -0.739 . . . . 53.310000000000002 112.448 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.63 ' CG ' HD12 ' A' ' 76' ' ' LEU . 0.6 OUTLIER -92.54 152.62 19.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.767 0.318 . . . . 72.209999999999994 110.881 -179.84 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 149' ' ' GLN . . . . . 0.488 ' CD ' HG21 ' A' ' 138' ' ' ILE . 47.2 mt-30 -88.25 150.34 23.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.256 -0.429 . . . . 73.239999999999995 110.893 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 150' ' ' TYR . . . . . 0.464 ' HB2' ' HB2' ' A' ' 139' ' ' PHE . 96.2 m-85 -130.5 122.42 27.62 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.164 -0.471 . . . . 75.519999999999996 110.906 -179.876 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.492 HD23 ' OH ' ' A' ' 50' ' ' TYR . 33.9 tp -62.49 134.51 56.51 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.098 -0.501 . . . . 75.319999999999993 110.946 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.952 HD13 ' O ' ' A' ' 152' ' ' LEU . 0.0 OUTLIER -63.8 133.24 53.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.17 -0.468 . . . . 75.450000000000003 110.878 179.991 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -165.76 25.21 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.174 -0.466 . . . . 71.319999999999993 110.875 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.802 ' HA ' ' CE1' ' A' ' 157' ' ' TYR . 0.2 OUTLIER -106.65 -156.62 0.58 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.182 -0.463 . . . . 71.519999999999996 110.876 179.991 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.855 ' HG2' HD22 ' A' ' 133' ' ' LEU . 0.0 OUTLIER 168.9 -132.95 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.179 -0.464 . . . . 74.310000000000002 110.868 179.888 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.478 ' HA ' ' HA ' ' A' ' 131' ' ' LYS . 2.6 tm-20 -61.57 3.29 0.14 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.176 -0.465 . . . . 55.299999999999997 110.886 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 157' ' ' TYR . . . . . 0.802 ' CE1' ' HA ' ' A' ' 154' ' ' LYS . 15.1 m-30 -34.37 150.22 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.184 -0.462 . . . . 64.230000000000004 110.865 -179.831 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 158' ' ' ARG . . . . . 0.518 ' O ' ' OG ' ' A' ' 129' ' ' SER . 0.0 OUTLIER -126.31 -38.69 2.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.073 -0.512 . . . . 65.420000000000002 110.84 -179.961 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 159' ' ' LYS . . . . . 0.446 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 0.3 OUTLIER -85.12 150.8 55.9 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.538 0.685 . . . . 73.150000000000006 110.915 179.969 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 160' ' ' PRO . . . . . 0.52 ' HB3' ' HB3' ' A' ' 168' ' ' PRO . 53.5 Cg_endo -69.78 -23.29 30.87 Favored 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.726 2.284 . . . . 65.329999999999998 112.339 179.892 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.65 HD12 ' H ' ' A' ' 161' ' ' ILE . 4.0 mp -75.47 -3.24 4.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.179 -0.464 . . . . 65.439999999999998 111.117 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.68 ' HB3' ' CD1' ' A' ' 157' ' ' TYR . 0.3 OUTLIER -76.53 -14.44 60.02 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.164 -0.471 . . . . 74.099999999999994 110.838 179.911 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 11.4 t90 -94.61 2.24 55.62 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.226 -0.443 . . . . 74.540000000000006 110.875 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 90.42 -36.21 3.64 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.752 -0.737 . . . . 74.409999999999997 112.526 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -71.77 128.12 34.75 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.766 0.317 . . . . 63.5 111.137 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -42.16 -34.89 0.82 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.198 -0.456 . . . . 44.329999999999998 111.086 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 167' ' ' SER . . . . . 0.486 ' C ' ' H ' ' A' ' 169' ' ' ALA . 0.3 OUTLIER -131.25 157.84 76.96 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.663 0.744 . . . . 75.25 110.861 -179.771 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 168' ' ' PRO . . . . . 0.52 ' HB3' ' HB3' ' A' ' 160' ' ' PRO . 54.3 Cg_endo -69.69 21.46 0.17 Allowed 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.699 2.266 . . . . 74.209999999999994 112.406 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.486 ' H ' ' C ' ' A' ' 167' ' ' SER . . . -62.47 102.05 0.29 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.181 -0.463 . . . . 55.210000000000001 111.129 179.881 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 2.8 t -154.12 155.63 5.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.188 -0.46 . . . . 53.520000000000003 111.129 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 171' ' ' GLN . . . . . 0.589 ' HB2' ' O ' ' A' ' 141' ' ' GLU . 1.5 tm0? -116.75 -134.71 0.34 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.162 -0.472 . . . . 75.329999999999998 110.935 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 172' ' ' SER . . . . . 0.792 ' OG ' ' O ' ' A' ' 143' ' ' PRO . 12.1 p -64.46 171.87 2.94 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.246 -0.434 . . . . 71.109999999999999 110.896 -179.843 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 173' ' ' PHE . . . . . 0.467 ' CG ' ' HH2' ' A' ' 137' ' ' TRP . 2.3 p90 -147.43 175.57 10.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.111 -0.495 . . . . 72.129999999999995 110.881 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 174' ' ' ARG . . . . . 0.45 ' HG2' ' O ' ' A' ' 174' ' ' ARG . 1.7 ptm180 -140.32 136.62 33.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.166 -0.47 . . . . 73.439999999999998 110.897 -179.912 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 175' ' ' ARG . . . . . 0.469 ' HB2' ' HB3' ' A' ' 94' ' ' TYR . 0.0 OUTLIER -105.56 138.26 42.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.18 -0.464 . . . . 70.120000000000005 110.881 -179.913 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 176' ' ' ILE . . . . . 0.933 HD12 ' HB ' ' A' ' 136' ' ' VAL . 1.9 mt -79.44 144.93 10.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.194 -0.457 . . . . 75.040000000000006 111.138 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 4.6 p -136.19 156.28 36.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.175 -0.466 . . . . 72.120000000000005 111.135 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 178' ' ' GLU . . . . . 0.731 ' HA ' HD13 ' A' ' 88' ' ' LEU . 1.1 mp0 . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.146 -0.479 . . . . 74.439999999999998 110.884 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.356 0 N-CA-C 112.531 -0.228 . . . . 73.13 112.531 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.494 ' C ' ' HE1' ' A' ' 47' ' ' TRP . 4.6 p -82.09 135.1 35.36 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.828 0.347 . . . . 73.43 111.151 -179.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 3.4 tttt -121.56 135.94 54.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.223 -0.444 . . . . 74.5 110.894 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.615 ' HB ' ' CD1' ' A' ' 47' ' ' TRP . 15.9 tt -136.78 153.39 30.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.208 -0.451 . . . . 51.54 111.127 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.524 ' HA ' ' O ' ' A' ' 21' ' ' TYR . 17.9 m -134.01 143.89 48.38 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.193 -0.458 . . . . 71.13 111.14 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.721 ' HB2' HD22 ' A' ' 34' ' ' LEU . 0.8 OUTLIER -131.28 127.9 38.71 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.203 -0.453 . . . . 71.43 110.894 -179.983 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.545 ' CG ' ' HA ' ' A' ' 16' ' ' PHE . 11.1 m-85 -113.19 132.51 55.46 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.161 -0.472 . . . . 71.12 110.868 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.424 ' HB2' ' HB2' ' A' ' 19' ' ' ARG . 0.0 OUTLIER -60.11 -16.07 28.89 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.102 -0.499 . . . . 73.42 110.876 179.998 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.437 ' HB2' ' O ' ' A' ' 17' ' ' GLN . 72.2 m-20 -134.68 150.54 50.64 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.174 -0.467 . . . . 71.11 110.847 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.489 ' N ' ' HB3' ' A' ' 38' ' ' ASN . 38.7 mtmt -55.25 -176.12 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.181 -0.463 . . . . 75.42 110.873 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 18.8 m120 46.54 32.48 1.65 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.193 -0.458 . . . . 70.33 110.869 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.545 ' HA ' ' CG ' ' A' ' 11' ' ' TYR . 3.0 m-85 49.68 63.94 1.96 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.174 -0.466 . . . . 72.54 110.887 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.437 ' O ' ' HB2' ' A' ' 13' ' ' ASP . 3.8 mt-30 -138.76 158.59 43.94 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.132 -0.485 . . . . 74.44 110.892 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 92.86 -148.86 19.25 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.716 -0.754 . . . . 32.35 112.473 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.75 ' O ' HD13 ' A' ' 34' ' ' LEU . 0.3 OUTLIER -69.04 78.06 0.33 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.767 0.318 . . . . 73.4 110.911 -179.861 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.486 ' HB2' ' CE1' ' A' ' 11' ' ' TYR . 0.6 OUTLIER -77.14 130.11 36.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.456 . . . . 73.43 110.891 -179.905 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.524 ' O ' ' HA ' ' A' ' 9' ' ' THR . 90.7 t80 -124.02 124.87 43.51 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.169 -0.469 . . . . 71.35 110.93 -179.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.446 ' CG ' HG23 ' A' ' 9' ' ' THR . 1.1 m-20 -121.9 134.45 54.86 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.109 -0.496 . . . . 64.35 110.833 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -167.86 135.81 2.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.167 -0.47 . . . . 73.53 110.882 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -101.27 0.04 36.62 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.212 -0.449 . . . . 73.12 110.863 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 16.5 t -104.37 164.88 11.42 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.172 -0.467 . . . . 64.54 110.914 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 35.6 m-20 -58.24 120.84 9.4 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.209 -0.451 . . . . 72.33 110.879 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.566 ' HB2' ' HB3' ' A' ' 30' ' ' PHE . 1.8 m -115.95 51.94 0.93 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.208 -0.451 . . . . 61.34 110.886 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.501 ' C ' ' HA ' ' A' ' 82' ' ' SER . . . -47.33 -21.27 0.27 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.223 -0.444 . . . . 74.14 111.083 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 56.8 t0 -128.54 42.33 3.34 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.223 -0.444 . . . . 63.42 110.866 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.785 ' O ' ' CD2' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -80.99 15.33 1.87 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.217 -0.447 . . . . 73.51 110.858 -179.852 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.48 ' HB2' ' HB3' ' A' ' 81' ' ' SER . 28.5 t60 -80.01 -39.57 29.68 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.142 -0.481 . . . . 74.21 110.885 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.7 t -57.93 -13.94 5.39 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.202 -0.454 . . . . 75.15 111.119 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -99.96 -27.14 13.73 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.27 -0.423 . . . . 73.33 110.907 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.75 HD13 ' O ' ' A' ' 19' ' ' ARG . 18.0 tp -142.65 136.31 28.97 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.162 -0.472 . . . . 70.22 110.916 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 23.8 m -98.81 -42.42 7.19 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.174 -0.467 . . . . 62.13 110.861 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -118.54 141.37 48.64 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.135 -0.484 . . . . 63.12 110.861 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.547 ' HB3' ' HB2' ' A' ' 80' ' ' LEU . 3.1 p -109.95 83.97 1.85 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.188 -0.46 . . . . 71.33 110.858 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.489 ' HB3' ' N ' ' A' ' 14' ' ' LYS . 0.2 OUTLIER -75.33 -70.64 0.41 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.157 -0.474 . . . . 52.12 110.872 -179.911 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 5.0 p -111.77 124.38 52.21 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.192 -0.458 . . . . 72.43 110.836 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.724 HD12 ' CH2' ' A' ' 73' ' ' TRP . 45.1 mt -117.67 148.36 20.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.123 -0.489 . . . . 72.51 111.149 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.464 ' HB3' ' HE2' ' A' ' 41' ' ' LYS . 0.0 OUTLIER -143.49 120.57 11.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.181 -0.463 . . . . 53.31 110.9 179.85 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.534 HG22 ' HB ' ' A' ' 8' ' ' ILE . 1.9 t -104.98 115.53 47.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.22 -0.446 . . . . 71.22 111.096 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -110.35 80.27 1.29 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.227 -0.442 . . . . 61.43 110.872 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.467 ' O ' ' HA ' ' A' ' 6' ' ' THR . . . 127.89 106.85 1.37 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.736 -0.745 . . . . 74.32 112.485 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 51.95 177.98 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.738 -0.744 . . . . 71.24 112.494 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.74 HG23 ' HA ' ' A' ' 63' ' ' PRO . 1.9 m -80.91 165.79 21.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.813 0.34 . . . . 61.21 111.112 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . 0.615 ' CD1' ' HB ' ' A' ' 8' ' ' ILE . 3.3 m95 -138.91 130.05 26.75 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.449 . . . . 74.15 110.901 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.802 ' HB2' ' CG2' ' A' ' 86' ' ' VAL . . . -94.09 129.66 40.56 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.214 -0.448 . . . . 64.33 111.103 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.63 HG11 ' CD1' ' A' ' 80' ' ' LEU . 12.5 m -126.86 131.32 71.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.259 -0.428 . . . . 74.1 111.121 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.777 ' HB3' ' HA ' ' A' ' 56' ' ' ALA . 42.1 m-85 -97.28 147.73 23.84 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.182 -0.463 . . . . 73.21 110.928 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.617 ' OE1' ' HB3' ' A' ' 57' ' ' TRP . 47.3 tt0 -49.97 -78.12 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.094 -0.503 . . . . 73.33 110.867 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.572 ' HB2' ' HB2' ' A' ' 57' ' ' TRP . 1.2 mtp180 -93.5 143.99 27.52 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.609 0.719 . . . . 75.43 110.875 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.748 ' HA ' ' OG ' ' A' ' 82' ' ' SER . 54.2 Cg_endo -69.71 141.11 44.54 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.754 2.303 . . . . 65.21 112.366 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 63.42 -11.13 0.1 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.238 -0.437 . . . . 71.24 110.903 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.6 ' H ' ' C ' ' A' ' 53' ' ' PRO . 2.5 m-30 -104.7 -20.58 13.59 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.168 -0.469 . . . . 64.32 110.899 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.777 ' HA ' ' HB3' ' A' ' 50' ' ' TYR . . . 50.29 25.58 1.9 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.134 -0.485 . . . . 71.3 111.09 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . 0.632 ' O ' ' C ' ' A' ' 58' ' ' TYR . 0.1 OUTLIER -49.21 -164.92 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.234 -0.439 . . . . 54.33 110.952 -179.929 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.632 ' C ' ' O ' ' A' ' 57' ' ' TRP . 7.0 m-30 -13.27 101.69 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.274 -0.421 . . . . 72.41 110.948 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.601 ' HB2' ' HA ' ' A' ' 150' ' ' TYR . 1.9 mpt? -65.45 157.56 29.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.136 -0.483 . . . . 74.44 110.936 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.795 ' CD2' HD12 ' A' ' 76' ' ' LEU . 3.2 t80 -175.01 101.37 0.08 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.255 -0.43 . . . . 71.43 110.927 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.708 HD11 ' HA ' ' A' ' 151' ' ' LEU . 4.4 mp -88.24 116.21 29.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.163 -0.471 . . . . 62.44 111.121 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.816 HD23 ' HD2' ' A' ' 63' ' ' PRO . 0.3 OUTLIER -80.33 128.24 73.57 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.605 0.717 . . . . 55.41 110.958 179.898 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.816 ' HD2' HD23 ' A' ' 62' ' ' LEU . 53.3 Cg_endo -69.78 -173.41 0.71 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.678 2.252 . . . . 65.04 112.357 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -88.44 161.6 16.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.265 -0.425 . . . . 74.24 110.924 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 112.64 -168.44 12.65 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.734 -0.746 . . . . 74.3 112.47 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -108.09 153.92 22.43 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.873 0.368 . . . . 74.14 110.915 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.613 ' HB2' ' O ' ' A' ' 40' ' ' ILE . 10.2 m-85 -143.48 83.83 10.51 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.625 0.726 . . . . 74.53 110.934 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.44 ' HD2' ' HG3' ' A' ' 72' ' ' ARG . 53.8 Cg_endo -69.77 0.78 5.16 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.679 2.253 . . . . 62.52 112.354 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.544 ' HB2' ' HG2' ' A' ' 72' ' ' ARG . 46.2 mt-10 -156.09 143.84 19.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.197 -0.456 . . . . 73.52 110.878 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.732 ' HA ' ' NE1' ' A' ' 73' ' ' TRP . 32.4 p90 -55.34 -21.98 17.37 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.157 -0.474 . . . . 74.15 110.944 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -79.14 -17.56 54.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.134 -0.484 . . . . 63.23 110.898 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.544 ' HG2' ' HB2' ' A' ' 69' ' ' GLU . 27.8 mmt180 -69.34 -8.11 43.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.185 -0.461 . . . . 71.33 110.889 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . 0.732 ' NE1' ' HA ' ' A' ' 70' ' ' TYR . 0.0 OUTLIER -136.94 18.99 3.01 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.169 -0.469 . . . . 75.14 110.876 -179.973 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . 0.481 ' C ' ' O ' ' A' ' 73' ' ' TRP . 0.0 OUTLIER 32.11 47.71 0.09 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.255 -0.43 . . . . 74.1 110.835 179.921 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -59.92 120.38 22.48 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.71 -0.757 . . . . 75.34 112.531 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 1.043 HD13 ' N ' ' A' ' 77' ' ' ASN . 0.0 OUTLIER -63.56 -15.42 57.98 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.809 0.338 . . . . 73.42 110.937 -179.91 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 1.043 ' N ' HD13 ' A' ' 76' ' ' LEU . 35.5 t-20 -156.38 134.62 11.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.185 -0.461 . . . . 72.53 110.896 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -83.27 23.06 0.93 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.17 -0.468 . . . . 64.22 110.839 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 4.1 ttm-85 -110.16 80.77 1.34 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.232 -0.44 . . . . 74.54 110.886 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.63 ' CD1' HG11 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -87.91 133.99 33.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.224 -0.443 . . . . 73.31 110.871 -179.932 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.63 ' HB3' ' HB3' ' A' ' 53' ' ' PRO . 1.0 OUTLIER -150.32 -124.94 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.188 -0.46 . . . . 61.22 110.83 -179.96 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.748 ' OG ' ' HA ' ' A' ' 53' ' ' PRO . 0.1 OUTLIER -36.15 104.89 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.145 -0.48 . . . . 63.44 110.86 -179.784 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . 0.611 ' HB3' HG12 ' A' ' 49' ' ' VAL . 19.5 p -121.32 135.3 55.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.096 -0.502 . . . . 71.43 110.935 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.587 ' N ' ' O ' ' A' ' 48' ' ' ALA . 9.4 mmt85 -120.62 138.46 53.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.254 -0.43 . . . . 72.51 110.883 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.434 ' N ' ' CZ3' ' A' ' 47' ' ' TRP . . . -59.42 129.02 39.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.196 -0.457 . . . . 64.54 111.115 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.894 ' CG1' HG11 ' A' ' 136' ' ' VAL . 40.9 t -113.24 129.9 68.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.239 -0.437 . . . . 64.23 111.085 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . 0.552 ' O ' HG23 ' A' ' 136' ' ' VAL . 82.9 m-70 -111.52 107.46 16.65 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.154 -0.476 . . . . 73.14 110.892 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.488 HD23 ' H ' ' A' ' 88' ' ' LEU . 0.0 OUTLIER -32.66 141.86 0.18 Allowed Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.645 0.736 . . . . 64.21 110.904 -179.92 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.471 ' HB3' ' H ' ' A' ' 136' ' ' VAL . 53.4 Cg_endo -69.79 98.02 0.67 Allowed 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.693 2.262 . . . . 63.51 112.329 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -100.76 138.72 37.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.231 -0.441 . . . . 70.44 110.831 -179.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 105.1 115.81 4.13 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.707 -0.759 . . . . 74.23 112.51 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 52.31 48.33 54.2 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.684 -0.769 . . . . 42.2 112.514 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 24.7 pt20 38.95 -153.31 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.778 0.323 . . . . 75.24 110.924 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.62 ' HA ' ' CG ' ' A' ' 134' ' ' GLU . 33.0 t80 -106.23 104.08 13.7 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.229 -0.441 . . . . 73.12 110.903 -179.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.467 ' H ' ' CG ' ' A' ' 134' ' ' GLU . 33.5 tptt -96.92 132.23 42.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.153 -0.476 . . . . 70.33 110.906 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.415 HD12 ' OH ' ' A' ' 94' ' ' TYR . 0.2 OUTLIER -149.42 135.91 12.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.197 -0.456 . . . . 72.13 111.166 179.891 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.587 ' HB2' HG23 ' A' ' 132' ' ' VAL . 0.8 OUTLIER -107.31 132.5 53.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.195 -0.457 . . . . 75.43 110.898 179.983 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.581 HD13 HD11 ' A' ' 118' ' ' ILE . 2.8 mt -118.18 130.84 72.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.234 -0.439 . . . . 75.22 111.149 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.688 ' HB2' ' HB2' ' A' ' 129' ' ' SER . 5.7 m-85 -120.21 152.59 37.49 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.141 -0.481 . . . . 72.34 110.948 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 70.7 tt0 -81.06 -68.83 0.65 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.206 -0.452 . . . . 61.2 110.865 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.526 ' C ' ' HB2' ' A' ' 128' ' ' HIS . 33.1 mttt -89.19 166.3 13.9 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.186 -0.461 . . . . 63.35 110.888 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -80.25 160.99 44.72 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.746 -0.74 . . . . 64.11 112.504 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.444 ' HA ' ' HB2' ' A' ' 158' ' ' ARG . 41.1 t0 66.08 52.05 1.23 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.81 0.338 . . . . 74.11 110.878 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.639 ' CE1' ' HD2' ' A' ' 131' ' ' LYS . 6.9 m-85 48.19 33.23 3.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.2 -0.455 . . . . 73.43 110.862 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.461 ' C ' ' HB2' ' A' ' 101' ' ' LYS . 43.8 m -108.97 155.53 20.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.125 -0.489 . . . . 61.5 110.875 -179.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 89.52 -163.83 31.4 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.776 -0.726 . . . . 72.43 112.488 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -76.36 123.49 26.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.794 0.33 . . . . 54.21 110.931 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 3.5 ttp -107.71 131.42 54.44 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.187 -0.46 . . . . 71.03 110.897 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -133.79 137.02 44.88 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.208 -0.451 . . . . 73.45 110.95 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -117.04 107.47 14.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.143 -0.48 . . . . 62.44 110.841 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 10.1 t -123.04 155.98 35.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.133 -0.485 . . . . 75.24 111.104 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.423 ' HA ' ' O ' ' A' ' 94' ' ' TYR . 1.7 t -135.47 45.68 2.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.208 -0.451 . . . . 73.22 111.132 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -152.72 158.66 42.64 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.229 -0.441 . . . . 73.54 110.87 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -51.33 156.4 1.2 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.126 -0.488 . . . . 62.14 110.862 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . 0.526 ' O ' ' HB2' ' A' ' 172' ' ' SER . 39.7 t -146.42 113.28 4.4 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.632 0.729 . . . . 52.02 110.862 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.419 ' O ' ' C ' ' A' ' 143' ' ' PRO . 53.4 Cg_endo -69.74 -30.71 21.93 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.665 2.243 . . . . 75.13 112.333 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.653 ' HB3' ' CB ' ' A' ' 120' ' ' GLU . 0.1 OUTLIER -149.57 101.35 3.08 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.211 -0.449 . . . . 75.33 110.848 -179.815 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.639 HD13 HD11 ' A' ' 127' ' ' ILE . 3.0 tt -54.66 -29.74 21.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.175 -0.466 . . . . 74.22 111.163 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' MET . . . . . 0.581 ' O ' ' HA ' ' A' ' 123' ' ' HIS . 0.6 OUTLIER -86.53 -45.08 11.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.145 -0.48 . . . . 72.33 110.899 179.817 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.653 ' CB ' ' HB3' ' A' ' 117' ' ' SER . 6.6 tp10 -65.78 -12.87 57.55 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.245 -0.434 . . . . 70.34 110.887 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 27.8 tp60 -114.51 -51.17 2.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.176 -0.466 . . . . 75.54 110.872 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.459 ' HB2' ' O ' ' A' ' 118' ' ' ILE . 44.0 m-85 -102.89 -19.65 14.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.197 -0.456 . . . . 73.2 110.872 -179.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . 0.581 ' HA ' ' O ' ' A' ' 119' ' ' MET . 29.6 m-70 71.72 28.63 2.69 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.16 -0.473 . . . . 73.22 110.896 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.412 ' HB3' ' CD1' ' A' ' 127' ' ' ILE . 10.7 mtt -103.95 85.94 2.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.234 -0.439 . . . . 63.05 110.91 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 4.0 ptp180 -51.44 -38.11 52.01 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.205 -0.452 . . . . 72.44 110.859 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.473 ' HG2' ' HA ' ' A' ' 169' ' ' ALA . 13.2 mt-10 -142.23 133.03 25.61 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.17 -0.468 . . . . 73.13 110.858 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.639 HD11 HD13 ' A' ' 118' ' ' ILE . 3.8 mm -92.08 97.07 6.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.155 -0.475 . . . . 70.24 111.13 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . 0.526 ' HB2' ' C ' ' A' ' 101' ' ' LYS . 13.9 m170 -67.75 -34.04 76.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.133 -0.485 . . . . 73.12 110.891 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . 0.688 ' HB2' ' HB2' ' A' ' 99' ' ' PHE . 58.2 m -129.43 136.61 50.15 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.184 -0.462 . . . . 75.24 110.868 -179.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . 0.526 ' O ' ' O ' ' A' ' 155' ' ' LYS . 3.4 m -131.74 119.93 22.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.128 -0.487 . . . . 64.3 110.894 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.693 ' HA ' ' HA ' ' A' ' 156' ' ' GLU . 2.0 mtpp -115.45 150.71 36.02 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.179 -0.464 . . . . 72.33 110.911 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.587 HG23 ' HB2' ' A' ' 97' ' ' GLN . 16.4 t 83.59 163.42 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.198 -0.456 . . . . 51.31 111.137 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.822 HD13 ' O ' ' A' ' 154' ' ' LYS . 0.0 OUTLIER -174.86 123.67 0.25 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.163 -0.471 . . . . 75.32 110.899 179.994 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.62 ' CG ' ' HA ' ' A' ' 94' ' ' TYR . 0.0 OUTLIER -91.86 172.85 8.19 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.231 -0.441 . . . . 73.44 110.894 179.923 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -41.96 -47.25 5.2 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.696 -0.764 . . . . 73.34 112.466 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.894 HG11 ' CG1' ' A' ' 86' ' ' VAL . 5.2 t -148.87 142.54 18.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.819 0.342 . . . . 75.12 111.093 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' TRP . . . . . 0.712 ' HB3' ' CB ' ' A' ' 152' ' ' LEU . 25.0 t90 -149.43 148.17 29.13 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.142 -0.481 . . . . 73.25 110.925 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.683 HG12 HD13 ' A' ' 61' ' ' ILE . 20.3 mt -125.75 132.5 70.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.224 -0.444 . . . . 75.34 111.175 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.673 ' CE1' HG11 ' A' ' 170' ' ' VAL . 0.1 OUTLIER -100.84 152.98 19.87 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.169 -0.468 . . . . 63.05 110.866 179.981 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . 0.502 ' CD2' ' HA ' ' A' ' 145' ' ' TYR . 0.8 OUTLIER -129.14 127.16 40.85 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.146 -0.479 . . . . 74.21 110.922 -179.832 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . 0.632 ' O ' ' HB2' ' A' ' 171' ' ' GLN . 0.6 OUTLIER -61.63 -25.86 67.63 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.14 -0.482 . . . . 63.0 110.884 179.998 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.711 ' HB3' ' HD2' ' A' ' 143' ' ' PRO . 9.3 mp -114.64 173.07 3.09 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.659 0.742 . . . . 71.34 110.891 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . 0.735 ' O ' ' OG ' ' A' ' 172' ' ' SER . 53.8 Cg_endo -69.77 -90.34 0.0 OUTLIER 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.665 2.243 . . . . 73.32 112.349 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . 0.697 ' O ' ' N ' ' A' ' 146' ' ' ARG . 0.7 OUTLIER -51.88 97.73 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.247 -0.433 . . . . 73.3 110.903 179.993 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . 0.636 ' C ' ' O ' ' A' ' 144' ' ' ASN . 0.1 OUTLIER 12.46 53.19 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.215 -0.448 . . . . 74.12 110.883 -179.941 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . 0.697 ' N ' ' O ' ' A' ' 144' ' ' ASN . 20.7 mtt180 -120.4 173.54 7.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.175 -0.466 . . . . 72.4 110.851 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 79.83 179.51 52.42 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.712 -0.756 . . . . 74.34 112.49 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -74.02 146.58 43.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.799 0.333 . . . . 73.2 110.894 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' GLN . . . . . 0.644 ' CD ' HG21 ' A' ' 138' ' ' ILE . 16.8 mt-30 -85.92 153.86 21.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.455 . . . . 74.3 110.895 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . 0.601 ' HA ' ' HB2' ' A' ' 59' ' ' MET . 76.8 m-85 -135.12 122.3 21.51 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.191 -0.458 . . . . 72.44 110.964 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.708 ' HA ' HD11 ' A' ' 61' ' ' ILE . 33.5 tp -66.55 135.94 54.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.067 -0.515 . . . . 70.2 110.935 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.944 ' O ' HD13 ' A' ' 152' ' ' LEU . 0.0 OUTLIER -70.08 133.97 47.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.223 -0.444 . . . . 75.43 110.878 179.906 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -163.21 25.42 0.09 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.167 -0.469 . . . . 75.22 110.853 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.822 ' O ' HD13 ' A' ' 133' ' ' LEU . 0.1 OUTLIER -113.03 -169.42 1.48 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.15 -0.477 . . . . 74.41 110.888 179.993 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.809 ' CG ' HD22 ' A' ' 133' ' ' LEU . 0.6 OUTLIER -167.25 -122.06 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.245 -0.434 . . . . 74.22 110.925 179.866 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.693 ' HA ' ' HA ' ' A' ' 131' ' ' LYS . 0.7 OUTLIER -73.03 -1.26 16.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.241 -0.436 . . . . 75.15 110.832 179.976 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . 0.723 ' CE1' ' HA ' ' A' ' 154' ' ' LYS . 20.1 m-30 -27.26 141.03 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.195 -0.457 . . . . 73.41 110.892 -179.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . 0.561 ' O ' ' OG ' ' A' ' 129' ' ' SER . 9.9 ptp180 -107.62 -41.14 5.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.129 -0.487 . . . . 51.35 110.868 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -87.43 150.34 48.73 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.562 0.696 . . . . 55.31 110.902 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . 0.494 ' HB3' ' HB3' ' A' ' 168' ' ' PRO . 53.7 Cg_endo -69.8 -24.17 29.8 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.64 2.227 . . . . 75.22 112.371 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.613 ' H ' HD12 ' A' ' 161' ' ' ILE . 3.6 mp -69.25 -10.82 14.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.23 -0.441 . . . . 72.53 111.107 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.644 ' HB3' ' CD1' ' A' ' 157' ' ' TYR . 0.5 OUTLIER -75.79 -14.11 60.3 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.19 -0.459 . . . . 65.54 110.869 179.879 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' TRP . . . . . 0.43 ' CE3' ' HB3' ' A' ' 165' ' ' ALA . 24.8 t90 -88.69 -12.7 41.6 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.189 -0.459 . . . . 72.31 110.933 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 106.66 -37.03 4.03 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.751 -0.738 . . . . 42.52 112.487 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.43 ' HB3' ' CE3' ' A' ' 163' ' ' TRP . . . -77.1 126.77 31.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.796 0.331 . . . . 63.23 111.062 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . 0.4 ' C ' ' O ' ' A' ' 165' ' ' ALA . . . -37.56 -41.36 0.46 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 74.43 111.101 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . 0.489 ' C ' ' H ' ' A' ' 169' ' ' ALA . 0.3 OUTLIER -130.28 155.64 80.6 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.66 0.743 . . . . 75.55 110.82 -179.778 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . 0.494 ' HB3' ' HB3' ' A' ' 160' ' ' PRO . 53.6 Cg_endo -69.78 27.29 0.18 Allowed 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.674 2.249 . . . . 72.14 112.312 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 0.489 ' H ' ' C ' ' A' ' 167' ' ' SER . . . -65.63 104.6 1.06 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.213 -0.449 . . . . 70.3 111.147 179.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.673 HG11 ' CE1' ' A' ' 139' ' ' PHE . 2.8 t -151.75 161.97 3.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.21 -0.45 . . . . 72.11 111.127 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' GLN . . . . . 0.632 ' HB2' ' O ' ' A' ' 141' ' ' GLU . 1.8 tm0? -109.4 -82.08 0.57 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.213 -0.449 . . . . 75.52 110.91 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . 0.735 ' OG ' ' O ' ' A' ' 143' ' ' PRO . 21.6 p -130.87 176.22 8.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.208 -0.451 . . . . 52.4 110.831 -179.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' PHE . . . . . 0.469 ' HB3' ' CD1' ' A' ' 139' ' ' PHE . 32.2 p90 -144.31 173.78 11.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.114 -0.494 . . . . 74.44 110.885 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . 0.443 ' HG2' ' CE2' ' A' ' 140' ' ' TYR . 0.0 OUTLIER -147.4 141.36 25.9 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.152 -0.476 . . . . 75.14 110.88 -179.883 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . 0.494 HH12 HG12 ' A' ' 177' ' ' VAL . 0.0 OUTLIER -86.32 -177.23 6.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.18 -0.464 . . . . 73.23 110.909 -179.945 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . 0.483 HD11 HG13 ' A' ' 138' ' ' ILE . 2.9 mt -132.51 139.09 50.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.215 -0.448 . . . . 61.45 111.11 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.494 HG12 HH12 ' A' ' 175' ' ' ARG . 2.1 p -149.32 155.4 8.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.185 -0.461 . . . . 64.4 111.173 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.2 -0.455 . . . . 74.23 110.859 -179.96 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.318 0 N-CA-C 112.492 -0.243 . . . . 63.02 112.492 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.439 ' HB ' ' O ' ' A' ' 44' ' ' GLY . 12.2 p -82.23 133.11 35.24 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.839 0.352 . . . . 71.11 111.134 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 3.1 tttt -122.37 138.33 54.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.241 -0.436 . . . . 71.34 110.888 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.593 ' HB ' ' CD1' ' A' ' 47' ' ' TRP . 12.5 tt -136.64 149.75 26.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.233 -0.44 . . . . 70.31 111.142 179.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.521 HG22 ' CE2' ' A' ' 11' ' ' TYR . 24.8 m -133.62 129.13 36.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.181 -0.463 . . . . 71.2 111.139 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.867 ' HB2' HD22 ' A' ' 34' ' ' LEU . 0.4 OUTLIER -117.3 131.89 56.72 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.208 -0.451 . . . . 75.3 110.845 -179.977 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.538 ' CG ' ' HA ' ' A' ' 16' ' ' PHE . 44.1 m-85 -114.95 132.35 56.6 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.138 -0.483 . . . . 74.25 110.94 -179.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.477 ' HG2' ' HB2' ' A' ' 36' ' ' ARG . 0.0 OUTLIER -61.98 -24.63 67.14 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.162 -0.472 . . . . 70.54 110.876 -179.949 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 65.7 m-20 -126.12 150.42 48.25 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.16 -0.473 . . . . 72.31 110.836 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.537 ' N ' ' HB3' ' A' ' 38' ' ' ASN . 4.6 mtmm -55.04 -179.83 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.189 -0.46 . . . . 75.52 110.866 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 52.0 m-80 49.38 38.46 14.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.233 -0.44 . . . . 53.25 110.889 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.538 ' HA ' ' CG ' ' A' ' 11' ' ' TYR . 3.4 m-85 45.14 60.17 3.13 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.17 -0.468 . . . . 63.52 110.859 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -136.46 160.06 39.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.142 -0.481 . . . . 63.43 110.906 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 92.84 -150.99 20.26 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.751 -0.738 . . . . 50.2 112.518 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.767 ' O ' HD13 ' A' ' 34' ' ' LEU . 0.0 OUTLIER -67.49 79.62 0.17 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.812 0.339 . . . . 71.23 110.905 -179.888 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.44 ' HB2' ' CE1' ' A' ' 11' ' ' TYR . 0.7 OUTLIER -78.95 125.9 29.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 63.41 110.857 -179.897 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.483 ' CD2' ' CD2' ' A' ' 30' ' ' PHE . 82.4 t80 -121.18 124.35 44.5 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.182 -0.463 . . . . 75.14 110.905 -179.841 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.441 ' CG ' HG23 ' A' ' 9' ' ' THR . 1.0 OUTLIER -119.22 134.62 55.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.131 -0.486 . . . . 70.54 110.885 179.877 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -166.75 135.71 2.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.231 -0.44 . . . . 72.51 110.851 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -105.07 5.72 32.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.187 -0.461 . . . . 72.14 110.882 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 12.1 t -108.73 168.38 9.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.168 -0.469 . . . . 53.43 110.886 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 78.8 m-20 -64.64 116.72 6.5 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.232 -0.44 . . . . 74.34 110.887 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.477 ' HB2' ' HB3' ' A' ' 30' ' ' PHE . 7.4 m -119.42 54.4 0.99 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.203 -0.453 . . . . 74.51 110.872 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.539 ' C ' ' HA ' ' A' ' 82' ' ' SER . . . -45.88 -20.28 0.08 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.183 -0.462 . . . . 72.33 111.095 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.406 ' N ' ' C ' ' A' ' 27' ' ' CYS . 59.7 t0 -128.32 43.56 3.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.224 -0.444 . . . . 75.41 110.879 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.776 ' O ' ' CD2' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -80.97 14.72 2.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.174 -0.466 . . . . 74.02 110.884 -179.873 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.489 ' HB2' ' HB3' ' A' ' 53' ' ' PRO . 27.6 t60 -77.72 -38.66 46.7 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.159 -0.473 . . . . 74.23 110.845 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.6 t -58.22 -12.57 3.73 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.208 -0.451 . . . . 73.23 111.121 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -101.48 -28.37 12.6 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.18 -0.464 . . . . 75.45 110.941 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.867 HD22 ' HB2' ' A' ' 10' ' ' PHE . 16.0 tp -141.15 141.7 34.12 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.149 -0.478 . . . . 72.01 110.927 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -111.57 -31.11 7.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.187 -0.46 . . . . 70.21 110.908 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.485 ' O ' HD21 ' A' ' 34' ' ' LEU . 1.6 mtp85 -116.78 142.41 46.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.092 -0.504 . . . . 74.22 110.845 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.643 ' SG ' ' HB2' ' A' ' 80' ' ' LEU . 1.8 p -118.99 51.44 1.12 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.188 -0.46 . . . . 72.34 110.864 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.537 ' HB3' ' N ' ' A' ' 14' ' ' LYS . 1.9 m-80 -52.35 -62.68 1.48 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.165 -0.471 . . . . 54.14 110.896 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.433 ' HB2' ' HA ' ' A' ' 68' ' ' PRO . 9.3 p -121.8 127.78 50.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.201 -0.454 . . . . 75.01 110.809 -179.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.592 HG21 HD13 ' A' ' 62' ' ' LEU . 4.5 mt -127.15 148.59 31.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.124 -0.489 . . . . 65.01 111.135 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.46 122.0 15.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.17 -0.468 . . . . 74.13 110.863 179.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.585 ' CG2' HD12 ' A' ' 8' ' ' ILE . 0.9 OUTLIER -103.92 117.43 49.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.189 -0.459 . . . . 62.43 111.145 179.876 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -112.44 81.14 1.43 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.223 -0.444 . . . . 73.24 110.89 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.439 ' O ' ' HB ' ' A' ' 6' ' ' THR . . . 130.63 100.02 0.86 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.736 -0.745 . . . . 71.13 112.534 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 55.21 175.85 0.14 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.712 -0.756 . . . . 64.42 112.491 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.75 HG23 ' HA ' ' A' ' 63' ' ' PRO . 5.9 m -80.29 165.99 21.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.812 0.339 . . . . 65.54 111.137 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . 0.593 ' CD1' ' HB ' ' A' ' 8' ' ' ILE . 14.6 m95 -136.76 129.94 31.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.208 -0.451 . . . . 62.41 110.909 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.656 ' HB2' ' CG2' ' A' ' 86' ' ' VAL . . . -97.46 114.06 25.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.456 . . . . 72.02 111.111 179.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.921 HG11 HD11 ' A' ' 80' ' ' LEU . 5.1 m -116.8 134.04 61.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.243 -0.435 . . . . 70.14 111.151 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.741 ' HB3' ' HA ' ' A' ' 56' ' ' ALA . 35.1 m-85 -97.07 151.86 19.33 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.185 -0.461 . . . . 72.32 110.954 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.59 ' HB2' ' O ' ' A' ' 58' ' ' TYR . 8.8 tt0 -47.76 -78.84 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.143 -0.48 . . . . 55.0 110.892 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.618 ' HB3' ' CD1' ' A' ' 55' ' ' PHE . 4.7 mtp180 -90.25 143.95 30.33 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.656 0.741 . . . . 64.1 110.826 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.756 ' HA ' ' OG ' ' A' ' 82' ' ' SER . 53.9 Cg_endo -69.75 134.56 28.29 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.66 2.24 . . . . 62.51 112.372 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 66.2 -8.55 0.34 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.233 -0.439 . . . . 74.21 110.847 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.618 ' CD1' ' HB3' ' A' ' 52' ' ' ARG . 4.6 m-30 -101.75 -26.81 13.35 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.216 -0.447 . . . . 54.33 110.919 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.741 ' HA ' ' HB3' ' A' ' 50' ' ' TYR . . . 58.71 22.87 10.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.145 -0.479 . . . . 75.24 111.109 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . 0.645 ' O ' ' C ' ' A' ' 58' ' ' TYR . 2.4 m95 -52.17 -165.89 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.251 -0.432 . . . . 64.53 110.925 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.645 ' C ' ' O ' ' A' ' 57' ' ' TRP . 6.5 m-30 -12.46 103.62 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.231 -0.441 . . . . 74.31 110.936 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.523 ' HB2' ' O ' ' A' ' 149' ' ' GLN . 2.5 mpt? -62.29 147.48 47.99 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.128 -0.487 . . . . 73.04 110.903 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.617 ' O ' HG23 ' A' ' 49' ' ' VAL . 0.3 OUTLIER -164.29 92.27 0.64 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.236 -0.438 . . . . 74.21 110.865 -179.88 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.716 ' N ' HD12 ' A' ' 61' ' ' ILE . 1.6 mp -85.06 120.2 35.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.154 -0.475 . . . . 61.54 111.117 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.817 HD23 ' HD2' ' A' ' 63' ' ' PRO . 0.3 OUTLIER -87.55 126.15 62.96 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-O 121.658 0.742 . . . . 72.45 110.878 179.91 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.817 ' HD2' HD23 ' A' ' 62' ' ' LEU . 53.5 Cg_endo -69.83 -168.03 0.26 Allowed 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.684 2.256 . . . . 70.43 112.307 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.05 161.12 14.57 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.24 -0.437 . . . . 62.55 110.931 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 111.66 -157.52 14.9 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.775 -0.726 . . . . 64.41 112.507 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 5.3 mp0 -115.0 158.75 21.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.85 0.357 . . . . 64.4 110.904 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.472 ' N ' ' O ' ' A' ' 40' ' ' ILE . 7.2 m-85 -149.52 79.73 7.93 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 121.676 0.75 . . . . 75.23 110.976 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.532 ' HD2' ' HG3' ' A' ' 72' ' ' ARG . 53.6 Cg_endo -69.81 1.11 4.77 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.7 2.266 . . . . 65.44 112.29 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 86.3 mt-10 -159.15 154.36 25.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.25 -0.432 . . . . 74.33 110.903 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.836 ' O ' ' CD1' ' A' ' 73' ' ' TRP . 25.6 p90 -65.39 -12.19 49.75 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.135 -0.484 . . . . 75.52 110.949 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -86.75 -13.65 44.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.127 -0.488 . . . . 64.24 110.878 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.532 ' HG3' ' HD2' ' A' ' 68' ' ' PRO . 24.1 mmt180 -73.58 -27.09 61.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.221 -0.445 . . . . 74.22 110.919 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . 0.836 ' CD1' ' O ' ' A' ' 70' ' ' TYR . 0.6 OUTLIER -105.97 11.22 31.9 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.157 -0.474 . . . . 75.24 110.957 179.979 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . 0.506 ' C ' ' O ' ' A' ' 73' ' ' TRP . 0.4 OUTLIER 29.19 56.76 0.13 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.212 -0.449 . . . . 74.22 110.849 179.909 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.609 ' HA3' ' OH ' ' A' ' 60' ' ' TYR . . . -96.92 -140.27 11.19 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.733 -0.746 . . . . 63.13 112.51 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.758 HD21 ' HA ' ' A' ' 148' ' ' ARG . 0.0 OUTLIER -141.95 -84.1 0.19 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.831 0.348 . . . . 71.45 110.905 -179.946 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 -77.47 145.85 36.81 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.465 . . . . 63.11 110.915 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 -101.44 33.29 2.98 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.198 -0.456 . . . . 51.41 110.858 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -104.78 72.13 1.01 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.208 -0.451 . . . . 63.13 110.874 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.921 HD11 HG11 ' A' ' 49' ' ' VAL . 0.1 OUTLIER -77.83 130.25 36.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.162 -0.472 . . . . 74.54 110.906 -179.955 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.609 ' HB3' ' HB3' ' A' ' 53' ' ' PRO . 0.9 OUTLIER -146.92 -127.93 0.06 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.218 -0.446 . . . . 63.03 110.874 -179.929 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.756 ' OG ' ' HA ' ' A' ' 53' ' ' PRO . 0.7 OUTLIER -27.58 123.49 0.1 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.117 -0.492 . . . . 75.44 110.872 -179.845 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . 0.53 ' CB ' HG12 ' A' ' 49' ' ' VAL . 5.4 p -131.14 143.06 50.35 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.146 -0.479 . . . . 74.25 110.87 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.483 ' N ' ' O ' ' A' ' 48' ' ' ALA . 5.7 mmt85 -140.59 131.37 25.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.189 -0.459 . . . . 62.42 110.9 -179.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.412 ' N ' ' CZ3' ' A' ' 47' ' ' TRP . . . -56.27 123.88 16.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.22 -0.446 . . . . 74.32 111.043 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.965 HG11 HG11 ' A' ' 136' ' ' VAL . 1.9 t -115.93 143.31 26.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.21 -0.45 . . . . 62.41 111.113 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . 0.572 ' O ' ' CG2' ' A' ' 136' ' ' VAL . 34.9 m80 -111.23 106.45 15.44 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.184 -0.462 . . . . 73.41 110.878 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.501 HD23 ' H ' ' A' ' 88' ' ' LEU . 0.0 OUTLIER -31.64 150.17 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.659 0.742 . . . . 73.44 110.909 -179.975 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.58 ' HB3' ' H ' ' A' ' 136' ' ' VAL . 53.5 Cg_endo -69.77 83.39 0.7 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.674 2.249 . . . . 53.21 112.326 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -88.76 -173.35 4.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.188 -0.46 . . . . 73.33 110.832 -179.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 51.26 58.49 9.69 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.761 -0.733 . . . . 73.12 112.439 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 117.68 26.22 2.89 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.724 -0.751 . . . . 73.03 112.454 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 27.5 pt20 39.56 -148.57 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.826 0.346 . . . . 73.41 110.916 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.506 ' HA ' ' HG2' ' A' ' 134' ' ' GLU . 8.2 t80 -98.79 101.02 12.29 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.26 -0.427 . . . . 75.55 110.906 -179.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.429 ' HG3' HG11 ' A' ' 132' ' ' VAL . 38.2 tptt -107.91 130.34 55.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.126 -0.488 . . . . 62.3 110.896 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 4.2 tt -147.36 137.72 17.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.238 -0.437 . . . . 73.22 111.131 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.517 ' HB2' HG23 ' A' ' 132' ' ' VAL . 0.5 OUTLIER -109.92 113.35 26.01 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.211 -0.449 . . . . 74.01 110.942 179.905 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.578 HD11 HG22 ' A' ' 111' ' ' THR . 2.7 mp -93.66 136.17 26.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.163 -0.471 . . . . 75.0 111.15 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.646 ' HB2' ' HB2' ' A' ' 129' ' ' SER . 53.2 m-85 -124.73 140.1 53.24 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.194 -0.457 . . . . 70.52 110.855 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 64.6 tt0 -69.68 -75.17 0.12 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.148 -0.478 . . . . 70.14 110.889 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 16.5 mttt -84.51 170.41 13.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.138 -0.483 . . . . 73.35 110.893 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.441 ' CA ' ' HB3' ' A' ' 128' ' ' HIS . . . -73.73 159.62 53.1 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.724 -0.75 . . . . 72.01 112.478 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.486 ' HA ' ' HB2' ' A' ' 158' ' ' ARG . 60.9 t0 64.17 37.18 9.04 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.819 0.342 . . . . 73.41 110.844 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.57 ' CZ ' ' HB3' ' A' ' 158' ' ' ARG . 5.0 m-85 51.66 45.19 28.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.192 -0.458 . . . . 73.24 110.89 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 5.1 m -112.45 148.87 33.48 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.112 -0.495 . . . . 64.3 110.865 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 95.34 -132.5 11.13 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.776 -0.726 . . . . 63.03 112.519 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 43.3 tp60 -91.68 126.11 36.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.813 0.339 . . . . 61.24 110.948 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' MET . . . . . 0.459 ' HB2' ' CE1' ' A' ' 99' ' ' PHE . 4.8 ttt -113.55 131.56 56.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.168 -0.469 . . . . 71.44 110.849 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -136.26 136.38 39.79 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.215 -0.448 . . . . 64.12 110.93 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -118.37 109.2 16.0 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.115 -0.493 . . . . 65.32 110.896 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.578 HG22 HD11 ' A' ' 98' ' ' ILE . 14.1 t -123.46 145.68 48.63 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.132 -0.486 . . . . 65.44 111.18 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.474 ' O ' ' OG1' ' A' ' 112' ' ' THR . 0.8 OUTLIER -118.2 38.31 3.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.249 -0.432 . . . . 54.45 111.133 -179.944 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -150.94 170.43 19.35 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.228 -0.442 . . . . 72.02 110.898 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 -65.79 176.11 1.7 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.201 -0.454 . . . . 71.33 110.868 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 46.6 t -156.01 122.62 2.64 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.599 0.714 . . . . 52.54 110.891 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.475 ' C ' ' OG ' ' A' ' 172' ' ' SER . 54.0 Cg_endo -69.79 -31.24 20.76 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.646 2.23 . . . . 52.23 112.338 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.662 ' HB3' ' CB ' ' A' ' 120' ' ' GLU . 0.1 OUTLIER -152.99 92.97 1.69 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.222 -0.445 . . . . 43.44 110.872 -179.86 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.679 ' HB ' ' O ' ' A' ' 171' ' ' GLN . 5.0 tt -49.01 -28.78 2.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.157 -0.474 . . . . 74.02 111.155 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' MET . . . . . 0.581 ' O ' ' HA ' ' A' ' 123' ' ' HIS . 15.7 ttp -86.36 -45.19 11.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.186 -0.461 . . . . 74.55 110.848 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.662 ' CB ' ' HB3' ' A' ' 117' ' ' SER . 10.1 tp10 -66.75 -13.37 61.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.232 -0.44 . . . . 61.5 110.875 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -114.52 -51.9 2.73 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.185 -0.461 . . . . 74.14 110.897 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.48 ' HB2' ' O ' ' A' ' 118' ' ' ILE . 14.6 m-85 -101.89 -18.67 15.6 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.24 -0.437 . . . . 73.33 110.935 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . 0.581 ' HA ' ' O ' ' A' ' 119' ' ' MET . 16.6 m80 68.42 32.72 4.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.078 -0.51 . . . . 74.14 110.892 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.483 ' SD ' HG22 ' A' ' 98' ' ' ILE . 9.3 mtt -111.04 84.62 1.96 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.183 -0.462 . . . . 63.32 110.819 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 3.9 ptp180 -52.93 -34.87 57.41 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.23 -0.441 . . . . 63.33 110.884 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.475 ' HG2' ' HA ' ' A' ' 169' ' ' ALA . 35.0 mt-10 -142.34 128.77 20.1 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.192 -0.458 . . . . 74.04 110.864 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.545 HD11 HD13 ' A' ' 118' ' ' ILE . 4.1 mm -87.89 101.16 11.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.146 -0.479 . . . . 74.13 111.159 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . 0.441 ' HB3' ' CA ' ' A' ' 102' ' ' GLY . 22.3 m80 -69.65 -35.24 75.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.165 -0.471 . . . . 72.45 110.861 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . 0.646 ' HB2' ' HB2' ' A' ' 99' ' ' PHE . 6.2 m -135.4 152.2 51.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.255 -0.43 . . . . 72.11 110.87 -179.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . 0.498 ' HB2' ' CH2' ' A' ' 163' ' ' TRP . 0.0 OUTLIER -156.22 118.24 3.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.144 -0.48 . . . . 70.05 110.901 -179.934 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.523 ' C ' HG23 ' A' ' 132' ' ' VAL . 3.7 mtpp -105.66 161.2 14.59 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.182 -0.463 . . . . 74.5 110.875 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.572 HG12 ' N ' ' A' ' 133' ' ' LEU . 16.0 t 86.03 165.97 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.469 . . . . 21.52 111.154 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.657 HD13 ' CE ' ' A' ' 155' ' ' LYS . 1.0 OUTLIER -166.2 131.19 2.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.182 -0.463 . . . . 74.11 110.895 179.941 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.506 ' HG2' ' HA ' ' A' ' 94' ' ' TYR . 0.8 OUTLIER -105.29 147.72 27.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.192 -0.458 . . . . 72.23 110.9 179.921 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . 0.483 ' C ' ' O ' ' A' ' 134' ' ' GLU . . . -31.37 -45.63 0.14 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.746 -0.74 . . . . 25.32 112.508 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.982 ' HB ' HD12 ' A' ' 176' ' ' ILE . 0.7 OUTLIER -149.94 135.6 11.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.823 0.344 . . . . 75.31 111.116 -179.98 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' TRP . . . . . 0.647 ' HB3' ' CB ' ' A' ' 152' ' ' LEU . 24.0 t90 -150.14 149.59 30.46 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.131 -0.486 . . . . 72.41 110.92 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.415 ' HA ' ' O ' ' A' ' 150' ' ' TYR . 16.6 mt -124.17 132.04 71.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.275 -0.421 . . . . 71.51 111.118 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.759 ' CE2' HG11 ' A' ' 170' ' ' VAL . 0.1 OUTLIER -99.09 139.13 35.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.167 -0.47 . . . . 74.33 110.884 179.966 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . 0.495 ' CD2' ' HA ' ' A' ' 145' ' ' TYR . 0.1 OUTLIER -110.59 126.86 54.89 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.159 -0.473 . . . . 74.23 110.914 -179.843 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . 0.564 ' O ' ' HB2' ' A' ' 171' ' ' GLN . 26.6 tt0 -66.08 -27.83 68.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.101 -0.5 . . . . 71.24 110.886 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.601 ' HB3' ' HD2' ' A' ' 143' ' ' PRO . 9.9 mp -109.73 169.71 6.13 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.632 0.729 . . . . 73.45 110.929 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . 0.718 ' O ' ' HB2' ' A' ' 172' ' ' SER . 53.5 Cg_endo -69.73 -89.15 0.0 OUTLIER 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.713 2.276 . . . . 72.41 112.338 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . 0.73 ' O ' ' N ' ' A' ' 146' ' ' ARG . 1.1 m-20 -48.43 96.43 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.218 -0.446 . . . . 75.13 110.924 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . 0.636 ' C ' ' O ' ' A' ' 144' ' ' ASN . 20.1 m-85 12.54 51.6 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.191 -0.459 . . . . 72.41 110.905 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . 0.73 ' N ' ' O ' ' A' ' 144' ' ' ASN . 11.4 mtp85 -127.01 178.62 5.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.132 -0.485 . . . . 72.31 110.876 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 86.78 167.16 43.39 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.73 -0.747 . . . . 61.35 112.469 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.758 ' HA ' HD21 ' A' ' 76' ' ' LEU . 2.8 mpt_? -65.48 142.18 58.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.796 0.331 . . . . 71.12 110.86 -179.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' GLN . . . . . 0.523 ' O ' ' HB2' ' A' ' 59' ' ' MET . 51.4 mt-30 -81.29 155.57 25.98 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.173 -0.467 . . . . 64.14 110.907 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . 0.524 ' HB2' ' CB ' ' A' ' 139' ' ' PHE . 95.9 m-85 -138.29 123.01 18.71 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.231 -0.44 . . . . 74.42 110.924 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.559 ' HB2' HD11 ' A' ' 61' ' ' ILE . 21.3 tp -64.66 132.7 50.42 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.101 -0.499 . . . . 64.11 110.97 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.918 ' O ' HD13 ' A' ' 152' ' ' LEU . 0.0 OUTLIER -68.45 133.29 48.41 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.218 -0.446 . . . . 73.24 110.906 179.912 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -163.28 25.95 0.09 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.147 -0.479 . . . . 74.45 110.907 179.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.743 ' HA ' ' CE1' ' A' ' 157' ' ' TYR . 0.0 OUTLIER -108.89 -173.86 2.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.148 -0.478 . . . . 71.13 110.872 -179.99 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.657 ' CE ' HD13 ' A' ' 133' ' ' LEU . 4.0 mptt -164.93 -124.43 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.218 -0.446 . . . . 74.35 110.911 179.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.504 ' HA ' ' HA ' ' A' ' 131' ' ' LYS . 4.4 tm-20 -71.5 1.37 6.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.223 -0.444 . . . . 71.52 110.851 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . 0.743 ' CE1' ' HA ' ' A' ' 154' ' ' LYS . 21.3 m-30 -31.23 143.81 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.191 -0.459 . . . . 70.25 110.938 -179.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . 0.57 ' HB3' ' CZ ' ' A' ' 104' ' ' PHE . 0.0 OUTLIER -115.35 -40.68 3.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.128 -0.487 . . . . 54.32 110.897 -179.989 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . 0.472 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 0.2 OUTLIER -81.01 150.89 69.59 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.553 0.692 . . . . 73.34 110.918 179.966 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . 0.565 ' HA ' ' NE1' ' A' ' 163' ' ' TRP . 53.5 Cg_endo -69.78 -27.47 26.35 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.655 2.237 . . . . 74.31 112.346 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.65 ' H ' HD12 ' A' ' 161' ' ' ILE . 3.8 mp -67.21 -3.5 2.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.236 -0.438 . . . . 73.54 111.114 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.654 ' HB3' ' CD1' ' A' ' 157' ' ' TYR . 0.3 OUTLIER -76.61 -23.21 53.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.215 -0.448 . . . . 71.33 110.876 179.818 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' TRP . . . . . 0.565 ' NE1' ' HA ' ' A' ' 160' ' ' PRO . 1.7 m95 -79.96 -1.37 39.19 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.198 -0.455 . . . . 74.24 110.931 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 92.46 -35.22 4.12 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.728 -0.749 . . . . 74.25 112.475 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.415 ' O ' ' C ' ' A' ' 166' ' ' ALA . . . -77.37 129.2 35.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.826 0.346 . . . . 71.31 111.091 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . 0.415 ' C ' ' O ' ' A' ' 165' ' ' ALA . . . -37.08 -40.08 0.28 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.224 -0.443 . . . . 65.12 111.117 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . 0.479 ' C ' ' H ' ' A' ' 169' ' ' ALA . 0.3 OUTLIER -129.29 157.32 76.53 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.61 0.719 . . . . 74.15 110.867 -179.767 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . 0.517 ' HD3' ' HB2' ' A' ' 160' ' ' PRO . 53.4 Cg_endo -69.73 29.07 0.18 Allowed 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.667 2.245 . . . . 34.22 112.324 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 0.479 ' H ' ' C ' ' A' ' 167' ' ' SER . . . -66.01 106.58 1.63 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.244 -0.435 . . . . 62.12 111.094 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.759 HG11 ' CE2' ' A' ' 139' ' ' PHE . 3.3 t -152.08 165.92 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.224 -0.444 . . . . 72.43 111.083 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' GLN . . . . . 0.679 ' O ' ' HB ' ' A' ' 118' ' ' ILE . 2.6 mm-40 -123.72 -87.11 0.63 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.142 -0.481 . . . . 63.25 110.884 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . 0.718 ' HB2' ' O ' ' A' ' 143' ' ' PRO . 3.1 m -111.11 175.65 5.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.174 -0.466 . . . . 61.34 110.897 -179.804 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' PHE . . . . . 0.452 ' HB3' ' CD2' ' A' ' 139' ' ' PHE . 1.8 p90 -147.94 158.58 44.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.168 -0.469 . . . . 71.42 110.899 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . 0.429 ' HG2' ' CD2' ' A' ' 140' ' ' TYR . 0.0 OUTLIER -133.93 139.75 46.34 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.12 -0.491 . . . . 73.34 110.837 -179.857 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -95.38 -170.08 2.1 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.177 -0.465 . . . . 70.52 110.851 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . 0.982 HD12 ' HB ' ' A' ' 136' ' ' VAL . 3.3 mt -139.21 135.79 41.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.145 -0.479 . . . . 72.44 111.16 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 25.9 t -148.8 150.11 14.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.192 -0.458 . . . . 70.33 111.1 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.259 0 CA-C-N 116.134 -0.484 . . . . 74.12 110.936 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.312 0 N-CA-C 112.462 -0.255 . . . . 71.32 112.462 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.515 ' C ' ' HE1' ' A' ' 47' ' ' TRP . 11.2 p -82.58 133.1 35.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.882 0.372 . . . . 62.13 111.122 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 3.5 tttt -121.15 137.65 54.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.242 -0.435 . . . . 65.25 110.895 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.617 HD12 ' CG2' ' A' ' 42' ' ' VAL . 11.6 tt -137.33 149.41 25.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.209 -0.451 . . . . 71.1 111.166 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.525 HG22 ' CE2' ' A' ' 11' ' ' TYR . 24.5 m -131.74 129.02 40.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.178 -0.464 . . . . 61.34 111.133 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.818 ' HB2' HD22 ' A' ' 34' ' ' LEU . 0.6 OUTLIER -116.15 132.35 56.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.16 -0.473 . . . . 71.34 110.875 -179.957 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.556 ' CG ' ' HA ' ' A' ' 16' ' ' PHE . 49.1 m-85 -116.01 131.92 56.8 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.16 -0.473 . . . . 73.23 110.966 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.481 ' HG2' ' HB2' ' A' ' 36' ' ' ARG . 0.0 OUTLIER -60.7 -25.73 66.61 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 74.34 110.92 179.987 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 -125.96 151.23 47.28 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.114 -0.494 . . . . 75.1 110.855 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.441 ' HG3' ' HB3' ' A' ' 38' ' ' ASN . 19.7 mtmt -54.94 -178.21 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 62.24 110.936 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 24.7 m-20 47.68 38.72 8.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.256 -0.429 . . . . 62.41 110.894 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.556 ' HA ' ' CG ' ' A' ' 11' ' ' TYR . 3.0 m-85 44.71 60.48 2.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.15 -0.477 . . . . 60.32 110.885 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -135.97 158.78 43.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.088 -0.505 . . . . 74.12 110.882 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 93.47 -151.51 20.39 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.76 -0.733 . . . . 73.45 112.491 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.787 ' O ' HD13 ' A' ' 34' ' ' LEU . 0.3 OUTLIER -67.27 80.85 0.14 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.794 0.331 . . . . 74.24 110.937 -179.869 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.43 ' HA ' ' O ' ' A' ' 10' ' ' PHE . 0.7 OUTLIER -79.38 126.31 30.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.209 -0.45 . . . . 72.34 110.911 -179.89 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.478 ' CD2' ' CD2' ' A' ' 30' ' ' PHE . 85.9 t80 -121.46 124.03 43.47 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.221 -0.445 . . . . 74.41 110.909 -179.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.456 ' CG ' HG23 ' A' ' 9' ' ' THR . 1.0 OUTLIER -119.14 134.84 54.97 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.134 -0.485 . . . . 70.3 110.835 179.934 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -166.94 135.81 2.78 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.156 -0.474 . . . . 73.23 110.899 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -104.53 5.75 34.19 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 72.25 110.844 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 13.9 t -110.71 164.49 12.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.193 -0.458 . . . . 73.24 110.868 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -60.82 117.54 5.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.186 -0.461 . . . . 65.25 110.86 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.465 ' HB2' ' SG ' ' A' ' 83' ' ' CYS . 18.7 m -117.48 55.51 0.85 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.245 -0.434 . . . . 54.51 110.864 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.526 ' C ' ' HA ' ' A' ' 82' ' ' SER . . . -46.64 -19.14 0.08 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.208 -0.451 . . . . 53.52 111.158 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.402 ' N ' ' C ' ' A' ' 27' ' ' CYS . 52.4 t0 -128.71 42.14 3.37 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.212 -0.449 . . . . 65.14 110.872 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.805 ' O ' ' CD2' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -80.45 15.75 1.54 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.459 . . . . 74.15 110.864 -179.893 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.501 ' HB2' ' HB3' ' A' ' 81' ' ' SER . 33.2 t60 -80.65 -38.15 29.67 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.163 -0.471 . . . . 75.45 110.785 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.7 t -60.16 -12.52 8.77 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.245 -0.434 . . . . 62.02 111.137 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -101.34 -27.6 13.08 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.246 -0.434 . . . . 72.45 110.925 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.818 HD22 ' HB2' ' A' ' 10' ' ' PHE . 19.1 tp -141.94 140.53 32.8 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.133 -0.485 . . . . 71.31 110.888 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.1 m -109.07 -31.95 7.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.221 -0.445 . . . . 55.3 110.883 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.561 ' NH2' HD21 ' A' ' 38' ' ' ASN . 1.8 mtp85 -116.82 142.0 47.49 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.128 -0.487 . . . . 70.25 110.872 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.582 ' HB3' ' HB2' ' A' ' 80' ' ' LEU . 0.9 OUTLIER -118.37 52.09 1.05 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.22 -0.445 . . . . 61.45 110.869 -179.957 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.561 HD21 ' NH2' ' A' ' 36' ' ' ARG . 3.0 m120 -53.01 -70.78 0.08 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.203 -0.453 . . . . 73.41 110.866 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 8.7 p -112.86 128.42 56.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.203 -0.453 . . . . 74.24 110.887 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.659 HG21 HD13 ' A' ' 62' ' ' LEU . 5.4 mt -127.41 150.1 32.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.097 -0.501 . . . . 71.31 111.131 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.47 122.75 14.83 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.17 -0.468 . . . . 75.21 110.892 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.617 ' CG2' HD12 ' A' ' 8' ' ' ILE . 1.4 t -104.43 116.59 48.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.23 -0.441 . . . . 70.35 111.176 179.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -111.55 80.97 1.37 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.161 -0.472 . . . . 74.25 110.866 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.411 ' O ' ' HA ' ' A' ' 6' ' ' THR . . . 128.75 103.69 1.13 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.745 -0.74 . . . . 64.22 112.527 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.464 ' HA2' HD21 ' A' ' 88' ' ' LEU . . . 53.97 178.09 0.12 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.75 -0.738 . . . . 71.43 112.464 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.762 HG23 ' HA ' ' A' ' 63' ' ' PRO . 3.1 m -81.36 165.66 21.14 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.729 0.299 . . . . 74.31 111.177 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . 0.598 ' CD1' ' HB ' ' A' ' 8' ' ' ILE . 6.2 m95 -139.86 130.09 25.22 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.216 -0.447 . . . . 73.51 110.925 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.842 ' HB2' ' CG2' ' A' ' 86' ' ' VAL . . . -95.12 129.01 42.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.203 -0.453 . . . . 65.54 111.152 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.788 HG12 ' HB3' ' A' ' 83' ' ' CYS . 14.1 m -127.47 127.27 68.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.233 -0.439 . . . . 74.51 111.115 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.756 ' HB3' ' HA ' ' A' ' 56' ' ' ALA . 45.8 m-85 -93.36 147.51 22.87 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.137 -0.483 . . . . 74.43 110.927 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.655 ' OE1' ' HB3' ' A' ' 57' ' ' TRP . 54.7 tt0 -48.5 -78.48 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.113 -0.494 . . . . 75.21 110.862 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.544 ' HB3' ' CD1' ' A' ' 55' ' ' PHE . 0.0 OUTLIER -92.98 143.81 27.41 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.652 0.739 . . . . 72.14 110.878 -179.907 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.769 ' HA ' ' OG ' ' A' ' 82' ' ' SER . 53.8 Cg_endo -69.75 141.59 45.67 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.688 2.259 . . . . 62.41 112.34 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 62.53 -10.98 0.08 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.19 -0.459 . . . . 74.31 110.876 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.614 ' H ' ' C ' ' A' ' 53' ' ' PRO . 2.6 m-30 -104.34 -20.19 13.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.455 . . . . 74.43 110.869 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.756 ' HA ' ' HB3' ' A' ' 50' ' ' TYR . . . 48.55 26.44 1.19 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.168 -0.469 . . . . 72.55 111.117 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . 0.655 ' HB3' ' OE1' ' A' ' 51' ' ' GLU . 0.0 OUTLIER -50.7 -159.98 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.233 -0.44 . . . . 72.33 110.919 -179.978 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.627 ' C ' ' O ' ' A' ' 57' ' ' TRP . 6.0 m-30 -15.5 103.84 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.213 -0.448 . . . . 71.41 110.914 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.468 ' HB2' ' O ' ' A' ' 149' ' ' GLN . 0.8 OUTLIER -62.44 145.14 54.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.124 -0.489 . . . . 73.14 110.892 179.891 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.646 ' O ' ' O ' ' A' ' 49' ' ' VAL . 0.4 OUTLIER -160.76 100.12 1.27 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.218 -0.447 . . . . 74.13 110.945 -179.89 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.796 ' N ' HD12 ' A' ' 61' ' ' ILE . 1.3 mp -94.22 117.17 37.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.101 -0.5 . . . . 54.43 111.157 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.741 HD23 ' HD2' ' A' ' 63' ' ' PRO . 0.4 OUTLIER -84.21 125.84 71.25 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.618 0.723 . . . . 61.24 110.92 179.928 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.762 ' HA ' HG23 ' A' ' 46' ' ' THR . 53.7 Cg_endo -69.68 -165.58 0.16 Allowed 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.68 2.253 . . . . 54.01 112.381 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.22 159.86 14.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.238 -0.437 . . . . 63.01 110.885 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 113.62 -149.95 18.58 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.791 -0.719 . . . . 60.42 112.495 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -122.94 160.36 26.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.859 0.362 . . . . 75.23 110.93 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.551 ' CE1' HD22 ' A' ' 62' ' ' LEU . 5.9 m-85 -150.05 79.1 7.78 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.668 0.747 . . . . 65.34 110.924 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.498 ' HD2' ' HG3' ' A' ' 72' ' ' ARG . 53.4 Cg_endo -69.81 0.48 5.62 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.721 2.281 . . . . 74.44 112.305 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 76.3 mt-10 -157.31 156.17 31.92 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.247 -0.433 . . . . 75.32 110.906 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.832 ' O ' ' CD1' ' A' ' 73' ' ' TRP . 11.7 p90 -68.35 -6.87 26.69 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.248 -0.433 . . . . 75.23 110.895 -179.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -87.12 -13.48 44.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.141 -0.481 . . . . 70.43 110.891 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.498 ' HG3' ' HD2' ' A' ' 68' ' ' PRO . 21.2 mmt180 -73.5 -24.64 60.2 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.224 -0.444 . . . . 70.21 110.891 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . 0.832 ' CD1' ' O ' ' A' ' 70' ' ' TYR . 0.5 OUTLIER -111.8 25.13 11.93 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.179 -0.464 . . . . 75.3 110.934 -179.975 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . 0.552 ' CB ' ' O ' ' A' ' 73' ' ' TRP . 2.0 mmt 87.38 -38.47 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.248 -0.433 . . . . 75.14 110.927 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 88.93 45.83 4.7 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.724 -0.751 . . . . 53.32 112.495 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.595 HD21 ' HA ' ' A' ' 148' ' ' ARG . 0.4 OUTLIER -67.08 -74.95 0.1 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.837 0.351 . . . . 61.35 110.94 -179.957 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -129.28 136.13 49.66 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.188 -0.46 . . . . 71.53 110.859 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.424 ' C ' ' SG ' ' A' ' 37' ' ' CYS . 24.4 m-20 -90.35 18.54 6.0 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.187 -0.46 . . . . 72.31 110.858 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.406 ' HD2' ' HG2' ' A' ' 51' ' ' GLU . 0.6 OUTLIER -112.33 86.45 2.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.199 -0.455 . . . . 73.32 110.874 -179.914 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.806 HD12 ' CD1' ' A' ' 10' ' ' PHE . 0.0 OUTLIER -89.86 133.24 34.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.216 -0.447 . . . . 72.43 110.947 -179.992 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.641 ' HB3' ' HB3' ' A' ' 53' ' ' PRO . 0.8 OUTLIER -151.23 -127.93 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.203 -0.453 . . . . 62.41 110.875 -179.923 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.769 ' OG ' ' HA ' ' A' ' 53' ' ' PRO . 0.1 OUTLIER -33.98 102.16 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 62.51 110.847 -179.845 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . 0.788 ' HB3' HG12 ' A' ' 49' ' ' VAL . 30.2 p -118.82 133.35 55.9 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.125 -0.488 . . . . 75.3 110.882 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.599 ' N ' ' O ' ' A' ' 48' ' ' ALA . 13.7 mmt85 -119.94 144.25 47.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.228 -0.442 . . . . 73.02 110.862 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.419 ' N ' ' CZ3' ' A' ' 47' ' ' TRP . . . -63.61 127.66 32.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.178 -0.465 . . . . 64.12 111.095 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.842 ' CG2' ' HB2' ' A' ' 48' ' ' ALA . 46.7 t -115.78 137.86 48.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 74.12 111.113 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . 0.558 ' O ' HG23 ' A' ' 136' ' ' VAL . 34.0 m80 -111.58 112.82 24.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.205 -0.452 . . . . 74.22 110.825 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.471 HD23 ' H ' ' A' ' 88' ' ' LEU . 0.0 OUTLIER -35.82 143.23 0.27 Allowed Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.594 0.712 . . . . 61.45 110.872 -179.967 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.58 ' HB3' ' H ' ' A' ' 136' ' ' VAL . 53.9 Cg_endo -69.81 78.62 1.01 Allowed 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.695 2.263 . . . . 64.15 112.334 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -78.03 -177.01 4.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.223 -0.444 . . . . 73.24 110.852 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 74.8 -97.46 1.0 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.736 -0.745 . . . . 60.23 112.466 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.411 ' O ' ' C ' ' A' ' 93' ' ' GLN . . . -90.29 44.61 2.94 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.779 -0.724 . . . . 72.24 112.496 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.469 ' O ' ' HG2' ' A' ' 134' ' ' GLU . 5.9 pt20 37.19 -122.17 0.19 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.876 0.37 . . . . 72.12 110.917 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.558 ' OH ' HG22 ' A' ' 177' ' ' VAL . 0.1 OUTLIER -121.41 103.59 9.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.196 -0.456 . . . . 72.14 110.934 -179.9 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.559 ' HG3' HG11 ' A' ' 132' ' ' VAL . 41.4 tptt -114.83 126.15 54.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.114 -0.494 . . . . 73.32 110.862 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 8.2 tt -147.57 137.94 17.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.23 -0.441 . . . . 74.12 111.127 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.487 ' HB2' HG23 ' A' ' 132' ' ' VAL . 0.6 OUTLIER -108.7 131.67 54.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.182 -0.463 . . . . 74.31 110.877 179.937 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.805 HG23 HG13 ' A' ' 127' ' ' ILE . 1.1 mp -115.64 134.5 58.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.455 . . . . 72.22 111.136 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.607 ' HB2' ' CB ' ' A' ' 129' ' ' SER . 7.1 m-85 -122.66 155.15 36.99 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.197 -0.456 . . . . 71.42 110.855 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.534 ' HA ' ' CE ' ' A' ' 124' ' ' MET . 56.6 tt0 -84.75 -44.0 13.74 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.183 -0.462 . . . . 71.24 110.854 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.468 ' HB2' ' C ' ' A' ' 105' ' ' SER . 55.9 mttt -117.61 155.0 30.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.182 -0.463 . . . . 62.04 110.894 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -73.82 169.48 53.57 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.757 -0.735 . . . . 73.53 112.436 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.44 ' HA ' ' HB2' ' A' ' 158' ' ' ARG . 36.9 t70 63.25 40.3 8.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.798 0.333 . . . . 65.44 110.814 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.623 ' CE1' ' HD2' ' A' ' 131' ' ' LYS . 11.6 m-85 54.89 49.27 18.16 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.25 -0.432 . . . . 54.14 110.867 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.468 ' C ' ' HB2' ' A' ' 101' ' ' LYS . 69.5 m -127.93 161.85 28.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.169 -0.469 . . . . 73.44 110.841 -179.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 83.04 -172.48 51.5 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.715 -0.755 . . . . 71.22 112.472 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 36.8 tp60 -67.62 120.59 14.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.78 0.324 . . . . 71.2 110.921 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 5.6 ttp -106.65 132.01 53.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.191 -0.459 . . . . 75.22 110.89 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -137.12 137.45 39.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.274 -0.421 . . . . 75.43 110.909 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -114.66 112.76 23.38 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.092 -0.504 . . . . 72.13 110.903 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 13.9 t -121.28 132.18 54.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.168 -0.469 . . . . 74.34 111.168 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.51 ' HA ' ' O ' ' A' ' 94' ' ' TYR . 1.8 t -112.29 37.1 3.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.246 -0.434 . . . . 72.15 111.129 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -151.03 165.43 33.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.229 -0.441 . . . . 63.41 110.857 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -53.11 161.22 0.88 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.142 -0.481 . . . . 74.35 110.83 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . 0.606 ' O ' ' HB2' ' A' ' 172' ' ' SER . 20.4 t -146.9 110.92 4.11 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.651 0.738 . . . . 75.1 110.882 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.512 ' O ' ' C ' ' A' ' 143' ' ' PRO . 53.6 Cg_endo -69.82 -38.6 7.45 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.647 2.231 . . . . 74.4 112.309 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.617 ' HB3' ' CB ' ' A' ' 120' ' ' GLU . 0.1 OUTLIER -147.28 105.41 3.75 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.238 -0.437 . . . . 75.23 110.839 -179.839 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.614 ' HB ' ' O ' ' A' ' 171' ' ' GLN . 3.4 tt -58.07 -27.94 32.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.125 -0.489 . . . . 54.22 111.118 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' MET . . . . . 0.684 ' O ' ' HA ' ' A' ' 123' ' ' HIS . 8.6 ttp -86.77 -40.57 14.86 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.17 -0.468 . . . . 73.33 110.875 179.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.617 ' CB ' ' HB3' ' A' ' 117' ' ' SER . 14.7 tp10 -70.52 -13.52 62.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.264 -0.426 . . . . 72.31 110.879 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 7.6 tp-100 -116.25 -50.71 2.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.152 -0.477 . . . . 73.15 110.944 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.482 ' HB2' ' O ' ' A' ' 118' ' ' ILE . 46.8 m-85 -101.26 -13.85 17.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.222 -0.445 . . . . 74.53 110.917 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . 0.684 ' HA ' ' O ' ' A' ' 119' ' ' MET . 27.9 m-70 69.16 24.86 5.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.125 -0.488 . . . . 64.24 110.828 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.534 ' CE ' ' HA ' ' A' ' 100' ' ' GLU . 0.9 OUTLIER -96.47 145.24 25.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.248 -0.433 . . . . 71.33 110.891 179.975 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 5.1 ptp180 -110.62 -40.91 4.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.249 -0.432 . . . . 74.31 110.862 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.442 ' HB3' ' HG2' ' A' ' 168' ' ' PRO . 17.6 mt-10 -141.05 116.13 9.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.205 -0.452 . . . . 70.51 110.864 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.805 HG13 HG23 ' A' ' 98' ' ' ILE . 1.0 OUTLIER -74.8 99.78 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.149 -0.478 . . . . 61.03 111.126 179.954 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . 0.427 ' CD2' ' HG3' ' A' ' 168' ' ' PRO . 24.8 m170 -73.33 -28.13 61.9 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.113 -0.494 . . . . 72.52 110.884 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . 0.607 ' CB ' ' HB2' ' A' ' 99' ' ' PHE . 0.5 OUTLIER -132.31 136.93 47.24 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.225 -0.443 . . . . 74.24 110.872 -179.741 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . 0.614 ' SG ' HG21 ' A' ' 127' ' ' ILE . 0.1 OUTLIER -135.09 118.15 16.43 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.218 -0.446 . . . . 64.03 110.881 -179.977 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.65 ' HA ' ' HA ' ' A' ' 156' ' ' GLU . 6.0 mtpp -118.59 152.53 35.85 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.153 -0.476 . . . . 61.43 110.859 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.559 HG11 ' HG3' ' A' ' 95' ' ' LYS . 16.6 t 82.74 163.4 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.217 -0.447 . . . . 51.3 111.108 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.829 HD13 ' O ' ' A' ' 154' ' ' LYS . 0.0 OUTLIER -179.73 123.57 0.07 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.17 -0.468 . . . . 71.55 110.911 179.942 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.516 ' O ' ' C ' ' A' ' 135' ' ' GLY . 0.1 OUTLIER -94.27 167.1 11.75 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.153 -0.476 . . . . 65.12 110.915 179.908 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . 0.516 ' C ' ' O ' ' A' ' 134' ' ' GLU . . . -27.93 -57.82 0.12 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.745 -0.74 . . . . 51.11 112.463 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.689 HG21 HG13 ' A' ' 86' ' ' VAL . 2.8 t -145.66 144.44 21.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.809 0.338 . . . . 74.11 111.167 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' TRP . . . . . 0.588 ' HB3' ' HB3' ' A' ' 152' ' ' LEU . 7.4 t-105 -143.52 152.98 42.13 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.22 -0.445 . . . . 75.45 110.974 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.493 ' CD1' ' HB ' ' A' ' 61' ' ' ILE . 2.8 mm -119.21 132.02 70.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.271 -0.422 . . . . 64.42 111.156 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.707 ' CE2' HG11 ' A' ' 170' ' ' VAL . 0.2 OUTLIER -111.41 146.37 37.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.187 -0.46 . . . . 72.52 110.858 179.951 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . 0.422 ' CD2' ' HA ' ' A' ' 145' ' ' TYR . 3.4 m-85 -127.79 130.01 47.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.069 -0.514 . . . . 74.23 110.889 -179.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . 0.613 ' O ' ' HB2' ' A' ' 171' ' ' GLN . 0.2 OUTLIER -60.34 -25.78 66.08 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.081 -0.509 . . . . 75.22 110.877 -179.984 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.748 ' HB3' ' HD2' ' A' ' 143' ' ' PRO . 9.7 mp -114.66 173.88 2.66 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.657 0.742 . . . . 70.3 110.88 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . 0.751 ' O ' ' OG ' ' A' ' 172' ' ' SER . 53.7 Cg_endo -69.77 -91.62 0.01 OUTLIER 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.726 2.284 . . . . 75.45 112.281 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . 0.71 ' O ' ' N ' ' A' ' 146' ' ' ARG . 0.9 OUTLIER -50.98 97.89 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.154 -0.476 . . . . 52.34 110.858 -179.926 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . 0.641 ' C ' ' O ' ' A' ' 144' ' ' ASN . 0.1 OUTLIER 12.1 53.09 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.143 -0.48 . . . . 72.13 110.923 -179.924 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . 0.71 ' N ' ' O ' ' A' ' 144' ' ' ASN . 11.3 mtp85 -118.76 174.71 6.12 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.095 -0.502 . . . . 75.04 110.844 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 80.84 -173.0 54.62 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.733 -0.746 . . . . 41.33 112.495 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.595 ' HA ' HD21 ' A' ' 76' ' ' LEU . 0.8 OUTLIER -80.58 150.46 29.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.749 0.309 . . . . 61.54 110.893 -179.906 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' GLN . . . . . 0.468 ' O ' ' HB2' ' A' ' 59' ' ' MET . 8.4 mt-30 -81.73 153.62 26.45 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.185 -0.461 . . . . 74.34 110.889 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . 0.585 ' HB2' ' CB ' ' A' ' 139' ' ' PHE . 98.3 m-85 -139.28 129.44 25.26 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.218 -0.446 . . . . 44.03 110.945 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.602 ' HB2' HD11 ' A' ' 61' ' ' ILE . 13.3 tp -81.78 121.72 26.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.092 -0.504 . . . . 43.23 110.911 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 1.02 ' O ' HD13 ' A' ' 152' ' ' LEU . 0.0 OUTLIER -53.77 135.86 40.82 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.191 -0.459 . . . . 73.32 110.948 179.886 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -164.07 27.75 0.08 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.206 -0.452 . . . . 74.15 110.828 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.829 ' O ' HD13 ' A' ' 133' ' ' LEU . 0.0 OUTLIER -116.71 -172.74 2.25 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.214 -0.448 . . . . 74.55 110.889 179.969 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.804 ' HG3' HD22 ' A' ' 133' ' ' LEU . 0.0 OUTLIER -162.39 -128.92 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.221 -0.445 . . . . 42.12 110.908 179.875 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.65 ' HA ' ' HA ' ' A' ' 131' ' ' LYS . 0.2 OUTLIER -68.0 1.13 2.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.213 -0.449 . . . . 74.14 110.936 179.956 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . 0.746 ' CE1' ' HA ' ' A' ' 154' ' ' LYS . 20.3 m-30 -28.78 143.47 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.094 -0.503 . . . . 75.25 110.933 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . 0.44 ' HB2' ' HA ' ' A' ' 103' ' ' ASP . 9.5 ptp180 -110.91 -43.4 3.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.158 -0.474 . . . . 71.54 110.921 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -82.45 151.24 65.16 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.519 0.676 . . . . 70.53 110.93 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . 0.541 ' HB3' ' HB3' ' A' ' 168' ' ' PRO . 54.0 Cg_endo -69.74 -26.67 27.45 Favored 'Trans proline' 0 C--O 1.231 0.136 0 C-N-CA 122.7 2.266 . . . . 75.15 112.347 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.598 ' H ' HD12 ' A' ' 161' ' ' ILE . 3.6 mp -65.44 -11.78 12.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.224 -0.444 . . . . 74.04 111.074 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.67 ' HB3' ' CD1' ' A' ' 157' ' ' TYR . 0.3 OUTLIER -75.0 -18.88 60.29 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.151 -0.477 . . . . 74.54 110.837 179.936 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 13.3 t90 -82.06 0.23 41.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.197 -0.456 . . . . 73.45 110.938 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 91.91 -36.2 3.74 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.75 -0.738 . . . . 65.54 112.507 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -79.68 128.39 33.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.777 0.322 . . . . 74.54 111.099 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -39.41 -38.28 0.54 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.194 -0.457 . . . . 50.02 111.101 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . 0.496 ' C ' ' H ' ' A' ' 169' ' ' ALA . 0.5 OUTLIER -128.18 154.26 78.77 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.642 0.734 . . . . 64.31 110.892 -179.822 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . 0.541 ' HB3' ' HB3' ' A' ' 160' ' ' PRO . 54.4 Cg_endo -69.74 25.13 0.17 Allowed 'Trans proline' 0 C--O 1.231 0.147 0 C-N-CA 122.742 2.294 . . . . 73.54 112.352 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 0.496 ' H ' ' C ' ' A' ' 167' ' ' SER . . . -65.89 103.65 0.96 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.223 -0.444 . . . . 72.13 111.11 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.707 HG11 ' CE2' ' A' ' 139' ' ' PHE . 2.6 t -152.14 163.43 2.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.225 -0.443 . . . . 63.22 111.145 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' GLN . . . . . 0.64 ' OE1' ' HB3' ' A' ' 143' ' ' PRO . 1.8 mm-40 -114.26 -89.57 0.54 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.19 -0.459 . . . . 74.42 110.914 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . 0.751 ' OG ' ' O ' ' A' ' 143' ' ' PRO . 12.6 p -126.9 177.05 6.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.194 -0.457 . . . . 61.1 110.852 -179.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' PHE . . . . . 0.604 ' CE1' HD11 ' A' ' 98' ' ' ILE . 1.4 p90 -145.8 174.38 11.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.105 -0.498 . . . . 72.42 110.883 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.18 154.61 46.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.179 -0.464 . . . . 73.01 110.88 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.15 -169.91 2.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.16 -0.473 . . . . 72.34 110.864 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . 0.422 HD12 ' HB ' ' A' ' 136' ' ' VAL . 4.5 mt -134.51 136.85 52.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.21 -0.45 . . . . 74.24 111.173 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.558 HG22 ' OH ' ' A' ' 94' ' ' TYR . 10.7 t -140.31 153.43 22.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.218 -0.446 . . . . 65.44 111.142 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . 0.445 ' HB3' HD13 ' A' ' 88' ' ' LEU . 10.6 pt-20 . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 116.133 -0.485 . . . . 61.22 110.855 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.376 0 N-CA-C 112.489 -0.245 . . . . 64.43 112.489 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.514 ' C ' ' HE1' ' A' ' 47' ' ' TRP . 6.9 p -82.8 135.81 34.85 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.908 0.385 . . . . 75.43 111.117 -179.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 3.6 tttt -122.54 135.24 54.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 72.42 110.937 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.591 ' HB ' HG22 ' A' ' 42' ' ' VAL . 15.2 tt -136.75 150.61 27.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.21 -0.45 . . . . 52.14 111.125 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.496 HG23 ' CG ' ' A' ' 22' ' ' ASP . 13.6 m -127.4 146.29 50.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.187 -0.461 . . . . 74.42 111.164 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.795 ' HB2' HD22 ' A' ' 34' ' ' LEU . 0.2 OUTLIER -134.07 127.17 31.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.206 -0.452 . . . . 71.43 110.888 179.999 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.551 ' CG ' ' HA ' ' A' ' 16' ' ' PHE . 26.2 m-85 -113.41 131.82 55.86 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.149 -0.478 . . . . 71.11 110.923 -179.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.458 ' N ' HD11 ' A' ' 34' ' ' LEU . 0.0 OUTLIER -60.26 -15.43 24.79 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.121 -0.49 . . . . 65.14 110.9 179.987 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.449 ' HB2' ' O ' ' A' ' 17' ' ' GLN . 71.2 m-20 -134.89 150.57 50.45 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.156 -0.475 . . . . 70.02 110.873 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.504 ' N ' ' HB3' ' A' ' 38' ' ' ASN . 39.4 mtmt -55.7 -177.78 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.182 -0.463 . . . . 74.13 110.857 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 22.7 m-20 48.14 33.26 3.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.17 -0.468 . . . . 75.3 110.888 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.551 ' HA ' ' CG ' ' A' ' 11' ' ' TYR . 3.3 m-85 49.22 64.3 1.79 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.164 -0.471 . . . . 71.44 110.853 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.449 ' O ' ' HB2' ' A' ' 13' ' ' ASP . 15.6 mt-30 -140.07 158.07 44.63 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.146 -0.479 . . . . 71.32 110.934 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 93.28 -150.63 20.0 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.775 -0.726 . . . . 74.43 112.476 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.715 ' O ' HD13 ' A' ' 34' ' ' LEU . 0.2 OUTLIER -66.72 78.51 0.11 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.754 0.311 . . . . 73.25 110.851 -179.829 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.475 ' HB2' ' CE1' ' A' ' 11' ' ' TYR . 0.7 OUTLIER -77.04 128.88 35.27 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.232 -0.44 . . . . 74.43 110.876 -179.921 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.475 ' O ' ' HA ' ' A' ' 9' ' ' THR . 88.1 t80 -123.06 125.72 45.73 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.21 -0.45 . . . . 73.14 110.943 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.496 ' CG ' HG23 ' A' ' 9' ' ' THR . 1.3 m-20 -123.33 132.63 54.05 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.156 -0.474 . . . . 72.31 110.857 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -166.0 138.33 3.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 65.34 110.927 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -104.72 4.48 32.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.195 -0.457 . . . . 73.12 110.846 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 14.9 t -108.55 164.2 12.56 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.21 -0.45 . . . . 64.35 110.882 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -60.25 117.49 5.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.173 -0.467 . . . . 73.31 110.832 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.469 ' HB3' ' CB ' ' A' ' 30' ' ' PHE . 16.6 m -117.07 54.05 0.88 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.173 -0.467 . . . . 61.03 110.894 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.525 ' O ' ' HA ' ' A' ' 82' ' ' SER . . . -47.67 -18.84 0.17 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 30.24 111.06 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 58.3 t0 -127.26 40.07 3.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.236 -0.438 . . . . 75.43 110.845 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.779 ' O ' ' CD2' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -80.77 14.12 2.3 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.224 -0.444 . . . . 72.45 110.896 -179.927 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.508 ' HB2' ' HB3' ' A' ' 53' ' ' PRO . 36.2 t60 -78.47 -37.75 42.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.121 -0.49 . . . . 71.32 110.893 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.5 t -58.19 -15.18 8.89 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.199 -0.455 . . . . 71.52 111.149 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -98.53 -27.97 13.8 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.243 -0.435 . . . . 73.44 110.899 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.795 HD22 ' HB2' ' A' ' 10' ' ' PHE . 15.6 tp -140.87 134.92 30.78 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.129 -0.487 . . . . 74.54 110.878 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 23.3 m -99.74 -41.49 7.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.187 -0.46 . . . . 73.0 110.866 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -119.14 143.08 47.4 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.13 -0.486 . . . . 73.43 110.865 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.64 ' SG ' ' HB2' ' A' ' 80' ' ' LEU . 1.8 p -115.65 89.75 3.17 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.193 -0.458 . . . . 74.51 110.919 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.504 ' HB3' ' N ' ' A' ' 14' ' ' LYS . 3.6 m-20 -85.46 -54.01 4.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.193 -0.458 . . . . 64.34 110.87 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 9.7 p -125.32 128.12 47.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 51.42 110.854 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.741 HG21 HD13 ' A' ' 62' ' ' LEU . 11.0 mt -127.05 152.08 34.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.11 -0.495 . . . . 74.25 111.123 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.435 ' N ' ' CG2' ' A' ' 40' ' ' ILE . 0.0 OUTLIER -142.78 118.33 10.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.188 -0.46 . . . . 74.55 110.877 179.852 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.591 HG22 ' HB ' ' A' ' 8' ' ' ILE . 1.9 t -101.2 115.15 42.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.187 -0.46 . . . . 72.22 111.111 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -111.28 79.96 1.26 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.181 -0.463 . . . . 72.21 110.889 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.454 ' O ' ' HA ' ' A' ' 6' ' ' THR . . . 129.44 103.33 1.07 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.72 -0.752 . . . . 74.44 112.467 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.475 ' HA2' HD21 ' A' ' 88' ' ' LEU . . . 52.84 178.1 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.704 -0.76 . . . . 63.13 112.49 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.758 HG23 ' HA ' ' A' ' 63' ' ' PRO . 3.0 m -79.65 164.78 23.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.794 0.331 . . . . 61.52 111.119 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . 0.575 ' CD1' ' HB ' ' A' ' 8' ' ' ILE . 2.7 m95 -137.69 130.02 29.34 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.155 -0.475 . . . . 74.55 110.857 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.805 ' HB2' ' CG2' ' A' ' 86' ' ' VAL . . . -92.77 131.26 37.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.227 -0.442 . . . . 74.21 111.151 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.907 HG11 HD11 ' A' ' 80' ' ' LEU . 19.6 m -132.56 127.51 56.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.241 -0.436 . . . . 73.24 111.105 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.75 ' HB3' ' HA ' ' A' ' 56' ' ' ALA . 38.9 m-85 -94.75 148.3 22.43 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.218 -0.447 . . . . 62.42 110.92 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.544 ' HB2' ' O ' ' A' ' 58' ' ' TYR . 7.1 tt0 -50.91 -76.55 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.148 -0.478 . . . . 43.24 110.855 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.571 ' HB3' ' CD1' ' A' ' 55' ' ' PHE . 19.2 mmm-85 -89.92 140.7 27.73 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.64 0.733 . . . . 72.2 110.846 -179.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.789 ' HA ' ' OG ' ' A' ' 82' ' ' SER . 54.1 Cg_endo -69.75 137.8 36.35 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.733 2.289 . . . . 71.45 112.322 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 65.32 -11.18 0.17 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.246 -0.434 . . . . 73.13 110.897 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.571 ' CD1' ' HB3' ' A' ' 52' ' ' ARG . 4.9 m-30 -100.85 -32.19 10.79 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.159 -0.473 . . . . 62.53 110.876 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.75 ' HA ' ' HB3' ' A' ' 50' ' ' TYR . . . 63.42 22.44 13.25 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.185 -0.461 . . . . 73.54 111.107 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . 0.629 ' O ' ' C ' ' A' ' 58' ' ' TYR . 1.2 t90 -51.4 -159.69 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.216 -0.447 . . . . 73.11 110.923 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.629 ' C ' ' O ' ' A' ' 57' ' ' TRP . 5.8 m-30 -13.72 101.43 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.278 -0.419 . . . . 71.54 110.929 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.407 ' HB2' ' HA ' ' A' ' 150' ' ' TYR . 2.1 mpt? -59.67 149.28 31.02 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.067 -0.515 . . . . 53.44 110.886 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.811 ' CE2' HD12 ' A' ' 76' ' ' LEU . 0.4 OUTLIER -163.93 105.08 0.91 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.232 -0.44 . . . . 72.11 110.923 -179.876 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.81 ' N ' HD12 ' A' ' 61' ' ' ILE . 0.9 OUTLIER -98.86 115.72 40.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.114 -0.494 . . . . 74.43 111.114 179.904 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.778 HD23 ' HD2' ' A' ' 63' ' ' PRO . 0.4 OUTLIER -83.64 123.71 76.07 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.6 0.714 . . . . 32.53 110.939 179.877 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.778 ' HD2' HD23 ' A' ' 62' ' ' LEU . 54.3 Cg_endo -69.74 -165.21 0.15 Allowed 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.73 2.286 . . . . 73.43 112.341 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.64 159.57 14.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.233 -0.44 . . . . 73.33 110.907 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 112.88 -155.52 16.23 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.715 -0.755 . . . . 62.54 112.448 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -114.81 160.42 19.47 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.877 0.37 . . . . 74.11 110.859 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.446 ' N ' ' O ' ' A' ' 40' ' ' ILE . 10.8 m-85 -149.58 83.81 6.27 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.71 0.766 . . . . 74.32 110.919 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.8 -4.73 14.65 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.65 2.234 . . . . 71.43 112.325 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -156.89 148.23 22.2 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.244 -0.435 . . . . 75.33 110.919 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.99 ' O ' ' CD1' ' A' ' 73' ' ' TRP . 44.6 p90 -57.44 -42.44 82.45 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.164 -0.471 . . . . 70.44 110.936 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -51.94 -15.79 0.6 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.102 -0.499 . . . . 63.42 110.89 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 28.7 mmt180 -69.16 -9.22 51.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.179 -0.464 . . . . 75.25 110.902 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . 0.99 ' CD1' ' O ' ' A' ' 70' ' ' TYR . 0.5 OUTLIER -128.8 21.63 5.9 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.18 -0.463 . . . . 71.32 110.905 -179.946 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . 0.623 ' O ' ' C ' ' A' ' 75' ' ' GLY . 24.1 mmt 79.54 27.44 0.36 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.276 -0.42 . . . . 72.23 110.878 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.623 ' C ' ' O ' ' A' ' 74' ' ' MET . . . 15.74 61.94 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.698 -0.763 . . . . 33.15 112.514 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.811 HD12 ' CE2' ' A' ' 60' ' ' TYR . 59.9 mt -58.89 -80.34 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.843 0.354 . . . . 73.55 110.902 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.589 ' O ' ' CB ' ' A' ' 78' ' ' ASP . 3.8 t-20 -113.56 -41.84 3.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.193 -0.458 . . . . 50.33 110.898 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.589 ' CB ' ' O ' ' A' ' 77' ' ' ASN . 2.6 t70 91.04 16.38 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.18 -0.464 . . . . 74.13 110.891 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.451 ' NE ' ' HD3' ' A' ' 52' ' ' ARG . 4.9 ttm105 -110.92 97.66 6.99 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.143 -0.481 . . . . 73.41 110.845 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.907 HD11 HG11 ' A' ' 49' ' ' VAL . 0.1 OUTLIER -95.6 131.7 41.53 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.18 -0.463 . . . . 71.11 110.912 -179.985 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.671 ' HB3' ' HB3' ' A' ' 53' ' ' PRO . 1.2 m -153.03 -123.58 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.208 -0.451 . . . . 65.34 110.877 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.789 ' OG ' ' HA ' ' A' ' 53' ' ' PRO . 0.0 OUTLIER -41.65 101.86 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.138 -0.483 . . . . 73.24 110.797 -179.757 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . 0.711 ' CB ' HG12 ' A' ' 49' ' ' VAL . 21.3 p -117.43 136.15 53.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.109 -0.496 . . . . 74.2 110.857 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.585 ' N ' ' O ' ' A' ' 48' ' ' ALA . 6.6 mmt85 -123.43 138.38 54.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.149 -0.478 . . . . 71.04 110.865 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.448 ' N ' ' CZ3' ' A' ' 47' ' ' TRP . . . -57.71 128.67 38.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.202 -0.454 . . . . 74.11 111.044 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.832 HG13 HG21 ' A' ' 136' ' ' VAL . 12.3 t -111.71 139.6 35.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.18 -0.463 . . . . 60.2 111.113 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . 0.637 ' O ' HG23 ' A' ' 136' ' ' VAL . 29.8 m80 -111.84 106.01 14.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.173 -0.467 . . . . 75.11 110.854 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.73 HD13 ' HA ' ' A' ' 178' ' ' GLU . 0.0 OUTLIER -31.9 143.22 0.13 Allowed Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.619 0.723 . . . . 71.03 110.888 -179.949 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.529 ' HB3' ' H ' ' A' ' 136' ' ' VAL . 53.7 Cg_endo -69.82 105.73 1.55 Allowed 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.652 2.235 . . . . 64.12 112.291 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.03 177.35 4.88 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.206 -0.452 . . . . 72.32 110.805 -179.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 50.12 63.16 4.48 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.741 -0.742 . . . . 35.23 112.486 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.424 ' O ' ' C ' ' A' ' 93' ' ' GLN . . . 124.25 21.72 2.24 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.754 -0.736 . . . . 61.32 112.454 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.471 ' O ' ' HG2' ' A' ' 134' ' ' GLU . 5.3 pt20 36.59 -121.29 0.16 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.815 0.341 . . . . 73.43 110.859 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.535 ' O ' ' HA ' ' A' ' 112' ' ' THR . 0.1 OUTLIER -120.92 100.8 7.29 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.141 -0.482 . . . . 65.53 110.911 -179.853 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.533 ' HG3' HG11 ' A' ' 132' ' ' VAL . 45.6 tptt -110.82 128.27 55.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.112 -0.494 . . . . 71.0 110.907 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.472 HG21 ' CH2' ' A' ' 137' ' ' TRP . 0.0 OUTLIER -149.11 142.38 18.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.253 -0.431 . . . . 70.3 111.12 179.82 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.532 ' HB2' HG23 ' A' ' 132' ' ' VAL . 2.8 mt-30 -112.1 126.94 55.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.137 -0.483 . . . . 74.42 110.911 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.625 HD13 ' HE1' ' A' ' 122' ' ' PHE . 4.9 mp -108.33 131.26 59.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.237 -0.438 . . . . 44.21 111.115 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.672 ' HB2' ' HB2' ' A' ' 129' ' ' SER . 6.4 m-85 -120.15 148.19 43.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.172 -0.467 . . . . 75.43 110.883 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -74.88 -75.59 0.16 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.159 -0.473 . . . . 73.4 110.912 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.439 ' C ' ' HB3' ' A' ' 128' ' ' HIS . 36.7 mttt -83.14 176.19 9.39 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.168 -0.469 . . . . 72.45 110.926 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -88.79 160.41 29.98 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.764 -0.731 . . . . 64.34 112.476 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.432 ' HA ' ' HB2' ' A' ' 158' ' ' ARG . 27.8 t0 65.15 53.42 1.35 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.883 0.373 . . . . 73.23 110.893 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.63 ' CE1' ' HD2' ' A' ' 131' ' ' LYS . 6.1 m-85 48.38 33.74 4.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.457 . . . . 64.11 110.876 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.419 ' HB2' ' HB2' ' A' ' 101' ' ' LYS . 45.4 m -109.47 151.61 26.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.101 -0.499 . . . . 74.25 110.848 -179.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 91.35 -164.4 29.44 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.675 -0.774 . . . . 71.25 112.467 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 5.0 tp-100 -75.41 129.65 37.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.805 0.336 . . . . 71.01 110.945 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 3.8 ttp -112.47 144.96 41.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.197 -0.456 . . . . 65.32 110.887 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 -148.84 141.73 24.72 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.212 -0.449 . . . . 70.51 110.949 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -123.78 108.66 12.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.1 -0.5 . . . . 73.34 110.938 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 5.0 t -121.47 145.69 47.68 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.175 -0.466 . . . . 64.34 111.132 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.535 ' HA ' ' O ' ' A' ' 94' ' ' TYR . 4.4 t -120.96 41.91 3.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.245 -0.434 . . . . 64.12 111.152 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -151.19 157.08 42.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.224 -0.444 . . . . 73.31 110.904 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -53.85 157.86 2.23 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.145 -0.479 . . . . 73.41 110.823 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . 0.671 ' O ' ' HB2' ' A' ' 172' ' ' SER . 73.2 m -146.89 115.2 4.36 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-O 121.626 0.727 . . . . 73.32 110.898 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.455 ' O ' ' C ' ' A' ' 143' ' ' PRO . 53.3 Cg_endo -69.82 -30.3 22.24 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.648 2.232 . . . . 73.32 112.328 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.634 ' HB3' ' CB ' ' A' ' 120' ' ' GLU . 0.1 OUTLIER -148.26 99.82 3.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.251 -0.431 . . . . 64.33 110.814 -179.854 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.642 HD13 HD11 ' A' ' 127' ' ' ILE . 5.6 tt -52.86 -26.56 11.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.12 -0.491 . . . . 45.31 111.124 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' MET . . . . . 0.602 ' O ' ' HA ' ' A' ' 123' ' ' HIS . 14.4 ttp -86.75 -41.26 14.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.198 -0.455 . . . . 73.13 110.89 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.634 ' CB ' ' HB3' ' A' ' 117' ' ' SER . 34.5 tp10 -64.33 -12.98 47.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.215 -0.448 . . . . 73.23 110.854 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.404 ' H ' ' HG3' ' A' ' 121' ' ' GLN . 0.0 OUTLIER -114.62 -51.56 2.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.189 -0.46 . . . . 71.51 110.946 -179.96 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.625 ' HE1' HD13 ' A' ' 98' ' ' ILE . 12.1 m-30 -101.22 -18.17 16.27 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.217 -0.447 . . . . 44.34 110.935 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . 0.602 ' HA ' ' O ' ' A' ' 119' ' ' MET . 11.8 m80 74.39 21.29 2.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.135 -0.484 . . . . 73.31 110.901 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.56 ' SD ' HG22 ' A' ' 98' ' ' ILE . 6.5 mtt -94.27 131.91 39.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.188 -0.46 . . . . 65.34 110.873 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 4.9 ptp180 -95.23 -38.55 10.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.181 -0.463 . . . . 65.22 110.877 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.464 ' HG2' ' HA ' ' A' ' 169' ' ' ALA . 25.2 mt-10 -141.25 118.62 11.45 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.159 -0.473 . . . . 64.14 110.875 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.642 HD11 HD13 ' A' ' 118' ' ' ILE . 3.0 mm -80.08 101.09 4.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.163 -0.471 . . . . 75.45 111.138 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . 0.439 ' HB3' ' C ' ' A' ' 101' ' ' LYS . 0.4 OUTLIER -73.19 -32.58 64.9 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.171 -0.468 . . . . 72.45 110.846 179.888 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . 0.672 ' HB2' ' HB2' ' A' ' 99' ' ' PHE . 66.5 m -128.47 138.89 52.51 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.193 -0.458 . . . . 65.02 110.83 -179.719 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . 0.573 ' O ' ' O ' ' A' ' 155' ' ' LYS . 3.8 m -136.05 120.43 18.02 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.149 -0.478 . . . . 61.41 110.865 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.67 ' HA ' ' HA ' ' A' ' 156' ' ' GLU . 3.6 mtpp -116.35 152.21 34.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.131 -0.486 . . . . 71.5 110.892 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.539 ' HB ' ' O ' ' A' ' 131' ' ' LYS . 19.4 t 85.6 162.46 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.226 -0.443 . . . . 75.31 111.145 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.812 HD22 ' CG ' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -177.33 124.59 0.14 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.223 -0.444 . . . . 64.24 110.929 179.933 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.501 ' O ' ' C ' ' A' ' 135' ' ' GLY . 0.1 OUTLIER -98.26 168.23 10.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.162 -0.472 . . . . 72.12 110.895 179.936 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . 0.501 ' C ' ' O ' ' A' ' 134' ' ' GLU . . . -29.17 -70.04 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.751 -0.738 . . . . 72.13 112.447 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.832 HG21 HG13 ' A' ' 86' ' ' VAL . 3.0 t -133.82 145.43 33.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.834 0.349 . . . . 73.55 111.109 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' TRP . . . . . 0.616 ' H ' HD12 ' A' ' 152' ' ' LEU . 0.1 OUTLIER -150.1 162.8 39.7 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.187 -0.461 . . . . 73.15 110.866 -179.975 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.456 HD12 HH11 ' A' ' 174' ' ' ARG . 22.6 mt -138.48 134.03 43.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.208 -0.451 . . . . 75.41 111.136 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.676 ' CE1' HG11 ' A' ' 170' ' ' VAL . 0.2 OUTLIER -103.68 159.16 15.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.176 -0.465 . . . . 73.33 110.884 179.957 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . 0.481 ' CD2' ' HA ' ' A' ' 145' ' ' TYR . 0.5 OUTLIER -131.61 128.46 39.18 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.123 -0.49 . . . . 75.43 110.905 -179.875 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . 0.576 ' O ' ' HB2' ' A' ' 171' ' ' GLN . 7.0 tt0 -60.76 -27.75 68.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.089 -0.505 . . . . 61.52 110.858 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.743 ' HB3' ' HD2' ' A' ' 143' ' ' PRO . 10.1 mp -114.97 173.46 2.89 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.588 0.709 . . . . 74.45 110.938 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . 0.758 ' O ' ' OG ' ' A' ' 172' ' ' SER . 53.2 Cg_endo -69.77 -90.61 0.0 OUTLIER 'Trans proline' 0 C--N 1.34 0.129 0 C-N-CA 122.694 2.263 . . . . 44.3 112.327 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . 0.723 ' O ' ' N ' ' A' ' 146' ' ' ARG . 2.4 m-20 -50.73 98.57 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.181 -0.463 . . . . 74.33 110.87 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . 0.638 ' C ' ' O ' ' A' ' 144' ' ' ASN . 0.1 OUTLIER 12.67 51.77 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.163 -0.471 . . . . 72.25 110.945 -179.959 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . 0.723 ' N ' ' O ' ' A' ' 144' ' ' ASN . 22.3 mtt-85 -119.46 173.43 6.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.132 -0.486 . . . . 75.34 110.921 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 79.84 172.27 43.6 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.737 -0.744 . . . . 62.05 112.462 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 19.3 mtp180 -68.55 150.61 47.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.755 0.312 . . . . 73.42 110.888 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' GLN . . . . . 0.688 ' HG3' HD11 ' A' ' 76' ' ' LEU . 55.4 mt-30 -86.02 153.21 22.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.236 -0.438 . . . . 75.4 110.932 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . 0.482 ' HB2' ' HB2' ' A' ' 139' ' ' PHE . 76.1 m-85 -133.91 123.02 23.98 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.222 -0.445 . . . . 74.13 110.934 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.663 HD23 ' OH ' ' A' ' 50' ' ' TYR . 12.1 tp -70.32 125.24 26.24 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.144 -0.48 . . . . 52.0 110.909 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 1.003 ' O ' HD13 ' A' ' 152' ' ' LEU . 0.0 OUTLIER -59.94 132.58 54.4 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.177 -0.465 . . . . 72.43 110.871 179.948 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -163.56 24.98 0.08 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.138 -0.483 . . . . 75.33 110.862 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.785 ' O ' HD13 ' A' ' 133' ' ' LEU . 0.1 OUTLIER -112.41 -171.1 1.79 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.186 -0.461 . . . . 70.25 110.923 179.954 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.812 ' CG ' HD22 ' A' ' 133' ' ' LEU . 0.2 OUTLIER -165.67 -122.39 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.207 -0.452 . . . . 75.33 110.858 179.87 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.67 ' HA ' ' HA ' ' A' ' 131' ' ' LYS . 0.4 OUTLIER -71.39 0.42 8.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.232 -0.44 . . . . 73.32 110.913 -179.99 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . 0.661 ' CE1' ' HA ' ' A' ' 154' ' ' LYS . 16.8 m-30 -28.49 142.49 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.128 -0.487 . . . . 74.32 110.938 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . 0.432 ' HB2' ' HA ' ' A' ' 103' ' ' ASP . 11.1 ptp180 -112.18 -33.74 6.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.126 -0.488 . . . . 65.11 110.862 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -101.1 152.28 37.85 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.541 0.686 . . . . 72.01 110.914 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.73 -22.64 31.92 Favored 'Trans proline' 0 C--O 1.232 0.206 0 C-N-CA 122.694 2.262 . . . . 65.34 112.354 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.656 ' H ' HD12 ' A' ' 161' ' ' ILE . 4.0 mp -76.67 -2.89 4.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.226 -0.443 . . . . 62.52 111.146 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.657 ' HB3' ' CD1' ' A' ' 157' ' ' TYR . 1.4 t0 -72.47 -17.34 61.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.19 -0.459 . . . . 74.31 110.878 179.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' TRP . . . . . 0.52 ' O ' ' CG ' ' A' ' 163' ' ' TRP . 6.2 t-105 -109.99 10.21 24.24 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.168 -0.469 . . . . 62.41 110.934 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 87.71 -31.63 4.53 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.69 -0.767 . . . . 64.42 112.503 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -54.35 119.35 5.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.799 0.333 . . . . 71.32 111.103 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -49.1 -26.14 2.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.202 -0.454 . . . . 63.0 111.1 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . 0.461 ' C ' ' H ' ' A' ' 169' ' ' ALA . 0.3 OUTLIER -154.98 159.36 31.89 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.635 0.731 . . . . 63.03 110.855 -179.794 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . 0.502 ' HB3' ' O ' ' A' ' 127' ' ' ILE . 53.5 Cg_endo -69.81 19.21 0.19 Allowed 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.679 2.253 . . . . 75.51 112.32 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 0.464 ' HA ' ' HG2' ' A' ' 126' ' ' GLU . . . -63.01 102.58 0.38 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.236 -0.438 . . . . 72.23 111.083 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.676 HG11 ' CE1' ' A' ' 139' ' ' PHE . 3.4 t -153.09 162.15 2.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.223 -0.444 . . . . 53.33 111.147 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' GLN . . . . . 0.669 ' OE1' ' HB3' ' A' ' 143' ' ' PRO . 1.7 mm-40 -112.21 -88.38 0.53 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.209 -0.45 . . . . 71.31 110.93 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . 0.758 ' OG ' ' O ' ' A' ' 143' ' ' PRO . 45.7 p -121.67 177.92 5.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.156 -0.475 . . . . 64.1 110.882 -179.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 2.0 p90 -141.97 168.34 19.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.161 -0.472 . . . . 71.0 110.861 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . 0.456 HH11 HD12 ' A' ' 138' ' ' ILE . 0.0 OUTLIER -135.21 156.16 49.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.11 -0.496 . . . . 60.04 110.911 -179.937 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . 0.404 ' HD2' ' CE2' ' A' ' 94' ' ' TYR . 0.0 OUTLIER -100.68 -164.48 1.12 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.178 -0.464 . . . . 73.04 110.868 -179.922 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . 0.768 HD12 ' HB ' ' A' ' 136' ' ' VAL . 5.6 mt -137.0 130.5 45.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.164 -0.471 . . . . 74.1 111.09 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 7.4 p -98.43 155.84 3.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.198 -0.456 . . . . 74.11 111.103 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . 0.73 ' HA ' HD13 ' A' ' 88' ' ' LEU . 3.4 mt-10 . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.174 -0.467 . . . . 73.34 110.877 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.352 0 N-CA-C 112.511 -0.235 . . . . 65.24 112.511 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.485 ' C ' ' HE1' ' A' ' 47' ' ' TRP . 9.9 p -82.67 133.78 35.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.871 0.367 . . . . 71.34 111.149 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 3.0 tttt -122.08 137.08 54.94 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.176 -0.465 . . . . 74.44 110.856 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.585 ' HB ' ' CD1' ' A' ' 47' ' ' TRP . 14.3 tt -137.16 152.94 28.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.197 -0.456 . . . . 60.24 111.148 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.492 ' HA ' ' O ' ' A' ' 21' ' ' TYR . 23.0 m -136.63 136.95 39.6 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.208 -0.451 . . . . 74.3 111.14 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.732 ' HB2' HD22 ' A' ' 34' ' ' LEU . 0.2 OUTLIER -125.23 129.3 49.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.225 -0.443 . . . . 71.21 110.883 -179.992 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.545 ' CG ' ' HA ' ' A' ' 16' ' ' PHE . 33.9 m-85 -112.38 131.93 55.28 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.138 -0.483 . . . . 72.3 110.953 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.443 ' HB2' ' HB2' ' A' ' 19' ' ' ARG . 0.1 OUTLIER -62.2 -16.45 53.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.147 -0.479 . . . . 74.21 110.89 -179.985 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.42 ' HB2' ' O ' ' A' ' 17' ' ' GLN . 70.7 m-20 -133.83 148.8 51.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.13 -0.487 . . . . 52.11 110.886 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.615 ' N ' ' HB3' ' A' ' 38' ' ' ASN . 3.5 mtmm -54.53 -179.19 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.217 -0.447 . . . . 71.24 110.927 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 22.3 m-20 49.64 32.87 5.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.259 -0.428 . . . . 74.22 110.906 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.545 ' HA ' ' CG ' ' A' ' 11' ' ' TYR . 4.0 m-85 49.79 62.45 2.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.137 -0.483 . . . . 75.24 110.919 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.42 ' O ' ' HB2' ' A' ' 13' ' ' ASP . 4.1 mt-30 -138.85 161.89 36.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.115 -0.493 . . . . 75.44 110.894 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 91.78 -149.76 19.93 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.771 -0.728 . . . . 52.31 112.493 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.734 ' O ' HD13 ' A' ' 34' ' ' LEU . 0.0 OUTLIER -69.41 77.58 0.39 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.812 0.339 . . . . 73.44 110.889 -179.845 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.433 ' HB2' ' CE1' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -75.79 129.11 36.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.181 -0.463 . . . . 74.23 110.871 -179.907 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.492 ' O ' ' HA ' ' A' ' 9' ' ' THR . 90.6 t80 -123.03 124.4 43.03 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.172 -0.467 . . . . 62.02 110.922 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.47 ' CG ' HG23 ' A' ' 9' ' ' THR . 1.1 m-20 -121.02 133.52 55.26 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.143 -0.481 . . . . 72.44 110.851 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -166.77 133.94 2.5 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.168 -0.469 . . . . 73.34 110.924 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -99.76 2.18 43.92 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.189 -0.459 . . . . 73.34 110.935 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 18.6 t -106.46 164.96 11.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.17 -0.468 . . . . 53.22 110.881 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -56.93 120.78 8.52 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.201 -0.454 . . . . 74.01 110.866 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.623 ' HB2' ' HB3' ' A' ' 30' ' ' PHE . 0.6 OUTLIER -115.64 50.14 1.03 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.212 -0.449 . . . . 70.23 110.875 -179.894 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.508 ' O ' ' HA ' ' A' ' 82' ' ' SER . . . -47.69 -21.43 0.37 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.163 -0.471 . . . . 63.33 111.093 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 58.5 t0 -128.68 42.11 3.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.235 -0.439 . . . . 72.2 110.89 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.731 ' O ' ' CD2' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -81.45 13.98 2.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.166 -0.47 . . . . 74.14 110.925 -179.932 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.454 ' HB2' ' HB3' ' A' ' 53' ' ' PRO . 29.7 t60 -78.19 -39.05 41.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.138 -0.483 . . . . 74.22 110.824 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.7 t -57.93 -14.93 7.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.221 -0.445 . . . . 73.4 111.139 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -99.6 -26.26 14.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.233 -0.44 . . . . 73.42 110.928 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.734 HD13 ' O ' ' A' ' 19' ' ' ARG . 15.5 tp -142.89 133.12 24.58 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.129 -0.487 . . . . 72.41 110.923 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 22.3 m -97.51 -43.28 7.32 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.169 -0.469 . . . . 71.24 110.865 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 1.6 tmm_? -117.27 142.57 46.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.146 -0.479 . . . . 72.41 110.886 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.658 ' SG ' ' HB2' ' A' ' 80' ' ' LEU . 1.5 p -111.65 89.19 2.99 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.204 -0.453 . . . . 63.14 110.893 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.615 ' HB3' ' N ' ' A' ' 14' ' ' LYS . 0.3 OUTLIER -81.73 -61.99 1.77 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.176 -0.465 . . . . 64.15 110.89 -179.906 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 10.4 p -124.17 125.93 45.29 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.196 -0.457 . . . . 74.44 110.847 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.603 HG21 HD13 ' A' ' 62' ' ' LEU . 2.6 mt -124.06 151.55 29.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.13 -0.486 . . . . 73.41 111.139 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.413 ' N ' ' CG2' ' A' ' 40' ' ' ILE . 0.0 OUTLIER -142.32 121.97 13.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.145 -0.479 . . . . 74.4 110.862 179.887 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.497 ' HA ' ' HA ' ' A' ' 8' ' ' ILE . 1.0 OUTLIER -104.82 118.84 52.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.22 -0.445 . . . . 54.25 111.118 179.876 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -114.07 77.73 1.09 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.146 -0.479 . . . . 61.1 110.836 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.403 ' O ' ' HA ' ' A' ' 6' ' ' THR . . . 135.46 99.14 0.58 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.714 -0.755 . . . . 42.24 112.476 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 54.75 176.8 0.14 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.733 -0.746 . . . . 72.22 112.473 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.773 HG23 ' HA ' ' A' ' 63' ' ' PRO . 1.9 m -75.82 169.24 18.53 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.789 0.328 . . . . 72.42 111.156 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . 0.585 ' CD1' ' HB ' ' A' ' 8' ' ' ILE . 6.0 m95 -143.02 129.35 19.94 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.251 -0.431 . . . . 73.44 110.907 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.879 ' HB2' ' CG2' ' A' ' 86' ' ' VAL . . . -90.98 129.19 37.01 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.206 -0.452 . . . . 75.02 111.143 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.862 HG11 HD11 ' A' ' 80' ' ' LEU . 17.3 m -129.34 125.66 62.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.277 -0.419 . . . . 65.34 111.107 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.796 ' HB3' ' HA ' ' A' ' 56' ' ' ALA . 44.0 m-85 -93.73 148.38 22.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.182 -0.463 . . . . 64.51 110.926 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.573 ' HB2' ' O ' ' A' ' 58' ' ' TYR . 7.0 tt0 -48.72 -79.89 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.152 -0.476 . . . . 75.44 110.877 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.541 ' HB3' ' CD1' ' A' ' 55' ' ' PHE . 0.0 OUTLIER -92.75 145.15 29.77 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.617 0.723 . . . . 63.22 110.845 -179.908 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.781 ' HA ' ' OG ' ' A' ' 82' ' ' SER . 53.9 Cg_endo -69.79 140.78 43.41 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.678 2.252 . . . . 73.33 112.381 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 62.9 -11.03 0.09 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.227 -0.442 . . . . 74.21 110.924 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.606 ' H ' ' C ' ' A' ' 53' ' ' PRO . 2.6 m-30 -104.0 -21.37 13.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.162 -0.472 . . . . 65.24 110.913 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.796 ' HA ' ' HB3' ' A' ' 50' ' ' TYR . . . 50.05 25.98 1.9 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.135 -0.484 . . . . 74.23 111.063 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . 0.637 ' O ' ' C ' ' A' ' 58' ' ' TYR . 0.0 OUTLIER -50.07 -161.36 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.233 -0.44 . . . . 73.32 110.941 -179.997 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.637 ' C ' ' O ' ' A' ' 57' ' ' TRP . 6.3 m-30 -14.24 101.59 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.227 -0.442 . . . . 72.02 110.926 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.467 ' HB2' ' HA ' ' A' ' 150' ' ' TYR . 0.5 OUTLIER -58.41 146.15 35.93 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.087 -0.506 . . . . 63.5 110.905 179.903 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.78 ' O ' ' O ' ' A' ' 49' ' ' VAL . 0.3 OUTLIER -159.07 112.28 2.29 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.253 -0.43 . . . . 74.23 110.885 -179.863 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.829 ' N ' HD12 ' A' ' 61' ' ' ILE . 1.0 OUTLIER -104.95 114.84 45.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.097 -0.502 . . . . 74.44 111.15 179.898 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.765 HD23 ' HD2' ' A' ' 63' ' ' PRO . 0.4 OUTLIER -84.95 124.86 71.97 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.617 0.722 . . . . 74.41 110.934 179.916 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.773 ' HA ' HG23 ' A' ' 46' ' ' THR . 53.7 Cg_endo -69.75 -165.29 0.15 Allowed 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.647 2.232 . . . . 75.35 112.357 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.42 160.37 14.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.223 -0.444 . . . . 65.41 110.887 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 112.91 -152.11 18.05 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.697 -0.763 . . . . 62.13 112.486 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 11.2 mp0 -118.69 159.44 23.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.844 0.354 . . . . 75.0 110.937 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.508 ' HB2' ' O ' ' A' ' 40' ' ' ILE . 13.0 m-85 -147.94 82.43 7.84 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.655 0.741 . . . . 52.42 110.924 -179.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.7 -3.67 12.44 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.731 2.288 . . . . 74.32 112.355 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -157.72 147.68 20.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.178 -0.464 . . . . 75.25 110.856 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.882 ' O ' ' CD1' ' A' ' 73' ' ' TRP . 44.6 p90 -57.53 -41.47 80.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.121 -0.49 . . . . 72.2 110.927 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -53.35 -17.1 1.63 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.138 -0.483 . . . . 72.0 110.945 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 29.3 mmt180 -63.62 -36.29 83.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 71.32 110.852 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . 0.882 ' CD1' ' O ' ' A' ' 70' ' ' TYR . 0.3 OUTLIER -98.61 25.41 6.47 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.243 -0.435 . . . . 63.43 110.907 -179.958 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . 0.566 ' O ' ' C ' ' A' ' 75' ' ' GLY . 1.6 mtp 75.53 26.87 1.08 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.264 -0.425 . . . . 62.25 110.886 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.566 ' C ' ' O ' ' A' ' 74' ' ' MET . . . 23.51 54.57 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.763 -0.732 . . . . 63.12 112.481 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.51 ' HB2' ' CE2' ' A' ' 60' ' ' TYR . 0.2 OUTLIER -56.69 -74.46 0.05 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.781 0.324 . . . . 63.02 110.918 -179.917 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.766 ' O ' ' CB ' ' A' ' 78' ' ' ASP . 28.0 t-20 -113.75 -80.55 0.59 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.214 -0.448 . . . . 73.44 110.897 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.766 ' CB ' ' O ' ' A' ' 77' ' ' ASN . 27.8 t70 129.45 5.38 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.182 -0.463 . . . . 75.22 110.911 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -107.3 92.28 4.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.211 -0.45 . . . . 71.55 110.893 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.862 HD11 HG11 ' A' ' 49' ' ' VAL . 0.2 OUTLIER -90.7 129.5 36.79 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.186 -0.461 . . . . 72.22 110.923 -179.959 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.6 ' HB3' ' HB3' ' A' ' 53' ' ' PRO . 0.9 OUTLIER -153.66 -123.42 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.23 -0.441 . . . . 74.41 110.897 -179.945 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.781 ' OG ' ' HA ' ' A' ' 53' ' ' PRO . 0.0 OUTLIER -41.46 101.91 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.168 -0.469 . . . . 71.12 110.877 -179.824 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . 0.705 ' HB3' HG12 ' A' ' 49' ' ' VAL . 31.5 p -121.16 135.38 55.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.095 -0.502 . . . . 70.11 110.887 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.585 ' N ' ' O ' ' A' ' 48' ' ' ALA . 10.9 mmt85 -119.62 150.94 39.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.2 -0.455 . . . . 44.12 110.832 -179.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -66.65 127.14 31.24 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.176 -0.465 . . . . 73.24 111.102 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.879 ' CG2' ' HB2' ' A' ' 48' ' ' ALA . 52.9 t -116.94 137.56 50.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.245 -0.434 . . . . 61.23 111.127 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . 0.438 ' O ' ' CG2' ' A' ' 136' ' ' VAL . 29.4 m80 -111.17 126.54 54.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.124 -0.489 . . . . 75.45 110.88 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.416 HD13 ' CB ' ' A' ' 178' ' ' GLU . 0.3 OUTLIER -39.63 137.99 1.03 Allowed Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.598 0.713 . . . . 62.34 110.899 -179.961 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.448 ' HB3' ' H ' ' A' ' 136' ' ' VAL . 53.8 Cg_endo -69.79 80.71 0.87 Allowed 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.713 2.275 . . . . 52.43 112.329 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -90.58 -177.12 4.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 64.41 110.838 -179.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 67.41 117.52 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.756 -0.735 . . . . 74.23 112.496 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 50.02 40.23 35.17 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.747 -0.74 . . . . 53.34 112.536 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.444 ' HB2' ' H ' ' A' ' 94' ' ' TYR . 5.2 pt20 40.21 -156.65 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.802 0.334 . . . . 75.02 110.901 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.634 ' OH ' HG23 ' A' ' 177' ' ' VAL . 0.1 OUTLIER -97.47 104.81 16.87 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.204 -0.453 . . . . 71.23 110.909 -179.875 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.496 ' HG3' HG11 ' A' ' 132' ' ' VAL . 45.7 tptt -105.99 131.34 53.4 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.132 -0.485 . . . . 74.14 110.885 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -150.23 137.38 13.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.252 -0.431 . . . . 75.15 111.141 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.446 ' HB2' ' O ' ' A' ' 131' ' ' LYS . 0.8 OUTLIER -112.77 135.6 53.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.205 -0.452 . . . . 74.02 110.93 179.935 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.635 HD13 HD11 ' A' ' 118' ' ' ILE . 1.5 mt -114.52 142.62 26.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.166 -0.47 . . . . 62.32 111.13 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.625 ' HB2' ' HB2' ' A' ' 129' ' ' SER . 57.1 m-85 -131.29 134.28 46.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.182 -0.463 . . . . 74.21 110.832 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 64.2 tt0 -63.59 -74.46 0.1 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.126 -0.488 . . . . 73.2 110.869 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.459 ' C ' ' HB3' ' A' ' 128' ' ' HIS . 9.7 mttt -83.11 177.45 8.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.142 -0.481 . . . . 74.24 110.854 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.427 ' HA2' ' HB3' ' A' ' 128' ' ' HIS . . . -83.61 161.1 38.34 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.732 -0.747 . . . . 75.32 112.49 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.444 ' HA ' ' HB2' ' A' ' 158' ' ' ARG . 30.4 t0 61.76 32.86 18.12 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.851 0.357 . . . . 71.35 110.885 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.576 ' HA ' ' CD2' ' A' ' 99' ' ' PHE . 21.1 m-85 59.35 48.88 9.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.191 -0.458 . . . . 75.15 110.924 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 4.4 m -114.25 150.06 34.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 55.52 110.85 -179.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 89.81 -127.73 8.88 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.721 -0.752 . . . . 43.52 112.506 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 -99.18 139.41 34.87 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.806 0.336 . . . . 73.43 110.885 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 4.4 ttp -128.74 146.17 50.97 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.183 -0.462 . . . . 73.43 110.862 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 18.9 m-85 -148.25 136.79 21.5 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.267 -0.424 . . . . 74.42 110.918 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -115.3 99.26 7.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.097 -0.501 . . . . 64.32 110.912 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 13.6 t -112.58 132.03 55.33 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.135 -0.484 . . . . 60.43 111.156 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.413 ' O ' ' OG1' ' A' ' 112' ' ' THR . 1.7 t -97.4 33.3 2.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.177 -0.465 . . . . 60.24 111.128 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -149.88 -176.05 5.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.199 -0.455 . . . . 64.13 110.917 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.509 ' CB ' ' HA ' ' A' ' 174' ' ' ARG . 5.3 p30 -103.45 171.29 7.45 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.184 -0.462 . . . . 74.01 110.895 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . 0.484 ' O ' ' HB2' ' A' ' 172' ' ' SER . 16.7 p -152.02 146.14 18.31 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.602 0.715 . . . . 64.2 110.908 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.417 ' O ' ' CA ' ' A' ' 143' ' ' PRO . 53.2 Cg_endo -69.8 -28.5 24.98 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.665 2.243 . . . . 62.03 112.305 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.633 ' HB3' ' CB ' ' A' ' 120' ' ' GLU . 0.1 OUTLIER -147.59 105.85 3.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.25 -0.432 . . . . 73.54 110.862 -179.858 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.737 HD13 HD11 ' A' ' 127' ' ' ILE . 3.6 tt -58.09 -29.77 37.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.165 -0.471 . . . . 53.44 111.146 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' MET . . . . . 0.596 ' O ' ' HA ' ' A' ' 123' ' ' HIS . 27.0 ttp -86.4 -43.72 12.61 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.458 . . . . 55.31 110.91 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.633 ' CB ' ' HB3' ' A' ' 117' ' ' SER . 9.4 tp10 -66.49 -13.21 60.56 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.223 -0.444 . . . . 74.21 110.857 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -114.62 -49.97 2.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.194 -0.457 . . . . 74.43 110.954 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.463 ' HB2' ' O ' ' A' ' 118' ' ' ILE . 63.2 m-85 -103.03 -20.37 14.22 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.2 -0.455 . . . . 74.42 110.874 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . 0.596 ' HA ' ' O ' ' A' ' 119' ' ' MET . 28.3 m-70 72.75 26.88 2.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.136 -0.484 . . . . 73.52 110.851 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.405 ' HB3' ' CD1' ' A' ' 127' ' ' ILE . 16.9 mtt -102.06 88.75 3.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.196 -0.456 . . . . 71.3 110.885 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 2.0 ptp85 -52.04 -42.86 63.43 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.26 -0.427 . . . . 74.11 110.869 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.465 ' HG2' ' HA ' ' A' ' 169' ' ' ALA . 13.4 mt-10 -137.2 130.75 31.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.213 -0.449 . . . . 71.25 110.902 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.737 HD11 HD13 ' A' ' 118' ' ' ILE . 3.4 mm -89.48 87.68 2.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.173 -0.467 . . . . 52.44 111.147 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . 0.459 ' HB3' ' C ' ' A' ' 101' ' ' LYS . 0.7 OUTLIER -62.4 -31.98 72.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.201 -0.454 . . . . 62.31 110.871 179.911 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . 0.625 ' HB2' ' HB2' ' A' ' 99' ' ' PHE . 0.4 OUTLIER -134.35 142.38 47.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.172 -0.467 . . . . 65.25 110.801 -179.747 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . 0.624 ' O ' ' O ' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -143.17 117.61 9.69 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.151 -0.477 . . . . 73.31 110.882 -179.987 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.732 ' HA ' ' HA ' ' A' ' 156' ' ' GLU . 4.6 mtpp -106.67 150.86 25.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.217 -0.447 . . . . 61.13 110.915 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.496 HG11 ' HG3' ' A' ' 95' ' ' LYS . 3.4 t 74.27 165.84 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.234 -0.439 . . . . 74.24 111.11 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.674 HD12 ' O ' ' A' ' 154' ' ' LYS . 0.2 OUTLIER 172.77 128.84 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.136 -0.484 . . . . 45.33 110.936 179.929 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.584 ' CG ' ' HA ' ' A' ' 94' ' ' TYR . 0.7 OUTLIER -79.83 163.1 24.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.213 -0.449 . . . . 71.31 110.876 179.944 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . 0.441 ' C ' ' O ' ' A' ' 134' ' ' GLU . . . -34.71 -42.98 0.36 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.777 -0.725 . . . . 74.41 112.455 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.665 HG11 ' CG1' ' A' ' 86' ' ' VAL . 2.1 t -146.61 137.74 18.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.825 0.345 . . . . 74.4 111.148 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' TRP . . . . . 0.6 ' HB3' ' HB3' ' A' ' 152' ' ' LEU . 9.9 t-105 -138.46 157.12 46.82 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.151 -0.477 . . . . 73.21 110.886 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.655 HG23 HE21 ' A' ' 149' ' ' GLN . 18.2 mm -121.44 132.31 70.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.206 -0.452 . . . . 73.35 111.142 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.575 ' CB ' ' HB2' ' A' ' 150' ' ' TYR . 0.1 OUTLIER -118.87 137.61 53.32 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.163 -0.471 . . . . 70.02 110.92 179.945 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . 0.477 ' CD2' ' HA ' ' A' ' 145' ' ' TYR . 3.4 m-85 -119.37 132.05 55.79 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.13 -0.486 . . . . 71.4 110.923 -179.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . 0.674 ' O ' ' HB2' ' A' ' 171' ' ' GLN . 10.9 tt0 -60.04 -27.61 67.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.096 -0.502 . . . . 73.53 110.895 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.746 ' HB3' ' HD2' ' A' ' 143' ' ' PRO . 10.0 mp -112.85 173.74 2.69 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-O 121.614 0.721 . . . . 51.34 110.899 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . 0.747 ' O ' ' OG ' ' A' ' 172' ' ' SER . 53.9 Cg_endo -69.79 -88.8 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.71 2.273 . . . . 73.12 112.312 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . 0.686 ' O ' ' N ' ' A' ' 146' ' ' ARG . 1.4 m-20 -52.91 96.56 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.26 -0.427 . . . . 74.2 110.861 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . 0.633 ' C ' ' O ' ' A' ' 144' ' ' ASN . 0.1 OUTLIER 13.12 52.9 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.144 -0.48 . . . . 62.35 110.935 -179.94 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . 0.686 ' N ' ' O ' ' A' ' 144' ' ' ASN . 8.8 mtp85 -119.38 179.36 4.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.141 -0.481 . . . . 73.43 110.89 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . 0.428 ' O ' HD21 ' A' ' 76' ' ' LEU . . . 77.02 -177.69 52.06 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.726 -0.749 . . . . 74.11 112.486 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.409 ' HG2' ' CD1' ' A' ' 58' ' ' TYR . 5.7 mtp180 -74.11 156.23 37.62 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.756 0.312 . . . . 64.54 110.913 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' GLN . . . . . 0.655 HE21 HG23 ' A' ' 138' ' ' ILE . 0.8 OUTLIER -85.67 151.24 24.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.256 -0.429 . . . . 73.33 110.909 -179.974 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . 0.575 ' HB2' ' CB ' ' A' ' 139' ' ' PHE . 73.8 m-85 -137.67 122.8 19.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.209 -0.45 . . . . 73.4 110.914 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.638 ' HB2' HD11 ' A' ' 61' ' ' ILE . 10.5 tp -81.56 121.9 26.89 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.147 -0.479 . . . . 74.42 110.932 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.98 ' O ' HD13 ' A' ' 152' ' ' LEU . 0.0 OUTLIER -51.71 139.33 21.4 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.162 -0.472 . . . . 75.14 110.925 179.916 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . 0.434 ' N ' HD22 ' A' ' 152' ' ' LEU . 1.1 t70 -162.68 26.45 0.1 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.208 -0.451 . . . . 64.43 110.822 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.935 ' HB2' ' CD1' ' A' ' 157' ' ' TYR . 2.9 ptmt -127.44 -173.49 2.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.162 -0.472 . . . . 70.43 110.906 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.733 ' HD2' ' C ' ' A' ' 154' ' ' LYS . 0.8 OUTLIER -161.58 -117.17 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.187 -0.46 . . . . 63.32 110.882 179.812 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.732 ' HA ' ' HA ' ' A' ' 131' ' ' LYS . 3.2 tm-20 -71.15 0.44 7.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.224 -0.444 . . . . 64.55 110.918 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . 0.935 ' CD1' ' HB2' ' A' ' 154' ' ' LYS . 13.6 m-30 -32.93 147.05 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.146 -0.479 . . . . 75.25 110.922 -179.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . 0.534 ' HB3' ' CZ ' ' A' ' 104' ' ' PHE . 9.8 ptp180 -113.0 -33.54 6.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.106 -0.497 . . . . 74.14 110.887 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 7.0 ptpt -99.04 151.86 37.55 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.597 0.713 . . . . 70.22 110.859 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.79 -25.71 28.16 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.716 2.278 . . . . 75.24 112.298 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.686 ' H ' HD12 ' A' ' 161' ' ' ILE . 3.8 mp -73.83 -6.03 7.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.251 -0.431 . . . . 51.44 111.111 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.676 ' HB3' ' CD1' ' A' ' 157' ' ' TYR . 1.7 t0 -73.04 -15.73 61.51 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.194 -0.457 . . . . 73.11 110.913 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 4.8 t90 -109.94 12.65 23.71 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.197 -0.456 . . . . 75.31 110.95 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 85.6 -34.51 3.31 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.753 -0.736 . . . . 55.31 112.493 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -55.31 119.86 6.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.772 0.32 . . . . 73.34 111.118 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -49.93 -26.69 4.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.216 -0.447 . . . . 73.0 111.098 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . 0.479 ' C ' ' H ' ' A' ' 169' ' ' ALA . 0.3 OUTLIER -154.55 158.18 32.25 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.688 0.756 . . . . 52.1 110.819 -179.772 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . 0.41 ' HG3' ' CD2' ' A' ' 128' ' ' HIS . 53.9 Cg_endo -69.7 18.5 0.19 Allowed 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.752 2.301 . . . . 61.21 112.321 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 0.479 ' H ' ' C ' ' A' ' 167' ' ' SER . . . -63.45 102.97 0.47 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.235 -0.439 . . . . 43.31 111.13 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.47 HG11 ' CD1' ' A' ' 139' ' ' PHE . 3.1 t -153.37 163.61 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.173 -0.467 . . . . 72.15 111.105 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' GLN . . . . . 0.674 ' HB2' ' O ' ' A' ' 141' ' ' GLU . 1.9 mm-40 -110.23 -87.07 0.53 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.146 -0.479 . . . . 73.12 110.898 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . 0.747 ' OG ' ' O ' ' A' ' 143' ' ' PRO . 47.0 p -125.48 172.92 9.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.213 -0.449 . . . . 71.03 110.857 -179.777 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 5.9 p90 -145.77 164.69 31.09 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.142 -0.481 . . . . 74.55 110.828 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . 0.509 ' HA ' ' CB ' ' A' ' 114' ' ' ASP . 0.0 OUTLIER -135.56 151.28 50.15 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.091 -0.504 . . . . 74.13 110.834 -179.909 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . 0.489 ' H ' ' HG3' ' A' ' 175' ' ' ARG . 0.0 OUTLIER -104.62 139.51 39.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.195 -0.457 . . . . 71.04 110.863 -179.911 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . 0.464 HG13 HG12 ' A' ' 138' ' ' ILE . 1.2 mt -77.25 132.45 32.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.17 -0.468 . . . . 61.11 111.172 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.634 HG23 ' OH ' ' A' ' 94' ' ' TYR . 7.7 p -118.21 155.73 20.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.189 -0.46 . . . . 73.04 111.103 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . 0.416 ' CB ' HD13 ' A' ' 88' ' ' LEU . 1.3 mp0 . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.14 -0.482 . . . . 71.25 110.88 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.304 0 N-CA-C 112.466 -0.254 . . . . 63.33 112.466 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.502 ' C ' ' HE1' ' A' ' 47' ' ' TRP . 5.7 p -82.1 136.03 35.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.886 0.374 . . . . 74.3 111.098 -179.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.407 ' HA ' ' HA ' ' A' ' 24' ' ' ASP . 3.2 tttt -122.24 136.11 54.85 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.178 -0.464 . . . . 75.51 110.899 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.627 ' HB ' ' CD1' ' A' ' 47' ' ' TRP . 15.4 tt -136.84 151.49 27.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.2 -0.454 . . . . 61.33 111.102 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.503 ' HA ' ' O ' ' A' ' 21' ' ' TYR . 17.1 m -132.81 140.07 47.8 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.161 -0.472 . . . . 62.23 111.165 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.718 ' HB2' HD22 ' A' ' 34' ' ' LEU . 1.0 OUTLIER -127.99 127.7 43.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.17 -0.468 . . . . 75.41 110.873 -179.947 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.539 ' CG ' ' HA ' ' A' ' 16' ' ' PHE . 14.1 m-85 -112.72 132.4 55.23 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.202 -0.454 . . . . 71.22 110.91 -179.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.445 ' HB2' ' HB2' ' A' ' 19' ' ' ARG . 0.0 OUTLIER -61.04 -14.71 25.3 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.125 -0.489 . . . . 74.22 110.924 179.991 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.438 ' HB2' ' O ' ' A' ' 17' ' ' GLN . 74.4 m-20 -135.93 150.43 49.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.137 -0.483 . . . . 73.15 110.868 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.486 ' N ' ' HB3' ' A' ' 38' ' ' ASN . 40.8 mtmt -55.25 -176.17 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.152 -0.476 . . . . 64.11 110.89 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 16.1 m120 46.43 32.43 1.58 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.227 -0.442 . . . . 71.44 110.939 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.539 ' HA ' ' CG ' ' A' ' 11' ' ' TYR . 3.6 m-85 49.67 64.33 1.81 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.154 -0.476 . . . . 73.34 110.877 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.438 ' O ' ' HB2' ' A' ' 13' ' ' ASP . 9.9 mt-30 -139.32 159.78 41.35 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.145 -0.48 . . . . 74.11 110.891 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 92.35 -148.19 19.03 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.786 -0.721 . . . . 71.43 112.455 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.759 ' O ' HD13 ' A' ' 34' ' ' LEU . 0.0 OUTLIER -70.02 77.78 0.49 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.859 0.361 . . . . 73.34 110.834 -179.795 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.469 ' HB2' ' CE1' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -76.87 129.1 35.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.163 -0.471 . . . . 74.11 110.877 -179.956 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.503 ' O ' ' HA ' ' A' ' 9' ' ' THR . 90.7 t80 -123.01 124.39 43.02 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.182 -0.463 . . . . 74.44 110.925 -179.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.472 ' CG ' HG23 ' A' ' 9' ' ' THR . 1.3 m-20 -121.06 133.99 55.26 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.142 -0.481 . . . . 74.31 110.856 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -168.13 135.59 2.17 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.213 -0.449 . . . . 55.21 110.908 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.407 ' HA ' ' HA ' ' A' ' 7' ' ' LYS . 4.8 p-10 -100.94 -2.6 31.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.193 -0.458 . . . . 61.25 110.871 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 15.6 t -100.9 165.68 11.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.201 -0.454 . . . . 72.0 110.904 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -59.14 120.26 8.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.2 -0.455 . . . . 74.51 110.855 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.578 ' HB2' ' HB3' ' A' ' 30' ' ' PHE . 1.7 m -115.29 51.0 0.94 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.204 -0.453 . . . . 52.44 110.879 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.495 ' C ' ' HA ' ' A' ' 82' ' ' SER . . . -46.43 -22.16 0.24 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.178 -0.464 . . . . 72.01 111.081 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 55.5 t0 -127.94 42.83 3.25 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.194 -0.457 . . . . 73.15 110.885 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.777 ' O ' ' CD2' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -81.17 15.68 1.83 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.459 . . . . 73.53 110.869 -179.929 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.495 ' HB2' ' HB3' ' A' ' 81' ' ' SER . 29.7 t60 -80.3 -39.26 29.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 74.22 110.889 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.7 t -58.43 -13.8 6.27 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.204 -0.453 . . . . 53.21 111.166 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -100.07 -26.95 13.79 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.236 -0.438 . . . . 74.21 110.947 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.759 HD13 ' O ' ' A' ' 19' ' ' ARG . 18.0 tp -142.79 135.11 27.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.144 -0.48 . . . . 64.33 110.93 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 25.3 m -97.63 -42.51 7.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.165 -0.47 . . . . 73.42 110.849 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -118.77 141.83 48.27 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.077 -0.511 . . . . 74.04 110.84 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.554 ' HB3' ' HB2' ' A' ' 80' ' ' LEU . 3.3 p -110.17 84.86 2.0 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.197 -0.456 . . . . 55.04 110.861 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.486 ' HB3' ' N ' ' A' ' 14' ' ' LYS . 0.2 OUTLIER -76.07 -71.1 0.4 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.238 -0.437 . . . . 73.43 110.871 -179.934 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 5.2 p -111.53 124.07 51.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.184 -0.462 . . . . 65.22 110.903 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.747 HD12 ' CH2' ' A' ' 73' ' ' TRP . 43.0 mt -117.25 149.32 19.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.151 -0.477 . . . . 73.44 111.113 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.465 ' HD2' ' CE2' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -144.67 120.36 10.49 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.126 -0.488 . . . . 65.44 110.93 179.812 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.497 ' CG2' HD12 ' A' ' 8' ' ' ILE . 1.5 t -105.25 116.32 48.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.216 -0.447 . . . . 61.01 111.123 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -111.11 79.22 1.18 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.174 -0.467 . . . . 73.43 110.897 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.468 ' O ' ' HA ' ' A' ' 6' ' ' THR . . . 129.9 104.31 1.08 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.74 -0.743 . . . . 54.23 112.513 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 53.08 175.18 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.681 -0.771 . . . . 63.42 112.526 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.733 HG23 ' HA ' ' A' ' 63' ' ' PRO . 1.0 OUTLIER -76.84 169.03 19.07 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.74 0.305 . . . . 71.34 111.148 -179.856 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . 0.627 ' CD1' ' HB ' ' A' ' 8' ' ' ILE . 3.6 m95 -141.68 130.18 22.58 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.238 -0.437 . . . . 73.14 110.917 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.835 ' HB2' ' CG2' ' A' ' 86' ' ' VAL . . . -94.16 127.12 39.81 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.212 -0.449 . . . . 54.03 111.066 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.625 HG11 ' CD1' ' A' ' 80' ' ' LEU . 12.2 m -125.33 131.01 72.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.203 -0.453 . . . . 73.41 111.119 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.771 ' HB3' ' HA ' ' A' ' 56' ' ' ALA . 43.1 m-85 -98.32 147.3 24.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.174 -0.466 . . . . 75.41 110.937 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.644 ' OE1' ' HB3' ' A' ' 57' ' ' TRP . 46.9 tt0 -48.93 -79.68 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.13 -0.487 . . . . 73.02 110.865 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.551 ' HB2' ' HB2' ' A' ' 57' ' ' TRP . 0.0 OUTLIER -92.24 143.82 28.05 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.599 0.714 . . . . 70.01 110.853 -179.856 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.754 ' HA ' ' OG ' ' A' ' 82' ' ' SER . 53.7 Cg_endo -69.73 141.38 45.2 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.694 2.263 . . . . 71.51 112.381 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 63.54 -11.22 0.11 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.261 -0.427 . . . . 74.32 110.85 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.596 ' H ' ' C ' ' A' ' 53' ' ' PRO . 2.6 m-30 -104.45 -21.47 13.46 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.228 -0.442 . . . . 73.34 110.863 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.771 ' HA ' ' HB3' ' A' ' 50' ' ' TYR . . . 51.35 25.85 2.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.116 -0.493 . . . . 31.33 111.108 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . 0.644 ' HB3' ' OE1' ' A' ' 51' ' ' GLU . 0.0 OUTLIER -49.48 -163.1 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.215 -0.448 . . . . 65.52 110.948 179.995 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.638 ' C ' ' O ' ' A' ' 57' ' ' TRP . 6.1 m-30 -13.41 102.6 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.219 -0.446 . . . . 74.22 110.992 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.433 ' HB2' ' O ' ' A' ' 149' ' ' GLN . 2.0 mpt? -67.85 148.26 51.42 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.13 -0.486 . . . . 75.44 110.872 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.766 ' CD2' HD12 ' A' ' 76' ' ' LEU . 3.0 t80 -164.7 108.17 0.89 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.211 -0.449 . . . . 71.43 110.905 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.765 ' N ' HD12 ' A' ' 61' ' ' ILE . 1.4 mp -93.67 116.88 35.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.131 -0.486 . . . . 63.54 111.089 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.83 HD23 ' HD2' ' A' ' 63' ' ' PRO . 0.3 OUTLIER -83.95 127.96 64.95 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.559 0.695 . . . . 74.35 110.901 179.891 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.83 ' HD2' HD23 ' A' ' 62' ' ' LEU . 53.6 Cg_endo -69.76 -172.85 0.62 Allowed 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.652 2.235 . . . . 75.42 112.344 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.35 161.79 16.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.225 -0.443 . . . . 73.45 110.864 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 112.83 -165.61 12.06 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.702 -0.761 . . . . 44.44 112.459 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -109.93 154.36 23.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.901 0.382 . . . . 74.0 110.881 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.604 ' HB2' ' O ' ' A' ' 40' ' ' ILE . 10.7 m-85 -143.88 83.75 10.19 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.699 0.762 . . . . 71.41 110.944 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.449 ' HD2' ' HG3' ' A' ' 72' ' ' ARG . 53.8 Cg_endo -69.74 0.79 5.11 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.709 2.272 . . . . 73.44 112.344 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.544 ' HB2' ' HG2' ' A' ' 72' ' ' ARG . 41.3 mt-10 -155.88 144.11 19.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.457 . . . . 64.0 110.929 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.724 ' HA ' ' NE1' ' A' ' 73' ' ' TRP . 32.3 p90 -55.92 -21.65 21.67 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.172 -0.467 . . . . 72.53 110.883 -179.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -79.78 -16.47 55.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.144 -0.48 . . . . 71.34 110.921 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.544 ' HG2' ' HB2' ' A' ' 69' ' ' GLU . 28.1 mmt180 -69.47 -9.17 52.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.161 -0.472 . . . . 74.15 110.848 -179.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . 0.747 ' CH2' HD12 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -134.49 16.52 3.68 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.197 -0.456 . . . . 74.44 110.911 -179.966 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . 0.406 ' C ' ' O ' ' A' ' 73' ' ' TRP . 0.0 OUTLIER 37.75 42.91 0.43 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.284 -0.416 . . . . 73.31 110.866 179.911 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -58.03 120.59 22.46 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.753 -0.737 . . . . 72.5 112.515 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.981 HD13 ' N ' ' A' ' 77' ' ' ASN . 0.0 OUTLIER -70.05 -10.7 59.56 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.787 0.327 . . . . 71.14 110.872 -179.898 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.981 ' N ' HD13 ' A' ' 76' ' ' LEU . 30.2 t-20 -156.36 131.24 9.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.199 -0.455 . . . . 72.2 110.904 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -83.95 23.06 1.06 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.186 -0.461 . . . . 63.22 110.868 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -109.92 78.47 1.13 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.195 -0.457 . . . . 61.21 110.891 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.625 ' CD1' HG11 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -85.77 133.51 33.99 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.167 -0.47 . . . . 73.32 110.929 -179.999 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.594 ' HB3' ' HB3' ' A' ' 53' ' ' PRO . 0.9 OUTLIER -150.03 -125.04 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.184 -0.462 . . . . 54.43 110.912 -179.947 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.754 ' OG ' ' HA ' ' A' ' 53' ' ' PRO . 0.0 OUTLIER -35.03 103.81 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.12 -0.491 . . . . 62.45 110.832 -179.833 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . 0.614 ' HB3' HG12 ' A' ' 49' ' ' VAL . 19.8 p -121.88 134.45 54.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.152 -0.476 . . . . 74.31 110.854 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.595 ' N ' ' O ' ' A' ' 48' ' ' ALA . 11.6 mmt85 -120.4 139.51 52.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.184 -0.462 . . . . 74.52 110.871 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.431 ' N ' ' CZ3' ' A' ' 47' ' ' TRP . . . -58.15 129.17 40.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 73.51 111.111 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.835 ' CG2' ' HB2' ' A' ' 48' ' ' ALA . 55.5 t -113.23 133.74 58.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.194 -0.457 . . . . 64.22 111.093 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . 0.628 ' O ' HG23 ' A' ' 136' ' ' VAL . 23.1 m80 -114.43 111.21 21.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.113 -0.494 . . . . 72.12 110.827 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.469 HD23 ' H ' ' A' ' 88' ' ' LEU . 0.0 OUTLIER -33.39 140.13 0.24 Allowed Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.564 0.697 . . . . 72.44 110.937 -179.986 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.558 ' HB3' ' H ' ' A' ' 136' ' ' VAL . 53.7 Cg_endo -69.79 105.13 1.44 Allowed 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.718 2.278 . . . . 64.21 112.331 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -106.16 -177.97 3.52 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.201 -0.454 . . . . 74.31 110.833 -179.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 45.45 63.22 2.82 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.74 -0.743 . . . . 23.04 112.476 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.41 ' O ' ' C ' ' A' ' 93' ' ' GLN . . . 123.82 20.65 2.53 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.716 -0.754 . . . . 64.54 112.493 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.478 ' O ' ' HG2' ' A' ' 134' ' ' GLU . 2.0 pt20 37.47 -120.67 0.2 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.839 0.352 . . . . 70.34 110.901 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.466 ' O ' ' HA ' ' A' ' 112' ' ' THR . 0.0 OUTLIER -124.87 100.78 6.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.19 -0.459 . . . . 73.35 110.945 -179.86 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.512 ' HG3' HG11 ' A' ' 132' ' ' VAL . 31.3 tptt -110.69 126.53 54.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.173 -0.467 . . . . 73.3 110.929 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 8.0 tt -147.54 136.17 15.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.198 -0.456 . . . . 74.24 111.108 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.428 ' HB2' ' O ' ' A' ' 131' ' ' LYS . 1.2 mt-30 -107.82 131.56 54.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.203 -0.453 . . . . 74.12 110.925 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.58 HD11 ' CD1' ' A' ' 122' ' ' PHE . 13.1 pt -111.41 136.79 46.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.192 -0.458 . . . . 71.3 111.117 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.575 ' HB2' ' CB ' ' A' ' 129' ' ' SER . 62.4 m-85 -124.82 136.9 54.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.196 -0.456 . . . . 62.22 110.895 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -68.95 -58.3 4.31 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.099 -0.501 . . . . 55.44 110.905 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 21.0 mttt -101.59 149.46 24.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.126 -0.488 . . . . 75.23 110.942 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -57.8 163.72 7.94 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.755 -0.736 . . . . 74.12 112.469 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.523 ' HA ' ' HB2' ' A' ' 158' ' ' ARG . 42.1 t0 64.13 29.0 14.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.853 0.359 . . . . 71.41 110.912 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.68 ' CZ ' ' HB3' ' A' ' 158' ' ' ARG . 5.1 m-85 57.51 46.07 18.48 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.174 -0.466 . . . . 75.01 110.888 -179.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 2.3 m -114.08 158.02 21.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.181 -0.463 . . . . 70.11 110.871 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 86.88 -137.09 14.52 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.711 -0.756 . . . . 53.51 112.488 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 38.1 tp60 -90.39 126.6 35.93 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.812 0.339 . . . . 71.2 110.934 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' MET . . . . . 0.445 ' HB2' ' CE1' ' A' ' 99' ' ' PHE . 19.1 ttp -113.17 146.3 39.49 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.215 -0.448 . . . . 73.34 110.875 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -152.6 137.19 16.87 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.192 -0.458 . . . . 52.22 110.95 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -119.31 113.8 21.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.161 -0.472 . . . . 74.21 110.905 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 14.6 t -124.24 145.9 49.07 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.163 -0.471 . . . . 61.05 111.108 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.466 ' HA ' ' O ' ' A' ' 94' ' ' TYR . 1.5 t -122.92 41.64 3.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.205 -0.452 . . . . 54.12 111.129 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -150.59 -172.74 4.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.262 -0.426 . . . . 72.23 110.888 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -84.39 164.57 18.83 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.159 -0.473 . . . . 74.2 110.836 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 8.2 t -157.89 129.14 3.77 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.64 0.733 . . . . 73.1 110.914 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.724 ' O ' ' HB2' ' A' ' 172' ' ' SER . 53.9 Cg_endo -69.75 -44.15 2.25 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.718 2.279 . . . . 61.22 112.384 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.636 ' HB3' ' CB ' ' A' ' 120' ' ' GLU . 0.1 OUTLIER -138.8 102.78 4.65 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.172 -0.467 . . . . 74.33 110.874 -179.859 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.615 ' HB ' ' O ' ' A' ' 171' ' ' GLN . 3.0 tt -51.13 -30.08 9.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.101 -0.5 . . . . 74.1 111.144 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' MET . . . . . 0.56 ' O ' ' HA ' ' A' ' 123' ' ' HIS . 3.6 ttt -85.32 -46.19 11.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.159 -0.473 . . . . 72.55 110.867 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.636 ' CB ' ' HB3' ' A' ' 117' ' ' SER . 14.1 tp10 -63.42 -13.6 41.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.183 -0.462 . . . . 73.51 110.866 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 26.3 tp60 -114.7 -52.91 2.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.156 -0.475 . . . . 72.34 110.931 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.58 ' CD1' HD11 ' A' ' 98' ' ' ILE . 86.7 m-85 -99.33 -22.44 15.58 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.456 . . . . 74.43 110.864 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . 0.56 ' HA ' ' O ' ' A' ' 119' ' ' MET . 0.5 OUTLIER 76.67 24.6 0.96 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.176 -0.466 . . . . 70.25 110.87 179.984 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.469 ' O ' ' CG2' ' A' ' 118' ' ' ILE . 9.4 mtt -103.38 81.79 1.97 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.186 -0.461 . . . . 74.42 110.865 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 2.1 ptp85 -46.82 -40.99 14.8 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.251 -0.431 . . . . 74.42 110.854 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.498 ' HB3' ' HG2' ' A' ' 168' ' ' PRO . 32.7 mt-10 -142.67 130.43 21.54 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.162 -0.472 . . . . 74.22 110.9 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.603 HG22 ' O ' ' A' ' 127' ' ' ILE . 1.3 mp -87.69 97.1 6.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.219 -0.446 . . . . 63.01 111.13 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . 0.452 ' HA ' ' HB3' ' A' ' 160' ' ' PRO . 16.8 m170 -69.67 -25.99 64.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.218 -0.446 . . . . 74.54 110.908 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . 0.575 ' CB ' ' HB2' ' A' ' 99' ' ' PHE . 0.0 OUTLIER -136.68 139.02 41.67 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.158 -0.474 . . . . 75.25 110.828 -179.788 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . 0.598 ' O ' ' O ' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -138.17 119.52 14.76 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.108 -0.497 . . . . 62.54 110.846 -179.975 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.646 ' HA ' ' HA ' ' A' ' 156' ' ' GLU . 4.4 mtpp -113.08 152.31 29.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.15 -0.477 . . . . 61.4 110.897 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.552 HG23 ' C ' ' A' ' 131' ' ' LYS . 10.8 t 84.15 163.58 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.183 -0.462 . . . . 72.53 111.13 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.746 HD22 ' CG ' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -177.45 124.58 0.13 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.198 -0.456 . . . . 71.4 110.973 179.943 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.542 ' O ' ' C ' ' A' ' 135' ' ' GLY . 0.2 OUTLIER -99.58 167.09 10.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.165 -0.471 . . . . 75.13 110.887 179.965 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . 0.542 ' C ' ' O ' ' A' ' 134' ' ' GLU . . . -24.93 -74.03 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.698 -0.763 . . . . 72.44 112.528 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.729 ' HB ' HD12 ' A' ' 176' ' ' ILE . 3.1 t -135.01 147.97 29.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.84 0.353 . . . . 72.13 111.127 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' TRP . . . . . 0.717 ' H ' HD12 ' A' ' 152' ' ' LEU . 0.0 OUTLIER -152.03 162.41 41.13 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.202 -0.454 . . . . 71.33 110.929 179.977 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.515 HG21 ' HD2' ' A' ' 174' ' ' ARG . 19.4 mt -135.15 137.69 49.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.234 -0.439 . . . . 74.04 111.1 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.562 ' CD2' HG11 ' A' ' 170' ' ' VAL . 0.2 OUTLIER -110.93 146.12 37.14 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.154 -0.475 . . . . 72.45 110.892 179.914 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . 0.714 ' CE2' ' HA ' ' A' ' 145' ' ' TYR . 0.6 OUTLIER -107.08 131.14 54.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.13 -0.486 . . . . 71.33 110.912 -179.831 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . 0.596 ' O ' ' NE2' ' A' ' 171' ' ' GLN . 7.5 tt0 -70.66 -27.3 63.93 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.086 -0.507 . . . . 73.22 110.9 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.574 ' O ' ' HB3' ' A' ' 172' ' ' SER . 5.8 mp -113.37 147.15 36.82 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.58 0.705 . . . . 73.43 110.931 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . 0.698 ' CD ' ' HG2' ' A' ' 171' ' ' GLN . 53.9 Cg_endo -69.7 43.68 0.38 Allowed 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.694 2.262 . . . . 74.05 112.349 179.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . 1.093 ' O ' ' N ' ' A' ' 146' ' ' ARG . 0.4 OUTLIER 177.87 111.49 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.209 -0.45 . . . . 71.42 110.888 179.96 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . 0.714 ' HA ' ' CE2' ' A' ' 140' ' ' TYR . 0.1 OUTLIER -6.59 52.18 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.156 -0.475 . . . . 73.15 110.876 -179.892 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . 1.093 ' N ' ' O ' ' A' ' 144' ' ' ASN . 40.7 mtt180 -140.16 170.52 15.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.121 -0.49 . . . . 72.52 110.885 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 81.0 -167.61 49.92 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.706 -0.759 . . . . 61.13 112.464 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.424 ' HG2' ' CD1' ' A' ' 58' ' ' TYR . 0.5 OUTLIER -88.58 142.98 27.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.778 0.323 . . . . 62.32 110.901 -179.935 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' GLN . . . . . 0.433 ' O ' ' HB2' ' A' ' 59' ' ' MET . 74.0 mt-30 -84.07 162.83 20.2 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.157 -0.474 . . . . 63.51 110.931 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . 0.412 ' HB2' ' HB2' ' A' ' 139' ' ' PHE . 92.8 m-85 -134.96 116.73 15.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.238 -0.437 . . . . 74.3 110.985 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.668 HD23 ' OH ' ' A' ' 50' ' ' TYR . 9.9 tp -68.6 119.09 12.48 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.129 -0.487 . . . . 74.25 110.877 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 1.055 ' O ' HD13 ' A' ' 152' ' ' LEU . 0.0 OUTLIER -51.4 135.45 27.22 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.18 -0.464 . . . . 61.55 110.903 179.899 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -163.37 24.84 0.08 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.177 -0.465 . . . . 75.43 110.848 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.783 ' HB2' ' CD1' ' A' ' 157' ' ' TYR . 0.0 OUTLIER -115.47 -173.54 2.35 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.252 -0.431 . . . . 73.45 110.913 -179.996 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.746 ' CG ' HD22 ' A' ' 133' ' ' LEU . 0.8 OUTLIER -161.48 -124.56 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.264 -0.425 . . . . 73.33 110.904 179.907 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.646 ' HA ' ' HA ' ' A' ' 131' ' ' LYS . 1.7 tm-20 -70.43 2.74 3.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 73.44 110.876 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . 0.783 ' CD1' ' HB2' ' A' ' 154' ' ' LYS . 18.4 m-30 -32.79 147.04 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.167 -0.469 . . . . 72.14 110.904 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . 0.68 ' HB3' ' CZ ' ' A' ' 104' ' ' PHE . 8.2 ptp180 -113.5 -37.45 4.63 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.097 -0.501 . . . . 73.3 110.844 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -89.01 152.54 48.44 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.576 0.703 . . . . 55.15 110.869 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . 0.544 ' HB3' ' HB3' ' A' ' 168' ' ' PRO . 54.3 Cg_endo -69.74 -29.29 24.2 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.658 2.239 . . . . 71.11 112.369 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.684 ' H ' HD12 ' A' ' 161' ' ' ILE . 4.3 mp -66.37 -10.5 11.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.216 -0.447 . . . . 74.32 111.161 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.671 ' HB3' ' CD1' ' A' ' 157' ' ' TYR . 0.5 OUTLIER -77.0 -13.94 59.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.143 -0.481 . . . . 74.04 110.853 179.848 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' TRP . . . . . 0.447 ' CE3' ' HB3' ' A' ' 165' ' ' ALA . 26.3 t90 -87.95 -7.68 56.78 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.245 -0.434 . . . . 63.02 110.921 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 99.3 -36.82 3.81 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.755 -0.736 . . . . 24.11 112.454 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.447 ' HB3' ' CE3' ' A' ' 163' ' ' TRP . . . -76.88 126.7 31.42 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.8 0.333 . . . . 72.23 111.149 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -37.27 -42.83 0.49 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.229 -0.441 . . . . 62.3 111.053 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . 0.491 ' C ' ' H ' ' A' ' 169' ' ' ALA . 0.5 OUTLIER -127.64 152.34 76.65 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.68 0.752 . . . . 71.45 110.835 -179.786 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . 0.544 ' HB3' ' HB3' ' A' ' 160' ' ' PRO . 53.7 Cg_endo -69.76 27.97 0.18 Allowed 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.689 2.259 . . . . 71.02 112.379 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 0.491 ' H ' ' C ' ' A' ' 167' ' ' SER . . . -67.6 99.98 0.83 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.215 -0.448 . . . . 55.32 111.149 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.582 HG12 ' H ' ' A' ' 171' ' ' GLN . 1.4 t -155.41 173.62 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.195 -0.457 . . . . 62.42 111.108 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' GLN . . . . . 0.698 ' HG2' ' CD ' ' A' ' 143' ' ' PRO . 0.0 OUTLIER -159.17 -97.55 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.165 -0.47 . . . . 75.43 110.91 -179.998 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . 0.724 ' HB2' ' O ' ' A' ' 116' ' ' PRO . 0.0 OUTLIER -64.62 153.77 38.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.23 -0.441 . . . . 51.11 110.851 -179.791 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' PHE . . . . . 0.404 ' HB3' ' CD2' ' A' ' 139' ' ' PHE . 1.2 p90 -151.96 158.21 42.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.146 -0.479 . . . . 71.35 110.888 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . 0.515 ' HD2' HG21 ' A' ' 138' ' ' ILE . 1.3 ptp180 -130.22 142.39 50.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.17 -0.468 . . . . 73.44 110.935 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . 0.432 ' HD2' ' CE2' ' A' ' 94' ' ' TYR . 0.0 OUTLIER -98.19 -169.21 1.77 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.21 -0.45 . . . . 72.05 110.902 -179.882 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . 0.729 HD12 ' HB ' ' A' ' 136' ' ' VAL . 4.1 mt -139.05 132.03 38.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.222 -0.444 . . . . 53.13 111.17 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 4.8 p -144.62 155.83 14.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.208 -0.451 . . . . 75.34 111.085 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.125 -0.488 . . . . 72.04 110.933 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.287 0 N-CA-C 112.475 -0.25 . . . . 73.2 112.475 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.429 ' HA ' ' O ' ' A' ' 44' ' ' GLY . 10.9 p -82.33 136.11 35.07 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.898 0.38 . . . . 63.01 111.122 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.472 ' N ' ' HE1' ' A' ' 47' ' ' TRP . 2.6 tttt -127.91 138.12 52.54 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.203 -0.453 . . . . 62.24 110.852 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.514 HD12 ' CG2' ' A' ' 42' ' ' VAL . 16.0 tt -136.68 150.89 27.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.165 -0.47 . . . . 74.34 111.084 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.484 HG22 ' CE2' ' A' ' 11' ' ' TYR . 9.3 m -132.55 140.94 48.51 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.159 -0.473 . . . . 62.32 111.111 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.722 ' HB2' HD22 ' A' ' 34' ' ' LEU . 1.6 m-85 -129.2 131.68 47.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.228 -0.442 . . . . 72.41 110.924 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.54 ' CG ' ' HA ' ' A' ' 16' ' ' PHE . 6.2 m-85 -117.41 134.09 55.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.142 -0.481 . . . . 74.35 110.915 -179.825 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.46 ' HB2' ' H ' ' A' ' 19' ' ' ARG . 0.0 OUTLIER -56.83 -28.56 61.74 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.129 -0.487 . . . . 60.42 110.848 -179.968 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 49.4 m-20 -123.29 155.42 37.26 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.201 -0.454 . . . . 44.11 110.855 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 7.9 mtmm -57.41 -173.35 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 54.13 110.884 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 23.3 m-20 44.34 34.76 1.11 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.2 -0.454 . . . . 75.25 110.851 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.54 ' HA ' ' CG ' ' A' ' 11' ' ' TYR . 2.6 m-85 47.7 59.8 3.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.227 -0.442 . . . . 60.11 110.878 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 10.6 mt-30 -133.23 154.14 50.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.172 -0.467 . . . . 73.32 110.918 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 95.67 -154.43 20.96 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.768 -0.73 . . . . 42.14 112.446 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.752 ' O ' HD13 ' A' ' 34' ' ' LEU . 0.6 OUTLIER -63.65 81.7 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.857 0.361 . . . . 71.33 110.86 -179.838 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.516 ' HB2' ' CE1' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -81.05 127.52 32.69 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.193 -0.458 . . . . 75.04 110.859 -179.918 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.449 ' CZ ' ' CD1' ' A' ' 33' ' ' TYR . 82.8 t80 -124.23 125.71 44.86 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.217 -0.447 . . . . 65.23 110.903 -179.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -111.25 131.45 55.13 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.11 -0.495 . . . . 74.23 110.876 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -142.58 143.12 32.31 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.19 -0.459 . . . . 54.55 110.856 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -125.64 5.09 7.5 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.191 -0.459 . . . . 74.23 110.894 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 50.6 t -129.71 159.19 37.25 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.137 -0.483 . . . . 64.1 110.91 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -42.87 108.48 0.1 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.177 -0.465 . . . . 50.44 110.878 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.608 ' HB3' ' HB3' ' A' ' 30' ' ' PHE . 0.1 OUTLIER -119.8 51.38 1.18 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.202 -0.453 . . . . 52.13 110.887 -179.92 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.546 ' C ' ' HA ' ' A' ' 82' ' ' SER . . . -50.61 -14.61 0.2 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.209 -0.451 . . . . 65.53 111.08 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 63.6 t0 -127.3 42.21 3.37 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.227 -0.442 . . . . 64.51 110.88 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.819 ' O ' ' CD2' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -82.28 14.34 3.0 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.192 -0.458 . . . . 73.44 110.849 -179.885 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.536 ' HB2' ' HB3' ' A' ' 53' ' ' PRO . 31.3 t60 -76.8 -44.4 32.82 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.158 -0.474 . . . . 65.42 110.854 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.428 HG23 ' CD2' ' A' ' 33' ' ' TYR . 9.7 t -54.7 -13.57 1.06 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.156 -0.475 . . . . 73.52 111.147 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.498 ' CD1' ' HA ' ' A' ' 30' ' ' PHE . 12.3 m-85 -97.27 -29.65 13.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.224 -0.444 . . . . 71.3 110.91 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.752 HD13 ' O ' ' A' ' 19' ' ' ARG . 31.7 tp -137.85 140.35 40.41 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.101 -0.5 . . . . 71.41 110.907 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 2.6 m -104.16 -38.71 6.8 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.155 -0.475 . . . . 60.31 110.861 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.491 ' O ' HD21 ' A' ' 34' ' ' LEU . 0.2 OUTLIER -111.18 140.85 45.4 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.172 -0.467 . . . . 63.32 110.839 -179.928 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.471 ' SG ' ' CB ' ' A' ' 80' ' ' LEU . 2.0 m -122.46 76.35 1.32 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.157 -0.474 . . . . 71.54 110.871 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -80.15 -71.11 0.47 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.142 -0.481 . . . . 73.1 110.842 -179.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 4.8 p -104.52 134.54 47.53 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.157 -0.474 . . . . 73.15 110.869 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.744 HD12 ' CH2' ' A' ' 73' ' ' TRP . 19.4 mt -126.86 151.69 33.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.124 -0.489 . . . . 73.41 111.147 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.475 ' HD2' ' CE2' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -146.59 122.12 10.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.201 -0.454 . . . . 74.41 110.856 179.894 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.528 ' O ' HG12 ' A' ' 42' ' ' VAL . 1.4 t -108.41 114.63 47.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.259 -0.428 . . . . 74.3 111.134 179.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.407 ' N ' ' O ' ' A' ' 7' ' ' LYS . 1.5 mm-40 -109.79 79.06 1.17 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.193 -0.458 . . . . 72.41 110.827 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.429 ' O ' ' HA ' ' A' ' 6' ' ' THR . . . 134.2 102.72 0.76 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.794 -0.717 . . . . 55.01 112.524 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 52.21 -178.26 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.723 -0.751 . . . . 72.23 112.471 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.737 HG23 ' HA ' ' A' ' 63' ' ' PRO . 0.6 OUTLIER -81.57 172.19 13.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.809 0.338 . . . . 55.4 111.117 -179.846 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . 0.558 ' H ' HG22 ' A' ' 46' ' ' THR . 13.2 m95 -142.59 130.04 21.23 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.214 -0.448 . . . . 70.31 110.898 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.841 ' HB2' ' CG2' ' A' ' 86' ' ' VAL . . . -97.39 108.89 21.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.234 -0.439 . . . . 71.43 111.109 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.849 HG11 HD11 ' A' ' 80' ' ' LEU . 4.2 m -111.45 130.96 64.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.215 -0.448 . . . . 73.14 111.13 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.663 ' HB3' ' HA ' ' A' ' 56' ' ' ALA . 56.6 m-85 -93.88 148.56 22.02 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.177 -0.465 . . . . 73.04 110.947 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.651 ' HB2' ' HB2' ' A' ' 58' ' ' TYR . 39.1 tt0 -45.38 -78.22 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.103 -0.499 . . . . 63.5 110.892 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.645 ' HB3' ' CD2' ' A' ' 55' ' ' PHE . 0.2 OUTLIER -90.78 144.77 30.81 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.574 0.702 . . . . 71.33 110.906 -179.924 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.745 ' HA ' ' OG ' ' A' ' 82' ' ' SER . 54.0 Cg_endo -69.79 131.38 21.08 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.688 2.259 . . . . 73.25 112.35 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 67.8 -8.2 0.54 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.218 -0.446 . . . . 72.3 110.891 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.645 ' CD2' ' HB3' ' A' ' 52' ' ' ARG . 6.2 m-30 -98.43 -27.73 13.94 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.181 -0.463 . . . . 73.14 110.884 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.663 ' HA ' ' HB3' ' A' ' 50' ' ' TYR . . . 62.79 16.42 9.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.173 -0.467 . . . . 64.32 111.153 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . 0.646 ' O ' ' C ' ' A' ' 58' ' ' TYR . 0.1 OUTLIER -49.02 -167.94 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.176 -0.465 . . . . 70.43 110.923 -179.958 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.651 ' HB2' ' HB2' ' A' ' 51' ' ' GLU . 8.1 m-30 -13.06 103.08 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.217 -0.447 . . . . 72.34 110.908 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.432 ' HB2' ' O ' ' A' ' 149' ' ' GLN . 1.9 mpt? -68.54 148.66 50.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.148 -0.478 . . . . 71.32 110.844 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.79 ' CD2' HD12 ' A' ' 76' ' ' LEU . 3.3 t80 -163.66 108.77 1.05 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.232 -0.44 . . . . 65.45 110.943 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.789 ' N ' HD12 ' A' ' 61' ' ' ILE . 1.5 mp -95.02 116.13 35.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.081 -0.508 . . . . 74.1 111.121 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.77 HD23 ' HD2' ' A' ' 63' ' ' PRO . 0.2 OUTLIER -84.07 128.78 61.23 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.611 0.719 . . . . 75.41 110.932 179.888 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.77 ' HD2' HD23 ' A' ' 62' ' ' LEU . 53.8 Cg_endo -69.74 -172.74 0.61 Allowed 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.705 2.27 . . . . 74.13 112.368 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -88.12 161.96 17.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.246 -0.434 . . . . 75.25 110.877 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 112.2 -167.94 12.55 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.719 -0.753 . . . . 42.11 112.457 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -108.05 156.44 19.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.855 0.359 . . . . 73.21 110.862 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.622 ' HB2' ' O ' ' A' ' 40' ' ' ILE . 15.7 m-85 -144.19 84.39 9.5 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.684 0.754 . . . . 73.21 110.904 -179.869 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.419 ' HD2' ' HG3' ' A' ' 72' ' ' ARG . 53.2 Cg_endo -69.83 2.83 3.21 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.7 2.267 . . . . 71.3 112.344 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.608 ' HB2' ' HG2' ' A' ' 72' ' ' ARG . 52.6 mt-10 -157.38 143.45 17.7 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.199 -0.455 . . . . 75.3 110.889 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.741 ' HA ' ' NE1' ' A' ' 73' ' ' TRP . 30.6 p90 -55.35 -21.39 14.99 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.161 -0.472 . . . . 40.53 110.916 -179.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -81.25 -17.15 50.48 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.099 -0.501 . . . . 74.02 110.876 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.608 ' HG2' ' HB2' ' A' ' 69' ' ' GLU . 33.0 mmt180 -68.32 -10.61 56.06 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.233 -0.439 . . . . 74.35 110.853 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . 0.744 ' CH2' HD12 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -133.13 17.7 4.1 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.182 -0.463 . . . . 74.43 110.869 -179.953 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 40.56 37.45 0.47 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.275 -0.42 . . . . 73.33 110.868 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -52.06 114.22 3.08 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.738 -0.744 . . . . 64.4 112.521 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 1.016 HD13 ' N ' ' A' ' 77' ' ' ASN . 0.0 OUTLIER -63.82 -16.7 61.93 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.781 0.324 . . . . 74.32 110.87 -179.889 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 1.016 ' N ' HD13 ' A' ' 76' ' ' LEU . 57.8 t-20 -157.87 130.53 7.32 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.194 -0.457 . . . . 73.41 110.936 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -77.5 9.17 3.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.174 -0.466 . . . . 62.15 110.879 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.416 ' HG2' ' O ' ' A' ' 79' ' ' ARG . 24.1 ttt85 -88.9 38.38 0.88 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.205 -0.452 . . . . 65.54 110.889 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.849 HD11 HG11 ' A' ' 49' ' ' VAL . 0.1 OUTLIER -56.7 126.84 28.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.143 -0.481 . . . . 51.33 110.87 -179.931 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.655 ' HB3' ' HB3' ' A' ' 53' ' ' PRO . 4.4 m -142.8 -117.55 0.1 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.191 -0.459 . . . . 73.34 110.889 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.745 ' OG ' ' HA ' ' A' ' 53' ' ' PRO . 0.4 OUTLIER -30.38 130.36 0.1 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.127 -0.488 . . . . 75.4 110.844 -179.848 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . 0.545 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 11.0 p -138.74 144.43 39.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.176 -0.466 . . . . 73.12 110.855 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.508 ' N ' ' O ' ' A' ' 48' ' ' ALA . 0.6 OUTLIER -141.31 128.17 20.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.165 -0.47 . . . . 72.24 110.905 -179.865 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.429 ' N ' ' CZ3' ' A' ' 47' ' ' TRP . . . -49.64 126.89 14.61 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.24 -0.437 . . . . 51.32 111.126 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.841 ' CG2' ' HB2' ' A' ' 48' ' ' ALA . 48.4 t -114.17 132.9 61.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.214 -0.448 . . . . 64.41 111.126 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . 0.769 ' O ' HG23 ' A' ' 136' ' ' VAL . 20.3 m-70 -108.15 105.18 14.8 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.16 -0.473 . . . . 62.14 110.872 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.627 HD12 ' HB3' ' A' ' 178' ' ' GLU . 0.0 OUTLIER -35.55 144.29 0.24 Allowed Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.566 0.698 . . . . 72.31 110.931 179.993 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.472 ' HA ' ' HA3' ' A' ' 135' ' ' GLY . 54.1 Cg_endo -69.76 87.67 0.55 Allowed 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.684 2.256 . . . . 53.34 112.323 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -105.92 -177.57 3.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.265 -0.425 . . . . 51.52 110.846 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 60.88 23.94 61.96 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.74 -0.743 . . . . 73.33 112.5 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.413 ' O ' ' C ' ' A' ' 93' ' ' GLN . . . 153.24 34.33 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.735 -0.745 . . . . 44.41 112.452 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.492 ' O ' ' CG ' ' A' ' 134' ' ' GLU . 23.6 pt20 36.37 -135.07 0.05 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.811 0.339 . . . . 62.15 110.916 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.465 ' O ' ' HA ' ' A' ' 112' ' ' THR . 13.9 t80 -119.71 106.8 12.49 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.184 -0.462 . . . . 70.35 110.907 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.541 ' HG3' HG11 ' A' ' 132' ' ' VAL . 36.3 tptt -108.65 128.69 55.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.107 -0.497 . . . . 75.3 110.922 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.425 HD12 ' OH ' ' A' ' 94' ' ' TYR . 6.8 tt -148.39 144.17 18.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.231 -0.44 . . . . 70.53 111.116 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.589 ' O ' ' HA ' ' A' ' 130' ' ' CYS . 1.3 mt-30 -115.97 111.57 20.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.153 -0.476 . . . . 74.53 110.897 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.563 ' CG2' HD12 ' A' ' 127' ' ' ILE . 2.7 mm -86.49 140.97 15.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.222 -0.445 . . . . 75.42 111.11 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.565 ' HB2' ' HB2' ' A' ' 129' ' ' SER . 57.4 m-85 -130.91 133.16 45.6 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.201 -0.454 . . . . 72.03 110.878 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 60.6 tt0 -61.4 -80.14 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.189 -0.459 . . . . 55.21 110.878 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 12.2 mttt -85.51 162.44 18.92 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.145 -0.479 . . . . 63.13 110.898 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -67.86 162.28 48.55 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.691 -0.766 . . . . 62.45 112.512 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.516 ' HA ' ' HB2' ' A' ' 158' ' ' ARG . 36.5 t70 64.46 27.16 13.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.861 0.362 . . . . 75.15 110.876 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.54 ' CZ ' ' HB3' ' A' ' 158' ' ' ARG . 8.8 m-85 59.57 48.14 9.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.153 -0.476 . . . . 74.42 110.915 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 2.9 m -113.45 143.92 43.68 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.148 -0.478 . . . . 75.32 110.85 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 96.41 -124.15 7.98 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.74 -0.743 . . . . 74.14 112.447 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 4.9 tp-100 -102.77 143.62 32.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.799 0.333 . . . . 74.25 110.841 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 2.9 ttp -130.33 146.43 51.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.182 -0.463 . . . . 73.54 110.84 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 11.8 m-85 -148.13 137.5 22.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.174 -0.466 . . . . 75.23 110.925 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -118.63 101.24 7.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.121 -0.49 . . . . 75.3 110.88 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 8.1 t -118.24 153.21 34.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 64.41 111.177 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.465 ' HA ' ' O ' ' A' ' 94' ' ' TYR . 1.4 t -125.45 47.25 2.22 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.223 -0.444 . . . . 65.15 111.116 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 75.0 mm-40 -148.32 -175.2 4.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.264 -0.426 . . . . 60.42 110.863 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -101.94 150.96 22.67 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.134 -0.485 . . . . 71.05 110.884 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 11.1 m -143.03 136.83 14.37 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.638 0.732 . . . . 74.21 110.857 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.765 ' O ' ' HB2' ' A' ' 172' ' ' SER . 53.9 Cg_endo -69.72 -34.34 14.9 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.752 2.301 . . . . 73.23 112.354 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.64 ' HB3' ' CB ' ' A' ' 120' ' ' GLU . 0.1 OUTLIER -140.79 97.96 3.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.178 -0.464 . . . . 74.11 110.839 -179.831 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.782 HD13 HD11 ' A' ' 127' ' ' ILE . 5.0 tt -49.54 -28.33 3.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.146 -0.479 . . . . 63.53 111.132 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' MET . . . . . 0.568 ' O ' ' HA ' ' A' ' 123' ' ' HIS . 7.2 ttt -84.71 -42.61 15.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.157 -0.474 . . . . 65.34 110.89 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.64 ' CB ' ' HB3' ' A' ' 117' ' ' SER . 24.3 tp10 -62.5 -13.22 28.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.218 -0.446 . . . . 63.22 110.907 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.92 -52.93 2.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.152 -0.476 . . . . 73.12 110.931 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 12.0 m-30 -101.93 -18.93 15.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.205 -0.452 . . . . 64.32 110.885 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . 0.568 ' HA ' ' O ' ' A' ' 119' ' ' MET . 10.7 m80 74.5 24.62 1.74 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.136 -0.484 . . . . 74.11 110.86 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.465 ' SD ' HG22 ' A' ' 98' ' ' ILE . 8.6 mtt -100.39 83.31 2.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.223 -0.444 . . . . 75.32 110.921 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 3.6 ptp180 -49.5 -33.05 13.5 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.186 -0.461 . . . . 72.23 110.888 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.536 ' HB3' ' HG2' ' A' ' 168' ' ' PRO . 16.0 mt-10 -145.44 129.23 17.26 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.122 -0.49 . . . . 75.43 110.886 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.782 HD11 HD13 ' A' ' 118' ' ' ILE . 3.0 mm -87.33 91.13 3.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.147 -0.479 . . . . 72.43 111.122 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . 0.408 ' CD2' ' HG3' ' A' ' 168' ' ' PRO . 13.7 m170 -61.9 -34.45 76.07 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.187 -0.461 . . . . 70.52 110.865 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . 0.565 ' HB2' ' HB2' ' A' ' 99' ' ' PHE . 0.6 OUTLIER -135.05 152.13 51.41 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.224 -0.444 . . . . 74.42 110.887 -179.751 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . 0.597 ' O ' ' O ' ' A' ' 155' ' ' LYS . 0.1 OUTLIER -155.25 121.04 5.07 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.157 -0.474 . . . . 54.4 110.852 -179.94 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.657 ' HA ' ' HA ' ' A' ' 156' ' ' GLU . 8.7 mtpp -108.57 153.85 22.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.191 -0.459 . . . . 71.23 110.88 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.57 HG23 ' C ' ' A' ' 131' ' ' LYS . 11.3 t 85.76 164.7 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.197 -0.456 . . . . 72.5 111.14 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.747 HD22 ' CG ' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -176.93 122.76 0.14 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.189 -0.46 . . . . 63.41 110.921 179.918 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.614 ' O ' ' C ' ' A' ' 135' ' ' GLY . 0.0 OUTLIER -98.75 159.12 15.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.13 -0.486 . . . . 73.02 110.873 179.95 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . 0.614 ' C ' ' O ' ' A' ' 134' ' ' GLU . . . -13.57 -75.63 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.769 -0.729 . . . . 63.44 112.497 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.821 HG21 HG13 ' A' ' 86' ' ' VAL . 5.6 t -136.1 148.81 27.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.821 0.343 . . . . 75.54 111.129 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' TRP . . . . . 0.631 ' HB3' ' HB3' ' A' ' 152' ' ' LEU . 22.8 t90 -146.2 148.65 32.74 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.157 -0.474 . . . . 71.51 110.934 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.46 HD13 ' HB ' ' A' ' 61' ' ' ILE . 0.4 OUTLIER -118.05 135.11 59.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.245 -0.434 . . . . 41.23 111.123 179.953 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.533 ' CZ ' HG11 ' A' ' 170' ' ' VAL . 0.1 OUTLIER -110.07 147.51 33.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.173 -0.467 . . . . 74.25 110.863 179.977 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . 0.711 ' HB2' ' O ' ' A' ' 172' ' ' SER . 0.8 OUTLIER -115.32 129.67 56.67 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.18 -0.464 . . . . 74.33 110.898 -179.855 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . 0.625 ' O ' ' NE2' ' A' ' 171' ' ' GLN . 8.1 tt0 -69.34 -28.6 66.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.126 -0.488 . . . . 73.44 110.926 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.775 ' O ' ' HB3' ' A' ' 172' ' ' SER . 5.9 mp -113.41 148.48 39.73 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.629 0.728 . . . . 71.34 110.876 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . 0.684 ' CD ' ' HG2' ' A' ' 171' ' ' GLN . 53.5 Cg_endo -69.74 43.95 0.39 Allowed 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.695 2.263 . . . . 73.34 112.328 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . 1.093 ' O ' ' N ' ' A' ' 146' ' ' ARG . 0.4 OUTLIER 177.47 111.23 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.261 -0.427 . . . . 75.42 110.928 179.996 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . 0.66 ' HA ' ' CE2' ' A' ' 140' ' ' TYR . 0.2 OUTLIER -6.36 52.37 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.159 -0.473 . . . . 72.44 110.911 -179.895 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . 1.093 ' N ' ' O ' ' A' ' 144' ' ' ASN . 26.9 mtt180 -138.85 167.12 22.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.11 -0.495 . . . . 73.24 110.858 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 83.89 -165.35 41.79 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.692 -0.766 . . . . 64.44 112.5 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -88.07 146.45 25.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.751 0.31 . . . . 72.02 110.912 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' GLN . . . . . 0.432 ' O ' ' HB2' ' A' ' 59' ' ' MET . 28.2 mt-30 -88.59 161.91 16.66 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.239 -0.437 . . . . 75.22 110.903 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . 0.465 ' HB2' ' CB ' ' A' ' 139' ' ' PHE . 85.9 m-85 -135.72 130.87 34.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.162 -0.472 . . . . 73.2 110.932 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.649 HD23 ' OH ' ' A' ' 50' ' ' TYR . 9.2 tp -82.87 120.34 25.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.152 -0.476 . . . . 72.52 110.914 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.935 ' O ' HD13 ' A' ' 152' ' ' LEU . 0.0 OUTLIER -51.62 136.77 26.17 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.208 -0.451 . . . . 75.13 110.888 179.877 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -164.53 24.93 0.06 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.207 -0.451 . . . . 75.52 110.834 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.843 ' HB2' ' CD1' ' A' ' 157' ' ' TYR . 0.0 OUTLIER -119.42 -176.57 3.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.239 -0.437 . . . . 75.34 110.936 179.968 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.747 ' CG ' HD22 ' A' ' 133' ' ' LEU . 1.1 mptt -159.09 -121.72 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.216 -0.447 . . . . 74.44 110.912 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.657 ' HA ' ' HA ' ' A' ' 131' ' ' LYS . 2.9 tm-20 -68.93 0.09 4.91 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.175 -0.466 . . . . 52.54 110.881 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . 0.843 ' CD1' ' HB2' ' A' ' 154' ' ' LYS . 16.5 m-30 -32.01 147.5 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.151 -0.477 . . . . 72.12 110.968 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . 0.54 ' HB3' ' CZ ' ' A' ' 104' ' ' PHE . 6.8 ptp180 -112.5 -41.78 3.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.145 -0.479 . . . . 74.13 110.85 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -85.95 150.57 53.11 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.56 0.695 . . . . 75.34 110.906 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . 0.52 ' HB3' ' HB3' ' A' ' 168' ' ' PRO . 54.1 Cg_endo -69.74 -31.57 20.36 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.719 2.279 . . . . 71.02 112.364 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.761 ' H ' HD12 ' A' ' 161' ' ' ILE . 3.5 mp -62.25 -12.75 8.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.236 -0.438 . . . . 72.0 111.115 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.587 ' HB3' ' CD1' ' A' ' 157' ' ' TYR . 0.5 OUTLIER -70.44 -12.26 61.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.216 -0.447 . . . . 55.2 110.874 179.842 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 75.4 t-105 -90.95 -12.96 34.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.23 -0.441 . . . . 74.5 110.928 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 93.03 -35.25 4.17 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.769 -0.729 . . . . 43.33 112.487 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -79.84 123.24 27.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.818 0.342 . . . . 61.23 111.076 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -49.38 122.6 6.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.167 -0.469 . . . . 42.02 111.094 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . 0.469 ' C ' ' H ' ' A' ' 169' ' ' ALA . 0.5 OUTLIER 64.89 140.86 0.06 OUTLIER Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.637 0.732 . . . . 71.32 110.909 -179.768 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . 0.536 ' HG2' ' HB3' ' A' ' 126' ' ' GLU . 53.5 Cg_endo -69.8 33.6 0.2 Allowed 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.717 2.278 . . . . 64.05 112.317 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 0.473 ' O ' HG22 ' A' ' 170' ' ' VAL . . . -67.19 98.28 0.59 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.233 -0.44 . . . . 71.23 111.148 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.597 HG12 ' H ' ' A' ' 171' ' ' GLN . 1.1 t -156.97 175.32 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.221 -0.445 . . . . 65.25 111.13 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' GLN . . . . . 0.701 ' CD ' ' N ' ' A' ' 171' ' ' GLN . 0.0 OUTLIER -160.66 -99.93 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.146 -0.479 . . . . 54.3 110.911 -179.957 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . 0.775 ' HB3' ' O ' ' A' ' 142' ' ' LEU . 0.1 OUTLIER -52.46 140.61 22.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.168 -0.469 . . . . 34.23 110.868 -179.793 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' PHE . . . . . 0.484 ' HB3' ' CE1' ' A' ' 139' ' ' PHE . 18.9 p90 -156.44 149.84 24.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.114 -0.494 . . . . 64.54 110.89 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . 0.478 ' HD3' ' CE2' ' A' ' 140' ' ' TYR . 0.0 OUTLIER -149.21 157.58 43.48 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.128 -0.487 . . . . 70.53 110.851 -179.899 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . 0.415 ' H ' ' HD2' ' A' ' 175' ' ' ARG . 0.0 OUTLIER -106.29 172.08 7.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.221 -0.445 . . . . 73.13 110.854 -179.938 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . 0.806 HD12 ' HB ' ' A' ' 136' ' ' VAL . 6.5 mt -97.78 143.38 12.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.175 -0.466 . . . . 72.21 111.132 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 67.8 t -48.36 140.72 2.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.164 -0.471 . . . . 73.4 111.128 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . 0.627 ' HB3' HD12 ' A' ' 88' ' ' LEU . 1.2 mm-40 . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 116.213 -0.448 . . . . 74.24 110.907 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.322 0 N-CA-C 112.468 -0.253 . . . . 34.23 112.468 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.503 ' C ' ' HE1' ' A' ' 47' ' ' TRP . 5.2 p -82.41 134.3 35.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.906 0.384 . . . . 64.31 111.105 -179.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 3.9 tttt -120.06 135.87 54.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.176 -0.465 . . . . 73.31 110.906 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.616 ' HB ' ' CD1' ' A' ' 47' ' ' TRP . 15.5 tt -137.14 151.88 27.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.231 -0.44 . . . . 61.31 111.159 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.499 ' HA ' ' O ' ' A' ' 21' ' ' TYR . 18.1 m -132.86 142.45 48.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.192 -0.458 . . . . 61.43 111.153 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.722 ' HB2' HD22 ' A' ' 34' ' ' LEU . 0.8 OUTLIER -130.08 129.03 43.07 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.25 -0.432 . . . . 73.42 110.875 -179.965 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.547 ' CG ' ' HA ' ' A' ' 16' ' ' PHE . 12.5 m-85 -114.4 131.65 56.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.136 -0.484 . . . . 53.51 110.93 -179.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.438 ' HB2' ' HB2' ' A' ' 19' ' ' ARG . 0.1 OUTLIER -59.5 -16.49 24.83 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.117 -0.492 . . . . 72.43 110.864 -179.97 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.443 ' HB2' ' O ' ' A' ' 17' ' ' GLN . 72.2 m-20 -134.14 150.56 51.12 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.167 -0.469 . . . . 71.12 110.885 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.469 ' N ' ' HB3' ' A' ' 38' ' ' ASN . 34.2 mtmt -55.61 -176.58 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.196 -0.456 . . . . 64.3 110.864 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 20.2 m120 47.22 32.45 2.1 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.194 -0.457 . . . . 50.31 110.908 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.547 ' HA ' ' CG ' ' A' ' 11' ' ' TYR . 3.3 m-85 49.74 62.66 2.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 72.2 110.916 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.443 ' O ' ' HB2' ' A' ' 13' ' ' ASP . 18.3 mt-30 -137.75 159.22 42.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.116 -0.493 . . . . 71.12 110.895 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 92.7 -148.49 19.11 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.765 -0.731 . . . . 74.14 112.482 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.757 ' O ' HD13 ' A' ' 34' ' ' LEU . 0.3 OUTLIER -69.75 78.43 0.45 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.797 0.332 . . . . 75.54 110.844 -179.8 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.487 ' HB2' ' CE1' ' A' ' 11' ' ' TYR . 0.6 OUTLIER -76.88 130.35 37.46 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.188 -0.46 . . . . 65.13 110.845 -179.91 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.499 ' O ' ' HA ' ' A' ' 9' ' ' THR . 89.2 t80 -124.33 123.65 40.67 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.193 -0.458 . . . . 74.25 110.895 -179.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.471 ' CG ' HG23 ' A' ' 9' ' ' THR . 1.2 m-20 -121.14 133.78 55.21 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.089 -0.505 . . . . 73.4 110.856 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -168.31 136.67 2.26 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.196 -0.457 . . . . 62.05 110.916 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -101.93 -0.69 33.46 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.185 -0.461 . . . . 74.3 110.839 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 16.8 t -102.85 164.34 11.68 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.226 -0.443 . . . . 71.24 110.911 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -57.68 120.86 9.1 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.238 -0.437 . . . . 70.42 110.894 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.55 ' HB2' ' HB3' ' A' ' 30' ' ' PHE . 1.8 m -116.63 51.13 1.0 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.185 -0.461 . . . . 72.42 110.853 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.495 ' C ' ' HA ' ' A' ' 82' ' ' SER . . . -47.07 -21.1 0.2 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.226 -0.443 . . . . 73.02 111.099 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 55.0 t0 -128.17 41.77 3.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.202 -0.454 . . . . 74.42 110.862 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.773 ' O ' ' CD2' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -81.35 13.18 3.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.184 -0.462 . . . . 73.04 110.851 -179.881 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.479 ' HB2' ' HB3' ' A' ' 53' ' ' PRO . 28.8 t60 -78.75 -40.44 33.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.143 -0.48 . . . . 73.1 110.803 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.7 t -56.33 -16.14 5.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.197 -0.456 . . . . 74.11 111.126 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -98.26 -25.95 14.69 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.21 -0.45 . . . . 64.02 110.932 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.757 HD13 ' O ' ' A' ' 19' ' ' ARG . 16.3 tp -144.13 131.58 20.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.076 -0.511 . . . . 43.3 110.901 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 24.5 m -93.81 -42.88 8.88 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.193 -0.458 . . . . 63.42 110.839 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 1.1 tmm_? -118.41 140.64 49.54 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.163 -0.471 . . . . 72.1 110.861 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.493 ' HB3' ' HB2' ' A' ' 80' ' ' LEU . 4.0 p -108.71 81.08 1.4 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.164 -0.471 . . . . 74.43 110.913 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.469 ' HB3' ' N ' ' A' ' 14' ' ' LYS . 0.2 OUTLIER -70.4 -73.26 0.17 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.17 -0.468 . . . . 75.11 110.879 -179.882 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 4.3 p -109.21 125.03 51.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.208 -0.451 . . . . 74.11 110.841 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.756 HG21 HD13 ' A' ' 62' ' ' LEU . 45.3 mt -118.05 148.83 20.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.127 -0.488 . . . . 73.42 111.11 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.468 ' HD2' ' CE2' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -144.69 119.26 9.73 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.207 -0.451 . . . . 64.42 110.847 179.868 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.535 HG22 ' HB ' ' A' ' 8' ' ' ILE . 2.0 t -104.04 115.66 46.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.186 -0.461 . . . . 72.14 111.121 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -110.27 79.39 1.2 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.202 -0.454 . . . . 71.01 110.884 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.438 ' O ' ' HA ' ' A' ' 6' ' ' THR . . . 129.31 106.89 1.25 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.704 -0.76 . . . . 70.42 112.501 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 51.89 -178.75 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.764 -0.732 . . . . 54.32 112.463 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.705 HG23 ' HA ' ' A' ' 63' ' ' PRO . 1.2 m -83.23 168.29 16.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.749 0.309 . . . . 73.44 111.137 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . 0.616 ' CD1' ' HB ' ' A' ' 8' ' ' ILE . 3.4 m95 -141.04 130.19 23.44 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.276 -0.42 . . . . 74.01 110.918 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.882 ' HB2' ' CG2' ' A' ' 86' ' ' VAL . . . -93.52 129.27 39.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.275 -0.42 . . . . 74.33 111.102 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.665 HG11 ' CD1' ' A' ' 80' ' ' LEU . 15.5 m -129.02 125.83 63.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.206 -0.452 . . . . 75.21 111.108 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.73 ' HB3' ' HA ' ' A' ' 56' ' ' ALA . 42.8 m-85 -92.16 150.11 21.1 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.16 -0.473 . . . . 72.43 110.929 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.648 ' OE1' ' HB3' ' A' ' 57' ' ' TRP . 54.2 tt0 -49.99 -78.94 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.099 -0.5 . . . . 55.24 110.865 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.544 ' HB3' ' CD2' ' A' ' 55' ' ' PHE . 0.0 OUTLIER -93.66 144.68 28.58 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.626 0.727 . . . . 74.35 110.848 -179.867 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.772 ' HA ' ' OG ' ' A' ' 82' ' ' SER . 53.8 Cg_endo -69.78 141.76 46.01 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.702 2.268 . . . . 64.31 112.346 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 63.38 -11.89 0.09 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.226 -0.443 . . . . 75.21 110.878 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.61 ' H ' ' C ' ' A' ' 53' ' ' PRO . 2.5 m-30 -104.01 -19.13 14.31 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.148 -0.478 . . . . 73.12 110.893 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.73 ' HA ' ' HB3' ' A' ' 50' ' ' TYR . . . 49.47 25.46 1.37 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.138 -0.483 . . . . 71.3 111.09 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . 0.648 ' HB3' ' OE1' ' A' ' 51' ' ' GLU . 0.0 OUTLIER -50.01 -166.06 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.243 -0.435 . . . . 74.55 110.982 -179.988 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.636 ' C ' ' O ' ' A' ' 57' ' ' TRP . 10.0 m-30 -14.1 101.32 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.267 -0.424 . . . . 75.34 110.913 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.482 ' HB2' ' HA ' ' A' ' 150' ' ' TYR . 1.6 mpt? -64.14 157.57 25.22 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.089 -0.505 . . . . 73.34 110.879 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.723 ' CD2' HD12 ' A' ' 76' ' ' LEU . 2.6 t80 -170.48 103.98 0.27 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.259 -0.428 . . . . 64.32 110.925 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.625 HD11 ' HB2' ' A' ' 151' ' ' LEU . 0.8 OUTLIER -91.23 115.09 29.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.115 -0.493 . . . . 64.3 111.113 179.904 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.79 HD23 ' HD2' ' A' ' 63' ' ' PRO . 0.3 OUTLIER -81.84 126.32 75.65 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.595 0.712 . . . . 73.23 110.949 179.861 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.79 ' HD2' HD23 ' A' ' 62' ' ' LEU . 53.9 Cg_endo -69.71 -176.1 1.36 Allowed 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.729 2.286 . . . . 71.05 112.348 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -84.51 161.66 20.16 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.238 -0.437 . . . . 73.5 110.899 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 113.64 -162.47 12.37 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.74 -0.743 . . . . 55.54 112.491 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -115.68 156.45 25.89 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.899 0.38 . . . . 74.35 110.847 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.554 ' HB2' ' O ' ' A' ' 40' ' ' ILE . 9.4 m-85 -145.17 83.72 9.07 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.669 0.747 . . . . 74.54 110.943 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.409 ' HD2' ' HG3' ' A' ' 72' ' ' ARG . 53.8 Cg_endo -69.77 0.67 5.32 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.686 2.257 . . . . 54.33 112.326 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.483 ' HB2' ' HG2' ' A' ' 72' ' ' ARG . 42.4 mt-10 -155.79 142.72 18.99 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.268 -0.424 . . . . 74.31 110.922 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.693 ' HA ' ' NE1' ' A' ' 73' ' ' TRP . 24.1 p90 -56.11 -21.38 21.97 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.205 -0.452 . . . . 72.24 110.899 -179.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -78.2 -18.42 55.51 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.094 -0.503 . . . . 62.15 110.894 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.483 ' HG2' ' HB2' ' A' ' 69' ' ' GLU . 29.4 mmt180 -67.52 -9.25 40.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.213 -0.449 . . . . 71.3 110.919 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . 0.714 ' N ' ' CD1' ' A' ' 73' ' ' TRP . 0.0 OUTLIER -135.51 5.89 3.22 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.175 -0.466 . . . . 74.04 110.93 -179.979 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 11.6 mtp 45.42 68.64 0.54 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.234 -0.439 . . . . 64.42 110.934 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -60.66 120.79 24.33 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.749 -0.739 . . . . 71.23 112.47 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.876 HD13 ' N ' ' A' ' 77' ' ' ASN . 0.0 OUTLIER -70.75 -8.79 54.82 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.805 0.336 . . . . 71.42 110.897 -179.954 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.876 ' N ' HD13 ' A' ' 76' ' ' LEU . 10.7 t-20 -151.46 -41.83 0.12 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.217 -0.447 . . . . 73.22 110.885 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.581 ' CB ' ' O ' ' A' ' 77' ' ' ASN . 1.8 t70 89.88 7.68 0.1 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.186 -0.461 . . . . 72.51 110.872 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -105.81 91.43 3.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.181 -0.463 . . . . 73.52 110.888 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.665 ' CD1' HG11 ' A' ' 49' ' ' VAL . 0.1 OUTLIER -90.28 135.54 33.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.172 -0.467 . . . . 65.11 110.965 -180.0 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.631 ' HB3' ' HB3' ' A' ' 53' ' ' PRO . 1.2 m -151.94 -118.66 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.198 -0.455 . . . . 75.1 110.884 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.772 ' OG ' ' HA ' ' A' ' 53' ' ' PRO . 0.2 OUTLIER -44.57 101.8 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.142 -0.481 . . . . 70.13 110.851 -179.824 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . 0.601 ' HB3' HG12 ' A' ' 49' ' ' VAL . 15.9 p -115.77 141.43 48.11 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.133 -0.485 . . . . 75.41 110.887 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.6 ' N ' ' O ' ' A' ' 48' ' ' ALA . 13.8 mmt85 -128.38 134.7 48.88 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.218 -0.447 . . . . 63.24 110.884 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.465 ' N ' ' CZ3' ' A' ' 47' ' ' TRP . . . -53.06 127.44 24.05 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.456 . . . . 45.42 111.08 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.882 ' CG2' ' HB2' ' A' ' 48' ' ' ALA . 73.7 t -115.05 135.43 55.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.238 -0.437 . . . . 71.13 111.136 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 28.7 m-70 -112.08 120.2 41.03 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.15 -0.477 . . . . 74.35 110.859 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.763 HD13 ' HB3' ' A' ' 178' ' ' GLU . 0.1 OUTLIER -40.04 137.65 1.18 Allowed Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.62 0.724 . . . . 72.1 110.942 -179.961 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.65 ' HB3' ' H ' ' A' ' 136' ' ' VAL . 53.9 Cg_endo -69.72 81.17 0.83 Allowed 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.7 2.266 . . . . 75.52 112.363 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -98.72 119.15 36.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.242 -0.435 . . . . 72.12 110.881 -179.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 130.51 85.98 0.39 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.755 -0.735 . . . . 53.13 112.496 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 88.1 35.63 8.81 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.782 -0.723 . . . . 73.52 112.471 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.46 ' O ' ' HG3' ' A' ' 134' ' ' GLU . 12.4 pt20 39.47 -154.18 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.832 0.349 . . . . 73.4 110.917 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.596 ' O ' ' HA ' ' A' ' 112' ' ' THR . 28.0 m-85 -96.17 102.35 14.12 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.199 -0.455 . . . . 71.34 110.919 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.506 ' H ' ' CG ' ' A' ' 134' ' ' GLU . 35.4 tptt -109.58 126.18 53.33 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.139 -0.482 . . . . 72.44 110.895 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 5.3 tt -150.6 137.19 12.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.189 -0.46 . . . . 74.34 111.119 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -108.14 135.11 50.04 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.17 -0.468 . . . . 72.12 110.917 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.582 ' CG2' HD12 ' A' ' 127' ' ' ILE . 26.0 mm -115.37 134.7 57.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.231 -0.44 . . . . 72.42 111.113 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.589 ' HB2' ' HB2' ' A' ' 129' ' ' SER . 61.7 m-85 -123.13 140.07 53.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 74.33 110.885 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.551 ' HA ' ' CE ' ' A' ' 124' ' ' MET . 58.6 tt0 -75.06 -52.64 10.54 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.161 -0.472 . . . . 72.34 110.922 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 40.8 mttt -106.8 155.29 19.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.136 -0.484 . . . . 63.45 110.932 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.406 ' N ' ' HB3' ' A' ' 128' ' ' HIS . . . -62.24 157.3 36.6 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.772 -0.728 . . . . 65.12 112.467 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.55 ' HA ' ' HB2' ' A' ' 158' ' ' ARG . 12.8 t70 69.48 39.92 1.52 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.896 0.379 . . . . 63.44 110.878 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.526 ' HA ' ' CD1' ' A' ' 99' ' ' PHE . 2.1 m-85 55.32 25.13 7.16 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.176 -0.465 . . . . 74.12 110.886 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 68.0 m -92.94 166.83 12.19 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.18 -0.464 . . . . 70.13 110.831 -179.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 79.18 -157.66 43.16 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.75 -0.738 . . . . 72.05 112.511 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 4.3 tp-100 -75.08 119.58 19.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.794 0.33 . . . . 73.24 110.931 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' MET . . . . . 0.462 ' HB2' ' CE1' ' A' ' 99' ' ' PHE . 18.8 ttp -104.36 145.46 30.22 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.23 -0.441 . . . . 74.1 110.864 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -148.66 134.84 19.29 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.195 -0.457 . . . . 70.4 110.926 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -113.38 89.28 3.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 74.34 110.907 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 15.0 t -101.04 130.55 47.07 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.115 -0.493 . . . . 72.34 111.163 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.596 ' HA ' ' O ' ' A' ' 94' ' ' TYR . 0.6 OUTLIER -104.83 30.68 5.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.229 -0.441 . . . . 71.33 111.148 -179.974 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -154.05 133.12 12.49 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.216 -0.447 . . . . 75.52 110.876 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.4 ' HB2' ' HA ' ' A' ' 174' ' ' ARG . 39.1 p30 -51.3 170.24 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.141 -0.481 . . . . 74.34 110.864 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . 0.486 ' O ' ' HB2' ' A' ' 172' ' ' SER . 14.1 p -152.37 144.24 16.44 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.594 0.711 . . . . 71.41 110.915 -179.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.434 ' O ' ' C ' ' A' ' 143' ' ' PRO . 53.6 Cg_endo -69.76 -31.16 21.08 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.712 2.275 . . . . 71.44 112.385 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.634 ' HB3' ' CB ' ' A' ' 120' ' ' GLU . 0.1 OUTLIER -147.41 106.66 3.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.193 -0.458 . . . . 50.53 110.88 -179.875 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.656 ' HB ' ' O ' ' A' ' 171' ' ' GLN . 4.0 tt -58.14 -28.18 33.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.131 -0.486 . . . . 75.12 111.088 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' MET . . . . . 0.695 ' O ' ' HA ' ' A' ' 123' ' ' HIS . 27.1 ttp -87.46 -41.47 13.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.185 -0.462 . . . . 74.51 110.915 179.831 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.634 ' CB ' ' HB3' ' A' ' 117' ' ' SER . 15.5 tp10 -68.65 -12.33 61.23 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.223 -0.444 . . . . 72.45 110.876 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 18.6 tp60 -115.94 -48.46 2.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.167 -0.469 . . . . 62.4 110.917 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.477 ' HB2' ' O ' ' A' ' 118' ' ' ILE . 44.6 m-85 -103.99 -13.78 16.19 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.189 -0.46 . . . . 73.41 110.897 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . 0.695 ' HA ' ' O ' ' A' ' 119' ' ' MET . 10.8 m80 71.46 20.18 4.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.106 -0.497 . . . . 74.1 110.825 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.551 ' CE ' ' HA ' ' A' ' 100' ' ' GLU . 0.0 OUTLIER -93.42 139.59 30.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.208 -0.451 . . . . 74.13 110.854 179.97 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 5.3 ptp180 -102.36 -44.92 5.25 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.188 -0.46 . . . . 72.54 110.827 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.451 ' HG2' ' HA ' ' A' ' 169' ' ' ALA . 10.8 mt-10 -138.17 117.23 12.54 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.209 -0.45 . . . . 72.04 110.858 -179.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.645 HG21 ' SG ' ' A' ' 130' ' ' CYS . 2.5 mm -77.41 93.93 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.131 -0.486 . . . . 72.25 111.087 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . 0.406 ' HB3' ' N ' ' A' ' 102' ' ' GLY . 0.6 OUTLIER -63.78 -36.08 82.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.467 . . . . 74.12 110.877 179.849 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . 0.589 ' HB2' ' HB2' ' A' ' 99' ' ' PHE . 0.6 OUTLIER -132.32 146.21 51.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.205 -0.452 . . . . 72.41 110.851 -179.756 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . 0.645 ' SG ' HG21 ' A' ' 127' ' ' ILE . 0.5 OUTLIER -145.27 120.49 10.18 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.15 -0.477 . . . . 73.33 110.849 -179.937 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.653 ' HA ' ' HA ' ' A' ' 156' ' ' GLU . 1.3 mtpt -107.39 153.93 22.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.152 -0.477 . . . . 74.35 110.894 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.592 HG23 ' C ' ' A' ' 131' ' ' LYS . 4.8 t 82.71 165.27 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.207 -0.451 . . . . 74.4 111.119 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.795 HD13 ' O ' ' A' ' 154' ' ' LYS . 0.0 OUTLIER -176.47 126.02 0.18 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.187 -0.46 . . . . 52.23 110.884 179.988 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.506 ' CG ' ' H ' ' A' ' 95' ' ' LYS . 0.0 OUTLIER -94.39 159.23 15.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.172 -0.467 . . . . 75.1 110.893 179.95 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . 0.485 ' C ' ' O ' ' A' ' 134' ' ' GLU . . . -31.05 -48.82 0.2 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.764 -0.732 . . . . 72.41 112.451 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.799 ' HB ' HD12 ' A' ' 176' ' ' ILE . 2.3 t -150.99 133.5 6.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.814 0.34 . . . . 74.21 111.105 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' TRP . . . . . 0.596 ' H ' ' CG ' ' A' ' 152' ' ' LEU . 3.6 t-105 -133.5 150.7 51.7 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.173 -0.467 . . . . 74.45 110.88 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.721 HG23 ' NE2' ' A' ' 149' ' ' GLN . 22.1 mm -114.12 128.77 70.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.18 -0.463 . . . . 73.54 111.139 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.518 ' CB ' ' HB2' ' A' ' 150' ' ' TYR . 0.5 OUTLIER -114.91 149.59 36.99 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.217 -0.447 . . . . 74.24 110.875 179.953 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . 0.492 ' CD2' ' HA ' ' A' ' 145' ' ' TYR . 2.3 m-85 -134.98 133.17 39.2 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.131 -0.486 . . . . 60.35 110.902 -179.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . 0.69 ' O ' ' HB2' ' A' ' 171' ' ' GLN . 0.8 OUTLIER -59.93 -26.49 65.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.147 -0.478 . . . . 63.11 110.911 179.966 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.728 ' HB3' ' HD2' ' A' ' 143' ' ' PRO . 9.7 mp -112.15 173.13 3.03 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.595 0.712 . . . . 65.31 110.883 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . 0.728 ' HD2' ' HB3' ' A' ' 142' ' ' LEU . 53.8 Cg_endo -69.76 -89.68 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.645 2.23 . . . . 74.3 112.357 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . 0.686 ' O ' ' N ' ' A' ' 146' ' ' ARG . 2.3 m-20 -52.81 97.0 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.183 -0.462 . . . . 71.14 110.923 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . 0.64 ' C ' ' O ' ' A' ' 144' ' ' ASN . 0.1 OUTLIER 12.78 53.25 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.18 -0.463 . . . . 74.34 110.962 -179.899 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . 0.686 ' N ' ' O ' ' A' ' 144' ' ' ASN . 38.1 mtt85 -119.46 179.1 4.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.1 -0.5 . . . . 74.45 110.865 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 73.98 -174.05 49.59 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.723 -0.751 . . . . 70.33 112.509 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.427 ' HG2' ' CD1' ' A' ' 58' ' ' TYR . 0.2 OUTLIER -75.91 151.75 37.27 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.758 0.313 . . . . 72.21 110.868 -179.883 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' GLN . . . . . 0.721 ' NE2' HG23 ' A' ' 138' ' ' ILE . 0.0 OUTLIER -88.5 149.82 23.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.186 -0.461 . . . . 74.11 110.946 -179.979 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . 0.518 ' HB2' ' CB ' ' A' ' 139' ' ' PHE . 82.4 m-85 -134.07 129.5 36.12 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.205 -0.452 . . . . 72.31 110.9 -179.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.625 ' HB2' HD11 ' A' ' 61' ' ' ILE . 16.8 tp -81.67 122.72 27.99 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.129 -0.487 . . . . 65.42 110.882 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.921 ' O ' HD13 ' A' ' 152' ' ' LEU . 0.0 OUTLIER -54.54 135.36 46.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.2 -0.455 . . . . 72.53 110.915 179.871 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -163.25 25.74 0.09 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.183 -0.462 . . . . 62.33 110.9 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.795 ' O ' HD13 ' A' ' 133' ' ' LEU . 0.0 OUTLIER -117.27 -173.7 2.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.133 -0.485 . . . . 71.42 110.874 179.984 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.753 ' CG ' HD22 ' A' ' 133' ' ' LEU . 0.5 OUTLIER -161.87 -124.77 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.18 -0.464 . . . . 73.41 110.901 179.886 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.653 ' HA ' ' HA ' ' A' ' 131' ' ' LYS . 0.7 OUTLIER -69.09 -0.41 5.79 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.226 -0.443 . . . . 74.2 110.921 179.928 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . 0.785 ' CE1' ' HA ' ' A' ' 154' ' ' LYS . 18.5 m-30 -31.08 146.95 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.122 -0.49 . . . . 72.02 110.93 -179.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . 0.55 ' HB2' ' HA ' ' A' ' 103' ' ' ASP . 8.5 ptp180 -112.29 -39.49 4.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.117 -0.492 . . . . 70.24 110.867 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . 0.457 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 2.6 ptpp? -92.01 150.96 41.43 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.602 0.715 . . . . 72.43 110.881 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . 0.423 ' HA ' ' CZ2' ' A' ' 163' ' ' TRP . 53.9 Cg_endo -69.7 -23.05 31.49 Favored 'Trans proline' 0 C--O 1.232 0.214 0 C-N-CA 122.717 2.278 . . . . 72.41 112.352 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.674 ' H ' HD12 ' A' ' 161' ' ' ILE . 3.9 mp -76.62 2.32 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.226 -0.443 . . . . 63.32 111.105 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.667 ' HB3' ' CD1' ' A' ' 157' ' ' TYR . 0.6 OUTLIER -73.07 -19.86 61.08 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.176 -0.465 . . . . 74.2 110.855 179.855 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' TRP . . . . . 0.605 ' CD1' ' N ' ' A' ' 163' ' ' TRP . 0.0 OUTLIER -109.13 13.92 24.21 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.182 -0.463 . . . . 74.22 110.928 -179.965 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 85.04 -30.53 3.93 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.75 -0.738 . . . . 74.43 112.496 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -54.19 120.1 6.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.742 0.306 . . . . 71.02 111.1 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -49.67 -25.65 3.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.214 -0.448 . . . . 51.3 111.136 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . 0.477 ' C ' ' H ' ' A' ' 169' ' ' ALA . 0.3 OUTLIER -155.61 160.13 31.09 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.708 0.766 . . . . 55.1 110.85 -179.804 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . 0.437 ' HB3' ' O ' ' A' ' 127' ' ' ILE . 53.8 Cg_endo -69.78 20.36 0.18 Allowed 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.717 2.278 . . . . 64.33 112.296 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 0.477 ' H ' ' C ' ' A' ' 167' ' ' SER . . . -63.18 103.64 0.5 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.245 -0.434 . . . . 71.41 111.124 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.425 HG12 ' N ' ' A' ' 171' ' ' GLN . 3.4 t -152.91 160.87 2.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.24 -0.436 . . . . 73.22 111.15 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' GLN . . . . . 0.69 ' HB2' ' O ' ' A' ' 141' ' ' GLU . 1.9 mm-40 -109.73 -88.03 0.5 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.215 -0.448 . . . . 73.54 110.913 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . 0.699 ' OG ' ' O ' ' A' ' 143' ' ' PRO . 15.4 p -130.6 178.39 6.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.177 -0.465 . . . . 73.24 110.817 -179.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -143.79 168.07 20.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.107 -0.497 . . . . 74.23 110.864 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . 0.676 ' NE ' HG21 ' A' ' 138' ' ' ILE . 2.1 ppt_? -133.39 156.66 47.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.163 -0.471 . . . . 74.25 110.913 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . 0.43 ' HB2' ' CE1' ' A' ' 94' ' ' TYR . 6.2 ptt85 -98.18 150.72 21.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.259 -0.428 . . . . 61.55 110.869 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . 0.799 HD12 ' HB ' ' A' ' 136' ' ' VAL . 15.4 mt -83.1 152.31 3.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.217 -0.447 . . . . 53.11 111.116 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 7.5 p -126.29 147.2 31.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.129 -0.487 . . . . 63.22 111.132 179.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . 0.763 ' HB3' HD13 ' A' ' 88' ' ' LEU . 1.6 pt-20 . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.215 -0.448 . . . . 63.53 110.933 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.304 0 N-CA-C 112.444 -0.262 . . . . 55.25 112.444 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.439 ' C ' ' HE1' ' A' ' 47' ' ' TRP . 9.8 p -82.68 135.61 34.98 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.837 0.351 . . . . 41.1 111.158 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.422 ' HA ' ' HA ' ' A' ' 24' ' ' ASP . 2.8 tttt -123.47 135.75 54.23 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.217 -0.447 . . . . 65.21 110.9 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.498 ' HA ' ' HA ' ' A' ' 42' ' ' VAL . 14.5 tt -136.71 152.05 28.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.25 -0.432 . . . . 54.14 111.148 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.478 HG23 ' CG ' ' A' ' 22' ' ' ASP . 15.3 m -133.98 142.66 47.75 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.19 -0.459 . . . . 60.34 111.129 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.551 ' HD1' HD11 ' A' ' 40' ' ' ILE . 0.3 OUTLIER -130.01 128.72 42.59 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.226 -0.443 . . . . 73.44 110.92 179.997 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.544 ' CG ' ' HA ' ' A' ' 16' ' ' PHE . 24.1 m-85 -113.54 131.96 55.88 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.164 -0.471 . . . . 72.34 110.973 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.434 ' HA ' ' O ' ' A' ' 36' ' ' ARG . 0.0 OUTLIER -61.08 -13.63 18.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.123 -0.489 . . . . 63.3 110.914 -179.955 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.437 ' HB2' ' O ' ' A' ' 17' ' ' GLN . 77.1 m-20 -136.95 150.78 48.38 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.124 -0.489 . . . . 60.54 110.868 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 4.8 mtmm -55.22 -175.95 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.198 -0.456 . . . . 53.53 110.852 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 20.2 m-20 45.53 33.25 1.3 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.156 -0.475 . . . . 74.4 110.885 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.544 ' HA ' ' CG ' ' A' ' 11' ' ' TYR . 2.7 m-85 49.22 64.77 1.6 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.169 -0.469 . . . . 71.01 110.896 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.437 ' O ' ' HB2' ' A' ' 13' ' ' ASP . 8.0 mt-30 -139.46 159.96 40.96 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.154 -0.476 . . . . 70.25 110.886 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 92.7 -150.03 19.84 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.78 -0.724 . . . . 55.11 112.521 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.741 ' O ' HD13 ' A' ' 34' ' ' LEU . 0.3 OUTLIER -69.9 78.79 0.47 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.803 0.335 . . . . 72.55 110.89 -179.885 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.456 ' HA ' ' O ' ' A' ' 10' ' ' PHE . 0.0 OUTLIER -76.24 129.51 36.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.205 -0.452 . . . . 72.22 110.856 -179.871 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.469 ' CD2' ' CD2' ' A' ' 30' ' ' PHE . 69.2 t80 -124.26 125.31 44.16 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.184 -0.462 . . . . 65.22 110.903 -179.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.478 ' CG ' HG23 ' A' ' 9' ' ' THR . 1.2 m-20 -118.83 134.54 55.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.113 -0.494 . . . . 65.22 110.925 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 8.8 t -161.17 129.66 4.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.23 -0.441 . . . . 74.51 110.897 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.422 ' HA ' ' HA ' ' A' ' 7' ' ' LYS . 14.1 p-10 -97.33 4.39 50.81 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.178 -0.465 . . . . 70.21 110.89 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 46.9 t -113.52 159.66 19.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.179 -0.464 . . . . 74.1 110.855 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -42.67 119.67 1.51 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.162 -0.472 . . . . 71.33 110.854 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.558 ' HB2' ' HB3' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -114.6 40.55 2.54 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.187 -0.461 . . . . 74.33 110.9 -179.913 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.563 ' O ' ' HA ' ' A' ' 82' ' ' SER . . . -51.12 -21.22 1.81 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.15 -0.477 . . . . 71.44 111.119 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 59.9 t0 -128.86 38.32 3.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.168 -0.469 . . . . 75.31 110.888 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.773 ' O ' ' CD2' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -80.27 13.92 2.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.186 -0.461 . . . . 64.13 110.878 -179.885 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.437 ' CG ' ' HG3' ' A' ' 53' ' ' PRO . 36.2 t60 -77.65 -36.81 51.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.147 -0.479 . . . . 65.42 110.875 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.7 t -59.81 -14.52 15.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.196 -0.456 . . . . 65.32 111.156 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -100.99 -24.97 14.23 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.202 -0.454 . . . . 71.13 110.877 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.741 HD13 ' O ' ' A' ' 19' ' ' ARG . 23.9 tp -141.62 123.93 15.67 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.125 -0.489 . . . . 51.11 110.943 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 27.0 m -82.83 -49.32 9.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.211 -0.45 . . . . 74.02 110.829 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.434 ' O ' ' HA ' ' A' ' 12' ' ' GLU . 0.1 OUTLIER -114.04 143.25 45.07 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.131 -0.486 . . . . 72.02 110.834 -179.925 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.586 ' HB2' ' HB2' ' A' ' 80' ' ' LEU . 57.6 m -122.93 104.76 9.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.174 -0.466 . . . . 74.21 110.906 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 10.9 m-20 -97.49 -67.15 0.86 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.226 -0.443 . . . . 71.52 110.892 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 10.6 p -105.68 133.66 50.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.207 -0.451 . . . . 74.31 110.895 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.666 HD12 ' HZ3' ' A' ' 73' ' ' TRP . 6.9 mt -130.01 149.53 33.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.135 -0.484 . . . . 65.4 111.114 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.426 ' HD2' ' CE2' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -142.51 119.07 11.0 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.155 -0.475 . . . . 75.01 110.906 179.853 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.613 HG21 ' HB2' ' A' ' 47' ' ' TRP . 1.0 OUTLIER -104.76 117.47 50.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.268 -0.424 . . . . 61.23 111.098 179.908 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -112.55 76.67 0.99 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.155 -0.475 . . . . 74.44 110.896 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.427 ' O ' ' HA ' ' A' ' 6' ' ' THR . . . 139.21 99.61 0.45 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.723 -0.751 . . . . 54.04 112.479 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.415 ' HA2' HD21 ' A' ' 88' ' ' LEU . . . 55.59 177.78 0.25 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.743 -0.741 . . . . 75.11 112.479 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.725 HG23 ' HA ' ' A' ' 63' ' ' PRO . 2.2 m -76.46 168.7 19.61 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.719 0.295 . . . . 75.34 111.18 -179.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . 0.613 ' HB2' HG21 ' A' ' 42' ' ' VAL . 7.7 m95 -143.32 128.36 18.54 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.261 -0.427 . . . . 74.41 110.93 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.778 ' HB2' ' CG2' ' A' ' 86' ' ' VAL . . . -89.83 127.62 36.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.221 -0.445 . . . . 63.0 111.093 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.826 HG11 HD11 ' A' ' 80' ' ' LEU . 26.9 m -127.62 141.72 45.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.181 -0.463 . . . . 43.02 111.144 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.804 ' HB3' ' CB ' ' A' ' 56' ' ' ALA . 5.0 m-85 -122.53 155.44 36.22 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.189 -0.459 . . . . 74.1 110.903 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.685 ' N ' ' HB1' ' A' ' 56' ' ' ALA . 35.3 mp0 -53.19 -94.8 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.081 -0.509 . . . . 75.52 110.928 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.839 ' O ' ' HB2' ' A' ' 56' ' ' ALA . 3.4 mtp180 -72.0 136.46 82.31 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.556 0.693 . . . . 75.25 110.863 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.643 ' HA ' ' OG ' ' A' ' 82' ' ' SER . 53.8 Cg_endo -69.79 131.64 21.62 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.676 2.251 . . . . 72.23 112.321 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.458 ' H ' ' HB3' ' A' ' 82' ' ' SER . 4.3 t-20 77.07 -5.35 2.19 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.169 -0.469 . . . . 75.12 110.916 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.413 ' CE1' ' HB3' ' A' ' 54' ' ' ASN . 0.1 OUTLIER -144.73 -73.4 0.25 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.158 -0.474 . . . . 74.01 110.852 -179.981 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.839 ' HB2' ' O ' ' A' ' 52' ' ' ARG . . . 37.96 80.29 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.177 -0.465 . . . . 75.23 111.107 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . 0.458 ' O ' ' CG ' ' A' ' 58' ' ' TYR . 31.4 m95 -64.96 53.07 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.215 -0.448 . . . . 72.12 110.903 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.575 ' CB ' ' OE1' ' A' ' 51' ' ' GLU . 0.5 OUTLIER -177.19 124.39 0.14 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.252 -0.431 . . . . 74.24 110.911 -179.921 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.526 ' HG3' ' CE2' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -81.79 139.71 34.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.136 -0.484 . . . . 70.42 110.874 179.903 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.715 ' OH ' ' O ' ' A' ' 73' ' ' TRP . 1.0 OUTLIER -154.7 86.24 1.13 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.248 -0.433 . . . . 55.21 110.906 -179.876 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.782 HD11 ' HA ' ' A' ' 151' ' ' LEU . 1.6 mp -80.42 118.88 28.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.145 -0.48 . . . . 63.32 111.109 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.783 HD23 ' HD2' ' A' ' 63' ' ' PRO . 0.3 OUTLIER -87.06 127.86 57.83 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.615 0.721 . . . . 74.52 110.929 179.853 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.783 ' HD2' HD23 ' A' ' 62' ' ' LEU . 53.4 Cg_endo -69.81 -174.24 0.88 Allowed 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.701 2.268 . . . . 71.54 112.34 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -87.02 162.89 17.37 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.203 -0.453 . . . . 60.22 110.943 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 113.37 -161.03 12.82 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.767 -0.73 . . . . 73.22 112.469 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -111.99 160.24 17.65 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.862 0.363 . . . . 72.14 110.906 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.479 ' N ' ' O ' ' A' ' 40' ' ' ILE . 20.6 m-85 -149.16 81.6 7.39 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.646 0.736 . . . . 74.44 110.898 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.475 ' HD2' ' HG3' ' A' ' 72' ' ' ARG . 53.8 Cg_endo -69.7 -3.57 12.24 Favored 'Trans proline' 0 C--O 1.231 0.155 0 C-N-CA 122.706 2.271 . . . . 50.22 112.345 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -157.77 149.36 21.75 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.224 -0.443 . . . . 75.22 110.927 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.778 ' O ' ' CD1' ' A' ' 73' ' ' TRP . 35.4 p90 -55.28 -41.27 72.06 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.163 -0.471 . . . . 71.31 110.979 -179.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -51.66 -21.89 2.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.099 -0.5 . . . . 64.34 110.938 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.475 ' HG3' ' HD2' ' A' ' 68' ' ' PRO . 28.9 mmt180 -61.8 -39.74 92.8 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.189 -0.46 . . . . 74.34 110.891 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . 0.778 ' CD1' ' O ' ' A' ' 70' ' ' TYR . 0.3 OUTLIER -92.88 34.17 1.11 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.168 -0.469 . . . . 64.0 110.934 -179.999 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 34.5 mmm 75.19 17.66 2.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.258 -0.428 . . . . 65.55 110.913 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.427 ' N ' ' HD1' ' A' ' 73' ' ' TRP . . . 42.98 44.0 5.6 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.759 -0.734 . . . . 71.31 112.484 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.462 ' CB ' ' CE2' ' A' ' 60' ' ' TYR . 0.5 OUTLIER -67.45 -74.12 0.12 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.877 0.37 . . . . 72.52 110.933 -179.907 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 12.6 t-20 -154.02 138.96 17.22 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.164 -0.471 . . . . 75.3 110.879 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -87.61 13.61 10.0 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.164 -0.471 . . . . 73.25 110.87 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.511 ' HD3' ' HB3' ' A' ' 51' ' ' GLU . 38.7 ttt85 -84.29 44.97 1.06 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.182 -0.463 . . . . 71.34 110.866 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.826 HD11 HG11 ' A' ' 49' ' ' VAL . 0.1 OUTLIER -66.12 125.59 25.99 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.2 -0.454 . . . . 62.31 110.928 -179.995 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.56 ' HB3' ' HB3' ' A' ' 53' ' ' PRO . 3.7 m -151.07 -109.2 0.06 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.186 -0.461 . . . . 73.52 110.879 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.643 ' OG ' ' HA ' ' A' ' 53' ' ' PRO . 0.0 OUTLIER -51.32 102.23 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.147 -0.479 . . . . 74.53 110.869 -179.827 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . 0.819 ' HB3' HG12 ' A' ' 49' ' ' VAL . 14.6 p -126.55 135.33 51.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.155 -0.475 . . . . 65.04 110.855 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.598 ' N ' ' O ' ' A' ' 48' ' ' ALA . 2.1 mmt85 -118.29 159.87 22.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.162 -0.472 . . . . 72.13 110.863 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -74.3 125.96 29.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.208 -0.451 . . . . 73.3 111.067 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.778 ' CG2' ' HB2' ' A' ' 48' ' ' ALA . 18.0 t -120.31 145.31 26.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.202 -0.454 . . . . 41.5 111.102 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . 0.558 ' O ' HG23 ' A' ' 136' ' ' VAL . 70.0 m-70 -110.78 112.36 24.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.176 -0.465 . . . . 74.34 110.905 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.467 HD23 ' H ' ' A' ' 88' ' ' LEU . 0.0 OUTLIER -37.91 152.28 0.15 Allowed Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 121.626 0.727 . . . . 51.03 110.887 -179.956 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.529 ' HB3' ' H ' ' A' ' 136' ' ' VAL . 54.3 Cg_endo -69.67 83.15 0.69 Allowed 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.673 2.248 . . . . 72.34 112.361 179.809 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.2 t -90.23 -177.34 5.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.275 -0.42 . . . . 72.05 110.846 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 70.35 -81.94 0.37 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.702 -0.761 . . . . 65.14 112.489 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.41 ' O ' ' C ' ' A' ' 93' ' ' GLN . . . -92.58 34.16 4.63 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.739 -0.743 . . . . 54.4 112.53 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.459 ' O ' ' HG2' ' A' ' 134' ' ' GLU . 14.6 pt20 37.54 -121.58 0.21 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.868 0.366 . . . . 75.43 110.903 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.684 ' CZ ' ' HA ' ' A' ' 175' ' ' ARG . 1.4 t80 -121.91 99.29 6.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.228 -0.442 . . . . 74.24 110.945 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.559 ' HG3' HG11 ' A' ' 132' ' ' VAL . 23.8 tptt -119.27 127.14 52.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.153 -0.476 . . . . 63.34 110.846 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.589 HD13 ' H ' ' A' ' 97' ' ' GLN . 0.4 OUTLIER -150.1 138.61 14.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.189 -0.46 . . . . 73.21 111.099 179.901 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.589 ' H ' HD13 ' A' ' 96' ' ' ILE . 0.7 OUTLIER -110.38 124.3 51.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.175 -0.466 . . . . 63.43 110.916 179.904 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.545 HG22 ' SD ' ' A' ' 124' ' ' MET . 29.6 mm -107.19 133.23 52.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.172 -0.467 . . . . 71.44 111.168 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.66 ' HB2' ' HB2' ' A' ' 129' ' ' SER . 7.7 m-85 -123.41 144.76 49.28 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.199 -0.455 . . . . 72.2 110.896 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 71.7 tt0 -72.85 -74.43 0.17 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.16 -0.473 . . . . 74.43 110.923 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.503 ' C ' ' HB2' ' A' ' 128' ' ' HIS . 31.9 mttt -85.2 167.12 15.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.09 -0.505 . . . . 63.44 110.887 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.424 ' HA2' ' OG ' ' A' ' 129' ' ' SER . . . -80.9 158.03 40.17 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.77 -0.729 . . . . 31.05 112.495 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.48 ' HA ' ' HB2' ' A' ' 158' ' ' ARG . 33.2 t70 68.1 54.27 0.6 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.799 0.333 . . . . 72.51 110.833 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.697 ' CE1' ' HD2' ' A' ' 131' ' ' LYS . 7.2 m-85 47.39 29.99 1.45 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.197 -0.456 . . . . 62.44 110.905 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.446 ' C ' ' HB2' ' A' ' 101' ' ' LYS . 48.0 m -105.47 152.11 23.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.103 -0.499 . . . . 75.44 110.889 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 89.42 -165.2 32.36 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.723 -0.751 . . . . 30.43 112.441 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 5.9 tp-100 -73.43 129.09 37.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.827 0.346 . . . . 73.44 110.867 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 1.6 ttt -114.76 131.39 56.8 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.215 -0.448 . . . . 54.13 110.89 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -134.94 137.2 42.89 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.229 -0.441 . . . . 74.3 110.918 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -110.8 94.48 5.02 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.119 -0.491 . . . . 65.34 110.884 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 9.1 t -102.38 130.29 49.09 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.14 -0.482 . . . . 72.11 111.111 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.54 ' O ' ' OG1' ' A' ' 112' ' ' THR . 0.0 OUTLIER -109.84 37.3 2.7 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.206 -0.452 . . . . 64.23 111.103 -179.952 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -151.78 -176.36 5.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.22 -0.446 . . . . 51.2 110.853 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -80.49 179.58 7.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.107 -0.497 . . . . 71.43 110.839 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . 0.567 ' O ' ' HB2' ' A' ' 172' ' ' SER . 45.7 t -167.3 125.02 0.97 Allowed Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.549 0.69 . . . . 75.32 110.903 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.72 -30.37 22.58 Favored 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.657 2.238 . . . . 73.42 112.33 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.629 ' HB3' ' CB ' ' A' ' 120' ' ' GLU . 0.1 OUTLIER -150.19 101.93 3.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.202 -0.454 . . . . 71.34 110.86 -179.843 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.7 HD13 HD11 ' A' ' 127' ' ' ILE . 4.0 tt -52.56 -29.67 13.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.145 -0.48 . . . . 73.14 111.1 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' MET . . . . . 0.578 ' O ' ' HA ' ' A' ' 123' ' ' HIS . 0.8 OUTLIER -85.55 -45.11 12.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.184 -0.462 . . . . 75.23 110.848 179.906 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.629 ' CB ' ' HB3' ' A' ' 117' ' ' SER . 8.4 tp10 -65.45 -13.75 59.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.262 -0.427 . . . . 62.01 110.859 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -114.22 -51.97 2.75 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.169 -0.469 . . . . 74.52 110.896 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.45 ' HB2' ' O ' ' A' ' 118' ' ' ILE . 54.1 m-85 -101.24 -20.3 15.32 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.195 -0.457 . . . . 73.42 110.902 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . 0.578 ' HA ' ' O ' ' A' ' 119' ' ' MET . 12.6 m80 71.24 30.61 2.58 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.132 -0.485 . . . . 62.4 110.869 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.545 ' SD ' HG22 ' A' ' 98' ' ' ILE . 5.2 mtt -108.99 86.42 2.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.224 -0.444 . . . . 61.45 110.902 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 2.0 ptp85 -51.94 -35.57 46.4 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.209 -0.45 . . . . 75.25 110.877 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.502 ' HB3' ' HG2' ' A' ' 168' ' ' PRO . 28.9 mt-10 -142.39 131.7 23.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.201 -0.454 . . . . 72.32 110.896 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.7 HD11 HD13 ' A' ' 118' ' ' ILE . 3.5 mm -91.38 91.46 3.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.17 -0.468 . . . . 74.41 111.14 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . 0.503 ' HB2' ' C ' ' A' ' 101' ' ' LYS . 13.3 m170 -60.58 -35.43 76.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.183 -0.462 . . . . 74.21 110.86 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . 0.66 ' HB2' ' HB2' ' A' ' 99' ' ' PHE . 66.5 m -131.09 140.08 49.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.222 -0.444 . . . . 65.45 110.829 -179.763 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . 0.616 ' O ' ' O ' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -139.18 121.59 16.09 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.134 -0.484 . . . . 70.44 110.855 179.999 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.697 ' HD2' ' CE1' ' A' ' 104' ' ' PHE . 6.3 mtpp -115.33 153.15 31.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.153 -0.476 . . . . 74.03 110.925 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.562 HG12 ' N ' ' A' ' 133' ' ' LEU . 16.1 t 84.34 164.57 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.242 -0.435 . . . . 61.11 111.126 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.728 HD22 ' CG ' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -178.44 121.98 0.1 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.136 -0.484 . . . . 44.53 110.91 179.976 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.513 ' O ' ' C ' ' A' ' 135' ' ' GLY . 0.1 OUTLIER -94.03 167.02 11.86 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.186 -0.461 . . . . 71.2 110.89 179.922 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . 0.513 ' C ' ' O ' ' A' ' 134' ' ' GLU . . . -27.8 -55.89 0.12 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.717 -0.754 . . . . 74.31 112.517 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.602 HG21 ' CG1' ' A' ' 86' ' ' VAL . 3.2 t -144.51 137.36 22.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.806 0.336 . . . . 71.42 111.12 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' TRP . . . . . 0.715 ' CB ' ' HB3' ' A' ' 152' ' ' LEU . 0.0 OUTLIER -129.82 142.46 50.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.157 -0.474 . . . . 73.05 110.92 179.914 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.766 HD13 HD13 ' A' ' 61' ' ' ILE . 11.4 mm -114.99 134.35 58.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.195 -0.457 . . . . 64.44 111.12 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.54 ' CD1' HG11 ' A' ' 170' ' ' VAL . 0.8 OUTLIER -123.33 145.38 48.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.172 -0.467 . . . . 61.34 110.881 179.932 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . 0.483 ' CE2' ' CD ' ' A' ' 174' ' ' ARG . 0.3 OUTLIER -126.99 133.85 50.48 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.164 -0.471 . . . . 64.43 110.93 -179.899 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . 0.654 ' O ' ' HB2' ' A' ' 171' ' ' GLN . 0.2 OUTLIER -59.97 -27.2 66.63 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.105 -0.498 . . . . 61.2 110.89 -179.979 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.686 ' HB3' ' HD2' ' A' ' 143' ' ' PRO . 9.7 mp -112.91 171.79 4.04 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.617 0.722 . . . . 72.44 110.897 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . 0.757 ' O ' ' OG ' ' A' ' 172' ' ' SER . 54.0 Cg_endo -69.74 -92.71 0.01 OUTLIER 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.737 2.291 . . . . 74.44 112.323 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . 0.732 ' O ' ' N ' ' A' ' 146' ' ' ARG . 0.8 OUTLIER -49.99 99.21 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.217 -0.447 . . . . 64.44 110.913 -179.984 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . 0.641 ' C ' ' O ' ' A' ' 144' ' ' ASN . 19.8 m-85 11.64 52.44 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.218 -0.446 . . . . 74.33 110.928 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . 0.732 ' N ' ' O ' ' A' ' 144' ' ' ASN . 21.1 mtt180 -118.6 173.28 6.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.098 -0.501 . . . . 72.42 110.875 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 78.97 -176.1 54.82 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.713 -0.756 . . . . 51.34 112.52 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -80.64 144.01 32.65 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.746 0.308 . . . . 74.03 110.87 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' GLN . . . . . 0.402 ' HB3' ' HA ' ' A' ' 60' ' ' TYR . 2.8 mt-30 -71.63 162.93 28.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.218 -0.446 . . . . 64.22 110.904 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . 0.531 ' HB2' ' CB ' ' A' ' 139' ' ' PHE . 78.9 m-85 -145.89 128.19 15.82 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.202 -0.454 . . . . 64.42 110.945 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.782 ' HA ' HD11 ' A' ' 61' ' ' ILE . 15.1 tp -85.94 123.21 31.02 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.161 -0.472 . . . . 64.2 110.89 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.989 ' O ' HD13 ' A' ' 152' ' ' LEU . 0.0 OUTLIER -58.33 142.23 48.72 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.183 -0.462 . . . . 64.31 110.903 179.887 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . 0.469 ' N ' HD22 ' A' ' 152' ' ' LEU . 5.4 t70 -162.99 25.44 0.09 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.156 -0.474 . . . . 64.03 110.88 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.926 ' HB2' ' CD1' ' A' ' 157' ' ' TYR . 3.1 ptmt -123.17 -172.38 2.49 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.189 -0.459 . . . . 73.35 110.874 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.728 ' CG ' HD22 ' A' ' 133' ' ' LEU . 0.4 OUTLIER -159.8 -123.79 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.236 -0.438 . . . . 73.02 110.903 179.91 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.655 ' HA ' ' HA ' ' A' ' 131' ' ' LYS . 0.8 OUTLIER -66.02 -3.74 5.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.208 -0.451 . . . . 64.42 110.897 179.96 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . 0.926 ' CD1' ' HB2' ' A' ' 154' ' ' LYS . 13.3 m-30 -27.62 140.01 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.158 -0.473 . . . . 73.14 110.946 -179.847 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . 0.543 ' O ' ' OG ' ' A' ' 129' ' ' SER . 8.2 ptp180 -103.8 -46.18 4.57 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.159 -0.473 . . . . 75.41 110.853 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 2.4 ptpp? -81.68 149.25 63.78 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.546 0.688 . . . . 71.14 110.87 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . 0.439 ' CB ' ' HD3' ' A' ' 168' ' ' PRO . 53.7 Cg_endo -69.74 -26.74 27.38 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.703 2.269 . . . . 71.21 112.34 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.705 ' H ' HD12 ' A' ' 161' ' ' ILE . 4.1 mp -69.95 -10.62 13.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.215 -0.448 . . . . 70.3 111.152 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.598 ' HB3' ' CD1' ' A' ' 157' ' ' TYR . 1.0 OUTLIER -70.65 -12.79 61.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 73.33 110.859 179.865 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' TRP . . . . . 0.551 ' CD1' ' HB3' ' A' ' 165' ' ' ALA . 11.5 t-105 -90.13 -19.65 24.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.193 -0.458 . . . . 72.23 110.879 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 103.21 -37.11 3.89 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.772 -0.727 . . . . 75.13 112.536 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.551 ' HB3' ' CD1' ' A' ' 163' ' ' TRP . . . -78.29 123.1 26.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.843 0.354 . . . . 73.01 111.03 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -49.79 121.46 5.3 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.192 -0.458 . . . . 71.44 111.133 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . 0.472 ' C ' ' H ' ' A' ' 169' ' ' ALA . 0.4 OUTLIER 64.94 143.81 0.08 OUTLIER Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.623 0.725 . . . . 72.55 110.886 -179.781 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . 0.502 ' HG2' ' HB3' ' A' ' 126' ' ' GLU . 53.8 Cg_endo -69.74 33.12 0.19 Allowed 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.675 2.25 . . . . 55.21 112.319 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 0.474 ' HA ' ' HG2' ' A' ' 126' ' ' GLU . . . -67.32 105.17 1.69 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.27 -0.423 . . . . 74.31 111.077 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.54 HG11 ' CD1' ' A' ' 139' ' ' PHE . 3.3 t -153.5 163.4 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.203 -0.453 . . . . 73.25 111.176 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' GLN . . . . . 0.654 ' HB2' ' O ' ' A' ' 141' ' ' GLU . 2.0 mm-40 -111.77 -90.21 0.5 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.192 -0.458 . . . . 74.32 110.913 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . 0.757 ' OG ' ' O ' ' A' ' 143' ' ' PRO . 36.2 p -122.19 -179.72 4.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.187 -0.46 . . . . 63.41 110.851 -179.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -146.54 174.78 11.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.113 -0.494 . . . . 72.0 110.898 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . 0.52 ' HG2' ' HB ' ' A' ' 138' ' ' ILE . 0.0 OUTLIER -147.01 158.05 43.8 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.144 -0.48 . . . . 63.35 110.911 -179.933 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . 0.684 ' HA ' ' CZ ' ' A' ' 94' ' ' TYR . 0.0 OUTLIER -95.14 -179.95 4.99 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.198 -0.455 . . . . 75.32 110.847 -179.908 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . 0.476 ' CD1' ' HB ' ' A' ' 136' ' ' VAL . 1.8 mt -126.45 132.45 70.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.161 -0.472 . . . . 73.21 111.119 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 42.2 t -126.09 150.08 31.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.199 -0.455 . . . . 74.13 111.156 179.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.193 -0.458 . . . . 73.42 110.935 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.326 0 N-CA-C 112.49 -0.244 . . . . 14.14 112.49 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.475 ' C ' ' HE1' ' A' ' 47' ' ' TRP . 2.8 p -82.83 135.15 35.04 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.858 0.361 . . . . 65.13 111.17 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 3.9 tttt -121.2 137.12 54.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.244 -0.434 . . . . 74.33 110.89 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.614 ' HB ' HG22 ' A' ' 42' ' ' VAL . 13.3 tt -137.32 147.07 26.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.214 -0.448 . . . . 73.25 111.145 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.502 HG22 ' CE2' ' A' ' 11' ' ' TYR . 13.8 m -126.5 129.16 48.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.168 -0.469 . . . . 52.43 111.132 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.779 ' HB2' HD22 ' A' ' 34' ' ' LEU . 1.5 m-85 -114.69 130.15 56.78 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.245 -0.434 . . . . 74.22 110.906 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.52 ' CG ' ' HA ' ' A' ' 16' ' ' PHE . 41.4 m-85 -115.67 130.86 57.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.156 -0.475 . . . . 75.14 110.938 -179.839 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.493 ' HG2' ' HB2' ' A' ' 36' ' ' ARG . 0.0 OUTLIER -60.24 -26.52 66.5 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.172 -0.467 . . . . 74.54 110.871 -179.976 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 68.9 m-20 -124.32 151.22 44.55 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.119 -0.491 . . . . 74.03 110.872 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.53 ' N ' ' HB3' ' A' ' 38' ' ' ASN . 35.0 mtmt -56.26 -178.58 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.162 -0.472 . . . . 63.31 110.885 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 28.1 m-20 49.78 35.41 9.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.239 -0.437 . . . . 75.23 110.893 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.52 ' HA ' ' CG ' ' A' ' 11' ' ' TYR . 3.8 m-85 48.05 57.6 5.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.17 -0.468 . . . . 74.21 110.894 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -134.46 160.26 38.55 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.125 -0.488 . . . . 75.13 110.943 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 94.0 -151.47 20.27 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.776 -0.726 . . . . 55.23 112.501 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.775 ' O ' HD13 ' A' ' 34' ' ' LEU . 0.0 OUTLIER -68.71 80.0 0.29 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.813 0.34 . . . . 75.12 110.864 -179.874 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.466 ' HA ' ' O ' ' A' ' 10' ' ' PHE . 0.5 OUTLIER -78.28 124.89 28.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.169 -0.468 . . . . 73.32 110.879 -179.922 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.424 ' CD2' ' CD2' ' A' ' 30' ' ' PHE . 86.9 t80 -122.42 124.87 44.65 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.194 -0.457 . . . . 72.53 110.917 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -109.94 130.33 55.54 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.146 -0.479 . . . . 73.13 110.852 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.409 ' HB3' ' CE2' ' A' ' 21' ' ' TYR . 0.1 OUTLIER -142.0 145.96 35.03 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.173 -0.467 . . . . 64.43 110.868 -179.892 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -130.73 5.7 4.66 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.178 -0.465 . . . . 53.53 110.905 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.42 ' O ' ' C ' ' A' ' 26' ' ' ASP . 38.2 t -132.15 160.41 36.12 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.151 -0.477 . . . . 75.1 110.897 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.42 ' C ' ' O ' ' A' ' 25' ' ' CYS . 6.2 m-20 -35.59 108.88 0.08 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.168 -0.469 . . . . 54.41 110.853 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.713 ' HB3' ' HB3' ' A' ' 30' ' ' PHE . 0.5 OUTLIER -119.24 45.82 2.03 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.167 -0.469 . . . . 71.43 110.883 -179.892 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.592 ' O ' ' HA ' ' A' ' 82' ' ' SER . . . -55.08 -11.14 0.62 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.204 -0.453 . . . . 61.31 111.143 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 60.6 t0 -130.81 39.13 3.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.219 -0.446 . . . . 71.12 110.831 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.833 ' O ' ' CD2' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -82.8 16.55 2.19 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.232 -0.44 . . . . 70.2 110.897 -179.916 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.475 ' HB2' ' HB3' ' A' ' 81' ' ' SER . 46.5 t60 -81.78 -29.61 32.66 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.172 -0.467 . . . . 73.02 110.851 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.7 t -68.66 -7.07 29.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.218 -0.446 . . . . 53.13 111.14 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -107.01 -29.44 9.42 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.197 -0.456 . . . . 75.12 110.925 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.779 HD22 ' HB2' ' A' ' 10' ' ' PHE . 24.0 tp -138.26 145.32 41.18 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.139 -0.482 . . . . 74.24 110.903 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.2 m -113.37 -32.51 6.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.158 -0.474 . . . . 72.32 110.837 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.521 ' O ' HD21 ' A' ' 34' ' ' LEU . 1.4 mtp85 -116.22 142.37 46.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.162 -0.472 . . . . 71.14 110.869 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.632 ' SG ' ' HB2' ' A' ' 80' ' ' LEU . 1.7 p -119.91 54.94 1.0 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.184 -0.462 . . . . 72.52 110.917 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.53 ' HB3' ' N ' ' A' ' 14' ' ' LYS . 1.8 m-80 -55.59 -64.96 0.68 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.156 -0.474 . . . . 73.34 110.871 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 5.9 p -116.95 130.94 57.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.261 -0.427 . . . . 73.23 110.863 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.618 HG21 HD13 ' A' ' 62' ' ' LEU . 12.1 mt -126.87 149.15 31.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.164 -0.471 . . . . 64.42 111.066 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.405 ' HE3' ' CD1' ' A' ' 16' ' ' PHE . 0.0 OUTLIER -143.73 120.7 11.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.125 -0.488 . . . . 65.21 110.884 179.83 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.614 HG22 ' HB ' ' A' ' 8' ' ' ILE . 2.1 t -102.85 115.04 44.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.21 -0.45 . . . . 75.0 111.133 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -109.47 81.05 1.38 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.203 -0.453 . . . . 65.42 110.895 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.438 ' O ' ' HA ' ' A' ' 6' ' ' THR . . . 127.32 108.52 1.51 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.776 -0.726 . . . . 62.41 112.478 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 50.78 -179.54 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.72 -0.753 . . . . 72.33 112.511 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.715 HG23 ' HA ' ' A' ' 63' ' ' PRO . 15.3 m -84.47 159.64 20.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.736 0.303 . . . . 62.45 111.203 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . 0.598 ' CD1' ' HB ' ' A' ' 8' ' ' ILE . 3.3 m95 -131.92 130.24 41.31 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.264 -0.426 . . . . 65.54 110.914 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.727 ' HB2' ' CG2' ' A' ' 86' ' ' VAL . . . -91.4 124.6 35.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.236 -0.438 . . . . 41.0 111.103 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.754 HG11 HD11 ' A' ' 80' ' ' LEU . 13.7 m -126.87 131.35 71.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.204 -0.453 . . . . 63.44 111.133 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.971 ' HB3' ' CB ' ' A' ' 56' ' ' ALA . 4.6 m-85 -106.68 145.37 32.07 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.141 -0.481 . . . . 72.44 110.864 -179.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.451 ' N ' ' HB1' ' A' ' 56' ' ' ALA . 0.8 OUTLIER -50.51 -86.41 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.079 -0.509 . . . . 61.43 110.829 -179.936 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.874 ' O ' ' HB2' ' A' ' 56' ' ' ALA . 7.7 mmm180 -77.63 138.34 62.77 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.608 0.718 . . . . 72.34 110.84 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.741 ' HA ' ' OG ' ' A' ' 82' ' ' SER . 53.7 Cg_endo -69.81 136.41 32.8 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.702 2.268 . . . . 53.31 112.352 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.427 ' C ' ' CD1' ' A' ' 55' ' ' PHE . 1.3 m120 64.99 -4.92 0.44 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.201 -0.454 . . . . 63.0 110.889 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.485 ' H ' ' C ' ' A' ' 53' ' ' PRO . 0.1 OUTLIER -137.86 -70.39 0.44 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.153 -0.476 . . . . 71.23 110.878 -179.989 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.971 ' CB ' ' HB3' ' A' ' 50' ' ' TYR . . . 38.87 74.9 0.08 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.168 -0.469 . . . . 62.11 111.088 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . 0.415 ' O ' ' CD2' ' A' ' 58' ' ' TYR . 9.8 m0 -63.6 30.59 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.174 -0.466 . . . . 65.4 110.924 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.639 ' H ' ' C ' ' A' ' 56' ' ' ALA . 1.2 m-30 -163.13 109.5 1.16 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.233 -0.439 . . . . 74.13 110.898 -179.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.437 ' HG3' ' CE2' ' A' ' 50' ' ' TYR . 0.3 OUTLIER -68.79 140.24 55.28 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.166 -0.47 . . . . 73.42 110.88 179.879 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.626 ' O ' HG23 ' A' ' 49' ' ' VAL . 0.9 OUTLIER -150.47 81.97 1.35 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.221 -0.445 . . . . 74.54 110.879 -179.875 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.524 HD11 HD22 ' A' ' 151' ' ' LEU . 1.1 mp -75.14 115.5 16.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.139 -0.482 . . . . 72.22 111.107 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.776 HD23 ' HD2' ' A' ' 63' ' ' PRO . 0.3 OUTLIER -82.4 124.05 78.4 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.579 0.704 . . . . 73.13 110.88 179.911 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.776 ' HD2' HD23 ' A' ' 62' ' ' LEU . 53.2 Cg_endo -69.82 -174.04 0.84 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.604 2.203 . . . . 73.13 112.373 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.0 163.33 18.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.26 -0.427 . . . . 74.13 110.925 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 113.05 -160.41 13.14 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.75 -0.738 . . . . 41.15 112.509 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -115.13 158.25 22.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.858 0.361 . . . . 74.53 110.869 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.464 ' N ' ' O ' ' A' ' 40' ' ' ILE . 11.2 m-85 -148.21 83.24 7.29 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.671 0.748 . . . . 74.5 110.878 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.414 ' HD2' ' HG3' ' A' ' 72' ' ' ARG . 53.5 Cg_endo -69.77 -4.98 15.12 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.728 2.285 . . . . 73.02 112.324 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -157.58 141.14 15.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.202 -0.454 . . . . 75.43 110.94 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.896 ' O ' ' CD1' ' A' ' 73' ' ' TRP . 44.9 p90 -51.55 -41.24 60.95 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.177 -0.465 . . . . 72.05 110.896 -179.834 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -52.02 -20.05 2.2 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.156 -0.474 . . . . 74.54 110.917 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.414 ' HG3' ' HD2' ' A' ' 68' ' ' PRO . 28.2 mmt180 -64.03 -30.24 71.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.188 -0.46 . . . . 65.01 110.872 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . 0.896 ' CD1' ' O ' ' A' ' 70' ' ' TYR . 0.5 OUTLIER -103.88 30.66 4.97 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.192 -0.458 . . . . 73.53 110.951 179.983 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . 0.439 ' O ' ' C ' ' A' ' 75' ' ' GLY . 0.0 OUTLIER 74.64 23.82 1.79 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.225 -0.443 . . . . 63.52 110.88 179.918 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.449 ' N ' ' HD1' ' A' ' 73' ' ' TRP . . . 33.03 49.37 0.43 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.697 -0.763 . . . . 23.22 112.525 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.764 HD21 ' HA ' ' A' ' 148' ' ' ARG . 0.6 OUTLIER -65.46 -77.61 0.06 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.806 0.336 . . . . 73.23 110.909 -179.908 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -135.79 134.17 38.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.161 -0.472 . . . . 63.41 110.888 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -90.09 17.0 7.42 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.122 -0.49 . . . . 74.22 110.88 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 6.0 ttm105 -107.36 77.18 1.12 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.174 -0.466 . . . . 72.43 110.844 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.754 HD11 HG11 ' A' ' 49' ' ' VAL . 0.1 OUTLIER -82.32 134.43 35.26 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.172 -0.467 . . . . 51.44 110.928 -179.99 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.702 ' HB3' ' HB3' ' A' ' 53' ' ' PRO . 1.5 m -154.32 -124.38 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.196 -0.456 . . . . 63.23 110.866 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.741 ' OG ' ' HA ' ' A' ' 53' ' ' PRO . 0.0 OUTLIER -36.28 106.88 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 72.33 110.891 -179.846 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . 0.691 ' HB3' HG12 ' A' ' 49' ' ' VAL . 27.9 p -130.13 132.78 46.24 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.147 -0.479 . . . . 75.41 110.881 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.565 ' N ' ' O ' ' A' ' 48' ' ' ALA . 4.1 mmt180 -123.41 146.46 47.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.205 -0.452 . . . . 72.32 110.876 -179.839 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -64.99 124.97 23.46 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.244 -0.434 . . . . 61.42 111.11 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.727 ' CG2' ' HB2' ' A' ' 48' ' ' ALA . 2.7 t -118.67 146.67 22.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.185 -0.461 . . . . 63.12 111.127 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . 0.558 ' O ' HG23 ' A' ' 136' ' ' VAL . 22.3 m-70 -110.11 112.5 24.53 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.189 -0.459 . . . . 71.42 110.92 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.533 HD13 ' HB3' ' A' ' 178' ' ' GLU . 0.0 OUTLIER -38.04 151.27 0.16 Allowed Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.647 0.737 . . . . 72.03 110.875 -179.944 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.552 ' HB3' ' H ' ' A' ' 136' ' ' VAL . 53.8 Cg_endo -69.76 98.78 0.7 Allowed 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.644 2.23 . . . . 61.3 112.354 179.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -105.56 -178.44 3.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.199 -0.455 . . . . 60.24 110.826 -179.822 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 48.9 84.89 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.764 -0.731 . . . . 41.11 112.443 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 100.72 29.45 6.55 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.777 -0.725 . . . . 73.51 112.475 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.473 ' O ' ' HG2' ' A' ' 134' ' ' GLU . 6.1 pt20 38.35 -129.6 0.22 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.852 0.358 . . . . 74.33 110.912 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.64 ' HA ' ' HG2' ' A' ' 134' ' ' GLU . 0.4 OUTLIER -117.13 103.73 10.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.211 -0.45 . . . . 72.31 110.943 -179.878 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.554 ' HG3' HG11 ' A' ' 132' ' ' VAL . 38.9 tptt -110.8 125.77 53.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.129 -0.487 . . . . 75.15 110.886 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.721 HD13 ' N ' ' A' ' 97' ' ' GLN . 0.0 OUTLIER -149.84 136.96 13.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.238 -0.437 . . . . 73.5 111.149 179.829 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.721 ' N ' HD13 ' A' ' 96' ' ' ILE . 2.4 mt-30 -107.86 132.7 53.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.183 -0.462 . . . . 74.11 110.917 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.769 HD11 HG22 ' A' ' 111' ' ' THR . 1.2 mp -111.29 140.8 28.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.176 -0.466 . . . . 62.23 111.158 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.634 ' HB2' ' HB2' ' A' ' 129' ' ' SER . 47.5 m-85 -130.97 134.65 46.92 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.192 -0.458 . . . . 73.31 110.868 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 51.1 tt0 -62.82 -78.86 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.15 -0.477 . . . . 74.03 110.907 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 6.6 mttt -83.97 162.68 20.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.117 -0.492 . . . . 73.21 110.851 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.419 ' CA ' ' HB3' ' A' ' 128' ' ' HIS . . . -70.4 163.2 53.09 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.726 -0.75 . . . . 72.43 112.466 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.497 ' HA ' ' HB2' ' A' ' 158' ' ' ARG . 33.4 t0 63.62 26.29 14.58 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.842 0.353 . . . . 45.11 110.888 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.48 ' CZ ' ' HB3' ' A' ' 158' ' ' ARG . 14.8 m-85 61.49 48.48 5.84 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.207 -0.451 . . . . 54.23 110.831 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 2.3 m -113.67 148.04 37.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.16 -0.473 . . . . 73.54 110.807 -179.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 92.27 -121.81 6.6 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.692 -0.766 . . . . 74.41 112.452 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 7.5 tp-100 -104.88 147.21 27.99 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.822 0.344 . . . . 64.41 110.916 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 3.7 ttp -136.65 136.79 39.42 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.205 -0.452 . . . . 75.43 110.919 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . 0.473 ' O ' HD12 ' A' ' 98' ' ' ILE . 12.9 m-85 -143.95 137.41 27.76 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.249 -0.432 . . . . 72.34 110.959 -179.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -114.93 111.14 20.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.153 -0.476 . . . . 75.45 110.933 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.769 HG22 HD11 ' A' ' 98' ' ' ILE . 11.7 t -118.1 139.46 51.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.157 -0.474 . . . . 70.32 111.122 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.556 ' HA ' ' O ' ' A' ' 94' ' ' TYR . 2.1 t -117.66 40.49 3.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.177 -0.465 . . . . 45.32 111.152 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -153.15 163.31 40.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.227 -0.442 . . . . 65.44 110.887 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -51.34 159.3 0.7 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.182 -0.463 . . . . 72.15 110.855 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . 0.607 ' O ' ' HB2' ' A' ' 172' ' ' SER . 41.9 t -147.85 111.34 3.86 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.589 0.709 . . . . 62.21 110.892 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.456 ' O ' ' C ' ' A' ' 143' ' ' PRO . 53.7 Cg_endo -69.8 -31.98 19.3 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.663 2.242 . . . . 74.32 112.303 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.641 ' HB3' ' CB ' ' A' ' 120' ' ' GLU . 0.2 OUTLIER -149.06 105.5 3.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.238 -0.437 . . . . 62.21 110.865 -179.819 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.656 HD13 HD11 ' A' ' 127' ' ' ILE . 3.7 tt -61.93 -30.52 48.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.15 -0.477 . . . . 63.21 111.153 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' MET . . . . . 0.628 ' O ' ' HA ' ' A' ' 123' ' ' HIS . 38.5 ttp -86.68 -38.6 16.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 73.23 110.894 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.641 ' CB ' ' HB3' ' A' ' 117' ' ' SER . 5.3 tp10 -72.71 -13.44 61.34 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.222 -0.445 . . . . 73.51 110.89 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 28.1 tp60 -114.8 -41.18 3.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.126 -0.488 . . . . 72.23 110.914 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.511 ' HB2' ' O ' ' A' ' 118' ' ' ILE . 51.8 m-85 -112.05 -20.61 11.89 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.216 -0.447 . . . . 65.44 110.913 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . 0.628 ' HA ' ' O ' ' A' ' 119' ' ' MET . 13.0 m80 72.8 27.02 2.25 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.124 -0.489 . . . . 72.01 110.856 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.454 ' SD ' HG22 ' A' ' 98' ' ' ILE . 9.3 mtt -101.31 90.75 4.22 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.183 -0.462 . . . . 65.11 110.861 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 4.1 ptp180 -53.49 -43.94 68.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.268 -0.424 . . . . 64.23 110.912 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.472 ' HG2' ' HA ' ' A' ' 169' ' ' ALA . 8.7 mt-10 -137.59 130.55 30.34 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.146 -0.479 . . . . 75.11 110.883 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.656 HD11 HD13 ' A' ' 118' ' ' ILE . 3.5 mm -88.79 91.48 3.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.104 -0.498 . . . . 74.23 111.165 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . 0.544 ' CD2' ' HG3' ' A' ' 168' ' ' PRO . 52.4 m80 -65.51 -30.16 70.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.147 -0.478 . . . . 74.02 110.857 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . 0.634 ' HB2' ' HB2' ' A' ' 99' ' ' PHE . 0.4 OUTLIER -135.08 144.42 47.2 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.205 -0.452 . . . . 75.53 110.865 -179.765 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . 0.662 ' O ' ' O ' ' A' ' 155' ' ' LYS . 0.1 OUTLIER -146.53 119.71 8.89 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.138 -0.483 . . . . 72.22 110.858 -179.934 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.653 ' HA ' ' HA ' ' A' ' 156' ' ' GLU . 6.0 mtpp -107.38 153.54 22.63 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.172 -0.467 . . . . 64.13 110.859 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.554 HG11 ' HG3' ' A' ' 95' ' ' LYS . 9.8 t 82.28 165.54 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.239 -0.437 . . . . 61.41 111.133 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.768 HD22 ' CG ' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -176.91 124.2 0.15 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.17 -0.468 . . . . 63.32 110.934 179.956 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.64 ' HG2' ' HA ' ' A' ' 94' ' ' TYR . 0.0 OUTLIER -97.44 164.02 12.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.227 -0.442 . . . . 64.1 110.924 179.919 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . 0.544 ' C ' ' O ' ' A' ' 134' ' ' GLU . . . -24.7 -61.18 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.746 -0.74 . . . . 62.21 112.451 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.707 HG21 ' CG1' ' A' ' 86' ' ' VAL . 1.7 t -147.44 154.19 11.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.817 0.341 . . . . 62.1 111.15 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' TRP . . . . . 0.943 ' H ' HD12 ' A' ' 152' ' ' LEU . 0.7 OUTLIER -152.09 149.05 28.39 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.188 -0.46 . . . . 72.01 110.887 -179.994 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.485 ' CD1' ' HB ' ' A' ' 61' ' ' ILE . 5.6 mm -116.55 135.42 56.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.21 -0.45 . . . . 65.22 111.163 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.515 ' HB2' ' HB2' ' A' ' 150' ' ' TYR . 1.4 m-85 -112.25 165.02 12.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.209 -0.451 . . . . 72.33 110.866 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . 0.461 ' HB3' ' O ' ' A' ' 146' ' ' ARG . 5.2 m-85 -144.8 132.03 20.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.147 -0.479 . . . . 75.22 110.887 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . 0.641 ' O ' ' HB2' ' A' ' 171' ' ' GLN . 0.0 OUTLIER -57.92 -27.79 63.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.091 -0.504 . . . . 55.24 110.876 -179.997 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.727 ' HB3' ' HD2' ' A' ' 143' ' ' PRO . 9.5 mp -114.1 173.28 2.96 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.614 0.721 . . . . 74.34 110.94 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . 0.734 ' O ' ' OG ' ' A' ' 172' ' ' SER . 53.3 Cg_endo -69.8 -90.46 0.0 OUTLIER 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.697 2.264 . . . . 71.42 112.324 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . 0.721 ' O ' ' N ' ' A' ' 146' ' ' ARG . 0.5 OUTLIER -50.79 97.81 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.213 -0.449 . . . . 75.24 110.937 179.985 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . 0.653 ' C ' ' O ' ' A' ' 144' ' ' ASN . 0.2 OUTLIER 11.46 53.34 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.173 -0.467 . . . . 64.14 110.937 -179.875 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . 0.721 ' N ' ' O ' ' A' ' 144' ' ' ASN . 22.5 mtt180 -121.5 160.2 24.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.148 -0.478 . . . . 74.42 110.859 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 93.26 -172.4 33.33 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.696 -0.764 . . . . 33.42 112.493 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.764 ' HA ' HD21 ' A' ' 76' ' ' LEU . 4.1 mpt_? -79.65 155.05 28.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.79 0.328 . . . . 73.54 110.88 -179.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' GLN . . . . . 0.403 ' HB3' ' HA ' ' A' ' 60' ' ' TYR . 0.4 OUTLIER -81.56 151.83 27.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.213 -0.449 . . . . 71.31 110.919 -179.941 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . 0.515 ' HB2' ' HB2' ' A' ' 139' ' ' PHE . 69.4 m-85 -151.96 103.11 2.87 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.178 -0.464 . . . . 73.11 110.893 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.524 HD22 HD11 ' A' ' 61' ' ' ILE . 0.1 OUTLIER -69.92 137.33 51.48 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.096 -0.502 . . . . 73.04 110.892 179.988 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 1.022 ' O ' HD13 ' A' ' 152' ' ' LEU . 0.0 OUTLIER -72.7 151.87 41.97 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.189 -0.46 . . . . 70.3 110.905 179.898 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . 0.743 ' N ' HD22 ' A' ' 152' ' ' LEU . 6.0 t0 -162.66 24.34 0.1 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.165 -0.471 . . . . 74.34 110.859 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 1.029 ' HB2' ' CD1' ' A' ' 157' ' ' TYR . 6.1 ptmt -115.29 -166.79 1.16 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.187 -0.461 . . . . 70.25 110.895 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.768 ' CG ' HD22 ' A' ' 133' ' ' LEU . 0.9 OUTLIER -158.47 -122.42 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.238 -0.437 . . . . 74.13 110.914 179.852 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.653 ' HA ' ' HA ' ' A' ' 131' ' ' LYS . 2.4 tm-20 -68.56 -0.33 4.99 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.222 -0.445 . . . . 75.33 110.943 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . 1.029 ' CD1' ' HB2' ' A' ' 154' ' ' LYS . 9.5 m-30 -32.55 146.15 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.12 -0.491 . . . . 54.54 110.901 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . 0.497 ' HB2' ' HA ' ' A' ' 103' ' ' ASP . 7.5 ptp180 -110.13 -39.7 4.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.107 -0.497 . . . . 74.54 110.902 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 2.4 ptpp? -91.39 151.2 42.49 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.58 0.705 . . . . 73.11 110.896 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 -25.73 28.28 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.734 2.289 . . . . 74.22 112.295 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.668 ' H ' HD12 ' A' ' 161' ' ' ILE . 4.0 mp -73.98 -6.16 7.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.265 -0.425 . . . . 71.04 111.129 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.594 ' HB3' ' CD1' ' A' ' 157' ' ' TYR . 1.6 t0 -72.54 -13.45 61.41 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.197 -0.456 . . . . 54.31 110.868 179.842 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 82.2 t90 -107.14 -3.43 19.91 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.189 -0.46 . . . . 72.14 110.917 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 100.12 -35.35 4.84 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.753 -0.737 . . . . 71.13 112.475 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -57.1 121.07 9.16 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.812 0.339 . . . . 63.1 111.098 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -46.99 -30.48 2.62 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.224 -0.444 . . . . 74.04 111.087 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . 0.486 ' C ' ' H ' ' A' ' 169' ' ' ALA . 0.5 OUTLIER -151.49 154.41 33.4 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.697 0.76 . . . . 35.42 110.826 -179.74 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . 0.544 ' HG3' ' CD2' ' A' ' 128' ' ' HIS . 53.5 Cg_endo -69.73 22.53 0.17 Allowed 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.639 2.226 . . . . 63.44 112.399 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 0.486 ' H ' ' C ' ' A' ' 167' ' ' SER . . . -65.65 101.25 0.6 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.201 -0.454 . . . . 73.12 111.121 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.482 HG11 ' CD1' ' A' ' 139' ' ' PHE . 2.4 t -153.59 163.77 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.235 -0.439 . . . . 71.31 111.133 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' GLN . . . . . 0.641 ' HB2' ' O ' ' A' ' 141' ' ' GLU . 1.8 mm-40 -111.23 -87.2 0.54 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.21 -0.45 . . . . 71.42 110.941 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . 0.734 ' OG ' ' O ' ' A' ' 143' ' ' PRO . 24.8 p -125.97 175.53 7.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.218 -0.446 . . . . 71.0 110.86 -179.792 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 10.7 p90 -144.14 168.25 20.47 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.166 -0.47 . . . . 75.42 110.889 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.32 156.6 48.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.133 -0.485 . . . . 75.25 110.862 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . 0.451 ' HD2' ' CE2' ' A' ' 94' ' ' TYR . 0.8 OUTLIER -88.68 -175.76 5.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.194 -0.457 . . . . 73.44 110.838 -179.916 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . 0.506 HD12 ' C ' ' A' ' 136' ' ' VAL . 5.6 mt -129.7 131.69 66.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.151 -0.477 . . . . 65.32 111.127 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 18.9 t -125.38 153.22 32.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.177 -0.465 . . . . 64.43 111.149 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . 0.533 ' HB3' HD13 ' A' ' 88' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.218 -0.446 . . . . 75.14 110.847 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.266 0 N-CA-C 112.465 -0.254 . . . . 53.15 112.465 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.457 ' C ' ' HE1' ' A' ' 47' ' ' TRP . 14.7 p -81.85 137.32 35.28 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.852 0.358 . . . . 72.11 111.143 -179.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.435 ' HA ' ' HA ' ' A' ' 24' ' ' ASP . 2.4 tttt -125.69 135.62 52.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.238 -0.437 . . . . 73.5 110.887 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.516 ' HA ' ' HA ' ' A' ' 42' ' ' VAL . 14.6 tt -135.98 153.78 32.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.216 -0.447 . . . . 74.32 111.094 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.481 HG23 ' CG ' ' A' ' 22' ' ' ASP . 12.9 m -135.77 145.91 47.06 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.151 -0.477 . . . . 65.21 111.143 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.567 ' CE1' HD12 ' A' ' 80' ' ' LEU . 0.3 OUTLIER -133.6 128.52 35.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.208 -0.451 . . . . 75.13 110.835 -179.954 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.556 ' CG ' ' HA ' ' A' ' 16' ' ' PHE . 22.1 m-85 -113.65 132.54 55.73 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.182 -0.463 . . . . 61.41 110.914 -179.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.409 ' HA ' ' O ' ' A' ' 36' ' ' ARG . 0.0 OUTLIER -60.71 -14.38 20.68 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.108 -0.496 . . . . 72.24 110.883 -179.989 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.447 ' HB2' ' O ' ' A' ' 17' ' ' GLN . 78.1 m-20 -136.38 150.96 49.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.146 -0.479 . . . . 72.34 110.852 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.441 ' HG3' ' HB3' ' A' ' 38' ' ' ASN . 4.5 mtmm -55.25 -176.2 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.165 -0.471 . . . . 74.44 110.919 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 19.4 m120 45.31 34.18 1.42 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.234 -0.439 . . . . 70.24 110.849 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.556 ' HA ' ' CG ' ' A' ' 11' ' ' TYR . 2.2 m-85 48.39 67.32 0.87 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.211 -0.449 . . . . 74.52 110.905 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.447 ' O ' ' HB2' ' A' ' 13' ' ' ASP . 4.7 mt-30 -141.78 158.13 44.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.145 -0.48 . . . . 75.03 110.876 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 92.85 -150.29 19.92 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.759 -0.734 . . . . 24.03 112.497 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.732 ' O ' HD13 ' A' ' 34' ' ' LEU . 2.2 mtt180 -68.74 79.9 0.29 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.827 0.346 . . . . 64.33 110.872 -179.855 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.478 ' HA ' ' O ' ' A' ' 10' ' ' PHE . 0.5 OUTLIER -77.96 129.13 34.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.199 -0.455 . . . . 61.33 110.89 -179.953 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.428 ' O ' ' HA ' ' A' ' 9' ' ' THR . 70.3 t80 -123.86 125.98 45.61 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.177 -0.465 . . . . 64.2 110.948 -179.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.481 ' CG ' HG23 ' A' ' 9' ' ' THR . 1.3 m-20 -119.41 134.81 55.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.109 -0.496 . . . . 74.15 110.85 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 9.4 t -160.44 129.4 4.87 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.177 -0.465 . . . . 62.41 110.858 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.435 ' HA ' ' HA ' ' A' ' 7' ' ' LYS . 2.5 p30 -97.65 5.36 49.48 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.157 -0.474 . . . . 64.44 110.841 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 47.5 t -114.91 160.65 19.27 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.186 -0.461 . . . . 63.11 110.892 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 87.4 m-20 -43.06 120.11 1.72 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.202 -0.453 . . . . 71.34 110.904 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.572 ' CB ' ' HB3' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -114.37 40.35 2.55 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.21 -0.45 . . . . 73.12 110.862 -179.907 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.564 ' O ' ' HB3' ' A' ' 82' ' ' SER . . . -50.47 -21.76 1.62 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.239 -0.437 . . . . 54.33 111.126 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 60.8 t0 -130.5 40.02 3.56 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.212 -0.449 . . . . 72.2 110.871 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.762 ' O ' ' CD2' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -80.04 14.54 1.8 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.15 -0.477 . . . . 62.34 110.911 -179.914 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.427 ' CG ' ' HG3' ' A' ' 53' ' ' PRO . 40.7 t60 -77.63 -35.11 52.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.138 -0.483 . . . . 64.32 110.842 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.6 t -61.95 -12.23 17.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.254 -0.43 . . . . 74.31 111.119 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -102.29 -26.56 13.27 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.265 -0.425 . . . . 73.13 110.894 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.732 HD13 ' O ' ' A' ' 19' ' ' ARG . 28.0 tp -139.33 130.43 26.54 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.146 -0.479 . . . . 72.14 110.944 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 21.1 m -91.24 -44.73 9.04 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.167 -0.469 . . . . 71.21 110.866 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.409 ' O ' ' HA ' ' A' ' 12' ' ' GLU . 0.0 OUTLIER -114.28 145.49 41.68 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.103 -0.499 . . . . 65.24 110.893 -179.918 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.576 ' SG ' ' CB ' ' A' ' 80' ' ' LEU . 3.5 m -126.76 106.35 9.3 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.184 -0.462 . . . . 63.33 110.861 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.441 ' HB3' ' HG3' ' A' ' 14' ' ' LYS . 11.3 m-20 -104.07 -62.43 1.31 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.174 -0.466 . . . . 74.44 110.905 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 9.7 p -111.96 133.19 54.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.46 . . . . 70.22 110.903 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.628 HD12 ' HZ3' ' A' ' 73' ' ' TRP . 8.9 mt -129.19 151.56 35.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.14 -0.482 . . . . 64.32 111.122 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.431 ' HE3' ' CD1' ' A' ' 16' ' ' PHE . 0.0 OUTLIER -143.05 121.03 12.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.149 -0.478 . . . . 75.41 110.862 179.84 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.654 HG21 ' HB2' ' A' ' 47' ' ' TRP . 1.3 t -107.62 116.79 51.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.212 -0.449 . . . . 75.05 111.148 179.833 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -112.18 76.5 0.98 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.177 -0.465 . . . . 72.33 110.932 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.421 ' O ' ' HA ' ' A' ' 6' ' ' THR . . . 142.37 94.09 0.21 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.738 -0.744 . . . . 54.21 112.441 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 56.49 174.26 0.21 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.763 -0.732 . . . . 43.22 112.49 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.708 HG23 ' HA ' ' A' ' 63' ' ' PRO . 1.2 m -69.09 169.99 10.84 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.793 0.33 . . . . 74.43 111.126 -179.867 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . 0.654 ' HB2' HG21 ' A' ' 42' ' ' VAL . 5.3 m95 -145.53 128.91 16.88 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.208 -0.451 . . . . 74.41 110.924 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.903 ' HB2' ' CG2' ' A' ' 86' ' ' VAL . . . -88.54 126.62 35.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.234 -0.439 . . . . 73.21 111.105 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.785 HG11 HD11 ' A' ' 80' ' ' LEU . 27.2 m -126.77 139.58 51.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.211 -0.45 . . . . 74.31 111.177 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.895 ' HB3' ' CB ' ' A' ' 56' ' ' ALA . 5.0 m-85 -116.55 144.47 44.33 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.17 -0.468 . . . . 73.12 110.949 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.555 ' HG2' ' N ' ' A' ' 52' ' ' ARG . 0.3 OUTLIER -48.61 -84.67 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.141 -0.481 . . . . 73.52 110.867 -179.971 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.896 ' O ' ' HB2' ' A' ' 56' ' ' ALA . 0.2 OUTLIER -81.46 136.72 48.78 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.573 0.701 . . . . 73.52 110.915 -179.935 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.654 ' HB3' ' HB3' ' A' ' 81' ' ' SER . 53.8 Cg_endo -69.7 137.89 36.7 Favored 'Trans proline' 0 C--N 1.341 0.14 0 C-N-CA 122.681 2.254 . . . . 74.14 112.376 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.468 ' C ' ' CD2' ' A' ' 55' ' ' PHE . 2.0 m120 69.22 -5.87 1.03 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.277 -0.419 . . . . 62.53 110.885 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.468 ' CD2' ' C ' ' A' ' 54' ' ' ASN . 0.1 OUTLIER -143.51 -75.43 0.26 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.131 -0.486 . . . . 75.53 110.875 -179.913 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.896 ' HB2' ' O ' ' A' ' 52' ' ' ARG . . . 45.87 81.27 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.14 -0.482 . . . . 72.34 111.09 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . 0.455 ' O ' ' CD2' ' A' ' 58' ' ' TYR . 18.9 m0 -65.32 35.48 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.227 -0.442 . . . . 74.53 110.908 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.586 ' H ' ' C ' ' A' ' 56' ' ' ALA . 1.2 m-30 -165.06 117.26 1.18 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.257 -0.429 . . . . 74.55 110.913 -179.844 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.453 ' HB2' ' HA ' ' A' ' 150' ' ' TYR . 1.0 OUTLIER -78.7 130.66 36.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.105 -0.498 . . . . 71.22 110.899 179.925 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.909 ' CD2' HD12 ' A' ' 76' ' ' LEU . 13.8 t80 -139.51 98.17 3.43 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.262 -0.427 . . . . 72.11 110.922 -179.864 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.584 HD12 ' H ' ' A' ' 61' ' ' ILE . 4.0 mp -83.56 111.16 19.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.1 -0.5 . . . . 74.41 111.15 179.873 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.874 HD23 ' HD2' ' A' ' 63' ' ' PRO . 0.3 OUTLIER -79.88 127.05 78.68 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.608 0.718 . . . . 71.04 110.923 179.898 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.874 ' HD2' HD23 ' A' ' 62' ' ' LEU . 53.7 Cg_endo -69.76 -165.04 0.14 Allowed 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.688 2.259 . . . . 72.31 112.348 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.91 160.68 14.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.236 -0.438 . . . . 75.13 110.928 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 112.61 -151.92 18.03 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.71 -0.757 . . . . 62.32 112.498 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -116.05 161.57 18.69 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.863 0.363 . . . . 74.03 110.884 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.498 ' N ' ' O ' ' A' ' 40' ' ' ILE . 13.6 m-85 -149.56 82.38 6.81 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.69 0.757 . . . . 71.44 110.929 -179.857 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.437 ' HD2' ' HG3' ' A' ' 72' ' ' ARG . 53.9 Cg_endo -69.74 -0.3 6.7 Favored 'Trans proline' 0 N--CA 1.465 -0.19 0 C-N-CA 122.72 2.28 . . . . 61.34 112.379 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -157.99 155.39 29.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.181 -0.463 . . . . 73.43 110.867 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.594 ' O ' ' CD1' ' A' ' 73' ' ' TRP . 24.9 p90 -62.18 -37.46 85.34 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.152 -0.476 . . . . 63.21 110.915 -179.854 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.585 ' HA ' ' CA ' ' A' ' 75' ' ' GLY . 6.6 pt20 -61.25 -10.6 7.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.12 -0.491 . . . . 64.3 110.922 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.437 ' HG3' ' HD2' ' A' ' 68' ' ' PRO . 25.2 mmt180 -65.82 -45.11 83.53 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.186 -0.461 . . . . 71.2 110.872 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . 0.757 ' O ' ' CB ' ' A' ' 74' ' ' MET . 0.4 OUTLIER -81.11 -5.45 57.68 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.182 -0.463 . . . . 74.52 110.902 -179.944 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . 0.757 ' CB ' ' O ' ' A' ' 73' ' ' TRP . 8.4 mmm 131.21 -3.98 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.207 -0.451 . . . . 73.22 110.889 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.585 ' CA ' ' HA ' ' A' ' 71' ' ' GLN . . . 76.2 17.22 80.14 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.7 -0.762 . . . . 62.55 112.451 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.909 HD12 ' CD2' ' A' ' 60' ' ' TYR . 0.0 OUTLIER -63.45 -154.25 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.787 0.327 . . . . 65.44 110.963 -179.905 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.473 ' H ' HD13 ' A' ' 76' ' ' LEU . 2.9 t-20 -65.06 131.71 47.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.275 -0.421 . . . . 73.54 110.87 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -87.93 11.91 14.58 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.178 -0.465 . . . . 63.12 110.878 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.539 ' O ' ' O ' ' A' ' 51' ' ' GLU . 0.0 OUTLIER -87.95 49.44 1.8 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.169 -0.469 . . . . 61.33 110.852 -179.872 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.785 HD11 HG11 ' A' ' 49' ' ' VAL . 0.1 OUTLIER -59.89 127.08 30.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.191 -0.458 . . . . 62.41 110.891 -179.943 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.654 ' HB3' ' HB3' ' A' ' 53' ' ' PRO . 5.3 m -149.83 -114.99 0.06 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.188 -0.46 . . . . 53.2 110.897 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.626 ' OG ' ' HA ' ' A' ' 53' ' ' PRO . 0.1 OUTLIER -42.43 102.48 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.155 -0.475 . . . . 71.52 110.849 -179.776 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . 0.721 ' HB3' HG12 ' A' ' 49' ' ' VAL . 8.7 p -130.42 134.02 46.8 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.133 -0.485 . . . . 71.51 110.865 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.627 ' N ' ' O ' ' A' ' 48' ' ' ALA . 0.9 OUTLIER -117.33 158.44 24.39 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.16 -0.473 . . . . 65.51 110.854 -179.862 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -70.58 131.77 44.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.2 -0.454 . . . . 63.33 111.075 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.903 ' CG2' ' HB2' ' A' ' 48' ' ' ALA . 71.3 t -117.06 129.07 74.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.162 -0.472 . . . . 62.23 111.142 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . 0.664 ' O ' HG23 ' A' ' 136' ' ' VAL . 16.9 m80 -113.79 107.39 15.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.179 -0.464 . . . . 74.31 110.824 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.479 HD23 ' H ' ' A' ' 88' ' ' LEU . 0.0 OUTLIER -31.69 148.67 0.05 OUTLIER Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.574 0.702 . . . . 73.24 110.955 -179.999 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.548 ' HB3' ' H ' ' A' ' 136' ' ' VAL . 53.4 Cg_endo -69.8 93.23 0.52 Allowed 'Trans proline' 0 C--O 1.231 0.136 0 C-N-CA 122.689 2.259 . . . . 73.22 112.323 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -104.61 -174.22 2.49 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.205 -0.452 . . . . 73.01 110.881 -179.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 49.55 64.18 3.6 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.755 -0.736 . . . . 53.34 112.464 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 122.6 24.22 2.17 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.751 -0.738 . . . . 71.21 112.515 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 41.5 -158.73 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.822 0.344 . . . . 53.22 110.892 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.506 ' HA ' ' HG2' ' A' ' 134' ' ' GLU . 31.5 t80 -99.77 102.78 14.33 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.187 -0.46 . . . . 74.45 110.905 -179.837 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.498 ' HG3' HG11 ' A' ' 132' ' ' VAL . 42.8 tptt -112.61 130.03 56.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.132 -0.485 . . . . 72.14 110.887 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.478 ' HB ' ' OE1' ' A' ' 134' ' ' GLU . 0.0 OUTLIER -148.83 137.44 15.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.232 -0.44 . . . . 75.14 111.127 179.888 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.474 ' N ' HD13 ' A' ' 96' ' ' ILE . 0.9 OUTLIER -111.16 132.2 54.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.15 -0.477 . . . . 72.31 110.905 179.935 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.571 ' CG2' HD12 ' A' ' 127' ' ' ILE . 3.1 mp -113.17 135.54 52.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.211 -0.45 . . . . 54.04 111.094 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.653 ' HB2' ' HB2' ' A' ' 129' ' ' SER . 48.7 m-85 -126.48 136.34 52.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.148 -0.478 . . . . 74.52 110.835 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 51.9 tt0 -65.6 -75.29 0.09 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.101 -0.499 . . . . 70.52 110.883 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.429 ' C ' ' HB2' ' A' ' 128' ' ' HIS . 6.0 mttt -85.64 158.6 20.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.143 -0.481 . . . . 71.41 110.939 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -66.54 164.4 41.93 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.782 -0.723 . . . . 71.44 112.512 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.426 ' HA ' ' HB2' ' A' ' 158' ' ' ARG . 38.7 t70 61.67 27.89 17.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.88 0.371 . . . . 65.32 110.843 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.506 ' HA ' ' CD2' ' A' ' 99' ' ' PHE . 14.9 m-85 59.52 52.68 5.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.193 -0.458 . . . . 74.51 110.916 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.2 m -118.13 148.9 41.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.102 -0.499 . . . . 62.33 110.827 -179.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 90.8 -125.19 7.86 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.724 -0.75 . . . . 74.3 112.532 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -98.85 139.55 34.36 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.756 0.312 . . . . 72.44 110.958 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 1.3 ttp -130.99 137.0 49.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.214 -0.448 . . . . 74.12 110.857 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 13.3 m-85 -141.29 136.56 31.72 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.244 -0.434 . . . . 75.05 110.953 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -117.74 103.85 10.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.146 -0.479 . . . . 70.32 110.874 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 13.1 t -117.33 140.69 49.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.166 -0.47 . . . . 60.35 111.166 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.522 ' O ' ' OG1' ' A' ' 112' ' ' THR . 0.1 OUTLIER -101.52 27.72 6.1 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.209 -0.45 . . . . 64.54 111.142 -179.962 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -143.67 -174.96 4.39 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.213 -0.449 . . . . 72.43 110.852 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.48 ' CB ' ' HA ' ' A' ' 174' ' ' ARG . 9.2 p30 -107.96 177.43 4.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.146 -0.479 . . . . 74.2 110.899 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . 0.434 ' O ' ' HB2' ' A' ' 172' ' ' SER . 18.4 p -155.98 148.86 18.14 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 121.578 0.704 . . . . 74.2 110.916 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 -25.65 28.36 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.68 2.253 . . . . 72.35 112.364 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.626 ' HB3' ' CB ' ' A' ' 120' ' ' GLU . 0.1 OUTLIER -150.77 107.4 3.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.192 -0.458 . . . . 72.12 110.879 -179.861 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.659 HD13 HD11 ' A' ' 127' ' ' ILE . 4.0 tt -59.08 -29.81 42.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.142 -0.481 . . . . 72.31 111.152 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' MET . . . . . 0.596 ' O ' ' HA ' ' A' ' 123' ' ' HIS . 54.8 ttp -86.39 -42.66 13.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.168 -0.469 . . . . 73.31 110.877 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.626 ' CB ' ' HB3' ' A' ' 117' ' ' SER . 8.5 tp10 -67.59 -13.14 61.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.24 -0.437 . . . . 75.34 110.9 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 22.2 tp60 -114.53 -48.11 2.88 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.158 -0.473 . . . . 64.51 110.944 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.443 ' HB2' ' O ' ' A' ' 118' ' ' ILE . 47.6 m-85 -105.68 -20.1 13.56 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.217 -0.447 . . . . 71.13 110.878 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . 0.596 ' HA ' ' O ' ' A' ' 119' ' ' MET . 10.7 m80 72.61 28.14 2.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.201 -0.454 . . . . 63.53 110.83 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.533 ' SD ' HG22 ' A' ' 98' ' ' ILE . 4.6 mtt -105.44 84.49 2.1 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.222 -0.444 . . . . 70.45 110.873 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 3.7 ptp180 -50.98 -34.81 30.6 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.196 -0.456 . . . . 75.01 110.885 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.51 ' HG2' ' HA ' ' A' ' 169' ' ' ALA . 18.4 mt-10 -144.8 135.27 24.39 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.16 -0.473 . . . . 73.43 110.872 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.659 HD11 HD13 ' A' ' 118' ' ' ILE . 3.7 mm -96.04 100.71 11.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.147 -0.478 . . . . 74.23 111.122 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . 0.429 ' HB2' ' C ' ' A' ' 101' ' ' LYS . 14.7 m170 -71.34 -30.77 66.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.194 -0.457 . . . . 62.13 110.879 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . 0.653 ' HB2' ' HB2' ' A' ' 99' ' ' PHE . 0.4 OUTLIER -133.85 140.08 46.64 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.158 -0.473 . . . . 73.14 110.87 -179.778 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . 0.573 ' O ' ' O ' ' A' ' 155' ' ' LYS . 2.7 m -140.45 117.59 11.24 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.112 -0.494 . . . . 64.42 110.846 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.697 ' HA ' ' HA ' ' A' ' 156' ' ' GLU . 2.9 mtpp -106.44 154.55 20.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.196 -0.456 . . . . 64.23 110.872 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.537 HG23 ' C ' ' A' ' 131' ' ' LYS . 4.8 t 79.59 166.38 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.203 -0.453 . . . . 75.12 111.115 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.676 HD22 ' CG ' ' A' ' 155' ' ' LYS . 0.1 OUTLIER -171.19 128.52 0.71 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.159 -0.473 . . . . 72.4 110.905 179.992 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.536 ' CD ' ' H ' ' A' ' 134' ' ' GLU . 0.3 OUTLIER -97.3 155.98 16.64 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.181 -0.463 . . . . 75.53 110.877 179.905 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . 0.519 ' HA3' ' HA ' ' A' ' 89' ' ' PRO . . . -30.53 -48.42 0.16 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.75 -0.738 . . . . 65.21 112.488 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.816 HG11 ' CG1' ' A' ' 86' ' ' VAL . 3.1 t -150.18 137.68 13.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.842 0.353 . . . . 62.34 111.136 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' TRP . . . . . 0.729 ' HB3' ' CB ' ' A' ' 152' ' ' LEU . 16.5 t90 -144.3 137.63 27.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.19 -0.459 . . . . 75.15 110.897 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.544 ' CG2' ' HB2' ' A' ' 149' ' ' GLN . 34.2 mt -111.69 132.05 61.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.212 -0.449 . . . . 72.45 111.097 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.561 ' CD2' ' HB3' ' A' ' 173' ' ' PHE . 0.1 OUTLIER -96.88 178.25 5.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.181 -0.463 . . . . 73.14 110.844 179.994 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . 0.527 ' CE2' ' HG2' ' A' ' 174' ' ' ARG . 0.3 OUTLIER -155.07 124.06 6.21 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.143 -0.48 . . . . 71.43 110.921 -179.836 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . 0.612 ' O ' ' HB2' ' A' ' 171' ' ' GLN . 0.1 OUTLIER -61.44 -29.71 70.12 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.158 -0.474 . . . . 62.3 110.859 -179.982 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.704 ' HB3' ' HD2' ' A' ' 143' ' ' PRO . 9.1 mp -114.54 172.89 3.22 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.562 0.696 . . . . 53.14 110.94 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . 0.74 ' O ' ' OG ' ' A' ' 172' ' ' SER . 53.4 Cg_endo -69.76 -90.73 0.01 OUTLIER 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.669 2.246 . . . . 72.51 112.324 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . 0.698 ' O ' ' N ' ' A' ' 146' ' ' ARG . 1.6 m-20 -54.21 95.79 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.201 -0.454 . . . . 61.14 110.907 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . 0.649 ' C ' ' O ' ' A' ' 144' ' ' ASN . 0.1 OUTLIER 12.08 53.94 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.175 -0.466 . . . . 72.43 110.95 -179.876 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . 0.698 ' N ' ' O ' ' A' ' 144' ' ' ASN . 8.8 mtp85 -116.38 163.03 16.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.098 -0.501 . . . . 73.24 110.851 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 74.31 -172.67 51.86 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.722 -0.752 . . . . 50.02 112.481 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 4.7 mpt_? -86.7 134.02 33.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.764 0.316 . . . . 63.14 110.88 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' GLN . . . . . 0.641 ' OE1' ' HA ' ' A' ' 60' ' ' TYR . 0.3 OUTLIER -87.76 163.42 16.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.163 -0.471 . . . . 74.05 110.957 -179.952 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . 0.459 ' HB2' ' HB2' ' A' ' 139' ' ' PHE . 5.2 m-85 -126.8 151.42 48.3 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.234 -0.439 . . . . 75.3 110.958 -179.896 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.409 HD12 ' H ' ' A' ' 152' ' ' LEU . 29.7 tp -85.65 140.08 30.86 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.125 -0.489 . . . . 74.42 110.868 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.973 ' O ' HD13 ' A' ' 152' ' ' LEU . 0.0 OUTLIER -69.96 138.24 52.14 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.167 -0.47 . . . . 71.35 110.893 179.883 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -165.84 27.53 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.216 -0.447 . . . . 72.1 110.872 179.783 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.826 ' HB2' ' CD1' ' A' ' 157' ' ' TYR . 0.0 OUTLIER -118.61 -172.42 2.28 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.177 -0.465 . . . . 71.32 110.931 179.952 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.742 ' HD2' ' C ' ' A' ' 154' ' ' LYS . 1.0 OUTLIER -161.63 -123.2 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.236 -0.438 . . . . 73.54 110.855 179.844 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.697 ' HA ' ' HA ' ' A' ' 131' ' ' LYS . 2.7 tm-20 -71.65 2.63 4.95 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.207 -0.451 . . . . 74.22 110.911 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . 0.826 ' CD1' ' HB2' ' A' ' 154' ' ' LYS . 18.5 m-30 -32.33 147.3 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.14 -0.482 . . . . 74.53 110.91 -179.836 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . 0.491 ' HB3' ' CZ ' ' A' ' 104' ' ' PHE . 8.7 ptp180 -113.64 -35.76 5.1 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.133 -0.485 . . . . 75.51 110.885 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -92.27 152.94 42.9 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.551 0.691 . . . . 51.51 110.905 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . 0.477 ' HB3' ' HB3' ' A' ' 168' ' ' PRO . 53.7 Cg_endo -69.75 -35.0 13.49 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.679 2.252 . . . . 65.21 112.35 179.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.706 ' H ' HD12 ' A' ' 161' ' ' ILE . 3.2 mp -57.56 -15.85 4.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.444 . . . . 75.22 111.125 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.643 ' HB3' ' CD1' ' A' ' 157' ' ' TYR . 0.4 OUTLIER -71.69 -13.74 61.83 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.206 -0.452 . . . . 51.13 110.829 179.884 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' TRP . . . . . 0.475 ' CE3' ' HB3' ' A' ' 165' ' ' ALA . 22.3 t90 -87.98 -16.28 34.2 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.192 -0.458 . . . . 71.22 110.881 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 109.82 -37.36 3.81 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.758 -0.734 . . . . 54.31 112.483 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.475 ' HB3' ' CE3' ' A' ' 163' ' ' TRP . . . -78.92 127.17 31.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.797 0.332 . . . . 61.52 111.066 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . 0.424 ' C ' ' O ' ' A' ' 165' ' ' ALA . . . -35.94 -42.18 0.27 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.231 -0.44 . . . . 72.04 111.11 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . 0.486 ' C ' ' H ' ' A' ' 169' ' ' ALA . 0.5 OUTLIER -129.78 153.57 80.88 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.654 0.74 . . . . 75.22 110.864 -179.811 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . 0.49 ' HB3' ' O ' ' A' ' 127' ' ' ILE . 53.9 Cg_endo -69.72 29.04 0.18 Allowed 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.691 2.261 . . . . 75.23 112.357 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 0.51 ' HA ' ' HG2' ' A' ' 126' ' ' GLU . . . -66.28 103.95 1.1 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.236 -0.438 . . . . 43.43 111.09 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.543 HG11 ' CE2' ' A' ' 139' ' ' PHE . 2.6 t -151.57 163.33 2.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.459 . . . . 63.34 111.127 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' GLN . . . . . 0.652 ' OE1' ' HB3' ' A' ' 143' ' ' PRO . 1.6 tm0? -112.26 -83.31 0.59 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.157 -0.474 . . . . 75.22 110.897 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . 0.74 ' OG ' ' O ' ' A' ' 143' ' ' PRO . 54.4 p -124.55 174.91 7.51 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.203 -0.453 . . . . 70.42 110.805 -179.788 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 173' ' ' PHE . . . . . 0.561 ' HB3' ' CD2' ' A' ' 139' ' ' PHE . 39.6 p90 -148.76 164.83 33.25 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.101 -0.5 . . . . 74.43 110.919 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . 0.527 ' HG2' ' CE2' ' A' ' 140' ' ' TYR . 0.0 OUTLIER -136.16 142.75 44.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.209 -0.45 . . . . 64.44 110.906 -179.921 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . 0.405 ' HG3' ' OD1' ' A' ' 114' ' ' ASP . 0.0 OUTLIER -90.59 -176.62 4.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.199 -0.455 . . . . 73.04 110.838 -179.911 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . 0.704 HD12 ' HB ' ' A' ' 136' ' ' VAL . 2.4 mt -133.84 132.21 56.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.174 -0.467 . . . . 71.43 111.112 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 83.1 t -150.04 140.56 16.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.213 -0.449 . . . . 61.22 111.138 179.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.163 -0.471 . . . . 71.31 110.894 -179.986 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.293 0 N-CA-C 112.491 -0.244 . . . . 53.5 112.491 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.478 ' C ' ' HE1' ' A' ' 47' ' ' TRP . 6.6 p -81.94 133.61 35.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.833 0.349 . . . . 61.54 111.151 -179.88 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 2.7 tttt -120.94 136.93 54.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.262 -0.426 . . . . 74.11 110.912 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.577 ' HB ' ' CD1' ' A' ' 47' ' ' TRP . 13.7 tt -136.92 152.18 28.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.236 -0.438 . . . . 65.11 111.153 179.821 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.498 HG23 ' CG ' ' A' ' 22' ' ' ASP . 15.5 m -134.0 138.15 45.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.192 -0.458 . . . . 74.2 111.113 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.716 ' HB2' HD22 ' A' ' 34' ' ' LEU . 0.2 OUTLIER -126.74 128.53 46.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.2 -0.455 . . . . 43.14 110.882 179.995 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.549 ' CG ' ' HA ' ' A' ' 16' ' ' PHE . 26.3 m-85 -113.45 132.0 55.82 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.118 -0.492 . . . . 71.35 110.876 -179.833 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.441 ' HB2' ' HB2' ' A' ' 19' ' ' ARG . 0.1 OUTLIER -61.69 -15.14 37.71 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.107 -0.497 . . . . 73.43 110.89 179.99 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.435 ' HB2' ' O ' ' A' ' 17' ' ' GLN . 72.5 m-20 -134.91 150.42 50.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.142 -0.481 . . . . 64.32 110.865 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.546 ' N ' ' HB3' ' A' ' 38' ' ' ASN . 36.7 mtmt -56.16 -178.77 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.224 -0.443 . . . . 63.11 110.914 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 25.4 m-20 49.44 31.52 4.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.212 -0.449 . . . . 62.32 110.898 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.549 ' HA ' ' CG ' ' A' ' 11' ' ' TYR . 3.7 m-85 50.9 63.54 2.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.179 -0.464 . . . . 73.23 110.922 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.435 ' O ' ' HB2' ' A' ' 13' ' ' ASP . 24.6 mt-30 -139.52 160.85 38.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.15 -0.477 . . . . 74.04 110.898 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 92.0 -149.29 19.62 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.8 -0.714 . . . . 64.34 112.485 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.721 ' O ' HD13 ' A' ' 34' ' ' LEU . 0.0 OUTLIER -69.21 77.8 0.36 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.756 0.312 . . . . 74.14 110.852 -179.865 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.46 ' HB2' ' CE1' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -76.3 129.01 36.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 72.11 110.882 -179.919 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.485 ' O ' ' HA ' ' A' ' 9' ' ' THR . 91.4 t80 -122.95 125.57 45.55 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.213 -0.449 . . . . 71.54 110.888 -179.81 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.498 ' CG ' HG23 ' A' ' 9' ' ' THR . 1.4 m-20 -121.73 133.51 54.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.121 -0.49 . . . . 75.53 110.866 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -166.99 135.43 2.67 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.217 -0.447 . . . . 72.11 110.878 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -103.22 5.55 37.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.17 -0.468 . . . . 50.15 110.815 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 49.7 t -110.08 158.85 17.86 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.231 -0.44 . . . . 72.02 110.864 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -43.3 120.17 1.8 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.172 -0.467 . . . . 70.33 110.83 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.632 ' HB2' ' HB3' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -115.6 42.33 2.31 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.204 -0.453 . . . . 53.41 110.868 -179.951 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.563 ' O ' ' HA ' ' A' ' 82' ' ' SER . . . -51.12 -20.11 1.37 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.229 -0.441 . . . . 74.11 111.126 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 63.2 t0 -128.5 37.57 4.1 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.218 -0.446 . . . . 65.52 110.864 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.763 ' O ' ' CD2' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -80.97 15.68 1.74 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.198 -0.456 . . . . 64.04 110.857 -179.892 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.412 ' CG ' ' HG3' ' A' ' 53' ' ' PRO . 39.3 t60 -80.02 -34.0 38.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.189 -0.459 . . . . 71.03 110.864 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.6 t -63.24 -10.84 17.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.216 -0.447 . . . . 71.52 111.136 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -103.32 -28.87 11.6 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.193 -0.458 . . . . 74.21 110.925 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.721 HD13 ' O ' ' A' ' 19' ' ' ARG . 16.0 tp -139.02 141.25 38.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.133 -0.485 . . . . 74.4 110.89 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 20.7 m -105.35 -42.05 5.36 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.174 -0.466 . . . . 64.43 110.863 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -118.49 143.0 47.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.178 -0.464 . . . . 73.54 110.907 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.683 ' SG ' ' HB2' ' A' ' 80' ' ' LEU . 3.9 p -115.05 87.22 2.61 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.204 -0.453 . . . . 72.24 110.9 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.546 ' HB3' ' N ' ' A' ' 14' ' ' LYS . 3.3 m-20 -82.76 -50.85 8.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 62.41 110.852 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.403 ' OG ' ' HB2' ' A' ' 11' ' ' TYR . 9.8 p -129.4 127.14 40.37 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.163 -0.472 . . . . 74.11 110.821 -179.815 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.538 HG21 HD13 ' A' ' 62' ' ' LEU . 13.5 mt -125.44 152.1 31.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.103 -0.499 . . . . 71.34 111.15 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.426 ' N ' ' CG2' ' A' ' 40' ' ' ILE . 0.0 OUTLIER -144.85 118.55 9.2 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.201 -0.454 . . . . 64.01 110.932 179.845 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.513 ' HA ' ' HA ' ' A' ' 8' ' ' ILE . 1.3 t -104.02 116.7 48.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.259 -0.428 . . . . 64.51 111.175 179.85 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -111.54 77.65 1.06 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.197 -0.456 . . . . 63.54 110.887 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.432 ' O ' ' HA ' ' A' ' 6' ' ' THR . . . 135.4 101.87 0.68 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.762 -0.732 . . . . 51.24 112.512 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.501 ' HA2' HD21 ' A' ' 88' ' ' LEU . . . 53.91 179.65 0.14 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.767 -0.73 . . . . 74.2 112.493 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.748 HG23 ' HA ' ' A' ' 63' ' ' PRO . 1.4 m -80.25 169.28 18.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.797 0.332 . . . . 43.21 111.12 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . 0.577 ' CD1' ' HB ' ' A' ' 8' ' ' ILE . 5.7 m95 -141.18 130.1 23.13 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.194 -0.457 . . . . 65.11 110.945 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.948 ' HB2' ' CG2' ' A' ' 86' ' ' VAL . . . -90.58 127.02 36.13 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.222 -0.445 . . . . 64.54 111.125 179.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.871 HG11 HD11 ' A' ' 80' ' ' LEU . 35.7 m -128.84 124.48 61.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.213 -0.449 . . . . 63.44 111.135 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.73 ' HB3' ' HA ' ' A' ' 56' ' ' ALA . 49.5 m-85 -94.51 150.15 20.53 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.21 -0.45 . . . . 70.55 110.901 -179.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.675 ' OE1' ' HB3' ' A' ' 57' ' ' TRP . 58.1 tt0 -49.27 -79.51 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.106 -0.497 . . . . 74.1 110.901 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.57 ' HB2' ' HB2' ' A' ' 57' ' ' TRP . 0.0 OUTLIER -92.54 143.77 27.73 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.607 0.718 . . . . 74.43 110.893 -179.951 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.69 ' HA ' ' OG ' ' A' ' 82' ' ' SER . 53.3 Cg_endo -69.82 142.41 47.57 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.739 2.293 . . . . 44.51 112.301 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 61.95 -9.75 0.08 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.236 -0.438 . . . . 73.52 110.89 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.611 ' H ' ' C ' ' A' ' 53' ' ' PRO . 2.7 m-30 -105.92 -20.4 13.44 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.184 -0.462 . . . . 73.43 110.901 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.73 ' HA ' ' HB3' ' A' ' 50' ' ' TYR . . . 50.02 27.15 2.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.168 -0.469 . . . . 72.1 111.068 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . 0.675 ' HB3' ' OE1' ' A' ' 51' ' ' GLU . 0.1 OUTLIER -50.69 -163.69 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.23 -0.441 . . . . 74.04 110.907 -179.959 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.636 ' C ' ' O ' ' A' ' 57' ' ' TRP . 5.4 m-30 -13.1 101.2 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.235 -0.439 . . . . 64.53 110.954 -179.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.43 142.89 36.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.072 -0.513 . . . . 73.32 110.873 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.788 ' O ' ' O ' ' A' ' 49' ' ' VAL . 0.3 OUTLIER -153.4 112.41 3.75 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.255 -0.43 . . . . 71.45 110.938 -179.896 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.81 ' N ' HD12 ' A' ' 61' ' ' ILE . 1.1 mp -102.82 114.19 41.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.13 -0.486 . . . . 64.21 111.153 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.849 HD23 ' HD2' ' A' ' 63' ' ' PRO . 0.6 OUTLIER -85.41 122.46 73.56 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 121.632 0.73 . . . . 72.41 110.89 179.962 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.849 ' HD2' HD23 ' A' ' 62' ' ' LEU . 54.1 Cg_endo -69.7 -166.34 0.18 Allowed 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.699 2.266 . . . . 75.01 112.339 179.868 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.44 160.96 14.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.164 -0.471 . . . . 75.03 110.896 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 113.48 -152.7 17.93 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.743 -0.741 . . . . 52.44 112.517 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -118.4 159.26 23.76 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.867 0.365 . . . . 74.15 110.891 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.479 ' N ' ' O ' ' A' ' 40' ' ' ILE . 11.5 m-85 -147.32 84.02 7.47 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.665 0.745 . . . . 73.34 110.942 -179.85 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 -4.68 14.51 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.655 2.237 . . . . 65.31 112.393 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 89.3 mt-10 -157.49 147.84 20.88 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.158 -0.474 . . . . 75.33 110.889 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.941 ' O ' ' CD1' ' A' ' 73' ' ' TRP . 44.4 p90 -57.97 -41.07 82.16 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.181 -0.463 . . . . 73.43 110.911 -179.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -52.8 -15.69 0.8 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.098 -0.501 . . . . 71.53 110.948 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 29.2 mmt180 -65.77 -17.6 64.74 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.189 -0.46 . . . . 72.4 110.845 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . 0.941 ' CD1' ' O ' ' A' ' 70' ' ' TYR . 0.4 OUTLIER -121.14 22.39 10.95 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.2 -0.455 . . . . 64.34 110.896 -179.948 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . 0.594 ' O ' ' C ' ' A' ' 75' ' ' GLY . 0.0 OUTLIER 75.67 30.22 0.8 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.278 -0.419 . . . . 72.1 110.9 179.943 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.594 ' C ' ' O ' ' A' ' 74' ' ' MET . . . 17.11 59.06 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.678 -0.773 . . . . 61.35 112.508 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.727 HD12 HE21 ' A' ' 149' ' ' GLN . 0.0 OUTLIER -55.01 -72.38 0.07 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.836 0.35 . . . . 72.52 110.944 -179.955 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.498 ' O ' ' CB ' ' A' ' 78' ' ' ASP . 16.3 t-20 -121.16 -37.93 2.88 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.172 -0.467 . . . . 73.41 110.857 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.498 ' CB ' ' O ' ' A' ' 77' ' ' ASN . 0.0 OUTLIER 83.83 10.35 0.47 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.206 -0.452 . . . . 64.01 110.882 179.925 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -105.74 86.89 2.47 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.186 -0.461 . . . . 71.23 110.88 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.871 HD11 HG11 ' A' ' 49' ' ' VAL . 0.1 OUTLIER -86.95 131.38 34.11 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.182 -0.463 . . . . 70.31 110.886 -179.965 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.645 ' HB3' ' HB3' ' A' ' 53' ' ' PRO . 1.4 m -153.82 -119.23 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.158 -0.473 . . . . 74.4 110.843 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.69 ' OG ' ' HA ' ' A' ' 53' ' ' PRO . 0.1 OUTLIER -46.38 97.76 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.142 -0.481 . . . . 71.51 110.871 -179.814 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . 0.786 ' CB ' HG12 ' A' ' 49' ' ' VAL . 9.7 p -122.78 134.96 54.41 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.186 -0.461 . . . . 74.01 110.86 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.613 ' N ' ' O ' ' A' ' 48' ' ' ALA . 2.2 mmt85 -117.66 156.57 27.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.176 -0.466 . . . . 73.41 110.87 -179.843 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -68.42 129.05 38.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 72.15 111.119 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.948 ' CG2' ' HB2' ' A' ' 48' ' ' ALA . 38.3 t -115.56 139.17 43.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.24 -0.437 . . . . 64.24 111.114 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . 0.682 ' O ' HG23 ' A' ' 136' ' ' VAL . 9.2 m170 -114.12 108.59 17.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.161 -0.472 . . . . 62.13 110.892 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.56 HD13 ' HB3' ' A' ' 178' ' ' GLU . 0.0 OUTLIER -32.79 148.15 0.06 OUTLIER Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.577 0.703 . . . . 65.12 110.908 -179.972 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.582 ' HA ' ' HA3' ' A' ' 135' ' ' GLY . 53.3 Cg_endo -69.82 100.38 0.82 Allowed 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.658 2.239 . . . . 65.14 112.303 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -105.72 -175.65 2.85 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.194 -0.457 . . . . 73.23 110.867 -179.855 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 46.36 57.91 6.17 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.7 -0.762 . . . . 72.1 112.509 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 125.44 26.63 1.29 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.763 -0.732 . . . . 73.33 112.49 -179.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.518 ' O ' ' CG ' ' A' ' 134' ' ' GLU . 5.7 pt20 38.27 -124.49 0.27 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.792 0.33 . . . . 71.13 110.935 -179.861 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.589 ' HA ' ' HG2' ' A' ' 134' ' ' GLU . 0.0 OUTLIER -125.76 103.38 7.78 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.173 -0.467 . . . . 75.33 110.888 -179.857 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.538 ' HG3' HG11 ' A' ' 132' ' ' VAL . 12.6 tptp -113.34 130.96 56.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.079 -0.51 . . . . 71.15 110.875 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.717 HD11 ' NZ ' ' A' ' 154' ' ' LYS . 7.6 tt -149.05 138.25 15.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.185 -0.461 . . . . 71.12 111.13 179.864 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.488 ' HB2' ' O ' ' A' ' 131' ' ' LYS . 0.9 OUTLIER -110.52 139.38 45.81 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.153 -0.476 . . . . 73.33 110.878 179.962 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.649 HD12 ' O ' ' A' ' 109' ' ' TYR . 1.2 mp -116.74 148.58 19.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 53.52 111.102 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.62 ' HB2' ' HB2' ' A' ' 129' ' ' SER . 38.6 m-85 -134.1 133.94 41.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.205 -0.452 . . . . 75.23 110.848 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 77.2 tt0 -65.26 -61.25 2.24 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.159 -0.473 . . . . 72.2 110.878 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 35.4 mttt -99.79 162.21 13.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.134 -0.485 . . . . 73.13 110.872 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -68.16 159.83 51.18 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.73 -0.747 . . . . 72.15 112.48 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.513 ' HA ' ' HB2' ' A' ' 158' ' ' ARG . 25.7 t0 67.22 39.0 3.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.855 0.359 . . . . 44.33 110.888 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.597 ' CZ ' ' HB3' ' A' ' 158' ' ' ARG . 3.6 m-85 58.06 19.65 6.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.202 -0.454 . . . . 74.25 110.894 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 70.4 m -88.23 161.55 17.15 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.15 -0.477 . . . . 74.55 110.88 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 82.26 -159.0 38.65 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.726 -0.75 . . . . 40.32 112.454 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 4.1 tp-100 -82.86 129.19 34.97 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.786 0.327 . . . . 73.01 110.887 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' MET . . . . . 0.474 ' HB2' ' CD1' ' A' ' 99' ' ' PHE . 0.0 OUTLIER -118.69 160.39 21.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.195 -0.457 . . . . 43.45 110.862 179.954 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . 0.649 ' O ' HD12 ' A' ' 98' ' ' ILE . 29.9 m-85 -154.72 135.87 13.94 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.205 -0.452 . . . . 75.45 110.911 -179.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -110.98 102.0 10.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.139 -0.482 . . . . 73.2 110.906 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.405 HG22 HD11 ' A' ' 98' ' ' ILE . 9.0 t -113.38 128.56 56.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.148 -0.478 . . . . 52.4 111.14 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.42 ' HA ' ' HA ' ' A' ' 95' ' ' LYS . 1.8 t -93.4 32.6 1.33 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.222 -0.444 . . . . 74.32 111.162 -180.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -153.79 -174.85 5.11 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.211 -0.449 . . . . 71.13 110.895 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -90.16 -175.18 4.45 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.154 -0.475 . . . . 63.13 110.839 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . 0.654 ' O ' ' HB2' ' A' ' 172' ' ' SER . 39.0 t -161.19 136.17 5.53 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.606 0.717 . . . . 75.3 110.854 -179.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.497 ' O ' ' C ' ' A' ' 143' ' ' PRO . 53.4 Cg_endo -69.81 -34.51 14.28 Favored 'Trans proline' 0 C--N 1.341 0.134 0 C-N-CA 122.669 2.246 . . . . 62.14 112.324 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.635 ' HB3' ' CB ' ' A' ' 120' ' ' GLU . 0.1 OUTLIER -147.04 97.28 2.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.228 -0.442 . . . . 65.43 110.88 -179.844 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.696 HD13 HD11 ' A' ' 127' ' ' ILE . 3.7 tt -50.81 -28.8 6.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.158 -0.473 . . . . 71.22 111.107 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' MET . . . . . 0.571 ' O ' ' HA ' ' A' ' 123' ' ' HIS . 21.7 ttp -85.95 -44.96 11.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.169 -0.469 . . . . 72.44 110.896 179.848 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.635 ' CB ' ' HB3' ' A' ' 117' ' ' SER . 17.5 tp10 -66.17 -14.14 61.36 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.242 -0.435 . . . . 74.13 110.9 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 7.1 tp-100 -113.69 -51.49 2.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.121 -0.491 . . . . 63.24 110.882 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.483 ' HB2' ' O ' ' A' ' 118' ' ' ILE . 77.2 m-85 -101.81 -21.53 14.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.187 -0.46 . . . . 51.33 110.845 -179.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . 0.571 ' HA ' ' O ' ' A' ' 119' ' ' MET . 29.3 m-70 71.87 30.83 2.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.155 -0.475 . . . . 72.41 110.91 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 4.1 mtt -106.79 88.65 2.8 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.174 -0.466 . . . . 73.42 110.829 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 4.0 ptp180 -53.34 -38.44 63.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.252 -0.431 . . . . 74.53 110.864 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.476 ' HB3' ' HG2' ' A' ' 168' ' ' PRO . 18.2 mt-10 -140.2 130.58 25.31 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.166 -0.47 . . . . 75.23 110.87 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.696 HD11 HD13 ' A' ' 118' ' ' ILE . 3.0 mm -87.57 96.88 6.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.173 -0.467 . . . . 73.02 111.09 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . 0.443 ' HA ' ' HB3' ' A' ' 160' ' ' PRO . 17.0 m170 -66.03 -35.93 81.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.132 -0.485 . . . . 63.33 110.867 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . 0.62 ' HB2' ' HB2' ' A' ' 99' ' ' PHE . 0.6 OUTLIER -135.54 147.45 48.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.225 -0.443 . . . . 64.01 110.884 -179.809 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . 0.553 ' O ' ' O ' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -144.78 120.39 10.43 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.192 -0.458 . . . . 64.45 110.924 -179.989 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.64 ' HA ' ' HA ' ' A' ' 156' ' ' GLU . 4.4 mtpt -111.25 154.32 24.62 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.156 -0.475 . . . . 65.33 110.938 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.538 HG11 ' HG3' ' A' ' 95' ' ' LYS . 13.0 t 83.32 163.59 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 71.12 111.131 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.847 HD13 ' O ' ' A' ' 154' ' ' LYS . 0.0 OUTLIER -178.86 122.2 0.09 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.176 -0.465 . . . . 64.22 110.898 179.95 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.589 ' HG2' ' HA ' ' A' ' 94' ' ' TYR . 0.1 OUTLIER -96.13 166.6 11.67 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.165 -0.47 . . . . 63.44 110.895 179.923 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . 0.582 ' HA3' ' HA ' ' A' ' 89' ' ' PRO . . . -24.42 -73.71 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.691 -0.766 . . . . 53.01 112.532 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.744 HG21 HG13 ' A' ' 86' ' ' VAL . 4.7 t -132.45 146.97 32.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.833 0.349 . . . . 72.44 111.126 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' TRP . . . . . 0.616 ' HB3' ' HB3' ' A' ' 152' ' ' LEU . 2.6 t-105 -149.6 141.98 24.25 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.17 -0.468 . . . . 75.11 110.924 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.573 HG13 HD11 ' A' ' 176' ' ' ILE . 59.5 mt -115.59 132.34 65.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.258 -0.428 . . . . 74.04 111.177 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.473 ' CD2' HG11 ' A' ' 170' ' ' VAL . 0.3 OUTLIER -99.74 179.58 4.49 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.166 -0.47 . . . . 64.1 110.878 179.99 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . 0.553 ' CE1' ' HB3' ' A' ' 149' ' ' GLN . 1.4 m-85 -152.39 126.08 8.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.136 -0.483 . . . . 74.53 110.905 -179.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . 0.606 ' O ' ' HB2' ' A' ' 171' ' ' GLN . 3.2 tt0 -61.05 -26.49 67.66 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.142 -0.481 . . . . 70.32 110.907 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.709 ' HB3' ' HD2' ' A' ' 143' ' ' PRO . 8.4 mp -116.24 173.29 3.12 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.59 0.709 . . . . 74.22 110.892 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . 0.747 ' O ' ' OG ' ' A' ' 172' ' ' SER . 54.0 Cg_endo -69.73 -89.68 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.145 0 C-N-CA 122.724 2.283 . . . . 64.44 112.373 179.813 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . 0.704 ' O ' ' N ' ' A' ' 146' ' ' ARG . 1.0 OUTLIER -54.69 95.7 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.232 -0.44 . . . . 72.12 110.931 179.957 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . 0.646 ' C ' ' O ' ' A' ' 144' ' ' ASN . 0.1 OUTLIER 12.69 53.01 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.17 -0.468 . . . . 74.31 110.89 -179.913 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . 0.704 ' N ' ' O ' ' A' ' 144' ' ' ASN . 10.1 mtp85 -118.69 172.46 7.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.159 -0.473 . . . . 73.12 110.862 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 70.59 -175.34 37.41 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.713 -0.756 . . . . 72.34 112.479 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.436 ' HA ' HD11 ' A' ' 76' ' ' LEU . 3.9 mtp180 -83.28 130.7 35.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.776 0.322 . . . . 62.21 110.87 -179.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' GLN . . . . . 0.735 ' OE1' ' HA ' ' A' ' 60' ' ' TYR . 0.3 OUTLIER -85.79 158.7 19.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.178 -0.464 . . . . 74.2 110.9 -179.926 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -123.59 158.27 31.84 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.206 -0.452 . . . . 72.43 110.957 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.64 ' HB2' HD11 ' A' ' 61' ' ' ILE . 13.4 tp -92.01 134.65 34.62 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.108 -0.496 . . . . 63.32 110.917 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 1.041 ' O ' HD13 ' A' ' 152' ' ' LEU . 0.0 OUTLIER -63.94 132.59 51.17 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.218 -0.446 . . . . 75.31 110.895 179.884 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -163.69 26.04 0.08 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.174 -0.467 . . . . 62.4 110.854 179.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.847 ' O ' HD13 ' A' ' 133' ' ' LEU . 5.6 pttt -116.13 -173.03 2.28 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.167 -0.469 . . . . 54.4 110.854 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.838 ' HG3' HD22 ' A' ' 133' ' ' LEU . 0.1 OUTLIER -161.75 -124.53 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.183 -0.462 . . . . 65.43 110.898 179.867 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.64 ' HA ' ' HA ' ' A' ' 131' ' ' LYS . 0.3 OUTLIER -71.42 2.2 5.27 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.228 -0.442 . . . . 64.42 110.904 179.976 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . 0.795 ' CD1' ' HB2' ' A' ' 154' ' ' LYS . 20.5 m-30 -30.17 144.85 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.153 -0.476 . . . . 70.22 110.93 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . 0.597 ' HB3' ' CZ ' ' A' ' 104' ' ' PHE . 9.4 ptp180 -112.67 -44.13 3.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.128 -0.487 . . . . 73.54 110.881 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -80.48 152.17 72.65 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.596 0.712 . . . . 74.42 110.865 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . 0.443 ' HB3' ' HA ' ' A' ' 128' ' ' HIS . 54.2 Cg_endo -69.76 -32.83 17.8 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.693 2.262 . . . . 71.42 112.335 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.61 ' H ' HD12 ' A' ' 161' ' ' ILE . 3.6 mp -55.34 -19.04 4.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.224 -0.444 . . . . 74.24 111.143 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.654 ' HB3' ' CD1' ' A' ' 157' ' ' TYR . 0.3 OUTLIER -73.57 -23.0 59.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.202 -0.454 . . . . 70.33 110.891 179.826 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' TRP . . . . . 0.407 ' HB3' ' O ' ' A' ' 160' ' ' PRO . 2.1 t-105 -67.53 -17.7 64.76 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.2 -0.455 . . . . 73.32 110.963 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 114.3 -38.63 3.09 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.689 -0.767 . . . . 72.35 112.473 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -90.91 140.68 29.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.81 0.338 . . . . 63.14 111.063 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -40.97 -35.13 0.48 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.196 -0.456 . . . . 54.34 111.09 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . 0.498 ' C ' ' H ' ' A' ' 169' ' ' ALA . 0.3 OUTLIER -129.51 156.82 78.02 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.665 0.745 . . . . 75.55 110.9 -179.803 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . 0.476 ' HG2' ' HB3' ' A' ' 126' ' ' GLU . 53.9 Cg_endo -69.76 25.27 0.17 Allowed 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.697 2.264 . . . . 74.41 112.356 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 0.498 ' H ' ' C ' ' A' ' 167' ' ' SER . . . -64.3 103.88 0.69 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.197 -0.456 . . . . 62.14 111.149 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.473 HG11 ' CD2' ' A' ' 139' ' ' PHE . 3.5 t -153.66 162.17 2.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.238 -0.437 . . . . 51.24 111.122 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' GLN . . . . . 0.647 ' O ' ' HB ' ' A' ' 118' ' ' ILE . 1.9 mm-40 -112.54 -85.19 0.58 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.15 -0.477 . . . . 62.32 110.926 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . 0.747 ' OG ' ' O ' ' A' ' 143' ' ' PRO . 32.0 p -129.54 178.78 6.22 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.204 -0.453 . . . . 74.14 110.87 -179.84 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -145.91 176.44 9.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.092 -0.504 . . . . 72.13 110.894 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . 0.434 ' HG2' ' HB ' ' A' ' 138' ' ' ILE . 0.2 OUTLIER -134.47 151.15 50.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.179 -0.464 . . . . 72.42 110.86 -179.903 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . 0.553 ' HD2' ' CE1' ' A' ' 94' ' ' TYR . 1.7 ptt180 -102.34 147.98 26.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.186 -0.461 . . . . 74.34 110.835 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . 0.573 HD11 HG13 ' A' ' 138' ' ' ILE . 3.9 mt -100.34 126.66 53.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.16 -0.473 . . . . 75.33 111.126 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 9.6 p -127.38 153.09 36.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.161 -0.472 . . . . 53.21 111.083 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . 0.56 ' HB3' HD13 ' A' ' 88' ' ' LEU . 1.5 pt-20 . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.142 -0.481 . . . . 75.1 110.904 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.314 0 N-CA-C 112.508 -0.237 . . . . 73.35 112.508 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.431 ' C ' ' HE1' ' A' ' 47' ' ' TRP . 5.3 p -82.23 134.05 35.28 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.872 0.367 . . . . 72.32 111.126 -179.832 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 2.8 tttt -121.44 136.44 54.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.26 -0.427 . . . . 63.51 110.899 179.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.583 ' HB ' ' CD1' ' A' ' 47' ' ' TRP . 12.7 tt -136.69 147.49 27.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.271 -0.422 . . . . 75.14 111.156 179.827 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.552 HG22 ' CE2' ' A' ' 11' ' ' TYR . 15.9 m -130.01 129.95 44.36 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.175 -0.466 . . . . 75.03 111.106 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.799 ' HB2' HD22 ' A' ' 34' ' ' LEU . 0.4 OUTLIER -117.05 131.1 57.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.171 -0.468 . . . . 61.44 110.896 -179.988 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.552 ' CE2' HG22 ' A' ' 9' ' ' THR . 43.5 m-85 -116.46 131.21 57.01 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.179 -0.464 . . . . 42.21 110.916 -179.86 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.516 ' HG2' ' HB2' ' A' ' 36' ' ' ARG . 0.0 OUTLIER -60.91 -23.94 65.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.092 -0.504 . . . . 73.35 110.899 -179.999 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 68.6 m-20 -127.87 152.48 47.79 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.187 -0.46 . . . . 73.44 110.848 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.48 ' N ' ' HB3' ' A' ' 38' ' ' ASN . 4.2 mtmm -56.05 -176.98 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.175 -0.466 . . . . 75.11 110.893 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 69.9 m-20 46.99 37.74 5.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.209 -0.45 . . . . 73.03 110.896 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.535 ' HA ' ' CG ' ' A' ' 11' ' ' TYR . 4.3 m-85 45.91 56.59 5.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.145 -0.48 . . . . 72.33 110.93 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 4.1 mt-30 -132.16 159.91 37.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.142 -0.481 . . . . 74.34 110.928 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 93.81 -150.93 20.05 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.722 -0.752 . . . . 71.41 112.449 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.768 ' O ' HD13 ' A' ' 34' ' ' LEU . 0.0 OUTLIER -68.9 80.02 0.3 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.81 0.338 . . . . 75.54 110.843 -179.811 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.478 ' HB2' ' CE1' ' A' ' 11' ' ' TYR . 0.8 OUTLIER -77.99 127.99 33.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.203 -0.453 . . . . 73.15 110.862 -179.891 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.411 ' CD2' ' CD2' ' A' ' 30' ' ' PHE . 90.5 t80 -124.25 125.59 44.65 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.223 -0.444 . . . . 53.45 110.957 -179.883 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.46 ' CG ' HG23 ' A' ' 9' ' ' THR . 1.5 m-20 -118.99 132.49 56.07 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.14 -0.482 . . . . 70.42 110.865 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 12.6 t -161.3 131.01 4.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.208 -0.451 . . . . 65.41 110.888 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -102.12 4.17 39.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 71.24 110.888 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 48.7 t -112.9 159.46 19.04 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.46 . . . . 71.11 110.893 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -42.24 119.97 1.51 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.165 -0.47 . . . . 64.04 110.847 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.636 ' HB2' ' HB3' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -114.83 43.32 1.98 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.18 -0.464 . . . . 71.23 110.895 -179.925 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.532 ' O ' ' HA ' ' A' ' 82' ' ' SER . . . -49.97 -21.22 1.13 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.179 -0.464 . . . . 65.03 111.093 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 64.7 t0 -129.47 40.63 3.57 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.224 -0.444 . . . . 75.11 110.867 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.763 ' O ' ' CD2' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -82.06 16.39 1.95 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.207 -0.451 . . . . 75.5 110.833 -179.904 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.432 ' HB2' ' HB3' ' A' ' 81' ' ' SER . 34.4 t60 -78.62 -40.82 33.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.213 -0.449 . . . . 75.52 110.891 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.43 HG23 ' CD2' ' A' ' 33' ' ' TYR . 10.0 t -61.73 -10.65 9.24 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.201 -0.454 . . . . 73.42 111.12 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.501 ' CD1' ' HA ' ' A' ' 30' ' ' PHE . 12.2 m-85 -99.43 -30.77 12.0 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.217 -0.447 . . . . 74.02 110.95 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.799 HD22 ' HB2' ' A' ' 10' ' ' PHE . 16.7 tp -141.54 146.15 36.0 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.126 -0.488 . . . . 65.41 110.933 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.2 m -112.09 -34.65 5.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.154 -0.475 . . . . 61.22 110.847 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.579 ' O ' HD21 ' A' ' 34' ' ' LEU . 1.8 mtp85 -115.6 140.87 48.77 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.119 -0.491 . . . . 75.51 110.884 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.595 ' SG ' ' HB2' ' A' ' 80' ' ' LEU . 1.6 p -116.86 54.45 0.86 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.184 -0.462 . . . . 73.11 110.899 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.48 ' HB3' ' N ' ' A' ' 14' ' ' LYS . 1.9 m-80 -55.02 -65.71 0.53 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.182 -0.463 . . . . 73.41 110.91 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.406 ' HB2' ' HA ' ' A' ' 68' ' ' PRO . 7.6 p -116.27 128.15 55.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.181 -0.463 . . . . 71.42 110.832 -179.857 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.593 HD12 ' CZ3' ' A' ' 73' ' ' TRP . 12.0 mt -124.67 147.47 29.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.088 -0.505 . . . . 72.44 111.13 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.423 ' HD2' ' CE2' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -141.67 118.7 11.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.149 -0.478 . . . . 73.45 110.884 179.86 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.504 ' O ' HG12 ' A' ' 42' ' ' VAL . 1.0 OUTLIER -104.35 117.46 49.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.461 . . . . 64.44 111.088 179.908 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -112.34 77.68 1.06 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.173 -0.467 . . . . 51.41 110.868 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.417 ' O ' ' HA ' ' A' ' 6' ' ' THR . . . 136.88 98.31 0.51 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.73 -0.748 . . . . 70.21 112.468 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.447 ' HA2' HD21 ' A' ' 88' ' ' LEU . . . 55.36 177.86 0.22 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.725 -0.75 . . . . 65.35 112.426 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.735 HG23 ' HA ' ' A' ' 63' ' ' PRO . 1.0 OUTLIER -76.32 171.13 15.08 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.77 0.319 . . . . 73.04 111.166 -179.901 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . 0.583 ' CD1' ' HB ' ' A' ' 8' ' ' ILE . 6.1 m95 -143.47 128.77 18.85 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.251 -0.431 . . . . 43.44 110.921 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.888 ' HB2' ' CG2' ' A' ' 86' ' ' VAL . . . -90.88 126.33 36.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.191 -0.459 . . . . 54.32 111.096 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.823 HG11 HD11 ' A' ' 80' ' ' LEU . 26.9 m -126.32 130.1 71.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.202 -0.454 . . . . 75.33 111.083 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.8 ' HB3' ' HA ' ' A' ' 56' ' ' ALA . 52.4 m-85 -100.41 148.02 25.19 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.161 -0.472 . . . . 74.21 110.973 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.568 ' HB3' ' HB3' ' A' ' 57' ' ' TRP . 58.4 tt0 -49.75 -78.07 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.105 -0.498 . . . . 73.22 110.873 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.484 ' HB3' ' CD1' ' A' ' 55' ' ' PHE . 0.1 OUTLIER -93.36 141.57 24.13 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.614 0.721 . . . . 71.54 110.859 -179.878 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.661 ' HB3' ' HB3' ' A' ' 81' ' ' SER . 53.7 Cg_endo -69.76 145.25 56.6 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.691 2.261 . . . . 61.21 112.341 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 61.9 -11.02 0.07 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.201 -0.454 . . . . 74.33 110.925 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.625 ' H ' ' C ' ' A' ' 53' ' ' PRO . 1.8 m-30 -108.16 -21.29 12.85 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.163 -0.472 . . . . 74.01 110.831 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.8 ' HA ' ' HB3' ' A' ' 50' ' ' TYR . . . 50.96 26.77 2.85 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.183 -0.462 . . . . 43.43 111.069 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . 0.641 ' O ' ' C ' ' A' ' 58' ' ' TYR . 0.8 OUTLIER -48.63 -164.5 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.245 -0.434 . . . . 73.0 110.899 -179.967 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.641 ' C ' ' O ' ' A' ' 57' ' ' TRP . 5.3 m-30 -11.76 100.15 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.236 -0.438 . . . . 73.21 110.933 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.475 ' HB2' ' HA ' ' A' ' 150' ' ' TYR . 0.0 OUTLIER -60.41 153.36 23.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.154 -0.476 . . . . 62.44 110.869 179.911 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.659 ' CE2' HD12 ' A' ' 76' ' ' LEU . 2.1 t80 -168.65 107.95 0.48 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.193 -0.458 . . . . 74.42 110.914 -179.871 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.865 HD13 HG23 ' A' ' 138' ' ' ILE . 4.9 mp -95.73 118.65 42.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.148 -0.478 . . . . 64.04 111.131 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.848 HD23 ' HD2' ' A' ' 63' ' ' PRO . 0.3 OUTLIER -87.45 126.0 63.64 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.587 0.708 . . . . 73.14 110.927 179.904 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.848 ' HD2' HD23 ' A' ' 62' ' ' LEU . 54.0 Cg_endo -69.76 -172.81 0.62 Allowed 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.662 2.241 . . . . 63.21 112.346 179.871 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.67 161.71 15.96 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.209 -0.451 . . . . 75.11 110.917 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 112.87 -159.49 13.64 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.707 -0.758 . . . . 72.12 112.5 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -114.71 158.5 21.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.865 0.364 . . . . 72.33 110.913 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.493 ' N ' ' O ' ' A' ' 40' ' ' ILE . 7.2 m-85 -149.44 80.42 7.69 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.681 0.753 . . . . 74.02 110.895 -179.837 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.573 ' HD2' ' HG3' ' A' ' 72' ' ' ARG . 53.7 Cg_endo -69.78 1.13 4.73 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.682 2.255 . . . . 75.12 112.321 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -157.91 155.1 28.96 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.24 -0.436 . . . . 75.34 110.873 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.807 ' O ' ' CD1' ' A' ' 73' ' ' TRP . 18.9 p90 -66.97 -7.97 26.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.164 -0.471 . . . . 74.2 110.947 -179.883 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -90.44 -16.32 29.23 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.102 -0.499 . . . . 63.23 110.909 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.573 ' HG3' ' HD2' ' A' ' 68' ' ' PRO . 25.5 mmt180 -75.01 -22.87 58.23 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.203 -0.453 . . . . 72.33 110.919 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . 0.807 ' CD1' ' O ' ' A' ' 70' ' ' TYR . 0.5 OUTLIER -109.39 8.22 25.35 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.148 -0.478 . . . . 65.43 110.927 -179.967 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . 0.504 ' C ' ' O ' ' A' ' 73' ' ' TRP . 0.0 OUTLIER 30.23 55.48 0.17 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.205 -0.452 . . . . 71.13 110.903 179.954 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.527 ' CA ' ' OH ' ' A' ' 60' ' ' TYR . . . -91.77 -170.14 41.65 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.781 -0.723 . . . . 72.11 112.469 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.671 HD21 ' HA ' ' A' ' 148' ' ' ARG . 0.1 OUTLIER -107.87 -74.28 0.66 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.834 0.35 . . . . 74.03 110.915 -179.936 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -96.84 147.01 24.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.146 -0.479 . . . . 74.24 110.914 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.406 ' O ' ' SG ' ' A' ' 37' ' ' CYS . 15.8 p30 -95.71 34.05 1.56 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.203 -0.453 . . . . 41.34 110.877 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 4.3 ttm-85 -105.69 79.47 1.44 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 72.03 110.851 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.823 HD11 HG11 ' A' ' 49' ' ' VAL . 0.1 OUTLIER -82.82 130.3 35.11 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.179 -0.464 . . . . 73.02 110.955 179.976 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.661 ' HB3' ' HB3' ' A' ' 53' ' ' PRO . 1.3 m -152.24 -123.51 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.22 -0.446 . . . . 64.23 110.858 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.619 ' OG ' ' HA ' ' A' ' 53' ' ' PRO . 0.2 OUTLIER -41.0 99.98 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.118 -0.492 . . . . 60.33 110.855 -179.82 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . 0.72 ' HB3' HG12 ' A' ' 49' ' ' VAL . 8.9 p -127.0 134.38 50.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.131 -0.486 . . . . 64.3 110.863 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.617 ' N ' ' O ' ' A' ' 48' ' ' ALA . 4.5 mmt85 -115.47 158.32 22.72 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.194 -0.457 . . . . 64.51 110.902 -179.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -72.08 129.61 38.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.46 . . . . 72.45 111.104 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.888 ' CG2' ' HB2' ' A' ' 48' ' ' ALA . 61.5 t -116.02 136.23 53.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.213 -0.449 . . . . 62.32 111.142 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . 0.587 ' O ' HG23 ' A' ' 136' ' ' VAL . 40.2 m80 -113.89 108.09 16.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.162 -0.472 . . . . 74.13 110.872 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.465 HD23 ' H ' ' A' ' 88' ' ' LEU . 0.0 OUTLIER -35.39 144.94 0.22 Allowed Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.621 0.724 . . . . 75.33 110.91 -179.971 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.475 ' HB3' ' H ' ' A' ' 136' ' ' VAL . 53.9 Cg_endo -69.73 104.24 1.28 Allowed 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.678 2.252 . . . . 74.04 112.317 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -103.16 165.68 10.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.231 -0.441 . . . . 65.45 110.859 -179.836 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 66.65 129.02 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.737 -0.744 . . . . 73.13 112.535 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.417 ' C ' ' HG2' ' A' ' 93' ' ' GLN . . . 51.1 33.92 30.78 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.721 -0.752 . . . . 43.01 112.495 -179.893 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.453 ' O ' ' CG ' ' A' ' 134' ' ' GLU . 6.3 pt20 39.07 -154.72 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.848 0.356 . . . . 71.24 110.911 -179.883 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.48 ' HA ' ' CG ' ' A' ' 134' ' ' GLU . 25.2 t80 -95.19 108.26 20.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.178 -0.464 . . . . 73.44 110.935 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.527 ' HG3' HG11 ' A' ' 132' ' ' VAL . 11.7 tptt -107.88 127.94 54.18 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.111 -0.495 . . . . 72.13 110.89 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.585 HD13 ' H ' ' A' ' 97' ' ' GLN . 0.4 OUTLIER -152.25 134.37 5.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.186 -0.461 . . . . 71.1 111.138 179.85 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.585 ' H ' HD13 ' A' ' 96' ' ' ILE . 1.2 mt-30 -109.08 124.63 51.07 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.169 -0.469 . . . . 61.53 110.913 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.767 HD13 HD11 ' A' ' 118' ' ' ILE . 7.9 mt -101.19 140.64 19.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.2 -0.455 . . . . 70.44 111.136 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.522 ' CD2' ' HA ' ' A' ' 104' ' ' PHE . 48.1 m-85 -129.0 146.02 51.09 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 64.22 110.835 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -80.19 -28.65 38.67 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.095 -0.502 . . . . 71.4 110.866 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 29.5 mttt -122.11 166.26 14.82 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.152 -0.476 . . . . 64.01 110.908 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.472 ' HA2' ' HB3' ' A' ' 129' ' ' SER . . . -68.48 178.98 22.13 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.751 -0.738 . . . . 41.52 112.473 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.403 ' C ' ' CG ' ' A' ' 104' ' ' PHE . 38.4 t70 40.91 36.26 0.41 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.845 0.355 . . . . 73.41 110.865 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.672 ' N ' ' CD2' ' A' ' 104' ' ' PHE . 0.0 OUTLIER 50.95 73.13 0.31 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.171 -0.468 . . . . 74.12 110.918 -179.877 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 1.2 m -139.52 161.04 38.46 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.119 -0.491 . . . . 35.15 110.879 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 79.79 -142.2 24.28 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.78 -0.724 . . . . 74.24 112.49 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 3.1 tp-100 -71.03 111.76 6.65 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.749 0.309 . . . . 71.02 110.933 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' MET . . . . . 0.495 ' HB2' ' CE2' ' A' ' 99' ' ' PHE . 5.9 ttp -106.62 149.12 27.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.254 -0.43 . . . . 73.13 110.894 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -153.19 135.15 14.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.227 -0.442 . . . . 73.41 110.891 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -110.19 97.55 7.0 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.117 -0.492 . . . . 74.13 110.888 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 9.7 t -110.3 132.19 54.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.141 -0.481 . . . . 71.54 111.134 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.445 ' O ' ' OG1' ' A' ' 112' ' ' THR . 1.1 t -119.37 36.43 4.48 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.182 -0.463 . . . . 74.14 111.162 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 53.5 mt-10 -151.34 165.59 33.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.241 -0.436 . . . . 63.31 110.891 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -56.25 164.24 1.38 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.136 -0.484 . . . . 52.32 110.856 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . 0.494 ' O ' ' HB2' ' A' ' 172' ' ' SER . 18.4 t -153.12 117.59 2.84 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.617 0.722 . . . . 62.03 110.886 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.426 ' O ' ' C ' ' A' ' 143' ' ' PRO . 53.4 Cg_endo -69.75 -31.97 19.52 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.716 2.277 . . . . 73.22 112.311 -179.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.642 ' HB3' ' CB ' ' A' ' 120' ' ' GLU . 0.1 OUTLIER -148.82 104.51 3.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.23 -0.441 . . . . 54.12 110.914 -179.834 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.767 HD11 HD13 ' A' ' 98' ' ' ILE . 2.9 tt -57.84 -29.46 35.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.131 -0.486 . . . . 61.34 111.129 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' MET . . . . . 0.598 ' O ' ' HA ' ' A' ' 123' ' ' HIS . 11.6 ttp -86.77 -42.96 12.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 64.51 110.835 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.642 ' CB ' ' HB3' ' A' ' 117' ' ' SER . 6.7 tp10 -67.66 -13.23 61.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.271 -0.422 . . . . 71.03 110.856 -179.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 28.3 tp60 -115.48 -48.72 2.78 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.151 -0.477 . . . . 72.43 110.894 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.5 ' HB2' ' O ' ' A' ' 118' ' ' ILE . 33.8 m-85 -103.69 -20.28 14.03 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.253 -0.431 . . . . 75.13 110.912 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . 0.598 ' HA ' ' O ' ' A' ' 119' ' ' MET . 0.2 OUTLIER 71.9 26.41 2.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.114 -0.493 . . . . 71.33 110.854 -179.977 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.463 ' SD ' HG22 ' A' ' 98' ' ' ILE . 7.1 mtt -102.56 83.99 2.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.214 -0.448 . . . . 72.11 110.868 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 1.8 ptp85 -52.12 -29.94 24.11 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.264 -0.426 . . . . 72.4 110.852 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.504 ' HG2' ' HA ' ' A' ' 169' ' ' ALA . 20.9 mt-10 -146.22 130.73 17.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.215 -0.448 . . . . 63.55 110.921 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.653 HD11 HD13 ' A' ' 118' ' ' ILE . 4.4 mm -91.37 103.92 14.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.15 -0.477 . . . . 71.13 111.137 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . 0.421 ' HB3' ' N ' ' A' ' 102' ' ' GLY . 2.3 m170 -71.53 -29.61 64.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.169 -0.469 . . . . 75.13 110.865 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . 0.472 ' HB3' ' HA2' ' A' ' 102' ' ' GLY . 0.3 OUTLIER -153.55 152.74 31.26 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.182 -0.463 . . . . 73.53 110.824 -179.819 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . 0.72 ' O ' ' HB2' ' A' ' 157' ' ' TYR . 0.0 OUTLIER -146.57 112.12 5.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.085 -0.507 . . . . 51.54 110.885 -179.942 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.765 ' HA ' ' HA ' ' A' ' 156' ' ' GLU . 13.4 mtpt -90.78 147.74 23.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 73.14 110.908 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.553 HG12 ' N ' ' A' ' 133' ' ' LEU . 11.3 t 85.03 165.33 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.283 -0.417 . . . . 52.13 111.149 179.875 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.774 HD22 ' HA ' ' A' ' 155' ' ' LYS . 0.3 OUTLIER -179.1 127.79 0.1 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.176 -0.466 . . . . 71.43 110.876 179.959 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.48 ' CG ' ' HA ' ' A' ' 94' ' ' TYR . 0.0 OUTLIER -89.14 -171.51 3.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.116 -0.493 . . . . 60.21 110.881 179.94 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -48.79 -52.83 19.7 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.77 -0.729 . . . . 50.32 112.463 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.81 ' HB ' HD12 ' A' ' 176' ' ' ILE . 3.6 t -147.48 146.92 17.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.841 0.353 . . . . 53.32 111.1 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' TRP . . . . . 0.667 ' HB3' ' CB ' ' A' ' 152' ' ' LEU . 23.0 t90 -147.04 143.13 28.14 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.196 -0.457 . . . . 73.22 110.932 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.865 HG23 HD13 ' A' ' 61' ' ' ILE . 14.0 mt -123.53 133.69 68.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.244 -0.434 . . . . 60.41 111.119 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.517 ' CE1' ' HB3' ' A' ' 173' ' ' PHE . 0.1 OUTLIER -99.41 166.42 11.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.173 -0.467 . . . . 73.02 110.918 179.936 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -142.17 125.96 17.05 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.159 -0.473 . . . . 62.22 110.925 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . 0.623 ' O ' ' HB2' ' A' ' 171' ' ' GLN . 0.5 OUTLIER -58.77 -25.22 62.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.119 -0.492 . . . . 72.41 110.928 179.977 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.742 ' HB3' ' HD2' ' A' ' 143' ' ' PRO . 9.3 mp -115.65 173.67 2.84 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.635 0.731 . . . . 73.12 110.898 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . 0.805 ' O ' ' OG ' ' A' ' 172' ' ' SER . 54.3 Cg_endo -69.74 -87.59 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.667 2.245 . . . . 62.5 112.325 179.826 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . 0.699 ' O ' ' N ' ' A' ' 146' ' ' ARG . 1.1 m-20 -53.71 96.23 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.205 -0.452 . . . . 54.44 110.889 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . 0.641 ' C ' ' O ' ' A' ' 144' ' ' ASN . 0.0 OUTLIER 13.23 52.6 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.136 -0.484 . . . . 74.55 110.933 -179.933 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . 0.699 ' N ' ' O ' ' A' ' 144' ' ' ASN . 10.6 mtp85 -119.49 174.66 6.25 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.108 -0.496 . . . . 74.3 110.843 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 79.64 -179.96 52.71 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.754 -0.736 . . . . 74.31 112.469 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.671 ' HA ' HD21 ' A' ' 76' ' ' LEU . 17.2 mtt180 -71.67 144.41 49.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.808 0.337 . . . . 71.13 110.896 -179.893 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' GLN . . . . . 0.536 ' HB2' ' HA ' ' A' ' 60' ' ' TYR . 49.5 mt-30 -83.28 148.51 27.33 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.158 -0.474 . . . . 74.43 110.937 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . 0.496 ' HB2' ' HB2' ' A' ' 139' ' ' PHE . 87.3 m-85 -132.81 118.92 19.59 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.221 -0.445 . . . . 74.2 110.902 -179.824 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.756 ' CA ' HD11 ' A' ' 61' ' ' ILE . 18.7 tp -69.91 136.37 50.53 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.095 -0.502 . . . . 71.23 110.951 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 1.055 ' O ' HD13 ' A' ' 152' ' ' LEU . 0.0 OUTLIER -74.02 135.81 43.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.208 -0.451 . . . . 74.35 110.945 179.873 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . 0.93 ' O ' ' HB2' ' A' ' 154' ' ' LYS . 54.5 t0 -161.39 109.65 1.51 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.21 -0.45 . . . . 65.41 110.877 179.852 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.93 ' HB2' ' O ' ' A' ' 153' ' ' ASP . 0.4 OUTLIER 156.07 -133.29 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.235 -0.439 . . . . 74.43 110.913 179.996 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.774 ' HA ' HD22 ' A' ' 133' ' ' LEU . 0.4 OUTLIER -164.98 -94.78 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.185 -0.461 . . . . 75.4 110.868 179.861 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.765 ' HA ' ' HA ' ' A' ' 131' ' ' LYS . 0.3 OUTLIER -89.76 9.34 27.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.262 -0.426 . . . . 74.25 110.908 179.927 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . 0.813 ' CZ ' ' HB3' ' A' ' 154' ' ' LYS . 1.9 m-85 20.4 108.14 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.124 -0.489 . . . . 65.05 110.945 -179.859 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.35 -34.03 8.9 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.151 -0.477 . . . . 74.02 110.856 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . 0.4 ' HB2' ' HD2' ' A' ' 160' ' ' PRO . 2.8 ptpt -108.92 158.72 33.43 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.654 0.74 . . . . 71.45 110.862 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . 0.463 ' HB2' ' HD3' ' A' ' 168' ' ' PRO . 53.9 Cg_endo -69.73 -21.57 33.43 Favored 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.7 2.267 . . . . 60.42 112.322 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.624 ' H ' HD12 ' A' ' 161' ' ' ILE . 3.4 mp -82.5 3.75 2.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.244 -0.435 . . . . 53.44 111.149 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.402 ' HB3' ' CD1' ' A' ' 157' ' ' TYR . 3.7 m-20 -64.58 -12.85 49.47 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.163 -0.471 . . . . 65.51 110.839 179.896 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' TRP . . . . . 0.492 ' CZ2' ' HB2' ' A' ' 130' ' ' CYS . 19.7 m-90 -105.47 -16.24 14.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.217 -0.447 . . . . 72.11 110.957 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 112.13 -35.33 4.72 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.743 -0.741 . . . . 44.04 112.491 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -62.68 126.58 27.81 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.759 0.314 . . . . 52.33 111.126 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -41.01 -37.5 0.83 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.217 -0.447 . . . . 74.04 111.135 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . 0.483 ' C ' ' H ' ' A' ' 169' ' ' ALA . 0.3 OUTLIER -130.66 157.33 78.0 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.665 0.745 . . . . 64.35 110.863 -179.811 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . 0.463 ' HD3' ' HB2' ' A' ' 160' ' ' PRO . 53.6 Cg_endo -69.74 24.0 0.17 Allowed 'Trans proline' 0 C--N 1.341 0.137 0 C-N-CA 122.642 2.228 . . . . 75.41 112.397 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 0.504 ' HA ' ' HG2' ' A' ' 126' ' ' GLU . . . -65.57 107.02 1.58 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.204 -0.453 . . . . 75.2 111.097 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.441 HG11 ' CE1' ' A' ' 139' ' ' PHE . 3.3 t -152.94 159.83 3.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.195 -0.457 . . . . 74.21 111.155 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' GLN . . . . . 0.623 ' HB2' ' O ' ' A' ' 141' ' ' GLU . 1.7 tm0? -105.7 -81.19 0.54 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.202 -0.454 . . . . 74.31 110.933 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . 0.805 ' OG ' ' O ' ' A' ' 143' ' ' PRO . 51.6 p -127.2 -178.23 4.36 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 55.12 110.88 -179.817 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 173' ' ' PHE . . . . . 0.517 ' HB3' ' CE1' ' A' ' 139' ' ' PHE . 27.5 p90 -142.66 167.07 22.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.181 -0.463 . . . . 74.45 110.871 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.88 130.1 19.74 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.127 -0.488 . . . . 62.14 110.852 -179.876 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.47 -169.96 1.62 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.179 -0.464 . . . . 73.54 110.849 -179.896 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . 0.81 HD12 ' HB ' ' A' ' 136' ' ' VAL . 3.7 mt -137.12 134.19 47.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 65.34 111.141 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 95.3 t -150.45 142.37 16.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.181 -0.463 . . . . 74.35 111.121 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . 0.432 ' HB3' HD13 ' A' ' 88' ' ' LEU . 5.3 pt-20 . . . . . 0 C--N 1.33 -0.261 0 CA-C-N 116.175 -0.466 . . . . 72.03 110.922 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.317 0 N-CA-C 112.49 -0.244 . . . . 71.22 112.49 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.446 ' HB ' ' O ' ' A' ' 44' ' ' GLY . 12.8 p -82.56 133.18 35.19 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.847 0.356 . . . . 72.25 111.132 -179.844 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 3.0 tttt -122.4 137.74 54.76 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.214 -0.448 . . . . 73.54 110.908 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.587 ' HB ' ' CD1' ' A' ' 47' ' ' TRP . 15.1 tt -138.38 149.48 24.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.181 -0.463 . . . . 71.33 111.168 179.871 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.497 HG23 ' CG ' ' A' ' 22' ' ' ASP . 15.3 m -129.22 140.4 51.49 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.174 -0.466 . . . . 54.55 111.105 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.82 ' HB2' HD22 ' A' ' 34' ' ' LEU . 0.7 OUTLIER -126.56 130.86 51.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.183 -0.462 . . . . 65.11 110.855 -179.973 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.547 ' CG ' ' HA ' ' A' ' 16' ' ' PHE . 44.5 m-85 -117.41 129.82 56.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.114 -0.494 . . . . 71.14 110.926 -179.877 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.498 ' HG2' ' HB2' ' A' ' 36' ' ' ARG . 0.0 OUTLIER -59.04 -23.95 62.44 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.105 -0.498 . . . . 75.14 110.864 -179.951 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 -127.54 152.67 47.31 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.144 -0.48 . . . . 71.52 110.853 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.436 ' N ' ' HB3' ' A' ' 38' ' ' ASN . 4.2 mtmp? -56.02 -175.36 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.16 -0.473 . . . . 61.22 110.916 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 22.0 m-20 46.02 36.08 2.83 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.242 -0.435 . . . . 73.54 110.879 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.547 ' HA ' ' CG ' ' A' ' 11' ' ' TYR . 4.4 m-85 47.12 57.7 5.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.218 -0.446 . . . . 74.34 110.901 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -132.85 159.91 38.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.141 -0.481 . . . . 74.15 110.879 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 93.41 -151.39 20.34 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.74 -0.743 . . . . 63.45 112.486 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.786 ' O ' HD13 ' A' ' 34' ' ' LEU . 0.0 OUTLIER -67.95 80.92 0.21 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.788 0.327 . . . . 74.41 110.854 -179.84 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.494 ' HA ' ' O ' ' A' ' 10' ' ' PHE . 0.0 OUTLIER -78.83 128.91 33.99 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.222 -0.445 . . . . 75.3 110.864 -179.926 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.511 ' CD2' ' CD2' ' A' ' 30' ' ' PHE . 81.3 t80 -124.57 123.6 40.44 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.174 -0.466 . . . . 73.43 110.876 -179.825 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.497 ' CG ' HG23 ' A' ' 9' ' ' THR . 1.3 m-20 -119.17 134.02 55.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.116 -0.493 . . . . 74.45 110.871 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -165.95 136.61 3.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.234 -0.439 . . . . 64.24 110.887 -179.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -105.1 4.82 31.84 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.202 -0.454 . . . . 74.4 110.85 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 13.4 t -108.14 165.98 11.08 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.22 -0.445 . . . . 55.24 110.916 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -62.67 116.75 5.45 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.195 -0.457 . . . . 62.32 110.857 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.476 ' HB2' ' HB3' ' A' ' 30' ' ' PHE . 7.9 m -118.11 53.93 0.94 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.194 -0.457 . . . . 74.14 110.87 -179.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.53 ' C ' ' HA ' ' A' ' 82' ' ' SER . . . -45.83 -19.72 0.07 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.156 -0.474 . . . . 54.21 111.106 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 53.1 t0 -128.46 42.01 3.39 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.246 -0.433 . . . . 54.51 110.853 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.784 ' O ' ' CD2' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -80.63 13.98 2.3 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.214 -0.448 . . . . 61.43 110.87 -179.899 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.493 ' HB2' ' HB3' ' A' ' 53' ' ' PRO . 29.0 t60 -78.74 -37.18 41.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.157 -0.474 . . . . 75.1 110.852 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.5 t -59.27 -13.17 6.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.182 -0.463 . . . . 75.43 111.095 -179.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -101.39 -26.41 13.6 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.263 -0.426 . . . . 74.03 110.95 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.82 HD22 ' HB2' ' A' ' 10' ' ' PHE . 16.6 tp -142.87 139.96 31.05 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.073 -0.512 . . . . 72.25 110.966 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.1 m -109.05 -32.16 7.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.201 -0.454 . . . . 74.12 110.859 -179.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.498 ' HB2' ' HG2' ' A' ' 12' ' ' GLU . 1.9 mtp85 -115.59 140.36 49.25 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.102 -0.499 . . . . 74.42 110.905 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.543 ' SG ' ' O ' ' A' ' 78' ' ' ASP . 1.3 p -117.65 54.23 0.91 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.249 -0.432 . . . . 71.43 110.866 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.436 ' HB3' ' N ' ' A' ' 14' ' ' LYS . 1.9 m-80 -54.29 -70.09 0.11 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.465 . . . . 74.2 110.9 -179.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 6.4 p -111.83 129.53 56.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.175 -0.466 . . . . 74.23 110.85 -179.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.649 HG21 HD13 ' A' ' 62' ' ' LEU . 20.1 mt -126.08 151.35 32.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.104 -0.498 . . . . 61.14 111.09 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.421 ' N ' ' CG2' ' A' ' 40' ' ' ILE . 0.0 OUTLIER -143.74 119.33 10.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.147 -0.479 . . . . 72.42 110.894 179.825 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.534 HG22 ' HB ' ' A' ' 8' ' ' ILE . 1.2 t -103.98 116.13 47.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.227 -0.442 . . . . 62.31 111.134 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -112.36 80.53 1.35 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.199 -0.455 . . . . 70.4 110.894 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.446 ' O ' ' HB ' ' A' ' 6' ' ' THR . . . 130.34 102.06 0.95 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.727 -0.749 . . . . 73.12 112.493 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 54.35 178.36 0.14 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.763 -0.732 . . . . 72.03 112.523 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.728 HG23 ' HA ' ' A' ' 63' ' ' PRO . 1.3 m -81.99 171.47 14.37 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.725 0.297 . . . . 62.31 111.153 -179.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . 0.597 ' H ' HG22 ' A' ' 46' ' ' THR . 15.9 m95 -141.92 130.0 22.04 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.217 -0.447 . . . . 74.22 110.915 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.905 ' HB2' ' CG2' ' A' ' 86' ' ' VAL . . . -95.37 111.99 23.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.231 -0.44 . . . . 70.43 111.113 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.626 HG11 HD13 ' A' ' 80' ' ' LEU . 5.6 m -115.0 129.55 71.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.218 -0.447 . . . . 73.01 111.153 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.771 ' HB3' ' HA ' ' A' ' 56' ' ' ALA . 35.7 m-85 -95.61 150.6 20.16 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.148 -0.478 . . . . 73.31 110.89 -179.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.626 ' HB2' ' O ' ' A' ' 58' ' ' TYR . 7.1 tt0 -46.51 -77.77 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.104 -0.498 . . . . 74.55 110.889 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.622 ' HB3' ' CD1' ' A' ' 55' ' ' PHE . 1.6 mtp180 -93.44 145.95 30.93 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.567 0.699 . . . . 70.4 110.877 -179.853 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.731 ' HA ' ' OG ' ' A' ' 82' ' ' SER . 53.7 Cg_endo -69.76 134.12 27.22 Favored 'Trans proline' 0 C--N 1.34 0.126 0 C-N-CA 122.715 2.276 . . . . 74.02 112.329 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 66.38 -9.88 0.29 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.267 -0.424 . . . . 71.31 110.899 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.622 ' CD1' ' HB3' ' A' ' 52' ' ' ARG . 4.2 m-30 -100.22 -25.92 14.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.176 -0.465 . . . . 73.4 110.868 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.771 ' HA ' ' HB3' ' A' ' 50' ' ' TYR . . . 57.09 23.0 7.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.17 -0.468 . . . . 75.35 111.092 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . 0.643 ' O ' ' C ' ' A' ' 58' ' ' TYR . 3.4 m0 -52.49 -165.0 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.21 -0.45 . . . . 72.44 110.897 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.643 ' C ' ' O ' ' A' ' 57' ' ' TRP . 5.4 m-30 -12.1 103.84 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.246 -0.434 . . . . 73.35 110.917 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.52 ' HB2' ' HA ' ' A' ' 150' ' ' TYR . 2.0 mpt? -61.52 148.12 43.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.138 -0.483 . . . . 73.32 110.848 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.617 ' O ' HG23 ' A' ' 49' ' ' VAL . 0.3 OUTLIER -161.01 97.66 1.15 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.204 -0.453 . . . . 74.24 110.919 -179.834 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.745 HD11 ' HA ' ' A' ' 151' ' ' LEU . 4.6 mp -89.18 114.52 27.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.14 -0.482 . . . . 74.13 111.101 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.832 HD23 ' HD2' ' A' ' 63' ' ' PRO . 0.6 OUTLIER -85.16 122.21 73.96 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.598 0.713 . . . . 72.12 110.927 179.906 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.832 ' HD2' HD23 ' A' ' 62' ' ' LEU . 54.0 Cg_endo -69.71 -167.49 0.23 Allowed 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.736 2.291 . . . . 71.21 112.324 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.55 160.98 14.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.205 -0.452 . . . . 72.0 110.941 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 114.93 -146.57 18.83 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.714 -0.755 . . . . 73.33 112.516 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -128.3 158.37 38.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.876 0.369 . . . . 72.3 110.912 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.508 ' N ' ' O ' ' A' ' 40' ' ' ILE . 5.7 m-85 -146.78 81.62 9.06 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.648 0.737 . . . . 72.42 110.911 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.468 ' HD2' ' HG3' ' A' ' 72' ' ' ARG . 53.8 Cg_endo -69.81 1.4 4.51 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.643 2.229 . . . . 74.23 112.344 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.413 ' HA ' ' HG2' ' A' ' 14' ' ' LYS . 86.2 mt-10 -156.9 155.08 30.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.212 -0.449 . . . . 62.32 110.891 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.82 ' O ' ' CD1' ' A' ' 73' ' ' TRP . 8.9 p90 -70.6 -1.93 12.67 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.161 -0.472 . . . . 74.11 110.954 -179.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -91.22 -13.82 32.12 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.132 -0.485 . . . . 72.54 110.968 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.468 ' HG3' ' HD2' ' A' ' 68' ' ' PRO . 23.2 mmt180 -73.7 -5.35 40.04 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.162 -0.472 . . . . 75.3 110.902 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . 0.82 ' CD1' ' O ' ' A' ' 70' ' ' TYR . 0.4 OUTLIER -134.71 4.93 3.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.165 -0.47 . . . . 73.41 110.877 -179.933 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . 0.466 ' CB ' ' O ' ' A' ' 73' ' ' TRP . 0.0 OUTLIER 81.13 -17.89 0.53 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.263 -0.426 . . . . 61.52 110.893 179.956 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.458 ' N ' ' CD1' ' A' ' 73' ' ' TRP . . . 40.32 57.66 2.59 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.757 -0.735 . . . . 64.54 112.461 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.577 ' HG ' ' CE2' ' A' ' 60' ' ' TYR . 3.1 pp -50.85 -36.84 39.73 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.787 0.327 . . . . 43.35 110.878 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.562 ' O ' ' CB ' ' A' ' 78' ' ' ASP . 23.7 t-20 -121.82 -47.13 2.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.202 -0.454 . . . . 74.12 110.864 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.562 ' CB ' ' O ' ' A' ' 77' ' ' ASN . 6.3 t0 89.61 5.3 0.14 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.193 -0.458 . . . . 52.13 110.862 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 1.2 ttm-85 -110.46 102.29 10.92 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.176 -0.465 . . . . 74.41 110.898 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.626 HD13 HG11 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -101.12 134.68 43.77 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.225 -0.443 . . . . 73.52 110.93 -179.996 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.578 ' HB3' ' HB3' ' A' ' 53' ' ' PRO . 1.2 m -151.15 -119.35 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.212 -0.449 . . . . 74.54 110.859 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.731 ' OG ' ' HA ' ' A' ' 53' ' ' PRO . 0.5 OUTLIER -38.31 107.65 0.07 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.168 -0.469 . . . . 52.31 110.882 -179.789 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . 0.529 ' HA ' ' O ' ' A' ' 48' ' ' ALA . 8.3 p -115.96 146.66 41.92 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.164 -0.471 . . . . 73.14 110.859 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.54 ' N ' ' O ' ' A' ' 48' ' ' ALA . 0.1 OUTLIER -144.59 128.95 17.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.192 -0.458 . . . . 71.21 110.866 -179.834 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.46 ' N ' ' CZ3' ' A' ' 47' ' ' TRP . . . -48.47 127.81 13.76 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.209 -0.45 . . . . 60.03 111.101 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.905 ' CG2' ' HB2' ' A' ' 48' ' ' ALA . 25.0 t -115.17 139.02 43.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.2 -0.454 . . . . 60.44 111.14 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . 0.556 ' O ' ' CG2' ' A' ' 136' ' ' VAL . 11.8 m170 -112.41 107.11 15.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.164 -0.471 . . . . 74.3 110.835 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.472 ' C ' ' O ' ' A' ' 87' ' ' HIS . 0.0 OUTLIER -32.57 152.96 0.04 OUTLIER Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.619 0.723 . . . . 73.13 110.906 -179.996 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.557 ' HB3' ' H ' ' A' ' 136' ' ' VAL . 53.6 Cg_endo -69.79 84.72 0.65 Allowed 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.689 2.26 . . . . 74.23 112.335 179.845 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -83.27 -171.29 3.49 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.228 -0.442 . . . . 72.12 110.832 -179.842 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 72.05 68.03 1.7 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.754 -0.736 . . . . 73.21 112.442 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 97.03 -69.88 0.79 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.764 -0.731 . . . . 71.11 112.513 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.417 ' HB2' ' H ' ' A' ' 94' ' ' TYR . 6.0 pt20 171.39 -148.88 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.774 0.321 . . . . 65.13 110.933 -179.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.504 ' O ' ' HA ' ' A' ' 112' ' ' THR . 0.0 OUTLIER -107.53 101.78 11.09 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.184 -0.462 . . . . 74.41 110.918 -179.865 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.442 ' HG3' HG11 ' A' ' 132' ' ' VAL . 28.2 tptt -102.07 130.0 48.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.096 -0.502 . . . . 63.41 110.917 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -149.29 135.26 11.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.238 -0.437 . . . . 54.22 111.158 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.426 ' HB2' HG23 ' A' ' 132' ' ' VAL . 1.6 mt-30 -107.87 131.59 54.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.156 -0.474 . . . . 62.34 110.915 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.529 ' CG2' HD12 ' A' ' 127' ' ' ILE . 1.5 mp -113.46 131.31 65.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.186 -0.461 . . . . 72.15 111.104 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.605 ' HB2' ' HB2' ' A' ' 129' ' ' SER . 74.0 m-85 -122.19 136.87 54.97 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.162 -0.472 . . . . 73.14 110.895 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 57.3 tt0 -67.31 -73.94 0.13 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.167 -0.469 . . . . 75.32 110.867 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.518 ' C ' ' HB2' ' A' ' 128' ' ' HIS . 5.1 mttt -84.54 165.73 17.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.193 -0.458 . . . . 74.2 110.954 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -72.23 160.58 54.1 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.757 -0.735 . . . . 40.03 112.461 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.443 ' HA ' ' HB2' ' A' ' 158' ' ' ARG . 29.5 t70 62.56 32.68 16.35 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.819 0.343 . . . . 74.25 110.878 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.508 ' CZ ' ' HB3' ' A' ' 158' ' ' ARG . 13.5 m-85 56.98 49.16 14.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.185 -0.461 . . . . 72.03 110.866 -179.892 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.1 m -113.62 150.97 32.37 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.206 -0.452 . . . . 74.04 110.85 -179.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 89.24 -123.67 6.98 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.762 -0.733 . . . . 72.44 112.471 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 54.8 tp60 -101.21 141.26 34.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.79 0.329 . . . . 74.44 110.877 -179.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 3.2 ttp -131.5 131.52 43.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.211 -0.45 . . . . 74.35 110.876 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 10.0 m-85 -136.81 137.31 39.64 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.451 . . . . 70.43 110.958 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -118.91 112.71 19.98 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.12 -0.491 . . . . 61.35 110.891 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.471 HG22 HD11 ' A' ' 98' ' ' ILE . 11.9 t -125.51 150.41 47.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.152 -0.476 . . . . 72.02 111.104 -179.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.504 ' HA ' ' O ' ' A' ' 94' ' ' TYR . 1.4 t -124.49 47.76 2.06 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.177 -0.465 . . . . 74.31 111.112 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -152.58 -178.21 6.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.227 -0.442 . . . . 63.5 110.893 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -73.86 164.98 25.93 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.165 -0.47 . . . . 63.24 110.849 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . 0.536 ' O ' ' HB2' ' A' ' 172' ' ' SER . 4.8 t -154.33 113.69 2.47 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.591 0.71 . . . . 63.35 110.889 -179.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.41 ' O ' ' CA ' ' A' ' 143' ' ' PRO . 53.1 Cg_endo -69.81 -30.2 22.4 Favored 'Trans proline' 0 C--O 1.231 0.15 0 C-N-CA 122.686 2.257 . . . . 51.55 112.328 -179.895 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.653 ' HB3' ' CB ' ' A' ' 120' ' ' GLU . 0.1 OUTLIER -149.97 98.02 2.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.19 -0.459 . . . . 73.12 110.898 -179.857 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.646 HD13 HD11 ' A' ' 127' ' ' ILE . 3.0 tt -50.55 -29.16 6.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.132 -0.486 . . . . 43.24 111.099 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' MET . . . . . 0.572 ' O ' ' HA ' ' A' ' 123' ' ' HIS . 0.0 OUTLIER -86.39 -45.94 10.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.198 -0.456 . . . . 74.34 110.876 179.866 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.653 ' CB ' ' HB3' ' A' ' 117' ' ' SER . 16.5 tp10 -64.87 -12.94 54.34 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.222 -0.445 . . . . 73.14 110.868 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -113.25 -51.88 2.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.184 -0.462 . . . . 73.02 110.968 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.417 ' HB2' ' O ' ' A' ' 118' ' ' ILE . 93.8 m-85 -103.4 -20.05 14.21 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.155 -0.475 . . . . 73.23 110.905 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . 0.572 ' HA ' ' O ' ' A' ' 119' ' ' MET . 10.9 m80 73.26 26.62 2.06 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.177 -0.465 . . . . 63.12 110.867 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.479 ' SD ' HG22 ' A' ' 98' ' ' ILE . 6.0 mtt -101.16 85.55 2.85 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.221 -0.445 . . . . 70.12 110.862 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 1.7 ptp85 -51.33 -34.11 32.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.254 -0.43 . . . . 74.22 110.89 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.528 ' C ' HD13 ' A' ' 127' ' ' ILE . 40.7 mt-10 -144.34 138.07 27.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.19 -0.459 . . . . 64.53 110.883 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.646 HD11 HD13 ' A' ' 118' ' ' ILE . 3.4 mm -99.88 96.6 5.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.115 -0.493 . . . . 71.33 111.129 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . 0.525 ' CD2' ' HG3' ' A' ' 168' ' ' PRO . 11.0 m170 -69.43 -31.69 70.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.232 -0.44 . . . . 72.3 110.831 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . 0.605 ' HB2' ' HB2' ' A' ' 99' ' ' PHE . 0.3 OUTLIER -132.65 145.34 51.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.247 -0.433 . . . . 73.12 110.854 -179.778 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . 0.609 ' SG ' HG21 ' A' ' 127' ' ' ILE . 0.3 OUTLIER -147.25 119.1 8.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.149 -0.478 . . . . 34.01 110.874 -179.931 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.604 ' C ' HG23 ' A' ' 132' ' ' VAL . 6.9 mtpp -108.14 157.83 17.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.176 -0.466 . . . . 73.24 110.924 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.604 HG23 ' C ' ' A' ' 131' ' ' LYS . 3.5 t 81.58 169.06 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.237 -0.438 . . . . 75.34 111.089 179.836 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.972 HD23 ' HG3' ' A' ' 155' ' ' LYS . 0.2 OUTLIER -165.85 128.18 2.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.138 -0.483 . . . . 74.53 110.912 179.927 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.516 ' O ' ' C ' ' A' ' 135' ' ' GLY . 1.4 mp0 -98.15 141.26 31.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.456 . . . . 62.5 110.888 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . 0.55 ' HA3' ' HA ' ' A' ' 89' ' ' PRO . . . -27.25 -44.79 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.735 -0.745 . . . . 62.0 112.479 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.871 ' HB ' HD12 ' A' ' 176' ' ' ILE . 2.0 t -149.85 127.88 2.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.834 0.349 . . . . 75.33 111.157 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' TRP . . . . . 0.673 ' HB3' ' CB ' ' A' ' 152' ' ' LEU . 26.1 t90 -142.08 145.53 34.42 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.173 -0.467 . . . . 73.53 110.893 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.61 HG23 HD13 ' A' ' 61' ' ' ILE . 7.1 mt -123.19 130.01 74.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.252 -0.431 . . . . 74.13 111.11 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.623 ' CE1' HG11 ' A' ' 170' ' ' VAL . 0.1 OUTLIER -97.36 147.36 24.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.155 -0.475 . . . . 72.24 110.897 179.965 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . 0.446 ' CD2' ' HA ' ' A' ' 145' ' ' TYR . 8.6 m-85 -124.26 124.69 42.97 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.124 -0.489 . . . . 74.25 110.895 -179.846 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . 0.56 ' O ' ' HB2' ' A' ' 171' ' ' GLN . 0.0 OUTLIER -58.96 -25.24 63.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.133 -0.485 . . . . 72.21 110.909 179.996 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.823 ' HB3' ' HD2' ' A' ' 143' ' ' PRO . 9.1 mp -118.06 175.9 1.87 Allowed Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.603 0.716 . . . . 74.12 110.886 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . 0.823 ' HD2' ' HB3' ' A' ' 142' ' ' LEU . 54.0 Cg_endo -69.74 -90.98 0.01 OUTLIER 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.66 2.24 . . . . 73.15 112.378 179.836 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . 0.981 ' O ' ' HG2' ' A' ' 146' ' ' ARG . 0.0 OUTLIER -49.6 86.26 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.175 -0.466 . . . . 74.42 110.872 -179.968 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . 0.59 ' C ' ' O ' ' A' ' 144' ' ' ASN . 2.6 m-85 19.73 43.03 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.185 -0.461 . . . . 70.21 110.897 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . 0.981 ' HG2' ' O ' ' A' ' 144' ' ' ASN . 12.8 mmm-85 -101.21 178.49 4.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.092 -0.504 . . . . 75.23 110.853 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 73.51 -166.31 54.65 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.735 -0.745 . . . . 55.55 112.467 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -86.25 159.81 19.34 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.77 0.319 . . . . 72.11 110.848 -179.806 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' GLN . . . . . 0.511 ' HB2' ' HA ' ' A' ' 60' ' ' TYR . 50.3 mt-30 -94.41 153.16 18.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.163 -0.471 . . . . 74.04 110.874 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . 0.562 ' HB2' ' CB ' ' A' ' 139' ' ' PHE . 95.9 m-85 -135.11 119.2 17.55 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.183 -0.462 . . . . 71.41 110.976 -179.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.745 ' HA ' HD11 ' A' ' 61' ' ' ILE . 22.8 tp -65.11 136.8 57.14 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.09 -0.505 . . . . 61.15 110.894 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.931 ' O ' HD13 ' A' ' 152' ' ' LEU . 0.0 OUTLIER -73.03 134.23 44.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.222 -0.445 . . . . 54.44 110.945 179.85 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -165.27 30.88 0.06 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.212 -0.449 . . . . 54.33 110.908 179.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.754 ' O ' ' HG3' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -111.76 -172.27 2.01 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.16 -0.473 . . . . 70.02 110.945 179.947 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.972 ' HG3' HD23 ' A' ' 133' ' ' LEU . 0.0 OUTLIER -159.86 -129.43 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.239 -0.437 . . . . 73.43 110.869 179.849 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.579 ' HA ' ' HA ' ' A' ' 131' ' ' LYS . 2.1 tm-20 -70.27 4.94 1.92 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.215 -0.448 . . . . 74.24 110.883 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . 0.783 ' CD1' ' HB3' ' A' ' 162' ' ' ASP . 21.2 m-30 -30.7 148.19 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.135 -0.484 . . . . 72.0 110.895 -179.818 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . 0.508 ' HB3' ' CZ ' ' A' ' 104' ' ' PHE . 10.4 ptp180 -118.54 -31.87 4.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.065 -0.516 . . . . 75.3 110.841 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . 0.53 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 2.1 ptpp? -99.64 153.22 37.89 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.584 0.707 . . . . 72.04 110.889 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . 0.473 ' HB3' ' HB3' ' A' ' 168' ' ' PRO . 53.4 Cg_endo -69.82 -25.23 28.54 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.693 2.262 . . . . 75.31 112.312 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.681 ' H ' HD12 ' A' ' 161' ' ' ILE . 3.8 mp -75.46 4.19 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.229 -0.441 . . . . 73.04 111.131 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.783 ' HB3' ' CD1' ' A' ' 157' ' ' TYR . 0.2 OUTLIER -72.63 -21.12 61.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.151 -0.477 . . . . 72.23 110.831 179.856 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' TRP . . . . . 0.51 ' CD1' ' N ' ' A' ' 163' ' ' TRP . 0.0 OUTLIER -108.65 13.47 25.16 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.238 -0.437 . . . . 73.14 110.92 -179.934 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 84.94 -29.21 4.26 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.724 -0.75 . . . . 13.42 112.502 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -53.65 118.95 4.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.798 0.332 . . . . 61.02 111.092 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -48.78 -26.1 2.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.249 -0.432 . . . . 70.1 111.123 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . 0.484 ' C ' ' H ' ' A' ' 169' ' ' ALA . 0.3 OUTLIER -155.71 157.19 31.4 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.69 0.757 . . . . 71.23 110.791 -179.779 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . 0.525 ' HG3' ' CD2' ' A' ' 128' ' ' HIS . 54.0 Cg_endo -69.78 22.24 0.17 Allowed 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.666 2.244 . . . . 73.32 112.353 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 0.494 ' HA ' ' HG2' ' A' ' 126' ' ' GLU . . . -64.66 103.76 0.73 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.239 -0.437 . . . . 52.12 111.071 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.623 HG11 ' CE1' ' A' ' 139' ' ' PHE . 2.9 t -152.59 160.91 2.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.169 -0.469 . . . . 74.41 111.11 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' GLN . . . . . 0.619 ' OE1' ' HB3' ' A' ' 143' ' ' PRO . 1.7 tm0? -108.13 -81.66 0.56 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.194 -0.457 . . . . 71.43 110.877 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . 0.702 ' OG ' ' O ' ' A' ' 143' ' ' PRO . 24.9 p -129.8 179.48 5.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 65.4 110.834 -179.795 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 173' ' ' PHE . . . . . 0.405 ' HB3' ' CD1' ' A' ' 139' ' ' PHE . 27.4 p90 -144.2 167.81 21.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.14 -0.482 . . . . 65.52 110.853 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . 0.408 ' CD ' HD12 ' A' ' 138' ' ' ILE . 0.1 OUTLIER -139.13 135.98 34.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.139 -0.482 . . . . 73.24 110.876 -179.918 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . 0.486 ' HD2' ' CE2' ' A' ' 94' ' ' TYR . 0.1 OUTLIER -82.93 -167.04 1.5 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.196 -0.456 . . . . 64.15 110.879 -179.937 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . 0.871 HD12 ' HB ' ' A' ' 136' ' ' VAL . 4.2 mt -139.75 132.72 35.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.194 -0.457 . . . . 75.31 111.151 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 11.5 t -132.77 147.68 31.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.159 -0.473 . . . . 52.24 111.08 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . 0.417 ' HB3' HD13 ' A' ' 88' ' ' LEU . 3.6 pt-20 . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.178 -0.464 . . . . 73.14 110.852 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.315 0 N-CA-C 112.554 -0.218 . . . . 65.32 112.554 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.497 ' C ' ' HE1' ' A' ' 47' ' ' TRP . 6.3 p -81.76 135.72 35.46 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.859 0.361 . . . . 53.21 111.135 -179.884 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.408 ' HA ' ' HA ' ' A' ' 24' ' ' ASP . 3.2 tttt -121.93 135.84 54.89 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.198 -0.455 . . . . 70.14 110.911 179.869 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.604 ' HB ' ' CD1' ' A' ' 47' ' ' TRP . 15.1 tt -136.91 150.54 26.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.232 -0.44 . . . . 74.52 111.132 179.839 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.492 HG23 ' CG ' ' A' ' 22' ' ' ASP . 9.9 m -131.01 142.05 50.29 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.162 -0.472 . . . . 61.44 111.158 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.774 ' HB2' HD22 ' A' ' 34' ' ' LEU . 1.2 m-85 -128.48 129.95 46.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 74.15 110.863 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.533 ' CG ' ' HA ' ' A' ' 16' ' ' PHE . 18.9 m-85 -116.23 131.4 56.95 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.188 -0.46 . . . . 74.23 110.886 -179.832 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.495 ' HG2' ' HB2' ' A' ' 36' ' ' ARG . 0.0 OUTLIER -58.24 -25.41 61.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.141 -0.481 . . . . 73.41 110.897 179.978 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 59.5 m-20 -127.16 152.57 47.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.144 -0.48 . . . . 71.34 110.905 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.49 ' N ' ' HB3' ' A' ' 38' ' ' ASN . 34.8 mtmt -56.08 -175.35 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.266 -0.424 . . . . 41.44 110.938 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 18.6 m120 46.96 34.13 2.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.233 -0.44 . . . . 75.3 110.882 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.533 ' HA ' ' CG ' ' A' ' 11' ' ' TYR . 4.2 m-85 48.51 57.18 6.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.217 -0.447 . . . . 73.2 110.867 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 14.7 mt-30 -131.98 157.24 44.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.12 -0.491 . . . . 71.44 110.92 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 95.5 -150.79 19.78 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.775 -0.726 . . . . 45.12 112.537 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.805 ' O ' HD13 ' A' ' 34' ' ' LEU . 0.1 OUTLIER -69.45 81.08 0.39 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.746 0.308 . . . . 73.23 110.889 -179.878 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.477 ' HB2' ' CE1' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -79.21 128.67 33.59 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.203 -0.453 . . . . 74.45 110.862 -179.884 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.47 ' CD2' ' CD2' ' A' ' 30' ' ' PHE . 75.6 t80 -124.41 125.06 43.65 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.181 -0.463 . . . . 65.02 110.944 -179.849 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.492 ' CG ' HG23 ' A' ' 9' ' ' THR . 1.4 m-20 -119.08 133.7 55.65 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.136 -0.484 . . . . 71.32 110.83 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 10.1 t -161.33 133.05 5.61 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 63.14 110.885 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.408 ' HA ' ' HA ' ' A' ' 7' ' ' LYS . 12.3 p-10 -100.86 -3.07 30.47 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.16 -0.473 . . . . 73.42 110.875 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 34.3 t -106.61 160.99 15.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.456 . . . . 71.45 110.905 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -48.16 120.38 3.52 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.216 -0.447 . . . . 73.51 110.828 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.67 ' HB2' ' HB3' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -115.54 46.61 1.46 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.218 -0.446 . . . . 70.11 110.832 -179.884 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.563 ' O ' ' HA ' ' A' ' 82' ' ' SER . . . -49.12 -21.01 0.65 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.191 -0.458 . . . . 62.32 111.1 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 60.8 t0 -128.56 40.86 3.59 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.224 -0.444 . . . . 72.0 110.889 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.792 ' O ' ' CD2' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -81.46 16.92 1.51 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.177 -0.465 . . . . 75.32 110.842 -179.874 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.501 ' HB2' ' HB3' ' A' ' 81' ' ' SER . 37.6 t60 -81.45 -35.14 30.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.158 -0.474 . . . . 73.52 110.9 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.8 t -64.52 -7.93 11.98 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.169 -0.469 . . . . 72.21 111.152 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -106.09 -28.21 10.64 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.215 -0.448 . . . . 65.41 110.895 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.805 HD13 ' O ' ' A' ' 19' ' ' ARG . 19.1 tp -141.36 144.83 34.75 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.121 -0.49 . . . . 73.14 110.882 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.1 m -111.29 -33.79 6.33 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.138 -0.483 . . . . 73.34 110.842 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.542 ' O ' HD21 ' A' ' 34' ' ' LEU . 2.3 mtp85 -116.66 140.64 49.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.095 -0.502 . . . . 74.25 110.903 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.626 ' HB3' ' HB2' ' A' ' 80' ' ' LEU . 6.3 p -117.37 59.08 0.78 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.199 -0.455 . . . . 74.04 110.873 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.49 ' HB3' ' N ' ' A' ' 14' ' ' LYS . 1.3 m-80 -57.38 -72.55 0.08 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.224 -0.443 . . . . 62.33 110.849 -179.859 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 4.5 p -108.08 127.06 53.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.204 -0.453 . . . . 63.52 110.901 -179.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.765 HD12 ' CH2' ' A' ' 73' ' ' TRP . 23.3 mt -120.55 149.18 23.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.187 -0.46 . . . . 74.22 111.127 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.446 ' HD2' ' CE2' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -143.73 121.55 11.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.122 -0.49 . . . . 60.01 110.89 179.842 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.524 HG22 ' HB ' ' A' ' 8' ' ' ILE . 1.5 t -107.04 115.65 48.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.203 -0.453 . . . . 64.04 111.074 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -111.36 79.26 1.19 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.116 -0.493 . . . . 74.33 110.908 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.429 ' O ' ' HB ' ' A' ' 6' ' ' THR . . . 132.75 102.12 0.81 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.737 -0.744 . . . . 44.42 112.508 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 53.2 178.12 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.761 -0.733 . . . . 72.23 112.469 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.718 HG23 ' HA ' ' A' ' 63' ' ' PRO . 0.7 OUTLIER -76.78 170.63 16.11 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.729 0.3 . . . . 45.35 111.168 -179.875 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . 0.604 ' CD1' ' HB ' ' A' ' 8' ' ' ILE . 4.0 m95 -144.66 129.98 18.75 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.215 -0.448 . . . . 74.13 110.938 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.804 ' HB2' ' CG2' ' A' ' 86' ' ' VAL . . . -93.2 126.1 38.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.243 -0.435 . . . . 60.04 111.136 179.893 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.702 HG12 ' HB3' ' A' ' 83' ' ' CYS . 17.2 m -124.58 142.18 42.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.22 -0.446 . . . . 71.32 111.113 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.925 ' HB3' ' CB ' ' A' ' 56' ' ' ALA . 7.0 m-85 -116.92 143.53 45.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.127 -0.488 . . . . 73.23 110.977 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.554 ' HG2' ' N ' ' A' ' 52' ' ' ARG . 0.3 OUTLIER -49.47 -83.63 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.154 -0.475 . . . . 70.0 110.865 -179.976 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.903 ' O ' ' HB2' ' A' ' 56' ' ' ALA . 1.2 mtp180 -81.67 138.58 47.26 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.562 0.696 . . . . 75.23 110.914 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.746 ' HA ' ' OG ' ' A' ' 82' ' ' SER . 53.8 Cg_endo -69.75 138.14 37.17 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.672 2.248 . . . . 53.34 112.366 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.467 ' C ' ' CD2' ' A' ' 55' ' ' PHE . 6.3 m-20 66.67 -6.75 0.5 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.245 -0.434 . . . . 65.03 110.87 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.473 ' H ' ' C ' ' A' ' 53' ' ' PRO . 0.0 OUTLIER -139.86 -75.82 0.34 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.223 -0.444 . . . . 74.23 110.885 -179.966 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.925 ' CB ' ' HB3' ' A' ' 50' ' ' TYR . . . 45.71 79.98 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.19 -0.459 . . . . 74.31 111.044 179.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . 0.546 ' O ' ' CD2' ' A' ' 58' ' ' TYR . 54.1 m95 -64.72 33.71 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.257 -0.429 . . . . 71.3 110.901 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.603 ' H ' ' C ' ' A' ' 56' ' ' ALA . 1.4 m-30 -163.25 120.61 1.88 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.22 -0.446 . . . . 72.35 110.91 -179.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.496 ' HB2' ' HA ' ' A' ' 150' ' ' TYR . 1.0 OUTLIER -85.74 138.84 31.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.099 -0.5 . . . . 65.04 110.873 179.895 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.519 ' CE2' ' HG ' ' A' ' 76' ' ' LEU . 2.8 t80 -153.28 101.68 2.55 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.223 -0.444 . . . . 74.44 110.92 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.747 ' N ' HD12 ' A' ' 61' ' ' ILE . 1.8 mp -90.25 116.98 32.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.134 -0.485 . . . . 74.43 111.156 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.76 HD23 ' HD2' ' A' ' 63' ' ' PRO . 0.2 OUTLIER -82.74 130.88 56.46 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 121.554 0.693 . . . . 75.32 110.962 179.917 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.76 ' HD2' HD23 ' A' ' 62' ' ' LEU . 53.9 Cg_endo -69.72 -171.94 0.52 Allowed 'Trans proline' 0 C--N 1.341 0.132 0 C-N-CA 122.663 2.242 . . . . 74.12 112.359 179.887 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.92 162.53 14.73 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.219 -0.446 . . . . 63.21 110.937 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 112.3 -168.47 12.7 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.78 -0.724 . . . . 64.35 112.498 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -107.47 152.29 24.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.893 0.378 . . . . 72.31 110.89 -179.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.62 ' HB2' ' O ' ' A' ' 40' ' ' ILE . 11.2 m-85 -141.25 84.95 12.29 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.716 0.77 . . . . 70.55 110.935 -179.864 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.427 ' HD2' ' HG3' ' A' ' 72' ' ' ARG . 53.8 Cg_endo -69.79 0.17 6.06 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.701 2.267 . . . . 64.31 112.353 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.524 ' HB2' ' HG2' ' A' ' 72' ' ' ARG . 51.7 mt-10 -155.47 142.43 19.1 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.21 -0.45 . . . . 75.12 110.917 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.703 ' HA ' ' CE2' ' A' ' 73' ' ' TRP . 26.8 p90 -55.75 -20.06 13.38 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.145 -0.48 . . . . 73.12 110.963 -179.878 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -80.97 -16.01 54.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.093 -0.503 . . . . 73.5 110.9 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.524 ' HG2' ' HB2' ' A' ' 69' ' ' GLU . 27.9 mmt180 -69.88 -9.26 54.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.212 -0.449 . . . . 74.15 110.894 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . 0.765 ' CH2' HD12 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -133.74 17.53 3.9 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.187 -0.46 . . . . 71.43 110.919 -179.976 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . 0.443 ' C ' ' O ' ' A' ' 73' ' ' TRP . 19.8 ptp 34.82 47.64 0.26 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.232 -0.44 . . . . 70.01 110.882 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -66.75 117.75 9.72 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.701 -0.761 . . . . 65.12 112.49 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.519 ' HG ' ' CE2' ' A' ' 60' ' ' TYR . 0.7 OUTLIER -61.08 -34.78 75.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.824 0.345 . . . . 65.41 110.927 -179.936 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.427 ' HB2' HD12 ' A' ' 76' ' ' LEU . 13.5 t-20 -125.57 134.12 52.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.183 -0.462 . . . . 70.42 110.889 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -88.4 16.36 6.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.181 -0.463 . . . . 54.44 110.886 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.4 ' HD3' ' HA ' ' A' ' 52' ' ' ARG . 0.9 OUTLIER -108.51 80.19 1.32 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.16 -0.473 . . . . 75.22 110.834 -179.895 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.626 ' HB2' ' HB3' ' A' ' 37' ' ' CYS . 0.0 OUTLIER -81.39 134.36 35.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 74.51 110.905 179.992 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.662 ' HB3' ' HB3' ' A' ' 53' ' ' PRO . 1.5 m -150.74 -118.89 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.188 -0.46 . . . . 74.52 110.86 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.746 ' OG ' ' HA ' ' A' ' 53' ' ' PRO . 0.0 OUTLIER -41.19 103.03 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.151 -0.477 . . . . 73.55 110.872 -179.815 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . 0.702 ' HB3' HG12 ' A' ' 49' ' ' VAL . 24.7 p -126.83 131.67 51.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.138 -0.483 . . . . 43.24 110.883 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.596 ' N ' ' O ' ' A' ' 48' ' ' ALA . 8.9 mmt85 -113.63 151.21 32.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.181 -0.463 . . . . 75.55 110.852 -179.86 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -68.41 128.34 36.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.19 -0.459 . . . . 63.14 111.095 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.885 ' CG1' HG11 ' A' ' 136' ' ' VAL . 90.4 t -115.63 128.46 72.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.225 -0.443 . . . . 55.23 111.126 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . 0.523 ' O ' HG23 ' A' ' 136' ' ' VAL . 62.3 m80 -108.34 121.71 45.49 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.143 -0.48 . . . . 74.32 110.831 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.411 ' C ' ' O ' ' A' ' 87' ' ' HIS . 0.2 OUTLIER -37.47 138.01 0.62 Allowed Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.578 0.704 . . . . 75.31 110.904 -179.979 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.706 ' HB3' ' H ' ' A' ' 136' ' ' VAL . 53.7 Cg_endo -69.76 98.53 0.69 Allowed 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.662 2.241 . . . . 63.01 112.352 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -101.19 -176.29 3.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.204 -0.453 . . . . 61.21 110.868 -179.854 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 53.98 51.49 49.48 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.742 -0.742 . . . . 52.21 112.505 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.428 ' O ' ' C ' ' A' ' 93' ' ' GLN . . . 126.41 28.24 1.01 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.752 -0.737 . . . . 71.54 112.476 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.507 ' O ' ' HG2' ' A' ' 134' ' ' GLU . 11.4 pt20 36.25 -117.92 0.13 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.839 0.352 . . . . 75.32 110.893 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.53 ' O ' ' HA ' ' A' ' 112' ' ' THR . 0.0 OUTLIER -123.57 99.75 6.46 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.159 -0.473 . . . . 73.12 110.881 -179.863 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.526 ' HG3' HG11 ' A' ' 132' ' ' VAL . 46.2 tptt -111.07 128.32 55.84 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.118 -0.492 . . . . 64.34 110.915 179.863 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.485 HD13 ' N ' ' A' ' 97' ' ' GLN . 0.0 OUTLIER -150.55 141.36 16.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.229 -0.441 . . . . 72.31 111.157 179.831 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.528 ' HB2' HG23 ' A' ' 132' ' ' VAL . 2.2 mt-30 -108.44 130.93 55.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.214 -0.448 . . . . 71.43 110.874 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.679 HD11 HG22 ' A' ' 111' ' ' THR . 1.3 mp -111.25 135.38 50.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.162 -0.472 . . . . 63.44 111.146 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.652 ' HB2' ' HB2' ' A' ' 129' ' ' SER . 8.3 m-85 -125.15 144.27 50.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.199 -0.455 . . . . 72.51 110.934 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 78.5 tt0 -71.36 -75.92 0.12 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.2 -0.454 . . . . 75.02 110.892 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.474 ' C ' ' HB3' ' A' ' 128' ' ' HIS . 41.4 mttt -82.35 175.06 10.55 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.178 -0.464 . . . . 65.34 110.906 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.438 ' N ' ' HB3' ' A' ' 128' ' ' HIS . . . -88.24 158.24 28.8 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.736 -0.745 . . . . 13.13 112.497 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.466 ' HA ' ' HB2' ' A' ' 158' ' ' ARG . 27.9 t0 67.2 54.42 0.73 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.819 0.342 . . . . 71.52 110.82 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.66 ' CE1' ' HD2' ' A' ' 131' ' ' LYS . 6.8 m-85 48.19 31.64 2.68 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.202 -0.454 . . . . 64.41 110.912 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.418 ' C ' ' HB2' ' A' ' 101' ' ' LYS . 49.2 m -107.36 150.62 26.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.159 -0.473 . . . . 73.52 110.873 -179.796 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 91.32 -164.65 29.63 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.69 -0.767 . . . . 50.34 112.441 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 45.0 tp60 -74.67 130.27 39.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.802 0.334 . . . . 71.11 110.938 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -115.76 131.82 56.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.207 -0.451 . . . . 63.41 110.904 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -137.63 138.09 39.12 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.222 -0.444 . . . . 72.44 110.932 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -114.86 111.66 21.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.145 -0.48 . . . . 65.45 110.937 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.679 HG22 HD11 ' A' ' 98' ' ' ILE . 12.2 t -122.06 142.2 50.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.165 -0.47 . . . . 74.25 111.115 -179.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.53 ' HA ' ' O ' ' A' ' 94' ' ' TYR . 3.8 t -119.02 39.14 3.62 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.182 -0.463 . . . . 75.2 111.125 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -151.29 156.32 40.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.233 -0.44 . . . . 74.55 110.912 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -53.7 159.68 1.53 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.131 -0.486 . . . . 73.51 110.914 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . 0.549 ' O ' ' HB2' ' A' ' 172' ' ' SER . 29.4 t -146.32 120.17 5.23 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-O 121.6 0.714 . . . . 74.21 110.918 -179.884 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.452 ' O ' ' C ' ' A' ' 143' ' ' PRO . 53.7 Cg_endo -69.67 -32.76 18.31 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.668 2.245 . . . . 71.25 112.361 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.65 ' HB3' ' CB ' ' A' ' 120' ' ' GLU . 0.1 OUTLIER -148.63 101.72 3.24 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.186 -0.461 . . . . 71.44 110.842 -179.772 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.713 HD13 HD11 ' A' ' 127' ' ' ILE . 3.3 tt -54.47 -29.57 20.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.123 -0.49 . . . . 63.24 111.156 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' MET . . . . . 0.591 ' O ' ' HA ' ' A' ' 123' ' ' HIS . 49.2 ttp -86.2 -44.29 12.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 63.01 110.902 179.819 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.65 ' CB ' ' HB3' ' A' ' 117' ' ' SER . 12.6 tp10 -66.48 -12.47 57.53 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.223 -0.444 . . . . 73.0 110.865 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 25.0 tp60 -114.64 -49.06 2.83 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.156 -0.474 . . . . 72.34 110.934 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.437 ' HB2' ' O ' ' A' ' 118' ' ' ILE . 86.1 m-85 -105.23 -19.15 13.9 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.197 -0.456 . . . . 71.14 110.865 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . 0.591 ' HA ' ' O ' ' A' ' 119' ' ' MET . 11.4 m80 72.18 26.94 2.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.154 -0.475 . . . . 73.34 110.875 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.473 ' SD ' HG22 ' A' ' 98' ' ' ILE . 8.9 mtt -102.2 86.44 2.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.182 -0.463 . . . . 72.33 110.876 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 1.7 ptp85 -51.59 -34.54 37.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.245 -0.434 . . . . 70.44 110.913 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.486 ' HG2' ' HA ' ' A' ' 169' ' ' ALA . 35.9 mt-10 -144.89 133.57 22.19 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.152 -0.476 . . . . 73.43 110.897 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.713 HD11 HD13 ' A' ' 118' ' ' ILE . 3.5 mm -94.73 89.77 2.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.147 -0.478 . . . . 72.14 111.15 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . 0.474 ' HB3' ' C ' ' A' ' 101' ' ' LYS . 0.6 OUTLIER -62.58 -33.27 74.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.2 -0.455 . . . . 63.42 110.846 179.862 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . 0.652 ' HB2' ' HB2' ' A' ' 99' ' ' PHE . 69.9 m -130.58 141.53 50.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 63.43 110.871 -179.747 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . 0.614 ' O ' ' O ' ' A' ' 155' ' ' LYS . 0.1 OUTLIER -142.84 122.31 13.19 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.178 -0.464 . . . . 62.24 110.91 -179.959 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.66 ' HD2' ' CE1' ' A' ' 104' ' ' PHE . 7.1 mtpp -115.74 155.61 27.46 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.169 -0.469 . . . . 63.24 110.861 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.546 HG12 ' N ' ' A' ' 133' ' ' LEU . 18.1 t 84.92 163.72 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.242 -0.435 . . . . 72.42 111.114 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.731 HD22 ' CG ' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -178.95 122.86 0.09 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.162 -0.472 . . . . 73.14 110.898 180.0 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.507 ' HG2' ' O ' ' A' ' 93' ' ' GLN . 0.0 OUTLIER -92.49 171.23 9.17 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.225 -0.443 . . . . 63.32 110.912 179.863 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . 0.455 ' C ' ' O ' ' A' ' 134' ' ' GLU . . . -32.67 -53.08 0.47 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.754 -0.736 . . . . 50.01 112.482 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.885 HG11 ' CG1' ' A' ' 86' ' ' VAL . 4.1 t -148.81 146.13 17.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.858 0.361 . . . . 63.51 111.109 -179.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' TRP . . . . . 0.65 ' H ' HD12 ' A' ' 152' ' ' LEU . 0.7 OUTLIER -150.01 163.34 38.4 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.146 -0.479 . . . . 74.42 110.893 179.975 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.557 HD12 HH11 ' A' ' 174' ' ' ARG . 4.7 mt -143.18 136.65 25.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.186 -0.461 . . . . 60.44 111.109 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.689 ' CD1' HG11 ' A' ' 170' ' ' VAL . 0.2 OUTLIER -102.55 168.79 9.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.204 -0.453 . . . . 73.33 110.882 179.989 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . 0.47 ' CD2' ' HA ' ' A' ' 145' ' ' TYR . 0.5 OUTLIER -139.88 127.65 21.91 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.131 -0.486 . . . . 51.44 110.959 -179.85 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . 0.602 ' O ' ' HB2' ' A' ' 171' ' ' GLN . 0.7 OUTLIER -60.79 -28.41 68.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.134 -0.484 . . . . 75.42 110.893 -179.986 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.736 ' HB3' ' HD2' ' A' ' 143' ' ' PRO . 9.2 mp -115.06 173.63 2.81 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.621 0.724 . . . . 73.32 110.909 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . 0.742 ' O ' ' OG ' ' A' ' 172' ' ' SER . 53.8 Cg_endo -69.76 -89.59 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.603 2.202 . . . . 62.21 112.363 179.852 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . 0.711 ' O ' ' N ' ' A' ' 146' ' ' ARG . 1.3 m-20 -53.13 97.63 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.203 -0.453 . . . . 72.41 110.911 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . 0.637 ' C ' ' O ' ' A' ' 144' ' ' ASN . 33.1 m-85 12.51 52.36 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.169 -0.469 . . . . 72.15 110.932 -179.882 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . 0.711 ' N ' ' O ' ' A' ' 144' ' ' ASN . 19.5 mtt-85 -117.85 172.6 7.28 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.095 -0.502 . . . . 63.22 110.91 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 77.55 -176.86 53.35 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.759 -0.734 . . . . 54.34 112.523 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -78.08 149.62 33.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.76 0.314 . . . . 72.22 110.895 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 63.3 mt-30 -85.71 157.24 20.34 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.217 -0.447 . . . . 75.52 110.945 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . 0.509 ' HB2' ' HB2' ' A' ' 139' ' ' PHE . 88.8 m-85 -137.78 109.78 7.22 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.229 -0.441 . . . . 74.03 110.905 -179.837 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.637 ' HB2' HD11 ' A' ' 61' ' ' ILE . 20.2 tp -59.76 136.11 57.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.097 -0.502 . . . . 73.52 110.924 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 1.045 ' O ' HD13 ' A' ' 152' ' ' LEU . 0.0 OUTLIER -68.93 137.17 53.57 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.18 -0.464 . . . . 71.51 110.905 179.881 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . 0.442 ' N ' HD22 ' A' ' 152' ' ' LEU . 1.3 t70 -164.15 24.94 0.07 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.223 -0.444 . . . . 73.24 110.922 179.814 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.924 ' HB2' ' CD1' ' A' ' 157' ' ' TYR . 2.2 ptmt -122.0 -174.62 2.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.131 -0.486 . . . . 44.01 110.872 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.731 ' CG ' HD22 ' A' ' 133' ' ' LEU . 0.0 OUTLIER -158.66 -124.8 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.243 -0.435 . . . . 74.14 110.891 179.871 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.629 ' HA ' ' HA ' ' A' ' 131' ' ' LYS . 0.5 OUTLIER -64.75 -4.67 4.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.45 . . . . 74.43 110.89 179.943 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . 0.924 ' CD1' ' HB2' ' A' ' 154' ' ' LYS . 14.2 m-30 -26.42 141.33 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.143 -0.48 . . . . 54.32 110.899 -179.854 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . 0.466 ' HB2' ' HA ' ' A' ' 103' ' ' ASP . 8.2 ptp180 -105.17 -46.04 4.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.158 -0.474 . . . . 74.54 110.843 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . 0.485 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 3.3 ptpp? -84.59 150.42 56.63 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.537 0.684 . . . . 71.14 110.92 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . 0.654 ' O ' ' CD1' ' A' ' 163' ' ' TRP . 54.0 Cg_endo -69.77 -29.49 23.72 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.692 2.261 . . . . 73.21 112.33 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.746 ' H ' HD12 ' A' ' 161' ' ' ILE . 2.0 mp -71.96 6.85 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.197 -0.456 . . . . 71.22 111.169 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.602 ' HB3' ' CD1' ' A' ' 157' ' ' TYR . 0.9 OUTLIER -76.99 -18.05 58.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.109 -0.496 . . . . 73.15 110.838 179.896 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' TRP . . . . . 0.835 ' NE1' ' HB3' ' A' ' 165' ' ' ALA . 0.4 OUTLIER -109.21 12.83 24.73 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.25 -0.432 . . . . 73.12 110.955 -179.941 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 81.25 -44.08 2.99 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.706 -0.759 . . . . 71.24 112.488 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.835 ' HB3' ' NE1' ' A' ' 163' ' ' TRP . . . -52.3 121.49 7.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.813 0.339 . . . . 61.52 111.095 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -64.67 122.14 16.15 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.208 -0.451 . . . . 65.0 111.126 179.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . 0.488 ' C ' ' H ' ' A' ' 169' ' ' ALA . 0.4 OUTLIER 63.23 146.46 0.09 OUTLIER Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 121.673 0.749 . . . . 54.23 110.866 -179.786 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . 0.489 ' HB2' ' N ' ' A' ' 127' ' ' ILE . 53.5 Cg_endo -69.81 23.75 0.17 Allowed 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.664 2.243 . . . . 72.22 112.37 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 0.488 ' H ' ' C ' ' A' ' 167' ' ' SER . . . -62.39 102.75 0.34 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.189 -0.46 . . . . 50.41 111.086 179.848 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.689 HG11 ' CD1' ' A' ' 139' ' ' PHE . 3.4 t -154.87 162.49 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.208 -0.451 . . . . 72.25 111.112 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 171' ' ' GLN . . . . . 0.653 ' OE1' ' HB3' ' A' ' 143' ' ' PRO . 1.6 tm0? -109.93 -83.05 0.57 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.156 -0.474 . . . . 64.23 110.925 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . 0.742 ' OG ' ' O ' ' A' ' 143' ' ' PRO . 52.5 p -123.83 177.14 5.88 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.234 -0.439 . . . . 64.33 110.878 -179.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -140.45 168.0 20.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.136 -0.484 . . . . 73.12 110.893 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . 0.557 HH11 HD12 ' A' ' 138' ' ' ILE . 0.1 OUTLIER -134.66 152.64 51.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.112 -0.494 . . . . 74.53 110.866 -179.904 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.29 167.77 10.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.184 -0.462 . . . . 55.33 110.886 -179.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 2.6 mt -116.63 141.52 34.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.165 -0.47 . . . . 53.33 111.16 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 3.2 p -149.97 155.85 7.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.195 -0.457 . . . . 70.4 111.108 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 116.143 -0.48 . . . . 64.4 110.895 179.996 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.305 0 N-CA-C 112.466 -0.254 . . . . 65.4 112.466 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.496 ' C ' ' HE1' ' A' ' 47' ' ' TRP . 7.2 p -82.46 136.72 34.86 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.867 0.365 . . . . 75.13 111.153 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.447 ' N ' ' HE1' ' A' ' 47' ' ' TRP . 2.5 tttt -126.93 136.76 52.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.236 -0.438 . . . . 64.31 110.907 179.878 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.517 ' HA ' ' HA ' ' A' ' 42' ' ' VAL . 16.5 tt -136.5 154.56 32.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.22 -0.445 . . . . 73.24 111.129 179.881 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.488 HG23 ' CG ' ' A' ' 22' ' ' ASP . 13.7 m -134.55 151.41 51.08 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.162 -0.472 . . . . 61.13 111.157 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.662 ' HB2' HD22 ' A' ' 34' ' ' LEU . 1.2 m-85 -140.45 129.59 23.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.454 . . . . 75.04 110.863 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.55 ' CG ' ' HA ' ' A' ' 16' ' ' PHE . 8.2 m-85 -115.36 133.15 56.3 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.154 -0.475 . . . . 74.34 110.942 -179.872 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.454 ' HG2' ' HB2' ' A' ' 36' ' ' ARG . 0.0 OUTLIER -56.6 -25.0 51.6 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.181 -0.463 . . . . 72.54 110.89 -179.974 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.413 ' HB2' ' O ' ' A' ' 17' ' ' GLN . 62.8 m-20 -126.38 155.8 41.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.159 -0.473 . . . . 74.41 110.91 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.412 ' HG2' ' HA ' ' A' ' 69' ' ' GLU . 11.2 mtmt -57.99 -173.58 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.206 -0.452 . . . . 72.02 110.899 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 23.9 m-20 43.95 34.41 0.92 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.244 -0.435 . . . . 64.25 110.867 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.55 ' HA ' ' CG ' ' A' ' 11' ' ' TYR . 3.1 m-85 48.05 62.9 2.27 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.21 -0.45 . . . . 73.41 110.829 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.413 ' O ' ' HB2' ' A' ' 13' ' ' ASP . 10.6 mt-30 -136.55 154.68 50.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.181 -0.463 . . . . 71.21 110.902 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 95.28 -152.94 20.6 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.711 -0.757 . . . . 60.1 112.485 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.795 ' O ' HD13 ' A' ' 34' ' ' LEU . 0.0 OUTLIER -65.21 81.13 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.844 0.354 . . . . 73.11 110.891 -179.867 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.466 ' HB2' ' CE1' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -79.97 128.92 34.04 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.189 -0.46 . . . . 70.31 110.835 -179.859 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.471 ' CD2' ' CD2' ' A' ' 30' ' ' PHE . 72.2 t80 -123.53 126.12 46.11 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.221 -0.445 . . . . 70.42 110.944 -179.854 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.488 ' CG ' HG23 ' A' ' 9' ' ' THR . 1.1 m-20 -121.71 134.41 54.95 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.17 -0.468 . . . . 40.12 110.874 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 6.7 t -163.02 134.39 4.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.165 -0.471 . . . . 52.35 110.922 -179.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.417 ' HA ' ' HA ' ' A' ' 7' ' ' LYS . 5.0 p-10 -101.96 3.56 39.11 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.203 -0.453 . . . . 72.21 110.875 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 42.2 t -110.62 158.79 18.2 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.197 -0.456 . . . . 53.2 110.893 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -40.7 119.75 1.16 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.234 -0.439 . . . . 70.23 110.889 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.567 ' HB2' ' HB3' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -114.51 39.95 2.68 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.175 -0.466 . . . . 73.34 110.879 -179.896 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.583 ' O ' ' HB3' ' A' ' 82' ' ' SER . . . -50.86 -21.35 1.65 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.218 -0.447 . . . . 63.42 111.078 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 58.1 t0 -130.45 39.44 3.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.215 -0.448 . . . . 75.0 110.843 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.81 ' O ' ' CD2' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -81.09 15.27 1.94 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.213 -0.449 . . . . 71.21 110.885 -179.876 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.419 ' CG ' ' HG3' ' A' ' 53' ' ' PRO . 44.5 t60 -80.57 -35.02 34.86 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.157 -0.474 . . . . 73.3 110.867 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.7 t -62.96 -10.65 14.46 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.169 -0.469 . . . . 75.5 111.154 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -103.53 -27.29 12.45 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.231 -0.44 . . . . 64.12 110.92 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.795 HD13 ' O ' ' A' ' 19' ' ' ARG . 30.4 tp -138.17 138.73 38.88 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.137 -0.483 . . . . 75.24 110.905 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.5 m -104.11 -36.15 7.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.169 -0.469 . . . . 62.43 110.824 -179.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.458 ' O ' HD21 ' A' ' 34' ' ' LEU . 0.7 OUTLIER -112.98 139.86 48.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.131 -0.486 . . . . 72.34 110.863 -179.92 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.476 ' SG ' ' CB ' ' A' ' 80' ' ' LEU . 2.2 m -121.41 69.87 0.92 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.193 -0.458 . . . . 73.35 110.93 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -72.04 -71.86 0.26 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.214 -0.448 . . . . 70.02 110.889 -179.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 4.9 p -104.54 134.61 47.43 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.165 -0.47 . . . . 61.22 110.867 -179.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.576 HD12 ' CH2' ' A' ' 73' ' ' TRP . 20.8 mt -126.51 151.65 33.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.135 -0.484 . . . . 74.34 111.124 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.481 ' HD2' ' CE2' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -145.0 124.75 13.34 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.155 -0.475 . . . . 62.13 110.918 179.834 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.517 ' HA ' ' HA ' ' A' ' 8' ' ' ILE . 1.2 t -111.99 116.03 51.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.214 -0.448 . . . . 72.34 111.16 179.882 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -112.95 77.63 1.06 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.217 -0.447 . . . . 73.14 110.886 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.415 ' O ' ' HB ' ' A' ' 6' ' ' THR . . . 139.08 97.49 0.38 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.685 -0.769 . . . . 72.52 112.464 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.419 ' HA2' HD21 ' A' ' 88' ' ' LEU . . . 52.52 -179.9 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.729 -0.748 . . . . 63.55 112.476 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.7 HG23 ' HA ' ' A' ' 63' ' ' PRO . 1.4 m -74.52 170.05 16.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.75 0.31 . . . . 74.41 111.162 -179.886 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . 0.57 ' H ' HG22 ' A' ' 46' ' ' THR . 4.5 m95 -142.92 130.03 20.77 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.245 -0.434 . . . . 74.04 110.887 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.891 ' HB2' ' CG2' ' A' ' 86' ' ' VAL . . . -87.36 127.09 35.2 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.225 -0.443 . . . . 75.44 111.115 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.908 HG11 HD11 ' A' ' 80' ' ' LEU . 34.5 m -129.7 131.71 66.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.263 -0.426 . . . . 64.31 111.127 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.726 ' HB3' ' HA ' ' A' ' 56' ' ' ALA . 58.8 m-85 -103.01 147.92 26.34 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.192 -0.458 . . . . 71.31 110.913 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.651 ' OE1' ' HB3' ' A' ' 57' ' ' TRP . 63.7 tt0 -50.19 -78.99 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.133 -0.485 . . . . 64.54 110.858 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.598 ' HB3' ' HB2' ' A' ' 55' ' ' PHE . 0.5 OUTLIER -91.04 138.01 26.22 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.618 0.723 . . . . 73.11 110.869 -179.908 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.739 ' HB3' ' HB3' ' A' ' 81' ' ' SER . 53.7 Cg_endo -69.82 145.98 58.43 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.655 2.237 . . . . 35.53 112.349 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 63.15 -7.67 0.15 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.239 -0.437 . . . . 73.25 110.917 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.614 ' CD1' ' O ' ' A' ' 53' ' ' PRO . 30.8 m-85 -113.72 -20.32 11.21 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.173 -0.467 . . . . 72.21 110.864 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.726 ' HA ' ' HB3' ' A' ' 50' ' ' TYR . . . 52.37 27.27 4.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.188 -0.46 . . . . 63.23 111.105 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . 0.651 ' HB3' ' OE1' ' A' ' 51' ' ' GLU . 0.0 OUTLIER -49.28 -164.36 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.225 -0.443 . . . . 74.41 110.888 -179.956 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.637 ' C ' ' O ' ' A' ' 57' ' ' TRP . 4.7 m-30 -12.55 101.39 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.182 -0.463 . . . . 73.23 110.951 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.451 ' HB2' ' O ' ' A' ' 149' ' ' GLN . 2.3 mpt? -60.74 155.93 18.1 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.17 -0.468 . . . . 63.51 110.856 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.68 ' O ' ' O ' ' A' ' 49' ' ' VAL . 2.7 t80 -170.74 120.63 0.56 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.202 -0.454 . . . . 72.14 110.972 -179.872 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.854 ' N ' HD12 ' A' ' 61' ' ' ILE . 1.0 OUTLIER -106.2 114.24 44.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.165 -0.47 . . . . 62.22 111.15 179.923 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.614 HD23 ' HD2' ' A' ' 63' ' ' PRO . 0.3 OUTLIER -83.75 124.65 74.82 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.583 0.706 . . . . 75.24 110.933 179.943 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.7 ' HA ' HG23 ' A' ' 46' ' ' THR . 53.3 Cg_endo -69.75 -171.3 0.46 Allowed 'Trans proline' 0 C--O 1.231 0.141 0 C-N-CA 122.706 2.271 . . . . 74.34 112.295 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.79 163.2 15.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.189 -0.459 . . . . 72.1 110.908 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 114.35 -158.42 14.33 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.795 -0.717 . . . . 73.45 112.472 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -118.28 154.3 32.53 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.871 0.367 . . . . 74.04 110.868 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.55 ' HB2' ' O ' ' A' ' 40' ' ' ILE . 17.5 m-85 -140.94 84.14 13.47 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.691 0.758 . . . . 72.34 110.959 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.409 ' HD2' ' HG3' ' A' ' 72' ' ' ARG . 53.1 Cg_endo -69.84 2.79 3.25 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.643 2.229 . . . . 72.54 112.35 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.603 ' HB2' ' HG2' ' A' ' 72' ' ' ARG . 48.4 mt-10 -157.56 144.21 17.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.183 -0.462 . . . . 74.03 110.893 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.707 ' HA ' ' NE1' ' A' ' 73' ' ' TRP . 35.4 p90 -55.78 -25.97 43.74 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.127 -0.488 . . . . 71.25 110.896 -179.801 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -76.51 -15.81 59.79 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.154 -0.475 . . . . 64.43 110.931 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.603 ' HG2' ' HB2' ' A' ' 69' ' ' GLU . 32.0 mmt180 -67.27 -15.98 64.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.201 -0.454 . . . . 75.22 110.874 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . 0.745 ' N ' ' CD1' ' A' ' 73' ' ' TRP . 0.0 OUTLIER -125.14 21.88 7.99 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.202 -0.454 . . . . 72.45 110.939 -179.959 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . 0.574 ' O ' ' C ' ' A' ' 75' ' ' GLY . 2.1 ttm 75.87 -16.4 0.6 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.258 -0.428 . . . . 51.42 110.88 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.574 ' C ' ' O ' ' A' ' 74' ' ' MET . . . 21.93 57.5 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.762 -0.732 . . . . 51.21 112.496 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.93 HD13 ' N ' ' A' ' 77' ' ' ASN . 0.0 OUTLIER -56.48 -10.93 1.07 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.835 0.35 . . . . 65.34 110.927 -179.935 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.93 ' N ' HD13 ' A' ' 76' ' ' LEU . 37.0 t-20 -149.33 -48.67 0.14 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.219 -0.446 . . . . 74.32 110.853 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.556 ' CB ' ' O ' ' A' ' 77' ' ' ASN . 5.2 t0 87.22 -7.73 0.64 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.192 -0.458 . . . . 72.4 110.901 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.457 ' HG2' ' O ' ' A' ' 79' ' ' ARG . 8.7 ttt85 -85.39 50.15 1.9 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.178 -0.464 . . . . 60.1 110.874 -179.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.908 HD11 HG11 ' A' ' 49' ' ' VAL . 0.1 OUTLIER -59.36 130.65 47.95 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.195 -0.457 . . . . 61.03 110.937 179.998 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.739 ' HB3' ' HB3' ' A' ' 53' ' ' PRO . 12.3 m -151.6 -111.77 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.182 -0.463 . . . . 73.43 110.849 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.601 ' OG ' ' HA ' ' A' ' 53' ' ' PRO . 1.0 OUTLIER -47.87 97.12 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.155 -0.475 . . . . 52.53 110.851 -179.802 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . 0.784 ' CB ' HG12 ' A' ' 49' ' ' VAL . 7.6 p -123.89 135.23 53.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.167 -0.469 . . . . 61.23 110.858 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.633 ' N ' ' O ' ' A' ' 48' ' ' ALA . 0.9 OUTLIER -115.12 154.82 28.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.154 -0.475 . . . . 74.32 110.89 -179.9 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -68.17 130.06 41.77 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.191 -0.458 . . . . 72.45 111.048 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.891 ' CG2' ' HB2' ' A' ' 48' ' ' ALA . 37.7 t -115.03 133.34 61.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.208 -0.451 . . . . 62.11 111.179 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . 0.646 ' O ' HG23 ' A' ' 136' ' ' VAL . 39.9 m80 -111.26 108.48 18.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.202 -0.454 . . . . 72.31 110.87 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.477 HD23 ' H ' ' A' ' 88' ' ' LEU . 0.0 OUTLIER -33.4 147.04 0.1 OUTLIER Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.566 0.698 . . . . 74.34 110.943 -179.96 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.521 ' HB3' ' H ' ' A' ' 136' ' ' VAL . 53.6 Cg_endo -69.78 95.52 0.56 Allowed 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.68 2.253 . . . . 62.02 112.328 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -88.89 -174.87 4.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.225 -0.443 . . . . 72.12 110.844 -179.847 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 64.0 108.48 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.766 -0.731 . . . . 65.35 112.525 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 69.41 -84.34 0.26 Allowed Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.695 -0.764 . . . . 74.44 112.481 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.446 ' O ' ' HG2' ' A' ' 134' ' ' GLU . 19.5 pt20 178.74 -136.79 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.842 0.353 . . . . 63.45 110.945 -179.863 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.671 ' HA ' ' HG2' ' A' ' 134' ' ' GLU . 0.0 OUTLIER -113.86 103.2 10.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.202 -0.454 . . . . 74.43 110.96 -179.877 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.492 ' HG3' HG11 ' A' ' 132' ' ' VAL . 29.1 tptt -107.41 128.79 54.79 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.127 -0.488 . . . . 73.44 110.896 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.528 HD13 ' N ' ' A' ' 97' ' ' GLN . 0.1 OUTLIER -151.08 133.97 6.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.194 -0.457 . . . . 74.32 111.136 179.828 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.528 ' N ' HD13 ' A' ' 96' ' ' ILE . 0.3 OUTLIER -105.76 126.61 52.37 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.142 -0.481 . . . . 74.34 110.911 179.948 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.626 HD13 HD11 ' A' ' 118' ' ' ILE . 13.0 mt -105.08 138.51 29.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.186 -0.461 . . . . 72.52 111.103 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.663 ' HB2' ' HB2' ' A' ' 129' ' ' SER . 46.7 m-85 -125.75 139.9 53.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.166 -0.47 . . . . 51.22 110.87 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 79.0 tt0 -71.89 -70.8 0.31 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.119 -0.491 . . . . 70.24 110.875 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 41.4 mttt -87.9 171.02 10.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.157 -0.474 . . . . 71.52 110.858 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -75.47 155.05 46.58 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.801 -0.714 . . . . 72.4 112.481 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.615 ' HA ' ' HB2' ' A' ' 158' ' ' ARG . 16.1 t0 68.03 45.26 1.35 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.85 0.357 . . . . 63.12 110.863 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.441 ' HA ' ' CD1' ' A' ' 99' ' ' PHE . 0.7 OUTLIER 50.7 29.17 4.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.183 -0.462 . . . . 70.51 110.89 -179.905 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 71.2 m -96.82 159.06 15.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.149 -0.478 . . . . 74.05 110.911 -179.821 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 87.1 -145.06 19.64 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.774 -0.727 . . . . 75.13 112.493 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 3.8 tp-100 -87.66 125.01 34.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.8 0.333 . . . . 70.41 110.906 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' MET . . . . . 0.48 ' HB2' ' CE1' ' A' ' 99' ' ' PHE . 23.4 ttp -107.64 144.35 34.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.198 -0.455 . . . . 74.51 110.889 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -149.51 135.5 18.85 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.275 -0.421 . . . . 75.4 110.884 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -114.93 102.68 10.19 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.102 -0.499 . . . . 62.41 110.909 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 14.6 t -114.07 144.19 43.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 74.32 111.102 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.479 ' O ' ' OG1' ' A' ' 112' ' ' THR . 0.8 OUTLIER -124.4 36.35 4.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.252 -0.431 . . . . 51.34 111.135 -179.988 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -143.84 -172.52 3.76 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.232 -0.44 . . . . 73.0 110.867 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -86.31 162.54 18.18 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.112 -0.494 . . . . 74.43 110.88 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . 0.419 ' HB3' ' CE2' ' A' ' 173' ' ' PHE . 0.8 OUTLIER -157.25 120.76 2.21 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-O 121.585 0.707 . . . . 73.52 110.92 -179.918 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.586 ' O ' ' OG ' ' A' ' 172' ' ' SER . 54.1 Cg_endo -69.73 -33.5 16.6 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.642 2.228 . . . . 63.13 112.401 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.669 ' HB3' ' CB ' ' A' ' 120' ' ' GLU . 0.2 OUTLIER -138.68 103.57 4.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.22 -0.445 . . . . 71.51 110.846 -179.862 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.674 ' HB ' ' O ' ' A' ' 171' ' ' GLN . 4.9 tt -57.91 -29.87 36.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.135 -0.484 . . . . 51.44 111.148 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' MET . . . . . 0.594 ' O ' ' HA ' ' A' ' 123' ' ' HIS . 2.8 ttt -87.89 -45.62 10.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.165 -0.47 . . . . 63.44 110.864 179.873 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.669 ' CB ' ' HB3' ' A' ' 117' ' ' SER . 6.7 tp10 -62.86 -13.5 34.7 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.235 -0.439 . . . . 75.24 110.89 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 7.8 tp-100 -114.64 -50.09 2.8 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.186 -0.461 . . . . 74.4 110.963 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.569 ' HB2' ' O ' ' A' ' 118' ' ' ILE . 96.1 m-85 -100.07 -20.64 15.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.165 -0.47 . . . . 54.04 110.881 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . 0.594 ' HA ' ' O ' ' A' ' 119' ' ' MET . 13.4 m-70 76.42 22.07 1.3 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.17 -0.468 . . . . 74.25 110.888 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.506 ' O ' HG23 ' A' ' 118' ' ' ILE . 3.5 mtt -97.67 118.74 34.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.174 -0.466 . . . . 64.53 110.856 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 5.8 ptp180 -79.58 -45.79 18.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.203 -0.453 . . . . 65.53 110.863 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.44 ' HB3' ' HG2' ' A' ' 168' ' ' PRO . 19.9 mt-10 -140.45 117.36 11.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.181 -0.463 . . . . 71.42 110.836 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.642 HG21 ' SG ' ' A' ' 130' ' ' CYS . 3.2 mm -73.52 92.49 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.128 -0.487 . . . . 74.12 111.112 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -64.89 -34.0 77.35 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.156 -0.475 . . . . 72.13 110.868 179.874 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . 0.663 ' HB2' ' HB2' ' A' ' 99' ' ' PHE . 4.7 m -133.97 155.03 50.68 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.207 -0.452 . . . . 62.43 110.845 -179.802 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . 0.663 ' O ' ' O ' ' A' ' 155' ' ' LYS . 0.1 OUTLIER -156.59 123.04 5.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.112 -0.494 . . . . 60.14 110.844 -179.951 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.636 ' HA ' ' HA ' ' A' ' 156' ' ' GLU . 1.9 mtpt -108.22 154.21 22.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.16 -0.473 . . . . 71.51 110.885 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.553 HG23 ' C ' ' A' ' 131' ' ' LYS . 8.3 t 83.45 165.03 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.215 -0.448 . . . . 74.31 111.136 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.789 HD22 ' CG ' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -178.49 123.69 0.1 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.125 -0.489 . . . . 55.22 110.905 179.977 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.671 ' HG2' ' HA ' ' A' ' 94' ' ' TYR . 0.1 OUTLIER -98.64 164.41 12.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.21 -0.45 . . . . 73.53 110.856 179.928 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . 0.557 ' C ' ' O ' ' A' ' 134' ' ' GLU . . . -23.06 -63.1 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.736 -0.745 . . . . 42.5 112.487 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.795 ' HB ' HD12 ' A' ' 176' ' ' ILE . 3.1 t -144.44 146.34 20.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.804 0.335 . . . . 72.33 111.126 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' TRP . . . . . 0.645 ' HB3' ' HB3' ' A' ' 152' ' ' LEU . 6.3 t-105 -143.19 149.56 38.17 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.164 -0.471 . . . . 74.1 110.945 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.412 HD12 ' HB ' ' A' ' 61' ' ' ILE . 3.5 mm -114.59 134.73 56.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.285 -0.416 . . . . 61.41 111.161 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.524 ' CD1' HG11 ' A' ' 170' ' ' VAL . 0.1 OUTLIER -117.23 142.65 46.79 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.204 -0.453 . . . . 72.34 110.846 -179.989 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . 0.512 ' CE2' ' HA ' ' A' ' 145' ' ' TYR . 3.9 m-85 -120.79 130.4 53.98 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.14 -0.482 . . . . 73.51 110.932 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . 0.452 ' O ' ' HB2' ' A' ' 171' ' ' GLN . 2.9 tt0 -61.77 -47.62 84.35 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.121 -0.49 . . . . 75.41 110.885 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 1.057 ' O ' ' HB2' ' A' ' 172' ' ' SER . 7.1 mp -97.41 152.56 38.29 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.588 0.709 . . . . 74.51 110.922 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . 0.684 ' HB3' ' OE1' ' A' ' 171' ' ' GLN . 54.3 Cg_endo -69.68 44.76 0.42 Allowed 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.709 2.273 . . . . 54.31 112.379 179.854 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . 1.084 ' O ' ' N ' ' A' ' 146' ' ' ARG . 0.0 OUTLIER 179.06 106.62 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.228 -0.442 . . . . 74.34 110.885 -179.989 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . 0.668 ' C ' ' O ' ' A' ' 144' ' ' ASN . 0.0 OUTLIER -3.51 51.25 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.204 -0.453 . . . . 64.0 110.938 -179.948 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . 1.084 ' N ' ' O ' ' A' ' 144' ' ' ASN . 36.7 mtt180 -131.47 163.27 28.33 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.118 -0.492 . . . . 63.51 110.881 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 82.8 -162.69 41.34 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.75 -0.738 . . . . 73.5 112.472 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -84.97 148.96 25.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.753 0.311 . . . . 74.33 110.84 -179.848 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' GLN . . . . . 0.451 ' O ' ' HB2' ' A' ' 59' ' ' MET . 19.3 mt-30 -95.73 135.09 37.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.159 -0.473 . . . . 70.12 110.901 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . 0.471 ' HB2' ' HB2' ' A' ' 139' ' ' PHE . 41.6 m-85 -109.95 127.06 54.54 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.164 -0.471 . . . . 73.14 110.856 -179.841 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.509 ' HB2' HD11 ' A' ' 61' ' ' ILE . 6.8 tp -83.01 120.89 26.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.088 -0.505 . . . . 52.22 110.947 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 1.043 ' O ' HD13 ' A' ' 152' ' ' LEU . 0.0 OUTLIER -50.46 133.11 25.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.2 -0.454 . . . . 73.55 110.962 179.887 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -162.09 23.16 0.11 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.216 -0.447 . . . . 52.31 110.868 179.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.83 ' HB2' ' CD1' ' A' ' 157' ' ' TYR . 3.2 ptmt -119.97 -174.02 2.67 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.191 -0.459 . . . . 43.41 110.91 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.789 ' CG ' HD22 ' A' ' 133' ' ' LEU . 1.7 mptt -158.4 -119.43 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.249 -0.432 . . . . 75.35 110.934 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.636 ' HA ' ' HA ' ' A' ' 131' ' ' LYS . 1.2 tm-20 -72.47 0.74 9.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.201 -0.454 . . . . 73.5 110.931 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . 0.83 ' CD1' ' HB2' ' A' ' 154' ' ' LYS . 12.9 m-30 -34.97 154.11 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.106 -0.497 . . . . 75.42 110.929 -179.868 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . 0.615 ' HB2' ' HA ' ' A' ' 103' ' ' ASP . 8.0 ptp180 -116.7 -44.22 2.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.074 -0.512 . . . . 71.11 110.883 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . 0.42 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 3.1 ptpp? -86.25 150.13 51.3 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.6 0.714 . . . . 73.44 110.854 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . 0.445 ' HA ' ' HE1' ' A' ' 163' ' ' TRP . 54.2 Cg_endo -69.78 -23.49 30.66 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.64 2.227 . . . . 74.12 112.377 179.86 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.648 ' H ' HD12 ' A' ' 161' ' ' ILE . 3.5 mp -78.71 4.09 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.212 -0.449 . . . . 73.14 111.138 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.529 ' HB3' ' CD1' ' A' ' 157' ' ' TYR . 1.0 OUTLIER -72.96 -16.91 61.52 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.19 -0.459 . . . . 71.5 110.819 179.853 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' TRP . . . . . 0.673 ' CD1' ' N ' ' A' ' 163' ' ' TRP . 0.0 OUTLIER -115.82 13.54 16.11 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.217 -0.447 . . . . 75.45 110.864 -179.943 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 88.64 -31.88 4.74 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.762 -0.732 . . . . 75.03 112.489 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -51.53 118.55 3.4 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.783 0.325 . . . . 62.41 111.1 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -50.73 -31.5 16.81 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.248 -0.433 . . . . 72.23 111.114 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . 0.493 ' C ' ' H ' ' A' ' 169' ' ' ALA . 0.3 OUTLIER -149.98 156.44 38.01 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.701 0.763 . . . . 52.15 110.835 -179.826 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . 0.444 ' HB3' ' O ' ' A' ' 127' ' ' ILE . 53.9 Cg_endo -69.73 24.95 0.17 Allowed 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.727 2.285 . . . . 60.5 112.312 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 0.493 ' H ' ' C ' ' A' ' 167' ' ' SER . . . -65.55 100.93 0.55 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.265 -0.425 . . . . 64.42 111.082 179.91 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.524 HG11 ' CD1' ' A' ' 139' ' ' PHE . 1.9 t -154.42 165.35 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.213 -0.449 . . . . 74.44 111.12 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 171' ' ' GLN . . . . . 0.684 ' OE1' ' HB3' ' A' ' 143' ' ' PRO . 2.2 mm-40 -147.53 -101.2 0.09 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.128 -0.487 . . . . 75.44 110.876 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . 1.057 ' HB2' ' O ' ' A' ' 142' ' ' LEU . 0.3 OUTLIER -56.31 143.73 33.03 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.196 -0.456 . . . . 44.24 110.902 -179.8 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 173' ' ' PHE . . . . . 0.419 ' CE2' ' HB3' ' A' ' 115' ' ' CYS . 31.2 p90 -152.1 132.79 13.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.184 -0.462 . . . . 72.12 110.92 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.51 165.47 23.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.186 -0.461 . . . . 75.34 110.861 -179.878 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . 0.404 ' HG3' ' CZ ' ' A' ' 94' ' ' TYR . 0.0 OUTLIER -104.12 -161.28 0.82 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.209 -0.45 . . . . 71.14 110.877 -179.943 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . 0.795 HD12 ' HB ' ' A' ' 136' ' ' VAL . 3.5 mt -139.3 138.79 40.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 63.24 111.144 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 5.0 p -145.34 152.34 14.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.188 -0.46 . . . . 72.0 111.106 179.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.149 -0.478 . . . . 72.11 110.896 -179.961 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.366 0 N-CA-C 112.497 -0.241 . . . . 72.1 112.497 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.518 ' C ' ' HE1' ' A' ' 47' ' ' TRP . 8.0 p -82.98 135.87 34.73 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.867 0.365 . . . . 71.25 111.155 -179.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.408 ' HA ' ' HA ' ' A' ' 24' ' ' ASP . 3.2 tttt -123.94 136.17 54.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.189 -0.459 . . . . 70.14 110.9 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.576 ' HB ' ' CD1' ' A' ' 47' ' ' TRP . 16.2 tt -137.47 150.89 25.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.223 -0.444 . . . . 75.21 111.151 179.861 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.481 HG23 ' CG ' ' A' ' 22' ' ' ASP . 10.1 m -130.21 146.08 51.8 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.196 -0.456 . . . . 72.34 111.163 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.792 ' HB2' HD22 ' A' ' 34' ' ' LEU . 1.5 m-85 -132.33 129.1 39.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.205 -0.452 . . . . 64.35 110.865 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.544 ' CG ' ' HA ' ' A' ' 16' ' ' PHE . 18.4 m-85 -115.65 132.13 56.73 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.135 -0.484 . . . . 73.03 110.974 -179.894 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.475 ' HG2' ' HB2' ' A' ' 36' ' ' ARG . 0.0 OUTLIER -58.6 -24.36 60.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.123 -0.49 . . . . 74.33 110.891 -179.976 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 64.9 m-20 -127.63 152.73 47.3 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.113 -0.494 . . . . 64.52 110.89 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.429 ' N ' ' HB3' ' A' ' 38' ' ' ASN . 32.5 mtmt -56.09 -175.25 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 75.12 110.922 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 25.7 m-20 46.51 33.6 2.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.258 -0.428 . . . . 64.11 110.897 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.544 ' HA ' ' CG ' ' A' ' 11' ' ' TYR . 3.4 m-85 48.91 58.9 4.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.147 -0.478 . . . . 75.01 110.842 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -133.49 157.78 44.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 53.31 110.905 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 94.25 -149.88 19.57 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.679 -0.772 . . . . 72.33 112.474 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.79 ' O ' HD13 ' A' ' 34' ' ' LEU . 0.1 OUTLIER -69.06 81.59 0.32 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.833 0.349 . . . . 74.24 110.881 -179.832 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.49 ' HB2' ' CE1' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -79.63 129.6 34.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.201 -0.454 . . . . 72.21 110.874 -179.898 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.444 ' O ' ' HA ' ' A' ' 9' ' ' THR . 88.8 t80 -125.54 125.32 43.03 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.204 -0.453 . . . . 73.42 110.899 -179.842 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.481 ' CG ' HG23 ' A' ' 9' ' ' THR . 1.4 m-20 -119.9 134.47 55.23 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.121 -0.491 . . . . 62.12 110.895 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 11.3 t -162.98 135.19 5.31 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.158 -0.474 . . . . 63.23 110.915 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.408 ' HA ' ' HA ' ' A' ' 7' ' ' LYS . 5.5 p-10 -102.66 -5.19 24.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.188 -0.46 . . . . 74.34 110.928 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.448 ' O ' ' SG ' ' A' ' 27' ' ' CYS . 20.0 t -102.54 165.08 11.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.14 -0.482 . . . . 71.42 110.851 -179.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -55.26 120.95 7.83 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.155 -0.475 . . . . 62.31 110.878 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.639 ' HB2' ' HB3' ' A' ' 30' ' ' PHE . 0.2 OUTLIER -116.39 49.97 1.09 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.225 -0.443 . . . . 62.52 110.924 -179.93 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.527 ' O ' ' HA ' ' A' ' 82' ' ' SER . . . -46.86 -22.23 0.29 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.191 -0.458 . . . . 72.43 111.096 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 63.3 t0 -129.19 42.76 3.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.189 -0.46 . . . . 64.41 110.85 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.775 ' O ' ' CD2' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -79.13 15.82 1.08 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.192 -0.458 . . . . 64.23 110.887 -179.936 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.448 ' HB2' ' HB3' ' A' ' 53' ' ' PRO . 27.1 t60 -77.2 -45.67 25.84 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.161 -0.472 . . . . 75.45 110.841 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.444 HG23 ' CD2' ' A' ' 33' ' ' TYR . 8.9 t -55.69 -14.5 2.27 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.191 -0.458 . . . . 70.33 111.175 -179.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.506 ' CD1' ' HA ' ' A' ' 30' ' ' PHE . 11.4 m-85 -96.1 -30.26 13.64 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.197 -0.456 . . . . 70.43 110.865 -179.907 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.792 HD22 ' HB2' ' A' ' 10' ' ' PHE . 19.3 tp -143.5 143.12 31.42 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.178 -0.464 . . . . 71.3 110.94 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.2 m -108.52 -34.73 6.66 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.185 -0.461 . . . . 61.23 110.883 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.545 ' O ' HD21 ' A' ' 34' ' ' LEU . 1.8 mtp85 -115.89 139.8 49.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.13 -0.486 . . . . 75.44 110.86 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.61 ' HB3' ' HB2' ' A' ' 80' ' ' LEU . 5.2 p -117.28 61.31 0.75 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.144 -0.48 . . . . 74.33 110.894 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.504 HD21 ' NH2' ' A' ' 36' ' ' ARG . 3.0 m120 -60.26 -69.62 0.21 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.133 -0.485 . . . . 73.14 110.869 -179.874 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 5.0 p -110.67 127.28 55.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.18 -0.463 . . . . 73.13 110.873 -179.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.757 HD12 ' CH2' ' A' ' 73' ' ' TRP . 29.9 mt -121.01 148.49 24.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.134 -0.485 . . . . 72.31 111.126 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.453 ' HD2' ' CE2' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -142.27 121.99 13.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 71.22 110.902 179.823 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.546 HG22 ' HB ' ' A' ' 8' ' ' ILE . 1.5 t -106.64 115.27 47.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.22 -0.445 . . . . 52.31 111.114 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -111.58 79.93 1.26 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.165 -0.47 . . . . 63.43 110.895 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.434 ' O ' ' HA ' ' A' ' 6' ' ' THR . . . 132.13 100.63 0.8 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.75 -0.738 . . . . 55.0 112.531 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.481 ' HA2' HD21 ' A' ' 88' ' ' LEU . . . 53.47 178.36 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.724 -0.75 . . . . 64.44 112.467 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.715 HG23 ' HA ' ' A' ' 63' ' ' PRO . 0.8 OUTLIER -76.74 168.06 20.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.774 0.321 . . . . 73.34 111.11 -179.831 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . 0.576 ' CD1' ' HB ' ' A' ' 8' ' ' ILE . 3.6 m95 -142.87 129.42 20.19 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.191 -0.459 . . . . 73.13 110.897 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.83 ' HB2' ' CG2' ' A' ' 86' ' ' VAL . . . -92.69 126.84 37.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.191 -0.459 . . . . 55.53 111.086 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.639 HG12 ' HB3' ' A' ' 83' ' ' CYS . 15.1 m -124.49 145.73 31.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.231 -0.44 . . . . 44.15 111.105 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.926 ' HB3' ' CB ' ' A' ' 56' ' ' ALA . 6.8 m-85 -119.31 141.35 49.07 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.125 -0.489 . . . . 63.24 110.925 -179.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.531 ' HG2' ' N ' ' A' ' 52' ' ' ARG . 0.3 OUTLIER -48.87 -82.18 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.166 -0.47 . . . . 74.54 110.903 179.99 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.904 ' O ' ' HB2' ' A' ' 56' ' ' ALA . 2.1 mtp180 -82.92 137.58 43.48 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.607 0.718 . . . . 61.4 110.88 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.746 ' HA ' ' OG ' ' A' ' 82' ' ' SER . 54.1 Cg_endo -69.76 137.53 35.69 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.703 2.269 . . . . 74.24 112.33 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.462 ' C ' ' CD2' ' A' ' 55' ' ' PHE . 0.9 OUTLIER 67.16 -6.27 0.61 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.241 -0.436 . . . . 75.34 110.904 179.994 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.463 ' H ' ' C ' ' A' ' 53' ' ' PRO . 0.0 OUTLIER -140.22 -74.91 0.34 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.165 -0.47 . . . . 73.42 110.905 -179.962 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.926 ' CB ' ' HB3' ' A' ' 50' ' ' TYR . . . 45.16 78.91 0.05 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.117 -0.492 . . . . 43.04 111.128 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . 0.557 ' O ' ' CD2' ' A' ' 58' ' ' TYR . 24.9 t-105 -64.18 31.55 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.279 -0.418 . . . . 74.11 110.939 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.623 ' H ' ' C ' ' A' ' 56' ' ' ALA . 1.9 m-30 -162.57 116.75 1.76 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.189 -0.46 . . . . 65.24 110.929 -179.848 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.548 ' HB2' ' HA ' ' A' ' 150' ' ' TYR . 1.8 mpt? -81.9 143.51 31.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.085 -0.507 . . . . 72.11 110.884 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.831 ' CD2' HD12 ' A' ' 76' ' ' LEU . 3.1 t80 -156.95 107.15 2.28 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.223 -0.444 . . . . 74.13 110.963 -179.861 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.811 ' N ' HD12 ' A' ' 61' ' ' ILE . 1.3 mp -94.57 116.66 36.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.096 -0.502 . . . . 72.21 111.102 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.798 HD23 ' HD2' ' A' ' 63' ' ' PRO . 0.2 OUTLIER -82.73 130.17 59.29 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.569 0.699 . . . . 71.13 110.92 179.915 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.798 ' HD2' HD23 ' A' ' 62' ' ' LEU . 53.7 Cg_endo -69.71 -173.64 0.75 Allowed 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.645 2.23 . . . . 72.21 112.38 179.869 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.21 162.17 16.04 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.221 -0.445 . . . . 72.4 110.903 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 112.01 -168.69 12.81 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.752 -0.737 . . . . 72.04 112.512 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 8.7 mp0 -107.07 152.97 23.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.842 0.353 . . . . 72.11 110.898 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.639 ' HB2' ' O ' ' A' ' 40' ' ' ILE . 12.9 m-85 -141.84 84.72 11.76 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.75 0.785 . . . . 74.2 110.914 -179.864 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.423 ' HD2' ' HG3' ' A' ' 72' ' ' ARG . 53.7 Cg_endo -69.75 0.48 5.58 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.693 2.262 . . . . 74.43 112.341 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.524 ' HB2' ' HG2' ' A' ' 72' ' ' ARG . 48.6 mt-10 -155.37 142.49 19.26 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.231 -0.441 . . . . 70.11 110.88 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.708 ' HA ' ' NE1' ' A' ' 73' ' ' TRP . 28.4 p90 -55.7 -20.27 13.75 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.169 -0.468 . . . . 73.12 110.956 -179.887 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -80.41 -16.93 53.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.121 -0.49 . . . . 73.24 110.908 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.524 ' HG2' ' HB2' ' A' ' 69' ' ' GLU . 31.3 mmt180 -69.49 -8.76 49.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.229 -0.442 . . . . 72.53 110.876 -179.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . 0.757 ' CH2' HD12 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -135.35 16.79 3.41 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.208 -0.451 . . . . 72.11 110.893 -179.95 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . 0.411 ' C ' ' O ' ' A' ' 73' ' ' TRP . 15.8 mtm 36.95 43.95 0.33 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.266 -0.425 . . . . 63.15 110.896 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -56.51 119.14 13.61 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.741 -0.742 . . . . 33.35 112.451 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.903 HD13 ' N ' ' A' ' 77' ' ' ASN . 0.0 OUTLIER -68.69 -8.7 44.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.792 0.33 . . . . 74.33 110.913 -179.911 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.903 ' N ' HD13 ' A' ' 76' ' ' LEU . 12.8 t-20 -152.77 138.15 17.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.189 -0.46 . . . . 71.31 110.884 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -89.67 13.15 14.9 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.185 -0.461 . . . . 63.31 110.85 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.426 ' HD3' ' HA ' ' A' ' 52' ' ' ARG . 1.2 ttm-85 -110.95 81.64 1.46 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.217 -0.447 . . . . 74.13 110.85 -179.869 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.61 ' HB2' ' HB3' ' A' ' 37' ' ' CYS . 0.0 OUTLIER -83.77 134.65 34.72 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.198 -0.456 . . . . 51.03 110.935 179.993 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.643 ' HB3' ' HB3' ' A' ' 53' ' ' PRO . 1.3 m -150.38 -123.79 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.173 -0.467 . . . . 72.24 110.832 -179.907 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.746 ' OG ' ' HA ' ' A' ' 53' ' ' PRO . 0.0 OUTLIER -34.28 105.79 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.172 -0.467 . . . . 55.3 110.841 -179.826 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . 0.639 ' HB3' HG12 ' A' ' 49' ' ' VAL . 31.7 p -128.2 132.4 48.83 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.149 -0.478 . . . . 32.25 110.89 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.603 ' N ' ' O ' ' A' ' 48' ' ' ALA . 10.7 mmt85 -116.61 149.39 39.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.188 -0.46 . . . . 74.34 110.918 -179.894 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -66.33 129.37 39.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.253 -0.431 . . . . 44.03 111.094 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.83 ' CG2' ' HB2' ' A' ' 48' ' ' ALA . 76.2 t -114.76 135.65 53.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.211 -0.45 . . . . 55.42 111.167 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . 0.659 ' O ' HG23 ' A' ' 136' ' ' VAL . 6.1 m-70 -111.8 113.03 25.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 74.22 110.836 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.481 HD21 ' HA2' ' A' ' 45' ' ' GLY . 0.0 OUTLIER -38.07 141.12 0.53 Allowed Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.587 0.708 . . . . 61.54 110.939 -179.966 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.59 ' HB3' ' H ' ' A' ' 136' ' ' VAL . 53.6 Cg_endo -69.79 79.95 0.92 Allowed 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.654 2.236 . . . . 74.55 112.365 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -91.55 -177.15 4.72 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.174 -0.467 . . . . 70.5 110.855 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 61.15 38.87 96.31 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.717 -0.754 . . . . 71.0 112.487 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.415 ' O ' ' C ' ' A' ' 93' ' ' GLN . . . 134.14 33.55 0.32 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.728 -0.749 . . . . 64.33 112.48 -179.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.596 ' O ' ' HG3' ' A' ' 134' ' ' GLU . 21.6 pt20 37.26 -131.38 0.13 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.846 0.355 . . . . 70.34 110.89 -179.874 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.575 ' HA ' ' HG3' ' A' ' 134' ' ' GLU . 0.1 OUTLIER -117.37 112.1 20.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.45 . . . . 74.41 110.9 -179.831 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.571 ' H ' ' CG ' ' A' ' 134' ' ' GLU . 31.8 tptt -119.16 128.66 54.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.134 -0.484 . . . . 71.05 110.886 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.429 HG13 ' CZ3' ' A' ' 137' ' ' TRP . 0.0 OUTLIER -152.26 139.54 13.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.24 -0.436 . . . . 64.54 111.111 179.865 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -105.85 122.8 46.84 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.159 -0.473 . . . . 71.32 110.947 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.532 HG22 ' SD ' ' A' ' 124' ' ' MET . 2.6 mt -101.93 130.61 51.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.232 -0.44 . . . . 72.4 111.127 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.69 ' HB2' ' HB2' ' A' ' 129' ' ' SER . 43.9 m-85 -118.46 147.84 43.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.18 -0.463 . . . . 73.32 110.87 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 56.5 tt0 -81.69 -56.15 4.18 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.13 -0.486 . . . . 74.41 110.906 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 45.9 mttt -101.92 172.32 7.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.134 -0.485 . . . . 72.32 110.921 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.407 ' HA2' ' OG ' ' A' ' 129' ' ' SER . . . -71.52 153.09 50.19 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.703 -0.761 . . . . 62.3 112.467 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.47 ' HA ' ' HB2' ' A' ' 158' ' ' ARG . 41.0 t0 65.42 46.22 2.61 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.894 0.378 . . . . 64.52 110.892 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.576 ' N ' ' CD2' ' A' ' 104' ' ' PHE . 0.2 OUTLIER 47.66 32.1 2.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.184 -0.462 . . . . 73.12 110.864 -179.898 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 57.7 m -94.03 164.04 13.24 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.179 -0.464 . . . . 74.14 110.879 -179.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 80.57 -136.29 16.31 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.763 -0.732 . . . . 72.42 112.52 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -90.89 121.07 32.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.784 0.325 . . . . 71.24 110.895 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 4.6 ttp -106.57 134.97 48.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.218 -0.446 . . . . 62.01 110.929 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -141.39 136.67 31.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.252 -0.431 . . . . 64.54 110.952 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -117.3 111.55 19.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.115 -0.493 . . . . 74.02 110.847 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.458 HG22 ' CD1' ' A' ' 98' ' ' ILE . 11.8 t -119.96 147.62 44.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.195 -0.457 . . . . 61.14 111.185 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.478 ' O ' ' OG1' ' A' ' 112' ' ' THR . 0.6 OUTLIER -128.38 27.73 5.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.242 -0.436 . . . . 65.44 111.153 179.982 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -141.06 156.64 45.97 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.249 -0.432 . . . . 74.24 110.933 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -50.32 162.35 0.23 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.179 -0.464 . . . . 73.25 110.881 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . 0.538 ' O ' ' HB2' ' A' ' 172' ' ' SER . 52.6 t -153.18 120.31 3.0 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.647 0.737 . . . . 75.04 110.816 -179.884 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.41 ' O ' ' CA ' ' A' ' 143' ' ' PRO . 53.3 Cg_endo -69.83 -30.85 21.33 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.708 2.272 . . . . 32.25 112.315 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.655 ' HB3' ' CB ' ' A' ' 120' ' ' GLU . 0.1 OUTLIER -149.58 112.8 4.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.254 -0.43 . . . . 71.41 110.828 -179.836 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.673 HD13 HD11 ' A' ' 127' ' ' ILE . 3.9 tt -64.54 -31.6 54.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.129 -0.487 . . . . 62.24 111.116 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' MET . . . . . 0.642 ' O ' ' HA ' ' A' ' 123' ' ' HIS . 0.0 OUTLIER -86.33 -39.2 16.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.206 -0.452 . . . . 54.12 110.928 179.807 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.655 ' CB ' ' HB3' ' A' ' 117' ' ' SER . 4.7 tp10 -70.79 -13.88 62.21 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.212 -0.449 . . . . 71.13 110.924 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 25.2 tp60 -114.72 -46.26 2.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.114 -0.493 . . . . 73.32 110.926 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.469 ' HB2' ' O ' ' A' ' 118' ' ' ILE . 74.5 m-85 -106.98 -19.08 13.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.189 -0.459 . . . . 73.41 110.9 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . 0.642 ' HA ' ' O ' ' A' ' 119' ' ' MET . 30.4 m-70 72.35 26.87 2.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.11 -0.496 . . . . 75.44 110.8 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.532 ' SD ' HG22 ' A' ' 98' ' ' ILE . 7.6 mtt -108.93 74.76 0.92 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.243 -0.435 . . . . 62.22 110.878 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 1.7 ptp85 -49.96 -26.31 4.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.229 -0.442 . . . . 74.25 110.849 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.431 ' C ' HD13 ' A' ' 127' ' ' ILE . 24.7 mt-10 -144.01 130.38 19.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.149 -0.478 . . . . 54.43 110.878 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.673 HD11 HD13 ' A' ' 118' ' ' ILE . 4.0 mm -96.45 104.76 16.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.072 -0.513 . . . . 65.3 111.107 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 8.2 m80 -72.22 -33.0 67.24 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.201 -0.454 . . . . 74.53 110.872 179.833 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . 0.69 ' HB2' ' HB2' ' A' ' 99' ' ' PHE . 16.8 m -134.77 144.04 47.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.225 -0.443 . . . . 63.02 110.857 -179.81 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . 0.565 ' O ' ' O ' ' A' ' 155' ' ' LYS . 1.1 m -142.52 115.04 8.51 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.129 -0.487 . . . . 45.11 110.885 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.58 ' HA ' ' HA ' ' A' ' 156' ' ' GLU . 7.2 mtpp -109.62 153.57 24.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.166 -0.47 . . . . 62.13 110.914 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.528 HG12 ' N ' ' A' ' 133' ' ' LEU . 16.2 t 85.25 162.87 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.247 -0.433 . . . . 73.31 111.1 179.855 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.784 HD22 ' CG ' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -175.77 126.61 0.23 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.134 -0.485 . . . . 74.4 110.897 179.944 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.596 ' HG3' ' O ' ' A' ' 93' ' ' GLN . 10.1 mm-40 -99.99 164.38 12.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.186 -0.461 . . . . 72.32 110.881 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . 0.552 ' C ' ' O ' ' A' ' 134' ' ' GLU . . . -23.91 -63.07 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.746 -0.74 . . . . 73.22 112.467 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.718 HG21 HG13 ' A' ' 86' ' ' VAL . 10.4 t -144.45 145.99 20.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.858 0.361 . . . . 61.54 111.089 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' TRP . . . . . 0.617 ' HB3' ' HB3' ' A' ' 152' ' ' LEU . 4.7 t90 -140.12 156.64 46.47 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.161 -0.472 . . . . 73.11 110.929 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.425 HD12 ' HB ' ' A' ' 61' ' ' ILE . 6.4 mm -122.37 134.98 63.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.242 -0.435 . . . . 75.31 111.14 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.556 ' CE2' HG11 ' A' ' 170' ' ' VAL . 0.0 OUTLIER -112.73 151.97 29.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.156 -0.474 . . . . 64.43 110.878 179.922 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . 0.42 ' CD2' ' HA ' ' A' ' 145' ' ' TYR . 5.5 m-85 -133.7 129.79 37.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.111 -0.495 . . . . 75.42 110.912 -179.85 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . 0.698 ' O ' ' HB2' ' A' ' 171' ' ' GLN . 0.8 OUTLIER -63.03 -30.43 71.59 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.102 -0.499 . . . . 64.14 110.849 -179.949 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.696 ' HB3' ' HD2' ' A' ' 143' ' ' PRO . 8.9 mp -112.02 172.93 3.15 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.637 0.732 . . . . 72.04 110.909 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . 0.721 ' O ' ' OG ' ' A' ' 172' ' ' SER . 53.9 Cg_endo -69.77 -90.51 0.0 OUTLIER 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.701 2.267 . . . . 75.21 112.337 179.857 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . 0.705 ' O ' ' N ' ' A' ' 146' ' ' ARG . 0.7 OUTLIER -53.48 96.21 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.215 -0.448 . . . . 61.12 110.881 -179.976 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . 0.642 ' C ' ' O ' ' A' ' 144' ' ' ASN . 0.0 OUTLIER 13.33 51.97 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.115 -0.493 . . . . 73.12 110.934 -179.911 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . 0.705 ' N ' ' O ' ' A' ' 144' ' ' ASN . 21.2 mtt180 -117.84 163.87 15.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.108 -0.496 . . . . 74.13 110.893 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 84.85 -171.6 47.05 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.742 -0.742 . . . . 50.02 112.482 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -82.05 155.02 25.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.741 0.305 . . . . 74.22 110.87 -179.869 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -92.81 159.99 15.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.15 -0.477 . . . . 70.13 110.897 -179.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . 0.548 ' HA ' ' HB2' ' A' ' 59' ' ' MET . 79.8 m-85 -140.85 130.76 24.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.182 -0.463 . . . . 73.43 110.903 -179.835 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.665 ' HB2' HD11 ' A' ' 61' ' ' ILE . 20.2 tp -78.9 123.95 27.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.104 -0.498 . . . . 61.55 110.89 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 1.01 ' O ' HD13 ' A' ' 152' ' ' LEU . 0.0 OUTLIER -53.82 137.06 39.26 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.222 -0.445 . . . . 74.1 110.951 179.832 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . 0.439 ' N ' HD22 ' A' ' 152' ' ' LEU . 11.3 t0 -161.09 25.92 0.14 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.173 -0.467 . . . . 72.33 110.851 179.876 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.797 ' HB2' ' CD1' ' A' ' 157' ' ' TYR . 0.0 OUTLIER -118.06 -177.32 3.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.207 -0.451 . . . . 52.23 110.852 -179.971 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.784 ' CG ' HD22 ' A' ' 133' ' ' LEU . 0.3 OUTLIER -161.23 -124.39 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.197 -0.456 . . . . 64.14 110.924 179.834 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.58 ' HA ' ' HA ' ' A' ' 131' ' ' LYS . 3.0 tm-20 -67.27 4.19 1.02 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.184 -0.462 . . . . 73.23 110.866 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . 0.797 ' CD1' ' HB2' ' A' ' 154' ' ' LYS . 18.0 m-30 -35.08 151.33 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.168 -0.469 . . . . 74.42 110.918 -179.856 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . 0.47 ' HB2' ' HA ' ' A' ' 103' ' ' ASP . 0.0 OUTLIER -122.93 -35.53 3.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.109 -0.496 . . . . 75.21 110.916 179.985 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -88.44 150.93 47.63 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.553 0.692 . . . . 61.45 110.891 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 -26.32 27.69 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.648 2.232 . . . . 72.54 112.36 179.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.655 ' H ' HD12 ' A' ' 161' ' ' ILE . 4.2 mp -70.46 -8.81 11.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.232 -0.44 . . . . 72.35 111.139 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.644 ' HB3' ' CD1' ' A' ' 157' ' ' TYR . 0.4 OUTLIER -75.81 -14.26 60.29 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.173 -0.467 . . . . 62.35 110.852 179.829 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 28.1 t-105 -89.63 -9.44 49.64 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.233 -0.44 . . . . 74.24 110.97 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 101.88 -36.51 4.19 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.707 -0.759 . . . . 73.0 112.509 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -75.46 127.69 33.67 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.816 0.341 . . . . 72.41 111.117 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -38.1 -39.96 0.45 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.249 -0.432 . . . . 50.52 111.105 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . 0.496 ' C ' ' H ' ' A' ' 169' ' ' ALA . 0.3 OUTLIER -132.11 157.71 77.5 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.673 0.749 . . . . 73.41 110.824 -179.775 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . 0.501 ' HB3' ' O ' ' A' ' 127' ' ' ILE . 54.0 Cg_endo -69.75 28.43 0.18 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.668 2.245 . . . . 63.5 112.372 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 0.496 ' H ' ' C ' ' A' ' 167' ' ' SER . . . -68.84 106.58 2.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.217 -0.447 . . . . 54.54 111.069 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.556 HG11 ' CE2' ' A' ' 139' ' ' PHE . 2.6 t -153.43 164.63 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.233 -0.439 . . . . 55.13 111.143 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 171' ' ' GLN . . . . . 0.698 ' HB2' ' O ' ' A' ' 141' ' ' GLU . 2.1 mm-40 -112.85 -86.81 0.56 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.162 -0.472 . . . . 64.25 110.9 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . 0.721 ' OG ' ' O ' ' A' ' 143' ' ' PRO . 56.7 p -124.41 176.91 6.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.465 . . . . 70.3 110.85 -179.8 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 173' ' ' PHE . . . . . 0.407 ' HB3' ' CD1' ' A' ' 139' ' ' PHE . 0.5 OUTLIER -144.81 168.83 19.29 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.103 -0.498 . . . . 74.42 110.911 -179.974 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 7.8 mtp85 -138.73 139.25 38.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.144 -0.48 . . . . 54.53 110.882 -179.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . 0.402 ' HB2' ' CG ' ' A' ' 94' ' ' TYR . 0.0 OUTLIER -95.7 154.73 17.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.19 -0.459 . . . . 75.13 110.885 -179.951 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . 0.525 HD12 ' O ' ' A' ' 136' ' ' VAL . 2.2 mt -96.0 132.83 39.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.197 -0.456 . . . . 74.02 111.143 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 11.5 p -51.62 147.38 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.224 -0.444 . . . . 73.03 111.104 179.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.167 -0.47 . . . . 75.45 110.847 179.947 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.345 0 N-CA-C 112.468 -0.253 . . . . 74.35 112.468 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.44 ' C ' ' HE1' ' A' ' 47' ' ' TRP . 19.3 p -82.66 133.73 35.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.864 0.364 . . . . 75.12 111.135 -179.865 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 2.9 tttt -123.44 136.94 54.87 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.213 -0.449 . . . . 74.12 110.918 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.654 ' HB ' ' CD1' ' A' ' 47' ' ' TRP . 16.9 tt -137.48 152.1 26.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.199 -0.455 . . . . 71.34 111.101 179.908 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.53 ' HA ' ' O ' ' A' ' 21' ' ' TYR . 13.5 m -132.74 145.13 50.77 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.149 -0.478 . . . . 72.24 111.144 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.756 ' HB2' HD22 ' A' ' 34' ' ' LEU . 1.1 m-85 -132.42 126.03 32.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.214 -0.448 . . . . 72.33 110.831 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.551 ' CG ' ' HA ' ' A' ' 16' ' ' PHE . 12.8 m-85 -112.01 132.83 54.56 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.132 -0.486 . . . . 54.13 110.935 -179.877 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.47 ' HB2' ' HB2' ' A' ' 19' ' ' ARG . 0.0 OUTLIER -61.92 -15.04 40.04 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.115 -0.493 . . . . 71.34 110.935 179.96 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.452 ' HB2' ' O ' ' A' ' 17' ' ' GLN . 71.4 m-20 -134.67 149.01 50.46 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.125 -0.489 . . . . 72.32 110.901 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.557 ' N ' ' HB3' ' A' ' 38' ' ' ASN . 5.8 mtmt -54.26 -176.94 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.198 -0.456 . . . . 55.4 110.911 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 16.6 m120 47.52 30.99 1.81 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.255 -0.43 . . . . 64.34 110.919 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.551 ' HA ' ' CG ' ' A' ' 11' ' ' TYR . 3.3 m-85 51.05 64.51 1.81 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.175 -0.466 . . . . 74.22 110.862 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.452 ' O ' ' HB2' ' A' ' 13' ' ' ASP . 14.2 mt-30 -139.76 158.92 43.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.141 -0.482 . . . . 75.12 110.89 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 92.61 -148.79 19.26 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.729 -0.748 . . . . 35.21 112.51 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.704 ' O ' HD13 ' A' ' 34' ' ' LEU . 0.0 OUTLIER -68.12 77.65 0.24 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.852 0.358 . . . . 71.55 110.879 -179.834 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.474 ' HB2' ' CE1' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -77.86 129.36 35.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.178 -0.465 . . . . 73.2 110.863 -179.882 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.53 ' O ' ' HA ' ' A' ' 9' ' ' THR . 90.8 t80 -123.49 123.99 41.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 62.32 110.888 -179.823 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.481 ' CG ' HG23 ' A' ' 9' ' ' THR . 1.3 m-20 -120.57 133.96 55.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.141 -0.481 . . . . 74.54 110.885 179.873 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -167.72 136.79 2.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.168 -0.469 . . . . 72.35 110.86 -179.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -105.37 5.18 31.57 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.157 -0.474 . . . . 72.35 110.919 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 11.7 t -107.1 169.35 8.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.183 -0.462 . . . . 54.24 110.897 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -64.66 116.89 6.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.172 -0.467 . . . . 74.23 110.874 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.46 ' HB2' ' HB3' ' A' ' 30' ' ' PHE . 4.7 m -118.06 53.67 0.95 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.198 -0.456 . . . . 74.25 110.852 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.529 ' C ' ' HA ' ' A' ' 82' ' ' SER . . . -46.28 -21.05 0.13 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.157 -0.474 . . . . 63.42 111.099 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -127.71 43.61 3.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.209 -0.45 . . . . 74.31 110.895 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.777 ' O ' ' CD2' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -81.11 15.51 1.86 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.19 -0.459 . . . . 64.02 110.837 -179.885 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.535 ' HB2' ' HB3' ' A' ' 81' ' ' SER . 30.7 t60 -78.86 -39.3 35.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.145 -0.48 . . . . 71.34 110.826 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.6 t -56.83 -13.89 2.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.229 -0.441 . . . . 65.24 111.155 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -99.61 -28.08 13.37 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.216 -0.447 . . . . 61.31 110.906 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.756 HD22 ' HB2' ' A' ' 10' ' ' PHE . 18.2 tp -141.12 137.25 32.64 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.157 -0.474 . . . . 64.5 110.916 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 30.6 m -101.07 -43.06 6.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.184 -0.462 . . . . 60.04 110.867 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -118.0 140.97 48.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.118 -0.492 . . . . 64.32 110.854 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.702 ' SG ' ' HB2' ' A' ' 80' ' ' LEU . 5.6 p -110.21 87.4 2.51 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.225 -0.443 . . . . 63.23 110.904 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.557 ' HB3' ' N ' ' A' ' 14' ' ' LYS . 0.2 OUTLIER -78.62 -65.17 1.02 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.186 -0.461 . . . . 75.31 110.881 -179.878 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 5.0 p -118.41 123.9 46.36 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.157 -0.474 . . . . 42.1 110.856 -179.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.908 HD12 ' CH2' ' A' ' 73' ' ' TRP . 25.6 mt -117.27 150.62 19.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.13 -0.486 . . . . 64.1 111.094 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.458 ' HD2' ' CE2' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -145.53 119.22 9.18 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.108 -0.497 . . . . 73.15 110.877 179.871 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.511 ' CG2' HD12 ' A' ' 8' ' ' ILE . 1.4 t -103.54 116.21 46.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.238 -0.437 . . . . 64.44 111.14 179.89 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -111.04 79.94 1.25 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.233 -0.44 . . . . 74.42 110.884 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.436 ' O ' ' HA ' ' A' ' 6' ' ' THR . . . 127.17 108.84 1.55 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.793 -0.717 . . . . 43.31 112.476 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.418 ' HA3' HG22 ' A' ' 6' ' ' THR . . . 52.44 179.79 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.706 -0.759 . . . . 74.42 112.491 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.753 HG23 ' HA ' ' A' ' 63' ' ' PRO . 1.3 m -86.39 169.89 12.5 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.78 0.324 . . . . 60.05 111.154 -179.887 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . 0.654 ' CD1' ' HB ' ' A' ' 8' ' ' ILE . 17.8 m95 -140.86 130.8 24.51 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.203 -0.453 . . . . 75.41 110.913 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.909 ' HB2' ' CG2' ' A' ' 86' ' ' VAL . . . -100.28 107.53 19.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.257 -0.429 . . . . 50.12 111.099 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.756 HG11 HD11 ' A' ' 80' ' ' LEU . 4.9 m -107.7 125.52 64.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.205 -0.452 . . . . 54.43 111.157 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.734 ' HB3' ' HA ' ' A' ' 56' ' ' ALA . 39.9 m-85 -89.05 148.12 23.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.222 -0.445 . . . . 74.31 110.899 -179.89 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.567 ' HB2' ' HB2' ' A' ' 58' ' ' TYR . 59.6 tt0 -48.06 -77.85 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.134 -0.485 . . . . 72.41 110.889 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.579 ' HB3' ' HB2' ' A' ' 55' ' ' PHE . 0.2 OUTLIER -89.76 141.37 28.32 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.623 0.725 . . . . 73.51 110.868 -179.914 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.75 ' HA ' ' OG ' ' A' ' 82' ' ' SER . 53.6 Cg_endo -69.78 138.17 37.11 Favored 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.675 2.25 . . . . 60.43 112.356 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 2.3 t30 65.15 -10.0 0.19 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.264 -0.426 . . . . 73.13 110.884 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.579 ' HB2' ' HB3' ' A' ' 52' ' ' ARG . 3.3 m-30 -103.19 -23.32 13.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.175 -0.466 . . . . 72.53 110.856 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.734 ' HA ' ' HB3' ' A' ' 50' ' ' TYR . . . 55.61 23.36 6.02 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.194 -0.457 . . . . 63.43 111.095 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . 0.63 ' O ' ' C ' ' A' ' 58' ' ' TYR . 0.7 OUTLIER -51.67 -165.79 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.236 -0.438 . . . . 74.41 110.887 -179.975 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.63 ' C ' ' O ' ' A' ' 57' ' ' TRP . 11.1 m-30 -14.08 100.57 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.281 -0.418 . . . . 54.03 110.886 -179.85 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.515 ' HB2' ' HA ' ' A' ' 150' ' ' TYR . 0.0 OUTLIER -58.7 158.87 7.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.151 -0.477 . . . . 75.04 110.876 179.91 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.608 ' OH ' ' O ' ' A' ' 73' ' ' TRP . 0.4 OUTLIER -172.23 97.3 0.16 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.257 -0.429 . . . . 72.12 110.906 -179.843 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.776 HD11 ' HB2' ' A' ' 151' ' ' LEU . 2.5 mp -94.32 119.01 41.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.103 -0.498 . . . . 71.34 111.129 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.849 HD13 HG21 ' A' ' 40' ' ' ILE . 0.3 OUTLIER -88.06 128.92 51.96 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-O 121.557 0.694 . . . . 75.22 110.938 179.912 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.787 ' HD2' HD23 ' A' ' 62' ' ' LEU . 53.5 Cg_endo -69.72 -170.53 0.4 Allowed 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.688 2.259 . . . . 64.43 112.358 179.885 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -88.69 161.36 16.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.244 -0.435 . . . . 65.04 110.892 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 112.58 -166.37 12.16 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.759 -0.734 . . . . 53.43 112.534 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -111.04 150.99 28.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.913 0.387 . . . . 73.45 110.867 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.636 ' HB2' ' O ' ' A' ' 40' ' ' ILE . 10.0 m-85 -140.13 84.44 14.82 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.707 0.765 . . . . 61.31 110.911 -179.874 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 -1.06 7.83 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.739 2.293 . . . . 42.51 112.329 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.495 ' HB2' ' HG2' ' A' ' 72' ' ' ARG . 80.7 mt-10 -154.63 142.6 20.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.23 -0.441 . . . . 75.14 110.905 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.743 ' HA ' ' NE1' ' A' ' 73' ' ' TRP . 35.9 p90 -55.13 -23.79 22.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.464 . . . . 73.32 110.93 -179.865 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -76.43 -16.53 59.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.166 -0.47 . . . . 74.42 110.93 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.495 ' HG2' ' HB2' ' A' ' 69' ' ' GLU . 28.3 mmt180 -70.64 -6.36 36.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.209 -0.45 . . . . 73.12 110.879 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . 0.908 ' CH2' HD12 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -139.35 26.58 2.37 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.181 -0.463 . . . . 72.42 110.933 -179.951 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . 0.463 ' HB2' ' O ' ' A' ' 73' ' ' TRP . 0.0 OUTLIER 75.84 -11.0 1.18 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.23 -0.441 . . . . 72.23 110.891 179.954 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.413 ' C ' ' O ' ' A' ' 74' ' ' MET . . . 37.27 46.55 1.38 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.76 -0.733 . . . . 41.31 112.456 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.731 HD12 ' HG3' ' A' ' 149' ' ' GLN . 0.1 OUTLIER -45.83 -63.25 1.01 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.819 0.342 . . . . 54.21 110.92 -179.927 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -127.32 126.11 42.01 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.208 -0.451 . . . . 42.31 110.873 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -76.03 1.69 14.78 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.187 -0.461 . . . . 65.24 110.889 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -99.89 73.85 1.79 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.176 -0.465 . . . . 74.53 110.837 -179.873 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.756 HD11 HG11 ' A' ' 49' ' ' VAL . 0.1 OUTLIER -81.87 133.08 35.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.155 -0.475 . . . . 74.12 110.874 -179.977 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.622 ' HB3' ' HB3' ' A' ' 53' ' ' PRO . 0.9 OUTLIER -148.31 -130.45 0.06 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.193 -0.458 . . . . 73.21 110.921 -179.957 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.75 ' OG ' ' HA ' ' A' ' 53' ' ' PRO . 0.6 OUTLIER -25.78 131.4 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.124 -0.489 . . . . 65.05 110.893 -179.851 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . 0.512 ' HA ' ' O ' ' A' ' 48' ' ' ALA . 6.9 p -138.1 140.87 40.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.141 -0.482 . . . . 62.41 110.87 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.521 ' N ' ' O ' ' A' ' 48' ' ' ALA . 6.4 mmt85 -139.78 128.36 23.01 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.225 -0.443 . . . . 70.14 110.851 -179.823 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.449 ' N ' ' CZ3' ' A' ' 47' ' ' TRP . . . -50.56 129.59 22.6 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.195 -0.457 . . . . 64.42 111.096 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.909 ' CG2' ' HB2' ' A' ' 48' ' ' ALA . 25.5 t -114.51 142.04 28.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.276 -0.42 . . . . 75.2 111.09 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . 0.59 ' O ' HG23 ' A' ' 136' ' ' VAL . 6.7 m-70 -112.24 110.56 20.88 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.161 -0.472 . . . . 74.23 110.851 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.595 HD13 ' HB3' ' A' ' 178' ' ' GLU . 0.0 OUTLIER -35.95 144.13 0.26 Allowed Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.646 0.736 . . . . 60.3 110.9 -179.959 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.534 ' HB3' ' H ' ' A' ' 136' ' ' VAL . 53.7 Cg_endo -69.7 98.66 0.69 Allowed 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.671 2.247 . . . . 70.12 112.357 179.857 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -104.51 -175.35 2.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.263 -0.426 . . . . 74.02 110.878 -179.84 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 50.95 58.84 8.8 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.757 -0.735 . . . . 71.31 112.523 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.412 ' O ' ' C ' ' A' ' 93' ' ' GLN . . . 123.46 26.07 1.68 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.747 -0.74 . . . . 70.51 112.488 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.45 ' O ' ' HG2' ' A' ' 134' ' ' GLU . 14.6 pt20 37.32 -123.05 0.21 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.834 0.35 . . . . 75.53 110.905 -179.856 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.541 ' HA ' ' HG2' ' A' ' 134' ' ' GLU . 0.1 OUTLIER -123.75 104.41 8.96 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.172 -0.467 . . . . 73.21 110.907 -179.852 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.562 ' HG3' HG11 ' A' ' 132' ' ' VAL . 34.1 tptt -114.37 127.78 56.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.099 -0.5 . . . . 62.15 110.895 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.584 HG21 ' HE2' ' A' ' 173' ' ' PHE . 6.3 tt -149.45 136.93 13.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.221 -0.445 . . . . 73.43 111.073 179.898 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.461 ' HB2' ' O ' ' A' ' 131' ' ' LYS . 0.7 OUTLIER -107.25 123.91 48.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.15 -0.477 . . . . 74.24 110.907 179.949 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.437 ' CG2' HD12 ' A' ' 127' ' ' ILE . 43.9 mm -105.39 131.06 55.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.193 -0.458 . . . . 70.12 111.121 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.7 ' HB2' ' HB2' ' A' ' 129' ' ' SER . 45.9 m-85 -118.79 150.39 39.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.152 -0.476 . . . . 74.34 110.897 179.911 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 50.8 tt0 -85.76 -56.08 3.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.187 -0.461 . . . . 71.1 110.852 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 47.6 mttt -101.01 164.93 11.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.167 -0.47 . . . . 65.14 110.89 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.402 ' HA2' ' OG ' ' A' ' 129' ' ' SER . . . -65.53 152.4 51.51 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.768 -0.73 . . . . 73.12 112.49 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.425 ' HA ' ' HB2' ' A' ' 158' ' ' ARG . 27.8 t0 65.76 45.37 2.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.831 0.348 . . . . 75.14 110.852 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.576 ' N ' ' CD2' ' A' ' 104' ' ' PHE . 0.1 OUTLIER 47.48 33.81 3.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.233 -0.44 . . . . 75.24 110.912 -179.881 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 53.3 m -96.35 159.61 14.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.164 -0.471 . . . . 75.04 110.861 -179.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 83.91 -135.67 14.01 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.695 -0.764 . . . . 70.25 112.49 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 37.7 tp60 -88.65 120.67 30.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.783 0.325 . . . . 61.14 110.879 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 3.5 ttp -108.25 132.8 53.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.154 -0.475 . . . . 72.11 110.862 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -137.72 137.09 37.97 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.221 -0.445 . . . . 70.24 110.925 -179.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -119.33 104.43 10.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.097 -0.501 . . . . 75.42 110.854 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 8.9 t -112.82 133.38 54.85 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.183 -0.462 . . . . 54.41 111.152 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.475 ' HA ' ' O ' ' A' ' 94' ' ' TYR . 1.6 t -115.5 32.49 6.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.22 -0.446 . . . . 72.34 111.131 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -142.38 -173.91 3.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.219 -0.446 . . . . 75.33 110.88 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -72.08 150.66 43.71 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.117 -0.492 . . . . 75.13 110.837 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . 0.424 ' O ' ' HB2' ' A' ' 172' ' ' SER . 57.4 m -140.99 107.16 6.27 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-O 121.631 0.729 . . . . 71.34 110.884 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.618 ' O ' ' CB ' ' A' ' 172' ' ' SER . 53.3 Cg_endo -69.74 -35.97 11.73 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.657 2.238 . . . . 71.25 112.311 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.611 ' HB3' ' CB ' ' A' ' 120' ' ' GLU . 0.1 OUTLIER -142.0 112.37 7.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.228 -0.442 . . . . 60.45 110.865 -179.78 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.54 ' HB ' ' O ' ' A' ' 171' ' ' GLN . 5.4 tt -67.24 -32.87 59.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.18 -0.463 . . . . 72.53 111.104 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' MET . . . . . 0.643 ' O ' ' HA ' ' A' ' 123' ' ' HIS . 0.0 OUTLIER -87.28 -38.99 15.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.178 -0.464 . . . . 72.11 110.897 179.855 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.611 ' CB ' ' HB3' ' A' ' 117' ' ' SER . 3.9 tp10 -72.18 -15.43 61.96 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.218 -0.446 . . . . 55.52 110.896 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 13.0 mm100 -114.44 -45.82 3.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.123 -0.49 . . . . 75.05 110.925 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.538 ' HB2' ' O ' ' A' ' 118' ' ' ILE . 47.4 m-85 -106.23 -19.71 13.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.195 -0.457 . . . . 74.31 110.879 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . 0.643 ' HA ' ' O ' ' A' ' 119' ' ' MET . 12.3 m80 70.58 29.21 3.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.137 -0.483 . . . . 73.14 110.889 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.403 ' SD ' HG22 ' A' ' 98' ' ' ILE . 4.0 mtt -107.19 83.42 1.82 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.208 -0.451 . . . . 71.43 110.838 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 4.0 ptp180 -50.58 -35.43 30.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.239 -0.437 . . . . 65.03 110.86 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.462 ' HB3' ' HG2' ' A' ' 168' ' ' PRO . 18.8 mt-10 -142.42 136.14 29.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.231 -0.44 . . . . 75.15 110.899 -179.915 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.529 HD11 HD13 ' A' ' 118' ' ' ILE . 3.9 mm -96.3 104.47 15.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.174 -0.466 . . . . 64.54 111.076 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 12.6 m170 -70.79 -34.95 72.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.157 -0.474 . . . . 72.34 110.833 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . 0.7 ' HB2' ' HB2' ' A' ' 99' ' ' PHE . 13.7 m -133.75 149.85 51.47 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.204 -0.453 . . . . 53.23 110.883 -179.822 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . 0.496 ' O ' ' HE3' ' A' ' 154' ' ' LYS . 0.1 OUTLIER -148.68 117.92 6.85 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.151 -0.477 . . . . 74.13 110.865 -179.913 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.501 ' HG2' ' HG2' ' A' ' 156' ' ' GLU . 11.2 mtpt -113.87 155.56 25.53 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.21 -0.45 . . . . 70.31 110.892 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.562 HG11 ' HG3' ' A' ' 95' ' ' LYS . 15.5 t 83.43 160.91 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.221 -0.445 . . . . 54.44 111.104 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.863 HD22 ' O ' ' A' ' 133' ' ' LEU . 0.0 OUTLIER -177.79 127.3 0.13 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.166 -0.47 . . . . 70.5 110.923 179.911 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.541 ' HG2' ' HA ' ' A' ' 94' ' ' TYR . 0.1 OUTLIER -97.8 171.34 8.37 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.162 -0.472 . . . . 70.04 110.898 179.938 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . 0.493 ' C ' ' O ' ' A' ' 134' ' ' GLU . . . -30.41 -78.84 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.741 -0.742 . . . . 72.43 112.468 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.79 HG21 HG13 ' A' ' 86' ' ' VAL . 2.8 t -128.53 144.91 36.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.781 0.324 . . . . 72.13 111.158 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' TRP . . . . . 0.65 ' HB3' ' CB ' ' A' ' 152' ' ' LEU . 60.2 t-105 -146.14 163.94 33.77 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.214 -0.448 . . . . 74.53 110.897 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.511 ' CD1' ' HB ' ' A' ' 61' ' ' ILE . 5.8 mm -132.74 138.07 52.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.231 -0.441 . . . . 64.51 111.091 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.748 ' HB2' ' HB2' ' A' ' 150' ' ' TYR . 69.7 m-85 -114.49 152.48 31.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.139 -0.482 . . . . 64.24 110.855 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . 0.734 ' CD2' ' HA ' ' A' ' 145' ' ' TYR . 13.7 m-85 -128.34 144.19 51.1 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.149 -0.478 . . . . 74.44 110.878 -179.874 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . 0.57 ' C ' ' HB2' ' A' ' 171' ' ' GLN . 27.4 tt0 -84.77 -7.96 59.0 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.106 -0.497 . . . . 75.22 110.864 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.476 ' C ' ' H ' ' A' ' 144' ' ' ASN . 7.2 mp -120.05 149.07 48.29 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.579 0.704 . . . . 74.01 110.954 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . 0.709 ' HD3' ' CD ' ' A' ' 171' ' ' GLN . 54.0 Cg_endo -69.71 32.75 0.19 Allowed 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.695 2.264 . . . . 73.13 112.375 179.857 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . 1.007 ' O ' ' N ' ' A' ' 146' ' ' ARG . 0.0 OUTLIER -169.34 101.91 0.35 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.201 -0.454 . . . . 73.43 110.923 -179.961 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . 0.734 ' HA ' ' CD2' ' A' ' 140' ' ' TYR . 0.3 OUTLIER 3.59 48.39 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.155 -0.475 . . . . 74.4 110.945 -179.866 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . 1.007 ' N ' ' O ' ' A' ' 144' ' ' ASN . 1.1 mtp85 -136.16 178.02 7.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.069 -0.514 . . . . 61.34 110.835 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . 0.445 ' O ' HD11 ' A' ' 76' ' ' LEU . . . 83.04 -175.48 53.01 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.764 -0.731 . . . . 44.14 112.482 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 53.3 mtt180 -62.45 146.22 52.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.705 0.288 . . . . 73.41 110.852 -179.84 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' GLN . . . . . 0.731 ' HG3' HD12 ' A' ' 76' ' ' LEU . 1.4 mt-30 -98.22 135.39 39.92 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.202 -0.454 . . . . 74.02 110.933 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . 0.748 ' HB2' ' HB2' ' A' ' 139' ' ' PHE . 54.5 m-85 -121.46 125.43 46.84 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.23 -0.441 . . . . 73.51 110.888 -179.863 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.776 ' HB2' HD11 ' A' ' 61' ' ' ILE . 19.8 tp -76.89 122.71 25.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.113 -0.494 . . . . 70.31 110.908 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 1.034 ' O ' HD13 ' A' ' 152' ' ' LEU . 0.0 OUTLIER -50.74 130.71 25.19 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.156 -0.475 . . . . 60.42 110.893 179.893 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -163.86 26.48 0.08 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.21 -0.45 . . . . 75.21 110.837 179.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.826 ' O ' ' HG3' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -108.09 -174.76 2.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.191 -0.458 . . . . 62.13 110.865 -179.999 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.826 ' HG3' ' O ' ' A' ' 154' ' ' LYS . 1.5 mptt -162.44 -127.74 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.195 -0.457 . . . . 54.41 110.936 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.569 ' HG2' ' O ' ' A' ' 156' ' ' GLU . 2.2 tm-20 -70.46 6.91 1.2 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.247 -0.433 . . . . 74.51 110.835 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . 0.701 ' CE1' ' HA ' ' A' ' 154' ' ' LYS . 18.9 m-30 -32.44 149.97 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.176 -0.466 . . . . 71.11 110.894 -179.835 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . 0.442 ' HB3' ' CE2' ' A' ' 104' ' ' PHE . 0.0 OUTLIER -126.5 -34.73 2.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.108 -0.496 . . . . 73.5 110.864 -179.992 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -89.07 151.69 47.22 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.638 0.732 . . . . 71.35 110.892 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . 0.485 ' HB2' ' HD3' ' A' ' 168' ' ' PRO . 54.1 Cg_endo -69.72 -24.11 30.2 Favored 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 122.645 2.23 . . . . 75.55 112.401 179.896 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.6 ' H ' HD12 ' A' ' 161' ' ' ILE . 3.7 mp -69.41 -9.39 12.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.189 -0.459 . . . . 63.4 111.131 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.67 ' HB3' ' CD1' ' A' ' 157' ' ' TYR . 0.3 OUTLIER -77.2 -13.38 59.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.14 -0.482 . . . . 72.42 110.87 179.88 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -87.64 3.17 48.78 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.186 -0.461 . . . . 73.22 110.968 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 88.42 -36.15 3.47 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.713 -0.756 . . . . 72.23 112.516 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -80.76 129.86 34.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.795 0.331 . . . . 61.33 111.086 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -37.95 -38.33 0.3 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.218 -0.447 . . . . 74.3 111.121 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . 0.485 ' C ' ' H ' ' A' ' 169' ' ' ALA . 0.3 OUTLIER -127.12 158.88 67.67 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.647 0.737 . . . . 74.1 110.857 -179.785 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . 0.485 ' HD3' ' HB2' ' A' ' 160' ' ' PRO . 54.5 Cg_endo -69.7 26.3 0.17 Allowed 'Trans proline' 0 C--N 1.341 0.132 0 C-N-CA 122.715 2.277 . . . . 75.33 112.355 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 0.485 ' H ' ' C ' ' A' ' 167' ' ' SER . . . -65.95 107.81 1.98 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.25 -0.432 . . . . 70.4 111.129 179.909 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.505 HG12 ' N ' ' A' ' 171' ' ' GLN . 19.2 t -151.15 160.52 3.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.215 -0.448 . . . . 64.23 111.141 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 171' ' ' GLN . . . . . 0.709 ' CD ' ' HD3' ' A' ' 143' ' ' PRO . 6.5 mm-40 -109.41 -91.85 0.44 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.175 -0.466 . . . . 74.41 110.922 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . 0.618 ' CB ' ' O ' ' A' ' 116' ' ' PRO . 60.1 p -127.98 168.91 14.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.199 -0.455 . . . . 72.23 110.873 -179.821 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 173' ' ' PHE . . . . . 0.612 ' CD1' ' N ' ' A' ' 173' ' ' PHE . 0.1 OUTLIER -146.75 165.79 28.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.146 -0.479 . . . . 70.45 110.918 -179.953 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . 0.414 ' HG2' ' HE2' ' A' ' 140' ' ' TYR . 0.7 OUTLIER -146.33 169.93 17.82 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.185 -0.462 . . . . 74.13 110.852 -179.916 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . 0.507 ' HB3' ' CZ3' ' A' ' 137' ' ' TRP . 0.0 OUTLIER -89.1 -162.26 0.85 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.12 -0.491 . . . . 73.43 110.86 -179.913 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . 0.489 HD11 HG12 ' A' ' 136' ' ' VAL . 27.4 mt -124.68 141.82 43.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.157 -0.474 . . . . 73.04 111.133 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 44.1 t -75.25 140.88 16.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.171 -0.468 . . . . 54.15 111.123 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . 0.595 ' HB3' HD13 ' A' ' 88' ' ' LEU . 35.8 mt-10 . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.217 -0.447 . . . . 75.21 110.856 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.339 0 N-CA-C 112.501 -0.239 . . . . 61.51 112.501 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.451 ' C ' ' HE1' ' A' ' 47' ' ' TRP . 20.0 p -82.35 138.84 34.39 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.89 0.376 . . . . 71.53 111.105 -179.833 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.492 ' N ' ' HE1' ' A' ' 47' ' ' TRP . 2.9 tttt -124.91 134.66 52.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.232 -0.44 . . . . 74.32 110.878 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.483 HG13 HG23 ' A' ' 42' ' ' VAL . 15.4 tt -136.56 149.2 26.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.21 -0.45 . . . . 74.15 111.189 179.833 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.51 HG23 ' CG ' ' A' ' 22' ' ' ASP . 10.3 m -130.87 141.35 50.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.184 -0.462 . . . . 63.32 111.145 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.781 ' HB2' HD22 ' A' ' 34' ' ' LEU . 0.9 OUTLIER -128.83 128.36 43.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.275 -0.421 . . . . 72.3 110.845 -179.981 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.539 ' CG ' ' HA ' ' A' ' 16' ' ' PHE . 22.9 m-85 -114.28 132.12 56.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.102 -0.499 . . . . 60.34 110.927 -179.862 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.458 ' HG2' ' HB2' ' A' ' 36' ' ' ARG . 0.0 OUTLIER -60.01 -23.47 63.7 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.145 -0.479 . . . . 64.12 110.888 -179.98 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 65.6 m-20 -128.58 152.41 48.35 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.142 -0.481 . . . . 73.33 110.869 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.445 ' N ' ' HB3' ' A' ' 38' ' ' ASN . 31.8 mtmt -55.67 -175.18 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.166 -0.47 . . . . 75.31 110.897 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 17.8 m120 46.43 33.58 1.98 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.237 -0.438 . . . . 63.13 110.84 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.539 ' HA ' ' CG ' ' A' ' 11' ' ' TYR . 4.0 m-85 48.95 57.97 5.86 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.181 -0.463 . . . . 71.24 110.899 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 -132.81 158.56 42.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.153 -0.476 . . . . 64.43 110.931 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 94.7 -150.52 19.76 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.746 -0.74 . . . . 53.03 112.447 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.796 ' O ' HD13 ' A' ' 34' ' ' LEU . 0.0 OUTLIER -69.6 80.45 0.41 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.794 0.33 . . . . 74.43 110.875 -179.838 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.466 ' HB2' ' CE1' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -79.11 128.5 33.36 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.188 -0.46 . . . . 73.51 110.835 -179.927 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.471 ' CD2' ' CD2' ' A' ' 30' ' ' PHE . 71.2 t80 -124.49 125.36 44.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.15 -0.477 . . . . 74.45 110.921 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.51 ' CG ' HG23 ' A' ' 9' ' ' THR . 1.2 m-20 -119.48 132.61 55.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.128 -0.487 . . . . 72.01 110.91 179.899 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 10.4 t -157.09 130.25 7.83 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.195 -0.457 . . . . 54.32 110.907 -179.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.415 ' HA ' ' HA ' ' A' ' 7' ' ' LYS . 3.9 p30 -99.4 5.76 46.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.214 -0.448 . . . . 60.02 110.866 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 47.1 t -117.68 161.46 19.63 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.208 -0.451 . . . . 74.44 110.9 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 31.5 m-20 -45.12 120.51 2.44 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.176 -0.465 . . . . 72.1 110.887 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.62 ' HB2' ' HB3' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -114.27 43.87 1.8 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.185 -0.461 . . . . 61.22 110.869 -179.909 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.546 ' O ' ' HA ' ' A' ' 82' ' ' SER . . . -49.67 -21.53 1.07 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 35.04 111.105 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 60.2 t0 -129.58 40.99 3.51 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.222 -0.445 . . . . 73.44 110.862 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.795 ' O ' ' CD2' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -81.48 17.79 1.31 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.211 -0.449 . . . . 63.14 110.907 -179.934 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.54 ' HB2' ' HB3' ' A' ' 81' ' ' SER . 40.7 t60 -81.98 -33.56 30.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.166 -0.47 . . . . 50.31 110.845 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.0 t -66.96 -5.67 13.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.194 -0.457 . . . . 50.1 111.114 -179.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -108.29 -27.68 9.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.231 -0.44 . . . . 74.42 110.92 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.796 HD13 ' O ' ' A' ' 19' ' ' ARG . 23.3 tp -141.51 145.99 35.85 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.111 -0.495 . . . . 72.15 110.95 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.3 m -112.66 -34.93 5.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.181 -0.463 . . . . 45.33 110.806 -179.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.51 ' NH2' HD21 ' A' ' 38' ' ' ASN . 2.0 mtp85 -115.79 142.09 47.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.148 -0.478 . . . . 72.04 110.842 -179.877 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.616 ' SG ' ' HB2' ' A' ' 80' ' ' LEU . 6.3 p -120.02 64.81 0.82 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.139 -0.482 . . . . 74.31 110.899 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.51 HD21 ' NH2' ' A' ' 36' ' ' ARG . 3.0 m120 -63.66 -66.64 0.51 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.17 -0.468 . . . . 74.41 110.893 -179.885 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 5.0 p -113.81 127.31 55.95 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.113 -0.494 . . . . 71.21 110.881 -179.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.797 HD12 ' CH2' ' A' ' 73' ' ' TRP . 18.7 mt -120.95 149.37 23.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.131 -0.486 . . . . 70.21 111.146 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.462 ' HD2' ' CE2' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -143.5 119.3 10.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.189 -0.459 . . . . 71.01 110.902 179.874 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.571 HG21 ' HB2' ' A' ' 47' ' ' TRP . 1.0 OUTLIER -106.06 118.07 52.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.245 -0.434 . . . . 74.23 111.152 179.877 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -114.76 76.73 1.01 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.178 -0.465 . . . . 62.21 110.888 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.4 ' O ' ' HB ' ' A' ' 6' ' ' THR . . . 140.87 90.13 0.17 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.788 -0.72 . . . . 74.45 112.524 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 58.46 172.36 0.36 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.75 -0.738 . . . . 45.42 112.484 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.749 HG23 ' HA ' ' A' ' 63' ' ' PRO . 0.2 OUTLIER -66.01 172.35 3.79 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.828 0.347 . . . . 73.31 111.132 -179.867 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . 0.571 ' HB2' HG21 ' A' ' 42' ' ' VAL . 6.6 m95 -146.97 129.55 15.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.2 -0.454 . . . . 73.11 110.948 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.798 ' HB2' ' CG2' ' A' ' 86' ' ' VAL . . . -91.13 127.7 36.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.263 -0.426 . . . . 75.04 111.092 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.729 HG11 HD11 ' A' ' 80' ' ' LEU . 21.1 m -125.86 145.0 34.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.215 -0.448 . . . . 72.02 111.115 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.895 ' HB3' ' CB ' ' A' ' 56' ' ' ALA . 6.7 m-85 -122.84 143.68 49.7 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.212 -0.449 . . . . 75.52 110.925 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.584 ' HG2' ' N ' ' A' ' 52' ' ' ARG . 0.5 OUTLIER -49.46 -84.04 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.176 -0.465 . . . . 55.1 110.871 179.987 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.862 ' O ' ' HB2' ' A' ' 56' ' ' ALA . 0.8 OUTLIER -81.91 136.43 47.59 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.586 0.707 . . . . 75.11 110.866 -179.89 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.635 ' HB3' ' HB3' ' A' ' 81' ' ' SER . 53.4 Cg_endo -69.74 135.79 31.41 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.668 2.245 . . . . 71.43 112.326 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.437 ' HB3' ' CE2' ' A' ' 55' ' ' PHE . 7.1 t-20 72.17 -6.15 1.59 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.174 -0.466 . . . . 74.34 110.945 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.437 ' CE2' ' HB3' ' A' ' 54' ' ' ASN . 0.1 OUTLIER -144.46 -75.36 0.24 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.136 -0.484 . . . . 72.31 110.877 -179.996 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.895 ' CB ' ' HB3' ' A' ' 50' ' ' TYR . . . 47.58 82.55 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.132 -0.485 . . . . 63.25 111.059 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . 0.61 ' O ' ' CD2' ' A' ' 58' ' ' TYR . 28.5 m0 -64.41 31.08 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.254 -0.43 . . . . 73.42 110.938 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.635 ' H ' ' C ' ' A' ' 56' ' ' ALA . 3.8 m-85 -160.29 115.6 2.3 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.264 -0.426 . . . . 73.25 110.935 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -82.39 136.59 34.94 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.128 -0.487 . . . . 63.34 110.85 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.629 ' HA ' ' OE1' ' A' ' 149' ' ' GLN . 5.4 t80 -146.39 124.86 12.37 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.243 -0.435 . . . . 74.43 110.9 -179.899 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.847 ' N ' HD12 ' A' ' 61' ' ' ILE . 1.0 OUTLIER -109.21 116.95 53.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.13 -0.486 . . . . 74.14 111.164 179.883 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.804 HD23 ' HD2' ' A' ' 63' ' ' PRO . 0.3 OUTLIER -89.34 129.17 48.48 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.635 0.731 . . . . 64.32 110.909 179.93 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.804 ' HD2' HD23 ' A' ' 62' ' ' LEU . 53.5 Cg_endo -69.8 -175.28 1.11 Allowed 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.664 2.242 . . . . 72.52 112.323 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.48 162.7 15.58 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.216 -0.447 . . . . 73.23 110.897 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 112.34 -171.56 14.15 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.797 -0.716 . . . . 73.45 112.533 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -103.5 150.96 23.4 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.871 0.367 . . . . 74.14 110.885 -179.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.662 ' HB2' ' O ' ' A' ' 40' ' ' ILE . 19.7 m-85 -139.26 85.34 15.59 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.669 0.747 . . . . 74.22 110.923 -179.853 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 -0.01 6.26 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.687 2.258 . . . . 64.35 112.373 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.553 ' HB2' ' HG2' ' A' ' 72' ' ' ARG . 49.3 mt-10 -155.81 142.18 18.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.177 -0.465 . . . . 63.34 110.855 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.737 ' HA ' ' NE1' ' A' ' 73' ' ' TRP . 30.0 p90 -54.85 -20.52 8.9 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.158 -0.473 . . . . 72.22 110.918 -179.857 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -80.41 -18.72 48.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.144 -0.48 . . . . 72.43 110.945 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.553 ' HG2' ' HB2' ' A' ' 69' ' ' GLU . 26.5 mmt180 -69.9 -7.35 39.62 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.466 . . . . 71.0 110.887 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . 0.797 ' CH2' HD12 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -139.28 18.49 2.58 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.176 -0.465 . . . . 71.51 110.929 -179.957 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . 0.461 ' C ' ' O ' ' A' ' 73' ' ' TRP . 0.0 OUTLIER 33.54 43.98 0.06 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.212 -0.449 . . . . 73.23 110.863 179.95 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -53.31 125.44 31.43 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.784 -0.722 . . . . 53.44 112.472 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.499 HD11 ' HA ' ' A' ' 148' ' ' ARG . 6.2 mt -52.85 -53.98 40.98 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.862 0.363 . . . . 72.23 110.9 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 -130.68 151.66 50.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.198 -0.456 . . . . 64.43 110.866 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -84.22 13.29 5.38 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.201 -0.454 . . . . 62.33 110.864 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.406 ' HD2' ' HG2' ' A' ' 51' ' ' GLU . 0.0 OUTLIER -103.6 67.72 0.91 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 73.52 110.87 -179.904 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.729 HD11 HG11 ' A' ' 49' ' ' VAL . 0.1 OUTLIER -72.0 132.9 44.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.225 -0.443 . . . . 72.23 110.919 -179.98 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.635 ' HB3' ' HB3' ' A' ' 53' ' ' PRO . 1.3 m -151.09 -122.48 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.193 -0.458 . . . . 73.21 110.841 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.606 ' OG ' ' HA ' ' A' ' 53' ' ' PRO . 0.1 OUTLIER -38.33 106.06 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.136 -0.484 . . . . 74.23 110.844 -179.782 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . 0.67 ' HB3' HG12 ' A' ' 49' ' ' VAL . 9.3 p -134.38 131.34 38.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.15 -0.477 . . . . 72.32 110.904 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.602 ' N ' ' O ' ' A' ' 48' ' ' ALA . 2.9 mmt-85 -113.76 164.75 13.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 60.32 110.874 -179.835 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -79.82 130.31 35.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.219 -0.446 . . . . 53.33 111.084 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.798 ' CG2' ' HB2' ' A' ' 48' ' ' ALA . 54.3 t -116.07 136.05 54.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.195 -0.457 . . . . 75.34 111.162 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . 0.641 ' O ' HG23 ' A' ' 136' ' ' VAL . 45.8 m80 -114.92 105.8 13.42 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.183 -0.462 . . . . 64.15 110.854 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.577 HD13 ' HB3' ' A' ' 178' ' ' GLU . 0.0 OUTLIER -34.02 146.55 0.13 Allowed Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.56 0.695 . . . . 63.23 110.926 -179.976 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.548 ' HB3' ' H ' ' A' ' 136' ' ' VAL . 53.5 Cg_endo -69.77 109.99 2.45 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.669 2.246 . . . . 71.03 112.356 179.843 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -106.83 158.84 16.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.236 -0.438 . . . . 74.23 110.841 -179.818 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 49.7 79.52 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.743 -0.742 . . . . 40.34 112.488 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 124.64 11.19 4.59 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.725 -0.75 . . . . 54.45 112.492 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.46 ' O ' ' HG2' ' A' ' 134' ' ' GLU . 14.8 pt20 38.02 -122.84 0.25 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.824 0.345 . . . . 72.44 110.923 -179.833 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.475 ' CE2' ' HD2' ' A' ' 175' ' ' ARG . 0.2 OUTLIER -124.19 101.97 7.47 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.209 -0.45 . . . . 74.2 110.903 -179.876 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.505 ' HG3' HG11 ' A' ' 132' ' ' VAL . 47.4 tptt -110.89 126.55 54.82 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.07 -0.514 . . . . 75.44 110.893 179.886 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.75 HD13 ' N ' ' A' ' 97' ' ' GLN . 0.0 OUTLIER -149.38 138.04 14.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.262 -0.426 . . . . 52.14 111.146 179.808 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.75 ' N ' HD13 ' A' ' 96' ' ' ILE . 2.2 mt-30 -105.52 121.23 43.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.182 -0.463 . . . . 64.01 110.889 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.59 ' CD1' HD12 ' A' ' 96' ' ' ILE . 23.0 mm -97.75 131.23 45.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.15 -0.477 . . . . 71.33 111.125 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.675 ' CB ' ' HB2' ' A' ' 129' ' ' SER . 37.6 m-85 -120.96 140.54 51.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.181 -0.463 . . . . 75.13 110.868 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 59.6 tt0 -75.79 -61.7 1.84 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.15 -0.477 . . . . 73.13 110.907 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 39.9 mttt -96.6 171.42 8.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.128 -0.487 . . . . 71.13 110.898 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.424 ' HA2' ' OG ' ' A' ' 129' ' ' SER . . . -70.5 153.46 51.68 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.719 -0.753 . . . . 71.52 112.493 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.461 ' HA ' ' HB2' ' A' ' 158' ' ' ARG . 26.8 t0 65.27 46.11 2.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.802 0.334 . . . . 73.13 110.861 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.593 ' N ' ' CD2' ' A' ' 104' ' ' PHE . 0.1 OUTLIER 47.54 33.18 2.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.227 -0.442 . . . . 75.12 110.853 -179.948 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 57.8 m -96.13 159.45 14.95 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.168 -0.469 . . . . 51.42 110.847 -179.774 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 84.92 -137.29 15.4 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.748 -0.739 . . . . 74.21 112.504 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 30.1 tp60 -88.84 114.2 25.2 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.805 0.336 . . . . 64.11 110.94 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 1.5 ttp -101.36 144.12 30.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.185 -0.461 . . . . 64.35 110.9 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -149.47 136.01 19.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.218 -0.446 . . . . 75.02 110.899 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -117.36 102.49 9.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.107 -0.497 . . . . 65.32 110.867 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 11.9 t -113.05 129.15 56.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.166 -0.47 . . . . 61.23 111.134 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.474 ' HA ' ' O ' ' A' ' 94' ' ' TYR . 1.5 t -96.74 22.52 8.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.224 -0.443 . . . . 74.53 111.199 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -151.2 137.56 18.53 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.155 -0.475 . . . . 74.15 110.848 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 30.7 p30 -53.89 178.27 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.16 -0.473 . . . . 64.13 110.882 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . 0.498 ' O ' ' HB2' ' A' ' 172' ' ' SER . 0.8 OUTLIER -155.65 151.31 21.89 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.57 0.7 . . . . 64.45 110.888 -179.92 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.453 ' O ' ' C ' ' A' ' 143' ' ' PRO . 54.1 Cg_endo -69.77 -33.94 15.54 Favored 'Trans proline' 0 C--O 1.231 0.134 0 C-N-CA 122.659 2.24 . . . . 64.35 112.383 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.632 ' HB3' ' CB ' ' A' ' 120' ' ' GLU . 0.1 OUTLIER -148.3 109.55 4.35 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 64.41 110.83 -179.821 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.636 HD13 HD11 ' A' ' 127' ' ' ILE . 4.3 tt -60.45 -30.0 45.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.156 -0.475 . . . . 72.33 111.125 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' MET . . . . . 0.603 ' O ' ' HA ' ' A' ' 123' ' ' HIS . 5.0 ttt -86.14 -41.91 14.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.227 -0.442 . . . . 74.34 110.835 179.873 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.632 ' CB ' ' HB3' ' A' ' 117' ' ' SER . 10.0 tp10 -68.03 -14.11 62.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.229 -0.441 . . . . 63.11 110.913 -179.924 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 6.9 tp-100 -115.17 -48.27 2.82 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.092 -0.503 . . . . 71.45 110.91 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.516 ' HB2' ' O ' ' A' ' 118' ' ' ILE . 53.4 m-85 -103.34 -20.4 14.1 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.198 -0.455 . . . . 75.12 110.879 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . 0.603 ' HA ' ' O ' ' A' ' 119' ' ' MET . 0.1 OUTLIER 71.33 29.87 2.68 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.104 -0.498 . . . . 63.04 110.859 -179.997 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.557 ' SD ' HG22 ' A' ' 98' ' ' ILE . 4.5 mtt -107.85 86.34 2.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.256 -0.429 . . . . 62.41 110.892 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 1.9 ptp85 -51.97 -40.44 60.89 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.239 -0.437 . . . . 72.3 110.886 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.469 ' HB3' ' HG2' ' A' ' 168' ' ' PRO . 12.9 mt-10 -137.51 133.51 34.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.191 -0.458 . . . . 73.51 110.907 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.636 HD11 HD13 ' A' ' 118' ' ' ILE . 3.7 mm -93.48 101.57 12.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.135 -0.484 . . . . 65.23 111.149 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 11.8 m80 -69.9 -34.16 73.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.2 -0.455 . . . . 74.21 110.855 179.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . 0.675 ' HB2' ' CB ' ' A' ' 99' ' ' PHE . 8.3 m -134.02 154.3 51.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.231 -0.44 . . . . 34.15 110.838 -179.756 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . 0.615 ' SG ' HD11 ' A' ' 96' ' ' ILE . 0.1 OUTLIER -155.13 118.54 4.46 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.154 -0.475 . . . . 75.43 110.886 -179.929 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.561 ' C ' HG23 ' A' ' 132' ' ' VAL . 7.7 mtpp -112.86 154.0 27.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.201 -0.454 . . . . 55.34 110.912 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.561 HG23 ' C ' ' A' ' 131' ' ' LYS . 15.2 t 87.17 162.57 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.218 -0.446 . . . . 54.23 111.127 179.9 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.819 HD22 ' HG3' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -179.65 125.63 0.08 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.161 -0.472 . . . . 70.01 110.895 179.939 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.46 ' HG2' ' O ' ' A' ' 93' ' ' GLN . 0.0 OUTLIER -93.71 176.9 6.19 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.186 -0.461 . . . . 71.44 110.867 179.953 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . 0.452 ' HA3' ' HA ' ' A' ' 89' ' ' PRO . . . -37.26 -67.41 0.45 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.768 -0.73 . . . . 65.14 112.488 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.789 HG11 ' CG1' ' A' ' 86' ' ' VAL . 13.4 t -140.65 145.24 25.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.913 0.387 . . . . 74.21 111.073 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' TRP . . . . . 0.679 ' H ' HD12 ' A' ' 152' ' ' LEU . 0.1 OUTLIER -147.51 168.68 21.33 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.117 -0.492 . . . . 52.23 110.898 179.988 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.574 ' CG2' ' HB2' ' A' ' 149' ' ' GLN . 63.0 mt -138.13 133.72 44.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.219 -0.446 . . . . 73.32 111.153 179.879 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.466 ' HB2' ' HB2' ' A' ' 150' ' ' TYR . 83.6 m-85 -98.4 179.92 4.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.191 -0.459 . . . . 72.34 110.855 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . 0.42 ' CD2' ' HA ' ' A' ' 145' ' ' TYR . 0.4 OUTLIER -153.54 126.0 8.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.145 -0.479 . . . . 73.44 110.936 -179.829 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . 0.59 ' O ' ' HB2' ' A' ' 171' ' ' GLN . 27.0 tt0 -62.85 -28.1 69.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.125 -0.489 . . . . 61.42 110.926 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.726 ' HB3' ' HD2' ' A' ' 143' ' ' PRO . 9.4 mp -115.88 173.5 2.96 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.565 0.698 . . . . 71.24 110.928 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . 0.726 ' HD2' ' HB3' ' A' ' 142' ' ' LEU . 54.0 Cg_endo -69.73 -90.92 0.01 OUTLIER 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.653 2.235 . . . . 71.43 112.373 179.836 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . 0.727 ' O ' ' N ' ' A' ' 146' ' ' ARG . 1.6 m-80 -54.05 96.69 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 62.0 110.881 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . 0.652 ' C ' ' O ' ' A' ' 144' ' ' ASN . 5.8 m-85 11.87 53.1 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.157 -0.474 . . . . 52.23 110.895 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . 0.727 ' N ' ' O ' ' A' ' 144' ' ' ASN . 19.5 mtt-85 -116.8 170.41 8.63 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.113 -0.494 . . . . 73.24 110.88 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 70.39 -172.08 42.41 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.747 -0.74 . . . . 75.11 112.481 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.499 ' HA ' HD11 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -87.75 132.62 34.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.761 0.315 . . . . 72.41 110.897 -179.851 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' GLN . . . . . 0.629 ' OE1' ' HA ' ' A' ' 60' ' ' TYR . 0.8 OUTLIER -88.53 157.73 18.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.204 -0.453 . . . . 71.24 110.928 -179.922 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . 0.466 ' HB2' ' HB2' ' A' ' 139' ' ' PHE . 12.6 m-85 -122.84 141.48 51.82 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.187 -0.46 . . . . 64.3 110.891 -179.83 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.579 ' HB2' HD11 ' A' ' 61' ' ' ILE . 7.8 tp -76.16 123.65 26.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.105 -0.498 . . . . 75.33 110.858 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 1.08 ' O ' HD13 ' A' ' 152' ' ' LEU . 0.0 OUTLIER -50.9 135.5 24.24 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.179 -0.464 . . . . 74.11 110.911 179.847 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . 0.46 ' N ' HD22 ' A' ' 152' ' ' LEU . 7.9 t0 -165.4 27.68 0.05 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.193 -0.458 . . . . 72.53 110.882 179.845 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.817 ' O ' HD13 ' A' ' 133' ' ' LEU . 0.0 OUTLIER -114.88 -175.23 2.64 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.224 -0.444 . . . . 60.24 110.874 -179.993 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.819 ' HG3' HD22 ' A' ' 133' ' ' LEU . 0.0 OUTLIER -161.02 -127.54 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.202 -0.454 . . . . 64.44 110.887 179.878 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.562 ' HG2' ' O ' ' A' ' 156' ' ' GLU . 2.9 tm-20 -68.54 6.0 0.92 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.245 -0.434 . . . . 74.15 110.895 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . 0.769 ' CE1' ' HA ' ' A' ' 154' ' ' LYS . 20.4 m-30 -34.61 152.85 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.141 -0.481 . . . . 75.21 110.869 -179.828 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . 0.461 ' HB2' ' HA ' ' A' ' 103' ' ' ASP . 0.0 OUTLIER -125.76 -35.74 2.48 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.132 -0.486 . . . . 65.25 110.865 -179.99 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -86.72 151.23 52.32 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.563 0.697 . . . . 63.14 110.866 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . 0.455 ' HB2' ' HD3' ' A' ' 168' ' ' PRO . 53.6 Cg_endo -69.74 -28.01 25.85 Favored 'Trans proline' 0 C--O 1.232 0.207 0 C-N-CA 122.658 2.238 . . . . 71.35 112.316 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.622 ' H ' HD12 ' A' ' 161' ' ' ILE . 3.6 mp -64.08 -11.75 10.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.258 -0.428 . . . . 62.4 111.133 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.635 ' HB3' ' CD1' ' A' ' 157' ' ' TYR . 0.3 OUTLIER -75.32 -13.42 60.42 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.152 -0.477 . . . . 72.22 110.896 179.813 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' TRP . . . . . 0.44 ' CH2' ' CE1' ' A' ' 139' ' ' PHE . 3.4 m95 -87.16 0.16 55.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.227 -0.442 . . . . 71.22 110.93 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 91.64 -35.68 3.89 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.743 -0.741 . . . . 55.04 112.461 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -82.05 130.75 35.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.798 0.332 . . . . 61.53 111.144 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -39.01 -38.42 0.45 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.244 -0.435 . . . . 72.33 111.069 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . 0.487 ' C ' ' H ' ' A' ' 169' ' ' ALA . 0.3 OUTLIER -128.35 156.35 76.99 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.666 0.746 . . . . 64.15 110.858 -179.765 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . 0.469 ' HG2' ' HB3' ' A' ' 126' ' ' GLU . 54.1 Cg_endo -69.72 27.86 0.18 Allowed 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.715 2.277 . . . . 64.1 112.332 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 0.487 ' H ' ' C ' ' A' ' 167' ' ' SER . . . -68.27 104.61 1.89 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.246 -0.434 . . . . 74.42 111.111 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.472 HG12 ' N ' ' A' ' 171' ' ' GLN . 3.4 t -152.94 164.37 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.188 -0.46 . . . . 72.54 111.149 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 171' ' ' GLN . . . . . 0.65 ' OE1' ' HB3' ' A' ' 143' ' ' PRO . 1.7 mm-40 -113.88 -85.79 0.59 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.244 -0.435 . . . . 71.51 110.867 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . 0.706 ' OG ' ' O ' ' A' ' 143' ' ' PRO . 33.6 p -127.05 -179.53 4.89 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.198 -0.456 . . . . 73.52 110.863 -179.815 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -145.49 170.89 15.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.077 -0.511 . . . . 75.24 110.875 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . 0.419 ' HD2' ' CE2' ' A' ' 140' ' ' TYR . 0.0 OUTLIER -136.09 157.58 46.49 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.152 -0.477 . . . . 74.55 110.865 -179.89 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . 0.475 ' HD2' ' CE2' ' A' ' 94' ' ' TYR . 1.8 ptt180 -98.86 -171.93 2.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.142 -0.481 . . . . 74.42 110.905 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . 0.556 HD11 HG12 ' A' ' 136' ' ' VAL . 3.5 mt -125.33 130.99 72.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.223 -0.444 . . . . 75.05 111.085 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 9.1 p -53.84 137.67 14.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.182 -0.463 . . . . 72.24 111.135 179.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . 0.577 ' HB3' HD13 ' A' ' 88' ' ' LEU . 1.8 mm-40 . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.203 -0.453 . . . . 73.23 110.883 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.323 0 N-CA-C 112.491 -0.244 . . . . 70.31 112.491 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.404 ' HB ' ' O ' ' A' ' 44' ' ' GLY . 26.2 p -81.54 136.48 35.6 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.85 0.357 . . . . 74.43 111.165 -179.876 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.425 ' N ' ' HE1' ' A' ' 47' ' ' TRP . 2.6 tttt -124.67 136.96 54.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.228 -0.442 . . . . 54.44 110.919 179.912 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.524 ' HB ' ' CD1' ' A' ' 47' ' ' TRP . 16.0 tt -136.98 148.98 26.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.219 -0.446 . . . . 71.44 111.168 179.862 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.548 HG22 ' CE2' ' A' ' 11' ' ' TYR . 19.0 m -132.58 137.36 47.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.218 -0.446 . . . . 64.1 111.184 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.771 ' HB2' HD22 ' A' ' 34' ' ' LEU . 0.5 OUTLIER -125.46 128.06 47.47 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.183 -0.462 . . . . 75.35 110.874 -179.982 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.564 ' CG ' ' HA ' ' A' ' 16' ' ' PHE . 17.0 m-85 -113.16 131.98 55.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.103 -0.499 . . . . 73.42 110.937 -179.831 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.464 ' HB2' ' HB2' ' A' ' 19' ' ' ARG . 0.0 OUTLIER -61.71 -14.53 32.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.162 -0.472 . . . . 74.33 110.852 -179.958 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.424 ' HB2' ' O ' ' A' ' 17' ' ' GLN . 77.4 m-20 -135.41 149.56 49.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.138 -0.483 . . . . 63.52 110.89 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.526 ' N ' ' HB3' ' A' ' 38' ' ' ASN . 30.3 mtmm -54.61 -176.68 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.224 -0.444 . . . . 72.22 110.874 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 16.5 m120 46.99 30.58 1.29 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.185 -0.461 . . . . 71.33 110.908 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.564 ' HA ' ' CG ' ' A' ' 11' ' ' TYR . 3.6 m-85 51.24 65.38 1.5 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.152 -0.477 . . . . 62.31 110.867 -180.0 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.424 ' O ' ' HB2' ' A' ' 13' ' ' ASP . 16.9 mt-30 -140.26 160.87 38.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.113 -0.494 . . . . 72.22 110.899 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 90.98 -147.99 19.16 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.736 -0.745 . . . . 73.42 112.519 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.709 ' O ' HD13 ' A' ' 34' ' ' LEU . 0.0 OUTLIER -68.9 77.47 0.32 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.83 0.348 . . . . 65.23 110.908 -179.893 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.457 ' HB2' ' CE1' ' A' ' 11' ' ' TYR . 0.7 OUTLIER -77.83 127.82 33.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.148 -0.478 . . . . 75.1 110.846 -179.892 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.491 ' O ' ' HA ' ' A' ' 9' ' ' THR . 88.2 t80 -122.01 124.0 42.97 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.199 -0.455 . . . . 72.32 110.922 -179.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.473 ' CG ' HG23 ' A' ' 9' ' ' THR . 1.2 m-20 -120.19 134.37 55.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.1 -0.5 . . . . 74.23 110.86 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -167.49 134.32 2.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.199 -0.455 . . . . 70.0 110.889 -179.887 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.406 ' HA ' ' HA ' ' A' ' 7' ' ' LYS . 6.1 p-10 -102.2 5.45 40.2 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.174 -0.466 . . . . 73.03 110.857 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 11.7 t -107.79 169.38 8.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.171 -0.468 . . . . 71.21 110.932 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -64.96 117.15 7.19 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.198 -0.455 . . . . 51.1 110.875 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.473 ' HB2' ' HB3' ' A' ' 30' ' ' PHE . 4.4 m -116.95 53.65 0.89 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.178 -0.465 . . . . 73.24 110.876 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.533 ' C ' ' HA ' ' A' ' 82' ' ' SER . . . -46.44 -20.72 0.13 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.176 -0.465 . . . . 70.42 111.126 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 57.0 t0 -128.3 42.71 3.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.21 -0.45 . . . . 72.31 110.877 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.76 ' O ' ' CD2' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -80.0 14.44 1.83 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.187 -0.461 . . . . 74.42 110.92 -179.905 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.503 ' HB2' ' HB3' ' A' ' 81' ' ' SER . 28.3 t60 -77.61 -40.13 43.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.104 -0.498 . . . . 71.21 110.853 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.6 t -56.15 -14.98 3.08 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.215 -0.448 . . . . 63.55 111.129 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -99.07 -27.23 13.93 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.258 -0.428 . . . . 65.22 110.896 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.771 HD22 ' HB2' ' A' ' 10' ' ' PHE . 17.4 tp -141.97 135.84 29.75 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.146 -0.479 . . . . 74.3 110.909 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 20.5 m -99.36 -42.62 6.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 74.42 110.876 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -118.15 141.48 48.45 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.104 -0.498 . . . . 73.34 110.849 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.633 ' SG ' ' HB2' ' A' ' 80' ' ' LEU . 4.6 p -110.73 86.77 2.38 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.148 -0.478 . . . . 71.31 110.877 -179.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.526 ' HB3' ' N ' ' A' ' 14' ' ' LYS . 0.2 OUTLIER -77.97 -66.29 0.86 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.175 -0.466 . . . . 75.1 110.851 -179.863 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 6.1 p -117.08 123.11 46.01 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.201 -0.454 . . . . 63.22 110.84 -179.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.767 HD12 ' CH2' ' A' ' 73' ' ' TRP . 27.2 mt -116.27 150.2 18.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.092 -0.503 . . . . 72.3 111.107 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.486 ' HD2' ' CE2' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -145.63 118.51 8.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.211 -0.45 . . . . 64.21 110.901 179.832 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.503 ' O ' HG12 ' A' ' 42' ' ' VAL . 1.3 t -104.87 115.7 47.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.244 -0.435 . . . . 75.15 111.172 179.836 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -110.84 77.82 1.07 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.164 -0.471 . . . . 71.31 110.901 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.404 ' O ' ' HB ' ' A' ' 6' ' ' THR . . . 135.28 101.98 0.69 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.768 -0.729 . . . . 55.33 112.493 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 53.74 179.17 0.12 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.747 -0.739 . . . . 73.01 112.515 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.747 HG23 ' HA ' ' A' ' 63' ' ' PRO . 0.6 OUTLIER -79.67 172.61 13.56 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.819 0.342 . . . . 64.2 111.121 -179.885 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . 0.586 ' H ' HG22 ' A' ' 46' ' ' THR . 14.8 m95 -144.07 130.2 19.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 73.54 110.906 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.883 ' HB2' ' CG2' ' A' ' 86' ' ' VAL . . . -97.18 112.0 23.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.288 -0.415 . . . . 74.02 111.158 179.858 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.564 HG11 ' CD1' ' A' ' 80' ' ' LEU . 3.6 m -113.12 129.73 68.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.227 -0.442 . . . . 71.14 111.117 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.692 ' HB3' ' HA ' ' A' ' 56' ' ' ALA . 33.0 m-85 -95.78 148.59 22.42 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.156 -0.475 . . . . 74.44 110.92 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.659 ' HB2' ' HB2' ' A' ' 58' ' ' TYR . 35.1 tt0 -45.43 -80.85 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.099 -0.501 . . . . 73.35 110.885 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.622 ' HB3' ' CD2' ' A' ' 55' ' ' PHE . 0.3 OUTLIER -90.54 146.38 34.22 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.621 0.724 . . . . 74.5 110.88 -179.891 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.751 ' HA ' ' OG ' ' A' ' 82' ' ' SER . 54.2 Cg_endo -69.71 134.71 28.74 Favored 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.701 2.267 . . . . 74.34 112.38 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 1.5 t30 65.63 -9.84 0.23 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.214 -0.448 . . . . 75.15 110.884 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.622 ' CD2' ' HB3' ' A' ' 52' ' ' ARG . 4.7 m-30 -98.75 -24.16 15.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.173 -0.467 . . . . 73.33 110.914 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.692 ' HA ' ' HB3' ' A' ' 50' ' ' TYR . . . 56.62 20.83 5.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.102 -0.499 . . . . 62.44 111.141 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . 0.634 ' HB3' ' OE1' ' A' ' 51' ' ' GLU . 0.1 OUTLIER -50.7 -166.11 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.167 -0.47 . . . . 71.41 110.93 -179.958 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.775 ' HB3' HD11 ' A' ' 76' ' ' LEU . 6.9 m-30 -13.08 101.87 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.251 -0.431 . . . . 71.5 110.877 -179.866 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.41 ' HB2' ' HA ' ' A' ' 150' ' ' TYR . 0.0 OUTLIER -68.73 154.24 42.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.12 -0.491 . . . . 62.01 110.883 179.881 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.89 ' CD2' HD22 ' A' ' 76' ' ' LEU . 5.1 t80 -173.72 102.13 0.11 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.213 -0.449 . . . . 73.34 110.906 -179.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.74 HD13 HG12 ' A' ' 138' ' ' ILE . 4.8 mp -88.21 118.71 34.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.093 -0.503 . . . . 73.21 111.076 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.775 HD23 ' HD2' ' A' ' 63' ' ' PRO . 0.2 OUTLIER -83.61 129.59 59.21 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.603 0.716 . . . . 61.21 110.856 179.924 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.775 ' HD2' HD23 ' A' ' 62' ' ' LEU . 53.3 Cg_endo -69.87 -172.34 0.58 Allowed 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.652 2.234 . . . . 65.44 112.288 179.878 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -88.74 161.9 16.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 73.4 110.911 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 112.07 -167.74 12.5 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.778 -0.725 . . . . 74.14 112.511 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -109.08 154.45 22.24 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.901 0.381 . . . . 71.21 110.862 -179.863 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.632 ' HB2' ' O ' ' A' ' 40' ' ' ILE . 14.6 m-85 -142.05 84.96 11.3 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.667 0.746 . . . . 74.02 110.925 -179.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.438 ' HD2' ' HG3' ' A' ' 72' ' ' ARG . 53.8 Cg_endo -69.73 -0.06 6.34 Favored 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.682 2.254 . . . . 54.21 112.335 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.564 ' HB2' ' HG2' ' A' ' 72' ' ' ARG . 47.9 mt-10 -156.5 143.53 18.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.226 -0.443 . . . . 64.24 110.891 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.739 ' HA ' ' NE1' ' A' ' 73' ' ' TRP . 35.9 p90 -54.43 -22.35 12.35 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.161 -0.472 . . . . 74.11 110.915 -179.836 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -79.55 -18.05 52.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.121 -0.491 . . . . 74.42 110.907 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.564 ' HG2' ' HB2' ' A' ' 69' ' ' GLU . 28.2 mmt180 -69.28 -7.75 39.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.453 . . . . 65.52 110.883 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . 0.767 ' CH2' HD12 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -138.6 15.82 2.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.183 -0.462 . . . . 64.12 110.925 -179.971 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . 0.431 ' C ' ' O ' ' A' ' 73' ' ' TRP . 0.0 OUTLIER 36.0 43.84 0.22 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.213 -0.449 . . . . 72.33 110.894 179.93 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -51.93 123.92 22.31 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.763 -0.732 . . . . 32.0 112.506 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.89 HD22 ' CD2' ' A' ' 60' ' ' TYR . 1.1 pt? -59.09 -33.2 70.56 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.803 0.335 . . . . 73.23 110.864 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.704 ' H ' HD23 ' A' ' 76' ' ' LEU . 17.7 t-20 -147.49 139.43 24.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.239 -0.437 . . . . 74.4 110.902 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -78.12 18.51 0.51 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.168 -0.469 . . . . 75.01 110.896 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -107.17 73.28 0.92 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.186 -0.461 . . . . 64.53 110.873 -179.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.633 ' HB2' ' SG ' ' A' ' 37' ' ' CYS . 0.0 OUTLIER -82.31 133.98 35.25 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.228 -0.442 . . . . 71.21 110.871 -179.955 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.575 ' HB3' ' HB3' ' A' ' 53' ' ' PRO . 0.9 OUTLIER -147.56 -126.34 0.06 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.173 -0.467 . . . . 71.41 110.889 -179.942 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.751 ' OG ' ' HA ' ' A' ' 53' ' ' PRO . 0.4 OUTLIER -29.88 123.34 0.17 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.148 -0.478 . . . . 72.23 110.866 -179.844 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . 0.528 ' HA ' ' O ' ' A' ' 48' ' ' ALA . 9.2 p -133.42 141.56 47.91 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.149 -0.478 . . . . 72.35 110.873 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.466 ' N ' ' O ' ' A' ' 48' ' ' ALA . 1.5 mmt85 -138.44 130.22 28.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.204 -0.453 . . . . 74.14 110.886 -179.872 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.451 ' N ' ' CZ3' ' A' ' 47' ' ' TRP . . . -50.87 128.84 22.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.21 -0.45 . . . . 74.35 111.095 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.883 ' CG2' ' HB2' ' A' ' 48' ' ' ALA . 54.3 t -114.61 130.64 68.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.19 -0.459 . . . . 63.44 111.16 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . 0.483 ' O ' HG23 ' A' ' 136' ' ' VAL . 72.1 m-70 -114.67 119.03 35.33 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.154 -0.475 . . . . 71.31 110.881 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.731 HD13 ' HA ' ' A' ' 178' ' ' GLU . 0.0 OUTLIER -33.64 146.1 0.12 Allowed Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.556 0.693 . . . . 74.02 110.915 -179.956 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.676 ' HA ' ' HA3' ' A' ' 135' ' ' GLY . 53.4 Cg_endo -69.74 -79.29 0.01 OUTLIER 'Trans proline' 0 C--O 1.231 0.151 0 C-N-CA 122.721 2.281 . . . . 74.43 112.306 179.879 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.452 ' H ' ' HG2' ' A' ' 89' ' ' PRO . 67.2 m -109.07 -178.56 3.61 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.183 -0.462 . . . . 73.24 110.893 -179.827 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -100.94 4.15 55.96 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.794 -0.717 . . . . 31.04 112.488 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -125.19 -55.43 0.17 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.744 -0.741 . . . . 62.13 112.523 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.485 ' HG3' ' OG1' ' A' ' 112' ' ' THR . 11.5 pt20 -165.88 -170.05 1.66 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.837 0.351 . . . . 74.22 110.888 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.774 ' CD2' ' HB2' ' A' ' 134' ' ' GLU . 38.8 t80 -116.43 106.07 13.21 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.199 -0.455 . . . . 74.34 110.919 -179.859 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.467 ' HA ' ' HB ' ' A' ' 112' ' ' THR . 36.7 tptt -74.95 126.2 30.49 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.131 -0.486 . . . . 74.3 110.913 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.54 HD13 ' N ' ' A' ' 97' ' ' GLN . 0.0 OUTLIER -149.1 140.92 17.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.228 -0.442 . . . . 74.42 111.122 179.896 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.54 ' N ' HD13 ' A' ' 96' ' ' ILE . 1.3 mt-30 -109.63 125.84 53.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.197 -0.456 . . . . 73.14 110.888 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.55 ' CG2' HD12 ' A' ' 127' ' ' ILE . 2.3 mp -106.05 132.86 52.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.153 -0.476 . . . . 72.51 111.15 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.715 ' HB2' ' HB2' ' A' ' 129' ' ' SER . 46.3 m-85 -119.38 150.45 40.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.18 -0.464 . . . . 73.4 110.925 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.554 ' HA ' ' CE ' ' A' ' 124' ' ' MET . 62.9 tt0 -85.15 -52.18 6.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.177 -0.465 . . . . 61.21 110.892 -179.873 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 40.7 mttt -105.48 166.47 10.41 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.099 -0.501 . . . . 75.13 110.868 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.404 ' HA2' ' OG ' ' A' ' 129' ' ' SER . . . -67.12 152.46 52.75 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.722 -0.751 . . . . 73.31 112.522 179.885 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.44 ' HA ' ' HB2' ' A' ' 158' ' ' ARG . 42.3 t0 66.78 46.16 1.76 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.829 0.347 . . . . 72.01 110.885 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.546 ' N ' ' CD2' ' A' ' 104' ' ' PHE . 0.3 OUTLIER 48.3 33.08 3.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.208 -0.451 . . . . 74.2 110.866 -179.904 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 57.8 m -96.5 160.82 14.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.16 -0.473 . . . . 72.4 110.846 -179.802 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 81.97 -143.74 23.39 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.712 -0.756 . . . . 61.44 112.479 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 38.1 tp60 -80.13 120.45 24.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.755 0.312 . . . . 32.35 110.877 -179.837 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 5.7 ttp -108.84 134.17 51.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.212 -0.449 . . . . 62.13 110.886 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -139.22 135.5 34.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.205 -0.452 . . . . 60.2 110.925 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -114.83 94.52 4.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.061 -0.518 . . . . 75.24 110.872 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.502 HG22 ' CD1' ' A' ' 98' ' ' ILE . 5.7 t -114.77 144.13 43.98 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.148 -0.478 . . . . 70.32 111.165 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.485 ' OG1' ' HG3' ' A' ' 93' ' ' GLN . 6.6 t -129.66 47.28 2.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.234 -0.439 . . . . 51.12 111.112 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -151.54 157.92 42.89 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.221 -0.445 . . . . 73.51 110.882 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.404 ' OD1' ' HG3' ' A' ' 175' ' ' ARG . 2.6 m-20 -56.2 148.46 18.21 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.112 -0.494 . . . . 75.01 110.874 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . 0.741 ' O ' ' HB2' ' A' ' 172' ' ' SER . 42.7 t -139.23 124.3 11.69 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.616 0.722 . . . . 63.42 110.899 -179.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.532 ' O ' ' C ' ' A' ' 143' ' ' PRO . 53.6 Cg_endo -69.78 -30.44 22.16 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.688 2.259 . . . . 72.53 112.322 -179.89 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.623 ' HB3' ' CB ' ' A' ' 120' ' ' GLU . 0.1 OUTLIER -149.18 106.72 3.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.201 -0.454 . . . . 42.13 110.853 -179.877 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.609 HD13 HD11 ' A' ' 127' ' ' ILE . 3.9 tt -61.7 -30.48 48.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.127 -0.488 . . . . 62.13 111.1 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' MET . . . . . 0.702 ' O ' ' HA ' ' A' ' 123' ' ' HIS . 0.1 OUTLIER -91.02 -42.01 10.77 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.186 -0.461 . . . . 75.35 110.949 179.819 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.623 ' CB ' ' HB3' ' A' ' 117' ' ' SER . 2.9 tp10 -70.26 -11.79 61.15 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.201 -0.454 . . . . 63.42 110.861 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 29.8 mm100 -112.93 -52.14 2.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.183 -0.462 . . . . 63.12 110.966 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 30.9 m-85 -102.75 14.18 32.59 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.194 -0.457 . . . . 64.54 110.88 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . 0.702 ' HA ' ' O ' ' A' ' 119' ' ' MET . 21.5 m-70 47.13 25.11 0.48 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.118 -0.492 . . . . 74.43 110.835 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.606 ' HE2' HD13 ' A' ' 127' ' ' ILE . 0.0 OUTLIER -100.78 124.93 47.13 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.239 -0.437 . . . . 74.42 110.892 179.953 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 3.0 ptp85 -96.71 -35.05 11.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.257 -0.428 . . . . 74.2 110.838 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.473 ' HB3' ' HG2' ' A' ' 168' ' ' PRO . 34.8 mt-10 -145.54 115.52 7.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.18 -0.464 . . . . 64.13 110.859 -179.905 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.609 HD11 HD13 ' A' ' 118' ' ' ILE . 3.1 mm -74.13 100.45 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.121 -0.49 . . . . 74.44 111.11 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . 0.436 ' CD2' ' HG3' ' A' ' 168' ' ' PRO . 12.9 m170 -69.04 -36.21 77.46 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.138 -0.483 . . . . 72.12 110.867 179.85 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . 0.715 ' HB2' ' HB2' ' A' ' 99' ' ' PHE . 19.3 m -134.03 144.18 48.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.193 -0.458 . . . . 73.12 110.875 -179.795 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . 0.629 ' O ' ' O ' ' A' ' 155' ' ' LYS . 1.4 m -140.31 114.65 9.24 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.124 -0.489 . . . . 63.02 110.925 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.523 ' HA ' ' O ' ' A' ' 155' ' ' LYS . 5.5 mtpp -110.22 150.63 28.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.178 -0.465 . . . . 72.44 110.92 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.471 ' HB ' ' O ' ' A' ' 131' ' ' LYS . 12.6 t 81.2 158.49 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.233 -0.44 . . . . 73.01 111.164 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.855 HD22 ' HG2' ' A' ' 155' ' ' LYS . 0.1 OUTLIER 176.27 124.29 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.213 -0.449 . . . . 62.12 110.96 179.957 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.774 ' HB2' ' CD2' ' A' ' 94' ' ' TYR . 3.7 mm-40 -86.8 -167.82 2.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.196 -0.456 . . . . 62.51 110.884 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . 0.676 ' HA3' ' HA ' ' A' ' 89' ' ' PRO . . . -48.77 -92.85 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.759 -0.734 . . . . 45.11 112.465 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.933 ' HB ' HD12 ' A' ' 176' ' ' ILE . 2.3 t -103.21 148.26 8.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.779 0.323 . . . . 54.25 111.17 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' TRP . . . . . 0.641 ' HB2' ' CE2' ' A' ' 94' ' ' TYR . 0.0 OUTLIER -156.73 158.84 37.64 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.227 -0.442 . . . . 75.01 110.932 179.919 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.74 HG12 HD13 ' A' ' 61' ' ' ILE . 5.0 mt -134.25 136.44 53.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.262 -0.426 . . . . 74.12 111.145 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.464 ' HB2' ' HB2' ' A' ' 150' ' ' TYR . 0.1 OUTLIER -102.15 160.36 14.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.157 -0.474 . . . . 72.31 110.848 179.983 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -129.33 115.51 17.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.124 -0.489 . . . . 64.25 110.908 -179.846 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . 0.589 ' O ' ' HB2' ' A' ' 171' ' ' GLN . 0.6 OUTLIER -54.91 -33.39 62.04 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.128 -0.487 . . . . 61.11 110.841 -179.983 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.696 ' HB3' ' HD2' ' A' ' 143' ' ' PRO . 8.8 mp -113.36 172.81 3.25 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.643 0.735 . . . . 63.32 110.914 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . 0.792 ' O ' ' OG ' ' A' ' 172' ' ' SER . 53.1 Cg_endo -69.78 -93.15 0.01 OUTLIER 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.7 2.266 . . . . 65.23 112.355 179.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . 0.745 ' O ' ' N ' ' A' ' 146' ' ' ARG . 0.3 OUTLIER -50.18 99.05 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.22 -0.445 . . . . 75.44 110.906 179.971 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . 0.643 ' C ' ' O ' ' A' ' 144' ' ' ASN . 34.5 m-85 11.59 52.23 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.199 -0.455 . . . . 75.43 110.942 -179.905 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . 0.745 ' N ' ' O ' ' A' ' 144' ' ' ASN . 12.4 mtp85 -117.86 172.14 7.59 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.128 -0.487 . . . . 73.33 110.892 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 80.11 -170.27 53.58 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.747 -0.739 . . . . 53.31 112.448 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.63 ' CG ' HD12 ' A' ' 76' ' ' LEU . 0.6 OUTLIER -92.54 152.62 19.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.767 0.318 . . . . 72.21 110.881 -179.84 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' GLN . . . . . 0.488 ' CD ' HG21 ' A' ' 138' ' ' ILE . 47.2 mt-30 -88.25 150.34 23.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.256 -0.429 . . . . 73.24 110.893 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . 0.464 ' HB2' ' HB2' ' A' ' 139' ' ' PHE . 96.2 m-85 -130.5 122.42 27.62 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.164 -0.471 . . . . 75.52 110.906 -179.876 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.492 HD23 ' OH ' ' A' ' 50' ' ' TYR . 33.9 tp -62.49 134.51 56.51 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.098 -0.501 . . . . 75.32 110.946 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.952 ' O ' HD13 ' A' ' 152' ' ' LEU . 0.0 OUTLIER -63.8 133.24 53.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.17 -0.468 . . . . 75.45 110.878 179.991 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -165.76 25.21 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.174 -0.466 . . . . 71.32 110.875 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.802 ' HA ' ' CE1' ' A' ' 157' ' ' TYR . 0.2 OUTLIER -106.65 -156.62 0.58 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.182 -0.463 . . . . 71.52 110.876 179.991 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.855 ' HG2' HD22 ' A' ' 133' ' ' LEU . 0.0 OUTLIER 168.9 -132.95 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.179 -0.464 . . . . 74.31 110.868 179.888 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.478 ' HA ' ' HA ' ' A' ' 131' ' ' LYS . 2.6 tm-20 -61.57 3.29 0.14 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.176 -0.465 . . . . 55.3 110.886 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . 0.802 ' CE1' ' HA ' ' A' ' 154' ' ' LYS . 15.1 m-30 -34.37 150.22 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.184 -0.462 . . . . 64.23 110.865 -179.831 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . 0.518 ' O ' ' OG ' ' A' ' 129' ' ' SER . 0.0 OUTLIER -126.31 -38.69 2.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.073 -0.512 . . . . 65.42 110.84 -179.961 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . 0.446 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 0.3 OUTLIER -85.12 150.8 55.9 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.538 0.685 . . . . 73.15 110.915 179.969 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . 0.52 ' HB3' ' HB3' ' A' ' 168' ' ' PRO . 53.5 Cg_endo -69.78 -23.29 30.87 Favored 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.726 2.284 . . . . 65.33 112.339 179.892 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.65 ' H ' HD12 ' A' ' 161' ' ' ILE . 4.0 mp -75.47 -3.24 4.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.179 -0.464 . . . . 65.44 111.117 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.68 ' HB3' ' CD1' ' A' ' 157' ' ' TYR . 0.3 OUTLIER -76.53 -14.44 60.02 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.164 -0.471 . . . . 74.1 110.838 179.911 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 11.4 t90 -94.61 2.24 55.62 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.226 -0.443 . . . . 74.54 110.875 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 90.42 -36.21 3.64 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.752 -0.737 . . . . 74.41 112.526 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -71.77 128.12 34.75 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.766 0.317 . . . . 63.5 111.137 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -42.16 -34.89 0.82 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.198 -0.456 . . . . 44.33 111.086 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . 0.486 ' C ' ' H ' ' A' ' 169' ' ' ALA . 0.3 OUTLIER -131.25 157.84 76.96 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.663 0.744 . . . . 75.25 110.861 -179.771 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . 0.52 ' HB3' ' HB3' ' A' ' 160' ' ' PRO . 54.3 Cg_endo -69.69 21.46 0.17 Allowed 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.699 2.266 . . . . 74.21 112.406 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 0.486 ' H ' ' C ' ' A' ' 167' ' ' SER . . . -62.47 102.05 0.29 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.181 -0.463 . . . . 55.21 111.129 179.881 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 2.8 t -154.12 155.63 5.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.188 -0.46 . . . . 53.52 111.129 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 171' ' ' GLN . . . . . 0.589 ' HB2' ' O ' ' A' ' 141' ' ' GLU . 1.5 tm0? -116.75 -134.71 0.34 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.162 -0.472 . . . . 75.33 110.935 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . 0.792 ' OG ' ' O ' ' A' ' 143' ' ' PRO . 12.1 p -64.46 171.87 2.94 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.246 -0.434 . . . . 71.11 110.896 -179.843 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 173' ' ' PHE . . . . . 0.467 ' CG ' ' HH2' ' A' ' 137' ' ' TRP . 2.3 p90 -147.43 175.57 10.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.111 -0.495 . . . . 72.13 110.881 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . 0.45 ' O ' ' HG2' ' A' ' 174' ' ' ARG . 1.7 ptm180 -140.32 136.62 33.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.166 -0.47 . . . . 73.44 110.897 -179.912 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . 0.469 ' HB2' ' HB3' ' A' ' 94' ' ' TYR . 0.0 OUTLIER -105.56 138.26 42.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.18 -0.464 . . . . 70.12 110.881 -179.913 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . 0.933 HD12 ' HB ' ' A' ' 136' ' ' VAL . 1.9 mt -79.44 144.93 10.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.194 -0.457 . . . . 75.04 111.138 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 4.6 p -136.19 156.28 36.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.175 -0.466 . . . . 72.12 111.135 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . 0.731 ' HA ' HD13 ' A' ' 88' ' ' LEU . 1.1 mp0 . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.146 -0.479 . . . . 74.44 110.884 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 38.9 mtm . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.764 0.316 . . . . 72.34 110.871 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -60.71 -66.32 0.55 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.234 -0.439 . . . . 73.11 110.867 -179.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 51.48 34.32 11.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.148 -0.478 . . . . 74.22 110.951 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 4.0 t -71.24 -32.26 68.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.172 -0.467 . . . . 54.45 111.182 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 160.32 125.45 0.78 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.781 -0.724 . . . . 73.13 112.531 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.494 ' C ' ' HE1' ' A' ' 47' ' ' TRP . 4.6 p -82.09 135.1 35.36 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.828 0.347 . . . . 73.43 111.151 -179.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 3.4 tttt -121.56 135.94 54.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.223 -0.444 . . . . 74.5 110.894 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.615 ' HB ' ' CD1' ' A' ' 47' ' ' TRP . 15.9 tt -136.78 153.39 30.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.208 -0.451 . . . . 51.54 111.127 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.524 ' HA ' ' O ' ' A' ' 21' ' ' TYR . 17.9 m -134.01 143.89 48.38 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.193 -0.458 . . . . 71.13 111.14 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.721 ' HB2' HD22 ' A' ' 34' ' ' LEU . 0.8 OUTLIER -131.28 127.9 38.71 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.203 -0.453 . . . . 71.43 110.894 -179.983 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.545 ' CG ' ' HA ' ' A' ' 16' ' ' PHE . 11.1 m-85 -113.19 132.51 55.46 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.161 -0.472 . . . . 71.12 110.868 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.424 ' HB2' ' HB2' ' A' ' 19' ' ' ARG . 0.0 OUTLIER -60.11 -16.07 28.89 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.102 -0.499 . . . . 73.42 110.876 179.998 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.437 ' HB2' ' O ' ' A' ' 17' ' ' GLN . 72.2 m-20 -134.68 150.54 50.64 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.174 -0.467 . . . . 71.11 110.847 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.489 ' N ' ' HB3' ' A' ' 38' ' ' ASN . 38.7 mtmt -55.25 -176.12 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.181 -0.463 . . . . 75.42 110.873 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 18.8 m120 46.54 32.48 1.65 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.193 -0.458 . . . . 70.33 110.869 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.545 ' HA ' ' CG ' ' A' ' 11' ' ' TYR . 3.0 m-85 49.68 63.94 1.96 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.174 -0.466 . . . . 72.54 110.887 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.437 ' O ' ' HB2' ' A' ' 13' ' ' ASP . 3.8 mt-30 -138.76 158.59 43.94 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.132 -0.485 . . . . 74.44 110.892 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 92.86 -148.86 19.25 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.716 -0.754 . . . . 32.35 112.473 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.75 ' O ' HD13 ' A' ' 34' ' ' LEU . 0.3 OUTLIER -69.04 78.06 0.33 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.767 0.318 . . . . 73.4 110.911 -179.861 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.486 ' HB2' ' CE1' ' A' ' 11' ' ' TYR . 0.6 OUTLIER -77.14 130.11 36.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.456 . . . . 73.43 110.891 -179.905 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.524 ' O ' ' HA ' ' A' ' 9' ' ' THR . 90.7 t80 -124.02 124.87 43.51 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.169 -0.469 . . . . 71.35 110.93 -179.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.446 ' CG ' HG23 ' A' ' 9' ' ' THR . 1.1 m-20 -121.9 134.45 54.86 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.109 -0.496 . . . . 64.35 110.833 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -167.86 135.81 2.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.167 -0.47 . . . . 73.53 110.882 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -101.27 0.04 36.62 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.212 -0.449 . . . . 73.12 110.863 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 16.5 t -104.37 164.88 11.42 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.172 -0.467 . . . . 64.54 110.914 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 35.6 m-20 -58.24 120.84 9.4 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.209 -0.451 . . . . 72.33 110.879 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.566 ' HB2' ' HB3' ' A' ' 30' ' ' PHE . 1.8 m -115.95 51.94 0.93 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.208 -0.451 . . . . 61.34 110.886 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.501 ' C ' ' HA ' ' A' ' 82' ' ' SER . . . -47.33 -21.27 0.27 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.223 -0.444 . . . . 74.14 111.083 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 56.8 t0 -128.54 42.33 3.34 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.223 -0.444 . . . . 63.42 110.866 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.785 ' O ' ' CD2' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -80.99 15.33 1.87 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.217 -0.447 . . . . 73.51 110.858 -179.852 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.48 ' HB2' ' HB3' ' A' ' 81' ' ' SER . 28.5 t60 -80.01 -39.57 29.68 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.142 -0.481 . . . . 74.21 110.885 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.7 t -57.93 -13.94 5.39 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.202 -0.454 . . . . 75.15 111.119 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -99.96 -27.14 13.73 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.27 -0.423 . . . . 73.33 110.907 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.75 HD13 ' O ' ' A' ' 19' ' ' ARG . 18.0 tp -142.65 136.31 28.97 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.162 -0.472 . . . . 70.22 110.916 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 23.8 m -98.81 -42.42 7.19 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.174 -0.467 . . . . 62.13 110.861 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -118.54 141.37 48.64 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.135 -0.484 . . . . 63.12 110.861 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.547 ' HB3' ' HB2' ' A' ' 80' ' ' LEU . 3.1 p -109.95 83.97 1.85 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.188 -0.46 . . . . 71.33 110.858 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.489 ' HB3' ' N ' ' A' ' 14' ' ' LYS . 0.2 OUTLIER -75.33 -70.64 0.41 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.157 -0.474 . . . . 52.12 110.872 -179.911 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 5.0 p -111.77 124.38 52.21 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.192 -0.458 . . . . 72.43 110.836 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.724 HD12 ' CH2' ' A' ' 73' ' ' TRP . 45.1 mt -117.67 148.36 20.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.123 -0.489 . . . . 72.51 111.149 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.464 ' HB3' ' HE2' ' A' ' 41' ' ' LYS . 0.0 OUTLIER -143.49 120.57 11.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.181 -0.463 . . . . 53.31 110.9 179.85 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.534 HG22 ' HB ' ' A' ' 8' ' ' ILE . 1.9 t -104.98 115.53 47.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.22 -0.446 . . . . 71.22 111.096 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -110.35 80.27 1.29 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.227 -0.442 . . . . 61.43 110.872 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.467 ' O ' ' HA ' ' A' ' 6' ' ' THR . . . 127.89 106.85 1.37 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.736 -0.745 . . . . 74.32 112.485 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 51.95 177.98 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.738 -0.744 . . . . 71.24 112.494 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.74 HG23 ' HA ' ' A' ' 63' ' ' PRO . 1.9 m -80.91 165.79 21.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.813 0.34 . . . . 61.21 111.112 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.615 ' CD1' ' HB ' ' A' ' 8' ' ' ILE . 3.3 m95 -138.91 130.05 26.75 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.449 . . . . 74.15 110.901 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.802 ' HB2' ' CG2' ' A' ' 86' ' ' VAL . . . -94.09 129.66 40.56 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.214 -0.448 . . . . 64.33 111.103 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.63 HG11 ' CD1' ' A' ' 80' ' ' LEU . 12.5 m -126.86 131.32 71.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.259 -0.428 . . . . 74.1 111.121 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.777 ' HB3' ' HA ' ' A' ' 56' ' ' ALA . 42.1 m-85 -97.28 147.73 23.84 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.182 -0.463 . . . . 73.21 110.928 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.617 ' OE1' ' HB3' ' A' ' 57' ' ' TRP . 47.3 tt0 -49.97 -78.12 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.094 -0.503 . . . . 73.33 110.867 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.572 ' HB2' ' HB2' ' A' ' 57' ' ' TRP . 1.2 mtp180 -93.5 143.99 27.52 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.609 0.719 . . . . 75.43 110.875 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.748 ' HA ' ' OG ' ' A' ' 82' ' ' SER . 54.2 Cg_endo -69.71 141.11 44.54 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.754 2.303 . . . . 65.21 112.366 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 63.42 -11.13 0.1 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.238 -0.437 . . . . 71.24 110.903 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.6 ' H ' ' C ' ' A' ' 53' ' ' PRO . 2.5 m-30 -104.7 -20.58 13.59 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.168 -0.469 . . . . 64.32 110.899 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.777 ' HA ' ' HB3' ' A' ' 50' ' ' TYR . . . 50.29 25.58 1.9 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.134 -0.485 . . . . 71.3 111.09 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . 0.632 ' O ' ' C ' ' A' ' 58' ' ' TYR . 0.1 OUTLIER -49.21 -164.92 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.234 -0.439 . . . . 54.33 110.952 -179.929 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.632 ' C ' ' O ' ' A' ' 57' ' ' TRP . 7.0 m-30 -13.27 101.69 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.274 -0.421 . . . . 72.41 110.948 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.601 ' HB2' ' HA ' ' A' ' 150' ' ' TYR . 1.9 mpt? -65.45 157.56 29.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.136 -0.483 . . . . 74.44 110.936 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.795 ' CD2' HD12 ' A' ' 76' ' ' LEU . 3.2 t80 -175.01 101.37 0.08 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.255 -0.43 . . . . 71.43 110.927 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.708 HD11 ' HA ' ' A' ' 151' ' ' LEU . 4.4 mp -88.24 116.21 29.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.163 -0.471 . . . . 62.44 111.121 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.816 HD23 ' HD2' ' A' ' 63' ' ' PRO . 0.3 OUTLIER -80.33 128.24 73.57 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.605 0.717 . . . . 55.41 110.958 179.898 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.816 ' HD2' HD23 ' A' ' 62' ' ' LEU . 53.3 Cg_endo -69.78 -173.41 0.71 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.678 2.252 . . . . 65.04 112.357 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -88.44 161.6 16.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.265 -0.425 . . . . 74.24 110.924 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 112.64 -168.44 12.65 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.734 -0.746 . . . . 74.3 112.47 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -108.09 153.92 22.43 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.873 0.368 . . . . 74.14 110.915 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.613 ' HB2' ' O ' ' A' ' 40' ' ' ILE . 10.2 m-85 -143.48 83.83 10.51 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.625 0.726 . . . . 74.53 110.934 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.44 ' HD2' ' HG3' ' A' ' 72' ' ' ARG . 53.8 Cg_endo -69.77 0.78 5.16 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.679 2.253 . . . . 62.52 112.354 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.544 ' HB2' ' HG2' ' A' ' 72' ' ' ARG . 46.2 mt-10 -156.09 143.84 19.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.197 -0.456 . . . . 73.52 110.878 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.732 ' HA ' ' NE1' ' A' ' 73' ' ' TRP . 32.4 p90 -55.34 -21.98 17.37 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.157 -0.474 . . . . 74.15 110.944 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -79.14 -17.56 54.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.134 -0.484 . . . . 63.23 110.898 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.544 ' HG2' ' HB2' ' A' ' 69' ' ' GLU . 27.8 mmt180 -69.34 -8.11 43.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.185 -0.461 . . . . 71.33 110.889 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . 0.732 ' NE1' ' HA ' ' A' ' 70' ' ' TYR . 0.0 OUTLIER -136.94 18.99 3.01 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.169 -0.469 . . . . 75.14 110.876 -179.973 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.481 ' C ' ' O ' ' A' ' 73' ' ' TRP . 0.0 OUTLIER 32.11 47.71 0.09 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.255 -0.43 . . . . 74.1 110.835 179.921 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -59.92 120.38 22.48 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.71 -0.757 . . . . 75.34 112.531 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 1.043 HD13 ' N ' ' A' ' 77' ' ' ASN . 0.0 OUTLIER -63.56 -15.42 57.98 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.809 0.338 . . . . 73.42 110.937 -179.91 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 1.043 ' N ' HD13 ' A' ' 76' ' ' LEU . 35.5 t-20 -156.38 134.62 11.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.185 -0.461 . . . . 72.53 110.896 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -83.27 23.06 0.93 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.17 -0.468 . . . . 64.22 110.839 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 4.1 ttm-85 -110.16 80.77 1.34 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.232 -0.44 . . . . 74.54 110.886 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.63 ' CD1' HG11 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -87.91 133.99 33.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.224 -0.443 . . . . 73.31 110.871 -179.932 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.63 ' HB3' ' HB3' ' A' ' 53' ' ' PRO . 1.0 OUTLIER -150.32 -124.94 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.188 -0.46 . . . . 61.22 110.83 -179.96 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.748 ' OG ' ' HA ' ' A' ' 53' ' ' PRO . 0.1 OUTLIER -36.15 104.89 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.145 -0.48 . . . . 63.44 110.86 -179.784 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . 0.611 ' HB3' HG12 ' A' ' 49' ' ' VAL . 19.5 p -121.32 135.3 55.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.096 -0.502 . . . . 71.43 110.935 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.587 ' N ' ' O ' ' A' ' 48' ' ' ALA . 9.4 mmt85 -120.62 138.46 53.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.254 -0.43 . . . . 72.51 110.883 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.434 ' N ' ' CZ3' ' A' ' 47' ' ' TRP . . . -59.42 129.02 39.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.196 -0.457 . . . . 64.54 111.115 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.894 ' CG1' HG11 ' A' ' 136' ' ' VAL . 40.9 t -113.24 129.9 68.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.239 -0.437 . . . . 64.23 111.085 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . 0.552 ' O ' HG23 ' A' ' 136' ' ' VAL . 82.9 m-70 -111.52 107.46 16.65 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.154 -0.476 . . . . 73.14 110.892 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.488 HD23 ' H ' ' A' ' 88' ' ' LEU . 0.0 OUTLIER -32.66 141.86 0.18 Allowed Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.645 0.736 . . . . 64.21 110.904 -179.92 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.471 ' HB3' ' H ' ' A' ' 136' ' ' VAL . 53.4 Cg_endo -69.79 98.02 0.67 Allowed 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.693 2.262 . . . . 63.51 112.329 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -100.76 138.72 37.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.231 -0.441 . . . . 70.44 110.831 -179.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 105.1 115.81 4.13 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.707 -0.759 . . . . 74.23 112.51 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 52.31 48.33 54.2 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.684 -0.769 . . . . 42.2 112.514 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 24.7 pt20 38.95 -153.31 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.778 0.323 . . . . 75.24 110.924 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.62 ' HA ' ' CG ' ' A' ' 134' ' ' GLU . 33.0 t80 -106.23 104.08 13.7 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.229 -0.441 . . . . 73.12 110.903 -179.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.467 ' H ' ' CG ' ' A' ' 134' ' ' GLU . 33.5 tptt -96.92 132.23 42.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.153 -0.476 . . . . 70.33 110.906 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.415 HD12 ' OH ' ' A' ' 94' ' ' TYR . 0.2 OUTLIER -149.42 135.91 12.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.197 -0.456 . . . . 72.13 111.166 179.891 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.587 ' HB2' HG23 ' A' ' 132' ' ' VAL . 0.8 OUTLIER -107.31 132.5 53.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.195 -0.457 . . . . 75.43 110.898 179.983 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.581 HD13 HD11 ' A' ' 118' ' ' ILE . 2.8 mt -118.18 130.84 72.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.234 -0.439 . . . . 75.22 111.149 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.688 ' HB2' ' HB2' ' A' ' 129' ' ' SER . 5.7 m-85 -120.21 152.59 37.49 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.141 -0.481 . . . . 72.34 110.948 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 70.7 tt0 -81.06 -68.83 0.65 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.206 -0.452 . . . . 61.2 110.865 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.526 ' C ' ' HB2' ' A' ' 128' ' ' HIS . 33.1 mttt -89.19 166.3 13.9 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.186 -0.461 . . . . 63.35 110.888 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -80.25 160.99 44.72 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.746 -0.74 . . . . 64.11 112.504 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.444 ' HA ' ' HB2' ' A' ' 158' ' ' ARG . 41.1 t0 66.08 52.05 1.23 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.81 0.338 . . . . 74.11 110.878 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.639 ' CE1' ' HD2' ' A' ' 131' ' ' LYS . 6.9 m-85 48.19 33.23 3.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.2 -0.455 . . . . 73.43 110.862 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.461 ' C ' ' HB2' ' A' ' 101' ' ' LYS . 43.8 m -108.97 155.53 20.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.125 -0.489 . . . . 61.5 110.875 -179.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 89.52 -163.83 31.4 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.776 -0.726 . . . . 72.43 112.488 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -76.36 123.49 26.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.794 0.33 . . . . 54.21 110.931 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 3.5 ttp -107.71 131.42 54.44 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.187 -0.46 . . . . 71.03 110.897 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -133.79 137.02 44.88 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.208 -0.451 . . . . 73.45 110.95 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -117.04 107.47 14.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.143 -0.48 . . . . 62.44 110.841 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 10.1 t -123.04 155.98 35.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.133 -0.485 . . . . 75.24 111.104 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.423 ' HA ' ' O ' ' A' ' 94' ' ' TYR . 1.7 t -135.47 45.68 2.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.208 -0.451 . . . . 73.22 111.132 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -152.72 158.66 42.64 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.229 -0.441 . . . . 73.54 110.87 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -51.33 156.4 1.2 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.126 -0.488 . . . . 62.14 110.862 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . 0.526 ' O ' ' HB2' ' A' ' 172' ' ' SER . 39.7 t -146.42 113.28 4.4 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.632 0.729 . . . . 52.02 110.862 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.419 ' O ' ' C ' ' A' ' 143' ' ' PRO . 53.4 Cg_endo -69.74 -30.71 21.93 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.665 2.243 . . . . 75.13 112.333 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.653 ' HB3' ' CB ' ' A' ' 120' ' ' GLU . 0.1 OUTLIER -149.57 101.35 3.08 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.211 -0.449 . . . . 75.33 110.848 -179.815 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.639 HD13 HD11 ' A' ' 127' ' ' ILE . 3.0 tt -54.66 -29.74 21.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.175 -0.466 . . . . 74.22 111.163 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' MET . . . . . 0.581 ' O ' ' HA ' ' A' ' 123' ' ' HIS . 0.6 OUTLIER -86.53 -45.08 11.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.145 -0.48 . . . . 72.33 110.899 179.817 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.653 ' CB ' ' HB3' ' A' ' 117' ' ' SER . 6.6 tp10 -65.78 -12.87 57.55 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.245 -0.434 . . . . 70.34 110.887 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 27.8 tp60 -114.51 -51.17 2.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.176 -0.466 . . . . 75.54 110.872 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.459 ' HB2' ' O ' ' A' ' 118' ' ' ILE . 44.0 m-85 -102.89 -19.65 14.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.197 -0.456 . . . . 73.2 110.872 -179.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.581 ' HA ' ' O ' ' A' ' 119' ' ' MET . 29.6 m-70 71.72 28.63 2.69 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.16 -0.473 . . . . 73.22 110.896 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.412 ' HB3' ' CD1' ' A' ' 127' ' ' ILE . 10.7 mtt -103.95 85.94 2.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.234 -0.439 . . . . 63.05 110.91 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 4.0 ptp180 -51.44 -38.11 52.01 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.205 -0.452 . . . . 72.44 110.859 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.473 ' HG2' ' HA ' ' A' ' 169' ' ' ALA . 13.2 mt-10 -142.23 133.03 25.61 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.17 -0.468 . . . . 73.13 110.858 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.639 HD11 HD13 ' A' ' 118' ' ' ILE . 3.8 mm -92.08 97.07 6.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.155 -0.475 . . . . 70.24 111.13 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . 0.526 ' HB2' ' C ' ' A' ' 101' ' ' LYS . 13.9 m170 -67.75 -34.04 76.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.133 -0.485 . . . . 73.12 110.891 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.688 ' HB2' ' HB2' ' A' ' 99' ' ' PHE . 58.2 m -129.43 136.61 50.15 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.184 -0.462 . . . . 75.24 110.868 -179.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . 0.526 ' O ' ' O ' ' A' ' 155' ' ' LYS . 3.4 m -131.74 119.93 22.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.128 -0.487 . . . . 64.3 110.894 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.693 ' HA ' ' HA ' ' A' ' 156' ' ' GLU . 2.0 mtpp -115.45 150.71 36.02 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.179 -0.464 . . . . 72.33 110.911 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.587 HG23 ' HB2' ' A' ' 97' ' ' GLN . 16.4 t 83.59 163.42 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.198 -0.456 . . . . 51.31 111.137 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.822 HD13 ' O ' ' A' ' 154' ' ' LYS . 0.0 OUTLIER -174.86 123.67 0.25 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.163 -0.471 . . . . 75.32 110.899 179.994 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.62 ' CG ' ' HA ' ' A' ' 94' ' ' TYR . 0.0 OUTLIER -91.86 172.85 8.19 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.231 -0.441 . . . . 73.44 110.894 179.923 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -41.96 -47.25 5.2 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.696 -0.764 . . . . 73.34 112.466 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.894 HG11 ' CG1' ' A' ' 86' ' ' VAL . 5.2 t -148.87 142.54 18.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.819 0.342 . . . . 75.12 111.093 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . 0.712 ' HB3' ' CB ' ' A' ' 152' ' ' LEU . 25.0 t90 -149.43 148.17 29.13 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.142 -0.481 . . . . 73.25 110.925 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.683 HG12 HD13 ' A' ' 61' ' ' ILE . 20.3 mt -125.75 132.5 70.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.224 -0.444 . . . . 75.34 111.175 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.673 ' CE1' HG11 ' A' ' 170' ' ' VAL . 0.1 OUTLIER -100.84 152.98 19.87 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.169 -0.468 . . . . 63.05 110.866 179.981 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.502 ' CD2' ' HA ' ' A' ' 145' ' ' TYR . 0.8 OUTLIER -129.14 127.16 40.85 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.146 -0.479 . . . . 74.21 110.922 -179.832 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.632 ' O ' ' HB2' ' A' ' 171' ' ' GLN . 0.6 OUTLIER -61.63 -25.86 67.63 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.14 -0.482 . . . . 63.0 110.884 179.998 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.711 ' HB3' ' HD2' ' A' ' 143' ' ' PRO . 9.3 mp -114.64 173.07 3.09 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.659 0.742 . . . . 71.34 110.891 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . 0.735 ' O ' ' OG ' ' A' ' 172' ' ' SER . 53.8 Cg_endo -69.77 -90.34 0.0 OUTLIER 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.665 2.243 . . . . 73.32 112.349 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . 0.697 ' O ' ' N ' ' A' ' 146' ' ' ARG . 0.7 OUTLIER -51.88 97.73 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.247 -0.433 . . . . 73.3 110.903 179.993 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . 0.636 ' C ' ' O ' ' A' ' 144' ' ' ASN . 0.1 OUTLIER 12.46 53.19 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.215 -0.448 . . . . 74.12 110.883 -179.941 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.697 ' N ' ' O ' ' A' ' 144' ' ' ASN . 20.7 mtt180 -120.4 173.54 7.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.175 -0.466 . . . . 72.4 110.851 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 79.83 179.51 52.42 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.712 -0.756 . . . . 74.34 112.49 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -74.02 146.58 43.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.799 0.333 . . . . 73.2 110.894 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . 0.644 ' CD ' HG21 ' A' ' 138' ' ' ILE . 16.8 mt-30 -85.92 153.86 21.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.455 . . . . 74.3 110.895 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . 0.601 ' HA ' ' HB2' ' A' ' 59' ' ' MET . 76.8 m-85 -135.12 122.3 21.51 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.191 -0.458 . . . . 72.44 110.964 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.708 ' HA ' HD11 ' A' ' 61' ' ' ILE . 33.5 tp -66.55 135.94 54.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.067 -0.515 . . . . 70.2 110.935 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.944 ' O ' HD13 ' A' ' 152' ' ' LEU . 0.0 OUTLIER -70.08 133.97 47.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.223 -0.444 . . . . 75.43 110.878 179.906 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -163.21 25.42 0.09 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.167 -0.469 . . . . 75.22 110.853 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.822 ' O ' HD13 ' A' ' 133' ' ' LEU . 0.1 OUTLIER -113.03 -169.42 1.48 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.15 -0.477 . . . . 74.41 110.888 179.993 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.809 ' CG ' HD22 ' A' ' 133' ' ' LEU . 0.6 OUTLIER -167.25 -122.06 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.245 -0.434 . . . . 74.22 110.925 179.866 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.693 ' HA ' ' HA ' ' A' ' 131' ' ' LYS . 0.7 OUTLIER -73.03 -1.26 16.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.241 -0.436 . . . . 75.15 110.832 179.976 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . 0.723 ' CE1' ' HA ' ' A' ' 154' ' ' LYS . 20.1 m-30 -27.26 141.03 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.195 -0.457 . . . . 73.41 110.892 -179.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . 0.561 ' O ' ' OG ' ' A' ' 129' ' ' SER . 9.9 ptp180 -107.62 -41.14 5.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.129 -0.487 . . . . 51.35 110.868 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -87.43 150.34 48.73 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.562 0.696 . . . . 55.31 110.902 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . 0.494 ' HB3' ' HB3' ' A' ' 168' ' ' PRO . 53.7 Cg_endo -69.8 -24.17 29.8 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.64 2.227 . . . . 75.22 112.371 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.613 ' H ' HD12 ' A' ' 161' ' ' ILE . 3.6 mp -69.25 -10.82 14.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.23 -0.441 . . . . 72.53 111.107 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.644 ' HB3' ' CD1' ' A' ' 157' ' ' TYR . 0.5 OUTLIER -75.79 -14.11 60.3 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.19 -0.459 . . . . 65.54 110.869 179.879 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' TRP . . . . . 0.43 ' CE3' ' HB3' ' A' ' 165' ' ' ALA . 24.8 t90 -88.69 -12.7 41.6 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.189 -0.459 . . . . 72.31 110.933 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 106.66 -37.03 4.03 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.751 -0.738 . . . . 42.52 112.487 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.43 ' HB3' ' CE3' ' A' ' 163' ' ' TRP . . . -77.1 126.77 31.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.796 0.331 . . . . 63.23 111.062 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . 0.4 ' C ' ' O ' ' A' ' 165' ' ' ALA . . . -37.56 -41.36 0.46 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 74.43 111.101 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . 0.489 ' C ' ' H ' ' A' ' 169' ' ' ALA . 0.3 OUTLIER -130.28 155.64 80.6 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.66 0.743 . . . . 75.55 110.82 -179.778 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . 0.494 ' HB3' ' HB3' ' A' ' 160' ' ' PRO . 53.6 Cg_endo -69.78 27.29 0.18 Allowed 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.674 2.249 . . . . 72.14 112.312 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.489 ' H ' ' C ' ' A' ' 167' ' ' SER . . . -65.63 104.6 1.06 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.213 -0.449 . . . . 70.3 111.147 179.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.673 HG11 ' CE1' ' A' ' 139' ' ' PHE . 2.8 t -151.75 161.97 3.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.21 -0.45 . . . . 72.11 111.127 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' GLN . . . . . 0.632 ' HB2' ' O ' ' A' ' 141' ' ' GLU . 1.8 tm0? -109.4 -82.08 0.57 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.213 -0.449 . . . . 75.52 110.91 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . 0.735 ' OG ' ' O ' ' A' ' 143' ' ' PRO . 21.6 p -130.87 176.22 8.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.208 -0.451 . . . . 52.4 110.831 -179.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . 0.469 ' HB3' ' CD1' ' A' ' 139' ' ' PHE . 32.2 p90 -144.31 173.78 11.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.114 -0.494 . . . . 74.44 110.885 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . 0.443 ' HG2' ' CE2' ' A' ' 140' ' ' TYR . 0.0 OUTLIER -147.4 141.36 25.9 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.152 -0.476 . . . . 75.14 110.88 -179.883 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . 0.494 HH12 HG12 ' A' ' 177' ' ' VAL . 0.0 OUTLIER -86.32 -177.23 6.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.18 -0.464 . . . . 73.23 110.909 -179.945 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . 0.483 HD11 HG13 ' A' ' 138' ' ' ILE . 2.9 mt -132.51 139.09 50.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.215 -0.448 . . . . 61.45 111.11 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.494 HG12 HH12 ' A' ' 175' ' ' ARG . 2.1 p -149.32 155.4 8.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.185 -0.461 . . . . 64.4 111.173 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.2 -0.455 . . . . 74.23 110.859 -179.96 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.817 0.342 . . . . 73.42 110.902 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 57.1 p -167.37 148.44 5.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.254 -0.43 . . . . 53.12 110.896 -179.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.493 ' HE2' HD11 ' A' ' 88' ' ' LEU . 29.7 mmtp -99.43 36.49 1.75 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.15 -0.477 . . . . 73.15 110.87 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 5.0 t -147.34 122.86 10.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.25 -0.432 . . . . 51.41 111.137 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 61.24 92.7 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.733 -0.746 . . . . 63.02 112.492 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.439 ' HB ' ' O ' ' A' ' 44' ' ' GLY . 12.2 p -82.23 133.11 35.24 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.839 0.352 . . . . 71.11 111.134 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 3.1 tttt -122.37 138.33 54.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.241 -0.436 . . . . 71.34 110.888 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.593 ' HB ' ' CD1' ' A' ' 47' ' ' TRP . 12.5 tt -136.64 149.75 26.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.233 -0.44 . . . . 70.31 111.142 179.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.521 HG22 ' CE2' ' A' ' 11' ' ' TYR . 24.8 m -133.62 129.13 36.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.181 -0.463 . . . . 71.2 111.139 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.867 ' HB2' HD22 ' A' ' 34' ' ' LEU . 0.4 OUTLIER -117.3 131.89 56.72 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.208 -0.451 . . . . 75.3 110.845 -179.977 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.538 ' CG ' ' HA ' ' A' ' 16' ' ' PHE . 44.1 m-85 -114.95 132.35 56.6 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.138 -0.483 . . . . 74.25 110.94 -179.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.477 ' HG2' ' HB2' ' A' ' 36' ' ' ARG . 0.0 OUTLIER -61.98 -24.63 67.14 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.162 -0.472 . . . . 70.54 110.876 -179.949 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 65.7 m-20 -126.12 150.42 48.25 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.16 -0.473 . . . . 72.31 110.836 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.537 ' N ' ' HB3' ' A' ' 38' ' ' ASN . 4.6 mtmm -55.04 -179.83 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.189 -0.46 . . . . 75.52 110.866 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 52.0 m-80 49.38 38.46 14.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.233 -0.44 . . . . 53.25 110.889 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.538 ' HA ' ' CG ' ' A' ' 11' ' ' TYR . 3.4 m-85 45.14 60.17 3.13 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.17 -0.468 . . . . 63.52 110.859 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -136.46 160.06 39.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.142 -0.481 . . . . 63.43 110.906 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 92.84 -150.99 20.26 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.751 -0.738 . . . . 50.2 112.518 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.767 ' O ' HD13 ' A' ' 34' ' ' LEU . 0.0 OUTLIER -67.49 79.62 0.17 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.812 0.339 . . . . 71.23 110.905 -179.888 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.44 ' HB2' ' CE1' ' A' ' 11' ' ' TYR . 0.7 OUTLIER -78.95 125.9 29.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 63.41 110.857 -179.897 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.483 ' CD2' ' CD2' ' A' ' 30' ' ' PHE . 82.4 t80 -121.18 124.35 44.5 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.182 -0.463 . . . . 75.14 110.905 -179.841 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.441 ' CG ' HG23 ' A' ' 9' ' ' THR . 1.0 OUTLIER -119.22 134.62 55.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.131 -0.486 . . . . 70.54 110.885 179.877 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -166.75 135.71 2.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.231 -0.44 . . . . 72.51 110.851 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -105.07 5.72 32.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.187 -0.461 . . . . 72.14 110.882 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 12.1 t -108.73 168.38 9.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.168 -0.469 . . . . 53.43 110.886 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 78.8 m-20 -64.64 116.72 6.5 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.232 -0.44 . . . . 74.34 110.887 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.477 ' HB2' ' HB3' ' A' ' 30' ' ' PHE . 7.4 m -119.42 54.4 0.99 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.203 -0.453 . . . . 74.51 110.872 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.539 ' C ' ' HA ' ' A' ' 82' ' ' SER . . . -45.88 -20.28 0.08 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.183 -0.462 . . . . 72.33 111.095 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.406 ' N ' ' C ' ' A' ' 27' ' ' CYS . 59.7 t0 -128.32 43.56 3.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.224 -0.444 . . . . 75.41 110.879 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.776 ' O ' ' CD2' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -80.97 14.72 2.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.174 -0.466 . . . . 74.02 110.884 -179.873 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.489 ' HB2' ' HB3' ' A' ' 53' ' ' PRO . 27.6 t60 -77.72 -38.66 46.7 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.159 -0.473 . . . . 74.23 110.845 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.6 t -58.22 -12.57 3.73 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.208 -0.451 . . . . 73.23 111.121 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -101.48 -28.37 12.6 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.18 -0.464 . . . . 75.45 110.941 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.867 HD22 ' HB2' ' A' ' 10' ' ' PHE . 16.0 tp -141.15 141.7 34.12 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.149 -0.478 . . . . 72.01 110.927 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -111.57 -31.11 7.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.187 -0.46 . . . . 70.21 110.908 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.485 ' O ' HD21 ' A' ' 34' ' ' LEU . 1.6 mtp85 -116.78 142.41 46.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.092 -0.504 . . . . 74.22 110.845 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.643 ' SG ' ' HB2' ' A' ' 80' ' ' LEU . 1.8 p -118.99 51.44 1.12 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.188 -0.46 . . . . 72.34 110.864 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.537 ' HB3' ' N ' ' A' ' 14' ' ' LYS . 1.9 m-80 -52.35 -62.68 1.48 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.165 -0.471 . . . . 54.14 110.896 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.433 ' HB2' ' HA ' ' A' ' 68' ' ' PRO . 9.3 p -121.8 127.78 50.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.201 -0.454 . . . . 75.01 110.809 -179.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.592 HG21 HD13 ' A' ' 62' ' ' LEU . 4.5 mt -127.15 148.59 31.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.124 -0.489 . . . . 65.01 111.135 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.46 122.0 15.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.17 -0.468 . . . . 74.13 110.863 179.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.585 ' CG2' HD12 ' A' ' 8' ' ' ILE . 0.9 OUTLIER -103.92 117.43 49.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.189 -0.459 . . . . 62.43 111.145 179.876 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -112.44 81.14 1.43 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.223 -0.444 . . . . 73.24 110.89 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.439 ' O ' ' HB ' ' A' ' 6' ' ' THR . . . 130.63 100.02 0.86 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.736 -0.745 . . . . 71.13 112.534 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 55.21 175.85 0.14 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.712 -0.756 . . . . 64.42 112.491 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.75 HG23 ' HA ' ' A' ' 63' ' ' PRO . 5.9 m -80.29 165.99 21.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.812 0.339 . . . . 65.54 111.137 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.593 ' CD1' ' HB ' ' A' ' 8' ' ' ILE . 14.6 m95 -136.76 129.94 31.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.208 -0.451 . . . . 62.41 110.909 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.656 ' HB2' ' CG2' ' A' ' 86' ' ' VAL . . . -97.46 114.06 25.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.456 . . . . 72.02 111.111 179.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.921 HG11 HD11 ' A' ' 80' ' ' LEU . 5.1 m -116.8 134.04 61.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.243 -0.435 . . . . 70.14 111.151 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.741 ' HB3' ' HA ' ' A' ' 56' ' ' ALA . 35.1 m-85 -97.07 151.86 19.33 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.185 -0.461 . . . . 72.32 110.954 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.59 ' HB2' ' O ' ' A' ' 58' ' ' TYR . 8.8 tt0 -47.76 -78.84 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.143 -0.48 . . . . 55.0 110.892 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.618 ' HB3' ' CD1' ' A' ' 55' ' ' PHE . 4.7 mtp180 -90.25 143.95 30.33 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.656 0.741 . . . . 64.1 110.826 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.756 ' HA ' ' OG ' ' A' ' 82' ' ' SER . 53.9 Cg_endo -69.75 134.56 28.29 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.66 2.24 . . . . 62.51 112.372 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 66.2 -8.55 0.34 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.233 -0.439 . . . . 74.21 110.847 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.618 ' CD1' ' HB3' ' A' ' 52' ' ' ARG . 4.6 m-30 -101.75 -26.81 13.35 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.216 -0.447 . . . . 54.33 110.919 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.741 ' HA ' ' HB3' ' A' ' 50' ' ' TYR . . . 58.71 22.87 10.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.145 -0.479 . . . . 75.24 111.109 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . 0.645 ' O ' ' C ' ' A' ' 58' ' ' TYR . 2.4 m95 -52.17 -165.89 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.251 -0.432 . . . . 64.53 110.925 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.645 ' C ' ' O ' ' A' ' 57' ' ' TRP . 6.5 m-30 -12.46 103.62 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.231 -0.441 . . . . 74.31 110.936 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.523 ' HB2' ' O ' ' A' ' 149' ' ' GLN . 2.5 mpt? -62.29 147.48 47.99 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.128 -0.487 . . . . 73.04 110.903 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.617 ' O ' HG23 ' A' ' 49' ' ' VAL . 0.3 OUTLIER -164.29 92.27 0.64 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.236 -0.438 . . . . 74.21 110.865 -179.88 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.716 ' N ' HD12 ' A' ' 61' ' ' ILE . 1.6 mp -85.06 120.2 35.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.154 -0.475 . . . . 61.54 111.117 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.817 HD23 ' HD2' ' A' ' 63' ' ' PRO . 0.3 OUTLIER -87.55 126.15 62.96 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-O 121.658 0.742 . . . . 72.45 110.878 179.91 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.817 ' HD2' HD23 ' A' ' 62' ' ' LEU . 53.5 Cg_endo -69.83 -168.03 0.26 Allowed 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.684 2.256 . . . . 70.43 112.307 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.05 161.12 14.57 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.24 -0.437 . . . . 62.55 110.931 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 111.66 -157.52 14.9 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.775 -0.726 . . . . 64.41 112.507 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 5.3 mp0 -115.0 158.75 21.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.85 0.357 . . . . 64.4 110.904 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.472 ' N ' ' O ' ' A' ' 40' ' ' ILE . 7.2 m-85 -149.52 79.73 7.93 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 121.676 0.75 . . . . 75.23 110.976 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.532 ' HD2' ' HG3' ' A' ' 72' ' ' ARG . 53.6 Cg_endo -69.81 1.11 4.77 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.7 2.266 . . . . 65.44 112.29 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 86.3 mt-10 -159.15 154.36 25.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.25 -0.432 . . . . 74.33 110.903 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.836 ' O ' ' CD1' ' A' ' 73' ' ' TRP . 25.6 p90 -65.39 -12.19 49.75 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.135 -0.484 . . . . 75.52 110.949 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -86.75 -13.65 44.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.127 -0.488 . . . . 64.24 110.878 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.532 ' HG3' ' HD2' ' A' ' 68' ' ' PRO . 24.1 mmt180 -73.58 -27.09 61.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.221 -0.445 . . . . 74.22 110.919 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . 0.836 ' CD1' ' O ' ' A' ' 70' ' ' TYR . 0.6 OUTLIER -105.97 11.22 31.9 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.157 -0.474 . . . . 75.24 110.957 179.979 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.506 ' C ' ' O ' ' A' ' 73' ' ' TRP . 0.4 OUTLIER 29.19 56.76 0.13 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.212 -0.449 . . . . 74.22 110.849 179.909 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.609 ' HA3' ' OH ' ' A' ' 60' ' ' TYR . . . -96.92 -140.27 11.19 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.733 -0.746 . . . . 63.13 112.51 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.758 HD21 ' HA ' ' A' ' 148' ' ' ARG . 0.0 OUTLIER -141.95 -84.1 0.19 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.831 0.348 . . . . 71.45 110.905 -179.946 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 -77.47 145.85 36.81 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.465 . . . . 63.11 110.915 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 -101.44 33.29 2.98 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.198 -0.456 . . . . 51.41 110.858 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -104.78 72.13 1.01 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.208 -0.451 . . . . 63.13 110.874 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.921 HD11 HG11 ' A' ' 49' ' ' VAL . 0.1 OUTLIER -77.83 130.25 36.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.162 -0.472 . . . . 74.54 110.906 -179.955 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.609 ' HB3' ' HB3' ' A' ' 53' ' ' PRO . 0.9 OUTLIER -146.92 -127.93 0.06 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.218 -0.446 . . . . 63.03 110.874 -179.929 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.756 ' OG ' ' HA ' ' A' ' 53' ' ' PRO . 0.7 OUTLIER -27.58 123.49 0.1 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.117 -0.492 . . . . 75.44 110.872 -179.845 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . 0.53 ' CB ' HG12 ' A' ' 49' ' ' VAL . 5.4 p -131.14 143.06 50.35 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.146 -0.479 . . . . 74.25 110.87 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.483 ' N ' ' O ' ' A' ' 48' ' ' ALA . 5.7 mmt85 -140.59 131.37 25.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.189 -0.459 . . . . 62.42 110.9 -179.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.412 ' N ' ' CZ3' ' A' ' 47' ' ' TRP . . . -56.27 123.88 16.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.22 -0.446 . . . . 74.32 111.043 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.965 HG11 HG11 ' A' ' 136' ' ' VAL . 1.9 t -115.93 143.31 26.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.21 -0.45 . . . . 62.41 111.113 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . 0.572 ' O ' ' CG2' ' A' ' 136' ' ' VAL . 34.9 m80 -111.23 106.45 15.44 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.184 -0.462 . . . . 73.41 110.878 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.501 HD23 ' H ' ' A' ' 88' ' ' LEU . 0.0 OUTLIER -31.64 150.17 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.659 0.742 . . . . 73.44 110.909 -179.975 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.58 ' HB3' ' H ' ' A' ' 136' ' ' VAL . 53.5 Cg_endo -69.77 83.39 0.7 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.674 2.249 . . . . 53.21 112.326 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -88.76 -173.35 4.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.188 -0.46 . . . . 73.33 110.832 -179.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 51.26 58.49 9.69 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.761 -0.733 . . . . 73.12 112.439 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 117.68 26.22 2.89 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.724 -0.751 . . . . 73.03 112.454 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 27.5 pt20 39.56 -148.57 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.826 0.346 . . . . 73.41 110.916 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.506 ' HA ' ' HG2' ' A' ' 134' ' ' GLU . 8.2 t80 -98.79 101.02 12.29 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.26 -0.427 . . . . 75.55 110.906 -179.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.429 ' HG3' HG11 ' A' ' 132' ' ' VAL . 38.2 tptt -107.91 130.34 55.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.126 -0.488 . . . . 62.3 110.896 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 4.2 tt -147.36 137.72 17.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.238 -0.437 . . . . 73.22 111.131 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.517 ' HB2' HG23 ' A' ' 132' ' ' VAL . 0.5 OUTLIER -109.92 113.35 26.01 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.211 -0.449 . . . . 74.01 110.942 179.905 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.578 HD11 HG22 ' A' ' 111' ' ' THR . 2.7 mp -93.66 136.17 26.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.163 -0.471 . . . . 75.0 111.15 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.646 ' HB2' ' HB2' ' A' ' 129' ' ' SER . 53.2 m-85 -124.73 140.1 53.24 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.194 -0.457 . . . . 70.52 110.855 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 64.6 tt0 -69.68 -75.17 0.12 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.148 -0.478 . . . . 70.14 110.889 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 16.5 mttt -84.51 170.41 13.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.138 -0.483 . . . . 73.35 110.893 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.441 ' CA ' ' HB3' ' A' ' 128' ' ' HIS . . . -73.73 159.62 53.1 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.724 -0.75 . . . . 72.01 112.478 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.486 ' HA ' ' HB2' ' A' ' 158' ' ' ARG . 60.9 t0 64.17 37.18 9.04 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.819 0.342 . . . . 73.41 110.844 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.57 ' CZ ' ' HB3' ' A' ' 158' ' ' ARG . 5.0 m-85 51.66 45.19 28.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.192 -0.458 . . . . 73.24 110.89 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 5.1 m -112.45 148.87 33.48 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.112 -0.495 . . . . 64.3 110.865 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 95.34 -132.5 11.13 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.776 -0.726 . . . . 63.03 112.519 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 43.3 tp60 -91.68 126.11 36.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.813 0.339 . . . . 61.24 110.948 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' MET . . . . . 0.459 ' HB2' ' CE1' ' A' ' 99' ' ' PHE . 4.8 ttt -113.55 131.56 56.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.168 -0.469 . . . . 71.44 110.849 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -136.26 136.38 39.79 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.215 -0.448 . . . . 64.12 110.93 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -118.37 109.2 16.0 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.115 -0.493 . . . . 65.32 110.896 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.578 HG22 HD11 ' A' ' 98' ' ' ILE . 14.1 t -123.46 145.68 48.63 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.132 -0.486 . . . . 65.44 111.18 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.474 ' O ' ' OG1' ' A' ' 112' ' ' THR . 0.8 OUTLIER -118.2 38.31 3.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.249 -0.432 . . . . 54.45 111.133 -179.944 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -150.94 170.43 19.35 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.228 -0.442 . . . . 72.02 110.898 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 -65.79 176.11 1.7 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.201 -0.454 . . . . 71.33 110.868 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 46.6 t -156.01 122.62 2.64 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.599 0.714 . . . . 52.54 110.891 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.475 ' C ' ' OG ' ' A' ' 172' ' ' SER . 54.0 Cg_endo -69.79 -31.24 20.76 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.646 2.23 . . . . 52.23 112.338 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.662 ' HB3' ' CB ' ' A' ' 120' ' ' GLU . 0.1 OUTLIER -152.99 92.97 1.69 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.222 -0.445 . . . . 43.44 110.872 -179.86 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.679 ' HB ' ' O ' ' A' ' 171' ' ' GLN . 5.0 tt -49.01 -28.78 2.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.157 -0.474 . . . . 74.02 111.155 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' MET . . . . . 0.581 ' O ' ' HA ' ' A' ' 123' ' ' HIS . 15.7 ttp -86.36 -45.19 11.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.186 -0.461 . . . . 74.55 110.848 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.662 ' CB ' ' HB3' ' A' ' 117' ' ' SER . 10.1 tp10 -66.75 -13.37 61.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.232 -0.44 . . . . 61.5 110.875 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -114.52 -51.9 2.73 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.185 -0.461 . . . . 74.14 110.897 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.48 ' HB2' ' O ' ' A' ' 118' ' ' ILE . 14.6 m-85 -101.89 -18.67 15.6 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.24 -0.437 . . . . 73.33 110.935 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.581 ' HA ' ' O ' ' A' ' 119' ' ' MET . 16.6 m80 68.42 32.72 4.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.078 -0.51 . . . . 74.14 110.892 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.483 ' SD ' HG22 ' A' ' 98' ' ' ILE . 9.3 mtt -111.04 84.62 1.96 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.183 -0.462 . . . . 63.32 110.819 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 3.9 ptp180 -52.93 -34.87 57.41 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.23 -0.441 . . . . 63.33 110.884 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.475 ' HG2' ' HA ' ' A' ' 169' ' ' ALA . 35.0 mt-10 -142.34 128.77 20.1 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.192 -0.458 . . . . 74.04 110.864 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.545 HD11 HD13 ' A' ' 118' ' ' ILE . 4.1 mm -87.89 101.16 11.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.146 -0.479 . . . . 74.13 111.159 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . 0.441 ' HB3' ' CA ' ' A' ' 102' ' ' GLY . 22.3 m80 -69.65 -35.24 75.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.165 -0.471 . . . . 72.45 110.861 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.646 ' HB2' ' HB2' ' A' ' 99' ' ' PHE . 6.2 m -135.4 152.2 51.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.255 -0.43 . . . . 72.11 110.87 -179.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . 0.498 ' HB2' ' CH2' ' A' ' 163' ' ' TRP . 0.0 OUTLIER -156.22 118.24 3.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.144 -0.48 . . . . 70.05 110.901 -179.934 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.523 ' C ' HG23 ' A' ' 132' ' ' VAL . 3.7 mtpp -105.66 161.2 14.59 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.182 -0.463 . . . . 74.5 110.875 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.572 HG12 ' N ' ' A' ' 133' ' ' LEU . 16.0 t 86.03 165.97 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.469 . . . . 21.52 111.154 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.657 HD13 ' CE ' ' A' ' 155' ' ' LYS . 1.0 OUTLIER -166.2 131.19 2.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.182 -0.463 . . . . 74.11 110.895 179.941 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.506 ' HG2' ' HA ' ' A' ' 94' ' ' TYR . 0.8 OUTLIER -105.29 147.72 27.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.192 -0.458 . . . . 72.23 110.9 179.921 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.483 ' C ' ' O ' ' A' ' 134' ' ' GLU . . . -31.37 -45.63 0.14 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.746 -0.74 . . . . 25.32 112.508 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.982 ' HB ' HD12 ' A' ' 176' ' ' ILE . 0.7 OUTLIER -149.94 135.6 11.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.823 0.344 . . . . 75.31 111.116 -179.98 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . 0.647 ' HB3' ' CB ' ' A' ' 152' ' ' LEU . 24.0 t90 -150.14 149.59 30.46 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.131 -0.486 . . . . 72.41 110.92 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.415 ' HA ' ' O ' ' A' ' 150' ' ' TYR . 16.6 mt -124.17 132.04 71.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.275 -0.421 . . . . 71.51 111.118 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.759 ' CE2' HG11 ' A' ' 170' ' ' VAL . 0.1 OUTLIER -99.09 139.13 35.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.167 -0.47 . . . . 74.33 110.884 179.966 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.495 ' CD2' ' HA ' ' A' ' 145' ' ' TYR . 0.1 OUTLIER -110.59 126.86 54.89 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.159 -0.473 . . . . 74.23 110.914 -179.843 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.564 ' O ' ' HB2' ' A' ' 171' ' ' GLN . 26.6 tt0 -66.08 -27.83 68.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.101 -0.5 . . . . 71.24 110.886 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.601 ' HB3' ' HD2' ' A' ' 143' ' ' PRO . 9.9 mp -109.73 169.71 6.13 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.632 0.729 . . . . 73.45 110.929 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . 0.718 ' O ' ' HB2' ' A' ' 172' ' ' SER . 53.5 Cg_endo -69.73 -89.15 0.0 OUTLIER 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.713 2.276 . . . . 72.41 112.338 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . 0.73 ' O ' ' N ' ' A' ' 146' ' ' ARG . 1.1 m-20 -48.43 96.43 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.218 -0.446 . . . . 75.13 110.924 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . 0.636 ' C ' ' O ' ' A' ' 144' ' ' ASN . 20.1 m-85 12.54 51.6 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.191 -0.459 . . . . 72.41 110.905 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.73 ' N ' ' O ' ' A' ' 144' ' ' ASN . 11.4 mtp85 -127.01 178.62 5.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.132 -0.485 . . . . 72.31 110.876 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 86.78 167.16 43.39 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.73 -0.747 . . . . 61.35 112.469 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.758 ' HA ' HD21 ' A' ' 76' ' ' LEU . 2.8 mpt_? -65.48 142.18 58.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.796 0.331 . . . . 71.12 110.86 -179.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . 0.523 ' O ' ' HB2' ' A' ' 59' ' ' MET . 51.4 mt-30 -81.29 155.57 25.98 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.173 -0.467 . . . . 64.14 110.907 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . 0.524 ' HB2' ' CB ' ' A' ' 139' ' ' PHE . 95.9 m-85 -138.29 123.01 18.71 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.231 -0.44 . . . . 74.42 110.924 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.559 ' HB2' HD11 ' A' ' 61' ' ' ILE . 21.3 tp -64.66 132.7 50.42 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.101 -0.499 . . . . 64.11 110.97 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.918 ' O ' HD13 ' A' ' 152' ' ' LEU . 0.0 OUTLIER -68.45 133.29 48.41 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.218 -0.446 . . . . 73.24 110.906 179.912 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -163.28 25.95 0.09 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.147 -0.479 . . . . 74.45 110.907 179.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.743 ' HA ' ' CE1' ' A' ' 157' ' ' TYR . 0.0 OUTLIER -108.89 -173.86 2.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.148 -0.478 . . . . 71.13 110.872 -179.99 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.657 ' CE ' HD13 ' A' ' 133' ' ' LEU . 4.0 mptt -164.93 -124.43 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.218 -0.446 . . . . 74.35 110.911 179.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.504 ' HA ' ' HA ' ' A' ' 131' ' ' LYS . 4.4 tm-20 -71.5 1.37 6.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.223 -0.444 . . . . 71.52 110.851 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . 0.743 ' CE1' ' HA ' ' A' ' 154' ' ' LYS . 21.3 m-30 -31.23 143.81 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.191 -0.459 . . . . 70.25 110.938 -179.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . 0.57 ' HB3' ' CZ ' ' A' ' 104' ' ' PHE . 0.0 OUTLIER -115.35 -40.68 3.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.128 -0.487 . . . . 54.32 110.897 -179.989 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . 0.472 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 0.2 OUTLIER -81.01 150.89 69.59 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.553 0.692 . . . . 73.34 110.918 179.966 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . 0.565 ' HA ' ' NE1' ' A' ' 163' ' ' TRP . 53.5 Cg_endo -69.78 -27.47 26.35 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.655 2.237 . . . . 74.31 112.346 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.65 ' H ' HD12 ' A' ' 161' ' ' ILE . 3.8 mp -67.21 -3.5 2.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.236 -0.438 . . . . 73.54 111.114 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.654 ' HB3' ' CD1' ' A' ' 157' ' ' TYR . 0.3 OUTLIER -76.61 -23.21 53.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.215 -0.448 . . . . 71.33 110.876 179.818 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' TRP . . . . . 0.565 ' NE1' ' HA ' ' A' ' 160' ' ' PRO . 1.7 m95 -79.96 -1.37 39.19 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.198 -0.455 . . . . 74.24 110.931 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 92.46 -35.22 4.12 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.728 -0.749 . . . . 74.25 112.475 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.415 ' O ' ' C ' ' A' ' 166' ' ' ALA . . . -77.37 129.2 35.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.826 0.346 . . . . 71.31 111.091 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . 0.415 ' C ' ' O ' ' A' ' 165' ' ' ALA . . . -37.08 -40.08 0.28 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.224 -0.443 . . . . 65.12 111.117 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . 0.479 ' C ' ' H ' ' A' ' 169' ' ' ALA . 0.3 OUTLIER -129.29 157.32 76.53 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.61 0.719 . . . . 74.15 110.867 -179.767 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . 0.517 ' HD3' ' HB2' ' A' ' 160' ' ' PRO . 53.4 Cg_endo -69.73 29.07 0.18 Allowed 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.667 2.245 . . . . 34.22 112.324 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.479 ' H ' ' C ' ' A' ' 167' ' ' SER . . . -66.01 106.58 1.63 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.244 -0.435 . . . . 62.12 111.094 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.759 HG11 ' CE2' ' A' ' 139' ' ' PHE . 3.3 t -152.08 165.92 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.224 -0.444 . . . . 72.43 111.083 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' GLN . . . . . 0.679 ' O ' ' HB ' ' A' ' 118' ' ' ILE . 2.6 mm-40 -123.72 -87.11 0.63 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.142 -0.481 . . . . 63.25 110.884 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . 0.718 ' HB2' ' O ' ' A' ' 143' ' ' PRO . 3.1 m -111.11 175.65 5.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.174 -0.466 . . . . 61.34 110.897 -179.804 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . 0.452 ' HB3' ' CD2' ' A' ' 139' ' ' PHE . 1.8 p90 -147.94 158.58 44.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.168 -0.469 . . . . 71.42 110.899 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . 0.429 ' HG2' ' CD2' ' A' ' 140' ' ' TYR . 0.0 OUTLIER -133.93 139.75 46.34 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.12 -0.491 . . . . 73.34 110.837 -179.857 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -95.38 -170.08 2.1 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.177 -0.465 . . . . 70.52 110.851 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . 0.982 HD12 ' HB ' ' A' ' 136' ' ' VAL . 3.3 mt -139.21 135.79 41.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.145 -0.479 . . . . 72.44 111.16 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 25.9 t -148.8 150.11 14.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.192 -0.458 . . . . 70.33 111.1 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.259 0 CA-C-N 116.134 -0.484 . . . . 74.12 110.936 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.79 0.329 . . . . 74.42 110.903 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -169.96 175.83 4.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.231 -0.441 . . . . 53.0 110.879 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 3.0 mtpm? -73.84 -36.75 64.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.151 -0.477 . . . . 74.11 110.879 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 8.8 t -51.83 -36.2 47.28 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.265 -0.425 . . . . 75.0 111.131 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -118.44 101.51 0.9 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.75 -0.738 . . . . 71.32 112.462 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.515 ' C ' ' HE1' ' A' ' 47' ' ' TRP . 11.2 p -82.58 133.1 35.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.882 0.372 . . . . 62.13 111.122 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 3.5 tttt -121.15 137.65 54.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.242 -0.435 . . . . 65.25 110.895 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.617 HD12 ' CG2' ' A' ' 42' ' ' VAL . 11.6 tt -137.33 149.41 25.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.209 -0.451 . . . . 71.1 111.166 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.525 HG22 ' CE2' ' A' ' 11' ' ' TYR . 24.5 m -131.74 129.02 40.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.178 -0.464 . . . . 61.34 111.133 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.818 ' HB2' HD22 ' A' ' 34' ' ' LEU . 0.6 OUTLIER -116.15 132.35 56.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.16 -0.473 . . . . 71.34 110.875 -179.957 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.556 ' CG ' ' HA ' ' A' ' 16' ' ' PHE . 49.1 m-85 -116.01 131.92 56.8 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.16 -0.473 . . . . 73.23 110.966 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.481 ' HG2' ' HB2' ' A' ' 36' ' ' ARG . 0.0 OUTLIER -60.7 -25.73 66.61 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 74.34 110.92 179.987 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 -125.96 151.23 47.28 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.114 -0.494 . . . . 75.1 110.855 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.441 ' HG3' ' HB3' ' A' ' 38' ' ' ASN . 19.7 mtmt -54.94 -178.21 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 62.24 110.936 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 24.7 m-20 47.68 38.72 8.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.256 -0.429 . . . . 62.41 110.894 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.556 ' HA ' ' CG ' ' A' ' 11' ' ' TYR . 3.0 m-85 44.71 60.48 2.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.15 -0.477 . . . . 60.32 110.885 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -135.97 158.78 43.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.088 -0.505 . . . . 74.12 110.882 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 93.47 -151.51 20.39 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.76 -0.733 . . . . 73.45 112.491 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.787 ' O ' HD13 ' A' ' 34' ' ' LEU . 0.3 OUTLIER -67.27 80.85 0.14 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.794 0.331 . . . . 74.24 110.937 -179.869 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.43 ' HA ' ' O ' ' A' ' 10' ' ' PHE . 0.7 OUTLIER -79.38 126.31 30.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.209 -0.45 . . . . 72.34 110.911 -179.89 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.478 ' CD2' ' CD2' ' A' ' 30' ' ' PHE . 85.9 t80 -121.46 124.03 43.47 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.221 -0.445 . . . . 74.41 110.909 -179.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.456 ' CG ' HG23 ' A' ' 9' ' ' THR . 1.0 OUTLIER -119.14 134.84 54.97 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.134 -0.485 . . . . 70.3 110.835 179.934 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -166.94 135.81 2.78 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.156 -0.474 . . . . 73.23 110.899 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -104.53 5.75 34.19 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 72.25 110.844 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 13.9 t -110.71 164.49 12.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.193 -0.458 . . . . 73.24 110.868 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -60.82 117.54 5.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.186 -0.461 . . . . 65.25 110.86 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.465 ' HB2' ' SG ' ' A' ' 83' ' ' CYS . 18.7 m -117.48 55.51 0.85 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.245 -0.434 . . . . 54.51 110.864 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.526 ' C ' ' HA ' ' A' ' 82' ' ' SER . . . -46.64 -19.14 0.08 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.208 -0.451 . . . . 53.52 111.158 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.402 ' N ' ' C ' ' A' ' 27' ' ' CYS . 52.4 t0 -128.71 42.14 3.37 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.212 -0.449 . . . . 65.14 110.872 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.805 ' O ' ' CD2' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -80.45 15.75 1.54 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.459 . . . . 74.15 110.864 -179.893 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.501 ' HB2' ' HB3' ' A' ' 81' ' ' SER . 33.2 t60 -80.65 -38.15 29.67 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.163 -0.471 . . . . 75.45 110.785 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.7 t -60.16 -12.52 8.77 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.245 -0.434 . . . . 62.02 111.137 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -101.34 -27.6 13.08 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.246 -0.434 . . . . 72.45 110.925 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.818 HD22 ' HB2' ' A' ' 10' ' ' PHE . 19.1 tp -141.94 140.53 32.8 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.133 -0.485 . . . . 71.31 110.888 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.1 m -109.07 -31.95 7.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.221 -0.445 . . . . 55.3 110.883 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.561 ' NH2' HD21 ' A' ' 38' ' ' ASN . 1.8 mtp85 -116.82 142.0 47.49 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.128 -0.487 . . . . 70.25 110.872 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.582 ' HB3' ' HB2' ' A' ' 80' ' ' LEU . 0.9 OUTLIER -118.37 52.09 1.05 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.22 -0.445 . . . . 61.45 110.869 -179.957 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.561 HD21 ' NH2' ' A' ' 36' ' ' ARG . 3.0 m120 -53.01 -70.78 0.08 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.203 -0.453 . . . . 73.41 110.866 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 8.7 p -112.86 128.42 56.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.203 -0.453 . . . . 74.24 110.887 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.659 HG21 HD13 ' A' ' 62' ' ' LEU . 5.4 mt -127.41 150.1 32.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.097 -0.501 . . . . 71.31 111.131 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.47 122.75 14.83 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.17 -0.468 . . . . 75.21 110.892 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.617 ' CG2' HD12 ' A' ' 8' ' ' ILE . 1.4 t -104.43 116.59 48.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.23 -0.441 . . . . 70.35 111.176 179.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -111.55 80.97 1.37 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.161 -0.472 . . . . 74.25 110.866 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.411 ' O ' ' HA ' ' A' ' 6' ' ' THR . . . 128.75 103.69 1.13 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.745 -0.74 . . . . 64.22 112.527 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.464 ' HA2' HD21 ' A' ' 88' ' ' LEU . . . 53.97 178.09 0.12 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.75 -0.738 . . . . 71.43 112.464 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.762 HG23 ' HA ' ' A' ' 63' ' ' PRO . 3.1 m -81.36 165.66 21.14 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.729 0.299 . . . . 74.31 111.177 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.598 ' CD1' ' HB ' ' A' ' 8' ' ' ILE . 6.2 m95 -139.86 130.09 25.22 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.216 -0.447 . . . . 73.51 110.925 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.842 ' HB2' ' CG2' ' A' ' 86' ' ' VAL . . . -95.12 129.01 42.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.203 -0.453 . . . . 65.54 111.152 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.788 HG12 ' HB3' ' A' ' 83' ' ' CYS . 14.1 m -127.47 127.27 68.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.233 -0.439 . . . . 74.51 111.115 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.756 ' HB3' ' HA ' ' A' ' 56' ' ' ALA . 45.8 m-85 -93.36 147.51 22.87 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.137 -0.483 . . . . 74.43 110.927 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.655 ' OE1' ' HB3' ' A' ' 57' ' ' TRP . 54.7 tt0 -48.5 -78.48 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.113 -0.494 . . . . 75.21 110.862 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.544 ' HB3' ' CD1' ' A' ' 55' ' ' PHE . 0.0 OUTLIER -92.98 143.81 27.41 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.652 0.739 . . . . 72.14 110.878 -179.907 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.769 ' HA ' ' OG ' ' A' ' 82' ' ' SER . 53.8 Cg_endo -69.75 141.59 45.67 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.688 2.259 . . . . 62.41 112.34 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 62.53 -10.98 0.08 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.19 -0.459 . . . . 74.31 110.876 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.614 ' H ' ' C ' ' A' ' 53' ' ' PRO . 2.6 m-30 -104.34 -20.19 13.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.455 . . . . 74.43 110.869 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.756 ' HA ' ' HB3' ' A' ' 50' ' ' TYR . . . 48.55 26.44 1.19 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.168 -0.469 . . . . 72.55 111.117 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . 0.655 ' HB3' ' OE1' ' A' ' 51' ' ' GLU . 0.0 OUTLIER -50.7 -159.98 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.233 -0.44 . . . . 72.33 110.919 -179.978 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.627 ' C ' ' O ' ' A' ' 57' ' ' TRP . 6.0 m-30 -15.5 103.84 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.213 -0.448 . . . . 71.41 110.914 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.468 ' HB2' ' O ' ' A' ' 149' ' ' GLN . 0.8 OUTLIER -62.44 145.14 54.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.124 -0.489 . . . . 73.14 110.892 179.891 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.646 ' O ' ' O ' ' A' ' 49' ' ' VAL . 0.4 OUTLIER -160.76 100.12 1.27 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.218 -0.447 . . . . 74.13 110.945 -179.89 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.796 ' N ' HD12 ' A' ' 61' ' ' ILE . 1.3 mp -94.22 117.17 37.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.101 -0.5 . . . . 54.43 111.157 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.741 HD23 ' HD2' ' A' ' 63' ' ' PRO . 0.4 OUTLIER -84.21 125.84 71.25 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.618 0.723 . . . . 61.24 110.92 179.928 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.762 ' HA ' HG23 ' A' ' 46' ' ' THR . 53.7 Cg_endo -69.68 -165.58 0.16 Allowed 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.68 2.253 . . . . 54.01 112.381 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.22 159.86 14.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.238 -0.437 . . . . 63.01 110.885 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 113.62 -149.95 18.58 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.791 -0.719 . . . . 60.42 112.495 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -122.94 160.36 26.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.859 0.362 . . . . 75.23 110.93 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.551 ' CE1' HD22 ' A' ' 62' ' ' LEU . 5.9 m-85 -150.05 79.1 7.78 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.668 0.747 . . . . 65.34 110.924 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.498 ' HD2' ' HG3' ' A' ' 72' ' ' ARG . 53.4 Cg_endo -69.81 0.48 5.62 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.721 2.281 . . . . 74.44 112.305 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 76.3 mt-10 -157.31 156.17 31.92 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.247 -0.433 . . . . 75.32 110.906 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.832 ' O ' ' CD1' ' A' ' 73' ' ' TRP . 11.7 p90 -68.35 -6.87 26.69 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.248 -0.433 . . . . 75.23 110.895 -179.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -87.12 -13.48 44.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.141 -0.481 . . . . 70.43 110.891 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.498 ' HG3' ' HD2' ' A' ' 68' ' ' PRO . 21.2 mmt180 -73.5 -24.64 60.2 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.224 -0.444 . . . . 70.21 110.891 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . 0.832 ' CD1' ' O ' ' A' ' 70' ' ' TYR . 0.5 OUTLIER -111.8 25.13 11.93 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.179 -0.464 . . . . 75.3 110.934 -179.975 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.552 ' CB ' ' O ' ' A' ' 73' ' ' TRP . 2.0 mmt 87.38 -38.47 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.248 -0.433 . . . . 75.14 110.927 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 88.93 45.83 4.7 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.724 -0.751 . . . . 53.32 112.495 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.595 HD21 ' HA ' ' A' ' 148' ' ' ARG . 0.4 OUTLIER -67.08 -74.95 0.1 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.837 0.351 . . . . 61.35 110.94 -179.957 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -129.28 136.13 49.66 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.188 -0.46 . . . . 71.53 110.859 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.424 ' C ' ' SG ' ' A' ' 37' ' ' CYS . 24.4 m-20 -90.35 18.54 6.0 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.187 -0.46 . . . . 72.31 110.858 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.406 ' HD2' ' HG2' ' A' ' 51' ' ' GLU . 0.6 OUTLIER -112.33 86.45 2.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.199 -0.455 . . . . 73.32 110.874 -179.914 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.806 HD12 ' CD1' ' A' ' 10' ' ' PHE . 0.0 OUTLIER -89.86 133.24 34.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.216 -0.447 . . . . 72.43 110.947 -179.992 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.641 ' HB3' ' HB3' ' A' ' 53' ' ' PRO . 0.8 OUTLIER -151.23 -127.93 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.203 -0.453 . . . . 62.41 110.875 -179.923 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.769 ' OG ' ' HA ' ' A' ' 53' ' ' PRO . 0.1 OUTLIER -33.98 102.16 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 62.51 110.847 -179.845 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . 0.788 ' HB3' HG12 ' A' ' 49' ' ' VAL . 30.2 p -118.82 133.35 55.9 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.125 -0.488 . . . . 75.3 110.882 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.599 ' N ' ' O ' ' A' ' 48' ' ' ALA . 13.7 mmt85 -119.94 144.25 47.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.228 -0.442 . . . . 73.02 110.862 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.419 ' N ' ' CZ3' ' A' ' 47' ' ' TRP . . . -63.61 127.66 32.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.178 -0.465 . . . . 64.12 111.095 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.842 ' CG2' ' HB2' ' A' ' 48' ' ' ALA . 46.7 t -115.78 137.86 48.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 74.12 111.113 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . 0.558 ' O ' HG23 ' A' ' 136' ' ' VAL . 34.0 m80 -111.58 112.82 24.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.205 -0.452 . . . . 74.22 110.825 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.471 HD23 ' H ' ' A' ' 88' ' ' LEU . 0.0 OUTLIER -35.82 143.23 0.27 Allowed Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.594 0.712 . . . . 61.45 110.872 -179.967 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.58 ' HB3' ' H ' ' A' ' 136' ' ' VAL . 53.9 Cg_endo -69.81 78.62 1.01 Allowed 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.695 2.263 . . . . 64.15 112.334 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -78.03 -177.01 4.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.223 -0.444 . . . . 73.24 110.852 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 74.8 -97.46 1.0 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.736 -0.745 . . . . 60.23 112.466 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.411 ' O ' ' C ' ' A' ' 93' ' ' GLN . . . -90.29 44.61 2.94 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.779 -0.724 . . . . 72.24 112.496 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.469 ' O ' ' HG2' ' A' ' 134' ' ' GLU . 5.9 pt20 37.19 -122.17 0.19 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.876 0.37 . . . . 72.12 110.917 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.558 ' OH ' HG22 ' A' ' 177' ' ' VAL . 0.1 OUTLIER -121.41 103.59 9.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.196 -0.456 . . . . 72.14 110.934 -179.9 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.559 ' HG3' HG11 ' A' ' 132' ' ' VAL . 41.4 tptt -114.83 126.15 54.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.114 -0.494 . . . . 73.32 110.862 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 8.2 tt -147.57 137.94 17.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.23 -0.441 . . . . 74.12 111.127 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.487 ' HB2' HG23 ' A' ' 132' ' ' VAL . 0.6 OUTLIER -108.7 131.67 54.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.182 -0.463 . . . . 74.31 110.877 179.937 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.805 HG23 HG13 ' A' ' 127' ' ' ILE . 1.1 mp -115.64 134.5 58.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.455 . . . . 72.22 111.136 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.607 ' HB2' ' CB ' ' A' ' 129' ' ' SER . 7.1 m-85 -122.66 155.15 36.99 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.197 -0.456 . . . . 71.42 110.855 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.534 ' HA ' ' CE ' ' A' ' 124' ' ' MET . 56.6 tt0 -84.75 -44.0 13.74 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.183 -0.462 . . . . 71.24 110.854 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.468 ' HB2' ' C ' ' A' ' 105' ' ' SER . 55.9 mttt -117.61 155.0 30.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.182 -0.463 . . . . 62.04 110.894 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -73.82 169.48 53.57 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.757 -0.735 . . . . 73.53 112.436 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.44 ' HA ' ' HB2' ' A' ' 158' ' ' ARG . 36.9 t70 63.25 40.3 8.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.798 0.333 . . . . 65.44 110.814 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.623 ' CE1' ' HD2' ' A' ' 131' ' ' LYS . 11.6 m-85 54.89 49.27 18.16 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.25 -0.432 . . . . 54.14 110.867 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.468 ' C ' ' HB2' ' A' ' 101' ' ' LYS . 69.5 m -127.93 161.85 28.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.169 -0.469 . . . . 73.44 110.841 -179.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 83.04 -172.48 51.5 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.715 -0.755 . . . . 71.22 112.472 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 36.8 tp60 -67.62 120.59 14.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.78 0.324 . . . . 71.2 110.921 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 5.6 ttp -106.65 132.01 53.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.191 -0.459 . . . . 75.22 110.89 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -137.12 137.45 39.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.274 -0.421 . . . . 75.43 110.909 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -114.66 112.76 23.38 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.092 -0.504 . . . . 72.13 110.903 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 13.9 t -121.28 132.18 54.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.168 -0.469 . . . . 74.34 111.168 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.51 ' HA ' ' O ' ' A' ' 94' ' ' TYR . 1.8 t -112.29 37.1 3.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.246 -0.434 . . . . 72.15 111.129 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -151.03 165.43 33.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.229 -0.441 . . . . 63.41 110.857 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -53.11 161.22 0.88 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.142 -0.481 . . . . 74.35 110.83 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . 0.606 ' O ' ' HB2' ' A' ' 172' ' ' SER . 20.4 t -146.9 110.92 4.11 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.651 0.738 . . . . 75.1 110.882 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.512 ' O ' ' C ' ' A' ' 143' ' ' PRO . 53.6 Cg_endo -69.82 -38.6 7.45 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.647 2.231 . . . . 74.4 112.309 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.617 ' HB3' ' CB ' ' A' ' 120' ' ' GLU . 0.1 OUTLIER -147.28 105.41 3.75 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.238 -0.437 . . . . 75.23 110.839 -179.839 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.614 ' HB ' ' O ' ' A' ' 171' ' ' GLN . 3.4 tt -58.07 -27.94 32.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.125 -0.489 . . . . 54.22 111.118 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' MET . . . . . 0.684 ' O ' ' HA ' ' A' ' 123' ' ' HIS . 8.6 ttp -86.77 -40.57 14.86 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.17 -0.468 . . . . 73.33 110.875 179.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.617 ' CB ' ' HB3' ' A' ' 117' ' ' SER . 14.7 tp10 -70.52 -13.52 62.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.264 -0.426 . . . . 72.31 110.879 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 7.6 tp-100 -116.25 -50.71 2.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.152 -0.477 . . . . 73.15 110.944 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.482 ' HB2' ' O ' ' A' ' 118' ' ' ILE . 46.8 m-85 -101.26 -13.85 17.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.222 -0.445 . . . . 74.53 110.917 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.684 ' HA ' ' O ' ' A' ' 119' ' ' MET . 27.9 m-70 69.16 24.86 5.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.125 -0.488 . . . . 64.24 110.828 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.534 ' CE ' ' HA ' ' A' ' 100' ' ' GLU . 0.9 OUTLIER -96.47 145.24 25.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.248 -0.433 . . . . 71.33 110.891 179.975 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 5.1 ptp180 -110.62 -40.91 4.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.249 -0.432 . . . . 74.31 110.862 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.442 ' HB3' ' HG2' ' A' ' 168' ' ' PRO . 17.6 mt-10 -141.05 116.13 9.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.205 -0.452 . . . . 70.51 110.864 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.805 HG13 HG23 ' A' ' 98' ' ' ILE . 1.0 OUTLIER -74.8 99.78 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.149 -0.478 . . . . 61.03 111.126 179.954 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . 0.427 ' CD2' ' HG3' ' A' ' 168' ' ' PRO . 24.8 m170 -73.33 -28.13 61.9 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.113 -0.494 . . . . 72.52 110.884 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.607 ' CB ' ' HB2' ' A' ' 99' ' ' PHE . 0.5 OUTLIER -132.31 136.93 47.24 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.225 -0.443 . . . . 74.24 110.872 -179.741 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . 0.614 ' SG ' HG21 ' A' ' 127' ' ' ILE . 0.1 OUTLIER -135.09 118.15 16.43 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.218 -0.446 . . . . 64.03 110.881 -179.977 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.65 ' HA ' ' HA ' ' A' ' 156' ' ' GLU . 6.0 mtpp -118.59 152.53 35.85 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.153 -0.476 . . . . 61.43 110.859 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.559 HG11 ' HG3' ' A' ' 95' ' ' LYS . 16.6 t 82.74 163.4 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.217 -0.447 . . . . 51.3 111.108 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.829 HD13 ' O ' ' A' ' 154' ' ' LYS . 0.0 OUTLIER -179.73 123.57 0.07 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.17 -0.468 . . . . 71.55 110.911 179.942 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.516 ' O ' ' C ' ' A' ' 135' ' ' GLY . 0.1 OUTLIER -94.27 167.1 11.75 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.153 -0.476 . . . . 65.12 110.915 179.908 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.516 ' C ' ' O ' ' A' ' 134' ' ' GLU . . . -27.93 -57.82 0.12 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.745 -0.74 . . . . 51.11 112.463 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.689 HG21 HG13 ' A' ' 86' ' ' VAL . 2.8 t -145.66 144.44 21.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.809 0.338 . . . . 74.11 111.167 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . 0.588 ' HB3' ' HB3' ' A' ' 152' ' ' LEU . 7.4 t-105 -143.52 152.98 42.13 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.22 -0.445 . . . . 75.45 110.974 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.493 ' CD1' ' HB ' ' A' ' 61' ' ' ILE . 2.8 mm -119.21 132.02 70.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.271 -0.422 . . . . 64.42 111.156 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.707 ' CE2' HG11 ' A' ' 170' ' ' VAL . 0.2 OUTLIER -111.41 146.37 37.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.187 -0.46 . . . . 72.52 110.858 179.951 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.422 ' CD2' ' HA ' ' A' ' 145' ' ' TYR . 3.4 m-85 -127.79 130.01 47.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.069 -0.514 . . . . 74.23 110.889 -179.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.613 ' O ' ' HB2' ' A' ' 171' ' ' GLN . 0.2 OUTLIER -60.34 -25.78 66.08 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.081 -0.509 . . . . 75.22 110.877 -179.984 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.748 ' HB3' ' HD2' ' A' ' 143' ' ' PRO . 9.7 mp -114.66 173.88 2.66 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.657 0.742 . . . . 70.3 110.88 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . 0.751 ' O ' ' OG ' ' A' ' 172' ' ' SER . 53.7 Cg_endo -69.77 -91.62 0.01 OUTLIER 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.726 2.284 . . . . 75.45 112.281 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . 0.71 ' O ' ' N ' ' A' ' 146' ' ' ARG . 0.9 OUTLIER -50.98 97.89 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.154 -0.476 . . . . 52.34 110.858 -179.926 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . 0.641 ' C ' ' O ' ' A' ' 144' ' ' ASN . 0.1 OUTLIER 12.1 53.09 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.143 -0.48 . . . . 72.13 110.923 -179.924 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.71 ' N ' ' O ' ' A' ' 144' ' ' ASN . 11.3 mtp85 -118.76 174.71 6.12 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.095 -0.502 . . . . 75.04 110.844 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 80.84 -173.0 54.62 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.733 -0.746 . . . . 41.33 112.495 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.595 ' HA ' HD21 ' A' ' 76' ' ' LEU . 0.8 OUTLIER -80.58 150.46 29.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.749 0.309 . . . . 61.54 110.893 -179.906 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . 0.468 ' O ' ' HB2' ' A' ' 59' ' ' MET . 8.4 mt-30 -81.73 153.62 26.45 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.185 -0.461 . . . . 74.34 110.889 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . 0.585 ' HB2' ' CB ' ' A' ' 139' ' ' PHE . 98.3 m-85 -139.28 129.44 25.26 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.218 -0.446 . . . . 44.03 110.945 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.602 ' HB2' HD11 ' A' ' 61' ' ' ILE . 13.3 tp -81.78 121.72 26.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.092 -0.504 . . . . 43.23 110.911 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 1.02 ' O ' HD13 ' A' ' 152' ' ' LEU . 0.0 OUTLIER -53.77 135.86 40.82 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.191 -0.459 . . . . 73.32 110.948 179.886 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -164.07 27.75 0.08 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.206 -0.452 . . . . 74.15 110.828 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.829 ' O ' HD13 ' A' ' 133' ' ' LEU . 0.0 OUTLIER -116.71 -172.74 2.25 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.214 -0.448 . . . . 74.55 110.889 179.969 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.804 ' HG3' HD22 ' A' ' 133' ' ' LEU . 0.0 OUTLIER -162.39 -128.92 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.221 -0.445 . . . . 42.12 110.908 179.875 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.65 ' HA ' ' HA ' ' A' ' 131' ' ' LYS . 0.2 OUTLIER -68.0 1.13 2.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.213 -0.449 . . . . 74.14 110.936 179.956 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . 0.746 ' CE1' ' HA ' ' A' ' 154' ' ' LYS . 20.3 m-30 -28.78 143.47 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.094 -0.503 . . . . 75.25 110.933 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . 0.44 ' HB2' ' HA ' ' A' ' 103' ' ' ASP . 9.5 ptp180 -110.91 -43.4 3.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.158 -0.474 . . . . 71.54 110.921 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -82.45 151.24 65.16 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.519 0.676 . . . . 70.53 110.93 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . 0.541 ' HB3' ' HB3' ' A' ' 168' ' ' PRO . 54.0 Cg_endo -69.74 -26.67 27.45 Favored 'Trans proline' 0 C--O 1.231 0.136 0 C-N-CA 122.7 2.266 . . . . 75.15 112.347 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.598 ' H ' HD12 ' A' ' 161' ' ' ILE . 3.6 mp -65.44 -11.78 12.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.224 -0.444 . . . . 74.04 111.074 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.67 ' HB3' ' CD1' ' A' ' 157' ' ' TYR . 0.3 OUTLIER -75.0 -18.88 60.29 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.151 -0.477 . . . . 74.54 110.837 179.936 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 13.3 t90 -82.06 0.23 41.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.197 -0.456 . . . . 73.45 110.938 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 91.91 -36.2 3.74 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.75 -0.738 . . . . 65.54 112.507 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -79.68 128.39 33.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.777 0.322 . . . . 74.54 111.099 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -39.41 -38.28 0.54 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.194 -0.457 . . . . 50.02 111.101 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . 0.496 ' C ' ' H ' ' A' ' 169' ' ' ALA . 0.5 OUTLIER -128.18 154.26 78.77 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.642 0.734 . . . . 64.31 110.892 -179.822 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . 0.541 ' HB3' ' HB3' ' A' ' 160' ' ' PRO . 54.4 Cg_endo -69.74 25.13 0.17 Allowed 'Trans proline' 0 C--O 1.231 0.147 0 C-N-CA 122.742 2.294 . . . . 73.54 112.352 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.496 ' H ' ' C ' ' A' ' 167' ' ' SER . . . -65.89 103.65 0.96 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.223 -0.444 . . . . 72.13 111.11 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.707 HG11 ' CE2' ' A' ' 139' ' ' PHE . 2.6 t -152.14 163.43 2.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.225 -0.443 . . . . 63.22 111.145 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' GLN . . . . . 0.64 ' OE1' ' HB3' ' A' ' 143' ' ' PRO . 1.8 mm-40 -114.26 -89.57 0.54 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.19 -0.459 . . . . 74.42 110.914 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . 0.751 ' OG ' ' O ' ' A' ' 143' ' ' PRO . 12.6 p -126.9 177.05 6.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.194 -0.457 . . . . 61.1 110.852 -179.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . 0.604 ' CE1' HD11 ' A' ' 98' ' ' ILE . 1.4 p90 -145.8 174.38 11.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.105 -0.498 . . . . 72.42 110.883 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.18 154.61 46.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.179 -0.464 . . . . 73.01 110.88 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.15 -169.91 2.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.16 -0.473 . . . . 72.34 110.864 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . 0.422 HD12 ' HB ' ' A' ' 136' ' ' VAL . 4.5 mt -134.51 136.85 52.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.21 -0.45 . . . . 74.24 111.173 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.558 HG22 ' OH ' ' A' ' 94' ' ' TYR . 10.7 t -140.31 153.43 22.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.218 -0.446 . . . . 65.44 111.142 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . 0.445 ' HB3' HD13 ' A' ' 88' ' ' LEU . 10.6 pt-20 . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 116.133 -0.485 . . . . 61.22 110.855 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.81 0.338 . . . . 71.31 110.857 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.8 m -156.84 176.55 12.6 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.215 -0.448 . . . . 72.13 110.816 -179.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -73.01 -37.21 67.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.14 -0.482 . . . . 72.41 110.925 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER 51.98 -172.42 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.216 -0.447 . . . . 71.43 111.116 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -79.61 146.6 28.77 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.765 -0.731 . . . . 64.43 112.489 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.514 ' C ' ' HE1' ' A' ' 47' ' ' TRP . 6.9 p -82.8 135.81 34.85 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.908 0.385 . . . . 75.43 111.117 -179.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 3.6 tttt -122.54 135.24 54.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 72.42 110.937 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.591 ' HB ' HG22 ' A' ' 42' ' ' VAL . 15.2 tt -136.75 150.61 27.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.21 -0.45 . . . . 52.14 111.125 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.496 HG23 ' CG ' ' A' ' 22' ' ' ASP . 13.6 m -127.4 146.29 50.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.187 -0.461 . . . . 74.42 111.164 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.795 ' HB2' HD22 ' A' ' 34' ' ' LEU . 0.2 OUTLIER -134.07 127.17 31.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.206 -0.452 . . . . 71.43 110.888 179.999 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.551 ' CG ' ' HA ' ' A' ' 16' ' ' PHE . 26.2 m-85 -113.41 131.82 55.86 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.149 -0.478 . . . . 71.11 110.923 -179.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.458 ' N ' HD11 ' A' ' 34' ' ' LEU . 0.0 OUTLIER -60.26 -15.43 24.79 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.121 -0.49 . . . . 65.14 110.9 179.987 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.449 ' HB2' ' O ' ' A' ' 17' ' ' GLN . 71.2 m-20 -134.89 150.57 50.45 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.156 -0.475 . . . . 70.02 110.873 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.504 ' N ' ' HB3' ' A' ' 38' ' ' ASN . 39.4 mtmt -55.7 -177.78 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.182 -0.463 . . . . 74.13 110.857 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 22.7 m-20 48.14 33.26 3.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.17 -0.468 . . . . 75.3 110.888 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.551 ' HA ' ' CG ' ' A' ' 11' ' ' TYR . 3.3 m-85 49.22 64.3 1.79 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.164 -0.471 . . . . 71.44 110.853 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.449 ' O ' ' HB2' ' A' ' 13' ' ' ASP . 15.6 mt-30 -140.07 158.07 44.63 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.146 -0.479 . . . . 71.32 110.934 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 93.28 -150.63 20.0 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.775 -0.726 . . . . 74.43 112.476 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.715 ' O ' HD13 ' A' ' 34' ' ' LEU . 0.2 OUTLIER -66.72 78.51 0.11 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.754 0.311 . . . . 73.25 110.851 -179.829 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.475 ' HB2' ' CE1' ' A' ' 11' ' ' TYR . 0.7 OUTLIER -77.04 128.88 35.27 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.232 -0.44 . . . . 74.43 110.876 -179.921 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.475 ' O ' ' HA ' ' A' ' 9' ' ' THR . 88.1 t80 -123.06 125.72 45.73 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.21 -0.45 . . . . 73.14 110.943 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.496 ' CG ' HG23 ' A' ' 9' ' ' THR . 1.3 m-20 -123.33 132.63 54.05 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.156 -0.474 . . . . 72.31 110.857 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -166.0 138.33 3.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 65.34 110.927 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -104.72 4.48 32.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.195 -0.457 . . . . 73.12 110.846 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 14.9 t -108.55 164.2 12.56 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.21 -0.45 . . . . 64.35 110.882 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -60.25 117.49 5.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.173 -0.467 . . . . 73.31 110.832 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.469 ' HB3' ' CB ' ' A' ' 30' ' ' PHE . 16.6 m -117.07 54.05 0.88 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.173 -0.467 . . . . 61.03 110.894 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.525 ' O ' ' HA ' ' A' ' 82' ' ' SER . . . -47.67 -18.84 0.17 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 30.24 111.06 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 58.3 t0 -127.26 40.07 3.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.236 -0.438 . . . . 75.43 110.845 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.779 ' O ' ' CD2' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -80.77 14.12 2.3 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.224 -0.444 . . . . 72.45 110.896 -179.927 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.508 ' HB2' ' HB3' ' A' ' 53' ' ' PRO . 36.2 t60 -78.47 -37.75 42.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.121 -0.49 . . . . 71.32 110.893 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.5 t -58.19 -15.18 8.89 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.199 -0.455 . . . . 71.52 111.149 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -98.53 -27.97 13.8 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.243 -0.435 . . . . 73.44 110.899 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.795 HD22 ' HB2' ' A' ' 10' ' ' PHE . 15.6 tp -140.87 134.92 30.78 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.129 -0.487 . . . . 74.54 110.878 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 23.3 m -99.74 -41.49 7.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.187 -0.46 . . . . 73.0 110.866 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -119.14 143.08 47.4 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.13 -0.486 . . . . 73.43 110.865 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.64 ' SG ' ' HB2' ' A' ' 80' ' ' LEU . 1.8 p -115.65 89.75 3.17 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.193 -0.458 . . . . 74.51 110.919 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.504 ' HB3' ' N ' ' A' ' 14' ' ' LYS . 3.6 m-20 -85.46 -54.01 4.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.193 -0.458 . . . . 64.34 110.87 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 9.7 p -125.32 128.12 47.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 51.42 110.854 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.741 HG21 HD13 ' A' ' 62' ' ' LEU . 11.0 mt -127.05 152.08 34.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.11 -0.495 . . . . 74.25 111.123 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.435 ' N ' ' CG2' ' A' ' 40' ' ' ILE . 0.0 OUTLIER -142.78 118.33 10.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.188 -0.46 . . . . 74.55 110.877 179.852 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.591 HG22 ' HB ' ' A' ' 8' ' ' ILE . 1.9 t -101.2 115.15 42.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.187 -0.46 . . . . 72.22 111.111 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -111.28 79.96 1.26 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.181 -0.463 . . . . 72.21 110.889 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.454 ' O ' ' HA ' ' A' ' 6' ' ' THR . . . 129.44 103.33 1.07 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.72 -0.752 . . . . 74.44 112.467 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.475 ' HA2' HD21 ' A' ' 88' ' ' LEU . . . 52.84 178.1 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.704 -0.76 . . . . 63.13 112.49 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.758 HG23 ' HA ' ' A' ' 63' ' ' PRO . 3.0 m -79.65 164.78 23.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.794 0.331 . . . . 61.52 111.119 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.575 ' CD1' ' HB ' ' A' ' 8' ' ' ILE . 2.7 m95 -137.69 130.02 29.34 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.155 -0.475 . . . . 74.55 110.857 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.805 ' HB2' ' CG2' ' A' ' 86' ' ' VAL . . . -92.77 131.26 37.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.227 -0.442 . . . . 74.21 111.151 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.907 HG11 HD11 ' A' ' 80' ' ' LEU . 19.6 m -132.56 127.51 56.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.241 -0.436 . . . . 73.24 111.105 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.75 ' HB3' ' HA ' ' A' ' 56' ' ' ALA . 38.9 m-85 -94.75 148.3 22.43 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.218 -0.447 . . . . 62.42 110.92 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.544 ' HB2' ' O ' ' A' ' 58' ' ' TYR . 7.1 tt0 -50.91 -76.55 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.148 -0.478 . . . . 43.24 110.855 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.571 ' HB3' ' CD1' ' A' ' 55' ' ' PHE . 19.2 mmm-85 -89.92 140.7 27.73 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.64 0.733 . . . . 72.2 110.846 -179.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.789 ' HA ' ' OG ' ' A' ' 82' ' ' SER . 54.1 Cg_endo -69.75 137.8 36.35 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.733 2.289 . . . . 71.45 112.322 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 65.32 -11.18 0.17 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.246 -0.434 . . . . 73.13 110.897 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.571 ' CD1' ' HB3' ' A' ' 52' ' ' ARG . 4.9 m-30 -100.85 -32.19 10.79 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.159 -0.473 . . . . 62.53 110.876 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.75 ' HA ' ' HB3' ' A' ' 50' ' ' TYR . . . 63.42 22.44 13.25 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.185 -0.461 . . . . 73.54 111.107 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . 0.629 ' O ' ' C ' ' A' ' 58' ' ' TYR . 1.2 t90 -51.4 -159.69 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.216 -0.447 . . . . 73.11 110.923 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.629 ' C ' ' O ' ' A' ' 57' ' ' TRP . 5.8 m-30 -13.72 101.43 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.278 -0.419 . . . . 71.54 110.929 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.407 ' HB2' ' HA ' ' A' ' 150' ' ' TYR . 2.1 mpt? -59.67 149.28 31.02 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.067 -0.515 . . . . 53.44 110.886 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.811 ' CE2' HD12 ' A' ' 76' ' ' LEU . 0.4 OUTLIER -163.93 105.08 0.91 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.232 -0.44 . . . . 72.11 110.923 -179.876 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.81 ' N ' HD12 ' A' ' 61' ' ' ILE . 0.9 OUTLIER -98.86 115.72 40.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.114 -0.494 . . . . 74.43 111.114 179.904 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.778 HD23 ' HD2' ' A' ' 63' ' ' PRO . 0.4 OUTLIER -83.64 123.71 76.07 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.6 0.714 . . . . 32.53 110.939 179.877 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.778 ' HD2' HD23 ' A' ' 62' ' ' LEU . 54.3 Cg_endo -69.74 -165.21 0.15 Allowed 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.73 2.286 . . . . 73.43 112.341 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.64 159.57 14.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.233 -0.44 . . . . 73.33 110.907 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 112.88 -155.52 16.23 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.715 -0.755 . . . . 62.54 112.448 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -114.81 160.42 19.47 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.877 0.37 . . . . 74.11 110.859 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.446 ' N ' ' O ' ' A' ' 40' ' ' ILE . 10.8 m-85 -149.58 83.81 6.27 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.71 0.766 . . . . 74.32 110.919 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.8 -4.73 14.65 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.65 2.234 . . . . 71.43 112.325 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -156.89 148.23 22.2 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.244 -0.435 . . . . 75.33 110.919 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.99 ' O ' ' CD1' ' A' ' 73' ' ' TRP . 44.6 p90 -57.44 -42.44 82.45 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.164 -0.471 . . . . 70.44 110.936 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -51.94 -15.79 0.6 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.102 -0.499 . . . . 63.42 110.89 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 28.7 mmt180 -69.16 -9.22 51.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.179 -0.464 . . . . 75.25 110.902 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . 0.99 ' CD1' ' O ' ' A' ' 70' ' ' TYR . 0.5 OUTLIER -128.8 21.63 5.9 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.18 -0.463 . . . . 71.32 110.905 -179.946 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.623 ' O ' ' C ' ' A' ' 75' ' ' GLY . 24.1 mmt 79.54 27.44 0.36 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.276 -0.42 . . . . 72.23 110.878 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.623 ' C ' ' O ' ' A' ' 74' ' ' MET . . . 15.74 61.94 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.698 -0.763 . . . . 33.15 112.514 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.811 HD12 ' CE2' ' A' ' 60' ' ' TYR . 59.9 mt -58.89 -80.34 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.843 0.354 . . . . 73.55 110.902 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.589 ' O ' ' CB ' ' A' ' 78' ' ' ASP . 3.8 t-20 -113.56 -41.84 3.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.193 -0.458 . . . . 50.33 110.898 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.589 ' CB ' ' O ' ' A' ' 77' ' ' ASN . 2.6 t70 91.04 16.38 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.18 -0.464 . . . . 74.13 110.891 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.451 ' NE ' ' HD3' ' A' ' 52' ' ' ARG . 4.9 ttm105 -110.92 97.66 6.99 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.143 -0.481 . . . . 73.41 110.845 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.907 HD11 HG11 ' A' ' 49' ' ' VAL . 0.1 OUTLIER -95.6 131.7 41.53 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.18 -0.463 . . . . 71.11 110.912 -179.985 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.671 ' HB3' ' HB3' ' A' ' 53' ' ' PRO . 1.2 m -153.03 -123.58 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.208 -0.451 . . . . 65.34 110.877 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.789 ' OG ' ' HA ' ' A' ' 53' ' ' PRO . 0.0 OUTLIER -41.65 101.86 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.138 -0.483 . . . . 73.24 110.797 -179.757 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . 0.711 ' CB ' HG12 ' A' ' 49' ' ' VAL . 21.3 p -117.43 136.15 53.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.109 -0.496 . . . . 74.2 110.857 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.585 ' N ' ' O ' ' A' ' 48' ' ' ALA . 6.6 mmt85 -123.43 138.38 54.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.149 -0.478 . . . . 71.04 110.865 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.448 ' N ' ' CZ3' ' A' ' 47' ' ' TRP . . . -57.71 128.67 38.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.202 -0.454 . . . . 74.11 111.044 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.832 HG13 HG21 ' A' ' 136' ' ' VAL . 12.3 t -111.71 139.6 35.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.18 -0.463 . . . . 60.2 111.113 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . 0.637 ' O ' HG23 ' A' ' 136' ' ' VAL . 29.8 m80 -111.84 106.01 14.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.173 -0.467 . . . . 75.11 110.854 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.73 HD13 ' HA ' ' A' ' 178' ' ' GLU . 0.0 OUTLIER -31.9 143.22 0.13 Allowed Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.619 0.723 . . . . 71.03 110.888 -179.949 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.529 ' HB3' ' H ' ' A' ' 136' ' ' VAL . 53.7 Cg_endo -69.82 105.73 1.55 Allowed 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.652 2.235 . . . . 64.12 112.291 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.03 177.35 4.88 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.206 -0.452 . . . . 72.32 110.805 -179.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 50.12 63.16 4.48 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.741 -0.742 . . . . 35.23 112.486 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.424 ' O ' ' C ' ' A' ' 93' ' ' GLN . . . 124.25 21.72 2.24 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.754 -0.736 . . . . 61.32 112.454 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.471 ' O ' ' HG2' ' A' ' 134' ' ' GLU . 5.3 pt20 36.59 -121.29 0.16 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.815 0.341 . . . . 73.43 110.859 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.535 ' O ' ' HA ' ' A' ' 112' ' ' THR . 0.1 OUTLIER -120.92 100.8 7.29 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.141 -0.482 . . . . 65.53 110.911 -179.853 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.533 ' HG3' HG11 ' A' ' 132' ' ' VAL . 45.6 tptt -110.82 128.27 55.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.112 -0.494 . . . . 71.0 110.907 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.472 HG21 ' CH2' ' A' ' 137' ' ' TRP . 0.0 OUTLIER -149.11 142.38 18.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.253 -0.431 . . . . 70.3 111.12 179.82 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.532 ' HB2' HG23 ' A' ' 132' ' ' VAL . 2.8 mt-30 -112.1 126.94 55.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.137 -0.483 . . . . 74.42 110.911 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.625 HD13 ' HE1' ' A' ' 122' ' ' PHE . 4.9 mp -108.33 131.26 59.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.237 -0.438 . . . . 44.21 111.115 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.672 ' HB2' ' HB2' ' A' ' 129' ' ' SER . 6.4 m-85 -120.15 148.19 43.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.172 -0.467 . . . . 75.43 110.883 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -74.88 -75.59 0.16 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.159 -0.473 . . . . 73.4 110.912 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.439 ' C ' ' HB3' ' A' ' 128' ' ' HIS . 36.7 mttt -83.14 176.19 9.39 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.168 -0.469 . . . . 72.45 110.926 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -88.79 160.41 29.98 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.764 -0.731 . . . . 64.34 112.476 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.432 ' HA ' ' HB2' ' A' ' 158' ' ' ARG . 27.8 t0 65.15 53.42 1.35 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.883 0.373 . . . . 73.23 110.893 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.63 ' CE1' ' HD2' ' A' ' 131' ' ' LYS . 6.1 m-85 48.38 33.74 4.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.457 . . . . 64.11 110.876 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.419 ' HB2' ' HB2' ' A' ' 101' ' ' LYS . 45.4 m -109.47 151.61 26.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.101 -0.499 . . . . 74.25 110.848 -179.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 91.35 -164.4 29.44 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.675 -0.774 . . . . 71.25 112.467 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 5.0 tp-100 -75.41 129.65 37.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.805 0.336 . . . . 71.01 110.945 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 3.8 ttp -112.47 144.96 41.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.197 -0.456 . . . . 65.32 110.887 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 -148.84 141.73 24.72 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.212 -0.449 . . . . 70.51 110.949 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -123.78 108.66 12.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.1 -0.5 . . . . 73.34 110.938 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 5.0 t -121.47 145.69 47.68 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.175 -0.466 . . . . 64.34 111.132 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.535 ' HA ' ' O ' ' A' ' 94' ' ' TYR . 4.4 t -120.96 41.91 3.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.245 -0.434 . . . . 64.12 111.152 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -151.19 157.08 42.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.224 -0.444 . . . . 73.31 110.904 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -53.85 157.86 2.23 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.145 -0.479 . . . . 73.41 110.823 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . 0.671 ' O ' ' HB2' ' A' ' 172' ' ' SER . 73.2 m -146.89 115.2 4.36 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-O 121.626 0.727 . . . . 73.32 110.898 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.455 ' O ' ' C ' ' A' ' 143' ' ' PRO . 53.3 Cg_endo -69.82 -30.3 22.24 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.648 2.232 . . . . 73.32 112.328 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.634 ' HB3' ' CB ' ' A' ' 120' ' ' GLU . 0.1 OUTLIER -148.26 99.82 3.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.251 -0.431 . . . . 64.33 110.814 -179.854 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.642 HD13 HD11 ' A' ' 127' ' ' ILE . 5.6 tt -52.86 -26.56 11.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.12 -0.491 . . . . 45.31 111.124 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' MET . . . . . 0.602 ' O ' ' HA ' ' A' ' 123' ' ' HIS . 14.4 ttp -86.75 -41.26 14.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.198 -0.455 . . . . 73.13 110.89 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.634 ' CB ' ' HB3' ' A' ' 117' ' ' SER . 34.5 tp10 -64.33 -12.98 47.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.215 -0.448 . . . . 73.23 110.854 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.404 ' H ' ' HG3' ' A' ' 121' ' ' GLN . 0.0 OUTLIER -114.62 -51.56 2.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.189 -0.46 . . . . 71.51 110.946 -179.96 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.625 ' HE1' HD13 ' A' ' 98' ' ' ILE . 12.1 m-30 -101.22 -18.17 16.27 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.217 -0.447 . . . . 44.34 110.935 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.602 ' HA ' ' O ' ' A' ' 119' ' ' MET . 11.8 m80 74.39 21.29 2.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.135 -0.484 . . . . 73.31 110.901 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.56 ' SD ' HG22 ' A' ' 98' ' ' ILE . 6.5 mtt -94.27 131.91 39.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.188 -0.46 . . . . 65.34 110.873 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 4.9 ptp180 -95.23 -38.55 10.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.181 -0.463 . . . . 65.22 110.877 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.464 ' HG2' ' HA ' ' A' ' 169' ' ' ALA . 25.2 mt-10 -141.25 118.62 11.45 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.159 -0.473 . . . . 64.14 110.875 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.642 HD11 HD13 ' A' ' 118' ' ' ILE . 3.0 mm -80.08 101.09 4.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.163 -0.471 . . . . 75.45 111.138 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . 0.439 ' HB3' ' C ' ' A' ' 101' ' ' LYS . 0.4 OUTLIER -73.19 -32.58 64.9 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.171 -0.468 . . . . 72.45 110.846 179.888 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.672 ' HB2' ' HB2' ' A' ' 99' ' ' PHE . 66.5 m -128.47 138.89 52.51 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.193 -0.458 . . . . 65.02 110.83 -179.719 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . 0.573 ' O ' ' O ' ' A' ' 155' ' ' LYS . 3.8 m -136.05 120.43 18.02 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.149 -0.478 . . . . 61.41 110.865 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.67 ' HA ' ' HA ' ' A' ' 156' ' ' GLU . 3.6 mtpp -116.35 152.21 34.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.131 -0.486 . . . . 71.5 110.892 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.539 ' HB ' ' O ' ' A' ' 131' ' ' LYS . 19.4 t 85.6 162.46 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.226 -0.443 . . . . 75.31 111.145 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.812 HD22 ' CG ' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -177.33 124.59 0.14 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.223 -0.444 . . . . 64.24 110.929 179.933 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.501 ' O ' ' C ' ' A' ' 135' ' ' GLY . 0.1 OUTLIER -98.26 168.23 10.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.162 -0.472 . . . . 72.12 110.895 179.936 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.501 ' C ' ' O ' ' A' ' 134' ' ' GLU . . . -29.17 -70.04 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.751 -0.738 . . . . 72.13 112.447 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.832 HG21 HG13 ' A' ' 86' ' ' VAL . 3.0 t -133.82 145.43 33.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.834 0.349 . . . . 73.55 111.109 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . 0.616 ' H ' HD12 ' A' ' 152' ' ' LEU . 0.1 OUTLIER -150.1 162.8 39.7 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.187 -0.461 . . . . 73.15 110.866 -179.975 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.456 HD12 HH11 ' A' ' 174' ' ' ARG . 22.6 mt -138.48 134.03 43.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.208 -0.451 . . . . 75.41 111.136 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.676 ' CE1' HG11 ' A' ' 170' ' ' VAL . 0.2 OUTLIER -103.68 159.16 15.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.176 -0.465 . . . . 73.33 110.884 179.957 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.481 ' CD2' ' HA ' ' A' ' 145' ' ' TYR . 0.5 OUTLIER -131.61 128.46 39.18 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.123 -0.49 . . . . 75.43 110.905 -179.875 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.576 ' O ' ' HB2' ' A' ' 171' ' ' GLN . 7.0 tt0 -60.76 -27.75 68.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.089 -0.505 . . . . 61.52 110.858 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.743 ' HB3' ' HD2' ' A' ' 143' ' ' PRO . 10.1 mp -114.97 173.46 2.89 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.588 0.709 . . . . 74.45 110.938 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . 0.758 ' O ' ' OG ' ' A' ' 172' ' ' SER . 53.2 Cg_endo -69.77 -90.61 0.0 OUTLIER 'Trans proline' 0 C--N 1.34 0.129 0 C-N-CA 122.694 2.263 . . . . 44.3 112.327 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . 0.723 ' O ' ' N ' ' A' ' 146' ' ' ARG . 2.4 m-20 -50.73 98.57 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.181 -0.463 . . . . 74.33 110.87 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . 0.638 ' C ' ' O ' ' A' ' 144' ' ' ASN . 0.1 OUTLIER 12.67 51.77 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.163 -0.471 . . . . 72.25 110.945 -179.959 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.723 ' N ' ' O ' ' A' ' 144' ' ' ASN . 22.3 mtt-85 -119.46 173.43 6.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.132 -0.486 . . . . 75.34 110.921 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 79.84 172.27 43.6 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.737 -0.744 . . . . 62.05 112.462 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 19.3 mtp180 -68.55 150.61 47.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.755 0.312 . . . . 73.42 110.888 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . 0.688 ' HG3' HD11 ' A' ' 76' ' ' LEU . 55.4 mt-30 -86.02 153.21 22.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.236 -0.438 . . . . 75.4 110.932 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . 0.482 ' HB2' ' HB2' ' A' ' 139' ' ' PHE . 76.1 m-85 -133.91 123.02 23.98 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.222 -0.445 . . . . 74.13 110.934 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.663 HD23 ' OH ' ' A' ' 50' ' ' TYR . 12.1 tp -70.32 125.24 26.24 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.144 -0.48 . . . . 52.0 110.909 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 1.003 ' O ' HD13 ' A' ' 152' ' ' LEU . 0.0 OUTLIER -59.94 132.58 54.4 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.177 -0.465 . . . . 72.43 110.871 179.948 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -163.56 24.98 0.08 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.138 -0.483 . . . . 75.33 110.862 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.785 ' O ' HD13 ' A' ' 133' ' ' LEU . 0.1 OUTLIER -112.41 -171.1 1.79 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.186 -0.461 . . . . 70.25 110.923 179.954 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.812 ' CG ' HD22 ' A' ' 133' ' ' LEU . 0.2 OUTLIER -165.67 -122.39 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.207 -0.452 . . . . 75.33 110.858 179.87 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.67 ' HA ' ' HA ' ' A' ' 131' ' ' LYS . 0.4 OUTLIER -71.39 0.42 8.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.232 -0.44 . . . . 73.32 110.913 -179.99 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . 0.661 ' CE1' ' HA ' ' A' ' 154' ' ' LYS . 16.8 m-30 -28.49 142.49 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.128 -0.487 . . . . 74.32 110.938 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . 0.432 ' HB2' ' HA ' ' A' ' 103' ' ' ASP . 11.1 ptp180 -112.18 -33.74 6.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.126 -0.488 . . . . 65.11 110.862 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -101.1 152.28 37.85 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.541 0.686 . . . . 72.01 110.914 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.73 -22.64 31.92 Favored 'Trans proline' 0 C--O 1.232 0.206 0 C-N-CA 122.694 2.262 . . . . 65.34 112.354 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.656 ' H ' HD12 ' A' ' 161' ' ' ILE . 4.0 mp -76.67 -2.89 4.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.226 -0.443 . . . . 62.52 111.146 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.657 ' HB3' ' CD1' ' A' ' 157' ' ' TYR . 1.4 t0 -72.47 -17.34 61.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.19 -0.459 . . . . 74.31 110.878 179.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' TRP . . . . . 0.52 ' O ' ' CG ' ' A' ' 163' ' ' TRP . 6.2 t-105 -109.99 10.21 24.24 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.168 -0.469 . . . . 62.41 110.934 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 87.71 -31.63 4.53 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.69 -0.767 . . . . 64.42 112.503 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -54.35 119.35 5.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.799 0.333 . . . . 71.32 111.103 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -49.1 -26.14 2.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.202 -0.454 . . . . 63.0 111.1 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . 0.461 ' C ' ' H ' ' A' ' 169' ' ' ALA . 0.3 OUTLIER -154.98 159.36 31.89 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.635 0.731 . . . . 63.03 110.855 -179.794 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . 0.502 ' HB3' ' O ' ' A' ' 127' ' ' ILE . 53.5 Cg_endo -69.81 19.21 0.19 Allowed 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.679 2.253 . . . . 75.51 112.32 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.464 ' HA ' ' HG2' ' A' ' 126' ' ' GLU . . . -63.01 102.58 0.38 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.236 -0.438 . . . . 72.23 111.083 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.676 HG11 ' CE1' ' A' ' 139' ' ' PHE . 3.4 t -153.09 162.15 2.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.223 -0.444 . . . . 53.33 111.147 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' GLN . . . . . 0.669 ' OE1' ' HB3' ' A' ' 143' ' ' PRO . 1.7 mm-40 -112.21 -88.38 0.53 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.209 -0.45 . . . . 71.31 110.93 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . 0.758 ' OG ' ' O ' ' A' ' 143' ' ' PRO . 45.7 p -121.67 177.92 5.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.156 -0.475 . . . . 64.1 110.882 -179.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 2.0 p90 -141.97 168.34 19.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.161 -0.472 . . . . 71.0 110.861 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . 0.456 HH11 HD12 ' A' ' 138' ' ' ILE . 0.0 OUTLIER -135.21 156.16 49.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.11 -0.496 . . . . 60.04 110.911 -179.937 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . 0.404 ' HD2' ' CE2' ' A' ' 94' ' ' TYR . 0.0 OUTLIER -100.68 -164.48 1.12 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.178 -0.464 . . . . 73.04 110.868 -179.922 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . 0.768 HD12 ' HB ' ' A' ' 136' ' ' VAL . 5.6 mt -137.0 130.5 45.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.164 -0.471 . . . . 74.1 111.09 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 7.4 p -98.43 155.84 3.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.198 -0.456 . . . . 74.11 111.103 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . 0.73 ' HA ' HD13 ' A' ' 88' ' ' LEU . 3.4 mt-10 . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.174 -0.467 . . . . 73.34 110.877 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.78 0.324 . . . . 72.52 110.869 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.8 m -149.51 -175.96 5.21 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.216 -0.447 . . . . 50.21 110.864 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -99.17 36.41 1.73 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.15 -0.477 . . . . 72.11 110.889 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 15.2 t -94.94 35.5 1.26 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.235 -0.439 . . . . 73.35 111.168 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 141.83 117.11 1.28 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.729 -0.748 . . . . 65.24 112.511 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.485 ' C ' ' HE1' ' A' ' 47' ' ' TRP . 9.9 p -82.67 133.78 35.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.871 0.367 . . . . 71.34 111.149 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 3.0 tttt -122.08 137.08 54.94 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.176 -0.465 . . . . 74.44 110.856 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.585 ' HB ' ' CD1' ' A' ' 47' ' ' TRP . 14.3 tt -137.16 152.94 28.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.197 -0.456 . . . . 60.24 111.148 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.492 ' HA ' ' O ' ' A' ' 21' ' ' TYR . 23.0 m -136.63 136.95 39.6 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.208 -0.451 . . . . 74.3 111.14 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.732 ' HB2' HD22 ' A' ' 34' ' ' LEU . 0.2 OUTLIER -125.23 129.3 49.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.225 -0.443 . . . . 71.21 110.883 -179.992 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.545 ' CG ' ' HA ' ' A' ' 16' ' ' PHE . 33.9 m-85 -112.38 131.93 55.28 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.138 -0.483 . . . . 72.3 110.953 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.443 ' HB2' ' HB2' ' A' ' 19' ' ' ARG . 0.1 OUTLIER -62.2 -16.45 53.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.147 -0.479 . . . . 74.21 110.89 -179.985 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.42 ' HB2' ' O ' ' A' ' 17' ' ' GLN . 70.7 m-20 -133.83 148.8 51.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.13 -0.487 . . . . 52.11 110.886 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.615 ' N ' ' HB3' ' A' ' 38' ' ' ASN . 3.5 mtmm -54.53 -179.19 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.217 -0.447 . . . . 71.24 110.927 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 22.3 m-20 49.64 32.87 5.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.259 -0.428 . . . . 74.22 110.906 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.545 ' HA ' ' CG ' ' A' ' 11' ' ' TYR . 4.0 m-85 49.79 62.45 2.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.137 -0.483 . . . . 75.24 110.919 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.42 ' O ' ' HB2' ' A' ' 13' ' ' ASP . 4.1 mt-30 -138.85 161.89 36.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.115 -0.493 . . . . 75.44 110.894 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 91.78 -149.76 19.93 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.771 -0.728 . . . . 52.31 112.493 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.734 ' O ' HD13 ' A' ' 34' ' ' LEU . 0.0 OUTLIER -69.41 77.58 0.39 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.812 0.339 . . . . 73.44 110.889 -179.845 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.433 ' HB2' ' CE1' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -75.79 129.11 36.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.181 -0.463 . . . . 74.23 110.871 -179.907 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.492 ' O ' ' HA ' ' A' ' 9' ' ' THR . 90.6 t80 -123.03 124.4 43.03 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.172 -0.467 . . . . 62.02 110.922 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.47 ' CG ' HG23 ' A' ' 9' ' ' THR . 1.1 m-20 -121.02 133.52 55.26 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.143 -0.481 . . . . 72.44 110.851 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -166.77 133.94 2.5 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.168 -0.469 . . . . 73.34 110.924 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -99.76 2.18 43.92 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.189 -0.459 . . . . 73.34 110.935 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 18.6 t -106.46 164.96 11.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.17 -0.468 . . . . 53.22 110.881 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -56.93 120.78 8.52 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.201 -0.454 . . . . 74.01 110.866 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.623 ' HB2' ' HB3' ' A' ' 30' ' ' PHE . 0.6 OUTLIER -115.64 50.14 1.03 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.212 -0.449 . . . . 70.23 110.875 -179.894 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.508 ' O ' ' HA ' ' A' ' 82' ' ' SER . . . -47.69 -21.43 0.37 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.163 -0.471 . . . . 63.33 111.093 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 58.5 t0 -128.68 42.11 3.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.235 -0.439 . . . . 72.2 110.89 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.731 ' O ' ' CD2' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -81.45 13.98 2.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.166 -0.47 . . . . 74.14 110.925 -179.932 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.454 ' HB2' ' HB3' ' A' ' 53' ' ' PRO . 29.7 t60 -78.19 -39.05 41.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.138 -0.483 . . . . 74.22 110.824 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.7 t -57.93 -14.93 7.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.221 -0.445 . . . . 73.4 111.139 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -99.6 -26.26 14.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.233 -0.44 . . . . 73.42 110.928 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.734 HD13 ' O ' ' A' ' 19' ' ' ARG . 15.5 tp -142.89 133.12 24.58 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.129 -0.487 . . . . 72.41 110.923 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 22.3 m -97.51 -43.28 7.32 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.169 -0.469 . . . . 71.24 110.865 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 1.6 tmm_? -117.27 142.57 46.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.146 -0.479 . . . . 72.41 110.886 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.658 ' SG ' ' HB2' ' A' ' 80' ' ' LEU . 1.5 p -111.65 89.19 2.99 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.204 -0.453 . . . . 63.14 110.893 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.615 ' HB3' ' N ' ' A' ' 14' ' ' LYS . 0.3 OUTLIER -81.73 -61.99 1.77 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.176 -0.465 . . . . 64.15 110.89 -179.906 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 10.4 p -124.17 125.93 45.29 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.196 -0.457 . . . . 74.44 110.847 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.603 HG21 HD13 ' A' ' 62' ' ' LEU . 2.6 mt -124.06 151.55 29.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.13 -0.486 . . . . 73.41 111.139 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.413 ' N ' ' CG2' ' A' ' 40' ' ' ILE . 0.0 OUTLIER -142.32 121.97 13.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.145 -0.479 . . . . 74.4 110.862 179.887 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.497 ' HA ' ' HA ' ' A' ' 8' ' ' ILE . 1.0 OUTLIER -104.82 118.84 52.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.22 -0.445 . . . . 54.25 111.118 179.876 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -114.07 77.73 1.09 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.146 -0.479 . . . . 61.1 110.836 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.403 ' O ' ' HA ' ' A' ' 6' ' ' THR . . . 135.46 99.14 0.58 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.714 -0.755 . . . . 42.24 112.476 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 54.75 176.8 0.14 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.733 -0.746 . . . . 72.22 112.473 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.773 HG23 ' HA ' ' A' ' 63' ' ' PRO . 1.9 m -75.82 169.24 18.53 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.789 0.328 . . . . 72.42 111.156 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.585 ' CD1' ' HB ' ' A' ' 8' ' ' ILE . 6.0 m95 -143.02 129.35 19.94 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.251 -0.431 . . . . 73.44 110.907 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.879 ' HB2' ' CG2' ' A' ' 86' ' ' VAL . . . -90.98 129.19 37.01 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.206 -0.452 . . . . 75.02 111.143 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.862 HG11 HD11 ' A' ' 80' ' ' LEU . 17.3 m -129.34 125.66 62.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.277 -0.419 . . . . 65.34 111.107 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.796 ' HB3' ' HA ' ' A' ' 56' ' ' ALA . 44.0 m-85 -93.73 148.38 22.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.182 -0.463 . . . . 64.51 110.926 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.573 ' HB2' ' O ' ' A' ' 58' ' ' TYR . 7.0 tt0 -48.72 -79.89 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.152 -0.476 . . . . 75.44 110.877 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.541 ' HB3' ' CD1' ' A' ' 55' ' ' PHE . 0.0 OUTLIER -92.75 145.15 29.77 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.617 0.723 . . . . 63.22 110.845 -179.908 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.781 ' HA ' ' OG ' ' A' ' 82' ' ' SER . 53.9 Cg_endo -69.79 140.78 43.41 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.678 2.252 . . . . 73.33 112.381 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 62.9 -11.03 0.09 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.227 -0.442 . . . . 74.21 110.924 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.606 ' H ' ' C ' ' A' ' 53' ' ' PRO . 2.6 m-30 -104.0 -21.37 13.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.162 -0.472 . . . . 65.24 110.913 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.796 ' HA ' ' HB3' ' A' ' 50' ' ' TYR . . . 50.05 25.98 1.9 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.135 -0.484 . . . . 74.23 111.063 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . 0.637 ' O ' ' C ' ' A' ' 58' ' ' TYR . 0.0 OUTLIER -50.07 -161.36 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.233 -0.44 . . . . 73.32 110.941 -179.997 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.637 ' C ' ' O ' ' A' ' 57' ' ' TRP . 6.3 m-30 -14.24 101.59 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.227 -0.442 . . . . 72.02 110.926 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.467 ' HB2' ' HA ' ' A' ' 150' ' ' TYR . 0.5 OUTLIER -58.41 146.15 35.93 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.087 -0.506 . . . . 63.5 110.905 179.903 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.78 ' O ' ' O ' ' A' ' 49' ' ' VAL . 0.3 OUTLIER -159.07 112.28 2.29 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.253 -0.43 . . . . 74.23 110.885 -179.863 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.829 ' N ' HD12 ' A' ' 61' ' ' ILE . 1.0 OUTLIER -104.95 114.84 45.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.097 -0.502 . . . . 74.44 111.15 179.898 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.765 HD23 ' HD2' ' A' ' 63' ' ' PRO . 0.4 OUTLIER -84.95 124.86 71.97 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.617 0.722 . . . . 74.41 110.934 179.916 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.773 ' HA ' HG23 ' A' ' 46' ' ' THR . 53.7 Cg_endo -69.75 -165.29 0.15 Allowed 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.647 2.232 . . . . 75.35 112.357 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.42 160.37 14.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.223 -0.444 . . . . 65.41 110.887 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 112.91 -152.11 18.05 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.697 -0.763 . . . . 62.13 112.486 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 11.2 mp0 -118.69 159.44 23.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.844 0.354 . . . . 75.0 110.937 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.508 ' HB2' ' O ' ' A' ' 40' ' ' ILE . 13.0 m-85 -147.94 82.43 7.84 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.655 0.741 . . . . 52.42 110.924 -179.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.7 -3.67 12.44 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.731 2.288 . . . . 74.32 112.355 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -157.72 147.68 20.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.178 -0.464 . . . . 75.25 110.856 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.882 ' O ' ' CD1' ' A' ' 73' ' ' TRP . 44.6 p90 -57.53 -41.47 80.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.121 -0.49 . . . . 72.2 110.927 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -53.35 -17.1 1.63 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.138 -0.483 . . . . 72.0 110.945 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 29.3 mmt180 -63.62 -36.29 83.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 71.32 110.852 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . 0.882 ' CD1' ' O ' ' A' ' 70' ' ' TYR . 0.3 OUTLIER -98.61 25.41 6.47 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.243 -0.435 . . . . 63.43 110.907 -179.958 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.566 ' O ' ' C ' ' A' ' 75' ' ' GLY . 1.6 mtp 75.53 26.87 1.08 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.264 -0.425 . . . . 62.25 110.886 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.566 ' C ' ' O ' ' A' ' 74' ' ' MET . . . 23.51 54.57 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.763 -0.732 . . . . 63.12 112.481 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.51 ' HB2' ' CE2' ' A' ' 60' ' ' TYR . 0.2 OUTLIER -56.69 -74.46 0.05 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.781 0.324 . . . . 63.02 110.918 -179.917 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.766 ' O ' ' CB ' ' A' ' 78' ' ' ASP . 28.0 t-20 -113.75 -80.55 0.59 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.214 -0.448 . . . . 73.44 110.897 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.766 ' CB ' ' O ' ' A' ' 77' ' ' ASN . 27.8 t70 129.45 5.38 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.182 -0.463 . . . . 75.22 110.911 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -107.3 92.28 4.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.211 -0.45 . . . . 71.55 110.893 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.862 HD11 HG11 ' A' ' 49' ' ' VAL . 0.2 OUTLIER -90.7 129.5 36.79 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.186 -0.461 . . . . 72.22 110.923 -179.959 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.6 ' HB3' ' HB3' ' A' ' 53' ' ' PRO . 0.9 OUTLIER -153.66 -123.42 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.23 -0.441 . . . . 74.41 110.897 -179.945 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.781 ' OG ' ' HA ' ' A' ' 53' ' ' PRO . 0.0 OUTLIER -41.46 101.91 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.168 -0.469 . . . . 71.12 110.877 -179.824 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . 0.705 ' HB3' HG12 ' A' ' 49' ' ' VAL . 31.5 p -121.16 135.38 55.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.095 -0.502 . . . . 70.11 110.887 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.585 ' N ' ' O ' ' A' ' 48' ' ' ALA . 10.9 mmt85 -119.62 150.94 39.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.2 -0.455 . . . . 44.12 110.832 -179.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -66.65 127.14 31.24 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.176 -0.465 . . . . 73.24 111.102 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.879 ' CG2' ' HB2' ' A' ' 48' ' ' ALA . 52.9 t -116.94 137.56 50.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.245 -0.434 . . . . 61.23 111.127 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . 0.438 ' O ' ' CG2' ' A' ' 136' ' ' VAL . 29.4 m80 -111.17 126.54 54.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.124 -0.489 . . . . 75.45 110.88 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.416 HD13 ' CB ' ' A' ' 178' ' ' GLU . 0.3 OUTLIER -39.63 137.99 1.03 Allowed Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.598 0.713 . . . . 62.34 110.899 -179.961 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.448 ' HB3' ' H ' ' A' ' 136' ' ' VAL . 53.8 Cg_endo -69.79 80.71 0.87 Allowed 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.713 2.275 . . . . 52.43 112.329 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -90.58 -177.12 4.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 64.41 110.838 -179.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 67.41 117.52 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.756 -0.735 . . . . 74.23 112.496 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 50.02 40.23 35.17 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.747 -0.74 . . . . 53.34 112.536 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.444 ' HB2' ' H ' ' A' ' 94' ' ' TYR . 5.2 pt20 40.21 -156.65 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.802 0.334 . . . . 75.02 110.901 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.634 ' OH ' HG23 ' A' ' 177' ' ' VAL . 0.1 OUTLIER -97.47 104.81 16.87 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.204 -0.453 . . . . 71.23 110.909 -179.875 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.496 ' HG3' HG11 ' A' ' 132' ' ' VAL . 45.7 tptt -105.99 131.34 53.4 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.132 -0.485 . . . . 74.14 110.885 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -150.23 137.38 13.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.252 -0.431 . . . . 75.15 111.141 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.446 ' HB2' ' O ' ' A' ' 131' ' ' LYS . 0.8 OUTLIER -112.77 135.6 53.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.205 -0.452 . . . . 74.02 110.93 179.935 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.635 HD13 HD11 ' A' ' 118' ' ' ILE . 1.5 mt -114.52 142.62 26.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.166 -0.47 . . . . 62.32 111.13 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.625 ' HB2' ' HB2' ' A' ' 129' ' ' SER . 57.1 m-85 -131.29 134.28 46.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.182 -0.463 . . . . 74.21 110.832 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 64.2 tt0 -63.59 -74.46 0.1 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.126 -0.488 . . . . 73.2 110.869 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.459 ' C ' ' HB3' ' A' ' 128' ' ' HIS . 9.7 mttt -83.11 177.45 8.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.142 -0.481 . . . . 74.24 110.854 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.427 ' HA2' ' HB3' ' A' ' 128' ' ' HIS . . . -83.61 161.1 38.34 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.732 -0.747 . . . . 75.32 112.49 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.444 ' HA ' ' HB2' ' A' ' 158' ' ' ARG . 30.4 t0 61.76 32.86 18.12 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.851 0.357 . . . . 71.35 110.885 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.576 ' HA ' ' CD2' ' A' ' 99' ' ' PHE . 21.1 m-85 59.35 48.88 9.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.191 -0.458 . . . . 75.15 110.924 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 4.4 m -114.25 150.06 34.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 55.52 110.85 -179.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 89.81 -127.73 8.88 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.721 -0.752 . . . . 43.52 112.506 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 -99.18 139.41 34.87 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.806 0.336 . . . . 73.43 110.885 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 4.4 ttp -128.74 146.17 50.97 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.183 -0.462 . . . . 73.43 110.862 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 18.9 m-85 -148.25 136.79 21.5 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.267 -0.424 . . . . 74.42 110.918 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -115.3 99.26 7.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.097 -0.501 . . . . 64.32 110.912 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 13.6 t -112.58 132.03 55.33 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.135 -0.484 . . . . 60.43 111.156 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.413 ' O ' ' OG1' ' A' ' 112' ' ' THR . 1.7 t -97.4 33.3 2.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.177 -0.465 . . . . 60.24 111.128 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -149.88 -176.05 5.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.199 -0.455 . . . . 64.13 110.917 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.509 ' CB ' ' HA ' ' A' ' 174' ' ' ARG . 5.3 p30 -103.45 171.29 7.45 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.184 -0.462 . . . . 74.01 110.895 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . 0.484 ' O ' ' HB2' ' A' ' 172' ' ' SER . 16.7 p -152.02 146.14 18.31 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.602 0.715 . . . . 64.2 110.908 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.417 ' O ' ' CA ' ' A' ' 143' ' ' PRO . 53.2 Cg_endo -69.8 -28.5 24.98 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.665 2.243 . . . . 62.03 112.305 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.633 ' HB3' ' CB ' ' A' ' 120' ' ' GLU . 0.1 OUTLIER -147.59 105.85 3.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.25 -0.432 . . . . 73.54 110.862 -179.858 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.737 HD13 HD11 ' A' ' 127' ' ' ILE . 3.6 tt -58.09 -29.77 37.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.165 -0.471 . . . . 53.44 111.146 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' MET . . . . . 0.596 ' O ' ' HA ' ' A' ' 123' ' ' HIS . 27.0 ttp -86.4 -43.72 12.61 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.458 . . . . 55.31 110.91 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.633 ' CB ' ' HB3' ' A' ' 117' ' ' SER . 9.4 tp10 -66.49 -13.21 60.56 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.223 -0.444 . . . . 74.21 110.857 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -114.62 -49.97 2.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.194 -0.457 . . . . 74.43 110.954 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.463 ' HB2' ' O ' ' A' ' 118' ' ' ILE . 63.2 m-85 -103.03 -20.37 14.22 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.2 -0.455 . . . . 74.42 110.874 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.596 ' HA ' ' O ' ' A' ' 119' ' ' MET . 28.3 m-70 72.75 26.88 2.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.136 -0.484 . . . . 73.52 110.851 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.405 ' HB3' ' CD1' ' A' ' 127' ' ' ILE . 16.9 mtt -102.06 88.75 3.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.196 -0.456 . . . . 71.3 110.885 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 2.0 ptp85 -52.04 -42.86 63.43 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.26 -0.427 . . . . 74.11 110.869 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.465 ' HG2' ' HA ' ' A' ' 169' ' ' ALA . 13.4 mt-10 -137.2 130.75 31.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.213 -0.449 . . . . 71.25 110.902 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.737 HD11 HD13 ' A' ' 118' ' ' ILE . 3.4 mm -89.48 87.68 2.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.173 -0.467 . . . . 52.44 111.147 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . 0.459 ' HB3' ' C ' ' A' ' 101' ' ' LYS . 0.7 OUTLIER -62.4 -31.98 72.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.201 -0.454 . . . . 62.31 110.871 179.911 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.625 ' HB2' ' HB2' ' A' ' 99' ' ' PHE . 0.4 OUTLIER -134.35 142.38 47.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.172 -0.467 . . . . 65.25 110.801 -179.747 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . 0.624 ' O ' ' O ' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -143.17 117.61 9.69 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.151 -0.477 . . . . 73.31 110.882 -179.987 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.732 ' HA ' ' HA ' ' A' ' 156' ' ' GLU . 4.6 mtpp -106.67 150.86 25.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.217 -0.447 . . . . 61.13 110.915 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.496 HG11 ' HG3' ' A' ' 95' ' ' LYS . 3.4 t 74.27 165.84 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.234 -0.439 . . . . 74.24 111.11 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.674 HD12 ' O ' ' A' ' 154' ' ' LYS . 0.2 OUTLIER 172.77 128.84 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.136 -0.484 . . . . 45.33 110.936 179.929 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.584 ' CG ' ' HA ' ' A' ' 94' ' ' TYR . 0.7 OUTLIER -79.83 163.1 24.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.213 -0.449 . . . . 71.31 110.876 179.944 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.441 ' C ' ' O ' ' A' ' 134' ' ' GLU . . . -34.71 -42.98 0.36 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.777 -0.725 . . . . 74.41 112.455 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.665 HG11 ' CG1' ' A' ' 86' ' ' VAL . 2.1 t -146.61 137.74 18.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.825 0.345 . . . . 74.4 111.148 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . 0.6 ' HB3' ' HB3' ' A' ' 152' ' ' LEU . 9.9 t-105 -138.46 157.12 46.82 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.151 -0.477 . . . . 73.21 110.886 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.655 HG23 HE21 ' A' ' 149' ' ' GLN . 18.2 mm -121.44 132.31 70.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.206 -0.452 . . . . 73.35 111.142 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.575 ' CB ' ' HB2' ' A' ' 150' ' ' TYR . 0.1 OUTLIER -118.87 137.61 53.32 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.163 -0.471 . . . . 70.02 110.92 179.945 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.477 ' CD2' ' HA ' ' A' ' 145' ' ' TYR . 3.4 m-85 -119.37 132.05 55.79 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.13 -0.486 . . . . 71.4 110.923 -179.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.674 ' O ' ' HB2' ' A' ' 171' ' ' GLN . 10.9 tt0 -60.04 -27.61 67.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.096 -0.502 . . . . 73.53 110.895 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.746 ' HB3' ' HD2' ' A' ' 143' ' ' PRO . 10.0 mp -112.85 173.74 2.69 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-O 121.614 0.721 . . . . 51.34 110.899 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . 0.747 ' O ' ' OG ' ' A' ' 172' ' ' SER . 53.9 Cg_endo -69.79 -88.8 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.71 2.273 . . . . 73.12 112.312 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . 0.686 ' O ' ' N ' ' A' ' 146' ' ' ARG . 1.4 m-20 -52.91 96.56 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.26 -0.427 . . . . 74.2 110.861 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . 0.633 ' C ' ' O ' ' A' ' 144' ' ' ASN . 0.1 OUTLIER 13.12 52.9 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.144 -0.48 . . . . 62.35 110.935 -179.94 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.686 ' N ' ' O ' ' A' ' 144' ' ' ASN . 8.8 mtp85 -119.38 179.36 4.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.141 -0.481 . . . . 73.43 110.89 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . 0.428 ' O ' HD21 ' A' ' 76' ' ' LEU . . . 77.02 -177.69 52.06 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.726 -0.749 . . . . 74.11 112.486 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.409 ' HG2' ' CD1' ' A' ' 58' ' ' TYR . 5.7 mtp180 -74.11 156.23 37.62 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.756 0.312 . . . . 64.54 110.913 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . 0.655 HE21 HG23 ' A' ' 138' ' ' ILE . 0.8 OUTLIER -85.67 151.24 24.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.256 -0.429 . . . . 73.33 110.909 -179.974 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . 0.575 ' HB2' ' CB ' ' A' ' 139' ' ' PHE . 73.8 m-85 -137.67 122.8 19.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.209 -0.45 . . . . 73.4 110.914 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.638 ' HB2' HD11 ' A' ' 61' ' ' ILE . 10.5 tp -81.56 121.9 26.89 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.147 -0.479 . . . . 74.42 110.932 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.98 ' O ' HD13 ' A' ' 152' ' ' LEU . 0.0 OUTLIER -51.71 139.33 21.4 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.162 -0.472 . . . . 75.14 110.925 179.916 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . 0.434 ' N ' HD22 ' A' ' 152' ' ' LEU . 1.1 t70 -162.68 26.45 0.1 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.208 -0.451 . . . . 64.43 110.822 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.935 ' HB2' ' CD1' ' A' ' 157' ' ' TYR . 2.9 ptmt -127.44 -173.49 2.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.162 -0.472 . . . . 70.43 110.906 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.733 ' HD2' ' C ' ' A' ' 154' ' ' LYS . 0.8 OUTLIER -161.58 -117.17 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.187 -0.46 . . . . 63.32 110.882 179.812 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.732 ' HA ' ' HA ' ' A' ' 131' ' ' LYS . 3.2 tm-20 -71.15 0.44 7.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.224 -0.444 . . . . 64.55 110.918 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . 0.935 ' CD1' ' HB2' ' A' ' 154' ' ' LYS . 13.6 m-30 -32.93 147.05 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.146 -0.479 . . . . 75.25 110.922 -179.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . 0.534 ' HB3' ' CZ ' ' A' ' 104' ' ' PHE . 9.8 ptp180 -113.0 -33.54 6.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.106 -0.497 . . . . 74.14 110.887 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 7.0 ptpt -99.04 151.86 37.55 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.597 0.713 . . . . 70.22 110.859 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.79 -25.71 28.16 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.716 2.278 . . . . 75.24 112.298 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.686 ' H ' HD12 ' A' ' 161' ' ' ILE . 3.8 mp -73.83 -6.03 7.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.251 -0.431 . . . . 51.44 111.111 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.676 ' HB3' ' CD1' ' A' ' 157' ' ' TYR . 1.7 t0 -73.04 -15.73 61.51 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.194 -0.457 . . . . 73.11 110.913 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 4.8 t90 -109.94 12.65 23.71 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.197 -0.456 . . . . 75.31 110.95 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 85.6 -34.51 3.31 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.753 -0.736 . . . . 55.31 112.493 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -55.31 119.86 6.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.772 0.32 . . . . 73.34 111.118 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -49.93 -26.69 4.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.216 -0.447 . . . . 73.0 111.098 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . 0.479 ' C ' ' H ' ' A' ' 169' ' ' ALA . 0.3 OUTLIER -154.55 158.18 32.25 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.688 0.756 . . . . 52.1 110.819 -179.772 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . 0.41 ' HG3' ' CD2' ' A' ' 128' ' ' HIS . 53.9 Cg_endo -69.7 18.5 0.19 Allowed 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.752 2.301 . . . . 61.21 112.321 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.479 ' H ' ' C ' ' A' ' 167' ' ' SER . . . -63.45 102.97 0.47 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.235 -0.439 . . . . 43.31 111.13 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.47 HG11 ' CD1' ' A' ' 139' ' ' PHE . 3.1 t -153.37 163.61 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.173 -0.467 . . . . 72.15 111.105 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' GLN . . . . . 0.674 ' HB2' ' O ' ' A' ' 141' ' ' GLU . 1.9 mm-40 -110.23 -87.07 0.53 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.146 -0.479 . . . . 73.12 110.898 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . 0.747 ' OG ' ' O ' ' A' ' 143' ' ' PRO . 47.0 p -125.48 172.92 9.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.213 -0.449 . . . . 71.03 110.857 -179.777 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 5.9 p90 -145.77 164.69 31.09 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.142 -0.481 . . . . 74.55 110.828 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . 0.509 ' HA ' ' CB ' ' A' ' 114' ' ' ASP . 0.0 OUTLIER -135.56 151.28 50.15 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.091 -0.504 . . . . 74.13 110.834 -179.909 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . 0.489 ' H ' ' HG3' ' A' ' 175' ' ' ARG . 0.0 OUTLIER -104.62 139.51 39.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.195 -0.457 . . . . 71.04 110.863 -179.911 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . 0.464 HG13 HG12 ' A' ' 138' ' ' ILE . 1.2 mt -77.25 132.45 32.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.17 -0.468 . . . . 61.11 111.172 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.634 HG23 ' OH ' ' A' ' 94' ' ' TYR . 7.7 p -118.21 155.73 20.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.189 -0.46 . . . . 73.04 111.103 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . 0.416 ' CB ' HD13 ' A' ' 88' ' ' LEU . 1.3 mp0 . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.14 -0.482 . . . . 71.25 110.88 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.757 0.313 . . . . 74.43 110.842 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.8 m -157.7 -174.64 4.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.262 -0.426 . . . . 73.01 110.854 -179.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 12.6 mttt -77.21 59.59 1.79 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.117 -0.492 . . . . 74.13 110.891 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 3.2 t -127.64 64.48 1.35 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.237 -0.438 . . . . 71.22 111.155 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -162.71 57.78 0.29 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.751 -0.737 . . . . 63.33 112.466 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.502 ' C ' ' HE1' ' A' ' 47' ' ' TRP . 5.7 p -82.1 136.03 35.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.886 0.374 . . . . 74.3 111.098 -179.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.407 ' HA ' ' HA ' ' A' ' 24' ' ' ASP . 3.2 tttt -122.24 136.11 54.85 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.178 -0.464 . . . . 75.51 110.899 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.627 ' HB ' ' CD1' ' A' ' 47' ' ' TRP . 15.4 tt -136.84 151.49 27.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.2 -0.454 . . . . 61.33 111.102 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.503 ' HA ' ' O ' ' A' ' 21' ' ' TYR . 17.1 m -132.81 140.07 47.8 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.161 -0.472 . . . . 62.23 111.165 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.718 ' HB2' HD22 ' A' ' 34' ' ' LEU . 1.0 OUTLIER -127.99 127.7 43.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.17 -0.468 . . . . 75.41 110.873 -179.947 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.539 ' CG ' ' HA ' ' A' ' 16' ' ' PHE . 14.1 m-85 -112.72 132.4 55.23 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.202 -0.454 . . . . 71.22 110.91 -179.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.445 ' HB2' ' HB2' ' A' ' 19' ' ' ARG . 0.0 OUTLIER -61.04 -14.71 25.3 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.125 -0.489 . . . . 74.22 110.924 179.991 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.438 ' HB2' ' O ' ' A' ' 17' ' ' GLN . 74.4 m-20 -135.93 150.43 49.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.137 -0.483 . . . . 73.15 110.868 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.486 ' N ' ' HB3' ' A' ' 38' ' ' ASN . 40.8 mtmt -55.25 -176.17 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.152 -0.476 . . . . 64.11 110.89 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 16.1 m120 46.43 32.43 1.58 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.227 -0.442 . . . . 71.44 110.939 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.539 ' HA ' ' CG ' ' A' ' 11' ' ' TYR . 3.6 m-85 49.67 64.33 1.81 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.154 -0.476 . . . . 73.34 110.877 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.438 ' O ' ' HB2' ' A' ' 13' ' ' ASP . 9.9 mt-30 -139.32 159.78 41.35 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.145 -0.48 . . . . 74.11 110.891 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 92.35 -148.19 19.03 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.786 -0.721 . . . . 71.43 112.455 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.759 ' O ' HD13 ' A' ' 34' ' ' LEU . 0.0 OUTLIER -70.02 77.78 0.49 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.859 0.361 . . . . 73.34 110.834 -179.795 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.469 ' HB2' ' CE1' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -76.87 129.1 35.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.163 -0.471 . . . . 74.11 110.877 -179.956 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.503 ' O ' ' HA ' ' A' ' 9' ' ' THR . 90.7 t80 -123.01 124.39 43.02 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.182 -0.463 . . . . 74.44 110.925 -179.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.472 ' CG ' HG23 ' A' ' 9' ' ' THR . 1.3 m-20 -121.06 133.99 55.26 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.142 -0.481 . . . . 74.31 110.856 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -168.13 135.59 2.17 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.213 -0.449 . . . . 55.21 110.908 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.407 ' HA ' ' HA ' ' A' ' 7' ' ' LYS . 4.8 p-10 -100.94 -2.6 31.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.193 -0.458 . . . . 61.25 110.871 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 15.6 t -100.9 165.68 11.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.201 -0.454 . . . . 72.0 110.904 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -59.14 120.26 8.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.2 -0.455 . . . . 74.51 110.855 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.578 ' HB2' ' HB3' ' A' ' 30' ' ' PHE . 1.7 m -115.29 51.0 0.94 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.204 -0.453 . . . . 52.44 110.879 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.495 ' C ' ' HA ' ' A' ' 82' ' ' SER . . . -46.43 -22.16 0.24 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.178 -0.464 . . . . 72.01 111.081 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 55.5 t0 -127.94 42.83 3.25 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.194 -0.457 . . . . 73.15 110.885 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.777 ' O ' ' CD2' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -81.17 15.68 1.83 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.459 . . . . 73.53 110.869 -179.929 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.495 ' HB2' ' HB3' ' A' ' 81' ' ' SER . 29.7 t60 -80.3 -39.26 29.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 74.22 110.889 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.7 t -58.43 -13.8 6.27 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.204 -0.453 . . . . 53.21 111.166 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -100.07 -26.95 13.79 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.236 -0.438 . . . . 74.21 110.947 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.759 HD13 ' O ' ' A' ' 19' ' ' ARG . 18.0 tp -142.79 135.11 27.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.144 -0.48 . . . . 64.33 110.93 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 25.3 m -97.63 -42.51 7.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.165 -0.47 . . . . 73.42 110.849 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -118.77 141.83 48.27 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.077 -0.511 . . . . 74.04 110.84 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.554 ' HB3' ' HB2' ' A' ' 80' ' ' LEU . 3.3 p -110.17 84.86 2.0 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.197 -0.456 . . . . 55.04 110.861 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.486 ' HB3' ' N ' ' A' ' 14' ' ' LYS . 0.2 OUTLIER -76.07 -71.1 0.4 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.238 -0.437 . . . . 73.43 110.871 -179.934 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 5.2 p -111.53 124.07 51.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.184 -0.462 . . . . 65.22 110.903 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.747 HD12 ' CH2' ' A' ' 73' ' ' TRP . 43.0 mt -117.25 149.32 19.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.151 -0.477 . . . . 73.44 111.113 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.465 ' HD2' ' CE2' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -144.67 120.36 10.49 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.126 -0.488 . . . . 65.44 110.93 179.812 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.497 ' CG2' HD12 ' A' ' 8' ' ' ILE . 1.5 t -105.25 116.32 48.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.216 -0.447 . . . . 61.01 111.123 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -111.11 79.22 1.18 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.174 -0.467 . . . . 73.43 110.897 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.468 ' O ' ' HA ' ' A' ' 6' ' ' THR . . . 129.9 104.31 1.08 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.74 -0.743 . . . . 54.23 112.513 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 53.08 175.18 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.681 -0.771 . . . . 63.42 112.526 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.733 HG23 ' HA ' ' A' ' 63' ' ' PRO . 1.0 OUTLIER -76.84 169.03 19.07 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.74 0.305 . . . . 71.34 111.148 -179.856 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.627 ' CD1' ' HB ' ' A' ' 8' ' ' ILE . 3.6 m95 -141.68 130.18 22.58 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.238 -0.437 . . . . 73.14 110.917 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.835 ' HB2' ' CG2' ' A' ' 86' ' ' VAL . . . -94.16 127.12 39.81 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.212 -0.449 . . . . 54.03 111.066 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.625 HG11 ' CD1' ' A' ' 80' ' ' LEU . 12.2 m -125.33 131.01 72.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.203 -0.453 . . . . 73.41 111.119 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.771 ' HB3' ' HA ' ' A' ' 56' ' ' ALA . 43.1 m-85 -98.32 147.3 24.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.174 -0.466 . . . . 75.41 110.937 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.644 ' OE1' ' HB3' ' A' ' 57' ' ' TRP . 46.9 tt0 -48.93 -79.68 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.13 -0.487 . . . . 73.02 110.865 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.551 ' HB2' ' HB2' ' A' ' 57' ' ' TRP . 0.0 OUTLIER -92.24 143.82 28.05 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.599 0.714 . . . . 70.01 110.853 -179.856 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.754 ' HA ' ' OG ' ' A' ' 82' ' ' SER . 53.7 Cg_endo -69.73 141.38 45.2 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.694 2.263 . . . . 71.51 112.381 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 63.54 -11.22 0.11 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.261 -0.427 . . . . 74.32 110.85 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.596 ' H ' ' C ' ' A' ' 53' ' ' PRO . 2.6 m-30 -104.45 -21.47 13.46 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.228 -0.442 . . . . 73.34 110.863 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.771 ' HA ' ' HB3' ' A' ' 50' ' ' TYR . . . 51.35 25.85 2.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.116 -0.493 . . . . 31.33 111.108 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . 0.644 ' HB3' ' OE1' ' A' ' 51' ' ' GLU . 0.0 OUTLIER -49.48 -163.1 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.215 -0.448 . . . . 65.52 110.948 179.995 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.638 ' C ' ' O ' ' A' ' 57' ' ' TRP . 6.1 m-30 -13.41 102.6 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.219 -0.446 . . . . 74.22 110.992 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.433 ' HB2' ' O ' ' A' ' 149' ' ' GLN . 2.0 mpt? -67.85 148.26 51.42 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.13 -0.486 . . . . 75.44 110.872 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.766 ' CD2' HD12 ' A' ' 76' ' ' LEU . 3.0 t80 -164.7 108.17 0.89 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.211 -0.449 . . . . 71.43 110.905 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.765 ' N ' HD12 ' A' ' 61' ' ' ILE . 1.4 mp -93.67 116.88 35.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.131 -0.486 . . . . 63.54 111.089 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.83 HD23 ' HD2' ' A' ' 63' ' ' PRO . 0.3 OUTLIER -83.95 127.96 64.95 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.559 0.695 . . . . 74.35 110.901 179.891 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.83 ' HD2' HD23 ' A' ' 62' ' ' LEU . 53.6 Cg_endo -69.76 -172.85 0.62 Allowed 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.652 2.235 . . . . 75.42 112.344 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.35 161.79 16.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.225 -0.443 . . . . 73.45 110.864 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 112.83 -165.61 12.06 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.702 -0.761 . . . . 44.44 112.459 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -109.93 154.36 23.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.901 0.382 . . . . 74.0 110.881 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.604 ' HB2' ' O ' ' A' ' 40' ' ' ILE . 10.7 m-85 -143.88 83.75 10.19 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.699 0.762 . . . . 71.41 110.944 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.449 ' HD2' ' HG3' ' A' ' 72' ' ' ARG . 53.8 Cg_endo -69.74 0.79 5.11 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.709 2.272 . . . . 73.44 112.344 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.544 ' HB2' ' HG2' ' A' ' 72' ' ' ARG . 41.3 mt-10 -155.88 144.11 19.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.457 . . . . 64.0 110.929 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.724 ' HA ' ' NE1' ' A' ' 73' ' ' TRP . 32.3 p90 -55.92 -21.65 21.67 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.172 -0.467 . . . . 72.53 110.883 -179.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -79.78 -16.47 55.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.144 -0.48 . . . . 71.34 110.921 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.544 ' HG2' ' HB2' ' A' ' 69' ' ' GLU . 28.1 mmt180 -69.47 -9.17 52.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.161 -0.472 . . . . 74.15 110.848 -179.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . 0.747 ' CH2' HD12 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -134.49 16.52 3.68 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.197 -0.456 . . . . 74.44 110.911 -179.966 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.406 ' C ' ' O ' ' A' ' 73' ' ' TRP . 0.0 OUTLIER 37.75 42.91 0.43 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.284 -0.416 . . . . 73.31 110.866 179.911 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -58.03 120.59 22.46 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.753 -0.737 . . . . 72.5 112.515 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.981 HD13 ' N ' ' A' ' 77' ' ' ASN . 0.0 OUTLIER -70.05 -10.7 59.56 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.787 0.327 . . . . 71.14 110.872 -179.898 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.981 ' N ' HD13 ' A' ' 76' ' ' LEU . 30.2 t-20 -156.36 131.24 9.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.199 -0.455 . . . . 72.2 110.904 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -83.95 23.06 1.06 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.186 -0.461 . . . . 63.22 110.868 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -109.92 78.47 1.13 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.195 -0.457 . . . . 61.21 110.891 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.625 ' CD1' HG11 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -85.77 133.51 33.99 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.167 -0.47 . . . . 73.32 110.929 -179.999 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.594 ' HB3' ' HB3' ' A' ' 53' ' ' PRO . 0.9 OUTLIER -150.03 -125.04 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.184 -0.462 . . . . 54.43 110.912 -179.947 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.754 ' OG ' ' HA ' ' A' ' 53' ' ' PRO . 0.0 OUTLIER -35.03 103.81 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.12 -0.491 . . . . 62.45 110.832 -179.833 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . 0.614 ' HB3' HG12 ' A' ' 49' ' ' VAL . 19.8 p -121.88 134.45 54.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.152 -0.476 . . . . 74.31 110.854 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.595 ' N ' ' O ' ' A' ' 48' ' ' ALA . 11.6 mmt85 -120.4 139.51 52.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.184 -0.462 . . . . 74.52 110.871 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.431 ' N ' ' CZ3' ' A' ' 47' ' ' TRP . . . -58.15 129.17 40.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 73.51 111.111 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.835 ' CG2' ' HB2' ' A' ' 48' ' ' ALA . 55.5 t -113.23 133.74 58.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.194 -0.457 . . . . 64.22 111.093 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . 0.628 ' O ' HG23 ' A' ' 136' ' ' VAL . 23.1 m80 -114.43 111.21 21.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.113 -0.494 . . . . 72.12 110.827 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.469 HD23 ' H ' ' A' ' 88' ' ' LEU . 0.0 OUTLIER -33.39 140.13 0.24 Allowed Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.564 0.697 . . . . 72.44 110.937 -179.986 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.558 ' HB3' ' H ' ' A' ' 136' ' ' VAL . 53.7 Cg_endo -69.79 105.13 1.44 Allowed 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.718 2.278 . . . . 64.21 112.331 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -106.16 -177.97 3.52 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.201 -0.454 . . . . 74.31 110.833 -179.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 45.45 63.22 2.82 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.74 -0.743 . . . . 23.04 112.476 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.41 ' O ' ' C ' ' A' ' 93' ' ' GLN . . . 123.82 20.65 2.53 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.716 -0.754 . . . . 64.54 112.493 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.478 ' O ' ' HG2' ' A' ' 134' ' ' GLU . 2.0 pt20 37.47 -120.67 0.2 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.839 0.352 . . . . 70.34 110.901 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.466 ' O ' ' HA ' ' A' ' 112' ' ' THR . 0.0 OUTLIER -124.87 100.78 6.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.19 -0.459 . . . . 73.35 110.945 -179.86 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.512 ' HG3' HG11 ' A' ' 132' ' ' VAL . 31.3 tptt -110.69 126.53 54.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.173 -0.467 . . . . 73.3 110.929 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 8.0 tt -147.54 136.17 15.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.198 -0.456 . . . . 74.24 111.108 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.428 ' HB2' ' O ' ' A' ' 131' ' ' LYS . 1.2 mt-30 -107.82 131.56 54.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.203 -0.453 . . . . 74.12 110.925 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.58 HD11 ' CD1' ' A' ' 122' ' ' PHE . 13.1 pt -111.41 136.79 46.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.192 -0.458 . . . . 71.3 111.117 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.575 ' HB2' ' CB ' ' A' ' 129' ' ' SER . 62.4 m-85 -124.82 136.9 54.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.196 -0.456 . . . . 62.22 110.895 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -68.95 -58.3 4.31 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.099 -0.501 . . . . 55.44 110.905 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 21.0 mttt -101.59 149.46 24.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.126 -0.488 . . . . 75.23 110.942 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -57.8 163.72 7.94 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.755 -0.736 . . . . 74.12 112.469 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.523 ' HA ' ' HB2' ' A' ' 158' ' ' ARG . 42.1 t0 64.13 29.0 14.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.853 0.359 . . . . 71.41 110.912 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.68 ' CZ ' ' HB3' ' A' ' 158' ' ' ARG . 5.1 m-85 57.51 46.07 18.48 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.174 -0.466 . . . . 75.01 110.888 -179.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 2.3 m -114.08 158.02 21.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.181 -0.463 . . . . 70.11 110.871 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 86.88 -137.09 14.52 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.711 -0.756 . . . . 53.51 112.488 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 38.1 tp60 -90.39 126.6 35.93 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.812 0.339 . . . . 71.2 110.934 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' MET . . . . . 0.445 ' HB2' ' CE1' ' A' ' 99' ' ' PHE . 19.1 ttp -113.17 146.3 39.49 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.215 -0.448 . . . . 73.34 110.875 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -152.6 137.19 16.87 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.192 -0.458 . . . . 52.22 110.95 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -119.31 113.8 21.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.161 -0.472 . . . . 74.21 110.905 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 14.6 t -124.24 145.9 49.07 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.163 -0.471 . . . . 61.05 111.108 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.466 ' HA ' ' O ' ' A' ' 94' ' ' TYR . 1.5 t -122.92 41.64 3.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.205 -0.452 . . . . 54.12 111.129 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -150.59 -172.74 4.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.262 -0.426 . . . . 72.23 110.888 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -84.39 164.57 18.83 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.159 -0.473 . . . . 74.2 110.836 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 8.2 t -157.89 129.14 3.77 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.64 0.733 . . . . 73.1 110.914 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.724 ' O ' ' HB2' ' A' ' 172' ' ' SER . 53.9 Cg_endo -69.75 -44.15 2.25 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.718 2.279 . . . . 61.22 112.384 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.636 ' HB3' ' CB ' ' A' ' 120' ' ' GLU . 0.1 OUTLIER -138.8 102.78 4.65 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.172 -0.467 . . . . 74.33 110.874 -179.859 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.615 ' HB ' ' O ' ' A' ' 171' ' ' GLN . 3.0 tt -51.13 -30.08 9.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.101 -0.5 . . . . 74.1 111.144 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' MET . . . . . 0.56 ' O ' ' HA ' ' A' ' 123' ' ' HIS . 3.6 ttt -85.32 -46.19 11.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.159 -0.473 . . . . 72.55 110.867 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.636 ' CB ' ' HB3' ' A' ' 117' ' ' SER . 14.1 tp10 -63.42 -13.6 41.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.183 -0.462 . . . . 73.51 110.866 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 26.3 tp60 -114.7 -52.91 2.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.156 -0.475 . . . . 72.34 110.931 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.58 ' CD1' HD11 ' A' ' 98' ' ' ILE . 86.7 m-85 -99.33 -22.44 15.58 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.456 . . . . 74.43 110.864 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.56 ' HA ' ' O ' ' A' ' 119' ' ' MET . 0.5 OUTLIER 76.67 24.6 0.96 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.176 -0.466 . . . . 70.25 110.87 179.984 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.469 ' O ' ' CG2' ' A' ' 118' ' ' ILE . 9.4 mtt -103.38 81.79 1.97 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.186 -0.461 . . . . 74.42 110.865 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 2.1 ptp85 -46.82 -40.99 14.8 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.251 -0.431 . . . . 74.42 110.854 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.498 ' HB3' ' HG2' ' A' ' 168' ' ' PRO . 32.7 mt-10 -142.67 130.43 21.54 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.162 -0.472 . . . . 74.22 110.9 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.603 HG22 ' O ' ' A' ' 127' ' ' ILE . 1.3 mp -87.69 97.1 6.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.219 -0.446 . . . . 63.01 111.13 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . 0.452 ' HA ' ' HB3' ' A' ' 160' ' ' PRO . 16.8 m170 -69.67 -25.99 64.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.218 -0.446 . . . . 74.54 110.908 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.575 ' CB ' ' HB2' ' A' ' 99' ' ' PHE . 0.0 OUTLIER -136.68 139.02 41.67 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.158 -0.474 . . . . 75.25 110.828 -179.788 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . 0.598 ' O ' ' O ' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -138.17 119.52 14.76 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.108 -0.497 . . . . 62.54 110.846 -179.975 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.646 ' HA ' ' HA ' ' A' ' 156' ' ' GLU . 4.4 mtpp -113.08 152.31 29.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.15 -0.477 . . . . 61.4 110.897 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.552 HG23 ' C ' ' A' ' 131' ' ' LYS . 10.8 t 84.15 163.58 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.183 -0.462 . . . . 72.53 111.13 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.746 HD22 ' CG ' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -177.45 124.58 0.13 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.198 -0.456 . . . . 71.4 110.973 179.943 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.542 ' O ' ' C ' ' A' ' 135' ' ' GLY . 0.2 OUTLIER -99.58 167.09 10.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.165 -0.471 . . . . 75.13 110.887 179.965 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.542 ' C ' ' O ' ' A' ' 134' ' ' GLU . . . -24.93 -74.03 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.698 -0.763 . . . . 72.44 112.528 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.729 ' HB ' HD12 ' A' ' 176' ' ' ILE . 3.1 t -135.01 147.97 29.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.84 0.353 . . . . 72.13 111.127 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . 0.717 ' H ' HD12 ' A' ' 152' ' ' LEU . 0.0 OUTLIER -152.03 162.41 41.13 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.202 -0.454 . . . . 71.33 110.929 179.977 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.515 HG21 ' HD2' ' A' ' 174' ' ' ARG . 19.4 mt -135.15 137.69 49.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.234 -0.439 . . . . 74.04 111.1 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.562 ' CD2' HG11 ' A' ' 170' ' ' VAL . 0.2 OUTLIER -110.93 146.12 37.14 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.154 -0.475 . . . . 72.45 110.892 179.914 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.714 ' CE2' ' HA ' ' A' ' 145' ' ' TYR . 0.6 OUTLIER -107.08 131.14 54.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.13 -0.486 . . . . 71.33 110.912 -179.831 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.596 ' O ' ' NE2' ' A' ' 171' ' ' GLN . 7.5 tt0 -70.66 -27.3 63.93 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.086 -0.507 . . . . 73.22 110.9 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.574 ' O ' ' HB3' ' A' ' 172' ' ' SER . 5.8 mp -113.37 147.15 36.82 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.58 0.705 . . . . 73.43 110.931 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . 0.698 ' CD ' ' HG2' ' A' ' 171' ' ' GLN . 53.9 Cg_endo -69.7 43.68 0.38 Allowed 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.694 2.262 . . . . 74.05 112.349 179.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . 1.093 ' O ' ' N ' ' A' ' 146' ' ' ARG . 0.4 OUTLIER 177.87 111.49 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.209 -0.45 . . . . 71.42 110.888 179.96 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . 0.714 ' HA ' ' CE2' ' A' ' 140' ' ' TYR . 0.1 OUTLIER -6.59 52.18 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.156 -0.475 . . . . 73.15 110.876 -179.892 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 1.093 ' N ' ' O ' ' A' ' 144' ' ' ASN . 40.7 mtt180 -140.16 170.52 15.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.121 -0.49 . . . . 72.52 110.885 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 81.0 -167.61 49.92 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.706 -0.759 . . . . 61.13 112.464 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.424 ' HG2' ' CD1' ' A' ' 58' ' ' TYR . 0.5 OUTLIER -88.58 142.98 27.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.778 0.323 . . . . 62.32 110.901 -179.935 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . 0.433 ' O ' ' HB2' ' A' ' 59' ' ' MET . 74.0 mt-30 -84.07 162.83 20.2 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.157 -0.474 . . . . 63.51 110.931 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . 0.412 ' HB2' ' HB2' ' A' ' 139' ' ' PHE . 92.8 m-85 -134.96 116.73 15.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.238 -0.437 . . . . 74.3 110.985 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.668 HD23 ' OH ' ' A' ' 50' ' ' TYR . 9.9 tp -68.6 119.09 12.48 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.129 -0.487 . . . . 74.25 110.877 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 1.055 ' O ' HD13 ' A' ' 152' ' ' LEU . 0.0 OUTLIER -51.4 135.45 27.22 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.18 -0.464 . . . . 61.55 110.903 179.899 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -163.37 24.84 0.08 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.177 -0.465 . . . . 75.43 110.848 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.783 ' HB2' ' CD1' ' A' ' 157' ' ' TYR . 0.0 OUTLIER -115.47 -173.54 2.35 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.252 -0.431 . . . . 73.45 110.913 -179.996 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.746 ' CG ' HD22 ' A' ' 133' ' ' LEU . 0.8 OUTLIER -161.48 -124.56 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.264 -0.425 . . . . 73.33 110.904 179.907 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.646 ' HA ' ' HA ' ' A' ' 131' ' ' LYS . 1.7 tm-20 -70.43 2.74 3.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 73.44 110.876 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . 0.783 ' CD1' ' HB2' ' A' ' 154' ' ' LYS . 18.4 m-30 -32.79 147.04 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.167 -0.469 . . . . 72.14 110.904 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . 0.68 ' HB3' ' CZ ' ' A' ' 104' ' ' PHE . 8.2 ptp180 -113.5 -37.45 4.63 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.097 -0.501 . . . . 73.3 110.844 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -89.01 152.54 48.44 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.576 0.703 . . . . 55.15 110.869 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . 0.544 ' HB3' ' HB3' ' A' ' 168' ' ' PRO . 54.3 Cg_endo -69.74 -29.29 24.2 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.658 2.239 . . . . 71.11 112.369 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.684 ' H ' HD12 ' A' ' 161' ' ' ILE . 4.3 mp -66.37 -10.5 11.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.216 -0.447 . . . . 74.32 111.161 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.671 ' HB3' ' CD1' ' A' ' 157' ' ' TYR . 0.5 OUTLIER -77.0 -13.94 59.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.143 -0.481 . . . . 74.04 110.853 179.848 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' TRP . . . . . 0.447 ' CE3' ' HB3' ' A' ' 165' ' ' ALA . 26.3 t90 -87.95 -7.68 56.78 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.245 -0.434 . . . . 63.02 110.921 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 99.3 -36.82 3.81 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.755 -0.736 . . . . 24.11 112.454 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.447 ' HB3' ' CE3' ' A' ' 163' ' ' TRP . . . -76.88 126.7 31.42 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.8 0.333 . . . . 72.23 111.149 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -37.27 -42.83 0.49 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.229 -0.441 . . . . 62.3 111.053 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . 0.491 ' C ' ' H ' ' A' ' 169' ' ' ALA . 0.5 OUTLIER -127.64 152.34 76.65 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.68 0.752 . . . . 71.45 110.835 -179.786 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . 0.544 ' HB3' ' HB3' ' A' ' 160' ' ' PRO . 53.7 Cg_endo -69.76 27.97 0.18 Allowed 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.689 2.259 . . . . 71.02 112.379 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.491 ' H ' ' C ' ' A' ' 167' ' ' SER . . . -67.6 99.98 0.83 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.215 -0.448 . . . . 55.32 111.149 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.582 HG12 ' H ' ' A' ' 171' ' ' GLN . 1.4 t -155.41 173.62 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.195 -0.457 . . . . 62.42 111.108 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' GLN . . . . . 0.698 ' HG2' ' CD ' ' A' ' 143' ' ' PRO . 0.0 OUTLIER -159.17 -97.55 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.165 -0.47 . . . . 75.43 110.91 -179.998 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . 0.724 ' HB2' ' O ' ' A' ' 116' ' ' PRO . 0.0 OUTLIER -64.62 153.77 38.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.23 -0.441 . . . . 51.11 110.851 -179.791 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . 0.404 ' HB3' ' CD2' ' A' ' 139' ' ' PHE . 1.2 p90 -151.96 158.21 42.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.146 -0.479 . . . . 71.35 110.888 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . 0.515 ' HD2' HG21 ' A' ' 138' ' ' ILE . 1.3 ptp180 -130.22 142.39 50.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.17 -0.468 . . . . 73.44 110.935 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . 0.432 ' HD2' ' CE2' ' A' ' 94' ' ' TYR . 0.0 OUTLIER -98.19 -169.21 1.77 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.21 -0.45 . . . . 72.05 110.902 -179.882 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . 0.729 HD12 ' HB ' ' A' ' 136' ' ' VAL . 4.1 mt -139.05 132.03 38.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.222 -0.444 . . . . 53.13 111.17 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 4.8 p -144.62 155.83 14.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.208 -0.451 . . . . 75.34 111.085 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.125 -0.488 . . . . 72.04 110.933 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.066 0 CA-C-O 120.829 0.347 . . . . 70.12 110.903 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.4 p -95.24 73.81 3.36 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.206 -0.452 . . . . 65.13 110.839 -179.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.51 61.09 3.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.115 -0.493 . . . . 61.44 110.911 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 27.1 p -53.98 -35.79 62.2 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.178 -0.464 . . . . 64.34 111.142 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 159.8 128.27 0.96 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.727 -0.749 . . . . 73.2 112.475 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.429 ' HA ' ' O ' ' A' ' 44' ' ' GLY . 10.9 p -82.33 136.11 35.07 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.898 0.38 . . . . 63.01 111.122 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.472 ' N ' ' HE1' ' A' ' 47' ' ' TRP . 2.6 tttt -127.91 138.12 52.54 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.203 -0.453 . . . . 62.24 110.852 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.514 HD12 ' CG2' ' A' ' 42' ' ' VAL . 16.0 tt -136.68 150.89 27.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.165 -0.47 . . . . 74.34 111.084 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.484 HG22 ' CE2' ' A' ' 11' ' ' TYR . 9.3 m -132.55 140.94 48.51 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.159 -0.473 . . . . 62.32 111.111 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.722 ' HB2' HD22 ' A' ' 34' ' ' LEU . 1.6 m-85 -129.2 131.68 47.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.228 -0.442 . . . . 72.41 110.924 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.54 ' CG ' ' HA ' ' A' ' 16' ' ' PHE . 6.2 m-85 -117.41 134.09 55.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.142 -0.481 . . . . 74.35 110.915 -179.825 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.46 ' HB2' ' H ' ' A' ' 19' ' ' ARG . 0.0 OUTLIER -56.83 -28.56 61.74 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.129 -0.487 . . . . 60.42 110.848 -179.968 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 49.4 m-20 -123.29 155.42 37.26 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.201 -0.454 . . . . 44.11 110.855 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 7.9 mtmm -57.41 -173.35 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 54.13 110.884 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 23.3 m-20 44.34 34.76 1.11 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.2 -0.454 . . . . 75.25 110.851 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.54 ' HA ' ' CG ' ' A' ' 11' ' ' TYR . 2.6 m-85 47.7 59.8 3.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.227 -0.442 . . . . 60.11 110.878 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 10.6 mt-30 -133.23 154.14 50.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.172 -0.467 . . . . 73.32 110.918 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 95.67 -154.43 20.96 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.768 -0.73 . . . . 42.14 112.446 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.752 ' O ' HD13 ' A' ' 34' ' ' LEU . 0.6 OUTLIER -63.65 81.7 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.857 0.361 . . . . 71.33 110.86 -179.838 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.516 ' HB2' ' CE1' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -81.05 127.52 32.69 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.193 -0.458 . . . . 75.04 110.859 -179.918 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.449 ' CZ ' ' CD1' ' A' ' 33' ' ' TYR . 82.8 t80 -124.23 125.71 44.86 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.217 -0.447 . . . . 65.23 110.903 -179.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -111.25 131.45 55.13 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.11 -0.495 . . . . 74.23 110.876 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -142.58 143.12 32.31 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.19 -0.459 . . . . 54.55 110.856 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -125.64 5.09 7.5 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.191 -0.459 . . . . 74.23 110.894 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 50.6 t -129.71 159.19 37.25 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.137 -0.483 . . . . 64.1 110.91 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -42.87 108.48 0.1 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.177 -0.465 . . . . 50.44 110.878 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.608 ' HB3' ' HB3' ' A' ' 30' ' ' PHE . 0.1 OUTLIER -119.8 51.38 1.18 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.202 -0.453 . . . . 52.13 110.887 -179.92 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.546 ' C ' ' HA ' ' A' ' 82' ' ' SER . . . -50.61 -14.61 0.2 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.209 -0.451 . . . . 65.53 111.08 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 63.6 t0 -127.3 42.21 3.37 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.227 -0.442 . . . . 64.51 110.88 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.819 ' O ' ' CD2' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -82.28 14.34 3.0 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.192 -0.458 . . . . 73.44 110.849 -179.885 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.536 ' HB2' ' HB3' ' A' ' 53' ' ' PRO . 31.3 t60 -76.8 -44.4 32.82 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.158 -0.474 . . . . 65.42 110.854 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.428 HG23 ' CD2' ' A' ' 33' ' ' TYR . 9.7 t -54.7 -13.57 1.06 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.156 -0.475 . . . . 73.52 111.147 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.498 ' CD1' ' HA ' ' A' ' 30' ' ' PHE . 12.3 m-85 -97.27 -29.65 13.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.224 -0.444 . . . . 71.3 110.91 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.752 HD13 ' O ' ' A' ' 19' ' ' ARG . 31.7 tp -137.85 140.35 40.41 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.101 -0.5 . . . . 71.41 110.907 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 2.6 m -104.16 -38.71 6.8 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.155 -0.475 . . . . 60.31 110.861 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.491 ' O ' HD21 ' A' ' 34' ' ' LEU . 0.2 OUTLIER -111.18 140.85 45.4 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.172 -0.467 . . . . 63.32 110.839 -179.928 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.471 ' SG ' ' CB ' ' A' ' 80' ' ' LEU . 2.0 m -122.46 76.35 1.32 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.157 -0.474 . . . . 71.54 110.871 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -80.15 -71.11 0.47 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.142 -0.481 . . . . 73.1 110.842 -179.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 4.8 p -104.52 134.54 47.53 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.157 -0.474 . . . . 73.15 110.869 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.744 HD12 ' CH2' ' A' ' 73' ' ' TRP . 19.4 mt -126.86 151.69 33.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.124 -0.489 . . . . 73.41 111.147 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.475 ' HD2' ' CE2' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -146.59 122.12 10.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.201 -0.454 . . . . 74.41 110.856 179.894 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.528 ' O ' HG12 ' A' ' 42' ' ' VAL . 1.4 t -108.41 114.63 47.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.259 -0.428 . . . . 74.3 111.134 179.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.407 ' N ' ' O ' ' A' ' 7' ' ' LYS . 1.5 mm-40 -109.79 79.06 1.17 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.193 -0.458 . . . . 72.41 110.827 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.429 ' O ' ' HA ' ' A' ' 6' ' ' THR . . . 134.2 102.72 0.76 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.794 -0.717 . . . . 55.01 112.524 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 52.21 -178.26 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.723 -0.751 . . . . 72.23 112.471 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.737 HG23 ' HA ' ' A' ' 63' ' ' PRO . 0.6 OUTLIER -81.57 172.19 13.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.809 0.338 . . . . 55.4 111.117 -179.846 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.558 ' H ' HG22 ' A' ' 46' ' ' THR . 13.2 m95 -142.59 130.04 21.23 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.214 -0.448 . . . . 70.31 110.898 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.841 ' HB2' ' CG2' ' A' ' 86' ' ' VAL . . . -97.39 108.89 21.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.234 -0.439 . . . . 71.43 111.109 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.849 HG11 HD11 ' A' ' 80' ' ' LEU . 4.2 m -111.45 130.96 64.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.215 -0.448 . . . . 73.14 111.13 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.663 ' HB3' ' HA ' ' A' ' 56' ' ' ALA . 56.6 m-85 -93.88 148.56 22.02 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.177 -0.465 . . . . 73.04 110.947 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.651 ' HB2' ' HB2' ' A' ' 58' ' ' TYR . 39.1 tt0 -45.38 -78.22 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.103 -0.499 . . . . 63.5 110.892 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.645 ' HB3' ' CD2' ' A' ' 55' ' ' PHE . 0.2 OUTLIER -90.78 144.77 30.81 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.574 0.702 . . . . 71.33 110.906 -179.924 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.745 ' HA ' ' OG ' ' A' ' 82' ' ' SER . 54.0 Cg_endo -69.79 131.38 21.08 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.688 2.259 . . . . 73.25 112.35 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 67.8 -8.2 0.54 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.218 -0.446 . . . . 72.3 110.891 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.645 ' CD2' ' HB3' ' A' ' 52' ' ' ARG . 6.2 m-30 -98.43 -27.73 13.94 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.181 -0.463 . . . . 73.14 110.884 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.663 ' HA ' ' HB3' ' A' ' 50' ' ' TYR . . . 62.79 16.42 9.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.173 -0.467 . . . . 64.32 111.153 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . 0.646 ' O ' ' C ' ' A' ' 58' ' ' TYR . 0.1 OUTLIER -49.02 -167.94 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.176 -0.465 . . . . 70.43 110.923 -179.958 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.651 ' HB2' ' HB2' ' A' ' 51' ' ' GLU . 8.1 m-30 -13.06 103.08 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.217 -0.447 . . . . 72.34 110.908 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.432 ' HB2' ' O ' ' A' ' 149' ' ' GLN . 1.9 mpt? -68.54 148.66 50.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.148 -0.478 . . . . 71.32 110.844 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.79 ' CD2' HD12 ' A' ' 76' ' ' LEU . 3.3 t80 -163.66 108.77 1.05 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.232 -0.44 . . . . 65.45 110.943 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.789 ' N ' HD12 ' A' ' 61' ' ' ILE . 1.5 mp -95.02 116.13 35.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.081 -0.508 . . . . 74.1 111.121 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.77 HD23 ' HD2' ' A' ' 63' ' ' PRO . 0.2 OUTLIER -84.07 128.78 61.23 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.611 0.719 . . . . 75.41 110.932 179.888 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.77 ' HD2' HD23 ' A' ' 62' ' ' LEU . 53.8 Cg_endo -69.74 -172.74 0.61 Allowed 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.705 2.27 . . . . 74.13 112.368 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -88.12 161.96 17.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.246 -0.434 . . . . 75.25 110.877 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 112.2 -167.94 12.55 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.719 -0.753 . . . . 42.11 112.457 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -108.05 156.44 19.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.855 0.359 . . . . 73.21 110.862 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.622 ' HB2' ' O ' ' A' ' 40' ' ' ILE . 15.7 m-85 -144.19 84.39 9.5 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.684 0.754 . . . . 73.21 110.904 -179.869 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.419 ' HD2' ' HG3' ' A' ' 72' ' ' ARG . 53.2 Cg_endo -69.83 2.83 3.21 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.7 2.267 . . . . 71.3 112.344 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.608 ' HB2' ' HG2' ' A' ' 72' ' ' ARG . 52.6 mt-10 -157.38 143.45 17.7 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.199 -0.455 . . . . 75.3 110.889 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.741 ' HA ' ' NE1' ' A' ' 73' ' ' TRP . 30.6 p90 -55.35 -21.39 14.99 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.161 -0.472 . . . . 40.53 110.916 -179.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -81.25 -17.15 50.48 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.099 -0.501 . . . . 74.02 110.876 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.608 ' HG2' ' HB2' ' A' ' 69' ' ' GLU . 33.0 mmt180 -68.32 -10.61 56.06 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.233 -0.439 . . . . 74.35 110.853 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . 0.744 ' CH2' HD12 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -133.13 17.7 4.1 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.182 -0.463 . . . . 74.43 110.869 -179.953 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 40.56 37.45 0.47 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.275 -0.42 . . . . 73.33 110.868 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -52.06 114.22 3.08 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.738 -0.744 . . . . 64.4 112.521 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 1.016 HD13 ' N ' ' A' ' 77' ' ' ASN . 0.0 OUTLIER -63.82 -16.7 61.93 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.781 0.324 . . . . 74.32 110.87 -179.889 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 1.016 ' N ' HD13 ' A' ' 76' ' ' LEU . 57.8 t-20 -157.87 130.53 7.32 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.194 -0.457 . . . . 73.41 110.936 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -77.5 9.17 3.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.174 -0.466 . . . . 62.15 110.879 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.416 ' HG2' ' O ' ' A' ' 79' ' ' ARG . 24.1 ttt85 -88.9 38.38 0.88 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.205 -0.452 . . . . 65.54 110.889 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.849 HD11 HG11 ' A' ' 49' ' ' VAL . 0.1 OUTLIER -56.7 126.84 28.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.143 -0.481 . . . . 51.33 110.87 -179.931 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.655 ' HB3' ' HB3' ' A' ' 53' ' ' PRO . 4.4 m -142.8 -117.55 0.1 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.191 -0.459 . . . . 73.34 110.889 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.745 ' OG ' ' HA ' ' A' ' 53' ' ' PRO . 0.4 OUTLIER -30.38 130.36 0.1 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.127 -0.488 . . . . 75.4 110.844 -179.848 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . 0.545 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 11.0 p -138.74 144.43 39.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.176 -0.466 . . . . 73.12 110.855 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.508 ' N ' ' O ' ' A' ' 48' ' ' ALA . 0.6 OUTLIER -141.31 128.17 20.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.165 -0.47 . . . . 72.24 110.905 -179.865 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.429 ' N ' ' CZ3' ' A' ' 47' ' ' TRP . . . -49.64 126.89 14.61 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.24 -0.437 . . . . 51.32 111.126 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.841 ' CG2' ' HB2' ' A' ' 48' ' ' ALA . 48.4 t -114.17 132.9 61.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.214 -0.448 . . . . 64.41 111.126 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . 0.769 ' O ' HG23 ' A' ' 136' ' ' VAL . 20.3 m-70 -108.15 105.18 14.8 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.16 -0.473 . . . . 62.14 110.872 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.627 HD12 ' HB3' ' A' ' 178' ' ' GLU . 0.0 OUTLIER -35.55 144.29 0.24 Allowed Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.566 0.698 . . . . 72.31 110.931 179.993 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.472 ' HA ' ' HA3' ' A' ' 135' ' ' GLY . 54.1 Cg_endo -69.76 87.67 0.55 Allowed 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.684 2.256 . . . . 53.34 112.323 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -105.92 -177.57 3.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.265 -0.425 . . . . 51.52 110.846 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 60.88 23.94 61.96 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.74 -0.743 . . . . 73.33 112.5 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.413 ' O ' ' C ' ' A' ' 93' ' ' GLN . . . 153.24 34.33 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.735 -0.745 . . . . 44.41 112.452 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.492 ' O ' ' CG ' ' A' ' 134' ' ' GLU . 23.6 pt20 36.37 -135.07 0.05 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.811 0.339 . . . . 62.15 110.916 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.465 ' O ' ' HA ' ' A' ' 112' ' ' THR . 13.9 t80 -119.71 106.8 12.49 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.184 -0.462 . . . . 70.35 110.907 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.541 ' HG3' HG11 ' A' ' 132' ' ' VAL . 36.3 tptt -108.65 128.69 55.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.107 -0.497 . . . . 75.3 110.922 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.425 HD12 ' OH ' ' A' ' 94' ' ' TYR . 6.8 tt -148.39 144.17 18.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.231 -0.44 . . . . 70.53 111.116 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.589 ' O ' ' HA ' ' A' ' 130' ' ' CYS . 1.3 mt-30 -115.97 111.57 20.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.153 -0.476 . . . . 74.53 110.897 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.563 ' CG2' HD12 ' A' ' 127' ' ' ILE . 2.7 mm -86.49 140.97 15.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.222 -0.445 . . . . 75.42 111.11 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.565 ' HB2' ' HB2' ' A' ' 129' ' ' SER . 57.4 m-85 -130.91 133.16 45.6 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.201 -0.454 . . . . 72.03 110.878 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 60.6 tt0 -61.4 -80.14 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.189 -0.459 . . . . 55.21 110.878 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 12.2 mttt -85.51 162.44 18.92 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.145 -0.479 . . . . 63.13 110.898 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -67.86 162.28 48.55 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.691 -0.766 . . . . 62.45 112.512 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.516 ' HA ' ' HB2' ' A' ' 158' ' ' ARG . 36.5 t70 64.46 27.16 13.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.861 0.362 . . . . 75.15 110.876 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.54 ' CZ ' ' HB3' ' A' ' 158' ' ' ARG . 8.8 m-85 59.57 48.14 9.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.153 -0.476 . . . . 74.42 110.915 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 2.9 m -113.45 143.92 43.68 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.148 -0.478 . . . . 75.32 110.85 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 96.41 -124.15 7.98 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.74 -0.743 . . . . 74.14 112.447 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 4.9 tp-100 -102.77 143.62 32.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.799 0.333 . . . . 74.25 110.841 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 2.9 ttp -130.33 146.43 51.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.182 -0.463 . . . . 73.54 110.84 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 11.8 m-85 -148.13 137.5 22.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.174 -0.466 . . . . 75.23 110.925 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -118.63 101.24 7.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.121 -0.49 . . . . 75.3 110.88 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 8.1 t -118.24 153.21 34.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 64.41 111.177 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.465 ' HA ' ' O ' ' A' ' 94' ' ' TYR . 1.4 t -125.45 47.25 2.22 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.223 -0.444 . . . . 65.15 111.116 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 75.0 mm-40 -148.32 -175.2 4.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.264 -0.426 . . . . 60.42 110.863 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -101.94 150.96 22.67 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.134 -0.485 . . . . 71.05 110.884 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 11.1 m -143.03 136.83 14.37 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.638 0.732 . . . . 74.21 110.857 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.765 ' O ' ' HB2' ' A' ' 172' ' ' SER . 53.9 Cg_endo -69.72 -34.34 14.9 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.752 2.301 . . . . 73.23 112.354 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.64 ' HB3' ' CB ' ' A' ' 120' ' ' GLU . 0.1 OUTLIER -140.79 97.96 3.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.178 -0.464 . . . . 74.11 110.839 -179.831 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.782 HD13 HD11 ' A' ' 127' ' ' ILE . 5.0 tt -49.54 -28.33 3.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.146 -0.479 . . . . 63.53 111.132 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' MET . . . . . 0.568 ' O ' ' HA ' ' A' ' 123' ' ' HIS . 7.2 ttt -84.71 -42.61 15.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.157 -0.474 . . . . 65.34 110.89 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.64 ' CB ' ' HB3' ' A' ' 117' ' ' SER . 24.3 tp10 -62.5 -13.22 28.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.218 -0.446 . . . . 63.22 110.907 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.92 -52.93 2.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.152 -0.476 . . . . 73.12 110.931 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 12.0 m-30 -101.93 -18.93 15.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.205 -0.452 . . . . 64.32 110.885 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.568 ' HA ' ' O ' ' A' ' 119' ' ' MET . 10.7 m80 74.5 24.62 1.74 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.136 -0.484 . . . . 74.11 110.86 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.465 ' SD ' HG22 ' A' ' 98' ' ' ILE . 8.6 mtt -100.39 83.31 2.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.223 -0.444 . . . . 75.32 110.921 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 3.6 ptp180 -49.5 -33.05 13.5 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.186 -0.461 . . . . 72.23 110.888 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.536 ' HB3' ' HG2' ' A' ' 168' ' ' PRO . 16.0 mt-10 -145.44 129.23 17.26 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.122 -0.49 . . . . 75.43 110.886 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.782 HD11 HD13 ' A' ' 118' ' ' ILE . 3.0 mm -87.33 91.13 3.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.147 -0.479 . . . . 72.43 111.122 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . 0.408 ' CD2' ' HG3' ' A' ' 168' ' ' PRO . 13.7 m170 -61.9 -34.45 76.07 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.187 -0.461 . . . . 70.52 110.865 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.565 ' HB2' ' HB2' ' A' ' 99' ' ' PHE . 0.6 OUTLIER -135.05 152.13 51.41 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.224 -0.444 . . . . 74.42 110.887 -179.751 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . 0.597 ' O ' ' O ' ' A' ' 155' ' ' LYS . 0.1 OUTLIER -155.25 121.04 5.07 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.157 -0.474 . . . . 54.4 110.852 -179.94 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.657 ' HA ' ' HA ' ' A' ' 156' ' ' GLU . 8.7 mtpp -108.57 153.85 22.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.191 -0.459 . . . . 71.23 110.88 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.57 HG23 ' C ' ' A' ' 131' ' ' LYS . 11.3 t 85.76 164.7 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.197 -0.456 . . . . 72.5 111.14 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.747 HD22 ' CG ' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -176.93 122.76 0.14 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.189 -0.46 . . . . 63.41 110.921 179.918 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.614 ' O ' ' C ' ' A' ' 135' ' ' GLY . 0.0 OUTLIER -98.75 159.12 15.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.13 -0.486 . . . . 73.02 110.873 179.95 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.614 ' C ' ' O ' ' A' ' 134' ' ' GLU . . . -13.57 -75.63 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.769 -0.729 . . . . 63.44 112.497 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.821 HG21 HG13 ' A' ' 86' ' ' VAL . 5.6 t -136.1 148.81 27.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.821 0.343 . . . . 75.54 111.129 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . 0.631 ' HB3' ' HB3' ' A' ' 152' ' ' LEU . 22.8 t90 -146.2 148.65 32.74 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.157 -0.474 . . . . 71.51 110.934 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.46 HD13 ' HB ' ' A' ' 61' ' ' ILE . 0.4 OUTLIER -118.05 135.11 59.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.245 -0.434 . . . . 41.23 111.123 179.953 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.533 ' CZ ' HG11 ' A' ' 170' ' ' VAL . 0.1 OUTLIER -110.07 147.51 33.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.173 -0.467 . . . . 74.25 110.863 179.977 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.711 ' HB2' ' O ' ' A' ' 172' ' ' SER . 0.8 OUTLIER -115.32 129.67 56.67 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.18 -0.464 . . . . 74.33 110.898 -179.855 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.625 ' O ' ' NE2' ' A' ' 171' ' ' GLN . 8.1 tt0 -69.34 -28.6 66.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.126 -0.488 . . . . 73.44 110.926 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.775 ' O ' ' HB3' ' A' ' 172' ' ' SER . 5.9 mp -113.41 148.48 39.73 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.629 0.728 . . . . 71.34 110.876 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . 0.684 ' CD ' ' HG2' ' A' ' 171' ' ' GLN . 53.5 Cg_endo -69.74 43.95 0.39 Allowed 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.695 2.263 . . . . 73.34 112.328 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . 1.093 ' O ' ' N ' ' A' ' 146' ' ' ARG . 0.4 OUTLIER 177.47 111.23 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.261 -0.427 . . . . 75.42 110.928 179.996 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . 0.66 ' HA ' ' CE2' ' A' ' 140' ' ' TYR . 0.2 OUTLIER -6.36 52.37 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.159 -0.473 . . . . 72.44 110.911 -179.895 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 1.093 ' N ' ' O ' ' A' ' 144' ' ' ASN . 26.9 mtt180 -138.85 167.12 22.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.11 -0.495 . . . . 73.24 110.858 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 83.89 -165.35 41.79 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.692 -0.766 . . . . 64.44 112.5 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -88.07 146.45 25.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.751 0.31 . . . . 72.02 110.912 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . 0.432 ' O ' ' HB2' ' A' ' 59' ' ' MET . 28.2 mt-30 -88.59 161.91 16.66 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.239 -0.437 . . . . 75.22 110.903 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . 0.465 ' HB2' ' CB ' ' A' ' 139' ' ' PHE . 85.9 m-85 -135.72 130.87 34.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.162 -0.472 . . . . 73.2 110.932 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.649 HD23 ' OH ' ' A' ' 50' ' ' TYR . 9.2 tp -82.87 120.34 25.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.152 -0.476 . . . . 72.52 110.914 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.935 ' O ' HD13 ' A' ' 152' ' ' LEU . 0.0 OUTLIER -51.62 136.77 26.17 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.208 -0.451 . . . . 75.13 110.888 179.877 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -164.53 24.93 0.06 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.207 -0.451 . . . . 75.52 110.834 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.843 ' HB2' ' CD1' ' A' ' 157' ' ' TYR . 0.0 OUTLIER -119.42 -176.57 3.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.239 -0.437 . . . . 75.34 110.936 179.968 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.747 ' CG ' HD22 ' A' ' 133' ' ' LEU . 1.1 mptt -159.09 -121.72 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.216 -0.447 . . . . 74.44 110.912 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.657 ' HA ' ' HA ' ' A' ' 131' ' ' LYS . 2.9 tm-20 -68.93 0.09 4.91 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.175 -0.466 . . . . 52.54 110.881 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . 0.843 ' CD1' ' HB2' ' A' ' 154' ' ' LYS . 16.5 m-30 -32.01 147.5 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.151 -0.477 . . . . 72.12 110.968 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . 0.54 ' HB3' ' CZ ' ' A' ' 104' ' ' PHE . 6.8 ptp180 -112.5 -41.78 3.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.145 -0.479 . . . . 74.13 110.85 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -85.95 150.57 53.11 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.56 0.695 . . . . 75.34 110.906 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . 0.52 ' HB3' ' HB3' ' A' ' 168' ' ' PRO . 54.1 Cg_endo -69.74 -31.57 20.36 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.719 2.279 . . . . 71.02 112.364 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.761 ' H ' HD12 ' A' ' 161' ' ' ILE . 3.5 mp -62.25 -12.75 8.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.236 -0.438 . . . . 72.0 111.115 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.587 ' HB3' ' CD1' ' A' ' 157' ' ' TYR . 0.5 OUTLIER -70.44 -12.26 61.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.216 -0.447 . . . . 55.2 110.874 179.842 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 75.4 t-105 -90.95 -12.96 34.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.23 -0.441 . . . . 74.5 110.928 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 93.03 -35.25 4.17 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.769 -0.729 . . . . 43.33 112.487 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -79.84 123.24 27.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.818 0.342 . . . . 61.23 111.076 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -49.38 122.6 6.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.167 -0.469 . . . . 42.02 111.094 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . 0.469 ' C ' ' H ' ' A' ' 169' ' ' ALA . 0.5 OUTLIER 64.89 140.86 0.06 OUTLIER Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.637 0.732 . . . . 71.32 110.909 -179.768 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . 0.536 ' HG2' ' HB3' ' A' ' 126' ' ' GLU . 53.5 Cg_endo -69.8 33.6 0.2 Allowed 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.717 2.278 . . . . 64.05 112.317 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.473 ' O ' HG22 ' A' ' 170' ' ' VAL . . . -67.19 98.28 0.59 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.233 -0.44 . . . . 71.23 111.148 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.597 HG12 ' H ' ' A' ' 171' ' ' GLN . 1.1 t -156.97 175.32 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.221 -0.445 . . . . 65.25 111.13 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' GLN . . . . . 0.701 ' CD ' ' N ' ' A' ' 171' ' ' GLN . 0.0 OUTLIER -160.66 -99.93 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.146 -0.479 . . . . 54.3 110.911 -179.957 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . 0.775 ' HB3' ' O ' ' A' ' 142' ' ' LEU . 0.1 OUTLIER -52.46 140.61 22.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.168 -0.469 . . . . 34.23 110.868 -179.793 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . 0.484 ' HB3' ' CE1' ' A' ' 139' ' ' PHE . 18.9 p90 -156.44 149.84 24.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.114 -0.494 . . . . 64.54 110.89 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . 0.478 ' HD3' ' CE2' ' A' ' 140' ' ' TYR . 0.0 OUTLIER -149.21 157.58 43.48 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.128 -0.487 . . . . 70.53 110.851 -179.899 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . 0.415 ' H ' ' HD2' ' A' ' 175' ' ' ARG . 0.0 OUTLIER -106.29 172.08 7.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.221 -0.445 . . . . 73.13 110.854 -179.938 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . 0.806 HD12 ' HB ' ' A' ' 136' ' ' VAL . 6.5 mt -97.78 143.38 12.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.175 -0.466 . . . . 72.21 111.132 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 67.8 t -48.36 140.72 2.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.164 -0.471 . . . . 73.4 111.128 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . 0.627 ' HB3' HD12 ' A' ' 88' ' ' LEU . 1.2 mm-40 . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 116.213 -0.448 . . . . 74.24 110.907 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.066 0 CA-C-O 120.803 0.335 . . . . 71.25 110.846 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.7 p -65.36 -61.34 2.17 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.206 -0.452 . . . . 71.52 110.847 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 52.29 59.66 4.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.103 -0.499 . . . . 64.14 110.935 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 6.9 p -83.68 53.4 2.53 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.174 -0.466 . . . . 74.34 111.114 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 68.05 125.81 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.798 -0.715 . . . . 34.23 112.468 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.503 ' C ' ' HE1' ' A' ' 47' ' ' TRP . 5.2 p -82.41 134.3 35.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.906 0.384 . . . . 64.31 111.105 -179.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 3.9 tttt -120.06 135.87 54.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.176 -0.465 . . . . 73.31 110.906 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.616 ' HB ' ' CD1' ' A' ' 47' ' ' TRP . 15.5 tt -137.14 151.88 27.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.231 -0.44 . . . . 61.31 111.159 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.499 ' HA ' ' O ' ' A' ' 21' ' ' TYR . 18.1 m -132.86 142.45 48.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.192 -0.458 . . . . 61.43 111.153 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.722 ' HB2' HD22 ' A' ' 34' ' ' LEU . 0.8 OUTLIER -130.08 129.03 43.07 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.25 -0.432 . . . . 73.42 110.875 -179.965 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.547 ' CG ' ' HA ' ' A' ' 16' ' ' PHE . 12.5 m-85 -114.4 131.65 56.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.136 -0.484 . . . . 53.51 110.93 -179.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.438 ' HB2' ' HB2' ' A' ' 19' ' ' ARG . 0.1 OUTLIER -59.5 -16.49 24.83 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.117 -0.492 . . . . 72.43 110.864 -179.97 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.443 ' HB2' ' O ' ' A' ' 17' ' ' GLN . 72.2 m-20 -134.14 150.56 51.12 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.167 -0.469 . . . . 71.12 110.885 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.469 ' N ' ' HB3' ' A' ' 38' ' ' ASN . 34.2 mtmt -55.61 -176.58 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.196 -0.456 . . . . 64.3 110.864 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 20.2 m120 47.22 32.45 2.1 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.194 -0.457 . . . . 50.31 110.908 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.547 ' HA ' ' CG ' ' A' ' 11' ' ' TYR . 3.3 m-85 49.74 62.66 2.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 72.2 110.916 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.443 ' O ' ' HB2' ' A' ' 13' ' ' ASP . 18.3 mt-30 -137.75 159.22 42.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.116 -0.493 . . . . 71.12 110.895 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 92.7 -148.49 19.11 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.765 -0.731 . . . . 74.14 112.482 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.757 ' O ' HD13 ' A' ' 34' ' ' LEU . 0.3 OUTLIER -69.75 78.43 0.45 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.797 0.332 . . . . 75.54 110.844 -179.8 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.487 ' HB2' ' CE1' ' A' ' 11' ' ' TYR . 0.6 OUTLIER -76.88 130.35 37.46 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.188 -0.46 . . . . 65.13 110.845 -179.91 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.499 ' O ' ' HA ' ' A' ' 9' ' ' THR . 89.2 t80 -124.33 123.65 40.67 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.193 -0.458 . . . . 74.25 110.895 -179.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.471 ' CG ' HG23 ' A' ' 9' ' ' THR . 1.2 m-20 -121.14 133.78 55.21 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.089 -0.505 . . . . 73.4 110.856 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -168.31 136.67 2.26 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.196 -0.457 . . . . 62.05 110.916 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -101.93 -0.69 33.46 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.185 -0.461 . . . . 74.3 110.839 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 16.8 t -102.85 164.34 11.68 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.226 -0.443 . . . . 71.24 110.911 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -57.68 120.86 9.1 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.238 -0.437 . . . . 70.42 110.894 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.55 ' HB2' ' HB3' ' A' ' 30' ' ' PHE . 1.8 m -116.63 51.13 1.0 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.185 -0.461 . . . . 72.42 110.853 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.495 ' C ' ' HA ' ' A' ' 82' ' ' SER . . . -47.07 -21.1 0.2 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.226 -0.443 . . . . 73.02 111.099 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 55.0 t0 -128.17 41.77 3.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.202 -0.454 . . . . 74.42 110.862 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.773 ' O ' ' CD2' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -81.35 13.18 3.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.184 -0.462 . . . . 73.04 110.851 -179.881 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.479 ' HB2' ' HB3' ' A' ' 53' ' ' PRO . 28.8 t60 -78.75 -40.44 33.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.143 -0.48 . . . . 73.1 110.803 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.7 t -56.33 -16.14 5.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.197 -0.456 . . . . 74.11 111.126 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -98.26 -25.95 14.69 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.21 -0.45 . . . . 64.02 110.932 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.757 HD13 ' O ' ' A' ' 19' ' ' ARG . 16.3 tp -144.13 131.58 20.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.076 -0.511 . . . . 43.3 110.901 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 24.5 m -93.81 -42.88 8.88 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.193 -0.458 . . . . 63.42 110.839 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 1.1 tmm_? -118.41 140.64 49.54 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.163 -0.471 . . . . 72.1 110.861 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.493 ' HB3' ' HB2' ' A' ' 80' ' ' LEU . 4.0 p -108.71 81.08 1.4 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.164 -0.471 . . . . 74.43 110.913 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.469 ' HB3' ' N ' ' A' ' 14' ' ' LYS . 0.2 OUTLIER -70.4 -73.26 0.17 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.17 -0.468 . . . . 75.11 110.879 -179.882 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 4.3 p -109.21 125.03 51.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.208 -0.451 . . . . 74.11 110.841 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.756 HG21 HD13 ' A' ' 62' ' ' LEU . 45.3 mt -118.05 148.83 20.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.127 -0.488 . . . . 73.42 111.11 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.468 ' HD2' ' CE2' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -144.69 119.26 9.73 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.207 -0.451 . . . . 64.42 110.847 179.868 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.535 HG22 ' HB ' ' A' ' 8' ' ' ILE . 2.0 t -104.04 115.66 46.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.186 -0.461 . . . . 72.14 111.121 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -110.27 79.39 1.2 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.202 -0.454 . . . . 71.01 110.884 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.438 ' O ' ' HA ' ' A' ' 6' ' ' THR . . . 129.31 106.89 1.25 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.704 -0.76 . . . . 70.42 112.501 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 51.89 -178.75 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.764 -0.732 . . . . 54.32 112.463 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.705 HG23 ' HA ' ' A' ' 63' ' ' PRO . 1.2 m -83.23 168.29 16.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.749 0.309 . . . . 73.44 111.137 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.616 ' CD1' ' HB ' ' A' ' 8' ' ' ILE . 3.4 m95 -141.04 130.19 23.44 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.276 -0.42 . . . . 74.01 110.918 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.882 ' HB2' ' CG2' ' A' ' 86' ' ' VAL . . . -93.52 129.27 39.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.275 -0.42 . . . . 74.33 111.102 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.665 HG11 ' CD1' ' A' ' 80' ' ' LEU . 15.5 m -129.02 125.83 63.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.206 -0.452 . . . . 75.21 111.108 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.73 ' HB3' ' HA ' ' A' ' 56' ' ' ALA . 42.8 m-85 -92.16 150.11 21.1 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.16 -0.473 . . . . 72.43 110.929 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.648 ' OE1' ' HB3' ' A' ' 57' ' ' TRP . 54.2 tt0 -49.99 -78.94 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.099 -0.5 . . . . 55.24 110.865 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.544 ' HB3' ' CD2' ' A' ' 55' ' ' PHE . 0.0 OUTLIER -93.66 144.68 28.58 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.626 0.727 . . . . 74.35 110.848 -179.867 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.772 ' HA ' ' OG ' ' A' ' 82' ' ' SER . 53.8 Cg_endo -69.78 141.76 46.01 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.702 2.268 . . . . 64.31 112.346 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 63.38 -11.89 0.09 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.226 -0.443 . . . . 75.21 110.878 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.61 ' H ' ' C ' ' A' ' 53' ' ' PRO . 2.5 m-30 -104.01 -19.13 14.31 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.148 -0.478 . . . . 73.12 110.893 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.73 ' HA ' ' HB3' ' A' ' 50' ' ' TYR . . . 49.47 25.46 1.37 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.138 -0.483 . . . . 71.3 111.09 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . 0.648 ' HB3' ' OE1' ' A' ' 51' ' ' GLU . 0.0 OUTLIER -50.01 -166.06 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.243 -0.435 . . . . 74.55 110.982 -179.988 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.636 ' C ' ' O ' ' A' ' 57' ' ' TRP . 10.0 m-30 -14.1 101.32 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.267 -0.424 . . . . 75.34 110.913 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.482 ' HB2' ' HA ' ' A' ' 150' ' ' TYR . 1.6 mpt? -64.14 157.57 25.22 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.089 -0.505 . . . . 73.34 110.879 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.723 ' CD2' HD12 ' A' ' 76' ' ' LEU . 2.6 t80 -170.48 103.98 0.27 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.259 -0.428 . . . . 64.32 110.925 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.625 HD11 ' HB2' ' A' ' 151' ' ' LEU . 0.8 OUTLIER -91.23 115.09 29.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.115 -0.493 . . . . 64.3 111.113 179.904 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.79 HD23 ' HD2' ' A' ' 63' ' ' PRO . 0.3 OUTLIER -81.84 126.32 75.65 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.595 0.712 . . . . 73.23 110.949 179.861 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.79 ' HD2' HD23 ' A' ' 62' ' ' LEU . 53.9 Cg_endo -69.71 -176.1 1.36 Allowed 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.729 2.286 . . . . 71.05 112.348 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -84.51 161.66 20.16 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.238 -0.437 . . . . 73.5 110.899 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 113.64 -162.47 12.37 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.74 -0.743 . . . . 55.54 112.491 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -115.68 156.45 25.89 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.899 0.38 . . . . 74.35 110.847 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.554 ' HB2' ' O ' ' A' ' 40' ' ' ILE . 9.4 m-85 -145.17 83.72 9.07 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.669 0.747 . . . . 74.54 110.943 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.409 ' HD2' ' HG3' ' A' ' 72' ' ' ARG . 53.8 Cg_endo -69.77 0.67 5.32 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.686 2.257 . . . . 54.33 112.326 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.483 ' HB2' ' HG2' ' A' ' 72' ' ' ARG . 42.4 mt-10 -155.79 142.72 18.99 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.268 -0.424 . . . . 74.31 110.922 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.693 ' HA ' ' NE1' ' A' ' 73' ' ' TRP . 24.1 p90 -56.11 -21.38 21.97 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.205 -0.452 . . . . 72.24 110.899 -179.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -78.2 -18.42 55.51 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.094 -0.503 . . . . 62.15 110.894 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.483 ' HG2' ' HB2' ' A' ' 69' ' ' GLU . 29.4 mmt180 -67.52 -9.25 40.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.213 -0.449 . . . . 71.3 110.919 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . 0.714 ' N ' ' CD1' ' A' ' 73' ' ' TRP . 0.0 OUTLIER -135.51 5.89 3.22 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.175 -0.466 . . . . 74.04 110.93 -179.979 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 11.6 mtp 45.42 68.64 0.54 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.234 -0.439 . . . . 64.42 110.934 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -60.66 120.79 24.33 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.749 -0.739 . . . . 71.23 112.47 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.876 HD13 ' N ' ' A' ' 77' ' ' ASN . 0.0 OUTLIER -70.75 -8.79 54.82 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.805 0.336 . . . . 71.42 110.897 -179.954 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.876 ' N ' HD13 ' A' ' 76' ' ' LEU . 10.7 t-20 -151.46 -41.83 0.12 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.217 -0.447 . . . . 73.22 110.885 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.581 ' CB ' ' O ' ' A' ' 77' ' ' ASN . 1.8 t70 89.88 7.68 0.1 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.186 -0.461 . . . . 72.51 110.872 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -105.81 91.43 3.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.181 -0.463 . . . . 73.52 110.888 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.665 ' CD1' HG11 ' A' ' 49' ' ' VAL . 0.1 OUTLIER -90.28 135.54 33.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.172 -0.467 . . . . 65.11 110.965 -180.0 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.631 ' HB3' ' HB3' ' A' ' 53' ' ' PRO . 1.2 m -151.94 -118.66 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.198 -0.455 . . . . 75.1 110.884 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.772 ' OG ' ' HA ' ' A' ' 53' ' ' PRO . 0.2 OUTLIER -44.57 101.8 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.142 -0.481 . . . . 70.13 110.851 -179.824 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . 0.601 ' HB3' HG12 ' A' ' 49' ' ' VAL . 15.9 p -115.77 141.43 48.11 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.133 -0.485 . . . . 75.41 110.887 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.6 ' N ' ' O ' ' A' ' 48' ' ' ALA . 13.8 mmt85 -128.38 134.7 48.88 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.218 -0.447 . . . . 63.24 110.884 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.465 ' N ' ' CZ3' ' A' ' 47' ' ' TRP . . . -53.06 127.44 24.05 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.456 . . . . 45.42 111.08 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.882 ' CG2' ' HB2' ' A' ' 48' ' ' ALA . 73.7 t -115.05 135.43 55.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.238 -0.437 . . . . 71.13 111.136 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 28.7 m-70 -112.08 120.2 41.03 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.15 -0.477 . . . . 74.35 110.859 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.763 HD13 ' HB3' ' A' ' 178' ' ' GLU . 0.1 OUTLIER -40.04 137.65 1.18 Allowed Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.62 0.724 . . . . 72.1 110.942 -179.961 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.65 ' HB3' ' H ' ' A' ' 136' ' ' VAL . 53.9 Cg_endo -69.72 81.17 0.83 Allowed 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.7 2.266 . . . . 75.52 112.363 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -98.72 119.15 36.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.242 -0.435 . . . . 72.12 110.881 -179.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 130.51 85.98 0.39 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.755 -0.735 . . . . 53.13 112.496 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 88.1 35.63 8.81 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.782 -0.723 . . . . 73.52 112.471 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.46 ' O ' ' HG3' ' A' ' 134' ' ' GLU . 12.4 pt20 39.47 -154.18 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.832 0.349 . . . . 73.4 110.917 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.596 ' O ' ' HA ' ' A' ' 112' ' ' THR . 28.0 m-85 -96.17 102.35 14.12 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.199 -0.455 . . . . 71.34 110.919 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.506 ' H ' ' CG ' ' A' ' 134' ' ' GLU . 35.4 tptt -109.58 126.18 53.33 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.139 -0.482 . . . . 72.44 110.895 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 5.3 tt -150.6 137.19 12.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.189 -0.46 . . . . 74.34 111.119 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -108.14 135.11 50.04 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.17 -0.468 . . . . 72.12 110.917 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.582 ' CG2' HD12 ' A' ' 127' ' ' ILE . 26.0 mm -115.37 134.7 57.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.231 -0.44 . . . . 72.42 111.113 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.589 ' HB2' ' HB2' ' A' ' 129' ' ' SER . 61.7 m-85 -123.13 140.07 53.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 74.33 110.885 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.551 ' HA ' ' CE ' ' A' ' 124' ' ' MET . 58.6 tt0 -75.06 -52.64 10.54 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.161 -0.472 . . . . 72.34 110.922 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 40.8 mttt -106.8 155.29 19.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.136 -0.484 . . . . 63.45 110.932 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.406 ' N ' ' HB3' ' A' ' 128' ' ' HIS . . . -62.24 157.3 36.6 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.772 -0.728 . . . . 65.12 112.467 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.55 ' HA ' ' HB2' ' A' ' 158' ' ' ARG . 12.8 t70 69.48 39.92 1.52 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.896 0.379 . . . . 63.44 110.878 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.526 ' HA ' ' CD1' ' A' ' 99' ' ' PHE . 2.1 m-85 55.32 25.13 7.16 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.176 -0.465 . . . . 74.12 110.886 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 68.0 m -92.94 166.83 12.19 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.18 -0.464 . . . . 70.13 110.831 -179.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 79.18 -157.66 43.16 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.75 -0.738 . . . . 72.05 112.511 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 4.3 tp-100 -75.08 119.58 19.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.794 0.33 . . . . 73.24 110.931 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' MET . . . . . 0.462 ' HB2' ' CE1' ' A' ' 99' ' ' PHE . 18.8 ttp -104.36 145.46 30.22 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.23 -0.441 . . . . 74.1 110.864 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -148.66 134.84 19.29 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.195 -0.457 . . . . 70.4 110.926 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -113.38 89.28 3.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 74.34 110.907 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 15.0 t -101.04 130.55 47.07 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.115 -0.493 . . . . 72.34 111.163 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.596 ' HA ' ' O ' ' A' ' 94' ' ' TYR . 0.6 OUTLIER -104.83 30.68 5.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.229 -0.441 . . . . 71.33 111.148 -179.974 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -154.05 133.12 12.49 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.216 -0.447 . . . . 75.52 110.876 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.4 ' HB2' ' HA ' ' A' ' 174' ' ' ARG . 39.1 p30 -51.3 170.24 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.141 -0.481 . . . . 74.34 110.864 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . 0.486 ' O ' ' HB2' ' A' ' 172' ' ' SER . 14.1 p -152.37 144.24 16.44 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.594 0.711 . . . . 71.41 110.915 -179.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.434 ' O ' ' C ' ' A' ' 143' ' ' PRO . 53.6 Cg_endo -69.76 -31.16 21.08 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.712 2.275 . . . . 71.44 112.385 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.634 ' HB3' ' CB ' ' A' ' 120' ' ' GLU . 0.1 OUTLIER -147.41 106.66 3.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.193 -0.458 . . . . 50.53 110.88 -179.875 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.656 ' HB ' ' O ' ' A' ' 171' ' ' GLN . 4.0 tt -58.14 -28.18 33.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.131 -0.486 . . . . 75.12 111.088 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' MET . . . . . 0.695 ' O ' ' HA ' ' A' ' 123' ' ' HIS . 27.1 ttp -87.46 -41.47 13.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.185 -0.462 . . . . 74.51 110.915 179.831 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.634 ' CB ' ' HB3' ' A' ' 117' ' ' SER . 15.5 tp10 -68.65 -12.33 61.23 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.223 -0.444 . . . . 72.45 110.876 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 18.6 tp60 -115.94 -48.46 2.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.167 -0.469 . . . . 62.4 110.917 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.477 ' HB2' ' O ' ' A' ' 118' ' ' ILE . 44.6 m-85 -103.99 -13.78 16.19 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.189 -0.46 . . . . 73.41 110.897 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.695 ' HA ' ' O ' ' A' ' 119' ' ' MET . 10.8 m80 71.46 20.18 4.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.106 -0.497 . . . . 74.1 110.825 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.551 ' CE ' ' HA ' ' A' ' 100' ' ' GLU . 0.0 OUTLIER -93.42 139.59 30.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.208 -0.451 . . . . 74.13 110.854 179.97 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 5.3 ptp180 -102.36 -44.92 5.25 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.188 -0.46 . . . . 72.54 110.827 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.451 ' HG2' ' HA ' ' A' ' 169' ' ' ALA . 10.8 mt-10 -138.17 117.23 12.54 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.209 -0.45 . . . . 72.04 110.858 -179.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.645 HG21 ' SG ' ' A' ' 130' ' ' CYS . 2.5 mm -77.41 93.93 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.131 -0.486 . . . . 72.25 111.087 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . 0.406 ' HB3' ' N ' ' A' ' 102' ' ' GLY . 0.6 OUTLIER -63.78 -36.08 82.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.467 . . . . 74.12 110.877 179.849 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.589 ' HB2' ' HB2' ' A' ' 99' ' ' PHE . 0.6 OUTLIER -132.32 146.21 51.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.205 -0.452 . . . . 72.41 110.851 -179.756 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . 0.645 ' SG ' HG21 ' A' ' 127' ' ' ILE . 0.5 OUTLIER -145.27 120.49 10.18 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.15 -0.477 . . . . 73.33 110.849 -179.937 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.653 ' HA ' ' HA ' ' A' ' 156' ' ' GLU . 1.3 mtpt -107.39 153.93 22.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.152 -0.477 . . . . 74.35 110.894 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.592 HG23 ' C ' ' A' ' 131' ' ' LYS . 4.8 t 82.71 165.27 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.207 -0.451 . . . . 74.4 111.119 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.795 HD13 ' O ' ' A' ' 154' ' ' LYS . 0.0 OUTLIER -176.47 126.02 0.18 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.187 -0.46 . . . . 52.23 110.884 179.988 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.506 ' CG ' ' H ' ' A' ' 95' ' ' LYS . 0.0 OUTLIER -94.39 159.23 15.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.172 -0.467 . . . . 75.1 110.893 179.95 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.485 ' C ' ' O ' ' A' ' 134' ' ' GLU . . . -31.05 -48.82 0.2 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.764 -0.732 . . . . 72.41 112.451 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.799 ' HB ' HD12 ' A' ' 176' ' ' ILE . 2.3 t -150.99 133.5 6.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.814 0.34 . . . . 74.21 111.105 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . 0.596 ' H ' ' CG ' ' A' ' 152' ' ' LEU . 3.6 t-105 -133.5 150.7 51.7 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.173 -0.467 . . . . 74.45 110.88 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.721 HG23 ' NE2' ' A' ' 149' ' ' GLN . 22.1 mm -114.12 128.77 70.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.18 -0.463 . . . . 73.54 111.139 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.518 ' CB ' ' HB2' ' A' ' 150' ' ' TYR . 0.5 OUTLIER -114.91 149.59 36.99 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.217 -0.447 . . . . 74.24 110.875 179.953 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.492 ' CD2' ' HA ' ' A' ' 145' ' ' TYR . 2.3 m-85 -134.98 133.17 39.2 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.131 -0.486 . . . . 60.35 110.902 -179.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.69 ' O ' ' HB2' ' A' ' 171' ' ' GLN . 0.8 OUTLIER -59.93 -26.49 65.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.147 -0.478 . . . . 63.11 110.911 179.966 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.728 ' HB3' ' HD2' ' A' ' 143' ' ' PRO . 9.7 mp -112.15 173.13 3.03 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.595 0.712 . . . . 65.31 110.883 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . 0.728 ' HD2' ' HB3' ' A' ' 142' ' ' LEU . 53.8 Cg_endo -69.76 -89.68 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.645 2.23 . . . . 74.3 112.357 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . 0.686 ' O ' ' N ' ' A' ' 146' ' ' ARG . 2.3 m-20 -52.81 97.0 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.183 -0.462 . . . . 71.14 110.923 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . 0.64 ' C ' ' O ' ' A' ' 144' ' ' ASN . 0.1 OUTLIER 12.78 53.25 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.18 -0.463 . . . . 74.34 110.962 -179.899 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.686 ' N ' ' O ' ' A' ' 144' ' ' ASN . 38.1 mtt85 -119.46 179.1 4.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.1 -0.5 . . . . 74.45 110.865 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 73.98 -174.05 49.59 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.723 -0.751 . . . . 70.33 112.509 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.427 ' HG2' ' CD1' ' A' ' 58' ' ' TYR . 0.2 OUTLIER -75.91 151.75 37.27 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.758 0.313 . . . . 72.21 110.868 -179.883 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . 0.721 ' NE2' HG23 ' A' ' 138' ' ' ILE . 0.0 OUTLIER -88.5 149.82 23.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.186 -0.461 . . . . 74.11 110.946 -179.979 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . 0.518 ' HB2' ' CB ' ' A' ' 139' ' ' PHE . 82.4 m-85 -134.07 129.5 36.12 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.205 -0.452 . . . . 72.31 110.9 -179.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.625 ' HB2' HD11 ' A' ' 61' ' ' ILE . 16.8 tp -81.67 122.72 27.99 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.129 -0.487 . . . . 65.42 110.882 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.921 ' O ' HD13 ' A' ' 152' ' ' LEU . 0.0 OUTLIER -54.54 135.36 46.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.2 -0.455 . . . . 72.53 110.915 179.871 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -163.25 25.74 0.09 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.183 -0.462 . . . . 62.33 110.9 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.795 ' O ' HD13 ' A' ' 133' ' ' LEU . 0.0 OUTLIER -117.27 -173.7 2.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.133 -0.485 . . . . 71.42 110.874 179.984 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.753 ' CG ' HD22 ' A' ' 133' ' ' LEU . 0.5 OUTLIER -161.87 -124.77 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.18 -0.464 . . . . 73.41 110.901 179.886 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.653 ' HA ' ' HA ' ' A' ' 131' ' ' LYS . 0.7 OUTLIER -69.09 -0.41 5.79 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.226 -0.443 . . . . 74.2 110.921 179.928 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . 0.785 ' CE1' ' HA ' ' A' ' 154' ' ' LYS . 18.5 m-30 -31.08 146.95 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.122 -0.49 . . . . 72.02 110.93 -179.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . 0.55 ' HB2' ' HA ' ' A' ' 103' ' ' ASP . 8.5 ptp180 -112.29 -39.49 4.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.117 -0.492 . . . . 70.24 110.867 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . 0.457 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 2.6 ptpp? -92.01 150.96 41.43 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.602 0.715 . . . . 72.43 110.881 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . 0.423 ' HA ' ' CZ2' ' A' ' 163' ' ' TRP . 53.9 Cg_endo -69.7 -23.05 31.49 Favored 'Trans proline' 0 C--O 1.232 0.214 0 C-N-CA 122.717 2.278 . . . . 72.41 112.352 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.674 ' H ' HD12 ' A' ' 161' ' ' ILE . 3.9 mp -76.62 2.32 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.226 -0.443 . . . . 63.32 111.105 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.667 ' HB3' ' CD1' ' A' ' 157' ' ' TYR . 0.6 OUTLIER -73.07 -19.86 61.08 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.176 -0.465 . . . . 74.2 110.855 179.855 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' TRP . . . . . 0.605 ' CD1' ' N ' ' A' ' 163' ' ' TRP . 0.0 OUTLIER -109.13 13.92 24.21 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.182 -0.463 . . . . 74.22 110.928 -179.965 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 85.04 -30.53 3.93 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.75 -0.738 . . . . 74.43 112.496 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -54.19 120.1 6.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.742 0.306 . . . . 71.02 111.1 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -49.67 -25.65 3.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.214 -0.448 . . . . 51.3 111.136 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . 0.477 ' C ' ' H ' ' A' ' 169' ' ' ALA . 0.3 OUTLIER -155.61 160.13 31.09 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.708 0.766 . . . . 55.1 110.85 -179.804 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . 0.437 ' HB3' ' O ' ' A' ' 127' ' ' ILE . 53.8 Cg_endo -69.78 20.36 0.18 Allowed 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.717 2.278 . . . . 64.33 112.296 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.477 ' H ' ' C ' ' A' ' 167' ' ' SER . . . -63.18 103.64 0.5 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.245 -0.434 . . . . 71.41 111.124 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.425 HG12 ' N ' ' A' ' 171' ' ' GLN . 3.4 t -152.91 160.87 2.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.24 -0.436 . . . . 73.22 111.15 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' GLN . . . . . 0.69 ' HB2' ' O ' ' A' ' 141' ' ' GLU . 1.9 mm-40 -109.73 -88.03 0.5 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.215 -0.448 . . . . 73.54 110.913 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . 0.699 ' OG ' ' O ' ' A' ' 143' ' ' PRO . 15.4 p -130.6 178.39 6.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.177 -0.465 . . . . 73.24 110.817 -179.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -143.79 168.07 20.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.107 -0.497 . . . . 74.23 110.864 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . 0.676 ' NE ' HG21 ' A' ' 138' ' ' ILE . 2.1 ppt_? -133.39 156.66 47.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.163 -0.471 . . . . 74.25 110.913 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . 0.43 ' HB2' ' CE1' ' A' ' 94' ' ' TYR . 6.2 ptt85 -98.18 150.72 21.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.259 -0.428 . . . . 61.55 110.869 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . 0.799 HD12 ' HB ' ' A' ' 136' ' ' VAL . 15.4 mt -83.1 152.31 3.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.217 -0.447 . . . . 53.11 111.116 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 7.5 p -126.29 147.2 31.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.129 -0.487 . . . . 63.22 111.132 179.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . 0.763 ' HB3' HD13 ' A' ' 88' ' ' LEU . 1.6 pt-20 . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.215 -0.448 . . . . 63.53 110.933 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.788 0.328 . . . . 71.31 110.849 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.9 m -140.48 -176.49 4.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.245 -0.434 . . . . 74.42 110.878 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 31.7 mttt -101.53 41.63 1.19 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.138 -0.483 . . . . 72.43 110.897 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 3.3 t -102.11 65.7 0.98 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.239 -0.437 . . . . 65.22 111.157 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 111.46 114.0 3.41 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.754 -0.736 . . . . 55.25 112.444 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.439 ' C ' ' HE1' ' A' ' 47' ' ' TRP . 9.8 p -82.68 135.61 34.98 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.837 0.351 . . . . 41.1 111.158 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.422 ' HA ' ' HA ' ' A' ' 24' ' ' ASP . 2.8 tttt -123.47 135.75 54.23 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.217 -0.447 . . . . 65.21 110.9 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.498 ' HA ' ' HA ' ' A' ' 42' ' ' VAL . 14.5 tt -136.71 152.05 28.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.25 -0.432 . . . . 54.14 111.148 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.478 HG23 ' CG ' ' A' ' 22' ' ' ASP . 15.3 m -133.98 142.66 47.75 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.19 -0.459 . . . . 60.34 111.129 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.551 ' HD1' HD11 ' A' ' 40' ' ' ILE . 0.3 OUTLIER -130.01 128.72 42.59 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.226 -0.443 . . . . 73.44 110.92 179.997 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.544 ' CG ' ' HA ' ' A' ' 16' ' ' PHE . 24.1 m-85 -113.54 131.96 55.88 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.164 -0.471 . . . . 72.34 110.973 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.434 ' HA ' ' O ' ' A' ' 36' ' ' ARG . 0.0 OUTLIER -61.08 -13.63 18.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.123 -0.489 . . . . 63.3 110.914 -179.955 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.437 ' HB2' ' O ' ' A' ' 17' ' ' GLN . 77.1 m-20 -136.95 150.78 48.38 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.124 -0.489 . . . . 60.54 110.868 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 4.8 mtmm -55.22 -175.95 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.198 -0.456 . . . . 53.53 110.852 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 20.2 m-20 45.53 33.25 1.3 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.156 -0.475 . . . . 74.4 110.885 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.544 ' HA ' ' CG ' ' A' ' 11' ' ' TYR . 2.7 m-85 49.22 64.77 1.6 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.169 -0.469 . . . . 71.01 110.896 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.437 ' O ' ' HB2' ' A' ' 13' ' ' ASP . 8.0 mt-30 -139.46 159.96 40.96 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.154 -0.476 . . . . 70.25 110.886 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 92.7 -150.03 19.84 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.78 -0.724 . . . . 55.11 112.521 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.741 ' O ' HD13 ' A' ' 34' ' ' LEU . 0.3 OUTLIER -69.9 78.79 0.47 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.803 0.335 . . . . 72.55 110.89 -179.885 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.456 ' HA ' ' O ' ' A' ' 10' ' ' PHE . 0.0 OUTLIER -76.24 129.51 36.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.205 -0.452 . . . . 72.22 110.856 -179.871 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.469 ' CD2' ' CD2' ' A' ' 30' ' ' PHE . 69.2 t80 -124.26 125.31 44.16 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.184 -0.462 . . . . 65.22 110.903 -179.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.478 ' CG ' HG23 ' A' ' 9' ' ' THR . 1.2 m-20 -118.83 134.54 55.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.113 -0.494 . . . . 65.22 110.925 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 8.8 t -161.17 129.66 4.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.23 -0.441 . . . . 74.51 110.897 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.422 ' HA ' ' HA ' ' A' ' 7' ' ' LYS . 14.1 p-10 -97.33 4.39 50.81 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.178 -0.465 . . . . 70.21 110.89 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 46.9 t -113.52 159.66 19.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.179 -0.464 . . . . 74.1 110.855 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -42.67 119.67 1.51 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.162 -0.472 . . . . 71.33 110.854 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.558 ' HB2' ' HB3' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -114.6 40.55 2.54 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.187 -0.461 . . . . 74.33 110.9 -179.913 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.563 ' O ' ' HA ' ' A' ' 82' ' ' SER . . . -51.12 -21.22 1.81 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.15 -0.477 . . . . 71.44 111.119 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 59.9 t0 -128.86 38.32 3.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.168 -0.469 . . . . 75.31 110.888 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.773 ' O ' ' CD2' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -80.27 13.92 2.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.186 -0.461 . . . . 64.13 110.878 -179.885 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.437 ' CG ' ' HG3' ' A' ' 53' ' ' PRO . 36.2 t60 -77.65 -36.81 51.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.147 -0.479 . . . . 65.42 110.875 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.7 t -59.81 -14.52 15.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.196 -0.456 . . . . 65.32 111.156 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -100.99 -24.97 14.23 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.202 -0.454 . . . . 71.13 110.877 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.741 HD13 ' O ' ' A' ' 19' ' ' ARG . 23.9 tp -141.62 123.93 15.67 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.125 -0.489 . . . . 51.11 110.943 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 27.0 m -82.83 -49.32 9.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.211 -0.45 . . . . 74.02 110.829 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.434 ' O ' ' HA ' ' A' ' 12' ' ' GLU . 0.1 OUTLIER -114.04 143.25 45.07 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.131 -0.486 . . . . 72.02 110.834 -179.925 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.586 ' HB2' ' HB2' ' A' ' 80' ' ' LEU . 57.6 m -122.93 104.76 9.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.174 -0.466 . . . . 74.21 110.906 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 10.9 m-20 -97.49 -67.15 0.86 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.226 -0.443 . . . . 71.52 110.892 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 10.6 p -105.68 133.66 50.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.207 -0.451 . . . . 74.31 110.895 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.666 HD12 ' HZ3' ' A' ' 73' ' ' TRP . 6.9 mt -130.01 149.53 33.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.135 -0.484 . . . . 65.4 111.114 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.426 ' HD2' ' CE2' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -142.51 119.07 11.0 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.155 -0.475 . . . . 75.01 110.906 179.853 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.613 HG21 ' HB2' ' A' ' 47' ' ' TRP . 1.0 OUTLIER -104.76 117.47 50.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.268 -0.424 . . . . 61.23 111.098 179.908 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -112.55 76.67 0.99 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.155 -0.475 . . . . 74.44 110.896 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.427 ' O ' ' HA ' ' A' ' 6' ' ' THR . . . 139.21 99.61 0.45 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.723 -0.751 . . . . 54.04 112.479 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.415 ' HA2' HD21 ' A' ' 88' ' ' LEU . . . 55.59 177.78 0.25 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.743 -0.741 . . . . 75.11 112.479 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.725 HG23 ' HA ' ' A' ' 63' ' ' PRO . 2.2 m -76.46 168.7 19.61 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.719 0.295 . . . . 75.34 111.18 -179.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.613 ' HB2' HG21 ' A' ' 42' ' ' VAL . 7.7 m95 -143.32 128.36 18.54 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.261 -0.427 . . . . 74.41 110.93 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.778 ' HB2' ' CG2' ' A' ' 86' ' ' VAL . . . -89.83 127.62 36.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.221 -0.445 . . . . 63.0 111.093 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.826 HG11 HD11 ' A' ' 80' ' ' LEU . 26.9 m -127.62 141.72 45.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.181 -0.463 . . . . 43.02 111.144 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.804 ' HB3' ' CB ' ' A' ' 56' ' ' ALA . 5.0 m-85 -122.53 155.44 36.22 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.189 -0.459 . . . . 74.1 110.903 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.685 ' N ' ' HB1' ' A' ' 56' ' ' ALA . 35.3 mp0 -53.19 -94.8 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.081 -0.509 . . . . 75.52 110.928 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.839 ' O ' ' HB2' ' A' ' 56' ' ' ALA . 3.4 mtp180 -72.0 136.46 82.31 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.556 0.693 . . . . 75.25 110.863 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.643 ' HA ' ' OG ' ' A' ' 82' ' ' SER . 53.8 Cg_endo -69.79 131.64 21.62 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.676 2.251 . . . . 72.23 112.321 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.458 ' H ' ' HB3' ' A' ' 82' ' ' SER . 4.3 t-20 77.07 -5.35 2.19 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.169 -0.469 . . . . 75.12 110.916 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.413 ' CE1' ' HB3' ' A' ' 54' ' ' ASN . 0.1 OUTLIER -144.73 -73.4 0.25 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.158 -0.474 . . . . 74.01 110.852 -179.981 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.839 ' HB2' ' O ' ' A' ' 52' ' ' ARG . . . 37.96 80.29 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.177 -0.465 . . . . 75.23 111.107 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . 0.458 ' O ' ' CG ' ' A' ' 58' ' ' TYR . 31.4 m95 -64.96 53.07 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.215 -0.448 . . . . 72.12 110.903 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.575 ' CB ' ' OE1' ' A' ' 51' ' ' GLU . 0.5 OUTLIER -177.19 124.39 0.14 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.252 -0.431 . . . . 74.24 110.911 -179.921 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.526 ' HG3' ' CE2' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -81.79 139.71 34.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.136 -0.484 . . . . 70.42 110.874 179.903 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.715 ' OH ' ' O ' ' A' ' 73' ' ' TRP . 1.0 OUTLIER -154.7 86.24 1.13 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.248 -0.433 . . . . 55.21 110.906 -179.876 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.782 HD11 ' HA ' ' A' ' 151' ' ' LEU . 1.6 mp -80.42 118.88 28.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.145 -0.48 . . . . 63.32 111.109 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.783 HD23 ' HD2' ' A' ' 63' ' ' PRO . 0.3 OUTLIER -87.06 127.86 57.83 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.615 0.721 . . . . 74.52 110.929 179.853 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.783 ' HD2' HD23 ' A' ' 62' ' ' LEU . 53.4 Cg_endo -69.81 -174.24 0.88 Allowed 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.701 2.268 . . . . 71.54 112.34 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -87.02 162.89 17.37 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.203 -0.453 . . . . 60.22 110.943 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 113.37 -161.03 12.82 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.767 -0.73 . . . . 73.22 112.469 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -111.99 160.24 17.65 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.862 0.363 . . . . 72.14 110.906 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.479 ' N ' ' O ' ' A' ' 40' ' ' ILE . 20.6 m-85 -149.16 81.6 7.39 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.646 0.736 . . . . 74.44 110.898 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.475 ' HD2' ' HG3' ' A' ' 72' ' ' ARG . 53.8 Cg_endo -69.7 -3.57 12.24 Favored 'Trans proline' 0 C--O 1.231 0.155 0 C-N-CA 122.706 2.271 . . . . 50.22 112.345 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -157.77 149.36 21.75 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.224 -0.443 . . . . 75.22 110.927 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.778 ' O ' ' CD1' ' A' ' 73' ' ' TRP . 35.4 p90 -55.28 -41.27 72.06 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.163 -0.471 . . . . 71.31 110.979 -179.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -51.66 -21.89 2.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.099 -0.5 . . . . 64.34 110.938 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.475 ' HG3' ' HD2' ' A' ' 68' ' ' PRO . 28.9 mmt180 -61.8 -39.74 92.8 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.189 -0.46 . . . . 74.34 110.891 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . 0.778 ' CD1' ' O ' ' A' ' 70' ' ' TYR . 0.3 OUTLIER -92.88 34.17 1.11 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.168 -0.469 . . . . 64.0 110.934 -179.999 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 34.5 mmm 75.19 17.66 2.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.258 -0.428 . . . . 65.55 110.913 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.427 ' N ' ' HD1' ' A' ' 73' ' ' TRP . . . 42.98 44.0 5.6 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.759 -0.734 . . . . 71.31 112.484 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.462 ' CB ' ' CE2' ' A' ' 60' ' ' TYR . 0.5 OUTLIER -67.45 -74.12 0.12 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.877 0.37 . . . . 72.52 110.933 -179.907 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 12.6 t-20 -154.02 138.96 17.22 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.164 -0.471 . . . . 75.3 110.879 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -87.61 13.61 10.0 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.164 -0.471 . . . . 73.25 110.87 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.511 ' HD3' ' HB3' ' A' ' 51' ' ' GLU . 38.7 ttt85 -84.29 44.97 1.06 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.182 -0.463 . . . . 71.34 110.866 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.826 HD11 HG11 ' A' ' 49' ' ' VAL . 0.1 OUTLIER -66.12 125.59 25.99 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.2 -0.454 . . . . 62.31 110.928 -179.995 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.56 ' HB3' ' HB3' ' A' ' 53' ' ' PRO . 3.7 m -151.07 -109.2 0.06 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.186 -0.461 . . . . 73.52 110.879 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.643 ' OG ' ' HA ' ' A' ' 53' ' ' PRO . 0.0 OUTLIER -51.32 102.23 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.147 -0.479 . . . . 74.53 110.869 -179.827 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . 0.819 ' HB3' HG12 ' A' ' 49' ' ' VAL . 14.6 p -126.55 135.33 51.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.155 -0.475 . . . . 65.04 110.855 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.598 ' N ' ' O ' ' A' ' 48' ' ' ALA . 2.1 mmt85 -118.29 159.87 22.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.162 -0.472 . . . . 72.13 110.863 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -74.3 125.96 29.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.208 -0.451 . . . . 73.3 111.067 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.778 ' CG2' ' HB2' ' A' ' 48' ' ' ALA . 18.0 t -120.31 145.31 26.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.202 -0.454 . . . . 41.5 111.102 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . 0.558 ' O ' HG23 ' A' ' 136' ' ' VAL . 70.0 m-70 -110.78 112.36 24.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.176 -0.465 . . . . 74.34 110.905 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.467 HD23 ' H ' ' A' ' 88' ' ' LEU . 0.0 OUTLIER -37.91 152.28 0.15 Allowed Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 121.626 0.727 . . . . 51.03 110.887 -179.956 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.529 ' HB3' ' H ' ' A' ' 136' ' ' VAL . 54.3 Cg_endo -69.67 83.15 0.69 Allowed 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.673 2.248 . . . . 72.34 112.361 179.809 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.2 t -90.23 -177.34 5.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.275 -0.42 . . . . 72.05 110.846 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 70.35 -81.94 0.37 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.702 -0.761 . . . . 65.14 112.489 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.41 ' O ' ' C ' ' A' ' 93' ' ' GLN . . . -92.58 34.16 4.63 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.739 -0.743 . . . . 54.4 112.53 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.459 ' O ' ' HG2' ' A' ' 134' ' ' GLU . 14.6 pt20 37.54 -121.58 0.21 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.868 0.366 . . . . 75.43 110.903 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.684 ' CZ ' ' HA ' ' A' ' 175' ' ' ARG . 1.4 t80 -121.91 99.29 6.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.228 -0.442 . . . . 74.24 110.945 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.559 ' HG3' HG11 ' A' ' 132' ' ' VAL . 23.8 tptt -119.27 127.14 52.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.153 -0.476 . . . . 63.34 110.846 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.589 HD13 ' H ' ' A' ' 97' ' ' GLN . 0.4 OUTLIER -150.1 138.61 14.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.189 -0.46 . . . . 73.21 111.099 179.901 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.589 ' H ' HD13 ' A' ' 96' ' ' ILE . 0.7 OUTLIER -110.38 124.3 51.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.175 -0.466 . . . . 63.43 110.916 179.904 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.545 HG22 ' SD ' ' A' ' 124' ' ' MET . 29.6 mm -107.19 133.23 52.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.172 -0.467 . . . . 71.44 111.168 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.66 ' HB2' ' HB2' ' A' ' 129' ' ' SER . 7.7 m-85 -123.41 144.76 49.28 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.199 -0.455 . . . . 72.2 110.896 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 71.7 tt0 -72.85 -74.43 0.17 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.16 -0.473 . . . . 74.43 110.923 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.503 ' C ' ' HB2' ' A' ' 128' ' ' HIS . 31.9 mttt -85.2 167.12 15.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.09 -0.505 . . . . 63.44 110.887 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.424 ' HA2' ' OG ' ' A' ' 129' ' ' SER . . . -80.9 158.03 40.17 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.77 -0.729 . . . . 31.05 112.495 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.48 ' HA ' ' HB2' ' A' ' 158' ' ' ARG . 33.2 t70 68.1 54.27 0.6 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.799 0.333 . . . . 72.51 110.833 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.697 ' CE1' ' HD2' ' A' ' 131' ' ' LYS . 7.2 m-85 47.39 29.99 1.45 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.197 -0.456 . . . . 62.44 110.905 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.446 ' C ' ' HB2' ' A' ' 101' ' ' LYS . 48.0 m -105.47 152.11 23.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.103 -0.499 . . . . 75.44 110.889 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 89.42 -165.2 32.36 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.723 -0.751 . . . . 30.43 112.441 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 5.9 tp-100 -73.43 129.09 37.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.827 0.346 . . . . 73.44 110.867 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 1.6 ttt -114.76 131.39 56.8 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.215 -0.448 . . . . 54.13 110.89 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -134.94 137.2 42.89 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.229 -0.441 . . . . 74.3 110.918 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -110.8 94.48 5.02 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.119 -0.491 . . . . 65.34 110.884 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 9.1 t -102.38 130.29 49.09 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.14 -0.482 . . . . 72.11 111.111 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.54 ' O ' ' OG1' ' A' ' 112' ' ' THR . 0.0 OUTLIER -109.84 37.3 2.7 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.206 -0.452 . . . . 64.23 111.103 -179.952 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -151.78 -176.36 5.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.22 -0.446 . . . . 51.2 110.853 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -80.49 179.58 7.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.107 -0.497 . . . . 71.43 110.839 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . 0.567 ' O ' ' HB2' ' A' ' 172' ' ' SER . 45.7 t -167.3 125.02 0.97 Allowed Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.549 0.69 . . . . 75.32 110.903 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.72 -30.37 22.58 Favored 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.657 2.238 . . . . 73.42 112.33 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.629 ' HB3' ' CB ' ' A' ' 120' ' ' GLU . 0.1 OUTLIER -150.19 101.93 3.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.202 -0.454 . . . . 71.34 110.86 -179.843 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.7 HD13 HD11 ' A' ' 127' ' ' ILE . 4.0 tt -52.56 -29.67 13.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.145 -0.48 . . . . 73.14 111.1 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' MET . . . . . 0.578 ' O ' ' HA ' ' A' ' 123' ' ' HIS . 0.8 OUTLIER -85.55 -45.11 12.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.184 -0.462 . . . . 75.23 110.848 179.906 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.629 ' CB ' ' HB3' ' A' ' 117' ' ' SER . 8.4 tp10 -65.45 -13.75 59.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.262 -0.427 . . . . 62.01 110.859 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -114.22 -51.97 2.75 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.169 -0.469 . . . . 74.52 110.896 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.45 ' HB2' ' O ' ' A' ' 118' ' ' ILE . 54.1 m-85 -101.24 -20.3 15.32 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.195 -0.457 . . . . 73.42 110.902 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.578 ' HA ' ' O ' ' A' ' 119' ' ' MET . 12.6 m80 71.24 30.61 2.58 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.132 -0.485 . . . . 62.4 110.869 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.545 ' SD ' HG22 ' A' ' 98' ' ' ILE . 5.2 mtt -108.99 86.42 2.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.224 -0.444 . . . . 61.45 110.902 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 2.0 ptp85 -51.94 -35.57 46.4 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.209 -0.45 . . . . 75.25 110.877 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.502 ' HB3' ' HG2' ' A' ' 168' ' ' PRO . 28.9 mt-10 -142.39 131.7 23.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.201 -0.454 . . . . 72.32 110.896 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.7 HD11 HD13 ' A' ' 118' ' ' ILE . 3.5 mm -91.38 91.46 3.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.17 -0.468 . . . . 74.41 111.14 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . 0.503 ' HB2' ' C ' ' A' ' 101' ' ' LYS . 13.3 m170 -60.58 -35.43 76.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.183 -0.462 . . . . 74.21 110.86 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.66 ' HB2' ' HB2' ' A' ' 99' ' ' PHE . 66.5 m -131.09 140.08 49.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.222 -0.444 . . . . 65.45 110.829 -179.763 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . 0.616 ' O ' ' O ' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -139.18 121.59 16.09 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.134 -0.484 . . . . 70.44 110.855 179.999 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.697 ' HD2' ' CE1' ' A' ' 104' ' ' PHE . 6.3 mtpp -115.33 153.15 31.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.153 -0.476 . . . . 74.03 110.925 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.562 HG12 ' N ' ' A' ' 133' ' ' LEU . 16.1 t 84.34 164.57 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.242 -0.435 . . . . 61.11 111.126 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.728 HD22 ' CG ' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -178.44 121.98 0.1 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.136 -0.484 . . . . 44.53 110.91 179.976 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.513 ' O ' ' C ' ' A' ' 135' ' ' GLY . 0.1 OUTLIER -94.03 167.02 11.86 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.186 -0.461 . . . . 71.2 110.89 179.922 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.513 ' C ' ' O ' ' A' ' 134' ' ' GLU . . . -27.8 -55.89 0.12 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.717 -0.754 . . . . 74.31 112.517 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.602 HG21 ' CG1' ' A' ' 86' ' ' VAL . 3.2 t -144.51 137.36 22.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.806 0.336 . . . . 71.42 111.12 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . 0.715 ' CB ' ' HB3' ' A' ' 152' ' ' LEU . 0.0 OUTLIER -129.82 142.46 50.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.157 -0.474 . . . . 73.05 110.92 179.914 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.766 HD13 HD13 ' A' ' 61' ' ' ILE . 11.4 mm -114.99 134.35 58.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.195 -0.457 . . . . 64.44 111.12 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.54 ' CD1' HG11 ' A' ' 170' ' ' VAL . 0.8 OUTLIER -123.33 145.38 48.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.172 -0.467 . . . . 61.34 110.881 179.932 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.483 ' CE2' ' CD ' ' A' ' 174' ' ' ARG . 0.3 OUTLIER -126.99 133.85 50.48 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.164 -0.471 . . . . 64.43 110.93 -179.899 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.654 ' O ' ' HB2' ' A' ' 171' ' ' GLN . 0.2 OUTLIER -59.97 -27.2 66.63 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.105 -0.498 . . . . 61.2 110.89 -179.979 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.686 ' HB3' ' HD2' ' A' ' 143' ' ' PRO . 9.7 mp -112.91 171.79 4.04 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.617 0.722 . . . . 72.44 110.897 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . 0.757 ' O ' ' OG ' ' A' ' 172' ' ' SER . 54.0 Cg_endo -69.74 -92.71 0.01 OUTLIER 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.737 2.291 . . . . 74.44 112.323 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . 0.732 ' O ' ' N ' ' A' ' 146' ' ' ARG . 0.8 OUTLIER -49.99 99.21 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.217 -0.447 . . . . 64.44 110.913 -179.984 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . 0.641 ' C ' ' O ' ' A' ' 144' ' ' ASN . 19.8 m-85 11.64 52.44 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.218 -0.446 . . . . 74.33 110.928 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.732 ' N ' ' O ' ' A' ' 144' ' ' ASN . 21.1 mtt180 -118.6 173.28 6.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.098 -0.501 . . . . 72.42 110.875 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 78.97 -176.1 54.82 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.713 -0.756 . . . . 51.34 112.52 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -80.64 144.01 32.65 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.746 0.308 . . . . 74.03 110.87 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . 0.402 ' HB3' ' HA ' ' A' ' 60' ' ' TYR . 2.8 mt-30 -71.63 162.93 28.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.218 -0.446 . . . . 64.22 110.904 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . 0.531 ' HB2' ' CB ' ' A' ' 139' ' ' PHE . 78.9 m-85 -145.89 128.19 15.82 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.202 -0.454 . . . . 64.42 110.945 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.782 ' HA ' HD11 ' A' ' 61' ' ' ILE . 15.1 tp -85.94 123.21 31.02 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.161 -0.472 . . . . 64.2 110.89 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.989 ' O ' HD13 ' A' ' 152' ' ' LEU . 0.0 OUTLIER -58.33 142.23 48.72 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.183 -0.462 . . . . 64.31 110.903 179.887 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . 0.469 ' N ' HD22 ' A' ' 152' ' ' LEU . 5.4 t70 -162.99 25.44 0.09 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.156 -0.474 . . . . 64.03 110.88 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.926 ' HB2' ' CD1' ' A' ' 157' ' ' TYR . 3.1 ptmt -123.17 -172.38 2.49 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.189 -0.459 . . . . 73.35 110.874 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.728 ' CG ' HD22 ' A' ' 133' ' ' LEU . 0.4 OUTLIER -159.8 -123.79 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.236 -0.438 . . . . 73.02 110.903 179.91 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.655 ' HA ' ' HA ' ' A' ' 131' ' ' LYS . 0.8 OUTLIER -66.02 -3.74 5.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.208 -0.451 . . . . 64.42 110.897 179.96 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . 0.926 ' CD1' ' HB2' ' A' ' 154' ' ' LYS . 13.3 m-30 -27.62 140.01 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.158 -0.473 . . . . 73.14 110.946 -179.847 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . 0.543 ' O ' ' OG ' ' A' ' 129' ' ' SER . 8.2 ptp180 -103.8 -46.18 4.57 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.159 -0.473 . . . . 75.41 110.853 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 2.4 ptpp? -81.68 149.25 63.78 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.546 0.688 . . . . 71.14 110.87 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . 0.439 ' CB ' ' HD3' ' A' ' 168' ' ' PRO . 53.7 Cg_endo -69.74 -26.74 27.38 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.703 2.269 . . . . 71.21 112.34 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.705 ' H ' HD12 ' A' ' 161' ' ' ILE . 4.1 mp -69.95 -10.62 13.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.215 -0.448 . . . . 70.3 111.152 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.598 ' HB3' ' CD1' ' A' ' 157' ' ' TYR . 1.0 OUTLIER -70.65 -12.79 61.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 73.33 110.859 179.865 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' TRP . . . . . 0.551 ' CD1' ' HB3' ' A' ' 165' ' ' ALA . 11.5 t-105 -90.13 -19.65 24.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.193 -0.458 . . . . 72.23 110.879 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 103.21 -37.11 3.89 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.772 -0.727 . . . . 75.13 112.536 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.551 ' HB3' ' CD1' ' A' ' 163' ' ' TRP . . . -78.29 123.1 26.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.843 0.354 . . . . 73.01 111.03 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -49.79 121.46 5.3 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.192 -0.458 . . . . 71.44 111.133 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . 0.472 ' C ' ' H ' ' A' ' 169' ' ' ALA . 0.4 OUTLIER 64.94 143.81 0.08 OUTLIER Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.623 0.725 . . . . 72.55 110.886 -179.781 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . 0.502 ' HG2' ' HB3' ' A' ' 126' ' ' GLU . 53.8 Cg_endo -69.74 33.12 0.19 Allowed 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.675 2.25 . . . . 55.21 112.319 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.474 ' HA ' ' HG2' ' A' ' 126' ' ' GLU . . . -67.32 105.17 1.69 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.27 -0.423 . . . . 74.31 111.077 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.54 HG11 ' CD1' ' A' ' 139' ' ' PHE . 3.3 t -153.5 163.4 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.203 -0.453 . . . . 73.25 111.176 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' GLN . . . . . 0.654 ' HB2' ' O ' ' A' ' 141' ' ' GLU . 2.0 mm-40 -111.77 -90.21 0.5 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.192 -0.458 . . . . 74.32 110.913 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . 0.757 ' OG ' ' O ' ' A' ' 143' ' ' PRO . 36.2 p -122.19 -179.72 4.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.187 -0.46 . . . . 63.41 110.851 -179.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -146.54 174.78 11.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.113 -0.494 . . . . 72.0 110.898 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . 0.52 ' HG2' ' HB ' ' A' ' 138' ' ' ILE . 0.0 OUTLIER -147.01 158.05 43.8 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.144 -0.48 . . . . 63.35 110.911 -179.933 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . 0.684 ' HA ' ' CZ ' ' A' ' 94' ' ' TYR . 0.0 OUTLIER -95.14 -179.95 4.99 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.198 -0.455 . . . . 75.32 110.847 -179.908 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . 0.476 ' CD1' ' HB ' ' A' ' 136' ' ' VAL . 1.8 mt -126.45 132.45 70.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.161 -0.472 . . . . 73.21 111.119 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 42.2 t -126.09 150.08 31.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.199 -0.455 . . . . 74.13 111.156 179.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.193 -0.458 . . . . 73.42 110.935 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.0 mtm . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.769 0.319 . . . . 62.53 110.894 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -152.11 129.44 11.3 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.227 -0.442 . . . . 74.32 110.835 -179.774 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.426 ' O ' ' C ' ' A' ' 4' ' ' THR . 0.0 OUTLIER -75.3 -65.85 0.84 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.098 -0.501 . . . . 74.24 110.947 179.913 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.426 ' C ' ' O ' ' A' ' 3' ' ' LYS . 7.4 t 36.15 48.6 0.56 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.229 -0.441 . . . . 72.01 111.13 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 70.67 125.57 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.765 -0.731 . . . . 14.14 112.49 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.475 ' C ' ' HE1' ' A' ' 47' ' ' TRP . 2.8 p -82.83 135.15 35.04 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.858 0.361 . . . . 65.13 111.17 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 3.9 tttt -121.2 137.12 54.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.244 -0.434 . . . . 74.33 110.89 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.614 ' HB ' HG22 ' A' ' 42' ' ' VAL . 13.3 tt -137.32 147.07 26.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.214 -0.448 . . . . 73.25 111.145 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.502 HG22 ' CE2' ' A' ' 11' ' ' TYR . 13.8 m -126.5 129.16 48.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.168 -0.469 . . . . 52.43 111.132 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.779 ' HB2' HD22 ' A' ' 34' ' ' LEU . 1.5 m-85 -114.69 130.15 56.78 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.245 -0.434 . . . . 74.22 110.906 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.52 ' CG ' ' HA ' ' A' ' 16' ' ' PHE . 41.4 m-85 -115.67 130.86 57.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.156 -0.475 . . . . 75.14 110.938 -179.839 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.493 ' HG2' ' HB2' ' A' ' 36' ' ' ARG . 0.0 OUTLIER -60.24 -26.52 66.5 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.172 -0.467 . . . . 74.54 110.871 -179.976 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 68.9 m-20 -124.32 151.22 44.55 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.119 -0.491 . . . . 74.03 110.872 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.53 ' N ' ' HB3' ' A' ' 38' ' ' ASN . 35.0 mtmt -56.26 -178.58 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.162 -0.472 . . . . 63.31 110.885 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 28.1 m-20 49.78 35.41 9.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.239 -0.437 . . . . 75.23 110.893 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.52 ' HA ' ' CG ' ' A' ' 11' ' ' TYR . 3.8 m-85 48.05 57.6 5.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.17 -0.468 . . . . 74.21 110.894 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -134.46 160.26 38.55 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.125 -0.488 . . . . 75.13 110.943 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 94.0 -151.47 20.27 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.776 -0.726 . . . . 55.23 112.501 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.775 ' O ' HD13 ' A' ' 34' ' ' LEU . 0.0 OUTLIER -68.71 80.0 0.29 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.813 0.34 . . . . 75.12 110.864 -179.874 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.466 ' HA ' ' O ' ' A' ' 10' ' ' PHE . 0.5 OUTLIER -78.28 124.89 28.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.169 -0.468 . . . . 73.32 110.879 -179.922 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.424 ' CD2' ' CD2' ' A' ' 30' ' ' PHE . 86.9 t80 -122.42 124.87 44.65 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.194 -0.457 . . . . 72.53 110.917 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -109.94 130.33 55.54 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.146 -0.479 . . . . 73.13 110.852 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.409 ' HB3' ' CE2' ' A' ' 21' ' ' TYR . 0.1 OUTLIER -142.0 145.96 35.03 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.173 -0.467 . . . . 64.43 110.868 -179.892 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -130.73 5.7 4.66 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.178 -0.465 . . . . 53.53 110.905 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.42 ' O ' ' C ' ' A' ' 26' ' ' ASP . 38.2 t -132.15 160.41 36.12 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.151 -0.477 . . . . 75.1 110.897 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.42 ' C ' ' O ' ' A' ' 25' ' ' CYS . 6.2 m-20 -35.59 108.88 0.08 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.168 -0.469 . . . . 54.41 110.853 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.713 ' HB3' ' HB3' ' A' ' 30' ' ' PHE . 0.5 OUTLIER -119.24 45.82 2.03 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.167 -0.469 . . . . 71.43 110.883 -179.892 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.592 ' O ' ' HA ' ' A' ' 82' ' ' SER . . . -55.08 -11.14 0.62 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.204 -0.453 . . . . 61.31 111.143 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 60.6 t0 -130.81 39.13 3.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.219 -0.446 . . . . 71.12 110.831 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.833 ' O ' ' CD2' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -82.8 16.55 2.19 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.232 -0.44 . . . . 70.2 110.897 -179.916 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.475 ' HB2' ' HB3' ' A' ' 81' ' ' SER . 46.5 t60 -81.78 -29.61 32.66 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.172 -0.467 . . . . 73.02 110.851 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.7 t -68.66 -7.07 29.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.218 -0.446 . . . . 53.13 111.14 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -107.01 -29.44 9.42 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.197 -0.456 . . . . 75.12 110.925 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.779 HD22 ' HB2' ' A' ' 10' ' ' PHE . 24.0 tp -138.26 145.32 41.18 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.139 -0.482 . . . . 74.24 110.903 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.2 m -113.37 -32.51 6.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.158 -0.474 . . . . 72.32 110.837 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.521 ' O ' HD21 ' A' ' 34' ' ' LEU . 1.4 mtp85 -116.22 142.37 46.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.162 -0.472 . . . . 71.14 110.869 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.632 ' SG ' ' HB2' ' A' ' 80' ' ' LEU . 1.7 p -119.91 54.94 1.0 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.184 -0.462 . . . . 72.52 110.917 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.53 ' HB3' ' N ' ' A' ' 14' ' ' LYS . 1.8 m-80 -55.59 -64.96 0.68 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.156 -0.474 . . . . 73.34 110.871 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 5.9 p -116.95 130.94 57.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.261 -0.427 . . . . 73.23 110.863 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.618 HG21 HD13 ' A' ' 62' ' ' LEU . 12.1 mt -126.87 149.15 31.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.164 -0.471 . . . . 64.42 111.066 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.405 ' HE3' ' CD1' ' A' ' 16' ' ' PHE . 0.0 OUTLIER -143.73 120.7 11.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.125 -0.488 . . . . 65.21 110.884 179.83 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.614 HG22 ' HB ' ' A' ' 8' ' ' ILE . 2.1 t -102.85 115.04 44.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.21 -0.45 . . . . 75.0 111.133 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -109.47 81.05 1.38 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.203 -0.453 . . . . 65.42 110.895 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.438 ' O ' ' HA ' ' A' ' 6' ' ' THR . . . 127.32 108.52 1.51 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.776 -0.726 . . . . 62.41 112.478 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 50.78 -179.54 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.72 -0.753 . . . . 72.33 112.511 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.715 HG23 ' HA ' ' A' ' 63' ' ' PRO . 15.3 m -84.47 159.64 20.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.736 0.303 . . . . 62.45 111.203 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.598 ' CD1' ' HB ' ' A' ' 8' ' ' ILE . 3.3 m95 -131.92 130.24 41.31 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.264 -0.426 . . . . 65.54 110.914 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.727 ' HB2' ' CG2' ' A' ' 86' ' ' VAL . . . -91.4 124.6 35.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.236 -0.438 . . . . 41.0 111.103 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.754 HG11 HD11 ' A' ' 80' ' ' LEU . 13.7 m -126.87 131.35 71.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.204 -0.453 . . . . 63.44 111.133 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.971 ' HB3' ' CB ' ' A' ' 56' ' ' ALA . 4.6 m-85 -106.68 145.37 32.07 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.141 -0.481 . . . . 72.44 110.864 -179.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.451 ' N ' ' HB1' ' A' ' 56' ' ' ALA . 0.8 OUTLIER -50.51 -86.41 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.079 -0.509 . . . . 61.43 110.829 -179.936 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.874 ' O ' ' HB2' ' A' ' 56' ' ' ALA . 7.7 mmm180 -77.63 138.34 62.77 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.608 0.718 . . . . 72.34 110.84 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.741 ' HA ' ' OG ' ' A' ' 82' ' ' SER . 53.7 Cg_endo -69.81 136.41 32.8 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.702 2.268 . . . . 53.31 112.352 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.427 ' C ' ' CD1' ' A' ' 55' ' ' PHE . 1.3 m120 64.99 -4.92 0.44 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.201 -0.454 . . . . 63.0 110.889 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.485 ' H ' ' C ' ' A' ' 53' ' ' PRO . 0.1 OUTLIER -137.86 -70.39 0.44 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.153 -0.476 . . . . 71.23 110.878 -179.989 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.971 ' CB ' ' HB3' ' A' ' 50' ' ' TYR . . . 38.87 74.9 0.08 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.168 -0.469 . . . . 62.11 111.088 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . 0.415 ' O ' ' CD2' ' A' ' 58' ' ' TYR . 9.8 m0 -63.6 30.59 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.174 -0.466 . . . . 65.4 110.924 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.639 ' H ' ' C ' ' A' ' 56' ' ' ALA . 1.2 m-30 -163.13 109.5 1.16 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.233 -0.439 . . . . 74.13 110.898 -179.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.437 ' HG3' ' CE2' ' A' ' 50' ' ' TYR . 0.3 OUTLIER -68.79 140.24 55.28 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.166 -0.47 . . . . 73.42 110.88 179.879 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.626 ' O ' HG23 ' A' ' 49' ' ' VAL . 0.9 OUTLIER -150.47 81.97 1.35 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.221 -0.445 . . . . 74.54 110.879 -179.875 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.524 HD11 HD22 ' A' ' 151' ' ' LEU . 1.1 mp -75.14 115.5 16.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.139 -0.482 . . . . 72.22 111.107 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.776 HD23 ' HD2' ' A' ' 63' ' ' PRO . 0.3 OUTLIER -82.4 124.05 78.4 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.579 0.704 . . . . 73.13 110.88 179.911 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.776 ' HD2' HD23 ' A' ' 62' ' ' LEU . 53.2 Cg_endo -69.82 -174.04 0.84 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.604 2.203 . . . . 73.13 112.373 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.0 163.33 18.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.26 -0.427 . . . . 74.13 110.925 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 113.05 -160.41 13.14 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.75 -0.738 . . . . 41.15 112.509 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -115.13 158.25 22.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.858 0.361 . . . . 74.53 110.869 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.464 ' N ' ' O ' ' A' ' 40' ' ' ILE . 11.2 m-85 -148.21 83.24 7.29 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.671 0.748 . . . . 74.5 110.878 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.414 ' HD2' ' HG3' ' A' ' 72' ' ' ARG . 53.5 Cg_endo -69.77 -4.98 15.12 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.728 2.285 . . . . 73.02 112.324 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -157.58 141.14 15.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.202 -0.454 . . . . 75.43 110.94 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.896 ' O ' ' CD1' ' A' ' 73' ' ' TRP . 44.9 p90 -51.55 -41.24 60.95 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.177 -0.465 . . . . 72.05 110.896 -179.834 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -52.02 -20.05 2.2 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.156 -0.474 . . . . 74.54 110.917 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.414 ' HG3' ' HD2' ' A' ' 68' ' ' PRO . 28.2 mmt180 -64.03 -30.24 71.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.188 -0.46 . . . . 65.01 110.872 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . 0.896 ' CD1' ' O ' ' A' ' 70' ' ' TYR . 0.5 OUTLIER -103.88 30.66 4.97 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.192 -0.458 . . . . 73.53 110.951 179.983 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.439 ' O ' ' C ' ' A' ' 75' ' ' GLY . 0.0 OUTLIER 74.64 23.82 1.79 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.225 -0.443 . . . . 63.52 110.88 179.918 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.449 ' N ' ' HD1' ' A' ' 73' ' ' TRP . . . 33.03 49.37 0.43 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.697 -0.763 . . . . 23.22 112.525 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.764 HD21 ' HA ' ' A' ' 148' ' ' ARG . 0.6 OUTLIER -65.46 -77.61 0.06 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.806 0.336 . . . . 73.23 110.909 -179.908 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -135.79 134.17 38.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.161 -0.472 . . . . 63.41 110.888 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -90.09 17.0 7.42 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.122 -0.49 . . . . 74.22 110.88 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 6.0 ttm105 -107.36 77.18 1.12 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.174 -0.466 . . . . 72.43 110.844 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.754 HD11 HG11 ' A' ' 49' ' ' VAL . 0.1 OUTLIER -82.32 134.43 35.26 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.172 -0.467 . . . . 51.44 110.928 -179.99 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.702 ' HB3' ' HB3' ' A' ' 53' ' ' PRO . 1.5 m -154.32 -124.38 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.196 -0.456 . . . . 63.23 110.866 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.741 ' OG ' ' HA ' ' A' ' 53' ' ' PRO . 0.0 OUTLIER -36.28 106.88 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 72.33 110.891 -179.846 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . 0.691 ' HB3' HG12 ' A' ' 49' ' ' VAL . 27.9 p -130.13 132.78 46.24 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.147 -0.479 . . . . 75.41 110.881 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.565 ' N ' ' O ' ' A' ' 48' ' ' ALA . 4.1 mmt180 -123.41 146.46 47.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.205 -0.452 . . . . 72.32 110.876 -179.839 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -64.99 124.97 23.46 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.244 -0.434 . . . . 61.42 111.11 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.727 ' CG2' ' HB2' ' A' ' 48' ' ' ALA . 2.7 t -118.67 146.67 22.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.185 -0.461 . . . . 63.12 111.127 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . 0.558 ' O ' HG23 ' A' ' 136' ' ' VAL . 22.3 m-70 -110.11 112.5 24.53 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.189 -0.459 . . . . 71.42 110.92 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.533 HD13 ' HB3' ' A' ' 178' ' ' GLU . 0.0 OUTLIER -38.04 151.27 0.16 Allowed Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.647 0.737 . . . . 72.03 110.875 -179.944 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.552 ' HB3' ' H ' ' A' ' 136' ' ' VAL . 53.8 Cg_endo -69.76 98.78 0.7 Allowed 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.644 2.23 . . . . 61.3 112.354 179.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -105.56 -178.44 3.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.199 -0.455 . . . . 60.24 110.826 -179.822 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 48.9 84.89 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.764 -0.731 . . . . 41.11 112.443 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 100.72 29.45 6.55 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.777 -0.725 . . . . 73.51 112.475 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.473 ' O ' ' HG2' ' A' ' 134' ' ' GLU . 6.1 pt20 38.35 -129.6 0.22 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.852 0.358 . . . . 74.33 110.912 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.64 ' HA ' ' HG2' ' A' ' 134' ' ' GLU . 0.4 OUTLIER -117.13 103.73 10.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.211 -0.45 . . . . 72.31 110.943 -179.878 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.554 ' HG3' HG11 ' A' ' 132' ' ' VAL . 38.9 tptt -110.8 125.77 53.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.129 -0.487 . . . . 75.15 110.886 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.721 HD13 ' N ' ' A' ' 97' ' ' GLN . 0.0 OUTLIER -149.84 136.96 13.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.238 -0.437 . . . . 73.5 111.149 179.829 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.721 ' N ' HD13 ' A' ' 96' ' ' ILE . 2.4 mt-30 -107.86 132.7 53.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.183 -0.462 . . . . 74.11 110.917 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.769 HD11 HG22 ' A' ' 111' ' ' THR . 1.2 mp -111.29 140.8 28.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.176 -0.466 . . . . 62.23 111.158 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.634 ' HB2' ' HB2' ' A' ' 129' ' ' SER . 47.5 m-85 -130.97 134.65 46.92 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.192 -0.458 . . . . 73.31 110.868 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 51.1 tt0 -62.82 -78.86 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.15 -0.477 . . . . 74.03 110.907 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 6.6 mttt -83.97 162.68 20.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.117 -0.492 . . . . 73.21 110.851 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.419 ' CA ' ' HB3' ' A' ' 128' ' ' HIS . . . -70.4 163.2 53.09 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.726 -0.75 . . . . 72.43 112.466 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.497 ' HA ' ' HB2' ' A' ' 158' ' ' ARG . 33.4 t0 63.62 26.29 14.58 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.842 0.353 . . . . 45.11 110.888 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.48 ' CZ ' ' HB3' ' A' ' 158' ' ' ARG . 14.8 m-85 61.49 48.48 5.84 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.207 -0.451 . . . . 54.23 110.831 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 2.3 m -113.67 148.04 37.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.16 -0.473 . . . . 73.54 110.807 -179.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 92.27 -121.81 6.6 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.692 -0.766 . . . . 74.41 112.452 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 7.5 tp-100 -104.88 147.21 27.99 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.822 0.344 . . . . 64.41 110.916 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 3.7 ttp -136.65 136.79 39.42 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.205 -0.452 . . . . 75.43 110.919 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . 0.473 ' O ' HD12 ' A' ' 98' ' ' ILE . 12.9 m-85 -143.95 137.41 27.76 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.249 -0.432 . . . . 72.34 110.959 -179.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -114.93 111.14 20.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.153 -0.476 . . . . 75.45 110.933 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.769 HG22 HD11 ' A' ' 98' ' ' ILE . 11.7 t -118.1 139.46 51.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.157 -0.474 . . . . 70.32 111.122 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.556 ' HA ' ' O ' ' A' ' 94' ' ' TYR . 2.1 t -117.66 40.49 3.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.177 -0.465 . . . . 45.32 111.152 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -153.15 163.31 40.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.227 -0.442 . . . . 65.44 110.887 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -51.34 159.3 0.7 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.182 -0.463 . . . . 72.15 110.855 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . 0.607 ' O ' ' HB2' ' A' ' 172' ' ' SER . 41.9 t -147.85 111.34 3.86 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.589 0.709 . . . . 62.21 110.892 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.456 ' O ' ' C ' ' A' ' 143' ' ' PRO . 53.7 Cg_endo -69.8 -31.98 19.3 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.663 2.242 . . . . 74.32 112.303 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.641 ' HB3' ' CB ' ' A' ' 120' ' ' GLU . 0.2 OUTLIER -149.06 105.5 3.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.238 -0.437 . . . . 62.21 110.865 -179.819 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.656 HD13 HD11 ' A' ' 127' ' ' ILE . 3.7 tt -61.93 -30.52 48.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.15 -0.477 . . . . 63.21 111.153 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' MET . . . . . 0.628 ' O ' ' HA ' ' A' ' 123' ' ' HIS . 38.5 ttp -86.68 -38.6 16.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 73.23 110.894 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.641 ' CB ' ' HB3' ' A' ' 117' ' ' SER . 5.3 tp10 -72.71 -13.44 61.34 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.222 -0.445 . . . . 73.51 110.89 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 28.1 tp60 -114.8 -41.18 3.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.126 -0.488 . . . . 72.23 110.914 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.511 ' HB2' ' O ' ' A' ' 118' ' ' ILE . 51.8 m-85 -112.05 -20.61 11.89 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.216 -0.447 . . . . 65.44 110.913 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.628 ' HA ' ' O ' ' A' ' 119' ' ' MET . 13.0 m80 72.8 27.02 2.25 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.124 -0.489 . . . . 72.01 110.856 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.454 ' SD ' HG22 ' A' ' 98' ' ' ILE . 9.3 mtt -101.31 90.75 4.22 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.183 -0.462 . . . . 65.11 110.861 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 4.1 ptp180 -53.49 -43.94 68.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.268 -0.424 . . . . 64.23 110.912 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.472 ' HG2' ' HA ' ' A' ' 169' ' ' ALA . 8.7 mt-10 -137.59 130.55 30.34 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.146 -0.479 . . . . 75.11 110.883 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.656 HD11 HD13 ' A' ' 118' ' ' ILE . 3.5 mm -88.79 91.48 3.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.104 -0.498 . . . . 74.23 111.165 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . 0.544 ' CD2' ' HG3' ' A' ' 168' ' ' PRO . 52.4 m80 -65.51 -30.16 70.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.147 -0.478 . . . . 74.02 110.857 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.634 ' HB2' ' HB2' ' A' ' 99' ' ' PHE . 0.4 OUTLIER -135.08 144.42 47.2 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.205 -0.452 . . . . 75.53 110.865 -179.765 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . 0.662 ' O ' ' O ' ' A' ' 155' ' ' LYS . 0.1 OUTLIER -146.53 119.71 8.89 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.138 -0.483 . . . . 72.22 110.858 -179.934 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.653 ' HA ' ' HA ' ' A' ' 156' ' ' GLU . 6.0 mtpp -107.38 153.54 22.63 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.172 -0.467 . . . . 64.13 110.859 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.554 HG11 ' HG3' ' A' ' 95' ' ' LYS . 9.8 t 82.28 165.54 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.239 -0.437 . . . . 61.41 111.133 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.768 HD22 ' CG ' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -176.91 124.2 0.15 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.17 -0.468 . . . . 63.32 110.934 179.956 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.64 ' HG2' ' HA ' ' A' ' 94' ' ' TYR . 0.0 OUTLIER -97.44 164.02 12.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.227 -0.442 . . . . 64.1 110.924 179.919 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.544 ' C ' ' O ' ' A' ' 134' ' ' GLU . . . -24.7 -61.18 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.746 -0.74 . . . . 62.21 112.451 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.707 HG21 ' CG1' ' A' ' 86' ' ' VAL . 1.7 t -147.44 154.19 11.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.817 0.341 . . . . 62.1 111.15 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . 0.943 ' H ' HD12 ' A' ' 152' ' ' LEU . 0.7 OUTLIER -152.09 149.05 28.39 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.188 -0.46 . . . . 72.01 110.887 -179.994 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.485 ' CD1' ' HB ' ' A' ' 61' ' ' ILE . 5.6 mm -116.55 135.42 56.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.21 -0.45 . . . . 65.22 111.163 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.515 ' HB2' ' HB2' ' A' ' 150' ' ' TYR . 1.4 m-85 -112.25 165.02 12.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.209 -0.451 . . . . 72.33 110.866 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.461 ' HB3' ' O ' ' A' ' 146' ' ' ARG . 5.2 m-85 -144.8 132.03 20.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.147 -0.479 . . . . 75.22 110.887 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.641 ' O ' ' HB2' ' A' ' 171' ' ' GLN . 0.0 OUTLIER -57.92 -27.79 63.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.091 -0.504 . . . . 55.24 110.876 -179.997 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.727 ' HB3' ' HD2' ' A' ' 143' ' ' PRO . 9.5 mp -114.1 173.28 2.96 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.614 0.721 . . . . 74.34 110.94 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . 0.734 ' O ' ' OG ' ' A' ' 172' ' ' SER . 53.3 Cg_endo -69.8 -90.46 0.0 OUTLIER 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.697 2.264 . . . . 71.42 112.324 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . 0.721 ' O ' ' N ' ' A' ' 146' ' ' ARG . 0.5 OUTLIER -50.79 97.81 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.213 -0.449 . . . . 75.24 110.937 179.985 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . 0.653 ' C ' ' O ' ' A' ' 144' ' ' ASN . 0.2 OUTLIER 11.46 53.34 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.173 -0.467 . . . . 64.14 110.937 -179.875 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.721 ' N ' ' O ' ' A' ' 144' ' ' ASN . 22.5 mtt180 -121.5 160.2 24.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.148 -0.478 . . . . 74.42 110.859 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 93.26 -172.4 33.33 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.696 -0.764 . . . . 33.42 112.493 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.764 ' HA ' HD21 ' A' ' 76' ' ' LEU . 4.1 mpt_? -79.65 155.05 28.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.79 0.328 . . . . 73.54 110.88 -179.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . 0.403 ' HB3' ' HA ' ' A' ' 60' ' ' TYR . 0.4 OUTLIER -81.56 151.83 27.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.213 -0.449 . . . . 71.31 110.919 -179.941 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . 0.515 ' HB2' ' HB2' ' A' ' 139' ' ' PHE . 69.4 m-85 -151.96 103.11 2.87 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.178 -0.464 . . . . 73.11 110.893 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.524 HD22 HD11 ' A' ' 61' ' ' ILE . 0.1 OUTLIER -69.92 137.33 51.48 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.096 -0.502 . . . . 73.04 110.892 179.988 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 1.022 ' O ' HD13 ' A' ' 152' ' ' LEU . 0.0 OUTLIER -72.7 151.87 41.97 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.189 -0.46 . . . . 70.3 110.905 179.898 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . 0.743 ' N ' HD22 ' A' ' 152' ' ' LEU . 6.0 t0 -162.66 24.34 0.1 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.165 -0.471 . . . . 74.34 110.859 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 1.029 ' HB2' ' CD1' ' A' ' 157' ' ' TYR . 6.1 ptmt -115.29 -166.79 1.16 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.187 -0.461 . . . . 70.25 110.895 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.768 ' CG ' HD22 ' A' ' 133' ' ' LEU . 0.9 OUTLIER -158.47 -122.42 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.238 -0.437 . . . . 74.13 110.914 179.852 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.653 ' HA ' ' HA ' ' A' ' 131' ' ' LYS . 2.4 tm-20 -68.56 -0.33 4.99 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.222 -0.445 . . . . 75.33 110.943 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . 1.029 ' CD1' ' HB2' ' A' ' 154' ' ' LYS . 9.5 m-30 -32.55 146.15 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.12 -0.491 . . . . 54.54 110.901 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . 0.497 ' HB2' ' HA ' ' A' ' 103' ' ' ASP . 7.5 ptp180 -110.13 -39.7 4.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.107 -0.497 . . . . 74.54 110.902 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 2.4 ptpp? -91.39 151.2 42.49 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.58 0.705 . . . . 73.11 110.896 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 -25.73 28.28 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.734 2.289 . . . . 74.22 112.295 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.668 ' H ' HD12 ' A' ' 161' ' ' ILE . 4.0 mp -73.98 -6.16 7.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.265 -0.425 . . . . 71.04 111.129 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.594 ' HB3' ' CD1' ' A' ' 157' ' ' TYR . 1.6 t0 -72.54 -13.45 61.41 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.197 -0.456 . . . . 54.31 110.868 179.842 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 82.2 t90 -107.14 -3.43 19.91 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.189 -0.46 . . . . 72.14 110.917 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 100.12 -35.35 4.84 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.753 -0.737 . . . . 71.13 112.475 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -57.1 121.07 9.16 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.812 0.339 . . . . 63.1 111.098 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -46.99 -30.48 2.62 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.224 -0.444 . . . . 74.04 111.087 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . 0.486 ' C ' ' H ' ' A' ' 169' ' ' ALA . 0.5 OUTLIER -151.49 154.41 33.4 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.697 0.76 . . . . 35.42 110.826 -179.74 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . 0.544 ' HG3' ' CD2' ' A' ' 128' ' ' HIS . 53.5 Cg_endo -69.73 22.53 0.17 Allowed 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.639 2.226 . . . . 63.44 112.399 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.486 ' H ' ' C ' ' A' ' 167' ' ' SER . . . -65.65 101.25 0.6 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.201 -0.454 . . . . 73.12 111.121 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.482 HG11 ' CD1' ' A' ' 139' ' ' PHE . 2.4 t -153.59 163.77 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.235 -0.439 . . . . 71.31 111.133 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' GLN . . . . . 0.641 ' HB2' ' O ' ' A' ' 141' ' ' GLU . 1.8 mm-40 -111.23 -87.2 0.54 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.21 -0.45 . . . . 71.42 110.941 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . 0.734 ' OG ' ' O ' ' A' ' 143' ' ' PRO . 24.8 p -125.97 175.53 7.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.218 -0.446 . . . . 71.0 110.86 -179.792 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 10.7 p90 -144.14 168.25 20.47 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.166 -0.47 . . . . 75.42 110.889 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.32 156.6 48.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.133 -0.485 . . . . 75.25 110.862 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . 0.451 ' HD2' ' CE2' ' A' ' 94' ' ' TYR . 0.8 OUTLIER -88.68 -175.76 5.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.194 -0.457 . . . . 73.44 110.838 -179.916 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . 0.506 HD12 ' C ' ' A' ' 136' ' ' VAL . 5.6 mt -129.7 131.69 66.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.151 -0.477 . . . . 65.32 111.127 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 18.9 t -125.38 153.22 32.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.177 -0.465 . . . . 64.43 111.149 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . 0.533 ' HB3' HD13 ' A' ' 88' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.218 -0.446 . . . . 75.14 110.847 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.9 mtt . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.79 0.328 . . . . 64.43 110.919 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 11.2 m -137.21 37.57 2.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.214 -0.448 . . . . 61.13 110.888 -179.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 52.79 39.3 28.52 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.112 -0.494 . . . . 54.34 110.92 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.8 t -114.65 -35.98 4.69 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.206 -0.452 . . . . 72.41 111.135 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -166.26 122.3 1.05 Allowed Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.727 -0.749 . . . . 53.15 112.465 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.457 ' C ' ' HE1' ' A' ' 47' ' ' TRP . 14.7 p -81.85 137.32 35.28 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.852 0.358 . . . . 72.11 111.143 -179.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.435 ' HA ' ' HA ' ' A' ' 24' ' ' ASP . 2.4 tttt -125.69 135.62 52.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.238 -0.437 . . . . 73.5 110.887 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.516 ' HA ' ' HA ' ' A' ' 42' ' ' VAL . 14.6 tt -135.98 153.78 32.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.216 -0.447 . . . . 74.32 111.094 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.481 HG23 ' CG ' ' A' ' 22' ' ' ASP . 12.9 m -135.77 145.91 47.06 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.151 -0.477 . . . . 65.21 111.143 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.567 ' CE1' HD12 ' A' ' 80' ' ' LEU . 0.3 OUTLIER -133.6 128.52 35.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.208 -0.451 . . . . 75.13 110.835 -179.954 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.556 ' CG ' ' HA ' ' A' ' 16' ' ' PHE . 22.1 m-85 -113.65 132.54 55.73 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.182 -0.463 . . . . 61.41 110.914 -179.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.409 ' HA ' ' O ' ' A' ' 36' ' ' ARG . 0.0 OUTLIER -60.71 -14.38 20.68 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.108 -0.496 . . . . 72.24 110.883 -179.989 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.447 ' HB2' ' O ' ' A' ' 17' ' ' GLN . 78.1 m-20 -136.38 150.96 49.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.146 -0.479 . . . . 72.34 110.852 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.441 ' HG3' ' HB3' ' A' ' 38' ' ' ASN . 4.5 mtmm -55.25 -176.2 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.165 -0.471 . . . . 74.44 110.919 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 19.4 m120 45.31 34.18 1.42 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.234 -0.439 . . . . 70.24 110.849 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.556 ' HA ' ' CG ' ' A' ' 11' ' ' TYR . 2.2 m-85 48.39 67.32 0.87 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.211 -0.449 . . . . 74.52 110.905 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.447 ' O ' ' HB2' ' A' ' 13' ' ' ASP . 4.7 mt-30 -141.78 158.13 44.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.145 -0.48 . . . . 75.03 110.876 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 92.85 -150.29 19.92 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.759 -0.734 . . . . 24.03 112.497 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.732 ' O ' HD13 ' A' ' 34' ' ' LEU . 2.2 mtt180 -68.74 79.9 0.29 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.827 0.346 . . . . 64.33 110.872 -179.855 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.478 ' HA ' ' O ' ' A' ' 10' ' ' PHE . 0.5 OUTLIER -77.96 129.13 34.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.199 -0.455 . . . . 61.33 110.89 -179.953 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.428 ' O ' ' HA ' ' A' ' 9' ' ' THR . 70.3 t80 -123.86 125.98 45.61 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.177 -0.465 . . . . 64.2 110.948 -179.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.481 ' CG ' HG23 ' A' ' 9' ' ' THR . 1.3 m-20 -119.41 134.81 55.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.109 -0.496 . . . . 74.15 110.85 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 9.4 t -160.44 129.4 4.87 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.177 -0.465 . . . . 62.41 110.858 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.435 ' HA ' ' HA ' ' A' ' 7' ' ' LYS . 2.5 p30 -97.65 5.36 49.48 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.157 -0.474 . . . . 64.44 110.841 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 47.5 t -114.91 160.65 19.27 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.186 -0.461 . . . . 63.11 110.892 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 87.4 m-20 -43.06 120.11 1.72 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.202 -0.453 . . . . 71.34 110.904 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.572 ' CB ' ' HB3' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -114.37 40.35 2.55 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.21 -0.45 . . . . 73.12 110.862 -179.907 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.564 ' O ' ' HB3' ' A' ' 82' ' ' SER . . . -50.47 -21.76 1.62 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.239 -0.437 . . . . 54.33 111.126 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 60.8 t0 -130.5 40.02 3.56 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.212 -0.449 . . . . 72.2 110.871 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.762 ' O ' ' CD2' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -80.04 14.54 1.8 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.15 -0.477 . . . . 62.34 110.911 -179.914 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.427 ' CG ' ' HG3' ' A' ' 53' ' ' PRO . 40.7 t60 -77.63 -35.11 52.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.138 -0.483 . . . . 64.32 110.842 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.6 t -61.95 -12.23 17.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.254 -0.43 . . . . 74.31 111.119 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -102.29 -26.56 13.27 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.265 -0.425 . . . . 73.13 110.894 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.732 HD13 ' O ' ' A' ' 19' ' ' ARG . 28.0 tp -139.33 130.43 26.54 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.146 -0.479 . . . . 72.14 110.944 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 21.1 m -91.24 -44.73 9.04 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.167 -0.469 . . . . 71.21 110.866 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.409 ' O ' ' HA ' ' A' ' 12' ' ' GLU . 0.0 OUTLIER -114.28 145.49 41.68 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.103 -0.499 . . . . 65.24 110.893 -179.918 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.576 ' SG ' ' CB ' ' A' ' 80' ' ' LEU . 3.5 m -126.76 106.35 9.3 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.184 -0.462 . . . . 63.33 110.861 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.441 ' HB3' ' HG3' ' A' ' 14' ' ' LYS . 11.3 m-20 -104.07 -62.43 1.31 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.174 -0.466 . . . . 74.44 110.905 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 9.7 p -111.96 133.19 54.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.46 . . . . 70.22 110.903 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.628 HD12 ' HZ3' ' A' ' 73' ' ' TRP . 8.9 mt -129.19 151.56 35.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.14 -0.482 . . . . 64.32 111.122 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.431 ' HE3' ' CD1' ' A' ' 16' ' ' PHE . 0.0 OUTLIER -143.05 121.03 12.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.149 -0.478 . . . . 75.41 110.862 179.84 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.654 HG21 ' HB2' ' A' ' 47' ' ' TRP . 1.3 t -107.62 116.79 51.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.212 -0.449 . . . . 75.05 111.148 179.833 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -112.18 76.5 0.98 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.177 -0.465 . . . . 72.33 110.932 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.421 ' O ' ' HA ' ' A' ' 6' ' ' THR . . . 142.37 94.09 0.21 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.738 -0.744 . . . . 54.21 112.441 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 56.49 174.26 0.21 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.763 -0.732 . . . . 43.22 112.49 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.708 HG23 ' HA ' ' A' ' 63' ' ' PRO . 1.2 m -69.09 169.99 10.84 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.793 0.33 . . . . 74.43 111.126 -179.867 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.654 ' HB2' HG21 ' A' ' 42' ' ' VAL . 5.3 m95 -145.53 128.91 16.88 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.208 -0.451 . . . . 74.41 110.924 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.903 ' HB2' ' CG2' ' A' ' 86' ' ' VAL . . . -88.54 126.62 35.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.234 -0.439 . . . . 73.21 111.105 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.785 HG11 HD11 ' A' ' 80' ' ' LEU . 27.2 m -126.77 139.58 51.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.211 -0.45 . . . . 74.31 111.177 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.895 ' HB3' ' CB ' ' A' ' 56' ' ' ALA . 5.0 m-85 -116.55 144.47 44.33 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.17 -0.468 . . . . 73.12 110.949 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.555 ' HG2' ' N ' ' A' ' 52' ' ' ARG . 0.3 OUTLIER -48.61 -84.67 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.141 -0.481 . . . . 73.52 110.867 -179.971 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.896 ' O ' ' HB2' ' A' ' 56' ' ' ALA . 0.2 OUTLIER -81.46 136.72 48.78 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.573 0.701 . . . . 73.52 110.915 -179.935 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.654 ' HB3' ' HB3' ' A' ' 81' ' ' SER . 53.8 Cg_endo -69.7 137.89 36.7 Favored 'Trans proline' 0 C--N 1.341 0.14 0 C-N-CA 122.681 2.254 . . . . 74.14 112.376 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.468 ' C ' ' CD2' ' A' ' 55' ' ' PHE . 2.0 m120 69.22 -5.87 1.03 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.277 -0.419 . . . . 62.53 110.885 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.468 ' CD2' ' C ' ' A' ' 54' ' ' ASN . 0.1 OUTLIER -143.51 -75.43 0.26 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.131 -0.486 . . . . 75.53 110.875 -179.913 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.896 ' HB2' ' O ' ' A' ' 52' ' ' ARG . . . 45.87 81.27 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.14 -0.482 . . . . 72.34 111.09 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . 0.455 ' O ' ' CD2' ' A' ' 58' ' ' TYR . 18.9 m0 -65.32 35.48 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.227 -0.442 . . . . 74.53 110.908 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.586 ' H ' ' C ' ' A' ' 56' ' ' ALA . 1.2 m-30 -165.06 117.26 1.18 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.257 -0.429 . . . . 74.55 110.913 -179.844 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.453 ' HB2' ' HA ' ' A' ' 150' ' ' TYR . 1.0 OUTLIER -78.7 130.66 36.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.105 -0.498 . . . . 71.22 110.899 179.925 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.909 ' CD2' HD12 ' A' ' 76' ' ' LEU . 13.8 t80 -139.51 98.17 3.43 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.262 -0.427 . . . . 72.11 110.922 -179.864 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.584 HD12 ' H ' ' A' ' 61' ' ' ILE . 4.0 mp -83.56 111.16 19.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.1 -0.5 . . . . 74.41 111.15 179.873 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.874 HD23 ' HD2' ' A' ' 63' ' ' PRO . 0.3 OUTLIER -79.88 127.05 78.68 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.608 0.718 . . . . 71.04 110.923 179.898 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.874 ' HD2' HD23 ' A' ' 62' ' ' LEU . 53.7 Cg_endo -69.76 -165.04 0.14 Allowed 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.688 2.259 . . . . 72.31 112.348 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.91 160.68 14.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.236 -0.438 . . . . 75.13 110.928 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 112.61 -151.92 18.03 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.71 -0.757 . . . . 62.32 112.498 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -116.05 161.57 18.69 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.863 0.363 . . . . 74.03 110.884 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.498 ' N ' ' O ' ' A' ' 40' ' ' ILE . 13.6 m-85 -149.56 82.38 6.81 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.69 0.757 . . . . 71.44 110.929 -179.857 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.437 ' HD2' ' HG3' ' A' ' 72' ' ' ARG . 53.9 Cg_endo -69.74 -0.3 6.7 Favored 'Trans proline' 0 N--CA 1.465 -0.19 0 C-N-CA 122.72 2.28 . . . . 61.34 112.379 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -157.99 155.39 29.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.181 -0.463 . . . . 73.43 110.867 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.594 ' O ' ' CD1' ' A' ' 73' ' ' TRP . 24.9 p90 -62.18 -37.46 85.34 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.152 -0.476 . . . . 63.21 110.915 -179.854 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.585 ' HA ' ' CA ' ' A' ' 75' ' ' GLY . 6.6 pt20 -61.25 -10.6 7.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.12 -0.491 . . . . 64.3 110.922 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.437 ' HG3' ' HD2' ' A' ' 68' ' ' PRO . 25.2 mmt180 -65.82 -45.11 83.53 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.186 -0.461 . . . . 71.2 110.872 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . 0.757 ' O ' ' CB ' ' A' ' 74' ' ' MET . 0.4 OUTLIER -81.11 -5.45 57.68 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.182 -0.463 . . . . 74.52 110.902 -179.944 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.757 ' CB ' ' O ' ' A' ' 73' ' ' TRP . 8.4 mmm 131.21 -3.98 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.207 -0.451 . . . . 73.22 110.889 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.585 ' CA ' ' HA ' ' A' ' 71' ' ' GLN . . . 76.2 17.22 80.14 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.7 -0.762 . . . . 62.55 112.451 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.909 HD12 ' CD2' ' A' ' 60' ' ' TYR . 0.0 OUTLIER -63.45 -154.25 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.787 0.327 . . . . 65.44 110.963 -179.905 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.473 ' H ' HD13 ' A' ' 76' ' ' LEU . 2.9 t-20 -65.06 131.71 47.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.275 -0.421 . . . . 73.54 110.87 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -87.93 11.91 14.58 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.178 -0.465 . . . . 63.12 110.878 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.539 ' O ' ' O ' ' A' ' 51' ' ' GLU . 0.0 OUTLIER -87.95 49.44 1.8 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.169 -0.469 . . . . 61.33 110.852 -179.872 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.785 HD11 HG11 ' A' ' 49' ' ' VAL . 0.1 OUTLIER -59.89 127.08 30.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.191 -0.458 . . . . 62.41 110.891 -179.943 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.654 ' HB3' ' HB3' ' A' ' 53' ' ' PRO . 5.3 m -149.83 -114.99 0.06 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.188 -0.46 . . . . 53.2 110.897 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.626 ' OG ' ' HA ' ' A' ' 53' ' ' PRO . 0.1 OUTLIER -42.43 102.48 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.155 -0.475 . . . . 71.52 110.849 -179.776 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . 0.721 ' HB3' HG12 ' A' ' 49' ' ' VAL . 8.7 p -130.42 134.02 46.8 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.133 -0.485 . . . . 71.51 110.865 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.627 ' N ' ' O ' ' A' ' 48' ' ' ALA . 0.9 OUTLIER -117.33 158.44 24.39 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.16 -0.473 . . . . 65.51 110.854 -179.862 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -70.58 131.77 44.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.2 -0.454 . . . . 63.33 111.075 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.903 ' CG2' ' HB2' ' A' ' 48' ' ' ALA . 71.3 t -117.06 129.07 74.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.162 -0.472 . . . . 62.23 111.142 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . 0.664 ' O ' HG23 ' A' ' 136' ' ' VAL . 16.9 m80 -113.79 107.39 15.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.179 -0.464 . . . . 74.31 110.824 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.479 HD23 ' H ' ' A' ' 88' ' ' LEU . 0.0 OUTLIER -31.69 148.67 0.05 OUTLIER Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.574 0.702 . . . . 73.24 110.955 -179.999 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.548 ' HB3' ' H ' ' A' ' 136' ' ' VAL . 53.4 Cg_endo -69.8 93.23 0.52 Allowed 'Trans proline' 0 C--O 1.231 0.136 0 C-N-CA 122.689 2.259 . . . . 73.22 112.323 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -104.61 -174.22 2.49 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.205 -0.452 . . . . 73.01 110.881 -179.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 49.55 64.18 3.6 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.755 -0.736 . . . . 53.34 112.464 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 122.6 24.22 2.17 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.751 -0.738 . . . . 71.21 112.515 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 41.5 -158.73 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.822 0.344 . . . . 53.22 110.892 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.506 ' HA ' ' HG2' ' A' ' 134' ' ' GLU . 31.5 t80 -99.77 102.78 14.33 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.187 -0.46 . . . . 74.45 110.905 -179.837 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.498 ' HG3' HG11 ' A' ' 132' ' ' VAL . 42.8 tptt -112.61 130.03 56.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.132 -0.485 . . . . 72.14 110.887 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.478 ' HB ' ' OE1' ' A' ' 134' ' ' GLU . 0.0 OUTLIER -148.83 137.44 15.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.232 -0.44 . . . . 75.14 111.127 179.888 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.474 ' N ' HD13 ' A' ' 96' ' ' ILE . 0.9 OUTLIER -111.16 132.2 54.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.15 -0.477 . . . . 72.31 110.905 179.935 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.571 ' CG2' HD12 ' A' ' 127' ' ' ILE . 3.1 mp -113.17 135.54 52.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.211 -0.45 . . . . 54.04 111.094 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.653 ' HB2' ' HB2' ' A' ' 129' ' ' SER . 48.7 m-85 -126.48 136.34 52.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.148 -0.478 . . . . 74.52 110.835 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 51.9 tt0 -65.6 -75.29 0.09 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.101 -0.499 . . . . 70.52 110.883 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.429 ' C ' ' HB2' ' A' ' 128' ' ' HIS . 6.0 mttt -85.64 158.6 20.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.143 -0.481 . . . . 71.41 110.939 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -66.54 164.4 41.93 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.782 -0.723 . . . . 71.44 112.512 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.426 ' HA ' ' HB2' ' A' ' 158' ' ' ARG . 38.7 t70 61.67 27.89 17.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.88 0.371 . . . . 65.32 110.843 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.506 ' HA ' ' CD2' ' A' ' 99' ' ' PHE . 14.9 m-85 59.52 52.68 5.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.193 -0.458 . . . . 74.51 110.916 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.2 m -118.13 148.9 41.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.102 -0.499 . . . . 62.33 110.827 -179.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 90.8 -125.19 7.86 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.724 -0.75 . . . . 74.3 112.532 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -98.85 139.55 34.36 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.756 0.312 . . . . 72.44 110.958 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 1.3 ttp -130.99 137.0 49.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.214 -0.448 . . . . 74.12 110.857 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 13.3 m-85 -141.29 136.56 31.72 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.244 -0.434 . . . . 75.05 110.953 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -117.74 103.85 10.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.146 -0.479 . . . . 70.32 110.874 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 13.1 t -117.33 140.69 49.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.166 -0.47 . . . . 60.35 111.166 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.522 ' O ' ' OG1' ' A' ' 112' ' ' THR . 0.1 OUTLIER -101.52 27.72 6.1 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.209 -0.45 . . . . 64.54 111.142 -179.962 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -143.67 -174.96 4.39 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.213 -0.449 . . . . 72.43 110.852 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.48 ' CB ' ' HA ' ' A' ' 174' ' ' ARG . 9.2 p30 -107.96 177.43 4.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.146 -0.479 . . . . 74.2 110.899 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . 0.434 ' O ' ' HB2' ' A' ' 172' ' ' SER . 18.4 p -155.98 148.86 18.14 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 121.578 0.704 . . . . 74.2 110.916 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 -25.65 28.36 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.68 2.253 . . . . 72.35 112.364 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.626 ' HB3' ' CB ' ' A' ' 120' ' ' GLU . 0.1 OUTLIER -150.77 107.4 3.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.192 -0.458 . . . . 72.12 110.879 -179.861 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.659 HD13 HD11 ' A' ' 127' ' ' ILE . 4.0 tt -59.08 -29.81 42.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.142 -0.481 . . . . 72.31 111.152 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' MET . . . . . 0.596 ' O ' ' HA ' ' A' ' 123' ' ' HIS . 54.8 ttp -86.39 -42.66 13.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.168 -0.469 . . . . 73.31 110.877 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.626 ' CB ' ' HB3' ' A' ' 117' ' ' SER . 8.5 tp10 -67.59 -13.14 61.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.24 -0.437 . . . . 75.34 110.9 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 22.2 tp60 -114.53 -48.11 2.88 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.158 -0.473 . . . . 64.51 110.944 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.443 ' HB2' ' O ' ' A' ' 118' ' ' ILE . 47.6 m-85 -105.68 -20.1 13.56 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.217 -0.447 . . . . 71.13 110.878 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.596 ' HA ' ' O ' ' A' ' 119' ' ' MET . 10.7 m80 72.61 28.14 2.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.201 -0.454 . . . . 63.53 110.83 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.533 ' SD ' HG22 ' A' ' 98' ' ' ILE . 4.6 mtt -105.44 84.49 2.1 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.222 -0.444 . . . . 70.45 110.873 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 3.7 ptp180 -50.98 -34.81 30.6 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.196 -0.456 . . . . 75.01 110.885 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.51 ' HG2' ' HA ' ' A' ' 169' ' ' ALA . 18.4 mt-10 -144.8 135.27 24.39 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.16 -0.473 . . . . 73.43 110.872 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.659 HD11 HD13 ' A' ' 118' ' ' ILE . 3.7 mm -96.04 100.71 11.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.147 -0.478 . . . . 74.23 111.122 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . 0.429 ' HB2' ' C ' ' A' ' 101' ' ' LYS . 14.7 m170 -71.34 -30.77 66.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.194 -0.457 . . . . 62.13 110.879 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.653 ' HB2' ' HB2' ' A' ' 99' ' ' PHE . 0.4 OUTLIER -133.85 140.08 46.64 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.158 -0.473 . . . . 73.14 110.87 -179.778 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . 0.573 ' O ' ' O ' ' A' ' 155' ' ' LYS . 2.7 m -140.45 117.59 11.24 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.112 -0.494 . . . . 64.42 110.846 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.697 ' HA ' ' HA ' ' A' ' 156' ' ' GLU . 2.9 mtpp -106.44 154.55 20.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.196 -0.456 . . . . 64.23 110.872 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.537 HG23 ' C ' ' A' ' 131' ' ' LYS . 4.8 t 79.59 166.38 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.203 -0.453 . . . . 75.12 111.115 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.676 HD22 ' CG ' ' A' ' 155' ' ' LYS . 0.1 OUTLIER -171.19 128.52 0.71 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.159 -0.473 . . . . 72.4 110.905 179.992 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.536 ' CD ' ' H ' ' A' ' 134' ' ' GLU . 0.3 OUTLIER -97.3 155.98 16.64 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.181 -0.463 . . . . 75.53 110.877 179.905 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.519 ' HA3' ' HA ' ' A' ' 89' ' ' PRO . . . -30.53 -48.42 0.16 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.75 -0.738 . . . . 65.21 112.488 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.816 HG11 ' CG1' ' A' ' 86' ' ' VAL . 3.1 t -150.18 137.68 13.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.842 0.353 . . . . 62.34 111.136 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . 0.729 ' HB3' ' CB ' ' A' ' 152' ' ' LEU . 16.5 t90 -144.3 137.63 27.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.19 -0.459 . . . . 75.15 110.897 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.544 ' CG2' ' HB2' ' A' ' 149' ' ' GLN . 34.2 mt -111.69 132.05 61.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.212 -0.449 . . . . 72.45 111.097 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.561 ' CD2' ' HB3' ' A' ' 173' ' ' PHE . 0.1 OUTLIER -96.88 178.25 5.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.181 -0.463 . . . . 73.14 110.844 179.994 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.527 ' CE2' ' HG2' ' A' ' 174' ' ' ARG . 0.3 OUTLIER -155.07 124.06 6.21 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.143 -0.48 . . . . 71.43 110.921 -179.836 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.612 ' O ' ' HB2' ' A' ' 171' ' ' GLN . 0.1 OUTLIER -61.44 -29.71 70.12 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.158 -0.474 . . . . 62.3 110.859 -179.982 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.704 ' HB3' ' HD2' ' A' ' 143' ' ' PRO . 9.1 mp -114.54 172.89 3.22 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.562 0.696 . . . . 53.14 110.94 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . 0.74 ' O ' ' OG ' ' A' ' 172' ' ' SER . 53.4 Cg_endo -69.76 -90.73 0.01 OUTLIER 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.669 2.246 . . . . 72.51 112.324 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . 0.698 ' O ' ' N ' ' A' ' 146' ' ' ARG . 1.6 m-20 -54.21 95.79 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.201 -0.454 . . . . 61.14 110.907 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . 0.649 ' C ' ' O ' ' A' ' 144' ' ' ASN . 0.1 OUTLIER 12.08 53.94 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.175 -0.466 . . . . 72.43 110.95 -179.876 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.698 ' N ' ' O ' ' A' ' 144' ' ' ASN . 8.8 mtp85 -116.38 163.03 16.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.098 -0.501 . . . . 73.24 110.851 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 74.31 -172.67 51.86 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.722 -0.752 . . . . 50.02 112.481 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 4.7 mpt_? -86.7 134.02 33.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.764 0.316 . . . . 63.14 110.88 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . 0.641 ' OE1' ' HA ' ' A' ' 60' ' ' TYR . 0.3 OUTLIER -87.76 163.42 16.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.163 -0.471 . . . . 74.05 110.957 -179.952 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . 0.459 ' HB2' ' HB2' ' A' ' 139' ' ' PHE . 5.2 m-85 -126.8 151.42 48.3 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.234 -0.439 . . . . 75.3 110.958 -179.896 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.409 HD12 ' H ' ' A' ' 152' ' ' LEU . 29.7 tp -85.65 140.08 30.86 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.125 -0.489 . . . . 74.42 110.868 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.973 ' O ' HD13 ' A' ' 152' ' ' LEU . 0.0 OUTLIER -69.96 138.24 52.14 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.167 -0.47 . . . . 71.35 110.893 179.883 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -165.84 27.53 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.216 -0.447 . . . . 72.1 110.872 179.783 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.826 ' HB2' ' CD1' ' A' ' 157' ' ' TYR . 0.0 OUTLIER -118.61 -172.42 2.28 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.177 -0.465 . . . . 71.32 110.931 179.952 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.742 ' HD2' ' C ' ' A' ' 154' ' ' LYS . 1.0 OUTLIER -161.63 -123.2 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.236 -0.438 . . . . 73.54 110.855 179.844 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.697 ' HA ' ' HA ' ' A' ' 131' ' ' LYS . 2.7 tm-20 -71.65 2.63 4.95 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.207 -0.451 . . . . 74.22 110.911 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . 0.826 ' CD1' ' HB2' ' A' ' 154' ' ' LYS . 18.5 m-30 -32.33 147.3 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.14 -0.482 . . . . 74.53 110.91 -179.836 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . 0.491 ' HB3' ' CZ ' ' A' ' 104' ' ' PHE . 8.7 ptp180 -113.64 -35.76 5.1 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.133 -0.485 . . . . 75.51 110.885 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -92.27 152.94 42.9 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.551 0.691 . . . . 51.51 110.905 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . 0.477 ' HB3' ' HB3' ' A' ' 168' ' ' PRO . 53.7 Cg_endo -69.75 -35.0 13.49 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.679 2.252 . . . . 65.21 112.35 179.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.706 ' H ' HD12 ' A' ' 161' ' ' ILE . 3.2 mp -57.56 -15.85 4.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.444 . . . . 75.22 111.125 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.643 ' HB3' ' CD1' ' A' ' 157' ' ' TYR . 0.4 OUTLIER -71.69 -13.74 61.83 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.206 -0.452 . . . . 51.13 110.829 179.884 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' TRP . . . . . 0.475 ' CE3' ' HB3' ' A' ' 165' ' ' ALA . 22.3 t90 -87.98 -16.28 34.2 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.192 -0.458 . . . . 71.22 110.881 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 109.82 -37.36 3.81 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.758 -0.734 . . . . 54.31 112.483 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.475 ' HB3' ' CE3' ' A' ' 163' ' ' TRP . . . -78.92 127.17 31.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.797 0.332 . . . . 61.52 111.066 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . 0.424 ' C ' ' O ' ' A' ' 165' ' ' ALA . . . -35.94 -42.18 0.27 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.231 -0.44 . . . . 72.04 111.11 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . 0.486 ' C ' ' H ' ' A' ' 169' ' ' ALA . 0.5 OUTLIER -129.78 153.57 80.88 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.654 0.74 . . . . 75.22 110.864 -179.811 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . 0.49 ' HB3' ' O ' ' A' ' 127' ' ' ILE . 53.9 Cg_endo -69.72 29.04 0.18 Allowed 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.691 2.261 . . . . 75.23 112.357 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.51 ' HA ' ' HG2' ' A' ' 126' ' ' GLU . . . -66.28 103.95 1.1 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.236 -0.438 . . . . 43.43 111.09 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.543 HG11 ' CE2' ' A' ' 139' ' ' PHE . 2.6 t -151.57 163.33 2.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.459 . . . . 63.34 111.127 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' GLN . . . . . 0.652 ' OE1' ' HB3' ' A' ' 143' ' ' PRO . 1.6 tm0? -112.26 -83.31 0.59 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.157 -0.474 . . . . 75.22 110.897 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . 0.74 ' OG ' ' O ' ' A' ' 143' ' ' PRO . 54.4 p -124.55 174.91 7.51 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.203 -0.453 . . . . 70.42 110.805 -179.788 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . 0.561 ' HB3' ' CD2' ' A' ' 139' ' ' PHE . 39.6 p90 -148.76 164.83 33.25 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.101 -0.5 . . . . 74.43 110.919 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . 0.527 ' HG2' ' CE2' ' A' ' 140' ' ' TYR . 0.0 OUTLIER -136.16 142.75 44.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.209 -0.45 . . . . 64.44 110.906 -179.921 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . 0.405 ' HG3' ' OD1' ' A' ' 114' ' ' ASP . 0.0 OUTLIER -90.59 -176.62 4.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.199 -0.455 . . . . 73.04 110.838 -179.911 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . 0.704 HD12 ' HB ' ' A' ' 136' ' ' VAL . 2.4 mt -133.84 132.21 56.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.174 -0.467 . . . . 71.43 111.112 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 83.1 t -150.04 140.56 16.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.213 -0.449 . . . . 61.22 111.138 179.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.163 -0.471 . . . . 71.31 110.894 -179.986 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.793 0.33 . . . . 64.13 110.881 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.4 m -152.54 -170.93 3.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.253 -0.43 . . . . 63.11 110.864 -179.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -90.88 63.5 5.26 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.129 -0.487 . . . . 74.01 110.913 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 8.1 t -167.18 -37.6 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.161 -0.472 . . . . 62.23 111.148 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -84.43 78.14 2.04 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.747 -0.739 . . . . 53.5 112.491 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.478 ' C ' ' HE1' ' A' ' 47' ' ' TRP . 6.6 p -81.94 133.61 35.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.833 0.349 . . . . 61.54 111.151 -179.88 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 2.7 tttt -120.94 136.93 54.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.262 -0.426 . . . . 74.11 110.912 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.577 ' HB ' ' CD1' ' A' ' 47' ' ' TRP . 13.7 tt -136.92 152.18 28.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.236 -0.438 . . . . 65.11 111.153 179.821 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.498 HG23 ' CG ' ' A' ' 22' ' ' ASP . 15.5 m -134.0 138.15 45.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.192 -0.458 . . . . 74.2 111.113 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.716 ' HB2' HD22 ' A' ' 34' ' ' LEU . 0.2 OUTLIER -126.74 128.53 46.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.2 -0.455 . . . . 43.14 110.882 179.995 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.549 ' CG ' ' HA ' ' A' ' 16' ' ' PHE . 26.3 m-85 -113.45 132.0 55.82 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.118 -0.492 . . . . 71.35 110.876 -179.833 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.441 ' HB2' ' HB2' ' A' ' 19' ' ' ARG . 0.1 OUTLIER -61.69 -15.14 37.71 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.107 -0.497 . . . . 73.43 110.89 179.99 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.435 ' HB2' ' O ' ' A' ' 17' ' ' GLN . 72.5 m-20 -134.91 150.42 50.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.142 -0.481 . . . . 64.32 110.865 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.546 ' N ' ' HB3' ' A' ' 38' ' ' ASN . 36.7 mtmt -56.16 -178.77 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.224 -0.443 . . . . 63.11 110.914 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 25.4 m-20 49.44 31.52 4.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.212 -0.449 . . . . 62.32 110.898 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.549 ' HA ' ' CG ' ' A' ' 11' ' ' TYR . 3.7 m-85 50.9 63.54 2.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.179 -0.464 . . . . 73.23 110.922 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.435 ' O ' ' HB2' ' A' ' 13' ' ' ASP . 24.6 mt-30 -139.52 160.85 38.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.15 -0.477 . . . . 74.04 110.898 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 92.0 -149.29 19.62 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.8 -0.714 . . . . 64.34 112.485 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.721 ' O ' HD13 ' A' ' 34' ' ' LEU . 0.0 OUTLIER -69.21 77.8 0.36 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.756 0.312 . . . . 74.14 110.852 -179.865 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.46 ' HB2' ' CE1' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -76.3 129.01 36.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 72.11 110.882 -179.919 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.485 ' O ' ' HA ' ' A' ' 9' ' ' THR . 91.4 t80 -122.95 125.57 45.55 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.213 -0.449 . . . . 71.54 110.888 -179.81 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.498 ' CG ' HG23 ' A' ' 9' ' ' THR . 1.4 m-20 -121.73 133.51 54.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.121 -0.49 . . . . 75.53 110.866 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -166.99 135.43 2.67 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.217 -0.447 . . . . 72.11 110.878 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -103.22 5.55 37.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.17 -0.468 . . . . 50.15 110.815 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 49.7 t -110.08 158.85 17.86 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.231 -0.44 . . . . 72.02 110.864 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -43.3 120.17 1.8 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.172 -0.467 . . . . 70.33 110.83 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.632 ' HB2' ' HB3' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -115.6 42.33 2.31 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.204 -0.453 . . . . 53.41 110.868 -179.951 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.563 ' O ' ' HA ' ' A' ' 82' ' ' SER . . . -51.12 -20.11 1.37 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.229 -0.441 . . . . 74.11 111.126 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 63.2 t0 -128.5 37.57 4.1 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.218 -0.446 . . . . 65.52 110.864 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.763 ' O ' ' CD2' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -80.97 15.68 1.74 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.198 -0.456 . . . . 64.04 110.857 -179.892 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.412 ' CG ' ' HG3' ' A' ' 53' ' ' PRO . 39.3 t60 -80.02 -34.0 38.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.189 -0.459 . . . . 71.03 110.864 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.6 t -63.24 -10.84 17.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.216 -0.447 . . . . 71.52 111.136 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -103.32 -28.87 11.6 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.193 -0.458 . . . . 74.21 110.925 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.721 HD13 ' O ' ' A' ' 19' ' ' ARG . 16.0 tp -139.02 141.25 38.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.133 -0.485 . . . . 74.4 110.89 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 20.7 m -105.35 -42.05 5.36 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.174 -0.466 . . . . 64.43 110.863 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -118.49 143.0 47.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.178 -0.464 . . . . 73.54 110.907 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.683 ' SG ' ' HB2' ' A' ' 80' ' ' LEU . 3.9 p -115.05 87.22 2.61 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.204 -0.453 . . . . 72.24 110.9 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.546 ' HB3' ' N ' ' A' ' 14' ' ' LYS . 3.3 m-20 -82.76 -50.85 8.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 62.41 110.852 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.403 ' OG ' ' HB2' ' A' ' 11' ' ' TYR . 9.8 p -129.4 127.14 40.37 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.163 -0.472 . . . . 74.11 110.821 -179.815 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.538 HG21 HD13 ' A' ' 62' ' ' LEU . 13.5 mt -125.44 152.1 31.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.103 -0.499 . . . . 71.34 111.15 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.426 ' N ' ' CG2' ' A' ' 40' ' ' ILE . 0.0 OUTLIER -144.85 118.55 9.2 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.201 -0.454 . . . . 64.01 110.932 179.845 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.513 ' HA ' ' HA ' ' A' ' 8' ' ' ILE . 1.3 t -104.02 116.7 48.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.259 -0.428 . . . . 64.51 111.175 179.85 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -111.54 77.65 1.06 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.197 -0.456 . . . . 63.54 110.887 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.432 ' O ' ' HA ' ' A' ' 6' ' ' THR . . . 135.4 101.87 0.68 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.762 -0.732 . . . . 51.24 112.512 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.501 ' HA2' HD21 ' A' ' 88' ' ' LEU . . . 53.91 179.65 0.14 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.767 -0.73 . . . . 74.2 112.493 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.748 HG23 ' HA ' ' A' ' 63' ' ' PRO . 1.4 m -80.25 169.28 18.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.797 0.332 . . . . 43.21 111.12 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.577 ' CD1' ' HB ' ' A' ' 8' ' ' ILE . 5.7 m95 -141.18 130.1 23.13 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.194 -0.457 . . . . 65.11 110.945 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.948 ' HB2' ' CG2' ' A' ' 86' ' ' VAL . . . -90.58 127.02 36.13 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.222 -0.445 . . . . 64.54 111.125 179.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.871 HG11 HD11 ' A' ' 80' ' ' LEU . 35.7 m -128.84 124.48 61.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.213 -0.449 . . . . 63.44 111.135 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.73 ' HB3' ' HA ' ' A' ' 56' ' ' ALA . 49.5 m-85 -94.51 150.15 20.53 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.21 -0.45 . . . . 70.55 110.901 -179.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.675 ' OE1' ' HB3' ' A' ' 57' ' ' TRP . 58.1 tt0 -49.27 -79.51 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.106 -0.497 . . . . 74.1 110.901 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.57 ' HB2' ' HB2' ' A' ' 57' ' ' TRP . 0.0 OUTLIER -92.54 143.77 27.73 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.607 0.718 . . . . 74.43 110.893 -179.951 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.69 ' HA ' ' OG ' ' A' ' 82' ' ' SER . 53.3 Cg_endo -69.82 142.41 47.57 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.739 2.293 . . . . 44.51 112.301 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 61.95 -9.75 0.08 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.236 -0.438 . . . . 73.52 110.89 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.611 ' H ' ' C ' ' A' ' 53' ' ' PRO . 2.7 m-30 -105.92 -20.4 13.44 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.184 -0.462 . . . . 73.43 110.901 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.73 ' HA ' ' HB3' ' A' ' 50' ' ' TYR . . . 50.02 27.15 2.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.168 -0.469 . . . . 72.1 111.068 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . 0.675 ' HB3' ' OE1' ' A' ' 51' ' ' GLU . 0.1 OUTLIER -50.69 -163.69 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.23 -0.441 . . . . 74.04 110.907 -179.959 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.636 ' C ' ' O ' ' A' ' 57' ' ' TRP . 5.4 m-30 -13.1 101.2 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.235 -0.439 . . . . 64.53 110.954 -179.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.43 142.89 36.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.072 -0.513 . . . . 73.32 110.873 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.788 ' O ' ' O ' ' A' ' 49' ' ' VAL . 0.3 OUTLIER -153.4 112.41 3.75 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.255 -0.43 . . . . 71.45 110.938 -179.896 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.81 ' N ' HD12 ' A' ' 61' ' ' ILE . 1.1 mp -102.82 114.19 41.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.13 -0.486 . . . . 64.21 111.153 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.849 HD23 ' HD2' ' A' ' 63' ' ' PRO . 0.6 OUTLIER -85.41 122.46 73.56 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 121.632 0.73 . . . . 72.41 110.89 179.962 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.849 ' HD2' HD23 ' A' ' 62' ' ' LEU . 54.1 Cg_endo -69.7 -166.34 0.18 Allowed 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.699 2.266 . . . . 75.01 112.339 179.868 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.44 160.96 14.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.164 -0.471 . . . . 75.03 110.896 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 113.48 -152.7 17.93 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.743 -0.741 . . . . 52.44 112.517 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -118.4 159.26 23.76 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.867 0.365 . . . . 74.15 110.891 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.479 ' N ' ' O ' ' A' ' 40' ' ' ILE . 11.5 m-85 -147.32 84.02 7.47 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.665 0.745 . . . . 73.34 110.942 -179.85 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 -4.68 14.51 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.655 2.237 . . . . 65.31 112.393 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 89.3 mt-10 -157.49 147.84 20.88 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.158 -0.474 . . . . 75.33 110.889 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.941 ' O ' ' CD1' ' A' ' 73' ' ' TRP . 44.4 p90 -57.97 -41.07 82.16 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.181 -0.463 . . . . 73.43 110.911 -179.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -52.8 -15.69 0.8 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.098 -0.501 . . . . 71.53 110.948 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 29.2 mmt180 -65.77 -17.6 64.74 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.189 -0.46 . . . . 72.4 110.845 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . 0.941 ' CD1' ' O ' ' A' ' 70' ' ' TYR . 0.4 OUTLIER -121.14 22.39 10.95 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.2 -0.455 . . . . 64.34 110.896 -179.948 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.594 ' O ' ' C ' ' A' ' 75' ' ' GLY . 0.0 OUTLIER 75.67 30.22 0.8 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.278 -0.419 . . . . 72.1 110.9 179.943 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.594 ' C ' ' O ' ' A' ' 74' ' ' MET . . . 17.11 59.06 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.678 -0.773 . . . . 61.35 112.508 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.727 HD12 HE21 ' A' ' 149' ' ' GLN . 0.0 OUTLIER -55.01 -72.38 0.07 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.836 0.35 . . . . 72.52 110.944 -179.955 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.498 ' O ' ' CB ' ' A' ' 78' ' ' ASP . 16.3 t-20 -121.16 -37.93 2.88 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.172 -0.467 . . . . 73.41 110.857 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.498 ' CB ' ' O ' ' A' ' 77' ' ' ASN . 0.0 OUTLIER 83.83 10.35 0.47 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.206 -0.452 . . . . 64.01 110.882 179.925 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -105.74 86.89 2.47 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.186 -0.461 . . . . 71.23 110.88 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.871 HD11 HG11 ' A' ' 49' ' ' VAL . 0.1 OUTLIER -86.95 131.38 34.11 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.182 -0.463 . . . . 70.31 110.886 -179.965 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.645 ' HB3' ' HB3' ' A' ' 53' ' ' PRO . 1.4 m -153.82 -119.23 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.158 -0.473 . . . . 74.4 110.843 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.69 ' OG ' ' HA ' ' A' ' 53' ' ' PRO . 0.1 OUTLIER -46.38 97.76 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.142 -0.481 . . . . 71.51 110.871 -179.814 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . 0.786 ' CB ' HG12 ' A' ' 49' ' ' VAL . 9.7 p -122.78 134.96 54.41 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.186 -0.461 . . . . 74.01 110.86 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.613 ' N ' ' O ' ' A' ' 48' ' ' ALA . 2.2 mmt85 -117.66 156.57 27.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.176 -0.466 . . . . 73.41 110.87 -179.843 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -68.42 129.05 38.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 72.15 111.119 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.948 ' CG2' ' HB2' ' A' ' 48' ' ' ALA . 38.3 t -115.56 139.17 43.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.24 -0.437 . . . . 64.24 111.114 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . 0.682 ' O ' HG23 ' A' ' 136' ' ' VAL . 9.2 m170 -114.12 108.59 17.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.161 -0.472 . . . . 62.13 110.892 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.56 HD13 ' HB3' ' A' ' 178' ' ' GLU . 0.0 OUTLIER -32.79 148.15 0.06 OUTLIER Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.577 0.703 . . . . 65.12 110.908 -179.972 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.582 ' HA ' ' HA3' ' A' ' 135' ' ' GLY . 53.3 Cg_endo -69.82 100.38 0.82 Allowed 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.658 2.239 . . . . 65.14 112.303 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -105.72 -175.65 2.85 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.194 -0.457 . . . . 73.23 110.867 -179.855 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 46.36 57.91 6.17 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.7 -0.762 . . . . 72.1 112.509 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 125.44 26.63 1.29 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.763 -0.732 . . . . 73.33 112.49 -179.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.518 ' O ' ' CG ' ' A' ' 134' ' ' GLU . 5.7 pt20 38.27 -124.49 0.27 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.792 0.33 . . . . 71.13 110.935 -179.861 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.589 ' HA ' ' HG2' ' A' ' 134' ' ' GLU . 0.0 OUTLIER -125.76 103.38 7.78 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.173 -0.467 . . . . 75.33 110.888 -179.857 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.538 ' HG3' HG11 ' A' ' 132' ' ' VAL . 12.6 tptp -113.34 130.96 56.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.079 -0.51 . . . . 71.15 110.875 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.717 HD11 ' NZ ' ' A' ' 154' ' ' LYS . 7.6 tt -149.05 138.25 15.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.185 -0.461 . . . . 71.12 111.13 179.864 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.488 ' HB2' ' O ' ' A' ' 131' ' ' LYS . 0.9 OUTLIER -110.52 139.38 45.81 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.153 -0.476 . . . . 73.33 110.878 179.962 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.649 HD12 ' O ' ' A' ' 109' ' ' TYR . 1.2 mp -116.74 148.58 19.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 53.52 111.102 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.62 ' HB2' ' HB2' ' A' ' 129' ' ' SER . 38.6 m-85 -134.1 133.94 41.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.205 -0.452 . . . . 75.23 110.848 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 77.2 tt0 -65.26 -61.25 2.24 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.159 -0.473 . . . . 72.2 110.878 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 35.4 mttt -99.79 162.21 13.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.134 -0.485 . . . . 73.13 110.872 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -68.16 159.83 51.18 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.73 -0.747 . . . . 72.15 112.48 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.513 ' HA ' ' HB2' ' A' ' 158' ' ' ARG . 25.7 t0 67.22 39.0 3.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.855 0.359 . . . . 44.33 110.888 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.597 ' CZ ' ' HB3' ' A' ' 158' ' ' ARG . 3.6 m-85 58.06 19.65 6.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.202 -0.454 . . . . 74.25 110.894 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 70.4 m -88.23 161.55 17.15 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.15 -0.477 . . . . 74.55 110.88 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 82.26 -159.0 38.65 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.726 -0.75 . . . . 40.32 112.454 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 4.1 tp-100 -82.86 129.19 34.97 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.786 0.327 . . . . 73.01 110.887 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' MET . . . . . 0.474 ' HB2' ' CD1' ' A' ' 99' ' ' PHE . 0.0 OUTLIER -118.69 160.39 21.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.195 -0.457 . . . . 43.45 110.862 179.954 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . 0.649 ' O ' HD12 ' A' ' 98' ' ' ILE . 29.9 m-85 -154.72 135.87 13.94 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.205 -0.452 . . . . 75.45 110.911 -179.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -110.98 102.0 10.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.139 -0.482 . . . . 73.2 110.906 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.405 HG22 HD11 ' A' ' 98' ' ' ILE . 9.0 t -113.38 128.56 56.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.148 -0.478 . . . . 52.4 111.14 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.42 ' HA ' ' HA ' ' A' ' 95' ' ' LYS . 1.8 t -93.4 32.6 1.33 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.222 -0.444 . . . . 74.32 111.162 -180.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -153.79 -174.85 5.11 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.211 -0.449 . . . . 71.13 110.895 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -90.16 -175.18 4.45 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.154 -0.475 . . . . 63.13 110.839 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . 0.654 ' O ' ' HB2' ' A' ' 172' ' ' SER . 39.0 t -161.19 136.17 5.53 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.606 0.717 . . . . 75.3 110.854 -179.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.497 ' O ' ' C ' ' A' ' 143' ' ' PRO . 53.4 Cg_endo -69.81 -34.51 14.28 Favored 'Trans proline' 0 C--N 1.341 0.134 0 C-N-CA 122.669 2.246 . . . . 62.14 112.324 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.635 ' HB3' ' CB ' ' A' ' 120' ' ' GLU . 0.1 OUTLIER -147.04 97.28 2.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.228 -0.442 . . . . 65.43 110.88 -179.844 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.696 HD13 HD11 ' A' ' 127' ' ' ILE . 3.7 tt -50.81 -28.8 6.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.158 -0.473 . . . . 71.22 111.107 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' MET . . . . . 0.571 ' O ' ' HA ' ' A' ' 123' ' ' HIS . 21.7 ttp -85.95 -44.96 11.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.169 -0.469 . . . . 72.44 110.896 179.848 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.635 ' CB ' ' HB3' ' A' ' 117' ' ' SER . 17.5 tp10 -66.17 -14.14 61.36 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.242 -0.435 . . . . 74.13 110.9 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 7.1 tp-100 -113.69 -51.49 2.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.121 -0.491 . . . . 63.24 110.882 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.483 ' HB2' ' O ' ' A' ' 118' ' ' ILE . 77.2 m-85 -101.81 -21.53 14.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.187 -0.46 . . . . 51.33 110.845 -179.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.571 ' HA ' ' O ' ' A' ' 119' ' ' MET . 29.3 m-70 71.87 30.83 2.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.155 -0.475 . . . . 72.41 110.91 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 4.1 mtt -106.79 88.65 2.8 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.174 -0.466 . . . . 73.42 110.829 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 4.0 ptp180 -53.34 -38.44 63.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.252 -0.431 . . . . 74.53 110.864 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.476 ' HB3' ' HG2' ' A' ' 168' ' ' PRO . 18.2 mt-10 -140.2 130.58 25.31 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.166 -0.47 . . . . 75.23 110.87 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.696 HD11 HD13 ' A' ' 118' ' ' ILE . 3.0 mm -87.57 96.88 6.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.173 -0.467 . . . . 73.02 111.09 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . 0.443 ' HA ' ' HB3' ' A' ' 160' ' ' PRO . 17.0 m170 -66.03 -35.93 81.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.132 -0.485 . . . . 63.33 110.867 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.62 ' HB2' ' HB2' ' A' ' 99' ' ' PHE . 0.6 OUTLIER -135.54 147.45 48.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.225 -0.443 . . . . 64.01 110.884 -179.809 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . 0.553 ' O ' ' O ' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -144.78 120.39 10.43 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.192 -0.458 . . . . 64.45 110.924 -179.989 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.64 ' HA ' ' HA ' ' A' ' 156' ' ' GLU . 4.4 mtpt -111.25 154.32 24.62 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.156 -0.475 . . . . 65.33 110.938 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.538 HG11 ' HG3' ' A' ' 95' ' ' LYS . 13.0 t 83.32 163.59 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 71.12 111.131 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.847 HD13 ' O ' ' A' ' 154' ' ' LYS . 0.0 OUTLIER -178.86 122.2 0.09 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.176 -0.465 . . . . 64.22 110.898 179.95 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.589 ' HG2' ' HA ' ' A' ' 94' ' ' TYR . 0.1 OUTLIER -96.13 166.6 11.67 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.165 -0.47 . . . . 63.44 110.895 179.923 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.582 ' HA3' ' HA ' ' A' ' 89' ' ' PRO . . . -24.42 -73.71 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.691 -0.766 . . . . 53.01 112.532 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.744 HG21 HG13 ' A' ' 86' ' ' VAL . 4.7 t -132.45 146.97 32.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.833 0.349 . . . . 72.44 111.126 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . 0.616 ' HB3' ' HB3' ' A' ' 152' ' ' LEU . 2.6 t-105 -149.6 141.98 24.25 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.17 -0.468 . . . . 75.11 110.924 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.573 HG13 HD11 ' A' ' 176' ' ' ILE . 59.5 mt -115.59 132.34 65.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.258 -0.428 . . . . 74.04 111.177 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.473 ' CD2' HG11 ' A' ' 170' ' ' VAL . 0.3 OUTLIER -99.74 179.58 4.49 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.166 -0.47 . . . . 64.1 110.878 179.99 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.553 ' CE1' ' HB3' ' A' ' 149' ' ' GLN . 1.4 m-85 -152.39 126.08 8.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.136 -0.483 . . . . 74.53 110.905 -179.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.606 ' O ' ' HB2' ' A' ' 171' ' ' GLN . 3.2 tt0 -61.05 -26.49 67.66 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.142 -0.481 . . . . 70.32 110.907 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.709 ' HB3' ' HD2' ' A' ' 143' ' ' PRO . 8.4 mp -116.24 173.29 3.12 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.59 0.709 . . . . 74.22 110.892 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . 0.747 ' O ' ' OG ' ' A' ' 172' ' ' SER . 54.0 Cg_endo -69.73 -89.68 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.145 0 C-N-CA 122.724 2.283 . . . . 64.44 112.373 179.813 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . 0.704 ' O ' ' N ' ' A' ' 146' ' ' ARG . 1.0 OUTLIER -54.69 95.7 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.232 -0.44 . . . . 72.12 110.931 179.957 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . 0.646 ' C ' ' O ' ' A' ' 144' ' ' ASN . 0.1 OUTLIER 12.69 53.01 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.17 -0.468 . . . . 74.31 110.89 -179.913 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.704 ' N ' ' O ' ' A' ' 144' ' ' ASN . 10.1 mtp85 -118.69 172.46 7.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.159 -0.473 . . . . 73.12 110.862 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 70.59 -175.34 37.41 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.713 -0.756 . . . . 72.34 112.479 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.436 ' HA ' HD11 ' A' ' 76' ' ' LEU . 3.9 mtp180 -83.28 130.7 35.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.776 0.322 . . . . 62.21 110.87 -179.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . 0.735 ' OE1' ' HA ' ' A' ' 60' ' ' TYR . 0.3 OUTLIER -85.79 158.7 19.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.178 -0.464 . . . . 74.2 110.9 -179.926 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -123.59 158.27 31.84 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.206 -0.452 . . . . 72.43 110.957 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.64 ' HB2' HD11 ' A' ' 61' ' ' ILE . 13.4 tp -92.01 134.65 34.62 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.108 -0.496 . . . . 63.32 110.917 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 1.041 ' O ' HD13 ' A' ' 152' ' ' LEU . 0.0 OUTLIER -63.94 132.59 51.17 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.218 -0.446 . . . . 75.31 110.895 179.884 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -163.69 26.04 0.08 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.174 -0.467 . . . . 62.4 110.854 179.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.847 ' O ' HD13 ' A' ' 133' ' ' LEU . 5.6 pttt -116.13 -173.03 2.28 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.167 -0.469 . . . . 54.4 110.854 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.838 ' HG3' HD22 ' A' ' 133' ' ' LEU . 0.1 OUTLIER -161.75 -124.53 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.183 -0.462 . . . . 65.43 110.898 179.867 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.64 ' HA ' ' HA ' ' A' ' 131' ' ' LYS . 0.3 OUTLIER -71.42 2.2 5.27 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.228 -0.442 . . . . 64.42 110.904 179.976 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . 0.795 ' CD1' ' HB2' ' A' ' 154' ' ' LYS . 20.5 m-30 -30.17 144.85 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.153 -0.476 . . . . 70.22 110.93 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . 0.597 ' HB3' ' CZ ' ' A' ' 104' ' ' PHE . 9.4 ptp180 -112.67 -44.13 3.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.128 -0.487 . . . . 73.54 110.881 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -80.48 152.17 72.65 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.596 0.712 . . . . 74.42 110.865 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . 0.443 ' HB3' ' HA ' ' A' ' 128' ' ' HIS . 54.2 Cg_endo -69.76 -32.83 17.8 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.693 2.262 . . . . 71.42 112.335 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.61 ' H ' HD12 ' A' ' 161' ' ' ILE . 3.6 mp -55.34 -19.04 4.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.224 -0.444 . . . . 74.24 111.143 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.654 ' HB3' ' CD1' ' A' ' 157' ' ' TYR . 0.3 OUTLIER -73.57 -23.0 59.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.202 -0.454 . . . . 70.33 110.891 179.826 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' TRP . . . . . 0.407 ' HB3' ' O ' ' A' ' 160' ' ' PRO . 2.1 t-105 -67.53 -17.7 64.76 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.2 -0.455 . . . . 73.32 110.963 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 114.3 -38.63 3.09 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.689 -0.767 . . . . 72.35 112.473 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -90.91 140.68 29.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.81 0.338 . . . . 63.14 111.063 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -40.97 -35.13 0.48 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.196 -0.456 . . . . 54.34 111.09 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . 0.498 ' C ' ' H ' ' A' ' 169' ' ' ALA . 0.3 OUTLIER -129.51 156.82 78.02 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.665 0.745 . . . . 75.55 110.9 -179.803 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . 0.476 ' HG2' ' HB3' ' A' ' 126' ' ' GLU . 53.9 Cg_endo -69.76 25.27 0.17 Allowed 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.697 2.264 . . . . 74.41 112.356 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.498 ' H ' ' C ' ' A' ' 167' ' ' SER . . . -64.3 103.88 0.69 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.197 -0.456 . . . . 62.14 111.149 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.473 HG11 ' CD2' ' A' ' 139' ' ' PHE . 3.5 t -153.66 162.17 2.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.238 -0.437 . . . . 51.24 111.122 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' GLN . . . . . 0.647 ' O ' ' HB ' ' A' ' 118' ' ' ILE . 1.9 mm-40 -112.54 -85.19 0.58 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.15 -0.477 . . . . 62.32 110.926 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . 0.747 ' OG ' ' O ' ' A' ' 143' ' ' PRO . 32.0 p -129.54 178.78 6.22 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.204 -0.453 . . . . 74.14 110.87 -179.84 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -145.91 176.44 9.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.092 -0.504 . . . . 72.13 110.894 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . 0.434 ' HG2' ' HB ' ' A' ' 138' ' ' ILE . 0.2 OUTLIER -134.47 151.15 50.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.179 -0.464 . . . . 72.42 110.86 -179.903 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . 0.553 ' HD2' ' CE1' ' A' ' 94' ' ' TYR . 1.7 ptt180 -102.34 147.98 26.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.186 -0.461 . . . . 74.34 110.835 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . 0.573 HD11 HG13 ' A' ' 138' ' ' ILE . 3.9 mt -100.34 126.66 53.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.16 -0.473 . . . . 75.33 111.126 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 9.6 p -127.38 153.09 36.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.161 -0.472 . . . . 53.21 111.083 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . 0.56 ' HB3' HD13 ' A' ' 88' ' ' LEU . 1.5 pt-20 . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.142 -0.481 . . . . 75.1 110.904 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.23 0.06 0 CA-C-O 120.811 0.339 . . . . 74.53 110.866 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -86.5 151.86 23.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.222 -0.445 . . . . 72.31 110.86 -179.803 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 20.8 mttt -90.84 64.18 5.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.149 -0.478 . . . . 75.25 110.933 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.0 t -116.32 70.43 0.76 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.225 -0.443 . . . . 71.31 111.165 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 101.71 117.65 4.26 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.748 -0.739 . . . . 73.35 112.508 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.431 ' C ' ' HE1' ' A' ' 47' ' ' TRP . 5.3 p -82.23 134.05 35.28 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.872 0.367 . . . . 72.32 111.126 -179.832 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 2.8 tttt -121.44 136.44 54.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.26 -0.427 . . . . 63.51 110.899 179.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.583 ' HB ' ' CD1' ' A' ' 47' ' ' TRP . 12.7 tt -136.69 147.49 27.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.271 -0.422 . . . . 75.14 111.156 179.827 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.552 HG22 ' CE2' ' A' ' 11' ' ' TYR . 15.9 m -130.01 129.95 44.36 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.175 -0.466 . . . . 75.03 111.106 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.799 ' HB2' HD22 ' A' ' 34' ' ' LEU . 0.4 OUTLIER -117.05 131.1 57.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.171 -0.468 . . . . 61.44 110.896 -179.988 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.552 ' CE2' HG22 ' A' ' 9' ' ' THR . 43.5 m-85 -116.46 131.21 57.01 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.179 -0.464 . . . . 42.21 110.916 -179.86 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.516 ' HG2' ' HB2' ' A' ' 36' ' ' ARG . 0.0 OUTLIER -60.91 -23.94 65.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.092 -0.504 . . . . 73.35 110.899 -179.999 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 68.6 m-20 -127.87 152.48 47.79 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.187 -0.46 . . . . 73.44 110.848 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.48 ' N ' ' HB3' ' A' ' 38' ' ' ASN . 4.2 mtmm -56.05 -176.98 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.175 -0.466 . . . . 75.11 110.893 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 69.9 m-20 46.99 37.74 5.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.209 -0.45 . . . . 73.03 110.896 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.535 ' HA ' ' CG ' ' A' ' 11' ' ' TYR . 4.3 m-85 45.91 56.59 5.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.145 -0.48 . . . . 72.33 110.93 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 4.1 mt-30 -132.16 159.91 37.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.142 -0.481 . . . . 74.34 110.928 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 93.81 -150.93 20.05 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.722 -0.752 . . . . 71.41 112.449 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.768 ' O ' HD13 ' A' ' 34' ' ' LEU . 0.0 OUTLIER -68.9 80.02 0.3 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.81 0.338 . . . . 75.54 110.843 -179.811 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.478 ' HB2' ' CE1' ' A' ' 11' ' ' TYR . 0.8 OUTLIER -77.99 127.99 33.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.203 -0.453 . . . . 73.15 110.862 -179.891 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.411 ' CD2' ' CD2' ' A' ' 30' ' ' PHE . 90.5 t80 -124.25 125.59 44.65 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.223 -0.444 . . . . 53.45 110.957 -179.883 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.46 ' CG ' HG23 ' A' ' 9' ' ' THR . 1.5 m-20 -118.99 132.49 56.07 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.14 -0.482 . . . . 70.42 110.865 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 12.6 t -161.3 131.01 4.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.208 -0.451 . . . . 65.41 110.888 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -102.12 4.17 39.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 71.24 110.888 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 48.7 t -112.9 159.46 19.04 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.46 . . . . 71.11 110.893 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -42.24 119.97 1.51 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.165 -0.47 . . . . 64.04 110.847 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.636 ' HB2' ' HB3' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -114.83 43.32 1.98 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.18 -0.464 . . . . 71.23 110.895 -179.925 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.532 ' O ' ' HA ' ' A' ' 82' ' ' SER . . . -49.97 -21.22 1.13 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.179 -0.464 . . . . 65.03 111.093 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 64.7 t0 -129.47 40.63 3.57 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.224 -0.444 . . . . 75.11 110.867 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.763 ' O ' ' CD2' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -82.06 16.39 1.95 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.207 -0.451 . . . . 75.5 110.833 -179.904 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.432 ' HB2' ' HB3' ' A' ' 81' ' ' SER . 34.4 t60 -78.62 -40.82 33.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.213 -0.449 . . . . 75.52 110.891 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.43 HG23 ' CD2' ' A' ' 33' ' ' TYR . 10.0 t -61.73 -10.65 9.24 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.201 -0.454 . . . . 73.42 111.12 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.501 ' CD1' ' HA ' ' A' ' 30' ' ' PHE . 12.2 m-85 -99.43 -30.77 12.0 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.217 -0.447 . . . . 74.02 110.95 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.799 HD22 ' HB2' ' A' ' 10' ' ' PHE . 16.7 tp -141.54 146.15 36.0 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.126 -0.488 . . . . 65.41 110.933 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.2 m -112.09 -34.65 5.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.154 -0.475 . . . . 61.22 110.847 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.579 ' O ' HD21 ' A' ' 34' ' ' LEU . 1.8 mtp85 -115.6 140.87 48.77 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.119 -0.491 . . . . 75.51 110.884 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.595 ' SG ' ' HB2' ' A' ' 80' ' ' LEU . 1.6 p -116.86 54.45 0.86 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.184 -0.462 . . . . 73.11 110.899 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.48 ' HB3' ' N ' ' A' ' 14' ' ' LYS . 1.9 m-80 -55.02 -65.71 0.53 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.182 -0.463 . . . . 73.41 110.91 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.406 ' HB2' ' HA ' ' A' ' 68' ' ' PRO . 7.6 p -116.27 128.15 55.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.181 -0.463 . . . . 71.42 110.832 -179.857 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.593 HD12 ' CZ3' ' A' ' 73' ' ' TRP . 12.0 mt -124.67 147.47 29.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.088 -0.505 . . . . 72.44 111.13 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.423 ' HD2' ' CE2' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -141.67 118.7 11.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.149 -0.478 . . . . 73.45 110.884 179.86 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.504 ' O ' HG12 ' A' ' 42' ' ' VAL . 1.0 OUTLIER -104.35 117.46 49.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.461 . . . . 64.44 111.088 179.908 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -112.34 77.68 1.06 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.173 -0.467 . . . . 51.41 110.868 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.417 ' O ' ' HA ' ' A' ' 6' ' ' THR . . . 136.88 98.31 0.51 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.73 -0.748 . . . . 70.21 112.468 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.447 ' HA2' HD21 ' A' ' 88' ' ' LEU . . . 55.36 177.86 0.22 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.725 -0.75 . . . . 65.35 112.426 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.735 HG23 ' HA ' ' A' ' 63' ' ' PRO . 1.0 OUTLIER -76.32 171.13 15.08 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.77 0.319 . . . . 73.04 111.166 -179.901 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.583 ' CD1' ' HB ' ' A' ' 8' ' ' ILE . 6.1 m95 -143.47 128.77 18.85 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.251 -0.431 . . . . 43.44 110.921 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.888 ' HB2' ' CG2' ' A' ' 86' ' ' VAL . . . -90.88 126.33 36.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.191 -0.459 . . . . 54.32 111.096 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.823 HG11 HD11 ' A' ' 80' ' ' LEU . 26.9 m -126.32 130.1 71.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.202 -0.454 . . . . 75.33 111.083 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.8 ' HB3' ' HA ' ' A' ' 56' ' ' ALA . 52.4 m-85 -100.41 148.02 25.19 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.161 -0.472 . . . . 74.21 110.973 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.568 ' HB3' ' HB3' ' A' ' 57' ' ' TRP . 58.4 tt0 -49.75 -78.07 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.105 -0.498 . . . . 73.22 110.873 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.484 ' HB3' ' CD1' ' A' ' 55' ' ' PHE . 0.1 OUTLIER -93.36 141.57 24.13 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.614 0.721 . . . . 71.54 110.859 -179.878 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.661 ' HB3' ' HB3' ' A' ' 81' ' ' SER . 53.7 Cg_endo -69.76 145.25 56.6 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.691 2.261 . . . . 61.21 112.341 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 61.9 -11.02 0.07 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.201 -0.454 . . . . 74.33 110.925 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.625 ' H ' ' C ' ' A' ' 53' ' ' PRO . 1.8 m-30 -108.16 -21.29 12.85 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.163 -0.472 . . . . 74.01 110.831 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.8 ' HA ' ' HB3' ' A' ' 50' ' ' TYR . . . 50.96 26.77 2.85 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.183 -0.462 . . . . 43.43 111.069 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . 0.641 ' O ' ' C ' ' A' ' 58' ' ' TYR . 0.8 OUTLIER -48.63 -164.5 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.245 -0.434 . . . . 73.0 110.899 -179.967 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.641 ' C ' ' O ' ' A' ' 57' ' ' TRP . 5.3 m-30 -11.76 100.15 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.236 -0.438 . . . . 73.21 110.933 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.475 ' HB2' ' HA ' ' A' ' 150' ' ' TYR . 0.0 OUTLIER -60.41 153.36 23.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.154 -0.476 . . . . 62.44 110.869 179.911 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.659 ' CE2' HD12 ' A' ' 76' ' ' LEU . 2.1 t80 -168.65 107.95 0.48 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.193 -0.458 . . . . 74.42 110.914 -179.871 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.865 HD13 HG23 ' A' ' 138' ' ' ILE . 4.9 mp -95.73 118.65 42.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.148 -0.478 . . . . 64.04 111.131 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.848 HD23 ' HD2' ' A' ' 63' ' ' PRO . 0.3 OUTLIER -87.45 126.0 63.64 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.587 0.708 . . . . 73.14 110.927 179.904 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.848 ' HD2' HD23 ' A' ' 62' ' ' LEU . 54.0 Cg_endo -69.76 -172.81 0.62 Allowed 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.662 2.241 . . . . 63.21 112.346 179.871 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.67 161.71 15.96 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.209 -0.451 . . . . 75.11 110.917 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 112.87 -159.49 13.64 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.707 -0.758 . . . . 72.12 112.5 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -114.71 158.5 21.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.865 0.364 . . . . 72.33 110.913 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.493 ' N ' ' O ' ' A' ' 40' ' ' ILE . 7.2 m-85 -149.44 80.42 7.69 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.681 0.753 . . . . 74.02 110.895 -179.837 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.573 ' HD2' ' HG3' ' A' ' 72' ' ' ARG . 53.7 Cg_endo -69.78 1.13 4.73 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.682 2.255 . . . . 75.12 112.321 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -157.91 155.1 28.96 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.24 -0.436 . . . . 75.34 110.873 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.807 ' O ' ' CD1' ' A' ' 73' ' ' TRP . 18.9 p90 -66.97 -7.97 26.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.164 -0.471 . . . . 74.2 110.947 -179.883 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -90.44 -16.32 29.23 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.102 -0.499 . . . . 63.23 110.909 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.573 ' HG3' ' HD2' ' A' ' 68' ' ' PRO . 25.5 mmt180 -75.01 -22.87 58.23 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.203 -0.453 . . . . 72.33 110.919 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . 0.807 ' CD1' ' O ' ' A' ' 70' ' ' TYR . 0.5 OUTLIER -109.39 8.22 25.35 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.148 -0.478 . . . . 65.43 110.927 -179.967 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.504 ' C ' ' O ' ' A' ' 73' ' ' TRP . 0.0 OUTLIER 30.23 55.48 0.17 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.205 -0.452 . . . . 71.13 110.903 179.954 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.527 ' CA ' ' OH ' ' A' ' 60' ' ' TYR . . . -91.77 -170.14 41.65 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.781 -0.723 . . . . 72.11 112.469 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.671 HD21 ' HA ' ' A' ' 148' ' ' ARG . 0.1 OUTLIER -107.87 -74.28 0.66 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.834 0.35 . . . . 74.03 110.915 -179.936 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -96.84 147.01 24.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.146 -0.479 . . . . 74.24 110.914 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.406 ' O ' ' SG ' ' A' ' 37' ' ' CYS . 15.8 p30 -95.71 34.05 1.56 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.203 -0.453 . . . . 41.34 110.877 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 4.3 ttm-85 -105.69 79.47 1.44 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 72.03 110.851 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.823 HD11 HG11 ' A' ' 49' ' ' VAL . 0.1 OUTLIER -82.82 130.3 35.11 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.179 -0.464 . . . . 73.02 110.955 179.976 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.661 ' HB3' ' HB3' ' A' ' 53' ' ' PRO . 1.3 m -152.24 -123.51 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.22 -0.446 . . . . 64.23 110.858 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.619 ' OG ' ' HA ' ' A' ' 53' ' ' PRO . 0.2 OUTLIER -41.0 99.98 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.118 -0.492 . . . . 60.33 110.855 -179.82 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . 0.72 ' HB3' HG12 ' A' ' 49' ' ' VAL . 8.9 p -127.0 134.38 50.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.131 -0.486 . . . . 64.3 110.863 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.617 ' N ' ' O ' ' A' ' 48' ' ' ALA . 4.5 mmt85 -115.47 158.32 22.72 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.194 -0.457 . . . . 64.51 110.902 -179.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -72.08 129.61 38.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.46 . . . . 72.45 111.104 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.888 ' CG2' ' HB2' ' A' ' 48' ' ' ALA . 61.5 t -116.02 136.23 53.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.213 -0.449 . . . . 62.32 111.142 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . 0.587 ' O ' HG23 ' A' ' 136' ' ' VAL . 40.2 m80 -113.89 108.09 16.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.162 -0.472 . . . . 74.13 110.872 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.465 HD23 ' H ' ' A' ' 88' ' ' LEU . 0.0 OUTLIER -35.39 144.94 0.22 Allowed Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.621 0.724 . . . . 75.33 110.91 -179.971 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.475 ' HB3' ' H ' ' A' ' 136' ' ' VAL . 53.9 Cg_endo -69.73 104.24 1.28 Allowed 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.678 2.252 . . . . 74.04 112.317 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -103.16 165.68 10.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.231 -0.441 . . . . 65.45 110.859 -179.836 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 66.65 129.02 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.737 -0.744 . . . . 73.13 112.535 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.417 ' C ' ' HG2' ' A' ' 93' ' ' GLN . . . 51.1 33.92 30.78 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.721 -0.752 . . . . 43.01 112.495 -179.893 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.453 ' O ' ' CG ' ' A' ' 134' ' ' GLU . 6.3 pt20 39.07 -154.72 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.848 0.356 . . . . 71.24 110.911 -179.883 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.48 ' HA ' ' CG ' ' A' ' 134' ' ' GLU . 25.2 t80 -95.19 108.26 20.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.178 -0.464 . . . . 73.44 110.935 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.527 ' HG3' HG11 ' A' ' 132' ' ' VAL . 11.7 tptt -107.88 127.94 54.18 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.111 -0.495 . . . . 72.13 110.89 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.585 HD13 ' H ' ' A' ' 97' ' ' GLN . 0.4 OUTLIER -152.25 134.37 5.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.186 -0.461 . . . . 71.1 111.138 179.85 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.585 ' H ' HD13 ' A' ' 96' ' ' ILE . 1.2 mt-30 -109.08 124.63 51.07 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.169 -0.469 . . . . 61.53 110.913 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.767 HD13 HD11 ' A' ' 118' ' ' ILE . 7.9 mt -101.19 140.64 19.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.2 -0.455 . . . . 70.44 111.136 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.522 ' CD2' ' HA ' ' A' ' 104' ' ' PHE . 48.1 m-85 -129.0 146.02 51.09 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 64.22 110.835 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -80.19 -28.65 38.67 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.095 -0.502 . . . . 71.4 110.866 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 29.5 mttt -122.11 166.26 14.82 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.152 -0.476 . . . . 64.01 110.908 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.472 ' HA2' ' HB3' ' A' ' 129' ' ' SER . . . -68.48 178.98 22.13 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.751 -0.738 . . . . 41.52 112.473 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.403 ' C ' ' CG ' ' A' ' 104' ' ' PHE . 38.4 t70 40.91 36.26 0.41 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.845 0.355 . . . . 73.41 110.865 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.672 ' N ' ' CD2' ' A' ' 104' ' ' PHE . 0.0 OUTLIER 50.95 73.13 0.31 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.171 -0.468 . . . . 74.12 110.918 -179.877 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 1.2 m -139.52 161.04 38.46 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.119 -0.491 . . . . 35.15 110.879 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 79.79 -142.2 24.28 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.78 -0.724 . . . . 74.24 112.49 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 3.1 tp-100 -71.03 111.76 6.65 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.749 0.309 . . . . 71.02 110.933 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' MET . . . . . 0.495 ' HB2' ' CE2' ' A' ' 99' ' ' PHE . 5.9 ttp -106.62 149.12 27.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.254 -0.43 . . . . 73.13 110.894 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -153.19 135.15 14.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.227 -0.442 . . . . 73.41 110.891 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -110.19 97.55 7.0 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.117 -0.492 . . . . 74.13 110.888 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 9.7 t -110.3 132.19 54.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.141 -0.481 . . . . 71.54 111.134 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.445 ' O ' ' OG1' ' A' ' 112' ' ' THR . 1.1 t -119.37 36.43 4.48 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.182 -0.463 . . . . 74.14 111.162 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 53.5 mt-10 -151.34 165.59 33.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.241 -0.436 . . . . 63.31 110.891 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -56.25 164.24 1.38 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.136 -0.484 . . . . 52.32 110.856 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . 0.494 ' O ' ' HB2' ' A' ' 172' ' ' SER . 18.4 t -153.12 117.59 2.84 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.617 0.722 . . . . 62.03 110.886 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.426 ' O ' ' C ' ' A' ' 143' ' ' PRO . 53.4 Cg_endo -69.75 -31.97 19.52 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.716 2.277 . . . . 73.22 112.311 -179.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.642 ' HB3' ' CB ' ' A' ' 120' ' ' GLU . 0.1 OUTLIER -148.82 104.51 3.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.23 -0.441 . . . . 54.12 110.914 -179.834 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.767 HD11 HD13 ' A' ' 98' ' ' ILE . 2.9 tt -57.84 -29.46 35.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.131 -0.486 . . . . 61.34 111.129 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' MET . . . . . 0.598 ' O ' ' HA ' ' A' ' 123' ' ' HIS . 11.6 ttp -86.77 -42.96 12.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 64.51 110.835 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.642 ' CB ' ' HB3' ' A' ' 117' ' ' SER . 6.7 tp10 -67.66 -13.23 61.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.271 -0.422 . . . . 71.03 110.856 -179.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 28.3 tp60 -115.48 -48.72 2.78 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.151 -0.477 . . . . 72.43 110.894 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.5 ' HB2' ' O ' ' A' ' 118' ' ' ILE . 33.8 m-85 -103.69 -20.28 14.03 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.253 -0.431 . . . . 75.13 110.912 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.598 ' HA ' ' O ' ' A' ' 119' ' ' MET . 0.2 OUTLIER 71.9 26.41 2.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.114 -0.493 . . . . 71.33 110.854 -179.977 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.463 ' SD ' HG22 ' A' ' 98' ' ' ILE . 7.1 mtt -102.56 83.99 2.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.214 -0.448 . . . . 72.11 110.868 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 1.8 ptp85 -52.12 -29.94 24.11 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.264 -0.426 . . . . 72.4 110.852 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.504 ' HG2' ' HA ' ' A' ' 169' ' ' ALA . 20.9 mt-10 -146.22 130.73 17.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.215 -0.448 . . . . 63.55 110.921 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.653 HD11 HD13 ' A' ' 118' ' ' ILE . 4.4 mm -91.37 103.92 14.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.15 -0.477 . . . . 71.13 111.137 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . 0.421 ' HB3' ' N ' ' A' ' 102' ' ' GLY . 2.3 m170 -71.53 -29.61 64.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.169 -0.469 . . . . 75.13 110.865 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.472 ' HB3' ' HA2' ' A' ' 102' ' ' GLY . 0.3 OUTLIER -153.55 152.74 31.26 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.182 -0.463 . . . . 73.53 110.824 -179.819 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . 0.72 ' O ' ' HB2' ' A' ' 157' ' ' TYR . 0.0 OUTLIER -146.57 112.12 5.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.085 -0.507 . . . . 51.54 110.885 -179.942 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.765 ' HA ' ' HA ' ' A' ' 156' ' ' GLU . 13.4 mtpt -90.78 147.74 23.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 73.14 110.908 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.553 HG12 ' N ' ' A' ' 133' ' ' LEU . 11.3 t 85.03 165.33 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.283 -0.417 . . . . 52.13 111.149 179.875 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.774 HD22 ' HA ' ' A' ' 155' ' ' LYS . 0.3 OUTLIER -179.1 127.79 0.1 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.176 -0.466 . . . . 71.43 110.876 179.959 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.48 ' CG ' ' HA ' ' A' ' 94' ' ' TYR . 0.0 OUTLIER -89.14 -171.51 3.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.116 -0.493 . . . . 60.21 110.881 179.94 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -48.79 -52.83 19.7 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.77 -0.729 . . . . 50.32 112.463 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.81 ' HB ' HD12 ' A' ' 176' ' ' ILE . 3.6 t -147.48 146.92 17.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.841 0.353 . . . . 53.32 111.1 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . 0.667 ' HB3' ' CB ' ' A' ' 152' ' ' LEU . 23.0 t90 -147.04 143.13 28.14 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.196 -0.457 . . . . 73.22 110.932 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.865 HG23 HD13 ' A' ' 61' ' ' ILE . 14.0 mt -123.53 133.69 68.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.244 -0.434 . . . . 60.41 111.119 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.517 ' CE1' ' HB3' ' A' ' 173' ' ' PHE . 0.1 OUTLIER -99.41 166.42 11.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.173 -0.467 . . . . 73.02 110.918 179.936 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -142.17 125.96 17.05 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.159 -0.473 . . . . 62.22 110.925 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.623 ' O ' ' HB2' ' A' ' 171' ' ' GLN . 0.5 OUTLIER -58.77 -25.22 62.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.119 -0.492 . . . . 72.41 110.928 179.977 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.742 ' HB3' ' HD2' ' A' ' 143' ' ' PRO . 9.3 mp -115.65 173.67 2.84 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.635 0.731 . . . . 73.12 110.898 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . 0.805 ' O ' ' OG ' ' A' ' 172' ' ' SER . 54.3 Cg_endo -69.74 -87.59 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.667 2.245 . . . . 62.5 112.325 179.826 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . 0.699 ' O ' ' N ' ' A' ' 146' ' ' ARG . 1.1 m-20 -53.71 96.23 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.205 -0.452 . . . . 54.44 110.889 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . 0.641 ' C ' ' O ' ' A' ' 144' ' ' ASN . 0.0 OUTLIER 13.23 52.6 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.136 -0.484 . . . . 74.55 110.933 -179.933 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.699 ' N ' ' O ' ' A' ' 144' ' ' ASN . 10.6 mtp85 -119.49 174.66 6.25 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.108 -0.496 . . . . 74.3 110.843 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 79.64 -179.96 52.71 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.754 -0.736 . . . . 74.31 112.469 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.671 ' HA ' HD21 ' A' ' 76' ' ' LEU . 17.2 mtt180 -71.67 144.41 49.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.808 0.337 . . . . 71.13 110.896 -179.893 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . 0.536 ' HB2' ' HA ' ' A' ' 60' ' ' TYR . 49.5 mt-30 -83.28 148.51 27.33 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.158 -0.474 . . . . 74.43 110.937 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . 0.496 ' HB2' ' HB2' ' A' ' 139' ' ' PHE . 87.3 m-85 -132.81 118.92 19.59 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.221 -0.445 . . . . 74.2 110.902 -179.824 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.756 ' CA ' HD11 ' A' ' 61' ' ' ILE . 18.7 tp -69.91 136.37 50.53 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.095 -0.502 . . . . 71.23 110.951 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 1.055 ' O ' HD13 ' A' ' 152' ' ' LEU . 0.0 OUTLIER -74.02 135.81 43.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.208 -0.451 . . . . 74.35 110.945 179.873 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . 0.93 ' O ' ' HB2' ' A' ' 154' ' ' LYS . 54.5 t0 -161.39 109.65 1.51 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.21 -0.45 . . . . 65.41 110.877 179.852 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.93 ' HB2' ' O ' ' A' ' 153' ' ' ASP . 0.4 OUTLIER 156.07 -133.29 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.235 -0.439 . . . . 74.43 110.913 179.996 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.774 ' HA ' HD22 ' A' ' 133' ' ' LEU . 0.4 OUTLIER -164.98 -94.78 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.185 -0.461 . . . . 75.4 110.868 179.861 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.765 ' HA ' ' HA ' ' A' ' 131' ' ' LYS . 0.3 OUTLIER -89.76 9.34 27.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.262 -0.426 . . . . 74.25 110.908 179.927 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . 0.813 ' CZ ' ' HB3' ' A' ' 154' ' ' LYS . 1.9 m-85 20.4 108.14 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.124 -0.489 . . . . 65.05 110.945 -179.859 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.35 -34.03 8.9 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.151 -0.477 . . . . 74.02 110.856 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . 0.4 ' HB2' ' HD2' ' A' ' 160' ' ' PRO . 2.8 ptpt -108.92 158.72 33.43 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.654 0.74 . . . . 71.45 110.862 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . 0.463 ' HB2' ' HD3' ' A' ' 168' ' ' PRO . 53.9 Cg_endo -69.73 -21.57 33.43 Favored 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.7 2.267 . . . . 60.42 112.322 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.624 ' H ' HD12 ' A' ' 161' ' ' ILE . 3.4 mp -82.5 3.75 2.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.244 -0.435 . . . . 53.44 111.149 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.402 ' HB3' ' CD1' ' A' ' 157' ' ' TYR . 3.7 m-20 -64.58 -12.85 49.47 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.163 -0.471 . . . . 65.51 110.839 179.896 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' TRP . . . . . 0.492 ' CZ2' ' HB2' ' A' ' 130' ' ' CYS . 19.7 m-90 -105.47 -16.24 14.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.217 -0.447 . . . . 72.11 110.957 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 112.13 -35.33 4.72 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.743 -0.741 . . . . 44.04 112.491 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -62.68 126.58 27.81 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.759 0.314 . . . . 52.33 111.126 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -41.01 -37.5 0.83 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.217 -0.447 . . . . 74.04 111.135 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . 0.483 ' C ' ' H ' ' A' ' 169' ' ' ALA . 0.3 OUTLIER -130.66 157.33 78.0 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.665 0.745 . . . . 64.35 110.863 -179.811 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . 0.463 ' HD3' ' HB2' ' A' ' 160' ' ' PRO . 53.6 Cg_endo -69.74 24.0 0.17 Allowed 'Trans proline' 0 C--N 1.341 0.137 0 C-N-CA 122.642 2.228 . . . . 75.41 112.397 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.504 ' HA ' ' HG2' ' A' ' 126' ' ' GLU . . . -65.57 107.02 1.58 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.204 -0.453 . . . . 75.2 111.097 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.441 HG11 ' CE1' ' A' ' 139' ' ' PHE . 3.3 t -152.94 159.83 3.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.195 -0.457 . . . . 74.21 111.155 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' GLN . . . . . 0.623 ' HB2' ' O ' ' A' ' 141' ' ' GLU . 1.7 tm0? -105.7 -81.19 0.54 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.202 -0.454 . . . . 74.31 110.933 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . 0.805 ' OG ' ' O ' ' A' ' 143' ' ' PRO . 51.6 p -127.2 -178.23 4.36 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 55.12 110.88 -179.817 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . 0.517 ' HB3' ' CE1' ' A' ' 139' ' ' PHE . 27.5 p90 -142.66 167.07 22.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.181 -0.463 . . . . 74.45 110.871 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.88 130.1 19.74 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.127 -0.488 . . . . 62.14 110.852 -179.876 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.47 -169.96 1.62 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.179 -0.464 . . . . 73.54 110.849 -179.896 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . 0.81 HD12 ' HB ' ' A' ' 136' ' ' VAL . 3.7 mt -137.12 134.19 47.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 65.34 111.141 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 95.3 t -150.45 142.37 16.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.181 -0.463 . . . . 74.35 111.121 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . 0.432 ' HB3' HD13 ' A' ' 88' ' ' LEU . 5.3 pt-20 . . . . . 0 C--N 1.33 -0.261 0 CA-C-N 116.175 -0.466 . . . . 72.03 110.922 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.753 0.311 . . . . 74.2 110.895 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -116.47 -62.57 1.57 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.226 -0.443 . . . . 73.22 110.816 -179.767 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 39.5 mmtm 51.35 34.73 12.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.142 -0.481 . . . . 74.13 110.894 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 6.7 t -74.23 -33.74 63.45 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.212 -0.449 . . . . 60.42 111.162 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 177.23 117.91 0.53 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.712 -0.756 . . . . 71.22 112.49 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.446 ' HB ' ' O ' ' A' ' 44' ' ' GLY . 12.8 p -82.56 133.18 35.19 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.847 0.356 . . . . 72.25 111.132 -179.844 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 3.0 tttt -122.4 137.74 54.76 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.214 -0.448 . . . . 73.54 110.908 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.587 ' HB ' ' CD1' ' A' ' 47' ' ' TRP . 15.1 tt -138.38 149.48 24.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.181 -0.463 . . . . 71.33 111.168 179.871 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.497 HG23 ' CG ' ' A' ' 22' ' ' ASP . 15.3 m -129.22 140.4 51.49 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.174 -0.466 . . . . 54.55 111.105 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.82 ' HB2' HD22 ' A' ' 34' ' ' LEU . 0.7 OUTLIER -126.56 130.86 51.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.183 -0.462 . . . . 65.11 110.855 -179.973 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.547 ' CG ' ' HA ' ' A' ' 16' ' ' PHE . 44.5 m-85 -117.41 129.82 56.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.114 -0.494 . . . . 71.14 110.926 -179.877 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.498 ' HG2' ' HB2' ' A' ' 36' ' ' ARG . 0.0 OUTLIER -59.04 -23.95 62.44 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.105 -0.498 . . . . 75.14 110.864 -179.951 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 -127.54 152.67 47.31 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.144 -0.48 . . . . 71.52 110.853 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.436 ' N ' ' HB3' ' A' ' 38' ' ' ASN . 4.2 mtmp? -56.02 -175.36 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.16 -0.473 . . . . 61.22 110.916 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 22.0 m-20 46.02 36.08 2.83 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.242 -0.435 . . . . 73.54 110.879 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.547 ' HA ' ' CG ' ' A' ' 11' ' ' TYR . 4.4 m-85 47.12 57.7 5.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.218 -0.446 . . . . 74.34 110.901 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -132.85 159.91 38.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.141 -0.481 . . . . 74.15 110.879 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 93.41 -151.39 20.34 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.74 -0.743 . . . . 63.45 112.486 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.786 ' O ' HD13 ' A' ' 34' ' ' LEU . 0.0 OUTLIER -67.95 80.92 0.21 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.788 0.327 . . . . 74.41 110.854 -179.84 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.494 ' HA ' ' O ' ' A' ' 10' ' ' PHE . 0.0 OUTLIER -78.83 128.91 33.99 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.222 -0.445 . . . . 75.3 110.864 -179.926 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.511 ' CD2' ' CD2' ' A' ' 30' ' ' PHE . 81.3 t80 -124.57 123.6 40.44 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.174 -0.466 . . . . 73.43 110.876 -179.825 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.497 ' CG ' HG23 ' A' ' 9' ' ' THR . 1.3 m-20 -119.17 134.02 55.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.116 -0.493 . . . . 74.45 110.871 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -165.95 136.61 3.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.234 -0.439 . . . . 64.24 110.887 -179.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -105.1 4.82 31.84 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.202 -0.454 . . . . 74.4 110.85 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 13.4 t -108.14 165.98 11.08 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.22 -0.445 . . . . 55.24 110.916 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -62.67 116.75 5.45 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.195 -0.457 . . . . 62.32 110.857 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.476 ' HB2' ' HB3' ' A' ' 30' ' ' PHE . 7.9 m -118.11 53.93 0.94 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.194 -0.457 . . . . 74.14 110.87 -179.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.53 ' C ' ' HA ' ' A' ' 82' ' ' SER . . . -45.83 -19.72 0.07 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.156 -0.474 . . . . 54.21 111.106 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 53.1 t0 -128.46 42.01 3.39 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.246 -0.433 . . . . 54.51 110.853 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.784 ' O ' ' CD2' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -80.63 13.98 2.3 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.214 -0.448 . . . . 61.43 110.87 -179.899 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.493 ' HB2' ' HB3' ' A' ' 53' ' ' PRO . 29.0 t60 -78.74 -37.18 41.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.157 -0.474 . . . . 75.1 110.852 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.5 t -59.27 -13.17 6.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.182 -0.463 . . . . 75.43 111.095 -179.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -101.39 -26.41 13.6 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.263 -0.426 . . . . 74.03 110.95 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.82 HD22 ' HB2' ' A' ' 10' ' ' PHE . 16.6 tp -142.87 139.96 31.05 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.073 -0.512 . . . . 72.25 110.966 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.1 m -109.05 -32.16 7.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.201 -0.454 . . . . 74.12 110.859 -179.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.498 ' HB2' ' HG2' ' A' ' 12' ' ' GLU . 1.9 mtp85 -115.59 140.36 49.25 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.102 -0.499 . . . . 74.42 110.905 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.543 ' SG ' ' O ' ' A' ' 78' ' ' ASP . 1.3 p -117.65 54.23 0.91 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.249 -0.432 . . . . 71.43 110.866 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.436 ' HB3' ' N ' ' A' ' 14' ' ' LYS . 1.9 m-80 -54.29 -70.09 0.11 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.465 . . . . 74.2 110.9 -179.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 6.4 p -111.83 129.53 56.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.175 -0.466 . . . . 74.23 110.85 -179.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.649 HG21 HD13 ' A' ' 62' ' ' LEU . 20.1 mt -126.08 151.35 32.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.104 -0.498 . . . . 61.14 111.09 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.421 ' N ' ' CG2' ' A' ' 40' ' ' ILE . 0.0 OUTLIER -143.74 119.33 10.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.147 -0.479 . . . . 72.42 110.894 179.825 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.534 HG22 ' HB ' ' A' ' 8' ' ' ILE . 1.2 t -103.98 116.13 47.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.227 -0.442 . . . . 62.31 111.134 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -112.36 80.53 1.35 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.199 -0.455 . . . . 70.4 110.894 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.446 ' O ' ' HB ' ' A' ' 6' ' ' THR . . . 130.34 102.06 0.95 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.727 -0.749 . . . . 73.12 112.493 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 54.35 178.36 0.14 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.763 -0.732 . . . . 72.03 112.523 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.728 HG23 ' HA ' ' A' ' 63' ' ' PRO . 1.3 m -81.99 171.47 14.37 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.725 0.297 . . . . 62.31 111.153 -179.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.597 ' H ' HG22 ' A' ' 46' ' ' THR . 15.9 m95 -141.92 130.0 22.04 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.217 -0.447 . . . . 74.22 110.915 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.905 ' HB2' ' CG2' ' A' ' 86' ' ' VAL . . . -95.37 111.99 23.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.231 -0.44 . . . . 70.43 111.113 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.626 HG11 HD13 ' A' ' 80' ' ' LEU . 5.6 m -115.0 129.55 71.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.218 -0.447 . . . . 73.01 111.153 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.771 ' HB3' ' HA ' ' A' ' 56' ' ' ALA . 35.7 m-85 -95.61 150.6 20.16 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.148 -0.478 . . . . 73.31 110.89 -179.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.626 ' HB2' ' O ' ' A' ' 58' ' ' TYR . 7.1 tt0 -46.51 -77.77 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.104 -0.498 . . . . 74.55 110.889 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.622 ' HB3' ' CD1' ' A' ' 55' ' ' PHE . 1.6 mtp180 -93.44 145.95 30.93 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.567 0.699 . . . . 70.4 110.877 -179.853 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.731 ' HA ' ' OG ' ' A' ' 82' ' ' SER . 53.7 Cg_endo -69.76 134.12 27.22 Favored 'Trans proline' 0 C--N 1.34 0.126 0 C-N-CA 122.715 2.276 . . . . 74.02 112.329 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 66.38 -9.88 0.29 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.267 -0.424 . . . . 71.31 110.899 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.622 ' CD1' ' HB3' ' A' ' 52' ' ' ARG . 4.2 m-30 -100.22 -25.92 14.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.176 -0.465 . . . . 73.4 110.868 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.771 ' HA ' ' HB3' ' A' ' 50' ' ' TYR . . . 57.09 23.0 7.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.17 -0.468 . . . . 75.35 111.092 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . 0.643 ' O ' ' C ' ' A' ' 58' ' ' TYR . 3.4 m0 -52.49 -165.0 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.21 -0.45 . . . . 72.44 110.897 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.643 ' C ' ' O ' ' A' ' 57' ' ' TRP . 5.4 m-30 -12.1 103.84 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.246 -0.434 . . . . 73.35 110.917 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.52 ' HB2' ' HA ' ' A' ' 150' ' ' TYR . 2.0 mpt? -61.52 148.12 43.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.138 -0.483 . . . . 73.32 110.848 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.617 ' O ' HG23 ' A' ' 49' ' ' VAL . 0.3 OUTLIER -161.01 97.66 1.15 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.204 -0.453 . . . . 74.24 110.919 -179.834 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.745 HD11 ' HA ' ' A' ' 151' ' ' LEU . 4.6 mp -89.18 114.52 27.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.14 -0.482 . . . . 74.13 111.101 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.832 HD23 ' HD2' ' A' ' 63' ' ' PRO . 0.6 OUTLIER -85.16 122.21 73.96 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.598 0.713 . . . . 72.12 110.927 179.906 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.832 ' HD2' HD23 ' A' ' 62' ' ' LEU . 54.0 Cg_endo -69.71 -167.49 0.23 Allowed 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.736 2.291 . . . . 71.21 112.324 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.55 160.98 14.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.205 -0.452 . . . . 72.0 110.941 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 114.93 -146.57 18.83 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.714 -0.755 . . . . 73.33 112.516 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -128.3 158.37 38.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.876 0.369 . . . . 72.3 110.912 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.508 ' N ' ' O ' ' A' ' 40' ' ' ILE . 5.7 m-85 -146.78 81.62 9.06 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.648 0.737 . . . . 72.42 110.911 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.468 ' HD2' ' HG3' ' A' ' 72' ' ' ARG . 53.8 Cg_endo -69.81 1.4 4.51 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.643 2.229 . . . . 74.23 112.344 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.413 ' HA ' ' HG2' ' A' ' 14' ' ' LYS . 86.2 mt-10 -156.9 155.08 30.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.212 -0.449 . . . . 62.32 110.891 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.82 ' O ' ' CD1' ' A' ' 73' ' ' TRP . 8.9 p90 -70.6 -1.93 12.67 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.161 -0.472 . . . . 74.11 110.954 -179.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -91.22 -13.82 32.12 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.132 -0.485 . . . . 72.54 110.968 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.468 ' HG3' ' HD2' ' A' ' 68' ' ' PRO . 23.2 mmt180 -73.7 -5.35 40.04 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.162 -0.472 . . . . 75.3 110.902 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . 0.82 ' CD1' ' O ' ' A' ' 70' ' ' TYR . 0.4 OUTLIER -134.71 4.93 3.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.165 -0.47 . . . . 73.41 110.877 -179.933 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.466 ' CB ' ' O ' ' A' ' 73' ' ' TRP . 0.0 OUTLIER 81.13 -17.89 0.53 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.263 -0.426 . . . . 61.52 110.893 179.956 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.458 ' N ' ' CD1' ' A' ' 73' ' ' TRP . . . 40.32 57.66 2.59 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.757 -0.735 . . . . 64.54 112.461 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.577 ' HG ' ' CE2' ' A' ' 60' ' ' TYR . 3.1 pp -50.85 -36.84 39.73 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.787 0.327 . . . . 43.35 110.878 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.562 ' O ' ' CB ' ' A' ' 78' ' ' ASP . 23.7 t-20 -121.82 -47.13 2.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.202 -0.454 . . . . 74.12 110.864 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.562 ' CB ' ' O ' ' A' ' 77' ' ' ASN . 6.3 t0 89.61 5.3 0.14 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.193 -0.458 . . . . 52.13 110.862 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 1.2 ttm-85 -110.46 102.29 10.92 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.176 -0.465 . . . . 74.41 110.898 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.626 HD13 HG11 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -101.12 134.68 43.77 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.225 -0.443 . . . . 73.52 110.93 -179.996 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.578 ' HB3' ' HB3' ' A' ' 53' ' ' PRO . 1.2 m -151.15 -119.35 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.212 -0.449 . . . . 74.54 110.859 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.731 ' OG ' ' HA ' ' A' ' 53' ' ' PRO . 0.5 OUTLIER -38.31 107.65 0.07 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.168 -0.469 . . . . 52.31 110.882 -179.789 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . 0.529 ' HA ' ' O ' ' A' ' 48' ' ' ALA . 8.3 p -115.96 146.66 41.92 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.164 -0.471 . . . . 73.14 110.859 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.54 ' N ' ' O ' ' A' ' 48' ' ' ALA . 0.1 OUTLIER -144.59 128.95 17.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.192 -0.458 . . . . 71.21 110.866 -179.834 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.46 ' N ' ' CZ3' ' A' ' 47' ' ' TRP . . . -48.47 127.81 13.76 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.209 -0.45 . . . . 60.03 111.101 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.905 ' CG2' ' HB2' ' A' ' 48' ' ' ALA . 25.0 t -115.17 139.02 43.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.2 -0.454 . . . . 60.44 111.14 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . 0.556 ' O ' ' CG2' ' A' ' 136' ' ' VAL . 11.8 m170 -112.41 107.11 15.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.164 -0.471 . . . . 74.3 110.835 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.472 ' C ' ' O ' ' A' ' 87' ' ' HIS . 0.0 OUTLIER -32.57 152.96 0.04 OUTLIER Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.619 0.723 . . . . 73.13 110.906 -179.996 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.557 ' HB3' ' H ' ' A' ' 136' ' ' VAL . 53.6 Cg_endo -69.79 84.72 0.65 Allowed 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.689 2.26 . . . . 74.23 112.335 179.845 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -83.27 -171.29 3.49 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.228 -0.442 . . . . 72.12 110.832 -179.842 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 72.05 68.03 1.7 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.754 -0.736 . . . . 73.21 112.442 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 97.03 -69.88 0.79 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.764 -0.731 . . . . 71.11 112.513 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.417 ' HB2' ' H ' ' A' ' 94' ' ' TYR . 6.0 pt20 171.39 -148.88 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.774 0.321 . . . . 65.13 110.933 -179.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.504 ' O ' ' HA ' ' A' ' 112' ' ' THR . 0.0 OUTLIER -107.53 101.78 11.09 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.184 -0.462 . . . . 74.41 110.918 -179.865 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.442 ' HG3' HG11 ' A' ' 132' ' ' VAL . 28.2 tptt -102.07 130.0 48.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.096 -0.502 . . . . 63.41 110.917 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -149.29 135.26 11.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.238 -0.437 . . . . 54.22 111.158 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.426 ' HB2' HG23 ' A' ' 132' ' ' VAL . 1.6 mt-30 -107.87 131.59 54.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.156 -0.474 . . . . 62.34 110.915 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.529 ' CG2' HD12 ' A' ' 127' ' ' ILE . 1.5 mp -113.46 131.31 65.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.186 -0.461 . . . . 72.15 111.104 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.605 ' HB2' ' HB2' ' A' ' 129' ' ' SER . 74.0 m-85 -122.19 136.87 54.97 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.162 -0.472 . . . . 73.14 110.895 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 57.3 tt0 -67.31 -73.94 0.13 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.167 -0.469 . . . . 75.32 110.867 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.518 ' C ' ' HB2' ' A' ' 128' ' ' HIS . 5.1 mttt -84.54 165.73 17.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.193 -0.458 . . . . 74.2 110.954 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -72.23 160.58 54.1 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.757 -0.735 . . . . 40.03 112.461 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.443 ' HA ' ' HB2' ' A' ' 158' ' ' ARG . 29.5 t70 62.56 32.68 16.35 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.819 0.343 . . . . 74.25 110.878 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.508 ' CZ ' ' HB3' ' A' ' 158' ' ' ARG . 13.5 m-85 56.98 49.16 14.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.185 -0.461 . . . . 72.03 110.866 -179.892 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.1 m -113.62 150.97 32.37 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.206 -0.452 . . . . 74.04 110.85 -179.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 89.24 -123.67 6.98 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.762 -0.733 . . . . 72.44 112.471 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 54.8 tp60 -101.21 141.26 34.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.79 0.329 . . . . 74.44 110.877 -179.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 3.2 ttp -131.5 131.52 43.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.211 -0.45 . . . . 74.35 110.876 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 10.0 m-85 -136.81 137.31 39.64 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.451 . . . . 70.43 110.958 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -118.91 112.71 19.98 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.12 -0.491 . . . . 61.35 110.891 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.471 HG22 HD11 ' A' ' 98' ' ' ILE . 11.9 t -125.51 150.41 47.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.152 -0.476 . . . . 72.02 111.104 -179.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.504 ' HA ' ' O ' ' A' ' 94' ' ' TYR . 1.4 t -124.49 47.76 2.06 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.177 -0.465 . . . . 74.31 111.112 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -152.58 -178.21 6.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.227 -0.442 . . . . 63.5 110.893 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -73.86 164.98 25.93 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.165 -0.47 . . . . 63.24 110.849 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . 0.536 ' O ' ' HB2' ' A' ' 172' ' ' SER . 4.8 t -154.33 113.69 2.47 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.591 0.71 . . . . 63.35 110.889 -179.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.41 ' O ' ' CA ' ' A' ' 143' ' ' PRO . 53.1 Cg_endo -69.81 -30.2 22.4 Favored 'Trans proline' 0 C--O 1.231 0.15 0 C-N-CA 122.686 2.257 . . . . 51.55 112.328 -179.895 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.653 ' HB3' ' CB ' ' A' ' 120' ' ' GLU . 0.1 OUTLIER -149.97 98.02 2.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.19 -0.459 . . . . 73.12 110.898 -179.857 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.646 HD13 HD11 ' A' ' 127' ' ' ILE . 3.0 tt -50.55 -29.16 6.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.132 -0.486 . . . . 43.24 111.099 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' MET . . . . . 0.572 ' O ' ' HA ' ' A' ' 123' ' ' HIS . 0.0 OUTLIER -86.39 -45.94 10.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.198 -0.456 . . . . 74.34 110.876 179.866 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.653 ' CB ' ' HB3' ' A' ' 117' ' ' SER . 16.5 tp10 -64.87 -12.94 54.34 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.222 -0.445 . . . . 73.14 110.868 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -113.25 -51.88 2.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.184 -0.462 . . . . 73.02 110.968 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.417 ' HB2' ' O ' ' A' ' 118' ' ' ILE . 93.8 m-85 -103.4 -20.05 14.21 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.155 -0.475 . . . . 73.23 110.905 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.572 ' HA ' ' O ' ' A' ' 119' ' ' MET . 10.9 m80 73.26 26.62 2.06 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.177 -0.465 . . . . 63.12 110.867 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.479 ' SD ' HG22 ' A' ' 98' ' ' ILE . 6.0 mtt -101.16 85.55 2.85 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.221 -0.445 . . . . 70.12 110.862 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 1.7 ptp85 -51.33 -34.11 32.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.254 -0.43 . . . . 74.22 110.89 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.528 ' C ' HD13 ' A' ' 127' ' ' ILE . 40.7 mt-10 -144.34 138.07 27.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.19 -0.459 . . . . 64.53 110.883 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.646 HD11 HD13 ' A' ' 118' ' ' ILE . 3.4 mm -99.88 96.6 5.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.115 -0.493 . . . . 71.33 111.129 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . 0.525 ' CD2' ' HG3' ' A' ' 168' ' ' PRO . 11.0 m170 -69.43 -31.69 70.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.232 -0.44 . . . . 72.3 110.831 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.605 ' HB2' ' HB2' ' A' ' 99' ' ' PHE . 0.3 OUTLIER -132.65 145.34 51.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.247 -0.433 . . . . 73.12 110.854 -179.778 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . 0.609 ' SG ' HG21 ' A' ' 127' ' ' ILE . 0.3 OUTLIER -147.25 119.1 8.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.149 -0.478 . . . . 34.01 110.874 -179.931 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.604 ' C ' HG23 ' A' ' 132' ' ' VAL . 6.9 mtpp -108.14 157.83 17.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.176 -0.466 . . . . 73.24 110.924 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.604 HG23 ' C ' ' A' ' 131' ' ' LYS . 3.5 t 81.58 169.06 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.237 -0.438 . . . . 75.34 111.089 179.836 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.972 HD23 ' HG3' ' A' ' 155' ' ' LYS . 0.2 OUTLIER -165.85 128.18 2.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.138 -0.483 . . . . 74.53 110.912 179.927 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.516 ' O ' ' C ' ' A' ' 135' ' ' GLY . 1.4 mp0 -98.15 141.26 31.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.456 . . . . 62.5 110.888 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.55 ' HA3' ' HA ' ' A' ' 89' ' ' PRO . . . -27.25 -44.79 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.735 -0.745 . . . . 62.0 112.479 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.871 ' HB ' HD12 ' A' ' 176' ' ' ILE . 2.0 t -149.85 127.88 2.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.834 0.349 . . . . 75.33 111.157 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . 0.673 ' HB3' ' CB ' ' A' ' 152' ' ' LEU . 26.1 t90 -142.08 145.53 34.42 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.173 -0.467 . . . . 73.53 110.893 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.61 HG23 HD13 ' A' ' 61' ' ' ILE . 7.1 mt -123.19 130.01 74.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.252 -0.431 . . . . 74.13 111.11 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.623 ' CE1' HG11 ' A' ' 170' ' ' VAL . 0.1 OUTLIER -97.36 147.36 24.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.155 -0.475 . . . . 72.24 110.897 179.965 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.446 ' CD2' ' HA ' ' A' ' 145' ' ' TYR . 8.6 m-85 -124.26 124.69 42.97 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.124 -0.489 . . . . 74.25 110.895 -179.846 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.56 ' O ' ' HB2' ' A' ' 171' ' ' GLN . 0.0 OUTLIER -58.96 -25.24 63.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.133 -0.485 . . . . 72.21 110.909 179.996 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.823 ' HB3' ' HD2' ' A' ' 143' ' ' PRO . 9.1 mp -118.06 175.9 1.87 Allowed Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.603 0.716 . . . . 74.12 110.886 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . 0.823 ' HD2' ' HB3' ' A' ' 142' ' ' LEU . 54.0 Cg_endo -69.74 -90.98 0.01 OUTLIER 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.66 2.24 . . . . 73.15 112.378 179.836 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . 0.981 ' O ' ' HG2' ' A' ' 146' ' ' ARG . 0.0 OUTLIER -49.6 86.26 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.175 -0.466 . . . . 74.42 110.872 -179.968 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . 0.59 ' C ' ' O ' ' A' ' 144' ' ' ASN . 2.6 m-85 19.73 43.03 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.185 -0.461 . . . . 70.21 110.897 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.981 ' HG2' ' O ' ' A' ' 144' ' ' ASN . 12.8 mmm-85 -101.21 178.49 4.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.092 -0.504 . . . . 75.23 110.853 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 73.51 -166.31 54.65 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.735 -0.745 . . . . 55.55 112.467 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -86.25 159.81 19.34 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.77 0.319 . . . . 72.11 110.848 -179.806 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . 0.511 ' HB2' ' HA ' ' A' ' 60' ' ' TYR . 50.3 mt-30 -94.41 153.16 18.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.163 -0.471 . . . . 74.04 110.874 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . 0.562 ' HB2' ' CB ' ' A' ' 139' ' ' PHE . 95.9 m-85 -135.11 119.2 17.55 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.183 -0.462 . . . . 71.41 110.976 -179.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.745 ' HA ' HD11 ' A' ' 61' ' ' ILE . 22.8 tp -65.11 136.8 57.14 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.09 -0.505 . . . . 61.15 110.894 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.931 ' O ' HD13 ' A' ' 152' ' ' LEU . 0.0 OUTLIER -73.03 134.23 44.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.222 -0.445 . . . . 54.44 110.945 179.85 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -165.27 30.88 0.06 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.212 -0.449 . . . . 54.33 110.908 179.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.754 ' O ' ' HG3' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -111.76 -172.27 2.01 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.16 -0.473 . . . . 70.02 110.945 179.947 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.972 ' HG3' HD23 ' A' ' 133' ' ' LEU . 0.0 OUTLIER -159.86 -129.43 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.239 -0.437 . . . . 73.43 110.869 179.849 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.579 ' HA ' ' HA ' ' A' ' 131' ' ' LYS . 2.1 tm-20 -70.27 4.94 1.92 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.215 -0.448 . . . . 74.24 110.883 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . 0.783 ' CD1' ' HB3' ' A' ' 162' ' ' ASP . 21.2 m-30 -30.7 148.19 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.135 -0.484 . . . . 72.0 110.895 -179.818 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . 0.508 ' HB3' ' CZ ' ' A' ' 104' ' ' PHE . 10.4 ptp180 -118.54 -31.87 4.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.065 -0.516 . . . . 75.3 110.841 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . 0.53 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 2.1 ptpp? -99.64 153.22 37.89 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.584 0.707 . . . . 72.04 110.889 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . 0.473 ' HB3' ' HB3' ' A' ' 168' ' ' PRO . 53.4 Cg_endo -69.82 -25.23 28.54 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.693 2.262 . . . . 75.31 112.312 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.681 ' H ' HD12 ' A' ' 161' ' ' ILE . 3.8 mp -75.46 4.19 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.229 -0.441 . . . . 73.04 111.131 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.783 ' HB3' ' CD1' ' A' ' 157' ' ' TYR . 0.2 OUTLIER -72.63 -21.12 61.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.151 -0.477 . . . . 72.23 110.831 179.856 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' TRP . . . . . 0.51 ' CD1' ' N ' ' A' ' 163' ' ' TRP . 0.0 OUTLIER -108.65 13.47 25.16 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.238 -0.437 . . . . 73.14 110.92 -179.934 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 84.94 -29.21 4.26 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.724 -0.75 . . . . 13.42 112.502 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -53.65 118.95 4.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.798 0.332 . . . . 61.02 111.092 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -48.78 -26.1 2.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.249 -0.432 . . . . 70.1 111.123 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . 0.484 ' C ' ' H ' ' A' ' 169' ' ' ALA . 0.3 OUTLIER -155.71 157.19 31.4 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.69 0.757 . . . . 71.23 110.791 -179.779 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . 0.525 ' HG3' ' CD2' ' A' ' 128' ' ' HIS . 54.0 Cg_endo -69.78 22.24 0.17 Allowed 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.666 2.244 . . . . 73.32 112.353 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.494 ' HA ' ' HG2' ' A' ' 126' ' ' GLU . . . -64.66 103.76 0.73 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.239 -0.437 . . . . 52.12 111.071 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.623 HG11 ' CE1' ' A' ' 139' ' ' PHE . 2.9 t -152.59 160.91 2.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.169 -0.469 . . . . 74.41 111.11 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' GLN . . . . . 0.619 ' OE1' ' HB3' ' A' ' 143' ' ' PRO . 1.7 tm0? -108.13 -81.66 0.56 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.194 -0.457 . . . . 71.43 110.877 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . 0.702 ' OG ' ' O ' ' A' ' 143' ' ' PRO . 24.9 p -129.8 179.48 5.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 65.4 110.834 -179.795 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . 0.405 ' HB3' ' CD1' ' A' ' 139' ' ' PHE . 27.4 p90 -144.2 167.81 21.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.14 -0.482 . . . . 65.52 110.853 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . 0.408 ' CD ' HD12 ' A' ' 138' ' ' ILE . 0.1 OUTLIER -139.13 135.98 34.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.139 -0.482 . . . . 73.24 110.876 -179.918 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . 0.486 ' HD2' ' CE2' ' A' ' 94' ' ' TYR . 0.1 OUTLIER -82.93 -167.04 1.5 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.196 -0.456 . . . . 64.15 110.879 -179.937 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . 0.871 HD12 ' HB ' ' A' ' 136' ' ' VAL . 4.2 mt -139.75 132.72 35.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.194 -0.457 . . . . 75.31 111.151 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 11.5 t -132.77 147.68 31.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.159 -0.473 . . . . 52.24 111.08 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . 0.417 ' HB3' HD13 ' A' ' 88' ' ' LEU . 3.6 pt-20 . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.178 -0.464 . . . . 73.14 110.852 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.2 mtm . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.839 0.352 . . . . 74.44 110.905 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -150.9 153.23 34.91 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.198 -0.456 . . . . 74.3 110.843 -179.796 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 30.8 mmtp -101.67 58.68 0.85 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.149 -0.478 . . . . 74.01 110.876 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 25.9 p -53.68 -39.77 65.4 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.255 -0.429 . . . . 61.04 111.126 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 161.83 145.99 4.51 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.747 -0.739 . . . . 65.32 112.554 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.497 ' C ' ' HE1' ' A' ' 47' ' ' TRP . 6.3 p -81.76 135.72 35.46 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.859 0.361 . . . . 53.21 111.135 -179.884 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.408 ' HA ' ' HA ' ' A' ' 24' ' ' ASP . 3.2 tttt -121.93 135.84 54.89 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.198 -0.455 . . . . 70.14 110.911 179.869 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.604 ' HB ' ' CD1' ' A' ' 47' ' ' TRP . 15.1 tt -136.91 150.54 26.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.232 -0.44 . . . . 74.52 111.132 179.839 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.492 HG23 ' CG ' ' A' ' 22' ' ' ASP . 9.9 m -131.01 142.05 50.29 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.162 -0.472 . . . . 61.44 111.158 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.774 ' HB2' HD22 ' A' ' 34' ' ' LEU . 1.2 m-85 -128.48 129.95 46.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 74.15 110.863 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.533 ' CG ' ' HA ' ' A' ' 16' ' ' PHE . 18.9 m-85 -116.23 131.4 56.95 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.188 -0.46 . . . . 74.23 110.886 -179.832 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.495 ' HG2' ' HB2' ' A' ' 36' ' ' ARG . 0.0 OUTLIER -58.24 -25.41 61.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.141 -0.481 . . . . 73.41 110.897 179.978 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 59.5 m-20 -127.16 152.57 47.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.144 -0.48 . . . . 71.34 110.905 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.49 ' N ' ' HB3' ' A' ' 38' ' ' ASN . 34.8 mtmt -56.08 -175.35 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.266 -0.424 . . . . 41.44 110.938 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 18.6 m120 46.96 34.13 2.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.233 -0.44 . . . . 75.3 110.882 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.533 ' HA ' ' CG ' ' A' ' 11' ' ' TYR . 4.2 m-85 48.51 57.18 6.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.217 -0.447 . . . . 73.2 110.867 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 14.7 mt-30 -131.98 157.24 44.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.12 -0.491 . . . . 71.44 110.92 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 95.5 -150.79 19.78 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.775 -0.726 . . . . 45.12 112.537 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.805 ' O ' HD13 ' A' ' 34' ' ' LEU . 0.1 OUTLIER -69.45 81.08 0.39 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.746 0.308 . . . . 73.23 110.889 -179.878 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.477 ' HB2' ' CE1' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -79.21 128.67 33.59 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.203 -0.453 . . . . 74.45 110.862 -179.884 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.47 ' CD2' ' CD2' ' A' ' 30' ' ' PHE . 75.6 t80 -124.41 125.06 43.65 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.181 -0.463 . . . . 65.02 110.944 -179.849 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.492 ' CG ' HG23 ' A' ' 9' ' ' THR . 1.4 m-20 -119.08 133.7 55.65 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.136 -0.484 . . . . 71.32 110.83 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 10.1 t -161.33 133.05 5.61 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 63.14 110.885 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.408 ' HA ' ' HA ' ' A' ' 7' ' ' LYS . 12.3 p-10 -100.86 -3.07 30.47 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.16 -0.473 . . . . 73.42 110.875 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 34.3 t -106.61 160.99 15.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.456 . . . . 71.45 110.905 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -48.16 120.38 3.52 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.216 -0.447 . . . . 73.51 110.828 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.67 ' HB2' ' HB3' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -115.54 46.61 1.46 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.218 -0.446 . . . . 70.11 110.832 -179.884 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.563 ' O ' ' HA ' ' A' ' 82' ' ' SER . . . -49.12 -21.01 0.65 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.191 -0.458 . . . . 62.32 111.1 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 60.8 t0 -128.56 40.86 3.59 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.224 -0.444 . . . . 72.0 110.889 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.792 ' O ' ' CD2' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -81.46 16.92 1.51 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.177 -0.465 . . . . 75.32 110.842 -179.874 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.501 ' HB2' ' HB3' ' A' ' 81' ' ' SER . 37.6 t60 -81.45 -35.14 30.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.158 -0.474 . . . . 73.52 110.9 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.8 t -64.52 -7.93 11.98 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.169 -0.469 . . . . 72.21 111.152 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -106.09 -28.21 10.64 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.215 -0.448 . . . . 65.41 110.895 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.805 HD13 ' O ' ' A' ' 19' ' ' ARG . 19.1 tp -141.36 144.83 34.75 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.121 -0.49 . . . . 73.14 110.882 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.1 m -111.29 -33.79 6.33 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.138 -0.483 . . . . 73.34 110.842 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.542 ' O ' HD21 ' A' ' 34' ' ' LEU . 2.3 mtp85 -116.66 140.64 49.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.095 -0.502 . . . . 74.25 110.903 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.626 ' HB3' ' HB2' ' A' ' 80' ' ' LEU . 6.3 p -117.37 59.08 0.78 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.199 -0.455 . . . . 74.04 110.873 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.49 ' HB3' ' N ' ' A' ' 14' ' ' LYS . 1.3 m-80 -57.38 -72.55 0.08 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.224 -0.443 . . . . 62.33 110.849 -179.859 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 4.5 p -108.08 127.06 53.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.204 -0.453 . . . . 63.52 110.901 -179.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.765 HD12 ' CH2' ' A' ' 73' ' ' TRP . 23.3 mt -120.55 149.18 23.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.187 -0.46 . . . . 74.22 111.127 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.446 ' HD2' ' CE2' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -143.73 121.55 11.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.122 -0.49 . . . . 60.01 110.89 179.842 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.524 HG22 ' HB ' ' A' ' 8' ' ' ILE . 1.5 t -107.04 115.65 48.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.203 -0.453 . . . . 64.04 111.074 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -111.36 79.26 1.19 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.116 -0.493 . . . . 74.33 110.908 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.429 ' O ' ' HB ' ' A' ' 6' ' ' THR . . . 132.75 102.12 0.81 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.737 -0.744 . . . . 44.42 112.508 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 53.2 178.12 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.761 -0.733 . . . . 72.23 112.469 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.718 HG23 ' HA ' ' A' ' 63' ' ' PRO . 0.7 OUTLIER -76.78 170.63 16.11 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.729 0.3 . . . . 45.35 111.168 -179.875 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.604 ' CD1' ' HB ' ' A' ' 8' ' ' ILE . 4.0 m95 -144.66 129.98 18.75 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.215 -0.448 . . . . 74.13 110.938 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.804 ' HB2' ' CG2' ' A' ' 86' ' ' VAL . . . -93.2 126.1 38.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.243 -0.435 . . . . 60.04 111.136 179.893 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.702 HG12 ' HB3' ' A' ' 83' ' ' CYS . 17.2 m -124.58 142.18 42.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.22 -0.446 . . . . 71.32 111.113 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.925 ' HB3' ' CB ' ' A' ' 56' ' ' ALA . 7.0 m-85 -116.92 143.53 45.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.127 -0.488 . . . . 73.23 110.977 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.554 ' HG2' ' N ' ' A' ' 52' ' ' ARG . 0.3 OUTLIER -49.47 -83.63 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.154 -0.475 . . . . 70.0 110.865 -179.976 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.903 ' O ' ' HB2' ' A' ' 56' ' ' ALA . 1.2 mtp180 -81.67 138.58 47.26 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.562 0.696 . . . . 75.23 110.914 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.746 ' HA ' ' OG ' ' A' ' 82' ' ' SER . 53.8 Cg_endo -69.75 138.14 37.17 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.672 2.248 . . . . 53.34 112.366 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.467 ' C ' ' CD2' ' A' ' 55' ' ' PHE . 6.3 m-20 66.67 -6.75 0.5 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.245 -0.434 . . . . 65.03 110.87 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.473 ' H ' ' C ' ' A' ' 53' ' ' PRO . 0.0 OUTLIER -139.86 -75.82 0.34 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.223 -0.444 . . . . 74.23 110.885 -179.966 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.925 ' CB ' ' HB3' ' A' ' 50' ' ' TYR . . . 45.71 79.98 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.19 -0.459 . . . . 74.31 111.044 179.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . 0.546 ' O ' ' CD2' ' A' ' 58' ' ' TYR . 54.1 m95 -64.72 33.71 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.257 -0.429 . . . . 71.3 110.901 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.603 ' H ' ' C ' ' A' ' 56' ' ' ALA . 1.4 m-30 -163.25 120.61 1.88 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.22 -0.446 . . . . 72.35 110.91 -179.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.496 ' HB2' ' HA ' ' A' ' 150' ' ' TYR . 1.0 OUTLIER -85.74 138.84 31.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.099 -0.5 . . . . 65.04 110.873 179.895 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.519 ' CE2' ' HG ' ' A' ' 76' ' ' LEU . 2.8 t80 -153.28 101.68 2.55 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.223 -0.444 . . . . 74.44 110.92 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.747 ' N ' HD12 ' A' ' 61' ' ' ILE . 1.8 mp -90.25 116.98 32.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.134 -0.485 . . . . 74.43 111.156 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.76 HD23 ' HD2' ' A' ' 63' ' ' PRO . 0.2 OUTLIER -82.74 130.88 56.46 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 121.554 0.693 . . . . 75.32 110.962 179.917 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.76 ' HD2' HD23 ' A' ' 62' ' ' LEU . 53.9 Cg_endo -69.72 -171.94 0.52 Allowed 'Trans proline' 0 C--N 1.341 0.132 0 C-N-CA 122.663 2.242 . . . . 74.12 112.359 179.887 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.92 162.53 14.73 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.219 -0.446 . . . . 63.21 110.937 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 112.3 -168.47 12.7 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.78 -0.724 . . . . 64.35 112.498 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -107.47 152.29 24.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.893 0.378 . . . . 72.31 110.89 -179.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.62 ' HB2' ' O ' ' A' ' 40' ' ' ILE . 11.2 m-85 -141.25 84.95 12.29 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.716 0.77 . . . . 70.55 110.935 -179.864 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.427 ' HD2' ' HG3' ' A' ' 72' ' ' ARG . 53.8 Cg_endo -69.79 0.17 6.06 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.701 2.267 . . . . 64.31 112.353 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.524 ' HB2' ' HG2' ' A' ' 72' ' ' ARG . 51.7 mt-10 -155.47 142.43 19.1 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.21 -0.45 . . . . 75.12 110.917 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.703 ' HA ' ' CE2' ' A' ' 73' ' ' TRP . 26.8 p90 -55.75 -20.06 13.38 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.145 -0.48 . . . . 73.12 110.963 -179.878 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -80.97 -16.01 54.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.093 -0.503 . . . . 73.5 110.9 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.524 ' HG2' ' HB2' ' A' ' 69' ' ' GLU . 27.9 mmt180 -69.88 -9.26 54.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.212 -0.449 . . . . 74.15 110.894 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . 0.765 ' CH2' HD12 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -133.74 17.53 3.9 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.187 -0.46 . . . . 71.43 110.919 -179.976 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.443 ' C ' ' O ' ' A' ' 73' ' ' TRP . 19.8 ptp 34.82 47.64 0.26 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.232 -0.44 . . . . 70.01 110.882 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -66.75 117.75 9.72 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.701 -0.761 . . . . 65.12 112.49 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.519 ' HG ' ' CE2' ' A' ' 60' ' ' TYR . 0.7 OUTLIER -61.08 -34.78 75.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.824 0.345 . . . . 65.41 110.927 -179.936 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.427 ' HB2' HD12 ' A' ' 76' ' ' LEU . 13.5 t-20 -125.57 134.12 52.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.183 -0.462 . . . . 70.42 110.889 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -88.4 16.36 6.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.181 -0.463 . . . . 54.44 110.886 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.4 ' HD3' ' HA ' ' A' ' 52' ' ' ARG . 0.9 OUTLIER -108.51 80.19 1.32 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.16 -0.473 . . . . 75.22 110.834 -179.895 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.626 ' HB2' ' HB3' ' A' ' 37' ' ' CYS . 0.0 OUTLIER -81.39 134.36 35.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 74.51 110.905 179.992 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.662 ' HB3' ' HB3' ' A' ' 53' ' ' PRO . 1.5 m -150.74 -118.89 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.188 -0.46 . . . . 74.52 110.86 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.746 ' OG ' ' HA ' ' A' ' 53' ' ' PRO . 0.0 OUTLIER -41.19 103.03 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.151 -0.477 . . . . 73.55 110.872 -179.815 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . 0.702 ' HB3' HG12 ' A' ' 49' ' ' VAL . 24.7 p -126.83 131.67 51.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.138 -0.483 . . . . 43.24 110.883 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.596 ' N ' ' O ' ' A' ' 48' ' ' ALA . 8.9 mmt85 -113.63 151.21 32.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.181 -0.463 . . . . 75.55 110.852 -179.86 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -68.41 128.34 36.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.19 -0.459 . . . . 63.14 111.095 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.885 ' CG1' HG11 ' A' ' 136' ' ' VAL . 90.4 t -115.63 128.46 72.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.225 -0.443 . . . . 55.23 111.126 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . 0.523 ' O ' HG23 ' A' ' 136' ' ' VAL . 62.3 m80 -108.34 121.71 45.49 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.143 -0.48 . . . . 74.32 110.831 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.411 ' C ' ' O ' ' A' ' 87' ' ' HIS . 0.2 OUTLIER -37.47 138.01 0.62 Allowed Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.578 0.704 . . . . 75.31 110.904 -179.979 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.706 ' HB3' ' H ' ' A' ' 136' ' ' VAL . 53.7 Cg_endo -69.76 98.53 0.69 Allowed 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.662 2.241 . . . . 63.01 112.352 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -101.19 -176.29 3.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.204 -0.453 . . . . 61.21 110.868 -179.854 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 53.98 51.49 49.48 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.742 -0.742 . . . . 52.21 112.505 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.428 ' O ' ' C ' ' A' ' 93' ' ' GLN . . . 126.41 28.24 1.01 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.752 -0.737 . . . . 71.54 112.476 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.507 ' O ' ' HG2' ' A' ' 134' ' ' GLU . 11.4 pt20 36.25 -117.92 0.13 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.839 0.352 . . . . 75.32 110.893 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.53 ' O ' ' HA ' ' A' ' 112' ' ' THR . 0.0 OUTLIER -123.57 99.75 6.46 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.159 -0.473 . . . . 73.12 110.881 -179.863 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.526 ' HG3' HG11 ' A' ' 132' ' ' VAL . 46.2 tptt -111.07 128.32 55.84 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.118 -0.492 . . . . 64.34 110.915 179.863 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.485 HD13 ' N ' ' A' ' 97' ' ' GLN . 0.0 OUTLIER -150.55 141.36 16.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.229 -0.441 . . . . 72.31 111.157 179.831 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.528 ' HB2' HG23 ' A' ' 132' ' ' VAL . 2.2 mt-30 -108.44 130.93 55.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.214 -0.448 . . . . 71.43 110.874 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.679 HD11 HG22 ' A' ' 111' ' ' THR . 1.3 mp -111.25 135.38 50.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.162 -0.472 . . . . 63.44 111.146 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.652 ' HB2' ' HB2' ' A' ' 129' ' ' SER . 8.3 m-85 -125.15 144.27 50.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.199 -0.455 . . . . 72.51 110.934 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 78.5 tt0 -71.36 -75.92 0.12 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.2 -0.454 . . . . 75.02 110.892 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.474 ' C ' ' HB3' ' A' ' 128' ' ' HIS . 41.4 mttt -82.35 175.06 10.55 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.178 -0.464 . . . . 65.34 110.906 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.438 ' N ' ' HB3' ' A' ' 128' ' ' HIS . . . -88.24 158.24 28.8 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.736 -0.745 . . . . 13.13 112.497 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.466 ' HA ' ' HB2' ' A' ' 158' ' ' ARG . 27.9 t0 67.2 54.42 0.73 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.819 0.342 . . . . 71.52 110.82 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.66 ' CE1' ' HD2' ' A' ' 131' ' ' LYS . 6.8 m-85 48.19 31.64 2.68 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.202 -0.454 . . . . 64.41 110.912 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.418 ' C ' ' HB2' ' A' ' 101' ' ' LYS . 49.2 m -107.36 150.62 26.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.159 -0.473 . . . . 73.52 110.873 -179.796 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 91.32 -164.65 29.63 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.69 -0.767 . . . . 50.34 112.441 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 45.0 tp60 -74.67 130.27 39.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.802 0.334 . . . . 71.11 110.938 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -115.76 131.82 56.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.207 -0.451 . . . . 63.41 110.904 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -137.63 138.09 39.12 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.222 -0.444 . . . . 72.44 110.932 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -114.86 111.66 21.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.145 -0.48 . . . . 65.45 110.937 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.679 HG22 HD11 ' A' ' 98' ' ' ILE . 12.2 t -122.06 142.2 50.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.165 -0.47 . . . . 74.25 111.115 -179.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.53 ' HA ' ' O ' ' A' ' 94' ' ' TYR . 3.8 t -119.02 39.14 3.62 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.182 -0.463 . . . . 75.2 111.125 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -151.29 156.32 40.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.233 -0.44 . . . . 74.55 110.912 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -53.7 159.68 1.53 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.131 -0.486 . . . . 73.51 110.914 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . 0.549 ' O ' ' HB2' ' A' ' 172' ' ' SER . 29.4 t -146.32 120.17 5.23 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-O 121.6 0.714 . . . . 74.21 110.918 -179.884 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.452 ' O ' ' C ' ' A' ' 143' ' ' PRO . 53.7 Cg_endo -69.67 -32.76 18.31 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.668 2.245 . . . . 71.25 112.361 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.65 ' HB3' ' CB ' ' A' ' 120' ' ' GLU . 0.1 OUTLIER -148.63 101.72 3.24 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.186 -0.461 . . . . 71.44 110.842 -179.772 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.713 HD13 HD11 ' A' ' 127' ' ' ILE . 3.3 tt -54.47 -29.57 20.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.123 -0.49 . . . . 63.24 111.156 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' MET . . . . . 0.591 ' O ' ' HA ' ' A' ' 123' ' ' HIS . 49.2 ttp -86.2 -44.29 12.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 63.01 110.902 179.819 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.65 ' CB ' ' HB3' ' A' ' 117' ' ' SER . 12.6 tp10 -66.48 -12.47 57.53 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.223 -0.444 . . . . 73.0 110.865 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 25.0 tp60 -114.64 -49.06 2.83 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.156 -0.474 . . . . 72.34 110.934 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.437 ' HB2' ' O ' ' A' ' 118' ' ' ILE . 86.1 m-85 -105.23 -19.15 13.9 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.197 -0.456 . . . . 71.14 110.865 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.591 ' HA ' ' O ' ' A' ' 119' ' ' MET . 11.4 m80 72.18 26.94 2.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.154 -0.475 . . . . 73.34 110.875 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.473 ' SD ' HG22 ' A' ' 98' ' ' ILE . 8.9 mtt -102.2 86.44 2.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.182 -0.463 . . . . 72.33 110.876 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 1.7 ptp85 -51.59 -34.54 37.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.245 -0.434 . . . . 70.44 110.913 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.486 ' HG2' ' HA ' ' A' ' 169' ' ' ALA . 35.9 mt-10 -144.89 133.57 22.19 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.152 -0.476 . . . . 73.43 110.897 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.713 HD11 HD13 ' A' ' 118' ' ' ILE . 3.5 mm -94.73 89.77 2.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.147 -0.478 . . . . 72.14 111.15 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . 0.474 ' HB3' ' C ' ' A' ' 101' ' ' LYS . 0.6 OUTLIER -62.58 -33.27 74.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.2 -0.455 . . . . 63.42 110.846 179.862 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.652 ' HB2' ' HB2' ' A' ' 99' ' ' PHE . 69.9 m -130.58 141.53 50.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 63.43 110.871 -179.747 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . 0.614 ' O ' ' O ' ' A' ' 155' ' ' LYS . 0.1 OUTLIER -142.84 122.31 13.19 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.178 -0.464 . . . . 62.24 110.91 -179.959 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.66 ' HD2' ' CE1' ' A' ' 104' ' ' PHE . 7.1 mtpp -115.74 155.61 27.46 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.169 -0.469 . . . . 63.24 110.861 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.546 HG12 ' N ' ' A' ' 133' ' ' LEU . 18.1 t 84.92 163.72 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.242 -0.435 . . . . 72.42 111.114 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.731 HD22 ' CG ' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -178.95 122.86 0.09 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.162 -0.472 . . . . 73.14 110.898 180.0 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.507 ' HG2' ' O ' ' A' ' 93' ' ' GLN . 0.0 OUTLIER -92.49 171.23 9.17 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.225 -0.443 . . . . 63.32 110.912 179.863 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.455 ' C ' ' O ' ' A' ' 134' ' ' GLU . . . -32.67 -53.08 0.47 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.754 -0.736 . . . . 50.01 112.482 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.885 HG11 ' CG1' ' A' ' 86' ' ' VAL . 4.1 t -148.81 146.13 17.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.858 0.361 . . . . 63.51 111.109 -179.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . 0.65 ' H ' HD12 ' A' ' 152' ' ' LEU . 0.7 OUTLIER -150.01 163.34 38.4 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.146 -0.479 . . . . 74.42 110.893 179.975 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.557 HD12 HH11 ' A' ' 174' ' ' ARG . 4.7 mt -143.18 136.65 25.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.186 -0.461 . . . . 60.44 111.109 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.689 ' CD1' HG11 ' A' ' 170' ' ' VAL . 0.2 OUTLIER -102.55 168.79 9.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.204 -0.453 . . . . 73.33 110.882 179.989 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.47 ' CD2' ' HA ' ' A' ' 145' ' ' TYR . 0.5 OUTLIER -139.88 127.65 21.91 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.131 -0.486 . . . . 51.44 110.959 -179.85 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.602 ' O ' ' HB2' ' A' ' 171' ' ' GLN . 0.7 OUTLIER -60.79 -28.41 68.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.134 -0.484 . . . . 75.42 110.893 -179.986 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.736 ' HB3' ' HD2' ' A' ' 143' ' ' PRO . 9.2 mp -115.06 173.63 2.81 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.621 0.724 . . . . 73.32 110.909 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . 0.742 ' O ' ' OG ' ' A' ' 172' ' ' SER . 53.8 Cg_endo -69.76 -89.59 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.603 2.202 . . . . 62.21 112.363 179.852 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . 0.711 ' O ' ' N ' ' A' ' 146' ' ' ARG . 1.3 m-20 -53.13 97.63 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.203 -0.453 . . . . 72.41 110.911 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . 0.637 ' C ' ' O ' ' A' ' 144' ' ' ASN . 33.1 m-85 12.51 52.36 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.169 -0.469 . . . . 72.15 110.932 -179.882 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.711 ' N ' ' O ' ' A' ' 144' ' ' ASN . 19.5 mtt-85 -117.85 172.6 7.28 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.095 -0.502 . . . . 63.22 110.91 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 77.55 -176.86 53.35 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.759 -0.734 . . . . 54.34 112.523 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -78.08 149.62 33.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.76 0.314 . . . . 72.22 110.895 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 63.3 mt-30 -85.71 157.24 20.34 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.217 -0.447 . . . . 75.52 110.945 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . 0.509 ' HB2' ' HB2' ' A' ' 139' ' ' PHE . 88.8 m-85 -137.78 109.78 7.22 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.229 -0.441 . . . . 74.03 110.905 -179.837 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.637 ' HB2' HD11 ' A' ' 61' ' ' ILE . 20.2 tp -59.76 136.11 57.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.097 -0.502 . . . . 73.52 110.924 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 1.045 ' O ' HD13 ' A' ' 152' ' ' LEU . 0.0 OUTLIER -68.93 137.17 53.57 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.18 -0.464 . . . . 71.51 110.905 179.881 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . 0.442 ' N ' HD22 ' A' ' 152' ' ' LEU . 1.3 t70 -164.15 24.94 0.07 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.223 -0.444 . . . . 73.24 110.922 179.814 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.924 ' HB2' ' CD1' ' A' ' 157' ' ' TYR . 2.2 ptmt -122.0 -174.62 2.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.131 -0.486 . . . . 44.01 110.872 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.731 ' CG ' HD22 ' A' ' 133' ' ' LEU . 0.0 OUTLIER -158.66 -124.8 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.243 -0.435 . . . . 74.14 110.891 179.871 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.629 ' HA ' ' HA ' ' A' ' 131' ' ' LYS . 0.5 OUTLIER -64.75 -4.67 4.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.45 . . . . 74.43 110.89 179.943 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . 0.924 ' CD1' ' HB2' ' A' ' 154' ' ' LYS . 14.2 m-30 -26.42 141.33 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.143 -0.48 . . . . 54.32 110.899 -179.854 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . 0.466 ' HB2' ' HA ' ' A' ' 103' ' ' ASP . 8.2 ptp180 -105.17 -46.04 4.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.158 -0.474 . . . . 74.54 110.843 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . 0.485 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 3.3 ptpp? -84.59 150.42 56.63 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.537 0.684 . . . . 71.14 110.92 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . 0.654 ' O ' ' CD1' ' A' ' 163' ' ' TRP . 54.0 Cg_endo -69.77 -29.49 23.72 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.692 2.261 . . . . 73.21 112.33 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.746 ' H ' HD12 ' A' ' 161' ' ' ILE . 2.0 mp -71.96 6.85 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.197 -0.456 . . . . 71.22 111.169 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.602 ' HB3' ' CD1' ' A' ' 157' ' ' TYR . 0.9 OUTLIER -76.99 -18.05 58.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.109 -0.496 . . . . 73.15 110.838 179.896 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' TRP . . . . . 0.835 ' NE1' ' HB3' ' A' ' 165' ' ' ALA . 0.4 OUTLIER -109.21 12.83 24.73 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.25 -0.432 . . . . 73.12 110.955 -179.941 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 81.25 -44.08 2.99 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.706 -0.759 . . . . 71.24 112.488 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.835 ' HB3' ' NE1' ' A' ' 163' ' ' TRP . . . -52.3 121.49 7.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.813 0.339 . . . . 61.52 111.095 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -64.67 122.14 16.15 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.208 -0.451 . . . . 65.0 111.126 179.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . 0.488 ' C ' ' H ' ' A' ' 169' ' ' ALA . 0.4 OUTLIER 63.23 146.46 0.09 OUTLIER Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 121.673 0.749 . . . . 54.23 110.866 -179.786 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . 0.489 ' HB2' ' N ' ' A' ' 127' ' ' ILE . 53.5 Cg_endo -69.81 23.75 0.17 Allowed 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.664 2.243 . . . . 72.22 112.37 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.488 ' H ' ' C ' ' A' ' 167' ' ' SER . . . -62.39 102.75 0.34 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.189 -0.46 . . . . 50.41 111.086 179.848 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.689 HG11 ' CD1' ' A' ' 139' ' ' PHE . 3.4 t -154.87 162.49 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.208 -0.451 . . . . 72.25 111.112 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' GLN . . . . . 0.653 ' OE1' ' HB3' ' A' ' 143' ' ' PRO . 1.6 tm0? -109.93 -83.05 0.57 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.156 -0.474 . . . . 64.23 110.925 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . 0.742 ' OG ' ' O ' ' A' ' 143' ' ' PRO . 52.5 p -123.83 177.14 5.88 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.234 -0.439 . . . . 64.33 110.878 -179.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -140.45 168.0 20.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.136 -0.484 . . . . 73.12 110.893 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . 0.557 HH11 HD12 ' A' ' 138' ' ' ILE . 0.1 OUTLIER -134.66 152.64 51.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.112 -0.494 . . . . 74.53 110.866 -179.904 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.29 167.77 10.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.184 -0.462 . . . . 55.33 110.886 -179.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 2.6 mt -116.63 141.52 34.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.165 -0.47 . . . . 53.33 111.16 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 3.2 p -149.97 155.85 7.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.195 -0.457 . . . . 70.4 111.108 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 116.143 -0.48 . . . . 64.4 110.895 179.996 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.786 0.327 . . . . 64.13 110.881 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -144.29 109.28 5.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.225 -0.443 . . . . 65.25 110.833 -179.775 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 9.1 mmtp -95.34 36.08 1.27 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.164 -0.471 . . . . 75.54 110.931 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.9 t -62.68 -33.66 75.54 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.254 -0.43 . . . . 61.4 111.156 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 160.97 139.76 2.73 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.768 -0.729 . . . . 65.4 112.466 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.496 ' C ' ' HE1' ' A' ' 47' ' ' TRP . 7.2 p -82.46 136.72 34.86 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.867 0.365 . . . . 75.13 111.153 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.447 ' N ' ' HE1' ' A' ' 47' ' ' TRP . 2.5 tttt -126.93 136.76 52.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.236 -0.438 . . . . 64.31 110.907 179.878 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.517 ' HA ' ' HA ' ' A' ' 42' ' ' VAL . 16.5 tt -136.5 154.56 32.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.22 -0.445 . . . . 73.24 111.129 179.881 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.488 HG23 ' CG ' ' A' ' 22' ' ' ASP . 13.7 m -134.55 151.41 51.08 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.162 -0.472 . . . . 61.13 111.157 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.662 ' HB2' HD22 ' A' ' 34' ' ' LEU . 1.2 m-85 -140.45 129.59 23.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.454 . . . . 75.04 110.863 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.55 ' CG ' ' HA ' ' A' ' 16' ' ' PHE . 8.2 m-85 -115.36 133.15 56.3 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.154 -0.475 . . . . 74.34 110.942 -179.872 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.454 ' HG2' ' HB2' ' A' ' 36' ' ' ARG . 0.0 OUTLIER -56.6 -25.0 51.6 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.181 -0.463 . . . . 72.54 110.89 -179.974 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.413 ' HB2' ' O ' ' A' ' 17' ' ' GLN . 62.8 m-20 -126.38 155.8 41.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.159 -0.473 . . . . 74.41 110.91 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.412 ' HG2' ' HA ' ' A' ' 69' ' ' GLU . 11.2 mtmt -57.99 -173.58 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.206 -0.452 . . . . 72.02 110.899 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 23.9 m-20 43.95 34.41 0.92 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.244 -0.435 . . . . 64.25 110.867 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.55 ' HA ' ' CG ' ' A' ' 11' ' ' TYR . 3.1 m-85 48.05 62.9 2.27 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.21 -0.45 . . . . 73.41 110.829 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.413 ' O ' ' HB2' ' A' ' 13' ' ' ASP . 10.6 mt-30 -136.55 154.68 50.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.181 -0.463 . . . . 71.21 110.902 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 95.28 -152.94 20.6 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.711 -0.757 . . . . 60.1 112.485 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.795 ' O ' HD13 ' A' ' 34' ' ' LEU . 0.0 OUTLIER -65.21 81.13 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.844 0.354 . . . . 73.11 110.891 -179.867 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.466 ' HB2' ' CE1' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -79.97 128.92 34.04 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.189 -0.46 . . . . 70.31 110.835 -179.859 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.471 ' CD2' ' CD2' ' A' ' 30' ' ' PHE . 72.2 t80 -123.53 126.12 46.11 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.221 -0.445 . . . . 70.42 110.944 -179.854 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.488 ' CG ' HG23 ' A' ' 9' ' ' THR . 1.1 m-20 -121.71 134.41 54.95 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.17 -0.468 . . . . 40.12 110.874 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 6.7 t -163.02 134.39 4.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.165 -0.471 . . . . 52.35 110.922 -179.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.417 ' HA ' ' HA ' ' A' ' 7' ' ' LYS . 5.0 p-10 -101.96 3.56 39.11 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.203 -0.453 . . . . 72.21 110.875 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 42.2 t -110.62 158.79 18.2 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.197 -0.456 . . . . 53.2 110.893 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -40.7 119.75 1.16 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.234 -0.439 . . . . 70.23 110.889 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.567 ' HB2' ' HB3' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -114.51 39.95 2.68 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.175 -0.466 . . . . 73.34 110.879 -179.896 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.583 ' O ' ' HB3' ' A' ' 82' ' ' SER . . . -50.86 -21.35 1.65 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.218 -0.447 . . . . 63.42 111.078 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 58.1 t0 -130.45 39.44 3.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.215 -0.448 . . . . 75.0 110.843 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.81 ' O ' ' CD2' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -81.09 15.27 1.94 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.213 -0.449 . . . . 71.21 110.885 -179.876 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.419 ' CG ' ' HG3' ' A' ' 53' ' ' PRO . 44.5 t60 -80.57 -35.02 34.86 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.157 -0.474 . . . . 73.3 110.867 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.7 t -62.96 -10.65 14.46 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.169 -0.469 . . . . 75.5 111.154 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -103.53 -27.29 12.45 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.231 -0.44 . . . . 64.12 110.92 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.795 HD13 ' O ' ' A' ' 19' ' ' ARG . 30.4 tp -138.17 138.73 38.88 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.137 -0.483 . . . . 75.24 110.905 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.5 m -104.11 -36.15 7.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.169 -0.469 . . . . 62.43 110.824 -179.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.458 ' O ' HD21 ' A' ' 34' ' ' LEU . 0.7 OUTLIER -112.98 139.86 48.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.131 -0.486 . . . . 72.34 110.863 -179.92 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.476 ' SG ' ' CB ' ' A' ' 80' ' ' LEU . 2.2 m -121.41 69.87 0.92 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.193 -0.458 . . . . 73.35 110.93 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -72.04 -71.86 0.26 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.214 -0.448 . . . . 70.02 110.889 -179.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 4.9 p -104.54 134.61 47.43 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.165 -0.47 . . . . 61.22 110.867 -179.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.576 HD12 ' CH2' ' A' ' 73' ' ' TRP . 20.8 mt -126.51 151.65 33.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.135 -0.484 . . . . 74.34 111.124 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.481 ' HD2' ' CE2' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -145.0 124.75 13.34 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.155 -0.475 . . . . 62.13 110.918 179.834 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.517 ' HA ' ' HA ' ' A' ' 8' ' ' ILE . 1.2 t -111.99 116.03 51.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.214 -0.448 . . . . 72.34 111.16 179.882 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -112.95 77.63 1.06 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.217 -0.447 . . . . 73.14 110.886 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.415 ' O ' ' HB ' ' A' ' 6' ' ' THR . . . 139.08 97.49 0.38 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.685 -0.769 . . . . 72.52 112.464 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.419 ' HA2' HD21 ' A' ' 88' ' ' LEU . . . 52.52 -179.9 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.729 -0.748 . . . . 63.55 112.476 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.7 HG23 ' HA ' ' A' ' 63' ' ' PRO . 1.4 m -74.52 170.05 16.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.75 0.31 . . . . 74.41 111.162 -179.886 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.57 ' H ' HG22 ' A' ' 46' ' ' THR . 4.5 m95 -142.92 130.03 20.77 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.245 -0.434 . . . . 74.04 110.887 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.891 ' HB2' ' CG2' ' A' ' 86' ' ' VAL . . . -87.36 127.09 35.2 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.225 -0.443 . . . . 75.44 111.115 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.908 HG11 HD11 ' A' ' 80' ' ' LEU . 34.5 m -129.7 131.71 66.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.263 -0.426 . . . . 64.31 111.127 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.726 ' HB3' ' HA ' ' A' ' 56' ' ' ALA . 58.8 m-85 -103.01 147.92 26.34 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.192 -0.458 . . . . 71.31 110.913 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.651 ' OE1' ' HB3' ' A' ' 57' ' ' TRP . 63.7 tt0 -50.19 -78.99 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.133 -0.485 . . . . 64.54 110.858 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.598 ' HB3' ' HB2' ' A' ' 55' ' ' PHE . 0.5 OUTLIER -91.04 138.01 26.22 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.618 0.723 . . . . 73.11 110.869 -179.908 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.739 ' HB3' ' HB3' ' A' ' 81' ' ' SER . 53.7 Cg_endo -69.82 145.98 58.43 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.655 2.237 . . . . 35.53 112.349 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 63.15 -7.67 0.15 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.239 -0.437 . . . . 73.25 110.917 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.614 ' CD1' ' O ' ' A' ' 53' ' ' PRO . 30.8 m-85 -113.72 -20.32 11.21 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.173 -0.467 . . . . 72.21 110.864 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.726 ' HA ' ' HB3' ' A' ' 50' ' ' TYR . . . 52.37 27.27 4.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.188 -0.46 . . . . 63.23 111.105 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . 0.651 ' HB3' ' OE1' ' A' ' 51' ' ' GLU . 0.0 OUTLIER -49.28 -164.36 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.225 -0.443 . . . . 74.41 110.888 -179.956 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.637 ' C ' ' O ' ' A' ' 57' ' ' TRP . 4.7 m-30 -12.55 101.39 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.182 -0.463 . . . . 73.23 110.951 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.451 ' HB2' ' O ' ' A' ' 149' ' ' GLN . 2.3 mpt? -60.74 155.93 18.1 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.17 -0.468 . . . . 63.51 110.856 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.68 ' O ' ' O ' ' A' ' 49' ' ' VAL . 2.7 t80 -170.74 120.63 0.56 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.202 -0.454 . . . . 72.14 110.972 -179.872 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.854 ' N ' HD12 ' A' ' 61' ' ' ILE . 1.0 OUTLIER -106.2 114.24 44.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.165 -0.47 . . . . 62.22 111.15 179.923 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.614 HD23 ' HD2' ' A' ' 63' ' ' PRO . 0.3 OUTLIER -83.75 124.65 74.82 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.583 0.706 . . . . 75.24 110.933 179.943 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.7 ' HA ' HG23 ' A' ' 46' ' ' THR . 53.3 Cg_endo -69.75 -171.3 0.46 Allowed 'Trans proline' 0 C--O 1.231 0.141 0 C-N-CA 122.706 2.271 . . . . 74.34 112.295 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.79 163.2 15.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.189 -0.459 . . . . 72.1 110.908 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 114.35 -158.42 14.33 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.795 -0.717 . . . . 73.45 112.472 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -118.28 154.3 32.53 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.871 0.367 . . . . 74.04 110.868 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.55 ' HB2' ' O ' ' A' ' 40' ' ' ILE . 17.5 m-85 -140.94 84.14 13.47 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.691 0.758 . . . . 72.34 110.959 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.409 ' HD2' ' HG3' ' A' ' 72' ' ' ARG . 53.1 Cg_endo -69.84 2.79 3.25 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.643 2.229 . . . . 72.54 112.35 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.603 ' HB2' ' HG2' ' A' ' 72' ' ' ARG . 48.4 mt-10 -157.56 144.21 17.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.183 -0.462 . . . . 74.03 110.893 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.707 ' HA ' ' NE1' ' A' ' 73' ' ' TRP . 35.4 p90 -55.78 -25.97 43.74 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.127 -0.488 . . . . 71.25 110.896 -179.801 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -76.51 -15.81 59.79 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.154 -0.475 . . . . 64.43 110.931 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.603 ' HG2' ' HB2' ' A' ' 69' ' ' GLU . 32.0 mmt180 -67.27 -15.98 64.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.201 -0.454 . . . . 75.22 110.874 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . 0.745 ' N ' ' CD1' ' A' ' 73' ' ' TRP . 0.0 OUTLIER -125.14 21.88 7.99 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.202 -0.454 . . . . 72.45 110.939 -179.959 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.574 ' O ' ' C ' ' A' ' 75' ' ' GLY . 2.1 ttm 75.87 -16.4 0.6 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.258 -0.428 . . . . 51.42 110.88 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.574 ' C ' ' O ' ' A' ' 74' ' ' MET . . . 21.93 57.5 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.762 -0.732 . . . . 51.21 112.496 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.93 HD13 ' N ' ' A' ' 77' ' ' ASN . 0.0 OUTLIER -56.48 -10.93 1.07 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.835 0.35 . . . . 65.34 110.927 -179.935 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.93 ' N ' HD13 ' A' ' 76' ' ' LEU . 37.0 t-20 -149.33 -48.67 0.14 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.219 -0.446 . . . . 74.32 110.853 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.556 ' CB ' ' O ' ' A' ' 77' ' ' ASN . 5.2 t0 87.22 -7.73 0.64 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.192 -0.458 . . . . 72.4 110.901 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.457 ' HG2' ' O ' ' A' ' 79' ' ' ARG . 8.7 ttt85 -85.39 50.15 1.9 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.178 -0.464 . . . . 60.1 110.874 -179.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.908 HD11 HG11 ' A' ' 49' ' ' VAL . 0.1 OUTLIER -59.36 130.65 47.95 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.195 -0.457 . . . . 61.03 110.937 179.998 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.739 ' HB3' ' HB3' ' A' ' 53' ' ' PRO . 12.3 m -151.6 -111.77 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.182 -0.463 . . . . 73.43 110.849 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.601 ' OG ' ' HA ' ' A' ' 53' ' ' PRO . 1.0 OUTLIER -47.87 97.12 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.155 -0.475 . . . . 52.53 110.851 -179.802 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . 0.784 ' CB ' HG12 ' A' ' 49' ' ' VAL . 7.6 p -123.89 135.23 53.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.167 -0.469 . . . . 61.23 110.858 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.633 ' N ' ' O ' ' A' ' 48' ' ' ALA . 0.9 OUTLIER -115.12 154.82 28.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.154 -0.475 . . . . 74.32 110.89 -179.9 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -68.17 130.06 41.77 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.191 -0.458 . . . . 72.45 111.048 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.891 ' CG2' ' HB2' ' A' ' 48' ' ' ALA . 37.7 t -115.03 133.34 61.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.208 -0.451 . . . . 62.11 111.179 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . 0.646 ' O ' HG23 ' A' ' 136' ' ' VAL . 39.9 m80 -111.26 108.48 18.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.202 -0.454 . . . . 72.31 110.87 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.477 HD23 ' H ' ' A' ' 88' ' ' LEU . 0.0 OUTLIER -33.4 147.04 0.1 OUTLIER Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.566 0.698 . . . . 74.34 110.943 -179.96 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.521 ' HB3' ' H ' ' A' ' 136' ' ' VAL . 53.6 Cg_endo -69.78 95.52 0.56 Allowed 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.68 2.253 . . . . 62.02 112.328 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -88.89 -174.87 4.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.225 -0.443 . . . . 72.12 110.844 -179.847 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 64.0 108.48 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.766 -0.731 . . . . 65.35 112.525 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 69.41 -84.34 0.26 Allowed Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.695 -0.764 . . . . 74.44 112.481 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.446 ' O ' ' HG2' ' A' ' 134' ' ' GLU . 19.5 pt20 178.74 -136.79 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.842 0.353 . . . . 63.45 110.945 -179.863 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.671 ' HA ' ' HG2' ' A' ' 134' ' ' GLU . 0.0 OUTLIER -113.86 103.2 10.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.202 -0.454 . . . . 74.43 110.96 -179.877 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.492 ' HG3' HG11 ' A' ' 132' ' ' VAL . 29.1 tptt -107.41 128.79 54.79 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.127 -0.488 . . . . 73.44 110.896 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.528 HD13 ' N ' ' A' ' 97' ' ' GLN . 0.1 OUTLIER -151.08 133.97 6.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.194 -0.457 . . . . 74.32 111.136 179.828 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.528 ' N ' HD13 ' A' ' 96' ' ' ILE . 0.3 OUTLIER -105.76 126.61 52.37 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.142 -0.481 . . . . 74.34 110.911 179.948 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.626 HD13 HD11 ' A' ' 118' ' ' ILE . 13.0 mt -105.08 138.51 29.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.186 -0.461 . . . . 72.52 111.103 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.663 ' HB2' ' HB2' ' A' ' 129' ' ' SER . 46.7 m-85 -125.75 139.9 53.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.166 -0.47 . . . . 51.22 110.87 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 79.0 tt0 -71.89 -70.8 0.31 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.119 -0.491 . . . . 70.24 110.875 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 41.4 mttt -87.9 171.02 10.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.157 -0.474 . . . . 71.52 110.858 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -75.47 155.05 46.58 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.801 -0.714 . . . . 72.4 112.481 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.615 ' HA ' ' HB2' ' A' ' 158' ' ' ARG . 16.1 t0 68.03 45.26 1.35 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.85 0.357 . . . . 63.12 110.863 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.441 ' HA ' ' CD1' ' A' ' 99' ' ' PHE . 0.7 OUTLIER 50.7 29.17 4.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.183 -0.462 . . . . 70.51 110.89 -179.905 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 71.2 m -96.82 159.06 15.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.149 -0.478 . . . . 74.05 110.911 -179.821 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 87.1 -145.06 19.64 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.774 -0.727 . . . . 75.13 112.493 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 3.8 tp-100 -87.66 125.01 34.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.8 0.333 . . . . 70.41 110.906 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' MET . . . . . 0.48 ' HB2' ' CE1' ' A' ' 99' ' ' PHE . 23.4 ttp -107.64 144.35 34.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.198 -0.455 . . . . 74.51 110.889 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -149.51 135.5 18.85 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.275 -0.421 . . . . 75.4 110.884 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -114.93 102.68 10.19 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.102 -0.499 . . . . 62.41 110.909 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 14.6 t -114.07 144.19 43.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 74.32 111.102 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.479 ' O ' ' OG1' ' A' ' 112' ' ' THR . 0.8 OUTLIER -124.4 36.35 4.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.252 -0.431 . . . . 51.34 111.135 -179.988 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -143.84 -172.52 3.76 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.232 -0.44 . . . . 73.0 110.867 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -86.31 162.54 18.18 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.112 -0.494 . . . . 74.43 110.88 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . 0.419 ' HB3' ' CE2' ' A' ' 173' ' ' PHE . 0.8 OUTLIER -157.25 120.76 2.21 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-O 121.585 0.707 . . . . 73.52 110.92 -179.918 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.586 ' O ' ' OG ' ' A' ' 172' ' ' SER . 54.1 Cg_endo -69.73 -33.5 16.6 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.642 2.228 . . . . 63.13 112.401 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.669 ' HB3' ' CB ' ' A' ' 120' ' ' GLU . 0.2 OUTLIER -138.68 103.57 4.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.22 -0.445 . . . . 71.51 110.846 -179.862 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.674 ' HB ' ' O ' ' A' ' 171' ' ' GLN . 4.9 tt -57.91 -29.87 36.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.135 -0.484 . . . . 51.44 111.148 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' MET . . . . . 0.594 ' O ' ' HA ' ' A' ' 123' ' ' HIS . 2.8 ttt -87.89 -45.62 10.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.165 -0.47 . . . . 63.44 110.864 179.873 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.669 ' CB ' ' HB3' ' A' ' 117' ' ' SER . 6.7 tp10 -62.86 -13.5 34.7 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.235 -0.439 . . . . 75.24 110.89 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 7.8 tp-100 -114.64 -50.09 2.8 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.186 -0.461 . . . . 74.4 110.963 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.569 ' HB2' ' O ' ' A' ' 118' ' ' ILE . 96.1 m-85 -100.07 -20.64 15.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.165 -0.47 . . . . 54.04 110.881 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.594 ' HA ' ' O ' ' A' ' 119' ' ' MET . 13.4 m-70 76.42 22.07 1.3 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.17 -0.468 . . . . 74.25 110.888 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.506 ' O ' HG23 ' A' ' 118' ' ' ILE . 3.5 mtt -97.67 118.74 34.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.174 -0.466 . . . . 64.53 110.856 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 5.8 ptp180 -79.58 -45.79 18.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.203 -0.453 . . . . 65.53 110.863 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.44 ' HB3' ' HG2' ' A' ' 168' ' ' PRO . 19.9 mt-10 -140.45 117.36 11.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.181 -0.463 . . . . 71.42 110.836 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.642 HG21 ' SG ' ' A' ' 130' ' ' CYS . 3.2 mm -73.52 92.49 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.128 -0.487 . . . . 74.12 111.112 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -64.89 -34.0 77.35 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.156 -0.475 . . . . 72.13 110.868 179.874 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.663 ' HB2' ' HB2' ' A' ' 99' ' ' PHE . 4.7 m -133.97 155.03 50.68 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.207 -0.452 . . . . 62.43 110.845 -179.802 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . 0.663 ' O ' ' O ' ' A' ' 155' ' ' LYS . 0.1 OUTLIER -156.59 123.04 5.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.112 -0.494 . . . . 60.14 110.844 -179.951 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.636 ' HA ' ' HA ' ' A' ' 156' ' ' GLU . 1.9 mtpt -108.22 154.21 22.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.16 -0.473 . . . . 71.51 110.885 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.553 HG23 ' C ' ' A' ' 131' ' ' LYS . 8.3 t 83.45 165.03 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.215 -0.448 . . . . 74.31 111.136 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.789 HD22 ' CG ' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -178.49 123.69 0.1 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.125 -0.489 . . . . 55.22 110.905 179.977 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.671 ' HG2' ' HA ' ' A' ' 94' ' ' TYR . 0.1 OUTLIER -98.64 164.41 12.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.21 -0.45 . . . . 73.53 110.856 179.928 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.557 ' C ' ' O ' ' A' ' 134' ' ' GLU . . . -23.06 -63.1 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.736 -0.745 . . . . 42.5 112.487 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.795 ' HB ' HD12 ' A' ' 176' ' ' ILE . 3.1 t -144.44 146.34 20.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.804 0.335 . . . . 72.33 111.126 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . 0.645 ' HB3' ' HB3' ' A' ' 152' ' ' LEU . 6.3 t-105 -143.19 149.56 38.17 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.164 -0.471 . . . . 74.1 110.945 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.412 HD12 ' HB ' ' A' ' 61' ' ' ILE . 3.5 mm -114.59 134.73 56.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.285 -0.416 . . . . 61.41 111.161 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.524 ' CD1' HG11 ' A' ' 170' ' ' VAL . 0.1 OUTLIER -117.23 142.65 46.79 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.204 -0.453 . . . . 72.34 110.846 -179.989 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.512 ' CE2' ' HA ' ' A' ' 145' ' ' TYR . 3.9 m-85 -120.79 130.4 53.98 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.14 -0.482 . . . . 73.51 110.932 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.452 ' O ' ' HB2' ' A' ' 171' ' ' GLN . 2.9 tt0 -61.77 -47.62 84.35 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.121 -0.49 . . . . 75.41 110.885 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 1.057 ' O ' ' HB2' ' A' ' 172' ' ' SER . 7.1 mp -97.41 152.56 38.29 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.588 0.709 . . . . 74.51 110.922 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . 0.684 ' HB3' ' OE1' ' A' ' 171' ' ' GLN . 54.3 Cg_endo -69.68 44.76 0.42 Allowed 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.709 2.273 . . . . 54.31 112.379 179.854 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . 1.084 ' O ' ' N ' ' A' ' 146' ' ' ARG . 0.0 OUTLIER 179.06 106.62 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.228 -0.442 . . . . 74.34 110.885 -179.989 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . 0.668 ' C ' ' O ' ' A' ' 144' ' ' ASN . 0.0 OUTLIER -3.51 51.25 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.204 -0.453 . . . . 64.0 110.938 -179.948 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 1.084 ' N ' ' O ' ' A' ' 144' ' ' ASN . 36.7 mtt180 -131.47 163.27 28.33 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.118 -0.492 . . . . 63.51 110.881 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 82.8 -162.69 41.34 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.75 -0.738 . . . . 73.5 112.472 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -84.97 148.96 25.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.753 0.311 . . . . 74.33 110.84 -179.848 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . 0.451 ' O ' ' HB2' ' A' ' 59' ' ' MET . 19.3 mt-30 -95.73 135.09 37.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.159 -0.473 . . . . 70.12 110.901 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . 0.471 ' HB2' ' HB2' ' A' ' 139' ' ' PHE . 41.6 m-85 -109.95 127.06 54.54 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.164 -0.471 . . . . 73.14 110.856 -179.841 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.509 ' HB2' HD11 ' A' ' 61' ' ' ILE . 6.8 tp -83.01 120.89 26.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.088 -0.505 . . . . 52.22 110.947 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 1.043 ' O ' HD13 ' A' ' 152' ' ' LEU . 0.0 OUTLIER -50.46 133.11 25.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.2 -0.454 . . . . 73.55 110.962 179.887 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -162.09 23.16 0.11 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.216 -0.447 . . . . 52.31 110.868 179.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.83 ' HB2' ' CD1' ' A' ' 157' ' ' TYR . 3.2 ptmt -119.97 -174.02 2.67 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.191 -0.459 . . . . 43.41 110.91 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.789 ' CG ' HD22 ' A' ' 133' ' ' LEU . 1.7 mptt -158.4 -119.43 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.249 -0.432 . . . . 75.35 110.934 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.636 ' HA ' ' HA ' ' A' ' 131' ' ' LYS . 1.2 tm-20 -72.47 0.74 9.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.201 -0.454 . . . . 73.5 110.931 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . 0.83 ' CD1' ' HB2' ' A' ' 154' ' ' LYS . 12.9 m-30 -34.97 154.11 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.106 -0.497 . . . . 75.42 110.929 -179.868 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . 0.615 ' HB2' ' HA ' ' A' ' 103' ' ' ASP . 8.0 ptp180 -116.7 -44.22 2.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.074 -0.512 . . . . 71.11 110.883 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . 0.42 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 3.1 ptpp? -86.25 150.13 51.3 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.6 0.714 . . . . 73.44 110.854 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . 0.445 ' HA ' ' HE1' ' A' ' 163' ' ' TRP . 54.2 Cg_endo -69.78 -23.49 30.66 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.64 2.227 . . . . 74.12 112.377 179.86 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.648 ' H ' HD12 ' A' ' 161' ' ' ILE . 3.5 mp -78.71 4.09 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.212 -0.449 . . . . 73.14 111.138 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.529 ' HB3' ' CD1' ' A' ' 157' ' ' TYR . 1.0 OUTLIER -72.96 -16.91 61.52 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.19 -0.459 . . . . 71.5 110.819 179.853 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' TRP . . . . . 0.673 ' CD1' ' N ' ' A' ' 163' ' ' TRP . 0.0 OUTLIER -115.82 13.54 16.11 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.217 -0.447 . . . . 75.45 110.864 -179.943 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 88.64 -31.88 4.74 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.762 -0.732 . . . . 75.03 112.489 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -51.53 118.55 3.4 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.783 0.325 . . . . 62.41 111.1 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -50.73 -31.5 16.81 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.248 -0.433 . . . . 72.23 111.114 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . 0.493 ' C ' ' H ' ' A' ' 169' ' ' ALA . 0.3 OUTLIER -149.98 156.44 38.01 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.701 0.763 . . . . 52.15 110.835 -179.826 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . 0.444 ' HB3' ' O ' ' A' ' 127' ' ' ILE . 53.9 Cg_endo -69.73 24.95 0.17 Allowed 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.727 2.285 . . . . 60.5 112.312 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.493 ' H ' ' C ' ' A' ' 167' ' ' SER . . . -65.55 100.93 0.55 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.265 -0.425 . . . . 64.42 111.082 179.91 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.524 HG11 ' CD1' ' A' ' 139' ' ' PHE . 1.9 t -154.42 165.35 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.213 -0.449 . . . . 74.44 111.12 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' GLN . . . . . 0.684 ' OE1' ' HB3' ' A' ' 143' ' ' PRO . 2.2 mm-40 -147.53 -101.2 0.09 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.128 -0.487 . . . . 75.44 110.876 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . 1.057 ' HB2' ' O ' ' A' ' 142' ' ' LEU . 0.3 OUTLIER -56.31 143.73 33.03 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.196 -0.456 . . . . 44.24 110.902 -179.8 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . 0.419 ' CE2' ' HB3' ' A' ' 115' ' ' CYS . 31.2 p90 -152.1 132.79 13.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.184 -0.462 . . . . 72.12 110.92 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.51 165.47 23.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.186 -0.461 . . . . 75.34 110.861 -179.878 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . 0.404 ' HG3' ' CZ ' ' A' ' 94' ' ' TYR . 0.0 OUTLIER -104.12 -161.28 0.82 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.209 -0.45 . . . . 71.14 110.877 -179.943 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . 0.795 HD12 ' HB ' ' A' ' 136' ' ' VAL . 3.5 mt -139.3 138.79 40.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 63.24 111.144 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 5.0 p -145.34 152.34 14.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.188 -0.46 . . . . 72.0 111.106 179.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.149 -0.478 . . . . 72.11 110.896 -179.961 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.7 mmt . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.76 0.315 . . . . 74.34 110.859 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.1 m -159.4 -171.5 3.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.212 -0.449 . . . . 65.5 110.892 -179.805 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.5 mmmp? -77.88 60.82 2.38 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.156 -0.475 . . . . 72.21 110.886 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.7 t -130.88 77.51 1.79 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.224 -0.444 . . . . 62.21 111.19 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -177.35 47.27 0.1 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.714 -0.755 . . . . 72.1 112.497 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.518 ' C ' ' HE1' ' A' ' 47' ' ' TRP . 8.0 p -82.98 135.87 34.73 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.867 0.365 . . . . 71.25 111.155 -179.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.408 ' HA ' ' HA ' ' A' ' 24' ' ' ASP . 3.2 tttt -123.94 136.17 54.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.189 -0.459 . . . . 70.14 110.9 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.576 ' HB ' ' CD1' ' A' ' 47' ' ' TRP . 16.2 tt -137.47 150.89 25.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.223 -0.444 . . . . 75.21 111.151 179.861 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.481 HG23 ' CG ' ' A' ' 22' ' ' ASP . 10.1 m -130.21 146.08 51.8 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.196 -0.456 . . . . 72.34 111.163 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.792 ' HB2' HD22 ' A' ' 34' ' ' LEU . 1.5 m-85 -132.33 129.1 39.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.205 -0.452 . . . . 64.35 110.865 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.544 ' CG ' ' HA ' ' A' ' 16' ' ' PHE . 18.4 m-85 -115.65 132.13 56.73 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.135 -0.484 . . . . 73.03 110.974 -179.894 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.475 ' HG2' ' HB2' ' A' ' 36' ' ' ARG . 0.0 OUTLIER -58.6 -24.36 60.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.123 -0.49 . . . . 74.33 110.891 -179.976 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 64.9 m-20 -127.63 152.73 47.3 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.113 -0.494 . . . . 64.52 110.89 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.429 ' N ' ' HB3' ' A' ' 38' ' ' ASN . 32.5 mtmt -56.09 -175.25 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 75.12 110.922 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 25.7 m-20 46.51 33.6 2.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.258 -0.428 . . . . 64.11 110.897 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.544 ' HA ' ' CG ' ' A' ' 11' ' ' TYR . 3.4 m-85 48.91 58.9 4.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.147 -0.478 . . . . 75.01 110.842 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -133.49 157.78 44.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 53.31 110.905 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 94.25 -149.88 19.57 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.679 -0.772 . . . . 72.33 112.474 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.79 ' O ' HD13 ' A' ' 34' ' ' LEU . 0.1 OUTLIER -69.06 81.59 0.32 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.833 0.349 . . . . 74.24 110.881 -179.832 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.49 ' HB2' ' CE1' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -79.63 129.6 34.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.201 -0.454 . . . . 72.21 110.874 -179.898 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.444 ' O ' ' HA ' ' A' ' 9' ' ' THR . 88.8 t80 -125.54 125.32 43.03 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.204 -0.453 . . . . 73.42 110.899 -179.842 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.481 ' CG ' HG23 ' A' ' 9' ' ' THR . 1.4 m-20 -119.9 134.47 55.23 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.121 -0.491 . . . . 62.12 110.895 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 11.3 t -162.98 135.19 5.31 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.158 -0.474 . . . . 63.23 110.915 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.408 ' HA ' ' HA ' ' A' ' 7' ' ' LYS . 5.5 p-10 -102.66 -5.19 24.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.188 -0.46 . . . . 74.34 110.928 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.448 ' O ' ' SG ' ' A' ' 27' ' ' CYS . 20.0 t -102.54 165.08 11.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.14 -0.482 . . . . 71.42 110.851 -179.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -55.26 120.95 7.83 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.155 -0.475 . . . . 62.31 110.878 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.639 ' HB2' ' HB3' ' A' ' 30' ' ' PHE . 0.2 OUTLIER -116.39 49.97 1.09 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.225 -0.443 . . . . 62.52 110.924 -179.93 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.527 ' O ' ' HA ' ' A' ' 82' ' ' SER . . . -46.86 -22.23 0.29 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.191 -0.458 . . . . 72.43 111.096 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 63.3 t0 -129.19 42.76 3.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.189 -0.46 . . . . 64.41 110.85 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.775 ' O ' ' CD2' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -79.13 15.82 1.08 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.192 -0.458 . . . . 64.23 110.887 -179.936 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.448 ' HB2' ' HB3' ' A' ' 53' ' ' PRO . 27.1 t60 -77.2 -45.67 25.84 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.161 -0.472 . . . . 75.45 110.841 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.444 HG23 ' CD2' ' A' ' 33' ' ' TYR . 8.9 t -55.69 -14.5 2.27 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.191 -0.458 . . . . 70.33 111.175 -179.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.506 ' CD1' ' HA ' ' A' ' 30' ' ' PHE . 11.4 m-85 -96.1 -30.26 13.64 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.197 -0.456 . . . . 70.43 110.865 -179.907 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.792 HD22 ' HB2' ' A' ' 10' ' ' PHE . 19.3 tp -143.5 143.12 31.42 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.178 -0.464 . . . . 71.3 110.94 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.2 m -108.52 -34.73 6.66 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.185 -0.461 . . . . 61.23 110.883 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.545 ' O ' HD21 ' A' ' 34' ' ' LEU . 1.8 mtp85 -115.89 139.8 49.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.13 -0.486 . . . . 75.44 110.86 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.61 ' HB3' ' HB2' ' A' ' 80' ' ' LEU . 5.2 p -117.28 61.31 0.75 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.144 -0.48 . . . . 74.33 110.894 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.504 HD21 ' NH2' ' A' ' 36' ' ' ARG . 3.0 m120 -60.26 -69.62 0.21 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.133 -0.485 . . . . 73.14 110.869 -179.874 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 5.0 p -110.67 127.28 55.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.18 -0.463 . . . . 73.13 110.873 -179.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.757 HD12 ' CH2' ' A' ' 73' ' ' TRP . 29.9 mt -121.01 148.49 24.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.134 -0.485 . . . . 72.31 111.126 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.453 ' HD2' ' CE2' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -142.27 121.99 13.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 71.22 110.902 179.823 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.546 HG22 ' HB ' ' A' ' 8' ' ' ILE . 1.5 t -106.64 115.27 47.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.22 -0.445 . . . . 52.31 111.114 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -111.58 79.93 1.26 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.165 -0.47 . . . . 63.43 110.895 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.434 ' O ' ' HA ' ' A' ' 6' ' ' THR . . . 132.13 100.63 0.8 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.75 -0.738 . . . . 55.0 112.531 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.481 ' HA2' HD21 ' A' ' 88' ' ' LEU . . . 53.47 178.36 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.724 -0.75 . . . . 64.44 112.467 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.715 HG23 ' HA ' ' A' ' 63' ' ' PRO . 0.8 OUTLIER -76.74 168.06 20.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.774 0.321 . . . . 73.34 111.11 -179.831 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.576 ' CD1' ' HB ' ' A' ' 8' ' ' ILE . 3.6 m95 -142.87 129.42 20.19 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.191 -0.459 . . . . 73.13 110.897 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.83 ' HB2' ' CG2' ' A' ' 86' ' ' VAL . . . -92.69 126.84 37.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.191 -0.459 . . . . 55.53 111.086 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.639 HG12 ' HB3' ' A' ' 83' ' ' CYS . 15.1 m -124.49 145.73 31.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.231 -0.44 . . . . 44.15 111.105 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.926 ' HB3' ' CB ' ' A' ' 56' ' ' ALA . 6.8 m-85 -119.31 141.35 49.07 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.125 -0.489 . . . . 63.24 110.925 -179.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.531 ' HG2' ' N ' ' A' ' 52' ' ' ARG . 0.3 OUTLIER -48.87 -82.18 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.166 -0.47 . . . . 74.54 110.903 179.99 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.904 ' O ' ' HB2' ' A' ' 56' ' ' ALA . 2.1 mtp180 -82.92 137.58 43.48 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.607 0.718 . . . . 61.4 110.88 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.746 ' HA ' ' OG ' ' A' ' 82' ' ' SER . 54.1 Cg_endo -69.76 137.53 35.69 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.703 2.269 . . . . 74.24 112.33 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.462 ' C ' ' CD2' ' A' ' 55' ' ' PHE . 0.9 OUTLIER 67.16 -6.27 0.61 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.241 -0.436 . . . . 75.34 110.904 179.994 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.463 ' H ' ' C ' ' A' ' 53' ' ' PRO . 0.0 OUTLIER -140.22 -74.91 0.34 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.165 -0.47 . . . . 73.42 110.905 -179.962 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.926 ' CB ' ' HB3' ' A' ' 50' ' ' TYR . . . 45.16 78.91 0.05 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.117 -0.492 . . . . 43.04 111.128 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . 0.557 ' O ' ' CD2' ' A' ' 58' ' ' TYR . 24.9 t-105 -64.18 31.55 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.279 -0.418 . . . . 74.11 110.939 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.623 ' H ' ' C ' ' A' ' 56' ' ' ALA . 1.9 m-30 -162.57 116.75 1.76 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.189 -0.46 . . . . 65.24 110.929 -179.848 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.548 ' HB2' ' HA ' ' A' ' 150' ' ' TYR . 1.8 mpt? -81.9 143.51 31.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.085 -0.507 . . . . 72.11 110.884 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.831 ' CD2' HD12 ' A' ' 76' ' ' LEU . 3.1 t80 -156.95 107.15 2.28 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.223 -0.444 . . . . 74.13 110.963 -179.861 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.811 ' N ' HD12 ' A' ' 61' ' ' ILE . 1.3 mp -94.57 116.66 36.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.096 -0.502 . . . . 72.21 111.102 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.798 HD23 ' HD2' ' A' ' 63' ' ' PRO . 0.2 OUTLIER -82.73 130.17 59.29 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.569 0.699 . . . . 71.13 110.92 179.915 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.798 ' HD2' HD23 ' A' ' 62' ' ' LEU . 53.7 Cg_endo -69.71 -173.64 0.75 Allowed 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.645 2.23 . . . . 72.21 112.38 179.869 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.21 162.17 16.04 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.221 -0.445 . . . . 72.4 110.903 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 112.01 -168.69 12.81 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.752 -0.737 . . . . 72.04 112.512 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 8.7 mp0 -107.07 152.97 23.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.842 0.353 . . . . 72.11 110.898 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.639 ' HB2' ' O ' ' A' ' 40' ' ' ILE . 12.9 m-85 -141.84 84.72 11.76 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.75 0.785 . . . . 74.2 110.914 -179.864 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.423 ' HD2' ' HG3' ' A' ' 72' ' ' ARG . 53.7 Cg_endo -69.75 0.48 5.58 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.693 2.262 . . . . 74.43 112.341 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.524 ' HB2' ' HG2' ' A' ' 72' ' ' ARG . 48.6 mt-10 -155.37 142.49 19.26 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.231 -0.441 . . . . 70.11 110.88 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.708 ' HA ' ' NE1' ' A' ' 73' ' ' TRP . 28.4 p90 -55.7 -20.27 13.75 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.169 -0.468 . . . . 73.12 110.956 -179.887 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -80.41 -16.93 53.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.121 -0.49 . . . . 73.24 110.908 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.524 ' HG2' ' HB2' ' A' ' 69' ' ' GLU . 31.3 mmt180 -69.49 -8.76 49.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.229 -0.442 . . . . 72.53 110.876 -179.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . 0.757 ' CH2' HD12 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -135.35 16.79 3.41 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.208 -0.451 . . . . 72.11 110.893 -179.95 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.411 ' C ' ' O ' ' A' ' 73' ' ' TRP . 15.8 mtm 36.95 43.95 0.33 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.266 -0.425 . . . . 63.15 110.896 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -56.51 119.14 13.61 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.741 -0.742 . . . . 33.35 112.451 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.903 HD13 ' N ' ' A' ' 77' ' ' ASN . 0.0 OUTLIER -68.69 -8.7 44.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.792 0.33 . . . . 74.33 110.913 -179.911 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.903 ' N ' HD13 ' A' ' 76' ' ' LEU . 12.8 t-20 -152.77 138.15 17.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.189 -0.46 . . . . 71.31 110.884 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -89.67 13.15 14.9 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.185 -0.461 . . . . 63.31 110.85 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.426 ' HD3' ' HA ' ' A' ' 52' ' ' ARG . 1.2 ttm-85 -110.95 81.64 1.46 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.217 -0.447 . . . . 74.13 110.85 -179.869 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.61 ' HB2' ' HB3' ' A' ' 37' ' ' CYS . 0.0 OUTLIER -83.77 134.65 34.72 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.198 -0.456 . . . . 51.03 110.935 179.993 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.643 ' HB3' ' HB3' ' A' ' 53' ' ' PRO . 1.3 m -150.38 -123.79 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.173 -0.467 . . . . 72.24 110.832 -179.907 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.746 ' OG ' ' HA ' ' A' ' 53' ' ' PRO . 0.0 OUTLIER -34.28 105.79 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.172 -0.467 . . . . 55.3 110.841 -179.826 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . 0.639 ' HB3' HG12 ' A' ' 49' ' ' VAL . 31.7 p -128.2 132.4 48.83 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.149 -0.478 . . . . 32.25 110.89 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.603 ' N ' ' O ' ' A' ' 48' ' ' ALA . 10.7 mmt85 -116.61 149.39 39.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.188 -0.46 . . . . 74.34 110.918 -179.894 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -66.33 129.37 39.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.253 -0.431 . . . . 44.03 111.094 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.83 ' CG2' ' HB2' ' A' ' 48' ' ' ALA . 76.2 t -114.76 135.65 53.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.211 -0.45 . . . . 55.42 111.167 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . 0.659 ' O ' HG23 ' A' ' 136' ' ' VAL . 6.1 m-70 -111.8 113.03 25.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 74.22 110.836 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.481 HD21 ' HA2' ' A' ' 45' ' ' GLY . 0.0 OUTLIER -38.07 141.12 0.53 Allowed Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.587 0.708 . . . . 61.54 110.939 -179.966 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.59 ' HB3' ' H ' ' A' ' 136' ' ' VAL . 53.6 Cg_endo -69.79 79.95 0.92 Allowed 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.654 2.236 . . . . 74.55 112.365 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -91.55 -177.15 4.72 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.174 -0.467 . . . . 70.5 110.855 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 61.15 38.87 96.31 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.717 -0.754 . . . . 71.0 112.487 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.415 ' O ' ' C ' ' A' ' 93' ' ' GLN . . . 134.14 33.55 0.32 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.728 -0.749 . . . . 64.33 112.48 -179.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.596 ' O ' ' HG3' ' A' ' 134' ' ' GLU . 21.6 pt20 37.26 -131.38 0.13 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.846 0.355 . . . . 70.34 110.89 -179.874 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.575 ' HA ' ' HG3' ' A' ' 134' ' ' GLU . 0.1 OUTLIER -117.37 112.1 20.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.45 . . . . 74.41 110.9 -179.831 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.571 ' H ' ' CG ' ' A' ' 134' ' ' GLU . 31.8 tptt -119.16 128.66 54.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.134 -0.484 . . . . 71.05 110.886 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.429 HG13 ' CZ3' ' A' ' 137' ' ' TRP . 0.0 OUTLIER -152.26 139.54 13.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.24 -0.436 . . . . 64.54 111.111 179.865 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -105.85 122.8 46.84 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.159 -0.473 . . . . 71.32 110.947 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.532 HG22 ' SD ' ' A' ' 124' ' ' MET . 2.6 mt -101.93 130.61 51.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.232 -0.44 . . . . 72.4 111.127 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.69 ' HB2' ' HB2' ' A' ' 129' ' ' SER . 43.9 m-85 -118.46 147.84 43.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.18 -0.463 . . . . 73.32 110.87 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 56.5 tt0 -81.69 -56.15 4.18 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.13 -0.486 . . . . 74.41 110.906 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 45.9 mttt -101.92 172.32 7.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.134 -0.485 . . . . 72.32 110.921 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.407 ' HA2' ' OG ' ' A' ' 129' ' ' SER . . . -71.52 153.09 50.19 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.703 -0.761 . . . . 62.3 112.467 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.47 ' HA ' ' HB2' ' A' ' 158' ' ' ARG . 41.0 t0 65.42 46.22 2.61 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.894 0.378 . . . . 64.52 110.892 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.576 ' N ' ' CD2' ' A' ' 104' ' ' PHE . 0.2 OUTLIER 47.66 32.1 2.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.184 -0.462 . . . . 73.12 110.864 -179.898 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 57.7 m -94.03 164.04 13.24 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.179 -0.464 . . . . 74.14 110.879 -179.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 80.57 -136.29 16.31 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.763 -0.732 . . . . 72.42 112.52 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -90.89 121.07 32.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.784 0.325 . . . . 71.24 110.895 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 4.6 ttp -106.57 134.97 48.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.218 -0.446 . . . . 62.01 110.929 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -141.39 136.67 31.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.252 -0.431 . . . . 64.54 110.952 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -117.3 111.55 19.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.115 -0.493 . . . . 74.02 110.847 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.458 HG22 ' CD1' ' A' ' 98' ' ' ILE . 11.8 t -119.96 147.62 44.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.195 -0.457 . . . . 61.14 111.185 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.478 ' O ' ' OG1' ' A' ' 112' ' ' THR . 0.6 OUTLIER -128.38 27.73 5.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.242 -0.436 . . . . 65.44 111.153 179.982 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -141.06 156.64 45.97 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.249 -0.432 . . . . 74.24 110.933 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -50.32 162.35 0.23 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.179 -0.464 . . . . 73.25 110.881 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . 0.538 ' O ' ' HB2' ' A' ' 172' ' ' SER . 52.6 t -153.18 120.31 3.0 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.647 0.737 . . . . 75.04 110.816 -179.884 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.41 ' O ' ' CA ' ' A' ' 143' ' ' PRO . 53.3 Cg_endo -69.83 -30.85 21.33 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.708 2.272 . . . . 32.25 112.315 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.655 ' HB3' ' CB ' ' A' ' 120' ' ' GLU . 0.1 OUTLIER -149.58 112.8 4.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.254 -0.43 . . . . 71.41 110.828 -179.836 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.673 HD13 HD11 ' A' ' 127' ' ' ILE . 3.9 tt -64.54 -31.6 54.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.129 -0.487 . . . . 62.24 111.116 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' MET . . . . . 0.642 ' O ' ' HA ' ' A' ' 123' ' ' HIS . 0.0 OUTLIER -86.33 -39.2 16.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.206 -0.452 . . . . 54.12 110.928 179.807 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.655 ' CB ' ' HB3' ' A' ' 117' ' ' SER . 4.7 tp10 -70.79 -13.88 62.21 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.212 -0.449 . . . . 71.13 110.924 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 25.2 tp60 -114.72 -46.26 2.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.114 -0.493 . . . . 73.32 110.926 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.469 ' HB2' ' O ' ' A' ' 118' ' ' ILE . 74.5 m-85 -106.98 -19.08 13.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.189 -0.459 . . . . 73.41 110.9 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.642 ' HA ' ' O ' ' A' ' 119' ' ' MET . 30.4 m-70 72.35 26.87 2.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.11 -0.496 . . . . 75.44 110.8 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.532 ' SD ' HG22 ' A' ' 98' ' ' ILE . 7.6 mtt -108.93 74.76 0.92 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.243 -0.435 . . . . 62.22 110.878 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 1.7 ptp85 -49.96 -26.31 4.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.229 -0.442 . . . . 74.25 110.849 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.431 ' C ' HD13 ' A' ' 127' ' ' ILE . 24.7 mt-10 -144.01 130.38 19.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.149 -0.478 . . . . 54.43 110.878 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.673 HD11 HD13 ' A' ' 118' ' ' ILE . 4.0 mm -96.45 104.76 16.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.072 -0.513 . . . . 65.3 111.107 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 8.2 m80 -72.22 -33.0 67.24 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.201 -0.454 . . . . 74.53 110.872 179.833 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.69 ' HB2' ' HB2' ' A' ' 99' ' ' PHE . 16.8 m -134.77 144.04 47.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.225 -0.443 . . . . 63.02 110.857 -179.81 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . 0.565 ' O ' ' O ' ' A' ' 155' ' ' LYS . 1.1 m -142.52 115.04 8.51 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.129 -0.487 . . . . 45.11 110.885 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.58 ' HA ' ' HA ' ' A' ' 156' ' ' GLU . 7.2 mtpp -109.62 153.57 24.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.166 -0.47 . . . . 62.13 110.914 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.528 HG12 ' N ' ' A' ' 133' ' ' LEU . 16.2 t 85.25 162.87 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.247 -0.433 . . . . 73.31 111.1 179.855 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.784 HD22 ' CG ' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -175.77 126.61 0.23 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.134 -0.485 . . . . 74.4 110.897 179.944 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.596 ' HG3' ' O ' ' A' ' 93' ' ' GLN . 10.1 mm-40 -99.99 164.38 12.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.186 -0.461 . . . . 72.32 110.881 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.552 ' C ' ' O ' ' A' ' 134' ' ' GLU . . . -23.91 -63.07 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.746 -0.74 . . . . 73.22 112.467 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.718 HG21 HG13 ' A' ' 86' ' ' VAL . 10.4 t -144.45 145.99 20.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.858 0.361 . . . . 61.54 111.089 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . 0.617 ' HB3' ' HB3' ' A' ' 152' ' ' LEU . 4.7 t90 -140.12 156.64 46.47 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.161 -0.472 . . . . 73.11 110.929 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.425 HD12 ' HB ' ' A' ' 61' ' ' ILE . 6.4 mm -122.37 134.98 63.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.242 -0.435 . . . . 75.31 111.14 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.556 ' CE2' HG11 ' A' ' 170' ' ' VAL . 0.0 OUTLIER -112.73 151.97 29.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.156 -0.474 . . . . 64.43 110.878 179.922 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.42 ' CD2' ' HA ' ' A' ' 145' ' ' TYR . 5.5 m-85 -133.7 129.79 37.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.111 -0.495 . . . . 75.42 110.912 -179.85 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.698 ' O ' ' HB2' ' A' ' 171' ' ' GLN . 0.8 OUTLIER -63.03 -30.43 71.59 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.102 -0.499 . . . . 64.14 110.849 -179.949 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.696 ' HB3' ' HD2' ' A' ' 143' ' ' PRO . 8.9 mp -112.02 172.93 3.15 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.637 0.732 . . . . 72.04 110.909 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . 0.721 ' O ' ' OG ' ' A' ' 172' ' ' SER . 53.9 Cg_endo -69.77 -90.51 0.0 OUTLIER 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.701 2.267 . . . . 75.21 112.337 179.857 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . 0.705 ' O ' ' N ' ' A' ' 146' ' ' ARG . 0.7 OUTLIER -53.48 96.21 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.215 -0.448 . . . . 61.12 110.881 -179.976 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . 0.642 ' C ' ' O ' ' A' ' 144' ' ' ASN . 0.0 OUTLIER 13.33 51.97 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.115 -0.493 . . . . 73.12 110.934 -179.911 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.705 ' N ' ' O ' ' A' ' 144' ' ' ASN . 21.2 mtt180 -117.84 163.87 15.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.108 -0.496 . . . . 74.13 110.893 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 84.85 -171.6 47.05 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.742 -0.742 . . . . 50.02 112.482 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -82.05 155.02 25.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.741 0.305 . . . . 74.22 110.87 -179.869 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -92.81 159.99 15.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.15 -0.477 . . . . 70.13 110.897 -179.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . 0.548 ' HA ' ' HB2' ' A' ' 59' ' ' MET . 79.8 m-85 -140.85 130.76 24.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.182 -0.463 . . . . 73.43 110.903 -179.835 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.665 ' HB2' HD11 ' A' ' 61' ' ' ILE . 20.2 tp -78.9 123.95 27.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.104 -0.498 . . . . 61.55 110.89 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 1.01 ' O ' HD13 ' A' ' 152' ' ' LEU . 0.0 OUTLIER -53.82 137.06 39.26 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.222 -0.445 . . . . 74.1 110.951 179.832 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . 0.439 ' N ' HD22 ' A' ' 152' ' ' LEU . 11.3 t0 -161.09 25.92 0.14 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.173 -0.467 . . . . 72.33 110.851 179.876 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.797 ' HB2' ' CD1' ' A' ' 157' ' ' TYR . 0.0 OUTLIER -118.06 -177.32 3.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.207 -0.451 . . . . 52.23 110.852 -179.971 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.784 ' CG ' HD22 ' A' ' 133' ' ' LEU . 0.3 OUTLIER -161.23 -124.39 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.197 -0.456 . . . . 64.14 110.924 179.834 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.58 ' HA ' ' HA ' ' A' ' 131' ' ' LYS . 3.0 tm-20 -67.27 4.19 1.02 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.184 -0.462 . . . . 73.23 110.866 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . 0.797 ' CD1' ' HB2' ' A' ' 154' ' ' LYS . 18.0 m-30 -35.08 151.33 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.168 -0.469 . . . . 74.42 110.918 -179.856 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . 0.47 ' HB2' ' HA ' ' A' ' 103' ' ' ASP . 0.0 OUTLIER -122.93 -35.53 3.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.109 -0.496 . . . . 75.21 110.916 179.985 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -88.44 150.93 47.63 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.553 0.692 . . . . 61.45 110.891 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 -26.32 27.69 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.648 2.232 . . . . 72.54 112.36 179.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.655 ' H ' HD12 ' A' ' 161' ' ' ILE . 4.2 mp -70.46 -8.81 11.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.232 -0.44 . . . . 72.35 111.139 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.644 ' HB3' ' CD1' ' A' ' 157' ' ' TYR . 0.4 OUTLIER -75.81 -14.26 60.29 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.173 -0.467 . . . . 62.35 110.852 179.829 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 28.1 t-105 -89.63 -9.44 49.64 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.233 -0.44 . . . . 74.24 110.97 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 101.88 -36.51 4.19 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.707 -0.759 . . . . 73.0 112.509 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -75.46 127.69 33.67 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.816 0.341 . . . . 72.41 111.117 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -38.1 -39.96 0.45 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.249 -0.432 . . . . 50.52 111.105 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . 0.496 ' C ' ' H ' ' A' ' 169' ' ' ALA . 0.3 OUTLIER -132.11 157.71 77.5 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.673 0.749 . . . . 73.41 110.824 -179.775 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . 0.501 ' HB3' ' O ' ' A' ' 127' ' ' ILE . 54.0 Cg_endo -69.75 28.43 0.18 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.668 2.245 . . . . 63.5 112.372 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.496 ' H ' ' C ' ' A' ' 167' ' ' SER . . . -68.84 106.58 2.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.217 -0.447 . . . . 54.54 111.069 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.556 HG11 ' CE2' ' A' ' 139' ' ' PHE . 2.6 t -153.43 164.63 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.233 -0.439 . . . . 55.13 111.143 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' GLN . . . . . 0.698 ' HB2' ' O ' ' A' ' 141' ' ' GLU . 2.1 mm-40 -112.85 -86.81 0.56 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.162 -0.472 . . . . 64.25 110.9 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . 0.721 ' OG ' ' O ' ' A' ' 143' ' ' PRO . 56.7 p -124.41 176.91 6.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.465 . . . . 70.3 110.85 -179.8 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . 0.407 ' HB3' ' CD1' ' A' ' 139' ' ' PHE . 0.5 OUTLIER -144.81 168.83 19.29 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.103 -0.498 . . . . 74.42 110.911 -179.974 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 7.8 mtp85 -138.73 139.25 38.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.144 -0.48 . . . . 54.53 110.882 -179.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . 0.402 ' HB2' ' CG ' ' A' ' 94' ' ' TYR . 0.0 OUTLIER -95.7 154.73 17.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.19 -0.459 . . . . 75.13 110.885 -179.951 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . 0.525 HD12 ' O ' ' A' ' 136' ' ' VAL . 2.2 mt -96.0 132.83 39.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.197 -0.456 . . . . 74.02 111.143 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 11.5 p -51.62 147.38 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.224 -0.444 . . . . 73.03 111.104 179.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.167 -0.47 . . . . 75.45 110.847 179.947 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.4 mtt . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.778 0.323 . . . . 62.45 110.864 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.5 m -160.5 -173.54 4.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.253 -0.431 . . . . 73.11 110.908 -179.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 20.0 mtpt -84.67 54.02 2.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.164 -0.471 . . . . 75.31 110.898 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.0 t -116.38 -33.68 4.86 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.213 -0.449 . . . . 73.11 111.129 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -76.13 71.12 2.02 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.781 -0.723 . . . . 74.35 112.468 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.44 ' C ' ' HE1' ' A' ' 47' ' ' TRP . 19.3 p -82.66 133.73 35.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.864 0.364 . . . . 75.12 111.135 -179.865 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 2.9 tttt -123.44 136.94 54.87 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.213 -0.449 . . . . 74.12 110.918 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.654 ' HB ' ' CD1' ' A' ' 47' ' ' TRP . 16.9 tt -137.48 152.1 26.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.199 -0.455 . . . . 71.34 111.101 179.908 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.53 ' HA ' ' O ' ' A' ' 21' ' ' TYR . 13.5 m -132.74 145.13 50.77 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.149 -0.478 . . . . 72.24 111.144 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.756 ' HB2' HD22 ' A' ' 34' ' ' LEU . 1.1 m-85 -132.42 126.03 32.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.214 -0.448 . . . . 72.33 110.831 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.551 ' CG ' ' HA ' ' A' ' 16' ' ' PHE . 12.8 m-85 -112.01 132.83 54.56 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.132 -0.486 . . . . 54.13 110.935 -179.877 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.47 ' HB2' ' HB2' ' A' ' 19' ' ' ARG . 0.0 OUTLIER -61.92 -15.04 40.04 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.115 -0.493 . . . . 71.34 110.935 179.96 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.452 ' HB2' ' O ' ' A' ' 17' ' ' GLN . 71.4 m-20 -134.67 149.01 50.46 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.125 -0.489 . . . . 72.32 110.901 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.557 ' N ' ' HB3' ' A' ' 38' ' ' ASN . 5.8 mtmt -54.26 -176.94 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.198 -0.456 . . . . 55.4 110.911 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 16.6 m120 47.52 30.99 1.81 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.255 -0.43 . . . . 64.34 110.919 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.551 ' HA ' ' CG ' ' A' ' 11' ' ' TYR . 3.3 m-85 51.05 64.51 1.81 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.175 -0.466 . . . . 74.22 110.862 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.452 ' O ' ' HB2' ' A' ' 13' ' ' ASP . 14.2 mt-30 -139.76 158.92 43.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.141 -0.482 . . . . 75.12 110.89 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 92.61 -148.79 19.26 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.729 -0.748 . . . . 35.21 112.51 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.704 ' O ' HD13 ' A' ' 34' ' ' LEU . 0.0 OUTLIER -68.12 77.65 0.24 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.852 0.358 . . . . 71.55 110.879 -179.834 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.474 ' HB2' ' CE1' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -77.86 129.36 35.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.178 -0.465 . . . . 73.2 110.863 -179.882 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.53 ' O ' ' HA ' ' A' ' 9' ' ' THR . 90.8 t80 -123.49 123.99 41.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 62.32 110.888 -179.823 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.481 ' CG ' HG23 ' A' ' 9' ' ' THR . 1.3 m-20 -120.57 133.96 55.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.141 -0.481 . . . . 74.54 110.885 179.873 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -167.72 136.79 2.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.168 -0.469 . . . . 72.35 110.86 -179.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -105.37 5.18 31.57 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.157 -0.474 . . . . 72.35 110.919 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 11.7 t -107.1 169.35 8.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.183 -0.462 . . . . 54.24 110.897 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -64.66 116.89 6.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.172 -0.467 . . . . 74.23 110.874 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.46 ' HB2' ' HB3' ' A' ' 30' ' ' PHE . 4.7 m -118.06 53.67 0.95 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.198 -0.456 . . . . 74.25 110.852 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.529 ' C ' ' HA ' ' A' ' 82' ' ' SER . . . -46.28 -21.05 0.13 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.157 -0.474 . . . . 63.42 111.099 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -127.71 43.61 3.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.209 -0.45 . . . . 74.31 110.895 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.777 ' O ' ' CD2' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -81.11 15.51 1.86 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.19 -0.459 . . . . 64.02 110.837 -179.885 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.535 ' HB2' ' HB3' ' A' ' 81' ' ' SER . 30.7 t60 -78.86 -39.3 35.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.145 -0.48 . . . . 71.34 110.826 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.6 t -56.83 -13.89 2.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.229 -0.441 . . . . 65.24 111.155 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -99.61 -28.08 13.37 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.216 -0.447 . . . . 61.31 110.906 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.756 HD22 ' HB2' ' A' ' 10' ' ' PHE . 18.2 tp -141.12 137.25 32.64 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.157 -0.474 . . . . 64.5 110.916 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 30.6 m -101.07 -43.06 6.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.184 -0.462 . . . . 60.04 110.867 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -118.0 140.97 48.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.118 -0.492 . . . . 64.32 110.854 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.702 ' SG ' ' HB2' ' A' ' 80' ' ' LEU . 5.6 p -110.21 87.4 2.51 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.225 -0.443 . . . . 63.23 110.904 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.557 ' HB3' ' N ' ' A' ' 14' ' ' LYS . 0.2 OUTLIER -78.62 -65.17 1.02 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.186 -0.461 . . . . 75.31 110.881 -179.878 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 5.0 p -118.41 123.9 46.36 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.157 -0.474 . . . . 42.1 110.856 -179.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.908 HD12 ' CH2' ' A' ' 73' ' ' TRP . 25.6 mt -117.27 150.62 19.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.13 -0.486 . . . . 64.1 111.094 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.458 ' HD2' ' CE2' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -145.53 119.22 9.18 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.108 -0.497 . . . . 73.15 110.877 179.871 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.511 ' CG2' HD12 ' A' ' 8' ' ' ILE . 1.4 t -103.54 116.21 46.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.238 -0.437 . . . . 64.44 111.14 179.89 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -111.04 79.94 1.25 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.233 -0.44 . . . . 74.42 110.884 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.436 ' O ' ' HA ' ' A' ' 6' ' ' THR . . . 127.17 108.84 1.55 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.793 -0.717 . . . . 43.31 112.476 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.418 ' HA3' HG22 ' A' ' 6' ' ' THR . . . 52.44 179.79 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.706 -0.759 . . . . 74.42 112.491 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.753 HG23 ' HA ' ' A' ' 63' ' ' PRO . 1.3 m -86.39 169.89 12.5 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.78 0.324 . . . . 60.05 111.154 -179.887 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.654 ' CD1' ' HB ' ' A' ' 8' ' ' ILE . 17.8 m95 -140.86 130.8 24.51 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.203 -0.453 . . . . 75.41 110.913 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.909 ' HB2' ' CG2' ' A' ' 86' ' ' VAL . . . -100.28 107.53 19.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.257 -0.429 . . . . 50.12 111.099 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.756 HG11 HD11 ' A' ' 80' ' ' LEU . 4.9 m -107.7 125.52 64.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.205 -0.452 . . . . 54.43 111.157 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.734 ' HB3' ' HA ' ' A' ' 56' ' ' ALA . 39.9 m-85 -89.05 148.12 23.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.222 -0.445 . . . . 74.31 110.899 -179.89 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.567 ' HB2' ' HB2' ' A' ' 58' ' ' TYR . 59.6 tt0 -48.06 -77.85 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.134 -0.485 . . . . 72.41 110.889 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.579 ' HB3' ' HB2' ' A' ' 55' ' ' PHE . 0.2 OUTLIER -89.76 141.37 28.32 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.623 0.725 . . . . 73.51 110.868 -179.914 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.75 ' HA ' ' OG ' ' A' ' 82' ' ' SER . 53.6 Cg_endo -69.78 138.17 37.11 Favored 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.675 2.25 . . . . 60.43 112.356 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 2.3 t30 65.15 -10.0 0.19 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.264 -0.426 . . . . 73.13 110.884 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.579 ' HB2' ' HB3' ' A' ' 52' ' ' ARG . 3.3 m-30 -103.19 -23.32 13.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.175 -0.466 . . . . 72.53 110.856 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.734 ' HA ' ' HB3' ' A' ' 50' ' ' TYR . . . 55.61 23.36 6.02 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.194 -0.457 . . . . 63.43 111.095 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . 0.63 ' O ' ' C ' ' A' ' 58' ' ' TYR . 0.7 OUTLIER -51.67 -165.79 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.236 -0.438 . . . . 74.41 110.887 -179.975 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.63 ' C ' ' O ' ' A' ' 57' ' ' TRP . 11.1 m-30 -14.08 100.57 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.281 -0.418 . . . . 54.03 110.886 -179.85 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.515 ' HB2' ' HA ' ' A' ' 150' ' ' TYR . 0.0 OUTLIER -58.7 158.87 7.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.151 -0.477 . . . . 75.04 110.876 179.91 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.608 ' OH ' ' O ' ' A' ' 73' ' ' TRP . 0.4 OUTLIER -172.23 97.3 0.16 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.257 -0.429 . . . . 72.12 110.906 -179.843 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.776 HD11 ' HB2' ' A' ' 151' ' ' LEU . 2.5 mp -94.32 119.01 41.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.103 -0.498 . . . . 71.34 111.129 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.849 HD13 HG21 ' A' ' 40' ' ' ILE . 0.3 OUTLIER -88.06 128.92 51.96 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-O 121.557 0.694 . . . . 75.22 110.938 179.912 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.787 ' HD2' HD23 ' A' ' 62' ' ' LEU . 53.5 Cg_endo -69.72 -170.53 0.4 Allowed 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.688 2.259 . . . . 64.43 112.358 179.885 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -88.69 161.36 16.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.244 -0.435 . . . . 65.04 110.892 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 112.58 -166.37 12.16 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.759 -0.734 . . . . 53.43 112.534 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -111.04 150.99 28.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.913 0.387 . . . . 73.45 110.867 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.636 ' HB2' ' O ' ' A' ' 40' ' ' ILE . 10.0 m-85 -140.13 84.44 14.82 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.707 0.765 . . . . 61.31 110.911 -179.874 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 -1.06 7.83 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.739 2.293 . . . . 42.51 112.329 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.495 ' HB2' ' HG2' ' A' ' 72' ' ' ARG . 80.7 mt-10 -154.63 142.6 20.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.23 -0.441 . . . . 75.14 110.905 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.743 ' HA ' ' NE1' ' A' ' 73' ' ' TRP . 35.9 p90 -55.13 -23.79 22.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.464 . . . . 73.32 110.93 -179.865 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -76.43 -16.53 59.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.166 -0.47 . . . . 74.42 110.93 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.495 ' HG2' ' HB2' ' A' ' 69' ' ' GLU . 28.3 mmt180 -70.64 -6.36 36.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.209 -0.45 . . . . 73.12 110.879 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . 0.908 ' CH2' HD12 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -139.35 26.58 2.37 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.181 -0.463 . . . . 72.42 110.933 -179.951 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.463 ' HB2' ' O ' ' A' ' 73' ' ' TRP . 0.0 OUTLIER 75.84 -11.0 1.18 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.23 -0.441 . . . . 72.23 110.891 179.954 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.413 ' C ' ' O ' ' A' ' 74' ' ' MET . . . 37.27 46.55 1.38 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.76 -0.733 . . . . 41.31 112.456 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.731 HD12 ' HG3' ' A' ' 149' ' ' GLN . 0.1 OUTLIER -45.83 -63.25 1.01 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.819 0.342 . . . . 54.21 110.92 -179.927 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -127.32 126.11 42.01 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.208 -0.451 . . . . 42.31 110.873 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -76.03 1.69 14.78 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.187 -0.461 . . . . 65.24 110.889 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -99.89 73.85 1.79 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.176 -0.465 . . . . 74.53 110.837 -179.873 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.756 HD11 HG11 ' A' ' 49' ' ' VAL . 0.1 OUTLIER -81.87 133.08 35.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.155 -0.475 . . . . 74.12 110.874 -179.977 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.622 ' HB3' ' HB3' ' A' ' 53' ' ' PRO . 0.9 OUTLIER -148.31 -130.45 0.06 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.193 -0.458 . . . . 73.21 110.921 -179.957 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.75 ' OG ' ' HA ' ' A' ' 53' ' ' PRO . 0.6 OUTLIER -25.78 131.4 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.124 -0.489 . . . . 65.05 110.893 -179.851 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . 0.512 ' HA ' ' O ' ' A' ' 48' ' ' ALA . 6.9 p -138.1 140.87 40.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.141 -0.482 . . . . 62.41 110.87 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.521 ' N ' ' O ' ' A' ' 48' ' ' ALA . 6.4 mmt85 -139.78 128.36 23.01 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.225 -0.443 . . . . 70.14 110.851 -179.823 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.449 ' N ' ' CZ3' ' A' ' 47' ' ' TRP . . . -50.56 129.59 22.6 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.195 -0.457 . . . . 64.42 111.096 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.909 ' CG2' ' HB2' ' A' ' 48' ' ' ALA . 25.5 t -114.51 142.04 28.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.276 -0.42 . . . . 75.2 111.09 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . 0.59 ' O ' HG23 ' A' ' 136' ' ' VAL . 6.7 m-70 -112.24 110.56 20.88 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.161 -0.472 . . . . 74.23 110.851 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.595 HD13 ' HB3' ' A' ' 178' ' ' GLU . 0.0 OUTLIER -35.95 144.13 0.26 Allowed Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.646 0.736 . . . . 60.3 110.9 -179.959 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.534 ' HB3' ' H ' ' A' ' 136' ' ' VAL . 53.7 Cg_endo -69.7 98.66 0.69 Allowed 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.671 2.247 . . . . 70.12 112.357 179.857 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -104.51 -175.35 2.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.263 -0.426 . . . . 74.02 110.878 -179.84 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 50.95 58.84 8.8 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.757 -0.735 . . . . 71.31 112.523 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.412 ' O ' ' C ' ' A' ' 93' ' ' GLN . . . 123.46 26.07 1.68 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.747 -0.74 . . . . 70.51 112.488 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.45 ' O ' ' HG2' ' A' ' 134' ' ' GLU . 14.6 pt20 37.32 -123.05 0.21 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.834 0.35 . . . . 75.53 110.905 -179.856 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.541 ' HA ' ' HG2' ' A' ' 134' ' ' GLU . 0.1 OUTLIER -123.75 104.41 8.96 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.172 -0.467 . . . . 73.21 110.907 -179.852 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.562 ' HG3' HG11 ' A' ' 132' ' ' VAL . 34.1 tptt -114.37 127.78 56.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.099 -0.5 . . . . 62.15 110.895 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.584 HG21 ' HE2' ' A' ' 173' ' ' PHE . 6.3 tt -149.45 136.93 13.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.221 -0.445 . . . . 73.43 111.073 179.898 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.461 ' HB2' ' O ' ' A' ' 131' ' ' LYS . 0.7 OUTLIER -107.25 123.91 48.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.15 -0.477 . . . . 74.24 110.907 179.949 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.437 ' CG2' HD12 ' A' ' 127' ' ' ILE . 43.9 mm -105.39 131.06 55.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.193 -0.458 . . . . 70.12 111.121 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.7 ' HB2' ' HB2' ' A' ' 129' ' ' SER . 45.9 m-85 -118.79 150.39 39.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.152 -0.476 . . . . 74.34 110.897 179.911 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 50.8 tt0 -85.76 -56.08 3.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.187 -0.461 . . . . 71.1 110.852 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 47.6 mttt -101.01 164.93 11.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.167 -0.47 . . . . 65.14 110.89 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.402 ' HA2' ' OG ' ' A' ' 129' ' ' SER . . . -65.53 152.4 51.51 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.768 -0.73 . . . . 73.12 112.49 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.425 ' HA ' ' HB2' ' A' ' 158' ' ' ARG . 27.8 t0 65.76 45.37 2.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.831 0.348 . . . . 75.14 110.852 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.576 ' N ' ' CD2' ' A' ' 104' ' ' PHE . 0.1 OUTLIER 47.48 33.81 3.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.233 -0.44 . . . . 75.24 110.912 -179.881 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 53.3 m -96.35 159.61 14.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.164 -0.471 . . . . 75.04 110.861 -179.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 83.91 -135.67 14.01 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.695 -0.764 . . . . 70.25 112.49 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 37.7 tp60 -88.65 120.67 30.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.783 0.325 . . . . 61.14 110.879 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 3.5 ttp -108.25 132.8 53.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.154 -0.475 . . . . 72.11 110.862 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -137.72 137.09 37.97 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.221 -0.445 . . . . 70.24 110.925 -179.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -119.33 104.43 10.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.097 -0.501 . . . . 75.42 110.854 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 8.9 t -112.82 133.38 54.85 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.183 -0.462 . . . . 54.41 111.152 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.475 ' HA ' ' O ' ' A' ' 94' ' ' TYR . 1.6 t -115.5 32.49 6.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.22 -0.446 . . . . 72.34 111.131 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -142.38 -173.91 3.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.219 -0.446 . . . . 75.33 110.88 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -72.08 150.66 43.71 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.117 -0.492 . . . . 75.13 110.837 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . 0.424 ' O ' ' HB2' ' A' ' 172' ' ' SER . 57.4 m -140.99 107.16 6.27 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-O 121.631 0.729 . . . . 71.34 110.884 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.618 ' O ' ' CB ' ' A' ' 172' ' ' SER . 53.3 Cg_endo -69.74 -35.97 11.73 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.657 2.238 . . . . 71.25 112.311 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.611 ' HB3' ' CB ' ' A' ' 120' ' ' GLU . 0.1 OUTLIER -142.0 112.37 7.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.228 -0.442 . . . . 60.45 110.865 -179.78 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.54 ' HB ' ' O ' ' A' ' 171' ' ' GLN . 5.4 tt -67.24 -32.87 59.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.18 -0.463 . . . . 72.53 111.104 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' MET . . . . . 0.643 ' O ' ' HA ' ' A' ' 123' ' ' HIS . 0.0 OUTLIER -87.28 -38.99 15.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.178 -0.464 . . . . 72.11 110.897 179.855 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.611 ' CB ' ' HB3' ' A' ' 117' ' ' SER . 3.9 tp10 -72.18 -15.43 61.96 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.218 -0.446 . . . . 55.52 110.896 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 13.0 mm100 -114.44 -45.82 3.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.123 -0.49 . . . . 75.05 110.925 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.538 ' HB2' ' O ' ' A' ' 118' ' ' ILE . 47.4 m-85 -106.23 -19.71 13.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.195 -0.457 . . . . 74.31 110.879 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.643 ' HA ' ' O ' ' A' ' 119' ' ' MET . 12.3 m80 70.58 29.21 3.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.137 -0.483 . . . . 73.14 110.889 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.403 ' SD ' HG22 ' A' ' 98' ' ' ILE . 4.0 mtt -107.19 83.42 1.82 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.208 -0.451 . . . . 71.43 110.838 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 4.0 ptp180 -50.58 -35.43 30.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.239 -0.437 . . . . 65.03 110.86 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.462 ' HB3' ' HG2' ' A' ' 168' ' ' PRO . 18.8 mt-10 -142.42 136.14 29.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.231 -0.44 . . . . 75.15 110.899 -179.915 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.529 HD11 HD13 ' A' ' 118' ' ' ILE . 3.9 mm -96.3 104.47 15.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.174 -0.466 . . . . 64.54 111.076 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 12.6 m170 -70.79 -34.95 72.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.157 -0.474 . . . . 72.34 110.833 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.7 ' HB2' ' HB2' ' A' ' 99' ' ' PHE . 13.7 m -133.75 149.85 51.47 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.204 -0.453 . . . . 53.23 110.883 -179.822 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . 0.496 ' O ' ' HE3' ' A' ' 154' ' ' LYS . 0.1 OUTLIER -148.68 117.92 6.85 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.151 -0.477 . . . . 74.13 110.865 -179.913 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.501 ' HG2' ' HG2' ' A' ' 156' ' ' GLU . 11.2 mtpt -113.87 155.56 25.53 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.21 -0.45 . . . . 70.31 110.892 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.562 HG11 ' HG3' ' A' ' 95' ' ' LYS . 15.5 t 83.43 160.91 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.221 -0.445 . . . . 54.44 111.104 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.863 HD22 ' O ' ' A' ' 133' ' ' LEU . 0.0 OUTLIER -177.79 127.3 0.13 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.166 -0.47 . . . . 70.5 110.923 179.911 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.541 ' HG2' ' HA ' ' A' ' 94' ' ' TYR . 0.1 OUTLIER -97.8 171.34 8.37 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.162 -0.472 . . . . 70.04 110.898 179.938 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.493 ' C ' ' O ' ' A' ' 134' ' ' GLU . . . -30.41 -78.84 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.741 -0.742 . . . . 72.43 112.468 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.79 HG21 HG13 ' A' ' 86' ' ' VAL . 2.8 t -128.53 144.91 36.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.781 0.324 . . . . 72.13 111.158 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . 0.65 ' HB3' ' CB ' ' A' ' 152' ' ' LEU . 60.2 t-105 -146.14 163.94 33.77 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.214 -0.448 . . . . 74.53 110.897 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.511 ' CD1' ' HB ' ' A' ' 61' ' ' ILE . 5.8 mm -132.74 138.07 52.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.231 -0.441 . . . . 64.51 111.091 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.748 ' HB2' ' HB2' ' A' ' 150' ' ' TYR . 69.7 m-85 -114.49 152.48 31.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.139 -0.482 . . . . 64.24 110.855 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.734 ' CD2' ' HA ' ' A' ' 145' ' ' TYR . 13.7 m-85 -128.34 144.19 51.1 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.149 -0.478 . . . . 74.44 110.878 -179.874 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.57 ' C ' ' HB2' ' A' ' 171' ' ' GLN . 27.4 tt0 -84.77 -7.96 59.0 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.106 -0.497 . . . . 75.22 110.864 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.476 ' C ' ' H ' ' A' ' 144' ' ' ASN . 7.2 mp -120.05 149.07 48.29 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.579 0.704 . . . . 74.01 110.954 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . 0.709 ' HD3' ' CD ' ' A' ' 171' ' ' GLN . 54.0 Cg_endo -69.71 32.75 0.19 Allowed 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.695 2.264 . . . . 73.13 112.375 179.857 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . 1.007 ' O ' ' N ' ' A' ' 146' ' ' ARG . 0.0 OUTLIER -169.34 101.91 0.35 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.201 -0.454 . . . . 73.43 110.923 -179.961 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . 0.734 ' HA ' ' CD2' ' A' ' 140' ' ' TYR . 0.3 OUTLIER 3.59 48.39 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.155 -0.475 . . . . 74.4 110.945 -179.866 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 1.007 ' N ' ' O ' ' A' ' 144' ' ' ASN . 1.1 mtp85 -136.16 178.02 7.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.069 -0.514 . . . . 61.34 110.835 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . 0.445 ' O ' HD11 ' A' ' 76' ' ' LEU . . . 83.04 -175.48 53.01 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.764 -0.731 . . . . 44.14 112.482 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 53.3 mtt180 -62.45 146.22 52.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.705 0.288 . . . . 73.41 110.852 -179.84 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . 0.731 ' HG3' HD12 ' A' ' 76' ' ' LEU . 1.4 mt-30 -98.22 135.39 39.92 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.202 -0.454 . . . . 74.02 110.933 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . 0.748 ' HB2' ' HB2' ' A' ' 139' ' ' PHE . 54.5 m-85 -121.46 125.43 46.84 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.23 -0.441 . . . . 73.51 110.888 -179.863 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.776 ' HB2' HD11 ' A' ' 61' ' ' ILE . 19.8 tp -76.89 122.71 25.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.113 -0.494 . . . . 70.31 110.908 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 1.034 ' O ' HD13 ' A' ' 152' ' ' LEU . 0.0 OUTLIER -50.74 130.71 25.19 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.156 -0.475 . . . . 60.42 110.893 179.893 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -163.86 26.48 0.08 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.21 -0.45 . . . . 75.21 110.837 179.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.826 ' O ' ' HG3' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -108.09 -174.76 2.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.191 -0.458 . . . . 62.13 110.865 -179.999 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.826 ' HG3' ' O ' ' A' ' 154' ' ' LYS . 1.5 mptt -162.44 -127.74 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.195 -0.457 . . . . 54.41 110.936 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.569 ' HG2' ' O ' ' A' ' 156' ' ' GLU . 2.2 tm-20 -70.46 6.91 1.2 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.247 -0.433 . . . . 74.51 110.835 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . 0.701 ' CE1' ' HA ' ' A' ' 154' ' ' LYS . 18.9 m-30 -32.44 149.97 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.176 -0.466 . . . . 71.11 110.894 -179.835 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . 0.442 ' HB3' ' CE2' ' A' ' 104' ' ' PHE . 0.0 OUTLIER -126.5 -34.73 2.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.108 -0.496 . . . . 73.5 110.864 -179.992 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -89.07 151.69 47.22 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.638 0.732 . . . . 71.35 110.892 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . 0.485 ' HB2' ' HD3' ' A' ' 168' ' ' PRO . 54.1 Cg_endo -69.72 -24.11 30.2 Favored 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 122.645 2.23 . . . . 75.55 112.401 179.896 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.6 ' H ' HD12 ' A' ' 161' ' ' ILE . 3.7 mp -69.41 -9.39 12.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.189 -0.459 . . . . 63.4 111.131 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.67 ' HB3' ' CD1' ' A' ' 157' ' ' TYR . 0.3 OUTLIER -77.2 -13.38 59.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.14 -0.482 . . . . 72.42 110.87 179.88 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -87.64 3.17 48.78 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.186 -0.461 . . . . 73.22 110.968 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 88.42 -36.15 3.47 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.713 -0.756 . . . . 72.23 112.516 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -80.76 129.86 34.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.795 0.331 . . . . 61.33 111.086 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -37.95 -38.33 0.3 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.218 -0.447 . . . . 74.3 111.121 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . 0.485 ' C ' ' H ' ' A' ' 169' ' ' ALA . 0.3 OUTLIER -127.12 158.88 67.67 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.647 0.737 . . . . 74.1 110.857 -179.785 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . 0.485 ' HD3' ' HB2' ' A' ' 160' ' ' PRO . 54.5 Cg_endo -69.7 26.3 0.17 Allowed 'Trans proline' 0 C--N 1.341 0.132 0 C-N-CA 122.715 2.277 . . . . 75.33 112.355 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.485 ' H ' ' C ' ' A' ' 167' ' ' SER . . . -65.95 107.81 1.98 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.25 -0.432 . . . . 70.4 111.129 179.909 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.505 HG12 ' N ' ' A' ' 171' ' ' GLN . 19.2 t -151.15 160.52 3.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.215 -0.448 . . . . 64.23 111.141 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' GLN . . . . . 0.709 ' CD ' ' HD3' ' A' ' 143' ' ' PRO . 6.5 mm-40 -109.41 -91.85 0.44 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.175 -0.466 . . . . 74.41 110.922 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . 0.618 ' CB ' ' O ' ' A' ' 116' ' ' PRO . 60.1 p -127.98 168.91 14.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.199 -0.455 . . . . 72.23 110.873 -179.821 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . 0.612 ' CD1' ' N ' ' A' ' 173' ' ' PHE . 0.1 OUTLIER -146.75 165.79 28.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.146 -0.479 . . . . 70.45 110.918 -179.953 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . 0.414 ' HG2' ' HE2' ' A' ' 140' ' ' TYR . 0.7 OUTLIER -146.33 169.93 17.82 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.185 -0.462 . . . . 74.13 110.852 -179.916 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . 0.507 ' HB3' ' CZ3' ' A' ' 137' ' ' TRP . 0.0 OUTLIER -89.1 -162.26 0.85 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.12 -0.491 . . . . 73.43 110.86 -179.913 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . 0.489 HD11 HG12 ' A' ' 136' ' ' VAL . 27.4 mt -124.68 141.82 43.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.157 -0.474 . . . . 73.04 111.133 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 44.1 t -75.25 140.88 16.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.171 -0.468 . . . . 54.15 111.123 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . 0.595 ' HB3' HD13 ' A' ' 88' ' ' LEU . 35.8 mt-10 . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.217 -0.447 . . . . 75.21 110.856 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.4 mtp . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.805 0.336 . . . . 31.32 110.899 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.3 m 53.59 -172.79 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.222 -0.445 . . . . 63.2 110.857 -179.78 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 53.7 mttt -90.03 45.85 1.31 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.12 -0.491 . . . . 62.14 110.915 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 11.5 p -63.79 -31.99 73.35 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.248 -0.433 . . . . 64.31 111.155 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -167.01 137.1 4.46 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.764 -0.731 . . . . 61.51 112.501 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.451 ' C ' ' HE1' ' A' ' 47' ' ' TRP . 20.0 p -82.35 138.84 34.39 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.89 0.376 . . . . 71.53 111.105 -179.833 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.492 ' N ' ' HE1' ' A' ' 47' ' ' TRP . 2.9 tttt -124.91 134.66 52.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.232 -0.44 . . . . 74.32 110.878 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.483 HG13 HG23 ' A' ' 42' ' ' VAL . 15.4 tt -136.56 149.2 26.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.21 -0.45 . . . . 74.15 111.189 179.833 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.51 HG23 ' CG ' ' A' ' 22' ' ' ASP . 10.3 m -130.87 141.35 50.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.184 -0.462 . . . . 63.32 111.145 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.781 ' HB2' HD22 ' A' ' 34' ' ' LEU . 0.9 OUTLIER -128.83 128.36 43.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.275 -0.421 . . . . 72.3 110.845 -179.981 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.539 ' CG ' ' HA ' ' A' ' 16' ' ' PHE . 22.9 m-85 -114.28 132.12 56.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.102 -0.499 . . . . 60.34 110.927 -179.862 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.458 ' HG2' ' HB2' ' A' ' 36' ' ' ARG . 0.0 OUTLIER -60.01 -23.47 63.7 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.145 -0.479 . . . . 64.12 110.888 -179.98 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 65.6 m-20 -128.58 152.41 48.35 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.142 -0.481 . . . . 73.33 110.869 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.445 ' N ' ' HB3' ' A' ' 38' ' ' ASN . 31.8 mtmt -55.67 -175.18 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.166 -0.47 . . . . 75.31 110.897 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 17.8 m120 46.43 33.58 1.98 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.237 -0.438 . . . . 63.13 110.84 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.539 ' HA ' ' CG ' ' A' ' 11' ' ' TYR . 4.0 m-85 48.95 57.97 5.86 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.181 -0.463 . . . . 71.24 110.899 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 -132.81 158.56 42.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.153 -0.476 . . . . 64.43 110.931 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 94.7 -150.52 19.76 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.746 -0.74 . . . . 53.03 112.447 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.796 ' O ' HD13 ' A' ' 34' ' ' LEU . 0.0 OUTLIER -69.6 80.45 0.41 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.794 0.33 . . . . 74.43 110.875 -179.838 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.466 ' HB2' ' CE1' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -79.11 128.5 33.36 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.188 -0.46 . . . . 73.51 110.835 -179.927 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.471 ' CD2' ' CD2' ' A' ' 30' ' ' PHE . 71.2 t80 -124.49 125.36 44.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.15 -0.477 . . . . 74.45 110.921 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.51 ' CG ' HG23 ' A' ' 9' ' ' THR . 1.2 m-20 -119.48 132.61 55.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.128 -0.487 . . . . 72.01 110.91 179.899 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 10.4 t -157.09 130.25 7.83 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.195 -0.457 . . . . 54.32 110.907 -179.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.415 ' HA ' ' HA ' ' A' ' 7' ' ' LYS . 3.9 p30 -99.4 5.76 46.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.214 -0.448 . . . . 60.02 110.866 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 47.1 t -117.68 161.46 19.63 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.208 -0.451 . . . . 74.44 110.9 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 31.5 m-20 -45.12 120.51 2.44 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.176 -0.465 . . . . 72.1 110.887 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.62 ' HB2' ' HB3' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -114.27 43.87 1.8 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.185 -0.461 . . . . 61.22 110.869 -179.909 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.546 ' O ' ' HA ' ' A' ' 82' ' ' SER . . . -49.67 -21.53 1.07 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 35.04 111.105 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 60.2 t0 -129.58 40.99 3.51 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.222 -0.445 . . . . 73.44 110.862 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.795 ' O ' ' CD2' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -81.48 17.79 1.31 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.211 -0.449 . . . . 63.14 110.907 -179.934 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.54 ' HB2' ' HB3' ' A' ' 81' ' ' SER . 40.7 t60 -81.98 -33.56 30.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.166 -0.47 . . . . 50.31 110.845 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.0 t -66.96 -5.67 13.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.194 -0.457 . . . . 50.1 111.114 -179.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -108.29 -27.68 9.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.231 -0.44 . . . . 74.42 110.92 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.796 HD13 ' O ' ' A' ' 19' ' ' ARG . 23.3 tp -141.51 145.99 35.85 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.111 -0.495 . . . . 72.15 110.95 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.3 m -112.66 -34.93 5.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.181 -0.463 . . . . 45.33 110.806 -179.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.51 ' NH2' HD21 ' A' ' 38' ' ' ASN . 2.0 mtp85 -115.79 142.09 47.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.148 -0.478 . . . . 72.04 110.842 -179.877 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.616 ' SG ' ' HB2' ' A' ' 80' ' ' LEU . 6.3 p -120.02 64.81 0.82 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.139 -0.482 . . . . 74.31 110.899 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.51 HD21 ' NH2' ' A' ' 36' ' ' ARG . 3.0 m120 -63.66 -66.64 0.51 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.17 -0.468 . . . . 74.41 110.893 -179.885 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 5.0 p -113.81 127.31 55.95 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.113 -0.494 . . . . 71.21 110.881 -179.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.797 HD12 ' CH2' ' A' ' 73' ' ' TRP . 18.7 mt -120.95 149.37 23.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.131 -0.486 . . . . 70.21 111.146 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.462 ' HD2' ' CE2' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -143.5 119.3 10.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.189 -0.459 . . . . 71.01 110.902 179.874 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.571 HG21 ' HB2' ' A' ' 47' ' ' TRP . 1.0 OUTLIER -106.06 118.07 52.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.245 -0.434 . . . . 74.23 111.152 179.877 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -114.76 76.73 1.01 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.178 -0.465 . . . . 62.21 110.888 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.4 ' O ' ' HB ' ' A' ' 6' ' ' THR . . . 140.87 90.13 0.17 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.788 -0.72 . . . . 74.45 112.524 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 58.46 172.36 0.36 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.75 -0.738 . . . . 45.42 112.484 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.749 HG23 ' HA ' ' A' ' 63' ' ' PRO . 0.2 OUTLIER -66.01 172.35 3.79 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.828 0.347 . . . . 73.31 111.132 -179.867 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.571 ' HB2' HG21 ' A' ' 42' ' ' VAL . 6.6 m95 -146.97 129.55 15.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.2 -0.454 . . . . 73.11 110.948 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.798 ' HB2' ' CG2' ' A' ' 86' ' ' VAL . . . -91.13 127.7 36.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.263 -0.426 . . . . 75.04 111.092 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.729 HG11 HD11 ' A' ' 80' ' ' LEU . 21.1 m -125.86 145.0 34.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.215 -0.448 . . . . 72.02 111.115 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.895 ' HB3' ' CB ' ' A' ' 56' ' ' ALA . 6.7 m-85 -122.84 143.68 49.7 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.212 -0.449 . . . . 75.52 110.925 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.584 ' HG2' ' N ' ' A' ' 52' ' ' ARG . 0.5 OUTLIER -49.46 -84.04 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.176 -0.465 . . . . 55.1 110.871 179.987 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.862 ' O ' ' HB2' ' A' ' 56' ' ' ALA . 0.8 OUTLIER -81.91 136.43 47.59 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.586 0.707 . . . . 75.11 110.866 -179.89 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.635 ' HB3' ' HB3' ' A' ' 81' ' ' SER . 53.4 Cg_endo -69.74 135.79 31.41 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.668 2.245 . . . . 71.43 112.326 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.437 ' HB3' ' CE2' ' A' ' 55' ' ' PHE . 7.1 t-20 72.17 -6.15 1.59 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.174 -0.466 . . . . 74.34 110.945 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.437 ' CE2' ' HB3' ' A' ' 54' ' ' ASN . 0.1 OUTLIER -144.46 -75.36 0.24 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.136 -0.484 . . . . 72.31 110.877 -179.996 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.895 ' CB ' ' HB3' ' A' ' 50' ' ' TYR . . . 47.58 82.55 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.132 -0.485 . . . . 63.25 111.059 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . 0.61 ' O ' ' CD2' ' A' ' 58' ' ' TYR . 28.5 m0 -64.41 31.08 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.254 -0.43 . . . . 73.42 110.938 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.635 ' H ' ' C ' ' A' ' 56' ' ' ALA . 3.8 m-85 -160.29 115.6 2.3 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.264 -0.426 . . . . 73.25 110.935 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -82.39 136.59 34.94 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.128 -0.487 . . . . 63.34 110.85 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.629 ' HA ' ' OE1' ' A' ' 149' ' ' GLN . 5.4 t80 -146.39 124.86 12.37 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.243 -0.435 . . . . 74.43 110.9 -179.899 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.847 ' N ' HD12 ' A' ' 61' ' ' ILE . 1.0 OUTLIER -109.21 116.95 53.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.13 -0.486 . . . . 74.14 111.164 179.883 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.804 HD23 ' HD2' ' A' ' 63' ' ' PRO . 0.3 OUTLIER -89.34 129.17 48.48 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.635 0.731 . . . . 64.32 110.909 179.93 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.804 ' HD2' HD23 ' A' ' 62' ' ' LEU . 53.5 Cg_endo -69.8 -175.28 1.11 Allowed 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.664 2.242 . . . . 72.52 112.323 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.48 162.7 15.58 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.216 -0.447 . . . . 73.23 110.897 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 112.34 -171.56 14.15 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.797 -0.716 . . . . 73.45 112.533 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -103.5 150.96 23.4 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.871 0.367 . . . . 74.14 110.885 -179.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.662 ' HB2' ' O ' ' A' ' 40' ' ' ILE . 19.7 m-85 -139.26 85.34 15.59 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.669 0.747 . . . . 74.22 110.923 -179.853 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 -0.01 6.26 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.687 2.258 . . . . 64.35 112.373 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.553 ' HB2' ' HG2' ' A' ' 72' ' ' ARG . 49.3 mt-10 -155.81 142.18 18.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.177 -0.465 . . . . 63.34 110.855 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.737 ' HA ' ' NE1' ' A' ' 73' ' ' TRP . 30.0 p90 -54.85 -20.52 8.9 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.158 -0.473 . . . . 72.22 110.918 -179.857 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -80.41 -18.72 48.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.144 -0.48 . . . . 72.43 110.945 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.553 ' HG2' ' HB2' ' A' ' 69' ' ' GLU . 26.5 mmt180 -69.9 -7.35 39.62 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.466 . . . . 71.0 110.887 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . 0.797 ' CH2' HD12 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -139.28 18.49 2.58 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.176 -0.465 . . . . 71.51 110.929 -179.957 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.461 ' C ' ' O ' ' A' ' 73' ' ' TRP . 0.0 OUTLIER 33.54 43.98 0.06 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.212 -0.449 . . . . 73.23 110.863 179.95 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -53.31 125.44 31.43 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.784 -0.722 . . . . 53.44 112.472 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.499 HD11 ' HA ' ' A' ' 148' ' ' ARG . 6.2 mt -52.85 -53.98 40.98 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.862 0.363 . . . . 72.23 110.9 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 -130.68 151.66 50.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.198 -0.456 . . . . 64.43 110.866 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -84.22 13.29 5.38 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.201 -0.454 . . . . 62.33 110.864 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.406 ' HD2' ' HG2' ' A' ' 51' ' ' GLU . 0.0 OUTLIER -103.6 67.72 0.91 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 73.52 110.87 -179.904 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.729 HD11 HG11 ' A' ' 49' ' ' VAL . 0.1 OUTLIER -72.0 132.9 44.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.225 -0.443 . . . . 72.23 110.919 -179.98 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.635 ' HB3' ' HB3' ' A' ' 53' ' ' PRO . 1.3 m -151.09 -122.48 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.193 -0.458 . . . . 73.21 110.841 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.606 ' OG ' ' HA ' ' A' ' 53' ' ' PRO . 0.1 OUTLIER -38.33 106.06 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.136 -0.484 . . . . 74.23 110.844 -179.782 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . 0.67 ' HB3' HG12 ' A' ' 49' ' ' VAL . 9.3 p -134.38 131.34 38.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.15 -0.477 . . . . 72.32 110.904 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.602 ' N ' ' O ' ' A' ' 48' ' ' ALA . 2.9 mmt-85 -113.76 164.75 13.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 60.32 110.874 -179.835 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -79.82 130.31 35.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.219 -0.446 . . . . 53.33 111.084 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.798 ' CG2' ' HB2' ' A' ' 48' ' ' ALA . 54.3 t -116.07 136.05 54.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.195 -0.457 . . . . 75.34 111.162 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . 0.641 ' O ' HG23 ' A' ' 136' ' ' VAL . 45.8 m80 -114.92 105.8 13.42 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.183 -0.462 . . . . 64.15 110.854 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.577 HD13 ' HB3' ' A' ' 178' ' ' GLU . 0.0 OUTLIER -34.02 146.55 0.13 Allowed Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.56 0.695 . . . . 63.23 110.926 -179.976 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.548 ' HB3' ' H ' ' A' ' 136' ' ' VAL . 53.5 Cg_endo -69.77 109.99 2.45 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.669 2.246 . . . . 71.03 112.356 179.843 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -106.83 158.84 16.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.236 -0.438 . . . . 74.23 110.841 -179.818 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 49.7 79.52 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.743 -0.742 . . . . 40.34 112.488 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 124.64 11.19 4.59 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.725 -0.75 . . . . 54.45 112.492 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.46 ' O ' ' HG2' ' A' ' 134' ' ' GLU . 14.8 pt20 38.02 -122.84 0.25 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.824 0.345 . . . . 72.44 110.923 -179.833 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.475 ' CE2' ' HD2' ' A' ' 175' ' ' ARG . 0.2 OUTLIER -124.19 101.97 7.47 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.209 -0.45 . . . . 74.2 110.903 -179.876 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.505 ' HG3' HG11 ' A' ' 132' ' ' VAL . 47.4 tptt -110.89 126.55 54.82 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.07 -0.514 . . . . 75.44 110.893 179.886 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.75 HD13 ' N ' ' A' ' 97' ' ' GLN . 0.0 OUTLIER -149.38 138.04 14.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.262 -0.426 . . . . 52.14 111.146 179.808 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.75 ' N ' HD13 ' A' ' 96' ' ' ILE . 2.2 mt-30 -105.52 121.23 43.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.182 -0.463 . . . . 64.01 110.889 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.59 ' CD1' HD12 ' A' ' 96' ' ' ILE . 23.0 mm -97.75 131.23 45.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.15 -0.477 . . . . 71.33 111.125 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.675 ' CB ' ' HB2' ' A' ' 129' ' ' SER . 37.6 m-85 -120.96 140.54 51.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.181 -0.463 . . . . 75.13 110.868 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 59.6 tt0 -75.79 -61.7 1.84 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.15 -0.477 . . . . 73.13 110.907 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 39.9 mttt -96.6 171.42 8.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.128 -0.487 . . . . 71.13 110.898 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.424 ' HA2' ' OG ' ' A' ' 129' ' ' SER . . . -70.5 153.46 51.68 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.719 -0.753 . . . . 71.52 112.493 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.461 ' HA ' ' HB2' ' A' ' 158' ' ' ARG . 26.8 t0 65.27 46.11 2.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.802 0.334 . . . . 73.13 110.861 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.593 ' N ' ' CD2' ' A' ' 104' ' ' PHE . 0.1 OUTLIER 47.54 33.18 2.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.227 -0.442 . . . . 75.12 110.853 -179.948 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 57.8 m -96.13 159.45 14.95 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.168 -0.469 . . . . 51.42 110.847 -179.774 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 84.92 -137.29 15.4 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.748 -0.739 . . . . 74.21 112.504 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 30.1 tp60 -88.84 114.2 25.2 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.805 0.336 . . . . 64.11 110.94 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 1.5 ttp -101.36 144.12 30.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.185 -0.461 . . . . 64.35 110.9 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -149.47 136.01 19.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.218 -0.446 . . . . 75.02 110.899 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -117.36 102.49 9.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.107 -0.497 . . . . 65.32 110.867 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 11.9 t -113.05 129.15 56.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.166 -0.47 . . . . 61.23 111.134 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.474 ' HA ' ' O ' ' A' ' 94' ' ' TYR . 1.5 t -96.74 22.52 8.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.224 -0.443 . . . . 74.53 111.199 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -151.2 137.56 18.53 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.155 -0.475 . . . . 74.15 110.848 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 30.7 p30 -53.89 178.27 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.16 -0.473 . . . . 64.13 110.882 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . 0.498 ' O ' ' HB2' ' A' ' 172' ' ' SER . 0.8 OUTLIER -155.65 151.31 21.89 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.57 0.7 . . . . 64.45 110.888 -179.92 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.453 ' O ' ' C ' ' A' ' 143' ' ' PRO . 54.1 Cg_endo -69.77 -33.94 15.54 Favored 'Trans proline' 0 C--O 1.231 0.134 0 C-N-CA 122.659 2.24 . . . . 64.35 112.383 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.632 ' HB3' ' CB ' ' A' ' 120' ' ' GLU . 0.1 OUTLIER -148.3 109.55 4.35 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 64.41 110.83 -179.821 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.636 HD13 HD11 ' A' ' 127' ' ' ILE . 4.3 tt -60.45 -30.0 45.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.156 -0.475 . . . . 72.33 111.125 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' MET . . . . . 0.603 ' O ' ' HA ' ' A' ' 123' ' ' HIS . 5.0 ttt -86.14 -41.91 14.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.227 -0.442 . . . . 74.34 110.835 179.873 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.632 ' CB ' ' HB3' ' A' ' 117' ' ' SER . 10.0 tp10 -68.03 -14.11 62.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.229 -0.441 . . . . 63.11 110.913 -179.924 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 6.9 tp-100 -115.17 -48.27 2.82 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.092 -0.503 . . . . 71.45 110.91 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.516 ' HB2' ' O ' ' A' ' 118' ' ' ILE . 53.4 m-85 -103.34 -20.4 14.1 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.198 -0.455 . . . . 75.12 110.879 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.603 ' HA ' ' O ' ' A' ' 119' ' ' MET . 0.1 OUTLIER 71.33 29.87 2.68 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.104 -0.498 . . . . 63.04 110.859 -179.997 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.557 ' SD ' HG22 ' A' ' 98' ' ' ILE . 4.5 mtt -107.85 86.34 2.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.256 -0.429 . . . . 62.41 110.892 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 1.9 ptp85 -51.97 -40.44 60.89 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.239 -0.437 . . . . 72.3 110.886 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.469 ' HB3' ' HG2' ' A' ' 168' ' ' PRO . 12.9 mt-10 -137.51 133.51 34.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.191 -0.458 . . . . 73.51 110.907 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.636 HD11 HD13 ' A' ' 118' ' ' ILE . 3.7 mm -93.48 101.57 12.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.135 -0.484 . . . . 65.23 111.149 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 11.8 m80 -69.9 -34.16 73.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.2 -0.455 . . . . 74.21 110.855 179.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.675 ' HB2' ' CB ' ' A' ' 99' ' ' PHE . 8.3 m -134.02 154.3 51.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.231 -0.44 . . . . 34.15 110.838 -179.756 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . 0.615 ' SG ' HD11 ' A' ' 96' ' ' ILE . 0.1 OUTLIER -155.13 118.54 4.46 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.154 -0.475 . . . . 75.43 110.886 -179.929 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.561 ' C ' HG23 ' A' ' 132' ' ' VAL . 7.7 mtpp -112.86 154.0 27.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.201 -0.454 . . . . 55.34 110.912 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.561 HG23 ' C ' ' A' ' 131' ' ' LYS . 15.2 t 87.17 162.57 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.218 -0.446 . . . . 54.23 111.127 179.9 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.819 HD22 ' HG3' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -179.65 125.63 0.08 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.161 -0.472 . . . . 70.01 110.895 179.939 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.46 ' HG2' ' O ' ' A' ' 93' ' ' GLN . 0.0 OUTLIER -93.71 176.9 6.19 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.186 -0.461 . . . . 71.44 110.867 179.953 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.452 ' HA3' ' HA ' ' A' ' 89' ' ' PRO . . . -37.26 -67.41 0.45 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.768 -0.73 . . . . 65.14 112.488 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.789 HG11 ' CG1' ' A' ' 86' ' ' VAL . 13.4 t -140.65 145.24 25.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.913 0.387 . . . . 74.21 111.073 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . 0.679 ' H ' HD12 ' A' ' 152' ' ' LEU . 0.1 OUTLIER -147.51 168.68 21.33 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.117 -0.492 . . . . 52.23 110.898 179.988 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.574 ' CG2' ' HB2' ' A' ' 149' ' ' GLN . 63.0 mt -138.13 133.72 44.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.219 -0.446 . . . . 73.32 111.153 179.879 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.466 ' HB2' ' HB2' ' A' ' 150' ' ' TYR . 83.6 m-85 -98.4 179.92 4.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.191 -0.459 . . . . 72.34 110.855 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.42 ' CD2' ' HA ' ' A' ' 145' ' ' TYR . 0.4 OUTLIER -153.54 126.0 8.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.145 -0.479 . . . . 73.44 110.936 -179.829 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.59 ' O ' ' HB2' ' A' ' 171' ' ' GLN . 27.0 tt0 -62.85 -28.1 69.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.125 -0.489 . . . . 61.42 110.926 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.726 ' HB3' ' HD2' ' A' ' 143' ' ' PRO . 9.4 mp -115.88 173.5 2.96 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.565 0.698 . . . . 71.24 110.928 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . 0.726 ' HD2' ' HB3' ' A' ' 142' ' ' LEU . 54.0 Cg_endo -69.73 -90.92 0.01 OUTLIER 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.653 2.235 . . . . 71.43 112.373 179.836 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . 0.727 ' O ' ' N ' ' A' ' 146' ' ' ARG . 1.6 m-80 -54.05 96.69 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 62.0 110.881 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . 0.652 ' C ' ' O ' ' A' ' 144' ' ' ASN . 5.8 m-85 11.87 53.1 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.157 -0.474 . . . . 52.23 110.895 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.727 ' N ' ' O ' ' A' ' 144' ' ' ASN . 19.5 mtt-85 -116.8 170.41 8.63 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.113 -0.494 . . . . 73.24 110.88 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 70.39 -172.08 42.41 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.747 -0.74 . . . . 75.11 112.481 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.499 ' HA ' HD11 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -87.75 132.62 34.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.761 0.315 . . . . 72.41 110.897 -179.851 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . 0.629 ' OE1' ' HA ' ' A' ' 60' ' ' TYR . 0.8 OUTLIER -88.53 157.73 18.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.204 -0.453 . . . . 71.24 110.928 -179.922 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . 0.466 ' HB2' ' HB2' ' A' ' 139' ' ' PHE . 12.6 m-85 -122.84 141.48 51.82 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.187 -0.46 . . . . 64.3 110.891 -179.83 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.579 ' HB2' HD11 ' A' ' 61' ' ' ILE . 7.8 tp -76.16 123.65 26.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.105 -0.498 . . . . 75.33 110.858 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 1.08 ' O ' HD13 ' A' ' 152' ' ' LEU . 0.0 OUTLIER -50.9 135.5 24.24 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.179 -0.464 . . . . 74.11 110.911 179.847 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . 0.46 ' N ' HD22 ' A' ' 152' ' ' LEU . 7.9 t0 -165.4 27.68 0.05 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.193 -0.458 . . . . 72.53 110.882 179.845 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.817 ' O ' HD13 ' A' ' 133' ' ' LEU . 0.0 OUTLIER -114.88 -175.23 2.64 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.224 -0.444 . . . . 60.24 110.874 -179.993 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.819 ' HG3' HD22 ' A' ' 133' ' ' LEU . 0.0 OUTLIER -161.02 -127.54 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.202 -0.454 . . . . 64.44 110.887 179.878 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.562 ' HG2' ' O ' ' A' ' 156' ' ' GLU . 2.9 tm-20 -68.54 6.0 0.92 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.245 -0.434 . . . . 74.15 110.895 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . 0.769 ' CE1' ' HA ' ' A' ' 154' ' ' LYS . 20.4 m-30 -34.61 152.85 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.141 -0.481 . . . . 75.21 110.869 -179.828 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . 0.461 ' HB2' ' HA ' ' A' ' 103' ' ' ASP . 0.0 OUTLIER -125.76 -35.74 2.48 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.132 -0.486 . . . . 65.25 110.865 -179.99 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -86.72 151.23 52.32 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.563 0.697 . . . . 63.14 110.866 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . 0.455 ' HB2' ' HD3' ' A' ' 168' ' ' PRO . 53.6 Cg_endo -69.74 -28.01 25.85 Favored 'Trans proline' 0 C--O 1.232 0.207 0 C-N-CA 122.658 2.238 . . . . 71.35 112.316 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.622 ' H ' HD12 ' A' ' 161' ' ' ILE . 3.6 mp -64.08 -11.75 10.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.258 -0.428 . . . . 62.4 111.133 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.635 ' HB3' ' CD1' ' A' ' 157' ' ' TYR . 0.3 OUTLIER -75.32 -13.42 60.42 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.152 -0.477 . . . . 72.22 110.896 179.813 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' TRP . . . . . 0.44 ' CH2' ' CE1' ' A' ' 139' ' ' PHE . 3.4 m95 -87.16 0.16 55.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.227 -0.442 . . . . 71.22 110.93 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 91.64 -35.68 3.89 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.743 -0.741 . . . . 55.04 112.461 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -82.05 130.75 35.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.798 0.332 . . . . 61.53 111.144 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -39.01 -38.42 0.45 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.244 -0.435 . . . . 72.33 111.069 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . 0.487 ' C ' ' H ' ' A' ' 169' ' ' ALA . 0.3 OUTLIER -128.35 156.35 76.99 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.666 0.746 . . . . 64.15 110.858 -179.765 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . 0.469 ' HG2' ' HB3' ' A' ' 126' ' ' GLU . 54.1 Cg_endo -69.72 27.86 0.18 Allowed 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.715 2.277 . . . . 64.1 112.332 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.487 ' H ' ' C ' ' A' ' 167' ' ' SER . . . -68.27 104.61 1.89 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.246 -0.434 . . . . 74.42 111.111 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.472 HG12 ' N ' ' A' ' 171' ' ' GLN . 3.4 t -152.94 164.37 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.188 -0.46 . . . . 72.54 111.149 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' GLN . . . . . 0.65 ' OE1' ' HB3' ' A' ' 143' ' ' PRO . 1.7 mm-40 -113.88 -85.79 0.59 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.244 -0.435 . . . . 71.51 110.867 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . 0.706 ' OG ' ' O ' ' A' ' 143' ' ' PRO . 33.6 p -127.05 -179.53 4.89 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.198 -0.456 . . . . 73.52 110.863 -179.815 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -145.49 170.89 15.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.077 -0.511 . . . . 75.24 110.875 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . 0.419 ' HD2' ' CE2' ' A' ' 140' ' ' TYR . 0.0 OUTLIER -136.09 157.58 46.49 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.152 -0.477 . . . . 74.55 110.865 -179.89 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . 0.475 ' HD2' ' CE2' ' A' ' 94' ' ' TYR . 1.8 ptt180 -98.86 -171.93 2.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.142 -0.481 . . . . 74.42 110.905 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . 0.556 HD11 HG12 ' A' ' 136' ' ' VAL . 3.5 mt -125.33 130.99 72.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.223 -0.444 . . . . 75.05 111.085 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 9.1 p -53.84 137.67 14.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.182 -0.463 . . . . 72.24 111.135 179.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . 0.577 ' HB3' HD13 ' A' ' 88' ' ' LEU . 1.8 mm-40 . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.203 -0.453 . . . . 73.23 110.883 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.796 0.331 . . . . 63.2 110.881 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.9 p -60.83 -68.6 0.29 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.196 -0.456 . . . . 63.43 110.87 -179.812 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 48.24 60.99 3.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.105 -0.498 . . . . 75.51 110.931 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 29.0 p -53.0 174.53 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.216 -0.447 . . . . 65.21 111.139 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -68.68 123.32 15.7 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.783 -0.723 . . . . 70.31 112.491 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.404 ' HB ' ' O ' ' A' ' 44' ' ' GLY . 26.2 p -81.54 136.48 35.6 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.85 0.357 . . . . 74.43 111.165 -179.876 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.425 ' N ' ' HE1' ' A' ' 47' ' ' TRP . 2.6 tttt -124.67 136.96 54.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.228 -0.442 . . . . 54.44 110.919 179.912 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.524 ' HB ' ' CD1' ' A' ' 47' ' ' TRP . 16.0 tt -136.98 148.98 26.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.219 -0.446 . . . . 71.44 111.168 179.862 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.548 HG22 ' CE2' ' A' ' 11' ' ' TYR . 19.0 m -132.58 137.36 47.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.218 -0.446 . . . . 64.1 111.184 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.771 ' HB2' HD22 ' A' ' 34' ' ' LEU . 0.5 OUTLIER -125.46 128.06 47.47 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.183 -0.462 . . . . 75.35 110.874 -179.982 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.564 ' CG ' ' HA ' ' A' ' 16' ' ' PHE . 17.0 m-85 -113.16 131.98 55.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.103 -0.499 . . . . 73.42 110.937 -179.831 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.464 ' HB2' ' HB2' ' A' ' 19' ' ' ARG . 0.0 OUTLIER -61.71 -14.53 32.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.162 -0.472 . . . . 74.33 110.852 -179.958 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.424 ' HB2' ' O ' ' A' ' 17' ' ' GLN . 77.4 m-20 -135.41 149.56 49.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.138 -0.483 . . . . 63.52 110.89 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.526 ' N ' ' HB3' ' A' ' 38' ' ' ASN . 30.3 mtmm -54.61 -176.68 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.224 -0.444 . . . . 72.22 110.874 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 16.5 m120 46.99 30.58 1.29 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.185 -0.461 . . . . 71.33 110.908 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.564 ' HA ' ' CG ' ' A' ' 11' ' ' TYR . 3.6 m-85 51.24 65.38 1.5 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.152 -0.477 . . . . 62.31 110.867 -180.0 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.424 ' O ' ' HB2' ' A' ' 13' ' ' ASP . 16.9 mt-30 -140.26 160.87 38.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.113 -0.494 . . . . 72.22 110.899 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 90.98 -147.99 19.16 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.736 -0.745 . . . . 73.42 112.519 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.709 ' O ' HD13 ' A' ' 34' ' ' LEU . 0.0 OUTLIER -68.9 77.47 0.32 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.83 0.348 . . . . 65.23 110.908 -179.893 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.457 ' HB2' ' CE1' ' A' ' 11' ' ' TYR . 0.7 OUTLIER -77.83 127.82 33.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.148 -0.478 . . . . 75.1 110.846 -179.892 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.491 ' O ' ' HA ' ' A' ' 9' ' ' THR . 88.2 t80 -122.01 124.0 42.97 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.199 -0.455 . . . . 72.32 110.922 -179.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.473 ' CG ' HG23 ' A' ' 9' ' ' THR . 1.2 m-20 -120.19 134.37 55.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.1 -0.5 . . . . 74.23 110.86 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -167.49 134.32 2.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.199 -0.455 . . . . 70.0 110.889 -179.887 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.406 ' HA ' ' HA ' ' A' ' 7' ' ' LYS . 6.1 p-10 -102.2 5.45 40.2 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.174 -0.466 . . . . 73.03 110.857 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 11.7 t -107.79 169.38 8.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.171 -0.468 . . . . 71.21 110.932 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -64.96 117.15 7.19 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.198 -0.455 . . . . 51.1 110.875 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.473 ' HB2' ' HB3' ' A' ' 30' ' ' PHE . 4.4 m -116.95 53.65 0.89 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.178 -0.465 . . . . 73.24 110.876 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.533 ' C ' ' HA ' ' A' ' 82' ' ' SER . . . -46.44 -20.72 0.13 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.176 -0.465 . . . . 70.42 111.126 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 57.0 t0 -128.3 42.71 3.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.21 -0.45 . . . . 72.31 110.877 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.76 ' O ' ' CD2' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -80.0 14.44 1.83 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.187 -0.461 . . . . 74.42 110.92 -179.905 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.503 ' HB2' ' HB3' ' A' ' 81' ' ' SER . 28.3 t60 -77.61 -40.13 43.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.104 -0.498 . . . . 71.21 110.853 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.6 t -56.15 -14.98 3.08 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.215 -0.448 . . . . 63.55 111.129 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -99.07 -27.23 13.93 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.258 -0.428 . . . . 65.22 110.896 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.771 HD22 ' HB2' ' A' ' 10' ' ' PHE . 17.4 tp -141.97 135.84 29.75 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.146 -0.479 . . . . 74.3 110.909 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 20.5 m -99.36 -42.62 6.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 74.42 110.876 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -118.15 141.48 48.45 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.104 -0.498 . . . . 73.34 110.849 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.633 ' SG ' ' HB2' ' A' ' 80' ' ' LEU . 4.6 p -110.73 86.77 2.38 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.148 -0.478 . . . . 71.31 110.877 -179.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.526 ' HB3' ' N ' ' A' ' 14' ' ' LYS . 0.2 OUTLIER -77.97 -66.29 0.86 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.175 -0.466 . . . . 75.1 110.851 -179.863 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 6.1 p -117.08 123.11 46.01 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.201 -0.454 . . . . 63.22 110.84 -179.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.767 HD12 ' CH2' ' A' ' 73' ' ' TRP . 27.2 mt -116.27 150.2 18.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.092 -0.503 . . . . 72.3 111.107 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.486 ' HD2' ' CE2' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -145.63 118.51 8.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.211 -0.45 . . . . 64.21 110.901 179.832 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.503 ' O ' HG12 ' A' ' 42' ' ' VAL . 1.3 t -104.87 115.7 47.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.244 -0.435 . . . . 75.15 111.172 179.836 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -110.84 77.82 1.07 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.164 -0.471 . . . . 71.31 110.901 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.404 ' O ' ' HB ' ' A' ' 6' ' ' THR . . . 135.28 101.98 0.69 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.768 -0.729 . . . . 55.33 112.493 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 53.74 179.17 0.12 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.747 -0.739 . . . . 73.01 112.515 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.747 HG23 ' HA ' ' A' ' 63' ' ' PRO . 0.6 OUTLIER -79.67 172.61 13.56 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.819 0.342 . . . . 64.2 111.121 -179.885 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.586 ' H ' HG22 ' A' ' 46' ' ' THR . 14.8 m95 -144.07 130.2 19.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 73.54 110.906 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.883 ' HB2' ' CG2' ' A' ' 86' ' ' VAL . . . -97.18 112.0 23.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.288 -0.415 . . . . 74.02 111.158 179.858 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.564 HG11 ' CD1' ' A' ' 80' ' ' LEU . 3.6 m -113.12 129.73 68.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.227 -0.442 . . . . 71.14 111.117 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.692 ' HB3' ' HA ' ' A' ' 56' ' ' ALA . 33.0 m-85 -95.78 148.59 22.42 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.156 -0.475 . . . . 74.44 110.92 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.659 ' HB2' ' HB2' ' A' ' 58' ' ' TYR . 35.1 tt0 -45.43 -80.85 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.099 -0.501 . . . . 73.35 110.885 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.622 ' HB3' ' CD2' ' A' ' 55' ' ' PHE . 0.3 OUTLIER -90.54 146.38 34.22 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.621 0.724 . . . . 74.5 110.88 -179.891 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.751 ' HA ' ' OG ' ' A' ' 82' ' ' SER . 54.2 Cg_endo -69.71 134.71 28.74 Favored 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.701 2.267 . . . . 74.34 112.38 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 1.5 t30 65.63 -9.84 0.23 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.214 -0.448 . . . . 75.15 110.884 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.622 ' CD2' ' HB3' ' A' ' 52' ' ' ARG . 4.7 m-30 -98.75 -24.16 15.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.173 -0.467 . . . . 73.33 110.914 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.692 ' HA ' ' HB3' ' A' ' 50' ' ' TYR . . . 56.62 20.83 5.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.102 -0.499 . . . . 62.44 111.141 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . 0.634 ' HB3' ' OE1' ' A' ' 51' ' ' GLU . 0.1 OUTLIER -50.7 -166.11 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.167 -0.47 . . . . 71.41 110.93 -179.958 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.775 ' HB3' HD11 ' A' ' 76' ' ' LEU . 6.9 m-30 -13.08 101.87 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.251 -0.431 . . . . 71.5 110.877 -179.866 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.41 ' HB2' ' HA ' ' A' ' 150' ' ' TYR . 0.0 OUTLIER -68.73 154.24 42.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.12 -0.491 . . . . 62.01 110.883 179.881 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.89 ' CD2' HD22 ' A' ' 76' ' ' LEU . 5.1 t80 -173.72 102.13 0.11 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.213 -0.449 . . . . 73.34 110.906 -179.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.74 HD13 HG12 ' A' ' 138' ' ' ILE . 4.8 mp -88.21 118.71 34.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.093 -0.503 . . . . 73.21 111.076 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.775 HD23 ' HD2' ' A' ' 63' ' ' PRO . 0.2 OUTLIER -83.61 129.59 59.21 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.603 0.716 . . . . 61.21 110.856 179.924 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.775 ' HD2' HD23 ' A' ' 62' ' ' LEU . 53.3 Cg_endo -69.87 -172.34 0.58 Allowed 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.652 2.234 . . . . 65.44 112.288 179.878 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -88.74 161.9 16.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 73.4 110.911 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 112.07 -167.74 12.5 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.778 -0.725 . . . . 74.14 112.511 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -109.08 154.45 22.24 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.901 0.381 . . . . 71.21 110.862 -179.863 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.632 ' HB2' ' O ' ' A' ' 40' ' ' ILE . 14.6 m-85 -142.05 84.96 11.3 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.667 0.746 . . . . 74.02 110.925 -179.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.438 ' HD2' ' HG3' ' A' ' 72' ' ' ARG . 53.8 Cg_endo -69.73 -0.06 6.34 Favored 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.682 2.254 . . . . 54.21 112.335 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.564 ' HB2' ' HG2' ' A' ' 72' ' ' ARG . 47.9 mt-10 -156.5 143.53 18.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.226 -0.443 . . . . 64.24 110.891 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.739 ' HA ' ' NE1' ' A' ' 73' ' ' TRP . 35.9 p90 -54.43 -22.35 12.35 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.161 -0.472 . . . . 74.11 110.915 -179.836 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -79.55 -18.05 52.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.121 -0.491 . . . . 74.42 110.907 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.564 ' HG2' ' HB2' ' A' ' 69' ' ' GLU . 28.2 mmt180 -69.28 -7.75 39.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.453 . . . . 65.52 110.883 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . 0.767 ' CH2' HD12 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -138.6 15.82 2.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.183 -0.462 . . . . 64.12 110.925 -179.971 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.431 ' C ' ' O ' ' A' ' 73' ' ' TRP . 0.0 OUTLIER 36.0 43.84 0.22 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.213 -0.449 . . . . 72.33 110.894 179.93 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -51.93 123.92 22.31 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.763 -0.732 . . . . 32.0 112.506 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.89 HD22 ' CD2' ' A' ' 60' ' ' TYR . 1.1 pt? -59.09 -33.2 70.56 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.803 0.335 . . . . 73.23 110.864 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.704 ' H ' HD23 ' A' ' 76' ' ' LEU . 17.7 t-20 -147.49 139.43 24.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.239 -0.437 . . . . 74.4 110.902 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -78.12 18.51 0.51 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.168 -0.469 . . . . 75.01 110.896 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -107.17 73.28 0.92 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.186 -0.461 . . . . 64.53 110.873 -179.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.633 ' HB2' ' SG ' ' A' ' 37' ' ' CYS . 0.0 OUTLIER -82.31 133.98 35.25 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.228 -0.442 . . . . 71.21 110.871 -179.955 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.575 ' HB3' ' HB3' ' A' ' 53' ' ' PRO . 0.9 OUTLIER -147.56 -126.34 0.06 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.173 -0.467 . . . . 71.41 110.889 -179.942 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.751 ' OG ' ' HA ' ' A' ' 53' ' ' PRO . 0.4 OUTLIER -29.88 123.34 0.17 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.148 -0.478 . . . . 72.23 110.866 -179.844 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . 0.528 ' HA ' ' O ' ' A' ' 48' ' ' ALA . 9.2 p -133.42 141.56 47.91 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.149 -0.478 . . . . 72.35 110.873 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.466 ' N ' ' O ' ' A' ' 48' ' ' ALA . 1.5 mmt85 -138.44 130.22 28.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.204 -0.453 . . . . 74.14 110.886 -179.872 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.451 ' N ' ' CZ3' ' A' ' 47' ' ' TRP . . . -50.87 128.84 22.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.21 -0.45 . . . . 74.35 111.095 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.883 ' CG2' ' HB2' ' A' ' 48' ' ' ALA . 54.3 t -114.61 130.64 68.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.19 -0.459 . . . . 63.44 111.16 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . 0.483 ' O ' HG23 ' A' ' 136' ' ' VAL . 72.1 m-70 -114.67 119.03 35.33 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.154 -0.475 . . . . 71.31 110.881 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.731 HD13 ' HA ' ' A' ' 178' ' ' GLU . 0.0 OUTLIER -33.64 146.1 0.12 Allowed Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.556 0.693 . . . . 74.02 110.915 -179.956 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.676 ' HA ' ' HA3' ' A' ' 135' ' ' GLY . 53.4 Cg_endo -69.74 -79.29 0.01 OUTLIER 'Trans proline' 0 C--O 1.231 0.151 0 C-N-CA 122.721 2.281 . . . . 74.43 112.306 179.879 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.452 ' H ' ' HG2' ' A' ' 89' ' ' PRO . 67.2 m -109.07 -178.56 3.61 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.183 -0.462 . . . . 73.24 110.893 -179.827 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -100.94 4.15 55.96 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.794 -0.717 . . . . 31.04 112.488 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -125.19 -55.43 0.17 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.744 -0.741 . . . . 62.13 112.523 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.485 ' HG3' ' OG1' ' A' ' 112' ' ' THR . 11.5 pt20 -165.88 -170.05 1.66 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.837 0.351 . . . . 74.22 110.888 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.774 ' CD2' ' HB2' ' A' ' 134' ' ' GLU . 38.8 t80 -116.43 106.07 13.21 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.199 -0.455 . . . . 74.34 110.919 -179.859 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.467 ' HA ' ' HB ' ' A' ' 112' ' ' THR . 36.7 tptt -74.95 126.2 30.49 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.131 -0.486 . . . . 74.3 110.913 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.54 HD13 ' N ' ' A' ' 97' ' ' GLN . 0.0 OUTLIER -149.1 140.92 17.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.228 -0.442 . . . . 74.42 111.122 179.896 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.54 ' N ' HD13 ' A' ' 96' ' ' ILE . 1.3 mt-30 -109.63 125.84 53.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.197 -0.456 . . . . 73.14 110.888 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.55 ' CG2' HD12 ' A' ' 127' ' ' ILE . 2.3 mp -106.05 132.86 52.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.153 -0.476 . . . . 72.51 111.15 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.715 ' HB2' ' HB2' ' A' ' 129' ' ' SER . 46.3 m-85 -119.38 150.45 40.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.18 -0.464 . . . . 73.4 110.925 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.554 ' HA ' ' CE ' ' A' ' 124' ' ' MET . 62.9 tt0 -85.15 -52.18 6.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.177 -0.465 . . . . 61.21 110.892 -179.873 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 40.7 mttt -105.48 166.47 10.41 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.099 -0.501 . . . . 75.13 110.868 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.404 ' HA2' ' OG ' ' A' ' 129' ' ' SER . . . -67.12 152.46 52.75 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.722 -0.751 . . . . 73.31 112.522 179.885 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.44 ' HA ' ' HB2' ' A' ' 158' ' ' ARG . 42.3 t0 66.78 46.16 1.76 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.829 0.347 . . . . 72.01 110.885 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.546 ' N ' ' CD2' ' A' ' 104' ' ' PHE . 0.3 OUTLIER 48.3 33.08 3.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.208 -0.451 . . . . 74.2 110.866 -179.904 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 57.8 m -96.5 160.82 14.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.16 -0.473 . . . . 72.4 110.846 -179.802 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 81.97 -143.74 23.39 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.712 -0.756 . . . . 61.44 112.479 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 38.1 tp60 -80.13 120.45 24.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.755 0.312 . . . . 32.35 110.877 -179.837 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 5.7 ttp -108.84 134.17 51.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.212 -0.449 . . . . 62.13 110.886 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -139.22 135.5 34.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.205 -0.452 . . . . 60.2 110.925 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -114.83 94.52 4.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.061 -0.518 . . . . 75.24 110.872 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.502 HG22 ' CD1' ' A' ' 98' ' ' ILE . 5.7 t -114.77 144.13 43.98 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.148 -0.478 . . . . 70.32 111.165 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.485 ' OG1' ' HG3' ' A' ' 93' ' ' GLN . 6.6 t -129.66 47.28 2.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.234 -0.439 . . . . 51.12 111.112 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -151.54 157.92 42.89 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.221 -0.445 . . . . 73.51 110.882 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.404 ' OD1' ' HG3' ' A' ' 175' ' ' ARG . 2.6 m-20 -56.2 148.46 18.21 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.112 -0.494 . . . . 75.01 110.874 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . 0.741 ' O ' ' HB2' ' A' ' 172' ' ' SER . 42.7 t -139.23 124.3 11.69 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.616 0.722 . . . . 63.42 110.899 -179.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.532 ' O ' ' C ' ' A' ' 143' ' ' PRO . 53.6 Cg_endo -69.78 -30.44 22.16 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.688 2.259 . . . . 72.53 112.322 -179.89 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.623 ' HB3' ' CB ' ' A' ' 120' ' ' GLU . 0.1 OUTLIER -149.18 106.72 3.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.201 -0.454 . . . . 42.13 110.853 -179.877 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.609 HD13 HD11 ' A' ' 127' ' ' ILE . 3.9 tt -61.7 -30.48 48.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.127 -0.488 . . . . 62.13 111.1 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' MET . . . . . 0.702 ' O ' ' HA ' ' A' ' 123' ' ' HIS . 0.1 OUTLIER -91.02 -42.01 10.77 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.186 -0.461 . . . . 75.35 110.949 179.819 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.623 ' CB ' ' HB3' ' A' ' 117' ' ' SER . 2.9 tp10 -70.26 -11.79 61.15 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.201 -0.454 . . . . 63.42 110.861 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 29.8 mm100 -112.93 -52.14 2.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.183 -0.462 . . . . 63.12 110.966 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 30.9 m-85 -102.75 14.18 32.59 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.194 -0.457 . . . . 64.54 110.88 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.702 ' HA ' ' O ' ' A' ' 119' ' ' MET . 21.5 m-70 47.13 25.11 0.48 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.118 -0.492 . . . . 74.43 110.835 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.606 ' HE2' HD13 ' A' ' 127' ' ' ILE . 0.0 OUTLIER -100.78 124.93 47.13 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.239 -0.437 . . . . 74.42 110.892 179.953 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 3.0 ptp85 -96.71 -35.05 11.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.257 -0.428 . . . . 74.2 110.838 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.473 ' HB3' ' HG2' ' A' ' 168' ' ' PRO . 34.8 mt-10 -145.54 115.52 7.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.18 -0.464 . . . . 64.13 110.859 -179.905 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.609 HD11 HD13 ' A' ' 118' ' ' ILE . 3.1 mm -74.13 100.45 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.121 -0.49 . . . . 74.44 111.11 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . 0.436 ' CD2' ' HG3' ' A' ' 168' ' ' PRO . 12.9 m170 -69.04 -36.21 77.46 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.138 -0.483 . . . . 72.12 110.867 179.85 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.715 ' HB2' ' HB2' ' A' ' 99' ' ' PHE . 19.3 m -134.03 144.18 48.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.193 -0.458 . . . . 73.12 110.875 -179.795 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . 0.629 ' O ' ' O ' ' A' ' 155' ' ' LYS . 1.4 m -140.31 114.65 9.24 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.124 -0.489 . . . . 63.02 110.925 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.523 ' HA ' ' O ' ' A' ' 155' ' ' LYS . 5.5 mtpp -110.22 150.63 28.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.178 -0.465 . . . . 72.44 110.92 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.471 ' HB ' ' O ' ' A' ' 131' ' ' LYS . 12.6 t 81.2 158.49 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.233 -0.44 . . . . 73.01 111.164 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.855 HD22 ' HG2' ' A' ' 155' ' ' LYS . 0.1 OUTLIER 176.27 124.29 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.213 -0.449 . . . . 62.12 110.96 179.957 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.774 ' HB2' ' CD2' ' A' ' 94' ' ' TYR . 3.7 mm-40 -86.8 -167.82 2.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.196 -0.456 . . . . 62.51 110.884 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.676 ' HA3' ' HA ' ' A' ' 89' ' ' PRO . . . -48.77 -92.85 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.759 -0.734 . . . . 45.11 112.465 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.933 ' HB ' HD12 ' A' ' 176' ' ' ILE . 2.3 t -103.21 148.26 8.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.779 0.323 . . . . 54.25 111.17 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . 0.641 ' HB2' ' CE2' ' A' ' 94' ' ' TYR . 0.0 OUTLIER -156.73 158.84 37.64 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.227 -0.442 . . . . 75.01 110.932 179.919 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.74 HG12 HD13 ' A' ' 61' ' ' ILE . 5.0 mt -134.25 136.44 53.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.262 -0.426 . . . . 74.12 111.145 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.464 ' HB2' ' HB2' ' A' ' 150' ' ' TYR . 0.1 OUTLIER -102.15 160.36 14.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.157 -0.474 . . . . 72.31 110.848 179.983 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -129.33 115.51 17.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.124 -0.489 . . . . 64.25 110.908 -179.846 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.589 ' O ' ' HB2' ' A' ' 171' ' ' GLN . 0.6 OUTLIER -54.91 -33.39 62.04 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.128 -0.487 . . . . 61.11 110.841 -179.983 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.696 ' HB3' ' HD2' ' A' ' 143' ' ' PRO . 8.8 mp -113.36 172.81 3.25 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.643 0.735 . . . . 63.32 110.914 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . 0.792 ' O ' ' OG ' ' A' ' 172' ' ' SER . 53.1 Cg_endo -69.78 -93.15 0.01 OUTLIER 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.7 2.266 . . . . 65.23 112.355 179.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . 0.745 ' O ' ' N ' ' A' ' 146' ' ' ARG . 0.3 OUTLIER -50.18 99.05 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.22 -0.445 . . . . 75.44 110.906 179.971 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . 0.643 ' C ' ' O ' ' A' ' 144' ' ' ASN . 34.5 m-85 11.59 52.23 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.199 -0.455 . . . . 75.43 110.942 -179.905 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.745 ' N ' ' O ' ' A' ' 144' ' ' ASN . 12.4 mtp85 -117.86 172.14 7.59 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.128 -0.487 . . . . 73.33 110.892 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 80.11 -170.27 53.58 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.747 -0.739 . . . . 53.31 112.448 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.63 ' CG ' HD12 ' A' ' 76' ' ' LEU . 0.6 OUTLIER -92.54 152.62 19.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.767 0.318 . . . . 72.21 110.881 -179.84 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . 0.488 ' CD ' HG21 ' A' ' 138' ' ' ILE . 47.2 mt-30 -88.25 150.34 23.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.256 -0.429 . . . . 73.24 110.893 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . 0.464 ' HB2' ' HB2' ' A' ' 139' ' ' PHE . 96.2 m-85 -130.5 122.42 27.62 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.164 -0.471 . . . . 75.52 110.906 -179.876 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.492 HD23 ' OH ' ' A' ' 50' ' ' TYR . 33.9 tp -62.49 134.51 56.51 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.098 -0.501 . . . . 75.32 110.946 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.952 ' O ' HD13 ' A' ' 152' ' ' LEU . 0.0 OUTLIER -63.8 133.24 53.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.17 -0.468 . . . . 75.45 110.878 179.991 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -165.76 25.21 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.174 -0.466 . . . . 71.32 110.875 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.802 ' HA ' ' CE1' ' A' ' 157' ' ' TYR . 0.2 OUTLIER -106.65 -156.62 0.58 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.182 -0.463 . . . . 71.52 110.876 179.991 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.855 ' HG2' HD22 ' A' ' 133' ' ' LEU . 0.0 OUTLIER 168.9 -132.95 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.179 -0.464 . . . . 74.31 110.868 179.888 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.478 ' HA ' ' HA ' ' A' ' 131' ' ' LYS . 2.6 tm-20 -61.57 3.29 0.14 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.176 -0.465 . . . . 55.3 110.886 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . 0.802 ' CE1' ' HA ' ' A' ' 154' ' ' LYS . 15.1 m-30 -34.37 150.22 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.184 -0.462 . . . . 64.23 110.865 -179.831 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . 0.518 ' O ' ' OG ' ' A' ' 129' ' ' SER . 0.0 OUTLIER -126.31 -38.69 2.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.073 -0.512 . . . . 65.42 110.84 -179.961 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . 0.446 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 0.3 OUTLIER -85.12 150.8 55.9 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.538 0.685 . . . . 73.15 110.915 179.969 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . 0.52 ' HB3' ' HB3' ' A' ' 168' ' ' PRO . 53.5 Cg_endo -69.78 -23.29 30.87 Favored 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.726 2.284 . . . . 65.33 112.339 179.892 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.65 ' H ' HD12 ' A' ' 161' ' ' ILE . 4.0 mp -75.47 -3.24 4.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.179 -0.464 . . . . 65.44 111.117 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.68 ' HB3' ' CD1' ' A' ' 157' ' ' TYR . 0.3 OUTLIER -76.53 -14.44 60.02 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.164 -0.471 . . . . 74.1 110.838 179.911 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 11.4 t90 -94.61 2.24 55.62 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.226 -0.443 . . . . 74.54 110.875 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 90.42 -36.21 3.64 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.752 -0.737 . . . . 74.41 112.526 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -71.77 128.12 34.75 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.766 0.317 . . . . 63.5 111.137 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -42.16 -34.89 0.82 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.198 -0.456 . . . . 44.33 111.086 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . 0.486 ' C ' ' H ' ' A' ' 169' ' ' ALA . 0.3 OUTLIER -131.25 157.84 76.96 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.663 0.744 . . . . 75.25 110.861 -179.771 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . 0.52 ' HB3' ' HB3' ' A' ' 160' ' ' PRO . 54.3 Cg_endo -69.69 21.46 0.17 Allowed 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.699 2.266 . . . . 74.21 112.406 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.486 ' H ' ' C ' ' A' ' 167' ' ' SER . . . -62.47 102.05 0.29 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.181 -0.463 . . . . 55.21 111.129 179.881 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 2.8 t -154.12 155.63 5.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.188 -0.46 . . . . 53.52 111.129 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' GLN . . . . . 0.589 ' HB2' ' O ' ' A' ' 141' ' ' GLU . 1.5 tm0? -116.75 -134.71 0.34 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.162 -0.472 . . . . 75.33 110.935 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . 0.792 ' OG ' ' O ' ' A' ' 143' ' ' PRO . 12.1 p -64.46 171.87 2.94 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.246 -0.434 . . . . 71.11 110.896 -179.843 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . 0.467 ' CG ' ' HH2' ' A' ' 137' ' ' TRP . 2.3 p90 -147.43 175.57 10.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.111 -0.495 . . . . 72.13 110.881 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . 0.45 ' O ' ' HG2' ' A' ' 174' ' ' ARG . 1.7 ptm180 -140.32 136.62 33.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.166 -0.47 . . . . 73.44 110.897 -179.912 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . 0.469 ' HB2' ' HB3' ' A' ' 94' ' ' TYR . 0.0 OUTLIER -105.56 138.26 42.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.18 -0.464 . . . . 70.12 110.881 -179.913 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . 0.933 HD12 ' HB ' ' A' ' 136' ' ' VAL . 1.9 mt -79.44 144.93 10.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.194 -0.457 . . . . 75.04 111.138 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 4.6 p -136.19 156.28 36.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.175 -0.466 . . . . 72.12 111.135 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . 0.731 ' HA ' HD13 ' A' ' 88' ' ' LEU . 1.1 mp0 . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.146 -0.479 . . . . 74.44 110.884 -179.944 . . . . . . . . 1 1 . 1 stop_ save_